PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Memmer, S; Weil, S; Beyer, S; Zoller, T; Peters, E; Hartmann, J; Steinle, A; Koch, J				Memmer, Stefanie; Weil, Sandra; Beyer, Steffen; Zoeller, Tobias; Peters, Eike; Hartmann, Jessica; Steinle, Alexander; Koch, Joachim			The Stalk Domain of NKp30 Contributes to Ligand Binding and Signaling of a Preassembled NKp30-CD3 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; cell surface receptor; membrane protein; natural killer cells (NK cells); protein-protein interaction; receptor modification; receptor regulation	NATURAL-KILLER-CELLS; N-GLYCOSYLATION MUTAGENESIS; CYTOTOXICITY RECEPTOR NKP30; T-CELLS; SURFACE EXPRESSION; IMMUNOGLOBULIN SUPERFAMILY; INHIBITORY LIGAND; ANION-EXCHANGER; TCR/CD3 COMPLEX; TUMOR-CELLS	The natural cytotoxicity receptor (NCR) NKp30 (CD337) is a key player for NK cell immunosurveillance of infections and cancer. The molecular details of ligand recognition and its connection to CD3 signaling remain unsolved. Here, we show that the stalk domain ((129)KEHPQLGAGTVLLLR(143)) of NKp30 is very sensitive to sequence alterations, as mutations lead to impaired ligand binding and/or signaling capacity. Surprisingly, the stalk domains of NKp30 and NKp46, another NCR employing CD3 for signaling, were not exchangeable without drastic deficiencies in folding, plasma membrane targeting, and/or ligand-induced receptor signaling. Further mutational studies, N-glycosylation mapping, and plasma membrane targeting studies in the absence and presence of CD3 suggest two interconvertible types of NCR-CD3 assemblies: 1) a signaling incompetent structural NKp30-CD3 complex and 2) a ligand-induced signaling competent NKp30-CD3 complex. Moreover, we propose that ligand binding triggers translocation of Arg-143 from the membrane interface into the membrane to enable alignment with oppositely charged aspartate residues within CD3 and activation of CD3-signaling.	[Memmer, Stefanie; Weil, Sandra; Koch, Joachim] Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Med Ctr, D-55131 Mainz, Germany; [Memmer, Stefanie; Weil, Sandra; Beyer, Steffen; Peters, Eike; Koch, Joachim] Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, D-60596 Frankfurt, Germany; [Zoeller, Tobias; Steinle, Alexander] Goethe Univ Frankfurt Main, Inst Mol Med, D-60528 Frankfurt, Germany; [Peters, Eike] Swiss Fed Inst Technol, Inst Microbiol, CH-8093 Zurich, Switzerland; [Hartmann, Jessica] Paul Ehrlich Inst, Div Mol Biotechnol & Gene Therapy, D-63225 Langen, Germany; [Koch, Joachim] LOEWE Excellence Ctr Cell & Gene Therapy, D-60590 Frankfurt, Germany	Johannes Gutenberg University of Mainz; Goethe University Frankfurt; Swiss Federal Institutes of Technology Domain; ETH Zurich; Paul Ehrlich Institute	Koch, J (corresponding author), Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Med Ctr, D-55131 Mainz, Germany.; Koch, J (corresponding author), Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, D-60596 Frankfurt, Germany.; Koch, J (corresponding author), LOEWE Excellence Ctr Cell & Gene Therapy, D-60590 Frankfurt, Germany.	joachim.koch@uni-mainz.de	Hartmann, Jessica/AAL-8849-2021	Hartmann, Jessica/0000-0001-9372-8954; Steinle, Alexander/0000-0001-5081-8503	Deutsche Forschungsgemeinschaft [KO 4368/3-1]; Hessisches Ministerium fur Wissenschaft und Kunst (HMWK) [III L 4-518/17.004]; Alfons und Gertrud Kassel-Stiftung; Research Support Foundation (Vaduz, Switzerland); Uniscientia Stiftung (Vaduz, Switzerland)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hessisches Ministerium fur Wissenschaft und Kunst (HMWK); Alfons und Gertrud Kassel-Stiftung; Research Support Foundation (Vaduz, Switzerland); Uniscientia Stiftung (Vaduz, Switzerland)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (KO 4368/3-1), the LOEWE Center for Cell and Gene Therapy Frankfurt supported by Hessisches Ministerium fur Wissenschaft und Kunst (HMWK) funding reference number III L 4-518/17.004 (2010), the Alfons und Gertrud Kassel-Stiftung, the Research Support Foundation (Vaduz, Switzerland), and the Uniscientia Stiftung (Vaduz, Switzerland). The authors declare that they have no conflicts of interest with the contents of this article.	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Arnaud J, 1996, J IMMUNOL, V156, P2155; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Baychelier F, 2013, BLOOD, V122, P2935, DOI 10.1182/blood-2013-03-489054; Binici J, 2014, CELL MOL LIFE SCI, V71, P1829, DOI 10.1007/s00018-013-1522-y; Binici J, 2013, J BIOL CHEM, V288, P34295, DOI 10.1074/jbc.M113.483602; Bolliger L, 1997, MOL IMMUNOL, V34, P819, DOI 10.1016/S0161-5890(97)00122-3; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Cheung JC, 2005, MOL MEMBR BIOL, V22, P203, DOI 10.1080/09687860500093115; Cheung JC, 2007, METHODS, V41, P451, DOI 10.1016/j.ymeth.2006.10.002; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; HALL C, 1991, INT IMMUNOL, V3, P359, DOI 10.1093/intimm/3.4.359; Hartmann J, 2012, J BIOL CHEM, V287, P31527, DOI 10.1074/jbc.M111.304238; Herrmann J, 2014, J BIOL CHEM, V289, P765, DOI 10.1074/jbc.M113.514786; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; JOHN S, 1989, EUR J IMMUNOL, V19, P335, DOI 10.1002/eji.1830190218; Joyce MG, 2011, P NATL ACAD SCI USA, V108, P6223, DOI 10.1073/pnas.1100622108; KAPPES DJ, 1991, P NATL ACAD SCI USA, V88, P10619, DOI 10.1073/pnas.88.23.10619; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Li YL, 2011, J EXP MED, V208, P703, DOI 10.1084/jem.20102548; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Popov M, 1999, BIOCHEM J, V339, P269, DOI 10.1042/0264-6021:3390269; Popov M, 1997, J BIOL CHEM, V272, P18325, DOI 10.1074/jbc.272.29.18325; Rosental B, 2011, J IMMUNOL, V187, P5693, DOI 10.4049/jimmunol.1102267; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Wang W, 2014, J BIOL CHEM, V289, P33311, DOI 10.1074/jbc.M114.603464	41	6	7	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25427	25438		10.1074/jbc.M116.742981	http://dx.doi.org/10.1074/jbc.M116.742981			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27754869	Green Published, hybrid			2022-12-26	WOS:000390095300013
J	Berrouiguet, S; Barrigon, ML; Brandt, SA; Ovejero-Garcia, S; Alvarez-Garcia, R; Carballo, JJ; Lenca, P; Courtet, P; Baca-Garcia, E				Berrouiguet, Sofian; Luisa Barrigon, Maria; Brandt, Sara A.; Ovejero-Garcia, Santiago; Alvarez-Garcia, Raquel; Jose Carballo, Juan; Lenca, Philippe; Courtet, Philippe; Baca-Garcia, Enrique		MEmind Study Grp	Development of a Web-Based Clinical Decision Support System for Drug Prescription: Non-Interventional Naturalistic Description of the Antipsychotic Prescription Patterns in 4345 Outpatients and Future Applications	PLOS ONE			English	Article							ELECTRONIC HEALTH RECORDS; 2ND-GENERATION ANTIPSYCHOTICS; ATYPICAL ANTIPSYCHOTICS; POLYPHARMACY; SCHIZOPHRENIA; EFFICACY; QUETIAPINE; CARE; METAANALYSIS; INPATIENTS	Purpose The emergence of electronic prescribing devices with clinical decision support systems (CDSS) is able to significantly improve management pharmacological treatments. We developed a web application available on smartphones in order to help clinicians monitor prescription and further propose CDSS. Method A web application (www.MEmind.net) was developed to assess patients and collect data regarding gender, age, diagnosis and treatment. We analyzed antipsychotic prescriptions in 4345 patients attended in five Psychiatric Community Mental Health Centers from June 2014 to October 2014. The web-application reported average daily dose prescribed for antipsychotics, prescribed daily dose (PDD), and the PDD to defined daily dose (DDD) ratio. Results The MEmind web-application reported that antipsychotics were used in 1116 patients out of the total sample, mostly in 486 (44%) patients with schizophrenia related disorders but also in other diagnoses. Second generation antipsychotics (quetiapine, aripiprazole and long-acting paliperidone) were preferably employed. Low doses were more frequently used than high doses. Long acting paliperidone and ziprasidone however, were the only two anti psychotics used at excessive dosing. Antipsychotic polypharmacy was used in 287 (26%) patients with classic depot drugs, clotiapine, amisulpride and clozapine. Conclusions In this study we describe the first step of the development of a web application that is able to make polypharmacy, high dose usage and off label usage of antipsychotics visible to clinicians. Current development of the MEmind web application may help to improve prescription security via momentary feedback of prescription and clinical decision support system.	[Berrouiguet, Sofian] Brest Med Univ Hosp, Dept Psychiat & Emergency, Brest, France; [Berrouiguet, Sofian; Courtet, Philippe] Telecom Bretagne, Log Uses Social Sci & Informat Sci Dept, Plouzane, France; [Luisa Barrigon, Maria; Ovejero-Garcia, Santiago; Jose Carballo, Juan] Jimenez Diaz Hosp, Dept Psychiat Fdn, Madrid, Spain; [Brandt, Sara A.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Alvarez-Garcia, Raquel] Univ Hosp Rey Juan Carlos, Dept Psychiat, Madrid, Spain; [Courtet, Philippe] Montpellier Univ Hosp, Dept Psychiat, U888, INSERM, Montpellier, France; [Baca-Garcia, Enrique] IIS Jimenez Diaz Fdn, Dept Psychiat, Madrid, Spain; [Baca-Garcia, Enrique] Univ Hosp Infanta Elena, Dept Psychiat, Valdemoro, Spain; [Baca-Garcia, Enrique] Univ Hosp Rey Juan Carlos, Dept Psychiat, Mostoles, Spain; [Baca-Garcia, Enrique] Univ Autonoma Madrid, Gen Hosp Villalba, Dept Psychiat, Madrid, Spain; [Baca-Garcia, Enrique] CIBERSAM, Madrid, Spain; [Baca-Garcia, Enrique] Columbia Univ, New York, NY USA	CHU Brest; IMT - Institut Mines-Telecom; IMT Atlantique; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Fundacion Jimenez Diaz; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Columbia University	Berrouiguet, S (corresponding author), Brest Med Univ Hosp, Dept Psychiat & Emergency, Brest, France.; Berrouiguet, S (corresponding author), Telecom Bretagne, Log Uses Social Sci & Informat Sci Dept, Plouzane, France.	sofian.berrouiguet@chu-brest.fr	Vian Lains, Antonio/ABC-8519-2021; Barrigón, Maria Luisa/ABI-6017-2020; Baca-García, Enrique/F-4106-2015; Carballo, Juan J/A-1965-2014; Baca-García, Enrique/ABH-9371-2020	Vian Lains, Antonio/0000-0002-6246-9301; Barrigón, Maria Luisa/0000-0002-2497-6353; Baca-García, Enrique/0000-0002-6963-6555; Carballo, Juan J/0000-0001-8446-8820; Baca-García, Enrique/0000-0002-6963-6555; Sanchez Pastor, Luis/0000-0002-5360-6351; Palomar-Ciria, Nora/0000-0002-2293-3106	French embassy in Madrid (Spain); Fondation de France; Fondo Europeo de Desarrollo Regional - FEDER [PI13/02200]; Institute de Salud Carlos III	French embassy in Madrid (Spain); Fondation de France(Fondation de France); Fondo Europeo de Desarrollo Regional - FEDER; Institute de Salud Carlos III(Instituto de Salud Carlos III)	The present study has been supported by the French embassy in Madrid (Spain), the Fondation de France and Institute de Salud Carlos III co-founded by Fondo Europeo de Desarrollo Regional - FEDER (PI13/02200 grant).	Alexander GC, 2011, PHARMACOEPIDEM DR S, V20, P177, DOI 10.1002/pds.2082; Anderson SL, 2014, AM J HEALTH-SYST PH, V71, P394, DOI 10.2146/ajhp130221; Baandrup L, 2012, EUR J HEALTH ECON, V13, P355, DOI 10.1007/s10198-011-0308-0; Ballard C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003476.pub2; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Berk M, 1996, CLOTIAPINE ACUTE PSY; Bernardo M, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-42; Carney AC, 2013, J PSYCHOSOC NURS MEN, V51, P11, DOI 10.3928/02793695-20130709-01; Carton L, 2015, CURR PHARM DESIGN, V21, P3280, DOI 10.2174/1381612821666150619092903; Centorrino F, 2012, HUM PSYCHOPHARM CLIN, V27, P521, DOI 10.1002/hup.2257; Christian R., 2012, 13 AG HEALTHC RES QU; Classen DC, 2011, J PATIENT SAF, V7, P61, DOI 10.1097/PTS.0b013e31821d6f6e; Connolly A, 2014, THER ADV PSYCHOPHARM, V4, P247, DOI 10.1177/2045125314540298; Correll CU, 2012, PSYCHIAT CLIN N AM, V35, P661, DOI 10.1016/j.psc.2012.06.007; Davis JM, 2003, ARCH GEN PSYCHIAT, V60, P553, DOI 10.1001/archpsyc.60.6.553; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Faries D, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-26; Gao KM, 2006, J CLIN PSYCHIAT, V67, P1327, DOI 10.4088/JCP.v67n0902; Gaviria AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139403; Gentile S, 2010, PSYCHOPHARMACOLOGY, V212, P119, DOI 10.1007/s00213-010-1939-z; Grupo de Trabajo de la Gufade Practica Clmicasobre la Esquizofreniay el Trastorno Psicotico Incipiente. Espanya. Ministerio de Sanidady Consumo. Plan de Calidad para el Sistema Nacional de Salud (Espanya) Catalunya. Departament de Salut, 2009, GUIA PRACT CLIN ESQ; Hartung DM, 2013, PSYCHIAT SERV, V64, P1236, DOI 10.1176/appi.ps.005482012; Hersh WR, 2013, MED CARE, V51, pS30, DOI 10.1097/MLR.0b013e31829b1dbd; Horsky J, 2012, J BIOMED INFORM, V45, P1202, DOI 10.1016/j.jbi.2012.09.002; Koppel R, 2010, STUD HEALTH TECHNOL, V157, P7, DOI 10.3233/978-1-60750-569-3-7; Kreys TJM, 2015, PHARMACOTHERAPY, V35, P175, DOI 10.1002/phar.1529; Lauriello J, 2015, J CLIN PSYCHIAT, V76, pE366, DOI 10.4088/JCP.14com09755; Leucht S, 1999, SCHIZOPHR RES, V35, P51, DOI 10.1016/S0920-9964(98)00105-4; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Linden M, 2004, HUM PSYCHOPHARM CLIN, V19, P111, DOI 10.1002/hup.574; Maher Alicia R, 2012, J Manag Care Pharm, V18, pS1; McElroy SL, 2010, EXPERT OPIN INV DRUG, V19, P1527, DOI 10.1517/13543784.2010.538048; Menendez GF, 2004, ACTAS ESP PSIQUIATRI, V32, P333; Montejo AL, 2006, ACTAS ESP PSIQUIATRI, V34, P323; Novick D, 2012, J NERV MENT DIS, V200, P637, DOI 10.1097/NMD.0b013e31825bfd95; Pani L, 2008, CLIN DRUG INVEST, V28, P465, DOI 10.2165/00044011-200828080-00001; Procyshyn RM, 2010, J CLIN PSYCHIAT, V71, P566, DOI 10.4088/JCP.08m04912gre; Ranceva N, 2010, J CLIN PHARMACOL, V50, P699, DOI 10.1177/0091270009350625; Roh D, 2014, AUST NZ J PSYCHIAT, V48, P52, DOI 10.1177/0004867413488221; Runyan JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071325; Schiff GD, 2010, NEW ENGL J MED, V362, P1066, DOI 10.1056/NEJMp0911734; Schwartz T, 2012, DRUG TODAY, V48, P283, DOI 10.1358/dot.2012.48.4.1745225; SIEGEL C, 1984, COMPUT BIOMED RES, V17, P419, DOI 10.1016/0010-4809(84)90011-9; Sim K, 2004, PHARMACOPSYCHIATRY, V37, P175, DOI 10.1055/s-2004-827174; Stoffers JM, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0534-0; Sun FF, 2014, AM J HEALTH-SYST PH, V71, P728, DOI 10.2146/ajhp130471; Taylor D, 2015, MAUDSLEY PRESCRIBING, V12th; Wang SJ, 2003, AM J MED, V114, P397, DOI 10.1016/S0002-9343(03)00057-3; Weiner MG, 2009, ANN INTERN MED, V151, P359, DOI 10.7326/0003-4819-151-5-200909010-00141; Weiskopf NG, 2013, J AM MED INFORM ASSN, V20, P144, DOI 10.1136/amiajnl-2011-000681; Windfuhr K, 2011, J PSYCHOPHARMACOL, V25, P1533, DOI 10.1177/0269881110379288; World Health Organization, 1992, 10 REV INT CLASS DIS; Wright BM, 2013, PHARMACOTHERAPY, V33, P344, DOI 10.1002/phar.1204; Zhornitsky S, 2010, J CLIN PSYCHOPHARM, V30, P417, DOI 10.1097/JCP.0b013e3181e7810a	54	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0163796	10.1371/journal.pone.0163796	http://dx.doi.org/10.1371/journal.pone.0163796			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9NZ	27764107	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500009
J	Briese, T; Williams, DT; Kapoor, V; Diviney, SM; Certoma, A; Wang, J; Johansen, CA; Chowdhary, R; Mackenzie, JS; Lipkin, WI				Briese, Thomas; Williams, David T.; Kapoor, Vishal; Diviney, Sinead M.; Certoma, Andrea; Wang, Jianning; Johansen, Cheryl A.; Chowdhary, Rashmi; Mackenzie, John S.; Lipkin, W. Ian			Analysis of Arbovirus Isolates from Australia Identifies Novel Bunyaviruses Including a Mapputta Group Virus from Western Australia That Links Gan Gan and Maprik Viruses	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN NSS; JAPANESE ENCEPHALITIS-VIRUS; M-SEGMENT REASSORTMENT; ROSS RIVER VIRUS; NEW-SOUTH-WALES; BATAI VIRUS; GENETIC-CHARACTERIZATION; EPIDEMIC POLYARTHRITIS; BUNYAMWERA GROUP; CHITTOOR VIRUS	The Mapputta group comprises antigenically related viruses indigenous to Australia and Papua New Guinea that are included in the family Bunyaviridae but not currently assigned to a specific genus. We determined and analyzed the genome sequences of five Australian viruses isolated from mosquitoes collected during routine arbovirus surveillance in Western Australia (K10441, SW27571, K13190, and K42904) and New South Wales (12005). Based on matching sequences of all three genome segments to prototype MRM3630 of Trubanaman virus (TRUV), NB6057 of Gan Gan virus (GGV), and MK7532 of Maprik virus (MPKV), isolates K13190 and SW27571 were identified as TRUV, 12005 as GGV, and K42904 as a Mapputta group virus from Western Australia linking GGV and MPKV. The results confirmed serum neutralization data that had linked SW27571 to TRUV. The fifth virus, K10441 from Willare, was most closely related to Batai orthobunyavirus, presumably representing an Australian variant of the virus. Phylogenetic analysis also confirmed the close relationship of our TRUV and GGV isolates to two other recently described Australian viruses, Murrumbidgee virus and Salt Ash virus, respectively. Our findings indicate that TRUV has a wide circulation throughout the Australian continent, demonstrating for the first time its presence in Western Australia. Similarly, the presence of a virus related to GGV, which had been linked to human disease and previously known only from the Australian southeast, was demonstrated in Western Australia. Finally, a Batai virus isolate was identified in Western Australia. The expanding availability of genomic sequence for novel Australian bunyavirus variants supports the identification of suitably conserved or diverse primer-binding target regions to establish group-wide as well as virus-specific nucleic acid tests in support of specific diagnostic and surveillance efforts throughout Australasia.	[Briese, Thomas; Kapoor, Vishal; Chowdhary, Rashmi; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Briese, Thomas; Lipkin, W. Ian] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Williams, David T.; Certoma, Andrea; Wang, Jianning] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Williams, David T.; Diviney, Sinead M.] Curtin Univ, Sch Biomed Sci, Perth, WA, Australia; [Johansen, Cheryl A.] Univ Western Australia, Arbovirus Surveillance & Res Lab, Nedlands, WA, Australia; [Mackenzie, John S.] Curtin Univ, Fac Hlth Sci, Perth, WA, Australia; [Kapoor, Vishal] Qiagen, Dept Infect Dis, Manchester, Lancs, England; [Chowdhary, Rashmi] All India Inst Med Sci Bhopal, Bhopal, India	Columbia University; Columbia University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Curtin University; University of Western Australia; Curtin University; All India Institute of Medical Sciences (AIIMS) Bhopal	Briese, T (corresponding author), Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY 10027 USA.; Briese, T (corresponding author), Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA.; Williams, DT (corresponding author), CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia.; Williams, DT (corresponding author), Curtin Univ, Sch Biomed Sci, Perth, WA, Australia.	thomas.briese@columbia.edu; D.Williams@csiro.au	Lipkin, W. Ian/ABE-6216-2020; Williams, Sinead M/P-7694-2018; Johansen, Cheryl A/A-2208-2009; /S-4986-2019; Williams, David T/H-6750-2013	Lipkin, W. Ian/0000-0002-8768-9386; Williams, Sinead M/0000-0003-2011-5289; /0000-0002-5918-2190; Williams, David T/0000-0002-7169-149X	National Institutes of Health [U19AI109761]; United States Agency for International Development [GHN-A-00-09-00010-00]; Western Australian Government Office of Science and Innovations; Western Australian Department of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Agency for International Development(United States Agency for International Development (USAID)); Western Australian Government Office of Science and Innovations; Western Australian Department of Health	This work was funded by National Institutes of Health, http://www.nih.gov, U19AI109761, WIL and TB; United States Agency for International Development, https://www.usaid.gov, GHN-A-00-09-00010-00, WIL; and Western Australian Government Office of Science and Innovations, JSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Western Australian Department of Health for funding and logistical support of the Arbovirus Surveillance Program, Dr Annette Broom for northern WA mosquito collections and virus isolations, the Department of Microbiology, John Curtin School of Medical Sciences, Australia National University for providing NB6057 and MRM3630 to CSIRO, and the Department of Medical Entomology, Westmead Hospital, University of Sydney and ICPMR, New South Wales for providing 12005 to the University of Western Australia. We also thank Alexandra Petrosov and Jeremiah Martino (CII), and Honglei Chen, Kelly Davies and Gemma Harvey (CSIRO) for expert technical assistance.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARDOS V., 1962, JOUR HYG EPIDEMIOL MICROBIOL AND IMMUNOL, V6, P186; BISHOP DHL, 1980, INTERVIROLOGY, V14, P125, DOI 10.1159/000149174; Blakqori G, 2007, J VIROL, V81, P4991, DOI 10.1128/JVI.01933-06; BOUGHTON CR, 1990, AUST NZ J MED, V20, P51, DOI 10.1111/j.1445-5994.1990.tb00371.x; Boyle DB, 2012, J VIROL, V86, P6724, DOI 10.1128/JVI.00182-12; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Briese T, 2007, ARCH VIROL, V152, P2237, DOI 10.1007/s00705-007-1069-z; Briese T, 2006, J VIROL, V80, P5627, DOI 10.1128/JVI.02448-05; Briese T, 2004, J GEN VIROL, V85, P3071, DOI 10.1099/vir.0.80122-0; BROOM A K, 1989, Journal of Medical Entomology, V26, P100, DOI 10.1093/jmedent/26.2.100; Broom AK, 2002, VECTOR-BORNE ZOONOT, V2, P87, DOI 10.1089/153036602321131887; Chowdhary R, 2012, J GEN VIROL, V93, P1023, DOI 10.1099/vir.0.039479-0; Coffey LL, 2014, VIROLOGY, V448, P146, DOI 10.1016/j.virol.2013.09.026; DOHERTY RL, 1970, T ROY SOC TROP MED H, V64, P748, DOI 10.1016/0035-9203(70)90017-9; DOHERTY RL, 1968, T ROY SOC TROP MED H, V62, P430, DOI 10.1016/0035-9203(68)90095-3; DOHERTY RL, 1963, AUST J EXP BIOL MED, V41, P17, DOI 10.1038/icb.1963.2; Eagles D, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-135; Eifan SA, 2009, J VIROL, V83, P11307, DOI 10.1128/JVI.01460-09; Fauquet CM, 2005, VIRUS TAXONOMY 8 REP; FAZAKERLEY JK, 1988, VIROLOGY, V167, P422, DOI 10.1016/0042-6822(88)90104-3; GAIDAMOVICH SY, 1973, ACTA VIROL, V17, P444; GARD G, 1973, AM J TROP MED HYG, V22, P551, DOI 10.4269/ajtmh.1973.22.551; Gauci PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116561; Gauci PJ., 2016, VIROL REP, V6, P1, DOI DOI 10.1016/J.VIREP.2015.11.001; GEEVARGHESE G, 1994, ACTA VIROL, V38, P239; Groseth A, 2012, J VIROL, V86, P13844, DOI 10.1128/JVI.02641-12; Hanna JN, 1996, MED J AUSTRALIA, V165, P256, DOI 10.5694/j.1326-5377.1996.tb124960.x; HAWKES RA, 1985, MED J AUSTRALIA, V143, P330, DOI 10.5694/j.1326-5377.1985.tb123054.x; Huang BX, 2016, EMERG INFECT DIS, V22, P833, DOI 10.3201/eid2205.151566; HUBALEK Z, 1993, J WILDLIFE DIS, V29, P604, DOI 10.7589/0090-3558-29.4.604; Huhtamo E, 2013, J GEN VIROL, V94, P1242, DOI 10.1099/vir.0.051359-0; HUNT AR, 1979, AM J TROP MED HYG, V28, P740, DOI 10.4269/ajtmh.1979.28.740; Johansen CA, 2005, AUST J ZOOL, V53, P51, DOI 10.1071/ZO03042; Johansen CA, 2000, AM J TROP MED HYG, V62, P631, DOI 10.4269/ajtmh.2000.62.631; Johansen CA., 1998, ECOLOGY EPIDEMIOLOGY; Lee DJ, 1987, ENTOMOL MONOGRAPH, V2; Leonard VHJ, 2005, J VIROL, V79, P13166, DOI 10.1128/JVI.79.20.13166-13172.2005; LINDSAY MDA, 1993, AM J TROP MED HYG, V49, P686, DOI 10.4269/ajtmh.1993.49.686; Liu H, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-138; Lundstrom JO, 1999, J VECTOR ECOL, V24, P1; Mackenzie JS, 2002, CURR TOP MICROBIOL, V267, P49; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARSHALL ID, 1980, AUST J EXP BIOL MED, V58, P91, DOI 10.1038/icb.1980.9; Mohamed M, 2009, J VIROL, V83, P7612, DOI 10.1128/JVI.02080-08; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; NEWTON SE, 1983, AUST J EXP BIOL MED, V61, P201, DOI 10.1038/icb.1983.19; PAVRI KM, 1966, INDIAN J MED RES, V54, P225; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Quan PL, 2007, J CLIN MICROBIOL, V45, P2359, DOI 10.1128/JCM.00737-07; Reguera J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001101; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Russell R. C., 1995, Review of Medical and Veterinary Entomology, V83, P141; Shchetinin AM, 2015, VIRUSES-BASEL, V7, P5987, DOI 10.3390/v7112918; Shi XH, 2006, J VIROL, V80, P8089, DOI 10.1128/JVI.00579-06; SINGH KRP, 1966, INDIAN J MED RES, V54, P220; Sudeep AB, 2014, J VECTOR DIS, V51, P251; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VALE TG, 1986, AUST J EXP BIOL MED, V64, P307, DOI 10.1038/icb.1986.32; VALE TG, 1991, AUST J ZOOL, V39, P1, DOI 10.1071/ZO9910001; Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002; Whelan P, 2000, Commun Dis Intell, V24 Suppl, P74; Yadav PD, 2012, INDIAN J MED RES, V136, P792	63	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164868	10.1371/journal.pone.0164868	http://dx.doi.org/10.1371/journal.pone.0164868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764175	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500074
J	Honert, EC; Zelik, KE				Honert, Eric C.; Zelik, Karl E.			Inferring Muscle-Tendon Unit Power from Ankle Joint Power during the Push-Off Phase of Human Walking: Insights from a Multiarticular EMG-Driven Model	PLOS ONE			English	Article							FOOT; FORCES; WORK; KNEE; KINETICS; BEHAVIOR; MOMENTS; REFLEX; MOTION	Introduction Inverse dynamics joint kinetics are often used to infer contributions from underlying groups of muscle-tendon units (MTUs). However, such interpretations are confounded by multiarticular (multi-joint) musculature, which can cause inverse dynamics to over-or under-estimate net MTU power. Misestimation of MTU power could lead to incorrect scientific conclusions, or to empirical estimates that misguide musculoskeletal simulations, assistive device designs, or clinical interventions. The objective of this study was to investigate the degree to which ankle joint power overestimates net plantarflexor MTU power during the Push-off phase of walking, due to the behavior of the flexor digitorum and hallucis longus (FDHL)-multiarticular MTUs crossing the ankle and metatarsophalangeal (toe) joints. Methods We performed a gait analysis study on six healthy participants, recording ground reaction forces, kinematics, and electromyography (EMG). Empirical data were input into an EMG-driven musculoskeletal model to estimate ankle power. This model enabled us to parse contributions from mono-and multi-articular MTUs, and required only one scaling and one time delay factor for each subject and speed, which were solved for based on empirical data. Net plantarflexing MTU power was computed by the model and quantitatively compared to inverse dynamics ankle power. Results The EMG-driven model was able to reproduce inverse dynamics ankle power across a range of gait speeds (R-2 >= 0.97), while also providing MTU-specific power estimates. We found that FDHL dynamics caused ankle power to slightly overestimate net plantarflexor MTU power, but only by similar to 2-7%. Conclusions During Push-off, FDHL MTU dynamics do not substantially confound the inference of net plantarflexor MTU power from inverse dynamics ankle power. However, other methodological limitations may cause inverse dynamics to overestimate net MTU power; for instance, due to rigid-body foot assumptions. Moving forward, the EMG-driven modeling approach presented could be applied to understand other tasks or larger multiarticular MTUs.	[Honert, Eric C.; Zelik, Karl E.] Vanderbilt Univ, Dept Mech Engn, Nashville, TN 37235 USA; [Zelik, Karl E.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Zelik, Karl E.] Vanderbilt Univ, Dept Phys Med & Rehabil, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Honert, EC (corresponding author), Vanderbilt Univ, Dept Mech Engn, Nashville, TN 37235 USA.	eric.c.honert@vanderbilt.edu	Honert, Eric/AAW-1370-2020	Honert, Eric/0000-0002-3865-5104; Zelik, Karl/0000-0002-5054-2479	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [K12HD073945]	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health	This research was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number K12HD073945. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aper RL, 1996, CLIN ORTHOP RELAT R, P209; Bogey RA, 2005, IEEE T NEUR SYS REH, V13, P302, DOI 10.1109/TNSRE.2005.851768; Bouillard K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029261; Bruening DA, 2012, GAIT POSTURE, V35, P535, DOI 10.1016/j.gaitpost.2011.11.012; Buchanan TS, 2004, J APPL BIOMECH, V20, P367, DOI 10.1123/jab.20.4.367; Donelan JM, 2002, J EXP BIOL, V205, P3717; Farris DJ, 2012, P NATL ACAD SCI USA, V109, P977, DOI 10.1073/pnas.1107972109; Finni T, 1998, EUR J APPL PHYSIOL O, V77, P289, DOI 10.1007/s004210050335; Fukunaga T, 2002, EXERC SPORT SCI REV, V30, P106, DOI 10.1097/00003677-200207000-00003; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Hermens H, 1999, ROESSING RES DEV ENS; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; Kelly LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1076; Kirane YM, 2008, J BIOMECH, V41, P1919, DOI 10.1016/j.jbiomech.2008.03.040; Konrad P, 2006, ABC EMG PRACTICAL IN; Krishnaswamy P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001107; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; La Scaleia V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00305; Lai A, 2015, J APPL PHYSIOL, V118, P1266, DOI 10.1152/japplphysiol.00128.2015; Leardini A, 2007, GAIT POSTURE, V25, P453, DOI 10.1016/j.gaitpost.2006.05.017; Lipfert SW, 2014, J EXP BIOL, V217, P1218, DOI 10.1242/jeb.097345; Lloyd DG, 2003, J BIOMECH, V36, P765, DOI 10.1016/S0021-9290(03)00010-1; MacWilliams BA, 2003, GAIT POSTURE, V17, P214, DOI 10.1016/S0966-6362(02)00103-0; McCullough MBA, 2011, FOOT ANKLE INT, V32, P300, DOI 10.3113/FAI.2011.0300; Meinders M, 1998, SCAND J REHABIL MED, V30, P39; Nussbaum MA, 1998, J BIOMECH, V31, P667, DOI 10.1016/S0021-9290(98)00055-4; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P1; Potvin JR, 2004, J ELECTROMYOGR KINES, V14, P389, DOI 10.1016/j.jelekin.2003.10.005; Robertson G, 2013, RES METHODS BIOMECHA; Sartori M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052618; SCHENAU GJV, 1987, J ANAT, V155, P1; STOKES IAF, 1979, J ANAT, V129, P579; Takahashi KZ, 2013, GAIT POSTURE, V38, P818, DOI 10.1016/j.gaitpost.2013.04.002; Thelen DG, 2006, J BIOMECH, V39, P1107, DOI 10.1016/j.jbiomech.2005.02.010; VIITASALO JT, 1981, ACTA PHYSIOL SCAND, V111, P97, DOI 10.1111/j.1748-1716.1981.tb06710.x; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147; WINTER DA, 1990, PHYS THER, V70, P340, DOI 10.1093/ptj/70.6.340; WINTER DA, 1978, BIOL CYBERN, V29, P137, DOI 10.1007/BF00337349; Zajac FE, 2002, GAIT POSTURE, V16, P215, DOI 10.1016/S0966-6362(02)00068-1; Zelik KE, 2015, J EXP BIOL, V218, P876, DOI 10.1242/jeb.115451; Zelik KE, 2015, EUR J APPL PHYSIOL, V115, P691, DOI 10.1007/s00421-014-3056-x; Zelik KE, 2014, J NEUROPHYSIOL, V111, P1686, DOI 10.1152/jn.00776.2013; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297; ZHOU S, 1995, EUR J APPL PHYSIOL, V70, P138, DOI 10.1007/BF00361541	45	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0163169	10.1371/journal.pone.0163169	http://dx.doi.org/10.1371/journal.pone.0163169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764110	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500008
J	Riemann-Lorenz, K; Eilers, M; von Geldern, G; Schulz, KH; Kopke, S; Heesen, C				Riemann-Lorenz, Karin; Eilers, Marlene; von Geldern, Gloria; Schulz, Karl-Heinz; Kopke, Sascha; Heesen, Christoph			Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; DOUBLE-BLIND TRIAL; SUPPLEMENTATION; VITAMIN-D-3; DISEASE; RISK	Background Dietary factors have been discussed to influence risk or disease course of multiple sclerosis (MS). Specific diets are widely used among patients with MS. Objective To design and pilot-test an evidence based patient education program on dietary factors in MS. Methods We performed a systematic literature search on the effectiveness of dietary interventions in MS. A web-based survey among 337 patients with MS and 136 healthy controls assessed knowledge, dietary habits and information needs. An interactive group education program was developed and pilot-tested. Results Fifteen randomised-controlled trials (RCTs) were included in the systematic review. Quality of evidence was low and no clear benefit could be seen. Patients with MS significantly more often adhered to a 'Mediterranean Diet'(29.7% versus 14.0%, p< 0.001) compared to controls. 143 (42%) of the patients with MS had tried special MS diets. Important information needs addressed effectiveness of MS diets (44%) and relation between nutrition and MS (43%). A pilot test of our newly developed patient education program with 13 participants showed excellent comprehensibility and the MS-specific content was judged as very important. However, the poor evidence base for dietary approaches in MS was perceived disappointing. Conclusions Development and pilot-testing of an evidence-based patient education program on nutrition and MS is feasible. Patient satisfaction with the program suffers from the lack of evidence. Further research should focus on generating evidence for the potential influence of lifestyle habits (diet, physical activity) on MS disease course thus meeting the needs of patients with MS.	[Riemann-Lorenz, Karin; Eilers, Marlene] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Inst Neuroimmunol & Multiple Sclerosis, Hamburg, Germany; [von Geldern, Gloria] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Schulz, Karl-Heinz] Univ Med Ctr Hamburg Eppendorf, Dept Psychosocial Med, Inst Med Psychol, Hamburg, Germany; [Schulz, Karl-Heinz] Univ Med Ctr Hamburg Eppendorf, Athleticum Competence Ctr Sports & Exercise Med, Hamburg, Germany; [Kopke, Sascha] Univ Lubeck, Inst Social Med & Epidemiol, Nursing Res Unit, Lubeck, Germany; [Heesen, Christoph] MS Day Hosp, Dept Neurol, Hamburg, Germany; [Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Multiple Sclerosis, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Washington; University of Washington Seattle; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf	Riemann-Lorenz, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Inst Neuroimmunol & Multiple Sclerosis, Hamburg, Germany.	k.riemann-lorenz@uke.de						Adam O, 2007, ERNAHRUNGSRICHTLINIE; BATES D, 1978, BMJ-BRIT MED J, V2, P1390, DOI 10.1136/bmj.2.6149.1390; BATES D, 1977, BMJ-BRIT MED J, V2, P932, DOI 10.1136/bmj.2.6092.932-a; BATES D, 1989, J NEUROL NEUROSUR PS, V52, P18, DOI 10.1136/jnnp.52.1.18; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Belbasis L, 2015, LANCET NEUROL, V14, P263, DOI 10.1016/S1474-4422(14)70267-4; Bunge M, 2010, PATIENT EDUC COUNS, V78, P316, DOI 10.1016/j.pec.2009.10.029; Burton JM, 2010, NEUROLOGY, V74, P1852, DOI 10.1212/WNL.0b013e3181e1cec2; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Derakhshandi H, 2013, ACTA NEUROL BELG, V113, P257, DOI 10.1007/s13760-012-0166-2; Deutsches Netzwerk Evidenzbasierte Medizin, 2015, GUT PRAX GES; Evans C, 2013, NEUROEPIDEMIOLOGY, V40, P195, DOI 10.1159/000342779; Evers J., 2002, DIABETES ANDEREN STO; Farinotti M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004192.pub3; Fratzer U., 1990, REPORT BETROFFENE; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Godin G., 1997, MED SCI SPORT EXER, V29, pS36, DOI DOI 10.1097/00005768-199706001-00009; Golan D, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-60; Hadgkiss EJ, 2015, NUTR NEUROSCI, V18, P125, DOI 10.1179/1476830514Y.0000000117; Harbige LS, 2007, BRIT J NUTR, V98, pS46, DOI 10.1017/S0007114507833010; Hedstrom AK, 2011, ANN NEUROL, V70, P733, DOI 10.1002/ana.22597; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; JAGANNATH VA, 2010, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD008422.PUB2]; Kampman MT, 2012, MULT SCLER J, V18, P1144, DOI 10.1177/1352458511434607; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Leong EM, 2009, COMPLEMENT THER MED, V17, P216, DOI 10.1016/j.ctim.2009.03.001; Max Rubner-Institut-Bundesforschungsinstitut fur Ernahrung und Lebensmittel, 2008, NAT VERZ STUD 2 ER 2; MILLAR JHD, 1973, BMJ-BRIT MED J, V1, P765, DOI 10.1136/bmj.1.5856.765; Mohler R, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0709-y; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mohr DC, 2007, MULT SCLER J, V13, P215, DOI 10.1177/1352458506070926; Overcomingms.org, AUSTR OV MULT SCLER; Pantzaris MC, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002170; PATY DW, 1983, ARCH NEUROL-CHICAGO, V40, P693, DOI 10.1001/archneur.1983.04050100033011; Schwarz S, 2008, MULT SCLER J, V14, P1113, DOI 10.1177/1352458508092808; Schwarzer R, 1999, DOKUMENTATION DER PS; Shaygannejad V, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/452541; Soilu-Hanninen M, 2012, J NEUROL NEUROSUR PS, V83, P566, DOI 10.1136/jnnp-2011-301876; Storoni M, 2015, MULT SCLER INT, V2015, DOI 10.1155/2015/681289; SWANK RL, 1990, LANCET, V336, P37, DOI 10.1016/0140-6736(90)91533-G; Torkildsen O, 2012, ARCH NEUROL-CHICAGO, V69, P1044, DOI 10.1001/archneurol.2012.283; Waubant E, 2014, LANCET NEUROL, V13, P11, DOI 10.1016/S1474-4422(13)70284-9; Weinstock-Guttman B, 2005, PROSTAG LEUKOTR ESS, V73, P397, DOI 10.1016/j.plefa.2005.05.024; Wekerle H, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14189	45	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165246	10.1371/journal.pone.0165246	http://dx.doi.org/10.1371/journal.pone.0165246			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764237	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500139
J	Wong, J; Zhang, YL; Patidar, A; Vilar, E; Finkelman, M; Farrington, K				Wong, Jonathan; Zhang, Yonglong; Patidar, Ashish; Vilar, Enric; Finkelman, Malcolm; Farrington, Ken			Is Endotoxemia in Stable Hemodialysis Patients an Artefact? Limitations of the Limulus Amebocyte Lysate Assay and Role of (1 -> 3)-beta-D Glucan	PLOS ONE			English	Article							SYSTEMIC INFLAMMATION; PLASMA; BLOOD; METAANALYSIS; CONTRIBUTES; ACTIVATION; REACTIVITY; DISEASE; ORGANS; CELL	Background Elevated blood endotoxin levels are frequently reported in the dialysis population and are strongly linked with inflammation, a major predictor of mortality. Virtually all studies have employed the Limulus Amoebocyte Lysate (LAL) assay to detect endotoxin. However this assay is not endotoxin-specific and can be activated by (1 -> 3)-beta-glucan (BG), a component of fungal cell walls leading to false positive signals. Very few studies have taken account of this. We examined the influence of BG-based activation of the LAL assay on the detection of endotoxemia in this setting. Method We measured plasma endotoxin levels in 50 hemodialysis patients with and without the use of BG-blocking buffers. These buffers inhibit BG activation of the LAL assay to ensure that any signal detected is endotoxin-specific. Blood samples were measured for BG, interleukin-6 (IL-6), tumor necrosis factor-alfa (TNF-alpha) to examine the association between endotoxin signals, BG and inflammation. Results Endotoxin signals were detected in 50% of patients. On repeat measurement with a BG-blocking buffer, all detected endotoxin signals were extinguished. No patient had detectable endotoxemia. Plasma BG levels were significantly elevated in 58% of patients and were higher in those with detectable endotoxin signals using the LAL assay without BG-blocking buffers (78vs.54pg/mL;p<0.001). Endotoxin signal and BG levels did not correlate with levels of TNF-alpha a or IL-6. Conclusion Use of the LAL assay for blood endotoxin detection in dialysis patients has its limitations due to high blood BG. Endotoxemia frequently reported in non-infected hemodialysis patients may be artefactual due to BG interference.	[Wong, Jonathan; Vilar, Enric; Farrington, Ken] Lister Renal Unit, Hatfield, Herts, England; [Wong, Jonathan; Patidar, Ashish; Vilar, Enric; Farrington, Ken] Univ Hertfordshire, Hatfield AL10 9AB, Herts, England; [Zhang, Yonglong; Finkelman, Malcolm] Associates Cape Cod Inc, East Falmouth, MA USA	University of Hertfordshire	Wong, J (corresponding author), Lister Renal Unit, Hatfield, Herts, England.; Wong, J (corresponding author), Univ Hertfordshire, Hatfield AL10 9AB, Herts, England.	Jonathan.wong@nhs.net	Farrington, Ken/V-1531-2019		East and North Herts NHS trust; Lister Nephrology Research Fund; Associates of Cape Cod, Inc.; University of Hertfordshire, UK	East and North Herts NHS trust; Lister Nephrology Research Fund; Associates of Cape Cod, Inc.; University of Hertfordshire, UK	The East and North Herts NHS trust sponsored the study. The Lister Nephrology Research Fund provided funding support in the form of salaries for JW and costs for research materials for endotoxin and cytokine measurements. Associates of Cape Cod, Inc. provided support in the form of salaries for MF and YZ and research materials for beta-glucan measurements. The salaries of EV and KF were funded by the East and North Herts NHS trust. The salary of AP was funded by the University of Hertfordshire, UK. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2013, US PHARMACOPOIEA 36, V37, P1; Associates of Cape Cod, 2011, FUNG ASS INSTR US; BODE C, 1993, EUR J GASTROEN HEPAT, V5, P257, DOI 10.1097/00042737-199304000-00011; Bryans Trabue D., 2004, Biomedical Instrumentation & Technology, V38, P73, DOI 10.2345/0899-8205(2004)38[73:BETARO]2.0.CO;2; Carrero JJ, 2010, SEMIN DIALYSIS, V23, P498, DOI 10.1111/j.1525-139X.2010.00784.x; El-Koraie AF, 2013, HEMODIAL INT, V17, P359, DOI 10.1111/hdi.12007; Feroze U, 2012, J RENAL NUTR, V22, P317, DOI 10.1053/j.jrn.2011.05.004; Fukui H., J GASTROENTEROL HEPA, V8, P577; GREISMAN SE, 1969, P SOC EXP BIOL MED, V131, P1154, DOI 10.3181/00379727-131-34059; Hauser AB, 2011, NEPHRON CLIN PRACT, V118, pC165, DOI 10.1159/000321438; He S, 2015, J MICROBIOL IMMUNOL, V48, P351, DOI 10.1016/j.jmii.2014.06.009; HOCHSTEIN HD, 1994, J ENDOTOXIN RES, V1, P52; Hong F, 2004, J IMMUNOL, V173, P797, DOI 10.4049/jimmunol.173.2.797; HURLEY JC, 1995, CLIN MICROBIOL REV, V8, P268, DOI 10.1128/CMR.8.2.268; HURLEY PJ, 1975, J NUCL MED, V16, P46; Jang H, 2009, BMB REP, V42, P462, DOI 10.5483/BMBRep.2009.42.7.462; Jefferies HJ, 2014, NEPHRON CLIN PRACT, V128, P141, DOI 10.1159/000366519; KAMBAYASHI J, 1991, J BIOCHEM BIOPH METH, V22, P93, DOI 10.1016/0165-022X(91)90022-O; Kanda H, 2001, KIDNEY INT, V60, P319, DOI 10.1046/j.1523-1755.2001.00802.x; Kikkert R, 2007, J ENDOTOXIN RES, V13, P140, DOI 10.1177/0968051907080024; Klein DJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-218; Kubala L, 2003, CARBOHYD RES, V338, P2835, DOI 10.1016/j.carres.2003.09.007; Kumar H., 2006, ENDOSAFE TIMES, V12; Kwan BCH, 2013, NEPHROL DIAL TRANSPL, V28, P2139, DOI 10.1093/ndt/gft100; Lemieszek M, 2012, WSPOLCZESNA ONKOL, V16, P285, DOI 10.5114/wo.2012.30055; McIntyre CW, 2011, CLIN J AM SOC NEPHRO, V6, P133, DOI 10.2215/CJN.04610510; MORITA T, 1981, FEBS LETT, V129, P318, DOI 10.1016/0014-5793(81)80192-5; Odabasi Z, 2004, CLIN INFECT DIS, V39, P199, DOI 10.1086/421944; OHNO N, 1990, CARBOHYD RES, V207, P311, DOI 10.1016/0008-6215(90)84058-3; Petraitiene R, 2008, ANTIMICROB AGENTS CH, V52, P4121, DOI 10.1128/AAC.00674-08; Raj DSC, 2009, AM J KIDNEY DIS, V54, P1072, DOI 10.1053/j.ajkd.2009.06.022; Rop O, 2009, NUTR REV, V67, P624, DOI 10.1111/j.1753-4887.2009.00230.x; Suzuki T, 2002, BIOL PHARM BULL, V25, P140, DOI 10.1248/bpb.25.140; Szeto C.-C., PERIT DIAL INT, V30, P178; Szeto CC, 2008, CLIN J AM SOC NEPHRO, V3, P431, DOI 10.2215/CJN.03600807; TANAKA S, 1993, CARBOHYD RES, V244, P115, DOI 10.1016/0008-6215(93)80008-3; TANIGUCHI T, 1990, NEPHRON, V56, P44, DOI 10.1159/000186099; Terawaki H, 2010, THER APHER DIAL, V14, P477, DOI 10.1111/j.1744-9987.2010.00815.x; TSUCHIYA M, 1990, Japanese Journal of Bacteriology, V45, P903; Vaziri ND, 2012, CURR OPIN NEPHROL HY, V21, P587, DOI 10.1097/MNH.0b013e328358c8d5; Wang FQ, 2012, DIGEST DIS SCI, V57, P2856, DOI 10.1007/s10620-012-2242-0; Wong J., 2014, SEMIN DIAL; Wong J, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-016-0132-5; Wong J, 2015, J CLIN PATHOL, V68, P73, DOI 10.1136/jclinpath-2014-202622; Yin X, 2015, INDIAN J CANCER, V52, pE29, DOI 10.4103/0019-509X.168953; Yoshida M, 1997, MEDIAT INFLAMM, V6, P279, DOI 10.1080/09629359791622; Yoshida M, 1996, J LAB CLIN MED, V128, P103, DOI 10.1016/S0022-2143(96)90119-5; Young SH, 2005, TOXICOLOGY OF 1- 3-BETA-GLUCANS: GLUCANS AS A MARKER FOR FUNGAL EXPOSURE, P65, DOI 10.1201/9780203020814.ch4	48	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164978	10.1371/journal.pone.0164978	http://dx.doi.org/10.1371/journal.pone.0164978			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764208	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204500091
J	Davis-Poynter, N; Yunis, J; Farrell, HE				Davis-Poynter, Nick; Yunis, Joseph; Farrell, Helen E.			The Cytoplasmic C-Tail of the Mouse Cytomegalovirus 7 Transmembrane Receptor Homologue, M78, Regulates Endocytosis of the Receptor and Modulates Virus Replication in Different Cell Types	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MURINE CYTOMEGALOVIRUS; CONSTITUTIVE ENDOCYTOSIS; PLASMA-MEMBRANE; TRAFFICKING; US28; GENE; PHOSPHORYLATION; DOMAIN; U51	Virus homologues of seven-transmembrane receptors (7TMR) are encoded by all beta-and gammaherpesviruses, suggesting important functional roles. M78 of mouse cytomegalovirus (MCMV) is representative of a family of 7TMR conserved in all betaherpesviruses. M78 family members have been found to exhibit cell-type specific effects upon virus replication in tissue culture and to affect virus pathogenesis in vivo. We reported previously that M78, for which no ligands are known, undergoes rapid, constitutive endocytosis. In this study, we have investigated the role of the M78 cytoplasmic C-tail in mediating endocytosis and consequences of C-tail deletion upon replication and pathogenesis. Mutations of M78 (C-tail truncations or point mutations) and CCR5-M78 chimeras identified two distinct regions affecting endocytosis. The first was a classical acidic di-leucine motif (DDxxxLL), located close to the C-terminus. The second region, the activity of which was suppressed by downstream sequences, included the putative 8th helix, located close to the 7th transmembrane domain. A recombinant MCMV expressing an endocytosis-deficient M78, lacking most of the C-tail (M78_C Delta 155), had a cell-type specific replication phenotype. M78_C Delta 155 had restricted replication in bone marrow macrophages, indistinguishable from an M78-null recombinant. In contrast, M78_C Delta 155 replicated normally or with enhanced titres to wild type virus in other tested cell-types, whereas M78-null was attenuated. Distinct phenotypes for M78_C Delta 155 and M78-null suggest that the C-tail deletion resulted in M78 dysfunction, rather than complete loss of function; furthermore, they highlight a cell-type specific role of M78 during replication. Infection of mice (intranasal) demonstrated that M78_C Delta 155, similar to M78-null, was cleared more rapidly from the lungs than wild type virus and was severely attenuated for replication in salivary glands. It may be speculated that attenuation of both M78_C Delta 155 and M78-null for replication in macrophages may have contributed to their similar pathogenic phenotypes.	[Davis-Poynter, Nick] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Davis-Poynter, Nick; Yunis, Joseph; Farrell, Helen E.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Farrell, HE (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	h.farrell1@uq.edu.au	Yunis, Joseph/AAK-2610-2021; Farrell, Helen/F-8583-2011; Davis-Poynter, Nick/B-3811-2010	Yunis, Joseph/0000-0002-0272-0605; Farrell, Helen/0000-0002-7214-2767; Davis-Poynter, Nick/0000-0001-7368-1925	Queensland Health [NG062]; University of Queensland [2007001062]	Queensland Health; University of Queensland(University of Queensland)	This study was supported by the Queensland Health, NG062, www.health.gld.gov.au, ND-P, and the University of Queensland, 2007001062, www.ug.edu.au, HF.	Alcendor DJ, 2009, VIROLOGY, V395, P21, DOI 10.1016/j.virol.2009.09.002; Beisser PS, 1999, J VIROL, V73, P7218, DOI 10.1128/JVI.73.9.7218-7230.1999; Bodaghi B, 1998, J EXP MED, V188, P855, DOI 10.1084/jem.188.5.855; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Case R, 2008, J VIROL, V82, P1884, DOI 10.1128/JVI.02550-06; CHEE MS, 1990, NATURE, V344, P774, DOI 10.1038/344774a0; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; DavisPoynter NJ, 1997, J VIROL, V71, P1521, DOI 10.1128/JVI.71.2.1521-1529.1997; Droese J, 2004, BIOCHEM BIOPH RES CO, V322, P42, DOI 10.1016/j.bbrc.2004.07.076; Fitzsimons CP, 2006, MOL PHARMACOL, V69, P888, DOI 10.1124/mol.105.015222; Fraile-Ramos A, 2002, TRAFFIC, V3, P218, DOI 10.1034/j.1600-0854.2002.030307.x; Fraile-Ramos A, 2001, MOL BIOL CELL, V12, P1737, DOI 10.1091/mbc.12.6.1737; Graham GJ, 2009, EUR J IMMUNOL, V39, P342, DOI 10.1002/eji.200838858; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; JONES BG, 1995, EMBO J, V14, P5869, DOI 10.1002/j.1460-2075.1995.tb00275.x; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; McCulloch CV, 2008, J BIOL CHEM, V283, P7972, DOI 10.1074/jbc.M710128200; Michel D, 2005, J GEN VIROL, V86, P297, DOI 10.1099/vir.0.80436-0; Miller WE, 2003, J BIOL CHEM, V278, P21663, DOI 10.1074/jbc.M303219200; Mokros T, 2002, J BIOL CHEM, V277, P45122, DOI 10.1074/jbc.M208214200; Molleskov-Jensen AS, 2015, PROG MOL BIOL TRANSL, V129, P353, DOI 10.1016/bs.pmbts.2014.10.010; Mueller A, 2002, BLOOD, V99, P785, DOI 10.1182/blood.V99.3.785; O'Connor CM, 2012, J VIROL, V86, P11425, DOI 10.1128/JVI.05900-11; Oliveira SA, 2001, P NATL ACAD SCI USA, V98, P3237, DOI 10.1073/pnas.051629898; Rosenkilde MM, 2006, CURR DRUG TARGETS, V7, P103, DOI 10.2174/138945006775270259; Sharp EL, 2009, J GEN VIROL, V90, P59, DOI 10.1099/vir.0.004853-0; Stapleton LK, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-42; STODDART CA, 1994, J VIROL, V68, P6243, DOI 10.1128/JVI.68.10.6243-6253.1994; Tadagaki K, 2005, J VIROL, V79, P7068, DOI 10.1128/JVI.79.11.7068-7076.2005; Tugizov S, 1999, J VIROL, V73, P8677, DOI 10.1128/JVI.73.10.8677-8688.1999; Vischer HF, 2014, NAT REV DRUG DISCOV, V13, P123, DOI 10.1038/nrd4189; Wagner S, 2012, ARCH VIROL, V157, P935, DOI 10.1007/s00705-012-1246-6; Waites CL, 2001, J CELL BIOL, V152, P1159, DOI 10.1083/jcb.152.6.1159; Waldhoer M, 2003, J BIOL CHEM, V278, P19473, DOI 10.1074/jbc.M213179200; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; Zhen Z, 2005, J VIROL, V79, P11914, DOI 10.1128/JVI.79.18.11914-11924.2005	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0165066	10.1371/journal.pone.0165066	http://dx.doi.org/10.1371/journal.pone.0165066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760189	gold, Green Submitted, Green Published			2022-12-26	WOS:000386204000082
J	Radomska, KA; Vaezirad, MM; Verstappen, KM; Wosten, MMSM; Wagenaar, JA; van Putten, JPM				Radomska, Katarzyna A.; Vaezirad, Mahdi M.; Verstappen, Koen M.; Wosten, Marc M. S. M.; Wagenaar, Jaap A.; van Putten, Jos P. M.			Chicken Immune Response after In Ovo Immunization with Chimeric TLR5 Activating Flagellin of Campylobacter jejuni	PLOS ONE			English	Article							REDUCE INTESTINAL COLONIZATION; ORAL VACCINATION; SUBUNIT VACCINE; SPECIFICITY; INFECTIONS; ANTIBODIES; PROTEINS; BURDEN	Campylobacter jejuni is the main cause of bacterial food-borne diseases in developed countries. Chickens are the most important source of human infection. Vaccination of poultry is an attractive strategy to reduce the number of C. jejuni in the intestinal tract of chickens. We investigated the immunogenicity and protective efficacy of a recombinant C. jejuni flagellin-based subunit vaccine with intrinsic adjuvant activity. Toll-like receptor activation assays demonstrated the purity and TLR5 stimulating (adjuvant) activity of the vaccine. The antigen (20-40 mu g) was administered in ovo to 18 day-old chicken embryos. Serum samples and intestinal content were assessed for antigen-specific systemic and mucosal humoral immune responses. In ovo vaccination resulted in the successful generation of IgY and IgM serum antibodies against the flagellin-based subunit vaccine as determined by ELISA and Western blotting. Vaccination did not induce significant amounts of flagellin-specific secretory IgA in the chicken intestine. Challenge of chickens with C. jejuni yielded similar intestinal colonization levels for vaccinated and control animals. Our results indicate that in ovo delivery of recombinant C. jejuni flagellin subunit vaccine is a feasible approach to yield a systemic humoral immune response in chickens but that a mucosal immune response may be needed to reduce C. jejuni colonization.	[Radomska, Katarzyna A.; Vaezirad, Mahdi M.; Verstappen, Koen M.; Wosten, Marc M. S. M.; Wagenaar, Jaap A.; van Putten, Jos P. M.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Wagenaar, Jaap A.] Cent Vet Inst Wageningen UR, Lelystad, Netherlands	Utrecht University; Wageningen University & Research	van Putten, JPM (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	j.vanputten@uu.nl		Wosten, Marc/0000-0002-7464-7232; van Putten, Jos/0000-0002-4126-8172	Danish Council for Strategic Research (project CamVac, Campylobacter Vaccination of Poultry) [09-067131]; CamCon project (Campylobacter Control - Novel Approaches in Primary Poultry Production) - European Community's Seventh Framework Programme (FP7) [244547]	Danish Council for Strategic Research (project CamVac, Campylobacter Vaccination of Poultry); CamCon project (Campylobacter Control - Novel Approaches in Primary Poultry Production) - European Community's Seventh Framework Programme (FP7)	This work was supported in part by The Danish Council for Strategic Research (project CamVac, Campylobacter Vaccination of Poultry, contract number 09-067131); by the CamCon project (Campylobacter Control - Novel Approaches in Primary Poultry Production), funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 244547. JW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Batz MB, 2013, INFECT DIS CLIN N AM, V27, P599, DOI 10.1016/j.idc.2013.05.003; CAWTHRAW S, 1994, AVIAN DIS, V38, P341, DOI 10.2307/1591960; de Zoete MR, 2010, J BIOL CHEM, V285, P12149, DOI 10.1074/jbc.M109.070227; de Zoete MR, 2010, INFECT IMMUN, V78, P1229, DOI 10.1128/IAI.00897-09; Ding XC, 2004, INFECT IMMUN, V72, P6939, DOI 10.1128/IAI.72.12.6939-6944.2004; EFSA, 2011, EFSA J, V9, P2105, DOI DOI 10.2903/J.EFSA.2011.2105; Fujita Y, 2012, THER DELIV, V3, P749, DOI 10.4155/TDE.12.52; Haagsma JA, 2010, EPIDEMIOL INFECT, V138, P1650, DOI 10.1017/S0950268810000531; Hamal KR, 2006, POULTRY SCI, V85, P1364, DOI 10.1093/ps/85.8.1364; Havelaar AH, 2000, EPIDEMIOL INFECT, V125, P505, DOI 10.1017/S0950268800004933; Helms M, 2003, BRIT MED J, V326, P357, DOI 10.1136/bmj.326.7385.357; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; Keestra AM, 2008, J IMMUNOL, V181, P4354, DOI 10.4049/jimmunol.181.6.4354; Keestra AM, 2008, MOL IMMUNOL, V45, P1298, DOI 10.1016/j.molimm.2007.09.013; Keestra AM, 2007, J IMMUNOL, V178, P7110, DOI 10.4049/jimmunol.178.11.7110; Keestra AM, 2010, J IMMUNOL, V185, P460, DOI 10.4049/jimmunol.0901921; Khoury CA, 1995, AVIAN DIS, V39, P812, DOI 10.2307/1592418; KOWALCZYK K, 1985, IMMUNOLOGY, V54, P755; Lee LH, 1999, INFECT IMMUN, V67, P5799, DOI 10.1128/IAI.67.11.5799-5805.1999; Lu YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18985; McSorley SJ, 2000, J IMMUNOL, V164, P986, DOI 10.4049/jimmunol.164.2.986; Meunier M, 2016, J APPL MICROBIOL, V120, P1139, DOI 10.1111/jam.12986; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Muir WI, 2000, DEV COMP IMMUNOL, V24, P325, DOI 10.1016/S0145-305X(99)00081-6; Noor S. M., 2000, Jurnal Ilmu Ternak dan Veteriner, V5, P119; NOOR SM, 1995, BRIT POULTRY SCI, V36, P563, DOI 10.1080/00071669508417802; NUIJTEN PJM, 1991, INFECT IMMUN, V59, P1100, DOI 10.1128/IAI.59.3.1100-1105.1991; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; Rice BE, 1997, VACCINE, V15, P1922, DOI 10.1016/S0264-410X(97)00126-6; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3; Shoaf-Sweeney KD, 2008, APPL ENVIRON MICROB, V74, P6867, DOI 10.1128/AEM.01097-08; Skarp CPA, 2016, CLIN MICROBIOL INFEC, V22, P103, DOI 10.1016/j.cmi.2015.11.019; Szymanski CM, 2003, TRENDS MICROBIOL, V11, P233, DOI 10.1016/S0966-842X(03)00079-9; Widders PR, 1996, BRIT POULTRY SCI, V37, P765, DOI 10.1080/00071669608417906; Widders PR, 1998, VET MICROBIOL, V64, P39, DOI 10.1016/S0378-1135(98)00251-X; Wigley P, 2013, DEV COMP IMMUNOL, V41, P413, DOI 10.1016/j.dci.2013.04.008	38	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164837	10.1371/journal.pone.0164837	http://dx.doi.org/10.1371/journal.pone.0164837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760175	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000057
J	Wu, CL; Zhong, SY; Chen, HC				Wu, Chinglin; Zhong, Suyu; Chen, Hsuehchih			Discriminating the Difference between Remote and Close Association with Relation to White-Matter Structural Connectivity	PLOS ONE			English	Article							RESTING FUNCTIONAL CONNECTIVITY; POSSIBLE BRAIN MECHANISMS; COGNITIVE STIMULATION; PREFRONTAL CORTEX; CREATIVE BRAIN; SMALL-WORLD; NETWORK; THOUGHT; FMRI; ORGANIZATION	Remote association is a core ability that influences creative output. In contrast to close association, remote association is commonly agreed to be connected with more original and unique concepts. However, although existing studies have discovered that creativity is closely related to the white-matter structure of the brain, there are no studies that examine the relevance between the connectivity efficiencies and creativity of the brain regions from the perspective of networks. Consequently, this study constructed a brain white matter network structure that consisted of cerebral tissues and nerve fibers and used graph theory to analyze the connection efficiencies among the network nodes, further illuminating the differences between remote and close association in relation to the connectivity of the brain network. Researchers analyzed correlations between the scores of 35 healthy adults with regard to remote and close associations and the connectivity efficiencies of the white-matter network of the brain. Controlling for gender, age, and verbal intelligence, the remote association positively correlated with the global efficiency and negatively correlated with the levels of small-world. A close association negatively correlated with the global efficiency. Notably, the node efficiency in the middle temporal gyrus (MTG) positively correlated with remote association and negatively correlated with close association. To summarize, remote and close associations work differently as patterns in the brain network. Remote association requires efficient and convenient mutual connections between different brain regions, while close association emphasizes the limited connections that exist in a local region. These results are consistent with previous results, which indicate that creativity is based on the efficient integration and connection between different regions of the brain and that temporal lobes are the key regions for discriminating remote and close associations.	[Wu, Chinglin; Chen, Hsuehchih] Taiwan Normal Univ, Dept Educ Psychol & Counseling, Taipei 10610, Taiwan; [Zhong, Suyu] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhong, Suyu] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Chen, HC (corresponding author), Taiwan Normal Univ, Dept Educ Psychol & Counseling, Taipei 10610, Taiwan.	chcjyh@gmail.com		Wu, Ching-Lin/0000-0001-8211-0446	Ministry of Science and Technology, Taiwan, ROC [MOST103-2420-H-003-023-DR]; "Aim for the Top University Project" and "Center of Learning Technology for Chinese" of National Taiwan Normal University (NTNU); Ministry of Education, Taiwan, ROC	Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan); "Aim for the Top University Project" and "Center of Learning Technology for Chinese" of National Taiwan Normal University (NTNU); Ministry of Education, Taiwan, ROC(Ministry of Education, Taiwan)	CW and HC were funded by Ministry of Science and Technology, Taiwan, ROC (MOST103-2420-H-003-023-DR), and the "Aim for the Top University Project" and "Center of Learning Technology for Chinese" of National Taiwan Normal University (NTNU), sponsored by the Ministry of Education, Taiwan, ROC.	Bai F, 2012, J NEUROSCI, V32, P4307, DOI 10.1523/JNEUROSCI.5061-11.2012; Beaty RE, 2016, TRENDS COGN SCI, V20, P87, DOI 10.1016/j.tics.2015.10.004; Beaty RE, 2015, SCI REP-UK, V5, DOI 10.1038/srep10964; Beaty RE, 2014, NEUROPSYCHOLOGIA, V64, P92, DOI 10.1016/j.neuropsychologia.2014.09.019; Bellec P, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00007; Benedek M, 2014, NEUROIMAGE, V88, P125, DOI 10.1016/j.neuroimage.2013.11.021; Benedek M, 2013, J CREATIVE BEHAV, V47, P273, DOI 10.1002/jocb.35; Bowden EM, 2007, METHODS, V42, P87, DOI 10.1016/j.ymeth.2006.11.007; Bowden EM, 2003, BEHAV RES METH INS C, V35, P634, DOI 10.3758/BF03195543; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cerruti C, 2009, J COGNITIVE NEUROSCI, V21, P1980, DOI 10.1162/jocn.2008.21143; Chavez RA, 2004, J PSYCHIATR MENT HLT, V27, P38; Chavez-Eakle RA, 2007, NEUROIMAGE, V38, P519, DOI 10.1016/j.neuroimage.2007.07.059; Chen H.C., 2014, J CHINESE CREATIVITY, V5, P51; Chen QL, 2015, NEUROPSYCHOLOGIA, V75, P441, DOI 10.1016/j.neuropsychologia.2015.07.001; Chen Y. H., 2002, WECHSLER ADULT INTEL; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Cousijn J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114619; Cranford EA, 2012, J PROBL SOLVING, V4, P128, DOI 10.7771/1932-6246.1129; Cropley A, 2006, CREATIVITY RES J, V18, P391, DOI 10.1207/s15326934crj1803_13; Cui ZX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00042; Dietrich A, 2004, PSYCHON B REV, V11, P1011, DOI 10.3758/BF03196731; Ellamil M, 2012, NEUROIMAGE, V59, P1783, DOI 10.1016/j.neuroimage.2011.08.008; Fink A, 2012, HUM BRAIN MAPP, V33, P2603, DOI 10.1002/hbm.21387; Fink A, 2010, NEUROIMAGE, V52, P1687, DOI 10.1016/j.neuroimage.2010.05.072; Fink A, 2009, HUM BRAIN MAPP, V30, P734, DOI 10.1002/hbm.20538; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gruszka A, 2002, CREATIVITY RES J, V14, P193, DOI 10.1207/S15326934CRJ1402_6; GUILFORD JP, 1957, PSYCHOL REV, V64, P110, DOI 10.1037/h0048280; Gupta N, 2012, PSYCHOL SCI, V23, P288, DOI 10.1177/0956797611429710; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Heilman KM, 2016, ARCH CLIN NEUROPSYCH, V31, P285, DOI 10.1093/arclin/acw009; Heilman KM, 2003, NEUROCASE, V9, P369, DOI 10.1076/neur.9.5.369.16553; Howard-Jones PA, 2005, COGNITIVE BRAIN RES, V25, P240, DOI 10.1016/j.cogbrainres.2005.05.013; Huang P.S., 2012, PSYCHOL TEST, V59, P581; Jen C.H., 2004, RES APPL PSYCHOL, V21, P195; Jung RE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009818; Jung-Beeman M, 2005, TRENDS COGN SCI, V9, P512, DOI 10.1016/j.tics.2005.09.009; Kleibeuker SW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00905; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; MEDNICK SA, 1968, J CREATIVE BEHAV, V2, P213, DOI 10.1002/j.2162-6057.1968.tb00104.x; MEDNICK SA, 1962, PSYCHOL REV, V69, P220, DOI 10.1037/h0048850; Ministry of Education, 1998, MAND DICT WORD FREQ; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Rossmann E, 2010, PERS INDIV DIFFER, V49, P891, DOI 10.1016/j.paid.2010.07.025; Ryman SG, 2014, NEUROIMAGE, V101, P380, DOI 10.1016/j.neuroimage.2014.07.027; Seger CA, 2000, NEUROPSYCHOLOGY, V14, P361, DOI 10.1037//0894-4105.14.3.361; Shah C, 2013, HUM BRAIN MAPP, V34, P1088, DOI 10.1002/hbm.21493; Sio UN, 2013, MEM COGNITION, V41, P159, DOI 10.3758/s13421-012-0256-7; Smith KA, 2013, COGNITION, V128, P64, DOI 10.1016/j.cognition.2013.03.001; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sternberg R.J., 1999, HDB CREAT, V1, P3; Storm BC, 2011, J EXP PSYCHOL LEARN, V37, P1287, DOI 10.1037/a0023921; Takeuchi H, 2012, CEREB CORTEX, V22, P2921, DOI 10.1093/cercor/bhr371; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Wang JH, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.2015.00386, 10.3389/fnhum.2015.00458]; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Ward J, 2008, BRIT J PSYCHOL, V99, P127, DOI 10.1348/000712607X204164; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wei DT, 2014, CORTEX, V51, P92, DOI 10.1016/j.cortex.2013.09.004; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhao Q, 2014, NEUROSCIENCE, V256, P334, DOI 10.1016/j.neuroscience.2013.10.019; Zhong CB, 2008, PSYCHOL SCI, V19, P912, DOI 10.1111/j.1467-9280.2008.02176.x	73	22	22	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0165053	10.1371/journal.pone.0165053	http://dx.doi.org/10.1371/journal.pone.0165053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760177	gold, Green Published			2022-12-26	WOS:000386204000080
J	Zanatta, RF; Esper, MALR; Valera, MC; Melo, RM; Bresciani, E				Zanatta, Rayssa Ferreira; Lacerda Rangel Esper, Maria Angela; Valera, Marcia Carneiro; Melo, Renata Marques; Bresciani, Eduardo			Harmful Effect of Beer on Bovine Enamel Microhardness - In Vitro Study	PLOS ONE			English	Article							ACIDIC BEVERAGES; DENTAL EROSION; TOOTH EROSION; PH; WEAR	This study aimed to evaluate the effect of beers on the bovine enamel microhardness. Fifty rectangular (1 x 3 x 1 mm - height x width x thickness) enamel specimens were obtained from permanent bovine incisors, and divided into five groups (n = 10) according to the treatment employed: Saliva, Coke, Brahma, Heineken, and Budweiser. Microhardness (Knoop) were obtained before; after 5, 30 and 60 min of immersion in each solution. The data were analyzed using repeated two-way ANOVA and Tukey's test (p<0.05). Coke decreased the microhardness in all immersion times, and Heineken, showed low values after 60 minutes. Beers tested have low potential to cause enamel erosion when compared to Coke.	[Zanatta, Rayssa Ferreira; Lacerda Rangel Esper, Maria Angela; Valera, Marcia Carneiro; Bresciani, Eduardo] Sao Paulo State Univ UNESP, Inst Sci & Technol, Dept Restorat Dent, Sao Paulo, Brazil; [Melo, Renata Marques] Sao Paulo State Univ UNESP, Inst Sci & Technol, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Zanatta, RF (corresponding author), Sao Paulo State Univ UNESP, Inst Sci & Technol, Dept Restorat Dent, Sao Paulo, Brazil.	zanatta.rayssa@gmail.com	Valera, Marcia Carneiro/ABC-3534-2020; Melo, R./ADG-1186-2022; Bresciani, Eduardo/GQH-0238-2022; Melo, Renata M/A-1818-2013; Zanatta, Rayssa F/C-6095-2013; Bresciani, Eduardo/C-9461-2012	Valera, Marcia Carneiro/0000-0001-7398-6438; Melo, R./0000-0003-0752-6294; Melo, Renata M/0000-0003-0752-6294; Zanatta, Rayssa F/0000-0001-5230-1508; Bresciani, Eduardo/0000-0001-9299-8792; LACERDA RANGEL ESPER, MARIA ANGELA/0000-0001-5218-9173				Attin T, 2014, MONOGR ORAL SCI, V25, P123, DOI 10.1159/000360355; Caneppele Taciana Marco Ferraz, 2012, Braz. Dent. J., V23, P373, DOI 10.1590/S0103-64402012000400011; COOTE N, 1976, J I BREWING, V82, P149, DOI 10.1002/j.2050-0416.1976.tb03739.x; D'Amore MM, 2011, J SUBST ABUSE TREAT, V41, P179, DOI 10.1016/j.jsat.2011.02.005; Ehlen LA, 2008, NUTR RES, V28, P299, DOI 10.1016/j.nutres.2008.03.001; Ganss C, 2006, MG ORAL SCI, V20, P9, DOI 10.1159/000093344; Hamamoto DT, 2009, ORAL DIS, V15, P27, DOI 10.1111/j.1601-0825.2008.01459.x; Hannig C, 2009, ARCH ORAL BIOL, V54, P518, DOI 10.1016/j.archoralbio.2009.02.009; Holbrook WP, 2009, J DENT RES, V88, P422, DOI 10.1177/0022034509336530; Jager DHJ, 2008, CARIES RES, V42, P98, DOI 10.1159/000116118; Jensdottir T, 2004, Clin Oral Investig, V8, P91; Johansson AK, 2004, EUR J ORAL SCI, V112, P484, DOI 10.1111/j.1600-0722.2004.00172.x; Kaneda H, 1997, J I BREWING, V103, P21, DOI 10.1002/j.2050-0416.1997.tb00932.x; Laurance-Young P, 2011, J DENT, V39, P266, DOI 10.1016/j.jdent.2011.01.008; Lissera R G, 1998, Acta Odontol Latinoam, V11, P55; Lussi A, 2006, MG ORAL SCI, V20, P1, DOI 10.1159/000093343; Lussi A, 2006, MG ORAL SCI, V20, P77, DOI 10.1159/000093353; Lussi A, 2014, MONOGR ORAL SCI, V25, P1, DOI 10.1159/000360380; Mardegan SF, 2013, J FOOD COMPOSITION A, V29; Moazzez R, 2014, MONOGR ORAL SCI, V25, P180, DOI 10.1159/000360369; Nogueira FN, 2000, J DENT, V28, P271, DOI 10.1016/S0300-5712(99)00072-X; RYTOMAA I, 1988, SCAND J DENT RES, V96, P324; Schlueter N, 2012, Adv Dent Res, V24, P68, DOI 10.1177/0022034512449836; SMITH BGN, 1989, J DENT, V17, P219, DOI 10.1016/0300-5712(89)90168-1	24	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0163440	10.1371/journal.pone.0163440	http://dx.doi.org/10.1371/journal.pone.0163440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760132	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000012
J	Huang, JJ; Li, KJ; Gribskov, M				Huang, Jiajie; Li, Kejie; Gribskov, Michael			Accurate Classification of RNA Structures Using Topological Fingerprints	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; DYNAMIC-PROGRAMMING ALGORITHM; PROTEIN DATA-BANK; INCLUDING PSEUDOKNOTS; NONCODING RNAS; ABSTRACT SHAPES; RIBONUCLEASE-P; RIBOSOMAL-RNA; SEQUENCE; GRAPHS	While RNAs are well known to possess complex structures, functionally similar RNAs often have little sequence similarity. While the exact size and spacing of base-paired regions vary, functionally similar RNAs have pronounced similarity in the arrangement, or topology, of base-paired stems. Furthermore, predicted RNA structures often lack pseudoknots (a crucial aspect of biological activity), and are only partially correct, or incomplete. A topological approach addresses all of these difficulties. In this work we describe each RNA structure as a graph that can be converted to a topological spectrum (RNA fingerprint). The set of subgraphs in an RNA structure, its RNA fingerprint, can be compared with the fingerprints of other RNA structures to identify and correctly classify functionally related RNAs. Topologically similar RNAs can be identified even when a large fraction, up to 30%, of the stems are omitted, indicating that highly accurate structures are not necessary. We investigate the performance of the RNA fingerprint approach on a set of eight highly curated RNA families, with diverse sizes and functions, containing pseudoknots, and with little sequence similarity-an especially difficult test set. In spite of the difficult test set, the RNA fingerprint approach is very successful (ROC AUC > 0.95). Due to the inclusion of pseudoknots, the RNA fingerprint approach both covers a wider range of possible structures than methods based only on secondary structure, and its tolerance for incomplete structures suggests that it can be applied even to predicted structures.	[Huang, Jiajie; Li, Kejie; Gribskov, Michael] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Huang, Jiajie] Thermo Fisher Sci, Life Sci Solut Grp, San Francisco, CA USA; [Li, Kejie] Biogen Idec Inc, Computat Biol Dept, Cambridge, MA USA; [Gribskov, Michael] Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Thermo Fisher Scientific; Biogen; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Gribskov, M (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	gribskov@purdue.edu	Gribskov, Michael/AAH-5905-2021; Huang, Jiajie/N-5114-2018	Huang, Jiajie/0000-0001-7458-0990; Gribskov, Michael/0000-0002-1718-0242	U.S. National Science Foundation [DBI-0850148]	U.S. National Science Foundation(National Science Foundation (NSF))	This work was supported by The U.S. National Science Foundation [DBI-0850148] (http://www.nsf.gov/). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The first author, Jiajie Huang, is currently employed by Thermo Fisher Scientific. The second author, Kejie Li, is currently employed by Biogen Idec. These commercial affiliations provided support in the form of salaries for these two authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Amit S., 2001, IEEE DATA ENG B, V24, P35; Andronescu M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-340; Avihoo A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-319; Barash D, 2004, J COMPUT BIOL, V11, P1169, DOI 10.1089/cmb.2004.11.1169; Barash D, 2004, BIOINFORMATICS, V20, P1861, DOI 10.1093/bioinformatics/bth157; Barash D, 2003, LECT NOTES COMPUT SC, V2695, P683; Barrandon C, 2008, BIOL CELL, V100, P83, DOI 10.1042/BC20070090; Bellaousov S, 2010, RNA, V16, P1870, DOI 10.1261/rna.2125310; Benedetti G, 1996, BIOPHYS CHEM, V59, P179, DOI 10.1016/0301-4622(95)00119-0; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beyer W, 2010, RNA SECONDARY STRUCT; Bindewald E, 2011, ACS NANO, V5, P9542, DOI 10.1021/nn202666w; Chen SH, 2014, J COMB OPTIM, V27, P778, DOI 10.1007/s10878-012-9552-1; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Churkin A, 2012, COMPUT BIOL CHEM, V41, P35, DOI 10.1016/j.compbiolchem.2012.10.004; Churkin A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-222; Costa F, 2010, PROCEEDINGS OF THE 2; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Egli M, 2003, HELV CHIM ACTA, V86, P1709, DOI 10.1002/hlca.200390142; Ellis JC, 2009, RNA BIOL, V6, P362, DOI 10.4161/rna.6.4.9241; Fan WF, 2010, PROC VLDB ENDOW, V3, P264, DOI 10.14778/1920841.1920878; Fera D, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-88; FONTANA W, 1993, BIOPOLYMERS, V33, P1389, DOI 10.1002/bip.360330909; Gan HH, 2004, BIOINFORMATICS, V20, P1285, DOI 10.1093/bioinformatics/bth084; Gan HH, 2003, NUCLEIC ACIDS RES, V31, P2926, DOI 10.1093/nar/gkg365; Garey M. R., 1979, COMPUTERS AND INTRAC; Giegerich R, 2004, NUCLEIC ACIDS RES, V32, P4843, DOI 10.1093/nar/gkh779; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Gupta A, 2012, RNA BIOL, V9, DOI [10.4161/rna.18386, 10.4161/rna.9.2.18386]; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Hedberg A, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-17; Heyne S, 2012, BIOINFORMATICS, V28, pI224, DOI 10.1093/bioinformatics/bts224; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Izzo JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-219; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Janssen S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-131; Jiang MH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-192; Johnsson P, 2014, BBA-GEN SUBJECTS, V1840, P1063, DOI 10.1016/j.bbagen.2013.10.035; Karklin Y, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P4; Kin Taishin, 2002, Genome Inform, V13, P112; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Laing C, 2011, CURR OPIN STRUC BIOL, V21, P306, DOI 10.1016/j.sbi.2011.03.015; Lehmann K, 2003, CRIT REV BIOCHEM MOL, V38, P249, DOI 10.1080/713609236; Li KJ, 2008, LECT N BIOINFORMAT, V4983, P317; Liu Q, 2008, J BIOMOL STRUCT DYN, V25, P685, DOI 10.1080/07391102.2008.10507214; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu ZJ, 2009, RNA, V15, P1805, DOI 10.1261/rna.1643609; MARGALIT H, 1989, NUCLEIC ACIDS RES, V17, P4829, DOI 10.1093/nar/17.12.4829; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Novikova IV, 2012, NUCLEIC ACIDS RES, V40, P5034, DOI 10.1093/nar/gks071; PACE NR, 1995, J BACTERIOL, V177, P1919, DOI 10.1128/jb.177.8.1919-1928.1995; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Petrov AS, 2013, NUCLEIC ACIDS RES, V41, P7522, DOI 10.1093/nar/gkt513; POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x; Reeder J, 2007, NUCLEIC ACIDS RES, V35, pW320, DOI 10.1093/nar/gkm258; Ren JH, 2005, RNA, V11, P1494, DOI 10.1261/rna.7284905; Rivas E, 1999, J MOL BIOL, V285, P2053, DOI 10.1006/jmbi.1998.2436; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Saito Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S48; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakakibara Yasubumi, 2007, J Bioinform Comput Biol, V5, P1103, DOI 10.1142/S0219720007003028; Sato K, 2011, BIOINFORMATICS, V27, pI85, DOI 10.1093/bioinformatics/btr215; Schattner P, 2002, NUCLEIC ACIDS RES, V30, P2076, DOI 10.1093/nar/30.9.2076; Seetin MG, 2012, METHOD MOL BIOL, P905; SHAPIRO BA, 1990, COMPUT APPL BIOSCI, V6, P309; SHAPIRO BA, 1988, COMPUT APPL BIOSCI, V4, P387; Shu WJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-188; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sorensen T., 1948, A METHOD OF ESTABLIS, P1; Staple DW, 2005, PLOS BIOL, V3, P956, DOI 10.1371/journal.pbio.0030213; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Waldispuhl J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000124; Waterman M.S., 1978, ADV MATH SUPPLEMENTA, V1, P167; Yan XF, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P721, DOI 10.1109/ICDM.2002.1184038; Zhang BY, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-S1-S3	82	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164726	10.1371/journal.pone.0164726	http://dx.doi.org/10.1371/journal.pone.0164726			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755571	Green Submitted, Green Published, gold			2022-12-26	WOS:000386203800030
J	van Andel, H; Kocemba, KA; de Haan-Kramer, A; Mellink, CH; Piwowar, M; Broijl, A; van Duin, M; Sonneveld, P; Maurice, MM; Kersten, MJ; Spaargaren, M; Pals, ST				van Andel, H.; Kocemba, K. A.; de Haan-Kramer, A.; Mellink, C. H.; Piwowar, M.; Broijl, A.; van Duin, M.; Sonneveld, P.; Maurice, M. M.; Kersten, M. J.; Spaargaren, M.; Pals, S. T.			Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease	ONCOGENE			English	Article							TUMOR-SUPPRESSOR CYLD; EPIGENETIC DYSREGULATION; PATHWAY; ENZYME; PROLIFERATION; PATHOGENESIS; ACTIVATION; MUTATIONS; RECEPTORS; APOPTOSIS	Deletion or mutation of the gene encoding the deubiquitinating enzyme CYLD is a common genomic aberration in multiple myeloma (MM). However, the functional consequence of CYLD loss and the mechanism underlying its putative role as a tumor suppressor gene in the pathogenesis of MM has not been established. Here, we show that CYLD expression is highly variable in myeloma cell lines and primary MMs and that low CYLD expression is associated with disease progression from monoclonal gammopathy of undetermined significance to MM, and with poor overall and progression free-survival of MM patients. Functional assays revealed that CYLD represses MM cell proliferation and survival. Furthermore, CYLD acts as a negative regulator of NF-kappa B and Wnt/beta-catenin signaling and loss of CYLD sensitizes MM cells to NF-kappa B-stimuli and Wnt ligands. Interestingly, in primary MMs, low CYLD expression strongly correlated with a proliferative and Wnt signaling-gene expression signature, but not with an NF kappa B target gene signature. Altogether, our findings identify CYLD as a negative regulator of NF-kappa B and Wnt/beta-catenin signaling in MM and indicate that loss of CYLD enhances MM aggressiveness through Wnt pathway activation. Thus, targeting the Wnt pathway could be a promising therapeutic strategy in MM with loss of CYLD activity.	[van Andel, H.; Kocemba, K. A.; de Haan-Kramer, A.; Spaargaren, M.; Pals, S. T.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [van Andel, H.; Kocemba, K. A.; de Haan-Kramer, A.; Kersten, M. J.; Spaargaren, M.; Pals, S. T.] Univ Amsterdam, Acad Med Ctr, Lymphoma & Myeloma Ctr Amsterdam LYMMCARE, Amsterdam, Netherlands; [Kocemba, K. A.] Jagiellonian Univ, Dept Med Biochem, Med Coll, Krakow, Poland; [Mellink, C. H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Piwowar, M.] Jagiellonian Univ, Dept Bioinformat & Telemed, Med Coll, Krakow, Poland; [Broijl, A.; van Duin, M.; Sonneveld, P.] Erasmus MC, Dept Hematol, Rotterdam, Netherlands; [Maurice, M. M.] Univ MC Utrecht, Dept Cell Biol, Utrecht, Netherlands; [Kersten, M. J.] Univ Amsterdam, Acad Med Ctr, Dept Hematol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Jagiellonian University; Collegium Medicum Jagiellonian University; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Pals, ST (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.t.pals@amc.uva.nl	kocemba, kinga/AAE-2305-2019; Spaargaren, Marcel/AAU-1298-2021; Kocemba, Kinga/AAE-6520-2021; Piwowar, Monika Weronika/L-5452-2013	kocemba, kinga/0000-0002-7119-2412; Spaargaren, Marcel/0000-0002-3135-5109; Piwowar, Monika Weronika/0000-0003-4645-8730; Pals, Steven/0000-0002-1419-0939; Maurice, Madelon/0000-0001-6885-5361	Dutch Cancer Society; EU-FP7 OVER-MYR	Dutch Cancer Society(KWF Kankerbestrijding); EU-FP7 OVER-MYR	This study was supported by grants from the Dutch Cancer Society and EU-FP7 OVER-MYR.	An CH, 2010, PATHOLOGY, V42, P583, DOI 10.3109/00313025.2010.508735; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chim CS, 2007, LEUKEMIA, V21, P2527, DOI 10.1038/sj.leu.2404939; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Derksen PWB, 2004, P NATL ACAD SCI USA, V101, P6122, DOI 10.1073/pnas.0305855101; Dutta-Simmons J, 2009, BLOOD, V114, P2699, DOI 10.1182/blood-2008-12-194290; Espinosa L, 2010, CANCER CELL, V18, P268, DOI 10.1016/j.ccr.2010.08.006; Hellerbrand C, 2007, CARCINOGENESIS, V28, P21, DOI 10.1093/carcin/bgl081; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Jenner MW, 2007, BLOOD, V110, P3291, DOI 10.1182/blood-2007-02-075069; Jost E, 2009, CANCER LETT, V281, P24, DOI 10.1016/j.canlet.2009.02.002; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kocemba KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030359; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kuehl WM, 2012, J CLIN INVEST, V122, P3456, DOI 10.1172/JCI61188; Kumar S, 2012, BLOOD, V119, P2100, DOI 10.1182/blood-2011-11-390658; Lawasut P, 2013, SEMIN ONCOL, V40, P537, DOI 10.1053/j.seminoncol.2013.07.010; Lim JH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1776; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Massoumi R, 2011, FUTURE ONCOL, V7, P285, DOI 10.2217/FON.10.187; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Mulligan G, 2007, BLOOD, V109, P3177, DOI 10.1182/blood-2006-09-044974; Rajan N, 2014, ONCOTARGET, V5, P12126, DOI 10.18632/oncotarget.2573; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Smith EM, 2015, ONCOTARGET, V6, P17314, DOI 10.18632/oncotarget.1168; Sonneveld P, 2012, J CLIN ONCOL, V30, P2946, DOI 10.1200/JCO.2011.39.6820; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Takada K, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003808; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; Walker BA, 2015, J CLIN ONCOL, V33, P3911, DOI 10.1200/JCO.2014.59.1503; Winterhalter C, 2014, BIOINFORMATICS, V30, P1029, DOI 10.1093/bioinformatics/btt732; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	42	31	32	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 13	2017	36	15					2105	2115		10.1038/onc.2016.368	http://dx.doi.org/10.1038/onc.2016.368			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DK	27775078				2022-12-26	WOS:000399782500007
J	Naninck, EFG; Oosterink, JE; Yam, KY; de Vries, LP; Schierbeek, H; van Goudoever, JB; Verkaik-Schakel, RN; Plantinga, JA; Plosch, T; Lucassen, PJ; Korosi, A				Naninck, Eva F. G.; Oosterink, J. Efraim; Yam, Kit-Yi; de Vries, Lennart P.; Schierbeek, Henk; van Goudoever, Johannes B.; Verkaik-Schakel, Rikst-Nynke; Plantinga, Josee A.; Plosch, Torsten; Lucassen, Paul J.; Korosi, Aniko			Early micronutrient supplementation protects against early stress-induced cognitive impairments	FASEB JOURNAL			English	Article						1-carbon metabolism; HPA-axis; hippocampus; limited nesting material; cognition	EARLY-LIFE STRESS; DNA METHYLATION; ADULT NEUROGENESIS; MATERNAL-CARE; HOMOCYSTEINE METABOLISM; INHIBITS PROLIFERATION; EMERGING ROLES; DENTATE GYRUS; FOLATE; METHIONINE	Early-life stress (ES) impairs cognition later in life. Because ES prevention is problematic, intervention is needed, yet the mechanisms that underlie ES remain largely unknown. So far, the role of early nutrition in brain programming has been largely ignored. Here, we demonstrate that essential 1-carbon metabolism-associated micronutrients (1-CMAMs; i.e., methionine and B vitamins) early in life are crucial in programming later cognition by ES. ES was induced in male C57Bl/6 mice from postnatal d (P) 2-9. 1-CMAM levels were measured centrally and peripherally by using liquid chromatography-mass spectroscopy. Next, we supplemented the maternal diet with 1-CMAM only during the ES period and studied cognitive, neuroendocrine, neurogenic, transcriptional, and epigenetic changes in adult offspring. We demonstrate that ES specifically reduces methionine in offspring plasma and brain. Of note, dietary 1-CMAM enrichment during P2-9 restored methionine levels and rescued ES-induced adult cognitive impairments. Beneficial effects of this early dietary enrichment were associated with prevention of the ES-induced rise in corticosterone and adrenal gland hypertrophy did not involve changes in maternal care, hippocampal volume, neurogenesis, or global/Nr3c1-specific DNA methylation. In summary, nutrition is important in brain programming by ES. A short, early supplementation with essential micronutrients can already prevent lasting effects of ES. This concept opens new avenues for nutritional intervention.-Naninck, E. F. G., Oosterink, J. E., Yam, K.-Y., deVries, L. P., Schierbeek, H., vanGoudoever, J. B., Verkaik-Schakel, R.-N., Plantinga, J. A., Plosch, T., Lucassen, P. J., Korosi, A. Early micronutrient supplementation protects against early stress-induced cognitive impairments.	[Naninck, Eva F. G.; Yam, Kit-Yi; de Vries, Lennart P.; Lucassen, Paul J.; Korosi, Aniko] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Oosterink, J. Efraim; Schierbeek, Henk; van Goudoever, Johannes B.] Emma Childrens Hosp, Acad Med Ctr, Dept Mother & Child, Amsterdam, Netherlands; [Verkaik-Schakel, Rikst-Nynke; Plantinga, Josee A.; Plosch, Torsten] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands	University of Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen	Korosi, A (corresponding author), Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Brain Plast Grp, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	a.korosi@uva.nl	Lucassen, Paul/ABA-3113-2020; van Goudoever, Johannes Bernard/Y-4520-2018; Plösch, Torsten/X-6808-2019	Lucassen, Paul/0000-0001-9708-9133; Plösch, Torsten/0000-0002-9305-4045; Yam, Kit-Yi/0000-0002-9181-5605; van Goudoever, Johannes (Hans)/0000-0003-3960-1703; Korosi, Aniko/0000-0001-9701-3331	Netherlands Organization for Scientific Research (NWO; Meervoud; Food, Cognition and Brain); HersenStichting, Internationale Stichting Alzheimer Onderzoek (ISAO); Alzheimer Nederland; ZonMW TOP grant	Netherlands Organization for Scientific Research (NWO; Meervoud; Food, Cognition and Brain); HersenStichting, Internationale Stichting Alzheimer Onderzoek (ISAO); Alzheimer Nederland; ZonMW TOP grant	A.K. is supported by grants from the Netherlands Organization for Scientific Research (NWO; Meervoud; Food, Cognition and Brain). P.J.L. is supported by HersenStichting, Internationale Stichting Alzheimer Onderzoek (ISAO), and Alzheimer Nederland. T.P. is supported by a ZonMW TOP grant.	Allen LH, 2005, AM J CLIN NUTR, V81, p1206S; Amarger V, 2014, NUTRIENTS, V6, P4200, DOI 10.3390/nu6104200; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; Benton D, 2010, MOL NUTR FOOD RES, V54, P457, DOI 10.1002/mnfr.200900158; Bjelland I, 2003, ARCH GEN PSYCHIAT, V60, P618, DOI 10.1001/archpsyc.60.6.618; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; Bockmuhl Y, 2015, EPIGENETICS-US, V10, P247, DOI 10.1080/15592294.2015.1017199; Boku S, 2015, BIOL PSYCHIAT, V77, P335, DOI 10.1016/j.biopsych.2014.07.008; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Cao XJ, 2008, EUR J PHARMACOL, V595, P30, DOI 10.1016/j.ejphar.2008.07.061; Cattaneo A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00040; Chehadeh SE, 2014, BRIT J NUTR, V111, P1021, DOI 10.1017/S0007114513003553; Craciunescu CN, 2004, J NUTR, V134, P162, DOI 10.1093/jn/134.1.162; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; de Oliveira AC, 2004, PHARMACOL BIOCHEM BE, V77, P269, DOI 10.1016/j.pbb.2003.11.003; de Souza FG, 2006, PHARMACOL BIOCHEM BE, V85, P400, DOI 10.1016/j.pbb.2006.09.008; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Fan GQ, 2010, TOXICOLOGY, V272, P23, DOI 10.1016/j.tox.2010.03.018; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Feldman R, 2010, DEVELOPMENTAL SCI, V13, P271, DOI 10.1111/j.1467-7687.2009.00890.x; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Freitag N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.353; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; Gunanti IR, 2014, J NUTR, V144, P2027, DOI 10.3945/jn.114.201202; Hanson JL, 2015, BIOL PSYCHIAT, V77, P314, DOI 10.1016/j.biopsych.2014.04.020; Herpfer I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046004; Hoeijmakers L, 2015, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00103; Hu P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046224; Ishii D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105750; Ivy AS, 2010, J NEUROSCI, V30, P13005, DOI 10.1523/JNEUROSCI.1784-10.2010; Kohl C, 2015, PSYCHONEUROENDOCRINO, V55, P128, DOI 10.1016/j.psyneuen.2015.02.016; Korosi A, 2012, BEHAV BRAIN RES, V227, P400, DOI 10.1016/j.bbr.2011.07.037; KOZAK M, 1983, MICROBIOL REV, V47, P1; Kruman II, 2005, NEUROREPORT, V16, P1055, DOI 10.1097/00001756-200507130-00005; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Lok A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.60; Lucassen PJ, 2013, TRENDS NEUROSCI, V36, P621, DOI 10.1016/j.tins.2013.08.002; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; McClelland S, 2011, NEUROBIOL LEARN MEM, V96, P79, DOI 10.1016/j.nlm.2011.02.008; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Mitchell LE, 2005, AM J MED GENET C, V135C, P88, DOI 10.1002/ajmg.c.30057; Molet J, 2014, DEV PSYCHOBIOL, V56, P1675, DOI 10.1002/dev.21230; Morris MJ, 2014, DIALOGUES CLIN NEURO, V16, P359; Mulligan CJ, 2012, EPIGENETICS-US, V7, P853, DOI 10.4161/epi.21180; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Murgatroyd CA, 2015, BEHAV PHARMACOL, V26, P642, DOI 10.1097/FBP.0000000000000147; Naninck E. F. G., 2013, OXFORD HDB MOL PSYCH, P311; Naninck EFG, 2015, HIPPOCAMPUS, V25, P309, DOI 10.1002/hipo.22374; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Nijhout HF, 2006, EPIGENETICS-US, V1, P81, DOI 10.4161/epi.1.2.2677; Oomen CA, 2011, PSYCHOPHARMACOLOGY, V214, P249, DOI 10.1007/s00213-010-1922-8; Oosterink JE, 2015, J CHROMATOGR B, V998, P106, DOI 10.1016/j.jchromb.2015.07.008; Parrish RR, 2015, ANN CLIN TRANSL NEUR, V2, P401, DOI 10.1002/acn3.183; Pena CJ, 2014, J MOL BIOL, V426, P3389, DOI 10.1016/j.jmb.2014.03.016; Pesonen AK, 2013, NEUROBIOL AGING, V34, P1674, DOI 10.1016/j.neurobiolaging.2012.12.012; Rabaneda LG, 2008, FASEB J, V22, P3823, DOI 10.1096/fj.08-109306; Ramaekers VT, 2004, DEV MED CHILD NEUROL, V46, P843, DOI 10.1017/S0012162204001471; Rice CJ, 2008, ENDOCRINOLOGY, V149, P4892, DOI 10.1210/en.2008-0633; Romens SE, 2015, CHILD DEV, V86, P303, DOI 10.1111/cdev.12270; Sarabdjitsingh RA, 2014, NEUROPHARMACOLOGY, V81, P231, DOI 10.1016/j.neuropharm.2014.01.042; Spencer SJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00109; Stoney CM, 2000, LIFE SCI, V66, P2267, DOI 10.1016/S0024-3205(00)00556-7; Struber N, 2014, NEUROSCI BIOBEHAV R, V38, P17, DOI 10.1016/j.neubiorev.2013.10.015; Sugden C, 2006, NUTR RES REV, V19, P117, DOI 10.1079/NRR2006119; Suri D, 2013, BIOL PSYCHIAT, V73, P658, DOI 10.1016/j.biopsych.2012.10.023; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Tian WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033435; Tomizawa H, 2015, GENES BRAIN BEHAV, V14, P301, DOI 10.1111/gbb.12207; Troen AM, 2008, J NUTR, V138, P2502, DOI 10.3945/jn.108.093641; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; van Oers HJJ, 1998, J NEUROSCI, V18, P10171; Wang XD, 2011, J NEUROSCI, V31, P13625, DOI 10.1523/JNEUROSCI.2259-11.2011; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Wright KN, 2015, J NEUROSCI, V35, P8948, DOI 10.1523/JNEUROSCI.5227-14.2015; Zhang Y, 2013, NEUROPSYCHOPHARMACOL, V38, P111, DOI 10.1038/npp.2012.149	78	33	34	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					505	518		10.1096/fj.201600834R	http://dx.doi.org/10.1096/fj.201600834R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27770020	Green Published			2022-12-26	WOS:000394235400007
J	Dong, L; Yuan, C; Orlando, BJ; Malkowski, MG; Smith, WL				Dong, Liang; Yuan, Chong; Orlando, Benjamin J.; Malkowski, Michael G.; Smith, William L.			Fatty Acid Binding to the Allosteric Subunit of Cyclooxygenase-2 Relieves a Tonic Inhibition of the Catalytic Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arachidonic acid (AA) (ARA); cyclooxygenase (COX); eicosanoid; fatty acid; prostaglandin; eicosapentaenoic acid; half-site; naproxen; oleic acid; palmitic acid	ENDOPEROXIDE-H SYNTHASE-1; ENDOCANNABINOID OXYGENATION; ARACHIDONIC-ACID; STRUCTURAL BASIS; SELECTIVE-INHIBITION; CRYSTAL-STRUCTURE; ARGININE 120; ACTIVE-SITE; CROSS-TALK; PROSTAGLANDIN	Prostaglandin endoperoxide H synthase-2 (PGHS-2), also called cyclooxygenase-2 (COX-2), converts arachidonic acid to PGH(2). PGHS-2 is a conformational heterodimer composed of allosteric (E-allo) and catalytic (E-cat) subunits. Fatty acids (FAs) bind to Arg-120 of E-allo increasing to different degrees, depending on the FA, the V-max of its E-cat partner. We report here that movement of helical residues 120-122 and loop residues 123-129 of E-allo underlies the allosteric effects of FAs and allosteric COX-2 inhibitors, including naproxen and flurbiprofen. An S121P substitution in both PGHS-2 monomers yields a variant (S121P/S121P PGHS-2) that has 1.7-1.8 times the V-max of native PGHS-2 and is relatively insensitive to activation by FAs or inhibition by allosteric inhibitors. The S121P substitution in E-allo is primarily responsible for these effects. In X-ray crystal structures, the C atoms of helical residues 119-122 of S121P/S121P PGHS-2 are displaced from their normal positions. Additionally, the S121P/S121P PGHS-2 variants in which Pro-127 and Ser-541 are replaced by cysteines spontaneously forms Cys-127 to Cys-541 cross-links between monomers. This is unlike the corresponding native PGHS-2 variant and suggests that S121P substitutions also unhinge the loop involving residues 123-129. We conclude the following: (a) the region involving residues 120-129 of unoccupied E-allo tonically inhibits E-cat; (b) binding of an activating FA (e.g. arachidonic, palmitic, or oleic acid) to E-allo or an S121P substitution in E-allo repositions this region to increase E-cat activity; and (c) allosteric COX inhibitors act by preventing FA binding to E-allo and additionally by relocating E-allo residues to inhibit E-cat.	[Dong, Liang; Yuan, Chong; Smith, William L.] Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA; [Orlando, Benjamin J.; Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA; [Orlando, Benjamin J.; Malkowski, Michael G.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA	University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Hauptman Woodward Medical Research Institute	Malkowski, MG; Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	malkowski@hwi.buffalo.edu; smithww@umich.edu		Malkowski, Michael/0000-0002-1203-7463	National Institutes of Health from NIGMS [GM077176, GM115386, GM68848]; NCI [CA130810]; NHLBI [HL117798]; NATIONAL CANCER INSTITUTE [P50CA130810] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068848, R01GM077176, R01GM115386] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM077176 (to M. G. M,), GM115386 (to M. G. M.), and GM68848 (to W. L. S.) from NIGMS, Grant CA130810 (to W. L. S.) from NCI, and Grant HL117798 (to W. L. S.) from NHLBI. William L. Smith has served as a consultant for Cayman Chemical Company, products from which were used in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Blobaum AL, 2015, J BIOL CHEM, V290, P12793, DOI 10.1074/jbc.M114.635987; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dong L, 2016, J LIPID RES, V57, P1043, DOI 10.1194/jlr.M067512; Dong L, 2016, J BIOL CHEM, V291, P4069, DOI 10.1074/jbc.M115.698001; Dong L, 2013, J BIOL CHEM, V288, P28641, DOI 10.1074/jbc.M113.505503; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans EJ, 2006, J BIOL CHEM, V281, P29309, DOI 10.1074/jbc.M601314200; Garavito RM, 2002, PROSTAG OTH LIPID M, V68-9, P129; Greig GM, 1997, MOL PHARMACOL, V52, P829, DOI 10.1124/mol.52.5.829; Jiang Y, 2014, CANCER PREV RES, V7, P1011, DOI 10.1158/1940-6207.CAPR-14-0134; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kudalkar SN, 2015, J BIOL CHEM, V290, P7897, DOI 10.1074/jbc.M114.634014; KULMACZ RJ, 1984, J BIOL CHEM, V259, P6358; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Liu JY, 2007, J BIOL CHEM, V282, P18233, DOI 10.1074/jbc.M701235200; Liu Y, 2016, J BIOL CHEM, V291, P948, DOI 10.1074/jbc.M115.668038; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Malkowski MG, 2000, ARCH BIOCHEM BIOPHYS, V380, P39, DOI 10.1006/abbi.2000.1906; MANCINI JA, 1995, J BIOL CHEM, V270, P29372, DOI 10.1074/jbc.270.49.29372; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Orlando BJ, 2016, J BIOL CHEM, V291, P15069, DOI 10.1074/jbc.M116.725713; Orlando BJ, 2015, J STRUCT BIOL, V189, P62, DOI 10.1016/j.jsb.2014.11.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Rieke CJ, 1999, J BIOL CHEM, V274, P17109, DOI 10.1074/jbc.274.24.17109; Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106; Sharma NP, 2010, MOL PHARMACOL, V77, P979, DOI 10.1124/mol.109.063115; Sidhu RS, 2010, BIOCHEMISTRY-US, V49, P7069, DOI 10.1021/bi1003298; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spencer AG, 1999, J BIOL CHEM, V274, P32936, DOI 10.1074/jbc.274.46.32936; Thuresson ED, 2001, J BIOL CHEM, V276, P10358, DOI 10.1074/jbc.M009378200; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; Vecchio AJ, 2012, J BIOL CHEM, V287, P24619, DOI 10.1074/jbc.M112.372243; Vecchio AJ, 2011, J STRUCT BIOL, V176, P254, DOI 10.1016/j.jsb.2011.07.019; Vecchio AJ, 2011, J BIOL CHEM, V286, P20736, DOI 10.1074/jbc.M111.230367; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wang JL, 2010, BIOORG MED CHEM LETT, V20, P7159, DOI 10.1016/j.bmcl.2010.07.054; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200; Zou HC, 2012, J LIPID RES, V53, P1336, DOI 10.1194/jlr.M026856	57	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25641	25655		10.1074/jbc.M116.757310	http://dx.doi.org/10.1074/jbc.M116.757310			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27756840	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000390095300030
J	Dudakovic, A; Camilleri, ET; Riester, SM; Paradise, CR; Gluscevic, M; O'Toole, TM; Thaler, R; Evans, JM; Yan, H; Subramaniam, M; Hawse, JR; Stein, GS; Montecino, MA; Mcgee-Lawrence, ME; Westendorf', JJ; van Wijnen, AJ				Dudakovic, Amel; Camilleri, Emily T.; Riester, Scott M.; Paradise, Christopher R.; Gluscevic, Martina; O'Toole, Thomas M.; Thaler, Roman; Evans, Jared M.; Yan, Huihuang; Subramaniam, Malayannan; Hawse, John R.; Stein, Gary S.; Montecino, Martin A.; Mcgee-Lawrence, Meghan E.; Westendorf', Jennifer J.; van Wijnen, Andre J.			Enhancer of Zeste Homolog 2 Inhibition Stimulates Bone Formation and Mitigates Bone Loss Caused by Ovariectomy in Skeletally Mature Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; HISTONE METHYLTRANSFERASE EZH2; CHIP-SEQ DATA; MUSCLE DIFFERENTIATION; INTEGRATIVE ANALYSIS; DEVELOPMENTAL GENES; DNA-METHYLATION; TARGETING EZH2; SELF-RENEWAL; OSTEOPOROSIS	Perturbations in skeletal development and bone degeneration may result in reduced bone mass and quality, leading to greater fracture risk. Bone loss is mitigated by bone protective therapies, but there is a clinical need for new bone-anabolic agents. Previous work has demonstrated that Ezh2 (enhancer of zeste homolog 2), a histone 3 lysine 27 (H3K27) methyltransferase, suppressed differentiation of osteogenic progenitors. Here, we investigated whether inhibition of Ezh2 can be leveraged for bone stimulatory applications. Pharmacologic inhibition and siRNA knockdown of Ezh2 enhanced osteogenic commitment of MC3T3 preosteoblasts. Next generation RNA sequencing of mRNAs and real time quantitative PCR profiling established that Ezh2 inactivation promotes expression of bone-related gene regulators and extracellular matrix proteins. Mechanistically, enhanced gene expression was linked to decreased H3K27 trimethylation (H3K27me3) near transcriptional start sites in genome-wide sequencing of chromatin immunoprecipitations assays. Administration of an Ezh2 inhibitor modestly increases bone density parameters of adult mice. Furthermore, Ezh2 inhibition also alleviated bone loss in an estrogen-deficient mammalian model for osteoporosis. Ezh2 inhibition enhanced expression of Wnt10B and Pth1r and increased the BMP-dependent phosphorylation of Smad1/5. Thus, these data suggest that inhibition of Ezh2 promotes paracrine signaling in osteoblasts and has bone anabolic and osteoprotective potential in adults.	[Dudakovic, Amel; Camilleri, Emily T.; Riester, Scott M.; Paradise, Christopher R.; O'Toole, Thomas M.; Thaler, Roman; Westendorf', Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA; [Subramaniam, Malayannan; Hawse, John R.; Westendorf', Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA; [Gluscevic, Martina] Mayo Clin, Initiat Maximum Student Dev, Rochester, MN 55905 USA; [Evans, Jared M.; Yan, Huihuang] Mayo Clin, Stat & Informat, Rochester, MN 55905 USA; [Stein, Gary S.] Univ Vermont, Dept Biochem, Sch Med, Burlington, VT 05405 USA; [Montecino, Martin A.] Univ Andres Bello, Ctr Invest Biomed, Santiago 8370146, Chile; [Montecino, Martin A.] Univ Andres Bello, FONDAP Ctr Genome Regulat, Santiago 8370146, Chile; [Mcgee-Lawrence, Meghan E.] Georgia Regents Univ, Dept Cellular Biol & Anat, Augusta, GA 30912 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Vermont; Universidad Andres Bello; Universidad Andres Bello; University System of Georgia; Augusta University	van Wijnen, AJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.; van Wijnen, AJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	vanwijnen.andre@mayo.edu	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946; Dudakovic, Amel/0000-0002-8850-3977; Camilleri, Emily/0000-0001-8982-6770	National Institutes of Health [F32 AR066508, R01 AR049069, R01 AR068103, R01 DE020194]; Fondo de Financiamiento de Centros de Investigation en Areas Prioritarias [15090007]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, R01AR068103, F32AR066508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo de Financiamiento de Centros de Investigation en Areas Prioritarias; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 AR066508 (to A. D.), R01 AR049069 (to A. J. v. W.), R01 AR068103 (to J. J. W.), and R01 DE020194 (to J. J. W.), Fondo de Financiamiento de Centros de Investigation en Areas Prioritarias 15090007 (to M. A. M.), and generous philanthropic support from William H. and Karen J. Eby and the charitable foundation in their names. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Bellido T, 2013, BONE, V54, P250, DOI 10.1016/j.bone.2012.09.016; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Black DM, 2016, NEW ENGL J MED, V374, P254, DOI 10.1056/NEJMcp1513724; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Cakouros D, 2012, MOL CELL BIOL, V32, P1433, DOI 10.1128/MCB.06315-11; Canalis E, 2013, NAT REV ENDOCRINOL, V9, P575, DOI 10.1038/nrendo.2013.154; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chou RH, 2015, CELL TRANSPLANT, V24, P313, DOI 10.3727/096368915X686823; de Gorter D.J.J., 2013, PRIMER METABOLIC BON, P15, DOI DOI 10.1002/9781118453926.CH2; Dennison E, 2000, HORM RES, V54, P58, DOI 10.1159/000053299; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852; Dudakovic A, 2013, J BIOL CHEM, V288, P28783, DOI 10.1074/jbc.M113.489732; Ge K., 2012, BIOCHIM BIOPHYS ACTA, V7, P727; GLAZER RI, 1986, BIOCHEM BIOPH RES CO, V135, P688, DOI 10.1016/0006-291X(86)90048-3; Gordon JAR, 2015, BONE, V81, P739, DOI 10.1016/j.bone.2015.03.011; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Huang D, 2016, ONCOL REP, V35, P1083, DOI 10.3892/or.2015.4467; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hui TQ, 2014, J ENDODONT, V40, P1132, DOI 10.1016/j.joen.2014.01.031; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jing H, 2016, MOL THER, V24, P217, DOI 10.1038/mt.2015.152; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Marchesi I, 2014, CELL CYCLE, V13, P516, DOI 10.4161/cc.27921; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McGee-Lawrence ME, 2011, BONE, V48, P1117, DOI 10.1016/j.bone.2011.01.007; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; PECK WA, 1993, AM J MED, V94, P646; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Pike JW, 2011, J BONE MINER RES, V26, P1155, DOI 10.1002/jbmr.317; Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018; Sanchez-Duffhues G, 2015, BONE, V80, P43, DOI 10.1016/j.bone.2015.05.025; Schellenberg A, 2011, AGING-US, V3, P873, DOI 10.18632/aging.100391; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; van Wijnen AJ, 2013, CURR OSTEOPOROS REP, V11, P72, DOI 10.1007/s11914-013-0143-6; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Wu H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r52; Yan HH, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-280; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhu L, 2013, BIOCHEM BIOPH RES CO, V432, P612, DOI 10.1016/j.bbrc.2013.02.036	52	54	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24594	24606		10.1074/jbc.M116.740571	http://dx.doi.org/10.1074/jbc.M116.740571			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27758858	Green Published, hybrid			2022-12-26	WOS:000388875500021
J	Mora, H; Mora-Pascual, JM; Garcia-Garcia, A; Martinez-Gonzalez, P				Mora, Higinio; Mora-Pascual, Jeroanimo M.; Garcia-Garcia, Alberto; Martinez-Gonzalez, Pablo			Computational Analysis of Distance Operators for the Iterative Closest Point Algorithm	PLOS ONE			English	Article							REGISTRATION; ACCURATE; MODEL	The Iterative Closest Point (ICP) algorithm is currently one of the most popular methods for rigid registration so that it has become the standard in the Robotics and Computer Vision communities. Many applications take advantage of it to align 2D/3D surfaces due to its popularity and simplicity. Nevertheless, some of its phases present a high computational cost thus rendering impossible some of its applications. In this work, it is proposed an efficient approach for the matching phase of the Iterative Closest Point algorithm. This stage is the main bottleneck of that method so that any efficiency improvement has a great positive impact on the performance of the algorithm. The proposal consists in using low computational cost point-to-point distance metrics instead of classic Euclidean one. The candidates analysed are the Chebyshev and Manhattan distance metrics due to their simpler formulation. The experiments carried out have validated the performance, robustness and quality of the proposal. Different experimental cases and configurations have been set up including a heterogeneous set of 3D figures, several scenarios with partial data and random noise. The results prove that an average speed up of 14% can be obtained while preserving the convergence properties of the algorithm and the quality of the final results.	[Mora, Higinio; Mora-Pascual, Jeroanimo M.; Garcia-Garcia, Alberto; Martinez-Gonzalez, Pablo] Univ Alicante, Dept Comp Technol & Computat, Specialized Processor Architecture Lab, Alicante, Spain	Universitat d'Alacant	Mora, H (corresponding author), Univ Alicante, Dept Comp Technol & Computat, Specialized Processor Architecture Lab, Alicante, Spain.	hmora@ua.es	Mora, Higinio/L-3347-2014; García, Alberto/HDO-5321-2022	Mora, Higinio/0000-0002-8591-0710; Mora Pascual, Jeronimo/0000-0002-6831-3279; Garcia-Garcia, Alberto/0000-0002-9575-6403; Martinez Gonzalez, Pablo/0000-0001-6037-9815				Amberg Brian, 2007, CVPR '07. IEEE Conference on Computer Vision and Pattern Recognition, P1; American National Standards Institute and Institute of Electrical and Electronic Engineers, 2008, 7542008 ANSIIEEE; Armesto L, 2010, IEEE INT CONF ROBOT, P1367, DOI 10.1109/ROBOT.2010.5509371; Audette MA, 2000, MED IMAGE ANAL, V4, P201, DOI 10.1016/S1361-8415(00)00014-1; Belshaw Michael S., 2009, 2009 IEEE 12th International Conference on Computer Vision Workshops, ICCV Workshops, P1449, DOI 10.1109/ICCVW.2009.5457442; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Billings SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117688; Bispo E.M., 1996, P 6 IMA C MATH SURF, P119; CHEN Y, 1991, 1991 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-3, P2724, DOI 10.1109/ROBOT.1991.132043; Chetverikov D, 2005, IMAGE VISION COMPUT, V23, P299, DOI 10.1016/j.imavis.2004.05.007; Combes B, 2009, I S BIOMED IMAGING, P370, DOI 10.1109/ISBI.2009.5193061; Costabello L, 2014, INT J SEMANT WEB INF, V10, P45, DOI 10.4018/ijswis.2014100103; Dorai C, 1998, IEEE T PATTERN ANAL, V20, P83, DOI 10.1109/34.655652; Eggert DW, 1997, MACH VISION APPL, V9, P272, DOI 10.1007/s001380050048; Godin G, 1994, 3 DIMENSIONAL REGIST, P279; Greenspan M, 2003, FOURTH INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P442, DOI 10.1109/IM.2003.1240280; Guo H., 2016, PLOS ONE; Hansen MF, 2007, MED IMAGING; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Langis C, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P195, DOI 10.1109/IM.2001.924434; Liu YH, 2007, PATTERN RECOGN, V40, P2418, DOI 10.1016/j.patcog.2006.11.025; Markovic M, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/6/066022; Masuda T., 1996, Proceedings of the 13th International Conference on Pattern Recognition, P879, DOI 10.1109/ICPR.1996.546150; Mora H., 2017, J COMPUTATIONAL APPL, V309, P575; Mora-Mora H, 2006, REAL-TIME SYST, V34, P53, DOI 10.1007/s11241-006-8753-z; Mora-Mora H, 2010, MATH COMPUT MODEL, V52, P1243, DOI 10.1016/j.mcm.2010.02.034; Munch D, 2010, SPIE MED IMAGING; Park SY, 2003, PATTERN RECOGN LETT, V24, P2967, DOI 10.1016/S0167-8655(03)00157-0; Pomidor BJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150368; Pulli K., 1999, Second International Conference on 3-D Digital Imaging and Modeling (Cat. No.PR00062), P160, DOI 10.1109/IM.1999.805346; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Salvi J, 2007, IMAGE VISION COMPUT, V25, P578, DOI 10.1016/j.imavis.2006.05.012; Simon DA, 1996, AAI9838226; Tam GKL, 2013, IEEE T VIS COMPUT GR, V19, P1199, DOI 10.1109/TVCG.2012.310; Signes MT, 2009, MATH COMPUT MODEL, V50, P750, DOI 10.1016/j.mcm.2009.05.004; Turk G., 1994, Computer Graphics Proceedings. Annual Conference Series 1994. SIGGRAPH 94 Conference Proceedings, P311, DOI 10.1145/192161.192241; van Kaick O, 2011, COMPUT GRAPH FORUM, V30, P1681, DOI 10.1111/j.1467-8659.2011.01884.x; Weik S, 1997, INTERNATIONAL CONFERENCE ON RECENT ADVANCES IN 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P93, DOI 10.1109/IM.1997.603853; Yan P, 2007, IEEE T PATTERN ANAL, V29, P1297, DOI 10.1109/TPAMI.2007.1067; Zabatani A, 2012, EUR C 3D OBJ RETR, P17	40	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164694	10.1371/journal.pone.0164694	http://dx.doi.org/10.1371/journal.pone.0164694			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768714	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400021
J	Pichon, S; Guex, R; Vuilleumier, P				Pichon, Swann; Guex, Raphael; Vuilleumier, Patrik			Influence of Temporal Expectations on Response Priming by Subliminal Faces	PLOS ONE			English	Article							EMOTIONAL FACIAL EXPRESSIONS; EVENT-RELATED FMRI; ATTENTIONAL MODULATION; AMYGDALA RESPONSES; REPETITION ATTENUATION; UNCONSCIOUS ACTIVATION; VISUAL AWARENESS; FRONTAL-CORTEX; FEARFUL FACES; MEMORY	Unconscious processes are often assumed immune from attention influence. Recent behavioral studies suggest however that the processing of subliminal information can be influenced by temporal attention. To examine the neural mechanisms underlying these effects, we used a stringent masking paradigm together with fMRI to investigate how temporal attention modulates the processing of unseen ( masked) faces. Participants performed a gender decision task on a visible neutral target face, preceded by a masked prime face that could vary in gender ( same or different than target) and emotion expression ( neutral or fearful). We manipulated temporal attention by instructing participants to expect targets to appear either early or late during the stimulus sequence. Orienting temporal attention to subliminal primes influenced response priming by masked faces, even when gender was incongruent. In addition, gender-congruent primes facilitated responses regardless of attention while gender-incongruent primes reduced accuracy when attended. Emotion produced no differential effects. At the neural level, incongruent and temporally unexpected primes increased brain response in regions of the fronto-parietal attention network, reflecting greater recruitment of executive control and reorienting processes. Congruent and expected primes produced higher activations in fusiform cortex, presumably reflecting facilitation of perceptual processing. These results indicate that temporal attention can influence subliminal processing of face features, and thus facilitate information integration according to task-relevance regardless of conscious awareness. They also suggest that task-congruent information between prime and target may facilitate response priming even when temporal attention is not selectively oriented to the prime onset time.	[Pichon, Swann; Guex, Raphael; Vuilleumier, Patrik] Univ Geneva, Lab Behav Neurol & Imaging Cognit, Dept Neurosci, Sch Med, Geneva, Switzerland; [Pichon, Swann; Guex, Raphael; Vuilleumier, Patrik] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Pichon, Swann] Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland; [Pichon, Swann; Guex, Raphael; Vuilleumier, Patrik] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva	Pichon, S (corresponding author), Univ Geneva, Lab Behav Neurol & Imaging Cognit, Dept Neurosci, Sch Med, Geneva, Switzerland.; Pichon, S (corresponding author), Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland.; Pichon, S (corresponding author), Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland.; Pichon, S (corresponding author), Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland.		pichon, swann JA/M-2966-2014; Vuilleumier, Patrik/AAJ-1839-2021	pichon, swann JA/0000-0001-5697-702X; Vuilleumier, Patrik/0000-0002-8198-9214	National Center of Competence in Research (NCCR) for Affective Sciences - Swiss National Science Foundation [51NF40-104897]; Academic Society of Geneva (Fund Foremane); Swiss National Science Foundation [PZ00P1_148035]	National Center of Competence in Research (NCCR) for Affective Sciences - Swiss National Science Foundation; Academic Society of Geneva (Fund Foremane); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the National Center of Competence in Research (NCCR) for Affective Sciences financed by the Swiss National Science Foundation (# 51NF40-104897, www.snf.ch) and hosted by the University of Geneva, as well as by the Academic Society of Geneva (Fund Foremane). SP is currently supported by the Swiss National Science Foundation (Ambizione grant No PZ00P1_148035).; This work was supported by the National Center of Competence in Research (NCCR) for Affective Sciences financed by the Swiss National Science Foundation (No 51NF40-104897, www.snf.ch) and hosted by the University of Geneva, as well as by the Academic Society of Geneva (Fund Foremane). SP is currently supported by the Swiss National Science Foundation (Ambizione grant No PZ00P1_148035).	Anderson AK, 2003, J NEUROSCI, V23, P5627; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Austen EL, 2003, J VISION, V3, P64, DOI 10.1167/3.1.7; Badcock NA, 2013, VISION RES, V76, P68, DOI 10.1016/j.visres.2012.10.010; Bausenhart KM, 2008, PERCEPT PSYCHOPHYS, V70, P1504, DOI 10.3758/PP.70.8.1504; Bausenhart KM, 2010, VISION RES, V50, P1025, DOI 10.1016/j.visres.2010.03.011; Bocanegra BR, 2009, PSYCHOL SCI, V20, P707, DOI 10.1111/j.1467-9280.2009.02354.x; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; Cant JS, 2015, CEREB CORTEX, V25, P4226, DOI 10.1093/cercor/bhu145; Cant JS, 2012, J NEUROSCI, V32, P7685, DOI 10.1523/JNEUROSCI.3325-11.2012; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Correa A, 2006, BRAIN RES, V1070, P202, DOI 10.1016/j.brainres.2005.11.094; Correa A, 2005, PSYCHON B REV, V12, P328, DOI 10.3758/BF03196380; Coull JT, 1998, J NEUROSCI, V18, P7426; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dolan RJ, 2003, ANN NY ACAD SCI, V985, P348, DOI 10.1111/j.1749-6632.2003.tb07093.x; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Enns James T, 2008, Adv Cogn Psychol, V3, P211, DOI 10.2478/v10053-008-0026-z; ESTEVES F, 1993, SCAND J PSYCHOL, V34, P1, DOI 10.1111/j.1467-9450.1993.tb01096.x; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fischer R, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00448; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kiefer M, 2006, J COGNITIVE NEUROSCI, V18, P184, DOI 10.1162/089892906775783688; Kiefer M, 2012, ADV COGN PSYCHOL, V8, P50, DOI [10.2478/v10053-008-0102-4, 10.5709/acp-0102-4]; Kiefer M, 2010, J EXP PSYCHOL GEN, V139, P464, DOI 10.1037/a0019561; Kilpatrick L, 2003, NEUROIMAGE, V20, P2091, DOI 10.1016/j.neuroimage.2003.08.006; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; Koban L., 2013, SOC COGN AFFECT NEUR; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lau HC, 2007, J NEUROSCI, V27, P5805, DOI 10.1523/JNEUROSCI.4335-06.2007; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Lundqvist D., 1998, AVERAGED KAROLINSKA; Martens S, 2005, MEM COGNITION, V33, P234, DOI 10.3758/BF03195312; Martens U, 2011, PSYCHOL SCI, V22, P282, DOI 10.1177/0956797610397056; Martens Ulla, 2009, Adv Cogn Psychol, V5, P56, DOI 10.2478/v10053-008-0067-3; Mathews A, 1997, TRENDS COGN SCI, V1, P340, DOI 10.1016/S1364-6613(97)01092-9; Moors A, 2005, Q J EXP PSYCHOL-A, V58, P1043, DOI 10.1080/02724980443000467; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morrison SE, 2010, CURR OPIN NEUROBIOL, V20, P221, DOI 10.1016/j.conb.2010.02.007; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nobre AC, 2001, NEUROPSYCHOLOGIA, V39, P1317; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Pasley BN, 2004, NEURON, V42, P163, DOI 10.1016/S0896-6273(04)00155-2; Pessoa L, 2006, CEREB CORTEX, V16, P366, DOI 10.1093/cercorbhi115; Pessoa L, 2005, EMOTION, V5, P243, DOI 10.1037/1528-3542.5.2.243; Pessoa L, 2005, CURR OPIN NEUROBIOL, V15, P188, DOI 10.1016/j.conb.2005.03.002; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pichon S, 2015, SOC COGN AFFECT NEUR, V10, P180, DOI 10.1093/scan/nsu044; Pichon S, 2012, NEUROIMAGE, V62, P1610, DOI 10.1016/j.neuroimage.2012.06.004; Pichon S, 2012, CEREB CORTEX, V22, P274, DOI 10.1093/cercor/bhr060; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Rolike B, 2007, PSYCHON B REV, V14, P522, DOI 10.3758/BF03194101; Rolke B, 2008, PERCEPT PSYCHOPHYS, V70, P1305, DOI 10.3758/PP.70.7.1305; Sambo CF, 2012, J NEUROSCI, V32, P12921, DOI 10.1523/JNEUROSCI.0607-12.2012; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; Seibold VC, 2011, ACTA PSYCHOL, V137, P56, DOI 10.1016/j.actpsy.2011.02.006; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Szczepanowski R, 2007, J VISION, V7, DOI 10.1167/7.4.10; Todd RM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00040; Tsuchiya N, 2007, TRENDS COGN SCI, V11, P158, DOI 10.1016/j.tics.2007.01.005; van Gaal S, 2010, J NEUROSCI, V30, P4143, DOI 10.1523/JNEUROSCI.2992-09.2010; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2012, ATTENTION AUTOMATICI; Vuilleumier P, 2015, BEHAV BRAIN SCI, V38, DOI 10.1017/S0140525X14001046; Vuilleumier P, 2015, CURR OPIN NEUROL, V28, P29, DOI 10.1097/WCO.0000000000000159; Whalen PJ, 1998, J NEUROSCI, V18, P411; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Yang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014641; Yi DJ, 2006, BRAIN RES, V1080, P53, DOI 10.1016/j.brainres.2006.01.090; Yi DJ, 2005, J NEUROSCI, V25, P3593, DOI 10.1523/JNEUROSCI.4677-04.2005	85	7	7	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164613	10.1371/journal.pone.0164613	http://dx.doi.org/10.1371/journal.pone.0164613			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9NZ	27764124	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500046
J	Sun, J; De Marinis, Y; Osmark, P; Singh, P; Bagge, A; Valtat, B; Vikman, P; Spegel, P; Mulder, H				Sun, Jiangming; De Marinis, Yang; Osmark, Peter; Singh, Pratibha; Bagge, Annika; Valtat, Berengere; Vikman, Petter; Spegel, Peter; Mulder, Hindrik			Discriminative Prediction of A-To-I RNA Editing Events from DNA Sequence	PLOS ONE			English	Article							ACCURATE IDENTIFICATION; DATABASE; SITES; TRANSCRIPTS; FRAMEWORK; REVEALS; SUPPORT; PROTEIN	RNA editing is a post-transcriptional alteration of RNA sequences that, via insertions, deletions or base substitutions, can affect protein structure as well as RNA and protein expression. Recently, it has been suggested that RNA editing may be more frequent than previously thought. A great impediment, however, to a deeper understanding of this process is the paramount sequencing effort that needs to be undertaken to identify RNA editing events. Here, we describe an in silico approach, based on machine learning, that ameliorates this problem. Using 41 nucleotide long DNA sequences, we show that novel A-to-I RNA editing events can be predicted from known A-to-I RNA editing events intra-and interspecies. The validity of the proposed method was verified in an independent experimental dataset. Using our approach, 203 202 putative A-to-I RNA editing events were predicted in the whole human genome. Out of these, 9% were previously reported. The remaining sites require further validation, e.g., by targeted deep sequencing. In conclusion, the approach described here is a useful tool to identify potential A-to-I RNA editing events without the requirement of extensive RNA sequencing.	[Sun, Jiangming; Singh, Pratibha; Bagge, Annika; Valtat, Berengere; Spegel, Peter; Mulder, Hindrik] Lund Univ, Ctr Diabet, CRC, Dept Clin Sci Malmo,Unit Mol Metab, Malmo, Sweden; [De Marinis, Yang; Osmark, Peter; Vikman, Petter] Lund Univ, Ctr Diabet, CRC, Dept Clin Sci Malmo,Unit Diabet & Endocrinol, Malmo, Sweden; [Spegel, Peter] Lund Univ, Dept Chem, Ctr Anal & Synth, Lund, Sweden	Lund University; Lund University; Lund University	Sun, J (corresponding author), Lund Univ, Ctr Diabet, CRC, Dept Clin Sci Malmo,Unit Mol Metab, Malmo, Sweden.	sunjiangming@gmail.com	De Marinis, Yang/AAK-2753-2020; De Marinis, Yang/D-4992-2016; Spégel, Peter/G-9947-2018; De Marinis, Yang/ABA-2931-2020; Sun, Jiangming/AFT-1203-2022; Bagge, Annika/A-4151-2015; Singh, Pratibha/E-6013-2014	Spégel, Peter/0000-0002-6092-2387; De Marinis, Yang/0000-0002-8081-2142; Bagge, Annika/0000-0002-3897-9512; Sun, Jiangming/0000-0001-6814-1297; Mulder, Hindrik/0000-0002-6593-8417; Singh, Pratibha/0000-0002-3088-3153	Crafoord; Novo Nordisk; Knut & Alice Wallenberg; Albert Pahlsson foundations; Medical Faculty in Lund; Swedish Research Council	Crafoord; Novo Nordisk(Novo Nordisk); Knut & Alice Wallenberg(Knut & Alice Wallenberg Foundation); Albert Pahlsson foundations; Medical Faculty in Lund; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Crafoord, Novo Nordisk, Knut & Alice Wallenberg, and Albert Pahlsson foundations, as well as The Medical Faculty in Lund and The Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Borchert GM, 2009, HUM MOL GENET, V18, P4801, DOI 10.1093/hmg/ddp443; Bundschuh R, 2004, BIOINFORMATICS, V20, P3214, DOI 10.1093/bioinformatics/bth387; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chen PH, 2005, APPL STOCH MODEL BUS, V21, P111, DOI 10.1002/asmb.537; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Eisenberg E, 2005, NUCLEIC ACIDS RES, V33, P4612, DOI 10.1093/nar/gki771; Fadista J, 2014, P NATL ACAD SCI USA, V111, P13924, DOI 10.1073/pnas.1402665111; Garrett S, 2012, SCIENCE, V335, P848, DOI 10.1126/science.1212795; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Kiran AM, 2013, NUCLEIC ACIDS RES, V41, pD258, DOI 10.1093/nar/gks961; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kubat M., 1997, ADDRESSING CURSE IMB, P179, DOI DOI 10.1007/S13398-014-0173-7.2; Lenz H, 2013, BIOINFORM BIOL INSIG, V7, P1, DOI 10.4137/BBI.S11059; LEVENSHT.VI, 1965, DOKL AKAD NAUK SSSR+, V163, P845; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang GX, 2013, P NATL ACAD SCI USA, V110, P2246, DOI 10.1073/pnas.1221921110; Lu F, 2005, P NATL ACAD SCI USA, V102, P12332, DOI 10.1073/pnas.0505411102; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Park E, 2012, GENOME RES, V22, P1626, DOI 10.1101/gr.134957.111; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Picardi E, 2013, BIOINFORMATICS, V29, P1813, DOI 10.1093/bioinformatics/btt287; Picardi E, 2011, BIOINFORMATICS, V27, P1311, DOI 10.1093/bioinformatics/btr117; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/nmeth.2330, 10.1038/NMETH.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; Schrider DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025842; Zhu SS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-206	36	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164962	10.1371/journal.pone.0164962	http://dx.doi.org/10.1371/journal.pone.0164962			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764195	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204500085
J	van Essen, TH; van Pelt, SI; Bronkhorst, IHG; Versluis, M; Nemati, F; Laurent, C; Luyten, GPM; van Hall, T; van den Elsen, PJ; Decaudin, D; Jager, MJ				van Essen, T. Huibertus; van Pelt, Sake I.; Bronkhorst, Inge H. G.; Versluis, Mieke; Nemati, Fariba; Laurent, Cecile; Luyten, Gregorius P. M.; van Hall, Thorbald; van den elsen, Peter J.; Decaudin, Didier; Jager, Martine J.			Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes	PLOS ONE			English	Article							CLASS-I EXPRESSION; RAW COPY NUMBERS; COMPLEX CLASS-I; ANTIGEN EXPRESSION; GENE-EXPRESSION; CELL LINES; MONOSOMY 3; SURVIVAL; BAP1; INFLAMMATION	Introduction Uveal melanoma (UM) with an inflammatory phenotype, characterized by infiltrating leukocytes and increased human leukocyte antigen (HLA) expression, carry an increased risk of death due to metastases. These tumors should be ideal for T-cell based therapies, yet it is not clear why prognostically-infaust tumors have a high HLA expression. We set out to determine whether the level of HLA molecules in UM is associated with other genetic factors, HLA transcriptional regulators, or microenvironmental factors. Methods 28 enucleated UM were used to study HLA class I and II expression, and several regulators of HLA by immunohistochemistry, PCR microarray, qPCR and chromosome SNP-array. Fresh tumor samples of eight primary UM and four metastases were compared to their corresponding xenograft in SCID mice, using a PCR microarray and SNP array. Results Increased expression levels of HLA class I and II showed no dosage effect of chromosome 6p, but, as expected, were associated with monosomy of chromosome 3. Increased HLA class I and II protein levels were positively associated with their gene expression and with raised levels of the peptide-loading gene TAP1, and HLA transcriptional regulators IRF1, IRF8, CIITA, and NLRC5, revealing a higher transcriptional activity in prognostically-bad tumors. Implantation of fresh human tumor samples into SCID mice led to a loss of infiltrating leukocytes, and to a decreased expression of HLA class I and II genes, and their regulators.	[van Essen, T. Huibertus; Bronkhorst, Inge H. G.; Versluis, Mieke; Luyten, Gregorius P. M.; van den elsen, Peter J.; Jager, Martine J.] LUMC, Dept Ophthalmol, Leiden, Netherlands; [van Pelt, Sake I.] LUMC, Dept Med Stat, Leiden, Netherlands; [Nemati, Fariba; Laurent, Cecile; Decaudin, Didier] Inst Curie, Translat Res Dept, Lab Preclin Invest, Paris, France; [van Hall, Thorbald] LUMC, Dept Clin Oncol, Leiden, Netherlands; [van den elsen, Peter J.] LUMC, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [van den elsen, Peter J.] Vrije Univ Amsterdam, Dept Pathol, Med Ctr, Amsterdam, Netherlands; [Decaudin, Didier] Inst Curie, Dept Clin Hematol, Paris, France	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Vrije Universiteit Amsterdam; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	van Essen, TH (corresponding author), LUMC, Dept Ophthalmol, Leiden, Netherlands.	T.H.van_Essen@lumc.nl	Jager, Martine/AAR-3525-2020; van Hall, Thorbald/Y-5651-2018	Jager, Martine/0000-0003-2261-3820; Laurent, Cecile/0000-0002-3022-2283; van Hall, Thorbald/0000-0002-9115-558X; van der Velden, Pieter/0000-0002-5710-9256	Dutch Cancer Society (KWF-Kankerbestrijding) [RUL 2011-4991]; LUMC Board of Directors excellence grant	Dutch Cancer Society (KWF-Kankerbestrijding)(KWF Kankerbestrijding); LUMC Board of Directors excellence grant	This work was supported by a grant from the Dutch Cancer Society (KWF-Kankerbestrijding) RUL 2011-4991. Inge H.G. Bronkhorst is the recipient of a LUMC Board of Directors excellence grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Aure MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053014; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Bengtsson H, 2012, 745 U CAL DEP STAT; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Blom DJR, 1997, INVEST OPHTH VIS SCI, V38, P1865; Blom DJR, 1997, BRIT J OPHTHALMOL, V81, P989, DOI 10.1136/bjo.81.11.989; Bronkhorst IHG, 2012, INVEST OPHTH VIS SCI, V53, P5370, DOI 10.1167/iovs.11-9280; Bronkhorst IHG, 2011, INVEST OPHTH VIS SCI, V52, P643, DOI 10.1167/iovs.10-5979; BUNCE M, 1994, TISSUE ANTIGENS, V43, P7, DOI 10.1111/j.1399-0039.1994.tb02290.x; Carbone M, 2013, NAT REV CANCER, V13, P153, DOI 10.1038/nrc3459; Cavallo F, 2011, CANCER IMMUNOL IMMUN, V60, P319, DOI 10.1007/s00262-010-0968-0; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coupland SE, 2013, EYE, V27, P230, DOI 10.1038/eye.2012.255; Daniels V.G., 1979, FUNCTIONAL HISTOLOGY; DEWAARDSIEBINGA I, 1995, BRIT J OPHTHALMOL, V79, P847, DOI 10.1136/bjo.79.9.847; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; el Filali M, 2008, MOL VIS, V14, P1752; Ericsson C, 2001, INVEST OPHTH VIS SCI, V42, P2153; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; Gobin SJP, 1997, IMMUNITY, V6, P601, DOI 10.1016/S1074-7613(00)80348-9; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Harbour JW, 2009, AM J OPHTHALMOL, V148, P823, DOI 10.1016/j.ajo.2009.07.004; Holling TM, 2007, J IMMUNOL, V179, P5317, DOI 10.4049/jimmunol.179.8.5317; Hurks HMH, 2000, INT J CANCER, V85, P697, DOI 10.1002/(SICI)1097-0215(20000301)85:5<697::AID-IJC16>3.3.CO;2-8; Jager MJ, 2002, HUM IMMUNOL, V63, P444, DOI 10.1016/S0198-8859(02)00389-0; Jehs T, 2014, INVEST OPHTH VIS SCI, V55, P5169, DOI 10.1167/iovs.14-14394; Kilic E, 2006, INVEST OPHTH VIS SCI, V47, P3703, DOI 10.1167/iovs.06-0101; Kobayashi KS, 2012, NAT REV IMMUNOL, V12, P813, DOI 10.1038/nri3339; Kujala E, 2003, INVEST OPHTH VIS SCI, V44, P4651, DOI 10.1167/iovs.03-0538; LaFave LM, 2015, NAT MED, V21, P1344, DOI 10.1038/nm.3947; Laurent C, 2013, MOL ONCOL, V7, P625, DOI 10.1016/j.molonc.2013.02.004; MA D, 1995, IMMUNOLOGY, V86, P263; Maat W, 2008, INVEST OPHTH VIS SCI, V49, P505, DOI 10.1167/iovs.07-0786; MCCUTCHEON JA, 1995, J EXP MED, V181, P2085, DOI 10.1084/jem.181.6.2085; McMichael A J, 1979, J Clin Pathol Suppl (R Coll Pathol), V13, P30; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Metzelaar-Blok JAW, 1999, HUM IMMUNOL, V60, P962, DOI 10.1016/S0198-8859(99)00067-1; Mine KL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2693; Mougiakakos D, 2010, CANCER-AM CANCER SOC, V116, P2224, DOI 10.1002/cncr.24999; Nemati F, 2010, CLIN CANCER RES, V16, P2352, DOI 10.1158/1078-0432.CCR-09-3066; Niederkorn JY, 2005, OCUL IMMUNOL INFLAMM, V13, P105, DOI 10.1080/09273940490518586; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Poggi A, 2006, ARCH IMMUNOL THER EX, V54, P323, DOI 10.1007/s00005-006-0038-7; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Scholes AGM, 2003, INVEST OPHTH VIS SCI, V44, P1008, DOI 10.1167/iovs.02-0159; Seitz C, 1998, MOL IMMUNOL, V35, P819, DOI 10.1016/S0161-5890(98)00077-7; Seliger B, 2008, J IMMUNOTOXICOL, V5, P361, DOI 10.1080/15476910802482870; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; STAM NJ, 1986, J IMMUNOL, V137, P2299; van Beek JGM, 2014, INVEST OPHTH VIS SCI, V55, P1284, DOI 10.1167/iovs.13-13670; van den Elsen PJ, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00048; van Essen TH, 2014, BRIT J OPHTHALMOL, V98, P1738, DOI 10.1136/bjophthalmol-2014-305047; van Essen TH, 2012, INVEST OPHTH VIS SCI, V53, P2640, DOI 10.1167/iovs.11-8901; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Versluis M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116371; White VA, 1998, CANCER, V83, P354, DOI 10.1002/(SICI)1097-0142(19980715)83:2<354::AID-CNCR20>3.3.CO;2-C	59	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164292	10.1371/journal.pone.0164292	http://dx.doi.org/10.1371/journal.pone.0164292			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764126	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500026
J	Coutu, AN; Lee-Thorp, J; Collins, MJ; Lane, PJ				Coutu, Ashley N.; Lee-Thorp, Julia; Collins, Matthew J.; Lane, Paul J.			Mapping the Elephants of the 19th Century East African Ivory Trade with a Multi-Isotope Approach	PLOS ONE			English	Article							NATURAL-ABUNDANCE; NITROGEN ISOTOPES; C-13/C-12 RATIOS; STABLE-ISOTOPES; SOUTHERN-AFRICA; NATIONAL-PARK; CARBON; BONE; VEGETATION; ECOLOGY	East African elephants have been hunted for their ivory for millennia but the nineteenth century witnessed strongly escalating demand from Europe and North America. It has been suggested that one consequence was that by the 1880s elephant herds along the coast had become scarce, and to meet demand, trade caravans trekked farther into interior regions of East Africa, extending the extraction frontier. The steady decimation of elephant populations coupled with the extension of trade networks have also been claimed to have triggered significant ecological and socio-economic changes that left lasting legacies across the region. To explore the feasibility of using an isotopic approach to uncover a 'moving frontier' of elephant extraction, we constructed a baseline isotope data set (delta C-13, delta N-15, delta O-18 and Sr-87/Sr-86) for historic East African elephants known to have come from three distinct regions (coastal, Rift Valley, and inland Lakes). Using the isotope results with other climate data and geographical mapping tools, it was possible to characterise elephants from different habitats across the region. This baseline data set was then used to provenance elephant ivory of unknown geographical provenance that was exported from East Africa during the late nineteenth and early twentieth centuries to determine its likely origin. This produced a better understanding of historic elephant geography in the region, and the data have the potential to be used to provenance older archaeological ivories, and to inform contemporary elephant conservation strategies.	[Coutu, Ashley N.; Collins, Matthew J.] Univ York, Dept Archaeol, BioArCh, York, N Yorkshire, England; [Coutu, Ashley N.] Univ Cape Town, Dept Archaeol, Rondebosch, South Africa; [Lee-Thorp, Julia] Univ Oxford, Res Lab Archaeol, Oxford, England; [Lane, Paul J.] Uppsala Univ, Dept Archaeol & Ancient Hist, Uppsala, Sweden; [Lane, Paul J.] Univ Witwatersrand, Sch Geog Archaeol & Environm Sci, ZA-2050 Johannesburg, South Africa	University of York - UK; University of Cape Town; University of Oxford; Uppsala University; University of Witwatersrand	Coutu, AN (corresponding author), Univ York, Dept Archaeol, BioArCh, York, N Yorkshire, England.; Coutu, AN (corresponding author), Univ Cape Town, Dept Archaeol, Rondebosch, South Africa.	ashley.coutu@york.ac.uk	Lane, Paul/AAK-1995-2020	Lane, Paul/0000-0002-9936-1310; Coutu, Ashley Nicole/0000-0002-5007-6914	European Union Marie Curie Excellence grant [MEXT-CT-2006-042704]; Worldwide Universities Network Research Mobility programme; Smithsonian Institution Fellowship programme; government of Tanzania (Tanzania Commission for Science and Technology (COSTECH)) [2009-111-NA-2008-78]; Tanzania National Parks; Tanzania Wildlife Research Institute; government of Kenya [MOHEST13/001/38C371]; Kenya National Museum; AHRC [AH/G015430/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/G015430/1] Funding Source: researchfish	European Union Marie Curie Excellence grant(European Commission); Worldwide Universities Network Research Mobility programme; Smithsonian Institution Fellowship programme; government of Tanzania (Tanzania Commission for Science and Technology (COSTECH)); Tanzania National Parks; Tanzania Wildlife Research Institute; government of Kenya; Kenya National Museum; AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	This research was funded by a European Union Marie Curie Excellence grant (MEXT-CT-2006-042704) awarded to PJL for the Historical Ecologies of East African Landscapes (HEEAL) project (http//cordis.europleu/projectircn/83961_enlytml). Additional funding came from the Worldwide Universities Network Research Mobility programme and the Smithsonian Institution Fellowship programme awarded to ANC. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research formed part of the Ph.D. research carried out by ANC at the University of York, UK, as part of the Historical Ecologies of East African Landscapes (HEEAL) project. Permits were awarded by the government of Tanzania (Tanzania Commission for Science and Technology (COSTECH) No. 2009-111-NA-2008-78), Tanzania National Parks, Tanzania Wildlife Research Institute, and government of Kenya (MOHEST13/001/38C371) as well as the Kenya National Museum to conduct this research and thanks go to all of these institutions. CITES permits 451717, 318736, 22225, 106189, and 450392, allowed for the transport and analysis of these samples. Isotope analysis was conducted at the University of Bradford with the help of Andrew Gledhill, the University of Cape Town with Petrus le Roux, and at the University of Illinois, Urbana-Champaign with the support of Stanley Ambrose. Many curators allowed access to material to support this project: the Powell-Cotton Museum (UK), Hawley Collection (UK), Deep River Museum and AcoustiCraft Inc. (USA), Smithsonian National Museum of Natural History (USA), Los Angeles County Museum (USA), Field Museum (USA), Museum of Vertebrate Zoology Berkeley (USA), National Museums Kenya, House of Wonders Zanzibar (Tanzania), Museum of History Vienna (Austria). HEEAL team members Daryl Stump, Matthias Heckmann, Thomas Biginagwa, and Pauline von Hellermann deserve thanks for their constant support.	Agbodeka Francis., 1971, AFRICAN POLITICS BRI; Alpers Edward A., 1975, IVORY SLAVES E CENTR; AMBROSE SH, 1986, OECOLOGIA, V69, P395, DOI 10.1007/BF00377062; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; [Anonymous], 1987, OECOLOGIA, V74, P236, DOI DOI 10.1007/BF00379365; [Anonymous], 1988, VICTORIAN THINGS; Araguas-Araguas L, 2000, HYDROL PROCESS, V14, P1341, DOI 10.1002/1099-1085(20000615)14:8&lt;1341::AID-HYP983&gt;3.0.CO;2-Z; Aranibar JN, 2004, GLOBAL CHANGE BIOL, V10, P359, DOI 10.1111/j.1365-2486.2003.00698.x; BEACHEY RW, 1967, J AFR HIST, V8, P269, DOI 10.1017/S0021853700007052; Blumenthal SA, 2016, AM J PRIMATOL, V78, DOI 10.1002/ajp.22488; Bouche P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020619; Bowen GJ, 2002, GEOLOGY; BRYANT JD, 1995, GEOCHIM COSMOCHIM AC, V59, P4523; Cerling TE, 2004, OECOLOGIA, V138, P5, DOI 10.1007/s00442-003-1375-4; Cerling TE, 1999, OECOLOGIA, V120, P364, DOI 10.1007/s004420050869; Cerling TE, 2007, AFR J ECOL, V45, P614, DOI 10.1111/j.1365-2028.2007.00784.x; Cerling TE, 2009, P NATL ACAD SCI USA, V106, P8093, DOI 10.1073/pnas.0902192106; Clark I., 1997, ENV ISOTOPES HYDROGE; Codron J, 2006, J MAMMAL, V87, P27, DOI 10.1644/05-MAMM-A-017R1.1; Codron J, 2013, CAN J ZOOL, V91, P124, DOI 10.1139/cjz-2012-0155; Codron J, 2012, P ROY SOC B-BIOL SCI, V279, P2433, DOI 10.1098/rspb.2011.2472; Copeland SR, 2008, RAPID COMMUN MASS SP, V22, P3187, DOI 10.1002/rcm.3717; Coutu A. N., 2011, THESIS; Coutu AN, 2015, WORLD ARCHAEOL, V47, P486, DOI 10.1080/00438243.2015.1016184; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Croucher S., 2007, NYAME AKUMA, V67, P91; Cutler A., 1985, CRAFT IVORY SOURCES; DANSGAARD W, 1964, TELLUS, V16, P436; DELWICHE CC, 1970, ENVIRON SCI TECHNOL, V4, P929, DOI 10.1021/es60046a004; European Space Agency, 2010, GLOBCOVER LAND COV V; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Farris F, 1996, GEOCHIM COSMOCHIM AC, V60, P4811; FIELD C R, 1971, East African Wildlife Journal, V9, P99, DOI 10.1111/j.1365-2028.1971.tb00223.x; Fisher DC, 2014, QUATERNARY RES, V82, P518, DOI 10.1016/j.yqres.2014.07.010; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; Gonfiantini R, 2001, CHEM GEOL, V181, P147, DOI 10.1016/S0009-2541(01)00279-0; Guerin SM, 2010, J MEDIEVAL HIST, V36, P156, DOI 10.1016/j.jmedhist.2010.03.003; Guldemond R, 2008, J WILDLIFE MANAGE, V72, P892, DOI 10.2193/2007-072; Hakansson NT, 2004, HUM ECOL, V32, P561, DOI 10.1007/s10745-004-6097-7; HANDLEY LL, 1992, PLANT CELL ENVIRON, V15, P965, DOI 10.1111/j.1365-3040.1992.tb01650.x; HEATON THE, 1986, NATURE, V322, P822, DOI 10.1038/322822a0; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobley C.W., 1929, KENYA CHARTERED CO C; Ishibashi H, B GRAD SCH SOC CULT; Ishida Y, 2013, EVOL APPL, V6, P253, DOI 10.1111/j.1752-4571.2012.00286.x; JACHMANN H, 1995, AFR J ECOL, V33, P230, DOI 10.1111/j.1365-2028.1995.tb00800.x; Jones P., 2008, CRU TIME SERIES TS H; KOCH PL, 1995, SCIENCE, V267, P1340, DOI 10.1126/science.267.5202.1340; Lane PJ, 2015, WORLD ARCHAEOL, V47, P317, DOI 10.1080/00438243.2015.1046252; Lane PJ, 2010, AFR STUD-UK, V69, P299, DOI 10.1080/00020184.2010.499203; LAWS RM, 1970, OIKOS, V21, P1, DOI 10.2307/3543832; Leuthold W, 1996, AFR J ECOL, V34, P101, DOI 10.1111/j.1365-2028.1996.tb00605.x; Linacre Adrian, 2011, Investig Genet, V2, P2, DOI 10.1186/2041-2223-2-2; Loesser Arthur, 1990, MEN WOMEN PIANOS SOC; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; Machado P., 2014, OCEAN TRADE; Malcarne DL, 2001, N AM ARCHAEOL, V22, P283, DOI 10.2190/VPH7-PWLR-JN9X-95G5; Malcarne Don, 2002, DEEP RIVER IVORYTON; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Murphy BP, 2009, FUNCT ECOL, V23, P1040, DOI 10.1111/j.1365-2435.2009.01576.x; NEGREL P, 1993, EARTH PLANET SC LETT, V120, P59, DOI 10.1016/0012-821X(93)90023-3; Northway P. H, 1954, ESSEX I HIST COLLECT, V90, P123; Okello JBA, 2008, MOL ECOL, V17, P3788, DOI 10.1111/j.1365-294X.2008.03871.x; Ometto JPHB, 2006, BIOGEOCHEMISTRY, V79, P251, DOI 10.1007/s10533-006-9008-8; Parker I., 1979, THE IVORY TRADE; Powell-Cotton, 1904, IN UNKNOWN AFRICA; Powell-Cotton P. H. G., 1902, SPORTING TRIP ABYSSI; Powell-Cotton PHG, 1905, DIARY ENTRY MAY 1905; Prestholdt J, 2004, AM HIST REV, V109, P755, DOI 10.1086/530554; RCore Team, 2020, R LANG ENV STAT COMP; Rempel R, 1998, REV CAN ETUD DEV, V19, P529; Rijkelijkhuizen MJ, 2015, WORLD ARCHAEOL, P1; Robinson D, 2001, TRENDS ECOL EVOL, V16, P153, DOI 10.1016/S0169-5347(00)02098-X; Rockel S., 2006, AZANIA, V41, P1; Rockel Stephen J., 2006, CARRIERS CULTURE LAB; Rogers N, 2000, EARTH PLANET SC LETT, V176, P387, DOI 10.1016/S0012-821X(00)00012-1; ROZANSKI K, 1992, SCIENCE, V258, P981, DOI 10.1126/science.258.5084.981; SEALY JC, 1987, GEOCHIM COSMOCHIM AC, V51, P2707, DOI 10.1016/0016-7037(87)90151-7; Shalem A, 2005, IVORIES MUSLIM SPAIN, P25; Shannon G, 2013, ACTA OECOL, V46, P48, DOI 10.1016/j.actao.2012.10.013; Shannon G, 2010, AUSTRAL ECOL, V35, P731, DOI 10.1111/j.1442-9993.2009.02080.x; SHEARER G, 1978, SOIL SCI SOC AM J, V42, P899, DOI 10.2136/sssaj1978.03615995004200060013x; Sheriff Abdul, 1987, SLAVES SPICES IVORY; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; SPINAGE C A, 1973, East African Wildlife Journal, V11, P281; Spinage CA., 2012, AFRICAN ECOLOGY BENC; Sponheimer M., 1999, THESIS; Steenkamp G, 2007, J S AFR VET ASSOC, V78, P75; Steinhart EI, 2000, INT J AFR HIST STUD, V33, P335, DOI 10.2307/220652; Stiles D, 2009, PACHYDERM, V45, P150; Swap RJ, 2004, GLOBAL CHANGE BIOL, V10, P350, DOI 10.1111/j.1365-2486.2003.00702.x; Symonds J, 2006, POST-MEDIEV ARCHAEOL, V40, P214; Talbot MR, 2000, GEOLOGY, V28, P343, DOI 10.1130/0091-7613(2000)28<343:SIEFLP>2.0.CO;2; Thorbahn Frederic Peter, 1979, DISSERTATION; TIESZEN LL, 1979, OECOLOGIA, V37, P337, DOI 10.1007/BF00347910; TIESZEN LL, 1979, OECOLOGIA, V37, P351, DOI 10.1007/BF00347911; TIESZEN LL, 1980, AFR J ECOL, V18, P237, DOI 10.1111/j.1365-2028.1980.tb01052.x; TIESZEN LL, 1989, AFR J ECOL, V27, P219, DOI 10.1111/j.1365-2028.1989.tb01015.x; Unwin J, 2014, ANTHROPOZOOLOGICA, V49, P121, DOI 10.5252/az2014n1a09; VANDERMERWE NJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1091, DOI 10.1016/0016-7037(89)90213-5; VANDERMERWE NJ, 1990, NATURE, V346, P744, DOI 10.1038/346744a0; VANDERMERWE NJ, 1988, AFR J ECOL, V26, P163, DOI 10.1111/j.1365-2028.1988.tb00966.x; VOGEL JC, 1990, NATURE, V346, P747, DOI 10.1038/346747a0; Wasser SK, 2015, SCIENCE, V349, P84, DOI 10.1126/science.aaa2457; Wasser SK, 2007, P NATL ACAD SCI USA, V104, P4228, DOI 10.1073/pnas.0609714104; WHITEHOUSE D, 1970, WORLD ARCHAEOL, V2, P141, DOI 10.1080/00438243.1970.9979471; Wynne-Jones S, 2010, J WORLD PREHIST, V23, P219, DOI 10.1007/s10963-010-9040-4; YAKIR D, 1992, PLANT CELL ENVIRON, V15, P1005, DOI 10.1111/j.1365-3040.1992.tb01652.x; Ylvisaker Marguerite, 1982, PAIDEUMA, V28, P221; Ziegler S, 2016, BIOL CONSERV, V197, P154, DOI 10.1016/j.biocon.2016.03.008	113	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0163606	10.1371/journal.pone.0163606	http://dx.doi.org/10.1371/journal.pone.0163606			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760152	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000386204000017
J	Dickinson, JL; McLeod, P; Bloomfield, R; Allred, S				Dickinson, Janis L.; McLeod, Poppy; Bloomfield, Robert; Allred, Shorna			Which Moral Foundations Predict Willingness to Make Lifestyle Changes to Avert Climate Change in the USA?	PLOS ONE			English	Article							SUSTAINABILITY; ATTITUDES; EVOLUTION; BEHAVIOR; TRAGEDY	Jonathan Haidt's Moral Foundations Theory identifies five moral axes that can influence human motivation to take action on vital problems like climate change. The theory focuses on five moral foundations, including compassion, fairness, purity, authority, and ingroup loyalty; these have been found to differ between liberals and conservatives as well as Democrats and Republicans. Here we show, based on the Cornell National Social Survey (USA), that valuations of compassion and fairness were strong, positive predictors of willingness to act on climate change, whereas purity had a non-significant tendency in the positive direction (p = 0.07). Ingroup loyalty and authority were not supported as important predictor variables using model selection (Delta AICc). Compassion and fairness were more highly valued by liberals, whereas purity, authority, and in-group loyalty were more highly valued by conservatives. As in previous studies, participants who were younger, more liberal, and reported greater belief in climate change, also showed increased willingness to act on climate change. Our research supports the potential importance of moral foundations as drivers of intentions with respect to climate change action, and suggests that compassion, fairness, and to a lesser extent, purity, are potential moral pathways for personal action on climate change in the USA.	[Dickinson, Janis L.; Allred, Shorna] Cornell Univ, Dept Nat Resources, Fernow Hall, Ithaca, NY 14853 USA; [McLeod, Poppy] Cornell Univ, Dept Commun, Ithaca, NY USA; [Bloomfield, Robert] Cornell Univ, Samuel Curtis Johnson Grad Sch Management, Ithaca, NY USA	Cornell University; Cornell University; Cornell University	Dickinson, JL (corresponding author), Cornell Univ, Dept Nat Resources, Fernow Hall, Ithaca, NY 14853 USA.	jld84@cornell.edu						AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 1965, LOGIC COLLECTIVE ACT; Arnocky S, 2007, J ENVIRON PSYCHOL, V27, P255, DOI 10.1016/j.jenvp.2007.06.005; Arnocky S, 2014, ENVIRON BEHAV, V46, P556, DOI 10.1177/0013916512474987; Brechin S. R., 2003, INT J SOCIOLOGY SOCI, V23, P106, DOI DOI 10.1108/01443330310790318; Burnham K P, 2003, MODEL SELECT MULTIMO; Crompton T, 2011, NAT CLIM CHANGE, V1, P276, DOI 10.1038/nclimate1196; Dawson SL, 2012, AUSTR COMMUNITY PSYC, V24, P8; Day MV, 2014, PERS SOC PSYCHOL B, V40, P1559, DOI 10.1177/0146167214551152; Dickinson JL, 2009, ECOL SOC, V14; Fehr E, 2004, NATURE, P449; Feinberg M, 2013, PSYCHOL SCI, V24, P56, DOI 10.1177/0956797612449177; Feinberg M, 2011, PSYCHOL SCI, V22, P34, DOI 10.1177/0956797610391911; Gardiner S., 2011, CLIMATE ETHICS ESSEN; Gardiner SM, 2006, ENVIRON VALUE, V15, P397, DOI 10.3197/096327106778226293; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2013, ADV EXP SOC PSYCHOL, V47, P55, DOI 10.1016/B978-0-12-407236-7.00002-4; Graham J, 2010, PERS SOC PSYCHOL REV, V14, P140, DOI 10.1177/1088868309353415; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Kahn PH, 2002, ENVIRON BEHAV, V34, P405, DOI 10.1177/00116502034004001; Koleva SP, 2012, J RES PERS, V46, P184, DOI 10.1016/j.jrp.2012.01.006; Kortenkamp KV, 2001, J ENVIRON PSYCHOL, V21, P261, DOI 10.1006/jevp.2001.0205; Kreuger JI, 2012, SOCIAL JUDGMENT DECI; Lu H, 2016, J ENVIRON PSYCHOL, V45, P192, DOI 10.1016/j.jenvp.2016.01.007; Markowitz EM, 2012, NAT CLIM CHANGE, V2, P243, DOI [10.1038/NCLIMATE1378, 10.1038/nclimate1378]; McKenzieMohr D, 1995, J SOC ISSUES, V51, P1, DOI 10.1111/j.1540-4560.1995.tb01345.x; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Moser G, 2009, J ENVIRON PSYCHOL, V29, P351, DOI 10.1016/j.jenvp.2009.02.002; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Ostrom E., 2008, HDB SOCIAL CAPITAL, P17; Pfattheicher S, 2016, ENVIRON BEHAV, V48, P929, DOI 10.1177/0013916515574549; Steg L, 2009, J ENVIRON PSYCHOL, V29, P309, DOI 10.1016/j.jenvp.2008.10.004; Stephens PHG, 2009, ENVIRON VALUE, V9, P267; Taufik D, 2015, NAT CLIM CHANGE, V5, P37, DOI [10.1038/nclimate2449, 10.1038/NCLIMATE2449]; Thogersen J, 1996, ENVIRON BEHAV, V28, P536, DOI 10.1177/0013916596284006; Thogersen J, 2000, J CONSUMER POLICY, V22, P439	40	44	45	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0163852	10.1371/journal.pone.0163852	http://dx.doi.org/10.1371/journal.pone.0163852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9NW	27760207	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000021
J	Ritz, KR; Noor, MAF				Ritz, Kathryn R.; Noor, Mohamed A. F.			Mistaken Identity: Another Bias in the Use of Relative Genetic Divergence Measures for Detecting Interspecies Introgression	PLOS ONE			English	Article							MOLECULAR POPULATION-GENETICS; DROSOPHILA-PSEUDOOBSCURA; ADAPTIVE INTROGRESSION; CLOSE RELATIVES; PERSIMILIS; SPECIATION; FLOW; DNA; RECOMBINATION; POLYMORPHISM	Measures of genetic divergence have long been used to identify evolutionary processes operating within and between species. However, recent reviews have described a bias in the use of relative divergence measures towards incorrectly identifying genomic regions that are seemingly immune to introgression. Here, we present a novel and opposite bias of relative divergence measures: misidentifying regions of introgression between sister species. We examine two distinct haplotypes of intermediate frequency within Drosophila pseudoobscura at the DPSX009 locus. One of these haplotypes had lower relative divergence than another to sister species D. persimilis. Although we and others initially presumed one haplotype have spread via introgression between D. pseudoobscura and D. persimilis, absolute divergence measures and individual sequence analysis suggest that haplotype structuring occurred as the result of within-species processes. The potential for this type of misinference may occur with any haplotype that recently spread within a species. We conclude that absolute measures of genetic divergence are necessary for confirming putative regions of introgression.	[Ritz, Kathryn R.; Noor, Mohamed A. F.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Ritz, KR (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	kathryn.ritz@duke.edu		Noor, Mohamed/0000-0002-5400-4408				Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; Clark AG, 1997, P NATL ACAD SCI USA, V94, P7730, DOI 10.1073/pnas.94.15.7730; Cruickshank TE, 2014, MOL ECOL, V23, P3133, DOI 10.1111/mec.12796; DOBZHANSKY T, 1973, AM NAT, V107, P312, DOI 10.1086/282833; Gloor G. B., 1992, DROSOPHILA INFORMATI, V71, P148; Gredler JN, 2015, J HERED, V106, P407, DOI 10.1093/jhered/esv027; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heil CSS, 2015, GENOME BIOL EVOL, V7, P2829, DOI 10.1093/gbe/evv182; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Kovacevic M, 2000, GENETICS, V156, P155; Llopart A, 2014, MOL ECOL, V23, P1124, DOI 10.1111/mec.12678; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; McGaugh SE, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001422; McGaugh SE, 2012, PHILOS T R SOC B, V367, P422, DOI 10.1098/rstb.2011.0250; Nei M., 1987, MOL EVOLUTIONARY GEN; Noor MAF, 2009, HEREDITY, V103, P439, DOI 10.1038/hdy.2009.151; Noor MAF, 2000, EVOLUTION, V54, P2174, DOI 10.1111/j.0014-3820.2000.tb01262.x; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Robinson O, 2016, MOL BIOL EVOL, V33, P2163, DOI 10.1093/molbev/msw080; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Staubach F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002891; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Wallace AG, 2013, G3-GENES GENOM GENET, V3, P1151, DOI 10.1534/g3.113.006122; Wang RL, 1997, GENETICS, V147, P1091	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0165032	10.1371/journal.pone.0165032	http://dx.doi.org/10.1371/journal.pone.0165032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760228	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204000078
J	Aaron, GJ; Strutt, N; Boateng, NA; Guevarra, E; Siling, K; Norris, A; Ghosh, S; Nyamikeh, M; Attiogbe, A; Burns, R; Foriwa, E; Toride, Y; Kitamura, S; Tano-Debrah, K; Sarpong, D; Myatt, M				Aaron, Grant J.; Strutt, Nicholas; Boateng, Nathaniel Amoh; Guevarra, Ernest; Siling, Katja; Norris, Alison; Ghosh, Shibani; Nyamikeh, Mercy; Attiogbe, Antoine; Burns, Richard; Foriwa, Esi; Toride, Yasuhiko; Kitamura, Satoshi; Tano-Debrah, Kwaku; Sarpong, Daniel; Myatt, Mark			Assessing Program Coverage of Two Approaches to Distributing a Complementary Feeding Supplement to Infants and Young Children in Ghana	PLOS ONE			English	Article							SAMPLE	The work reported here assesses the coverage achieved by two sales-based approaches to distributing a complementary food supplement (KOKO Plus (TM)) to infants and young children in Ghana. Delivery Model 1 was conducted in the Northern Region of Ghana and used a mixture of health extension workers (delivering behavior change communications and demand creation activities at primary healthcare centers and in the community) and petty traders recruited from among beneficiaries of a local microfinance initiative (responsible for the sale of the complementary food supplement at market stalls and house to house). Delivery Model 2 was conducted in the Eastern Region of Ghana and used a market-based approach, with the product being sold through micro-retail routes (i.e., small shops and roadside stalls) in three districts supported by behavior change communications and demand creation activities led by a local social marketing company. Both delivery models were implemented sub-nationally as 1-year pilot programs, with the aim of informing the design of a scaled-up program. A series of cross-sectional coverage surveys was implemented in each program area. Results from these surveys show that Delivery Model 1 was successful in achieving and sustaining high (i.e., 86%) effective coverage (i.e., the child had been given the product at least once in the previous 7 days) during implementation. Effective coverage fell to 62% within 3 months of the behavior change communications and demand creation activities stopping. Delivery Model 2 was successful in raising awareness of the product (i.e., 90% message coverage), but effective coverage was low (i.e., 9.4%). Future programming efforts should use the health extension/microfinance/petty trader approach in rural settings and consider adapting this approach for use in urban and peri-urban settings. Ongoing behavior change communications and demand creation activities is likely to be essential to the continued success of such programming.	[Aaron, Grant J.] Global Alliance Improved Nutr GAIN, Geneva, Switzerland; [Strutt, Nicholas; Ghosh, Shibani] Int Nutr Fdn INF, Boston, MA USA; [Boateng, Nathaniel Amoh; Tano-Debrah, Kwaku; Sarpong, Daniel] Univ Ghana UG, Accra, Ghana; [Guevarra, Ernest; Siling, Katja; Norris, Alison] Valid Int, Oxford, England; [Ghosh, Shibani] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Nyamikeh, Mercy; Attiogbe, Antoine] CARE Int Ghana, Accra, Ghana; [Burns, Richard] Exp Social Mkt, Accra, Ghana; [Foriwa, Esi] Ghana Hlth Serv, Accra, Ghana; [Toride, Yasuhiko; Kitamura, Satoshi] Ajinomoto Co Inc, Tokyo, Japan; [Myatt, Mark] Brixton Hlth, Llawryglyn, Wales	Tufts University; Ghana Health Service; Ajinomoto Co Inc	Aaron, GJ (corresponding author), Global Alliance Improved Nutr GAIN, Geneva, Switzerland.	grant@grantjaaron.com	Sarpong, Daniel/P-9584-2019	Amoh Boateng, Nathaniel/0000-0003-2320-8376; Guevarra, Ernest/0000-0002-4887-4415	Bill & Melinda Gates Foundation; United States Agency for International Development	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); United States Agency for International Development(United States Agency for International Development (USAID))	Funding for this research was provided by the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org) and the United States Agency for International Development (https://www.usaid.gov). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire S, 2014, WORLD DEV, V59, P251, DOI 10.1016/j.worlddev.2014.01.026; [Anonymous], 2005, STUDIES METHODS DE F, V98; Arimond M, 2003, GENERATING INDICATOR; Baker J. E., 1987, P 2 INT C GEN ALG TH; BENNETT S, 1994, INT J EPIDEMIOL, V23, P1282, DOI 10.1093/ije/23.6.1282; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Daelmans B, 2009, FOOD NUTR BULL, V30, pS236, DOI 10.1177/15648265090302S208; DEKIMPE MG, 1995, MARKET SCI, V14, P1, DOI 10.1287/mksc.14.1.1; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; FAO, IRR AFR FIG AQUASTAT; GEISSER S, 1975, J AM STAT ASSOC, V70, P320, DOI 10.2307/2285815; Ghana Statistical Service, 2011, MULT IND CLUST SURV; Ghana Statistical Service, 2011, GHAN DEM HLTH SURV 2; Ghosh S, 2014, ANN NY ACAD SCI, V1331, P76, DOI 10.1111/nyas.12596; GRODZINS M, 1957, SCI AM, V197, P33, DOI 10.1038/scientificamerican1057-33; Guevarra E., 2013, Field Exchange - Emergency Nutrition Network ENN, P19; Guevarra E., 2014, Field Exchange - Emergency Nutrition Network ENN, P60; Isaaks EH, 1989, APPL GEOSTATISTICS; Isserlis L, 1918, J R STAT SOC, V81, P75, DOI 10.2307/2340569; Kennedy G., 2010, GUID MEAS HOUS IND D; Lauritsen JM, 2004, EPIDATA ENTRY V3 1 C; Myatt M, 2012, SEMIQUANTITATIVE EVA; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; Piazza T., 2010, HDB SURVEY RES; Shepardd A, 1986, P 1968 ACM NAT C, P517; Suchdev PS, 2013, MATERN CHILD NUTR, V9, P78, DOI 10.1111/j.1740-8709.2012.00450.x; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; World Health Organization, 2013, CHILDH STUNT CONT CA; World Health Organization, 2010, IND ASS INF YOUNG CH; World Health Organization (Department of Child and Adolescent Health and Development), 2008, CONCL CONS M HELD 6	32	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0162462	10.1371/journal.pone.0162462	http://dx.doi.org/10.1371/journal.pone.0162462			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755554	gold, Green Published, Green Submitted			2022-12-26	WOS:000386203800003
J	Barbeyron, T; Brillet-Gueguen, L; Carre, W; Carriere, C; Caron, C; Czjzek, M; Hoebeke, M; Michel, G				Barbeyron, Tristan; Brillet-Gueguen, Loraine; Carre, Wilfrid; Carriere, Cathelene; Caron, Christophe; Czjzek, Mirjam; Hoebeke, Mark; Michel, Gurvan			Matching the Diversity of Sulfated Biomolecules: Creation of a Classification Database for Sulfatases Reflecting Their Substrate Specificity	PLOS ONE			English	Article							SYMBIOTIC HOST-SPECIFICITY; STEROID-SULFATASE; HUMAN ARYLSULFATASE; CRYSTAL-STRUCTURE; MOLECULAR CHARACTERIZATION; PSEUDOMONAS-AERUGINOSA; WIDESPREAD OCCURRENCE; RHIZOBIUM-MELILOTI; HYDROLASE FAMILY; BETA-LACTAMASE	Sulfatases cleave sulfate groups from various molecules and constitute a biologically and industrially important group of enzymes. However, the number of sulfatases whose substrate has been characterized is limited in comparison to the huge diversity of sulfated compounds, yielding functional annotations of sulfatases particularly prone to flaws and misinterpretations. In the context of the explosion of genomic data, a classification system allowing a better prediction of substrate specificity and for setting the limit of functional annotations is urgently needed for sulfatases. Here, after an overview on the diversity of sulfated compounds and on the known sulfatases, we propose a classification database, SulfAtlas (http://abims.sb-roscoff.fr/sulfatlas/), based on sequence homology and composed of four families of sulfatases. The formylglycine-dependent sulfatases, which constitute the largest family, are also divided by phylogenetic approach into 73 subfamilies, each subfamily corresponding to either a known specificity or to an uncharacterized substrate. SulfAtlas summarizes information about the different families of sulfatases. Within a family a web page displays the list of its subfamilies (when they exist) and the list of EC numbers. The family or subfamily page shows some descriptors and a table with all the UniProt accession numbers linked to the databases UniProt, ExplorEnz, and PDB.	[Barbeyron, Tristan; Carriere, Cathelene; Czjzek, Mirjam; Michel, Gurvan] Univ Paris 06, Sorbonne Univ, CNRS,CS 90074, UMR 8227,Integrat Biol Marine Models Stn Biol Ros, Roscoff, Bretagne, France; [Brillet-Gueguen, Loraine; Carre, Wilfrid; Caron, Christophe; Hoebeke, Mark] Univ Paris 06, Sorbonne Univ, CNRS FR 2424, FR2424,ABiMS Platform,Stn Biol Roscoff,CS 90074, Roscoff, Bretagne, France; [Carre, Wilfrid] CHU Pontchaillou, Lab Genet Mol & Genom, 2 Rue Henri Le Guilloux, F-35033 Rennes, Bretagne, France; [Carriere, Cathelene] INRIA, 2 Rue Simone Iff,CS 42112, F-75589 Paris 12, Ile De France, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; CHU Rennes; Inria	Barbeyron, T; Michel, G (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS,CS 90074, UMR 8227,Integrat Biol Marine Models Stn Biol Ros, Roscoff, Bretagne, France.	tristan.barbeyron@sb-roscoff.fr; gurvan.michel@sb-roscoff.fr		MICHEL, Gurvan/0000-0002-3009-6205; HOEBEKE, Mark/0000-0001-6311-9752	European Community within the Seventh Framework Program [222628]	European Community within the Seventh Framework Program	This research was supported by the European Community within the Seventh Framework Program under Grant agreement no 222628 (Large collaborative project PolyModE, http://www.polymode.eu/).; This research was supported by the European Community within the Seventh Framework Program under Grant agreement no 222628 (Large collaborative project PolyModE, http://www.polymode.eu/). We are grateful to Corinne Michel for her artistic drawing of the SulfAtlas logo. We also thank Dr. Elizabeth Ficko-Blean for critical reading and English corrections of our manuscript.	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Appel MJ, 2015, ACS CHEM BIOL, V10, P72, DOI 10.1021/cb500897w; Arias S, 2003, EXTREMOPHILES, V7, P319, DOI 10.1007/s00792-003-0325-8; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Barbeyron T, 1998, MOL BIOL EVOL, V15, P528, DOI 10.1093/oxfordjournals.molbev.a025952; BARBEYRON T, 1995, MICROBIOL-UK, V141, P2897, DOI 10.1099/13500872-141-11-2897; Barbeyron T, 2000, J BIOL CHEM, V275, P35499, DOI 10.1074/jbc.M003404200; BEIL S, 1995, EUR J BIOCHEM, V229, P385, DOI 10.1111/j.1432-1033.1995.0385k.x; Boltes I, 2001, STRUCTURE, V9, P483, DOI 10.1016/S0969-2126(01)00609-8; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; Bork P, 1998, NAT GENET, V18, P313, DOI 10.1038/ng0498-313; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Coetzee T, 1998, TRENDS NEUROSCI, V21, P126, DOI 10.1016/S0166-2236(97)01178-8; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dabin J., 2008, ETUDE STRUCTURALE TO, P6; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; DANIELE A, 1993, GENOMICS, V16, P755, DOI 10.1006/geno.1993.1259; Davies G. J., 2008, BIOCHEMIST, V30, P26, DOI DOI 10.1042/BJ20080382; DAVISON J, 1992, GENE, V114, P19, DOI 10.1016/0378-1119(92)90702-Q; DEHOSTOS EL, 1989, MOL GEN GENET, V218, P229, DOI 10.1007/BF00331273; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dierks T, 1999, EMBO J, V18, P2084, DOI 10.1093/emboj/18.8.2084; Dotson SB, 1996, J BIOL CHEM, V271, P25754, DOI 10.1074/jbc.271.42.25754; Eichhorn E, 1997, J BIOL CHEM, V272, P23031, DOI 10.1074/jbc.272.37.23031; Evers M, 1996, P NATL ACAD SCI USA, V93, P8214, DOI 10.1073/pnas.93.16.8214; Ferrante P, 2002, EUR J HUM GENET, V10, P813, DOI 10.1038/sj.ejhg.5200887; FICHTINGERSCHEPMAN AM, 1981, CARBOHYD RES, V93, P105, DOI 10.1016/S0008-6215(00)80756-9; Ficko-Blean E., 2015, PERSPECTIVES PHYCOLO, V2, P51, DOI [10.1127/pip/2015/0028, DOI 10.1127/PIP/2015/0028]; Ficko-Blean E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033524; FRANCO B, 1995, CELL, V81, P15, DOI 10.1016/0092-8674(95)90367-4; Frese MA, 2008, J BIOL CHEM, V283, P11388, DOI 10.1074/jbc.M709917200; FRIDERICI K, 1995, BBA-MOL BASIS DIS, V1271, P369, DOI 10.1016/0925-4439(95)00054-8; Gidda SK, 2003, J BIOL CHEM, V278, P17895, DOI 10.1074/jbc.M211943200; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; Grzyska PK, 2010, P NATL ACAD SCI USA, V107, P3982, DOI 10.1073/pnas.0911565107; Hagelueken G, 2006, P NATL ACAD SCI USA, V103, P7631, DOI 10.1073/pnas.0510501103; HALLMANN A, 1994, EUR J BIOCHEM, V221, P143, DOI 10.1111/j.1432-1033.1994.tb18723.x; HANSON AD, 1994, P NATL ACAD SCI USA, V91, P306, DOI 10.1073/pnas.91.1.306; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; Hehemann JH, 2012, J BIOL CHEM, V287, P30571, DOI 10.1074/jbc.M112.377184; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hernandez-Guzman FG, 2003, J BIOL CHEM, V278, P22989, DOI 10.1074/jbc.M211497200; HOAGLAND KD, 1993, J PHYCOL, V29, P537, DOI 10.1111/j.0022-3646.1993.00537.x; JACKSON CE, 1992, GENOMICS, V14, P403, DOI 10.1016/S0888-7543(05)80233-2; Jam M, 2005, BIOCHEM J, V385, P703, DOI 10.1042/BJ20041044; Jonas S, 2008, J MOL BIOL, V384, P120, DOI 10.1016/j.jmb.2008.08.072; Kahnert A, 2000, J BIOL CHEM, V275, P31661, DOI 10.1074/jbc.M005820200; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KAWANO J, 1989, BIOCHIM BIOPHYS ACTA, V997, P199, DOI 10.1016/0167-4838(89)90187-8; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kertesz MA, 2000, FEMS MICROBIOL REV, V24, P135, DOI 10.1016/S0168-6445(99)00033-9; Knaus T, 2012, FEBS J, V279, P4374, DOI 10.1111/febs.12027; Knaust A, 1998, BIOCHEMISTRY-US, V37, P13941, DOI 10.1021/bi9810205; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; KREYSING J, 1994, GENOMICS, V19, P249, DOI 10.1006/geno.1994.1055; KUNIEDA T, 1995, GENOMICS, V29, P582, DOI 10.1006/geno.1995.9962; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Mann AJ, 2013, APPL ENVIRON MICROB, V79, P6813, DOI 10.1128/AEM.01937-13; Medeiros GF, 2000, BBA-GEN SUBJECTS, V1475, P287, DOI 10.1016/S0304-4165(00)00079-9; Melino S, 1998, TRENDS BIOCHEM SCI, V23, P381, DOI 10.1016/S0968-0004(98)01264-X; Michel G, 2009, GLYCOBIOLOGY, V19, P615, DOI 10.1093/glycob/cwp028; Miech C, 1998, J BIOL CHEM, V273, P4835, DOI 10.1074/jbc.273.9.4835; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Montano AM, 2000, BBA-MOL BASIS DIS, V1500, P323, DOI 10.1016/S0925-4439(99)00119-2; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Mougous JD, 2002, CHEM BIOL, V9, P767, DOI 10.1016/S1074-5521(02)00175-8; Muller I, 2004, BIOCHEMISTRY-US, V43, P3075, DOI 10.1021/bi035752v; Muller I, 2005, J BIOL CHEM, V280, P5716, DOI 10.1074/jbc.M410840200; MUROOKA Y, 1990, J BACTERIOL, V172, P2131, DOI 10.1128/jb.172.4.2131-2140.1990; Myette JR, 2009, J BIOL CHEM, V284, P35189, DOI 10.1074/jbc.M109.053835; Myette JR, 2009, J BIOL CHEM, V284, P35177, DOI 10.1074/jbc.M109.053801; Myette JR, 2003, J BIOL CHEM, V278, P12157, DOI 10.1074/jbc.M211420200; Neres J, 2015, ACS CHEM BIOL, V10, P705, DOI 10.1021/cb5007163; Olsen JL, 2016, NATURE, V530, P331, DOI 10.1038/nature16548; Osteras M, 1998, P NATL ACAD SCI USA, V95, P11394, DOI 10.1073/pnas.95.19.11394; PAIETTA JV, 1989, MOL CELL BIOL, V9, P3630, DOI 10.1128/MCB.9.9.3630; Parolis H, 1996, CARBOHYD RES, V295, P147, DOI 10.1016/S0008-6215(96)00219-4; PETERS C, 1990, J BIOL CHEM, V265, P3374; Pomin VH, 2008, GLYCOBIOLOGY, V18, P1016, DOI 10.1093/glycob/cwn085; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; POULTON JE, 1993, METHODS PLANT BIOCH, V9, P209; Prechoux A, 2016, MAR BIOTECHNOL, V18, P133, DOI 10.1007/s10126-015-9675-3; Prechoux A, 2013, MAR BIOTECHNOL, V15, P265, DOI 10.1007/s10126-012-9483-y; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Reed MJ, 2005, ENDOCR REV, V26, P171, DOI 10.1210/er.2004-0003; Rivera-Colon Y, 2012, J MOL BIOL, V423, P736, DOI 10.1016/j.jmb.2012.08.020; ROBERTSON DA, 1992, BIOCHEM J, V288, P539, DOI 10.1042/bj2880539; ROCHE P, 1991, CELL, V67, P1131, DOI 10.1016/0092-8674(91)90290-F; Salido EC, 1996, NAT GENET, V13, P83, DOI 10.1038/ng0596-83; Sardiello M, 2005, HUM MOL GENET, V14, P3203, DOI 10.1093/hmg/ddi351; SASAKI H, 1988, EUR J BIOCHEM, V177, P9, DOI 10.1111/j.1432-1033.1988.tb14338.x; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; SCOTT HS, 1995, NAT GENET, V11, P465, DOI 10.1038/ng1295-465; Sidhu NS, 2014, ACTA CRYSTALLOGR D, V70, P1321, DOI 10.1107/S1399004714002739; Sieburth JM, 1999, J PHYCOL, V35, P1032, DOI 10.1046/j.1529-8817.1999.3551032.x; Simon-Bercovitch B, 1999, J PHYCOL, V35, P78, DOI 10.1046/j.1529-8817.1999.3510078.x; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Stamatakis A., 2015, CURRENT PROTOCOLS BI, V51, p6.14.1, DOI 10.1002/0471250953.bi0614s51; STEIN C, 1989, J BIOL CHEM, V264, P13865; STEIN C, 1989, J BIOL CHEM, V264, P1252; STREBER WR, 1987, J BACTERIOL, V169, P2950, DOI 10.1128/jb.169.7.2950-2955.1987; Szameit C, 1999, J BIOL CHEM, V274, P15375, DOI 10.1074/jbc.274.22.15375; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOMATSU S, 1991, BIOCHEM BIOPH RES CO, V181, P677, DOI 10.1016/0006-291X(91)91244-7; VARIN L, 1992, P NATL ACAD SCI USA, V89, P1286, DOI 10.1073/pnas.89.4.1286; Vreeland V, 1998, J PHYCOL, V34, P1, DOI 10.1046/j.1529-8817.1998.340001.x; Wegner CE, 2013, MAR GENOM, V9, P51, DOI 10.1016/j.margen.2012.12.001; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wright DP, 2000, J BACTERIOL, V182, P3002, DOI 10.1128/JB.182.11.3002-3007.2000; Yamakoshi Y, 2002, CONNECT TISSUE RES, V43, P167, DOI 10.1080/03008200290001131; YANG Q, 1989, DEV BIOL, V135, P53, DOI 10.1016/0012-1606(89)90157-7; YEN PH, 1987, CELL, V49, P443, DOI 10.1016/0092-8674(87)90447-8	120	78	79	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164846	10.1371/journal.pone.0164846	http://dx.doi.org/10.1371/journal.pone.0164846			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749924	Green Submitted, Green Published, gold			2022-12-26	WOS:000386202300035
J	Saetan, U; Sangket, U; Deachamag, P; Chotigeat, W				Saetan, Uraipan; Sangket, Unitsa; Deachamag, Panchalika; Chotigeat, Wilaiwan			Ovarian Transcriptome Analysis of Vitellogenic and Non-Vitellogenic Female Banana Shrimp (Fenneropenaeus merguiensis)	PLOS ONE			English	Article							FRESH-WATER PRAWN; WHITE SHRIMP; MOLECULAR-CLONING; GENE-EXPRESSION; MITTEN CRAB; DE-MAN; SEROTONIN; MATURATION; CALMODULIN; CALCIUM	The banana shrimp (Fenneropenaeus merguiensis) is one of the most commercially important penaeid species in the world. Its numbers are declining in the wild, leading to a loss of broodstock for farmers of the shrimp and a need for more successful breeding programs. However, the molecular mechanism of the genes involved in this shrimp's ovarian maturation is still unclear. Consequently, we compared transcriptomic profiles of ovarian tissue from females in both the vitellogenic stage and the non-vitellogenic stage. Using RNA-Seq technology to prepare the transcriptome libraries, a total of 12,187,412 and 11,694,326 sequencing reads were acquired from the non-vitellogenic and vitellogenic stages respectively. The analysis of the differentially expressed genes identified 1,025 which were significantly differentially expressed between the two stages, of which 694 were up-regulated and 331 down-regulated. Four genes putatively involved in the ovarian maturation pathway were chosen for validation by quantitative real-time PCR (RT-qPCR). The data from this study provided information about gene expression in ovarian tissue of the banana shrimp which could be useful for a better understanding of the regulation of this species' reproductive cycle.	[Saetan, Uraipan; Sangket, Unitsa; Deachamag, Panchalika; Chotigeat, Wilaiwan] Prince Songkla Univ, Fac Sci, Dept Mol Biotechnol & Bioinformat, Hat Yai, Songkhla, Thailand; [Sangket, Unitsa; Deachamag, Panchalika; Chotigeat, Wilaiwan] Prince Songkla Univ, Fac Sci, Ctr Excellent Genom & Bioinformat Res, Hat Yai, Songkhla, Thailand	Prince of Songkla University; Prince of Songkla University	Chotigeat, W (corresponding author), Prince Songkla Univ, Fac Sci, Dept Mol Biotechnol & Bioinformat, Hat Yai, Songkhla, Thailand.; Chotigeat, W (corresponding author), Prince Songkla Univ, Fac Sci, Ctr Excellent Genom & Bioinformat Res, Hat Yai, Songkhla, Thailand.	wilaiwan58@hotmail.com	Saetan, Uraipan/GQH-3395-2022; Saetan, Uraipan/AAO-7612-2021	Saetan, Uraipan/0000-0003-0554-0543	Science Achievement Scholarship of Thailand (SAST)	Science Achievement Scholarship of Thailand (SAST)	This study was financially supported by the Science Achievement Scholarship of Thailand (SAST).	Acevedo N, 2007, BIOL REPROD, V77, P872, DOI 10.1095/biolreprod.107.060152; Babu K. N., 2013, International Journal of Pharmacy and Life Sciences (IJPLS), V4, P2785; Benninghoff AD, 2005, GEN COMP ENDOCR, V144, P211, DOI 10.1016/j.ygcen.2005.06.005; CARNEGIE JA, 1984, BIOL REPROD, V30, P515, DOI 10.1095/biolreprod30.2.515; CHARNIAUXCOTTON H, 1985, AM ZOOL, V25, P197; CICIRELLI MF, 1987, DEV BIOL, V121, P48, DOI 10.1016/0012-1606(87)90137-0; Forsatkar M. N., 2013, International Research Journal of Applied and Basic Sciences, V4, P1272; FRANCISCO SKS, 1987, J EXP ZOOL, V244, P133, DOI 10.1002/jez.1402440116; Grey DL, 1983, GUIDE AUSTR PENAEID; Ikhwanuddin Mhd, 2012, World Applied Sciences Journal, V18, P436; Kezele PR, 2002, MOL CELL ENDOCRINOL, V192, P37, DOI 10.1016/S0303-7207(02)00114-4; Kishimoto T, 2003, CURR OPIN CELL BIOL, V15, P654, DOI 10.1016/j.ceb.2003.10.010; Klinbunga S, 2015, AQUACULTURE, V435, P18, DOI 10.1016/j.aquaculture.2014.09.013; Kuo CM, 2009, ZOOL STUD, V48, P597; Leelatanawit R, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-15; Maestro MA, 1997, BIOL REPROD, V56, P1126, DOI 10.1095/biolreprod56.5.1126; Makkapan W, 2011, AQUACULTURE, V321, P101, DOI 10.1016/j.aquaculture.2011.08.016; Miura T, 2008, CYBIUM, V32, P130; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakatsuji T, 2009, COMP BIOCHEM PHYS A, V152, P139, DOI 10.1016/j.cbpa.2008.10.012; Palasin K, 2014, AQUACULTURE, V432, P38, DOI 10.1016/j.aquaculture.2014.04.025; Ponza P, 2011, MOL REPROD DEV, V78, P347, DOI 10.1002/mrd.21310; Powell D, 2015, MAR GENOM, V22, P71, DOI 10.1016/j.margen.2015.04.006; Preechaphol R, 2007, J BIOCHEM MOL BIOL, V40, P501; Preechaphol R, 2010, GEN COMP ENDOCR, V168, P440, DOI 10.1016/j.ygcen.2010.06.002; QUACKENBUSH LS, 1992, COMP BIOCHEM PHYS A, V103, P711; Shen BL, 2009, MOL BIOL REP, V36, P1149, DOI 10.1007/s11033-008-9291-7; Subramoniam T, 2011, FISHERIES SCI, V77, P1, DOI 10.1007/s12562-010-0301-z; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tinikul Y, 2008, GEN COMP ENDOCR, V158, P250, DOI 10.1016/j.ygcen.2008.07.009; Uawisetwathana U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024427; Vaca AA, 2000, AQUACULTURE, V182, P373, DOI 10.1016/S0044-8486(99)00267-7; Wong QWL, 2008, MAR BIOTECHNOL, V10, P91, DOI 10.1007/s10126-007-9042-0; Wonglapsuwan M, 2010, MAR BIOTECHNOL, V12, P230, DOI 10.1007/s10126-009-9220-3; Wonglapsuwan M, 2009, AQUAC RES, V40, P633, DOI 10.1111/j.1365-2109.2008.02136.x; Wongprasert K, 2006, AQUACULTURE, V261, P1447, DOI 10.1016/j.aquaculture.2006.08.044; Yariez M, 2012, CALCIUM BINDING PROT; Zeng H, 2011, MAR BIOL RES, V7, P617, DOI 10.1080/17451000.2010.528775; Zhang EF, 2010, DEV GENES EVOL, V220, P151, DOI 10.1007/s00427-010-0336-2; Zhang W, 2011, GENET MOL BIOL, V34, P136, DOI 10.1590/S1415-47572010005000099; Zhao WH, 2011, MOL BIOL REP, V38, P1399, DOI 10.1007/s11033-010-0243-7; Zou ZH, 2011, COMP BIOCHEM PHYS D, V6, P150, DOI 10.1016/j.cbd.2010.12.003	43	15	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164724	10.1371/journal.pone.0164724	http://dx.doi.org/10.1371/journal.pone.0164724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741294	gold, Green Submitted, Green Published			2022-12-26	WOS:000385507000060
J	Sitters, H; York, A; Swan, M; Christie, F; Di Stefano, J				Sitters, Holly; York, Alan; Swan, Matthew; Christie, Fiona; Di Stefano, Julian			Opposing Responses of Bird Functional Diversity to Vegetation Structural Diversity in Wet and Dry Forest	PLOS ONE			English	Article							SPECIES RICHNESS; HABITAT STRUCTURE; FIRE; CONSERVATION; DISTURBANCE; LANDSCAPES; PATTERNS; PRODUCTIVITY; COMMUNITIES; DIVERGENCE	Disturbance regimes are changing worldwide, and the consequences for ecosystem function and resilience are largely unknown. Functional diversity (FD) provides a surrogate measure of ecosystem function by capturing the range, abundance and distribution of trait values in a community. Enhanced understanding of the responses of FD to measures of vegetation structure at landscape scales is needed to guide conservation management. To address this knowledge gap, we used a whole-of-landscape sampling approach to examine relationships between bird FD, vegetation diversity and time since fire. We surveyed birds and measured vegetation at 36 landscape sampling units in dry and wet forest in southeast Australia during 2010 and 2011. Four uncorrelated indices of bird FD (richness, evenness, divergence and dispersion) were derived from six bird traits, and we investigated responses of these indices and species richness to both vertical and horizontal vegetation diversity using linear mixed models. We also considered the extent to which the mean and diversity of time since fire were related to vegetation diversity. Results showed opposing responses of FD to vegetation diversity in dry and wet forest. In dry forest, where fire is frequent, species richness and two FD indices (richness and dispersion) were positively related to vertical vegetation diversity, consistent with theory relating to environmental variation and coexistence. However, in wet forest subject to infrequent fire, the same three response variables were negatively associated with vertical diversity. We suggest that competitive dominance by species results in lower FD as vegetation diversity increases in wet forest. The responses of functional evenness were opposite to those of species richness, functional richness and dispersion in both forest types, highlighting the value of examining multiple FD metrics at management-relevant scales. The mean and diversity of time since fire were uncorrelated with vegetation diversity in wet forest, but positively correlated with vegetation diversity in dry forest. We therefore suggest that protection of older vegetation is important, but controlled application of low-severity fire in dry forest may sustain ecosystem function by enhancing different elements of FD.	[Sitters, Holly; York, Alan; Swan, Matthew; Christie, Fiona; Di Stefano, Julian] Univ Melbourne, Sch Ecosyst & Forest Sci, Creswick, Vic, Australia	University of Melbourne	Sitters, H (corresponding author), Univ Melbourne, Sch Ecosyst & Forest Sci, Creswick, Vic, Australia.	holly.sitters@unimelb.edu.au	York, Alan/M-2443-2015; Di Stefano, Julian/M-9672-2019; Sitters, Holly/L-3302-2019	York, Alan/0000-0003-3161-4075; Di Stefano, Julian/0000-0001-7846-6642; Sitters, Holly/0000-0002-6313-6779; Swan, Matthew/0000-0001-6878-476X	Victorian State Government Department of Environment, Land, Water and Planning; Parks Victoria; Holsworth Wildlife Research Endowment	Victorian State Government Department of Environment, Land, Water and Planning; Parks Victoria; Holsworth Wildlife Research Endowment	This work was funded by the Victorian State Government Department of Environment, Land, Water and Planning (www delwp.vic.gov.au), Parks Victoria (www.parkweb.vic.gov.au) and a Holsworth Wildlife Research Endowment to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2013, FOREST ECOL MANAG, V294, P250, DOI 10.1016/j.foreco.2012.11.039; Bar-Massada A, 2014, ECOGRAPHY, V37, P528, DOI 10.1111/j.1600-0587.2013.00590.x; Barbaro L, 2014, DIVERS DISTRIB, V20, P149, DOI 10.1111/ddi.12132; Barton K, 2015, MUMIN MULTIMODEL INT, V1, P4, DOI DOI 10.1111/J.2041-210X.2012.00261.X; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; Bradstock RA, 2010, LANDSCAPE ECOL, V25, P607, DOI 10.1007/s10980-009-9443-8; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brotons L, 2005, J BIOGEOGR, V32, P789, DOI 10.1111/j.1365-2699.2004.01195.x; Brotons L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062392; Brown AM, 2014, METHODS ECOL EVOL, V5, P344, DOI 10.1111/2041-210X.12163; Bureau of Meteorology, 2015, CLIM DAT ONL; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cheal D., 2010, GROWTH STAGES TOLERA; Costermans L., 2006, NATIVE TREES SHRUBS; Cousin JA, 2008, AUST J ZOOL, V56, P95, DOI 10.1071/ZO07065; Culbert PD, 2013, AUK, V130, P656, DOI 10.1525/auk.2013.13007; Department of Environment and Primary Industries, 2013, 2013 14 2015 16 FIR; Di Stefano J, 2013, BIOL CONSERV, V166, P111, DOI 10.1016/j.biocon.2013.06.022; Dias DFC, 2016, RESTOR ECOL, V24, P259, DOI 10.1111/rec.12293; ESRI, 2011, ARCGIS VERS 10; FAO, 2020, GLOBAL FOREST RESOUR; Fernandes PM, 2013, FRONT ECOL ENVIRON, V11, pE4, DOI 10.1890/120298; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Gonzalez-Maya JF, 2016, DIVERS DISTRIB, V22, P43, DOI 10.1111/ddi.12373; Hidasi-Neto J, 2012, ANIM CONSERV, V15, P407, DOI 10.1111/j.1469-1795.2012.00528.x; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hovick TJ, 2015, ECOL APPL, V25, P662, DOI 10.1890/14-1067.1; Huston M. A., 1994, BIOL DIVERSITY; Huston MA, 2004, DIVERS DISTRIB, V10, P167, DOI 10.1111/j.1366-9516.2004.00083.x; Jankowski JE, 2013, J BIOGEOGR, V40, P950, DOI 10.1111/jbi.12041; Laliberte E., 2014, PACKAGE FD MEASURING; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lindenmayer D, 2015, DIVERS DISTRIB, V21, P836, DOI 10.1111/ddi.12328; Luck GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063671; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Maravalhas J, 2014, J APPL ECOL, V51, P1661, DOI 10.1111/1365-2664.12338; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McWethy DB, 2010, LANDSCAPE ECOL, V25, P533, DOI 10.1007/s10980-009-9437-6; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Parr CL, 2006, CONSERV BIOL, V20, P1610, DOI 10.1111/j.1523-1739.2006.00492.x; Pechony O, 2010, P NATL ACAD SCI USA, V107, P19167, DOI 10.1073/pnas.1003669107; Penman TD, 2007, FOREST ECOL MANAG, V252, P24, DOI 10.1016/j.foreco.2007.06.004; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; R Core Team, 2021, R LANGUAGE ENV STAT; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Seymour CL, 2015, ECOSYSTEMS, V18, P971, DOI 10.1007/s10021-015-9875-8; Sitters H, 2016, ECOL APPL, V26, P115, DOI 10.1890/14-1562; Sitters H, 2015, INT J WILDLAND FIRE, V24, P690, DOI 10.1071/WF14123; Sitters H, 2014, FOREST ECOL MANAG, V331, P227, DOI 10.1016/j.foreco.2014.08.013; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Stoklosa J, 2014, BIOMETRICS, V70, P110, DOI 10.1111/biom.12118; Swan M, 2015, ECOL APPL, V25, P2293, DOI 10.1890/14-1533.1; Taylor RS, 2012, DIVERS DISTRIB, V18, P519, DOI 10.1111/j.1472-4642.2011.00842.x; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thompson PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117595; Tibshirani R., 1996, J R STAT SOC B, V42, P143; Tilman D., 2001, ENCY BIODIVERSITY, P109, DOI DOI 10.1016/B0-12-226865-2/00132-2; Ibarra JT, 2015, BIOL CONSERV, V192, P418, DOI 10.1016/j.biocon.2015.11.008; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Verschuyl JP, 2008, ECOL APPL, V18, P1155, DOI 10.1890/07-0839.1; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; WALKER B, 1995, CONSERV BIOL, V9, P747, DOI 10.1046/j.1523-1739.1995.09040747.x; Wang Y., 2015, MVABUND STAT METHODS; Watson SJ, 2014, FRONT ECOL ENVIRON, V12, P241, DOI 10.1890/130097; Wilsey BJ, 2005, ECOLOGY, V86, P1178, DOI 10.1890/04-0394; Zhang J, 2013, J BIOGEOGR, V40, P1131, DOI 10.1111/jbi.12063; Zuur A, 2009, MIXED EFFECTS MODELS	74	13	13	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164917	10.1371/journal.pone.0164917	http://dx.doi.org/10.1371/journal.pone.0164917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741290	Green Published, gold			2022-12-26	WOS:000385507000082
J	Anazco, C; Lopez-Jimenez, AJ; Rafi, M; Vega-Montoto, L; Zhang, MZ; Hudson, BG; Vanacore, RM				Anazco, Carolina; Lopez-Jimenez, Alberto J.; Rafi, Mohamed; Vega-Montoto, Lorenzo; Zhang, Ming-Zhi; Hudson, Billy G.; Vanacore, Roberto M.			Lysyl Oxidase-like-2 Cross-links Collagen IV of Glomerular Basement Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGION 7S DOMAIN; ENZYMATIC-ACTIVITY; KIDNEY GLOMERULI; 7-S COLLAGEN; EXPRESSION; NETWORK; HYPOXIA; ORGANIZATION; IDENTIFICATION; STABILIZATION	The 7S dodecamer is recognized as an important structural cross-linking domain of collagen IV networks that provide mechanical stability to basement membranes, a specialized form of extracellular matrix essential for the development and maintenance of tissue architecture. Although the 7S dodecamer is stabilized by covalent cross-linking, the molecular mechanism by which such cross-links are formed has not been revealed. Here, we aimed to identify the enzyme(s) that crosslinks the 7S dodecamer and characterize its expression in the kidney glomerulus. Pharmacological inhibition of candidate extracellular matrix enzymes revealed that lysyl oxidase activity is required for cross-linking of 7S polypeptides. Among all lysyl oxidase family members, lysyl oxidase-like-2 (LOXL2) was identified as the isoform cross-linking collagen IV in mouse embryonal PFHR-9 cells. Biochemical analyses revealed that LOXL2 readily promoted the formation of lysyl-derived cross-links in the 7S dodecamer but not in the NC1 domain. We also established that LOXL2 is the main lysyl oxidase family member present in the glomerular extracellular matrix. Altogether, we demonstrate that LOXL2 is a novel component of the molecular machinery that forms cross-linked collagen IV networks, which are essential for glomerular basement membrane stability and molecular ultrafiltration function.	[Anazco, Carolina; Lopez-Jimenez, Alberto J.; Rafi, Mohamed; Vega-Montoto, Lorenzo; Zhang, Ming-Zhi; Hudson, Billy G.; Vanacore, Roberto M.] Vanderbilt Univ, Med Ctr, Div Nephrol & Hypertens, Dept Med, Nashville, TN 37232 USA; [Anazco, Carolina; Lopez-Jimenez, Alberto J.; Vega-Montoto, Lorenzo; Hudson, Billy G.; Vanacore, Roberto M.] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; [Vega-Montoto, Lorenzo] Idaho Natl Lab, Idaho Falls, ID 83415 USA	Vanderbilt University; Vanderbilt University; United States Department of Energy (DOE); Idaho National Laboratory	Vanacore, RM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, 1161 21st Ave S,B-3113 Med Ctr N, Nashville, TN 37232 USA.	roberto.vanacore@vanderbilt.edu	Vanacore, Roberto/AAD-6399-2020; Vega-Montoto, Lorenzo/B-9035-2017; Lopez, Alberto/GWC-5652-2022	Vanacore, Roberto/0000-0002-2886-0606; Vega-Montoto, Lorenzo/0000-0002-4096-1100; Lopez Jimenez, Alberto Jose/0000-0002-4992-631X; Anazco, Carolina/0000-0003-1311-9492; Hudson, Billy/0000-0002-5420-4100	NIDDK, National Institutes of Health [R01 DK099467, R01 DK18381, R01 DK051265]; Vanderbilt Division of Nephrology; Chilean Government; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051265, R01DK018381, R01DK099467] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Vanderbilt Division of Nephrology; Chilean Government; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the NIDDK, National Institutes of Health Grants R01 DK099467, R01 DK18381, and R01 DK051265 and Vanderbilt Division of Nephrology faculty development funds. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported in part by "Becas-Chile" scholarship provided by the Chilean Government.	BAILEY AJ, 1984, BIOCHEM J, V218, P713, DOI 10.1042/bj2180713; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Bignon M, 2011, BLOOD, V118, P3979, DOI 10.1182/blood-2010-10-313296; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; Brukamp K, 2007, AM J PHYSIOL-RENAL, V293, pF1397, DOI 10.1152/ajprenal.00133.2007; CARLSON EC, 1978, J ULTRA MOL STRUCT R, V62, P26, DOI 10.1016/S0022-5320(78)80028-8; Cummings CF, 2016, J CELL BIOL, V213, P479, DOI 10.1083/jcb.201510065; DiDonato A, 1997, NEPHRON, V76, P192, DOI 10.1159/000190168; DUNCAN KG, 1983, J BIOL CHEM, V258, P5869; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Fidler AL, 2014, P NATL ACAD SCI USA, V111, P331, DOI 10.1073/pnas.1318499111; Fong SFT, 2007, GENE CHROMOSOME CANC, V46, P644, DOI 10.1002/gcc.20444; GLANVILLE RW, 1985, EUR J BIOCHEM, V152, P213, DOI 10.1111/j.1432-1033.1985.tb09186.x; Grau-Bove X, 2015, SCI REP-UK, V5, DOI 10.1038/srep10568; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Kagan HM, 2011, BIOL EXTRACELL MATR, P303, DOI 10.1007/978-3-642-16555-9_9; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; LANGEVELD JPM, 1991, J BIOL CHEM, V266, P2622; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorz C, 2008, J AM SOC NEPHROL, V19, P904, DOI 10.1681/ASN.2007050581; Lugassy J, 2012, J BIOL CHEM, V287, P3541, DOI 10.1074/jbc.M111.261016; Martin A, 2015, EMBO J, V34, P1090, DOI 10.15252/embj.201489975; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; Miner JH, 2012, EXP CELL RES, V318, P973, DOI 10.1016/j.yexcr.2012.02.031; Molnar J, 2003, BBA-PROTEINS PROTEOM, V1647, P220, DOI 10.1016/S1570-9639(03)00053-0; Moon HJ, 2013, J BIOL CHEM, V288, P30000, DOI 10.1074/jbc.C113.502310; Neusser MA, 2010, AM J PATHOL, V176, P594, DOI 10.2353/ajpath.2010.090268; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Polgar N, 2007, J BIOL CHEM, V282, P3262, DOI 10.1074/jbc.M609407200; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; REISER K, 1992, FASEB J, V6, P2439, DOI 10.1096/fasebj.6.7.1348714; RISTELI J, 1980, EUR J BIOCHEM, V108, P239, DOI 10.1111/j.1432-1033.1980.tb04717.x; Robertson WE, 2014, J BIOL CHEM, V289, P25601, DOI 10.1074/jbc.M114.571844; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SIEBOLD B, 1987, EUR J BIOCHEM, V168, P569, DOI 10.1111/j.1432-1033.1987.tb13455.x; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; TANG SS, 1983, J BIOL CHEM, V258, P4331; TANZER ML, 1967, BIOCHIM BIOPHYS ACTA, V133, P584, DOI 10.1016/0005-2795(67)90564-8; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; TIMPL R, 1979, FEBS LETT, V101, P265, DOI 10.1016/0014-5793(79)81022-4; TRACKMAN PC, 1979, J BIOL CHEM, V254, P7831; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; Vanacore R, 2011, CLIN EXP IMMUNOL, V164, P4, DOI 10.1111/j.1365-2249.2011.04356.x; Vanacore RM, 2005, J BIOL CHEM, V280, P29300, DOI 10.1074/jbc.M502752200; Vanacore RM, 2004, J BIOL CHEM, V279, P44723, DOI 10.1074/jbc.M406344200; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078; YURCHENCO PD, 1984, BIOCHEMISTRY-US, V23, P1839, DOI 10.1021/bi00303a040; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zhang MZ, 2012, AM J PHYSIOL-RENAL, V302, pF433, DOI 10.1152/ajprenal.00292.2011; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798	62	40	40	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25999	26012		10.1074/jbc.M116.738856	http://dx.doi.org/10.1074/jbc.M116.738856			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27770022	Green Published, hybrid			2022-12-26	WOS:000390345200020
J	Glab, B; Beganovic, M; Anaokar, S; Hao, MS; Rasmusson, AG; Patton-Vogt, J; Banas, A; Stymne, S; Lager, I				Glab, Bartosz; Beganovic, Mirela; Anaokar, Sanket; Hao, Meng-Shu; Rasmusson, Allan G.; Patton-Vogt, Jana; Banas, Antoni; Stymne, Sten; Lager, Ida			Cloning of Glycerophosphocholine Acyltransferase (GPCAT) from Fungi and Plants A NOVEL ENZYME IN PHOSPHATIDYLCHOLINE SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSOMAL PREPARATIONS; BIOSYNTHESIS; GLYCEROPHOSPHOINOSITOL	Glycero-3-phosphocholine (GPC), the product of the complete deacylation of phosphatidylcholine (PC), was long thought to not be a substrate for reacylation. However, it was recently shown that cell-free extracts from yeast and plants could acylate GPC with acyl groups from acyl-CoA. By screening enzyme activities of extracts derived from a yeast knock-out collection, we were able to identify and clone the yeast gene (GPC1) encoding the enzyme, named glycerophosphocholine acyltransferase (GPCAT). By homology search, we also identified and cloned GPCAT genes from three plant species. All enzymes utilize acyl-CoA to acylate GPC, forming lyso-PC, and they show broad acyl specificities in both yeast and plants. In addition to acyl-CoA, GPCAT efficiently utilizes LPC and lysophosphatidylethanolamine as acyl donors in the acylation of GPC. GPCAT homologues were found in the major eukaryotic organism groups but not in prokaryotes or chordates. The enzyme forms its own protein family and does not contain any of the acyl binding or lipase motifs that are present in other studied acyltransferases and transacylases. In vivo labeling studies confirm a role for Gpc1p in PC biosynthesis in yeast. It is postulated that GPCATs contribute to the maintenance of PC homeostasis and also have specific functions in acyl editing of PC (e.g. in transferring acyl groups modified at the sn-2 position of PC to the sn-1 position of this molecule in plant cells).	[Glab, Bartosz; Banas, Antoni] Univ Gdansk, Intercollegiate Fac Biotechnol, PL-80822 Gdansk, Poland; [Glab, Bartosz; Banas, Antoni] Med Univ Gdansk, PL-80822 Gdansk, Poland; [Beganovic, Mirela; Stymne, Sten; Lager, Ida] Swedish Univ Agr Sci, Dept Plant Breeding, S-23053 Alnarp, Sweden; [Anaokar, Sanket; Patton-Vogt, Jana] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Hao, Meng-Shu; Rasmusson, Allan G.] Lund Univ, Dept Biol, Biol Bldg A,Solvegatan 35, S-22362 Lund, Sweden	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Swedish University of Agricultural Sciences; Duquesne University; Lund University	Lager, I (corresponding author), Swedish Univ Agr Sci, Dept Plant Breeding, S-23053 Alnarp, Sweden.	ida.lager@slu.se		Lager, Ida/0000-0001-9755-8534; Glab, Bartosz/0000-0001-6562-5608; Banas, Antoni/0000-0001-9397-7627	PlantLink, the Strategic Research Area project "Trees and Crops for the Future"; Foundation for Strategic research (SSF) project "Oil Crops for the Future"; National Institutes of Health [R15 GM104876]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM104876] Funding Source: NIH RePORTER	PlantLink, the Strategic Research Area project "Trees and Crops for the Future"; Foundation for Strategic research (SSF) project "Oil Crops for the Future"; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from PlantLink, the Strategic Research Area project "Trees and Crops for the Future," and the Foundation for Strategic research (SSF) project "Oil Crops for the Future" and by National Institutes of Health Grant R15 GM104876 (to J. P.-V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almaguer C, 2004, J BIOL CHEM, V279, P31937, DOI 10.1074/jbc.M403648200; BAFOR M, 1991, BIOCHEM J, V280, P507, DOI 10.1042/bj2800507; Bishop AC, 2013, J BIOL CHEM, V288, P33939, DOI 10.1074/jbc.M113.505735; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen GQ, 2015, LIPIDS, V50, P1057, DOI 10.1007/s11745-015-4069-x; Cheng LY, 2011, PLANT PHYSIOL, V156, P1131, DOI 10.1104/pp.111.173724; DAWSON RMC, 1955, BIOCHEM J, V59, P5, DOI 10.1042/bj0590005; De Smet CH, 2013, BBA-MOL CELL BIOL L, V1831, P1167, DOI 10.1016/j.bbalip.2013.03.002; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; Guan R, 2014, PLANT BIOTECHNOL J, V12, P193, DOI 10.1111/pbi.12128; Hanscho M, 2012, FEMS YEAST RES, V12, P796, DOI 10.1111/j.1567-1364.2012.00830.x; Jones AM, 2014, SCIENCE, V344, P711, DOI 10.1126/science.1251358; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lagace TA, 2013, BBA-MOL CELL RES, V1833, P2499, DOI 10.1016/j.bbamcr.2013.05.018; Lager I, 2015, PLANTA, V241, P347, DOI 10.1007/s00425-014-2184-1; Lager I, 2013, J BIOL CHEM, V288, P36902, DOI 10.1074/jbc.M113.521815; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Liu YF, 2015, J NANOMATER, V2015, DOI 10.1155/2015/792095; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Patton-Vogt JL, 1998, GENETICS, V149, P1707; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; SANCHEZ M, 1973, BIOCHEM J, V132, P697, DOI 10.1042/bj1320697; Siltberg-Liberles J, 2011, GENES-BASEL, V2, P748, DOI 10.3390/genes2040748; Stalberg K, 2008, J LIPID RES, V49, P1794, DOI 10.1194/jlr.M800129-JLR200; Surlow BA, 2014, J BIOL CHEM, V289, P31591, DOI 10.1074/jbc.M114.581157; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]	27	15	18	2	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25066	25076		10.1074/jbc.M116.743062	http://dx.doi.org/10.1074/jbc.M116.743062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27758859	Green Published, hybrid			2022-12-26	WOS:000388880100022
J	Koh, EH; Chen, Y; Bader, DA; Hamilton, MP; He, B; York, B; Kajimura, S; McGuire, SE; Hartig, SM				Koh, Eun Hee; Chen, Yong; Bader, David A.; Hamilton, Mark P.; He, Bin; York, Brian; Kajimura, Shingo; McGuire, Sean E.; Hartig, Sean M.			Mitochondrial Activity in Human White Adipocytes Is Regulated by the Ubiquitin Carrier Protein 9/microRNA-30a Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOSE-TISSUE; GLUCOSE-HOMEOSTASIS; HUMAN ADIPOGENESIS; BEIGE FAT; EXPRESSION; MICRORNA; PRDM16; CELLS; ACTIVATION; PROGRAM	The acquisition of beige adipocyte features by white fat cells corresponds to protection against obesity-induced metabolic diseases in humans and animal models of type 2 diabetes. In adipose tissue, expression of the F2 small ubiquitin-like modifier ligase ubiquitin carrier protein 9 (Ubc9) is positively correlated with markers of insulin resistance and corresponds with impaired browning of human white adipocytes. However, the molecular regulation of Ubc9 expression in adipocytes and other cells remains unclear. In this study, we demonstrate that the mRNA and protein expression of Ubc9 are regulated by the microRNA miRNA-30a (milk-30a) in human subcutaneous adipocytes. Ubc9 and miR-30a exhibit inverse expression in adipose tissue, with miR-30a robustly elevated in brown fat. Depletion of Ubc9 by siRNA or enforced expression of a miR-30a mimic augments mitochondrial volume and respiration in human white adipocytes, reflecting features of brown fat cells. Furthermore, Ubc9 depletion induces a brown fat gene program in human subcutaneous adipocytes. Induction of the beige-selective gene program corresponds to stabilization of the PR domain-containing 16 (PRDM16) protein, an obligate transcriptional regulator of the brown/beige fat metabolic program in white adipocytes that interacts with Ubc9. Taken together, our data demonstrate a previously unappreciated molecular axis that controls browning of human white adipocytes.	[Koh, Eun Hee; Bader, David A.; Hamilton, Mark P.; He, Bin; York, Brian; McGuire, Sean E.; Hartig, Sean M.] Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza,BCM130, Houston, TX 77030 USA; [He, Bin] Baylor Coll Med, Dept Med, Div Hematol & Oncol, Houston, TX 77030 USA; [Koh, Eun Hee] Asan Med Ctr, Dept Internal Med, Seoul 138736, South Korea; [Chen, Yong; Kajimura, Shingo] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Chen, Yong; Kajimura, Shingo] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [McGuire, Sean E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Ulsan; Asan Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center	Hartig, SM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza,BCM130, Houston, TX 77030 USA.	hartig@bcm.edu	Kajimura, Shingo/AAC-5090-2019	Kajimura, Shingo/0000-0003-0672-5910	National Institutes of Health [K01DK096093, R03DK105006, R21CA205257, F30CA196108, R01GM033976, K01DK081446, R01DK97441]; American Heart Association [15BGIA25850025]; Baylor College of Medicine Bridge to Independence program; Alkek Center for Molecular Discovery; Caroline Weiss Law Foundation; Prostate Cancer Research Foundation; American Cancer Society [RSG-13-061-01-TBE]; Baylor College of Medicine Diabetes and Endocrinology Research Center [P30-DK079638]; NATIONAL CANCER INSTITUTE [R21CA205257, F30CA196108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, K01DK096093, K01DK081446, P30DK079638, R03DK105006, R01DK097441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Baylor College of Medicine Bridge to Independence program; Alkek Center for Molecular Discovery; Caroline Weiss Law Foundation; Prostate Cancer Research Foundation; American Cancer Society(American Cancer Society); Baylor College of Medicine Diabetes and Endocrinology Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants K01DK096093 and R03DK105006, American Heart Association Beginning Grant-in-Aid 15BGIA25850025, the Baylor College of Medicine Bridge to Independence program, and the Alkek Center for Molecular Discovery (to S. M. H.). This work was also supported by the Caroline Weiss Law Foundation, National Institutes of Health Grant R21CA205257, and the Prostate Cancer Research Foundation (to S. E. M.). Additional support was provided by National Institutes of Health Grants F30CA196108 (to D. A. B.), R01GM033976 (to A. R. M.), K01DK081446 (to B. H.), and R01DK97441 (to S.K.); American Cancer Society Grant RSG-13-061-01-TBE (to B. H.), and Baylor College of Medicine Diabetes and Endocrinology Research Center Grant P30-DK079638. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Allgood VE, 1997, BIOCHEMISTRY-US, V36, P224, DOI 10.1021/bi961125c; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Civelek M, 2013, HUM MOL GENET, V22, P3023, DOI 10.1093/hmg/ddt159; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Forini F, 2014, ENDOCRINOLOGY, V155, P4581, DOI 10.1210/en.2014-1106; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Hamilton MP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3730; Harms MJ, 2015, GENE DEV, V29, P298, DOI 10.1101/gad.252734.114; Hartig SM, 2015, MOL ENDOCRINOL, V29, P1320, DOI 10.1210/me.2015-1084; Hartig SM, 2012, CHEM BIOL, V19, P1126, DOI 10.1016/j.chembiol.2012.07.020; Hu F, 2015, DIABETES, V64, P2056, DOI 10.2337/db14-1117; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Keuper M, 2014, FASEB J, V28, P761, DOI 10.1096/fj.13-238725; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Nishikata I, 2011, ONCOGENE, V30, P4194, DOI 10.1038/onc.2011.132; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Preusse M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151771; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2015, DIABETES, V64, P2369, DOI 10.2337/db15-0203; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110; Yehuda-Shnaidman E, 2010, DIABETES, V59, P2474, DOI 10.2337/db10-0245; Ying SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075695; Yu Y, 2012, LEUKEMIA, V26, P1752, DOI 10.1038/leu.2012.65; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zou ZY, 2012, J BIOL CHEM, V287, P4148, DOI 10.1074/jbc.M111.307405	47	18	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24747	24755		10.1074/jbc.M116.749408	http://dx.doi.org/10.1074/jbc.M116.749408			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27758866	Green Published, hybrid			2022-12-26	WOS:000388875500032
J	Silva, ND; Reis, RD; Cunha, RG; Oliveira, JFP; Santos, MD; Pombo-de-Oliveira, MS; de Camargo, B				Silva, Neimar de Paula; Reis, Rejane de Souza; Cunha, Rafael Garcia; Pinto Oliveira, Julio Fernando; Santos, Marceli de Oliveira; Pombo-de-Oliveira, Maria S.; de Camargo, Beatriz			Maternal and Birth Characteristics and Childhood Embryonal Solid Tumors: A Population-Based Report from Brazil	PLOS ONE			English	Article							RISK-FACTORS; WILMS-TUMOR; CANCER; CHILDREN; RETINOBLASTOMA; LEUKEMIA; QUALITY; WEIGHT; INDIVIDUALS; ANOMALIES	Background Several maternal and birth characteristics have been reported to be associated with an increased risk of many childhood cancers. Our goal was to evaluate the risk of childhood embryonal solid tumors in relation to pre- and perinatal characteristics. Methods A case-cohort study was performed using two population-based datasets, which were linked through R software. Tumors were classified as central nervous system (CNS) or non-CNS-embryonal (retinoblastoma, neuroblastoma, renal tumors, germ cell tumors, hepatoblastoma and soft tissue sarcoma). Children aged <6 years were selected. Adjustments were made for potential confounders. Odds ratios (OR) with 95% confidence intervals (CI) were computed by unconditional logistic regression analysis using SPSS. Results Males, high maternal education level, and birth anomalies were independent risk factors. Among children diagnosed older than 24 months of age, cesarean section (CS) was a significant risk factor. Five-minute Apgar <= 8 was an independent risk factor for renal tumors. A decreasing risk with increasing birth order was observed for all tumor types except for retinoblastoma. Among children with neuroblastoma, the risk decreased with increasing birth order (OR = 0.82 (95% CI 0.67-1.01)). Children delivered by CS had a marginally significantly increased OR for all tumors except retinoblastoma. High maternal education level showed a significant increase in the odds for all tumors together, CNS tumors, and neuroblastoma. Conclusion This evidence suggests that male gender, high maternal education level, and birth anomalies are risk factors for childhood tumors irrespective of the age at diagnosis. Cesarean section, birth order, and 5-minute Apgar score were risk factors for some tumor subtypes.	[Silva, Neimar de Paula; Pombo-de-Oliveira, Maria S.; de Camargo, Beatriz] Inst Nacl Canc, Res Ctr, Pediat Hematol & Oncol Program, Rio De Janeiro, RJ, Brazil; [Reis, Rejane de Souza; Cunha, Rafael Garcia; Pinto Oliveira, Julio Fernando; Santos, Marceli de Oliveira] Inst Nacl Canc, Div Vigilancia & Anal Situacao Coordenacao Preven, Rio De Janeiro, RJ, Brazil	National Cancer Institute (Inca); National Cancer Institute (Inca)	de Camargo, B (corresponding author), Inst Nacl Canc, Res Ctr, Pediat Hematol & Oncol Program, Rio De Janeiro, RJ, Brazil.	bdecamar@terra.com.br	de S Reis, Rejane/B-1513-2015; de Camargo, Beatriz/I-8414-2014; Pombo-de-Oliveira, Maria S./I-8884-2014	de S Reis, Rejane/0000-0003-3067-0526; de Camargo, Beatriz/0000-0002-5794-1042; DE PAULA SILVA, NEIMAR/0000-0002-0105-8509; Pombo-de-Oliveira, Maria S./0000-0002-1507-004X	CAPES/MS; CNPq [306291/2014-2]	CAPES/MS; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	NPS has a scholarship from CAPES/MS. BDC has a scholar grant from CNPq 306291/2014-2.; The authors are grateful to all of the coordinators of the PBCRs and SINASCs in Brazil who contributed the datasets that made this work possible. NPS has a scholarship from CAPES/MS. BDC has a scholar grant from CNPq 306291/2014-2.	Adams KM, 2004, JAMA-J AM MED ASSOC, V291, P1127, DOI 10.1001/jama.291.9.1127; Agboola AJ, 2009, MED J AUSTRALIA, V190, P12, DOI 10.5694/j.1326-5377.2009.tb02254.x; [Anonymous], 2014, CANC ATLAS; [Anonymous], 2014, R LANG ENV STAT COMP; Ferreira JSA, 2011, CIENC SAUDE COLETIVA, V16, P1241, DOI 10.1590/S1413-81232011000700056; APGAR V, 1953, Curr Res Anesth Analg, V32, P260; AUTRUP H, 1993, ENVIRON HEALTH PERSP, V101, P33, DOI 10.2307/3431373; Barahmani N, 2015, PEDIATR HEMAT ONCOL, V32, P382, DOI 10.3109/08880018.2015.1052867; Bhuvaneswari A, 2012, INDIAN J MED PAEDIAT, V33, P210, DOI 10.4103/0971-5851.107080; Borg A, RECORDLINKAGE RECORD; Botto LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069077; Carozza SE, 2010, BRIT J CANCER, V103, P136, DOI 10.1038/sj.bjc.6605732; Chen L, 2010, ENVIRON RES, V110, P162, DOI 10.1016/j.envres.2009.11.001; Chu AN, 2010, PAEDIATR PERINAT EP, V24, P449, DOI 10.1111/j.1365-3016.2010.01133.x; Clericuzio CL, 1999, AM J MED GENET, V89, P81, DOI 10.1002/(SICI)1096-8628(19990625)89:2<81::AID-AJMG5>3.0.CO;2-I; Dawson S, 2015, BIRTH DEFECTS RES A, V103, P284, DOI 10.1002/bdra.23364; de Camargo B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-160; de Frias PG, 2014, CAD SAUDE PUBLICA, V30, P2068, DOI 10.1590/0102-311X00196113; Dehner LP, 1998, MODERN PATHOL, V11, P669; Ekbom A, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P415, DOI 10.1017/CBO9780511544699.032; Fisher PG, 2012, J PEDIATR-US, V160, P978, DOI 10.1016/j.jpeds.2011.12.006; Forman D, 2013, CANC INCIDENCE 5 CON, VX; Francis SS, 2014, CANCER EPIDEM BIOMAR, V23, P876, DOI 10.1158/1055-9965.EPI-13-1098; Gatta G, 2012, EUR J CANCER, V48, P1425, DOI 10.1016/j.ejca.2011.12.027; GILSTRAP LC, 1987, OBSTET GYNECOL, V70, P191; Gomes UA, 1999, INT J EPIDEMIOL, V28, P687, DOI 10.1093/ije/28.4.687; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Hasle H, 2001, LANCET ONCOL, V2, P429, DOI 10.1016/S1470-2045(00)00435-6; Hitzler JK, 2005, NAT REV CANCER, V5, P11, DOI 10.1038/nrc1525; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2011, EST AN INF DEM SOC R; Johnson KJ, 2009, EPIDEMIOLOGY, V20, P475, DOI 10.1097/EDE.0b013e3181a5a332; Kobayashi T, 2014, PEDIATR BLOOD CANCER, V61, P363, DOI 10.1002/pbc.24693; Leal-Leal C, 2004, BRIT J OPHTHALMOL, V88, P1074, DOI 10.1136/bjo.2003.035642; Li J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001095; Lupo PJ, 2010, PAEDIATR PERINAT EP, V24, P200, DOI 10.1111/j.1365-3016.2010.01096.x; Luquetti DV, 2009, CAD SAUDE PUBLICA, V25, P1721, DOI 10.1590/S0102-311X2009000800008; Momen NC, 2014, BJOG-INT J OBSTET GY, V121, P1343, DOI 10.1111/1471-0528.12667; Narod SA, 1997, AM J HUM GENET, V60, P474; O'Neill KA, 2015, INT J EPIDEMIOL, V44, P153, DOI 10.1093/ije/dyu265; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Onubogu CU, 2016, PAEDIATR INT CHILD H, P1; Orjuela M, 2000, CLIN CANCER RES, V6, P4010; Partap S, 2011, PEDIATRICS, V128, pE652, DOI 10.1542/peds.2010-3637; Paula Silva N De, 2016, PAN AM J PUBLIC HLTH, V40, pxxx; Puumala SE, 2008, INT J CANCER, V122, P1368, DOI 10.1002/ijc.23275; Querec L J, 1980, Vital Health Stat 2, P1; Fernando ATRGI, 2008, CAD SAUDE PUBLICA, V24, P140, DOI 10.1590/S0102-311X2008000100014; Romero DE, 2007, CAD SAUDE PUBLICA, V23, P701, DOI 10.1590/S0102-311X2007000300028; Saletta F, 2015, TRANSL PEDIATR, V4, P67, DOI 10.3978/j.issn.2224-4336.2015.04.08; Sankaran H, 2016, PEDIATR BLOOD CANCER, V63, P1557, DOI 10.1002/pbc.26065; Schuz J, 2011, INT J CANCER, V128, P2166, DOI 10.1002/ijc.25541; Spector LG, 2015, PEDIATR CLIN N AM, V62, P11, DOI 10.1016/j.pcl.2014.09.013; Spracklen CN, 2014, CANCER EPIDEMIOL, V38, P538, DOI 10.1016/j.canep.2014.07.004; SZKLO M., 2014, EPIDEMIOLOGY BASICS, V3; Urayama KY, 2007, AM J EPIDEMIOL, V165, P486, DOI 10.1093/aje/kwk041; Von Behren J, 2011, INT J CANCER, V128, P2709, DOI 10.1002/ijc.25593; Wilne S, 2007, LANCET ONCOL, V8, P685, DOI 10.1016/S1470-2045(07)70207-3	57	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164398	10.1371/journal.pone.0164398	http://dx.doi.org/10.1371/journal.pone.0164398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768709	gold, Green Published, Green Submitted			2022-12-26	WOS:000386205400012
J	Chang, MH; Chu, XY; Lv, JZ; Li, QB; Tian, J; Wu, NF				Chang, Meihui; Chu, Xiaoyu; Lv, Jinzhi; Li, Qingbin; Tian, Jian; Wu, Ningfeng			Improving the Thermostability of Acidic Pullulanase from Bacillus naganoensis by Rational Design	PLOS ONE			English	Article							ESCHERICHIA-COLI; I PULLULANASE; SIMULTANEOUS SACCHARIFICATION; DERAMIFICANS PULLULANASE; ENHANCED THERMOSTABILITY; CATALYTIC EFFICIENCY; SOLUBLE EXPRESSION; DIRECTED EVOLUTION; CLONING; STARCH	Pullulanase (EC 3.2.1.41) plays an important role in the specific hydrolysis of branch points in amylopectin. Enhancing its thermostability is required for its industrial application. In this study, rational protein design was used to improve the thermostability of PulB from Bacillus naganoensis (AB231790.1), which has strong enzymatic properties. Three positive single-site mutants (PulB-D328H, PulB-N387D, and PulB-A414P) were selected from six mutants. After incubation at 65 degrees C for 5 min, the residual activities of PulB-D328H, PulB-N387D, and PulB-A414P were 4.5-, 1.7-, and 1.47-fold higher than PulB-WT, and their T-m values (the temperature at which half protein molecule denature) were 1.8 degrees C, 0.4 degrees C, and 0.9 degrees C higher than PulB-WT, respectively. Then the final combined mutant PulB-328/387/414 was constructed. The t(1/2) of it was 12.9-fold longer than that of PulB-WT at 65 degrees C and the total increase in T-m of it (5.0 degrees C) was almost 60% greater than the sum of individual increases (3.1 degrees C). In addition, kinetic studies revealed that the k(cat) and the k(cat)/K-m of PulB-328/387/414 increased by 38.8% and 12.9%. The remarkable improvement in thermostability and the high catalytic efficiency of PulB-328/387/414 make it suitable for industrial applications.	[Chang, Meihui; Chu, Xiaoyu; Tian, Jian; Wu, Ningfeng] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100081, Peoples R China; [Lv, Jinzhi] Jiangxi Agr Univ, Inst Food Sci & Engn, Nanchang 330045, Peoples R China; [Li, Qingbin] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Jiangxi Agricultural University; China Agricultural University	Wu, NF (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100081, Peoples R China.	wuningfeng@caas.cn			National High Technology Research and Development Program of China (863 Program) [2014AA021303]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (863 Program, 2014AA021303).	Bertoldo C, 2004, APPL ENVIRON MICROB, V70, P3407, DOI 10.1128/AEM.70.6.3407-3416.2004; Chai YY, 2012, ENVIRON TECHNOL, V33, P1231, DOI 10.1080/09593330.2011.618935; Chen A, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-015-0403-5; Chen A, 2015, ENZYME MICROB TECH, V78, P74, DOI 10.1016/j.enzmictec.2015.06.013; Cheng C., 1992, FOOD FERMENTATION PR, V6, P74; Crabb WD, 1999, CURR OPIN MICROBIOL, V2, P252, DOI 10.1016/S1369-5274(99)80044-7; Duan XG, 2015, APPL ENVIRON MICROB, V81, P1926, DOI 10.1128/AEM.03714-14; Duan XG, 2013, APPL ENVIRON MICROB, V79, P4072, DOI 10.1128/AEM.00457-13; Hii Siew Ling, 2012, Enzyme Res, V2012, P921362; Iv J., 2015, IMPROVING THERMAL ST; Jinzhi L, 2015, PROGR PULLULANASE GE, V17, P85; Kang J, 2011, ENZYME MICROB TECH, V48, P260, DOI 10.1016/j.enzmictec.2010.11.006; Kanth BK, 2010, COMPUT BIOL CHEM, V34, P226, DOI 10.1016/j.compbiolchem.2010.08.002; Kriegshauser G, 2000, J CHROMATOGR B, V737, P245, DOI 10.1016/S0378-4347(99)00373-4; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; Lehmann M, 2000, BBA-PROTEIN STRUCT M, V1543, P408, DOI 10.1016/S0167-4838(00)00238-7; Li SF, 2015, J BIOTECHNOL, V210, P8, DOI 10.1016/j.jbiotec.2015.06.406; Li YR, 2012, J AGR FOOD CHEM, V60, P11164, DOI 10.1021/jf303109u; Moshi AP, 2015, BIORESOURCE TECHNOL, V180, P128, DOI 10.1016/j.biortech.2014.12.087; Mu GC, 2015, APPL BIOCHEM BIOTECH, V176, P1736, DOI 10.1007/s12010-015-1675-2; Nie Y, 2012, Patent No. [CN102994425A, 102994425]; Nie Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078416; Nisha M, 2013, BIOENGINEERED, V4, P388, DOI 10.4161/bioe.24629; Nisha M, 2013, APPL MICROBIOL BIOT, V97, P6279, DOI 10.1007/s00253-012-4538-6; Nowacka O, 2016, INT J BIOL MACROMOL, V82, P54, DOI 10.1016/j.ijbiomac.2015.10.029; Oh KK, 1996, RENEW ENERG, V9, P962, DOI 10.1016/0960-1481(96)88440-0; Qin Yan, 2014, J BIOTECHNOL, V24, P53; Rajaei S, 2015, EXTREMOPHILES, V19, P1145, DOI 10.1007/s00792-015-0786-6; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Shi MM, 2013, FOOD HYDROCOLLOID, V33, P19, DOI 10.1016/j.foodhyd.2013.02.018; Stefanova ME, 1999, EXTREMOPHILES, V3, P147, DOI 10.1007/s007920050110; Sun X, 2011, CHIN M; Tester RF, 2004, WORLD POULTRY SCI J, V60, P186, DOI [10.1079/WPS200312, 10.1079/WPS200412, 10.1079/WPS20040014]; Thompson JD, 2006, CURR BIOINFORM, V1, P95, DOI 10.2174/157489306775330552; Tian J, 2013, APPL MICROBIOL BIOT, V97, P2997, DOI 10.1007/s00253-012-4411-7; Tian JA, 2010, FEBS J, V277, P4901, DOI 10.1111/j.1742-4658.2010.07895.x; Tian JA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-370; Ummirul Mukminin K, 2013, INT J MOL SCI, V14, P11302, DOI [10.3390/ijms140611302, DOI 10.3390/IJMS140611302]; Wang K, 2014, APPL ENVIRON MICROB, V80, P2158, DOI 10.1128/AEM.03458-13; Wang PL, 2016, PROTEIN EXPRES PURIF, V120, P35, DOI 10.1016/j.pep.2015.12.010; Xie N, 2012, Patent No. [CN102796751A, 102796751]; Xu B, 2006, J MICROBIOL BIOTECHN, V16, P1185; Yan Wei, 2013, Weishengwu Xuebao, V53, P145; Zafar A, 2016, APPL BIOCHEM BIOTECH, V178, P831, DOI 10.1007/s12010-015-1912-8; Zhang Y, 2015, DIFFERENTIAL SCANNIN, V1252, P101, DOI [10.1007/978-1-4939-2131-7_10, DOI 10.1007/978-1-4939-2131-7_10]; Zheng Xiaomei, 2012, Sheng Wu Gong Cheng Xue Bao, V28, P488; Zou C, 2014, BIORESOURCE TECHNOL, V172, P174, DOI 10.1016/j.biortech.2014.09.035	47	12	13	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165006	10.1371/journal.pone.0165006	http://dx.doi.org/10.1371/journal.pone.0165006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764201	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500101
J	Dutt-Mazumder, A; Slobounov, SM; Challis, JH; Newell, KM				Dutt-Mazumder, Aviroop; Slobounov, Seymon M.; Challis, John Henry; Newell, Karl Maxim			Postural Stability Margins as a Function of Support Surface Slopes	PLOS ONE			English	Article							OF-PRESSURE TRAJECTORIES; TIME; BOUNDARIES; BALANCE; STANCE; LIMITS	This investigation examined the effects of slope of the surface of support (35 degrees, 30 degrees, 20 degrees, 10 degrees Facing(Toe) Down, 0 degrees Flat and 10 degrees, 20 degrees, 25 degrees Facing (Toe) Up) and postural orientation on the margins of postural stability in quiet standing of young adults. The findings showed that the center of pressure-CoP (displacement, area and length) had least motion at the baseline (0 degrees Flat) platform condition that progressively increased as a function of platform angle in both facing up and down directions. The virtual time to collision (VTC) dynamics revealed that the spatio-temporal margins to the functional stability boundary were progressively smaller and the VTC time series also more regular (SampEn-Sample Entropy) as slope angle increased. Surface slope induces a restricted stability region with lower dimension VTC dynamics that is more constrained when postural orientation is facing down the slope. These findings provide further evidence that VTC acts as a control variable in standing posture that is influenced by the emergent dynamics of the individual-environment-task interaction.	[Dutt-Mazumder, Aviroop; Slobounov, Seymon M.; Challis, John Henry] Penn State Univ, Dept Kinesiol, State Coll, PA 16801 USA; [Newell, Karl Maxim] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University System of Georgia; University of Georgia	Dutt-Mazumder, A (corresponding author), Penn State Univ, Dept Kinesiol, State Coll, PA 16801 USA.	duttamaz@musc.edu	Dutt-Mazumder, Aviroop/H-6831-2019	Dutt-Mazumder, Aviroop/0000-0002-6256-0578				Adolph KE, 2000, INFANT BEHAV DEV, V23, P441, DOI 10.1016/S0163-6383(01)00052-2; ANISS AM, 1990, J NEUROPHYSIOL, V64, P661, DOI 10.1152/jn.1990.64.2.661; CARELLO C, 1985, BEHAV BRAIN SCI, V8, P151, DOI 10.1017/S0140525X00020021; CHAPMAN JP, 1987, NEUROPSYCHOLOGIA, V25, P579, DOI 10.1016/0028-3932(87)90082-0; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Duarte M, 2000, NEUROSCI LETT, V283, P173, DOI 10.1016/S0304-3940(00)00960-5; Duarte M, 2008, EXP BRAIN RES, V191, P265, DOI 10.1007/s00221-008-1521-7; Emerich R, 1993, ANN AM IND HYG C EXP, P104; GOLDIE PA, 1989, ARCH PHYS MED REHAB, V70, P510; Gutnik B, 2008, ACTA MED OKAYAMA, V62, P175; Haibach PS, 2007, EXP BRAIN RES, V177, P471, DOI 10.1007/s00221-006-0703-4; Holbein MA, 1997, INT J IND ERGONOM, V19, P387, DOI 10.1016/S0169-8141(96)00023-6; Ihlen EAF, 2013, J BIOMECH, V46, P484, DOI 10.1016/j.jbiomech.2012.10.016; Kilby MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108905; King DL, 1997, GAIT POSTURE, V6, P27, DOI 10.1016/S0966-6362(96)01101-0; Kluzik J, 2005, EXP BRAIN RES, V162, P474, DOI 10.1007/s00221-004-2124-6; Mayo AM, 2011, PSYCHOL SCI, V22, P118, DOI 10.1177/0956797610392927; MURRAY MP, 1975, J BONE JOINT SURG AM, VA 57, P510, DOI 10.2106/00004623-197557040-00012; Myklebust J. B., 1989, SOC NEUR M; Newell K.M., 1986, MOTOR DEV CHILDREN A, VVolume 34, P341, DOI DOI 10.1007/978-94-009-4460-2_19; Patton JL, 1999, GAIT POSTURE, V9, P38, DOI 10.1016/S0966-6362(98)00037-X; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; RICCIO GE, 1993, VARIABILITY AND MOTOR CONTROL, P317; Riley MA., 1997, MOT CONTROL, V1, P229, DOI [10.1123/mcj.1.3.229, DOI 10.1123/MCJ.1.3.229]; Rothwell J., 1994, CONTROL HUMAN VOLUNT, P252; Shin G, 2004, ERGONOMICS, V47, P646, DOI 10.1080/00140130310001653066; Slobounov S., 2006, EUR REV AGING PHYS A, V3, P55, DOI [10.1007/s11556-006-0012-8, DOI 10.1007/S11556-006-0012-8]; Slobounov SM, 1997, J MOTOR BEHAV, V29, P263, DOI 10.1080/00222899709600841; Slobounov SM, 1998, J GERONTOL A-BIOL, V53, pB71, DOI 10.1093/gerona/53A.1.B71; van Wegen EEH, 2001, MOTOR CONTROL, V5, P254, DOI 10.1123/mcj.5.3.254; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; ZHAO Y, 1987, ERGONOMICS, V30, P1671, DOI 10.1080/00140138708966057	33	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164913	10.1371/journal.pone.0164913	http://dx.doi.org/10.1371/journal.pone.0164913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764158	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204500080
J	Fang, L; Chen, Q; Shi, KR; Li, X; Shi, QC; He, F; Zhou, JC; Yu, YS; Hua, XT				Fang, Li; Chen, Qiong; Shi, Keren; Li, Xi; Shi, Qiucheng; He, Fang; Zhou, Jiancang; Yu, Yunsong; Hua, Xiaoting			Step-Wise Increase in Tigecycline Resistance in Klebsiella pneumoniae Associated with Mutations in ramR, lon and rpsJ	PLOS ONE			English	Article							MEDIATED MULTIDRUG-RESISTANCE; ENTERICA SEROVAR TYPHIMURIUM; RIBOSOMAL S10 PROTEIN; ESCHERICHIA-COLI; REDUCED SUSCEPTIBILITY; ANTIBIOTIC-RESISTANCE; GENE; EXPRESSION; MECHANISMS; MUTANTS	Klebsiella pneumoniae is a gram-negative bacterium that causes numerous diseases, including pneumonia and urinary tract infections. An increase in multidrug resistance has complicated the treatment of these bacterial infections, and although tigecycline shows activity against a broad spectrum of bacteria, resistant strains have emerged. In this study, the whole genomes of two clinical and six laboratory-evolved strains were sequenced to identify putative mutations related to tigecycline resistance. Of seven tigecycline-resistant strains, seven (100%) had ramR mutations, five (71.4%) had lon mutations, one (14.2%) had a ramA mutation, and one (14.2%) had an rpsJ mutation. A higher fitness cost was observed in the laboratory-evolved strains but not in the clinical strains. A transcriptome analysis demonstrated high expression of the ramR operon and acrA in all tigecycline-resistant strains. Genes involved in nitrogen metabolism were induced in the laboratory-evolved strains compared with the wild-type and clinical strains, and this difference in nitrogen metabolism reflected the variation between the laboratory-evolved and the clinical strains. Complementation experiments showed that both the wild-type ramR and the lon genes could partially restore the tigecycline sensitivity of K. pneumoniae. We believe that this manuscript describes the first construct of a lon mutant in K. pneumoniae, which allowed confirmation of its association with tigecycline resistance. Our findings illustrate the importance of the ramR operon and the lon and rpsJ genes in K. pneumoniae resistance to tigecycline.	[Fang, Li; Chen, Qiong; Shi, Keren; Li, Xi; Shi, Qiucheng; He, Fang; Zhou, Jiancang; Yu, Yunsong; Hua, Xiaoting] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Infect Dis, Coll Med, Hangzhou, Zhejiang, Peoples R China; [Yu, Yunsong] Zhejiang Univ, Affiliated Hosp 1, Coll Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yu, YS; Hua, XT (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Infect Dis, Coll Med, Hangzhou, Zhejiang, Peoples R China.; Yu, YS (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China.	yvys119@163.com; XiaotingHua@zju.edu.cn	Hua, Xiaoting/B-5786-2011	Hua, Xiaoting/0000-0001-8215-916X	National Natural Science of China [81230039, 81401708, 81101284]; Natural Science Foundation of Zhejiang Province, China [LY15H190004]; Zhejiang Province Medical Platform Backbone Talent Plan [2016DTA003]	National Natural Science of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Zhejiang Province Medical Platform Backbone Talent Plan	This work was supported by the National Natural Science of China (81230039, 81401708 and 81101284), the Natural Science Foundation of Zhejiang Province, China (LY15H190004), and the Zhejiang Province Medical Platform Backbone Talent Plan (2016DTA003). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeed YM, 2008, ANTIMICROB AGENTS CH, V52, P2428, DOI 10.1128/AAC.00084-08; Baucheron S, 2012, ANTIMICROB AGENTS CH, V56, P942, DOI 10.1128/AAC.05444-11; Beabout K, 2015, ANTIMICROB AGENTS CH, V59, P5561, DOI 10.1128/AAC.00547-15; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Braykov NP, 2013, INFECT CONT HOSP EP, V34, P259, DOI 10.1086/669523; Broberg Christopher A, 2014, F1000Prime Rep, V6, P64, DOI 10.12703/P6-64; Cattoir V, 2015, ANTIMICROB AGENTS CH, V59, P239, DOI 10.1128/AAC.04174-14; De Majumdar S, 2013, ANTIMICROB AGENTS CH, V57, P1603, DOI 10.1128/AAC.01998-12; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; Griffith KL, 2004, MOL MICROBIOL, V51, P1801, DOI 10.1046/j.1365-2958.2003.03952.x; Gutman BA, 2015, NEUROBIOL AGING, V36, pS69, DOI 10.1016/j.neurobiolaging.2014.05.038; Hentschke M, 2010, ANTIMICROB AGENTS CH, V54, P2720, DOI 10.1128/AAC.00085-10; Hu XT, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01337-14; Hua XT, 2014, INT J ANTIMICROB AG, V44, P337, DOI 10.1016/j.ijantimicag.2014.06.015; Huang Tzu-Wen, 2014, BMC Res Notes, V7, P13, DOI 10.1186/1756-0500-7-13; Jenner L, 2013, P NATL ACAD SCI USA, V110, P3812, DOI 10.1073/pnas.1216691110; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Linkevicius M, 2016, J ANTIMICROB CHEMOTH, V71, P1307, DOI 10.1093/jac/dkv486; Linkevicius M, 2013, J ANTIMICROB CHEMOTH, V68, P2809, DOI 10.1093/jac/dkt263; Luo X, 2008, MOL CELL, V32, P791, DOI 10.1016/j.molcel.2008.10.028; Lupien A, 2015, J ANTIMICROB CHEMOTH, V70, P2973, DOI 10.1093/jac/dkv211; McAleese F, 2005, ANTIMICROB AGENTS CH, V49, P1865, DOI 10.1128/AAC.49.5.1865-1871.2005; Nicoloff H, 2013, MOL MICROBIOL, V90, P1233, DOI 10.1111/mmi.12429; Nielsen LE, 2014, ANTIMICROB AGENTS CH, V58, P6151, DOI 10.1128/AAC.03053-14; Noskin GA, 2005, CLIN INFECT DIS, V41, pS303, DOI 10.1086/431672; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Ramos PIP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-54; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenblum R, 2011, INT J ANTIMICROB AG, V38, P39, DOI 10.1016/j.ijantimicag.2011.02.012; Ruzin A, 2005, ANTIMICROB AGENTS CH, V49, P1017, DOI 10.1128/AAC.49.3.1017-1022.2005; Sheng ZK, 2014, ANTIMICROB AGENTS CH, V58, P6982, DOI 10.1128/AAC.03808-14; van Duin D, 2013, DIAGN MICR INFEC DIS, V75, P115, DOI 10.1016/j.diagmicrobio.2012.11.009; Veleba M, 2012, ANTIMICROB AGENTS CH, V56, P4466, DOI 10.1128/AAC.06224-11; Villa L, 2014, ANTIMICROB AGENTS CH, V58, P1707, DOI 10.1128/AAC.01803-13; Wang ZS, 2011, GENET MOL BIOL, V34, P661, DOI 10.1590/S1415-47572011005000043; Yamasaki S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3078	38	31	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165019	10.1371/journal.pone.0165019	http://dx.doi.org/10.1371/journal.pone.0165019			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764207	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500103
J	Fernandez-Moreno, M; Hermida-Gomez, T; Gallardo, ME; Dalmao-Fernandez, A; Rego-Perez, I; Garesse, R; Blanco, FJ				Fernandez-Moreno, Mercedes; Hermida-Gomez, Tamara; Gallardo, M. Esther; Dalmao-Fernandez, Andrea; Rego-Perez, Ignacio; Garesse, Rafael; Blanco, Francisco J.			Generating Rho-0 Cells Using Mesenchymal Stem Cell Lines	PLOS ONE			English	Article							1-METHYL-4-PHENYLPYRIDINIUM ION MPP+; MITOCHONDRIAL RESPIRATORY-CHAIN; BONE-MARROW; METABOLIC PLASTICITY; ANTIOXIDANT ENZYMES; NUCLEOSIDE ANALOGS; OXIDATIVE STRESS; MTDNA MUTATIONS; RHODAMINE 6G; IN-VITRO	Introduction The generation of Rho-0 cells requires the use of an immortalization process, or tumor cell selection, followed by culture in the presence of ethidium bromide (EtBr), incurring the drawbacks its use entails. The purpose of this work was to generate Rho-0 cells using human mesenchymal stem cells (hMSCs) with reagents having the ability to remove mitochondrial DNA (mtDNA) more safely than by using EtBr. Methodology Two immortalized hMSC lines (3a6 and KP) were used; 143B. TK-Rho-0 cells were used as reference control. For generation of Rho-0 hMSCs, cells were cultured in medium supplemented with each tested reagent. Total DNA was isolated and mtDNA content was measured by real-time polymerase chain reaction (PCR). Phenotypic characterization and gene expression assays were performed to determine whether 3a6 Rho-0 hMSCs maintain the same stem properties as untreated 3a6 hMSCs. To evaluate whether 3a6 Rho-0 hMSCs had a phenotype similar to that of 143B. TK-Rho-0 cells, in terms of reactive oxygen species (ROS) production, apoptotic levels and mitochondrial membrane potential (Delta psi m) were measured by flow cytometry and mitochondrial respiration was evaluated using a SeaHorse XFp Extracellular Flux Analyzer. The differentiation capacity of 3a6 and 3a6 Rho-0 hMSCs was evaluated using real-time PCR, comparing the relative expression of genes involved in osteogenesis, adipogenesis and chondrogenesis. Results The results showed the capacity of the 3a6 cell line to deplete its mtDNA and to survive in culture with uridine. Of all tested drugs, Stavudine (dt4) was the most effective in producing 3a6-Rho cells. The data indicate that hMSC Rho-0 cells continue to express the characteristic MSC cell surface receptor pattern. Phenotypic characterization showed that 3a6 Rho-0 cells resembled 143B. TK-Rho-0 cells, indicating that hMSC Rho-0 cells are Rho-0 cells. While the adipogenic capability was higher in 3a6 Rho-0 cells than in 3a6 cells, the osteogenic and chondrogenic capacities were lower. Conclusion Among the drugs and conditions tested, the use of d4t was the best option for producing Rho-0 cells from hMSCs. Rho-0 cells are useful for studying the role of mitochondria in hMSC differentiation.	[Fernandez-Moreno, Mercedes; Hermida-Gomez, Tamara; Dalmao-Fernandez, Andrea; Rego-Perez, Ignacio; Blanco, Francisco J.] UDC, Sergas, Inst Invest Biomed A Coruna INIBIC, Serv Reumatol, CHUAC, La Coruna, Spain; [Garesse, Rafael] Inst Invest Biomed Alberto Sols UAM CSIC, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Dept Bioquim, Madrid, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Blanco, FJ (corresponding author), UDC, Sergas, Inst Invest Biomed A Coruna INIBIC, Serv Reumatol, CHUAC, La Coruna, Spain.	fblagar@sergas.es	fernandez-moreno, mercedes MFM/I-3219-2017; Dalmao-Fernandez, Andrea/AAC-6336-2020; Blanco, Francisco J./C-3192-2014; Garesse, Rafael/F-3836-2012; Gallardo, M. Esther/AFK-7298-2022; Rego-Pérez, Ignacio/B-1665-2012	fernandez-moreno, mercedes MFM/0000-0001-5077-1274; Dalmao-Fernandez, Andrea/0000-0003-4465-9328; Blanco, Francisco J./0000-0001-9821-7635; Gallardo, M. Esther/0000-0002-8699-8734; Rego-Pérez, Ignacio/0000-0003-1754-1164; Hermida Gomez, Tamara/0000-0001-7405-4595	Fundacion Espanola de Reumatologia (programa GEN-SER); Fondo de Investigacion Sanitaria [CIBERCB06/01/0040-Spain, PI 12/329, PI14/01254]; ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER), "A way of making Europe"; Contrato Miguel Servet-Fondo de Investigacion Sanitaria [CP12/03192]	Fundacion Espanola de Reumatologia (programa GEN-SER); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER), "A way of making Europe"; Contrato Miguel Servet-Fondo de Investigacion Sanitaria	This study was supported by grants from Fundacion Espanola de Reumatologia (programa GEN-SER) and Fondo de Investigacion Sanitaria CIBERCB06/01/0040-Spain, PI 12/329 and PI14/01254, integrated in the National Plan for Scientific Program, Development and Technological Innovation 2013-2016, and funded by the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER), "A way of making Europe." IRP is supported by Contrato Miguel Servet-Fondo de Investigacion Sanitaria (CP12/03192).	Acevedo-Torres K, 2009, DNA REPAIR, V8, P126, DOI 10.1016/j.dnarep.2008.09.004; ANDREWS PW, 1984, LAB INVEST, V50, P147; Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Chen CT., 2008, BIOCHIM BIOPHYS ACTA, V1800, P257; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Chen CT, 2012, BBA-GEN SUBJECTS, V1820, P571, DOI 10.1016/j.bbagen.2011.09.013; Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232; Cho YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032778; Choudhery MS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-8; Cohen N, 2003, CANCER GENET CYTOGEN, V143, P80, DOI 10.1016/S0165-4608(02)00835-X; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Fan WS, 2016, BIOCHEM BIOPH RES CO, V474, P338, DOI 10.1016/j.bbrc.2016.04.101; Fernandez-Caggiano M, 2013, MITOCHONDRION, V13, P263, DOI 10.1016/j.mito.2013.03.005; Fernandez-Moreno M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00129; Fernandez-Moreno M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-264; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Gallardo ME, 2012, EUR HEART J, V33, P346, DOI 10.1093/eurheartj/ehr280; GEAR ARL, 1974, J BIOL CHEM, V249, P3628; Govindaraj P, 2014, MITOCHONDRION, V16, P65, DOI 10.1016/j.mito.2013.10.006; Grazina M, 2006, GENES BRAIN BEHAV, V5, P92, DOI 10.1111/j.1601-183X.2006.00225.x; Hoschele D, 2006, TOXICOL IN VITRO, V20, P535, DOI 10.1016/j.tiv.2005.11.007; Hoffmann S, 2004, FREE RADICAL BIO MED, V36, P765, DOI 10.1016/j.freeradbiomed.2003.12.019; Hung SC, 2004, INT J CANCER, V110, P313, DOI 10.1002/ijc.20126; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kim GJ, 2001, CANCER GENET CYTOGEN, V129, P10, DOI 10.1016/S0165-4608(01)00418-6; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Komarov AM, 2004, BBA-MOL BASIS DIS, V1688, P257, DOI 10.1016/j.bbadis.2003.12.012; Kukat A, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn124; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Leng YL, 2015, MITOCHONDR DNA, V26, P208, DOI 10.3109/19401736.2014.905860; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; LI K, 1995, AM J PHYSIOL-CELL PH, V269, pC1265, DOI 10.1152/ajpcell.1995.269.5.C1265; Loiseau D, 2002, EXP CELL RES, V278, P12, DOI 10.1006/excr.2002.5553; Lund KC, 2007, ANTIMICROB AGENTS CH, V51, P2531, DOI 10.1128/AAC.00039-07; Lynx MD, 2009, ANTIMICROB AGENTS CH, V53, P1252, DOI 10.1128/AAC.01115-08; Ma YW, 2010, BBA-BIOENERGETICS, V1797, P29, DOI 10.1016/j.bbabio.2009.07.008; MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743; Marusich MF, 1997, BBA-MOL BASIS DIS, V1362, P145, DOI 10.1016/S0925-4439(97)00061-6; Miyako K, 1999, EUR J BIOCHEM, V259, P412, DOI 10.1046/j.1432-1327.1999.00056.x; Miyako K, 1997, J BIOL CHEM, V272, P9605; Muraglia A, 2000, J CELL SCI, V113, P1161; Pastore A, 2013, MOL GENET METAB, V109, P208, DOI 10.1016/j.ymgme.2013.03.011; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; POLLACK Y, 1984, NUCLEIC ACIDS RES, V12, P4811, DOI 10.1093/nar/12.12.4811; Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Rego-Perez I, 2008, ARTHRITIS RHEUM-US, V58, P2387, DOI 10.1002/art.23659; Rego-Perez Ignacio, 2013, Front Biosci (Schol Ed), V5, P360; Saitoh A, 2008, ANTIMICROB AGENTS CH, V52, P2825, DOI 10.1128/AAC.00434-08; Schauen M, 2006, J CELL PHYSIOL, V209, P103, DOI 10.1002/jcp.20711; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Siegel G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-146; SINGER TP, 1990, FEBS LETT, V274, P1, DOI 10.1016/0014-5793(90)81315-F; Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102; Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200; Spadafora D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154684; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Stankov MV, 2010, ANTIMICROB AGENTS CH, V54, P280, DOI 10.1128/AAC.00914-09; Trounce I, 1996, SOMAT CELL MOLEC GEN, V22, P81, DOI 10.1007/BF02374379; Tsai CC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-64; Umeda S, 2000, EUR J BIOCHEM, V267, P200, DOI 10.1046/j.1432-1327.2000.00990.x; Wei YH, 2001, ANN NY ACAD SCI, V928, P97; Williams AJ, 1999, HUM MOL GENET, V8, P1691, DOI 10.1093/hmg/8.9.1691; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056732; ZIEGLER ML, 1981, SOMAT CELL GENET, V7, P73, DOI 10.1007/BF01544749	73	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164199	10.1371/journal.pone.0164199	http://dx.doi.org/10.1371/journal.pone.0164199			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764131	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204500021
J	Gomez-Galan, M; Femenia, T; Aberg, E; Graae, L; Van Eeckhaut, A; Smolders, I; Brene, S; Lindskog, M				Gomez-Galan, Marta; Femenia, Teresa; Aberg, Elin; Graae, Lisette; Van Eeckhaut, Ann; Smolders, Ilse; Brene, Stefan; Lindskog, Maria			Running Opposes the Effects of Social Isolation on Synaptic Plasticity and Transmission in a Rat Model of Depression	PLOS ONE			English	Article							LONG-TERM POTENTIATION; OLDER MEN; STRESS; EXERCISE; VOLUNTARY; BEHAVIOR; ANTIDEPRESSANT; NEUROGENESIS; HIPPOCAMPUS; RECEPTOR	Stress, such as social isolation, is a well-known risk factor for depression, most probably in combination with predisposing genetic factors. Physical exercise on the other hand, is depicted as a wonder-treatment that makes you healthier, happier and live longer. However, the published results on the effects of exercise are ambiguous, especially when it comes to neuropsychiatric disorders. Here we combine a paradigm of social isolation with a genetic rat model of depression, the Flinders Sensitive Line (FSL), already known to have glutamatergic synaptic alterations. Compared to group-housed FSL rats, we found that social isolation further affects synaptic plasticity and increases basal synaptic transmission in hippocampal CA1 pyramidal neurons. These functional synaptic alterations co-exist with changes in hippocampal protein expression levels: social isolation in FSL rats reduce expression of the glial glutamate transporter GLT-1, and increase expression of the GluA2 AMPA-receptor subunit. We further show that physical exercise in form of voluntary running prevents the stress-induced synaptic effects but do not restore the endogenous mechanisms of depression already present in the FSL rat.	[Gomez-Galan, Marta; Femenia, Teresa; Graae, Lisette] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Aberg, Elin; Brene, Stefan; Lindskog, Maria] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Gomez-Galan, Marta; Femenia, Teresa] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Van Eeckhaut, Ann; Smolders, Ilse] Vrije Univ, Ctr Neurosci, Dept Pharmaceut Chem & Drug Anal, Brussels, Belgium	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Vrije Universiteit Brussel	Lindskog, M (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	mia.lindskog@ki.se	Smolders, Ilse J/J-9399-2013; Lindskog, Maria/F-1729-2011; Van Eeckhaut, Ann/G-3226-2013	Smolders, Ilse J/0000-0003-2140-0751; Lindskog, Maria/0000-0002-4178-2825; Van Eeckhaut, Ann/0000-0002-1695-7398; Gomez-Galan, Marta/0000-0002-8355-9795; FEMENIA CANTO, TERESA/0000-0003-0455-752X	Swedish research council [2007-5600]; WennerGrenn foundation; PKF foundation	Swedish research council(Swedish Research CouncilEuropean Commission); WennerGrenn foundation; PKF foundation	This work was supported by the Swedish research council (Nr. 2007-5600; www.vr.se; ML), the WennerGrenn foundation (www.swgc.org; MGG) and the PKF foundation (no webpage available; ML, EA).	Adlard PA, 2004, NEUROSCIENCE, V124, P985, DOI 10.1016/j.neuroscience.2003.12.039; Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Bjornebekk A, 2008, INT J NEUROPSYCHOPH, V11, P1135, DOI 10.1017/S1461145708008912; Bjornebekk A, 2010, HIPPOCAMPUS, V20, P820, DOI 10.1002/hipo.20683; Brene S, 2007, PHYSIOL BEHAV, V92, P136, DOI 10.1016/j.physbeh.2007.05.015; Chang CH, 2015, HIPPOCAMPUS, V25, P474, DOI 10.1002/hipo.22384; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Coyle EF, 2000, AM J CLIN NUTR, V72, p512S, DOI 10.1093/ajcn/72.2.512S; Czeh B, 2002, BIOL PSYCHIAT, V52, P1057, DOI 10.1016/S0006-3223(02)01457-9; Djordjevic J, 2012, NEUROPSYCHOBIOLOGY, V66, P112, DOI 10.1159/000338605; Duman CH, 2008, BRAIN RES, V1199, P148, DOI 10.1016/j.brainres.2007.12.047; Femenia T, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv032; Firth J, 2016, PSYCHOL MED, V46, P2869, DOI 10.1017/S0033291716001732; Fuss J, 2010, HIPPOCAMPUS, V20, P364, DOI 10.1002/hipo.20634; Gomez-Galan M, 2013, MOL PSYCHIATR, V18, P582, DOI 10.1038/mp.2012.10; Gomez-Galan M, 2012, MOL PSYCHIAT; Greenwood BN, 2008, NEUROMOL MED, V10, P81, DOI 10.1007/s12017-008-8029-y; Hackney Anthony C, 2006, Expert Rev Endocrinol Metab, V1, P783, DOI 10.1586/17446651.1.6.783; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Santini ZI, 2016, J AFFECT DISORDERS, V204, P59, DOI 10.1016/j.jad.2016.06.032; Kamal A, 2014, NEUROSCIENCE, V256, P262, DOI 10.1016/j.neuroscience.2013.10.016; King A, 2016, NATURE, V531, pS18, DOI 10.1038/531S18a; Lapmanee S, 2013, BEHAV BRAIN RES; Lindskog M, 2010, P NATL ACAD SCI USA, V107, P21806, DOI 10.1073/pnas.1016399107; Liu X, 2013, BRAIN RES, V1502, P71, DOI 10.1016/j.brainres.2013.01.044; Magara S, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00089; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; MARKOU A, 1994, BIOL PSYCHIAT, V36, P680, DOI 10.1016/0006-3223(94)91177-0; Novak CM, 2012, NEUROSCI BIOBEHAV R, V36, P1001, DOI 10.1016/j.neubiorev.2011.12.012; Overstreet DH, 2013, PHARMACOL REV, V65, P143, DOI 10.1124/pr.111.005397; OVERSTREET DH, 1982, PSYCHOPHARMACOLOGY, V78, P150, DOI 10.1007/BF00432254; Overstreet DH, 2002, BEHAV GENET, V32, P335, DOI 10.1023/A:1020262205227; PUCILOWSKI O, 1993, PHYSIOL BEHAV, V54, P1215, DOI 10.1016/0031-9384(93)90351-F; PUCILOWSKI O, 1991, NEUROPSYCHOBIOLOGY, V24, P37; Rimer J., 2012, COCHRANE DATABASE SY, V7; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036; Sanna E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00015; Shin SY, 2016, NEUROSCIENCE, V316, P221, DOI 10.1016/j.neuroscience.2015.12.041; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Teo AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062396; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; YANCEY SL, 1993, J APPL PHYSIOL, V75, P1334, DOI 10.1152/jappl.1993.75.3.1334; Yau SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024263; Zanier-Gomes PH, 2015, PHYSIOL BEHAV, V151, P292, DOI 10.1016/j.physbeh.2015.07.026; Zheng H, 2006, BEHAV BRAIN RES, V168, P47, DOI 10.1016/j.bbr.2005.10.007; Zlatkovic J, 2014, MOL CELL BIOCHEM, V393, P43, DOI 10.1007/s11010-014-2045-z	50	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165071	10.1371/journal.pone.0165071	http://dx.doi.org/10.1371/journal.pone.0165071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764188	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500111
J	Hahn, RG; Grankvist, N; Krizhanovskii, C				Hahn, Robert G.; Grankvist, Nina; Krizhanovskii, Camilla			Urinary Analysis of Fluid Retention in the General Population: A Cross-Sectional Study	PLOS ONE			English	Article							HIP FRACTURE SURGERY; HYDRATION STATUS; DIAGNOSTIC-ACCURACY; DEHYDRATION; WATER; ALBUMINURIA; GRAVITY; BALANCE	Objective Renal conservation (retention) of fluid might affect the outcome of hospital care and can be indicated by increased urinary concentrations of metabolic waste products. We obtained a reference material for further studies by exploring the prevalence of fluid retention in a healthy population. Methods Spot urine sampling was performed in 300 healthy hospital workers. A previously validated algorithm summarized the urine-specific gravity, osmolality, creatinine, and color to a fluid retention index (FRI), where 4.0 is the cut-off for fluid retention consistent with dehydration. In 50 of the volunteers, we also studied the relationships between FRI, plasma osmolality, and water-retaining hormones. Results The cut-off for fluid retention (FRI >= 4.0) was reached by 38% of the population. No correlation was found between the FRI and the time of the day of urine sample collection, and the FRI was only marginally correlated with the time period spent without fluid intake. Volunteers with fluid retention were younger, generally men, and more often had albuminuria (88% vs. 34%, P < 0.001). Plasma osmolality and plasma sodium were somewhat higher in those with a high FRI (mean 294.8 vs. 293.4 mosmol/kg and 140.3 vs. 139.9 mmol/l). Plasma vasopressin was consistently below the limit of detection, and the plasma cortisol, aldosterone, and renin concentrations were similar in subjects with a high or low FRI. The very highest FRI values (>= 5.0, N = 61) were always accompanied by albuminuria. Conclusion Fluid retention consistent with moderate dehydration is common in healthy staff working in a Swedish hospital.	[Hahn, Robert G.; Grankvist, Nina; Krizhanovskii, Camilla] Sodertalje Hosp, Res Unit, S-15286 Sodertalje, Sweden; [Grankvist, Nina] Solna Karolinska Inst, Dept Med, Stockholm, Sweden	Karolinska Institutet	Hahn, RG (corresponding author), Sodertalje Hosp, Res Unit, S-15286 Sodertalje, Sweden.	robert.hahn@sll.se		Hahn, Robert/0000-0002-1528-3803; Grankvist, Nina/0000-0002-3111-4575	Mats Kleberg Fund	Mats Kleberg Fund	This work was supported by Mats Kleberg Fund and local Hospital Funds.	Armstrong LE, 1998, INT J SPORT NUTR, V8, P345, DOI 10.1123/ijsn.8.4.345; Baron S, 2015, BRIT J NUTR, V113, P147, DOI 10.1017/S0007114514003213; Casa DJ, 2000, J ATHL TRAINING, V35, P212; Cheuvront SN, 2016, AM J CLIN NUTR, V104, P3, DOI 10.3945/ajcn.116.137703; Cheuvront SN, 2013, AM J CLIN NUTR, V97, P455, DOI 10.3945/ajcn.112.044172; Cheuvront SN, 2010, AM J CLIN NUTR, V92, P565, DOI 10.3945/ajcn.2010.29490; El-Sharkawy AM, 2016, CLIN NUTR, V35, P935, DOI 10.1016/j.clnu.2015.07.007; Hahn RG, 2016, ANAESTHESIA, V71, P155, DOI 10.1111/anae.13301; Hahn RG, 2014, ACTA ANAESTH SCAND, V58, P1258, DOI 10.1111/aas.12416; Hahn RG, 2016, J ANESTH CLIN RES, V7, P1, DOI [DOI 10.4172/2155-6148.1000597, 10.4172/2155-6148.1000597]; Hahn RG, 2015, ANAESTH INTENSIVE TH, V47, P284, DOI 10.5603/AIT.a2015.0029; Hahn RG, 2014, ANAESTH INTENSIVE TH, V46, P342, DOI 10.5603/AIT.2014.0058; Hahn RG, 2013, INT J SPORT NUTR EXE, V23, P303, DOI 10.1123/ijsnem.23.4.303; Home P, 2006, DIABETIC MED, V23, P579; Hooper L, 2016, AM J CLIN NUTR, V104, P121, DOI 10.3945/ajcn.115.119925; Jackson CE, 2009, LANCET, V374, P543, DOI 10.1016/S0140-6736(09)61378-7; Johnson EC, 2015, EUR J APPL PHYSIOL, V115, P1067, DOI 10.1007/s00421-014-3088-2; Johnson P, 2015, SCAND J CLIN LAB INV, V75, P444, DOI 10.3109/00365513.2015.1039057; Li YH, 2014, CLINICS, V69, P809, DOI 10.6061/clinics/2014(12)04; Masento NA, 2014, BRIT J NUTR, V111, P1841, DOI 10.1017/S0007114513004455; Popowski LA, 2001, MED SCI SPORT EXER, V33, P747; Rabelink TJ, 2015, NAT REV NEPHROL, V11, P667, DOI 10.1038/nrneph.2015.162; Riebl SK, 2013, ACSMS HEALTH FIT J, V17, P21, DOI 10.1249/FIT.0b013e3182a9570f; Stover EA, 2006, APPL PHYSIOL NUTR ME, V31, P320, DOI 10.1139/H06-004; Townsend AT, 2001, J ENVIRON MONITOR, V3, P113, DOI 10.1039/b008172h; Ylinenvaara SI, 2014, EUR J ANAESTH, V31, P85, DOI 10.1097/01.EJA.0000435057.72303.0e	26	14	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164152	10.1371/journal.pone.0164152	http://dx.doi.org/10.1371/journal.pone.0164152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764121	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500019
J	Knox, PC; MacCormick, IJC; Mbale, E; Malewa, M; Czanner, G; Harding, SP				Knox, Paul C.; MacCormick, Ian J. C.; Mbale, Emme; Malewa, Macpherson; Czanner, Gabriela; Harding, Simon P.			Longitudinal Visuomotor Development in a Malaria Endemic Area: Cerebral Malaria and Beyond	PLOS ONE			English	Article							SEVERE FALCIPARUM-MALARIA; ANTISACCADE TASK-PERFORMANCE; SACCADIC EYE-MOVEMENTS; ATTENTIONAL NETWORKS; COGNITIVE CONTROL; VOLUNTARY CONTROL; AFRICAN CHILDREN; RESEARCH TOOL; SEQUELAE; CHILDHOOD	Paediatric cerebral malaria is the most serious complication of Plasmodium falciparum infection. While the majority recover, long-term cognitive impairment has been highlighted as a significant and neglected problem. Persistent or serious deficits in processes such as attention or behavioural inhibition should be manifest in changes to performance on oculomotor tasks. Therefore we investigated the impact of cerebral malaria on the development of reflexive pro-saccades and antisaccades. In a longitudinal study, 47 children previously admitted with retinopathy-confirmed cerebral malaria (mean age at admission 54 months), were compared with 37 local healthy controls (mean ages at first study visit 117 and 110 months respectively). In each of three or four test sessions, over a period of up to 32 months, participants completed 100 prosaccade tasks and 100 antisaccade tasks. Eye movements were recorded using infrared reflectance oculography; prosaccade, correct antisaccade and error prosaccade latency, and antisaccade directional error rate were calculated. Hierarchical linear modelling was used to investigate the effect of age and the influence of cerebral malaria on these parameters. Data were also collected from an independent, older group (mean age 183 months) of 37 local healthy participants in a separate cross-sectional study. Longitudinal data exhibited the expected decrease in latency with age for all saccade types, and a decrease in the antisaccade directional error rate. Hierarchical linear modelling confirmed that age had a statistically significant effect on all parameters (p< = 0.001). However, there were no statistically significant differences between the cerebral malaria and control groups. Combining groups, comparison with the literature demonstrated that antisaccade directional error rate for the Malawi sample was significantly higher than expected, while latencies for all saccade types were indistinguishable from published. The high directional error rate was also confirmed in the older, healthy Malawian participants from the cross sectional study. Our observation of similar oculomotor performance in cerebral malaria and control groups at long follow-up periods suggests that cerebral malaria survivors are not at a generally increased risk of persistent cognitive deficits. Our data raise questions about the prevailing hypothesis that cerebral malaria has gross impacts on the development of processes such as attention and behavioural inhibition. More importantly, our novel finding of a clear difference in antisaccade performance between all of the Malawi participants and published data suggests that the Malawian paediatric population as a whole faces serious challenges to cognitive development beyond cerebral malaria.	[Knox, Paul C.; MacCormick, Ian J. C.; Czanner, Gabriela; Harding, Simon P.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Eye & Vis Sci, William Duncan Bldg, Liverpool L7 ATX, Merseyside, England; [MacCormick, Ian J. C.] Malawi Liverpool Wellcome Trust Clin Res Programm, POB 30096, Blantyre, Malawi; [Mbale, Emme; Malewa, Macpherson] Univ Malawi, Coll Med, P Bag 360 Chichiri, Blantyre, Malawi; [Czanner, Gabriela] Univ Liverpool, Dept Biostat, Waterhouse Bldg, Liverpool L69 3GL, Merseyside, England	University of Liverpool; University of Malawi; University of Malawi; University of Liverpool	Knox, PC (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Dept Eye & Vis Sci, William Duncan Bldg, Liverpool L7 ATX, Merseyside, England.	pcknox@liv.ac.uk	Czanner, Gabriela/ABC-7569-2021; MacCormick, Ian/GPW-8622-2022; MacCormick, Ian JC/AFW-1885-2022; Knox, Paul/Q-1920-2019	Czanner, Gabriela/0000-0002-1157-2093; MacCormick, Ian/0000-0002-8171-0332; MacCormick, Ian JC/0000-0002-8171-0332; Knox, Paul/0000-0002-2578-7335	Wellcome Trust [092668/Z/10/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This project was funded by a programme grant from The Wellcome Trust (Grant number 092668/Z/10/Z) to SH, PCK, MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahyane N, 2014, NEUROIMAGE, V98, P103, DOI 10.1016/j.neuroimage.2014.03.008; Amatya N, 2011, EXP BRAIN RES, V210, P117, DOI 10.1007/s00221-011-2609-z; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Bangirana P, 2014, CLIN INFECT DIS, V59, P336, DOI 10.1093/cid/ciu293; Bangirana P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-334; Beare NAV, 2006, AM J TROP MED HYG, V75, P790, DOI 10.4269/ajtmh.2006.75.790; Beare NAV, 2011, FUTURE MICROBIOL, V6, P349, DOI [10.2217/fmb.11.3, 10.2217/FMB.11.3]; Bergen DC, 2008, NEUROLOGY, V71, P447, DOI 10.1212/01.wnl.0000324420.03960.36; Birbeck GL, 2010, LANCET NEUROL, V9, P1173, DOI 10.1016/S1474-4422(10)70270-2; Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027; Boivin MJ, 2011, TROP MED INT HEALTH, V16, P263, DOI 10.1111/j.1365-3156.2010.02704.x; BONDI FS, 1992, T ROY SOC TROP MED H, V86, P17, DOI 10.1016/0035-9203(92)90420-H; BREWSTER DR, 1990, LANCET, V336, P1039, DOI 10.1016/0140-6736(90)92498-7; Bucci MP, 2012, EXP BRAIN RES, V222, P21, DOI 10.1007/s00221-012-3192-7; Carr L, 2010, J CLIN CHILD ADOLESC, V39, P726, DOI 10.1080/15374416.2010.517168; Carter JA, 2005, J NEUROL NEUROSUR PS, V76, P476, DOI 10.1136/jnnp.2004.043893; Carter JA, 2005, TROP MED INT HEALTH, V10, P3, DOI 10.1111/j.1365-3156.2004.01345.x; Carter JA, 2004, EPILEPSIA, V45, P978, DOI 10.1111/j.0013-9580.2004.65103.x; Crawford TJ, 2011, EXP BRAIN RES, V208, P385, DOI 10.1007/s00221-010-2488-8; Das Banerjee T, 2007, ACTA PAEDIATR, V96, P1269, DOI 10.1111/j.1651-2227.2007.00430.x; Fernando SD, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-366; Fischer B, 1997, BRAIN RES, V754, P285, DOI 10.1016/S0006-8993(97)00094-2; Goldberg MC, 2002, NEUROPSYCHOLOGIA, V40, P2039, DOI 10.1016/S0028-3932(02)00059-3; Goto Y, 2010, BRAIN DEV-JPN, V32, P347, DOI 10.1016/j.braindev.2009.04.017; Greenfield PM, 1997, AM PSYCHOL, V52, P1115, DOI 10.1037/0003-066X.52.10.1115; HARKNESS S, 1977, ANN NY ACAD SCI, V285, P326, DOI 10.1111/j.1749-6632.1977.tb29360.x; Harwood MR, 2008, J NEUROPHYSIOL, V99, P1743, DOI 10.1152/jn.00589.2007; Hellmuth J, 2012, NEUROLOGY, V78, P1824, DOI 10.1212/WNL.0b013e318258f785; Heuer HW, 2013, NEUROLOGY, V81, P1235, DOI 10.1212/WNL.0b013e3182a6cbfe; Holding PA, 1999, T ROY SOC TROP MED H, V93, P529, DOI 10.1016/S0035-9203(99)90368-1; Holding PA, 2004, J INT NEUROPSYCH SOC, V10, P246, DOI 10.1017/S1355617704102166; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Hutton SB, 2006, PSYCHOPHYSIOLOGY, V43, P302, DOI 10.1111/j.1469-8986.2006.00403.x; Idro R, 2010, PEDIATR RES, V68, P267, DOI 10.1203/00006450-201011001-00524; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; Kail RV, 2007, CHILD DEV, V78, P1760, DOI 10.1111/j.1467-8624.2007.01088.x; Karatekin C, 2007, DEV REV, V27, P283, DOI 10.1016/j.dr.2007.06.006; Kariuki SM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-365; Kihara M, 2010, J NEUROL SCI, V296, P88, DOI 10.1016/j.jns.2010.05.018; Kitsao-Wekulo PK, 2013, ASSESSMENT, V20, P776, DOI 10.1177/1073191112457408; Klein C, 2003, PSYCHOPHYSIOLOGY, V40, P17, DOI 10.1111/1469-8986.00003; Klein C, 2001, PSYCHOPHYSIOLOGY, V38, P179; Knox PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094424; Knox PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047688; Kowler E, 1995, VISION RES, V35, P1987; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Malaria S, 2014, TROP MED INT HEALTH, V19, P7, DOI [10.1111/tmi.12313, 10.1111/tmi.12313_2]; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; Mitchell JP, 2002, J COGNITIVE NEUROSCI, V14, P95, DOI 10.1162/089892902317205357; MOLYNEUX ME, 1989, Q J MED, V71, P441; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Munoz DP, 2003, J NEUROPHYSIOL, V90, P503, DOI 10.1152/jn.00192.2003; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Muntendam AH, 1996, T ROY SOC TROP MED H, V90, P391, DOI 10.1016/S0035-9203(96)90518-0; Newsham D, 2007, INVEST OPHTH VIS SCI, V48, P2595, DOI 10.1167/iovs.06-1425; Newton CRJC, 1998, AM J TROP MED HYG, V58, P673, DOI 10.4269/ajtmh.1998.58.673; Ngoungou EB, 2006, EPILEPSIA, V47, P873, DOI 10.1111/j.1528-1167.2006.00524.x; Nieman DH, 2000, NEUROLOGY, V54, P866, DOI 10.1212/WNL.54.4.866; Potchen MJ, 2013, TROP MED INT HEALTH, V18, P398, DOI 10.1111/tmi.12064; Potchen MJ, 2012, AM J NEURORADIOL, V33, P1740, DOI 10.3174/ajnr.A3035; Potchen MJ, 2010, EUR J RADIOL, V74, P262, DOI 10.1016/j.ejrad.2009.02.010; Reuter B, 2006, J PSYCHIATR RES, V40, P122, DOI 10.1016/j.jpsychires.2005.02.007; Roberts W, 2011, ACTA PSYCHOL, V138, P419, DOI 10.1016/j.actpsy.2011.09.002; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; vanHensbroek MB, 1997, J PEDIATR-US, V131, P125, DOI 10.1016/S0022-3476(97)70135-5; Waszak F, 2010, DEV PSYCHOL, V46, P337, DOI 10.1037/a0018541	70	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164885	10.1371/journal.pone.0164885	http://dx.doi.org/10.1371/journal.pone.0164885			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764173	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000386204500076
J	Wodziak, D; Dong, A; Basin, MF; Lowe, AW				Wodziak, Dariusz; Dong, Aiwen; Basin, Michael F.; Lowe, Anson W.			Anterior Gradient 2 (AGR2) Induced Epidermal Growth Factor Receptor (EGFR) Signaling Is Essential for Murine Pancreatitis-Associated Tissue Regeneration	PLOS ONE			English	Article							CERULEIN-INDUCED PANCREATITIS; ACTIVATED PROTEIN-KINASE; HIPPO PATHWAY; LIVER-REGENERATION; EXOCRINE PANCREAS; GENE-EXPRESSION; BETA-CATENIN; MICE; RAT; AMPHIREGULIN	A recently published study identified Anterior Gradient 2 (AGR2) as a regulator of EGFR signaling by promoting receptor presentation from the endoplasmic reticulum to the cell surface. AGR2 also promotes tissue regeneration in amphibians and fish. Whether AGR2-induced EGFR signaling is essential for tissue regeneration in higher vertebrates was evaluated using a well-characterized murine model for pancreatitis. The impact of AGR2 expression and EGFR signaling on tissue regeneration was evaluated using the caerulein-induced pancreatitis mouse model. EGFR signaling and cell proliferation were examined in the context of the AGR2(-/-) null mouse or with the EGFR-specific tyrosine kinase inhibitor, AG1478. In addition, the Hippo signaling coactivator YAP1 was evaluated in the context of AGR2 expression during pancreatitis. Pancreatitis-induced AGR2 expression enabled EGFR translocation to the plasma membrane, the initiation of cell signaling, and cell proliferation. EGFR signaling and tissue regeneration were partially inhibited by the tyrosine kinase inhibitor AG1478, but absent in the AGR2(-/-) null mouse. AG1478-treated and AGR2(-/-) null mice with pancreatitis died whereas all wild-type controls recovered. YAP1 activation was also dependent on pancreatitis-induced AGR2 expression. AGR2-induced EGFR signaling was essential for tissue regeneration and recovery from pancreatitis. The results establish tissue regeneration as a major function of AGR2-induced EGFR signaling in adult higher vertebrates. Enhanced AGR2 expression and EGFR signaling are also universally present in human pancreatic cancer, which support a linkage between tissue injury, regeneration, and cancer pathogenesis.	[Wodziak, Dariusz; Dong, Aiwen; Basin, Michael F.; Lowe, Anson W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Stanford University	Lowe, AW (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	lowe@stanford.edu						ADLER G, 1979, VIRCHOWS ARCH A, V382, P31, DOI 10.1007/BF01102739; ADLER G, 1983, AM J PHYSIOL, V244, pG623, DOI 10.1152/ajpgi.1983.244.6.G623; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Berasain C, 2005, GASTROENTEROLOGY, V128, P424, DOI 10.1053/j.gastro.2004.11.006; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Campbell G, 2002, NATURE, V418, P781, DOI 10.1038/nature00971; CAMPOSGONZALEZ R, 1992, J BIOL CHEM, V267, P14535; Chen R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-149; COKER KJ, 1994, P NATL ACAD SCI USA, V91, P6967, DOI 10.1073/pnas.91.15.6967; Dong AW, 2015, J BIOL CHEM, V290, P8016, DOI 10.1074/jbc.M114.623207; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Ewald JA, 2001, EXP CELL RES, V268, P262, DOI 10.1006/excr.2001.5271; Galindo MI, 2002, SCIENCE, V297, P256, DOI 10.1126/science.1072311; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Gupta A, 2012, J BIOL CHEM, V287, P4773, DOI 10.1074/jbc.M111.301531; Hayashi S, 2014, DEV BIOL, V388, P57, DOI 10.1016/j.ydbio.2014.01.018; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Ivanova AS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01279; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Keefe MD, 2012, DIS MODEL MECH, V5, P503, DOI 10.1242/dmm.007799; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Kumar A, 2012, TRENDS NEUROSCI, V35, P691, DOI 10.1016/j.tins.2012.08.003; LAMPEL M, 1977, VIRCHOWS ARCH A, V373, P97, DOI 10.1007/BF00432156; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Mead TJ, 2013, NUCLEIC ACIDS RES, V41, P4459, DOI 10.1093/nar/gkt140; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Murtaugh LC, 2005, DEVELOPMENT, V132, P4663, DOI 10.1242/dev.02063; Nakamura T, 2008, CELL MOL LIFE SCI, V65, P64, DOI 10.1007/s00018-007-7432-0; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; NEVALAINEN TJ, 1992, EUR SURG RES, V24, P14, DOI 10.1159/000129235; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; Osawa M, 2004, J BIOL CHEM, V279, P29691, DOI 10.1074/jbc.M309371200; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Reid LE, 1999, INT J EXP PATHOL, V80, P205, DOI 10.1046/j.1365-2613.1999.00116.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SELVA E, 1993, J BIOL CHEM, V268, P2250; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; SPORMANN H, 1989, PATHOL RES PRACT, V184, P507, DOI 10.1016/S0344-0338(89)80143-8; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Warzecha Z, 1999, DIGESTION, V60, P314, DOI 10.1159/000007677; Wells JM, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-4; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Yoshinari N, 2009, DEV BIOL, V325, P71, DOI 10.1016/j.ydbio.2008.09.028; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993	53	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164968	10.1371/journal.pone.0164968	http://dx.doi.org/10.1371/journal.pone.0164968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764193	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500088
J	Dalton, DL; Vermaak, E; Roelofse, M; Kotze, A				Dalton, Desire Lee; Vermaak, Elaine; Roelofse, Marli; Kotze, Antoinette			Diversity in the Toll-Like Receptor Genes of the African Penguin (Spheniscus demersus)	PLOS ONE			English	Article							SOUTH-AFRICA; POLYMORPHISM; RECOGNIZES; HOST; LIPOPROTEINS; POPULATIONS; EVOLUTION; SELECTION; PATHOGEN; VIRUSES	The African penguin, Spheniscus demersus, is listed as Endangered by the IUCN Red List of Threatened Species due to the drastic reduction in population numbers over the last 20 years. To date, the only studies on immunogenetic variation in penguins have been conducted on the major histocompatibility complex (MHC) genes. It was shown in humans that up to half of the genetic variability in immune responses to pathogens are located in non-MHC genes. Toll-like receptors (TLRs) are now increasingly being studied in a variety of taxa as a broader approach to determine functional genetic diversity. In this study, we confirm low genetic diversity in the innate immune region of African penguins similar to that observed in New Zealand robin that has undergone several severe population bottlenecks. Single nucleotide polymorphism (SNP) diversity across TLRs varied between ex situ and in situ penguins with the number of non-synonymous alterations in ex situ populations (n = 14) being reduced in comparison to in situ populations (n = 16). Maintaining adaptive diversity is of vital importance in the assurance populations as these animals may potentially be used in the future for re-introductions. Therefore, this study provides essential data on immune gene diversity in penguins and will assist in providing an additional monitoring tool for African penguin in the wild, as well as to monitor diversity in ex situ populations and to ensure that diversity found in the in situ populations are captured in the assurance populations.	[Dalton, Desire Lee; Vermaak, Elaine; Roelofse, Marli; Kotze, Antoinette] Natl Zool Gardens South Africa, Ctr Conservat Sci, Pretoria, Gauteng, South Africa; [Dalton, Desire Lee; Kotze, Antoinette] Univ Free State, Dept Genet, Bloemfontein, Free State, South Africa	National Research Foundation - South Africa; National Zoological Gardens of South Africa; University of the Free State	Dalton, DL (corresponding author), Natl Zool Gardens South Africa, Ctr Conservat Sci, Pretoria, Gauteng, South Africa.; Dalton, DL (corresponding author), Univ Free State, Dept Genet, Bloemfontein, Free State, South Africa.	desire@nzg.ac.za		Dalton, Desire Lee/0000-0001-5975-6425				Alcaide M, 2008, MOL ECOL, V17, P2652, DOI 10.1111/j.1365-294X.2008.03791.x; Alcaide M, 2011, MOL BIOL EVOL, V28, P1703, DOI 10.1093/molbev/msq351; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; BirdLife International, 2013, IUCN RED LIST THREAT; BOCK CE, 1976, BIRD BANDING, V47, P263, DOI 10.2307/4512240; Boehme KW, 2004, J VIROL, V78, P7867, DOI 10.1128/JVI.78.15.7867-7873.2004; Bowie AG, 2005, MOL IMMUNOL, V42, P859, DOI 10.1016/j.molimm.2004.11.007; Boyd AC, 2012, J IMMUNOL, V189, P4930, DOI 10.4049/jimmunol.1101790; Carulei O, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-52; Crawford RJM, 2011, AFR J MAR SCI, V33, P139, DOI 10.2989/1814232X.2011.572377; Crawford RJM, 1995, PENGUINS: ECOLOGY AND MANAGEMENT, P333; Crawford RJM, 1995, S AFR J MARINE SCI, V16, P101; Crawford RJM, S AFR J MAR SCI, V12, P675; Crawford Robert J. M., 1999, Marine Ornithology, V27, P139; Cummings SM, 2010, CONSERV GENET, V11, P1095, DOI 10.1007/s10592-009-9864-6; Downing T, 2010, J IMMUNOL, V184, P6993, DOI 10.4049/jimmunol.0903092; du Toit M, 2004, S AFR J WILDL RES, V34, P45; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Fredrickson RJ, 2007, P ROY SOC B-BIOL SCI, V274, P2365, DOI 10.1098/rspb.2007.0785; FROST P G H, 1976, Biological Conservation, V9, P79, DOI 10.1016/0006-3207(76)90042-2; GARCIABORBOROGL.P, 2008, MARINE POLLUTION NEW, P339; GRACZYK TK, 1995, J HELMINTHOL SOC W, V62, P135; Grueber CE, 2013, CONSERV GENET RESOUR, V5, P1043, DOI 10.1007/s12686-013-9965-x; Grueber CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045011; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hess CM, 2007, GENETICA, V129, P217, DOI 10.1007/s10709-006-9016-6; Higuchi M, 2008, DEV COMP IMMUNOL, V32, P147, DOI 10.1016/j.dci.2007.05.003; IUCN, IUCN RED LIST THREAT; KELLER LF, 1994, NATURE, V372, P356, DOI 10.1038/372356a0; Kemper J., 2007, FINAL REPORT BCLME B, P325; Kerry K. R., 2009, HLTH ANTARCTIC WILDL; Kikkawa EF, 2009, IMMUNOGENETICS, V61, P341, DOI 10.1007/s00251-009-0363-1; Labuschagne C, 2016, AFR ZOOL, V51, P83, DOI 10.1080/15627020.2016.1186499; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Shaw KA, 2012, BIODIVERSIT IN PRESS; Siegemund S, 2012, NAT IMMUNOL, V13, P1031, DOI 10.1038/ni.2452; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; Thomazelli LM, 2010, VET MICROBIOL, V146, P155, DOI 10.1016/j.vetmic.2010.05.006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uematsu Satoshi, 2008, V183, P1; Varsani A, 2014, J GEN VIROL, V95, P1352, DOI 10.1099/vir.0.064436-0; Villasenor-Cardoso MI, 2011, PARASITE IMMUNOL, V33, P643, DOI 10.1111/j.1365-3024.2011.01327.x; WHITTINGTON PA, 2000, AFRICAN PENGUIN POPU; Wochrle T, 2008, CYTOKINE, V41, P322, DOI 10.1016/j.cyto.2007.12.006	53	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0163331	10.1371/journal.pone.0163331	http://dx.doi.org/10.1371/journal.pone.0163331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760133	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204000009
J	Hrebien, S; O'Leary, B; Beaney, M; Schiavon, G; Fribbens, C; Bhambra, A; Johnson, R; Garcia-Murillas, I; Turner, N				Hrebien, Sarah; O'Leary, Ben; Beaney, Matthew; Schiavon, Gaia; Fribbens, Charlotte; Bhambra, Amarjit; Johnson, Richard; Garcia-Murillas, Isaac; Turner, Nicholas			Reproducibility of Digital PCR Assays for Circulating Tumor DNA Analysis in Advanced Breast Cancer	PLOS ONE			English	Article							BLOOD COLLECTION; ACQUIRED-RESISTANCE; SAMPLE STORAGE; CELLULAR-DNA; PLASMA	Circulating tumor DNA (ctDNA) analysis has the potential to allow non-invasive analysis of tumor mutations in advanced cancer. In this study we assessed the reproducibility of digital PCR (dPCR) assays of circulating tumor DNA in a cohort of patients with advanced breast cancer and assessed delayed plasma processing using cell free DNA preservative tubes. We recruited a cohort of 96 paired samples from 71 women with advanced breast cancer who had paired blood samples processed either immediately or delayed in preservative tubes with processing 48-72 hours after collection. Plasma DNA was analysed with multiplex digital PCR (mdPCR) assays for hotspot mutations in PIK3CA, ESR1 and ERBB2, and for AKT1 E17K. There was 94.8% (91/96) agreement in mutation calling between immediate and delayed processed tubes, kappa 0.88 95% CI 0.77-0.98). Discordance in mutation calling resulted from low allele frequency and likely stochastic effects. In concordant samples there was high correlation in mutant copies per ml plasma (r(2) = 0.98; p<0.0001). There was elevation of total cell free plasma DNA concentrations in 10.3% of delayed processed tubes, although overall quantification of total cell free plasma DNA had similar prognostic effects in immediate (HR 3.6) and delayed (HR 3.0) tubes. There was moderate agreement in changes in allele fraction between sequential samples in quantitative mutation tracking (r = 0.84, p = 0.0002). Delayed processing of samples using preservative tubes allows for centralized ctDNA digital PCR mutation screening in advanced breast cancer. The potential of preservative tubes in quantitative mutation tracking requires further research.	[Hrebien, Sarah; O'Leary, Ben; Beaney, Matthew; Fribbens, Charlotte; Garcia-Murillas, Isaac; Turner, Nicholas] Inst Canc Res, Breast Canc Now Res Ctr, London SW3 6JB, England; [O'Leary, Ben; Fribbens, Charlotte; Bhambra, Amarjit; Johnson, Richard; Turner, Nicholas] Royal Marsden Hosp, Breast Unit, Fulham Rd, London SW3 6JJ, England; [Schiavon, Gaia] AstraZeneca, Translat Sci, Oncol iMed, Cambridge CB4 0WG, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; AstraZeneca	Turner, N (corresponding author), Inst Canc Res, Breast Canc Now Res Ctr, London SW3 6JB, England.; Turner, N (corresponding author), Royal Marsden Hosp, Breast Unit, Fulham Rd, London SW3 6JJ, England.	nicholas.turner@icr.ac.uk		Turner, Nicholas/0000-0001-8937-0873; O'Leary, Ben/0000-0002-1092-9169; garcia-murillas, isaac/0000-0001-8183-7969; Fribbens, Charlotte/0000-0002-1500-6945	Breast Cancer; National Institute for Health Research; Cancer Research UK [C30746/A16642]; Le Cure; Cridlan trust; National Institute for Health Research [ACF-2012-22-007] Funding Source: researchfish	Breast Cancer; National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Le Cure; Cridlan trust; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by Breast Cancer Now (http://www.breastcancernow.org/, NT), National Institute for Health Research (http://www.nihr.ac.uk/, NT), Cancer Research UK, C30746/A16642 (http://www.cancerresearchuk.org/, NT), Le Cure (http://lecuredefrance.org/, NT), and Cridlan trust (httt://opencharities.org/charities/1112652, GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Das K, 2014, MOL DIAGN THER, V18, P647, DOI 10.1007/s40291-014-0118-z; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Denis MG, 2015, CLIN CHEM, V61, P886, DOI 10.1373/clinchem.2015.238352; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Garcia-Murillas Isaac S G, 2015, SCI TRANSLATIONAL ME; Gevensleben H, 2013, CLIN CANCER RES, V19, P3276, DOI 10.1158/1078-0432.CCR-12-3768; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Norton ME, 2015, NEW ENGL J MED, V372, P1589, DOI 10.1056/NEJMoa1407349; Norton SE, 2013, CLIN BIOCHEM, V46, P1561, DOI 10.1016/j.clinbiochem.2013.06.002; Norton SE, 2013, J CLIN LAB ANAL, V27, P305, DOI 10.1002/jcla.21603; Pender A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139074; Salmela L, 2017, BIOINFORMATICS, V33, P799, DOI 10.1093/bioinformatics/btw321; Sherwood JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150197; Toro PV, 2015, CLIN BIOCHEM, V48, P993, DOI 10.1016/j.clinbiochem.2015.07.097; Wang Q, 2015, GENET MOL RES, V14, P12797, DOI 10.4238/2015.October.19.23; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wong D, 2013, CLIN BIOCHEM, V46, P1099, DOI 10.1016/j.clinbiochem.2013.04.023	19	27	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0165023	10.1371/journal.pone.0165023	http://dx.doi.org/10.1371/journal.pone.0165023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760227	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000077
J	Kim, T; Cho, S; Lee, SM; Woo, HM; Lee, J; Um, Y; Seo, JH				Kim, Taeyeon; Cho, Sukhyeong; Lee, Sun-Mi; Woo, Han Min; Lee, Jinwon; Um, Youngsoon; Seo, Jin-Ho			High Production of 2,3-Butanediol (2,3-BD) by Raoultella ornithinolytica B6 via Optimizing Fermentation Conditions and Overexpressing 2,3-BD Synthesis Genes	PLOS ONE			English	Article							KLEBSIELLA-OXYTOCA; PATHWAY; IDENTIFICATION; OPTIMIZATION; TERRIGENA; ACETOIN; COMPLEX	Biological production of 2,3-butandiol (2,3-BD) has received great attention as an alternative to the petroleum-based 2,3-BD production. In this study, a high production of 2,3-BD in fed-batch fermentation was investigated with a newly isolated bacterium designated as Raoultella ornithinolytica B6. The isolate produced 2,3-BD as the main product using hexoses (glucose, galactose, and fructose), pentose (xylose) and disaccharide (sucrose). The effects of temperature, pH-control schemes, and agitation speeds on 2,3-BD production were explored to optimize the fermentation conditions. Notably, cell growth and 2,3-BD production by R. ornithinolytica B6 were higher at 25 degrees C than at 30 degrees C. When three pH control schemes (no pH control, pH control at 7, and pH control at 5.5 after the pH was decreased to 5.5 during fermentation) were tested, the best 2,3-BD titer and productivity along with reduced by-product formation were achieved with pH control at 5.5. Among different agitation speeds (300, 400, and 500 rpm), the optimum agitation speed was 400 rpm with 2,3-BD titer of 68.27 g/L, but acetic acid was accumulated up to 23.32 g/L. Further enhancement of the 2,3-BD titer (112.19 g/L), yield (0.38 g/g), and productivity (1.35 g/L/h) as well as a significant reduction of acetic acid accumulation (9.71 g/L) was achieved by the overexpression of homologous budABC genes, the 2,3-BD-synthesis genes involved in the conversion of pyruvate to 2,3-BD. This is the first report presenting a high 2,3-BD production by R. ornithinolytica which has attracted little attention with respect to 2,3-BD production, extending the microbial spectrum of 2,3-BD producers.	[Kim, Taeyeon; Seo, Jin-Ho] Seoul Natl Univ, Coll Agr & Life Sci, Interdisciplinary Program Agr Biotechnol, 1 Gwanak Ro, Seoul 151742, South Korea; [Kim, Taeyeon; Lee, Sun-Mi; Um, Youngsoon] Korea Inst Sci & Technol, Clean Energy Ctr, Seoul 136791, South Korea; [Lee, Sun-Mi; Um, Youngsoon] Korea Univ Sci & Technol, Clean Energy & Chem Engn, Daejeon, South Korea; [Seo, Jin-Ho] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea; [Seo, Jin-Ho] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul 151742, South Korea; [Woo, Han Min] Sungkyunkwan Univ SKKU, Dept Food Sci & Biotechnol, 2066 Seobu Ro, Suwon 16419, South Korea; [Cho, Sukhyeong; Lee, Jinwon] Sogang Univ, Korea Gas Refinery R&D Ctr C1, Seoul 121742, South Korea; [Lee, Jinwon] Sogang Univ, Dept Chem & Biomol Engn, Seoul 121742, South Korea	Seoul National University (SNU); Korea Institute of Science & Technology (KIST); University of Science & Technology (UST); Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Sogang University; Sogang University	Seo, JH (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Interdisciplinary Program Agr Biotechnol, 1 Gwanak Ro, Seoul 151742, South Korea.; Um, Y (corresponding author), Korea Inst Sci & Technol, Clean Energy Ctr, Seoul 136791, South Korea.; Um, Y (corresponding author), Korea Univ Sci & Technol, Clean Energy & Chem Engn, Daejeon, South Korea.; Seo, JH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea.; Seo, JH (corresponding author), Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul 151742, South Korea.	yum@kist.re.kr; jhseo94@snu.ac.kr	Woo, Han Min/J-1847-2015	Woo, Han Min/0000-0002-8797-0477; um, youngsoon/0000-0003-1695-1874; Lee, Jinwon/0000-0003-4153-0609; Lee, Sun-Mi/0000-0002-5303-5464	C1 Gas Refinery Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2016M3D3A1A01913249]; Korea Institute of Science and Technology (KIST)	C1 Gas Refinery Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Korea Institute of Science and Technology (KIST)(Korea Institute of Science & Technology (KIST))	This research was supported by C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2016M3D3A1A01913249). This work was also supported by Korea Institute of Science and Technology (KIST).	[Anonymous], 2016, BIORESOUR BIOPROCESS; BLOMQVIST K, 1993, J BACTERIOL, V175, P1392, DOI 10.1128/JB.175.5.1392-1404.1993; Celinska E, 2009, BIOTECHNOL ADV, V27, P715, DOI 10.1016/j.biotechadv.2009.05.002; Cho S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138109; Cho S, 2013, APPL BIOCHEM BIOTECH, V170, P1922, DOI 10.1007/s12010-013-0291-2; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Drancourt M, 2001, INT J SYST EVOL MICR, V51, P925, DOI 10.1099/00207713-51-3-925; Fiolka MJ, 2015, J APPL MICROBIOL, V118, P1357, DOI 10.1111/jam.12806; Fiolka MJ, 2013, PATHOG DIS, V69, P49, DOI 10.1111/2049-632X.12056; Hii LS, 2012, FOOD BIOPROCESS TECH, V5, P729, DOI 10.1007/s11947-010-0368-7; Jantama K, 2015, METAB ENG, V30, P16, DOI 10.1016/j.ymben.2015.04.004; Ji XJ, 2008, BIOTECHNOL LETT, V30, P731, DOI 10.1007/s10529-007-9599-8; Ji XJ, 2010, APPL MICROBIOL BIOT, V85, P1751, DOI 10.1007/s00253-009-2222-2; Ji XJ, 2009, BIORESOURCE TECHNOL, V100, P3410, DOI 10.1016/j.biortech.2009.02.031; Jung MY, 2012, APPL MICROBIOL BIOT, V95, P461, DOI 10.1007/s00253-012-3883-9; Kim B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105322; Kim B, 2012, J MICROBIOL BIOTECHN, V22, P1258, DOI 10.4014/jmb.1201.01044; Kim EM, 2015, J AGR FOOD CHEM, V63, P4606, DOI 10.1021/acs.jafc.5b01334; Kim SJ, 2014, J BIOTECHNOL, V192, P376, DOI 10.1016/j.jbiotec.2013.12.017; Ma CQ, 2009, APPL MICROBIOL BIOT, V82, P49, DOI 10.1007/s00253-008-1732-7; MAYER D, 1995, J BACTERIOL, V177, P5261, DOI 10.1128/jb.177.18.5261-5269.1995; Munoz C, 2014, APPL ENVIRON MICROB, V80, P4199, DOI 10.1128/AEM.00827-14; Park JM, 2013, J IND MICROBIOL BIOT, V40, P1057, DOI 10.1007/s10295-013-1298-y; Shi LT, 2014, BIOTECHNOL LETT, V36, P969, DOI 10.1007/s10529-013-1433-x; Shin SH, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00395-13; Sun FJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00458; Syu MJ, 2001, APPL MICROBIOL BIOT, V55, P10, DOI 10.1007/s002530000486; Tong YJ, 2016, APPL MICROBIOL BIOT, V100, P637, DOI 10.1007/s00253-015-7013-3; Wi SG, 2009, BIORESOURCE TECHNOL, V100, P6658, DOI 10.1016/j.biortech.2009.07.017; Yang TH, 2014, J BIOTECHNOL, V172, P59, DOI 10.1016/j.jbiotec.2013.12.007; Zhang LY, 2010, J IND MICROBIOL BIOT, V37, P857, DOI 10.1007/s10295-010-0733-6; Zhang LY, 2010, BIORESOURCE TECHNOL, V101, P1961, DOI 10.1016/j.biortech.2009.10.052	32	9	11	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0165076	10.1371/journal.pone.0165076	http://dx.doi.org/10.1371/journal.pone.0165076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760200	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204000083
J	Kwiatkowski, S; Dolegowska, B; Kwiatkowska, E; Rzepka, R; Torbe, A; Bednarek-Jedrzejek, M				Kwiatkowski, Sebastian; Dolegowska, Barbara; Kwiatkowska, Ewa; Rzepka, Rafal; Torbe, Andrzej; Bednarek-Jedrzejek, Magdalena			A Common Profile of Disordered Angiogenic Factor Production and the Exacerbation of Inflammation in Early Preeclampsia, Late Preeclampsia, and Intrauterine Growth Restriction	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PREGNANCIES; SERUM; HYPERTENSION; CYTOKINES; EXPRESSION; LESIONS; WOMEN; GAMMA; TERM	Preeclampsia and intrauterine growth restriction are two separate disease entities that, according to numerous reports, share the same pathogenesis. In both, angiogenesis disorders and generalized inflammation are the dominant symptoms. In this study, we hypothesized that both diseases demonstrate the same profile in early preeclampsia, late preeclampsia, and intrauterine growth restriction patients, with the only difference being the degree of exacerbation of lesions. One hundred sixty-seven patients were enrolled in the study and divided into four groups: early preeclampsia, late preeclampsia, and intrauterine growth restriction groups, and one control group. Concentrations of the angiogenesis and inflammatory markers soluble fms-like tyrosine kinase receptor 1, placental growth factor, high-sensitivity C-reactive protein, and interleukin-6 were determined, and the behavior of these markers and correlations among them were studied. Higher concentrations of soluble fms-like tyrosine kinase receptor 1, high-sensitivity C-reactive protein, and interleukin-6 and a lower concentration of placental growth factor were observed in the study groups compared with the control group. No differences in concentrations of the studied markers were found among the study groups but significant correlations were observed. The higher values for the angiogenesis and inflammatory markers both in preeclampsia patients and patients with intrauterine growth restriction of placental origin compared with the control group suggest the existence of the same underlying disorders in the development of these pathologies. The observed mutual correlations for disordered angiogenesis and inflammatory markers are suggestive of a mutual relationship between these processes in the development of pathologies evolving secondary to placental ischemia. The same lesion profile was observed for both preeclampsia and 'placental' intrauterine growth restriction patients, which could be used in developing common diagnostic criteria for pregnant patients.	[Kwiatkowski, Sebastian; Rzepka, Rafal; Torbe, Andrzej; Bednarek-Jedrzejek, Magdalena] Pomeranian Med Univ, Dept Gynecol & Obstet, Szczecin, Poland; [Kwiatkowska, Ewa] Pomeranian Med Univ, Dept Nephrol Transplantol & Internal Med, Szczecin, Poland; [Dolegowska, Barbara] Pomeranian Med Univ, Dept Microbiol & Immunol, Szczecin, Poland	Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University	Kwiatkowski, S (corresponding author), Pomeranian Med Univ, Dept Gynecol & Obstet, Szczecin, Poland.	kwiatkowskiseba@gmail.com	Torbé, Andrzej/I-2963-2014; Dolegowska, Barbara/O-4851-2014	Torbé, Andrzej/0000-0002-6344-4798; Dolegowska, Barbara/0000-0003-3138-1013; Kwiatkowski, Sebastian/0000-0003-1504-3639; Ewa, Kwiatkowska/0000-0002-9847-6589				Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Alahakoon TI, 2014, J MATERN-FETAL NEO M, V27, P1854, DOI 10.3109/14767058.2014.880882; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Can M, 2011, CLIN CHEM LAB MED, V49, P1469, DOI 10.1515/CCLM.2011.232; Cheng PJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002653; Cindrova-Davies T, 2013, AM J PATHOL, V182, P1448, DOI 10.1016/j.ajpath.2013.01.001; Crispi F, 2006, AM J OBSTET GYNECOL, V195, P201, DOI 10.1016/j.ajog.2006.01.014; Dong Q, 1996, J IMMUNOL, V156, P4815; Elfayomy AK, 2013, J OBSTET GYNAECOL, V33, P135, DOI 10.3109/01443615.2012.721821; Farzadnia M, 2013, IRAN J BASIC MED SCI, V16, P689; Figueras F, 2014, PRENATAL DIAG, V34, P655, DOI 10.1002/pd.4412; GERRETSEN G, 1981, BRIT J OBSTET GYNAEC, V88, P876, DOI 10.1111/j.1471-0528.1981.tb02222.x; Guan HJ, 2009, CLIN CHEM, V55, P274, DOI 10.1373/clinchem.2008.115857; Husse S, 2014, Z GEBURTSH NEONATOL, V218, P34, DOI 10.1055/s-0034-1368713; Jialal I, 2009, CLIN CHEM, V55, P206, DOI 10.1373/clinchem.2008.119206; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kobayashi S, 2003, ARTERIOSCL THROM VAS, V23, P1398, DOI 10.1161/01.ATV.0000081637.36475.BC; LABARRERE C, 1985, EUR J OBSTET GYN R B, V20, P1, DOI 10.1016/0028-2243(85)90077-2; LaMarca BD, 2007, CURR HYPERTENS REP, V9, P480, DOI 10.1007/s11906-007-0088-1; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Ouyang YQ, 2009, ARCH GYNECOL OBSTET, V280, P91, DOI 10.1007/s00404-008-0874-2; Pathak S, 2011, VIRCHOWS ARCH, V459, P565, DOI 10.1007/s00428-011-1157-z; Rahardjo B, 2014, PREGNANCY HYPERTENS, V4, P187, DOI 10.1016/j.preghy.2014.03.001; Reimer T, 2013, J MATERN-FETAL NEO M, V26, P263, DOI 10.3109/14767058.2012.733747; Saarelainen Heli, 2012, ISRN Obstet Gynecol, V2012, P709464, DOI 10.5402/2012/709464; Schoofs K, 2014, J PERINAT MED, V42, P61, DOI 10.1515/jpm-2013-0074; Timur H, 2016, PREGNANCY HYPERTENS, V6, P121, DOI 10.1016/j.preghy.2016.04.003; Udenze I, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.219.5317; Wallner W, 2007, CLIN SCI, V112, P51, DOI 10.1042/CS20060161	30	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0165060	10.1371/journal.pone.0165060	http://dx.doi.org/10.1371/journal.pone.0165060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760191	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000081
J	Shi, GH; Peng, CH; Wang, M; Shi, SW; Yang, YZ; Chu, JY; Zhang, JJ; Lin, GH; Shen, Y; Zhu, QA				Shi, Guohua; Peng, Changhui; Wang, Meng; Shi, Shengwei; Yang, Yanzheng; Chu, Junyao; Zhang, Junjun; Lin, Guanghui; Shen, Yan; Zhu, Qiuan			The Spatial and Temporal Distribution of Dissolved Organic Carbon Exported from Three Chinese Rivers to the China Sea	PLOS ONE			English	Article							CHANGJIANG YANGTZE RIVER; YELLOW-RIVER; CLIMATE-CHANGE; SEDIMENT DISCHARGE; PEARL RIVER; TRANSPORT; FLUXES; VARIABILITY; LAND; IMPACTS	The lateral transport of dissolved organic carbon (DOC) plays an important role in linking the carbon cycles of terrestrial and aquatic ecosystems. Neglecting the lateral flow of dissolved organic carbon can lead to an underestimation of the organic carbon budget of terrestrial ecosystems. It is thus necessary to integrate DOC concentrations and flux into carbon cycle models, particularly with regard to the development of models that are intended to directly link terrestrial and ocean carbon cycles. However, to achieve this goal, more accurate information is needed to better understand and predict DOC dynamics. In this study, we compiled an inclusive database of available data collected from the Yangtze River, Yellow River and Pearl River in China. The database is collected based on online literature survey and analysed by statistic method. Overall, our results revealed a positive correlation between DOC flux and discharge in all three rivers, whereas the DOC concentration was more strongly correlated with the regional net primary productivity (NPP). We estimated the total DOC flux exported by the three rivers into the China Sea to be approximately 2.73 Tg yr(-1). Specifically, the annual flux of DOC from the Yangtze River, Yellow River and Pearl River was estimated to be 1.85 Tg yr(-1), 0.06 Tg yr(-1) and 0.82 Tg yr(-1), respectively, and the average annual DOC concentrations were estimated to be 2.24 +/- 0.53 mg L-1, 2.70 +/- 0.38 mg L-1 and 1.51 +/- 0.09 mg L-1, respectively. Seasonal variations in DOC concentrations are greatly influenced by the interaction between temperature and precipitation. NPP is significantly and positively related to the DOC concentration in the Yangtze River and the Pearl River. In addition, differences in climate and the productivity of the vegetation may influence both the flux and concentrations of DOC transported by the rivers and thus potentially affect estuarine geochemistry.	[Shi, Guohua; Peng, Changhui; Wang, Meng; Shi, Shengwei; Yang, Yanzheng; Zhang, Junjun; Zhu, Qiuan] Northwest A&F Univ, Coll Forestry, Lab Ecol Forecasting & Global Change, Yangling 712100, Shaanxi, Peoples R China; [Peng, Changhui; Shi, Shengwei] Univ Quebec, Inst Environm Sci, Dept Biol Sci, CP 8888,Succ Ctr Ville, Montreal, PQ H3C 3P8, Canada; [Lin, Guanghui] Tsinghua Univ, Ctr Earth Syst Sci, Minist Educ, Key Lab Earth Syst Modeling, Beijing 100084, Peoples R China; [Chu, Junyao] Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China; [Chu, Junyao] AQSIQ, Natl Inst Metrol, Inst Metrol Adm & Strateg Planning, Beijing 100013, Peoples R China; [Shen, Yan] Cent South Univ Forestry & Technol, Fac Life Sci & Technol, Changsha 410004, Hunan, Peoples R China	Northwest A&F University - China; University of Quebec; University of Quebec Montreal; Tsinghua University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; National Institute of Metrology China; Central South University of Forestry & Technology	Peng, CH; Zhu, QA (corresponding author), Northwest A&F Univ, Coll Forestry, Lab Ecol Forecasting & Global Change, Yangling 712100, Shaanxi, Peoples R China.; Peng, CH (corresponding author), Univ Quebec, Inst Environm Sci, Dept Biol Sci, CP 8888,Succ Ctr Ville, Montreal, PQ H3C 3P8, Canada.	peng.changhui@uqam.ca; qiuan.zhu@gmail.com		Yang, Yanzheng/0000-0002-3299-0403; Wang, Meng/0000-0001-5291-5622	National Basic Research Program of China [2013CB956602]; International S&T Cooperation Program of China [2013DFA32190]; QianRen Program; Natural Sciences and Engineering Research Council of Canada (NSERC) Discover Grant	National Basic Research Program of China(National Basic Research Program of China); International S&T Cooperation Program of China; QianRen Program; Natural Sciences and Engineering Research Council of Canada (NSERC) Discover Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was financially supported by the National Basic Research Program of China (2013CB956602), the International S&T Cooperation Program of China (2013DFA32190), QianRen Program, and the Natural Sciences and Engineering Research Council of Canada (NSERC) Discover Grant.	Aitkenhead JA, 2000, GLOBAL BIOGEOCHEM CY, V14, P127, DOI 10.1029/1999GB900083; Alvarez-Cobelas M, 2012, BIOGEOCHEMISTRY, V107, P275, DOI 10.1007/s10533-010-9553-z; Aufdenkampe AK, 2011, FRONT ECOL ENVIRON, V9, P53, DOI 10.1890/100014; Camino-Serrano M, 2014, GLOBAL BIOGEOCHEM CY, V28, P497, DOI 10.1002/2013GB004726; Chen JS, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002325; Chu Ying, 2013, Journal of Resources and Ecology, V4, P105, DOI 10.5814/j.issn.1674-764x.2013.02.002; Dagg M, 2004, CONT SHELF RES, V24, P833, DOI 10.1016/j.csr.2004.02.003; Dai MH, 2012, CURR OPIN ENV SUST, V4, P170, DOI 10.1016/j.cosust.2012.03.003; Evans CD, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029431; Fu YC, 2014, J GEOGR SCI, V24, P143, DOI 10.1007/s11442-014-1078-2; Harrison AF, 2008, GLOBAL CHANGE BIOL, V14, P687, DOI 10.1111/j.1365-2486.2007.01504.x; Heinsch F.A., 2003, MOD17 USERS GUIDE, P1; HOPE D, 1994, ENVIRON POLLUT, V84, P301, DOI 10.1016/0269-7491(94)90142-2; HUTCHINSON MF, 1994, GEODERMA, V62, P45, DOI 10.1016/0016-7061(94)90027-2; [柯金虎 Ke Jinhu], 2003, [植物生态学报, Acta Phytoecologica Sinica], V27, P764; Laudon H, 2004, AQUAT SCI, V66, P223, DOI 10.1007/s00027-004-0700-2; Liu DM, 2010, PERIODICAL OCEAN U C, V40, P105; Lu XX, 2012, HYDROL PROCESS, V26, P1604, DOI 10.1002/hyp.8267; Ludwig W, 1996, GLOBAL BIOGEOCHEM CY, V10, P23, DOI 10.1029/95GB02925; McKee B, 2003, COMM WORKSH; MEYBECK M, 1982, AM J SCI, V282, P401, DOI 10.2475/ajs.282.4.401; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; Neff JC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028222; Palmer SM, 2001, BIOGEOCHEMISTRY, V52, P321, DOI 10.1023/A:1006447706565; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Ran L, 2014, BIOGEOSCIENCES, V11, P945, DOI 10.5194/bg-11-945-2014; Ran LS, 2013, J HYDROL, V498, P76, DOI 10.1016/j.jhydrol.2013.06.018; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/ngeo1830, 10.1038/NGEO1830]; Rui S, 2003, INT GEOSCI REMOTE SE, P3371; SCHLESINGER WH, 1981, TELLUS, V33, P172, DOI 10.1111/j.2153-3490.1981.tb01742.x; Smemo KA, 2007, ECOSYSTEMS, V10, P369, DOI 10.1007/s10021-007-9014-2; Sun HG, 2010, QUATERN INT, V226, P38, DOI 10.1016/j.quaint.2010.03.002; Sun HG, 2007, CHINESE SCI BULL, V52, P805, DOI 10.1007/s11434-007-0111-6; [Tao Bo 陶波], 2003, Journal of Geographical Sciences, V13, P163; Tao Z, 2011, J MT SCI-ENGL, V8, P694, DOI 10.1007/s11629-011-2000-3; Thurman E. M., 1985, ORG GEOCHEM, DOI 10.1007/978-94-009-5095-5; Tranvik LJ, 2002, NATURE, V415, P861, DOI 10.1038/415861b; Wang G, 2001, ENVIRON GEOL, V40, P884, DOI 10.1007/s002540100248; Wang M, 2010, THESIS; Wang XC, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004130; Wang Zhao-li, 2006, Acta Scientiarum Naturalium Universitatis Sunyatseni, V45, P106; Wei X, 2003, THESIS; Weiguo L., 2003, APPL GEOCHEM, V18, P1241, DOI [10.1016/S0883-2927(02)00249-4, DOI 10.1016/S0883-2927(02)00249-4]]; Wilson HF, 2008, ECOSYSTEMS, V11, P555, DOI 10.1007/s10021-008-9142-3; Wu LL, 2005, GEOCHIM COSMOCHIM AC, V69, P5279, DOI 10.1016/j.gca.2005.07.001; Wu Y, 2000, J OCEAN U QINGDAO, V30, P309; Yang DW, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002763; Yang Z, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR003970; Zhang LJ, 2013, BIOGEOSCIENCES, V10, P2513, DOI 10.5194/bg-10-2513-2013; Zhang Lian-kai, 2013, Huanjing Kexue, V34, P3025; [张龙军 ZHANG Longjun], 2007, [水科学进展, Advances in Water Science], V18, P674; Zhang LJ, 2014, J GEOPHYS RES-BIOGEO, V119, P741, DOI 10.1002/2012JG002230; ZHANG S, 1992, MAR CHEM, V38, P53, DOI 10.1016/0304-4203(92)90067-K; Zhang X.D., 2004, THESIS	54	12	12	17	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0165039	10.1371/journal.pone.0165039	http://dx.doi.org/10.1371/journal.pone.0165039			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755581	Green Published, Green Submitted, gold			2022-12-26	WOS:000386203800052
J	Wang, XL; Cai, B; Zhou, JK; Zhu, HJ; Niu, YY; Ma, BH; Yu, HH; Lei, AM; Yan, HL; Shen, QY; Shi, L; Zhao, X; Hua, JL; Huang, XX; Qu, L; Chen, YL				Wang, Xiaolong; Cai, Bei; Zhou, Jiankui; Zhu, Haijing; Niu, Yiyuan; Ma, Baohua; Yu, Honghao; Lei, Anmin; Yan, Hailong; Shen, Qiaoyan; Shi, Lei; Zhao, Xiaoe; Hua, Jinlian; Huang, Xingxu; Qu, Lei; Chen, Yulin			Disruption of FGF5 in Cashmere Goats Using CRISPR/Cas9 Results in More Secondary Hair Follicles and Longer Fibers	PLOS ONE			English	Article							GROWTH; GENE; GENERATION; REGULATOR; KNOCKOUT; LENGTH; MICE	Precision genetic engineering accelerates the genetic improvement of livestock for agriculture and biomedicine. We have recently reported our success in producing gene-modified goats using the CRISPR/Cas9 system through microinjection of Cas9 mRNA and sgRNAs targeting the MSTN and FGF5 genes in goat embryos. By investigating the influence of gene modification on the phenotypes of Cas9-mediated goats, we herein demonstrate that the utility of this approach involving the disruption of FGF5 results in increased number of second hair follicles and enhanced fiber length in Cas9-mediated goats, suggesting more cashmere will be produced. The effects of genome modifications were characterized using H&E and immunohistochemistry staining, quantitative PCR, and western blotting techniques. These results indicated that the gene modifications induced by the disruption of FGF5 had occurred at the morphological and genetic levels. We further show that the knockout alleles were likely capable of germline transmission, which is essential for goat population expansion. These results provide sufficient evidences of the merit of using the CRISPR/Cas9 approach for the generation of gene-modified goats displaying the corresponding mutant phenotypes.	[Wang, Xiaolong; Cai, Bei; Niu, Yiyuan; Yan, Hailong; Chen, Yulin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China; [Huang, Xingxu] Nanjing Univ, Natl Resource Ctr Mutant Mice, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; [Zhou, Jiankui; Huang, Xingxu] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Zhu, Haijing; Yu, Honghao; Yan, Hailong; Shi, Lei; Qu, Lei] Shaanxi Prov Engn & Technol Res Ctr Cashmere Goat, Yulin 719000, Peoples R China; [Zhu, Haijing; Yu, Honghao; Yan, Hailong; Shi, Lei; Qu, Lei] Yulin Univ, Life Sci Res Ctr, Yulin 719000, Peoples R China; [Ma, Baohua; Lei, Anmin; Shen, Qiaoyan; Zhao, Xiaoe; Hua, Jinlian] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Peoples R China	Northwest A&F University - China; Nanjing University; ShanghaiTech University; Yulin University; Northwest A&F University - China	Chen, YL (corresponding author), Nanjing Univ, Natl Resource Ctr Mutant Mice, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China.	xingxuhuang@mail.nju.edu.cn; ylqulei@126.com; chenyulin@nwafu.edu.cn		LEI, An-min/0000-0002-5066-8709; Ma, Baohua/0000-0002-8332-4275; huang, xingxu/0000-0001-8934-1247; Niu, Yiyuan/0000-0003-1195-0223	Major Projects for New Varieties of Genetically Modified Organisms of China [2016ZX08008-002]; National Natural Science Foundation of China [31372279, 31402038, 31171377, 31572369]; China Agriculture Research System [CARS-40-13]; Provincial Key Projects of Shaanxi [2014KTDZ02-01]	Major Projects for New Varieties of Genetically Modified Organisms of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Provincial Key Projects of Shaanxi	This work is supported by grants from the Major Projects for New Varieties of Genetically Modified Organisms of China (2016ZX08008-002), and by National Natural Science Foundation of China (31372279, 31402038, 31171377, 31572369), and China Agriculture Research System (CARS-40-13), as well as a Provincial Key Projects of Shaanxi (2014KTDZ02-01).	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Carlson DF, 2014, REPROD FERT DEVELOP, V26, P74, DOI 10.1071/RD13260; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Drogemuller C, 2007, ANIM GENET, V38, P218, DOI 10.1111/j.1365-2052.2007.01590.x; Ge SN, 2014, BRAIN STRUCT FUNCT, V219, P211, DOI 10.1007/s00429-012-0495-1; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; He XL, 2016, GENE, V575, P393, DOI 10.1016/j.gene.2015.09.034; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Higgins CA, 2014, P NATL ACAD SCI USA, V111, P10648, DOI 10.1073/pnas.1402862111; Housley DJE, 2006, ANIM GENET, V37, P309, DOI 10.1111/j.1365-2052.2006.01448.x; IBRAHEEM M, 1994, J ANAT, V185, P135; Kuramochi-Miyagawa S, 2010, GENE DEV, V24, P887, DOI 10.1101/gad.1902110; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Niu ZW, 2014, MOL BIOL REP, V41, P2697, DOI 10.1007/s11033-014-3156-z; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Proudfoot C, 2015, TRANSGENIC RES, V24, P147, DOI 10.1007/s11248-014-9832-x; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Wang X, 2015, SCI REPORTS, V5; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Zhang QL, 2014, GENET MOL RES, V13, P4433, DOI 10.4238/2014.June.16.2	23	50	55	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164640	10.1371/journal.pone.0164640	http://dx.doi.org/10.1371/journal.pone.0164640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755602	Green Published, gold, Green Submitted			2022-12-26	WOS:000386203800025
J	Onoabedje, EA; Ibezim, A; Okafor, SN; Onoabedje, US; Okoro, UC				Onoabedje, Efeturi Abraham; Ibezim, Akachukwu; Okafor, Sunday Nwankwor; Onoabedje, Ufuoma Shalom; Okoro, Uchechukwu Chris			Oxazin-5-Ones as a Novel Class of Penicillin Binding Protein Inhibitors: Design, Synthesis and Structure Activity Relationship	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; PHENOXAZINE; DERIVATIVES; DISCOVERY; DOCKING; DYES	Penicillin binding proteins (PBPs) are normal constituents of bacterial which are absent in mammalian cells. The theoretical binding modes of known oxazin-5-ones toward the protein were used as a guide to synthesis new inhibitors. Structural studies of protein-ligand complexes revealed that conformational discrepancies of the derivatives in the protein's binding site gave rise to the variation in their inhibition constant which ranged from 68.58 mu M to 2.04 mM. Biological assay results further confirmed the antibiotic potencies of the studied compounds. Although the outcome of biological screening does not parallel computational predictions, the results obtained from both methods suggest that the oxazin-5-one derivatives are potential PBP inhibitors, hence interesting antibiotic lead agents.	[Onoabedje, Efeturi Abraham; Okoro, Uchechukwu Chris] Univ Nigeria, Dept Pure & Ind Chem, Nsukka, Enugu State, Nigeria; [Ibezim, Akachukwu; Okafor, Sunday Nwankwor; Onoabedje, Ufuoma Shalom] Univ Nigeria, Fac Pharmaceut Sci, Nsukka, Enugu State, Nigeria	University of Nigeria; University of Nigeria	Onoabedje, EA (corresponding author), Univ Nigeria, Dept Pure & Ind Chem, Nsukka, Enugu State, Nigeria.; Ibezim, A (corresponding author), Univ Nigeria, Fac Pharmaceut Sci, Nsukka, Enugu State, Nigeria.	efeturi.onoabedje@unn.edu.ng; akachukwu.ibezim@unn.edu.ng	Sunday, Okafor/AGD-9335-2022	Sunday, Okafor/0000-0002-7476-3292				Balouiri M, 2016, J PHARM ANAL, V6, P71, DOI 10.1016/j.jpha.2015.11.005; Banuppriya G, 2016, BIOORG MED CHEM LETT, V26, P1655, DOI 10.1016/j.bmcl.2016.02.066; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BLANK B, 1968, J MED CHEM, V11, P807, DOI 10.1021/jm00310a024; Ge JF, 2010, ACS MED CHEM LETT, V1, P360, DOI 10.1021/ml100120a; Hamed-Akbari TS, 2010, PROTEIN PEPTIDE LETT, V17, P1524, DOI [10.2174/0020866511009011524, DOI 10.2174/0929866511009011524]; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Ibezim A., 2015, J APPL PHARM SCI, V5, P133; Ibezim A, 2016, J CHEMINFORMATICS S1, V8, pP12; Jose J, 2006, TETRAHEDRON, V62, P11021, DOI 10.1016/j.tet.2006.08.056; Knox JR, 1996, CEFOTAXIMECOMPLEXED, DOI [10.2210/pdb1cef/pdb, DOI 10.2210/PDB1CEF]; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Moosavi-Movahedi AA, 2003, BIOORGAN MED CHEM, V11, P4303, DOI 10.1016/S0968-0896(03)00524-8; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Ntie-Kang F, 2014, J CHEM INF MODEL, V54, P2433, DOI 10.1021/ci5003697; OKAFOR CO, 1977, HETEROCYCLES, V7, P391; Okafor CO, 1971, INT J SULFUR CHEM, V6, P4; Okoro U., 2009, INT J CHEM, V19, P197; Onoabedje EA, 2015, J HETEROCYCLIC CHEM; Onoabedje EA, 2017, J HETEROCYCLIC CHEM, V54, P206, DOI 10.1002/jhet.2569; Onoabedje EA, 2016, J SULFUR CHEM, V37, P269, DOI 10.1080/17415993.2015.1131827; Peitsaro N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-26; Pluta K, 2011, EUR J MED CHEM, V46, P3179, DOI 10.1016/j.ejmech.2011.05.013; Shimizu S, 2004, TOHOKU J EXP MED, V203, P47, DOI 10.1620/tjem.203.47; SPRATT BG, 1977, EUR J BIOCHEM, V72, P341, DOI 10.1111/j.1432-1033.1977.tb11258.x; Tian HN, 2011, J MATER CHEM, V21, P12462, DOI 10.1039/c1jm12071a; Vahedian-Movahed H, 2011, J BIOMOL STRUCT DYN, V28, P483, DOI 10.1080/07391102.2011.10508590; van de Waterbeemd H, 1998, J DRUG TARGET, V6, P151, DOI 10.3109/10611869808997889; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Wesolowska O, 2006, IN VIVO, V20, P109	30	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0163467	10.1371/journal.pone.0163467	http://dx.doi.org/10.1371/journal.pone.0163467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749913	Green Published, gold, Green Submitted			2022-12-26	WOS:000386202300005
J	Jafari, M; Mehrnejad, F				Jafari, Majid; Mehrnejad, Faramarz			Molecular Insight into Human Lysozyme and Its Ability to Form Amyloid Fibrils in High Concentrations of Sodium Dodecyl Sulfate: A View from Molecular Dynamics Simulations	PLOS ONE			English	Article							PROTEIN-SURFACTANT INTERACTIONS; SECONDARY STRUCTURE; GUANIDINIUM CHLORIDE; STRUCTURAL-CHANGES; GLOBULAR-PROTEINS; IONIC SURFACTANTS; ALPHA-LACTALBUMIN; RIBONUCLEASE-A; SDS; DENATURATION	Changes in the tertiary structure of proteins and the resultant fibrillary aggregation could result in fatal heredity diseases, such as lysozyme systemic amyloidosis. Human lysozyme is a globular protein with antimicrobial properties with tendencies to fibrillate and hence is known as a fibril-forming protein. Therefore, its behavior under different ambient conditions is of great importance. In this study, we conducted two 500000 ps molecular dynamics (MD) simulations of human lysozyme in sodium dodecyl sulfate (SDS) at two ambient temperatures. To achieve comparative results, we also performed two 500000 ps human lysozyme MD simulations in pure water as controls. The aim of this study was to provide further molecular insight into all interactions in the lysozyme-SDS complexes and to provide a perspective on the ability of human lysozyme to form amyloid fibrils in the presence of SDS surfactant molecules. SDS, which is an anionic detergent, contains a hydrophobic tail with 12 carbon atoms and a negatively charged head group. The SDS surfactant is known to be a stabilizer for helical structures above the critical micelle concentration (CMC) [1]. During the 500000 ps MD simulations, the helical structures were maintained by the SDS surfactant above its CMC at 300 K, while at 370 K, human lysozyme lost most of its helices and gained beta-sheets. Therefore, we suggest that future studies investigate the beta-amyloid formation of human lysozyme at SDS concentrations above the CMC and at high temperatures.	[Jafari, Majid; Mehrnejad, Faramarz] Univ Tehran, Fac New Sci & Technol, Dept Life Sci Engn, Tehran, Iran	University of Tehran	Mehrnejad, F (corresponding author), Univ Tehran, Fac New Sci & Technol, Dept Life Sci Engn, Tehran, Iran.	Mehrnejad@ut.ac.ir	Mehrnejad, Faramarz/AAU-1526-2020; Jafari, Majid/AAA-8934-2020	Mehrnejad, Faramarz/0000-0002-2991-3079; Jafari, Majid/0000-0001-5233-6882				ARTYMIUK PJ, 1981, J MOL BIOL, V152, P737, DOI 10.1016/0022-2836(81)90125-X; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berendsen HJC G J, 1987, THE JOURNAL OF PHYSI, V91, P3; Buell AK, 2011, J AM CHEM SOC, V133, P7737, DOI 10.1021/ja109620d; Chaari A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142095; Chaturvedi SK, 2016, INT J BIOL MACROMOL, V83, P315, DOI 10.1016/j.ijbiomac.2015.11.053; Chernysheva MG, 2012, COLLOID SURFACE A, V409, P130, DOI 10.1016/j.colsurfa.2012.05.048; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Dev SB, 2015, PROG BIOPHYS MOL BIO, V117, P232, DOI 10.1016/j.pbiomolbio.2015.02.001; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; Fabrizio Chiti, 2000, EMBO J, P19; Fano M, 2011, ARCH BIOCHEM BIOPHYS, V506, P92, DOI 10.1016/j.abb.2010.11.012; Ferrao-Gonzales Astria D, 2000, P NATL ACAD SCI US, V97; Frare E, 2009, J MOL BIOL, V387, P17, DOI 10.1016/j.jmb.2009.01.049; Gelamo EL, 2002, BBA-PROTEIN STRUCT M, V1594, P84, DOI 10.1016/S0167-4838(01)00287-4; Goldfeder M, 2013, APPL MICROBIOL BIOT, V97, P1953, DOI 10.1007/s00253-012-4050-z; Gunning PA, 2004, BIOMACROMOLECULES, V5, P984, DOI 10.1021/bm0344957; Harada A, 2008, BIOSCI BIOTECH BIOCH, V72, P1523, DOI 10.1271/bbb.80032; Hill SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018171; Hisashi Yagi, 2007, BIOCHEMISTRY-US, V46, DOI [10.1021/bi701842n, DOI 10.1021/BI701842N]; Hung Ying-Tz, 2010, COLLOID SURFACE B, p[81, 81]; Jacob J, 1998, ACTA CRYSTALLOGR D, V54, P74, DOI 10.1107/S0907444997010603; Jones M.N., 1995, MICELLES MONOLAYERS; JONES MN, 1980, J CHEM SOC FARAD T 1, V76, P654, DOI 10.1039/f19807600654; Kabsch W, 1993, BIOPOLYMERS, V33, P2577; Khan JM, 2014, SOFT MATTER, V10, P2591, DOI 10.1039/c3sm52435c; Kumar EK, 2015, INT J BIOL MACROMOL, V81, P754, DOI 10.1016/j.ijbiomac.2015.09.007; Kumar EK, 2014, PHYS CHEM CHEM PHYS, V16, P24076, DOI 10.1039/c4cp02423k; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; La Mesa C, 2005, J COLLOID INTERF SCI, V286, P148, DOI 10.1016/j.jcis.2004.12.038; LAPANJE S, 1978, PHYSICOCHEMICAL ASPE; Lara C, 2011, BIOMACROMOLECULES, V12, P1868, DOI 10.1021/bm200216u; Lu RC, 2005, BBA-GEN SUBJECTS, V1722, P271, DOI 10.1016/j.bbagen.2004.12.012; Luis Cruz, 2005, P NATL ACAD SCI USA, V102, P102, DOI [10.1073/pnas.0509276102, DOI 10.1073/PNAS.0509276102]; Manning M, 2004, BIOCHEMISTRY-US, V43, P11248, DOI 10.1021/bi0491898; Masood Khan Javed, 2012, PLOS ONE, DOI [10.1371/journal.pone.0029694, DOI 10.1371/JOURNAL.PONE.0029694]; MAYR LM, 1993, BIOCHEMISTRY-US, V32, P7994, DOI 10.1021/bi00082a021; McParland Victoria J, 2000, BIOCHEMISTRY-US, V39, DOI [10.1021/bi000276j, DOI 10.1021/BI000276J]; Mehrnejad F, 2010, J COMPUT AID MOL DES, V24, P829, DOI 10.1007/s10822-010-9377-x; Moosavi-Movahedi AA, 2007, COLLOID SURFACE B, V60, P55, DOI 10.1016/j.colsurfb.2007.05.018; Moosavi-Movahedi A.A, 2007, COLLOID SURFACE B, V60; MOREN AK, 1995, LANGMUIR, V11, P3636, DOI 10.1021/la00010a009; Moriyama Y, 2012, LANGMUIR, V28, P16268, DOI 10.1021/la3035598; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; Naidu KT, 2011, J PHYS CHEM B, V115, P14760, DOI 10.1021/jp2062496; Neira JL, 2013, STRUCTURE, V21, P1905, DOI 10.1016/j.str.2013.10.008; Nielsen MM, 2007, BIOPHYS J, V92, P3674, DOI 10.1529/biophysj.106.101238; Otzen DE, 1999, PROTEIN SCI, V8, P1878, DOI 10.1110/ps.8.9.1878; Otzen DE, 2002, BIOPHYS J, V83, P2219, DOI 10.1016/S0006-3495(02)73982-9; Ow SY, 2013, SOFT MATTER, V9, P9692, DOI 10.1039/c3sm51671g; Pelosi P, 2014, APPL MICROBIOL BIOT, V98, P61, DOI 10.1007/s00253-013-5383-y; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Petsko GA, 2000, NATURE, V403, P606, DOI 10.1038/35001176; Pirzadeh P, 2006, COLLOID SURFACE B, V52, P31, DOI 10.1016/j.colsurfb.2006.05.019; Rangachari V, 2006, BIOCHEMISTRY-US, V45, P8639, DOI 10.1021/bi060323t; RIZO J, 1993, BIOCHEMISTRY-US, V32, P4881, DOI 10.1021/bi00069a025; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Sammalkorpi M, 2007, J PHYS CHEM B, V111, P11722, DOI 10.1021/jp072587a; Schmittschmitt Jason P, 2003, ROLE PROTEIN STABILI, P12; Sharma P, 2016, SCI REP-UK, V6, DOI 10.1038/srep22475; Shukla N, 2005, FEBS J, V272, P2216, DOI 10.1111/j.1742-4658.2005.2005.04645.x; Sun Y, 2015, SOFT MATTER, V11, P7769, DOI 10.1039/c5sm01231g; Sureshbabu N, 2009, EUR BIOPHYS J BIOPHY, V38, P355, DOI 10.1007/s00249-008-0379-8; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Tanford C., 1980, HYDROPHOBIC EFFECT F, V2; TURRO NJ, 1995, LANGMUIR, V11, P2525, DOI 10.1021/la00007a035; Villegas V, 2000, PROTEIN ENG STRAT AV, P9; Wahlstrom A, 2008, FEBS J, V275, P5117, DOI 10.1111/j.1742-4658.2008.06643.x; WEBER K, 1971, J BIOL CHEM, V246, P4504; Wimmer R, 2006, BIOCHEMISTRY-US, V45, P481, DOI 10.1021/bi051876r; Xu Q, 2004, PROTEIN SCI, V13, P2949, DOI 10.1110/ps.04827604; YONATH A, 1977, BIOCHEMISTRY-US, V16, P1418, DOI 10.1021/bi00626a028; ZHONG LX, 1992, P NATL ACAD SCI USA, V89, P4462, DOI 10.1073/pnas.89.10.4462; Zhou HX, 2008, ARCH BIOCHEM BIOPHYS, V469, P76, DOI 10.1016/j.abb.2007.07.013	75	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165213	10.1371/journal.pone.0165213	http://dx.doi.org/10.1371/journal.pone.0165213			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768744	Green Submitted, Green Published, gold			2022-12-26	WOS:000386205400068
J	Zaporozhchenko, IA; Morozkin, ES; Skvortsova, TE; Ponomaryova, AA; Rykova, EY; Cherdyntseva, NV; Polovnikov, ES; Pashkovskaya, OA; Pokushalov, EA; Vlassov, VV; Laktionov, PP				Zaporozhchenko, Ivan A.; Morozkin, Evgeny S.; Skvortsova, Tatyana E.; Ponomaryova, Anastasia A.; Rykova, Elena Yu; Cherdyntseva, Nadezhda V.; Polovnikov, Evgeny S.; Pashkovskaya, Oksana A.; Pokushalov, Evgeny A.; Vlassov, Valentin V.; Laktionov, Pavel P.			Plasma miR-19b and miR-183 as Potential Biomarkers of Lung Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MICRORNA EXPRESSION; PROGNOSTIC VALUE; RT-PCR; ADENOCARCINOMA; METAANALYSIS; IDENTIFICATION; TISSUES; FAMILY; FLUIDS	Lung cancer is a complex disease that often manifests at the point when treatment is not effective. Introduction of blood-based complementary diagnostics using molecular markers may enhance early detection of this disease and help reduce the burden of lung cancer. Here we evaluated the diagnostic potential of seven plasma miRNA biomarkers (miR-21, -19b, -126, -25, -205, -183, -125b) by quantitative reverse transcription PCR. Influence clinical and demographical characteristics, including age, tumor stage and cancer subtype on miRNA levels was investigated. Four miRNAs were significantly dysregulated (miR-19b, -21, -25, -183) in lung cancer patients. Combination of miR-19b and miR-183 provided detection of lung cancer with 94.7% sensitivity and 95.2% specificity (AUC = 0.990). Thus, miRNAs have shown the potential to discriminate histological subtypes of lung cancer and reliably distinguish lung cancer patients from healthy individuals.	[Zaporozhchenko, Ivan A.; Morozkin, Evgeny S.; Skvortsova, Tatyana E.; Rykova, Elena Yu; Vlassov, Valentin V.; Laktionov, Pavel P.] SB RAS, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Zaporozhchenko, Ivan A.; Morozkin, Evgeny S.; Polovnikov, Evgeny S.; Pashkovskaya, Oksana A.; Pokushalov, Evgeny A.; Laktionov, Pavel P.] Novosibirsk Res Inst Circulat Pathol Academician, Novosibirsk, Russia; [Ponomaryova, Anastasia A.; Cherdyntseva, Nadezhda V.] SB RAMS, Tomsk Canc Res Inst, Tomsk, Russia; [Ponomaryova, Anastasia A.] Natl Res Tomsk Polytech Univ, Tomsk, Russia; [Cherdyntseva, Nadezhda V.] Natl Res Tomsk State Univ, Tomsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Meshalkin National Medical Research Center; Russian Academy of Medical Sciences; Russian Academy of Sciences; Tomsk National Research Medical Center; Cancer Research Institute of the RAS; Tomsk Polytechnic University; Tomsk State University	Zaporozhchenko, IA (corresponding author), SB RAS, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia.; Zaporozhchenko, IA (corresponding author), Novosibirsk Res Inst Circulat Pathol Academician, Novosibirsk, Russia.	ivanzap@niboch.nsc.ru	Ponomaryova, Anastasia/D-8734-2012; Pokushalov, Evgeny A/L-7993-2014; Cherdyntseva, Nadezhda/C-7943-2012; Morozkin, Evgeny/AAJ-1779-2020; Pokushalov, Evgeny/ABA-6205-2020; Vlassov, Valentin/F-4720-2013	Pokushalov, Evgeny A/0000-0002-2560-5167; Cherdyntseva, Nadezhda/0000-0003-1526-9013; Ponomaryova, Anastasia/0000-0003-2060-4840; Vlassov, Valentin/0000-0003-2845-2992; Morozkin, Evgeny/0000-0001-8407-2623	Russian Foundation for Basic Research (RFBR) [14-04-01881]; BOR grant [VI.62.1.4]; Presidium of RAS research program 'Molecular and Cellular Biology' [6.1]	Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); BOR grant; Presidium of RAS research program 'Molecular and Cellular Biology'	This study has been supported by Russian Foundation for Basic Research (RFBR, grant No. 14-04-01881), BOR grant VI.62.1.4, and Presidium of RAS research program 'Molecular and Cellular Biology' No. 6.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aushev VN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078649; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Concepcion CP, 2012, CANCER J, V18, P262, DOI 10.1097/PPO.0b013e318258b60a; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cui EH, 2013, ACTA PHARMACOL SIN, V34, P309, DOI 10.1038/aps.2012.125; Dacic S, 2010, MODERN PATHOL, V23, P1577, DOI 10.1038/modpathol.2010.152; Eberhardt WEE, 2015, ANN ONCOL, V26, P1573, DOI 10.1093/annonc/mdv187; Fan Y, 2014, RNA, V20, P765, DOI 10.1261/rna.043026.113; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hamamoto J, 2013, MOL MED REP, V8, P456, DOI 10.3892/mmr.2013.1517; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Khoo C, 2015, TRANSL LUNG CANCER R, V4, P126, DOI 10.3978/j.issn.2218-6751.2015.01.10; Lin QF, 2012, J CANCER RES CLIN, V138, P85, DOI 10.1007/s00432-011-1068-z; Liu XG, 2012, MED ONCOL, V29, P618, DOI 10.1007/s12032-011-9923-y; Lortet-Tieulent J, 2014, LUNG CANCER, V84, P13, DOI 10.1016/j.lungcan.2014.01.009; Ma YX, 2012, J CANCER RES CLIN, V138, P2045, DOI 10.1007/s00432-012-1285-0; Markou A, 2013, LUNG CANCER, V81, P388, DOI 10.1016/j.lungcan.2013.05.007; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Montani F, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv063; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Prosch H, 2014, TRANSL LUNG CANCER R, V3, P286, DOI 10.3978/j.issn.2218-6751.2014.09.11; Sanfiorenzo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054596; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Sozzi G, 2014, TRANSL LUNG CANCER R, V3, P139, DOI 10.3978/j.issn.2218-6751.2014.06.04; Sozzi G, 2014, J CLIN ONCOL, V32, P768, DOI 10.1200/JCO.2013.50.4357; Thomas A, 2015, NAT REV CLIN ONCOL, V12, P511, DOI 10.1038/nrclinonc.2015.90; Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981; Wang GF, 2008, FEBS LETT, V582, P3663, DOI 10.1016/j.febslet.2008.09.051; Wang Y, 2013, JPN J CLIN ONCOL, V43, P813, DOI 10.1093/jjco/hyt084; Wu CH, 2014, TOHOKU J EXP MED, V232, P85, DOI 10.1620/tjem.232.85; Xu F, 2014, CLIN TRANSL ONCOL, V16, P980, DOI 10.1007/s12094-014-1183-9; Zaporozhchenko IA, 2015, ANAL BIOCHEM, V479, P43, DOI 10.1016/j.ab.2015.03.028; Zhang QH, 2013, GENE, V527, P26, DOI 10.1016/j.gene.2013.06.006; Zhang YK, 2012, J CANCER RES CLIN, V138, P1641, DOI 10.1007/s00432-012-1240-0	39	33	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165261	10.1371/journal.pone.0165261	http://dx.doi.org/10.1371/journal.pone.0165261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768748	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400073
J	Chu, JS; Zhang, TZ; Chang, WD; Zhang, D; Zulfiqar, S; Fu, AG; Hao, YQ				Chu, Jiashu; Zhang, Tianzhe; Chang, Weidong; Zhang, Dan; Zulfiqar, Saman; Fu, Aigen; Hao, Yaqi			Impacts of Cropping Systems on Aggregates Associated Organic Carbon and Nitrogen in a Semiarid Highland Agroecosystem	PLOS ONE			English	Article							NO-TILLAGE SOILS; MATTER DYNAMICS; SEQUESTRATION; FERTILIZATION; ACCUMULATION; MANAGEMENT; DEPOSITION; FRACTIONS; ROTATION; STORAGE	The effect of cropping system on the distribution of organic carbon (OC) and nitrogen (N) in soil aggregates has not been well addressed, which is important for understanding the sequestration of OC and N in agricultural soils. We analyzed the distribution of OC and N associated with soil aggregates in three unfertilized cropping systems in a 27-year field experiment: continuously cropped alfalfa, continuously cropped wheat and a legume-grain rotation. The objectives were to understand the effect of cropping system on the distribution of OC and N in aggregates and to examine the relationships between the changes in OC and N stocks in total soils and in aggregates. The cropping systems increased the stocks of OC and N in total soils (0-40 cm) at mean rates of 15.6 g OC m(-2) yr(-1) and 1.2 g N m(-2) yr(-1) relative to a fallow control. The continuous cropping of alfalfa produced the largest increases at the 0-20 cm depth. The OC and N stocks in total soils were significantly correlated with the changes in the >0.053 mm aggregates. 27-year of cropping increased OC stocks in the >0.053 mm size class of aggregates and N stocks in the >0.25 mm size class but decreased OC stocks in the <0.053 mm size class and N stocks in the <0.25 mm size class. The increases in OC and N stocks in these aggregates accounted for 99.5 and 98.7% of the total increases, respectively, in the continuous alfalfa system. The increases in the OC and N stocks associated with the >0.25 mm aggregate size class accounted for more than 97% of the total increases in the continuous wheat and the legume-grain rotation systems. These results suggested that long-term cropping has the potential to sequester OC and N in soils and that the increases in soil OC and N stocks were mainly due to increases associated with aggregates >0.053 mm.	[Chu, Jiashu; Zhang, Tianzhe; Chang, Weidong; Zhang, Dan; Zulfiqar, Saman; Fu, Aigen; Hao, Yaqi] Northwest Univ, Minist Educ, Key Lab Resource Biol & Biotechnol Western China, Xian 710069, Shaanxi, Peoples R China	Northwest University Xi'an	Hao, YQ (corresponding author), Northwest Univ, Minist Educ, Key Lab Resource Biol & Biotechnol Western China, Xian 710069, Shaanxi, Peoples R China.	yaqihao@nwu.edu.cn			National Natural Science Foundation of China [31300204]; Northwest University [NH13025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwest University	This study was supported by the National Natural Science Foundation of China (31300204) to YH, and research fund from Northwest University (NH13025) to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the reviewers for their comments that improved the quality of this paper. This study was supported by the National Natural Science Foundation of China (31300204) to YH, and research fund from Northwest University (NH13025) to YH.	Acosta-Martinez V, 2008, BIOL FERT SOILS, V44, P681, DOI 10.1007/s00374-007-0251-5; Al-Kaisi MM, 2005, AGR ECOSYST ENVIRON, V105, P635, DOI 10.1016/j.agee.2004.08.002; Aziz I., 2013, INT J AGR APPL SCI, V5; Aziz I, 2014, PAK J AGR SCI, V51, P827; Aziz I, 2014, PAK J BOT, V46, P2157; Barreto RC, 2009, AGR ECOSYST ENVIRON, V132, P243, DOI 10.1016/j.agee.2009.04.008; CAMBARDELLA CA, 1993, SOIL SCI SOC AM J, V57, P1071, DOI 10.2136/sssaj1993.03615995005700040032x; Denef K, 2004, SOIL SCI SOC AM J, V68, P1935, DOI 10.2136/sssaj2004.1935; Dwivedi BS, 2003, FIELD CROP RES, V80, P167, DOI 10.1016/S0378-4290(02)00169-7; Fan J, 2011, CROP PASTURE SCI, V62, P437, DOI 10.1071/CP10370; Flerchinger GN, 1997, J ARID ENVIRON, V35, P641, DOI 10.1006/jare.1995.0167; Gal A, 2007, SOIL TILL RES, V96, P42, DOI 10.1016/j.still.2007.02.007; Grandy AS, 2006, SOIL SCI SOC AM J, V70, P1398, DOI 10.2136/sssaj2005.0313; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hajabbasi M A, 2010, 19 WORLD C SOIL SCI; Heal OW, 1997, PLANT LITTER QUALITY; Huggins DR, 2007, SOIL SCI SOC AM J, V71, P145, DOI 10.2136/sssaj2005.0231; Jagadamma S, 2008, SOIL TILL RES, V98, P120, DOI 10.1016/j.still.2007.10.008; Kader MA, 2010, AUST J SOIL RES, V48, P16, DOI 10.1071/SR09052; Kong AYY, 2009, SOIL TILL RES, V104, P256, DOI 10.1016/j.still.2009.03.004; Kristiansen SM, 2006, GEODERMA, V137, P147, DOI 10.1016/j.geoderma.2006.08.005; Liu JX, 2005, ECOL MODEL, V186, P178, DOI 10.1016/j.ecolmodel.2005.01.036; Masri Z, 2006, SOIL TILL RES, V87, P146, DOI 10.1016/j.still.2005.03.003; Matzner E, 2008, EUR J SOIL SCI, V59, P274, DOI 10.1111/j.1365-2389.2007.00992.x; Nie M, 2014, SOIL BIOL BIOCHEM, V68, P357, DOI 10.1016/j.soilbio.2013.10.012; Norton JB, 2012, SOIL SCI SOC AM J, V76, P505, DOI 10.2136/sssaj2011.0284; Paul BK, 2013, AGR ECOSYST ENVIRON, V164, P14, DOI 10.1016/j.agee.2012.10.003; POTTER CS, 1991, CAN J FOREST RES, V21, P222, DOI 10.1139/x91-027; Qiu LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055433; Qiu LP, 2012, PLANT SOIL, V355, P299, DOI 10.1007/s11104-011-1099-x; Simpson RT, 2004, SOIL SCI SOC AM J, V68, P1249, DOI 10.2136/sssaj2004.1249; Six J, 1999, SOIL SCI SOC AM J, V63, P1350, DOI 10.2136/sssaj1999.6351350x; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Six J., 2002, ENCY SOIL SCI, P936, DOI DOI 10.1081/E-ESS-120001812; Slobodian N, 2002, SOIL SCI SOC AM J, V66, P924, DOI 10.2136/sssaj2002.0924; Somnrero A, 2010, SOIL TILL RES, V107, P64; Thomas RQ, 2010, NAT GEOSCI, V3, P13, DOI 10.1038/NGEO721; Wang X, 2014, SOIL BIOL BIOCHEM, V72, P55, DOI 10.1016/j.soilbio.2014.01.018; Wei XR, 2006, SOIL TILL RES, V91, P120, DOI 10.1016/j.still.2005.11.009; Wei XR, 2013, SOIL BIOL BIOCHEM, V57, P876, DOI 10.1016/j.soilbio.2012.10.020; Wright AL, 2005, SOIL TILL RES, V84, P67, DOI 10.1016/j.still.2004.09.017; Yousefi M, 2008, SOIL TILL RES, V101, P57, DOI 10.1016/j.still.2008.06.003; [No title captured], DOI DOI 10.1111/J.1365-2389.1996.TB01843.X	43	9	9	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165018	10.1371/journal.pone.0165018	http://dx.doi.org/10.1371/journal.pone.0165018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764209	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500102
J	Hammarsten, P; Scherdin, TD; Hagglof, C; Andersson, P; Wikstrom, P; Stattin, P; Egevad, L; Granfors, T; Bergh, A				Hammarsten, Peter; Scherdin, Tove Dahl; Hagglof, Christina; Andersson, Pernilla; Wikstrom, Pernilla; Stattin, Par; Egevad, Lars; Granfors, Torvald; Bergh, Anders			High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting	PLOS ONE			English	Article							GLEASON SCORE; PROGNOSTIC MARKERS; VASCULAR DENSITY; FREE SURVIVAL; FOLLOW-UP; RECURRENCE; GROWTH; TISSUE; PROLIFERATION; PREDICTOR	In the present study we have investigated whether Caveolin-1 expression in non-malignant and malignant prostate tissue is a potential prognostic marker for outcome in prostate cancer patients managed by watchful waiting. Caveolin-1 was measured in prostate tissues obtained through transurethral resection of the prostate from 395 patients diagnosed with prostate cancer. The majority of the patients (n = 298) were followed by watchful waiting after diagnosis. Tissue microarrays constructed from malignant and non-malignant prostate tissue were stained with an antibody against Caveolin-1. The staining pattern was scored and related to clinicopathologic parameters and outcome. Microdissection and qRT-PCR analysis of Cav-1 was done of the prostate stroma from non-malignant tissue and stroma from Gleason 3 and 4 tumors. Cav-1 RNA expression was highest in non-malignant tissue and decreased during cancer progression. High expression of Caveolin-1 in tumor stroma was associated with significantly longer cancer specific survival in prostate cancer patients. This association remained significant when Gleason score and local tumor stage were combined with Caveolin-1 in a Cox regression model. High stromal Caveolin-1 immunoreactivity in prostate tumors is associated with a favourable prognosis in prostate cancer patients managed by watchful waiting. Caveolin-1 could possibly become a useful prognostic marker for prostate cancer patients that are potential candidates for active surveillance.	[Hammarsten, Peter; Scherdin, Tove Dahl; Hagglof, Christina; Andersson, Pernilla; Wikstrom, Pernilla; Bergh, Anders] Umea Univ, Dept Med Biosci, Umea, Sweden; [Stattin, Par] Umea Univ, Dept Surg & Perioperat Sci, Urol & Androl, Umea, Sweden; [Egevad, Lars] Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden; [Granfors, Torvald] Cent Hosp Vasteras, Dept Urol, Vasteras, Sweden	Umea University; Umea University; Karolinska Institutet; Karolinska University Hospital; Vasteras Central Hospital	Hammarsten, P (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	peter.hammarsten@umu.se			Swedish Research Council [521-2012-2573]; Swedish Cancer Society [150226]; Lion's Cancer Research Foundation [LP15-2078, LP15-2056]; Umea University; County of Vasterbotten	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Lion's Cancer Research Foundation; Umea University; County of Vasterbotten	This work was funded by the Swedish Research Council, grant number: 521-2012-2573, http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html, AB; Swedish Cancer Society, grant number: 150226, https://www.cancerfonden.se/om-cancerfonden/about-the-swedish-cancer-society, AB; Lion's Cancer Research Foundation grant number: LP15-2078 & LP15-2056, http://www.cancerforskningsfond-umea.lions.se, AB & PH; Umea University, http://www.umu.se/english/?languageId=1,no grant number exists, AB & PH; and County of Vasterbotten, http://www.vll.se, no grant number exists, AB & PH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren O, 2006, J UROLOGY, V175, P1337, DOI 10.1016/S0022-5347(05)00734-2; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Ayala G, 2013, J PATHOL, V231, P77, DOI 10.1002/path.4217; Di Vizio D, 2009, CELL CYCLE, V8, P2420, DOI 10.4161/cc.8.15.9116; Egevad L, 2002, BJU INT, V89, P538, DOI 10.1046/j.1464-410X.2002.02669.x; Ehnman M, 2014, EXPERT OPIN INV DRUG, V23, P211, DOI 10.1517/13543784.2014.847086; Franco OE, 2011, CANCER RES, V71, P1272, DOI 10.1158/0008-5472.CAN-10-3142; Freeman MR, 2012, ADV EXP MED BIOL, V729, P95, DOI 10.1007/978-1-4614-1222-9_7; Hagglof C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010747; Halin Sofia, 2011, Expert Opin Med Diagn, V5, P37, DOI 10.1517/17530059.2011.540009; Hammarsten P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047994; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Johansson A, 2010, AM J PATHOL, V177, P1031, DOI 10.2353/ajpath.2010.100070; Josefsson A, 2005, EUR UROL, V48, P577, DOI 10.1016/j.eururo.2005.05.016; Josefsson A, 2012, SCAND J UROL NEPHROL, V46, P247, DOI 10.3109/00365599.2012.669791; Josefsson A, 2011, AM J PATHOL, V179, P1961, DOI 10.1016/j.ajpath.2011.06.005; Karam JA, 2007, PROSTATE, V67, P614, DOI 10.1002/pros.20557; Kiskowski MA, 2011, CANCER RES, V71, P3459, DOI 10.1158/0008-5472.CAN-10-2999; Li X, 2008, ONCOGENE, V27, P7118, DOI 10.1038/onc.2008.293; Lissbrant IF, 2000, INT J ONCOL, V17, P445; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Merseburger AS, 2006, ONCOL REP, V16, P79; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Satoh T, 2003, CANCER-AM CANCER SOC, V97, P1225, DOI 10.1002/cncr.11198; Shaul PW, 1998, AM J PHYSIOL-LUNG C, V275, pL843, DOI 10.1152/ajplung.1998.275.5.L843; Sotgia F, 2012, ANNU REV PATHOL-MECH, V7, P423, DOI 10.1146/annurev-pathol-011811-120856; Stattin P, 1997, J UROLOGY, V157, P219, DOI 10.1016/S0022-5347(01)65330-8; Sternberg PW, 1999, NAT CELL BIOL, V1, pE35, DOI 10.1038/10028; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Thompson TC, 2010, PROSTATE CANCER P D, V13, P6, DOI 10.1038/pcan.2009.29; Wikstrom P, 2009, PROSTATE, V69, P799, DOI 10.1002/pros.20927; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873; Yang G, 1999, CANCER RES, V59, P5719	37	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164016	10.1371/journal.pone.0164016	http://dx.doi.org/10.1371/journal.pone.0164016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764093	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500015
J	Palanga, E; Filloux, D; Martin, DP; Fernandez, E; Gargani, D; Ferdinand, R; Zabre, J; Bouda, Z; Neya, JB; Sawadogo, M; Traore, O; Peterschmitt, M; Roumagnac, P				Palanga, Essowe; Filloux, Denis; Martin, Darren P.; Fernandez, Emmanuel; Gargani, Daniel; Ferdinand, Romain; Zabre, Jean; Bouda, Zakaria; Neya, James Bouma; Sawadogo, Mahamadou; Traore, Oumar; Peterschmitt, Michel; Roumagnac, Philippe			Metagenomic-Based Screening and Molecular Characterization of Cowpea-Infecting Viruses in Burkina Faso	PLOS ONE			English	Article							SEED-BORNE VIRUSES; TALLGRASS PRAIRIE PRESERVE; MOSAIC-VIRUS; MOTTLE VIRUS; VIGNA-UNGUICULATA; OSAGE COUNTY; IDENTIFICATION; SEQUENCE; TRANSMISSION; GERMPLASM	Cowpea, (Vigna unguiculata L. (Walp)) is an annual tropical grain legume. Often referred to as "poor man's meat", cowpea is one of the most important subsistence legumes cultivated in West Africa due to the high protein content of its seeds. However, African cowpea production can be seriously constrained by viral diseases that reduce yields. While twelve cowpea- infecting viruses have been reported from Africa, only three of these have so-far been reported from Burkina Faso. Here we use a virion-associated nucleic acids (VANA)-based metagenomics method to screen for the presence of cowpea viruses from plants collected from the three agro-climatic zones of Burkina Faso. Besides the three cowpea-infecting virus species which have previously been reported from Burkina Faso (Cowpea aphid borne mosaic virus [Family Potyviridae], the Blackeye cowpea mosaic virus-a strain of Bean common mosaic virus D [Family Potyviridae] and Cowpea mottle virus [Family Tombusviridae]) five additional viruses were identified: Southern cowpea mosaic virus (Sobemovirus genus), two previously uncharacterised polerovirus-like species (Family Luteoviridae), a previously uncharacterised tombusvirus-like species (Family Tombusviridae) and a previously uncharacterised mycotymovirus-like species (Family Tymoviridae). Overall, potyviruses were the most prevalent cowpea viruses (detected in 65.5% of samples) and the Southern Sudan zone of Burkina Faso was found to harbour the greatest degrees of viral diversity and viral prevalence. Partial genome sequences of the two novel polerovirus-like and tombusvirus-like species were determined and RT-PCR primers were designed for use in Burkina Faso to routinely detect all of these cowpea-associated viruses.	[Palanga, Essowe] Univ Ouagadougou, Lab Genet & Biotechnol Vegetales, 03 BP 7021, Ouagadougou, Burkina Faso; [Palanga, Essowe; Zabre, Jean; Bouda, Zakaria; Neya, James Bouma; Sawadogo, Mahamadou; Traore, Oumar] INERA, Lab Virol & Biotechnol Vegetales, 01 BP 476, Ouagadougou, Burkina Faso; [Filloux, Denis; Fernandez, Emmanuel; Gargani, Daniel; Ferdinand, Romain; Peterschmitt, Michel; Roumagnac, Philippe] CIRAD INRA SupAgro, UMR BGPI, F-34398 Montpellier, France; [Palanga, Essowe; Zabre, Jean; Bouda, Zakaria; Neya, James Bouma; Traore, Oumar] LMI Pathobios, 01 BP 476, Ouagadougou, Burkina Faso; [Martin, Darren P.] Univ Cape Town, Fac Hlth Sci, Computat Biol Grp, Inst Infect Dis & Mol Med, Observatory, South Africa	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; University of Cape Town	Roumagnac, P (corresponding author), CIRAD INRA SupAgro, UMR BGPI, F-34398 Montpellier, France.	philippe.roumagnac@cirad.fr	Martin, Darren P/C-4599-2008; Martin, Darren/ABE-3614-2021	PEREZ-ALBELA FERNANDEZ, EDUARDO/0000-0002-1428-6041; Roumagnac, Philippe/0000-0001-5002-6039	French Embassy of Togo [NN: 808087J]; Seventh Framework Programme [PIOF-GA-2013-622571]; EU grant FP7-PEOPLE-IOF [N PIOF-GA-2013-622571]	French Embassy of Togo; Seventh Framework Programme(European Commission); EU grant FP7-PEOPLE-IOF	This work was supported by NN: 808087J, http://www.ambafrance-tg.org/Resultats.de.La-campagne de. French Embassy of Togo (PhD fellowship grant), EP. Seventh Framework Programme PIOF-GA-2013-622571, PR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge INERA for kindly providing with us cowpea cultivars. EP's PhD fellowship was funded by the French Embassy of Togo (N : 808087J). This study was partially funded by EU grant FP7-PEOPLE-2013-IOF (N PIOF-GA-2013-622571).	Adams MJ, 2005, ARCH VIROL, V150, P459, DOI 10.1007/s00705-004-0440-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amayo R., 2012, African Journal of Biotechnology, V11, P14132; BASHIR M, 1993, PLANT DIS, V77, P948, DOI 10.1094/PD-77-0948; Bashir M, 1996, PLANT PATHOL, V45, P54, DOI 10.1046/j.1365-3059.1996.d01-97.x; Bernardo P, 2013, VIRUS RES, V177, P35, DOI 10.1016/j.virusres.2013.07.006; Blanc S, 1997, VIROLOGY, V231, P141, DOI 10.1006/viro.1997.8521; Booker HM, 2005, PLANT DIS, V89, P515, DOI 10.1094/PD-89-0515; Boonham N, 2014, VIRUS RES, V186, P20, DOI 10.1016/j.virusres.2013.12.007; Brault W, 2005, J VIROL, V79, P9685, DOI 10.1128/JVI.79.15.9685-9693.2005; Candresse T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102945; Dabire C, 1988, ETAT RECHERCHE CULTU; Domier LL, 2010, DESK ENCY PLANT FUNG, P197; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Filloux D, 2015, METHODS MOL BIOL, V1302, P249, DOI 10.1007/978-1-4939-2620-6_18; Francois S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01196-14; GILLASPIE AG, 1995, PLANT DIS, V79, P388, DOI 10.1094/PD-79-0388; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; GUMEDZOE MY, 1990, PHYTOPROTECTION, V71, P85, DOI 10.7202/705986ar; Gumedzoe MYD, 1996, AFRICAN CROP SCI J, V4, P215; Hall AE, 2003, FIELD CROP RES, V82, P103, DOI 10.1016/S0378-4290(03)00033-9; Hema M, 2014, ADV VIRUS RES, V90, P431, DOI 10.1016/B978-0-12-801246-8.00009-3; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huguenot C, 1996, ARCH VIROL, V141, P137, DOI 10.1007/BF01718594; KAREEM KT, 2007, VIROL J, V4, DOI DOI 10.1186/1743-; King AM., 2012, VIRUS TAXONOMY CLASS, P1185; Kraberger S, 2015, ARCH VIROL, V160, P1303, DOI 10.1007/s00705-015-2358-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li PF, 2016, VIROLOGY, V489, P86, DOI 10.1016/j.virol.2015.12.004; Marie-Jeanne V, 2000, J PHYTOPATHOL, V148, P141, DOI 10.1046/j.1439-0434.2000.00473.x; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Massart S, 2014, VIRUS RES, V188, P90, DOI 10.1016/j.virusres.2014.03.029; Mayo MA, 1999, ARCH VIROL, V144, P1659, DOI 10.1007/s007050050620; Moonan F, 2000, VIROLOGY, V269, P156, DOI 10.1006/viro.1999.0162; NDIAYE M, 1993, PLANT DIS, V77, P999, DOI 10.1094/PD-77-0999; Neya BJ., 2011, THESIS; NIELSEN SS, 1993, CROP SCI, V33, P469, DOI 10.2135/cropsci1993.0011183X003300030010x; Robertson NL, 2007, VIRUS GENES, V35, P807, DOI 10.1007/s11262-007-0139-3; Roossinck MJ, 2015, PHYTOPATHOLOGY, V105, P716, DOI 10.1094/PHYTO-12-14-0356-RVW; Roumagnac P, 2015, J VIROL, V89, P9683, DOI 10.1128/JVI.00453-15; Salem NM, 2010, PLANT PATHOL, V59, P773, DOI 10.1111/j.1365-3059.2010.02285.x; Scheets K, 2011, VIRUS RES, V160, P256, DOI 10.1016/j.virusres.2011.06.023; Sharman M, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01569-15; SHOYINKA SA, 1978, PHYTOPATHOLOGY, V68, P693, DOI 10.1094/Phyto-68-693; Some KKJ., 1989, CONTRIBUTION EPIDEMI; Taiwo MA, 2006, AFR J BIOTECHNOL, V5, P1749; Taiwo MA, 1988, VIRUS DIS PLANTS AFR, P93; Tamm T, 2000, J VIROL, V74, P6231, DOI 10.1128/JVI.74.14.6231-6241.2000; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thapa V, 2012, VIRUS RES, V167, P34, DOI 10.1016/j.virusres.2012.03.016; THOUVENEL JC, 1990, TROP AGRIC, V67, P280; WALTERS HJ, 1970, PHYTOPATHOLOGY, V60, P177, DOI 10.1094/Phyto-60-177; Wu S, 1992, US WINT 1992 TECHN C	53	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165188	10.1371/journal.pone.0165188	http://dx.doi.org/10.1371/journal.pone.0165188			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764211	Green Published, gold			2022-12-26	WOS:000386204500132
J	Takeuchi, H; Okuyama, M; Uchida, HA; Kakio, Y; Umebayashi, R; Okuyama, Y; Fujii, Y; Ozawa, S; Yoshida, M; Oshima, Y; Sano, S; Wada, J				Takeuchi, Hidemi; Okuyama, Michihiro; Uchida, Haruhito A.; Kakio, Yuki; Umebayashi, Ryoko; Okuyama, Yuka; Fujii, Yasuhiro; Ozawa, Susumu; Yoshida, Masashi; Oshima, Yu; Sano, Shunji; Wada, Jun			Chronic Kidney Disease Is Positively and Diabetes Mellitus Is Negatively Associated with Abdominal Aortic Aneurysm	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; GLOMERULAR-FILTRATION-RATE; ARTERIAL; RUPTURE; PREVALENCE; MORTALITY; HEALTH; ATHEROSCLEROSIS; DEFICIENCY; MANAGEMENT	Background and Aims Chronic kidney disease (CKD) and diabetes mellitus (DM) are considered as risk factors for cardiovascular diseases. The purpose of this study was to clarify the relationship of CKD and DM with the presence of abdominal aortic aneurysm (AAA). Methods We enrolled 261 patients with AAA (AAA+) and age-and-sex matched 261 patients without AAA (AAA-) at two hospitals between 2008 and 2014, and examined the association between the risk factors and the presence of AAA. Furthermore, in order to investigate the prevalence of AAA in each group, we enrolled 1126 patients with CKD and 400 patients with DM. Results The presence of CKD in patients with AAA+ was significantly higher than that in patients with AAA-(AAA+; 65%, AAA-; 52%, P = 0.004). The presence of DM in patients with AAA+ was significantly lower than that in patients with AAA-(AAA+; 17%, AAA-; 35%, P < 0.001). A multivariate logistic regression analysis demonstrated that hypertension, ischemic heart disease and CKD were independent determinants, whereas, DM was a negatively independent determinant, for the presence of AAA. The prevalence of AAA in patients with CKD 65 years old and above was 5.1%, whereas, that in patients with DM 65 years old and above was only 0.6%. Conclusion CKD is a positively associated with the presence of AAA. In contrast, DM is a negatively associated with the presence of AAA in Japanese population.	[Takeuchi, Hidemi; Kakio, Yuki; Umebayashi, Ryoko; Okuyama, Yuka; Wada, Jun] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan; [Okuyama, Michihiro; Fujii, Yasuhiro; Ozawa, Susumu; Sano, Shunji] Okayama Univ Hosp, Dept Cardiovasc Surg, Okayama, Japan; [Uchida, Haruhito A.; Yoshida, Masashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Chron Kidney Dis & Cardiovasc Dis, Okayama, Japan; [Oshima, Yu] Kure Kyosai Hosp, Dept Cardiovasc Surg, Hiroshima, Japan	Okayama University; Okayama University; Okayama University	Uchida, HA (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Chron Kidney Dis & Cardiovasc Dis, Okayama, Japan.	hauchida@okayama-u.ac.jp	WADA, Jun/B-2023-2011	WADA, Jun/0000-0003-1468-5170				Aronson D, 2003, J HYPERTENS, V21, P3, DOI 10.1097/00004872-200301000-00002; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Barisione C, 2016, INTERN EMERG MED, V11, P205, DOI 10.1007/s11739-015-1328-z; Bhak RH, 2015, JAMA SURG, V150, P44, DOI 10.1001/jamasurg.2014.2025; Blanchard JF, 2000, AM J EPIDEMIOL, V151, P575; Bouchi R, 2010, HYPERTENS RES, V33, P1298, DOI 10.1038/hr.2010.170; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Bryan DS, 2013, ANN VASC SURG, V27, P186, DOI 10.1016/j.avsg.2012.03.010; Carrell TWG, 2002, CIRCULATION, V105, P477, DOI 10.1161/hc0402.102621; Chun KC, 2014, ANN VASC SURG, V28, P87, DOI 10.1016/j.avsg.2013.06.016; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; De Rango P, 2014, EUR J VASC ENDOVASC, V47, P243, DOI 10.1016/j.ejvs.2013.12.007; Dilme JF, 2014, EUR J VASC ENDOVASC, V48, P374, DOI 10.1016/j.ejvs.2014.05.023; Fukuda S, 2015, CIRC J, V79, P524, DOI 10.1253/circj.CJ-14-0972; Gao L, 2007, J INT MED RES, V35, P709, DOI 10.1177/147323000703500517; Ghigliotti G, 2013, DIS MARKERS, V34, P131, DOI 10.1155/2013/836849; Golledge J, 2008, EUR HEART J, V29, P665, DOI 10.1093/eurheartj/ehm557; Group. JJW, 2011, GUID DIAGN TREATM AO; Guirguis-Blake JM, 2014, ANN INTERN MED, V160, P321, DOI 10.7326/M13-1844; Hirsch AT, 2006, J VASC INTERV RADIOL, V17, P1383, DOI 10.1097/01.RVI.0000240426.53079.46; Hui X, 2013, AM J KIDNEY DIS, V62, P691, DOI 10.1053/j.ajkd.2013.04.010; Iribarren C, 2007, ANN EPIDEMIOL, V17, P669, DOI 10.1016/j.annepidem.2007.02.004; Kent KC, 2010, J VASC SURG, V52, P539, DOI 10.1016/j.jvs.2010.05.090; Le MTQ, 2007, EUR J VASC ENDOVASC, V33, P599, DOI 10.1016/j.ejvs.2006.12.017; Lederle FA, 2000, ARCH INTERN MED, V160, P1425, DOI 10.1001/archinte.160.10.1425; Lederle FA, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1724; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081260; Liu ZY, 2012, CIRC RES, V111, P1261, DOI [10.1161/CIRCRESAHA.112.270520, 10.1161/circresaha.112.270520]; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Madi HA, 2009, AM J PHYSIOL-CELL PH, V297, pC1307, DOI 10.1152/ajpcell.00608.2008; Miyama N, 2010, J VASC SURG, V52, P975, DOI 10.1016/j.jvs.2010.05.086; NEVITT MP, 1989, NEW ENGL J MED, V321, P1009, DOI 10.1056/NEJM198910123211504; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; Norman PE, 2007, CONNECT TISSUE RES, V48, P125, DOI 10.1080/03008200701331524; Obama T, 2015, CLIN SCI, V128, P559, DOI 10.1042/CS20140696; Portik-Dobos V, 2002, DIABETES, V51, P3063, DOI 10.2337/diabetes.51.10.3063; Powell JT, 2003, NEW ENGL J MED, V348, P1895, DOI 10.1056/NEJMcp012641; Reeps C, 2013, BIOMECH MODEL MECHAN, V12, P717, DOI 10.1007/s10237-012-0436-1; Rodin MB, 2003, HYPERTENSION, V42, P61, DOI 10.1161/01.HYP.0000078829.02288.98; Rutledge R, 1996, ANN SURG, V223, P492, DOI 10.1097/00000658-199605000-00005; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Singh K, 2001, AM J EPIDEMIOL, V154, P236, DOI 10.1093/aje/154.3.236; Smelser DT, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-174; Stather PW, 2014, EUR J VASC ENDOVASC, V47, P240, DOI 10.1016/j.ejvs.2013.11.007; Sweeting MJ, 2012, BRIT J SURG, V99, P655, DOI 10.1002/bjs.8707; Tanaka A, 2015, ATHEROSCLEROSIS, V242, P123, DOI 10.1016/j.atherosclerosis.2015.07.016; Tsai CL, 2015, DIABETES-METAB RES, V31, P190, DOI 10.1002/dmrr.2585; Uchida HA, 2011, ARTERIOSCL THROM VAS, V31, P2845, DOI 10.1161/ATVBAHA.111.234997; Uchida HA, 2010, ATHEROSCLEROSIS, V211, P399, DOI 10.1016/j.atherosclerosis.2010.02.034	51	10	10	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164015	10.1371/journal.pone.0164015	http://dx.doi.org/10.1371/journal.pone.0164015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764090	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204500014
J	Cieslak, M; Mikkelsen, SS; Skall, HF; Baud, M; Diserens, N; Engelsma, MY; Haenen, OLM; Mousakhani, S; Panzarin, V; Wahli, T; Olesen, NJ; Schuetze, H				Cieslak, Michael; Mikkelsen, Susie S.; Skall, Helle F.; Baud, Marine; Diserens, Nicolas; Engelsma, Marc Y.; Haenen, Olga L. M.; Mousakhani, Shirin; Panzarin, Valentina; Wahli, Thomas; Olesen, Niels J.; Schuetze, Heike			Phylogeny of the Viral Hemorrhagic Septicemia Virus in European Aquaculture	PLOS ONE			English	Article							INFECTIOUS-DISEASES; GENETIC DIVERSITY; FISH; SEQUENCE; MARINE; EVOLUTION; IDENTIFICATION; PARAMETERS; SELECTION; NETWORKS	One of the most valuable aquaculture fish in Europe is the rainbow trout, Oncorhynchus mykiss, but the profitability of trout production is threatened by a highly lethal infectious disease, viral hemorrhagic septicemia (VHS), caused by the VHS virus (VHSV). For the past few decades, the subgenogroup la of VHSV has been the main cause of VHS outbreaks in European freshwater-farmed rainbow trout. Little is currently known, however, about the phylogenetic radiation of this la lineage into subordinate la clades and their subsequent geographical spread routes. We investigated this topic using the largest la-isolate dataset ever compiled, comprising 651 complete G gene sequences: 209 GenBank la isolates and 442 la isolates from this study. The sequences come from 11 European countries and cover the period 1971-2015. Based on this dataset, we documented the extensive spread of the la population and the strong mixing of la isolates, assumed to be the result of the Europe-wide trout trade. For example, the la lineage underwent a radiation into nine la clades, most of which are difficult to allocate to a specific geographic distribution. Furthermore, we found indications for two rapid, large-scale population growth events, and identified three polytomies among the la clades, both of which possibly indicate a rapid radiation. However, only about 4% of la haplotypes (out of 398) occur in more than one European country. This apparently conflicting finding regarding the Europe-wide spread and mixing of la isolates can be explained by the high mutation rate of VHSV. Accordingly, the mean period of occurrence of a single la haplotype was less than a full year, and we found a substitution rate of up to 7.813 x 10(-4) nucleotides per site per year. Finally, we documented significant differences between Germany and Denmark regarding their VHS epidemiology, apparently due to those countries' individual handling of VHS.	[Cieslak, Michael; Mousakhani, Shirin; Schuetze, Heike] Fed Res Inst Anim Hlth, FLI, Inst Infectol IMED, Inset Riems, Germany; [Mikkelsen, Susie S.; Olesen, Niels J.] DTU, Natl Vet Inst, Virol Sect, Frederiksberg, Denmark; [Skall, Helle F.] Aarhus Univ, Fish Hlth, Dept Anim Sci, Tjele, Denmark; [Baud, Marine] Univ Europeenne Bretagne, Viral Fish Pathol Unit, Ploufragan Plouzane Lab ANSES, Technopole Brest Iroise, Plouzane, France; [Diserens, Nicolas; Wahli, Thomas] Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth FIWI, Bern, Switzerland; [Engelsma, Marc Y.; Haenen, Olga L. M.] NRL Fish & Shellfish Dis, Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [Panzarin, Valentina] OIE Reference Lab Viral Encephalopathy & Retinopa, Ist Zooprofilatt Sperimentaledelle Venezie, Legnaro, Italy	Friedrich Loeffler Institute; Technical University of Denmark; Aarhus University; Universite de Bretagne Occidentale; University of Bern; Wageningen University & Research	Cieslak, M (corresponding author), Fed Res Inst Anim Hlth, FLI, Inst Infectol IMED, Inset Riems, Germany.	cieslak-michael@gmx.de	Diserens, Nicolas/ABC-2030-2021; Olesen, Niels Jørgen/AAJ-8851-2021; Skall, Helle Frank/B-1180-2014	Olesen, Niels Jørgen/0000-0002-0152-4135; Skall, Helle Frank/0000-0002-9489-1419; Diserens, Nicolas/0000-0002-8352-1076; Engelsma, Marc/0000-0001-7683-8596; Mikkelsen, Susie Sommer/0000-0003-1744-9106; Cieslak, Michael/0000-0002-6111-658X	EMIDA-ERA Net (EU 7th Framework programme); German Federal Office for Agriculture and Food [2811ERA174]; Dutch Ministry of Economic Affairs (CVI project) [1600074-01]; French Agency for Food, Environmental and Occupational Health Safety	EMIDA-ERA Net (EU 7th Framework programme); German Federal Office for Agriculture and Food; Dutch Ministry of Economic Affairs (CVI project); French Agency for Food, Environmental and Occupational Health Safety	This work was supported by EMIDA-ERA Net (EU 7th Framework programme), German Federal Office for Agriculture and Food (2811ERA174), Dutch Ministry of Economic Affairs (CVI project no. 1600074-01), and French Agency for Food, Environmental and Occupational Health & Safety. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Betts AM, 2000, VIRUS GENES, V20, P259, DOI 10.1023/A:1008148813746; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; deKinkelin P, 1977, CR ACAD SCI D NAT, V284D; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunham RA, 2009, COMP IMMUNOL MICROB, V32, P139, DOI 10.1016/j.cimid.2007.11.006; Einer-jensen K, 2004, J GEN VIROL, V85, P1167, DOI 10.1099/vir.0.79820-0; FEAP, 2015, EUR AQ PROD REP 2005; Frankham R, 2005, J EVOLUTION BIOL, V18, P750, DOI 10.1111/j.1420-9101.2005.00885.x; Fu YX, 1997, GENETICS, V147, P915; Gjedrem T., 2005, SELECTION BREEDING P; Grant WS, 2012, ENVIRON BIOL FISH, V94, P325, DOI 10.1007/s10641-011-9929-5; Hahn MW, 2002, GENETICS, V161, P11; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; He M, 2014, MOL PHYLOGENET EVOL, V77, P34, DOI 10.1016/j.ympev.2014.04.002; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; IFB-Potsdam, 2015, JAHR DTSCH BINN BINN; Isshiki T, 2001, DIS AQUAT ORGAN, V47, P87, DOI 10.3354/dao047087; JENSEN MH, 1965, ANN NY ACAD SCI, V126, P422, DOI 10.1111/j.1749-6632.1965.tb14292.x; Jonstrup SP, 2009, J FISH DIS, V32, P925, DOI 10.1111/j.1365-2761.2009.01073.x; Kahns S, 2012, DIS AQUAT ORGAN, V99, P23, DOI 10.3354/dao02444; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kuhn TS, 2011, METHODS ECOL EVOL, V2, P427, DOI 10.1111/j.2041-210X.2011.00103.x; Lafferty KD, 2015, ANNU REV MAR SCI, V7, P471, DOI 10.1146/annurev-marine-010814-015646; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin GN, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S2; OIE (World Organisation for Animal Health), 2015, MAN DIAGN TESTS AQ A; Pierce LR, 2012, MOL PHYLOGENET EVOL, V63, P327, DOI 10.1016/j.ympev.2011.12.024; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Real LA, 2007, J R SOC INTERFACE, V4, P935, DOI 10.1098/rsif.2007.1041; Ross K., 1994, Bulletin of the European Association of Fish Pathologists, V14, P213; Schaperclaus W., 1938, ALLG FISCHZTG, V41, P256; Schlotfeldt H.-J., 1991, Bulletin of the European Association of Fish Pathologists, V11, P105; SCHLOTFELDT HJ, 1988, J APPL ICHTHYOL, V4, P147, DOI 10.1111/j.1439-0426.1988.tb00554.x; Schneider S, 1999, GENETICS, V152, P1079; Schutze H, 1999, VIRUS GENES, V19, P59, DOI 10.1023/A:1008140707132; Schutze H, 1996, J GEN VIROL, V77, P1259, DOI 10.1099/0022-1317-77-6-1259; Skall HF, 2005, J FISH DIS, V28, P509, DOI 10.1111/j.1365-2761.2005.00654.x; Skall HF, 2004, DIS AQUAT ORGAN, V58, P99, DOI 10.3354/dao058099; Snow M, 2004, DIS AQUAT ORGAN, V61, P11, DOI 10.3354/dao061011; Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd; Swenson NG, 2014, USE R, P1, DOI 10.1007/978-1-4614-9542-0; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tort L, 2011, DEV COMP IMMUNOL, V35, P1366, DOI 10.1016/j.dci.2011.07.002; Volz EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002947; Walker P.J., 2000, FAMILY RHAB DOVIRIDA, P563; Wang L, 2012, INT J MOL SCI, V13, P5584, DOI 10.3390/ijms13055584; Winton JR, 1989, AM FISH SOC FISH HLT, V17, P2	51	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164475	10.1371/journal.pone.0164475	http://dx.doi.org/10.1371/journal.pone.0164475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760205	gold, Green Submitted, Green Published			2022-12-26	WOS:000386204000038
J	Qi, YF; Ma, XY; Li, G; Ma, XX; Wang, Q; Yu, DX				Qi, Yafei; Ma, Xiaoyuan; Li, Gang; Ma, Xiangxing; Wang, Qing; Yu, Dexin			Three-Dimensional Visualization and Imaging of the Entry Tear and Intimal Flap of Aortic Dissection Using CT Virtual Intravascular Endoscopy	PLOS ONE			English	Article							MULTIDETECTOR CT; STENT-GRAFTS; ANGIOGRAPHY; REPAIR; RISK; ARCH	Aims Conventional computed tomography (CT) approaches provides limited visualization of the entire endoluminal changes of aortic dissection (AD), which is essential for its treatment. As an important supplement, three-dimensional CT virtual intravascular endoscopy (VIE) can show relevant details. This study aims to determine the value of VIE in displaying the entry tear and intimal flap of AD. Methods and Results Among 127 consecutive symptomatic patients with suspected AD who underwent CT angiography (CTA), 84 subjects were confirmed to have AD and were included in the study. Conventional CT and VIE images were observed and evaluated. From the 92 entry tears revealed via conventional CT, 88 (95.7%) tears appeared on VIE with round (n = 26), slit shaped (n = 9), or irregular (n = 53) shapes, whereas the intimal flaps were sheetlike (n = 34), tubular (n = 34), wavelike (n = 13), or irregular (n = 7) in shape. The VIE also showed the spatial relationship between the torn flap and adjacent structures. Among 58 entry tears with multiple-line type flap shown on conventional CT, 41 (70.7%) appeared with an irregular shape on VIE, whereas among 30 tears with single-line type flap, 17 (56.7%) appeared as round or slit-shaped on VIE. These results demonstrated a significant difference (P < 0.05). The poor display of tears on VIE was related to the low CT attenuation values in lumen or in neighboring artifacts (P < 0.01). Conclusion CT VIE presents the complete configurations and details of the intimal tears and flaps of AD better than conventional CT approaches. Accordingly, it should be recommended as a necessary assessment tool for endovascular therapy and as part of strategy planning in pre-surgical patients.	[Qi, Yafei; Ma, Xiaoyuan] Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China; [Li, Gang] Jiaotong Hosp Shandong Prov, Dept Radiol, Jinan, Shandong, Peoples R China; [Ma, Xiangxing; Wang, Qing; Yu, Dexin] Shandong Univ, Qilu Hosp, Dept Radiol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University	Yu, DX (corresponding author), Shandong Univ, Qilu Hosp, Dept Radiol, Jinan, Shandong, Peoples R China.	yudexin0330@sina.com	yu, dexin/AAZ-7955-2021					Batra P, 2000, RADIOGRAPHICS, V20, P309, DOI 10.1148/radiographics.20.2.g00mc04309; Bean MJ, 2008, RADIOGRAPHICS, V28, P1835, DOI 10.1148/rg.287085055; Becker HC, 2012, EUR J RADIOL, V81, P3675, DOI 10.1016/j.ejrad.2011.05.038; Cao P, 2009, J CARDIOVASC SURG, V50, P483; Hayter RG, 2006, RADIOLOGY, V238, P841, DOI 10.1148/radiol.2383041528; Izquierdo L, 2010, CATHETER CARDIO INTE, V75, P32, DOI 10.1002/ccd.22202; Litmanovich D, 2009, AM J ROENTGENOL, V193, P928, DOI 10.2214/AJR.08.2166; Louis N, 2010, EUR J VASC ENDOVASC, V40, P340, DOI 10.1016/j.ejvs.2010.05.019; Louis N, 2009, CIRCULATION, V119, P1052, DOI 10.1161/CIRCULATIONAHA.108.795500; McMahon MA, 2010, RADIOGRAPHICS, V30, P445, DOI 10.1148/rg.302095104; Michael G, 2012, EUR J CARDIO-THORAC, V42, P566, DOI [10.1093/ejcts/ezs041, DOI 10.1093/EJCTS/EZS041]; Patterson BO, 2015, ANN THORAC SURG, V99, P95, DOI 10.1016/j.athoracsur.2014.08.022; Rosskopf AB, 2010, EMERG RADIOL, V17, P185, DOI 10.1007/s10140-009-0829-3; Shirali AS, 2013, JACC-CARDIOVASC IMAG, V6, P349, DOI 10.1016/j.jcmg.2012.07.018; Shu C, 2011, EUR J VASC ENDOVASC, V42, P448, DOI 10.1016/j.ejvs.2011.05.013; Sobocinski J, 2011, EUR J VASC ENDOVASC, V42, P442, DOI 10.1016/j.ejvs.2011.04.037; Sun ZH, 2008, J ENDOVASC THER, V15, P42, DOI 10.1583/07-2234.1; Sun ZH, 2014, QUANT IMAG MED SURG, V4, P376, DOI 10.3978/j.issn.2223-4292.2014.10.02; Sun Zhonghua, 2011, Front Med, V5, P254, DOI 10.1007/s11684-011-0153-7; Sun ZH, 2010, WORLD J RADIOL, V2, P440, DOI 10.4329/wjr.v2.i11.440; Ueda T, 2010, RADIOLOGY, V255, P645, DOI 10.1148/radiol.10091468; Urbania Thomas H, 2009, J Cardiovasc Comput Tomogr, V3, pS13, DOI 10.1016/j.jcct.2008.11.004; Wu WH, 2009, AM J ROENTGENOL, V193, P955, DOI 10.2214/AJR.08.2158	23	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164750	10.1371/journal.pone.0164750	http://dx.doi.org/10.1371/journal.pone.0164750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760170	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204000049
J	Puissant, E; Boonen, M				Puissant, Emeline; Boonen, Marielle			Monocytes/Macrophages Upregulate the Hyaluronidase HYAL1 and Adapt Its Subcellular Trafficking to Promote Extracellular Residency upon Differentiation into Osteoclasts	PLOS ONE			English	Article							MACROPHAGE MANNOSE RECEPTOR; BONE-RESORPTION; CATHEPSIN-K; PLASMA-MEMBRANE; LIVER LYSOSOMES; PROCESSED FORMS; H+-ATPASE; IN-VITRO; EXPRESSION; MICE	Osteoclasts are giant bone-resorbing cells originating from monocytes/macrophages. During their differentiation, they overexpress two lysosomal enzymes, cathepsin K and TRAP, which are secreted into the resorption lacuna, an acidified sealed area in contact with bone matrix where bone degradation takes place. Here we report that the acid hydrolase HYAL1, a hyaluronidase able to degrade the glycosaminoglycans hyaluronic acid (HA) and chondroitin sulfate, is also upregulated upon osteoclastogenesis. The mRNA expression and protein level of HYAL1 are markedly increased in osteoclasts differentiated from RAW264.7 mouse macrophages or primary mouse bone marrow monocytes compared to these precursor cells. As a result, the HYAL1-mediated HA hydrolysis ability of osteoclasts is strongly enhanced. Using subcellular fractionation, we demonstrate that HYAL1 proteins are sorted to the osteoclast lysosomes even though, in contrast to cathepsin K and TRAP, HYAL1 is poorly mannose 6-phosphorylated. We reported previously that macrophages secrete HYAL1 proforms by constitutive secretion, and that these are recaptured by the cell surface mannose receptor, processed in endosomes and sorted to lysosomes. Present work highlights that osteoclasts secrete HYAL1 in two ways, through lysosomal exocytosis and constitutive secretion, and that these cells promote the extracellular residency of HYAL1 through downregulation of the mannose receptor. Interestingly, the expression of the other main hyaluronidase, HYAL2, and of lysosomal exoglycosidases involved in HA degradation, does not increase similarly to HYAL1 upon osteoclastogenesis. Taken together, these findings point out the predominant involvement of HYAL1 in bone HA metabolism and perhaps bone remodeling via the resorption lacuna.	[Puissant, Emeline; Boonen, Marielle] Univ Namur, Lab Chim Physiol URPhyM, Namur, Belgium	University of Namur	Boonen, M (corresponding author), Univ Namur, Lab Chim Physiol URPhyM, Namur, Belgium.	marielle.boonen@unamur.be						ACHORD DT, 1978, CELL, V15, P269, DOI 10.1016/0092-8674(78)90102-2; Andre B, 2011, BIOCHEM BIOPH RES CO, V411, P175, DOI 10.1016/j.bbrc.2011.06.125; Ariyoshi W, 2005, J BIOL CHEM, V280, P18967, DOI 10.1074/jbc.M412740200; Atmuri V, 2008, MATRIX BIOL, V27, P653, DOI 10.1016/j.matbio.2008.07.006; Boonen M, 2016, J CELL SCI, V129, P557, DOI 10.1242/jcs.179374; Boonen M, 2014, BIOCHEM BIOPH RES CO, V446, P1155, DOI 10.1016/j.bbrc.2014.03.070; Bossard MJ, 1996, J BIOL CHEM, V271, P12517, DOI 10.1074/jbc.271.21.12517; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; Canuel M, 2008, BIOCHEM BIOPH RES CO, V373, P292, DOI 10.1016/j.bbrc.2008.06.021; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chang EJ, 2007, J CELL SCI, V120, P166, DOI 10.1242/jcs.03310; Czupalla C, 2006, MOL CELL PROTEOMICS, V5, P134, DOI 10.1074/mcp.M500291-MCP200; Derocq D, 2012, ONCOGENE, V31, P3202, DOI 10.1038/onc.2011.501; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Ek-Rylander B, 2010, EXP CELL RES, V316, P443, DOI 10.1016/j.yexcr.2009.10.019; Elvevold K, 2008, HEPATOLOGY, V48, P2007, DOI 10.1002/hep.22527; FISZERSZAFARZ B, 1984, ANAL BIOCHEM, V143, P76, DOI 10.1016/0003-2697(84)90560-8; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; GREEN SA, 1987, J CELL BIOL, V105, P1227, DOI 10.1083/jcb.105.3.1227; GUNTENHONER MW, 1992, MATRIX, V12, P388, DOI 10.1016/S0934-8832(11)80035-1; Halleen JM, 1999, J BIOL CHEM, V274, P22907, DOI 10.1074/jbc.274.33.22907; Hayman AR, 1996, DEVELOPMENT, V122, P3151; Hemming R, 2008, GLYCOBIOLOGY, V18, P280, DOI 10.1093/glycob/cwn006; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Lange Y, 1998, J BIOL CHEM, V273, P18915, DOI 10.1074/jbc.273.30.18915; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Markmann S, 2015, TRAFFIC, V16, P743, DOI 10.1111/tra.12284; Martin DC, 2008, HUM MOL GENET, V17, P1904, DOI 10.1093/hmg/ddn088; McAtee CO, 2015, J BIOL CHEM, V290, P13144, DOI 10.1074/jbc.M115.647446; MOKOENA T, 1985, J CLIN INVEST, V75, P624, DOI 10.1172/JCI111740; Pivetta E, 2011, J CELL PHYSIOL, V226, P769, DOI 10.1002/jcp.22398; Puissant E, 2014, TRAFFIC, V15, P500, DOI 10.1111/tra.12162; Qian MQ, 2008, MOL CELL PROTEOMICS, V7, P58, DOI 10.1074/mcp.M700217-MCP200; Rieman DJ, 2001, BONE, V28, P282, DOI 10.1016/S8756-3282(00)00445-2; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Salbach J, 2012, BIOMATERIALS, V33, P8418, DOI 10.1016/j.biomaterials.2012.08.028; Scheven BAA, 1997, BIOCHEM BIOPH RES CO, V231, P231, DOI 10.1006/bbrc.1996.6040; SCHREIBER S, 1990, CELL REGUL, V1, P403, DOI 10.1091/mbc.1.5.403; Shepherd VL, 1997, ARCH BIOCHEM BIOPHYS, V344, P350, DOI 10.1006/abbi.1997.0219; SHEPHERD VL, 1985, J BIOL CHEM, V260, P160; SHEPHERD VL, 1982, J RETICULOENDOTH SOC, V32, P423; Shuttleworth TL, 2002, J BIOL CHEM, V277, P23008, DOI 10.1074/jbc.M108991200; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stern R., 2003, GLYCOBIOLOGY, V13, P105, DOI DOI 10.1093/GLYC0B/CWG112; Sun PL, 2008, P NATL ACAD SCI USA, V105, P16590, DOI 10.1073/pnas.0807472105; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Vaananen HK, 2000, J CELL SCI, V113, P377; VAANANEN HK, 1990, J CELL BIOL, V111, P1305, DOI 10.1083/jcb.111.3.1305; Vaaraniemi J, 2004, J BONE MINER RES, V19, P1432, DOI 10.1359/JBMR.040603; van Meel E, 2011, TRAFFIC, V12, P912, DOI 10.1111/j.1600-0854.2011.01203.x; WILEMAN TE, 1986, P NATL ACAD SCI USA, V83, P2501, DOI 10.1073/pnas.83.8.2501; Zhao HB, 2008, DEV CELL, V14, P914, DOI 10.1016/j.devcel.2008.03.022; Zhu YX, 2004, J PHARMACOL EXP THER, V308, P705, DOI 10.1124/jpet.103.060236	57	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e165004	10.1371/journal.pone.0165004	http://dx.doi.org/10.1371/journal.pone.0165004			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755597	Green Published, Green Submitted, gold			2022-12-26	WOS:000386203800048
J	Jung, LA; Gebhardt, A; Koelmel, W; Ade, CP; Walz, S; Kuper, J; von Eyss, B; Letschert, S; Redel, C; d'Artista, L; Biankin, A; Zender, L; Sauer, M; Wolf, E; Evan, G; Kisker, C; Eilers, M				Jung, L. A.; Gebhardt, A.; Koelmel, W.; Ade, C. P.; Walz, S.; Kuper, J.; von Eyss, B.; Letschert, S.; Redel, C.; d'Artista, L.; Biankin, A.; Zender, L.; Sauer, M.; Wolf, E.; Evan, G.; Kisker, C.; Eilers, M.			OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors	ONCOGENE			English	Article							ANTI-APOPTOTIC FACTOR; DOMAIN-CONTAINING 3A; C-MYC; COLORECTAL TUMORIGENESIS; MITOCHONDRIAL DYNAMICS; UBIQUITIN RECEPTOR; BREAST-CANCER; DNA-BINDING; GENOME; CELLS	MYC genes have both essential roles during normal development and exert oncogenic functions during tumorigenesis. Expression of a dominant-negative allele of MYC, termed OmoMYC, can induce rapid tumor regression in mouse models with little toxicity for normal tissues. How OmoMYC discriminates between physiological and oncogenic functions of MYC is unclear. We have solved the crystal structure of OmoMYC and show that it forms a stable homodimer and as such recognizes DNA in the same manner as the MYC/MAX heterodimer. OmoMYC attenuates both MYC-dependent activation and repression by competing with MYC/MAX for binding to chromatin, effectively lowering MYC/MAX occupancy at its cognate binding sites. OmoMYC causes the largest decreases in promoter occupancy and changes in expression on genes that are invaded by oncogenic MYC levels. A signature of OmoMYC-regulated genes defines subgroups with high MYC levels in multiple tumor entities and identifies novel targets for the eradication of MYC-driven tumors.	[Jung, L. A.; Gebhardt, A.; Ade, C. P.; von Eyss, B.; Redel, C.; Wolf, E.; Eilers, M.] Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97074 Wurzburg, Germany; [Jung, L. A.; Koelmel, W.; Kuper, J.; Kisker, C.] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Wurzburg, Germany; [Walz, S.] Bioctr, Core Unit Bioinformat, Comprehens Canc Ctr, Wurzburg, Germany; [Letschert, S.; Sauer, M.] Univ Wurzburg, Bioctr, Dept Biotechnol & Biophys, Wurzburg, Germany; [d'Artista, L.; Zender, L.] Univ Tubingen, Dept Internal Med 1, Div Translat Gastrointestinal Oncol, Tubingen, Germany; [Biankin, A.] Univ Glasgow, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Garscube Estate,Switchback Rd, Glasgow, Lanark, Scotland; [Biankin, A.] Glasgow Royal Infirm, West Scotland Pancreat Unit, Glasgow, Lanark, Scotland; [Biankin, A.] Univ NSW, South Western Sydney Clin Sch, Fac Med, Liverpool, NSW, Australia; [Evan, G.] Univ Cambridge, Dept Biochem, Cambridge, England	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; Eberhard Karls University of Tubingen; University of Glasgow; University of Glasgow; University of Cambridge	Eilers, M (corresponding author), Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97074 Wurzburg, Germany.; Kisker, C (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Wurzburg, Germany.	caroline.kisker@virchow.uni-wuerzburg.de; martin.eilers@biozentrum.uni-wuerzburg.de	von Eyss, Bjoern/P-1077-2019; Wolf, Elmar/AAY-8493-2021; Kisker, Caroline/T-1724-2019; Sauer, Markus/C-4378-2017	von Eyss, Bjoern/0000-0002-4731-6841; Wolf, Elmar/0000-0002-5299-6335; Sauer, Markus/0000-0002-1692-3219; Redel, Cornelia/0000-0002-3632-3317; Evan, Gerard/0000-0003-0412-1216; Kisker, Caroline/0000-0002-0216-6026; Jung, Lisa Anna/0000-0003-4149-1662; Biankin, Andrew/0000-0002-0362-5597	Worldwide Cancer Research; German Research Foundation [2341]; German National Academic Foundation; Cancer Research UK [12077, 19013, 22585, 17263, 22533] Funding Source: researchfish; Pancreatic Cancer UK [FLF2015_04_Glasgow] Funding Source: researchfish	Worldwide Cancer Research; German Research Foundation(German Research Foundation (DFG)); German National Academic Foundation; Cancer Research UK(Cancer Research UK); Pancreatic Cancer UK	We thank Laura Soucek for sharing results before publication, Agnes Elias and Werner Schmitz for help with protein purification, Hermann Schindelin for help with determining the structures of OmoMYC, Christopher Bombeck for help with generating the targeted shRNA library and Jens Siveke (Technical University of Munich) for kindly providing KPCs. The expert technical assistance of Barbara Bauer, Andre Kutschke, Angela Grun and Renate Metz is gratefully acknowledged. This work was supported by grants from Worldwide Cancer Research and the German Research Foundation via Research Group 2341 to ME, GE, LZ and CK, and a pre-doctoral fellowship from the German National Academic Foundation to LAJ. High-throughput-sequencing data are available at the Gene Expression Omnibus under the accession number GEO: GSE77328. We thank the European Synchrotron Radiation Facility for beamtime and the staff of ID23-1 for technical support. We thank the Helmholtz Zentrum Berlin for the allocation of beamtime and the staff of BL14.1 for technical support. Atomic coordinates have been deposited in the Protein Data Bank under accession codes 5I4Z (apo structure) and 5I50 (DNA-bound structure).	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Anchoori RK, 2013, CANCER CELL, V24, P791, DOI 10.1016/j.ccr.2013.11.001; Annibali D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5632; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Chiang SF, 2012, INT J MOL MED, V29, P365, DOI 10.3892/ijmm.2011.849; Chung KY, 2011, HEPATOLOGY, V54, P307, DOI 10.1002/hep.24372; Cunningham JT, 2014, CELL, V157, P1088, DOI 10.1016/j.cell.2014.03.052; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Fang HY, 2010, J CELL SCI, V123, P1171, DOI 10.1242/jcs.062034; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10; Giuriato S, 2006, P NATL ACAD SCI USA, V103, P16266, DOI 10.1073/pnas.0608017103; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guo JN, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0482-3; Hoffmann M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007644; Hong SL, 2000, GENE DEV, V14, P17; Huang KH, 2011, INT J MOL MED, V28, P9, DOI 10.3892/ijmm.2011.670; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jaenicke LA, 2016, MOL CELL, V61, P54, DOI 10.1016/j.molcel.2015.11.007; Killian A, 2006, GENE CHROMOSOME CANC, V45, P874, DOI 10.1002/gcc.20351; Kress TR, 2015, NAT REV CANCER, V15, P593, DOI 10.1038/nrc3984; Kress TR, 2011, MOL CELL, V41, P445, DOI 10.1016/j.molcel.2011.01.023; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Lorenzin F, 2016, ELIFE, V5, DOI 10.7554/eLife.15161; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Perna D, 2012, ONCOGENE, V31, P1695, DOI 10.1038/onc.2011.359; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Ruggero D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012336; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Savino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022284; Scognamiglio R, 2016, CELL, V164, P668, DOI 10.1016/j.cell.2015.12.033; Sodir NM, 2011, GENE DEV, V25, P907, DOI 10.1101/gad.2038411; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas LR, 2015, MOL CELL, V58, P440, DOI 10.1016/j.molcel.2015.02.028; Truitt ML, 2015, CELL, V162, P59, DOI 10.1016/j.cell.2015.05.049; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; von Eyss B, 2015, CANCER CELL, V28, P743, DOI 10.1016/j.ccell.2015.10.013; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wolf E, 2015, TRENDS CELL BIOL, V25, P241, DOI 10.1016/j.tcb.2014.10.006	51	51	51	3	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 6	2017	36	14					1911	1924		10.1038/onc.2016.354	http://dx.doi.org/10.1038/onc.2016.354			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ER6EQ	27748763	Green Accepted, Green Submitted			2022-12-26	WOS:000398898500003
J	Yin, T; Wang, GP; He, SS; Shen, GB; Su, C; Zhang, Y; Wei, XW; Ye, TH; Li, L; Yang, SY; Li, D; Guo, FC; Mo, ZM; Wan, Y; Ai, P; Zhou, XJ; Liu, YT; Wang, YS; Wei, YQ				Yin, Tao; Wang, Guoping; He, Sisi; Shen, Guobo; Su, Chao; Zhang, Yan; Wei, Xiawei; Ye, Tinghong; Li, Ling; Yang, Shengyong; Li, Dan; Guo, Fuchun; Mo, Zeming; Wan, Yang; Ai, Ping; Zhou, Xiaojuan; Liu, Yantong; Wang, Yongsheng; Wei, Yuquan			Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN-CANCER; LUNG-CANCER; SELF-RENEWAL; THERAPY; BEVACIZUMAB; METASTASIS; DISSEMINATION; PROGRESSION; ACTIVATION; EXPRESSION	Malignant pleural effusion (PE) and ascites, common clinical manifestations in advanced cancer patients, are associated with a poor prognosis. However, the biological characteristics of malignant PE and ascites are not clarified. Here we report that malignant PE and ascites can induce a frequent epithelial-mesenchymal transition program and endow tumor cells with stem cell properties with high efficiency, which promotes tumor growth, chemoresistance, and immune evasion. We determine that this epithelial-mesenchymal transition process is mainly dependent on VEGF, one initiator of the PI3K/Akt/mechanistic target of rapamycin (mTOR) pathway. From the clinical observation, we define a therapeutic option with VEGF antibody for malignant PE and ascites. Taken together, our findings clarify a novel biological characteristic of malignant PE and ascites in cancer progression and provide a promising and available strategy for cancer patients with recurrent/refractory malignant PE and ascites.	[Wang, Yongsheng] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Thorac Oncol, 17,Sect 3 Peoples South Rd, Chengdu 610041, Peoples R China; [Wang, Yongsheng] Sichuan Univ, West China Hosp, Ctr Canc, 17,Sect 3 Peoples South Rd, Chengdu 610041, Peoples R China; [Wang, Yongsheng] Collaborat Innovat Ctr Biotherapy, 17,Sect 3 Peoples South Rd, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University	Wang, YS (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Thorac Oncol, 17,Sect 3 Peoples South Rd, Chengdu 610041, Peoples R China.; Wang, YS (corresponding author), Sichuan Univ, West China Hosp, Ctr Canc, 17,Sect 3 Peoples South Rd, Chengdu 610041, Peoples R China.; Wang, YS (corresponding author), Collaborat Innovat Ctr Biotherapy, 17,Sect 3 Peoples South Rd, Chengdu 610041, Peoples R China.	wangys75@gmail.com			National Natural Science Foundation of China [81272523, 81501609]; National Basic Research Program of China [2010CB529900]; Chinese Postdoctoral Special Funds [2016T90856]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Postdoctoral Special Funds	This work was supported by National Natural Science Foundation of China Grants 81272523 and 81501609, National Basic Research Program of China Grant 2010CB529900, and Chinese Postdoctoral Special Funds Grant 2016T90856. The authors declare that they have no conflicts of interest with the contents of this article.	Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Abiko K, 2013, CLIN CANCER RES, V19, P1363, DOI 10.1158/1078-0432.CCR-12-2199; Ahmed N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00256; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Chen SR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053662, 10.1371/journal.pone.0056380]; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Du N, 2013, ONCOL REP, V29, P2332, DOI 10.3892/or.2013.2349; Duysinx BC, 2008, RESP MED, V102, P1708, DOI 10.1016/j.rmed.2008.07.008; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Giarnieri E, 2015, J CELL PHYSIOL, V230, P272, DOI 10.1002/jcp.24806; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jewett A, 2012, CURR DRUG DELIV, V9, P5, DOI 10.2174/156720112798375989; Kobold S, 2009, ONCOLOGIST, V14, P1242, DOI 10.1634/theoncologist.2009-0109; Kolomainen DF, 2003, J CLIN ONCOL, V21, P3113, DOI 10.1200/JCO.2003.06.119; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Latifi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046858; Lee JY, 2011, AM J PHYSIOL-RENAL, V300, pF1214, DOI 10.1152/ajprenal.00710.2010; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Okano J, 2003, BIOCHEM BIOPH RES CO, V309, P298, DOI 10.1016/j.bbrc.2003.04.002; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; PLANTE M, 1994, CANCER, V73, P1882, DOI 10.1002/1097-0142(19940401)73:7<1882::AID-CNCR2820730718>3.0.CO;2-R; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Rafehi S, 2016, ENDOCR-RELAT CANCER, V23, P147, DOI 10.1530/ERC-15-0383; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ricci A, 2013, CELL CYCLE, V12, P1696, DOI 10.4161/cc.24759; RUNYON BA, 1994, NEW ENGL J MED, V330, P337, DOI 10.1056/NEJM199402033300508; Ryu JS, 2014, J CLIN ONCOL, V32, P960, DOI 10.1200/JCO.2013.50.5453; Sakr L, 2011, J THORAC ONCOL, V6, P592, DOI 10.1097/JTO.0b013e318208c7c1; Sakuma K, 2012, P NATL ACAD SCI USA, V109, P7776, DOI 10.1073/pnas.1111135109; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sasada T, 2003, CANCER-AM CANCER SOC, V98, P1089, DOI 10.1002/cncr.11618; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shen-Gunther J, 2002, GYNECOL ONCOL, V87, P77, DOI 10.1006/gyno.2002.6800; Shiota M, 2012, CANCER RES, V72, P5261, DOI 10.1158/0008-5472.CAN-12-0254; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Zebrowski BK, 1999, ANN SURG ONCOL, V6, P373, DOI 10.1007/s10434-999-0373-0; Zhao H, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0292-1	49	20	22	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26750	26761		10.1074/jbc.M116.753236	http://dx.doi.org/10.1074/jbc.M116.753236			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27756837	Green Published, hybrid			2022-12-26	WOS:000391571400014
J	Hasenhuetl, PS; Freissmuth, M; Sandtner, W				Hasenhuetl, Peter S.; Freissmuth, Michael; Sandtner, Walter			Electrogenic Binding of Intracellular Cations Defines a Kinetic Decision Point in the Transport Cycle of the Human Serotonin Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DOPAMINE TRANSPORTER; MEMBRANE-TRANSPORT; CONDUCTING STATES; SODIUM SYMPORTERS; CHLORIDE-ION; MECHANISM; NA+; NEUROTRANSMITTER; AMPHETAMINE; CURRENTS	The plasmalemmal monoamine transporters clear the extracellular space from their cognate substrates and sustain cellular monoamine stores even during neuronal activity. In some instances, however, the transporters enter a substrate-exchange mode, which results in release of intracellular substrate. Understanding what determines the switch between these two transport modes demands time-resolved measurements of intracellular (co-) substrate binding and release. Here, we report an electrophysiological investigation of intracellular solute-binding to the human serotonin transporter (SERT) expressed in HEK-293 cells. We measured currents induced by rapid application of serotonin employing varying intracellular (co-) substrate concentrations and interpreted the data using kinetic modeling. Our measurements revealed that the induction of the substrate-exchange mode depends on both voltage and intracellular Na+ concentrations because intracellular Na+ release occurs before serotonin release and is highly electrogenic. This voltage dependence was blunted by electrogenic binding of intracellular K+ and, notably, also H+. In addition, our data suggest that Cl- is bound to SERT during the entire catalytic cycle. Our experiments, therefore, document an essential role of electrogenic binding of K+ or of H+ to the inward-facing conformation of SERT in (i) cancelling out the electrogenic nature of intracellular Na+ release and (ii) in selecting the forward-transport over the substrate-exchange mode. Finally, the kinetics of intracellular Na+ release and K+ (or H+) binding result in a voltage-independent rate-limiting step where SERT may return to the outward-facing state in a KCl- or HCl-bound form.	[Hasenhuetl, Peter S.; Freissmuth, Michael; Sandtner, Walter] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringerstr 13a, A-1090 Vienna, Austria	Medical University of Vienna	Sandtner, W (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringerstr 13a, A-1090 Vienna, Austria.	walter.sandtner@meduniwien.ac.at		Freissmuth, Michael/0000-0001-9398-1765; Hasenhuetl, Peter/0000-0002-3121-9502	Austrian Science Fund/FWF [P28090, SFB35 (F3510)]; Medical University of Vienna	Austrian Science Fund/FWF(Austrian Science Fund (FWF)); Medical University of Vienna	This work was supported by the Austrian Science Fund/FWF Project P28090 (to W. S.), Project Program Grant SFB35 (F3510 to M. F.), and the MD/Ph.D. program of the Medical University of Vienna (to P. S. H.). This work is part of a dissertation submitted in partial fulfillment of the requirements of the Ph.D. degree. The authors declare that they have no conflicts of interest with the contents of this article.	Bicho A, 2005, BIOPHYS J, V89, P211, DOI 10.1529/biophysj.105.061002; Billesbolle CB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12755; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Cheng MH, 2015, STRUCTURE, V23, P2171, DOI 10.1016/j.str.2015.09.001; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Erreger K, 2008, J NEUROSCI, V28, P976, DOI 10.1523/JNEUROSCI.2796-07.2008; Felts B, 2014, J BIOL CHEM, V289, P1825, DOI 10.1074/jbc.M113.504654; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Grewer C, 2013, ANNU REV BIOPHYS, V42, P95, DOI 10.1146/annurev-biophys-083012-130312; Hasenhuetl PS, 2015, MOL PHARMACOL, V88, P12, DOI 10.1124/mol.115.099036; Henry LK, 2011, J BIOL CHEM, V286, P30823, DOI 10.1074/jbc.M111.250308; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; KEYES SR, 1982, J BIOL CHEM, V257, P1172; Khelashvili G, 2016, J BIOL CHEM, V291, P19786, DOI 10.1074/jbc.M116.731455; Khelashvili G, 2015, ACS CHEM NEUROSCI, V6, P1825, DOI 10.1021/acschemneuro.5b00179; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; Koldso H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063635; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Lauger P., 1991, ELECTROGENIC ION PUM; Li J, 2013, P NATL ACAD SCI USA, V110, P7696, DOI 10.1073/pnas.1218986110; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Lin F, 1996, BIOPHYS J, V71, P3126, DOI 10.1016/S0006-3495(96)79506-1; Loo DDF, 2000, J BIOL CHEM, V275, P37414, DOI 10.1074/jbc.M007241200; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; Malinauskaite L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11673; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Nakamura K, 2008, J NEUROSCI, V28, P5331, DOI 10.1523/JNEUROSCI.0021-08.2008; NELSON PJ, 1979, J BIOL CHEM, V254, P84; NELSON PJ, 1982, J BIOL CHEM, V257, P6151; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Richerson GB, 2003, J NEUROPHYSIOL, V90, P1363, DOI 10.1152/jn.00317.2003; Sandtner W, 2014, BRIT J PHARMACOL, V171, P1007, DOI 10.1111/bph.12520; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sonders MS, 1997, J NEUROSCI, V17, P960; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	43	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25864	25876		10.1074/jbc.M116.753319	http://dx.doi.org/10.1074/jbc.M116.753319			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27756841	Green Published, hybrid			2022-12-26	WOS:000390345200010
J	Bouche, L; Panico, M; Hitchen, P; Binet, D; Sastre, F; Faulds-Pain, A; Valiente, E; Vinogradov, E; Aubry, A; Fulton, K; Twine, S; Logan, SM; Wren, BW; Dell, A; Morris, HR				Bouche, Laura; Panico, Maria; Hitchen, Paul; Binet, Daniel; Sastre, Federico; Faulds-Pain, Alexandra; Valiente, Esmeralda; Vinogradov, Evgeny; Aubry, Annie; Fulton, Kelly; Twine, Susan; Logan, Susan M.; Wren, Brendan W.; Dell, Anne; Morris, Howard R.			The Type B Flagellin of Hypervirulent Clostridium difficile Is Modified with Novel Sulfonated Peptidylamido-glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; glycosylation; Gram-positive bacteria; mass spectrometry (MS); nuclear magnetic resonance (NMR); Clostridium difficile; flagellin; modification; sulfonated	TANDEM MASS-SPECTROMETRY; TYROBUTYRICUM ATCC 25755; PROTEIN GLYCOSYLATION; POSTTRANSLATIONAL MODIFICATION; IDENTIFICATION; MOTILITY; VIRULENCE; GENOME	Glycosylation of flagellins is a well recognized property of many bacterial species. In this study, we describe the structural characterization of novel flagellar glycans from a number of hypervirulent strains of C. difficile. We used mass spectrometry (nano-LC-MS and MS/MS analysis) to identify a number of putative glycopeptides that carried a variety of glycoform substitutions, each of which was linked through an initial N-acetylhexosamine residue to Ser or Thr. Detailed analysis of a LLDGSSTEIR glycopeptide released by tryptic digestion, which carried two variant structures, revealed that the glycopeptide contained, in addition to carbohydrate moieties, a novel structural entity. A variety of electrospray-MS strategies using Q-TOF technology were used to define this entity, including positive and negative ion collisionally activated decomposition MS/MS, which produced unique fragmentation patterns, and high resolution accurate mass measurement to allow derivation of atomic compositions, leading to the suggestion of a taurine-containing peptidylamido-glycan structure. Finally, NMR analysis of flagellin glycopeptides provided complementary information. The glycan portion of the modification was assigned as -Fuc3N-(13)--Rha-(12)--Rha3OMe-(13)--GlcNAc-(1)Ser, and the novel capping moiety was shown to be comprised of taurine, alanine, and glycine. This is the first report of a novel O-linked sulfonated peptidylamido-glycan moiety decorating a flagellin protein.	[Bouche, Laura; Panico, Maria; Hitchen, Paul; Sastre, Federico; Dell, Anne; Morris, Howard R.] Imperial Coll London, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England; [Faulds-Pain, Alexandra; Valiente, Esmeralda; Wren, Brendan W.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England; [Vinogradov, Evgeny; Aubry, Annie; Fulton, Kelly; Twine, Susan; Logan, Susan M.] CNR, Vaccine Program, Human Hlth Therapeut Portfolio, Ottawa, ON K1A 0R6, Canada; [Binet, Daniel; Morris, Howard R.] BioPharmaSpec, Suite 3-1 Lido Med Ctr,St Saviours Rd, Jersey JE2 7LA, England; [Sastre, Federico] Pontificia Univ Catolica Chile PUC, Escuela Ingn, Dept Ingn Quim & Bioproc, Av Vicuna Mackenna 4860, Santiago 7820436, Chile	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; National Research Council Canada; Pontificia Universidad Catolica de Chile	Dell, A (corresponding author), Imperial Coll London, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England.	a.dell@imperial.ac.uk		Dell, Anne/0000-0003-1380-2347	Wellcome Trust [102979/Z/13/Z]; Medical Research Council [MR/K000551/1]; Biotechnology and Biological Sciences Research Council [BB/K016164/1, BB/F008309/1]; Marie Curie Intra-European Fellowship [PIEF-GA-2009-252207-CDI]; Biotechnology and Biological Sciences Research Council [BB/D521849/1] Funding Source: researchfish; Medical Research Council [G1000214] Funding Source: researchfish; BBSRC [BB/D521849/1, BB/F008309/1, BB/K016164/1] Funding Source: UKRI; MRC [MR/K000551/1, G1000214] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie Intra-European Fellowship(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 102979/Z/13/Z, Medical Research Council Grant MR/K000551/1, and Biotechnology and Biological Sciences Research Council Grants BB/K016164/1 and BB/F008309/1. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Marie Curie Intra-European Fellowship for career development (PIEF-GA-2009-252207-CDI).	Alemka A, 2013, INFECT IMMUN, V81, P1674, DOI 10.1128/IAI.01370-12; Arnold F, 1998, MICROBIOL IMMUNOL, V42, P23, DOI 10.1111/j.1348-0421.1998.tb01965.x; Asakura H, 2010, MOL MICROBIOL, V78, P1130, DOI 10.1111/j.1365-2958.2010.07393.x; Barketi-Klai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096876; Bedouet L, 1998, MICROBIOS, V94, P183; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Cairns MD, 2012, FUTURE MICROBIOL, V7, P945, DOI [10.2217/FMB.12.73, 10.2217/fmb.12.73]; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; Faulds-Pain A, 2014, MOL MICROBIOL, V94, P272, DOI 10.1111/mmi.12755; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Hennequin C, 2003, MICROBIOL-SGM, V149, P2779, DOI 10.1099/mic.0.26145-0; HUNT E, 1973, BIOCHEM J, V135, P833, DOI 10.1042/bj1350833; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Janesch B, 2016, GLYCOBIOLOGY, V26, P74, DOI 10.1093/glycob/cwv087; Kirby JM, 2009, J BIOL CHEM, V284, P34666, DOI 10.1074/jbc.M109.051177; Larsen JC, 2004, J BACTERIOL, V186, P6508, DOI 10.1128/JB.186.19.6508-6514.2004; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Lyristis M, 2000, ANAEROBE, V6, P69, DOI 10.1006/anae.1999.0311; Merino S, 2014, INT J MOL SCI, V15, P2840, DOI 10.3390/ijms15022840; Miao JF, 2012, CYTOKINE, V59, P35, DOI 10.1016/j.cyto.2012.04.009; Morris HR, 1996, RAPID COMMUN MASS SP, V10, P889, DOI 10.1002/(SICI)1097-0231(19960610)10:8<889::AID-RCM615>3.0.CO;2-F; Morris HR, 1997, J PROTEIN CHEM, V16, P469, DOI 10.1023/A:1026309410737; Naundorf A, 1996, CARBOHYD RES, V285, P141, DOI 10.1016/S0008-6215(96)90180-9; Ni Eidhin D, 2006, J MED MICROBIOL, V55, P69, DOI 10.1099/jmm.0.46204-0; Pfoestl A, 2003, J BIOL CHEM, V278, P26410, DOI 10.1074/jbc.M300858200; Reynolds CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002024; Schirm M, 2005, ANAL CHEM, V77, P7774, DOI 10.1021/ac051316y; Schirm M, 2004, J BACTERIOL, V186, P6721, DOI 10.1128/JB.186.20.6721-6727.2004; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; Twine SM, 2008, FEBS J, V275, P4428, DOI 10.1111/j.1742-4658.2008.06589.x; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Valiente E, 2016, J BIOL CHEM, V291, P25450, DOI 10.1074/jbc.M116.749523	35	12	13	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25439	25449		10.1074/jbc.M116.749481	http://dx.doi.org/10.1074/jbc.M116.749481			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27758867	Green Accepted, hybrid, Green Submitted, Green Published			2022-12-26	WOS:000390095300014
J	Lamboni, Y; Nielsen, KF; Linnemann, AR; Gezgin, Y; Hell, K; Nout, MJR; Smid, EJ; Tamo, M; van Boekel, MAJS; Hoof, JB; Frisvad, JC				Lamboni, Yendouban; Nielsen, Kristian F.; Linnemann, Anita R.; Gezgin, Yuksel; Hell, Kerstin; Nout, Martinus J. R.; Smid, Eddy J.; Tamo, Manuele; van Boekel, Martinus A. J. S.; Hoof, Jakob Blaesbjerg; Frisvad, Jens Christian			Diversity in Secondary Metabolites Including Mycotoxins from Strains of Aspergillus Section Nigri Isolated from Raw Cashew Nuts from Benin, West Africa	PLOS ONE			English	Article							OCHRATOXIN-A PRODUCTION; DRIED VINE FRUITS; TOXIC METABOLITES; FUMONISIN B-2; NIGER; CARBONARIUS; GRAPES; FLAVI; IDENTIFICATION; CONTAMINATION	In a previous study, raw cashew kernels were assayed for the fungal contamination focusing on strains belonging to the genus Aspergillus and on aflatoxins producers. These samples showed high contamination with Aspergillus section Nigri species and absence of aflatoxins. To investigate the diversity of secondary metabolites, including mycotoxins, the species of A. section Nigri may produce and thus threaten to contaminate the raw cashew kernels, 150 strains were isolated from cashew samples and assayed for their production of secondary metabolites using liquid chromatography high resolution mass spectrometry (LC-HRMS). Seven species of black Aspergilli were isolated based on morphological and chemical identification: A. tubingensis (44%), A. niger (32%), A. brasiliensis (10%), A. carbonarius (8.7%), A. luchuensis (2.7%), A. aculeatus (2%) and A. aculeatinus (0.7%). From these, 45 metabolites and their isomers were identified. Aurasperone and pyranonigrin A, produced by all species excluding A. aculeatus and A. aculeatinus, were most prevalent and were encountered in 146 (97.3%) and 145 (95.7%) isolates, respectively. Three mycotoxins groups were detected: fumonisins (B-2 and B-4) (2.7%) ochratoxin A (13.3%), and secalonic acids (2%), indicating that these mycotoxins could occur in raw cashew nuts. Thirty strains of black Aspergilli were randomly sampled for verification of species identity based on sequences of beta-tubulin and calmodulin genes. Among them, 27 isolates were positive to the primers used and 11 were identified as A. niger, 7 as A. tubingensis, 6 as A. carbonarius, 2 as A. luchuensis and 1 as A. welwitschiae confirming the species names as based on morphology and chemical features. These strains clustered in 5 clades in A. section Nigri. Chemical profile clustering also showed also 5 groups confirming the species specific metabolites production.	[Lamboni, Yendouban; Hell, Kerstin; Tamo, Manuele] Int Inst Trop Agr, Cotonou, Benin; [Lamboni, Yendouban; Nielsen, Kristian F.; Gezgin, Yuksel; Hoof, Jakob Blaesbjerg; Frisvad, Jens Christian] Tech Univ Denmark, Dept Biotechnol & Bioengn, Lyngby, Denmark; [Lamboni, Yendouban; Linnemann, Anita R.; van Boekel, Martinus A. J. S.] Wageningen Univ, Food Qual & Design Grp, Wageningen, Netherlands; [Lamboni, Yendouban; Nout, Martinus J. R.; Smid, Eddy J.] Wageningen Univ, Food Microbiol Lab, Wageningen, Netherlands; [Gezgin, Yuksel] Ege Univ, Dept Bioengn, Izmir, Turkey	Technical University of Denmark; Wageningen University & Research; Wageningen University & Research; Ege University	Nielsen, KF (corresponding author), Tech Univ Denmark, Dept Biotechnol & Bioengn, Lyngby, Denmark.	kfn@bio.dtu.dk	Gezgin, Yüksel/AAX-8296-2020; Frisvad, Jens C/K-2818-2017; LAMBONI, Yendouban/A-6880-2012; van Boekel, Martinus A.J.S./F-2959-2017; Hoof, Jakob Blæsbjerg/L-6019-2015; Nielsen, Kristian Fog/C-7233-2011	Gezgin, Yüksel/0000-0001-5812-1882; Frisvad, Jens C/0000-0002-0573-4340; LAMBONI, Yendouban/0000-0002-8471-3432; van Boekel, Martinus A.J.S./0000-0001-8145-8715; Hoof, Jakob Blæsbjerg/0000-0002-7650-9300; Nielsen, Kristian Fog/0000-0002-5848-0911	EEC project MycoRed [KBBE-2007-222690-2]	EEC project MycoRed	The first author (YL) gratefully thanks Wageningen University, the International Institute of Tropical Agriculture in Benin, and the EEC project MycoRed (KBBE-2007-222690-2). The DTU Metabolomics Platform, Department of Systems Biology, Technical University of Denmark is acknowledged for access to UHPLC-QTOF instrument.	Abarca ML, 2003, J FOOD PROTECT, V66, P504, DOI 10.4315/0362-028X-66.3.504; Adeniyi D. O., 2015, Archives of Applied Science Research, V7, P30; Al-Musallam A., 1980, REVISION BLACK ASPER; ANDERSEN R, 1977, J ORG CHEM, V42, P352, DOI 10.1021/jo00422a042; [Anonymous], 1997, FUNGI FOOD SPOILAGE; Balajee SA, 2009, J CLIN MICROBIOL, V47, P877, DOI 10.1128/JCM.01685-08; BLASER P, 1980, LEBENSM WISS TECHNOL, V13, P66; Blumenthal CZ, 2004, REGUL TOXICOL PHARM, V39, P214, DOI 10.1016/j.yrtph.2003.09.002; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Chiotta ML, 2011, INT J FOOD MICROBIOL, V149, P171, DOI 10.1016/j.ijfoodmicro.2011.06.002; Chiotta ML, 2013, FOOD MICROBIOL, V36, P182, DOI 10.1016/j.fm.2013.04.003; Donner M, 2009, SOIL BIOL BIOCHEM, V41, P37, DOI 10.1016/j.soilbio.2008.09.013; Frisvad JC, 2011, WOODHEAD PUBL FOOD S, P279; Frisvad JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023496; GHOSAL S, 1979, J AGR FOOD CHEM, V27, P1347, DOI 10.1021/jf60226a018; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Greco M, 2015, TOXINS, V7, P3512, DOI 10.3390/toxins7093512; Gyedu-Akoto E., 2014, Journal of Scientific Research and Reports, V3, P953, DOI 10.9734/JSRR/2014/8242; Hong SB, 2006, INT J SYST EVOL MICR, V56, P477, DOI 10.1099/ijs.0.63980-0; Hong SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063769; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Jurjevic Z, 2012, IMA FUNGUS, V3, P159, DOI 10.5598/imafungus.2012.03.02.08; Klitgaard A, 2014, ANAL BIOANAL CHEM, V406, P1933, DOI 10.1007/s00216-013-7582-x; Lamboni Y, 2016, LWT-FOOD SCI TECHNOL, V70, P71, DOI 10.1016/j.lwt.2016.02.017; Larsen TO, 2005, NAT PROD REP, V22, P672, DOI 10.1039/b404943h; Lund B.M., 2000, MICROBIOLOGICAL SAFE; Mansson M, 2010, J AGR FOOD CHEM, V58, P949, DOI 10.1021/jf902834g; Marin S, 2008, FOOD MICROBIOL, V25, P683, DOI 10.1016/j.fm.2008.03.006; Massi FP, 2016, INT J FOOD MICROBIOL, V221, P19, DOI 10.1016/j.ijfoodmicro.2016.01.010; Medina A, 2005, APPL ENVIRON MICROB, V71, P4696, DOI 10.1128/AEM.71.8.4696-4702.2005; Mogensen JM, 2010, J AGR FOOD CHEM, V58, P954, DOI 10.1021/jf903116q; Molyneux RJ, 2007, INT J FOOD MICROBIOL, V119, P72, DOI 10.1016/j.ijfoodmicro.2007.07.028; MOSSERAY RAOUL, 1934, CELLULE, V43, P203; Nielsen KF, 2009, ANAL BIOANAL CHEM, V395, P1225, DOI 10.1007/s00216-009-3081-5; Noonim P, 2009, FOOD ADDIT CONTAM A, V26, P94, DOI 10.1080/02652030802366090; Noonim P, 2008, INT J SYST EVOL MICR, V58, P1727, DOI 10.1099/ijs.0.65694-0; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Oliveri C, 2008, INT J FOOD MICROBIOL, V127, P147, DOI 10.1016/j.ijfoodmicro.2008.06.021; Parenicova L, 2001, APPL ENVIRON MICROB, V67, P521, DOI 10.1128/AEM.67.2.521-527.2001; Perrone G, 2006, APPL ENVIRON MICROB, V72, P680, DOI 10.1128/AEM.72.1.680-685.2006; RAPER KENNETH B., 1965; Samson RA, 2014, STUD MYCOL, P141, DOI 10.1016/j.simyco.2014.07.004; Samson RA, 2004, STUD MYCOL, P45; Samson RA, 2000, INTRO FOOD AIRBORNE; Schuster E, 2002, APPL MICROBIOL BIOT, V59, P426, DOI 10.1007/s00253-002-1032-6; Skrbic B, 2014, J FOOD COMPOS ANAL, V34, P171, DOI 10.1016/j.jfca.2014.03.002; Storari M, 2012, FOOD ADDIT CONTAM A, V29, P1450, DOI 10.1080/19440049.2012.698656; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; USDA (United States Department of Agriculture), 2015, 12087 USDA; Vaamonde G, 2003, INT J FOOD MICROBIOL, V88, P79, DOI 10.1016/S0168-1605(03)00101-6; Varga J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.69.01; Varga J, 2010, INT J FOOD MICROBIOL, V143, P143, DOI 10.1016/j.ijfoodmicro.2010.08.008; VARGA J, 2000, INTEGRATION MODERN T, P397; Varoglu M, 1997, J ORG CHEM, V62, P7078, DOI 10.1021/jo970568z; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140069	57	21	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164310	10.1371/journal.pone.0164310	http://dx.doi.org/10.1371/journal.pone.0164310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768708	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400008
J	Lee, SH; Kang, EM; Kim, GA; Kwak, SW; Kim, JM; Bae, HW; Seong, GJ; Kim, CY				Lee, Si Hyung; Kang, Eun Min; Kim, Gyu Ah; Kwak, Seung Woo; Kim, Joon Mo; Bae, Hyoung Won; Seong, Gong Je; Kim, Chan Yun			Three Toxic Heavy Metals in Open-Angle Glaucoma with Low-Teen and High-Teen Intraocular Pressure: A Cross-Sectional Study from South Korea	PLOS ONE			English	Article							NATIONAL-HEALTH; BLOOD CADMIUM; PSEUDOEXFOLIATION SYNDROME; OPTIC-NERVE; ASSOCIATION; HYPERTENSION; EXPOSURE; METHYLMERCURY; PREVALENCE; ELEMENTS	Background To investigate the association between heavy metal levels and open-angle glaucoma (OAG) with low- and high-teen baseline intraocular pressure (IOP) using a population-based study design. Methods This cross-sectional study included 5,198 participants older than 19 years of age who participated in the Korean National Health and Nutrition Examination Survey (KNHANES) from 2008 to 2012 and had blood heavy metal levels available. The OAG with normal baseline IOP (IOP <= 21 mmHg) subjects were stratified into low-teen OAG (baseline IOP <= 15 mmHg) and high-teen OAG (15 mmHg < baseline IOP <= 21 mmHg), and the association between blood lead, mercury, and cadmium levels and glaucoma prevalence was assessed for low- and high-teen OAG. Results The adjusted geometric mean of blood cadmium levels was significantly higher in subjects with low- teen OAG than that of the non-glaucomatous group (P = 0.028), whereas there were no significant differences in blood lead and mercury levels. After adjusting for potential confounders, the low-teen OAG was positively associated with log-transformed blood cadmium levels (OR, 1.41; 95% confidence interval (CI), 1.03-1.93; P = 0.026). For high-teen OAG, log-transformed blood levels of the three heavy metals were not associated with disease prevalence. The association between log-transformed blood cadmium levels and low-teen OAG was significant only in men (OR, 1.65; 95% CI, 1.10-2.48; P = 0.016), and not in women (OR, 1.10; 95% CI, 0.66-1.85; P = 0.709). Conclusions The results of this study suggest that cadmium toxicity could play a role in glaucoma pathogenesis, particularly in men and in OAG with low-teen baseline IOP.	[Lee, Si Hyung; Kang, Eun Min; Kim, Gyu Ah; Bae, Hyoung Won; Seong, Gong Je; Kim, Chan Yun] Yonsei Univ, Coll Med, Severance Hosp, Inst Vis Res,Dept Ophthalmol, Seoul, South Korea; [Lee, Si Hyung] Eulji Univ Hosp, Dept Ophthalmol, Daejeon, South Korea; [Kwak, Seung Woo] Univ Georgia, Dept Stat, Athens, GA 30602 USA; [Kim, Joon Mo] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Ophthalmol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Eulji University; University System of Georgia; University of Georgia; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, CY (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Inst Vis Res,Dept Ophthalmol, Seoul, South Korea.	kcyeye@yuhs.ac		Kim, Chan Yun/0000-0002-8373-9999; Bae, Hyoung Won/0000-0002-8421-5636; Seong, Gong Je/0000-0002-5456-4296	World Class 300 Project of the SMBA, Republic of Korea [10031270]	World Class 300 Project of the SMBA, Republic of Korea(Small & Medium Business Administration (SMBA), Republic of Korea)	This work was supported by the World Class 300 Project (10031270) of the SMBA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the World Class 300 Project (10031270) of the SMBA, Republic of Korea. The sponsor or funding organization had no role in the design or conduct of this research.	Alissa EM, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/870125; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Ceylan OM, 2013, BIOL TRACE ELEM RES, V153, P28, DOI 10.1007/s12011-013-9644-5; Chen X, 2015, ENVIRON TOXICOL PHAR, V39, P208, DOI 10.1016/j.etap.2014.11.026; Chin-Chan M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00124; da Costa GM, 2008, ENVIRON RES, V107, P98, DOI [10.1016/j.envres.2007.08.004, 10.1016/j.envres.2007.10.007]; Demir N, 2003, INT J NEUROSCI, V113, P323, DOI 10.1080/00207450390162128; Ekinci M, 2014, CURR EYE RES, V39, P853, DOI 10.3109/02713683.2013.877934; Everett CJ, 2008, ENVIRON RES, V106, P284, DOI 10.1016/j.envres.2007.10.009; Feng W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123742; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Kalariya NM, 2010, TOXICOL LETT, V198, P56, DOI 10.1016/j.toxlet.2010.04.021; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kim DM, 2007, J GLAUCOMA, V16, P293, DOI 10.1097/IJG.0b013e31803bda3d; Kim EC, 2014, INVEST OPHTH VIS SCI, V55, P5702, DOI 10.1167/iovs.14-14774; Kim Jee Hyun, 2014, Korean J Ophthalmol, V28, P473, DOI 10.3341/kjo.2014.28.6.473; Korbas M, 2013, ACS CHEM BIOL, V8, P2256, DOI 10.1021/cb4004805; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee BK, 2014, SAF HEALTH WORK, V5, P113, DOI 10.1016/j.shaw.2014.06.005; Lee BK, 2013, AM J IND MED, V56, P682, DOI 10.1002/ajim.22107; Lee BK, 2012, AM J IND MED, V55, P1060, DOI 10.1002/ajim.22078; Lee J, 2014, J GLAUCOMA, V23, P553, DOI 10.1097/IJG.0b013e31829484c6; Lee SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148412; Lin SC, 2015, JAMA OPHTHALMOL, V133, P1144, DOI 10.1001/jamaophthalmol.2015.2438; Mela M, 2010, NEUROTOXICOLOGY, V31, P448, DOI 10.1016/j.neuro.2010.04.009; Messner B, 2009, ARTERIOSCL THROM VAS, V29, P1392, DOI 10.1161/ATVBAHA.109.190082; Mosad SM, 2010, CURR EYE RES, V35, P23, DOI 10.3109/02713680903362880; Myong JP, 2012, INT ARCH OCC ENV HEA, V85, P885, DOI 10.1007/s00420-012-0737-9; Neal RE, 2010, MOL VIS, V16, P2137; Nordberg GF, 2007, HDB TOXICOLOGY METAL, P445; Oh CM, 2014, ENVIRON RES, V132, P119, DOI 10.1016/j.envres.2014.04.008; Panteli VS, 2009, BIOL TRACE ELEM RES, V132, P9, DOI 10.1007/s12011-009-8380-3; Park SJ, 2015, OPHTHALMOLOGY, V122, P129, DOI 10.1016/j.ophtha.2014.07.039; Prozialeck WC, 2008, TOXICOL SCI, V102, P207, DOI 10.1093/toxsci/kfm263; Prozialeck WC, 2006, LIFE SCI, V79, P1493, DOI 10.1016/j.lfs.2006.05.007; Rai NK, 2013, TOXICOL APPL PHARM, V273, P242, DOI 10.1016/j.taap.2013.05.003; Rana SVS, 2014, BIOL TRACE ELEM RES, V160, P1, DOI 10.1007/s12011-014-0023-7; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rhee SY, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-9; Saint-Amour D, 2006, NEUROTOXICOLOGY, V27, P567, DOI 10.1016/j.neuro.2006.02.008; Sangartit W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114908; Seo JH, 2012, OPHTHALMOLOGY, V119, P2254, DOI 10.1016/j.ophtha.2012.06.007; Tellez-Plaza M, 2008, ENVIRON HEALTH PERSP, V116, P51, DOI 10.1289/ehp.10764; Tellez-Plaza M, 2010, AM J EPIDEMIOL, V172, P671, DOI 10.1093/aje/kwq172; Vahter M, 2002, ENVIRON RES, V88, P145, DOI 10.1006/enrs.2002.4338; YAMAGAMI J, 1990, Nippon Ganka Gakkai Zasshi, V94, P514; Yamamoto S, 2014, OPHTHALMOLOGY, V121, P1558, DOI 10.1016/j.ophtha.2014.03.003; Yildirim Z, 2007, ANN NY ACAD SCI, V1100, P207, DOI 10.1196/annals.1395.020; Yuki K, 2009, BIOL TRACE ELEM RES, V132, P1, DOI 10.1007/s12011-009-8376-z	50	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164983	10.1371/journal.pone.0164983	http://dx.doi.org/10.1371/journal.pone.0164983			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768724	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400041
J	Brown, AJ; Deutschman, DH; Braswell, J; McLaughlin, D				Brown, Alissa J.; Deutschman, Douglas H.; Braswell, Jessica; McLaughlin, Dana			Remote Cameras Reveal Experimental Artifact in a Study of Seed Predation in a Semi-Arid Shrubland	PLOS ONE			English	Article							SMALL MAMMALS; GRANIVORY; RODENTS; SIZE; DISPERSAL; REMOVAL; QUALITY; INSECTS; ECOLOGY; DESERT	Granivorous animals may prefer to predate or cache seed of certain plant species over others. Multiple studies have documented preference for larger, non-native seed by granivores. To accomplish this, researchers have traditionally used indirect inference by relating patterns of seed removal to the species composition of the granivorous animal community. To measure seed removal, researchers present seed to granivorous animals in the field using equipment intended to exclude certain animal taxa while permitting access to others. This approach allows researchers to differentiate patterns of seed removal among various taxa (e.g., birds, small mammals, and insects); however, it is unclear whether the animals of interest are freely using the exclusion devices, which may be a hindrance to discovering the seed dishes. We used video observation to perform a study of seed predation using a custom-built, infrared digital camera and recording system. We presented native and non-native seed mixtures in partitioned Petri dishes both within and outside of exclusion cages. The exclusion cages were intended to allow entrance by rodent taxa while preventing entrance by rabbits and birds. We documented all seed removal visits by granivorous animals, which we identified to the genus level. Genera exhibited varying seed removal patterns based on seed type (native vs. non-native) and dish type (open vs. enclosed). We documented avoidance of the enclosed dishes by all but one rodent taxa, even though these dishes were intended to be used freely by rodents. This suggests that preference for non-native seed occurs differentially among granivorous animals in this system; however, interpretation of these nuanced results would be difficult without the benefit of video observation. When feasible, video observation should accompany studies using in situ equipment to ensure incorrect assumptions do not lead to inappropriate interpretation of results.	[Brown, Alissa J.; Deutschman, Douglas H.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Braswell, Jessica] Queens Univ Charlotte, Dept Environm Sci, Charlotte, NC USA; [McLaughlin, Dana] SoCal Biol Consulting, Chula Vista, CA USA; [Brown, Alissa J.] Univ North Carolina Chapel Hill, Chapel Hill, NC 27514 USA	California State University System; San Diego State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Brown, AJ (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.; Brown, AJ (corresponding author), Univ North Carolina Chapel Hill, Chapel Hill, NC 27514 USA.	alissab@live.unc.edu		Brown, Alissa/0000-0002-1511-8496	San Diego State University; SoCal Biological Consulting	San Diego State University; SoCal Biological Consulting	San Diego State University: http://www.sdsu.edu/ (DHD); the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DM is affiliated to SoCal Biological Consulting. SoCal Biological Consulting provided support in the form of salary for author DM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alba-Lynn C, 2010, PLANT ECOL, V210, P291, DOI 10.1007/s11258-010-9757-2; Anderson CJ, 2001, J ARID ENVIRON, V49, P343, DOI 10.1006/jare.2000.0781; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beard KH, 2013, WEST N AM NATURALIST, V73, P426, DOI 10.3398/064.073.0415; Blackham GV, 2015, SCI REP-UK, V5, DOI 10.1038/srep14152; Braswell J., 2007, THESIS; Brock RE, 2004, BIOL CONSERV, V116, P131, DOI 10.1016/S0006-3207(03)00184-8; BROWN JH, 1975, ECOLOGY, V56, P987, DOI 10.2307/1936310; BROWN JH, 1990, SCIENCE, V250, P1705, DOI 10.1126/science.250.4988.1705; California Department of Fish and Wildlife, 2014, RANCH JAM EC RES RES; California Department of Forestry and Fire Protection, 2003, OT FIR INC INF; California Department of Forestry and Fire Protection, 2007, HARR FIR INC INF; Connolly BM, 2014, ECOLOGY, V95, P1759, DOI 10.1890/13-1774.1; Davis MK, 2015, J ARID ENVIRON, V116, P103, DOI 10.1016/j.jaridenv.2015.01.018; Folgarait PJ, 2002, ECOGRAPHY, V25, P417, DOI 10.1034/j.1600-0587.2002.250404.x; Jongejans E, 2015, ECOL RES, V30, P173, DOI 10.1007/s11284-014-1224-4; Kelt DA, 2004, ECOLOGY, V85, P383, DOI 10.1890/02-4065; Kelt DA, 2004, OIKOS, V104, P133, DOI 10.1111/j.0030-1299.2004.12714.x; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lobo N, 2013, J MAMMAL, V94, P1449, DOI 10.1644/12-MAMM-A-295.1; Munoz A, 2008, ANIM BEHAV, V76, P709, DOI 10.1016/j.anbehav.2008.03.017; Nopp-Mayr U, 2012, OIKOS, V121, P337, DOI 10.1111/j.1600-0706.2011.19099.x; Orrock JL, 2008, ECOLOGY, V89, P1168, DOI 10.1890/07-0223.1; Pearson DE, 2011, ECOLOGY, V92, P1748, DOI 10.1890/11-0164.1; Perea R, 2011, ANIM BEHAV, V82, P717, DOI 10.1016/j.anbehav.2011.07.001; Pinheiro J, 2020, R PACKAGE VERSION 31; Price M.V., 1986, P191; R Core Team, 2021, R LANGUAGE ENV STAT; Sidhu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134658; Souza L, 2016, OIKOS, V125, P566, DOI 10.1111/oik.02579; Sunyer P, 2013, FUNCT ECOL, V27, P1313, DOI 10.1111/1365-2435.12143; Valone TJ, 2007, ECOLOGY, V88, P26, DOI 10.1890/0012-9658(2007)88[26:RRBDPP]2.0.CO;2; Warzecha B, 2014, PLANT ECOL, V215, P1313, DOI 10.1007/s11258-014-0389-9; Xiao ZS, 2005, ACTA OECOL, V28, P221, DOI 10.1016/j.actao.2005.04.006; Zhang HM, 2015, WILDLIFE RES, V42, P149, DOI 10.1071/WR14211	35	4	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							0165024	10.1371/journal.pone.0165024	http://dx.doi.org/10.1371/journal.pone.0165024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764200	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500104
J	Kamata, R; Bumdelger, B; Kokubo, H; Fujii, M; Yoshimura, K; Ishida, T; Ishida, M; Yoshizumi, M				Kamata, Ryo; Bumdelger, Batmunkh; Kokubo, Hiroki; Fujii, Masayuki; Yoshimura, Koichi; Ishida, Takafumi; Ishida, Mari; Yoshizumi, Masao			EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; SMOOTH-MUSCLE-CELLS; MATRIX METALLOPROTEINASES; ARTERIAL CALCIFICATION; OSTEOPROTEGERIN; MICE; MATRIX-METALLOPROTEINASE-9; INFLAMMATION; INHIBITION; EXPRESSION	Abdominal aortic aneurysms (AAAs), which commonly occur among elderly individuals, are accompanied by a risk of rupture with a high mortality rate. Although eicosapentaenoic acid (EPA) has been reported to prevent AAA formation, the mechanism by which EPA works on vascular smooth muscle cells is unknown. This study aimed to investigate the mechanism by which orally-administered EPA prevents the formation of severe AAAs that develop in Osteoprotegerin (Opg) knockout ( KO) mice. In the CaCl2-induced AAA model, EPA attenuated the enhanced progression of AAAs in Opg-KO mice, including the increase in aortic diameter with destruction of elastic fibers in the media. Immunohistochemical analyses showed that EPA reduced the phosphorylation of transforming growth factor beta-activated kinase-1/Map3k7 (Tak-1) and c-Jun NH2-terminal kinase (JNK), as well as the expression of Matrix metalloproteinase-9 (Mmp-9) in the media of the aorta. In smooth muscle cell cultures, rh-TRAIL-induced activation of the Tak-1-JNK pathway and increase in Mmp-9 expression were inhibited by EPA. Moreover, GW9508, a specific ligand for Gprotein coupled receptor (Gpr)-120/Free fatty acid receptor (Ffar)-4, mimicked the effects of EPA. The effects of EPA were abrogated by knockdown of the Gpr-120/Ffar-4 receptor gene. Our data demonstrate that the Trail-Tak-1-JNK-Mmp-9 pathway is responsible for the enhancement of AAAs in Opg-KO mice, and that EPA inhibits the Tak-1-JNK pathway by activating Gpr-120/Ffar-4, which results in the attenuation of AAA development.	[Kamata, Ryo; Bumdelger, Batmunkh; Kokubo, Hiroki; Fujii, Masayuki; Ishida, Mari; Yoshizumi, Masao] Hiroshima Univ, Dept Cardiovasc Physiol & Med, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Yoshimura, Koichi] Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Ube, Yamaguchi, Japan; [Ishida, Takafumi] Fukushima Med Univ, Dept Cardiovasc Med, Fukushima, Japan	Hiroshima University; Yamaguchi University; Fukushima Medical University	Yoshizumi, M (corresponding author), Hiroshima Univ, Dept Cardiovasc Physiol & Med, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	yoshizum-tky@umin.ac.jp	Ishida, Mari/L-8208-2016	Kamata, Ryo/0000-0001-6970-9657	Japanese Ministry of Education, Culture, Sports, Science, and Technology [25461130]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology 25461130.	Ailawadi G, 2003, J VASC SURG, V38, P584, DOI 10.1016/S0741-5214(03)00324-0; Bennett BJ, 2006, ARTERIOSCL THROM VAS, V26, P2117, DOI 10.1161/01.ATV.0000236428.91125.e6; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Bumdelger B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147088; Bumdelger Batmunkh, 2013, Hiroshima Journal of Medical Sciences, V62, P63; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Elmore JR, 1998, ANN VASC SURG, V12, P221, DOI 10.1007/s100169900144; Eskandari MK, 2005, J SURG RES, V123, P289, DOI 10.1016/j.jss.2004.07.247; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Kagoya Y, 2014, J CLIN INVEST, V124, P528, DOI 10.1172/JCI68101; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Lee JH, 2008, MAYO CLIN PROC, V83, P324, DOI 10.4065/83.3.324; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Orita Y, 2007, ARTERIOSCL THROM VAS, V27, P2058, DOI 10.1161/ATVBAHA.107.147868; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; TRAVO P, 1980, BLOOD VESSELS, V17, P110; Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; Wang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096286; Yamashita A, 2001, WORLD J SURG, V25, P259, DOI 10.1007/s002680020062; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Yoshihara T, 2015, CIRC J, V79, P1470, DOI 10.1253/circj.CJ-14-0471; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335	24	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165132	10.1371/journal.pone.0165132	http://dx.doi.org/10.1371/journal.pone.0165132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764222	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500122
J	Quinet, C; Czaplicki, G; Dion, E; Dal Pozzo, F; Kurz, A; Saegerman, C				Quinet, Christian; Czaplicki, Guy; Dion, Elise; Dal Pozzo, Fabiana; Kurz, Anke; Saegerman, Claude			First Results in the Use of Bovine Ear Notch Tag for Bovine Viral Diarrhoea Virus Detection and Genetic Analysis	PLOS ONE			English	Article							BVDV; DIAGNOSIS	Background Infection due to bovine viral diarrhoea virus (BVDV) is endemic in most cattle-producing countries throughout the world. The key elements of a BVDV control programme are biosecurity, elimination of persistently infected animals and surveillance. Bovine viral diarrhoea (BVD) is a notifiable disease in Belgium and an official eradication programme started from January 2015, based on testing ear notches sampled during the official identification and registration of calves at birth. An antigen-capture ELISA test based on the detection of BVDV Erns protein is used. Ear notch sample may also be used to characterize the genotype of the calf when appropriate elution/dilution buffer is added. Both BVDV antigen-ELISA analysis and animal traceability could be performed. Methodology With regards to the reference protocol used in the preparation of ear notch samples, alternative procedures were tested in terms of BVDV analytic sensitivity, diagnostic sensitivity and specificity, as well as quality and purity of animal DNA. Principal Findings/Significance The Allflex DNA Buffer D showed promising results in BVDV diagnosis and genome analyses, opening new perspectives for the livestock industry by the exploitation of the animal genome. Due to the high number of cattle involved in the Belgian official BVDV eradication programme based on ear notch tags sample, a large database on both BVDV status of newborn calves and cattle genome could be created for subsequent different uses (e.g. traceability, determination of parentage, genetic signatures throughout the genome associated with particular traits) evolving through a more integrated animal health.	[Quinet, Christian; Czaplicki, Guy; Dion, Elise] Arsia, Dept Hlth, Ciney, Belgium; [Kurz, Anke] IFN Schonow GmbH, Bernau, Germany; [Dal Pozzo, Fabiana; Saegerman, Claude] Univ Liege, Fac Vet Med, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREAR, FARAH, Liege, Belgium	University of Liege	Quinet, C (corresponding author), Arsia, Dept Hlth, Ciney, Belgium.	christian.quinet@arsia.be		Saegerman, Claude/0000-0001-9087-7436	IFN Schonow GmbH	IFN Schonow GmbH	The author(s) received no specific funding for this work. IFN Schonow GmbH provided support in the form of salaries, analysis costs and the preparation of a report of results for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Allen A, 2008, LIVEST SCI, V116, P42, DOI 10.1016/j.livsci.2007.08.018; Cornish TE, 2005, J VET DIAGN INVEST, V17, P110, DOI 10.1177/104063870501700203; DAGNELIE P, 1998, INTERFERENCE STAT 2, P421; Fux R, 2012, VET MICROBIOL, V161, P13, DOI 10.1016/j.vetmic.2012.07.001; Harlizius B, 2011, J ANIM SCI, V89, P1661, DOI 10.2527/jas.2010-3347; Howard C J, 1990, Rev Sci Tech, V9, P95; Howell DC, 1998, METHODES STAT SCI HU; Jimenez Gamero I, 2006, SMALL RUMINANT RES, V65, P266; Lanyon SR, 2014, VET J, V199, P201, DOI 10.1016/j.tvjl.2013.07.024; Laureyns J., 2014, THESIS, P192; Lindberg A, 2006, REV SCI TECH OIE, V25, P961, DOI 10.20506/rst.25.3.1703; Lindberg A, 2005, PREV VET MED, V72, P55, DOI 10.1016/j.prevetmed.2005.07.018; McParland S., 2012, ICBF TEAG GEN C KILL; Minister for Agriculture Food and the Marine, 2015, BEEF DAT GEN PROGR B, P6; Minister for Agriculture Food and the Marine, 2014, TERMS COND 2014 FEEF, P11; Oettl J, 2010, VET MED AUSTRIA, V97, P203; Peterhans E, 2010, VET RES, V41, DOI 10.1051/vetres/2010016; Petrie A., 2006, STAT VET ANIMAL SCI, P299; Presi P, 2010, VET MICROBIOL, V142, P137, DOI 10.1016/j.vetmic.2009.09.054; Ridpath JF, 2003, BIOLOGICALS, V31, P127, DOI 10.1016/S1045-1056(03)00028-9; Sarrazin S, 2015, THESIS, P253; Sarrazin S, 2013, PREV VET MED, V108, P28, DOI 10.1016/j.prevetmed.2012.07.005; Wilkinson S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-45	23	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164451	10.1371/journal.pone.0164451	http://dx.doi.org/10.1371/journal.pone.0164451			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764130	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500035
J	Torres, VBL; Vassalo, J; Silva, UVA; Caruso, P; Torelly, AP; Silva, E; Teles, JMM; Knibel, M; Rezende, E; Netto, JJS; Piras, C; Azevedo, LCP; Bozza, FA; Spector, N; Salluh, JIF; Soares, M				Torres, Viviane B. L.; Vassalo, Juliana; Silva, Ulysses V. A.; Caruso, Pedro; Torelly, Andre P.; Silva, Eliezer; Teles, Jose M. M.; Knibel, Marcos; Rezende, Ederlon; Netto, Jose J. S.; Piras, Claudio; Azevedo, Luciano C. P.; Bozza, Fernando A.; Spector, Nelson; Salluh, Jorge I. F.; Soares, Marcio			Outcomes in Critically Ill Patients with Cancer-Related Complications	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ACUTE RESPIRATORY-FAILURE; LONG-TERM SURVIVAL; VENTILATORY SUPPORT; EMERGENCY-SURGERY; LUNG-CANCER; PROGNOSIS; ADMISSION; SEPSIS; PERFORATION	Introduction Cancer patients are at risk for severe complications related to the underlying malignancy or its treatment and, therefore, usually require admission to intensive care units (ICU). Here, we evaluated the clinical characteristics and outcomes in this subgroup of patients. Materials and Methods Secondary analysis of two prospective cohorts of cancer patients admitted to ICUs. We used multivariable logistic regression to identify variables associated with hospital mortality. Results Out of 2,028 patients, 456 (23%) had cancer-related complications. Compared to those without cancer-related complications, they more frequently had worse performance status (PS) (57% vs 36% with PS >= 2), active malignancy (95% vs 58%), need for vasopressors (45% vs 34%), mechanical ventilation (70% vs 51%) and dialysis (12% vs 8%) (P<0.001 for all analyses). ICU (47% vs. 27%) and hospital (63% vs. 38%) mortality rates were also higher in patients with cancer-related complications (P<0.001). Chemo/radiation therapyinduced toxicity (6%), venous thromboembolism (5%), respiratory failure (4%), gastrointestinal involvement (3%) and vena cava syndrome (VCS) (2%) were the most frequent cancer-related complications. In multivariable analysis, the presence of cancer-related complications per se was not associated with mortality [odds ratio (OR) = 1.25 (95% confidence interval, 0.94-1.66), P = 0.131]. However, among the individual cancer-related complications, VCS [OR = 3.79 (1.11-12.92), P = 0.033], gastrointestinal involvement [OR = 3.05 (1.57-5.91), P = <0.001] and respiratory failure [OR = 1.96(1.04-3.71), P = 0.038] were independently associated with in-hospital mortality. Conclusions The prognostic impact of cancer-related complications was variable. Although some complications were associated with worse outcomes, the presence of an acute cancer-related complication per se should not guide decisions to admit a patient to ICU.	[Torres, Viviane B. L.; Vassalo, Juliana; Spector, Nelson; Salluh, Jorge I. F.; Soares, Marcio] Univ Fed Rio de Janeiro, Sch Med, Postgrad Program Internal Med, Rio De Janeiro, RJ, Brazil; [Silva, Ulysses V. A.] Hosp Canc Barretos, Fundacao Pio 12, ICU, Barretos, Brazil; [Caruso, Pedro] AC Camargo Canc Ctr, ICU, Sao Paulo, Brazil; [Torelly, Andre P.] Irmandade Santa Casa Misericordia Porto Alegre, RIPIMI, Porto Alegre, RS, Brazil; [Silva, Eliezer] Hosp Israelita Albert Einstein, ICU, Sao Paulo, Brazil; [Teles, Jose M. M.] Hosp Portugues, ICU, Salvador, BA, Brazil; [Knibel, Marcos] Hosp Sao Lucas, Travessa Frederico Pamplona 32, Rio De Janeiro, Brazil; [Rezende, Ederlon] Hosp Servidor Publ Estadual, ICU, Sao Paulo, Brazil; [Netto, Jose J. S.] Hosp Canc II, Inst Nacl Canc, ICU, Rio De Janeiro, Brazil; [Piras, Claudio] Vitoria Apart Hosp, ICU, Vitoria, Brazil; [Azevedo, Luciano C. P.] Hosp Sirio Libanes, Res & Educ Inst, Sao Paulo, Brazil; [Bozza, Fernando A.; Salluh, Jorge I. F.; Soares, Marcio] DOr Inst Res & Educ, IDOR, Rio De Janeiro, Brazil; [Bozza, Fernando A.] Oswaldo Cruz Fdn FIOCRUZ, Natl Inst Infect Dis Evandro Chagas, Rio De Janeiro, Brazil; [Salluh, Jorge I. F.; Soares, Marcio] Inst Nacl Canc, Postgrad Program, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Hospital de Cancer de Barretos; A.C.Camargo Cancer Center; Hospital Israelita Albert Einstein; Instituto de Assistencia Medica ao Servidor Publico Estadual (IAMSPE); National Cancer Institute (Inca); Hospital Sirio Libanes; IDOR - Instituto D'Or de Ensino e Pesquisa; Fundacao Oswaldo Cruz; National Cancer Institute (Inca)	Soares, M (corresponding author), Univ Fed Rio de Janeiro, Sch Med, Postgrad Program Internal Med, Rio De Janeiro, RJ, Brazil.; Soares, M (corresponding author), DOr Inst Res & Educ, IDOR, Rio De Janeiro, Brazil.; Soares, M (corresponding author), Inst Nacl Canc, Postgrad Program, Rio De Janeiro, Brazil.	marciosoaresms@gmail.com	Bozza, Fernando A/A-2618-2013; Caruso, Pedro/AAY-8176-2021; dantas, vicente c souza/L-2648-2013; Salluh, Jorge/AAF-2682-2021; V.A.Silva, Ulysses/AAZ-3336-2020; Soares, Marcio/B-3083-2013; Azevedo, Luciano CP/H-2652-2012	Bozza, Fernando A/0000-0003-4878-0256; Salluh, Jorge/0000-0002-8164-1453; V.A.Silva, Ulysses/0000-0002-1284-2016; Soares, Marcio/0000-0003-2503-6088; Azevedo, Luciano CP/0000-0001-6759-3910	Institute National de Cancer; Brazilian Research in Intensive Care Network (BRICNet); National Council for Scientific and Technological Development of Brazil (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Institute National de Cancer; Brazilian Research in Intensive Care Network (BRICNet); National Council for Scientific and Technological Development of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported in part by Institute National de Cancer and sponsored by the Brazilian Research in Intensive Care Network (BRICNet). MS, FAB and JIFS are supported in part by individual research grants from National Council for Scientific and Technological Development of Brazil (CNPq) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funding institutions had no active role in the design, analysis and interpretation of the results or publication process.	Abdelrazeq AS, 2008, COLORECTAL DIS, V10, P775, DOI 10.1111/j.1463-1318.2007.01412.x; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Azevedo LCP, 2014, CHEST, V146, P257, DOI 10.1378/chest.13-1870; Azoulay E, 2004, MEDICINE, V83, P360, DOI 10.1097/01.md.0000145370.63676.fb; Azoulay E, 2003, AM J RESP CRIT CARE, V167, P1329, DOI 10.1164/rccm.200206-554OC; Azoulay E, 2013, J CLIN ONCOL, V31, P2810, DOI 10.1200/JCO.2012.47.2365; Azoulay E, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-5; Azoulay E, 2010, AM J RESP CRIT CARE, V182, P1038, DOI 10.1164/rccm.201001-0018OC; Baldwin KJ, 2012, NEUROL CLIN, V30, P101, DOI 10.1016/j.ncl.2011.09.004; Banaszkiewicz Z, 2014, WSPOLCZESNA ONKOL, V18, P414, DOI 10.5114/wo.2014.46362; Benoit DD, 2003, CRIT CARE MED, V31, P104, DOI 10.1097/00003246-200301000-00017; Benoit DD, 2014, INTENS CARE MED, V40, P1576, DOI 10.1007/s00134-014-3480-8; Brenner H, 2002, LANCET, V360, P1131, DOI 10.1016/S0140-6736(02)11199-8; Cairo MS, 2004, BRIT J HAEMATOL, V127, P3, DOI 10.1111/j.1365-2141.2004.05094.x; Caruso P, 2010, EUR J CANCER CARE, V19, P260, DOI 10.1111/j.1365-2354.2008.01031.x; Clines GA, 2005, ENDOCR-RELAT CANCER, V12, P549, DOI 10.1677/erc.1.00543; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kallogjeri D, 2012, J GERIATR ONCOL, V3, P238, DOI 10.1016/j.jgo.2012.01.006; Kasakura Y, 2002, J SURG ONCOL, V80, P181, DOI 10.1002/jso.10127; Katabathina VS, 2013, RADIOGRAPHICS, V33, P1533, DOI 10.1148/rg.336135508; Khan UA, 2014, EMERG MED CLIN N AM, V32, P495, DOI 10.1016/j.emc.2014.04.001; Khorana AA, 2009, J CLIN ONCOL, V27, P4839, DOI 10.1200/JCO.2009.22.3271; KIM HJ, 1993, AM J ROENTGENOL, V161, P539, DOI 10.2214/ajr.161.3.8352099; Lecuyer L, 2007, CRIT CARE MED, V35, P808, DOI 10.1097/01.CCM.0000256846.27192.7A; Lee HJ, 2006, DIGEST SURG, V23, P217, DOI 10.1159/000094753; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; McCurdy MT, 2012, CRIT CARE MED, V40, P2212, DOI 10.1097/CCM.0b013e31824e1865; Mokart D, 2015, INTENS CARE MED, V41, P296, DOI 10.1007/s00134-014-3615-y; Mokart D, 2013, LEUKEMIA LYMPHOMA, V54, P1724, DOI 10.3109/10428194.2012.753446; Nam HS, 2014, TUBERC RESPIR DIS, V76, P211, DOI 10.4046/trd.2014.76.5.211; Puxty K, 2014, INTENS CARE MED, V40, P1409, DOI 10.1007/s00134-014-3471-9; Reignier J, 2008, CRIT CARE MED, V36, P2076, DOI 10.1097/CCM.0b013e31817c0ea7; Rosolem MM, 2012, J CRIT CARE, V27, P301, DOI 10.1016/j.jcrc.2011.06.014; Shen HN, 2009, AM J CLIN ONCOL-CANC, V32, P467, DOI 10.1097/COC.0b013e3181931236; Soares M, 2005, CRIT CARE MED, V33, P520, DOI 10.1097/01.ccm.0000155783.46747.04; Soares M, 2014, ANN ONCOL, V25, P1829, DOI 10.1093/annonc/mdu234; Soares M, 2007, CHEST, V131, P840, DOI 10.1378/chest.06-2244; Soares M, 2006, J CLIN ONCOL, V24, P4003, DOI 10.1200/JCO.2006.05.7869; Soares M, 2013, LANCET ONCOL, V14, pE337, DOI 10.1016/S1470-2045(13)70269-9; Soares M, 2010, CRIT CARE MED, V38, P9, DOI 10.1097/CCM.0b013e3181c0349e; Song JU, 2012, INTENS CARE MED, V38, P1505, DOI 10.1007/s00134-012-2594-0; Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Valade S, 2015, THROMB RES, V135, P610, DOI 10.1016/j.thromres.2015.01.010; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Zubrod C.G., 1960, J CHRON DIS, V11, P7	49	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e016453	10.1371/journal.pone.0164537	http://dx.doi.org/10.1371/journal.pone.0164537			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764143	Green Published, gold			2022-12-26	WOS:000386204500040
J	Zhang, F; Wu, M; Kwoh, CK; Zheng, J				Zhang, Fan; Wu, Min; Kwoh, Chee Keong; Zheng, Jie			Power-Law Modeling of Cancer Cell Fates Driven by Signaling Data to Reveal Drug Effects	PLOS ONE			English	Article							BIOCHEMICAL SYSTEMS-ANALYSIS; OUTPUT PARAMETRIC MODELS; NON-LINEAR SYSTEMS; INDUCED APOPTOSIS; NETWORKS; CYTOKINES; DEATH	Extracellular signals are captured and transmitted by signaling proteins inside a cell. An important type of cellular responses to the signals is the cell fate decision, e.g., apoptosis. However, the underlying mechanisms of cell fate regulation are still unclear, thus comprehensive and detailed kinetic models are not yet available. Alternatively, data-driven models are promising to bridge signaling data with the phenotypic measurements of cell fates. The traditional linear model for data-driven modeling of signaling pathways has its limitations because it assumes that the a cell fate is proportional to the activities of signaling proteins, which is unlikely in the complex biological systems. Therefore, we propose a power-law model to relate the activities of all the measured signaling proteins to the probabilities of cell fates. In our experiments, we compared our nonlinear power-law model with the linear model on three cancer datasets with phosphoproteomics and cell fate measurements, which demonstrated that the nonlinear model has superior performance on cell fates prediction. By in silico simulation of virtual protein knock-down, the proposed model is able to reveal drug effects which can complement traditional approaches such as binding affinity analysis. Moreover, our model is able to capture cell line specific information to distinguish one cell line from another in cell fate prediction. Our results show that the power-law data-driven model is able to perform better in cell fate prediction and provide more insights into the signaling pathways for cancer cell fates than the linear model.	[Zhang, Fan; Kwoh, Chee Keong; Zheng, Jie] Nanyang Technol Univ, Sch Comp Sci & Engn, Biomed Informat Lab, Singapore 639798, Singapore; [Wu, Min] Agcy Sci Technol & Res, Data Analyt Dept, Inst Infocomm Res, Singapore 138632, Singapore; [Zheng, Jie] Nanyang Technol Univ, Complex Inst, Singapore 637723, Singapore; [Zheng, Jie] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Zheng, J (corresponding author), Nanyang Technol Univ, Sch Comp Sci & Engn, Biomed Informat Lab, Singapore 639798, Singapore.; Zheng, J (corresponding author), Nanyang Technol Univ, Complex Inst, Singapore 637723, Singapore.; Zheng, J (corresponding author), Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore.	zhengjie@ntu.edu.sg	Zheng, Jie/C-1356-2011; Zheng, Jie/AAX-1454-2021; Wu, Min/AAB-2446-2022	Zheng, Jie/0000-0001-6774-9786; Wu, Min/0000-0003-0977-3600; Zhang, Fan/0000-0001-8377-0235	MOE AcRF (Academic Research Fund) Tier 2 grant, Ministry of Education, Singapore [ARC39/13, MOE2013-T2-1-079]; Research Scholarship at NTU by Ministry of Education, Singapore; AcRF Tier 2 grant, Ministry of Education, Singapore [ARC39/13, MOE2013-T2-1-079]	MOE AcRF (Academic Research Fund) Tier 2 grant, Ministry of Education, Singapore; Research Scholarship at NTU by Ministry of Education, Singapore; AcRF Tier 2 grant, Ministry of Education, Singapore	This research has been supported by MOE AcRF (Academic Research Fund) Tier 2 grant (ARC39/13, MOE2013-T2-1-079), Ministry of Education, Singapore. FZ is supported by the PhD Research Scholarship at NTU, provided by Ministry of Education, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is based on an earlier work: Data-driven prediction of cancer cell fates with a nonlinear model of signaling pathways, Proceedings of the 5th ACM Conference on Bioinformatics, Computational Biology, and Health Informatics, pages 436-444, ACM New York, NY, USA, 2014, doi: 10.1115/2649387.2649425. This research has been supported by AcRF Tier 2 grant (ARC39/13, MOE2013-T2-1-079), Ministry of Education, Singapore.	Bode H. W., 1945, NETWORK ANAL FEEDBAC; Boeck S, 2013, BRIT J CANCER, V108, P469, DOI 10.1038/bjc.2012.495; Bullinger E, 2005, IEEE DECIS CONTR P, P7994; Callard R, 1999, IMMUNITY, V11, P507, DOI 10.1016/S1074-7613(00)80125-9; Calzone L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000702; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Dunster JL, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004589; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Ekins S, 2007, METH MOL B, V356, P319; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200; Higgins JP, 2002, YALE J BIOL MED, V75, P247; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; KLEIBER MAX, 1932, HILGARDIA, V6, P315; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; LEONTARITIS IJ, 1985, INT J CONTROL, V41, P329, DOI 10.1080/0020718508961130; LEONTARITIS IJ, 1985, INT J CONTROL, V41, P303, DOI 10.1080/0020718508961129; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; LU ET, 1991, ASTROPHYS J, V380, pL89, DOI 10.1086/186180; Mitsos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000591; Newman MEJ, 2004, PARETO DISTRIBUTIONS, V46, P323; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; Prescott TP, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004235; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P370, DOI 10.1016/S0022-5193(69)80027-5; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; TIAN TH, 2014, BMC SYST BIOL S1, V8, DOI DOI 10.1186/1752-; Zanette DH, 2001, PHYSICA A, V295, P1, DOI 10.1016/S0378-4371(01)00046-2; Zhang F, 2015, J BIOINF COMPUT BIOL, V13, DOI 10.1142/S0219720015410024; Zheng J, 2010, BIOINFORMATICS, V26, P141, DOI 10.1093/bioinformatics/btp617	32	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							0165049	10.1371/journal.pone.0165049	http://dx.doi.org/10.1371/journal.pone.0165049			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764199	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204500107
J	Kayipmaz, AE; Ciftci, O; Kavalci, C; Karacaglar, E; Muderrisoglu, H				Kayipmaz, Afsin Emre; Ciftci, Orcun; Kavalci, Cemil; Karacaglar, Emir; Muderrisoglu, Haldun			Demographics, Management Strategies, and Problems in ST-Elevation Myocardial Infarction from the Standpoint of Emergency Medicine Specialists: A Survey-Based Study from Seven Geographical Regions of Turkey	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; BALLOON TIMES; DOOR; THROMBOLYSIS; ANGIOPLASTY; BENEFIT; DELAYS; CARE	Background This study aimed to explore the ST segment elevation myocardial infarction (STEMI) management practices of emergency medicine specialists working in various healthcare institutions of seven different geographical regions of Turkey, and to examine the characteristics of STEMI presentation and patient admissions in these regions. Methods We included 225 emergency medicine specialists working in all geographical regions of Turkey. We e-mailed them a 20-item questionnaire comprising questions related to their STEMI management practices and characteristics of STEMI presentation and patient admissions. Results The regions were not significantly different with respect to primary percutaneous coronary intervention (PCI) resources (p = 0.286). Sixty six point two percent (66.2%) of emergency specialists stated that patients presented to emergency within 2 hours of symptom onset. Forty three point six percent (43.6%) of them contacted cardiology department within 10 minutes and 47.1% within 30 minutes. In addition, 68.3% of the participants improved themselves through various educational activities. The Southeastern Anatolian region had the longest time from symptom onset to emergency department admission and the least favorable hospital admission properties, not originating from physicians or 112 emergency healthcare services. Conclusion Seventy point seven percent (70.7%) of the emergency specialists working in all geographical regions of Turkey comply with the latest guidelines and current knowledge about STEMI care; they also try to improve themselves, and receive adequate support from 112 emergency healthcare services and cardiologists. While inter-regional gaps between the number of primary PCI capable centers and quality of STEMI care progressively narrow, there are still issues to address, such as delayed patient presentation after symptoms onset and difficulties in patient admission.	[Kayipmaz, Afsin Emre; Kavalci, Cemil] Baskent Univ, Fac Med, Dept Emergency, Ankara, Turkey; [Ciftci, Orcun; Karacaglar, Emir; Muderrisoglu, Haldun] Baskent Univ, Fac Med, Dept Cardiol, Ankara, Turkey	Baskent University; Baskent University	Kayipmaz, AE (corresponding author), Baskent Univ, Fac Med, Dept Emergency, Ankara, Turkey.	aekayipmaz@hotmail.com	Karaçağlar, Emir/ABI-6723-2020; , cemil/AGG-1308-2022; Muderrisoglu, Haldun/AAG-8233-2020; Kayipmaz, Afsin Emre/AAC-2597-2020; Çiftci, Orçun/W-5233-2018	Karaçağlar, Emir/0000-0002-2538-1642; , cemil/0000-0003-2529-2946; Muderrisoglu, Haldun/0000-0002-9635-6313; Çiftci, Orçun/0000-0001-8926-9142				APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Armstrong PW, 2009, CIRCULATION, V119, P1293, DOI 10.1161/CIRCULATIONAHA.108.796383; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Chen ZM, 2005, LANCET, V366, P1622; Cukurova Z, 2015, PUBLIC HOSP STAT YB; Gibler WB, 2005, CIRCULATION, V111, P2699, DOI 10.1161/01.CIR.0000165556.44271.BE; Giraldez RR, 2008, J AM COLL CARDIOL, V52, P914, DOI 10.1016/j.jacc.2008.05.046; Hirvonen TPJ, 1998, EUR HEART J, V19, P885, DOI 10.1053/euhj.1997.0866; Hong JS, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000287; Kwak MJ, 2008, J KOREAN MED SCI, V23, P706, DOI 10.3346/jkms.2008.23.4.706; Loch A, 2013, POSTGRAD MED J, V89, P335, DOI 10.1136/postgradmedj-2012-131174; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Ohman EM, 2001, CHEST, V119, p253S, DOI 10.1378/chest.119.1_suppl.253S; Patti G, 2011, CIRCULATION, V123, P1622, DOI 10.1161/CIRCULATIONAHA.110.002451; Ryan T J, 2001, Curr Cardiol Rep, V3, P273, DOI 10.1007/s11886-001-0080-3; Siddiqui M A, 2001, J La State Med Soc, V153, P292; Singer AJ, 2007, ANN EMERG MED, V50, P538, DOI 10.1016/j.annemergmed.2007.06.480; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; Thorn S, 2007, ARCH MAL COEUR VAISS, V100, P7; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164819	10.1371/journal.pone.0164819	http://dx.doi.org/10.1371/journal.pone.0164819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760229	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000054
J	Mitchell, AJ; Gray, WD; Schroeder, M; Yi, H; Taylor, JV; Dillard, RS; Ke, ZL; Wright, ER; Stephens, D; Roback, JD; Searles, CD				Mitchell, Adam J.; Gray, Warren D.; Schroeder, Max; Yi, Hong; Taylor, Jeannette V.; Dillard, Rebecca S.; Ke, Zunlong; Wright, Elizabeth R.; Stephens, David; Roback, John D.; Searles, Charles D.			Pleomorphic Structures in Human Blood Are Red Blood Cell-Derived Microparticles, Not Bacteria	PLOS ONE			English	Article							NANOBACTERIA; VESICLES; MICROSCOPY	Background Red blood cell (RBC) transfusions are a common, life-saving therapy for many patients, but they have also been associated with poor clinical outcomes. We identified unusual, pleomorphic structures in human RBC transfusion units by negative-stain electron microscopy that appeared identical to those previously reported to be bacteria in healthy human blood samples. The presence of viable, replicating bacteria in stored blood could explain poor outcomes in transfusion recipients and have major implications for transfusion medicine. Here, we investigated the possibility that these structures were bacteria. Results Flow cytometry, miRNA analysis, protein analysis, and additional electron microscopy studies strongly indicated that the pleomorphic structures in the supernatant of stored RBCs were RBC-derived microparticles (RMPs). Bacterial 16S rDNA PCR amplified from these samples were sequenced and was found to be highly similar to species that are known to commonly contaminate laboratory reagents. Conclusions These studies suggest that pleomorphic structures identified in human blood are RMPs and not bacteria, and they provide an example in which laboratory contaminants may can mislead investigators.	[Mitchell, Adam J.; Gray, Warren D.; Searles, Charles D.] Emory Univ, Dept Med, Div Cardiol, Atlanta, GA 30322 USA; [Schroeder, Max; Stephens, David] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Yi, Hong; Taylor, Jeannette V.; Wright, Elizabeth R.] Emory Univ, Robert P Apkarian Integrated Elect Microscopy Cor, Atlanta, GA 30322 USA; [Dillard, Rebecca S.; Wright, Elizabeth R.] Emory Univ, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA; [Ke, Zunlong] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Roback, John D.] Emory Univ, Dept Pathol & Lab Med, Ctr Transfus & Cellular Therapy, Atlanta, GA 30322 USA; [Searles, Charles D.] Atlanta VA Med Ctr, Cardiol Sect, Decatur, GA USA	Emory University; Emory University; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center	Searles, CD (corresponding author), Emory Univ, Dept Med, Div Cardiol, Atlanta, GA 30322 USA.; Searles, CD (corresponding author), Atlanta VA Med Ctr, Cardiol Sect, Decatur, GA USA.	csearle@emory.edu	Ke, Zunlong/HDO-6504-2022	Ke, Zunlong/0000-0002-8408-850X	National Institutes of Health [R01HL109559, R01HL124879, R01HL095476, 510RR025679]; VA Merit Award [101 BX000704]; National Heart, Lung, and Blood Institute of National Institutes of Health [T32HL007745]; NSF-MRI grant [0923395]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124879, T32HL069769, R01HL109559, R01HL095479, P01HL086773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); National Heart, Lung, and Blood Institute of National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NSF-MRI grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (R01HL109559, R01HL124879, R01HL095476, 510RR025679), and a VA Merit Award (101 BX000704). Research reported in this publication was also supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number T32HL007745. The JEOL JEM-1400 transmission electron microscope was acquired with an NIH S10 ' grant (S10RR025679). The JEOL JEM-2200FS transmission electron microscope was acquired with an NSF-MRI grant (0923395). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Azzouzi I, 2015, EXP HEMATOL, V43, P382, DOI 10.1016/j.exphem.2015.01.007; Bergallo M, 2006, NEW MICROBIOL, V29, P111; Dinakaran V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105221; Dinkla S, 2013, NANOMEDICINE-UK, V8, P1657, DOI [10.2217/NNM.13.149, 10.2217/nnm.13.149]; Gray WD, 2015, METHODSX, V2, P360, DOI 10.1016/j.mex.2015.08.002; Hopewell S, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2013-003342, 10.1136/bmjopen-2012-002154]; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McLaughlin RW, 2002, J CLIN MICROBIOL, V40, P4771, DOI 10.1128/JCM.40.12.4771-4775.2002; Raoult D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040041; Rubin O, 2012, TRANSFUS MED HEMOTH, V39, P342, DOI 10.1159/000342228; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Salzer U, 2008, TRANSFUSION, V48, P451, DOI 10.1111/j.1537-2995.2007.01549.x; Szymanski M, 2002, CLIN INFECT DIS, V34, pE16, DOI 10.1086/338158; Yi H, 2015, J HISTOCHEM CYTOCHEM, V63, P780, DOI 10.1369/0022155415593323; Young JD, 2010, SCI AM, V302, P52, DOI 10.1038/scientificamerican0110-52	17	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0163582	10.1371/journal.pone.0163582	http://dx.doi.org/10.1371/journal.pone.0163582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760197	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000015
J	Tilocca, B; Witzig, M; Rodehutscord, M; Seifert, J				Tilocca, Bruno; Witzig, Maren; Rodehutscord, Markus; Seifert, Jana			Variations of Phosphorous Accessibility Causing Changes in Microbiome Functions in the Gastrointestinal Tract of Chickens	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GUT MICROBIOTA; FECAL MICROBIOTA; COMMUNITY STRUCTURE; MINERAL PHOSPHORUS; REVEALS; METAPROTEOMICS; BROILERS; PROTEINS; PHYTASE	The chicken gastrointestinal tract (GIT) harbours a complex microbial community, involved in several physiological processes such as host immunomodulation and feed digestion. For the first time, the present study analysed dietary effects on the protein inventory of the microbiome in crop and ceca of broilers. We performed quantitative label-free metaproteomics by using 1-D-gel electrophoresis coupled with LC-MS/MS to identify the structural and functional changes triggered by diets supplied with varying amount of mineral phosphorous (P) and microbial phytase (MP). Phylogenetic assessment based on label-free quantification (LFQ) values of the proteins identified Lactobacillaceae as the major family in the crop section regardless of the diet, whereas proteins belonging to the family Veillonellaceae increased with the P supplementation. Within the ceca section, proteins of Bacteroidaceae were more abundant in the P-supplied diets, whereas proteins of Eubacteriaceae decreased with the P-addition. Proteins of the Ruminococcaceae increased with the amount of MP while proteins of Lactobacillaceae were more abundant in the MP-lacking diets. Classification of the identified proteins indicated a thriving microbial community in the case of P and MP supplementation, and stressed microbial community when no P and MP were supplied. Data are available via ProteomeXchange with identifier PXD003805.	[Tilocca, Bruno; Witzig, Maren; Rodehutscord, Markus; Seifert, Jana] Univ Hohenheim, Inst Anim Sci, Stuttgart, Germany	University Hohenheim	Seifert, J (corresponding author), Univ Hohenheim, Inst Anim Sci, Stuttgart, Germany.	jseifert@uni-hohenheim.de	Tilocca, Bruno/AAE-8112-2020	Tilocca, Bruno/0000-0001-6196-9358; Rodehutscord, Markus/0000-0003-3156-7889; Seifert, Jana/0000-0002-7690-8539	Ministerium fur Wissenschaft, Forschung and Kultur des Landes Baden-Wurttemberg; Carl-Zeiss-Stiftung	Ministerium fur Wissenschaft, Forschung and Kultur des Landes Baden-Wurttemberg; Carl-Zeiss-Stiftung	We would like to thank the Ministerium fur Wissenschaft, Forschung and Kultur des Landes Baden-Wurttemberg for funding of the projects METAPHOR and MICROP as well as the Carl-Zeiss-Stiftung for funding. There are no grant numbers available. The funders had no role study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Fattah WR, 2005, J BACTERIOL, V187, P5166, DOI 10.1128/JB.187.15.5166-5178.2005; Apajalahti J, 2004, WORLD POULTRY SCI J, V60, P223, DOI 10.1079/WPS200415; Apajalahti JHA, 1998, APPL ENVIRON MICROB, V64, P4084; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Deusch S, 2015, PROTEOMICS, V15, P3590, DOI 10.1002/pmic.201400556; Deusch S, 2015, COMPUT STRUCT BIOTEC, V13, P55, DOI 10.1016/j.csbj.2014.12.005; Dostal A, 2013, FEMS MICROBIOL ECOL, V83, P161, DOI 10.1111/j.1574-6941.2012.01461.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gong JH, 2007, FEMS MICROBIOL ECOL, V59, P147, DOI 10.1111/j.1574-6941.2006.00193.x; Haange SB, 2012, J PROTEOME RES, V11, P5406, DOI 10.1021/pr3006364; Hansen SH, 2014, PROTEOMICS, V14, P2535, DOI 10.1002/pmic.201400167; Hooda S, 2012, J NUTR, V142, P1259, DOI 10.3945/jn.112.158766; Huber K, 2015, POULTRY SCI, V94, P1009, DOI 10.3382/ps/pev065; Jagtap P, 2013, PROTEOMICS, V13, P1352, DOI 10.1002/pmic.201200352; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jehmlich N, 2008, RAPID COMMUN MASS SP, V22, P2889, DOI 10.1002/rcm.3684; Kang SS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-36; Konietzny U., 2003, ENCY FOOD SCI NUTR, P4555; Korobeinikova AV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P562, DOI 10.1134/S0006297912060028; Kostic AD, 2013, GENE DEV, V27, P701, DOI 10.1101/gad.212522.112; Lecomte V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126931; Metzler-Zebeli BU, 2013, APPL ENVIRON MICROB, V79, P7264, DOI 10.1128/AEM.02691-13; Neubauer G, 1999, ANAL CHEM, V71, P235, DOI 10.1021/ac9804902; Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608; OCHI K, 1995, INT J SYST BACTERIOL, V45, P507, DOI 10.1099/00207713-45-3-507; Onyango EM, 2006, BRIT POULTRY SCI, V47, P632, DOI 10.1080/00071660600963651; Peris-Bondia F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022448; Polansky O, 2016, APPL ENVIRON MICROB, V82, P1569, DOI 10.1128/AEM.03473-15; Ptak A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119770; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Rooks MG, 2014, ISME J, V8, P1403, DOI 10.1038/ismej.2014.3; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sekelja M, 2012, APPL ENVIRON MICROB, V78, P2941, DOI 10.1128/AEM.05391-11; Sergeant MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091941; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Singh KM, 2014, J APPL GENET, V55, P145, DOI 10.1007/s13353-013-0179-4; Stanley D, 2014, APPL MICROBIOL BIOT, V98, P4301, DOI 10.1007/s00253-014-5646-2; Tanca A, 2015, PROTEOMICS, V15, P3474, DOI 10.1002/pmic.201400573; Tang Y, 2014, APPL ENVIRON MICROB, V80, P478, DOI 10.1128/AEM.02472-13; Venables, 2009, GPLOTS VAR R PROGR T; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-30; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Waite DW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00673; Witzig M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145588; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14; Zeller E, 2015, POULTRY SCI, V94, P1018, DOI 10.3382/ps/pev087	52	29	30	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164735	10.1371/journal.pone.0164735	http://dx.doi.org/10.1371/journal.pone.0164735			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760159	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204000048
J	Baraldi, E; Giordano, G; Stocchero, M; Moschino, L; Zaramella, P; Tran, MR; Carraro, S; Romero, R; Gervasi, MT				Baraldi, Eugenio; Giordano, Giuseppe; Stocchero, Matteo; Moschino, Laura; Zaramella, Patrizia; Tran, Maria Rosa; Carraro, Silvia; Romero, Roberto; Gervasi, Maria Teresa			Untargeted Metabolomic Analysis of Amniotic Fluid in the Prediction of Preterm Delivery and Bronchopulmonary Dysplasia	PLOS ONE			English	Article							SUBSEQUENT DEVELOPMENT; PREMATURE-INFANTS; RISK; BIRTH; IDENTIFICATION; EPIDEMIOLOGY; DIAGNOSIS; DISEASE; HEALTH	Objective Bronchopulmonary dysplasia (BPD) is a serious complication associated with preterm birth. A growing body of evidence suggests a role for prenatal factors in its pathogenesis. Metabolomics allows simultaneous characterization of low molecular weight compounds and may provide a picture of such a complex condition. The aim of this study was to evaluate whether an unbiased metabolomic analysis of amniotic fluid (AF) can be used to investigate the risk of spontaneous preterm delivery (PTD) and BPD development in the offspring. Study design We conducted an exploratory study on 32 infants born from mothers who had undergone an amniocentesis between 21 and 28 gestational weeks because of spontaneous preterm labor with intact membranes. The AF samples underwent untargeted metabolomic analysis using mass spectrometry combined with ultra-performance liquid chromatography. The data obtained were analyzed using multivariate and univariate statistical data analysis tools. Results Orthogonally Constrained Projection to Latent Structures-Discriminant Analysis (oCPLS2-DA) excluded effects on data modelling of crucial clinical variables. oCPLS2-DA was able to find unique differences in select metabolites between term (n = 11) and preterm (n = 13) deliveries (negative ionization data set: R-2 = 0.47, mean AUC ROC in prediction = 0.65; positive ionization data set: R-2 = 0.47, mean AUC ROC in prediction = 0.70), and between PTD followed by the development of BPD (n = 10), and PTD without BPD (n = 11) (negative data set: R-2 = 0.48, mean AUC ROC in prediction = 0.73; positive data set: R-2 = 0.55, mean AUC ROC in prediction = 0.71). Conclusions This study suggests that amniotic fluid metabolic profiling may be promising for identifying spontaneous preterm birth and fetuses at risk for developing BPD. These findings support the hypothesis that some prenatal metabolic dysregulations may play a key role in the pathogenesis of PTD and the development of BPD.	[Baraldi, Eugenio; Giordano, Giuseppe; Moschino, Laura; Zaramella, Patrizia; Tran, Maria Rosa; Carraro, Silvia; Gervasi, Maria Teresa] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Baraldi, Eugenio; Giordano, Giuseppe; Moschino, Laura; Carraro, Silvia] Citta Speranza Inst Pediat Res IRP, Padua, Italy; [Stocchero, Matteo] S IN Soluz Informat, Vicenza, Italy; [Romero, Roberto] Wayne State Univ, Perinatol Res Branch, NICHD, NIH,DHHS,Hutzel Womens Hosp, Detroit, MI USA	University of Padua; Fondazione Citta della Speranza; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University	Baraldi, E (corresponding author), Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy.; Baraldi, E (corresponding author), Citta Speranza Inst Pediat Res IRP, Padua, Italy.	eugenio.baraldi@unipd.it	baraldi, eugenio/AAC-5233-2022; Romero, Roberto/A-5268-2019	Romero, Roberto/0000-0002-4448-5121	Bando Ricerca Pediatrica Fondazione Cassa di Risparmio di Padova e Rovigo; Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002401] Funding Source: NIH RePORTER	Bando Ricerca Pediatrica Fondazione Cassa di Risparmio di Padova e Rovigo; Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by "Bando Ricerca Pediatrica 2012-2014" Fondazione Cassa di Risparmio di Padova e Rovigo and, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH). The funding sources had no involvement in the study design, the collection, analysis, and interpretation of data, the writing of the report, and the decision to submit the manuscript for publication. The funding sources and the company S-IN Soluzioni Informatiche (MS) did not provide support in the form of salaries for any of the authors. S-IN Soluzioni Informatiche did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.; This work was supported by "Bando Ricerca Pediatrica 2012-2014" Fondazione Cassa di Risparmio di Padova e Rovigo and, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH).	American College of Obstetricians and Gynecologists Committee on Practice Bulletins, 2003, OBSTET GYNECOL, V101, P1039; Anesi A, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0584-4; Ardissone AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090784; Arredouani A., 2016, DIABETES; Bancalari EH, 2012, J PEDIATR-US, V161, P585, DOI 10.1016/j.jpeds.2012.05.054; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Carraro S, 2014, EUR RESPIR J, V44, P1682, DOI 10.1183/09031936.00084114; Carraro S, 2009, J PEDIATR-US, V154, P638, DOI 10.1016/j.jpeds.2009.01.014; Dall'Acqua S, 2014, J PHARMACEUT BIOMED, V100, P348, DOI 10.1016/j.jpba.2014.07.035; Ehrenkranz RA, 2005, PEDIATRICS, V116, P1353, DOI 10.1542/peds.2005-0249; Frey HA, 2016, SEMIN FETAL NEONAT M, V21, P68, DOI 10.1016/j.siny.2015.12.011; Gervasi MT, 2012, J PERINAT MED, V40, P329, DOI 10.1515/jpm-2012-0034; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Graca G, 2008, ANAL CHEM, V80, P6085, DOI 10.1021/ac800907f; Graca G, 2012, MOL BIOSYST, V8, P1243, DOI 10.1039/c2mb05424h; Jones MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081193; Kim A, 2013, PLACENTA, V34, P873, DOI 10.1016/j.placenta.2013.06.306; Kim SK, 2013, AM J REPROD IMMUNOL, V69, P105, DOI 10.1111/aji.12046; Kotecha SJ, 2013, THORAX, V68, P760, DOI 10.1136/thoraxjnl-2012-203079; Lee J, 2009, J MATERN-FETAL NEO M, V22, P917, DOI 10.1080/14767050902994705; McEvoy Cindy T, 2014, Ann Am Thorac Soc, V11 Suppl 3, pS146, DOI 10.1513/AnnalsATS.201312-424LD; Menon R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00567; Moncada CA, 2008, J BIOL CHEM, V283, P7690, DOI 10.1074/jbc.M709399200; Mourani PM, 2015, AM J RESP CRIT CARE, V191, P87, DOI 10.1164/rccm.201409-1594OC; Nykanen P, 2007, ACTA PAEDIATR, V96, P1600, DOI 10.1111/j.1651-2227.2007.00500.x; Orczyk-Pawilowicz M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152740; Panayiotidis MI, 2009, MUTAT RES-GEN TOX EN, V674, P23, DOI 10.1016/j.mrgentox.2008.10.006; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1344, DOI 10.3109/14767058.2010.482618; Saccenti E, 2014, METABOLOMICS, V10, P361, DOI 10.1007/s11306-013-0598-6; Stocks J, 2013, LANCET RESP MED, V1, P728, DOI 10.1016/S2213-2600(13)70118-8; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; vom Hove M, 2014, J PEDIATR-US, V164, P40, DOI 10.1016/j.jpeds.2013.07.045; Watterberg KL, 2001, PEDIATR RES, V50, P190, DOI 10.1203/00006450-200108000-00005; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wheelock CE, 2013, EUR RESPIR J, V42, P802, DOI 10.1183/09031936.00078812; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P825, DOI 10.1016/S0002-9378(97)70276-X	37	36	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164211	10.1371/journal.pone.0164211	http://dx.doi.org/10.1371/journal.pone.0164211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755564	Green Submitted, Green Published, gold			2022-12-26	WOS:000386203800013
J	de Avilla, AI; Gallego, I; Soria, ME; Gregori, J; Quer, J; Esteban, JI; Rice, CM; Domingo, E; Perales, C				de Avilla, Ana I.; Gallego, Isabel; Soria, Maria Eugenia; Gregori, Josep; Quer, Josep; Esteban, Juan Ignacio; Rice, Charles M.; Domingo, Esteban; Perales, Celia			Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir	PLOS ONE			English	Article							HCV GENOTYPE 1; SOFOSBUVIR PLUS RIBAVIRIN; TREATMENT-NAIVE PATIENTS; MOUTH-DISEASE VIRUS; TREATMENT-EXPERIENCED PATIENTS; IN-VIVO ACTIVITIES; OPEN-LABEL; T-705 FAVIPIRAVIR; POLYMERASE INHIBITOR; PEGYLATED INTERFERON	A Lethal mutagenesis is an antiviral approach that consists in extinguishing a virus by an excess of mutations acquired during replication in the presence of a mutagen. Here we show that favipiravir (T-705) is a potent mutagenic agent for hepatitis C virus (HCV) during its replication in human hepatoma cells. T-705 leads to an excess of G -> A and C -> U transitions in the mutant spectrum of preextinction HCV populations. Infectivity decreased significantly in the presence of concentrations of T-705 which are 2- to 8-fold lower than its cytotoxic concentration 50 (CC50). Passaging the virus five times in the presence of 400 mu M T-705 resulted in virus extinction. Since T-705 has undergone advanced clinical trials for approval for human use, the results open a new approach based on lethal mutagenesis to treat hepatitis C virus infections. If proven effective for HCV in vivo, this new anti-HCV agent may be useful in patient groups that fail current therapeutic regimens.	[de Avilla, Ana I.; Gallego, Isabel; Domingo, Esteban; Perales, Celia] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Gallego, Isabel; Gregori, Josep; Quer, Josep; Esteban, Juan Ignacio; Domingo, Esteban; Perales, Celia] CIBERehd, Barcelona, Spain; [Soria, Maria Eugenia; Gregori, Josep; Quer, Josep; Esteban, Juan Ignacio; Perales, Celia] Univ Autonoma Barcelona, VHIR HUVH, Lab Malalties Hepat, Liver Unit,Internal Med, Barcelona 08035, Spain; [Gregori, Josep] Roche Diagnost SL, Sant Cugat Del Valles, Spain; [Quer, Josep; Esteban, Juan Ignacio] Univ Autonoma Barcelona, Barcelona, Spain; [Rice, Charles M.] Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10021 USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Autonomous University of Barcelona; Roche Holding; Autonomous University of Barcelona; Rockefeller University	Perales, C (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, Campus Cantoblanco, Madrid 28049, Spain.	edomingo@cbm.csic.es; cperales@cbm.csic.es	Gregori, Josep/J-2586-2015; Quer, Josep/A-6741-2012; Domingo, Esteban/K-3937-2014	Gregori, Josep/0000-0002-4253-8015; Quer, Josep/0000-0003-0014-084X; Soria Benito, Maria Eugenia/0000-0002-4719-3351; Perales Viejo, Celia Belen/0000-0003-1618-1937; GALLEGO, ISABEL/0000-0002-7338-1778; Domingo, Esteban/0000-0002-0573-1676; de Avila Lucas, Ana Isabel/0000-0002-9381-0963	Comunidad de Madrid/FEDER [BFU-2011-23604, SAF2014-52400-R, S2013/ABI-2906]; Fundacion R. Areces; Institute de Salud Carlos III [PI13-00456, PI15-00829]; European Regional Development Fund (ERDF); Institute de Salud Carlos III; Miguel Servet program of the Institute de Salud Carlos III [CP14/00121]; U.S. Public Health Service; National Institute of Allergy and Infectious Diseases [R01 AI099284]	Comunidad de Madrid/FEDER(Comunidad de Madrid); Fundacion R. Areces(Instituto de Salud Carlos III); Institute de Salud Carlos III(Instituto de Salud Carlos III); European Regional Development Fund (ERDF)(European Commission); Institute de Salud Carlos III(Instituto de Salud Carlos III); Miguel Servet program of the Institute de Salud Carlos III; U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work in Madrid was supported by grants BFU-2011-23604, SAF2014-52400-R, S2013/ABI-2906 (PLATESA from Comunidad de Madrid/FEDER) and Fundacion R. Areces. The work in Barcelona was funded by Institute de Salud Carlos III, grants PI13-00456 and PI15-00829, cofinanced by the European Regional Development Fund (ERDF). CIBERehd (Centro de Investigacion en Red de Enfermedades Hepaticas y Digestivas) is funded by Institute de Salud Carlos III. C.P. is supported by the Miguel Servet program of the Institute de Salud Carlos III (CP14/00121) cofinanced by the European Regional Development Fund (ERDF). C.M.R. is supported by a grant from the U.S. Public Health Service, National Institute of Allergy and Infectious Diseases, R01 AI099284. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Agudo R, 2008, J MOL BIOL, V382, P652, DOI 10.1016/j.jmb.2008.07.033; Agudo R, 2016, VIROLOGY, V494, P257, DOI 10.1016/j.virol.2016.04.023; Agudo R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001072; Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2; Arias A, 2014, ELIFE, V3, DOI 10.7554/eLife.03679; Asselah T, 2016, LIVER INT, V36, P47, DOI 10.1111/liv.13027; Asselah T, 2014, J HEPATOL, V61, P435, DOI 10.1016/j.jhep.2014.04.042; Baranovich T, 2013, J VIROL, V87, P3741, DOI 10.1128/JVI.02346-12; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bougie I, 2003, J BIOL CHEM, V278, P52471, DOI 10.1074/jbc.M308917200; Buti M, 2015, J VIRAL HEPATITIS, V22, P683, DOI 10.1111/jvh.12419; Buti M, 2015, EXPERT REV GASTROENT, V9, P375, DOI 10.1586/17474124.2015.960396; Caroline AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002790; Cuevas JM, 2009, J VIROL, V83, P5760, DOI 10.1128/JVI.00201-09; Dapp MJ, 2013, TRENDS MICROBIOL, V21, P56, DOI 10.1016/j.tim.2012.10.006; Davidson A. C., 1997, BOOTSTRAP METHODS AN; Dietz J, 2013, J VIROL, V87, P6172, DOI 10.1128/JVI.02778-12; Domingo E, 2016, CURRENT TOPICS IN MI, V392; Domingo E., 2016, VIRUS AS POPULATIONS; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Dudoit S, 2008, SPRINGER SER STAT, P1; Efron B, 1994, AN INTRODUCTION TO T; Eigen M., 1979, THE HYPERCYCLE A PRI; ERIKSSON B, 1977, ANTIMICROB AGENTS CH, V11, P946, DOI 10.1128/AAC.11.6.946; Farci P, 2000, SEMIN LIVER DIS, V20, P103; Farci P, 2011, SEMIN LIVER DIS, V31, P356, DOI 10.1055/s-0031-1297925; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Ferenci P, 2015, NAT REV GASTRO HEPAT, V12, P284, DOI 10.1038/nrgastro.2015.53; Foster GR, 2015, GASTROENTEROLOGY, V149, P1462, DOI 10.1053/j.gastro.2015.07.043; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Furuta Y, 2004, ABSTR 44TH INTERSCI, P199; Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015; Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198; Gallego I, 2016, ANTIMICROB AGENTS CH, V60, P3786, DOI 10.1128/AAC.00581-16; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gonzalez-Lopez Claudia, 2005, Infection Genetics and Evolution, V5, P366, DOI 10.1016/j.meegid.2005.05.001; GOSWAMI BB, 1979, BIOCHEM BIOPH RES CO, V89, P830, DOI 10.1016/0006-291X(79)91853-9; Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07; Gowen BB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002614; Gowen BB, 2010, ANTIVIR RES, V86, P121, DOI 10.1016/j.antiviral.2009.10.015; Graci JD, 2008, FUTURE VIROL, V3, P553, DOI 10.2217/17460794.3.6.553; Grande-Perez A, 2005, J VIROL, V79, P10451, DOI 10.1128/JVI.79.16.10451-10459.2005; Grande-Perez A, 2005, P NATL ACAD SCI USA, V102, P4448, DOI 10.1073/pnas.0408871102; Gregori J, 2016, VIROLOGY, V493, P227, DOI 10.1016/j.virol.2016.03.017; Gregori J, 2014, BIOINFORMATICS, V30, P1104, DOI 10.1093/bioinformatics/btt768; Gregori J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083361; Harouaka D, 2016, P NATL ACAD SCI USA, V113, P1375, DOI 10.1073/pnas.1516879113; Hezode C, 2015, LANCET, V385, P2502, DOI 10.1016/S0140-6736(15)60159-3; HOLLAND JJ, 1990, J VIROL, V64, P3960, DOI 10.1128/JVI.64.8.3960-3962.1990; Hultgren C, 1998, J GEN VIROL, V79, P2381, DOI 10.1099/0022-1317-79-10-2381; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jin ZN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068347; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Julander JG, 2009, ANTIMICROB AGENTS CH, V53, P202, DOI 10.1128/AAC.01074-08; Keating GM, 2014, DRUGS, V74, P1127, DOI 10.1007/s40265-014-0247-z; Kiso M, 2010, P NATL ACAD SCI USA, V107, P882, DOI 10.1073/pnas.0909603107; Koff RS, 2014, ALIMENT PHARM THER, V39, P478, DOI 10.1111/apt.12601; Kohli A, 2015, LANCET INFECT DIS, V15, P1049, DOI 10.1016/S1473-3099(15)00157-7; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kowdley KV, 2013, LANCET, V381, P2100, DOI 10.1016/S0140-6736(13)60247-0; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Lindenbach Brett D, 2003, Hepatology, V38, P769; Lindenbach Brett D., 2009, V510, P329, DOI 10.1007/978-1-59745-394-3_24; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; Mendenhall M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001342; Morrey JD, 2008, ANTIVIR RES, V80, P377, DOI 10.1016/j.antiviral.2008.07.009; Ning Q, 1998, J IMMUNOL, V160, P3487; Oestereich L, 2016, J INFECT DIS, V213, P934, DOI 10.1093/infdis/jiv522; Ortega-Prieto AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071039; Perales C, 2013, J VIROL, V87, P7593, DOI 10.1128/JVI.02824-12; Perales C, 2011, J VIROL, V85, P12227, DOI 10.1128/JVI.00716-11; Ramirez C, 2013, ANTIVIR RES, V98, P273, DOI 10.1016/j.antiviral.2013.03.007; Reig M, 2016, J HEPATOL IN PRESS; Rocha-Pereira J, 2012, BIOCHEM BIOPH RES CO, V424, P777, DOI 10.1016/j.bbrc.2012.07.034; Safronetz D, 2015, SCI REP-UK, V5, DOI 10.1038/srep14775; Safronetz D, 2013, ANTIMICROB AGENTS CH, V57, P4673, DOI 10.1128/AAC.00886-13; Sakamoto K, 2006, THE INHIBITION OF FM; Sanchez G, 2003, VIROLOGY, V315, P34, DOI 10.1016/S0042-6822(03)00483-5; Sangawa H, 2013, ANTIMICROB AGENTS CH, V57, P5202, DOI 10.1128/AAC.00649-13; Sarrazin C, 2016, J HEPATOL, V64, P486, DOI 10.1016/j.jhep.2015.09.011; Sato M, 2015, J VIROL, V89, P6105, DOI 10.1128/JVI.03127-14; Scharton D, 2014, ANTIVIR RES, V104, P84, DOI 10.1016/j.antiviral.2014.01.016; Schuster P, 2016, CURR TOP MICROBIOL, V392, P61, DOI 10.1007/82_2015_469; Sheldon J, 2014, J VIROL, V88, P12098, DOI 10.1128/JVI.01860-14; Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06; Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967; Smee DF, 2013, FUTURE VIROL, V8, P1085, DOI 10.2217/fvl.13.98; Smee DF, 2009, J ANTIMICROB CHEMOTH, V64, P741, DOI 10.1093/jac/dkp274; STREETER DG, 1973, P NATL ACAD SCI USA, V70, P1174, DOI 10.1073/pnas.70.4.1174; Sullivan JC, 2013, CLIN INFECT DIS, V57, P221, DOI 10.1093/cid/cit226; Svarovskaia ES, 2014, CLIN INFECT DIS, V59, P1666, DOI 10.1093/cid/ciu697; Vandamme A, 2000, EVALUATING CLINICAL; Westover JB, 2016, ANTIVIR RES, V126, P62, DOI 10.1016/j.antiviral.2015.12.006; Wyles DL, 2014, J VIRAL HEPATITIS, V21, P229, DOI 10.1111/jvh.12230; Wyles D, 2015, HEPATOLOGY, V61, P1793, DOI 10.1002/hep.27814; Yamada K, 2016, J INFECT DIS, V213, P1253, DOI 10.1093/infdis/jiv586; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Zhang YH, 2003, J VIROL, V77, P5933, DOI 10.1128/JVI.77.10.5933-5947.2003	105	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164691	10.1371/journal.pone.0164691	http://dx.doi.org/10.1371/journal.pone.0164691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755573	Green Published, gold, Green Submitted			2022-12-26	WOS:000386203800027
J	Lutje, S; Blex, S; Gomez, B; Schaarschmidt, BM; Umutlu, L; Forsting, M; Jentzen, W; Bockisch, A; Poeppel, TD; Wetter, A				Luetje, Susanne; Blex, Sebastian; Gomez, Benedikt; Schaarschmidt, Benedikt M.; Umutlu, Lale; Forsting, Michael; Jentzen, Walter; Bockisch, Andreas; Poeppel, Thorsten D.; Wetter, Axel			Optimization of Acquisition time of Ga-68-PSMA-Ligand PET/MRI in Patients with Local and Metastatic Prostate Cancer	PLOS ONE			English	Article							MEMBRANE ANTIGEN-EXPRESSION; GA-68-LABELED PSMA LIGAND; PET/CT; EXPERIENCE; DIAGNOSIS	Objective The aim of this optimization study was to minimize the acquisition time of 68 Ga-HBED-CCPSMA positron emission tomography/magnetic resonance imaging (PET/MRI) in patients with local and metastatic prostate cancer (PCa) to obtain a sufficient image quality and quantification accuracy without any appreciable loss. Methods Twenty patients with PCa were administered intravenously with the 68 Ga-HBED-CC-PSMA ligand (mean activity 99 MBq/patient, range 76-148 MBq) and subsequently underwent PET/MRI at, on average, 168 min (range 77-320 min) after injection. PET and MR imaging data were acquired simultaneously. PET acquisition was performed in list mode and PET images were reconstructed at different time intervals (1, 2, 4, 6, 8, and 10 min). Data were analyzed regarding radiotracer uptake in tumors and muscle tissue and PET image quality. Tumor uptake was quantified in terms of the maximum and mean standardized uptake value (SUVmax, SUVmean) within a spherical volume of interest (VOI). Reference VOIs were drawn in the gluteus maximus muscle on the right side. PET image quality was evaluated by experienced nuclear physicians/radiologists using a five-point ordinal scale from 5-1 (excellent-insufficient). Results Lesion detectability linearly increased with increasing acquisition times, reaching its maximum at PET acquisition times of 4 min. At this image acquisition time, tumor lesions in 19/20 (95%) patients were detected. PET image quality showed a positive correlation with increasing acquisition time, reaching a plateau at 4-6 min image acquisition. Both SUVmax and SUVmean correlated inversely with acquisition time and reached a plateau at acquisition times after 4 min. Conclusion In the applied image acquisition settings, the optimal acquisition time of 68 Ga-PSMA-ligand PET/MRI in patients with local and metastatic PCa was identified to be 4 min per bed position. At this acquisition time, PET image quality and lesion detectability reach a maximum while SUVmax and SUVmean do not change significantly beyond this time point.	[Luetje, Susanne; Gomez, Benedikt; Jentzen, Walter; Bockisch, Andreas; Poeppel, Thorsten D.] Univ Hosp Essen, Clin Nucl Med, Hufelandstr 55, D-45122 Essen, Germany; [Blex, Sebastian; Umutlu, Lale; Forsting, Michael; Wetter, Axel] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Hufelandstr 55, D-45122 Essen, Germany; [Schaarschmidt, Benedikt M.] Univ Dusseldorf, Fac Med, Dept Diagnost & Intervent Radiol, Moorenstr 5, D-40225 Dusseldorf, Germany	University of Duisburg Essen; University of Duisburg Essen; Heinrich Heine University Dusseldorf	Lutje, S (corresponding author), Univ Hosp Essen, Clin Nucl Med, Hufelandstr 55, D-45122 Essen, Germany.	Susanne.Luetje@uk-essen.de	Lütje, Susanne/C-7665-2017	Lütje, Susanne/0000-0001-9738-4351; Schaarschmidt, Benedikt Michael/0000-0001-6331-7679				Afshar-Oromieh A, 2014, EUR J NUCL MED MOL I, V41, P887, DOI 10.1007/s00259-013-2660-z; Afshar-Oromieh A, 2015, EUR J NUCL MED MOL I, V42, P197, DOI 10.1007/s00259-014-2949-6; Ananias HJK, 2009, PROSTATE, V69, P1101, DOI 10.1002/pros.20957; Bauman G, 2012, PROSTATE CANCER P D, V15, P45, DOI 10.1038/pcan.2011.35; Bostwick DG, 1998, CANCER-AM CANCER SOC, V82, P2256, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO;2-S; Conway RE, 2006, MOL CELL BIOL, V26, P5310, DOI 10.1128/MCB.00084-06; Dietlein M, 2015, MOL IMAGING BIOL, V17, P575, DOI 10.1007/s11307-015-0866-0; Drzezga A, 2012, J NUCL MED, V53, P845, DOI 10.2967/jnumed.111.098608; Eiber M, 2015, J NUCL MED, V56, P668, DOI 10.2967/jnumed.115.154153; Graham K, 2012, J MED CHEM, V55, P9510, DOI 10.1021/jm300710j; Hartung-Knemeyer V, 2013, INVEST RADIOL, V48, P290, DOI 10.1097/RLI.0b013e3182823695; ISRAELI RS, 1993, CANCER RES, V53, P227; Kawakami M, 1997, CANCER RES, V57, P2321; Kitajima K, 2013, ANN NUCL MED, V27, P581, DOI 10.1007/s12149-013-0731-7; Krause BJ, 2013, UROL ONCOL-SEMIN ORI, V31, P427, DOI 10.1016/j.urolonc.2010.08.008; Lutje S, 2012, PROSTATE, V72, P1262, DOI 10.1002/pros.22462; Minner S, 2011, PROSTATE, V71, P281, DOI 10.1002/pros.21241; Rybalov M, 2014, INT J MOL SCI, V15, P6046, DOI 10.3390/ijms15046046; Silver DA, 1997, CLIN CANCER RES, V3, P81; TROYER JK, 1995, INT J CANCER, V62, P552, DOI 10.1002/ijc.2910620511; Umbehr MH, 2013, EUR UROL, V64, P106, DOI 10.1016/j.eururo.2013.04.019; Wetter A, 2014, EUR J NUCL MED MOL I, V41, P79, DOI 10.1007/s00259-013-2560-2	22	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164392	10.1371/journal.pone.0164392	http://dx.doi.org/10.1371/journal.pone.0164392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755548	Green Published, gold, Green Submitted			2022-12-26	WOS:000386203800019
J	Otaki, Y; Watanabe, T; Nishiyama, S; Takahashi, H; Arimoto, T; Shishido, T; Miyamoto, T; Konta, T; Shibata, Y; Sato, H; Kawasaki, R; Daimon, M; Ueno, Y; Kato, T; Kayama, T; Kubota, I				Otaki, Yoichiro; Watanabe, Tetsu; Nishiyama, Satoshi; Takahashi, Hiroki; Arimoto, Takanori; Shishido, Tetsuro; Miyamoto, Takuya; Konta, Tsuneo; Shibata, Yoko; Sato, Hidenori; Kawasaki, Ryo; Daimon, Makoto; Ueno, Yoshiyuki; Kato, Takeo; Kayama, Takamasa; Kubota, Isao			The Impact of Superoxide Dismutase-1 Genetic Variation on Cardiovascular and All-Cause Mortality in a Prospective Cohort Study: The Yamagata (Takahata) Study	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; HEART-FAILURE; ALLELIC VARIATIONS; DIABETIC SUBJECTS; FAMILY-HISTORY; SOD1 GENE; RISK; BRAIN; DISEASE; BNP	Background Oxidative stress is a major cause of cardiovascular disease. Superoxide dismutase-1 (SOD1) is an antioxidant that protects against oxidative stress. Deoxyribonucleic acid (DNA) variations such as single nucleotide polymorphism (SNP) or haplotypes within the SOD gene are reportedly associated with the development of cardiovascular disease. However, it remains to be determined whether SOD1 variability is associated with cardiovascular or all-cause mortality in the general population. Methods and Results This prospective cohort study included 2799 subjects who participated in a community-based health study with a 10-year follow-up. We genotyped 639 SNPs and found the association of SNP rs1041740 and rs17880487 within a SOD1 gene with cardiovascular mortality. There were 193 deaths during the follow-up period including 57 cardiovascular deaths. Multivariate Cox proportional hazard regression analysis revealed that the homozygous T-allele of rs1041740 was associated with all-cause and cardiovascular deaths after adjusting for confounding factors. The net reclassification index was significantly improved by adding rs1041740 as a cardiovascular risk factor. On the other hand, cardiovascular death was not observed in homozygous T-allele carriers of rs17880487. Haplotype analysis identified the haplotype with T-allele of rs1041740 and that with T-allele of rs17880487 as increasing and decreasing susceptibility for cardiovascular mortality, and it had complementary SNP sequences. Conclusion Variation in the SOD1 gene was associated with cardiovascular deaths in the general population.	[Otaki, Yoichiro; Watanabe, Tetsu; Nishiyama, Satoshi; Takahashi, Hiroki; Arimoto, Takanori; Shishido, Tetsuro; Miyamoto, Takuya; Konta, Tsuneo; Shibata, Yoko; Kubota, Isao] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata, Japan; [Sato, Hidenori] Yamagata Univ, Fac Med, Inst Promot Med Sci Res, Genome Informat Unit, Yamagata, Japan; [Kawasaki, Ryo] Yamagata Univ, Grad Sch Med Sci, Dept Publ Hlth, Yamagata, Japan; [Daimon, Makoto] Hirosaki Univ, Dept Endocrinol & Metab, Grad Sch Med, Aomori, Japan; [Ueno, Yoshiyuki; Kato, Takeo; Kayama, Takamasa] Yamagata Univ, Global Ctr Excellence Program Study Grp, Sch Med, Yamagata, Japan	Yamagata University; Yamagata University; Yamagata University; Hirosaki University; Yamagata University	Watanabe, T (corresponding author), Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata, Japan.	tewatana@med.id.yamagata-u.ac.jp	Daimon, Makoto/AAY-1289-2020; Kawasaki, Ryo/B-7266-2009; Kawasaki, Ryo/H-9716-2019; Ueno, Yoshiyuki/R-9242-2019; Konta, Tsuneo/AAO-9286-2021	Daimon, Makoto/0000-0002-3775-1719; Kawasaki, Ryo/0000-0002-7492-6303; Ueno, Yoshiyuki/0000-0001-5623-4250; 	Global COE in Japan; Molecular Epidemiological Study	Global COE in Japan; Molecular Epidemiological Study	This study was supported by the Molecular Epidemiological Study utilizing the resources of the Regional Characteristics of 21st Century Centers of Excellence (COE) Program and the Global COE in Japan.	Bachmann JM, 2012, CIRCULATION, V125, P3092, DOI 10.1161/CIRCULATIONAHA.111.065490; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; Charniot JC, 2011, FREE RADICAL RES, V45, P379, DOI 10.3109/10715762.2010.532792; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Christenson RH, 2010, CLIN CHEM, V56, P633, DOI 10.1373/clinchem.2009.129742; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Gao J, 2012, PFLUG ARCH EUR J PHY, V463, P297, DOI 10.1007/s00424-011-1036-0; Gray IC, 2000, HUM MOL GENET, V9, P2403, DOI 10.1093/hmg/9.16.2403; Greenwood TA, 2003, GENOMICS, V82, P511, DOI 10.1016/S0888-7543(03)00142-3; Hare JM, 2001, CIRC RES, V89, P198, DOI 10.1161/res.89.3.198; Jones DA, 2010, DIABETES RES CLIN PR, V90, P196, DOI 10.1016/j.diabres.2010.07.009; Kakko S, 2003, ATHEROSCLEROSIS, V168, P147, DOI 10.1016/S0021-9150(03)00091-1; Kao S. L., 2000, Annals Academy of Medicine Singapore, V29, P376; Kara K, 2014, CLIN RES CARDIOL, V103, P125, DOI 10.1007/s00392-013-0628-4; Kawai M, 2013, INTERNAL MED, V52, P171, DOI 10.2169/internalmedicine.52.8704; LaPointe MC, 2005, PEPTIDES, V26, P944, DOI 10.1016/j.peptides.2004.08.028; Lind C, 2014, CIRC-CARDIOVASC GENE, V7, P684, DOI 10.1161/CIRCGENETICS.114.000621; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McCarthy JJ, 2000, NAT BIOTECHNOL, V18, P505, DOI 10.1038/75360; Mohammedi K, 2011, MOL GENET METAB, V104, P654, DOI 10.1016/j.ymgme.2011.08.033; Musunuru K, 2008, CIRC-CARDIOVASC GENE, V1, P66, DOI 10.1161/CIRCGENETICS.108.813675; Neves AL, 2012, MOL GENET METAB, V106, P359, DOI 10.1016/j.ymgme.2012.04.023; Otaki Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094834; Takeishi Y, 2007, BIOCHEM BIOPH RES CO, V362, P480, DOI 10.1016/j.bbrc.2007.08.028; Tsutamoto T, 1997, CIRCULATION, V96, P509; van Kimmenade RRJ, 2009, J AM COLL CARDIOL, V53, P884, DOI 10.1016/j.jacc.2008.11.032; Wang L, 2014, BIOESSAYS, V36, P39, DOI 10.1002/bies.201300100; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Zhang YE, 2011, RESUSCITATION, V82, P1081, DOI 10.1016/j.resuscitation.2011.01.034	32	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164732	10.1371/journal.pone.0164732	http://dx.doi.org/10.1371/journal.pone.0164732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755600	gold, Green Submitted, Green Published			2022-12-26	WOS:000386203800031
J	Hoppins, JJ; Gruber, DR; Miears, HL; Kiryutin, AS; Kasymov, RD; Petrova, DV; Endutkin, AV; Popov, AV; Yurkovskaya, AV; Fedechkin, SO; Brockerman, JA; Zharkov, DO; Smirnov, SL				Hoppins, Joanna J.; Gruber, David R.; Miears, Heather L.; Kiryutin, Alexey S.; Kasymov, Rustem D.; Petrova, Darya V.; Endutkin, Anton V.; Popov, Alexander V.; Yurkovskaya, Alexandra V.; Fedechkin, Stanislav O.; Brockerman, Jacob A.; Zharkov, Dmitry O.; Smirnov, Serge L.			8-Oxoguanine Affects DNA Backbone Conformation in the EcoRI Recognition Site and Inhibits Its Cleavage by the Enzyme	PLOS ONE			English	Article							GRAPHICAL USER-INTERFACE; MOLECULAR-DYNAMICS; RESTRICTION-ENDONUCLEASE; OXIDATIVE DAMAGE; NUCLEIC-ACIDS; IONIZING-RADIATION; CRYSTAL-STRUCTURE; TOPOISOMERASE-I; FORCE-FIELD; REPAIR	8-oxoguanine is one of the most abundant and impactful oxidative DNA lesions. However, the reasons underlying its effects, especially those not directly explained by the altered base pairing ability, are poorly understood. We report the effect of the lesion on the action of EcoRI, a widely used restriction endonuclease. Introduction of 8-oxoguanine inside, or adjacent to, the GAATTC recognition site embedded within the Drew-Dickerson dodecamer sequence notably reduced the EcoRI activity. Solution NMR revealed that 8-oxoguanine in the DNA duplex causes substantial alterations in the sugar-phosphate backbone conformation, inducing a BI -> BII transition. Moreover, molecular dynamics of the complex suggested that 8-oxoguanine, although does not disrupt the sequence-specific contacts formed by the enzyme with DNA, shifts the distribution of BI/BII backbone conformers. Based on our data, we propose that the disruption of enzymatic cleavage can be linked with the altered backbone conformation and dynamics in the free oxidized DNA substrate and, possibly, at the protein-DNA interface.	[Hoppins, Joanna J.; Gruber, David R.; Miears, Heather L.; Fedechkin, Stanislav O.; Brockerman, Jacob A.; Smirnov, Serge L.] Western Washington Univ, Dept Chem, Bellingham, WA 98225 USA; [Kiryutin, Alexey S.; Yurkovskaya, Alexandra V.] SB RAS Int Tomog Ctr, Novosibirsk, Russia; [Kiryutin, Alexey S.; Petrova, Darya V.; Endutkin, Anton V.; Yurkovskaya, Alexandra V.; Zharkov, Dmitry O.] Novosibirsk State Univ, Novosibirsk, Russia; [Kasymov, Rustem D.; Petrova, Darya V.; Endutkin, Anton V.; Popov, Alexander V.; Zharkov, Dmitry O.] SB RAS Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Kasymov, Rustem D.] Univ Stuttgart, Inst Biochem, Stuttgart, Germany; [Fedechkin, Stanislav O.] Univ Calif Santa Cruz, Program Biomed Sci & Engn, Santa Cruz, CA 95064 USA; [Brockerman, Jacob A.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada	Western Washington University; International Tomography Center, Siberian Branch of Russian Academy of Sciences; Novosibirsk State University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; University of Stuttgart; University of California System; University of California Santa Cruz; University of British Columbia	Smirnov, SL (corresponding author), Western Washington Univ, Dept Chem, Bellingham, WA 98225 USA.; Zharkov, DO (corresponding author), Novosibirsk State Univ, Novosibirsk, Russia.; Zharkov, DO (corresponding author), SB RAS Inst Chem Biol & Fundamental Med, Novosibirsk, Russia.	dzharkov@niboch.nsc.ru; sergey.smimov@wwu.edu	Zharkov, Dmitry/K-2158-2012; Kiryutin, Alexey S/K-2059-2013; Endutkin, Anton V/G-6948-2013; Yurkovskaya, Alexandra V./S-6687-2016; Yurkovskaya, Alexandra/J-1966-2019	Zharkov, Dmitry/0000-0001-5013-0194; Kiryutin, Alexey S/0000-0001-8900-6318; Yurkovskaya, Alexandra V./0000-0002-2465-838X; Yurkovskaya, Alexandra/0000-0002-2465-838X; Endutkin, Anton/0000-0002-3647-6591	United States National Science Foundation (NSF) [1244641]; Russian Science Foundation [14-24-00093, 15-13-20035]; Russian Presidential Fellowship [SP- 673.2015.4]; Russian Ministry of Education and Science; NIGMS [P41-GM103311]; Direct For Biological Sciences [1244641] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	United States National Science Foundation (NSF)(National Science Foundation (NSF)); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Presidential Fellowship; Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research activity of SLS, DRG, JJH, HLM was supported by the United States National Science Foundation (NSF Award 1244641 to SLS). Enzyme kinetic studies and protein molecular dynamics were supported by Russian Science Foundation (14-24-00093 to DOZ). ASK and AVY acknowledge the Russian Science Foundation [grant No. 15-13-20035] for the NMR data collection. AVE is a recipient of the Russian Presidential Fellowship (SP- 673.2015.4). DOZ acknowledges the State Program of Research Support by the Russian Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research activity of SLS, DRG, JJH, HLM was supported by the United States National Science Foundation (NSF Award 1244641 to SLS). Enzyme kinetic studies and protein molecular dynamics were supported by Russian Science Foundation (14-24-00093 to DOZ). ASK and AVY acknowledge the Russian Science Foundation [grant No. 15-13-20035] for the NMR data collection. AVE is a recipient of the Russian Presidential Fellowship (SP- 673.2015.4). D.O.Z. acknowledges the State Program of Research Support by the Russian Ministry of Education and Science. Molecular graphics and analyses were performed with the UCSF Chimera developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS P41-GM103311). Computations were performed in part on the NKS-30T cluster at the SB RAS Supercomputing Center. Special thanks to Brennan Vanden Bos for help with the restrained molecular dynamics and Russell McFarland for assistance with proofreading the manuscript and figures.	Allinson SL, 2001, EMBO J, V20, P6919, DOI 10.1093/emboj/20.23.6919; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; BRENNAN CA, 1986, J BIOL CHEM, V261, P7270; Case DA, 2012, AMBER 12; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; CHO BP, 1993, MAGN RESON CHEM, V31, P1048, DOI 10.1002/mrc.1260311204; Collins A, 2002, CARCINOGENESIS, V23, P2129, DOI 10.1093/carcin/23.12.2129; Deibert M, 2000, NAT STRUCT BIOL, V7, P792, DOI 10.1038/79032; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DREW HR, 1981, P NATL ACAD SCI-BIOL, V78, P2179, DOI 10.1073/pnas.78.4.2179; Drsata T, 2013, J PHYS CHEM B, V117, P11617, DOI 10.1021/jp407562t; Du YF, 2009, FREE RADICAL BIO MED, V46, P492, DOI 10.1016/j.freeradbiomed.2008.11.003; Ghosh R, 1999, NUCLEIC ACIDS RES, V27, P3213, DOI 10.1093/nar/27.15.3213; Gilboa R, 2002, J BIOL CHEM, V277, P19811, DOI 10.1074/jbc.M202058200; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Gohda K, 1997, J BIOCHEM, V121, P219; Gorenstein DG, 1988, ASSIGNMENTS 31P NMR; GOYAL RN, 1982, J ELECTROANAL CHEM, V135, P75, DOI 10.1016/0022-0728(82)90006-7; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hailer-Morrison MK, 2003, BIOCHEMISTRY-US, V42, P9761, DOI 10.1021/bi034546k; HARE DR, 1983, J MOL BIOL, V171, P319, DOI 10.1016/0022-2836(83)90096-7; Heddi B, 2006, J AM CHEM SOC, V128, P9170, DOI 10.1021/ja061686j; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacob KD, 2013, MECH AGEING DEV, V134, P139, DOI 10.1016/j.mad.2013.02.008; JenJacobson L, 1995, METHOD ENZYMOL, V259, P305; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kamiya H, 2003, NUCLEIC ACIDS RES, V31, P517, DOI 10.1093/nar/gkg137; KIM YC, 1990, SCIENCE, V249, P1307, DOI 10.1126/science.2399465; KOUCHAKDJIAN M, 1991, BIOCHEMISTRY-US, V30, P1403, DOI 10.1021/bi00219a034; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Le Page F, 2000, CANCER RES, V60, P5548; Lesher DTT, 2002, P NATL ACAD SCI USA, V99, P12102, DOI 10.1073/pnas.192282699; LESSER DR, 1990, SCIENCE, V250, P776, DOI 10.1126/science.2237428; LIPSCOMB LA, 1995, P NATL ACAD SCI USA, V92, P719, DOI 10.1073/pnas.92.3.719; Loft S, 2008, BIOCHEM SOC T, V36, P1071, DOI 10.1042/BST0361071; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Maltseva DV, 2009, BIOCHEMISTRY-US, V48, P1361, DOI 10.1021/bi801947f; Miller JH, 2003, J AM CHEM SOC, V125, P6331, DOI 10.1021/ja029312n; Olinski R, 2003, MUTAT RES-FUND MOL M, V531, P177, DOI 10.1016/j.mrfmmm.2003.07.005; Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; Plum GE, 1995, BIOCHEMISTRY-US, V34, P16148, DOI 10.1021/bi00049a030; Popov AV, 2010, MOL BIOL+, V44, P648, DOI 10.1134/S0026893310040217; Popov AV, 2015, J BIOMOL STRUCT DYN, V33, P37, DOI 10.1080/07391102.2015.1032671; Popov AV, 2013, J COMPUT CHEM, V34, P319, DOI 10.1002/jcc.23135; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; RAVISHANKER G, 1997, REV COMP CH, V11, P317; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Rosati O, 2002, BIOCHEM BIOPH RES CO, V295, P198, DOI 10.1016/S0006-291X(02)00645-9; SKLENAR V, 1986, FEBS LETT, V208, P94, DOI 10.1016/0014-5793(86)81539-3; Trieb M, 2004, J PHYS CHEM B, V108, P2470, DOI 10.1021/jp037079p; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; TURK PW, 1995, CARCINOGENESIS, V16, P1253, DOI 10.1093/carcin/16.5.1253; TURK PW, 1995, FREE RADICAL RES, V23, P255, DOI 10.3109/10715769509064038; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Vorobjev YN, 2011, ADV PROTEIN CHEM STR, V85, P281, DOI 10.1016/B978-0-12-386485-7.00008-9; Wecker K, 2002, NUCLEIC ACIDS RES, V30, P4452, DOI 10.1093/nar/gkf559; WOOD ML, 1990, BIOCHEMISTRY-US, V29, P7024, DOI 10.1021/bi00482a011; Wright DJ, 1999, J BIOL CHEM, V274, P31896, DOI 10.1074/jbc.274.45.31896; Xu QS, 2005, PROTEIN SCI, V14, P2590, DOI 10.1110/ps.051565105	66	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164424	10.1371/journal.pone.0164424	http://dx.doi.org/10.1371/journal.pone.0164424			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749894	Green Published, Green Submitted, gold			2022-12-26	WOS:000386202300012
J	Willkomm, S; Zander, A; Grohmann, D; Restle, T				Willkomm, Sarah; Zander, Adrian; Grohmann, Dina; Restle, Tobias			Mechanistic Insights into Archaeal and Human Argonaute Substrate Binding and Cleavage Properties	PLOS ONE			English	Article							RISC-LOADING COMPLEX; RNAI ENZYME COMPLEX; DOUBLE-STRANDED-RNA; CRYSTAL-STRUCTURE; GUIDE-STRAND; SILENCING COMPLEX; STRUCTURAL BASIS; ARCHAEOGLOBUS-FULGIDUS; AEOLICUS ARGONAUTE; PASSENGER-STRAND	Argonaute (Ago) proteins from all three domains of life are key players in processes that specifically regulate cellular nucleic acid levels. Some of these Ago proteins, among them human Argonaute2 (hAgo2) and Ago from the archaeal organism Methanocaldococcus jannaschii (MjAgo), are able to cleave nucleic acid target strands that are recognised via an Ago-associated complementary guide strand. Here we present an in-depth kinetic side-by-side analysis of hAgo2 and MjAgo guide and target substrate binding as well as target strand cleavage, which enabled us to disclose similarities and differences in the mechanistic pathways as a function of the chemical nature of the substrate. Testing all possible guide-target combinations (i.e. RNA/RNA, RNA/DNA, DNA/RNA and DNA/DNA) with both Ago variants we demonstrate that the molecular mechanism of substrate association is highly conserved among archaeal-eukaryotic Argonautes. Furthermore, we show that hAgo2 binds RNA and DNA guide strands in the same fashion. On the other hand, despite striking homology between the two Ago variants, MjAgo cannot orientate guide RNA substrates in a way that allows interaction with the target DNA in a cleavage-compatible orientation.	[Willkomm, Sarah; Restle, Tobias] Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Mol Med, D-23538 Lubeck, Germany; [Willkomm, Sarah; Zander, Adrian; Grohmann, Dina] Univ Regensburg, Archaea Ctr, Inst Microbiol, Dept Biochem Genet & Microbiol, D-93053 Regensburg, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Regensburg	Restle, T (corresponding author), Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Mol Med, D-23538 Lubeck, Germany.	restle@imm.uni-luebeck.de			Graduate School for Computing in Medicine and Life Sciences at the University of Lubeck - Germany's Excellence Initiative [DFG GSC 235/1]; Deutsche Forschungsgemeinschaft [GR 3840/2-1]; University of Regensburg; University of Luebeck	Graduate School for Computing in Medicine and Life Sciences at the University of Lubeck - Germany's Excellence Initiative; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Regensburg; University of Luebeck	S. W. is supported by the Graduate School for Computing in Medicine and Life Sciences at the University of Lubeck funded by Germany's Excellence Initiative (DFG GSC 235/1). D. G. acknowledges funding by the Deutsche Forschungsgemeinschaft (GR 3840/2-1). D.G. and T.R. were supported by the Universities of Regensburg and Luebeck, respectively.	Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Conn GL, 1999, NUCLEIC ACIDS RES, V27, P555, DOI 10.1093/nar/27.2.555; Deerberg A, 2013, P NATL ACAD SCI USA, V110, P17850, DOI 10.1073/pnas.1217838110; Dornseifer S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1200; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Faehnle CR, 2013, CELL REP, V3, P1901, DOI 10.1016/j.celrep.2013.05.033; Faehnle CR, 2010, EMBO REP, V11, P564, DOI 10.1038/embor.2010.110; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Gottesman S, 2002, GENE DEV, V16, P2829, DOI 10.1101/gad.1030302; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hauptmann J, 2013, NAT STRUCT MOL BIOL, V20, P814, DOI 10.1038/nsmb.2577; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jung SR, 2013, J AM CHEM SOC, V135, P16865, DOI 10.1021/ja403138d; Klein RJ, 2002, P NATL ACAD SCI USA, V99, P7542, DOI 10.1073/pnas.112063799; Kwak PB, 2012, NAT STRUCT MOL BIOL, V19, P145, DOI 10.1038/nsmb.2232; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Lima WF, 2009, J BIOL CHEM, V284, P26017, DOI 10.1074/jbc.M109.010835; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Noland CL, 2011, MOL CELL, V43, P110, DOI 10.1016/j.molcel.2011.05.028; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rashid UJ, 2007, J BIOL CHEM, V282, P13824, DOI 10.1074/jbc.M608619200; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Schattner P, 2002, NUCLEIC ACIDS RES, V30, P2076, DOI 10.1093/nar/30.9.2076; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Schurmann N, 2013, NAT STRUCT MOL BIOL, V20, P818, DOI 10.1038/nsmb.2607; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501; Swarts DC, 2015, NUCLEIC ACIDS RES, V43, P5120, DOI 10.1093/nar/gkv415; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Willkomm Sarah, 2015, Life-Basel, V5, P538, DOI 10.3390/life5010538; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zander A, 2014, RNA BIOL, V11, P45, DOI 10.4161/rna.27446	57	15	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164695	10.1371/journal.pone.0164695	http://dx.doi.org/10.1371/journal.pone.0164695			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741323	Green Published, Green Submitted, gold			2022-12-26	WOS:000385507000058
J	Sekihara, S; Shibata, T; Hyakkendani, M; Kawabata, S				Sekihara, Sanae; Shibata, Toshio; Hyakkendani, Mai; Kawabata, Shun-ichiro			RNA Interference Directed against the Transglutaminase Gene Triggers Dysbiosis of Gut Microbiota in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-SYSTEM; HOST; MELANOGASTER; HOMEOSTASIS; PROVIDENCIA; BACTERIA; PROTEIN; MODEL; MUTUALISM; DUOX	We recently reported that transglutaminase (TG) suppresses immune deficiency pathway-controlled antimicrobial peptides (IMD-AMPs), thereby conferring immune tolerance to gut microbes, and that RNAi of the TG gene in flies decreases the lifespan compared with non-TG-RNAi flies. Here, analysis of the bacterial composition of the Drosophila gut by next-generation sequencing revealed that gut microbiota comprising one dominant genus of Acetobacter in non-TG-RNAi flies was shifted to that comprising two dominant genera of Acetobacter and Providencia in TG-RNAi flies. Four bacterial strains, including Acetobacter persici SK1 and Acetobacter indonesiensis SK2, Lactobacillus pentosus SK3, and Providencia rettgeri SK4, were isolated from the midgut of TG-RNAi flies. SK1 exhibited the highest resistance to the IMD-AMPs Cecropin A1 and Diptericin among the isolated bacteria. In contrast, SK4 exhibited considerably lower resistance against Cecropin A1, whereas SK4 exhibited high resistance to hypochlorous acid. The resistance of strains SK1-4 against IMD-AMPs in in vitro assays could not explain the shift of the microbiota in the gut of TG-RNAi flies. The lifespan was reduced in gnotobiotic flies that ingested both SK4 and SK1, concomitant with the production of reactive oxygen species and apoptosis in the midgut, whereas the survival rate was not altered in gnotobiotic flies that mono-ingested either SK4 or SK1. Interestingly, significant amounts of reactive oxygen species were detected in the midgut of gnotobiotic flies that ingested SK4 and SK2, concomitant with no significant apoptosis in the midgut. In gnotobiotic flies that co-ingested SK4 and SK1, an additional unknown factor(s) may be required to cause midgut apoptosis.	[Sekihara, Sanae; Shibata, Toshio; Kawabata, Shun-ichiro] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8190395, Japan; [Shibata, Toshio] Kyushu Univ, Inst Adv Study, Fukuoka 8190395, Japan; [Hyakkendani, Mai; Kawabata, Shun-ichiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8190395, Japan	Kyushu University; Kyushu University; Kyushu University	Kawabata, S (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8190395, Japan.	skawascb@kyudai.jp		Shibata, Toshio/0000-0003-0211-5525	Uehara Memorial Foundation; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development Fund (TT type) [26701];  [24570164];  [15H04353];  [24117712];  [26860333]	Uehara Memorial Foundation(Uehara Memorial Foundation); Kyushu University Interdisciplinary Programs in Education and Projects in Research Development Fund (TT type); ; ; ; 	This work was supported by Grant-in-Aid for Scientific Research (C) 24570164 (to S. K.); Grant-in-Aid for Scientific Research (B) 15H04353 (to S. K.); Grant-in-Aid for Scientific Research on Innovative Areas 24117712 (to S. K.); the Uehara Memorial Foundation (to S. K.); Grant-in-Aid for Young Scientists (B) 26860333 (to T. S.); and the Kyushu University Interdisciplinary Programs in Education and Projects in Research Development Fund (TT type) (Grant 26701) (to T. S.). The authors declare that they have no conflicts of interest regarding the content of this article.	Amir A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt1070; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Beninati S, 2004, AMINO ACIDS, V26, P367, DOI 10.1007/s00726-004-0091-7; Blum JE, 2013, MBIO, V4, DOI 10.1128/mBio.00860-13; Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Capo F, 2016, DEV COMP IMMUNOL, V64, P11, DOI 10.1016/j.dci.2016.01.001; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chambers MC, 2014, INFECT IMMUN, V82, P4380, DOI 10.1128/IAI.02415-14; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Conn H. J., 1957, MANUAL MICROBIOLOGIC, P99; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Elvin CM, 1996, J BIOL CHEM, V271, P8925, DOI 10.1074/jbc.271.15.8925; Erkosar B, 2014, FEBS LETT, V588, P4250, DOI 10.1016/j.febslet.2014.06.041; Fukuzaki S., 2007, J SURF FINISH SOC JP, V58, P465, DOI [10.4139/sfj.58.465, DOI 10.4139/SFJ.58.465]; Galac MR, 2011, MICROBES INFECT, V13, P673, DOI 10.1016/j.micinf.2011.02.005; Guinane CM, 2013, THER ADV GASTROENTER, V6, P295, DOI 10.1177/1756283X13482996; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hertig M, 1924, J MED RES, V44, P329; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; Kawabata S, 1996, J BIOCHEM-TOKYO, V120, P1253; Kawabata S, 2010, ADV EXP MED BIOL, V708, P122; Kim SH, 2014, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00116; KOPACEK P, 1993, EUR J BIOCHEM, V213, P591, DOI 10.1111/j.1432-1033.1993.tb17798.x; Kuraishi T, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00375; Lee KA, 2015, CELL HOST MICROBE, V17, P191, DOI 10.1016/j.chom.2014.12.012; Lee KA, 2014, DEV COMP IMMUNOL, V42, P102, DOI 10.1016/j.dci.2013.05.005; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; Lee WJ, 2014, NAT CHEM BIOL, V10, P416, DOI 10.1038/nchembio.1535; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Ma D, 2015, BIOMED J, V38, P285, DOI 10.4103/2319-4170.158620; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Senior BW, 1997, J MED MICROBIOL, V46, P524, DOI 10.1099/00222615-46-6-524; Shibata T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005244; Shibata T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003970; Shibata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013477; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Somvanshi VS, 2006, INT J SYST EVOL MICR, V56, P629, DOI 10.1099/ijs.0.63973-0; Spasova DS, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00318; Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Urano H, 2006, J BIOSCI BIOENG, V102, P457, DOI 10.1263/jbb.102.457; Wong ACN, 2015, APPL ENVIRON MICROB, V81, P6232, DOI 10.1128/AEM.01442-15; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Yoh M, 2005, J MED MICROBIOL, V54, P1077, DOI 10.1099/jmm.0.45846-0	57	9	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25077	25087		10.1074/jbc.M116.761791	http://dx.doi.org/10.1074/jbc.M116.761791			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27760824	Green Published, hybrid			2022-12-26	WOS:000388880100023
J	Wright, M; Adams, J; Yang, K; McManus, P; Jacobson, A; Gade, A; McLean, J; Britt, D; Anderson, A				Wright, Melanie; Adams, Joshua; Yang, Kwang; McManus, Paul; Jacobson, Astrid; Gade, Aniket; McLean, Joan; Britt, David; Anderson, Anne			A Root-Colonizing Pseudomonad Lessens Stress Responses in Wheat Imposed by CuO Nanoparticles	PLOS ONE			English	Article							COPPER-OXIDE NANOPARTICLES; GLUTATHIONE-S-TRANSFERASES; CHLORORAPHIS O6; SOIL BACTERIUM; NITRIC-OXIDE; NANO-CUO; PLANT; GROWTH; GENE; ZNO	Nanoparticle (NPs) containing essential metals are being considered in formulations of fertilizers to boost plant nutrition in soils with low metal bioavailability. This paper addresses whether colonization of wheat roots by the bacterium, Pseudomonas chlororaphis O6 (PcO6), protected roots from the reduced elongation caused by CuO NPs. There was a trend for slightly elongated roots when seedlings with roots colonized by PcO6 were grown with CuO NPs; the density of bacterial cells on the root surface was not altered by the NPs. Accumulations of reactive oxygen species in the plant root cells caused by CuO NPs were little affected by root colonization. However, bacterial colonization did reduce the extent of expression of an array of genes associated with plant responses to stress induced by root exposure to CuO NPs. PcO6 colonization also reduced the levels of two important chelators of Cu ions, citric and malic acids, in the rhizosphere solution; presumably because these acids were used as nutrients for bacterial growth. There was a trend for lower levels of soluble Cu in the rhizosphere solution and reduced Cu loads in the true leaves with PcO6 colonization. These studies indicate that root colonization by bacterial cells modulates plant responses to contact with CuO NPs.	[Wright, Melanie; Yang, Kwang; Gade, Aniket; Anderson, Anne] Utah State Univ, Dept Biol Engn, Logan, UT 84322 USA; [Adams, Joshua; Britt, David] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [McManus, Paul; McLean, Joan] Utah State Univ, Utah Water Res Lab, Logan, UT 84321 USA; [Jacobson, Astrid] Utah State Univ, Plants Soils & Climate, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Anderson, A (corresponding author), Utah State Univ, Dept Biol Engn, Logan, UT 84322 USA.	anne.Anderson@usu.edu	Gade, Aniket Krishnarao/C-5656-2016; Gade, Aniket/AAG-4974-2021	Gade, Aniket Krishnarao/0000-0002-1966-999X; Gade, Aniket/0000-0002-1966-999X; Britt, David/0000-0002-9753-6404	United States Department of Agriculture (USDA-CSREES) [2011-03581]; Utah Agricultural Experiment Station; Utah Water Research Laboratory	United States Department of Agriculture (USDA-CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Utah Agricultural Experiment Station; Utah Water Research Laboratory	AA, DB and JM are grateful to the United States Department of Agriculture (USDA-CSREES) grant 2011-03581, M and DB to support from the Utah Agricultural Experiment Station, and JM to funds from the Utah Water Research Laboratory. Utah Agricultural Experiment Station (Journal Paper 8921). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2016, PLANT PHYSL IN PRESS; Anderson AJ, 2001, CAN J MICROBIOL, V47, P222, DOI 10.1139/cjm-47-3-222; BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1016/j.chiabu.2021.105188; Cheloni G, 2013, CYTOM PART A, V83, P952, DOI 10.1002/cyto.a.22338; Cho SM, 2008, MOL PLANT MICROBE IN, V21, P1067, DOI 10.1094/MPMI-21-8-1067; Cho SM, 2013, PLANT PATHOLOGY J, V29, P427, DOI 10.5423/PPJ.OA.07.2013.0069; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Dimkpa CO, 2015, ECOTOXICOLOGY, V24, P119, DOI 10.1007/s10646-014-1364-x; Dimkpa CO, 2014, J BASIC MICROB, V54, P889, DOI 10.1002/jobm.201400298; Dimkpa CO, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1125-9; Dimkpa CO, 2012, NANOTOXICOLOGY, V6, P635, DOI 10.3109/17435390.2011.598246; Dimkpa CO, 2012, APPL ENVIRON MICROB, V78, P1404, DOI 10.1128/AEM.07424-11; Dimkpa CO, 2011, ENVIRON POLLUT, V159, P1749, DOI 10.1016/j.envpol.2011.04.020; Durenkamp M, 2016, ENVIRON POLLUT, V211, P399, DOI 10.1016/j.envpol.2015.12.063; Ebbs SD, 2015, ENV SCI NANO; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Feng H, 2014, MOL PLANT PATHOL, V15, P284, DOI 10.1111/mpp.12089; Fierens E, 2007, BIOCHEM J, V403, P583, DOI 10.1042/BJ20061291; Gade A, 2016, BIOMETALS, V29, P211, DOI 10.1007/s10534-015-9906-0; Gamalero E, 2015, PLANT PHYSIOL, V169, P13, DOI 10.1104/pp.15.00284; Gimenez MJ, 2011, PLANTA, V233, P163, DOI 10.1007/s00425-010-1290-y; Glick BR, 2011, INT J PHYTOREMEDIAT, V13, P4, DOI 10.1080/15226514.2011.568533; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Housley L, 2009, FEMS MICROBIOL LETT, V293, P148, DOI 10.1111/j.1574-6968.2009.01528.x; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Kang BR, 2004, GENE, V325, P137, DOI 10.1016/j.gene.2003.10.004; Keller A.A., 2013, J NANOPART RES, V15; Kim MS, 2004, PLANT BIOLOGY, V6, P105, DOI 10.1055/s-2004-817803; Kim YC, 2011, APPL ENVIRON MICROB, V77, P1548, DOI 10.1128/AEM.01867-10; Kopittke PM, 2011, ENVIRON SCI TECHNOL, V45, P4966, DOI 10.1021/es1041404; Kovacik J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091685; Landa P, 2015, ENVIRON SCI TECHNOL, V49, P14537, DOI 10.1021/acs.est.5b03330; Liu B, 2010, MOL BIOL REP, V37, P1045, DOI 10.1007/s11033-009-9823-9; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Ma JF, 1996, PHYSIOL PLANTARUM, V97, P609, DOI 10.1111/j.1399-3054.1996.tb00522.x; Ma Y, 2011, BIOTECHNOL ADV, V29, P248, DOI 10.1016/j.biotechadv.2010.12.001; Martineau N, 2014, ENVIRON POLLUT, V187, P65, DOI 10.1016/j.envpol.2013.12.022; MAUCH F, 1993, PLANT PHYSIOL, V102, P1193, DOI 10.1104/pp.102.4.1193; McLean JE, 2013, CHEMOSPHERE, V91, P374, DOI 10.1016/j.chemosphere.2012.11.071; Nair PMG, 2015, ECOTOX ENVIRON SAFE, V113, P302, DOI 10.1016/j.ecoenv.2014.12.013; Nian H, 2002, PHYSIOL PLANTARUM, V116, P328, DOI 10.1034/j.1399-3054.2002.1160307.x; Palmqvist NGM, 2015, SCI REP-UK, V5, DOI 10.1038/srep10146; Peng C, 2015, ENVIRON TOXICOL CHEM, V34, P1996, DOI 10.1002/etc.3016; RADTKE C, 1994, APPL MICROBIOL BIOT, V41, P274, DOI 10.1007/BF00186972; Rajkumar M, 2012, BIOTECHNOL ADV, V30, P1562, DOI 10.1016/j.biotechadv.2012.04.011; Sandalio LM, 2008, METHOD ENZYMOL, V440, P397, DOI 10.1016/S0076-6879(07)00825-7; Serra DO, 2014, ENVIRON MICROBIOL, V16, P1455, DOI 10.1111/1462-2920.12483; Shaw AK, 2013, CHEMOSPHERE, V93, P906, DOI 10.1016/j.chemosphere.2013.05.044; Shi JY, 2014, NANOTOXICOLOGY, V8, P179, DOI 10.3109/17435390.2013.766768; Spencer M, 2003, PHYSIOL MOL PLANT P, V63, P27, DOI 10.1016/j.pmpp.2003.09.002; Tang YL, 2016, ENVIRON POLLUT, V212, P605, DOI 10.1016/j.envpol.2016.03.019; Truernit E, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-15; Wang ZY, 2012, ENVIRON SCI TECHNOL, V46, P4434, DOI 10.1021/es204212z; Weyens N, 2009, TRENDS BIOTECHNOL, V27, P591, DOI 10.1016/j.tibtech.2009.07.006; Wu SW, 2007, MOL BIOTECHNOL, V36, P102, DOI 10.1007/s12033-007-0009-1; Zabrieski Z, 2015, ECOTOXICOLOGY, V24, P1305, DOI 10.1007/s10646-015-1505-x; Zhao CR, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-32	59	12	13	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164634	10.1371/journal.pone.0164635	http://dx.doi.org/10.1371/journal.pone.0164635			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776146	Green Published, gold, Green Submitted			2022-12-26	WOS:000389009200017
J	Detree, C; Nunez-Acuana, G; Roberts, S; Gallardo-Escarate, C				Detree, Camille; Nunez-Acuana, Gustavo; Roberts, Steven; Gallardo-Escarate, Cristian			Uncovering the Complex Transcriptome Response of Mytilus chilensis against Saxitoxin: Implications of Harmful Algal Blooms on Mussel Populations	PLOS ONE			English	Article							OYSTER CRASSOSTREA-GIGAS; TOLL-LIKE RECEPTORS; PROROCENTRUM-MINIMUM; PARALYTIC SHELLFISH; ALEXANDRIUM-MINUTUM; GENE-EXPRESSION; RUDITAPES-PHILIPPINARUM; TOXIC DINOFLAGELLATE; PERKINSUS-OLSENI; VARYING PARASITE	Saxitoxin (STX), a principal phycotoxin contributing to paralytic shellfish poisoning, is largely produced by marine microalgae of the genus Alexandrium. This toxin affects a wide range of species, inducing massive deaths in fish and other marine species. However, marine bivalves can resist and accumulate paralytic shellfish poisons. Despite numerous studies on the impact of STX in marine bivalves, knowledge regarding STX recognition at molecular level by benthic species remains scarce. Therefore, the aim of this study was to identify novel genes that interact with STX in the Chilean mussel Mytilus chilensis. For this, RNA-seq and RT-qPCR approaches were used to evaluate the transcriptomic response of M. chilensis to a purified STX as well as in vivo Alexandrium catenella exposure. Approximately 800 million reads were assembled, generating 138,883 contigs that were blasted against the UniProt Mollusca database. Pattern Recognition Receptors (PRRs) involved in mussel immunity, such as Toll-like receptors, tumor necrosis factor receptors, and scavenger-like receptors were found to be strongly upregulated at 8 and 16 h post-STX injection. These results suggest an involvement of PRRs in the response to STX, as well as identifying potential, novel STX-interacting receptors in this Chilean mussel. This study is the first transcriptomic overview of the STX-response in the edible species M. chilensis. However, the most significant contribution of this work is the identification of immune receptors and pathways potentially involved in the recognition and defense against STX's toxicity and its impact of harmful algae blooms on wild and cultivated mussel populations.	[Detree, Camille; Nunez-Acuana, Gustavo; Gallardo-Escarate, Cristian] Univ Concepcion, Lab Biotechnol & Aquat Genom, Interdisciplinary Ctr Aquaculture Res INCAR, Concepcion, Chile; [Roberts, Steven] Univ Washington, Sch Aquat & Fishery Sci SAFS, Seattle, WA 98195 USA	Universidad de Concepcion; University of Washington; University of Washington Seattle	Gallardo-Escarate, C (corresponding author), Univ Concepcion, Lab Biotechnol & Aquat Genom, Interdisciplinary Ctr Aquaculture Res INCAR, Concepcion, Chile.	crisgallardo@udec.cl	Detree, Camille/P-7073-2019; Gallardo-Escárate, Cristian/AAE-8980-2022	Gallardo-Escárate, Cristian/0000-0002-7094-6702; Nunez-Acuna, Gustavo/0000-0003-2568-0332; Roberts, Steven/0000-0001-8302-1138; Detree, Camille/0000-0001-5518-2380	Conicyt-Chile [FONDECYT 1120397, FONDAP 15110027]	Conicyt-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This study was funded by FONDECYT 1120397 and FONDAP 15110027 grants awarded by Conicyt-Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao JQ, 2007, MOL IMMUNOL, V44, P2541, DOI 10.1016/j.molimm.2006.12.024; Astuya A, 2015, INT J MOL SCI, V16, P15235, DOI 10.3390/ijms160715235; Blanco J, 2006, AQUAT LIVING RESOUR, V19, P267, DOI 10.1051/alr:2006027; Bricelj V. Monica, 1998, Reviews in Fisheries Science, V6, P315, DOI 10.1080/10641269891314294; da Silva PM, 2008, TOXICON, V51, P563, DOI 10.1016/j.toxicon.2007.11.006; Dizer H, 2001, AQUAT TOXICOL, V55, P149, DOI 10.1016/S0166-445X(01)00178-3; Estrada N, 2010, MAR BIOL, V157, P1401, DOI 10.1007/s00227-010-1418-4; Galimany E, 2008, HARMFUL ALGAE, V7, P702, DOI 10.1016/j.hal.2008.02.006; Garcia-Lagunas N, 2015, J MOLLUS STUD; Gerdol M, 2015, FISH SHELLFISH IMMUN, V46, P17, DOI 10.1016/j.fsi.2015.02.013; Gerdol Marco, 2014, BMC Research Notes, V7, P722, DOI 10.1186/1756-0500-7-722; Hegaret H, 2005, HARMFUL ALGAE, V4, P201, DOI 10.1016/j.hal.2003.12.005; Hegaret H, 2005, HARMFUL ALGAE, V4, P187, DOI 10.1016/j.hal.2003.12.004; Hegaret H, 2007, AQUAT TOXICOL, V84, P469, DOI 10.1016/j.aquatox.2007.07.007; Hegaret H, 2011, CELL BIOL TOXICOL, V27, P249, DOI 10.1007/s10565-011-9186-6; Hegaret H, 2010, MAR ENVIRON RES, V69, P337, DOI 10.1016/j.marenvres.2009.12.008; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Klemas V, 2011, J COASTAL RES, V27, P2, DOI 10.2112/JCOASTRES-D-10-00103.1; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lagos N, 1998, BIOL RES, V31, P375; Lassus P, 2004, AQUAT LIVING RESOUR, V17, P207, DOI 10.1051/alr:2004012; Liu L, 2011, DEV COMP IMMUNOL, V35, P227, DOI 10.1016/j.dci.2010.09.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llewellyn LE, 2006, NAT PROD REP, V23, P200, DOI 10.1039/b501296c; Mat AM, 2013, AQUAT TOXICOL, V140, P458, DOI 10.1016/j.aquatox.2013.07.008; Mello DF, 2013, HARMFUL ALGAE, V26, P45, DOI 10.1016/j.hal.2013.03.003; Mello DF, 2010, TOXINS, V2, P1166, DOI 10.3390/toxins2051166; Morono A, 2001, J EXP MAR BIOL ECOL, V257, P117, DOI 10.1016/S0022-0981(00)00336-1; Narahashi T, 1988, MECH TETRODOTOXIN SA; Nunez-Acuna G., 2013, J MOLLUS STUD; Perovic S, 2000, ENVIRON TOXICOL PHAR, V8, P83, DOI 10.1016/S1382-6689(99)00035-6; Philipp EER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033091; Rodrigues SM, 2012, TOXICON, V59, P558, DOI 10.1016/j.toxicon.2012.01.004; Samson JC, 2008, J FISH BIOL, V72, P168, DOI 10.1111/j.1095-8649.2007.01698.x; Shumway SE, 2006, HARMFUL ALGAE, V5, P442, DOI 10.1016/j.hal.2006.04.013; Silva CAd Morais ECPd, 2014, TOXICON, V86, P8, DOI [10.1016/j.toxicon.2014.04.016, DOI 10.1016/J.TOXICON.2014.04.016]; de Assis HCS, 2013, TOXICON, V66, P25, DOI 10.1016/j.toxicon.2013.01.012; Suarez-Ulloa V, 2015, PEERJ, V3, DOI 10.7717/peerj.1429; Sun Y, 2014, DEV COMP IMMUNOL, V45, P291, DOI 10.1016/j.dci.2014.03.007; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Takle H, 2007, J FISH BIOL, V71, P326, DOI 10.1111/j.1095-8649.2007.01665.x; Thottumkara AP, 2014, ANGEW CHEM INT EDIT, V53, P5760, DOI 10.1002/anie.201308235; Toubiana M, 2014, DEV COMP IMMUNOL, V45, P300, DOI 10.1016/j.dci.2014.03.021; Toubiana M, 2013, DEV COMP IMMUNOL, V40, P158, DOI 10.1016/j.dci.2013.02.006; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Vale P, 2010, PHYTOCHEM REV, V9, P525, DOI 10.1007/s11101-010-9196-7; Venier P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-69; Wang DZ, 2008, MAR DRUGS, V6, P349, DOI 10.3390/md20080016; Zhang R, 2015, FISH SHELLFISH IMMUN, V44, P547, DOI 10.1016/j.fsi.2015.03.015	50	23	24	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165231	10.1371/journal.pone.0165231	http://dx.doi.org/10.1371/journal.pone.0165231			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764234	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204500137
J	Sugawara, K; Honda, K; Reien, Y; Yokoi, N; Seki, C; Takahashi, H; Minami, K; Mori, I; Matsumoto, A; Nakaya, H; Seino, S				Sugawara, Kenji; Honda, Kohei; Reien, Yoshie; Yokoi, Norihide; Seki, Chihiro; Takahashi, Harumi; Minami, Kohtaro; Mori, Ichiro; Matsumoto, Akio; Nakaya, Haruaki; Seino, Susumu			A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agen	PLOS ONE			English	Article							SENSITIVE K+ CHANNELS; PANCREATIC BETA-CELL; SULFONYLUREA RECEPTOR; POTASSIUM CHANNELS; GK RAT; SECRETION; GLUCOSE; DRUG; SELECTIVITY; METABOLISM	Insulin secretagogues are used for treatment of type 2 diabetes. We attempted to discover novel small molecules to stimulate insulin secretion by using in silico similarity search using sulfonylureas as query, followed by measurement of insulin secretion. Among 38 compounds selected by in silico similarity search, we found three diphenylsemicarbazides and one quinolone that stimulate insulin secretion. We focused on compound 8 (C8), which had the strongest insulin-secreting effect. Based on the structure-activity relationship of C8 derivatives, we identified diphenylthiosemicarbazide (DSC) 108 as the most potent secretagogue. DSC108 increased the intracellular Ca2+ level in MINE-K8 cells. Competitive inhibition experiment and electrophysiological analysis revealed sulfonylurea receptor 1 (SUR1) to be the target of DSC108 and that this diphenylthiosemicarbazide directly inhibits ATP sensitive K+ (K-ATP) channels. Pharmacokinetic analysis showed that DSC108 has a short half-life in vivo. Oral administration of DSC108 significantly suppressed the rises in blood glucose levels after glucose load in wild-type mice and improved glucose tolerance in the Goto-Kakizaki (GK) rat, a model of type 2 diabetes with impaired insulin secretion. Our data indicate that DSC108 is a novel insulin secretagogue, and is a lead compound for development of a new anti-diabetic agent.	[Sugawara, Kenji; Honda, Kohei; Yokoi, Norihide; Seki, Chihiro; Takahashi, Harumi; Minami, Kohtaro; Seino, Susumu] Kobe Univ, Grad Sch Med, Div Mol & Metab Med, Kobe, Hyogo, Japan; [Sugawara, Kenji] Kobe Univ, Grad Sch Med, Div Diabet & Endocrinol, Kobe, Hyogo, Japan; [Reien, Yoshie; Matsumoto, Akio; Nakaya, Haruaki] Chiba Univ, Grad Sch Med, Dept Pharmacol, Chiba, Japan; [Mori, Ichiro] Kobe Univ, Grad Sch Sci Technol & Innovat, Div Adv Med Sci, Kobe, Hyogo, Japan	Kobe University; Kobe University; Chiba University; Kobe University	Seino, S (corresponding author), Kobe Univ, Grad Sch Med, Div Mol & Metab Med, Kobe, Hyogo, Japan.	seino@med.kobe-u.ac.jp		Matsumoto, Akio/0000-0002-3402-6992; Minami, Kohtaro/0000-0003-4698-6250	Ministry of Education, Culture, Sports, Science and Technology, Japan; MSD; Japan Association for Diabetes Education and Care; Grants-in-Aid for Scientific Research [15K06800, 16K09749] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MSD; Japan Association for Diabetes Education and Care; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This study was also supported in part by a research grant from MSD K.K. to SS and by a grant for Young Researchers from the Japan Association for Diabetes Education and Care to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AMIDON GL, 1995, PHARMACEUT RES, V12, P413, DOI 10.1023/A:1016212804288; Ashcroft FM, 2000, TRENDS PHARMACOL SCI, V21, P439; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Barg S, 1999, P NATL ACAD SCI USA, V96, P5539, DOI 10.1073/pnas.96.10.5539; Blickle JF, 2006, DIABETES METAB, V32, P113, DOI 10.1016/S1262-3636(07)70257-4; Braga RC, 2014, CURR TOP MED CHEM, V14, P1899, DOI 10.2174/1568026614666140929120749; Drwal Malgorzata N, 2013, Drug Discov Today Technol, V10, pe395, DOI 10.1016/j.ddtec.2013.02.002; Ewing T, 2006, J CHEM INF MODEL, V46, P2423, DOI 10.1021/ci060155b; GOTO Y, 1975, P JPN ACAD, V51, P80, DOI 10.2183/pjab1945.51.80; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Iwasaki M, 2010, J DIABETES INVEST, V1, P137, DOI 10.1111/j.2040-1124.2010.00026.x; Leuner C, 2000, EUR J PHARM BIOPHARM, V50, P47, DOI 10.1016/S0939-6411(00)00076-X; Miki T, 2005, DIABETES, V54, P1056, DOI 10.2337/diabetes.54.4.1056; MOGAMI H, 1994, EUR J PHARM-MOLEC PH, V269, P293, DOI 10.1016/0922-4106(94)90036-1; Nagashima K, 2004, DIABETES RES CLIN PR, V66, pS75, DOI 10.1016/j.diabres.2003.12.011; Nyenwe EA, 2011, METABOLISM, V60, P1, DOI 10.1016/j.metabol.2010.09.010; OHNOTA H, 1994, J PHARMACOL EXP THER, V269, P489; OSTENSON CG, 1993, DIABETOLOGIA, V36, P3, DOI 10.1007/BF00399086; OZANNE SE, 1995, DIABETOLOGIA, V38, P277; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Remedi MS, 2009, CELL METAB, V10, P442, DOI 10.1016/j.cmet.2009.10.011; Remko M, 2009, J MOL STRUC-THEOCHEM, V897, P73, DOI 10.1016/j.theochem.2008.11.021; Renstrom E, 2002, DIABETES, V51, pS33, DOI 10.2337/diabetes.51.2007.S33; SAKURA H, 1995, FEBS LETT, V367, P193, DOI 10.1016/0014-5793(95)00498-X; Seino S, 2012, DIABETES OBES METAB, V14, P9, DOI 10.1111/j.1463-1326.2011.01507.x; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Stein SA, 2013, EXPERT OPIN DRUG SAF, V12, P153, DOI 10.1517/14740338.2013.752813; Sunaga Y, 2001, EUR J PHARMACOL, V431, P119, DOI 10.1016/S0014-2999(01)01412-1; Takahashi H, 2015, DIABETES, V64, P1262, DOI 10.2337/db14-0576; Takahashi T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004581; Thule PM, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0473-5; TSUURA Y, 1993, DIABETES, V42, P1446, DOI 10.2337/diabetes.42.10.1446; Zhang CL, 2009, SCIENCE, V325, P607, DOI 10.1126/science.1172256	38	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164785	10.1371/journal.pone.0164785	http://dx.doi.org/10.1371/journal.pone.0164785			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764176	gold, Green Published			2022-12-26	WOS:000386204500063
J	Zihajehzadeh, S; Park, EJ				Zihajehzadeh, Shaghayegh; Park, Edward J.			Regression Model-Based Walking Speed Estimation Using Wrist-Worn Inertial Sensor	PLOS ONE			English	Article							GAIT-SPEED; TRACKING	Walking speed is widely used to study human health status. Wearable inertial measurement units (IMU) are promising tools for the ambulatory measurement of walking speed. Among wearable inertial sensors, the ones worn on the wrist, such as a watch or band, have relatively higher potential to be easily incorporated into daily lifestyle. Using the arm swing motion in walking, this paper proposes a regression model-based method for longitudinal walking speed estimation using a wrist-worn IMU. A novel kinematic variable is proposed, which finds the wrist acceleration in the principal axis (i.e. the direction of the arm swing). This variable (called pca-acc) is obtained by applying sensor fusion on IMU data to find the orientation followed by the use of principal component analysis. An experimental evaluation was performed on 15 healthy young subjects during free walking trials. The experimental results show that the use of the proposed pca-acc variable can significantly improve the walking speed estimation accuracy when compared to the use of raw acceleration information (p< 0.01). When Gaussian process regression is used, the resulting walking speed estimation accuracy and precision is about 5.9% and 4.7%, respectively.	[Zihajehzadeh, Shaghayegh; Park, Edward J.] Simon Fraser Univ, Sch Mechatron Syst Engn, 250-13450 102nd Ave, Surrey, BC V3T 0A3, Canada	Simon Fraser University	Park, EJ (corresponding author), Simon Fraser Univ, Sch Mechatron Syst Engn, 250-13450 102nd Ave, Surrey, BC V3T 0A3, Canada.	ed_park@sfu.ca		Zihajehzadeh, Shaghayegh/0000-0002-5909-1387	Natural Sciences and Engineering Research Council of Canada [SPG/430592-2012]; Vanier Canada Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Vanier Canada Graduate Scholarship	This work was fully funded by the Natural Sciences and Engineering Research Council of Canada (http.//www.nserc-crsng.gc.ca/): SPG/430592-2012, and Vanier Canada Graduate Scholarship. The funder provided support in the form of salaries for the first author [SZ] and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abe Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151037; AKL A, 2015, P IEEE ENG MED BIOL, P5175; Akl A, 2015, IEEE T BIO-MED ENG, V62, P1383, DOI 10.1109/TBME.2015.2389149; Altini M, 2014, INT CONF PERVAS COMP, P10, DOI 10.1109/PerComW.2014.6815158; Bautmans I, 2011, GAIT POSTURE, V33, P366, DOI 10.1016/j.gaitpost.2010.12.003; Bayle N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152469; Dadashi F, 2015, PERVASIVE MOB COMPUT, V19, P37, DOI 10.1016/j.pmcj.2014.03.001; Dodge HH, 2012, NEUROLOGY, V78, P1946, DOI 10.1212/WNL.0b013e318259e1de; Elhoushi M, 2016, IEEE T INSTRUM MEAS, V65, P208, DOI 10.1109/TIM.2015.2477159; Enright PL, 2003, CHEST, V123, P387, DOI 10.1378/chest.123.2.387; Foxlin E, 2005, IEEE COMPUT GRAPH, V25, P38, DOI 10.1109/MCG.2005.140; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; Greene BR, 2012, IEEE T BIO-MED ENG, V59, P988, DOI 10.1109/TBME.2011.2181844; Hagler S, 2010, IEEE T BIO-MED ENG, V57, P813, DOI 10.1109/TBME.2009.2036732; Harshvardhan V, 2010, P 4 INT C PERV COMP, P1, DOI DOI 10.4108/ICST.PERVASIVEHEALTH2010.8786; Heesen C, 2008, MULT SCLER, V14, P988, DOI 10.1177/1352458508088916; Hu JS, 2013, IEEE T BIO-MED ENG, V60, P2271, DOI 10.1109/TBME.2013.2252345; JACOBS PG, 2014, P 36 ANN INT C IEEE, P914; Jiang Y, 2017, IEEE T IND INFORM, V13, P1900, DOI 10.1109/TII.2016.2573762; Jiang Y, 2016, COMP MED SY, P60, DOI 10.1109/CBMS.2016.8; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Laudanski A, 2011, IEEE ENG MED BIO, P3484, DOI 10.1109/IEMBS.2011.6090941; Lee JK, 2012, IEEE T INSTRUM MEAS, V61, P2262, DOI 10.1109/TIM.2012.2187245; Lee JK, 2009, IEEE T BIO-MED ENG, V56, P1574, DOI 10.1109/TBME.2008.2001285; Ligorio G, 2015, IEEE T BIO-MED ENG, V62, P2033, DOI 10.1109/TBME.2015.2411431; LOH D, 2015, P IEEE ENG MED BIOL, P502; Maggio M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153583; Meng XL, 2013, IEEE T BIO-MED ENG, V60, P2052, DOI 10.1109/TBME.2013.2248085; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Robertson DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123260; Schimpl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023299; Schimpl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023080; Skog I, 2010, IEEE T BIO-MED ENG, V57, P2657, DOI 10.1109/TBME.2010.2060723; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vaney C, 1996, CLIN REHABIL, V10, P216, DOI DOI 10.1177/026921559601000306; Vathsangam H., 2011, 2011 5th International Conference on Pervasive Computing Technologies for Healthcare (PervasiveHealth 2011), P168, DOI 10.4108/icst.pervasivehealth.2011.246026; Vathsangam H, 2011, IEEE T BIO-MED ENG, V58, P2804, DOI 10.1109/TBME.2011.2159840; Wang F, 2013, IEEE J BIOMED HEALTH, V17, P346, DOI 10.1109/JBHI.2012.2233745; Zhang Y, 2014, IEEE INTERNET THINGS, V1, P311, DOI 10.1109/JIOT.2014.2329462; Zihajehzadeh S, 2016, P IEEE ENG MED BIOL; ZIHAJEHZADEH S, 2014, P IEEE ENG MED BIOL, P6270; Zihajehzadeh S, 2017, IEEE T SYST MAN CY-S, V47, P927, DOI 10.1109/TSMC.2016.2521823; Zihajehzadeh S, 2015, MEASUREMENT, V73, P200, DOI 10.1016/j.measurement.2015.05.023; Zihajehzadeh S, 2015, IEEE T INSTRUM MEAS, V64, P804, DOI 10.1109/TIM.2014.2359813	46	40	40	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165211	10.1371/journal.pone.0165211	http://dx.doi.org/10.1371/journal.pone.0165211			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764231	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500136
J	Delagnes, A; Schmidt, P; Douze, K; Wurz, S; Bellot-Gurlet, L; Conard, NJ; Nickel, KG; van Niekerk, KL; Henshilwood, CS				Delagnes, Anne; Schmidt, Patrick; Douze, Katja; Wurz, Sarah; Bellot-Gurlet, Ludovic; Conard, Nicholas J.; Nickel, Klaus G.; van Niekerk, Karen L.; Henshilwood, Christopher S.			Early Evidence for the Extensive Heat Treatment of Silcrete in the Howiesons Poort at Klipdrift Shelter (Layer PBD, 65 ka), South Africa	PLOS ONE			English	Article							MIDDLE STONE-AGE; DIEPKLOOF ROCK SHELTER; MODERN HUMAN-BEHAVIOR; BLOMBOS CAVE; WESTERN CAPE; COMPLEX COGNITION; KLASIES RIVER; TECHNOLOGY; SEQUENCE; TOOL	Heating stone to enhance its flaking qualities is among the multiple innovative adaptations introduced by early modern human groups in southern Africa, in particular during the Middle Stone Age Still Bay and Howiesons Poort traditions. Comparatively little is known about the role and impact of this technology on early modern human behaviors and cultural expressions, due, in part, to the lack of comprehensive studies of archaeological assemblages documenting the heat treatment of stone. We address this issue through an analysis of the procedure used for heating and a technological analysis of a lithic assemblage recovered from one Howiesons Poort assemblage at Klipdrift Shelter (southern Cape, South Africa). The resulting data show extensive silcrete heat treatment, which adds a new dimension to our understanding of fire-related behaviors during the Howiesons Poort, highlighting the important role played by a heat treatment stage in the production of silcrete blades. These results are made possible by our new analytical procedure that relies on the analysis of all silcrete artifacts. It provides direct evidence of a controlled use of fire which took place during an early stage of core exploitation, thereby impacting on all subsequent stages of the lithic chaine operatoire, which, to date, has no known equivalent in the Middle Stone Age or Middle Paleolithic record outside of southern Africa.	[Delagnes, Anne; Douze, Katja] Univ Bordeaux, CNRS, PACEA, Pessac, France; [Delagnes, Anne; Douze, Katja; Wurz, Sarah; van Niekerk, Karen L.; Henshilwood, Christopher S.] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa; [Delagnes, Anne; Douze, Katja; Wurz, Sarah; van Niekerk, Karen L.; Henshilwood, Christopher S.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Schmidt, Patrick; Conard, Nicholas J.] Univ Tubingen, Dept Prehist & Quaternary Ecol, Tubingen, Germany; [Wurz, Sarah; van Niekerk, Karen L.; Henshilwood, Christopher S.] Univ Bergen, Dept Archaeol Hist Cultural Studies & Relig, Bergen, Norway; [Bellot-Gurlet, Ludovic] Univ Paris 06, Sorbonne Univ, MONARIS, UMR 8233, Paris, France; [Nickel, Klaus G.] Univ Tubingen, Appl Mineral, Dept Geosci, Tubingen, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Witwatersrand; University of Witwatersrand; Eberhard Karls University of Tubingen; University of Bergen; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Eberhard Karls University of Tubingen	Delagnes, A (corresponding author), Univ Bordeaux, CNRS, PACEA, Pessac, France.; Delagnes, A (corresponding author), Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa.; Delagnes, A (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa.	a.delagnes@pacea.u-bordeaux1.fr	Henshilwood, Christopher S/K-3806-2014; van Niekerk, Karen/J-3511-2015; Schmidt, Patrick/D-3925-2016; Bellot-Gurlet, Ludovic/G-7132-2012; Nickel, Klaus G/B-7806-2008	Henshilwood, Christopher S/0000-0002-2818-293X; van Niekerk, Karen/0000-0003-2261-6861; Schmidt, Patrick/0000-0002-8727-6127; Bellot-Gurlet, Ludovic/0000-0002-7995-6261; Nickel, Klaus G/0000-0002-6986-2982; Wurz, Sarah/0000-0002-0949-5391; Conard, Nicholas/0000-0002-4633-0385; Douze, Katja/0000-0001-9997-1605	Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen; Deutsche Forschungsgemeinschaft (DFG) through the research project Heat Treatment in the South African MSA [CO 226/25-1, MI 1748/2-1, NI 299/25-1]; National Research Foundation/Department of Science and Technology; University of Bergen, Norway; Evolutionary Studies Institute (University of the Witwatersrand, Johannesburg); ANR [ANR-10-LABX-52]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen; Deutsche Forschungsgemeinschaft (DFG) through the research project Heat Treatment in the South African MSA; National Research Foundation/Department of Science and Technology(Department of Science & Technology (India)); University of Bergen, Norway; Evolutionary Studies Institute (University of the Witwatersrand, Johannesburg); ANR(French National Research Agency (ANR))	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. The research of PS was funded by the Deutsche Forschungsgemeinschaft (DFG) through the research project Heat Treatment in the South African MSA (Grant Nr: CO 226/25-1, MI 1748/2-1, NI 299/25-1). Financial support was provided to CSH for the excavation of the KDS site and subsequent analysis by a National Research Foundation/Department of Science and Technology funded Chair at the University of the Witwatersrand, South Africa and by the University of Bergen, Norway. AD and KD have benefited from the financial and logistical support of the Evolutionary Studies Institute (University of the Witwatersrand, Johannesburg) during their stay in Cape Town.; We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. The research of PS was funded by the Deutsche Forschungsgemeinschaft (DFG) through the research project Heat Treatment in the South African MSA (Grant Nr: CO 226/25-1, MI 1748/2-1, NI 299/25-1). Financial support was provided to CSH for the excavation of the KDS site and subsequent analysis by a National Research Foundation/Department of Science and Technology funded Chair at the University of the Witwatersrand, South Africa and by the University of Bergen, Norway. AD and KD have benefited from the financial and logistical support of the Evolutionary Studies Institute (University of the Witwatersrand, Johannesburg) during their stay in Cape Town. AD also wants to thank the Labex LaScArBx, which is a research programme supported by the ANR (ANR-10-LABX-52), for its support. We all warmly thank Petro Keene, Lisa Hulett and Samantha S. Mienies for their constant help and assistance at the Wits satellite laboratory in Cape Town during the analytical work, as well as Jens Axel Frick (University of Tubingen) for his help with knapping the reference collection, Simone Kaulfuss (University of Tubingen) for preparing the polished section for our microscopic analysis, Magnus Mathisen Haaland (university of Bergen) and Gauthier Devilder (PACEA-university of Bordeaux) for their last minute assistance in the achievement of the figures. The content of this article has also greatly benefited from the comments of Peter Hiscock, Yamandu H. Hilbert and of three anonymous reviewers.	[Anonymous], 1974, PLAINS ANTHROPOL; [Anonymous], 1964, TEBIWA; Archer W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132428; Bass M, 2009, HANDBOOK OF OPTICS V, V1; Bentsen S.E., 2013, S AFRICAN ARCHAEOLOG, V68, P137; Bentsen SE, 2014, J ARCHAEOL RES, V22, P141, DOI 10.1007/s10814-013-9069-x; Binder D, 1990, PALEO, V2, P257, DOI DOI 10.3406/PAL.1990.1004; Bordes F, 1969, B SOC PREHISTORIQUE, V66, P197, DOI DOI 10.3406/BSPF.1969.10404; Brown KS, 2011, THE SWORD IN THE STO; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Charrie-Duhaut A, 2013, J ARCHAEOL SCI, V40, P3506, DOI 10.1016/j.jas.2012.12.026; COLLINS MB, 1973, P PREHIST SOC, V39, P461, DOI 10.1017/S0079497X00011774; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; Dayet L, 2013, J ARCHAEOL SCI, V40, P3492, DOI 10.1016/j.jas.2013.01.025; DOMANSKI M, 1992, J ARCHAEOL SCI, V19, P601, DOI 10.1016/0305-4403(92)90031-W; Domanski M., 1994, ARCHAEOMETRY, V36, P177, DOI DOI 10.1111/J.1475-4754.1994.TB00963.X; Flenniken J.J., 1975, J FIELD ARCHAEOL, V2, P125, DOI [DOI 10.2307/529623, 10.2307/529623]; FLENNIKEN JJ, 1987, ARCTIC ANTHROPOL, V24, P117; Goldberg P, 2009, ARCHAEOL ANTHROP SCI, V1, P95, DOI 10.1007/s12520-009-0008-1; Gulbert R, 2003, B SOC PREHISTORIQUE, V100, P463; Henshilwood CS, 2014, J ARCHAEOL SCI, V45, P284, DOI 10.1016/j.jas.2014.01.033; Henshilwood CS, 2012, J WORLD PREHIST, V25, P205, DOI 10.1007/s10963-012-9060-3; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Hester TR, 1972, TEBIWA, V15, P63; Igreja M, 2013, J ARCHAEOL SCI, V40, P3475, DOI 10.1016/j.jas.2013.02.026; Lea V, 2005, ANTIQUITY, V79, P51, DOI 10.1017/S0003598X00113699; Lombard M., 2006, SO AFRICAN HUMANITIE, V18, P56; Lombard M, 2012, CAMB ARCHAEOL J, V22, P237, DOI 10.1017/S095977431200025X; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; Man EH, 1883, THE JOURNAL OF THE A, V12, P69, DOI [10.1038/032409a0, DOI 10.1038/032409A0]; Mandeville M.D., 1973, PLAINS ANTHROPOL, V18, P177, DOI [DOI 10.1080/2052546.1973.11908640, https://doi.org/10.1080/2052546.1973.11908640]; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Mercieca A., 2000, AUST ARCHAEOL, V51, P40, DOI DOI 10.1080/03122417.2000.11681679; Mercieca A, 2008, J ARCHAEOL SCI, V35, P2634, DOI 10.1016/j.jas.2008.04.021; Miller CE, 2013, J ARCHAEOL SCI, V40, P3432, DOI 10.1016/j.jas.2013.02.014; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; Nash DJ, 2013, J HUM EVOL, V64, P280, DOI 10.1016/j.jhevol.2013.01.010; Neves M, 2003, MULTIPLE APPROACHES, P165; Porraz G, 2013, J ARCHAEOL SCI, V40, P3376, DOI 10.1016/j.jas.2013.02.012; Roberts DL, 2003, AGE GENESIS AND SIGN; Robinson TR, 1938, MAN, V38, P208; SCHINDLER DL, 1982, AM ANTIQUITY, V47, P526, DOI 10.2307/280233; Schmidt P., 2016, AFRICAN ARCHAEOLOGIC; Schmidt P, 2016, ARCHAEOL ANTHROP SCI, V8, P839, DOI 10.1007/s12520-015-0259-y; Schmidt P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149243; Schmidt P, 2015, J HUM EVOL, V85, P22, DOI 10.1016/j.jhevol.2015.05.001; Schmidt P, 2014, ARCHAEOL ANTHROP SCI, V6, P107, DOI 10.1007/s12520-013-0162-3; Schmidt P, 2013, J ARCHAEOL SCI, V40, P3519, DOI 10.1016/j.jas.2012.10.016; Schmidt P, 2012, J ARCHAEOL SCI, V39, P135, DOI 10.1016/j.jas.2011.09.012; Schmidt P, 2011, SPECTROCHIM ACTA A, V81, P552, DOI 10.1016/j.saa.2011.06.050; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; SUMMERFIELD MA, 1983, J SEDIMENT PETROL, V53, P895; Taylor G. H., 1998, ORGANIC PETROLOGY NE; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; Tixier J., 2000, PALEORIENT, V26, P23, DOI DOI 10.3406/PALE0.2000.4707; Villa P, 2010, J ARCHAEOL SCI, V37, P630, DOI 10.1016/j.jas.2009.10.028; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; Wadley L, 2014, J HUM EVOL, V70, P49, DOI 10.1016/j.jhevol.2013.11.003; Wadley L, 2010, CURR ANTHROPOL, V51, pS111, DOI 10.1086/649836; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Wurz S, 2002, J ARCHAEOL SCI, V29, P1001, DOI 10.1006/jasc.2001.0799	66	43	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0163874	10.1371/journal.pone.0163874	http://dx.doi.org/10.1371/journal.pone.0163874			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DZ9NW	27760210	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000022
J	Massumi, M; Pourasgari, F; Nalla, A; Batchuluun, B; Nagy, K; Neely, E; Gull, R; Nagy, A; Wheeler, MB				Massumi, Mohammad; Pourasgari, Farzaneh; Nalla, Amarnadh; Batchuluun, Battsetseg; Nagy, Kristina; Neely, Eric; Gull, Rida; Nagy, Andras; Wheeler, Michael B.			An Abbreviated Protocol for In Vitro Generation of Functional Human Embryonic Stem Cell-Derived Beta-Like Cells	PLOS ONE			English	Article							PANCREATIC PROGENITORS; CAPACITY	The ability to yield glucose-responsive pancreatic beta-cells from human pluripotent stem cells in vitro will facilitate the development of the cell replacement therapies for the treatment of Type 1 Diabetes. Here, through the sequential in vitro targeting of selected signaling pathways, we have developed an abbreviated five-stage protocol (25-30 days) to generate human Embryonic Stem Cell-Derived Beta-like Cells (ES-DBCs). We showed that Geltrex, as an extracellular matrix, could support the generation of ES-DBCs more efficiently than that of the previously described culture systems. The activation of FGF and Retinoic Acid along with the inhibition of BMP, SHH and TGF-beta led to the generation of 75% NKX6.1(+)/NGN3(+) Endocrine Progenitors. The inhibition of Notch and tyrosine kinase receptor AXL, and the treatment with Exendin-4 and T3 in the final stage resulted in 35% mono-hormonal insulin positive cells, 1% insulin and glucagon positive cells and 30% insulin and NKX6.1 co-expressing cells. Functionally, ES-DBCs were responsive to high glucose in static incubation and perifusion studies, and could secrete insulin in response to successive glucose stimulations. Mitochondrial metabolic flux analyses using Seahorse demonstrated that the ES-DBCs could efficiently metabolize glucose and generate intracellular signals to trigger insulin secretion. In conclusion, targeting selected signaling pathways for 25-30 days was sufficient to generate ES-DBCs in vitro. The ability of ES-DBCs to secrete insulin in response to glucose renders them a promising model for the in vitro screening of drugs, small molecules or genes that may have potential to influence beta-cell function.	[Massumi, Mohammad; Pourasgari, Farzaneh; Nalla, Amarnadh; Batchuluun, Battsetseg; Gull, Rida; Wheeler, Michael B.] Univ Toronto, Fac Med, Dept Med, Toronto, ON M5S 1A1, Canada; [Massumi, Mohammad; Pourasgari, Farzaneh; Nalla, Amarnadh; Batchuluun, Battsetseg; Gull, Rida; Wheeler, Michael B.] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A1, Canada; [Massumi, Mohammad; Pourasgari, Farzaneh; Wheeler, Michael B.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada; [Massumi, Mohammad; Nagy, Kristina; Neely, Eric; Nagy, Andras] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Nalla, Amarnadh] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Copenhagen	Wheeler, MB (corresponding author), Univ Toronto, Fac Med, Dept Med, Toronto, ON M5S 1A1, Canada.	michael.wheeler@utoronto.ca	Nagy, Andras/G-6465-2013	Nagy, Andras/0000-0003-4311-0413	Canadian Institutes of Health Research [FDN-143219]; BBDC postdoctoral fellowship; Danish Diabetes Academy supported by Novo Nordisk Foundation, Denmark	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); BBDC postdoctoral fellowship; Danish Diabetes Academy supported by Novo Nordisk Foundation, Denmark	This work was supported by a grant from the Canadian Institutes of Health Research (FDN-143219). Mohammad Massumi was supported by BBDC (2014-2015) postdoctoral fellowship. Amarnadh Nalla was supported by postdoctoral fellowship from Danish Diabetes Academy supported by Novo Nordisk Foundation, Denmark.; We would like to thank Dr. Feihan Dai and Dr. Ying Liu for their constructive intellectual input. We also would like to thank Dr. Alireza Rezaneia from BetaLogics Venture, Janssen R&D LLC, Raritan, New Jersey, USA, for the MAFA antibody. This work was supported by a grant from the Canadian Institutes of Health Research (FDN-143219). MM was supported by BBDC (2014-2015) postdoctoral fellowship. AN was supported by postdoctoral fellowship from Danish Diabetes Academy supported by Novo Nordisk Foundation, Denmark.	Arda HE, 2013, DEV CELL, V25, P5, DOI 10.1016/j.devcel.2013.03.016; Basford CL, 2012, DIABETOLOGIA, V55, P358, DOI 10.1007/s00125-011-2335-x; Bellin MD, 2012, AM J TRANSPLANT, V12, P1576, DOI 10.1111/j.1600-6143.2011.03977.x; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Brinklov S, 2009, J EXP BIOL, V212, P11, DOI 10.1242/jeb.023226; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Greenwood AL, 2007, MECH DEVELOP, V124, P97, DOI 10.1016/j.mod.2006.11.002; Haase TN, 2013, DIABETOLOGIA, V56, P763, DOI 10.1007/s00125-012-2821-9; Hrvatin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089459; Hrvatin S, 2014, P NATL ACAD SCI USA, V111, P3038, DOI 10.1073/pnas.1400709111; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Kenty JHR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122044; Kim SK, 1998, P NATL ACAD SCI USA, V95, P13036, DOI 10.1073/pnas.95.22.13036; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Massumi M, 2014, EXP CELL RES, V322, P51, DOI 10.1016/j.yexcr.2014.01.006; Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391; Millman JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11463; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; ROBERTS TIFFINEY M., 2000, J VIROLOGY, V74; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Russ HA, 2015, EMBO J, V34, P1759, DOI 10.15252/embj.201591058; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Toivonen S, 2013, EXP CELL RES, V319, P2535, DOI 10.1016/j.yexcr.2013.07.007	30	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164457	10.1371/journal.pone.0164457	http://dx.doi.org/10.1371/journal.pone.0164457			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755557	Green Published, gold, Green Submitted			2022-12-26	WOS:000386203800020
J	Yan, ZZ; Hu, B; Huang, ZG; Zhong, L; Guo, XY; Weng, AX; Xiao, F; Zeng, WP; Zhang, Y; Ding, JP; Hou, PP				Yan, Zhenzhen; Hu, Bin; Huang, Zhigang; Zhong, Ling; Guo, Xiying; Weng, Anxi; Xiao, Feng; Zeng, Wenping; Zhang, Yan; Ding, Jiuping; Hou, Panpan			Single Channel Recordings Reveal Differential beta 2 Subunit Modulations Between Mammalian and Drosophila BKCa(beta 2) Channels	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; CA2+-ACTIVATED K+ CHANNELS; ADRENAL CHROMAFFIN CELLS; HUMAN BK CHANNEL; NH2 TERMINUS; RCK1 DOMAIN; SURFACE EXPRESSION; MOLECULAR-BASIS; VOLTAGE SENSOR; 2 COMPONENTS	Large-conductance Ca2+- and voltage-activated potassium (BK) channels are widely expressed in tissues. As a voltage and calcium sensor, BK channels play significant roles in regulating the action potential frequency, neurotransmitter release, and smooth muscle contraction. After associating with the auxiliary beta 2 subunit, mammalian BK(beta 2) channels (mouse or human Slo1/beta 2) exhibit enhanced activation and complete inactivation. However, how the beta 2 subunit modulates the Drosophila Sio1 channel remains elusive. In this study, by comparing the different functional effects on heterogeneous BK(beta 2) channel, we found that Drosophila Slo1/beta 2 channel exhibits "paralyzed"-like and incomplete inactivation as well as slow activation. Further, we determined three different modulations between mammalian and Drosophila BK(beta 2) channels: 1) dSlo1/beta 2 doesn't have complete inactivation. 2) beta 2(K33,R34,K35) delays the dSlo1/Delta 3-beta 2 channel activation. 3) dSlo1/beta 2 channel has enhanced pre-inactivation than mSlo1/beta 2 channel. The results in our study provide insights into the different modulations of beta 2 subunit between mammalian and Drosophila Slo1/beta 2 channels and structural basis underlie the activation and pre-inactivation of other BK(beta) complexes.	[Yan, Zhenzhen; Hu, Bin; Huang, Zhigang; Guo, Xiying; Weng, Anxi; Zeng, Wenping; Zhang, Yan; Ding, Jiuping; Hou, Panpan] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China; [Zhong, Ling; Hou, Panpan] Washington Univ, Dept Biomed Engn, Ctr Investigat Membrane Excitabil Dis, St Louis, MO 63130 USA; [Xiao, Feng] Huazhong Univ Sci & Technol, Key Lab Image Proc & Intelligent Control, Coll Life Sci & Technol, Minist Educ,Dept Biomed Engn, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Washington University (WUSTL); Huazhong University of Science & Technology	Ding, JP; Hou, PP (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China.; Hou, PP (corresponding author), Washington Univ, Dept Biomed Engn, Ctr Investigat Membrane Excitabil Dis, St Louis, MO 63130 USA.	jpding@mail.hust.edu.cn; panpanhou@email.wustl.edu	Hu, Bin/AAF-5908-2019; Hou, Panpan/Q-2941-2019	Hu, Bin/0000-0003-0646-0182; zeng, wenping/0000-0003-4501-939X; Hou, Panpan/0000-0001-7694-2262	National Basic Research Program of China [2010CB529804]; National Science Foundation of China [30971179, 31170814]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China (2010CB529804) and the National Science Foundation of China (30971179, 31170814).	ADAMS PR, 1982, NATURE, V296, P746, DOI 10.1038/296746a0; ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Bentrop D, 2001, J BIOL CHEM, V276, P42116, DOI 10.1074/jbc.M107118200; Benzinger GR, 2006, J GEN PHYSIOL, V127, P119, DOI 10.1085/jgp.200509425; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Brelidze TI, 2003, P NATL ACAD SCI USA, V100, P9017, DOI 10.1073/pnas.1532257100; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Brenner R, 2000, J NEUROCHEM, V75, P1310, DOI 10.1046/j.1471-4159.2000.751310.x; Bukiya AN, 2014, P NATL ACAD SCI USA, V111, P9313, DOI 10.1073/pnas.1317363111; Carvacho I, 2008, J GEN PHYSIOL, V131, P147, DOI 10.1085/jgp.200709862; Chen MR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002114; Chen XX, 2014, P NATL ACAD SCI USA, V111, pE79, DOI 10.1073/pnas.1321697111; Chen XX, 2011, J GEN PHYSIOL, V138, P137, DOI 10.1085/jgp.201110632; Ding JP, 1998, BIOPHYS J, V74, P268, DOI 10.1016/S0006-3495(98)77785-9; FUCHS PA, 1992, J NEUROSCI, V12, P800; Geng YY, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00532; Gessner G, 2012, P NATL ACAD SCI USA, V109, P3552, DOI 10.1073/pnas.1114321109; Guo ZH, 2008, BIOPHYS J, V94, P3714, DOI 10.1529/biophysj.107.120022; Hite RK, 2015, NATURE; Hoshi T, 2013, J GEN PHYSIOL, V142, P507, DOI 10.1085/jgp.201311061; Hou PP, 2013, SCI REP-UK, V3, DOI 10.1038/srep01666; Hou SW, 2008, NAT STRUCT MOL BIOL, V15, P403, DOI 10.1038/nsmb.1398; Hou SW, 2008, P NATL ACAD SCI USA, V105, P4039, DOI 10.1073/pnas.0800304105; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Krishnamoorthy G, 2005, J GEN PHYSIOL, V126, P227, DOI 10.1085/jgp.200509321; Lee US, 2010, J NEUROSCI, V30, P16170, DOI 10.1523/JNEUROSCI.2323-10.2010; Li H, 2007, J BIOL CHEM, V282, P17720, DOI 10.1074/jbc.M607063200; Lippiat JD, 2003, J MEMBRANE BIOL, V192, P141, DOI 10.1007/s00232-002-1070-0; Liu HW, 2014, J BIOL CHEM, V289, P16914, DOI 10.1074/jbc.M114.557991; Liu R, 2013, HYPERTENSION, V62, P415, DOI 10.1161/HYPERTENSIONAHA.111.01076; Lv CX, 2008, J BIOL CHEM, V283, P2709, DOI 10.1074/jbc.M704440200; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; MCMANUS OB, 1991, J PHYSIOL-LONDON, V443, P739, DOI 10.1113/jphysiol.1991.sp018861; NEELY A, 1992, J PHYSIOL-LONDON, V453, P97, DOI 10.1113/jphysiol.1992.sp019220; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; PETERSEN OH, 1984, NATURE, V307, P693, DOI 10.1038/307693a0; Qiu S, 2009, J CHEM INF MODEL, V49, P1831, DOI 10.1021/ci900025n; Quirk JC, 2001, NEURON, V32, P13, DOI 10.1016/S0896-6273(01)00444-5; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Sah P, 2000, CLIN EXP PHARMACOL P, V27, P657, DOI 10.1046/j.1440-1681.2000.03317.x; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Soom M, 2008, CHANNELS, V2, P278, DOI 10.4161/chan.2.4.6571; Tang QY, 2014, J BIOL CHEM, V289, P18860, DOI 10.1074/jbc.M113.538033; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061; TsengCrank J, 1996, P NATL ACAD SCI USA, V93, P9200, DOI 10.1073/pnas.93.17.9200; Uebele VN, 2000, J BIOL CHEM, V275, P23211, DOI 10.1074/jbc.M910187199; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077105; Wang YW, 2002, J NEUROSCI, V22, P1550, DOI 10.1523/JNEUROSCI.22-05-01550.2002; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Wu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078203; Wu Y, 2009, J BIOL CHEM, V284, P23353, DOI 10.1074/jbc.M109.027789; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xia XM, 2003, J GEN PHYSIOL, V121, P125, DOI 10.1085/jgp.20028667; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Yang H, 2007, P NATL ACAD SCI USA, V104, P18270, DOI 10.1073/pnas.0705873104; Yang HG, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00029; Yang JQ, 2010, NEURON, V66, P871, DOI 10.1016/j.neuron.2010.05.009; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zhang GH, 2014, J NEUROSCI, V34, P12280, DOI 10.1523/JNEUROSCI.1174-14.2014; Zhang GH, 2010, P NATL ACAD SCI USA, V107, P18700, DOI 10.1073/pnas.1010124107	70	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0163308	10.1371/journal.pone.0163308	http://dx.doi.org/10.1371/journal.pone.0163308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755549	Green Published, Green Submitted, gold			2022-12-26	WOS:000386203800004
J	Lee, DW; Choi, EY				Lee, Dong-Won; Choi, Eun-Young			Sarcopenia as an Independent Risk Factor for Decreased BMD in COPD Patients: Korean National Health and Nutrition Examination Surveys IV and V (2008-2011)	PLOS ONE			English	Article							BONE-MINERAL DENSITY; OBSTRUCTIVE PULMONARY-DISEASE; OSTEOPOROSIS; ASSOCIATION; PREDICTORS; MORTALITY; CONSENSUS; MASS	Background A decrease in bone mineral density (BMD) is a systemic consequence of chronic obstructive pulmonary disease (COPD). Past reports have rarely examined any correlation between sarcopenia and BMD. We investigated the relationship cross-sectionally between the presence of sarcopenia and BMD reduction in COPD patients. Methods COPD patients aged 50 or older with qualifying spirometry and dual-energy X-ray absorptiometry data were from participants in the Korean National Health and Nutrition Examination Surveys IV and V (2008-2011). Results There were 286 (33.3%) subjects in the sarcopenia group and 572 (66.7%) in the non-sarcopenia group. The sarcopenia group had lower T-scores than the non-sarcopenia group (femur: -0.73 +/- 0.88 vs. -0.18 +/- 0.97, p < 0.001; femur neck: -1.44 +/- 0.98 vs. -0.99 +/- 1.06, p < 0.001; lumbar: -1.38 +/- 1.36 vs. -0.84 +/- 1.38, p < 0.001). The prevalences of osteopenia and osteoporosis were 60.8% and 22.0%, respectively, in the sarcopenia group and 45.6% and 13.3% in the non-sarcopenia group (both p < 0.001). After adjusting for multiple variables, the presence of sarcopenia associated with increased the risk of osteopenia, osteoporosis, and a low BMD (OR = 3.227, 95% CI = 2.125-4.899, p < 0.001, OR = 6.952, 95% CI = 3.418-14.139, p < 0.001, and OR = 3.495, 95% CI = 2.315-5.278, p < 0.001, respectively). In a subgroup analysis, similar OR changes were confirmed in the high-body-weight group (n = 493) (OR = 2.248, 95% CI = 1.084-4.665, p = 0.030, OR = 4.621, 95% CI = 1.167-18.291, p = 0.029, and OR = 2.376, 95% CI = 1.158-4.877, p = 0.018, respectively). Conclusions The presence of sarcopenia was associated with increased the risk for decreased BMD in COPD.	[Lee, Dong-Won] Andong Sungso Hosp, Div Pulmonol, Dept Internal Med, Andong, South Korea; [Choi, Eun-Young] Yeungnam Univ Hosp, Div Pulmonol & Allergy, Dept Internal Med, Daegu, South Korea	Yeungnam University; Yeungnam University Hospital	Choi, EY (corresponding author), Yeungnam Univ Hosp, Div Pulmonol & Allergy, Dept Internal Med, Daegu, South Korea.	ietact@daum.net			YUMC Regional Center for Respiratory diseases	YUMC Regional Center for Respiratory diseases	This work was supported by the YUMC Regional Center for Respiratory diseases research grant.	Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Boyer L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121539; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Chung JH, 2015, COPD, V12, P82, DOI 10.3109/15412555.2014.908835; Coin A, 2010, AGING MALE, V13, P142, DOI 10.3109/13685531003657784; COMPSTON JE, 1992, CLIN ENDOCRINOL, V36, P223, DOI 10.1111/j.1365-2265.1992.tb01435.x; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Decramer M, 2008, COPD, V5, P235, DOI 10.1080/15412550802237531; Figueiredo CP, 2014, OSTEOPOROSIS INT, V25, P589, DOI 10.1007/s00198-013-2455-x; Graat-Verboom L, 2009, EUR RESPIR J, V34, P209, DOI 10.1183/09031936.50130408; Graat-Verboom L, 2012, BONE, V50, P1234, DOI 10.1016/j.bone.2012.02.638; Kim S, 2014, J KOREAN MED SCI, V29, P995, DOI 10.3346/jkms.2014.29.7.995; Kjensli A, 2007, BONE, V40, P493, DOI 10.1016/j.bone.2006.09.005; Lau EMC, 2006, OSTEOPOROSIS INT, V17, P297, DOI 10.1007/s00198-005-2019-9; Lehouck A, 2011, CHEST, V139, P648, DOI 10.1378/chest.10-1427; Lumachi F, 2007, ANN NY ACAD SCI, V1117, P357, DOI 10.1196/annals.1402.012; Maltais Francois, 2014, Am J Respir Crit Care Med, V189, pe15, DOI 10.1164/rccm.201402-0373ST; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Newman AB, 2003, J AM GERIATR SOC, V51, P1602, DOI 10.1046/j.1532-5415.2003.51534.x; Ogura-Tomomatsu H, 2012, COPD, V9, P332, DOI 10.3109/15412555.2012.667850; Remels AH, 2007, CLIN CHEST MED, V28, P537, DOI 10.1016/j.ccm.2007.06.003; Schett G, 2011, EUR J CLIN INVEST, V41, P1361, DOI 10.1111/j.1365-2362.2011.02545.x; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805; Sjoblom S, 2013, MATURITAS, V75, P175, DOI 10.1016/j.maturitas.2013.03.016; van de Bool C, 2015, EUR RESPIR J, V46, P336, DOI 10.1183/09031936.00197314; Verschueren S, 2013, OSTEOPOROSIS INT, V24, P87, DOI 10.1007/s00198-012-2057-z; Vrieze A, 2007, OSTEOPOROSIS INT, V18, P1197, DOI 10.1007/s00198-007-0355-7; Wu CH, 2013, J CLIN DENSITOM, V16, P98, DOI 10.1016/j.jocd.2012.07.010	29	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164303	10.1371/journal.pone.0164303	http://dx.doi.org/10.1371/journal.pone.0164303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749901	Green Published, Green Submitted, gold			2022-12-26	WOS:000386202300011
J	Laszlo, L; Sarkadi, B; Hegedus, T				Laszlo, Laura; Sarkadi, Balazs; Hegedus, Tamas			Jump into a New Fold-A Homology Based Model for the ABCG2/BCRP Multidrug Transporter	PLOS ONE			English	Article							RESISTANCE PROTEIN BCRP/ABCG2; MOLECULAR-DYNAMICS SIMULATIONS; NUCLEOTIDE-BINDING DOMAIN; ABC TRANSPORTER; P-GLYCOPROTEIN; ATP-BINDING; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; DRUG-RESISTANCE; FORCE-FIELD	ABCG2/BCRP is a membrane protein, involved in xenobiotic and endobiotic transport in key pharmacological barriers and drug metabolizing organs, in the protection of stem cells, and in multidrug resistance of cancer. Pharmacogenetic studies implicated the role of ABCG2 in response to widely used medicines and anticancer agents, as well as in gout. Its Q141K variant exhibits decreased functional expression thus increased drug accumulation and decreased urate secretion. Still, there has been no reliable molecular model available for this protein, as the published structures of other ABC transporters could not be properly fitted to the ABCG2 topology and experimental data. The recently published high resolution structure of a close homologue, the ABCG5-ABCG8 heterodimer, revealed a new ABC transporter fold, unique for ABCG proteins. Here we present a structural model of the ABCG2 homodimer based on this fold and detail the experimental results supporting this model. In order to describe the effect of mutations on structure and dynamics, and characterize substrate recognition and cholesterol regulation we performed molecular dynamics simulations using full length ABCG2 protein embedded in a membrane bilayer and in silico docking simulations. Our results show that in the Q141K variant the introduced positive charge diminishes the interaction between the nucleotide binding and transmembrane domains and the R482G variation alters the orientation of transmembrane helices. Moreover, the R482 position, which plays a role the substrate specificity of the transporter, is located in one of the substrate binding pockets identified by the in silico docking calculations. In summary, the ABCG2 model and in silico simulations presented here may have significant impact on understanding drug distribution and toxicity, as well as drug development against cancer chemotherapy resistance or gout.	[Laszlo, Laura; Sarkadi, Balazs; Hegedus, Tamas] Semmelweis Univ, Mol Biophys Res Grp, Budapest, Hungary; [Laszlo, Laura; Sarkadi, Balazs; Hegedus, Tamas] Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary; [Sarkadi, Balazs] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary	Semmelweis University; Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Hegedus, T (corresponding author), Semmelweis Univ, Mol Biophys Res Grp, Budapest, Hungary.; Hegedus, T (corresponding author), Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary.	tamas.hegedus@hegelab.org			National Research, Development and Innovation Office [K111678, K115375]; Hungarian Academy of Sciences; Bolyai Fellowship	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Bolyai Fellowship(Hungarian Academy of Sciences)	This work was supported by National Research, Development and Innovation Office, http://nkfih.gov.hu, K111678 (T.H.) and K115375 (B.S.); and Hungarian Academy of Sciences, http://mta.hu, Bolyai Fellowship (T.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Ambudkar SV, 2006, FEBS LETT, V580, P1049, DOI 10.1016/j.febslet.2005.12.051; Bessadok A, 2011, J BIOL CHEM, V286, P3552, DOI 10.1074/jbc.M110.155200; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Chang G, 2006, SCIENCE, V314, P1875, DOI 10.1126/science.314.5807.1875b; Corradi V, 2015, J BIOL CHEM, V290, P22891, DOI 10.1074/jbc.M115.665125; Csanady L, 2005, J GEN PHYSIOL, V125, P43, DOI 10.1085/jgp.200409174; Cusatis G, 2006, J NATL CANCER I, V98, P1739, DOI 10.1093/jnci/djj469; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Diop NK, 2005, BIOCHEMISTRY-US, V44, P5420, DOI 10.1021/bi0479858; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; Gal Z, 2015, BBA-BIOMEMBRANES, V1848, P477, DOI 10.1016/j.bbamem.2014.11.006; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gyimesi G, 2011, BBA-BIOMEMBRANES, V1808, P2954, DOI 10.1016/j.bbamem.2011.07.038; Hegedus C, 2015, ADV CANCER RES, V125, P97, DOI 10.1016/bs.acr.2014.10.004; Henriksen U, 2005, J BIOL CHEM, V280, P36926, DOI 10.1074/jbc.M502937200; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Honjo Y, 2001, CANCER RES, V61, P6635; Hou YX, 2009, BIOCHEMISTRY-US, V48, P9122, DOI 10.1021/bi900675v; Ieiri I, 2012, DRUG METAB PHARMACOK, V27, P85, DOI 10.2133/dmpk.DMPK-11-RV-098; Ivetac A, 2008, EUR BIOPHYS J BIOPHY, V37, P403, DOI 10.1007/s00249-007-0225-4; Kelly Libusha, 2009, Journal of Structural and Functional Genomics, V10, P269, DOI 10.1007/s10969-009-9069-8; Kerr ID, 2010, FEBS J, V277, P550, DOI 10.1111/j.1742-4658.2009.07486.x; Kondo C, 2004, PHARM RES-DORDR, V21, P1895, DOI 10.1023/B:PHAM.0000045245.21637.d4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lee JY, 2016, NATURE, V533, P561, DOI 10.1038/nature17666; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Li YF, 2007, J MOL GRAPH MODEL, V25, P837, DOI 10.1016/j.jmgm.2006.08.005; Litman T, 2000, J CELL SCI, V113, P2011; Liu Y, 2008, J PHARMACOL EXP THER, V326, P33, DOI 10.1124/jpet.108.138115; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Mizuarai S, 2004, INT J CANCER, V109, P238, DOI 10.1002/ijc.11669; Morisaki K, 2005, CANCER CHEMOTH PHARM, V56, P161, DOI 10.1007/s00280-004-0931-x; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Natarajan K, 2012, BIOCHEM PHARMACOL, V83, P1084, DOI 10.1016/j.bcp.2012.01.002; Ni ZL, 2011, BIOCHEMISTRY-US, V50, P8057, DOI 10.1021/bi200573t; Ni ZL, 2010, AM J PHYSIOL-CELL PH, V299, pC1100, DOI 10.1152/ajpcell.00160.2010; Noguchi K, 2014, PHARMACOGN PERS MED, V7, P53, DOI 10.2147/PGPM.S38295; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ozvegy C, 2002, J BIOL CHEM, V277, P47980, DOI 10.1074/jbc.M207857200; Ozvegy-Lacka C, 2005, BBA-BIOMEMBRANES, V1668, P53, DOI 10.1016/j.bbamem.2004.11.005; Ozvegy-Laczka C, 2008, J BIOL CHEM, V283, P26059, DOI 10.1074/jbc.M803230200; Pajeva IK, 2009, FEBS J, V276, P7016, DOI 10.1111/j.1742-4658.2009.07415.x; Polgar O, 2009, BBA-BIOMEMBRANES, V1788, P1434, DOI 10.1016/j.bbamem.2009.04.016; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rosenberg MF, 2010, STRUCTURE, V18, P482, DOI 10.1016/j.str.2010.01.017; Rutledge RM, 2011, J STRUCT BIOL, V173, P333, DOI 10.1016/j.jsb.2010.10.012; Saranko H, 2013, BIOCHEM BIOPH RES CO, V437, P140, DOI 10.1016/j.bbrc.2013.06.054; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Storch CH, 2007, J PHARMACOL EXP THER, V323, P257, DOI 10.1124/jpet.107.122994; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Telbisz A, 2007, BBA-BIOMEMBRANES, V1768, P2698, DOI 10.1016/j.bbamem.2007.06.026; Telbisz A, 2013, BIOCHEM J, V450, P387, DOI 10.1042/BJ20121485; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Velamakanni S, 2008, MOL PHARMACOL, V73, P12, DOI 10.1124/mol.108.038299; Wang HG, 2008, BIOCHEMISTRY-US, V47, P13778, DOI 10.1021/bi801644v; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114; Woodward OM, 2013, P NATL ACAD SCI USA, V110, P5223, DOI 10.1073/pnas.1214530110; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	72	40	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164426	10.1371/journal.pone.0164426	http://dx.doi.org/10.1371/journal.pone.0164426			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741279	gold, Green Published, Green Accepted			2022-12-26	WOS:000385507000032
J	Poveda-Martinez, D; Sosa, CC; Chacon-Vargas, K; Garcia-Merchan, VH				Poveda-Martinez, Daniel; Sosa, Chrystian C.; Chacon-Vargas, Katherine; Hugo Garcia-Merchan, Victor			Historical Biogeography of Five Characidium Fish Species: Dispersal from the Amazon Paleobasin to Southeastern South America	PLOS ONE			English	Article							FRESH-WATER FISHES; VICARIANCE ANALYSIS; GENETIC-STRUCTURE; GEOGRAPHIC RANGE; EVOLUTION; CHARACIFORMES; PALINURUS; RADIATION; ENDEMISM; BRAZIL	Characidium is a Neotropical fish genus. Its distribution ranges from eastern Panama to northern Argentina, and it is an important component of the Neotropical ichthyofauna present in the major rivers of South America. We here provide an approximation to the dispersal and historical distributions of Characidium. The biogeographic history of five species of the genus was analyzed through nuclear RAG-2 and mitochondrial 16S genes and a time-calibrated phylogenetic analysis using three outgroup species. A biogeographical reconstruction was performed to estimate ancestral geographic ranges and infer the historical events that impacted the geographic distributions of Characidium species. Our results showed Characidium as a monophyletic group. The molecular clock suggests that the most recent common ancestor of Characidium originated during the Eocene, about 50.2 Mya. In addition, different dispersion and vicariance events could be inferred, which possibly gave rise to the present geographical distribution of the genus. Our results point to the rise of the Andean mountains and sea fluctuations as being important events in the formations and delimitation of different rivers, which influenced the distribution of South American ichthyofauna.	[Poveda-Martinez, Daniel; Sosa, Chrystian C.; Chacon-Vargas, Katherine; Hugo Garcia-Merchan, Victor] Univ Quindio, Grp Evoluc Ecol & Conservac EECO, Armenia, Colombia; [Poveda-Martinez, Daniel; Sosa, Chrystian C.; Hugo Garcia-Merchan, Victor] Univ Quindio, Grp Invest & Asesoria Estadist, Armenia, Colombia; [Sosa, Chrystian C.] Ctr Int Agr Trop, Km 17 Recta Cali Palmira, Cali, Colombia	Universidad del Quindio; Universidad del Quindio; Alliance; International Center for Tropical Agriculture - CIAT	Poveda-Martinez, D (corresponding author), Univ Quindio, Grp Evoluc Ecol & Conservac EECO, Armenia, Colombia.; Poveda-Martinez, D (corresponding author), Univ Quindio, Grp Invest & Asesoria Estadist, Armenia, Colombia.	danielpovedam@gmail.com	Arango, Chrystian Camilo Sosa/N-3989-2019; Poveda Martínez, Daniel/HGU-5174-2022	Arango, Chrystian Camilo Sosa/0000-0002-3734-3248; Poveda-Martinez, Daniel/0000-0003-3657-8421	Universidad del Quindio	Universidad del Quindio	thank the anonymous reviewer who revised this manuscript and gave important comments. We deeply thank the comments of Pere Abello and Pedro Simoes for the revision of the manuscript and the Universidad del Quindio who support the publication.	Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P1; Beheregaray LB, 2002, P ROY SOC B-BIOL SCI, V269, P65, DOI 10.1098/rspb.2001.1838; Blakey R, 2006, PLATE TECTONICS CONT; Bracken-Grissom HD, 2014, SYST BIOL, V63, P457, DOI 10.1093/sysbio/syu008; Buckuo Paulo A., 2005, P193; BUCKUP PA, 1993, ZOOL J LINN SOC-LOND, V108, P225; BUCKUP PA, 1993, CLADISTICS, V9, P305, DOI 10.1111/j.1096-0031.1993.tb00227.x; Buckup PA, 2009, COPEIA, V3, P531; Buckup PA, 1998, INTERRELATIONSHIPS C, P123; Buckup PA, 2003, CLOFFSCA CHECK LIST; Calcagnotto D, 2005, MOL PHYLOGENET EVOL, V36, P135, DOI 10.1016/j.ympev.2005.01.004; Camelier P, 2014, NEOTROP ICHTHYOL, V12, P683, DOI 10.1590/1982-0224-20130228; Cardoso YP, 2013, THESIS; Carvalho TP, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P193; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chiachio MC, 2008, MOL PHYLOGENET EVOL, V49, P606, DOI 10.1016/j.ympev.2008.08.013; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Gonzalez-Ortegon E, 2016, SCI TOTAL ENVIRON, V540, P11, DOI 10.1016/j.scitotenv.2015.06.028; Google Earth, 2014, GOOGL EARTH VER 7 1; Harris A, 2007, DANCING STATE MAORI; Harris AJ, 2009, J SYST EVOL, V47, P349, DOI 10.1111/j.1759-6831.2009.00044.x; Hijmans RJ, 2001, DIVA GIS VER 1 4; Garcia-Merchan VH, 2012, MOL PHYLOGENET EVOL, V62, P664, DOI 10.1016/j.ympev.2011.11.009; Ivanyisky SJ, 2014, NEOTROP ICHTHYOL, V12, P565, DOI 10.1590/1982-0224-20130159; Leitao RP, 2014, COPEIA, P14, DOI 10.1643/CI-12-137; Lopez-Fernandez H, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P105; Lovejoy NR, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P405; Lujan NK, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P211; Lundberg JG, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P281; Melo MRS, 2015, COPEIA, V103, P281, DOI 10.1643/CI-14-073; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Palero F, 2011, BIOL J LINN SOC, V104, P407, DOI 10.1111/j.1095-8312.2011.01728.x; Palero F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-263; Pascual M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29892; PITMAN WC, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P15; Rambaut A, 2009, FIGTREE VER 1 3 1; Rambaut A., 2014, TRACER V1 6; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Reis R. E., 2003, CLOFFSCA CHECK LIST; Ribeiro AC, 2006, NEOTROP ICHTHYOL, V4, P225, DOI 10.1590/S1679-62252006000200009; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Rosa RS, 2004, ECOLOGIA CONSERVACAO, P135; Roxo FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105564; Roxo FF, 2012, ECOL EVOL, V2, P2438, DOI 10.1002/ece3.368; Schaefer SA, 2011, ZOOL J LINN SOC-LOND, V162, P90, DOI 10.1111/j.1096-3642.2010.00673.x; Smith BT, 2014, NATURE, V515, P406, DOI 10.1038/nature13687; Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109; Vari Richard P., 1998, P111; Vari RP, 1998, PHYLOGENY CLASSIFICA, P603; Warnock R, 2014, P BIOL SCI, V282, P1013; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087; Yu Y., 2011, RASP RECONSTRUCT ANC; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zamora H, 2009, ACTUAL BIOL, V31, P63	60	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164902	10.1371/journal.pone.0164902	http://dx.doi.org/10.1371/journal.pone.0164902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741308	gold, Green Published, Green Submitted			2022-12-26	WOS:000385507000081
J	Barri, FR				Rafael Barri, Fernando			Reintroducing Guanaco in the Upper Belt of Central Argentina: Using Population Viability Analysis to Evaluate Extinction Risk and Management Priorities	PLOS ONE			English	Article							CONDORITO NATIONAL-PARK; LAMA-GUANICOE POPULATION; MONTE DESERT; HABITAT USE; CONSERVATION; DEFAUNATION; MOUNTAINS; DIVERSITY; PATAGONIA; SURVIVAL	Wildlife reintroduction is an increasingly used strategy to reverse anthropocene defaunation. For the purpose of ecosystem restoration, in 2007 the guanaco (Lama guanicoe) was reintroduced to the Quebrada del Condorito National Park, situated in the mountains of central Argentina. With the aim of developing management recommendations, the project included permanently monitoring the population to evaluate its dynamics and the ecological response of the individuals released into the area. Nine years later and after two releases of guanacos (113 individuals in 2007 without and 25 in 2011 with a pre-adaptation period), only 24 individuals, which conform three reproductive groups, and one group of solitary males were settled in the Park. Here I modeled a population viability analysis to evaluate extinction risk, using VORTEX software. Initial population structure, specified age distribution, mortality and reproductive rates, and mate monopolization recorded during field work were used in the model, whereas the remaining used demographic parameters, such as age of first offspring, maximum number of broods per year, mean foaling rate, and length of fecundity period, were taken from the literature. Each of the three different scenarios (without supplementation of individuals, and with a realistic and optimistic supplementation) and two possible catastrophic events (fires and food shortage) covering 100 years was repeated 1000 times. Even though the guanaco reintroduction project can be considered to have been partially successful since its start, the model predicts that the current reintroduced population could be extinct in the next few decades if no reinforcements occur, and that only a continuous supplementation can reach the probability that the population survives over the next 100 years. I conclude that, so far, the current population is at a high risk of extinction if further supplementation of individuals is discontinued.	[Rafael Barri, Fernando] Univ Nacl Cordoba, CONICET UNC, IDEA, Av Velez Sarsfield 299, RA-5000 Cordoba, Argentina; [Rafael Barri, Fernando] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Av Velez Sarsfield 299, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba	Barri, FR (corresponding author), Univ Nacl Cordoba, CONICET UNC, IDEA, Av Velez Sarsfield 299, RA-5000 Cordoba, Argentina.; Barri, FR (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Av Velez Sarsfield 299, RA-5000 Cordoba, Argentina.	fernando.barri@unc.edu.ar			Secretaria de Ciencia y Tecnica (SECyT) of Universidad Nacional de Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) of Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Secretaria de Ciencia y Tecnica (SECyT) of Universidad Nacional de Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) of Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was funded by Secretaria de Ciencia y Tecnica (SECyT) of Universidad Nacional de Cordoba, and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) of Argentina.; We are grateful to the Delegacion Regional Centro of the Administracion de Parques Nacionales of Argentina for granting the permission to conduct the research in the Quebrada del Condorito National Park. German Jaacks contributed with field data monitoring, Daniel Renison and anonymous reviewer constructively criticized the manuscript and Jorgelina Brasca helped with the English. Financial support was provided by Secretaria de Ciencia y Tecnica (SECyT) of Universidad Nacional de Cordoba, and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET).	Acebes P, 2010, MAMMALIA, V74, P57, DOI 10.1515/MAMM.2009.071; Arganaraz JP, 2015, SCI TOTAL ENVIRON, V520, P1, DOI 10.1016/j.scitotenv.2015.02.081; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Armstrong DP, 2007, J APPL ECOL, V44, P953, DOI 10.1111/j.1365-2664.2007.01320.x; Armstrong Doug P., 2012, P165; Bach LA, 2010, J NAT CONSERV, V18, P237, DOI 10.1016/j.jnc.2009.09.001; Bank MS, 2003, BIOL CONSERV, V112, P427, DOI 10.1016/S0006-3207(02)00342-7; Barri Fernando R, 2014, Ecol. austral, V24, P203; Barri Fernando R, 2014, Mastozool. neotrop., V21, P09; Barri FR, 2011, ACTA ETHOL, V14, P103, DOI 10.1007/s10211-011-0098-5; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Berberian E., 2001, HIST ARGENTINA PREHI, V2, P635; Cabido D., 2003, SERIE C PUBLICACIONE; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Cingolani AM, 2008, J BIOGEOGR, V35, P538, DOI 10.1111/j.1365-2699.2007.01807.x; Cingolani AM, 2015, J HYDROL, V525, P178, DOI 10.1016/j.jhydrol.2015.03.041; Cingolani AM, 2013, RANGELAND J, V35, P285, DOI 10.1071/RJ12095; Cingolani AM, 2014, PERSPECT PLANT ECOL, V16, P143, DOI 10.1016/j.ppees.2014.04.002; Colladon, 2014, ANUARIO PLUVIOMETRIC; Converse SJ, 2013, J WILDLIFE MANAGE, V77, P1145, DOI 10.1002/jwmg.472; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Ellner SP, 2002, CONSERV BIOL, V16, P258, DOI 10.1046/j.1523-1739.2002.00553.x; Flores CE, 2012, RANGELAND J, V34, P439, DOI 10.1071/RJ12040; Forys EA, 1999, J WILDLIFE MANAGE, V63, P251, DOI 10.2307/3802507; Franklin W. L., 1982, MAMMALIAN BIOL S AM, P457; Franklin WL, 1999, BIOL CONSERV, V90, P33, DOI 10.1016/S0006-3207(99)00008-7; Garcia C, 2008, J APPL ECOL, V45, P351, DOI 10.1111/j.1365-2664.2007.01388.x; Gonzalez BA, 2006, MAMMAL REV, V36, P157, DOI 10.1111/j.1365-2907.2006.00084.x; Gustafson LL, 1998, J WILDLIFE MANAGE, V62, P24, DOI 10.2307/3802261; Haight RG, 2000, CONSERV BIOL, V14, P1298, DOI 10.1046/j.1523-1739.2000.99414.x; IUCN, 2016, GUID REINTR OTHER CO; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; Maguire L.A., 1987, P141, DOI 10.1017/CBO9780511623400.009; Marino A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089060; Meretsky VJ, 2000, CONSERV BIOL, V14, P957, DOI 10.1046/j.1523-1739.2000.99113.x; Parlato EH, 2012, CONSERV BIOL, V26, P97, DOI 10.1111/j.1523-1739.2011.01794.x; Pia MV, 2013, MAMMALIA, V77, P273, DOI 10.1515/mammalia-2012-0096; Puig S, 1997, J ARID ENVIRON, V36, P343, DOI 10.1006/jare.1996.0186; Puig S., 2000, MANEJO SUSTENTABLE V, P57; Puig S, 1995, COMPORTAMIENTO ORG S, P97; Raedeke K.J., 1979, POPULATION DYNAMICS; RALLS K, 1988, Conservation Biology, V2, P185, DOI 10.1111/j.1523-1739.1988.tb00169.x; Reed JM, 2002, CONSERV BIOL, V16, P7, DOI 10.1046/j.1523-1739.2002.99419.x; Renison D, 2010, AUSTRAL ECOL, V35, P435, DOI 10.1111/j.1442-9993.2009.02055.x; RIO M., 1905, GEOGRAFIA PROVINCIA; Sarasqueta D, 2001, CRIA REPR GUAN CAUT; Sarno RJ, 1999, J APPL ECOL, V36, P937, DOI 10.1046/j.1365-2664.1999.00449.x; Sarno RJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P22, DOI 10.1007/s00265-003-0604-5; Sarno RJ, 1999, BEHAV ECOL, V10, P41, DOI 10.1093/beheco/10.1.41; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Seddon PJ, 2014, SCIENCE, V345, P406, DOI 10.1126/science.1251818; Seddon PJ, 1999, CONSERV BIOL, V13, P177, DOI 10.1046/j.1523-1739.1999.97414.x; Slotta-Bachmayr L, 2004, J WILDLIFE MANAGE, V68, P790, DOI 10.2193/0022-541X(2004)068[0790:UOPVAT]2.0.CO;2; Soorae P.S., 2013, GLOBAL RE INTRO PERS; Sosa RA, 2005, EUR J WILDLIFE RES, V51, P207, DOI 10.1007/s10344-005-0105-0; Tavarone EG, 2007, PROYECTO PILOTO REIN; Young JK, 2004, REV CHIL HIST NAT, V77, P617, DOI 10.4067/S0716-078X2004000400005	59	6	7	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164806	10.1371/journal.pone.0164806	http://dx.doi.org/10.1371/journal.pone.0164806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741302	Green Published, Green Submitted, gold			2022-12-26	WOS:000385507000067
J	Sanghvi, GV; Baskaran, P; Roseler, W; Sieriebriennikov, B; Rodelsperger, C; Sommer, RJ				Sanghvi, Gaurav V.; Baskaran, Praveen; Roeseler, Waltraud; Sieriebriennikov, Bogdan; Roedelsperger, Christian; Sommer, Ralf J.			Life History Responses and Gene Expression Profiles of the Nematode Pristionchus pacificus Cultured on Cryptococcus Yeasts	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PLASTICITY; DIVERSITY; EVOLUTION; BIOLOGY; SYSTEM; MODEL	Nematodes, the earth's most abundant metazoa are found in all ecosystems. In order to survive in diverse environments, they have evolved distinct feeding strategies and they can use different food sources. While some nematodes are specialists, including parasites of plants and animals, others such as Pristionchus pacificus are omnivorous feeders, which can live on a diet of bacteria, protozoans, fungi or yeast. In the wild, P. pacificus is often found in a necromenic association with beetles and is known to be able to feed on a variety of microbes as well as on nematode prey. However, in laboratory studies Escherichia coli OP50 has been used as standard food source, similar to investigations in Caenorhabditis elegans and it is unclear to what extent this biases the obtained results and how relevant findings are in real nature. To gain first insight into the variation in traits induced by a non-bacterial food source, we study Pristionchus- fungi interactions under laboratory conditions. After screening different yeast strains, we were able to maintain P. pacificus for at least 50- 60 generations on Cryptococcus albidus and Cryptococcus curvatus. We describe life history traits of P. pacificus on both yeast strains, including developmental timing, survival and brood size. Despite a slight developmental delay and problems to digest yeast cells, which are both reflected at a transcriptomic level, all analyses support the potential of Cryptococcus strains as food source for P. pacificus. In summary, our work establishes two Cryptococcus strains as alternative food source for P. pacificus and shows change in various developmental, physiological and morphological traits, including the transcriptomic profiles.	[Sanghvi, Gaurav V.; Baskaran, Praveen; Roeseler, Waltraud; Sieriebriennikov, Bogdan; Roedelsperger, Christian; Sommer, Ralf J.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, Spemannstr 37, Tubingen, Germany	Max Planck Society	Sommer, RJ (corresponding author), Max Planck Inst Dev Biol, Dept Evolutionary Biol, Spemannstr 37, Tubingen, Germany.	ralf.sommer@tuebingen.mpg.de	Sanghvi, Gaurav/AIC-2480-2022; Sieriebriennikov, Bogdan/AAG-5293-2021; , roedelsberg/Q-3831-2019; Sanghvi, Gaurav/AAO-4605-2020	Sieriebriennikov, Bogdan/0000-0002-2948-7292; , roedelsberg/0000-0002-7905-9675; Baskaran, Praveen/0000-0003-2275-3516	Max-Planck Society	Max-Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the core funding of the Max-Planck Society to RJS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Matthias Herrmann for critical comments on the manuscript and the Sommer lab for discussions. This work was funded by the Max-Planck Society to RJS.	Baskaran P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131136; Bento G, 2010, NATURE, V466, P494, DOI 10.1038/nature09164; Bose N, 2012, ANGEW CHEM INT EDIT, V51, P12438, DOI 10.1002/anie.201206797; Bumbarger DJ, 2013, CELL, V152, P109, DOI 10.1016/j.cell.2012.12.013; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Ding X., 2013, CLIN CHEST MED, V16, P387, DOI DOI 10.1016/J.CMET.2012.08.002; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Herrmann M, 2010, BIOL J LINN SOC, V100, P170, DOI 10.1111/j.1095-8312.2010.01410.x; Hong RL, 2006, BIOESSAYS, V28, P651, DOI 10.1002/bies.20404; Hugot JP, 2001, NEMATOLOGY, V3, P199, DOI 10.1163/156854101750413270; Koehnle TJ, 2003, J NUTR, V133, P2331, DOI 10.1093/jn/133.7.2331; Lightfoot James W., 2016, BMC Research Notes, V9, P142, DOI 10.1186/s13104-016-1886-9; Markov GV, 2015, J MOL EVOL, V80, P18, DOI 10.1007/s00239-014-9651-y; Mayntz D, 2009, ANIM BEHAV, V77, P349, DOI 10.1016/j.anbehav.2008.09.036; Munn E. A, 2002, FEEDING DIGESTION, P211; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; Pigliucci M., 2001, SYN ECO EVO; Platt H. M., 1994, PHYLOGENETIC SYSTEMA; Rae R, 2008, J EXP BIOL, V211, P1927, DOI 10.1242/jeb.014944; Rae R, 2010, ENVIRON MICROBIOL, V12, P3007, DOI 10.1111/j.1462-2920.2010.02278.x; Ragsdale EJ, 2013, CELL, V155, P922, DOI 10.1016/j.cell.2013.09.054; Rodelsperger C, 2014, GENETICS, V196, P1153, DOI 10.1534/genetics.113.159855; Serobyan V, 2013, EVOL DEV, V15, P161, DOI 10.1111/ede.12030; Simpson SJ, 2000, ADV STUD BEHAV, V29, P1, DOI 10.1016/S0065-3454(08)60102-3; Sinha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044255; Sommer RJ, 2015, NEMATOL MONOGR PERSP, V11, P19; Sommer RJ, 2009, NAT REV GENET, V10, P416, DOI 10.1038/nrg2567; Sommer RJ, 2013, MOL ECOL, V22, P2380, DOI 10.1111/mec.12286; Sommer RJ, 1996, FUND APPL NEMATOL, V19, P511; Sudhaus Walter, 2010, Palaeodiversity, P117; Susoy V, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00023; Tian H, 2008, CURR BIOL, V18, P142, DOI 10.1016/j.cub.2007.12.048; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WALDBAUER GP, 1991, ANNU REV ENTOMOL, V36, P43, DOI 10.1146/annurev.en.36.010191.000355; Watson E, 2014, CELL, V156, P759, DOI 10.1016/j.cell.2014.01.047; Witte H, 2015, DEV GENES EVOL, V225, P55, DOI 10.1007/s00427-014-0486-8	36	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e164881	10.1371/journal.pone.0164881	http://dx.doi.org/10.1371/journal.pone.0164881			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741297	Green Published, gold, Green Submitted			2022-12-26	WOS:000385507000078
J	Zalas, M; Wawrzynczak, A; Polrolniczak, P; Sobus, J; Schroeder, G; Jurga, S; Selli, E				Zalas, Maciej; Wawrzynczak, Agata; Polrolniczak, Paulina; Sobus, Jan; Schroeder, Grzegorz; Jurga, Stefan; Selli, Elena			Effect of Solvent Variations in the Alcothermal Synthesis of Template-Free Mesoporous Titania for Dye-Sensitized Solar Cells Applications	PLOS ONE			English	Article							PHOTOCATALYTIC ACTIVITY; NANOCRYSTALLINE TIO2; CHARGE-TRANSFER; ANATASE TIO2; FREE ROUTE; LOW-COST; PERFORMANCE; FILMS; LIGHT; RECOMBINATION	A series of 14 mesoporous titania materials has been synthesized using the simple alcothermal template-free method and various alcohols, such as methanol, propanols and butanols, as solvents. All materials were characterized by both wide and small angle XRD, which exhibited the anatase phase with short-range ordered mesoporous structure that is still forming during post synthetic temperature treatment in most of the investigated materials. Nitrogen adsorption-desorption isotherms confirmed the mesoporous structure with surface area ranging from 241 to 383 m(2)g(-1) and pore volumes from 0.162 to 0.473 m(3)g(-1), UV-Vis diffuse reflectance showed the redshift of the absorption edge and the bandgap decrease after post synthetic calcination of the materials presented. The TEM, FT-IR, DTA and TG measurements have been made to well characterize the materials synthesized. The mesoporous samples obtained were applied as anode materials for dye-sensitized solar cells and showed good activity in photon-to-current conversion process with efficiency values ranging from 0.54% to 4.6% and fill factors in the 52% to 67% range. The photovoltaic performances were not as high as those obtained for the materials synthesized by us earlier employing ethanol as a solvent. The differences in the electron lifetime, calculated from electrochemical impedance spectroscopy results and varying between 4.3 to 17.5 ms, were found as a main factor determining the efficiency of the investigated photovoltaic cells.	[Zalas, Maciej; Wawrzynczak, Agata; Schroeder, Grzegorz] Adam Mickiewicz Univ, Fac Chem, Umultowska 89 B, PL-61614 Poznan, Poland; [Zalas, Maciej; Selli, Elena] Univ Milan, Dept Chem, Via Golgi 19, I-20133 Milan, Italy; [Polrolniczak, Paulina] Poznan Cent Lab Batteries & Cells, Inst Nonferrous Met Div, Forteczna 12, PL-61362 Poznan, Poland; [Sobus, Jan; Jurga, Stefan] Adam Mickiewicz Univ, NanoBioMed Ctr, Umultowska 85, PL-61614 Poznan, Poland; [Sobus, Jan] Adam Mickiewicz Univ, Quantum Elect Lab, Fac Phys, Umultowska 85, PL-61614 Poznan, Poland	Adam Mickiewicz University; University of Milan; Adam Mickiewicz University; Adam Mickiewicz University	Zalas, M (corresponding author), Adam Mickiewicz Univ, Fac Chem, Umultowska 89 B, PL-61614 Poznan, Poland.; Zalas, M (corresponding author), Univ Milan, Dept Chem, Via Golgi 19, I-20133 Milan, Italy.	maciej.zalas@amu.edu.pl	Jurga, Stefan/E-8862-2017; Sobus, Jan/P-3905-2017; Wawrzyńczak, Agata/AAX-3470-2021; Zalas, Maciej/AAY-3801-2020	Jurga, Stefan/0000-0002-1665-6077; Sobus, Jan/0000-0002-5132-8896; Wawrzyńczak, Agata/0000-0003-3815-4841; Zalas, Maciej/0000-0002-0702-1213; Polrolniczak, Paulina/0000-0002-9555-3323; Schroeder, Grzegorz/0000-0002-6626-9542	Fondazione Cariplo; Regione Lombardia [2013-1766]	Fondazione Cariplo(Fondazione Cariplo); Regione Lombardia(Regione Lombardia)	Fondazione Cariplo (http://www.fondazionecariplo.it) and Regione Lombardia (www.regione.lombardia.it) have funded the SmartMatLab project (users2.unimi.it/smartmatlab/wordpress grant No. 2013-1766) and MZ and ES were employed to this project and the lab facilities were used in some measurements in this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2006, J PHYS CHEM B, V110, P13872, DOI 10.1021/jp061693u; ALOthman ZA, 2012, MATERIALS, V5, P2874, DOI 10.3390/ma5122874; Berginc M, 2007, SOL ENERG MAT SOL C, V91, P821, DOI 10.1016/j.solmat.2007.02.001; Biswas S, 2008, THIN SOLID FILMS, V517, P1284, DOI 10.1016/j.tsf.2008.06.010; Collins A, 2004, CHEM COMMUN, P568, DOI 10.1039/b315018f; Fadadu KB, 2013, ELECTROCHIM ACTA, V88, P270, DOI 10.1016/j.electacta.2012.10.072; Fei HL, 2007, MICROPOR MESOPOR MAT, V102, P318, DOI 10.1016/j.micromeso.2007.01.021; Filho DAB, 2007, J APPL PHYS, V101; Gao YF, 2007, J AM CERAM SOC, V90, P831, DOI 10.1111/j.1551-2916.2007.01505.x; Green ANM, 2005, J PHYS CHEM B, V109, P12525, DOI 10.1021/jp050145y; Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; Huang CH, 2011, MICROPOR MESOPOR MAT, V142, P473, DOI 10.1016/j.micromeso.2010.12.038; Huang WX, 2015, CERAM INT, V41, P7573, DOI 10.1016/j.ceramint.2015.02.081; Innocenzi P, 2011, CHEM MATER, V23, P2501, DOI 10.1021/cm200050r; Jiang W, 2012, J POWER SOURCES, V218, P405, DOI 10.1016/j.jpowsour.2012.06.033; Kern R, 2002, ELECTROCHIM ACTA, V47, P4213, DOI 10.1016/S0013-4686(02)00444-9; Krasovec UO, 2009, SOL ENERG MAT SOL C, V93, P379, DOI 10.1016/j.solmat.2008.11.012; Kumar M, 2015, SCRIPTA MATER, V105, P46, DOI 10.1016/j.scriptamat.2015.04.030; Lakshminarasimhan N, 2007, J PHYS CHEM C, V111, P15244, DOI 10.1021/jp0752724; Lee CL, 2013, INT J PHOTOENERGY, V2013, DOI 10.1155/2013/250397; Lei BX, 2014, ELECTROCHIM ACTA, V143, P129, DOI 10.1016/j.electacta.2014.07.106; Liu CQ, 2004, J MATER CHEM, V14, P1187, DOI 10.1039/b316426h; Liu JM, 2016, SCI BULL, V61, P1543, DOI 10.1007/s11434-016-1162-3; Nahm C, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/36/365604; Nazeeruddin MK, 1999, INORG CHEM, V38, P6298, DOI 10.1021/ic990916a; Nazeeruddin MK, 2005, J AM CHEM SOC, V127, P16835, DOI 10.1021/ja052467l; NAZEERUDDIN MK, 1993, J AM CHEM SOC, V115, P6382, DOI 10.1021/ja00067a063; O'Regan BC, 2007, J PHYS CHEM C, V111, P14001, DOI 10.1021/jp073056p; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Petersch E., 2000, STRUCTURE DETERMINAT; Pradhan B, 2007, SOL ENERG MAT SOL C, V91, P769, DOI 10.1016/j.solmat.2007.01.006; Qi LM, 2002, J MATER SCI LETT, V21, P1301, DOI 10.1023/A:1016527707843; Qian JF, 2009, ADV MATER, V21, P3663, DOI 10.1002/adma.200900525; Raveendran P, 2008, J PHYS CHEM C, V112, P20007, DOI 10.1021/jp805963s; Rui YC, 2016, APPL SURF SCI, V369, P170, DOI 10.1016/j.apsusc.2016.02.049; Shih YC, 2012, J NANOSCI NANOTECHNO, V12, P3070, DOI 10.1166/jnn.2012.5840; Sing KSW, 1984, PURE APPL CHEM, V1985, P603, DOI DOI 10.1351/PAC198557040603; Vivero-Escoto JL, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/1/013003; Wang Y, 2006, MAT SCI ENG B-SOLID, V128, P229, DOI 10.1016/j.mseb.2005.12.004; Wei LG, 2013, RSC ADV, V3, P25908, DOI 10.1039/c3ra44194f; Xu P, 2010, J PHYS CHEM C, V114, P9510, DOI 10.1021/jp101634s; Yu H, 2009, ELECTROCHIM ACTA, V54, P1319, DOI 10.1016/j.electacta.2008.09.025; Yu JG, 2007, ADV FUNCT MATER, V17, P1984, DOI 10.1002/adfm.200600933; Zalas M, 2015, INT J PHOTOENERGY, V2015, DOI 10.1155/2015/653740; Zalas M, 2014, CATAL TODAY, V230, P91, DOI 10.1016/j.cattod.2013.12.032; Zalas M, 2012, MATER CHEM PHYS, V134, P170, DOI 10.1016/j.matchemphys.2012.02.047; Zhou F, 2004, SOLID STATE COMMUN, V132, P181, DOI 10.1016/j.ssc.2004.07.055; Zhou Q, 2014, MATER RES BULL, V51, P244, DOI 10.1016/j.materresbull.2013.12.034; Zhuang Y, 2016, J ALLOY COMPD, V662, P84, DOI 10.1016/j.jallcom.2015.08.067; Zukalova M, 2005, NANO LETT, V5, P1789, DOI 10.1021/nl051401l	50	1	1	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164670	10.1371/journal.pone.0164670	http://dx.doi.org/10.1371/journal.pone.0164670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741313	Green Published, gold, Green Submitted			2022-12-26	WOS:000385507000055
J	Zhang, LW; Kang, K; Jiang, SC; Zhang, YN; Wang, TT; Zhang, J; Sun, L; Yang, YQ; Huang, CC; Jiang, LY; Ding, DG				Zhang, Long-Wa; Kang, Ke; Jiang, Shi-Chang; Zhang, Ya-Nan; Wang, Tian-Tian; Zhang, Jing; Sun, Long; Yang, Yun-Qiu; Huang, Chang-Chun; Jiang, Li-Ya; Ding, De-Gui			Analysis of the Antennal Transcriptome and Insights into Olfactory Genes in Hyphantria cunea (Drury)	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; EXPRESSION; LEPIDOPTERA; FAMILY; IDENTIFICATION; RECEPTORS; PHEROMONE; GENOME; SILKWORM; SNMP-1	Hyphantria cunea (Drury) (Lepidoptera: Arctiidae) is an invasive insect pest which, in China, causes unprecedented damage and economic losses due to its extreme fecundity and wide host range, including forest and shade trees, and even crops. Compared to the better known lepidopteran species which use Type-I pheromones, little is known at the molecular level about the olfactory mechanisms of host location and mate choice in H. cunea, a species using Type-II lepidopteran pheromones. In the present study, the H. cunea antennal transcriptome was constructed by Illumina Hiseq 2500 TM sequencing, with the aim of discovering olfaction-related genes. We obtained 64,020,776 clean reads, and 59,243 unigenes from the analysis of the transcriptome, and the putative gene functions were annotated using gene ontology (GO) annotation. We further identified 124 putative chemosensory unigenes based on homology searches and phylogenetic analysis, including 30 odorant binding proteins (OBPs), 17 chemosensory proteins (CSPs), 52 odorant receptors (ORs), 14 ionotropic receptors (IRs), nine gustatory receptors (GRs) and two sensory neuron membrane proteins (SNMPs). We also found many conserved motif patterns of OBPs and CSPs using a MEME system. Moreover, we systematically analyzed expression patterns of OBPs and CSPs based on reverse transcription PCR and quantitative real time PCR (RT-qPCR) with RNA extracted from different tissues and life stages of both sexes in H. cunea. The antennae-biased expression may provide a deeper further understanding of olfactory processing in H. cunea. The first ever identification of olfactory genes in H. cunea may provide new leads for control of this major pest.	[Zhang, Long-Wa; Kang, Ke; Jiang, Shi-Chang; Wang, Tian-Tian; Zhang, Jing; Sun, Long; Yang, Yun-Qiu] Anhui Agr Univ, Sch Forestry & Landscape Architecture, Anhui Prov Key Lab Microbial Control, Hefei 230036, Peoples R China; [Zhang, Ya-Nan] Huaibei Normal Univ, Coll Life Sci, Huaibei 235000, Peoples R China; [Huang, Chang-Chun; Jiang, Li-Ya; Ding, De-Gui] Forest Pests Control & Quarantine Bur Anhui Prov, Hefei 230001, Peoples R China	Anhui Agricultural University; Huaibei Normal University	Zhang, LW (corresponding author), Anhui Agr Univ, Sch Forestry & Landscape Architecture, Anhui Prov Key Lab Microbial Control, Hefei 230036, Peoples R China.; Zhang, YN (corresponding author), Huaibei Normal Univ, Coll Life Sci, Huaibei 235000, Peoples R China.	zhanglw@ahau.edu.cn; ynzhang_insect@163.com		Zhang, Ya-Nan/0000-0001-7038-2292	Natural Science Foundation of Anhui Province [1508085SMC216]; National Natural Science Foundation of China [31170616, 31000304, 31200490]	Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of Anhui Province 1508085SMC216: L-WZ; National Natural Science Foundation of China 31170616: L-WZ; National Natural Science Foundation of China 31000304: Y-QY; and National Natural Science Foundation of China 31200490: Y-NZ. The funders had roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abraham D, 2005, INSECT BIOCHEM MOLEC, V35, P1100, DOI 10.1016/j.ibmb.2005.05.002; Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Ando T, 2004, CHEM PHEROMONES OTHE; Ando T, 2008, J PESTIC SCI, V33, P17, DOI 10.1584/jpestics.R07-06; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; do Nascimento ARB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2183-z; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; Corcoran JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128596; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; De Biasio F, 2015, INSECT SCI, V22, P220, DOI 10.1111/1744-7917.12118; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Elfekih S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19112; Feng Bo, 2015, BMC Genomics, V16; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087; Godfray H. C. J., 1994, Parasitoids: behavioral and evolutionary ecology.; Gomi T, 2007, ECOL RES, V22, P855, DOI 10.1007/s11284-006-0327-y; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13800; Gu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103420; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Gu XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125159; Hatano E, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0188-3; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hu P, 2016, SCI REP-UK, V6, DOI 10.1038/srep26652; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Liu CQ, 2014, POLYM DEGRAD STABIL, V102, P180, DOI 10.1016/j.polymdegradstab.2014.01.013; Liu H J, 2006, FRONTIERS FORESTRY C, V1, P328, DOI DOI 10.1007/S11461-006-0025-5; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Millar JG, 2000, ANNU REV ENTOMOL, V45, P575, DOI 10.1146/annurev.ento.45.1.575; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Pelletier J, 2011, J INSECT PHYSIOL, V57, P915, DOI 10.1016/j.jinsphys.2011.04.003; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Rogers ME, 2001, CELL TISSUE RES, V303, P433, DOI 10.1007/s004410000305; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang RB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045597, 10.1371/journal.pone.0049256]; Tang R, 2012, CHINESE SCI BULL, V57, P4560, DOI 10.1007/s11434-012-5356-z; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Yang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021128, 10.1371/journal.pone.0024111]; YANG Z, 1989, Entomotaxonomia, V11, P117; Yang ZQ, 2008, B ENTOMOL RES, V98, P293, DOI 10.1017/S0007485308005609; Yang ZQ, 2006, BIOCONTROL, V51, P401, DOI 10.1007/s10526-006-9010-z; Yang Zhong-Qi, 2004, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V77, P213; Yang Zhongqi, 2005, Scientia Silvae Sinicae, V41, P72; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhang DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep18576; Zhang J., 2015, J NANOMATER, V2015, P7, DOI DOI 10.1371/J0URNAL.P0NE; Zhang SF, 2014, INSECT BIOCHEM MOLEC, V52, P69, DOI 10.1016/j.ibmb.2014.06.006; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhao YN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148159	71	48	56	6	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164729	10.1371/journal.pone.0164729	http://dx.doi.org/10.1371/journal.pone.0164729			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741298	gold, Green Submitted, Green Published			2022-12-26	WOS:000385507000061
J	Cacace, A; Sboarina, M; Vazeille, T; Sonveaux, P				Cacace, A.; Sboarina, M.; Vazeille, T.; Sonveaux, P.			Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism	ONCOGENE			English	Article							PENTOSE-PHOSPHATE PATHWAY; TUMOR-CELLS; SERINE PHOSPHORYLATION; SIGNALING PATHWAYS; TRANSPORTER MCT4; GROWTH; LACTATE; HYPOXIA; RESISTANCE; INHIBITION	Cancer cells can use a variety of metabolic substrates to fulfill the bioenergetic and biosynthetic needs of their oncogenic program. Besides bioenergetics, cancer cell metabolism also directly influences genetic, epigenetic and signaling events associated with tumor progression. Many cancer cells are addicted to glutamine, and this addiction is observed in oxidative as well as in glycolytic cells. Although both oxidative and bioreductive glutamine metabolism can contribute to cancer progression and glutamine can further serve to generate peptides (including glutathione) and proteins, we report that glutamine promotes the proliferation of cancer cells independently of its use as a metabolic fuel or as a precursor of glutathione. Extracellular glutamine activates transcription factor signal transducer and activator of transcription 3 (STAT3), which is necessary and sufficient to mediate the proliferative effects of glutamine on glycolytic and oxidative cancer cells. Glutamine also activates transcription factors hypoxia-inducible factor-1, mammalian target of rapamycin and c-Myc, but these factors do not mediate the effects of glutamine on cancer cell proliferation. Our findings shed a new light on the anticancer effects of L-asparaginase that possesses glutaminase activity and converts glutamine into glutamate extracellularly. Conversely, cancer resistance to treatments that block glutamine metabolism could arise from glutamine-independent STAT3 reactivation.	[Cacace, A.; Sboarina, M.; Vazeille, T.; Sonveaux, P.] Catholic Univ Louvain, IREC, Pole Pharmacol, Ave Emmanuel Mounier 52 Box B1-53-09, B-1200 Brussels, Belgium	Universite Catholique Louvain	Sonveaux, P (corresponding author), Catholic Univ Louvain, IREC, Pole Pharmacol, Ave Emmanuel Mounier 52 Box B1-53-09, B-1200 Brussels, Belgium.	pierre.sonveaux@uclouvain.be			Starting Grant from the European Research Council (ERC) [243188 TUMETABO]; Interuniversity Attraction Pole (IAP) from the Belgian Science Policy Office (Belspo), an Action de Recherche Concertee from the Communaute Francaise de Belgique [UP7-03, ARC 14/19-058]; Belgian Fonds National de la Recherche Scientifique (FRS-FNRS); Televie and the Belgian Fondation contre le Cancer [2012-186]	Starting Grant from the European Research Council (ERC); Interuniversity Attraction Pole (IAP) from the Belgian Science Policy Office (Belspo), an Action de Recherche Concertee from the Communaute Francaise de Belgique; Belgian Fonds National de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Televie and the Belgian Fondation contre le Cancer	This work was supported by a Starting Grant from the European Research Council (ERC no. 243188 TUMETABO), Interuniversity Attraction Pole (IAP) grant #UP7-03 from the Belgian Science Policy Office (Belspo), an Action de Recherche Concertee from the Communaute Francaise de Belgique (ARC 14/19-058), the Belgian Fonds National de la Recherche Scientifique (FRS-FNRS), the Televie and the Belgian Fondation contre le Cancer (2012-186). PS is a FRS-FNRS Research Associate. AC is a Postdoctoral Fellow and MS a Research Fellow of the Televie. We thank Marylene Focant from Promega (Leiden, The Netherlands) for having provided glutamine/glutamate-Glo Assay kits.	Avramis VI, 2006, INT J NANOMED, V1, P241; Banda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081126; Bellance N, 2009, FRONT BIOSCI-LANDMRK, V14, P4015, DOI 10.2741/3509; BERGSTROM J, 1974, J APPL PHYSIOL, V36, P693, DOI 10.1152/jappl.1974.36.6.693; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chandra V, 2015, ARCH PHARM RES, V38, P321, DOI 10.1007/s12272-015-0561-3; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Corbet C, 2014, CANCER RES, V74, P5507, DOI 10.1158/0008-5472.CAN-14-0705; De Preter G, 2016, ONCOTARGET, V7, P2910, DOI 10.18632/oncotarget.6272; De Saedeleer CJ, 2014, ONCOGENE, V33, P4060, DOI 10.1038/onc.2013.454; De Saedeleer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046571; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Gough DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083395; Groner Bernd, 2012, JAKSTAT, V1, P211, DOI 10.4161/jkst.21469; Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110; HAKIMI J, 1979, RES COMMUN CHEM PATH, V26, P581; Hassanein M, 2013, CLIN CANCER RES, V19, P560, DOI 10.1158/1078-0432.CCR-12-2334; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Hou PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113865; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Jin LT, 2015, CANCER CELL, V27, P257, DOI 10.1016/j.ccell.2014.12.006; Kumarevel T, 2008, NUCLEIC ACIDS RES, V36, P4808, DOI 10.1093/nar/gkn456; Li F, 2013, J GENET GENOMICS, V40, P367, DOI 10.1016/j.jgg.2013.05.002; Lincet H, 2015, ONCOGENE, V34, P3751, DOI 10.1038/onc.2014.320; Mates JM, 2013, CURR MOL MED, V13, P514; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; METZEN E, 1995, RESP PHYSIOL, V100, P101, DOI 10.1016/0034-5687(94)00125-J; Munoz J, 2014, ONCOLOGIST, V19, P536, DOI 10.1634/theoncologist.2013-0407; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Niu GL, 2008, MOL CANCER RES, V6, P1099, DOI 10.1158/1541-7786.MCR-07-2177; Parmentier JH, 2015, LEUKEMIA RES, V39, P757, DOI 10.1016/j.leukres.2015.04.008; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pawlus MR, 2014, ONCOGENE, V33, P1670, DOI 10.1038/onc.2013.115; Payen VL, 2015, CANCER J, V21, P75, DOI 10.1097/PPO.0000000000000098; Poli V, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00121; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Prickett TD, 2012, CLIN CANCER RES, V18, P4240, DOI 10.1158/1078-0432.CCR-11-1217; Ratnikov B, 2015, ONCOTARGET, V6, P7379, DOI 10.18632/oncotarget.3132; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Roland CL, 2014, CANCER RES, V74, P5301, DOI 10.1158/0008-5472.CAN-14-0319; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shanware NP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5900; Siveen KS, 2014, BBA-REV CANCER, V1845, P136, DOI 10.1016/j.bbcan.2013.12.005; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Tardito S, 2015, NAT CELL BIOL, V17, P1556, DOI 10.1038/ncb3272; Thorne JL, 2015, INT J CANCER, V137, P1519, DOI 10.1002/ijc.29012; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Van Hee VF, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00228; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yaguchi T, 2010, CELL PHYSIOL BIOCHEM, V26, P125, DOI 10.1159/000320518; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yang LF, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.20134892; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zaganas IV, 2014, NEUROCHEM RES, V39, P471, DOI 10.1007/s11064-014-1251-0; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	64	43	44	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 13	2017	36	15					2074	2084		10.1038/onc.2016.364	http://dx.doi.org/10.1038/onc.2016.364			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DK	27748760	Green Accepted			2022-12-26	WOS:000399782500004
J	Jung, JY; Czabany, T; Wilding, B; Klempier, N; Nidetzky, B				Jung, Jihye; Czabany, Tibor; Wilding, Birgit; Klempier, Norbert; Nidetzky, Bernd			Kinetic Analysis and Probing with Substrate Analogues of the Reaction Pathway of the Nitrile Reductase QueF from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; enzyme mechanism; isothermal titration calorimetry (ITC); isotope effect; pre-steady-state kinetics; reductase; thermodynamics; NADPH; catalytic reaction pathway; nitrile reductase	ADENINE-DINUCLEOTIDE PHOSPHATE; RNA-GUANINE TRANSGLYCOSYLASE; UDP-GLUCOSE DEHYDROGENASE; CATALYTIC MECHANISM; BIOSYNTHESIS; BINDING; ENZYME; OXIDOREDUCTASE; SEQUENCES; INSIGHT	The enzyme QueF catalyzes a four-electron reduction of a nitrile group into an amine, the only reaction of this kind known in biology. In nature, QueF converts 7-cyano-7-deazaguanine (preQ(0)) into 7-aminomethyl-7-deazaguanine (preQ(1)) for the biosynthesis of the tRNA-inserted nucleoside queuosine. The proposed QueF mechanism involves a covalent thioimide adduct between preQ(0) and a cysteine nucleophile in the enzyme, and this adduct is subsequently converted into preQ(1) in two NADPH-dependent reduction steps. Here, we show that the Escherichia coli QueF binds preQ(0) in a strongly exothermic process (H = -80.3 kJ/mol; -TS = 37.9 kJ/mol, K-d = 39 nm) whereby the thioimide adduct is formed with half-of-the-sites reactivity in the homodimeric enzyme. Both steps of preQ(0) reduction involve transfer of the 4-pro-R-hydrogen from NADPH. They proceed about 4-7-fold more slowly than trapping of the enzyme-bound preQ(0) as covalent thioimide (1.63 s(-1)) and are thus mainly rate-limiting for the enzyme's k(cat) (=0.12 s(-1)). Kinetic studies combined with simulation reveal a large primary deuterium kinetic isotope effect of 3.3 on the covalent thioimide reduction and a smaller kinetic isotope effect of 1.8 on the imine reduction to preQ(1). 7-Formyl-7-deazaguanine, a carbonyl analogue of the imine intermediate, was synthesized chemically and is shown to be recognized by QueF as weak ligand for binding (H = -2.3 kJ/mol; -TS = -19.5 kJ/mol) but not as substrate for reduction or oxidation. A model of QueF substrate recognition and a catalytic pathway for the enzyme are proposed based on these data.	[Jung, Jihye; Wilding, Birgit; Nidetzky, Bernd] Austrian Ctr Ind Biotechnol, Petersgasse 14, A-8010 Graz, Austria; [Jung, Jihye; Czabany, Tibor; Nidetzky, Bernd] Graz Univ Technol, NAWIGraz, Inst Biotechnol & Biochem Engn, Petersgasse 12-1, A-8010 Graz, Austria; [Wilding, Birgit; Klempier, Norbert] Graz Univ Technol, Inst Organ Chem, Stremayrgasse 9, A-8010 Graz, Austria	Austrian Centre of Industrial Biotechnology; Graz University of Technology; Graz University of Technology	Nidetzky, B (corresponding author), Austrian Ctr Ind Biotechnol, Petersgasse 14, A-8010 Graz, Austria.; Nidetzky, B (corresponding author), Graz Univ Technol, NAWIGraz, Inst Biotechnol & Biochem Engn, Petersgasse 12-1, A-8010 Graz, Austria.	bernd.nidetzky@tugraz.at	Wilding, Birgit/D-3389-2017; Wilding, Birgit/AAL-8809-2020	Wilding, Birgit/0000-0002-1896-3708; Wilding, Birgit/0000-0002-1896-3708; Jung, Jihye/0000-0001-9186-7176; Czabany, Tibor/0000-0003-1754-6723	Federal Ministry of Economy, Family and Youth (BMWFW); Federal Ministry for Transport, Innovation and Technology (BMVIT); Styrian Business Promotion Agency (SFG); Vienna Business Agency; Standortagentur Tirol; Government of Lower Austria; Styrian Provincial Government Economic Affairs and Innovation through the COMET-Funding Program managed - Austrian Research Promotion Agency (FFG)	Federal Ministry of Economy, Family and Youth (BMWFW); Federal Ministry for Transport, Innovation and Technology (BMVIT); Styrian Business Promotion Agency (SFG); Vienna Business Agency; Standortagentur Tirol; Government of Lower Austria; Styrian Provincial Government Economic Affairs and Innovation through the COMET-Funding Program managed - Austrian Research Promotion Agency (FFG)	This work was supported by the Federal Ministry of Economy, Family and Youth (BMWFW), the Federal Ministry for Transport, Innovation and Technology (BMVIT), the Styrian Business Promotion Agency (SFG), the Vienna Business Agency, the Standortagentur Tirol, the Government of Lower Austria, and the Styrian Provincial Government Economic Affairs and Innovation through the COMET-Funding Program managed by the Austrian Research Promotion Agency (FFG). The authors declare that they have no conflicts of interest with the contents of this article.	ADKINS H, 1948, J AM CHEM SOC, V70, P695, DOI 10.1021/ja01182a080; Agrawal N, 2003, ANAL BIOCHEM, V322, P179, DOI 10.1016/j.ab.2003.08.012; AMUNDSEN LH, 1951, J AM CHEM SOC, V73, P242, DOI 10.1021/ja01145a082; Bagal DB, 2015, ADV SYNTH CATAL, V357, P883, DOI 10.1002/adsc.201400940; Brooks AF, 2010, TETRAHEDRON LETT, V51, P4163, DOI 10.1016/j.tetlet.2010.06.008; Caddick S, 2003, TETRAHEDRON, V59, P5417, DOI 10.1016/S0040-4020(03)00858-5; Chikwana VM, 2012, J BIOL CHEM, V287, P30560, DOI 10.1074/jbc.M112.388538; DURAND JM, 1994, J BACTERIOL, V176, P4627, DOI 10.1128/JB.176.15.4627-4634.1994; Egger S, 2011, J BIOL CHEM, V286, P23877, DOI 10.1074/jbc.M111.234682; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Ge X, 2004, EUR J BIOCHEM, V271, P14, DOI 10.1046/j.1432-1033.2003.03876.x; Ge X, 1998, J AM CHEM SOC, V120, P6613, DOI 10.1021/ja9805977; Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902; HARADA F, 1972, BIOCHEMISTRY-US, V11, P301, DOI 10.1021/bi00752a024; HOOPS GC, 1995, BIOCHEMISTRY-US, V34, P15381, DOI 10.1021/bi00046a047; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Iwata-Reuyl D, 2003, BIOORG CHEM, V31, P24, DOI 10.1016/S0045-2068(02)00513-8; JEONG SS, 1994, ANAL BIOCHEM, V221, P273, DOI 10.1006/abio.1994.1411; Kim Y, 2010, J MOL BIOL, V404, P127, DOI 10.1016/j.jmb.2010.09.042; Klepper F, 2005, HELV CHIM ACTA, V88, P2610, DOI 10.1002/hlca.200590201; Kozlov AG, 1999, BIOCHEMISTRY-US, V38, P7388, DOI 10.1021/bi990309z; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Lee BWK, 2007, BIOCHEMISTRY-US, V46, P12844, DOI 10.1021/bi701265r; Leroux AE, 2013, J BIOL CHEM, V288, P23751, DOI 10.1074/jbc.M113.483289; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; McCracken JA, 2004, ANAL BIOCHEM, V324, P131, DOI 10.1016/j.ab.2003.09.025; NAGAO T, 1992, J BACTERIOL, V174, P5013, DOI 10.1128/JB.174.15.5013-5020.1992; Olgen S, 2008, ARCH PHARM, V341, P113, DOI 10.1002/ardp.200700141; Olson LP, 1996, BIOCHEMISTRY-US, V35, P9782, DOI 10.1021/bi952020x; ORDMAN AB, 1977, BIOCHIM BIOPHYS ACTA, V481, P25, DOI 10.1016/0005-2744(77)90133-4; RAGG E, 1991, BIOCHIM BIOPHYS ACTA, V1076, P49, DOI 10.1016/0167-4838(91)90218-O; Ribeiro AJM, 2015, ACS CATAL, V5, P3740, DOI 10.1021/acscatal.5b00528; Van Lanen SG, 2005, P NATL ACAD SCI USA, V102, P4264, DOI 10.1073/pnas.0408056102; Wilding B, 2013, CHEM-EUR J, V19, P7007, DOI 10.1002/chem.201300163; Wilding B, 2012, ADV SYNTH CATAL, V354, P2191, DOI 10.1002/adsc.201200109	35	5	5	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25411	25426		10.1074/jbc.M116.747014	http://dx.doi.org/10.1074/jbc.M116.747014			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27754868	hybrid, Green Published			2022-12-26	WOS:000390095300012
J	Yoshida, T; Delafontaine, P				Yoshida, Tadashi; Delafontaine, Patrice			An Intronic Enhancer Element Regulates Angiotensin II Type 2 Receptor Expression during Satellite Cell Differentiation, and Its Activity Is Suppressed in Congestive Heart Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiotensin II; heart failure; muscle regeneration; skeletal muscle; stem cells; transcription enhancer	SKELETAL-MUSCLE REGENERATION; OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS; DIABETIC-RATS; VASTUS LATERALIS; CANCER CACHEXIA; SOLEUS MUSCLE; MURINE MODEL; WEIGHT-LOSS; TRANSCRIPTION	Patients with advanced congestive heart failure (CHF) or chronic kidney disease often have increased angiotensin II (Ang II) levels and cachexia. We previously demonstrated that Ang II, via its type 1 receptor, causes muscle protein breakdown and apoptosis and inhibits satellite cell (SC) proliferation and muscle regeneration, likely contributing to cachexia in CHF and chronic kidney disease. In contrast, Ang II, via its type 2 receptor (AT2R) expression, is robustly induced during SC differentiation, and it potentiates muscle regeneration. To understand the mechanisms regulating AT2R expression and its potential role in muscle regeneration in chronic diseases, we used a mouse model of CHF and found that muscle regeneration was markedly reduced and that this was accompanied by blunted increase of AT2R expression. We performed AT2R promoter reporter analysis during satellite cell differentiation and found that the 70 bp upstream of the AT2R transcription start site contain a core promoter region, and regions upstream of 70 bp to 3 kbp are dispensable for AT2R induction. Instead, AT2R intron 2 acts as a transcriptional enhancer during SC differentiation. Further deletion/mutation analysis revealed that multiple transcription factor binding sites in the +286/+690 region within intron 2 coordinately regulate AT2R transcription. Importantly, +286/+690 enhancer activity was suppressed in CHF mouse skeletal muscle, suggesting that AT2R expression is suppressed in CHF via inhibition of AT2R intronic enhancer activity, leading to lowered muscle regeneration. Thus targeting intron 2 enhancer element could lead to the development of a novel intervention to increase AT2R expression in SCs and potentiate skeletal muscle regenerative capacity in chronic diseases.	[Yoshida, Tadashi; Delafontaine, Patrice] Univ Missouri, Sch Med, Dept Med & Med Pharmacol & Physiol, One Hosp Dr,M742, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia	Yoshida, T (corresponding author), Univ Missouri, Sch Med, Dept Med & Med Pharmacol & Physiol, One Hosp Dr,M742, Columbia, MO 65212 USA.	yoshidata@health.missouri.edu		Yoshida, Tadashi/0000-0002-4544-1497	National Institutes of Health from NHLBI [R01HL070241, R01-HL080682]; National Institutes of Health from NIGMS [P20-GM103629, P30-GM103337, U54-GM104940]; American Heart Association [15SDG25240022]; University of Missouri Department of Medicine Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070241, R01HL080682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337, P20GM103629, U54GM104940] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); University of Missouri Department of Medicine Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01HL070241 and R01-HL080682 from NHLBI and P20-GM103629, P30-GM103337, and U54-GM104940 from NIGMS, American Heart Association Grant 15SDG25240022, and University of Missouri Department of Medicine Research Council. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anker SD, 2003, LANCET, V361, P1077, DOI 10.1016/S0140-6736(03)12892-9; Aragno M, 2004, DIABETES, V53, P1082, DOI 10.2337/diabetes.53.4.1082; Blanchette M, 2002, GENOME RES, V12, P739, DOI 10.1101/gr.6902; BRANNON MA, 1989, METABOLISM, V38, P348, DOI 10.1016/0026-0495(89)90123-6; Brink M, 1996, J CLIN INVEST, V97, P2509, DOI 10.1172/JCI118698; Cheung WW, 2012, AM J PHYSIOL-RENAL, V303, pF1315, DOI 10.1152/ajprenal.00341.2012; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Corrick KL, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00184; Crul T, 2007, EUR J CLIN INVEST, V37, P897, DOI 10.1111/j.1365-2362.2007.01867.x; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Deplancke B, 2016, CELL, V166, P538, DOI 10.1016/j.cell.2016.07.012; Fermoselle C, 2012, EUR RESPIR J, V40, P851, DOI 10.1183/09031936.00137211; Grabe Niels, 2002, In Silico Biology, V2, pS1; GULATI AK, 1991, ANAT RECORD, V229, P298, DOI 10.1002/ar.1092290303; Guo BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030348; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; ICHIKI T, 1995, HYPERTENSION, V25, P720, DOI 10.1161/01.HYP.25.4.720; ICHIKI T, 1995, CIRC RES, V76, P693, DOI 10.1161/01.RES.76.5.693; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Krause MP, 2011, DIABETES, V60, P1964, DOI 10.2337/db11-0007; Langen RCJ, 2006, AM J RESP CELL MOL, V35, P689, DOI 10.1165/rcmb.2006-0103OC; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Liu W, 2001, INT J DEV BIOL, V45, P415; Mastrocola R, 2008, FREE RADICAL BIO MED, V44, P584, DOI 10.1016/j.freeradbiomed.2007.10.047; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Matsuba Y, 2009, ACTA PHYSIOL, V196, P329, DOI 10.1111/j.1748-1716.2008.01943.x; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mehl KA, 2005, J APPL PHYSIOL, V99, P2379, DOI 10.1152/japplphysiol.00778.2005; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Mitchell PO, 2004, AM J PHYSIOL-CELL PH, V287, pC1753, DOI 10.1152/ajpcell.00292.2004; Mozdziak PE, 2001, J APPL PHYSIOL, V91, P183, DOI 10.1152/jappl.2001.91.1.183; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nguyen T, 2000, J APPL PHYSIOL, V88, P1446, DOI 10.1152/jappl.2000.88.4.1446; Penafuerte CA, 2016, BRIT J CANCER, V114, P680, DOI 10.1038/bjc.2016.3; Penna F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013604; Plank JL, 2014, STEM CELL RES, V12, P233, DOI 10.1016/j.scr.2013.10.008; Ramamoorthy S, 2009, AM J PHYSIOL-ENDOC M, V297, pE392, DOI 10.1152/ajpendo.90529.2008; Rezk BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030276; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Semprun-Prieto LC, 2011, BIOCHEM BIOPH RES CO, V409, P217, DOI 10.1016/j.bbrc.2011.04.122; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Stadhouders R, 2012, TRANSCR-AUSTIN, V3, P181, DOI 10.4161/trns.20720; Su Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134511; Tabony AM, 2011, HYPERTENSION, V58, P643, DOI 10.1161/HYPERTENSIONAHA.111.174839; Tabony AM, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-20; Theriault ME, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-35; Vogiatzis I, 2010, EUR RESPIR J, V36, P301, DOI 10.1183/09031936.00112909; Wanek LJ, 2000, ANAT REC, V258, P176; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wieteska-Skrzeczynska W, 2009, J PHYSIOL PHARMACOL, V60, P29; Wu XW, 2013, BURNS, V39, P736, DOI 10.1016/j.burns.2012.10.016; Xue Q, 2011, CARDIOVASC RES, V89, P300, DOI 10.1093/cvr/cvq303; Yanez-Cuna JO, 2013, TRENDS GENET, V29, P11, DOI 10.1016/j.tig.2012.09.007; Yanez-Cuna JO, 2012, GENOME RES, V22, P2018, DOI 10.1101/gr.132811.111; Yoshida T, 2015, AM J MED SCI, V350, P250, DOI 10.1097/MAJ.0000000000000511; Yoshida T, 2014, J BIOL CHEM, V289, P26239, DOI 10.1074/jbc.M114.585521; Yoshida T, 2013, INT J BIOCHEM CELL B, V45, P2322, DOI 10.1016/j.biocel.2013.05.035; Yoshida T, 2013, J BIOL CHEM, V288, P23823, DOI 10.1074/jbc.M112.449074; Yoshida T, 2012, ENDOCRINOLOGY, V153, P1411, DOI 10.1210/en.2011-1764; Yoshida T, 2010, AM J PHYSIOL-HEART C, V298, pH1565, DOI 10.1152/ajpheart.00146.2010; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571	62	3	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25578	25590		10.1074/jbc.M116.752501	http://dx.doi.org/10.1074/jbc.M116.752501			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27756842	Green Published, hybrid			2022-12-26	WOS:000390095300025
J	Zheng, W; Yang, J; Beauchamp, E; Cai, RQ; Hussein, S; Hofmann, L; Li, Q; Flockerzi, V; Berthiaume, LG; Tang, JF; Chen, XZ				Zheng, Wang; Yang, JungWoo; Beauchamp, Erwan; Cai, Ruiqi; Hussein, Shaimaa; Hofmann, Laura; Li, Qiang; Flockerzi, Veit; Berthiaume, Luc G.; Tang, Jingfeng; Chen, Xing-Zhen			Regulation of TRPP3 Channel Function by N-terminal Domain Palmitoylation and Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; electrophysiology; phosphorylation; post-translational modification (PTM); Xenopus	POLYCYSTIC KIDNEY-DISEASE; POSTTRANSLATIONAL MODIFICATIONS; BETA(2)-ADRENERGIC RECEPTOR; TRANSIENT RECEPTOR; S-PALMITOYLATION; CALCIUM-CHANNEL; OFF-RESPONSE; PKD2L1; ACTIVATION; IDENTIFICATION	Transient receptor potential polycystin-3 (TRPP3) is a cation channel activated by calcium and proton and is involved in hedgehog signaling, intestinal development, and sour tasting. How TRPP3 channel function is regulated remains poorly understood. By N-terminal truncation mutations, electrophysiology, and Xenopus oocyte expression, we first identified fragment Asp-21-Ser-42 to be functionally important. We then found that deletion mutant 1-36 (TRPP3 missing fragment Met-1-Arg-36) has a similar function as wild-type TRPP3, whereas 1-38 is functionally dead, suggesting the importance of Val-37 or Cys-38. Further studies found that Cys-38, but not Val-37, is functionally critical. Cys-38 is a predicted site of palmitoylation, and indeed TRPP3 channel activity was inhibited by palmitoylation inhibitor 2-bromopalmitate and rescued by palmitoylation substrate palmitic acid. The TRPP3 N terminus (TRPP3NT, Met-1-Leu-95) localized along the plasma membrane of HEK293 cells but stayed in the cytoplasm with 2-bromopalmitate treatment or C38A mutation, indicating that TRPP3NT anchors to the surface membrane through palmitoylation at Cys-38. By acyl-biotin exchange assays, we showed that TRPP3, but not mutant C38A, is indeed palmitoylated. When putative phosphorylation sites near Cys-38 were mutated to Asp or Glu to mimic phosphorylation, only T39D and T39E reduced TRPP3 function. Furthermore, TRPP3NT displayed double bands in which the upper band was abolished by phosphatase treatment or T39A mutation. However, palmitoylation at Cys-38 and phosphorylation at Thr-39 independently regulated TRPP3 channel function, in contrast to previous reports about correlated palmitoylation with a proximate phosphorylation. Palmitoylation at Cys-38 represents a novel mechanism of functional regulation for TRPP3.	[Zheng, Wang; Yang, JungWoo; Cai, Ruiqi; Hussein, Shaimaa; Li, Qiang; Chen, Xing-Zhen] Univ Alberta, Membrane Prot Dis Res Grp, Dept Physiol, Edmonton, AB T6G 2H7, Canada; [Beauchamp, Erwan; Berthiaume, Luc G.] Univ Alberta, Dept Cell Biol, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada; [Hofmann, Laura; Flockerzi, Veit] Univ Saarland, Expt & Klin Pharmakol & Toxikol, D-66421 Homburg, Germany; [Tang, Jingfeng; Chen, Xing-Zhen] Hubei Univ Technol, Inst Biomed & Pharmaceut Sci, Coll Bioengn, Wuhan 430068, Peoples R China; [Tang, Jingfeng; Chen, Xing-Zhen] Hubei Univ Technol, Prov Cooperat Innovat Ctr, Coll Bioengn, Wuhan 430068, Peoples R China	University of Alberta; University of Alberta; Saarland University; Hubei University of Technology; Hubei University of Technology	Chen, XZ (corresponding author), Univ Alberta, Membrane Prot Dis Res Grp, Dept Physiol, Edmonton, AB T6G 2H7, Canada.; Tang, JF; Chen, XZ (corresponding author), Hubei Univ Technol, Inst Biomed & Pharmaceut Sci, Coll Bioengn, Wuhan 430068, Peoples R China.; Tang, JF; Chen, XZ (corresponding author), Hubei Univ Technol, Prov Cooperat Innovat Ctr, Coll Bioengn, Wuhan 430068, Peoples R China.	jingfeng9930@163.com; xzchen@ualberta.ca	Hussein, Shaimaa/HHZ-5533-2022	Tang, jingfeng/0000-0002-5524-4518; Hussein, Shaimaa/0000-0003-0849-9670	Natural Sciences and Engineering Research Council of Canada; National Natural Science Foundation of China [8157041737, 81602448]; Alberta Innovates-Doctoral Graduate Student Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Alberta Innovates-Doctoral Graduate Student Scholarship	This work was supported in part by the Natural Sciences and Engineering Research Council of Canada and National Natural Science Foundation of China Grants 8157041737 (to X.Z.C.) and 81602448 (to J.T.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of the Alberta Innovates-Doctoral Graduate Student Scholarship.	Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Bosmans F, 2011, P NATL ACAD SCI USA, V108, P20213, DOI 10.1073/pnas.1108497108; Brigidi GS, 2013, JOVE-J VIS EXP, DOI 10.3791/50031; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Chandra M, 2011, GASTROENTEROLOGY, V140, P857, DOI 10.1053/j.gastro.2010.11.040; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43907; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; DeCaen PG, 2013, NATURE, V504, P315, DOI 10.1038/nature12832; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Djenoune L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00026; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Feng S, 2011, J BIOL CHEM, V286, P18994, DOI 10.1074/jbc.M110.192286; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Gauthier-Kemper A, 2014, MOL BIOL CELL, V25, P3284, DOI 10.1091/mbc.E13-12-0737; Horio N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020007; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Hussein S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15752; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Ishimaru Y, 2010, FASEB J, V24, P4058, DOI 10.1096/fj.10-162925; Li Q, 2002, FEBS LETT, V516, P270, DOI 10.1016/S0014-5793(02)02513-9; Li Q, 2007, J NEUROCHEM, V103, P2391, DOI 10.1111/j.1471-4159.2007.04940.x; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lin DTS, 2015, ELIFE, V4, DOI 10.7554/eLife.11306; Liu C, 2015, BIOCHEM BIOPH RES CO, V460, P22, DOI 10.1016/j.bbrc.2015.02.067; Loisel TP, 1999, J BIOL CHEM, V274, P31014, DOI 10.1074/jbc.274.43.31014; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moffett S, 1996, J BIOL CHEM, V271, P21490, DOI 10.1074/jbc.271.35.21490; Moffett S, 2001, J NEUROCHEM, V76, P269, DOI 10.1046/j.1471-4159.2001.00005.x; Moritz AE, 2015, J BIOL CHEM, V290, P29095, DOI 10.1074/jbc.M115.667055; Murakami M, 2005, J BIOL CHEM, V280, P5626, DOI 10.1074/jbc.M411496200; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nomura H, 1998, J BIOL CHEM, V273, P25967, DOI 10.1074/jbc.273.40.25967; Orts-Del'Immagine A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087748; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Saotome K, 2016, NATURE, V534, P506, DOI 10.1038/nature17975; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; SCHMIDT MFG, 1979, CELL, V17, P813, DOI 10.1016/0092-8674(79)90321-0; Shipston MJ, 2014, J GEN PHYSIOL, V143, P659, DOI 10.1085/jgp.201411176; Streets AJ, 2006, HUM MOL GENET, V15, P1465, DOI 10.1093/hmg/ddl070; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Voolstra O, 2014, CELLS-BASEL, V3, P258, DOI 10.3390/cells3020258; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Yang J, 2012, J BIOL CHEM, V287, P6551, DOI 10.1074/jbc.M111.305854; Yao G, 2016, HUM MOL GENET, V25, P448, DOI 10.1093/hmg/ddv484; Yeste-Velasco M, 2015, BBA-REV CANCER, V1856, P107, DOI 10.1016/j.bbcan.2015.06.004; Zheng W, 2015, SCI REP-UK, V5, DOI 10.1038/srep09460; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	53	11	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25678	25691		10.1074/jbc.M116.756544	http://dx.doi.org/10.1074/jbc.M116.756544			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27754867	Green Published, hybrid			2022-12-26	WOS:000390095300033
J	Huang, SL; Lv, ZQ; Guo, Y; Li, L; Zhang, YW; Zhou, L; Yang, BY; Wu, S; Zhang, Y; Xie, CH; Li, SS; Cheng, JQ				Huang, Suli; Lv, Ziquan; Guo, Yi; Li, Lu; Zhang, Yanwei; Zhou, Li; Yang, Binyao; Wu, Shuang; Zhang, Ying; Xie, Changhui; Li, Shanshan; Cheng, Jinquan			Identification of Blood Let-7e-5p as a Biomarker for Ischemic Stroke	PLoS One			English	Article							CORONARY-ARTERY-DISEASE; NEMO-LIKE KINASE; MICRORNA EXPRESSION; CIRCULATING MICRORNAS; MYOCARDIAL-INFARCTION; BRAIN; HYPERTENSION; SIGNATURE; APOPTOSIS; PROFILES	Circulating microRNAs (miRNAs) are emerging as novel disease biomarkers. Using a miRNA microarray, we previously showed that the whole blood level of let-7e-5p was significantly higher in ischemic stroke patients than in control subjects. However, the association between let-7e-5p expression and the occurrence of ischemic stroke remains unknown. In this study, we validated the expression levels of let-7e-5p in two case-control populations using miRNA TaqMan assays and further investigated the potential targets of let-7e-5p. The results suggest that the blood level of let-7e-5p was significantly higher in patients with ischemic stroke than in controls (p<0.05). Higher levels of let-7e-5p were associated with increased occurrence of ischemic stroke (adjusted OR, 1.89; 95% CI, 1.61 similar to 2.21, p<0.001) in the combined population. The addition of let-7e-5p to traditional risk factors led to an improvement in the area under the curve, which increased from 0.74 (95% CI, 0.70 similar to 0.78) to 0.82 (95% CI, 0.78 similar to 0.85), with a net reclassification improvement of 16.76% (p<0.0001) and an integrated discrimination improvement of 0.10 (p<0.0001) for patients with ischemic stroke. Bioinformatics prediction and cell experiments suggested that the expression levels of four genes enriched in the MAPK signaling pathway were down-regulated by let-7e-5p transfection. Specifically, the expression levels of the genes CASP3 and NLK were significantly lower in ischemic stroke patients than in controls and were negatively correlated with let-7e-5p expression. In summary, our study suggests the potential use of blood let-7e-5p as a biomarker for ischemic stroke and indicates its involvement in the related pathomechanism.	[Huang, Suli; Lv, Ziquan; Zhang, Yanwei; Zhou, Li; Wu, Shuang; Xie, Changhui; Li, Shanshan; Cheng, Jinquan] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China; [Guo, Yi] Peoples Hosp Shenzen, Dept Neurol, Shenzhen, Guangdong, Peoples R China; [Li, Lu] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth,Minist Educ, Wuhan, Hubei, Peoples R China; [Li, Lu] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Environm Protect, Wuhan, Hubei, Peoples R China; [Li, Lu] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubating, Wuhan, Hubei, Peoples R China; [Yang, Binyao] Guangzhou Med Univ, Sch Publ Hlth, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Shenzhen Center for Disease Control & Prevention (SZCDC); Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Cheng, JQ (corresponding author), Shenzhen Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China.	cjinquan@szcdc.net			National Natural Science Foundation of China [81402754, 81573242, 81502789]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by: National Natural Science Foundation of China [no. 81402754, SLH]; National Natural Science Foundation of China [no. 81573242, JQC]; National Natural Science Foundation of China [no. 81502789, ZQL]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cengiz M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000693; Dharap A, 2010, J NEUROCHEM, V113, P1685, DOI 10.1111/j.1471-4159.2010.06735.x; Feinberg MW, 2016, CIRC RES, V118, P703, DOI 10.1161/CIRCRESAHA.115.306300; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Grayson BL, 2011, GENES IMMUN, V12, P341, DOI 10.1038/gene.2011.13; Hoekstra M, 2010, BIOCHEM BIOPH RES CO, V394, P792, DOI 10.1016/j.bbrc.2010.03.075; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Huang SL, 2014, CIRC-CARDIOVASC GENE, V7, P189, DOI 10.1161/CIRCGENETICS.113.000294; Ishitani T, 2013, CELL SIGNAL, V25, P190, DOI 10.1016/j.cellsig.2012.09.017; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Lee ST, 2010, STROKE, V41, P1646, DOI 10.1161/STROKEAHA.110.579649; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Li Z, 2012, CELL MOL NEUROBIOL, V32, P381, DOI 10.1007/s10571-011-9766-2; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Peng GP, 2015, TRANSL STROKE RES, V6, P437, DOI 10.1007/s12975-015-0422-x; Peng GP, 2011, BRAIN RES BULL, V86, P272, DOI 10.1016/j.brainresbull.2011.07.017; Quinn EM, 2012, J LEUKOCYTE BIOL, V91, P721, DOI 10.1189/jlb.1111571; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sinnaeve PR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007037; Stather PW, 2013, CIRC-CARDIOVASC GENE, V6, P490, DOI 10.1161/CIRCGENETICS.111.000053; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Zampetaki A, 2012, J AM COLL CARDIOL, V60, P290, DOI 10.1016/j.jacc.2012.03.056; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang YW, 2014, MOL NEUROBIOL, V49, P852, DOI 10.1007/s12035-013-8561-0	29	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0163951	10.1371/journal.pone.0163951	http://dx.doi.org/10.1371/journal.pone.0163951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776139	Green Published, Green Submitted, gold			2022-12-26	WOS:000389009200009
J	Stevanovic, J; de Jong, LA; Kappelhoff, BS; Dvortsin, EP; Voorhaar, M; Postma, MJ				Stevanovic, J.; de Jong, L. A.; Kappelhoff, B. S.; Dvortsin, E. P.; Voorhaar, M.; Postma, M. J.			Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; ECONOMIC-EVALUATION; WARFARIN; HYPERTENSION; UTILITIES; CARE	Background Dabigatran was proven to have similar effect on the prevention of recurrence of venous thromboembolism (VTE) and a lower risk of bleeding compared to vitamin K antagonists (VKA). The aim of this study is to assess the cost-effectiveness (CE) of dabigatran for the treatment and secondary prevention in patients with VTE compared to VKAs in the Dutch setting. Methods Previously published Markov model was modified and updated to assess the CE of dabigatran and VKAs for the treatment and secondary prevention in patients with VTE from a societal perspective in the base-case analysis. The model was populated with efficacy and safety data from major dabigatran trials (i.e. RE-COVER, RECOVER II, RE-MEDY and RESONATE), Dutch specific costs, and utilities derived from dabigatran trials or other published literature. Univariate, probabilistic sensitivity and a number of scenario analyses evaluating various decision-analytic settings (e.g. the perspective of analysis, use of anticoagulants only for treatment or only for secondary prevention, or comparison to no treatment) were tested on the incremental cost-effectiveness ratio (ICER). Results In the base-case scenario, patients on dabigatran gained an additional 0.034 quality adjusted life year (QALY) while saving epsilon 1,598. Results of univariate sensitivity analysis were quite robust. The probability that dabigatran is cost-effective at a willingness-to-pay threshold of epsilon 20,000/ QALY was 98.1%. From the perspective of healthcare provider, extended anticoagulation with dabigatran compared to VKAs was estimated at epsilon 2,158 per QALY gained. The ICER for anticoagulation versus no treatment in patients with equipoise risk of recurrent VTE was estimated at epsilon 33,379 per QALY gained. Other scenarios showed dabigatran was cost-saving. Conclusion From a societal perspective, dabigatran is likely to be a cost-effective or even cost-saving strategy for treatment and secondary prevention of VTE compared to VKAs in the Netherlands.	[Stevanovic, J.; de Jong, L. A.; Dvortsin, E. P.; Postma, M. J.] Univ Groningen, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands; [Kappelhoff, B. S.; Voorhaar, M.] Boehringer Ingelheim GmbH & Co KG, Alkmaar, Netherlands; [Postma, M. J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Hlth Aging & healthcaRE SHARE, Groningen, Netherlands; [Postma, M. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; Boehringer Ingelheim; University of Groningen; University of Groningen	de Jong, LA (corresponding author), Univ Groningen, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands.	L.a.de.jong@student.rug.nl		de Jong, Lisa/0000-0001-8814-0670; Postma, Maarten/0000-0002-6306-3653	Boehringer Ingelheim NL	Boehringer Ingelheim NL(Boehringer Ingelheim)	This study was funded by Boehringer Ingelheim NL. The funder provided support in the form of salaries for authors BSK and MV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2012, 1213 CFH COLL ZORGV; Baeten Stefan A, 2010, Cost Eff Resour Alloc, V8, P21, DOI 10.1186/1478-7547-8-21; BOERSMA C, 2006, J MED ECON, V9, P121; Braidy Nady, 2011, Pharmacy Pract (Granada), V9, P1; Brouwer MA, 2002, CIRCULATION, V106, P659, DOI 10.1161/01.CIR.0000024408.81821.32; CBO, 2008, RICHTL DIAGN PREV BE; Cushman M, 2004, AM J MED, V117, P19, DOI 10.1016/j.amjmed.2004.01.018; Eikelboom JW, 2015, CIRCULATION, V132, P2412, DOI 10.1161/CIRCULATIONAHA.115.019628; Federation of Dutch thrombotic services (FNT), 2013, ANN MED REP; Federation of Dutch thrombotic services (FNT), 2015, KUNST DOS; Gerson LB, 2005, AM J GASTROENTEROL, V100, P524, DOI 10.1111/j.1572-0241.2005.40588.x; Goldhaber SZ, 2012, LANCET, V379, P1835, DOI 10.1016/S0140-6736(11)61904-1; Greving JP, 2011, BMJ-BRIT MED J, P342; Guyatt GH, 2012, CHEST, V141, p48S, DOI 10.1378/chest.11-2286; Hakkaart-van Roijen L, 2010, MANUAL DUTCH COST RE; Jugrin AV, 2015, THROMB HAEMOSTASIS, V114/4, P657; Lenert LA, 1997, J AM MED INFORM ASSN, V4, P49, DOI 10.1136/jamia.1997.0040049; Marchetti M, 2001, AM J MED, V111, P130, DOI 10.1016/S0002-9343(01)00793-8; McKenna SP, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-65; Nederlandse Zorgautoriteit (NZa), BEL TROMB; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Postma Maarten J, 2012, J Med Econ, V15, P878, DOI 10.3111/13696998.2012.691144; Prandoni P, 1997, HAEMATOLOGICA, V82, P423; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; Rijksinstituut voor Volksgezondheid en Milieu, 2010, 2602420012010 RIVM; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Rozenbaum MH, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2509; Schulman S, 2014, CIRCULATION, V130; Schulman S, 2013, NEW ENGL J MED, V368, P709, DOI 10.1056/NEJMoa1113697; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Soekhlal RR, 2013, NETHERLANDS HEART J, P1; Sullivan PW, 2011, MED DECIS MAKING, V31, P800, DOI 10.1177/0272989X11401031; Szende A., 2014, MEASURING SELF REPOR; ten Cate-Hoek AJ, 2009, J THROMB HAEMOST, V7, P2042, DOI 10.1111/j.1538-7836.2009.03627.x; van Bellen B, 2014, CURR MED RES OPIN, V30, P829, DOI 10.1185/03007995.2013.879439; van den Berg B, 2006, SOC SCI MED, V62, P835, DOI 10.1016/j.socscimed.2005.06.046; van Es J, 2013, THROMB RES, V132, P500, DOI 10.1016/j.thromres.2013.06.016	37	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0163550	10.1371/journal.pone.0163550	http://dx.doi.org/10.1371/journal.pone.0163550			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776137	Green Submitted, Green Published, gold			2022-12-26	WOS:000389009200006
J	Zhang, JL; Liu, WX; Chen, WY; Li, CC; Xie, MM; Bu, ZG				Zhang, Jialin; Liu, Wenxing; Chen, Weiye; Li, Cuicui; Xie, Meimei; Bu, Zhigao			Development of an Immunoperoxidase Monolayer Assay for the Detection of Antibodies against Peste des Petits Ruminants Virus Based on BHK-21 Cell Line Stably Expressing the Goat Signaling Lymphocyte Activation Molecule	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CANINE-DISTEMPER VIRUS; MEASLES-VIRUS; SLAM CD150; PPR VIRUS; RECEPTOR; ESTABLISHMENT; RINDERPEST; INFECTION; DIAGNOSIS	From 2013 to 2015, peste des petits ruminants (PPR) broke out in more than half of the provinces of China; thus, the application and development of diagnostic methods are very important for the control of PPR. Here, an immunoperoxidase monolayer assay (IPMA) was developed to detect antibodies against PPR. However, during IPMA development, we found that Vero cells were not the appropriate choice because staining results were not easily observed. Therefore, we first established a baby hamster kidney-goat signaling lymphocyte activation molecule (BHK-SLAM) cell line that could stably express goat SLAM for at least 20 generations. Compared with Vero cells, the PPR-mediated cytopathic effect occurred earlier in BHK-SLAM cells, and large syncytia appeared after virus infection. Based on this cell line and recombinant PPR virus expressing the green fluorescent protein (GFP) (rPPRV-GFP), an IPMA for PPR diagnosis was developed. One hundred and ninety-eight PPR serum samples from goats or sheep were tested by the IPMA and virus neutralization test (VNT). Compared with the VNT, the sensitivity and specificity of the IPMA were 91% and 100%, respectively, and the coincidence rate of the two methods was 95.5%. The IPMA assay could be completed in 4 h, compared with more than 6 d for the VNT using rPPRV-GFP, and it is easily performed, as the staining results can be observed under a microscope. Additionally, unlike the VNT, the IPMA does not require antigen purification, which will reduce its cost. In conclusion, the established IPMA will be an alternative method that replaces the VNT for detecting antibodies against PPRV in the field.	[Zhang, Jialin; Liu, Wenxing; Chen, Weiye; Li, Cuicui; Xie, Meimei; Bu, Zhigao] Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Chen, WY; Bu, ZG (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, Harbin, Peoples R China.	chenweiye1980@163.com; buzhigao@caas.cn			International S&T Cooperation Program of China (ISTCP) [2015DFA31300]; National Key Technology RD Program [2013BAD12B05]	International S&T Cooperation Program of China (ISTCP); National Key Technology RD Program(National Key Technology R&D Program)	This work was supported by the International S&T Cooperation Program of China (ISTCP) (2015DFA31300) and the National Key Technology R&D Program (2013BAD12B05).	Abera T, 2014, J VIROL METHODS, V209, P25, DOI 10.1016/j.jviromet.2014.08.017; ABUELZEIN EME, 1990, VET REC, V127, P309; Adombi CM, 2011, J VIROL METHODS, V173, P306, DOI 10.1016/j.jviromet.2011.02.024; Albina E, 2013, VET MICROBIOL, V165, P38, DOI 10.1016/j.vetmic.2012.12.013; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; Baron MD, 2005, J GEN VIROL, V86, P1753, DOI 10.1099/vir.0.80836-0; Chen WY, 2011, CYTOKINE, V54, P324, DOI 10.1016/j.cyto.2010.12.002; Chen WY, 2010, VACCINE, V28, P4742, DOI 10.1016/j.vaccine.2010.04.102; Choi KS, 2005, CLIN DIAGN LAB IMMUN, V12, P542, DOI 10.1128/CDLI.12.4.542-547.2005; Couacy-Hymann E, 2002, J VIROL METHODS, V100, P17, DOI 10.1016/S0166-0934(01)00386-X; Dalmasso A, 2007, VET RES COMMUN, V31, P355, DOI 10.1007/s11259-007-0036-1; Diallo A, 1989, Rev Elev Med Vet Pays Trop, V42, P311; Direksin K, 2002, J VET DIAGN INVEST, V14, P169, DOI 10.1177/104063870201400215; Forsyth MA, 1995, VIRUS RES, V39, P151, DOI 10.1016/0168-1702(95)00076-3; Guedes RMC, 2002, J VET DIAGN INVEST, V14, P420, DOI 10.1177/104063870201400512; HALBUR PG, 1994, J VET DIAGN INVEST, V6, P254, DOI 10.1177/104063879400600219; Hsu EC, 2001, VIROLOGY, V279, P9, DOI 10.1006/viro.2000.0711; Hu QQ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-48; Hua RH, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-62; Kul O, 2007, VET PATHOL, V44, P479, DOI 10.1354/vp.44-4-479; Kumar N, 2014, VIRUSES-BASEL, V6, P2287, DOI 10.3390/v6062287; Luka PD, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-32; Miest TS, 2013, MOL THER, V21, P2019, DOI 10.1038/mt.2013.171; Nakano H, 2009, VET MICROBIOL, V133, P179, DOI 10.1016/j.vetmic.2008.06.016; Nodelijk G, 1996, VET MICROBIOL, V49, P285, DOI 10.1016/0378-1135(95)00189-1; Pope RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055830; Raj GD, 2000, J VIROL METHODS, V89, P89, DOI 10.1016/S0166-0934(00)00206-8; REED L. J., 1938, AMER JOUR HYG, V27, P493; Seki F, 2003, J VIROL, V77, P9943, DOI 10.1128/JVI.77.18.9943-9950.2003; Singh RP, 2004, VET MICROBIOL, V98, P3, DOI 10.1016/j.vetmic.2003.07.007; Soliman AK, 1997, J VIROL METHODS, V65, P147, DOI 10.1016/S0166-0934(97)02185-X; Soltan MA, 2014, INFECT GENET EVOL, V28, P44, DOI 10.1016/j.meegid.2014.08.016; Sreenivasa BP, 2006, VET RES COMMUN, V30, P103, DOI 10.1007/s11259-005-3200-5; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; TAYLOR WP, 1979, RES VET SCI, V26, P236, DOI 10.1016/S0034-5288(18)32924-2; Tripathi B. N., 1996, Indian Journal of Veterinary Pathology, V20, P99; Wang JF, 2015, EMERG INFECT DIS, V21, P677, DOI 10.3201/eid2104.141627; WARIS M, 1990, J CLIN MICROBIOL, V28, P1159, DOI 10.1128/JCM.28.6.1159-1162.1990; Wu X, 2016, TRANSBOUND EMERG DIS, V63, pE441, DOI 10.1111/tbed.12308; ZIEGLER T, 1995, J CLIN MICROBIOL, V33, P318, DOI 10.1128/JCM.33.2.318-321.1995	41	2	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165088	10.1371/journal.pone.0165088	http://dx.doi.org/10.1371/journal.pone.0165088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768770	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400048
J	Fulcher, YG; Fotso, M; Chang, CH; Rindt, H; Reinero, CR; Van Doren, SR				Fulcher, Yan G.; Fotso, Martial; Chang, Chee-Hoon; Rindt, Hans; Reinero, Carol R.; Van Doren, Steven R.			Noninvasive Recognition and Biomarkers of Early Allergic Asthma in Cats Using Multivariate Statistical Analysis of NMR Spectra of Exhaled Breath Condensate	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; AIRWAY INFLAMMATION; CORRELATION SPECTROSCOPY; METABOLOMICS DATABASE; EXPERIMENTAL-MODEL; DIETARY-INTAKE; FELINE MODEL; EXPOSURE; NORMALIZATION; HYPERRESPONSIVENESS	Asthma is prevalent in children and cats, and needs means of noninvasive diagnosis. We sought to distinguish noninvasively the differences in 53 cats before and soon after induction of allergic asthma, using NMR spectra of exhaled breath condensate (EBC). Statistical pattern recognition was improved considerably by preprocessing the spectra with probabilistic quotient normalization and glog transformation. Classification of the 106 preprocessed spectra by principal component analysis and partial least squares with discriminant analysis (PLS-DA) appears to be impaired by variances unrelated to eosinophilic asthma. By filtering out confounding variances, orthogonal signal correction (OSC) PLS-DA greatly improved the separation of the healthy and early asthmatic states, attaining 94% specificity and 94% sensitivity in predictions. OSC enhancement of multi-level PLS-DA boosted the specificity of the prediction to 100%. OSC-PLS-DA of the normalized spectra suggest the most promising biomarkers of allergic asthma in cats to include increased acetone, metabolite( s) with overlapped NMR peaks near 5.8 ppm, and a hydroxyphenyl-containing metabolite, as well as decreased phthalate. Acetone is elevated in the EBC of 74% of the cats with early asthma. The noninvasive detection of early experimental asthma, biomarkers in EBC, and metabolic perturbation invite further investigation of the diagnostic potential in humans.	[Fulcher, Yan G.; Fotso, Martial; Van Doren, Steven R.] Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA; [Chang, Chee-Hoon; Rindt, Hans; Reinero, Carol R.] Univ Missouri, Dept Vet Med & Surg, Coll Vet Med, 900 East Campus Dr, Columbia, MO 65211 USA; [Chang, Chee-Hoon] Texas A&M Univ, Coll Vet Med, Dept Small Anim Clin Sci, College Stn, TX 77843 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Texas A&M University System; Texas A&M University College Station	Van Doren, SR (corresponding author), Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA.	vandorens@missouri.edu		Van Doren, Steven/0000-0003-2838-4598; Fulcher, Yan/0000-0002-7060-3523	Morris Animal Foundation [D14FE-507, D10FE-803A]; NIH/NCRR [1 S10 RR022341]; University of Missouri Research Council [URC-13-040]; MU-HHMI C3 fellowship	Morris Animal Foundation; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Missouri Research Council; MU-HHMI C3 fellowship	This work was supported by Morris Animal Foundation grants D14FE-507 and D10FE-803A to Prof. Carol R. Reinero (http://www.morrisanimalfoundation.org/researchers/); NIH/NCRR grant 1 S10 RR022341 to Prof. Steven R. Van Doren (http://dpcpsi.nih.gov/orip/diic/shared_instrumentation); University of Missouri Research Council grant URC-13-040 to Prof. Steven R. Van Doren (https://research.missouri.edu/internal/researchcouncl); MU-HHMI C3 fellowship to Martial Fotso (http://hhmi.missouri.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M. J., 2004, CHEMOMETRICS ANAL SP; Aroch I, 2012, VET J, V191, P240, DOI 10.1016/j.tvjl.2011.01.010; Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P287, DOI 10.1016/j.jaci.2012.04.025; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Beebe K.R., 1998, CHEMOMETRICS PRACTIC, V1st; Bingol K, 2015, ACS CHEM BIOL, V10, P452, DOI 10.1021/cb5006382; Bingol K, 2014, ANAL CHEM, V86, P5494, DOI 10.1021/ac500979g; BOHLEN JM, 1993, J MAGN RESON SER A, V102, P293, DOI 10.1006/jmra.1993.1107; Busse WW, 2007, 3 EXPERT PANEL DIAGN; Carraro S, 2013, ALLERGY, V68, P110, DOI 10.1111/all.12063; Carraro S, 2007, AM J RESP CRIT CARE, V175, P986, DOI 10.1164/rccm.200606-769OC; Cho HW, 2008, INT J DATA MIN BIOIN, V2, P176, DOI 10.1504/IJDMB.2008.019097; Cirillo T, 2011, J AGR FOOD CHEM, V59, P10532, DOI 10.1021/jf2020446; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; Cohn LA, 2010, J FELINE MED SURG, V12, P91, DOI 10.1016/j.jfms.2009.05.024; Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712; Craig A, 2006, ANAL CHEM, V78, P2262, DOI 10.1021/ac0519312; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Dallinga JW, 2010, CLIN EXP ALLERGY, V40, P68, DOI 10.1111/j.1365-2222.2009.03343.x; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Fens N, 2011, CLIN EXP ALLERGY, V41, P1371, DOI 10.1111/j.1365-2222.2011.03800.x; Gorman L, 2016, J VET INTERN MED, V30, P611, DOI 10.1111/jvim.13826; Greenwald R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011919; Grobman M, 2016, J FELINE MED SURG, V18, P273, DOI 10.1177/1098612X15581406; Heinemeyer G, 2013, INT J HYG ENVIR HEAL, V216, P472, DOI 10.1016/j.ijheh.2013.01.001; Heller M, 2014, VET IMMUNOL IMMUNOP, V160, P20, DOI 10.1016/j.vetimm.2014.03.006; HENDLER RW, 1994, J BIOCHEM BIOPH METH, V28, P1, DOI 10.1016/0165-022X(94)90061-2; Ibrahim B, 2013, ALLERGY, V68, P1050, DOI 10.1111/all.12211; Ibrahim B, 2011, THORAX, V66, P804, DOI 10.1136/thx.2010.156695; Jung J, 2013, CLIN EXP ALLERGY, V43, P425, DOI 10.1111/cea.12089; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim MA, 2014, CURR OPIN ALLERGY CL, V14, P49, DOI 10.1097/ACI.0000000000000028; Kirschvink N, 2007, VET J, V174, P541, DOI 10.1016/j.tvjl.2006.11.004; Lee-Fowler TM, 2012, INT ARCH ALLERGY IMM, V158, P369, DOI 10.1159/000335122; Lindon JC, 2001, PROG NUCL MAG RES SP, V39, P1, DOI 10.1016/S0079-6565(00)00036-4; Lindon JC, 2008, ANNU REV ANAL CHEM, V1, P45, DOI 10.1146/annurev.anchem.1.031207.113026; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Motta A, 2014, J PROTEOME RES, V13, P6107, DOI 10.1021/pr5010407; Nafe LA, 2010, AM J VET RES, V71, P583, DOI 10.2460/ajvr.71.5.583; PADRID P, 1995, AM J RESP CRIT CARE, V151, P184, DOI 10.1164/ajrccm.151.1.7812551; Padrid PH, 2009, CHRONIC BRONCHITIS A, P650; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Parsons HM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-234; Ravanbakhsh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124219; Registry AfTSaD, 2002, TOX SUBST PORT DI 2; Reinero C, 2012, VET J, V192, P412, DOI 10.1016/j.tvjl.2011.07.003; Reinero CR, 2009, INT ARCH ALLERGY IMM, V150, P43, DOI 10.1159/000210379; Reinero CRN, 2004, INT ARCH ALLERGY IMM, V135, P117, DOI 10.1159/000080654; Santini G, 2016, CURR TOP MED CHEM, V16, P1610, DOI 10.2174/1568026616666151223113540; Saude EJ, 2011, J ALLERGY CLIN IMMUN, V127, P757, DOI 10.1016/j.jaci.2010.12.1077; Schecter A, 2013, ENVIRON HEALTH PERSP, V121, P473, DOI 10.1289/ehp.1206367; SCHERK MA, 2005, TXB VET INTERNAL MED, P1464; Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x; SCHLEUCHER J, 1993, ANGEW CHEM INT EDIT, V32, P1489, DOI 10.1002/anie.199314891; Schooley EK, 2007, AM J VET RES, V68, P1265, DOI 10.2460/ajvr.68.11.1265; Sparkes AH, 2004, J FELINE MED SURG, V6, P335, DOI 10.1016/j.jfms.2003.12.002; Trasande L, 2013, ENVIRON RES, V126, P84, DOI 10.1016/j.envres.2013.07.007; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Trygg J, 2003, J CHEMOMETR, V17, P53, DOI 10.1002/cem.775; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Trzil JE, 2014, CLIN EXP ALLERGY, V44, P1546, DOI 10.1111/cea.12411; Trzil JE, 2014, VET CLIN N AM-SMALL, V44, P91, DOI 10.1016/j.cvsm.2013.08.006; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; van Velzen EJJ, 2008, J PROTEOME RES, V7, P4483, DOI 10.1021/pr800145j; Webb-Robertson BJM, 2005, J PHARMACEUT BIOMED, V39, P830, DOI 10.1016/j.jpba.2005.05.012; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Westerhuis JA, 2010, METABOLOMICS, V6, P119, DOI 10.1007/s11306-009-0185-z; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wold S, 1998, CHEMOMETR INTELL LAB, V44, P175, DOI 10.1016/S0169-7439(98)00109-9; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Zahran Hatice S., 2011, Morbidity and Mortality Weekly Report, V60, P547; Zeugswetter F, 2010, J FELINE MED SURG, V12, P300, DOI 10.1016/j.jfms.2009.10.002	74	6	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164394	10.1371/journal.pone.0164394	http://dx.doi.org/10.1371/journal.pone.0164394			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764146	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500030
J	Ghori, NUH; Shafique, A; Hayat, MQ; Anjum, S				Ghori, Noor-Ul-Huda; Shafique, Atif; Hayat, Muhammad Qasim; Anjum, Sadia			The Phylogeographic and Spatiotemporal Spread of HCV in Pakistani Population	PLOS ONE			English	Article							HEPATITIS-C VIRUS; GENETIC HISTORY; DRUG-USERS; MOLECULAR EPIDEMIOLOGY; INTERFERON-ALPHA; GENOTYPES; INFECTION; DYNAMICS; SUBTYPES; GENOME	Hepatitis C Virus (HCV) is the most prevalent human pathogen in Pakistan and is the major cause of liver cirrhosis and hepatocellular carcinoma in infected patients. It has shifted from being hypo-endemic to being hyper-endemic. There was no information about the origin and evolution of the local variants. Here we use newly developed phyloinformatic methods of sequence analysis to conduct the first comprehensive investigation of the evolutionary and biogeographic history in unprecedented detail and breadth. Considering evolutionary rate and molecular-clock hypothesis in context, we reconstructed the spatiotemporal spread of HCV in the whole territory of its circulation using a combination of Bayesian MCMC methods utilizing all sequences available in GenBank. Comparative analysis were performed and were addressed. Whole genome and individual gene analysis have shown that sub-types 1a, 1b and 3a are recognized as epidemic strains and are distributed globally. Here we confirm that the origin of HCV 3a genotypes is in South Asia and HCV has evolved in the region to become stably adapted to the host environment.	[Ghori, Noor-Ul-Huda] Univ Western Australia, Sch Earth & Environm, Perth, WA, Australia; [Ghori, Noor-Ul-Huda; Shafique, Atif; Hayat, Muhammad Qasim; Anjum, Sadia] NUST, Atta Ur Rahman Sch Appl Biosci ASAB, Islamabad, Pakistan; [Anjum, Sadia] Univ Hail, Dept Biol, Coll Sci, POB 2440, Hail, Saudi Arabia	University of Western Australia; National University of Sciences & Technology - Pakistan; University Ha'il	Ghori, NUH (corresponding author), Univ Western Australia, Sch Earth & Environm, Perth, WA, Australia.; Ghori, NUH (corresponding author), NUST, Atta Ur Rahman Sch Appl Biosci ASAB, Islamabad, Pakistan.	noor-ul-huda.ghori@research.uwa.edu.au	Hayat, Muhammad/HDN-8672-2022; Anjum, Sadia/AAR-7732-2021; Hayat, Muhammad Qasim/E-8340-2011	Anjum, Sadia/0000-0001-9678-7861; Hayat, Muhammad Qasim/0000-0003-1053-5327; Ghori, Noor-Ul-Huda/0000-0003-4294-7422	Higher Education Commission (HEC) Pakistan	Higher Education Commission (HEC) Pakistan(Higher Education Commission of Pakistan)	This work was supported by the Higher Education Commission (HEC) Pakistan (http://www.hec.gov.pk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Higher Education Commission (HEC) Pakistan for funds and National University of Sciences and Technology (NUST) H-12 Islamabad, Pakistan for infrastructure (ASAB) and supercomputing facilities (RCMS).	Afridi SQ, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-24; Ahmad W, 2010, WORLD J GASTROENTERO, V16, P4321, DOI 10.3748/wjg.v16.i34.4321; Akkarathamrongsin S, 2013, INTERVIROLOGY, V56, P284, DOI 10.1159/000351621; Attaullah S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-433; Bao YP, 2010, CURR OPIN PSYCHIATR, V23, P187, DOI 10.1097/YCO.0b013e328338658b; Bernier L, 1996, J CLIN MICROBIOL, V34, P2815, DOI 10.1128/JCM.34.11.2815-2818.1996; Ciccozzi M, 2011, J MED VIROL, V83, P1565, DOI 10.1002/jmv.22154; Cochrane A, 2002, J INFECT DIS, V186, P1212, DOI 10.1086/344314; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; Drake JW, 1998, GENETICS, V148, P1667; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Guettouche T, 2005, ANTIVIR THER, V10, P593; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Idrees M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-69; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan A, 2009, J MED VIROL, V81, P1189, DOI 10.1002/jmv.21466; Kuiken C, 2009, NOMENCLATURE NUMBERI, P33, DOI 10.1007/978-1-59745-394-3_4; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Mania A., 2012, INFECT DIS CLIN PRAC, V20, P141, DOI [DOI 10.1097/IPC.0B013E3182425B13, 10.1097/IPC.0b013e3182425b13]; McCaw R, 1997, J VIRAL HEPATITIS, V4, P351, DOI 10.1046/j.1365-2893.1997.00060.x; MELLOR J, 1995, J GEN VIROL, V76, P2493, DOI 10.1099/0022-1317-76-10-2493; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Morice Y, 2001, J GEN VIROL, V82, P1001, DOI 10.1099/0022-1317-82-5-1001; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Pawlotsky JM, 1996, J INFECT DIS, V174, P1, DOI 10.1093/infdis/174.1.1; PAWLOTSKY JM, 1995, VET RES, V26, P3; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Raja NS, 2008, J MICROBIOL IMMUNOL, V41, P4; Ramia S, 2006, INT J INFECT DIS, V10, P272, DOI 10.1016/j.ijid.2005.07.008; Ray SC, 2000, J INFECT DIS, V182, P698, DOI 10.1086/315786; Rehman IU, 2014, INFECT GENET EVOL, V27, P318, DOI 10.1016/j.meegid.2014.08.005; Salemi M, 2002, J MOL EVOL, V54, P62, DOI 10.1007/s00239-001-0018-9; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Simmonds P, 1997, GUT, V40, P291, DOI 10.1136/gut.40.3.291; Smith JE, 2014, CELL REP, V7, P1858, DOI 10.1016/j.celrep.2014.05.023; Stimson G. V., 1993, Bulletin on Narcotics, V45, P3; STUYVER L, 1995, VIRUS RES, V38, P137, DOI 10.1016/0168-1702(95)00052-R; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Sy Theodore, 2006, Int J Med Sci, V3, P41; TANAKA T, 1995, BIOCHEM BIOPH RES CO, V215, P744, DOI 10.1006/bbrc.1995.2526; Verbeeck J, 2006, J VIROL, V80, P4220, DOI 10.1128/JVI.80.9.4220-4226.2006; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186; Zehender G, 2013, INFECT GENET EVOL, V17, P223, DOI 10.1016/j.meegid.2013.04.003	52	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164265	10.1371/journal.pone.0164265	http://dx.doi.org/10.1371/journal.pone.0164265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764129	gold, Green Submitted, Green Published			2022-12-26	WOS:000386204500024
J	Mariano, VS; Lorenzi, AT; Scapulatempo, C; Stein, MD; Resende, JCP; Antoniazzi, M; Villa, LL; Levi, JE; Longatto, A; Fregnani, JHTG				Mariano, Vania Sammartino; Lorenzi, Adriana Tarla; Scapulatempo-Neto, Cristovam; Stein, Maira Degiovani; Possati Resende, Julio Cesar; Antoniazzi, Marcio; Villa, Luisa Lina; Levi, Jose Eduardo; Longatto-Filho, Adhemar; Tavares Guerreiro Fregnani, Jose Humberto			A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS E6; E6/E7 MESSENGER-RNA; RURAL CHINA; DNA TEST; CANCER; WOMEN; CYTOLOGY; TESTS; RISK; MANAGEMENT	Objective To evaluate the reproducibility and accuracy of the HPV16/18-E6 test. Methods The study population was comprised of 448 women with a previously abnormal Pap who were referred to the Barretos Cancer Hospital (Brazil) for diagnosis and treatment. Two cervical samples were collected immediately before colposcopy, one for the hr-HPV-DNA test and cytology and the other for the HPV16/18-E6 test using high-affinity monoclonal antibodies (mAb). Women with a histologic diagnosis of cervical intraepithelial neoplasia grade 2 or 3 were considered to be positive cases. Different strategies using a combination of screening methods (HPV-DNA) and triage tests (cytology and HPV16/18-E6) were also examined and compared. Results The HPV16/18-E6 test exhibited a lower positivity rate compared with the HPV-DNA test (19.0% vs. 29.3%, p<0.001) and a moderate/high agreement (kappa = 0.68, 95% CI: 0.60-0.75). It also exhibited a significantly lower sensitivity for CIN2+ and CIN3+ detection compared to the HPV-DNA test and a significantly higher specificity. The HPV16/18-E6 test was no different from cytology in terms of sensitivity, but it exhibited a significantly higher specificity in comparison to ASCH+. A triage test after HPV-DNA detection using the HPV16/18-E6 test exhibited a significantly higher specificity compared with a triage test of ASCH+ to CIN2+ (91.8% vs. 87.4%, p = 0.04) and CIN3+ (88.6% vs. 84.0%, p = 0.05). Conclusion The HPV16/18-E6 test exhibited moderate/high agreement with the HPV-DNA test but lower sensitivity and higher specificity for the detection of CIN2+ and CIN3+. In addition, its performance was quite similar to cytology, but because of the structural design addressed for the detection of HPV16/18-E6 protein, the test can miss some CIN2/3+ lesions caused by other high-risk HPV types.	[Mariano, Vania Sammartino; Lorenzi, Adriana Tarla; Longatto-Filho, Adhemar; Tavares Guerreiro Fregnani, Jose Humberto] Barretos Canc Hosp, Pio Fdn 12, Mol Oncol Res Ctr, Sao Paulo, Brazil; [Scapulatempo-Neto, Cristovam; Stein, Maira Degiovani] Barretos Canc Hosp, Pio Fdn 12, Dept Pathol, Sao Paulo, Brazil; [Possati Resende, Julio Cesar; Antoniazzi, Marcio] Barretos Canc Hosp, Pio Fdn 12, Canc Prevent Dept, Sao Paulo, Brazil; [Villa, Luisa Lina] Univ Sao Paulo, Fac Med, Dept Radiol & Oncol, Sao Paulo, Brazil; [Levi, Jose Eduardo] Univ Sao Paulo, Inst Trop Med, Virol Lab, LIM 52, Sao Paulo, Brazil; [Longatto-Filho, Adhemar] Univ Sao Paulo, Lab Med Res Lab, Dept Pathol, Fac Med, LIM 14, Sao Paulo, Brazil; [Longatto-Filho, Adhemar] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Longatto-Filho, Adhemar] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal	Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade do Minho	Fregnani, JHTG (corresponding author), Barretos Canc Hosp, Pio Fdn 12, Mol Oncol Res Ctr, Sao Paulo, Brazil.	mdfregnani@terra.com.br	longatto-filho, adhemar/D-7039-2013; Fregnani, José H/H-4238-2012; VILLA, LUISA/AAH-4761-2019; Mariano, Vania/O-1133-2016; Longatto-Filho, Adhemar/N-3397-2019; Mariano, Vânia Sammartino/AAV-1851-2020; Possati-Resende, Julio Cesar/C-8575-2016	longatto-filho, adhemar/0000-0002-5779-9752; Fregnani, José H/0000-0002-5235-6469; VILLA, LUISA/0000-0003-4074-2335; Longatto-Filho, Adhemar/0000-0002-5779-9752; Mariano, Vânia Sammartino/0000-0002-5399-5676; Possati-Resende, Julio Cesar/0000-0002-7869-3885; Scapulatempo-Neto, Cristovam/0000-0002-8920-6579	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2012/51221-4, 2008/57889-1]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [573799/2008-3]; CNPq [573799/2008-3]; FAPESP [2008/57889-1]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo to JHGF 2012/51221-4 and to LLV - 2008/57889-1, for HPV-DNA tests-Cobas test) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico to LLV - 573799/2008-3). Arbor Vita Corporation donated all OncoE6 tests and no role in decision to publish.; The authors would like to thank the following organizations: the Cancer Prevention Department, Center for the Researcher Support and Pathology Department of the Barretos Cancer Hospital. They would also like to thank Monique Ferreira Amendola and Ursula Moraes Leme for their technical laboratorial support. This study was supported by CNPq 573799/2008-3 and FAPESP 2008/57889-1.	Benevolo M, 2011, CANCER CAUSE CONTROL, V22, P869, DOI 10.1007/s10552-011-9757-0; Blumenthal PD, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.031; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Cattani P, 2009, J CLIN MICROBIOL, V47, P3895, DOI 10.1128/JCM.01275-09; Cox JT, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.020; Cronin AM, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-75; Cubie HA, 2013, CYTOPATHOLOGY, V24, P289, DOI 10.1111/cyt.12083; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; Cuzick J, 2015, INT J CANCER, V136, P2854, DOI 10.1002/ijc.29337; Cuzick J, 2012, VACCINE, V30, pF107, DOI 10.1016/j.vaccine.2012.05.088; Resende LSDA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-214; de Oliveira CM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-357; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; ELUFNETO J, 1994, BRIT J CANCER, V69, P114, DOI 10.1038/bjc.1994.18; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ganguly N, 2009, J BIOSCIENCES, V34, P113, DOI 10.1007/s12038-009-0013-7; Halfon P, 2010, J CLIN VIROL, V47, P177, DOI 10.1016/j.jcv.2009.11.011; IARC IAfRoC, 2005, IARC HDB CANC PREV C; International Agency for Research on Cancer World Health Organization, 2005, IARC HDB CANC PREV C, V10; Jeantet D, 2009, J CLIN VIROL, V45, pS29, DOI 10.1016/S1386-6532(09)70006-X; Kitchener HC, 2006, VACCINE, V24, P63, DOI 10.1016/j.vaccine.2006.05.113; Litjens Rogier J N T M, 2013, Expert Opin Med Diagn, V7, P365, DOI 10.1517/17530059.2013.808621; Longatto-Filho A, 2007, DIAGN CYTOPATHOL, V35, P672, DOI 10.1002/dc.20700; Lorenzi AT, 2013, GYNECOL ONCOL, V131, P131, DOI 10.1016/j.ygyno.2013.07.092; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Molden T, 2005, CANCER EPIDEM BIOMAR, V14, P367, DOI 10.1158/1055-9965.EPI-04-0410; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; Munkhdelger J, 2014, DIAGN MICR INFEC DIS, V79, P422, DOI 10.1016/j.diagmicrobio.2014.04.004; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Ntekim A, 2015, CANC MED; Oliveira A, 2013, J MED VIROL, V85, P1235, DOI 10.1002/jmv.23590; Castro SP, 2013, J MED VIROL, V85, P1063, DOI 10.1002/jmv.23544; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Qiao YL, 2014, INT J CANCER, V134, P2891, DOI 10.1002/ijc.28616; Rossi PG, 2012, AM J CLIN PATHOL, V138, P65, DOI 10.1309/AJCP6J2OEFOYTRFD; Ruttkay-Nedecky B, 2013, INT J ONCOL, V43, P1754, DOI 10.3892/ijo.2013.2105; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Schweizer J, 2010, J CLIN MICROBIOL, V48, P4646, DOI 10.1128/JCM.01315-10; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Sotlar K, 2004, J MED VIROL, V74, P107, DOI 10.1002/jmv.20153; Wechsler EI, 2012, J VIROL, V86, P6358, DOI 10.1128/JVI.07069-11; WHO/ICO Information Centre on HPV and Cervical Cancer, 2007, Vaccine, V25 Suppl 3, pC1; Yim Eun-Kyoung, 2005, Cancer Res Treat, V37, P319, DOI 10.4143/crt.2005.37.6.319; Zhao FH, 2013, CANCER PREV RES, V6, P938, DOI 10.1158/1940-6207.CAPR-13-0091; Zhao FH, 2012, J NATL CANCER I, V104, P178, DOI 10.1093/jnci/djr532	47	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164892	10.1371/journal.pone.0164892	http://dx.doi.org/10.1371/journal.pone.0164892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764154	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500077
J	Sano, M; Iijima, M; Ohtaka, M; Nakanishi, M				Sano, Masayuki; Iijima, Minoru; Ohtaka, Manami; Nakanishi, Mahito			Novel Strategy to Control Transgene Expression Mediated by a Sendai Virus-Based Vector Using a Nonstructural C Protein and Endogenous MicroRNAs	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; GENE-EXPRESSION; MESSENGER-RNA; GENOME REPLICATION; VIRAL GENOME; T-CELLS; INDUCTION; THERAPY; BIOGENESIS; INHIBITION	Tissue-specific control of gene expression is an invaluable tool for studying various biological processes and medical applications. Efficient regulatory systems have been utilized to control transgene expression in various types of DNA viral or integrating viral vectors. However, existing regulatory systems are difficult to transfer into negative-strand RNA virus vector platforms because of significant differences in their transcriptional machineries. In this study, we developed a novel strategy for regulating transgene expression mediated by a cytoplasmic RNA vector based on a replication-defective and persistent Sendai virus (SeVdp). Because of the capacity of Sendai virus (SeV) nonstructural C proteins to specifically inhibit viral RNA synthesis, overexpression of C protein significantly reduced trans gene expression mediated by SeVdp vectors. We found that SeV C overexpression concomitantly reduced SeVdp mRNA levels and genomic RNA synthesis. To control C expression, target sequences for an endogenous microRNA were incorporated into the 3' untranslated region of the Cgenes. Incorporation of target sequences for miR-21 into the SeVdp vector restored transgene expression in HeLa cells by decreasing C expression. Furthermore, the SeVdp vector containing target sequences for let-7a enabled cell-specific control of transgene expression in human fibroblasts and induced pluripotent stem cells. Our findings demonstrate that SeV C can be used as an effective regulator for controlling transgene expression. This strategy will contribute to efficient and less toxic SeVdp-mediated gene transfer in various biological applications.	[Sano, Masayuki; Iijima, Minoru; Ohtaka, Manami; Nakanishi, Mahito] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Sano, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba, Ibaraki, Japan.	m.sano@aist.go.jp	Sano, Masayuki/M-1685-2018; Nakanishi, Mahito/I-9888-2018	Sano, Masayuki/0000-0001-7117-0515; Nakanishi, Mahito/0000-0002-7068-7587	JSPS KAKENHI [24700490]; Program for Creating STart-ups from Advanced Research and Technology (START) (Japan Science and Technology Agency); Tokiwa-Bio. Inc.	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for Creating STart-ups from Advanced Research and Technology (START) (Japan Science and Technology Agency); Tokiwa-Bio. Inc.	This work was supported in part by JSPS KAKENHI Grant Number 24700490 (to MS) and by Program for Creating STart-ups from Advanced Research and Technology (START) (Japan Science and Technology Agency) (to MN). MN received support in the form of salary as founder and CTO (Chief Technology Officer) at Tokiwa-Bio. Inc. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Bukreyev A, 2006, J VIROL, V80, P10293, DOI 10.1128/JVI.00919-06; Cadd T, 1996, J VIROL, V70, P5067, DOI 10.1128/JVI.70.8.5067-5074.1996; CURRAN J, 1992, VIROLOGY, V189, P647, DOI 10.1016/0042-6822(92)90588-G; CURRAN J, 1991, EMBO J, V10, P3079, DOI 10.1002/j.1460-2075.1991.tb07860.x; DILLON PJ, 1989, J VIROL, V63, P974, DOI 10.1128/JVI.63.2.974-977.1989; Edge RE, 2008, MOL THER, V16, P1437, DOI 10.1038/mt.2008.130; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Garcin D, 1997, VIROLOGY, V238, P424, DOI 10.1006/viro.1997.8836; Geisler A, 2011, GENE THER, V18, P199, DOI 10.1038/gt.2010.141; Gerlier D, 2011, MICROBIOL MOL BIOL R, V75, P468, DOI 10.1128/MMBR.00007-11; Gotoh B, 1999, FEBS LETT, V459, P205, DOI 10.1016/S0014-5793(99)01241-7; Goverdhana S, 2005, MOL THER, V12, P189, DOI 10.1016/j.ymthe.2005.03.022; Grogan CC, 2001, VIROLOGY, V288, P96, DOI 10.1006/viro.2001.1068; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hasan MK, 2000, J VIROL, V74, P5619, DOI 10.1128/JVI.74.12.5619-5628.2000; Horikami SM, 1997, VIROLOGY, V235, P261, DOI 10.1006/viro.1997.8702; HORIKAMI SM, 1992, J VIROL, V66, P4901, DOI 10.1128/JVI.66.8.4901-4908.1992; Irie T, 2008, VIROLOGY, V374, P495, DOI 10.1016/j.virol.2008.01.004; Irie T, 2014, J VIROL, V88, P690, DOI 10.1128/JVI.02798-13; KAN T, 1970, BIKEN J, V13, P185; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Ketzer P, 2014, P NATL ACAD SCI USA, V111, pE554, DOI 10.1073/pnas.1318563111; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Koseki S, 1998, J CONTROL RELEASE, V53, P159, DOI 10.1016/S0168-3659(97)00250-2; Koyama AH, 2003, MICROBES INFECT, V5, P373, DOI 10.1016/S1286-4579(03)00043-1; Kyttala A, 2016, STEM CELL REP, V6, P200, DOI 10.1016/j.stemcr.2015.12.009; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee H, 2016, PROTEIN CELL, V7, P100, DOI 10.1007/s13238-015-0212-y; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Matveeva OV, 2015, MOL THER-ONCOLYTICS, V2, DOI 10.1038/mto.2015.11; Nakanishi M, 2012, CURR GENE THER, V12, P410, DOI 10.2174/156652312802762518; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Nishimura K, 2007, J BIOL CHEM, V282, P27383, DOI 10.1074/jbc.M702028200; Nishimura K, 2014, STEM CELL REP, V3, P915, DOI 10.1016/j.stemcr.2014.08.014; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Okabe J, 2000, HUM MOL GENET, V9, P2639, DOI 10.1093/hmg/9.18.2639; Plattet P, 2007, VIROLOGY, V362, P411, DOI 10.1016/j.virol.2006.12.033; Qiao C, 2011, GENE THER, V18, P403, DOI 10.1038/gt.2010.157; Sun KL, 2013, NAT REV GENET, V14, P535, DOI 10.1038/nrg3471; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tapparel C, 1997, J VIROL, V71, P9588, DOI 10.1128/JVI.71.12.9588-9599.1997; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wakao H, 2013, CELL STEM CELL, V12, P546, DOI 10.1016/j.stem.2013.03.001; Worringer KA, 2014, CELL STEM CELL, V14, P40, DOI 10.1016/j.stem.2013.11.001; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	52	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164720	10.1371/journal.pone.0164720	http://dx.doi.org/10.1371/journal.pone.0164720			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764162	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500053
J	Sasaki, K; Makiyama, T; Yoshida, Y; Wuriyanghai, Y; Kamakura, T; Nishiuchi, S; Hayano, M; Harita, T; Yamamoto, Y; Kohjitani, H; Hirose, S; Chen, JR; Kawamura, M; Ohno, S; Itoh, H; Takeuchi, A; Matsuoka, S; Miura, M; Sumitomo, N; Horie, M; Yamanaka, S; Kimura, T				Sasaki, Kenichi; Makiyama, Takeru; Yoshida, Yoshinori; Wuriyanghai, Yimin; Kamakura, Tsukasa; Nishiuchi, Suguru; Hayano, Mamoru; Harita, Takeshi; Yamamoto, Yuta; Kohjitani, Hirohiko; Hirose, Sayako; Chen, Jiarong; Kawamura, Mihoko; Ohno, Seiko; Itoh, Hideki; Takeuchi, Ayako; Matsuoka, Satoshi; Miura, Masaru; Sumitomo, Naokata; Horie, Minoru; Yamanaka, Shinya; Kimura, Takeshi			Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia	PLOS ONE			English	Article							CHANNEL RYANODINE RECEPTOR; CALCIUM-RELEASE CHANNELS; SUDDEN CARDIAC DEATH; RATE DEPENDENCE; FAILING HEARTS; MOUSE MODEL; CARDIOMYOCYTES; MUTATIONS; FKBP12.6; MUSCLE	Introduction Human induced pluripotent stem cells (hiPSCs) offer a unique opportunity for disease modeling. However, it is not invariably successful to recapitulate the disease phenotype because of the immaturity of hiPSC-derived cardiomyocytes (hiPSC-CMs). The purpose of this study was to establish and analyze iPSC-based model of catecholaminergic polymorphic ventricular tachycardia (CPVT), which is characterized by adrenergically mediated lethal arrhythmias, more precisely using electrical pacing that could promote the development of new pharmacotherapies. Method and Results We generated hiPSCs from a 37-year-old CPVT patient and differentiated them into cardiomyocytes. Under spontaneous beating conditions, no significant difference was found in the timing irregularity of spontaneous Ca2+ transients between control- and CPVT-hiPSC-CMs. Using Ca2+ imaging at 1 Hz electrical field stimulation, isoproterenol induced an abnormal diastolic Ca2+ increase more frequently in CPVT- than in control-hiPSC-CMs (control 12% vs. CPVT 43%, p<0.05). Action potential recordings of spontaneous beating hiPSC-CMs revealed no significant difference in the frequency of delayed after depolarizations (DADs) between control and CPVT cells. After isoproterenol application with pacing at 1 Hz, 87.5% of CPVT-hiPSC-CMs developed DADs, compared to 30% of control-hiPSC-CMs (p<0.05). Pre-incubation with 10 mu M S107, which stabilizes the closed state of the ryanodine receptor 2, significantly decreased the percentage of CPVT-hiPSC-CMs presenting DADs to 25% (p<0.05). Conclusions We recapitulated the electrophysiological features of CPVT-derived hiPSC-CMs using electrical pacing. The development of DADs in the presence of isoproterenol was significantly suppressed by S107. Our model provides a promising platform to study disease mechanisms and screen drugs.	[Sasaki, Kenichi; Makiyama, Takeru; Wuriyanghai, Yimin; Kamakura, Tsukasa; Nishiuchi, Suguru; Hayano, Mamoru; Harita, Takeshi; Yamamoto, Yuta; Kohjitani, Hirohiko; Hirose, Sayako; Chen, Jiarong; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Yoshida, Yoshinori; Yamanaka, Shinya] Kyoto Univ, IPS Cell Res & Applicat, Kyoto, Japan; [Wuriyanghai, Yimin; Kawamura, Mihoko; Ohno, Seiko; Itoh, Hideki; Horie, Minoru] Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Otsu, Shiga, Japan; [Takeuchi, Ayako; Matsuoka, Satoshi] Univ Fukui, Dept Integrat & Syst Physiol, Fac Med Sci, Fukui, Japan; [Miura, Masaru] Tokyo Metropolitan Childrens Med Ctr, Div Cardiol, Tokyo, Japan; [Sumitomo, Naokata] Saitama Med Univ, Dept Pediat Cardiol, Int Med Ctr, Saitama, Japan	Kyoto University; Kyoto University; Shiga University of Medical Science; University of Fukui; Tokyo Metropolitan Children's Medical Center; Saitama Medical University	Makiyama, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan.; Yoshida, Y (corresponding author), Kyoto Univ, IPS Cell Res & Applicat, Kyoto, Japan.	makiyama@kuhp.kyoto-u.ac.jp; yoshinor@cira.kyoto-u.ac.jp	Sumitomo, Naokata/I-4771-2019; matsuoka, satoshi/GWD-0440-2022; Makiyama, Takeru/W-9256-2019; Sumitomo, Naokata/AAH-1763-2021; Yoshida, Yoshinori/AAY-6009-2020; Horie, Minoru/ABG-7128-2020; Ohno, Seiko/AEL-3289-2022; Ohno, Seiko/Q-3969-2019	matsuoka, satoshi/0000-0003-3321-9749; Sumitomo, Naokata/0000-0001-7094-6772; Yoshida, Yoshinori/0000-0001-5511-9090; Ohno, Seiko/0000-0003-1209-8896; Ohno, Seiko/0000-0003-1209-8896; Yamamoto, Yuta/0000-0001-6129-9745; Kohjitani, Hirohiko/0000-0002-8281-8396	Japan Society for the Promotion of Science KAKENHI [25461054]; Suzuken Memorial Foundation [10-097]; Grants-in-Aid for Scientific Research [25460406, 26291019] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 25461054 and Suzuken Memorial Foundation Grant Number 10-097. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Chen YJ, 2008, BRIT J PHARMACOL, V153, P915, DOI 10.1038/sj.bjp.0707564; di Barletta MR, 2006, CIRCULATION, V114, P1012, DOI 10.1161/CIRCULATIONAHA.106.623793; Di Pasquale E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.369; Dochi K, 2007, JPN J ELECTROCARDIOL, V27, P7; Doss MX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040288; Fatima A, 2011, CELL PHYSIOL BIOCHEM, V28, P579, DOI 10.1159/000335753; Fernandez-Velasco M, 2009, CIRC RES, V104, P201, DOI 10.1161/CIRCRESAHA.108.177493; Hayashi M, 2009, CIRCULATION, V119, P2426, DOI 10.1161/CIRCULATIONAHA.108.829267; Hund TJ, 2004, CIRCULATION, V110, P3168, DOI 10.1161/01.CIR.0000147231.69595.D3; Hwang HS, 2014, CIRC RES, V114, P1114, DOI 10.1161/CIRCRESAHA.114.303391; Ikemoto N, 2000, TRENDS CARDIOVAS MED, V10, P310, DOI 10.1016/S1050-1738(01)00067-6; Itzhaki I, 2012, J AM COLL CARDIOL, V60, P990, DOI 10.1016/j.jacc.2012.02.066; Jung CB, 2012, EMBO MOL MED, V4, P180, DOI 10.1002/emmm.201100194; Kamakura T, 2013, CIRC J, V77, P1307, DOI 10.1253/circj.CJ-12-0987; Kashimura T, 2010, CIRC RES, V107, P1483, DOI 10.1161/CIRCRESAHA.110.227744; Kujala K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044660; Lahat H, 2001, CIRCULATION, V103, P2822; Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346; Liu J, 2007, STEM CELLS, V25, P3038, DOI 10.1634/stemcells.2007-0549; Liu N, 2006, CIRC RES, V99, P292, DOI 10.1161/01.RES.0000235869.50747.e1; Liu XP, 2012, CELL, V150, P1055, DOI 10.1016/j.cell.2012.06.052; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Makita N, 2014, CIRC-CARDIOVASC GENE, V7, P466, DOI 10.1161/CIRCGENETICS.113.000459; Maleckar MM, 2009, AM J PHYSIOL-HEART C, V297, pH1398, DOI 10.1152/ajpheart.00411.2009; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Priori SG, 2001, CIRCULATION, V103, P196; Roux-Buisson N, 2012, HUM MOL GENET, V21, P2759, DOI 10.1093/hmg/dds104; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Shan J, 2010, J CLIN INVEST, V120, P4375, DOI 10.1172/JCI37649; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tateishi H, 2009, CARDIOVASC RES, V81, P536, DOI 10.1093/cvr/cvn303; Tunwell REA, 1996, BIOCHEM J, V318, P477, DOI 10.1042/bj3180477; van der Werf C, 2011, J AM COLL CARDIOL, V57, P2244, DOI 10.1016/j.jacc.2011.01.026; Vega AL, 2009, CIRC-ARRHYTHMIA ELEC, V2, P540, DOI 10.1161/CIRCEP.109.872309; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; WILDERS R, 1993, BIOPHYS J, V65, P2601, DOI 10.1016/S0006-3495(93)81289-X; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zissimopoulos S, 2005, J BIOL CHEM, V280, P5475, DOI 10.1074/jbc.M412954200	42	41	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164795	10.1371/journal.pone.0164795	http://dx.doi.org/10.1371/journal.pone.0164795			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764147	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500066
J	Wheeler, LC; Donor, MT; Prell, JS; Harms, MJ				Wheeler, Lucas C.; Donor, Micah T.; Prell, James S.; Harms, Michael J.			Multiple Evolutionary Origins of Ubiquitous Cu2+ and Zn2+ Binding in the S100 Protein Family	PLOS ONE			English	Article							EF-HAND SUPERFAMILY; CALCIUM-BINDING; ZINC-BINDING; METAL-IONS; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; EXPRESSION; COMPLEX; OLIGOMERIZATION	The S100 proteins are a large family of signaling proteins that play critical roles in biology and disease. Many S100 proteins bind Zn2+, Cu2+, and/or Mn2+ as part of their biological functions; however, the evolutionary origins of binding remain obscure. One key question is whether divalent transition metal binding is ancestral, or instead arose independently on multiple lineages. To tackle this question, we combined phylogenetics with biophysical characterization of modern S100 proteins. We demonstrate an earlier origin for established S100 subfamilies than previously believed, and reveal that transition metal binding is widely distributed across the tree. Using isothermal titration calorimetry, we found that Cu2+ and Zn2+ binding are common features of the family: the full breadth of human S100 paralogs- as well as two early-branching S100 proteins found in the tunicate Oikopleura-dioica bind these metals with mu M affinity and stoichiometries ranging from 1:1 to 3:1 (metal:protein). While binding is consistent across the tree, structural responses to binding are quite variable. Further, mutational analysis and structural modeling revealed that transition metal binding occurs at different sites in different S100 proteins. This is consistent with multiple origins of transition metal binding over the evolution of this protein family. Our work reveals an evolutionary pattern in which the overall phenotype of binding is a constant feature of S100 proteins, even while the site and mechanism of binding is evolutionarily labile.	[Wheeler, Lucas C.; Donor, Micah T.; Prell, James S.; Harms, Michael J.] Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA; [Wheeler, Lucas C.; Harms, Michael J.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Harms, MJ (corresponding author), Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA.; Harms, MJ (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	harms@uoregon.edu		Harms, Michael/0000-0002-0241-4122; wheeler, lucas/0000-0002-9483-9792; Donor, Micah/0000-0002-1369-377X	NIH [7T32GM007759-37]; NSF/GRFP [DGE-1309047]; Sloan Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF/GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding came from NIH 7T32GM007759-37 (LCW), a NSF/GRFP DGE-1309047 (MTD), and a Sloan Research Fellowship (MJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank members of the Harms lab for technical assistance and useful conversations. We would also like to thank Stephen Weitzel in the von Hippel lab at UO for his assistance with the sedimentation velocity experiments. Funding came from NIH 7T32GM007759-37 (LCW), a NSF/GRFP DGE-1309047 (MTD), and a Sloan Research Fellowship (MJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer AJ, 2014, MOL BIOL EVOL, V31, P2553, DOI 10.1093/molbev/msu236; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Arnesano F, 2005, ANGEW CHEM INT EDIT, V44, P6341, DOI 10.1002/anie.200500540; Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; Babini E, 2011, J BIOL INORG CHEM, V16, P243, DOI 10.1007/s00775-010-0721-3; Babor M, 2008, PROTEINS, V70, P208, DOI 10.1002/prot.21587; BAUDIER J, 1986, J BIOL CHEM, V261, P8192; BECKER T, 1992, EUR J BIOCHEM, V207, P541, DOI 10.1111/j.1432-1033.1992.tb17080.x; Bertini I, 2013, J BIOL INORG CHEM, V18, P183, DOI 10.1007/s00775-012-0963-3; Bertini I, 2009, J BIOL INORG CHEM, V14, P1097, DOI 10.1007/s00775-009-0553-1; BIRDSALL B, 1983, ANAL BIOCHEM, V132, P353, DOI 10.1016/0003-2697(83)90020-9; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Chung HJ, 2016, BIOMACROMOLECULES, V17, P1075, DOI 10.1021/acs.biomac.5b01694; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Diaz-Jaimes P, 2016, META GENE, V7, P48, DOI 10.1016/j.mgene.2015.11.005; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; DORIN JR, 1990, GENOMICS, V8, P420, DOI 10.1016/0888-7543(90)90027-R; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; Fritz G, 2002, J BIOL CHEM, V277, P33092, DOI 10.1074/jbc.M200574200; Gagnon DM, 2015, J AM CHEM SOC, V137, P3004, DOI 10.1021/ja512204s; Gallus S, 2015, GENOME BIOL EVOL, V7, P985, DOI 10.1093/gbe/evv052; Garrett SC, 2008, BIOCHEMISTRY-US, V47, P986, DOI 10.1021/bi7021624; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gilston BA, 2016, SCI CHINA LIFE SCI, V59, P792, DOI 10.1007/s11427-016-5088-4; Grabarek Z, 2011, BBA-MOL CELL RES, V1813, P913, DOI 10.1016/j.bbamcr.2011.01.017; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Green RE, 2014, SCIENCE, V346, P1335, DOI 10.1126/science.1254449; Gribenko AV, 1998, J MOL BIOL, V283, P679, DOI 10.1006/jmbi.1998.2116; Gribenko AV, 2001, BIOCHEMISTRY-US, V40, P15538, DOI 10.1021/bi0114731; Gross SR, 2014, CELL MOL LIFE SCI, V71, P1551, DOI 10.1007/s00018-013-1400-7; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAIMOTO H, 1987, LAB INVEST, V57, P489; Hedges S. Blair, 2006, V27, P199; Heierhorst J, 1997, EUR J BIOCHEM, V249, P127, DOI 10.1111/j.1432-1033.1997.00127.x; Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hopt A, 2003, J NEUROSCI METH, V128, P159, DOI 10.1016/S0165-0270(03)00173-0; Hyun TH, 2004, AM J CLIN NUTR, V80, P715; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kerkhoff C, 1999, FEBS LETT, V460, P134, DOI 10.1016/S0014-5793(99)01322-8; Klingelhofer J, 2009, FEBS J, V276, P5936, DOI 10.1111/j.1742-4658.2009.07274.x; Koch M, 2007, BBA-MOL CELL RES, V1773, P457, DOI 10.1016/j.bbamcr.2006.12.006; Kordowska J, 1998, EUR J BIOCHEM, V253, P57, DOI 10.1046/j.1432-1327.1998.2530057.x; Kraemer AM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-48; KUZNICKI J, 1989, FEBS LETT, V254, P141, DOI 10.1016/0014-5793(89)81026-9; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Liu YC, 2010, BIOINFORMATICS, V26, P1958, DOI 10.1093/bioinformatics/btq338; MANI RS, 1983, FEBS LETT, V163, P282, DOI 10.1016/0014-5793(83)80836-9; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Maret W, 2013, ADV NUTR, V4, P82, DOI 10.3945/an.112.003038; MILLS JS, 1985, J BIOL CHEM, V260, P5100; Moroz OV, 2011, AMINO ACIDS, V41, P761, DOI 10.1007/s00726-010-0540-4; Moroz OV, 2009, J MOL BIOL, V391, P536, DOI 10.1016/j.jmb.2009.06.004; Moroz OV, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-11; Murray JI, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-16; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Ravasi T, 2004, GENOMICS, V84, P10, DOI 10.1016/j.ygeno.2004.02.002; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Riuzzi F, 2011, J CELL SCI, V124, P2389, DOI 10.1242/jcs.084491; Rubino JT, 2012, J INORG BIOCHEM, V107, P129, DOI 10.1016/j.jinorgbio.2011.11.024; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Satoh N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1729; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Schafer BW, 2000, J BIOL CHEM, V275, P30623, DOI 10.1074/jbc.M002260200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sedaghat F, 2008, HIPPOKRATIA, V12, P198; Shang X, 2008, GENET SEL EVOL, V40, P449, DOI 10.1051/gse:2008013; Shaw SS, 2003, DIABETES, V52, P2381, DOI 10.2337/diabetes.52.9.2381; Sivaraja V, 2006, BIOPHYS J, V91, P1832, DOI [10.1529/biophysj.105.079988, 10.1529/biophysj.106.079988]; Sorci G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001315; Streicher WW, 2010, BIOPHYS CHEM, V151, P181, DOI 10.1016/j.bpc.2010.06.003; Sturchler E, 2006, J BIOL CHEM, V281, P38905, DOI 10.1074/jbc.M605798200; Tarver JE, 2016, GENOME BIOL EVOL, V8, P330, DOI 10.1093/gbe/evv261; Tsvetkov PO, 2010, MOL BIOL+, V44, P832, DOI 10.1134/S0026893310050213; Vorum H, 1996, ELECTROPHORESIS, V17, P1787, DOI 10.1002/elps.1150171118; Walker J. M, 2005, PROTEOMICS PROTOCOLS; Wang XY, 2015, AM J CANCER RES, V5, P1484; Webb B, 2002, COMP PROTEIN STRUCTU; West NR, 2010, ONCOGENE, V29, P2083, DOI 10.1038/onc.2009.488; Wilcox DE, 2008, INORG CHIM ACTA, V361, P857, DOI 10.1016/j.ica.2007.10.032; Wilder PT, 2003, BIOCHEMISTRY-US, V42, P13410, DOI 10.1021/bi035334q; Wolf R, 2008, J IMMUNOL, V181, P1499, DOI 10.4049/jimmunol.181.2.1499; Wright NT, 2005, J MOL BIOL, V353, P410, DOI 10.1016/j.jmb.2005.08.027; Yamaoka M, 2013, BIOCHEM BIOPH RES CO, V433, P450, DOI 10.1016/j.bbrc.2013.02.096; YAMASHITA MM, 1990, P NATL ACAD SCI USA, V87, P5648, DOI 10.1073/pnas.87.15.5648; Yang Z, 2007, J ALLERGY CLIN IMMUN, V119, P106, DOI 10.1016/j.jaci.2006.08.021; Zackular JP, 2015, J BIOL CHEM, V290, P18991, DOI 10.1074/jbc.R115.645085; Zimmer Danna B, 2010, Cardiovasc Psychiatry Neurol, V2010, DOI 10.1155/2010/728052; Zimmer DB, 2013, CELL CALCIUM, V53, P170, DOI 10.1016/j.ceca.2012.11.006; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; ZIMMER DB, 1987, AM J PHYSIOL, V252, pC285, DOI 10.1152/ajpcell.1987.252.3.C285; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	107	21	22	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164740	10.1371/journal.pone.0164740	http://dx.doi.org/10.1371/journal.pone.0164740			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764152	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204500054
J	Slaoui, M; Mouh, FZ; Ghanname, I; Razine, R; El Mzibri, M; Amrani, M				Slaoui, Meriem; Mouh, Fatima Zahra; Ghanname, Imane; Razine, Rachid; El Mzibri, Mohammed; Amrani, Mariam			Outcome of Breast Cancer in Moroccan Young Women Correlated to Clinic-Pathological Features, Risk Factors and Treatment: A Comparative Study of 716 Cases in a Single Institution	PLOS ONE			English	Article							HORMONE-RECEPTOR STATUS; TUMOR CHARACTERISTICS; REPRODUCTIVE FACTORS; SURVIVAL; PROGNOSIS; PATIENT; AGE; SUBTYPES; IMPACT	Background Breast cancer in young women is quite uncommon and shows more aggressive characteristics with major disparities between worldwide populations. Prognosis and outcome of breast cancer in young patients are widely studied, but still no consensus is available. Methods We retrospectively included 716 cases of breast cancer women diagnosed in 2009 at the National Institute of Oncology of Rabat. Patients were divided into two groups according to their age: women aged <= 40 years (Group 1) and women aged >40 years (Group 2). Data were recorded from patients' medical files and analyzed using SPSS 13.0 software (IBM). Results Young patients represent 24.9% of all patients with breast cancer. The comparison between the two groups displayed significant differences regarding nulliparity (p = 0.001) and progesterone receptor negativity (p = 0.01). Moreover, more progression (Metastases/Relapse) was registered in young women as compared to older women with breast cancer (p = 0.03). The estimated median follow-up period was 31 months. The 5-years Event-Free Survival (EFS) of patients with local disease was 64.6% in young women and 71.5% in older women with breast cancer (p = 0.04). Multivariate analysis in young women showed that nulliparity (HR: 7.2; 95% CI: 1.16-44.54; p = 0.03), T3 tumors (HR: 17.39; 95% CI: 1.74-173.34; p = 0.01) and negative PgR status (HR: 19.85; 95% CI: 1.07-366.54; p = 0.04) can be considered as risk factors for poorer event free survival while hormone therapy was associated with better EFS (HR: 0.11; 95% CI: 0.00-0.75; p = 0.03). In Group 2, multivariate analysis showed that patients with inflammatory breast cancer, N+ status, absence of radiotherapy, absence of chemotherapy, and absence of hormone therapy are at increased risk of recurrence. Conclusions In Morocco, breast cancer is more frequent in young women as compared to western countries. Breast cancer in young women is more aggressive and is diagnosed late, leading to an intensive treatment. Moreover, the main factors associated with breast cancer development in young women would be hormonal and reproductive status. Analysis of other genetic biomarkers is needed to explain the high prevalence of breast cancer in young women to improve breast cancer management in Morocco.	[Slaoui, Meriem; Mouh, Fatima Zahra; Amrani, Mariam] Univ Mohamed V Rabat, Fac Med & Pharm Rabat, Equipe Rech ONCOGYMA, Ave Mohammed Belarbi El Alaoui Souissi,BP 6203, Rabat, Morocco; [Slaoui, Meriem; Mouh, Fatima Zahra; El Mzibri, Mohammed] Ctr Natl Energie Sci & Tech, Unite Biol & Rech Med, Rabat, Morocco; [Ghanname, Imane] Univ Mohammed V Rabat, Fac Med & Pharm, Ave Mohammed Belarbi El Alaoui Souissi,BP 6203, Rabat, Morocco; [Razine, Rachid] Univ Mohammed V Rabat, Fac Med & Pharm, Lab Biostat Epidemiol & Clin Res, Ave Mohammed Belarbi El Alaoui Souissi,BP 6203, Rabat, Morocco; [Razine, Rachid] Univ Mohammed V Rabat, Fac Med & Pharm, Dept Publ Hlth, Ave Mohammed Belarbi El Alaoui Souissi,BP 6203, Rabat, Morocco	Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Slaoui, M (corresponding author), Univ Mohamed V Rabat, Fac Med & Pharm Rabat, Equipe Rech ONCOGYMA, Ave Mohammed Belarbi El Alaoui Souissi,BP 6203, Rabat, Morocco.; Slaoui, M (corresponding author), Ctr Natl Energie Sci & Tech, Unite Biol & Rech Med, Rabat, Morocco.	meriem.slaoui@um5s.net.ma	Slaoui, Meriem/AAH-7274-2019	Slaoui, Meriem/0000-0001-8227-4504; rachid, razine/0000-0002-1576-5204				Abahssain Halima, 2010, BMC Res Notes, V3, P286, DOI 10.1186/1756-0500-3-286; Abbass F, 2011, EMHJ, V17; Althuis MD, 2003, CANCER CAUSE CONTROL, V14, P151, DOI 10.1023/A:1023006000760; Assi HA, 2013, J THORAC DIS, V5, pS2, DOI 10.3978/j.issn.2072-1439.2013.05.24; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Beaber EF, 2014, CANCER EPIDEM BIOMAR, V23, P755, DOI 10.1158/1055-9965.EPI-13-0944; Bethea TN, 2015, BREAST CANC RES BCR, V17, P535; Bharat A, 2009, J SURG ONCOL, V100, P248, DOI 10.1002/jso.21268; BLACK WC, 1995, J NATL CANCER I, V87, P720, DOI 10.1093/jnci/87.10.720; Bodmer A, 2015, BREAST, V24, P112, DOI 10.1016/j.breast.2014.11.004; Boufettal H, 2010, CANCER RADIOTHER, V14, P698, DOI 10.1016/j.canrad.2010.04.007; Butt S, 2009, EJSO-EUR J SURG ONC, V35, P702, DOI 10.1016/j.ejso.2008.03.017; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; El Saghir NS, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-194; Fredholm H, 2009, PLOS ONE, V4, pA38, DOI 10.1371/journal.pone.0007695; Gabriel CA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2647; Ghilli M. L F, 2014, BREAST, V23S1, pS12; Gleicher N, 2013, REPROD BIOMED ONLINE, V26, P416, DOI 10.1016/j.rbmo.2013.01.007; Gnerlich JL, 2009, J AM COLL SURGEONS, V208, P341, DOI 10.1016/j.jamcollsurg.2008.12.001; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Guendouz H. WC, 2010, SOC FRANCAISE SENOLO, DOI [10.1111/j.1349-7006.2004.00010.x, DOI 10.1111/J.1349-7006.2004.00010.X]; Han WS, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-82; International Agency for Research on Cancer, 2015, BREAST CANC EST INC; Jr HAA, 2014, BREAST CANCER RES, V16, P427, DOI [10.1186/s13058-014-0427-5, DOI 10.1186/S13058-014-0427-5]; Kallel M, 2015, REP PRACT ONCOL RADI, V20, P155, DOI 10.1016/j.rpor.2015.01.007; Keegan THM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3556; MACMAHON B, 1993, CANCER, V71, P3185, DOI 10.1002/1097-0142(19930515)71:10<3185::AID-CNCR2820711047>3.0.CO;2-C; Munsell MF, 2014, EPIDEMIOL REV, V36, P114, DOI 10.1093/epirev/mxt010; Nishimukai A, 2015, CLIN BREAST CANCER, V15, P204, DOI 10.1016/j.clbc.2014.12.007; Onitilo AA, 2009, CLIN MED RES, V7, P4, DOI 10.3121/cmr.2009.825; Parise CA, 2010, CRIT REV ONCOL HEMAT, V76, P44, DOI 10.1016/j.critrevonc.2009.09.002; Parsa P, 2009, ASIAN PAC J CANCER P, V10, P545; Reyna C, 2014, J MULTIDISCIP HEALTH, V7, P419, DOI 10.2147/JMDH.S49994; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Sinn HP, 2013, BREAST CARE, V8, P149, DOI 10.1159/000350774; Tamakoshi K, 2005, CANCER SCI, V96, P57, DOI 10.1111/j.1349-7006.2005.00010.x; Znati K, 2014, GYNECOL OBSTET FERTI, V42, P149, DOI 10.1016/j.gyobfe.2011.08.014	37	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164841	10.1371/journal.pone.0164841	http://dx.doi.org/10.1371/journal.pone.0164841			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760178	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204000059
J	Watson, CM; Burggren, WW				Watson, Charles M.; Burggren, Warren W.			Interspecific Differences in Metabolic Rate and Metabolic Temperature Sensitivity Create Distinct Thermal Ecological Niches in Lizards (Plestiodon)	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; DYNAMIC ACTION; REPTILIA; GECKOS; SKINK; MEAL; O-2	Three congeneric lizards from the southeastern United States (Plestiodon fasciatus, P. inexpectatus, and P. laticeps) exhibit a unique nested distribution. All three skink species inhabit the US Southeast, but two extend northward to central Ohio (P. fasciatus and P. laticeps) and P. fasciatus extends well into Canada. Distinct interspecific differences in microhabitat selection and behavior are associated with the cooler temperatures of the more Northern ranges. We hypothesized that interspecific differences in metabolic temperature sensitivity locally segregates them across their total range. Resting oxygen consumption was measured at 20 degrees, 25 degrees and 30 degrees C. Plestiodon fasciatus, from the coolest habitats, exhibited greatly elevated oxygen consumption compared to the other species at high ecologically-relevant temperatures (0.10, 0.17 and 0.83 ml O-2.g(-1).h(-1) at 20 degrees, 25 degrees and 30 degrees C, respectively). Yet, P. inexpectatus, from the warmest habitats, exhibited sharply decreased oxygen consumption compared to the other species at lower ecologically-relevant temperatures (0.09, 0.27 and 0.42 ml O-2.g(-1).h(-1) at 20 degrees, 25 degrees and 30 degrees C, respectively). Plestiodon laticeps, from both open and closed microhabitats and intermediate latitudinal range, exhibited oxygen consumptions significantly lower than the other two species (0.057, 0.104 and 0.172 ml O-2.g(-1).h(-1) at 20, 25 degrees and 30 degrees C, respectively). Overall, Plestiodon showed metabolic temperature sensitivities (Q(10)s) in the range of 2-3 over the middle of each species' normal temperature range. However, especially P. fasciatus and P. inexpectatus showed highly elevated Q(10)s (9 to 25) at the extreme ends of their temperature range. While morphologically similar, these skinks are metabolically distinct across the genus' habitat, likely having contributed to their current distribution.	[Watson, Charles M.] Midwestern State Univ, Dept Biol, Wichita Falls, TX 76308 USA; [Burggren, Warren W.] Univ North Texas, Dept Biol Sci, Denton, TX USA	University of North Texas System; University of North Texas Denton	Watson, CM (corresponding author), Midwestern State Univ, Dept Biol, Wichita Falls, TX 76308 USA.	charles.watson@mwsu.edu	Burggren, Warren W/A-1561-2016	Burggren, Warren W/0000-0001-8023-420X; Watson, Charles/0000-0001-8195-6044	National Science Foundation [IOS-1025823]; Laura Gough; Gough laboratory at UTexas-Arlington	National Science Foundation(National Science Foundation (NSF)); Laura Gough; Gough laboratory at UTexas-Arlington	National Science Foundation (www.nsf.gov) operating grant IOS-1025823 to WWB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Corey Roelke, Robert Makowsky, John Morse, Christian Cox, Brian Fontenot, Rebbekah Watson, Chris Winne, Whit Gibbons, Leslie Rissler, Lora Smith, and Craig Guyer for assistance in laboratory and field activities. Laura Gough and the Gough laboratory at UTexas-Arlington were particularly important to the completion of this project by providing funding and advice throughout this entire project.	Agutter PS, 2011, J EXP BIOL, V214, P1055, DOI 10.1242/jeb.054502; ALSADOON MK, 1989, J COMP PHYSIOL B, V159, P1, DOI 10.1007/BF00692676; ALSADOON MK, 1986, COMP BIOCHEM PHYS A, V84, P339, DOI 10.1016/0300-9629(86)90626-2; ANDREWS RM, 1985, PHYSIOL ZOOL, V58, P214, DOI 10.1086/physzool.58.2.30158569; Angilletta MJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P11; Barrionuevo WR, 1999, AM J PHYSIOL-REG I, V276, pR505, DOI 10.1152/ajpregu.1999.276.2.R505; Bennett A.F., 1982, Biology of Reptilia, V13, P155; Burggren W., 1991, ENV METABOLIC ANIMAL, P353; BURGGREN WW, 1990, J EXP BIOL, V152, P129; CAREY C, 1979, OECOLOGIA, V39, P201, DOI 10.1007/BF00348069; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Conant R., 1991, FIELD GUIDE REPTILES; Crocker-Buta SP, 2014, COMP BIOCHEM PHYS A, V169, P60, DOI 10.1016/j.cbpa.2013.12.008; Davis D, 1968, STUDY VARIATION N AM; FITCH HENRY S., 1954, UNIV KANSAS PUBL MUS NAT HIST, V8, P1; Gause G. F., 1934, STRUGGLE EXISTENCE; Glazier DS, 2015, BIOL REV, V90, P377, DOI 10.1111/brv.12115; Gore M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00035; HAMILTON W. J., 1961, HERPETOLOGICA, V17, P99; Harding J.H., 1997, MICHIGAN TURTLES LIZ; Hare KM, 2006, PHYSIOL BIOCHEM ZOOL, V79, P745, DOI 10.1086/504618; Hochscheid S, 2004, PHYSIOL BIOCHEM ZOOL, V77, P209, DOI 10.1086/381472; Holker F, 2003, J FISH BIOL, V62, P565, DOI 10.1046/j.1095-8649.2003.00048.x; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Iglesias S, 2003, COMP BIOCHEM PHYS A, V135, P377, DOI 10.1016/S1095-6433(03)00076-X; Jordan DS, 1908, AM NAT, V42, P73, DOI 10.1086/278905; Karasov WH, 1998, PHYSIOL ZOOL, V71, P93, DOI 10.1086/515887; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; McCue MD, PHYSL BIOCH ZOOLOGY; Mount R.H, 1975, REPTILES AMPHIBIANS; Murray IW, 2015, J ARID ENVIRON, V113, P35, DOI 10.1016/j.jaridenv.2014.09.006; NAGY KA, 1984, ECOLOGY, V65, P588, DOI 10.2307/1941421; Pan ZC, 2005, COMP BIOCHEM PHYS A, V140, P151, DOI 10.1016/j.cbpb.2004.11.013; Parker SL, 2014, HERPETOL CONSERV BIO, V9, P309; Pelster B, 1999, COMP BIOCHEM PHYS A, V124, P407, DOI 10.1016/S1095-6433(99)00132-4; Robert KA, 2000, COPEIA, P851; Secor SM, 2006, PHYSIOL BIOCHEM ZOOL, V79, P720, DOI 10.1086/505511; Taylor E. H., 1932, Kansas University Science Bulletin, V20, P251; Taylor E. H, 1935, U KANSAS SCI B, V23, P1, DOI DOI 10.2307/1436337; Taylor E.H., 1932, U KANSAS SCI B, V20, P263; VLECK D, 1987, J APPL PHYSIOL, V62, P2103, DOI 10.1152/jappl.1987.62.5.2103; WANG T, 1995, PHYSIOL ZOOL, V68, P192, DOI 10.1086/physzool.68.2.30166499; Watson CM, 2012, HERPETOL CONSERV BIO, V7, P75; Watson CM, 2012, J THERM BIOL, V37, P374, DOI 10.1016/j.jtherbio.2012.02.001; White CR, 2014, COMPREHENSIVE PHYSL; Zannoni JT., 1997, MEASURING EFFECTS TE; Zari TA, 2016, J THERM BIOL, V60, P180, DOI 10.1016/j.jtherbio.2016.07.014	47	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164713	10.1371/journal.pone.0164713	http://dx.doi.org/10.1371/journal.pone.0164713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760215	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204000046
J	Mrozkova, P; Spicarova, D; Palecek, J				Mrozkova, Petra; Spicarova, Diana; Palecek, Jiri			Hypersensitivity Induced by Activation of Spinal Cord PAR2 Receptors Is Partially Mediated by TRPV1 Receptors	PLOS ONE			English	Article							PRIMARY SENSORY NEURONS; SUBSTANTIA-GELATINOSA NEURONS; INDUCED NEUROPATHIC PAIN; POTENTIAL VANILLOID 4; BONE CANCER PAIN; KINASE-C-EPSILON; CAPSAICIN RECEPTOR; PROTEASE-ACTIVATED-RECEPTOR-2 SENSITIZES; INFLAMMATORY PAIN; CA2+ CHANNELS	Protease-activated receptors 2 (PAR2) and transient receptor potential vanilloid 1 (TRPV1) receptors in the peripheral nerve endings are implicated in the development of increased sensitivity to mechanical and thermal stimuli, especially during inflammatory states. Both PAR2 and TRPV1 receptors are co-expressed in nociceptive dorsal root ganglion (DRG) neurons on their peripheral endings and also on presynaptic endings in the spinal cord dorsal horn. However, the modulation of nociceptive synaptic transmission in the superficial dorsal horn after activation of PAR2 and their functional coupling with TRPV1 is not clear. To investigate the role of spinal PAR2 activation on nociceptive modulation, intrathecal drug application was used in behavioural experiments and patch-clamp recordings of spontaneous, miniature and dorsal root stimulation-evoked excitatory postsynaptic currents (sEPSCs, mEPSCs, eEPSCs) were performed on superficial dorsal horn neurons in acute rat spinal cord slices. Intrathecal application of PAR2 activating peptide SLIGKV-NH2 induced thermal hyperalgesia, which was prevented by pretreatment with TRPV1 antagonist SB 366791 and was reduced by protein kinases inhibitor staurosporine. Patch-clamp experiments revealed robust decrease of mEPSC frequency (62.8 +/- 4.9%), increase of sEPSC frequency (127.0 +/- 5.9%) and eEPSC amplitude (126.9 +/- 12.0%) in dorsal horn neurons after acute SLIGKV-NH2 application. All these EPSC changes, induced by PAR2 activation, were prevented by SB 366791 and staurosporine pretreatment. Our results demonstrate an important role of spinal PAR2 receptors in modulation of nociceptive transmission in the spinal cord dorsal horn at least partially mediated by activation of presynaptic TRPV1 receptors. The functional coupling between the PAR2 and TRPV1 receptors on the central branches of DRG neurons may be important especially during different pathological states when it may enhance pain perception.	[Mrozkova, Petra; Spicarova, Diana; Palecek, Jiri] Acad Sci Czech Republic, Inst Physiol, Dept Funct Morphol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Palecek, J (corresponding author), Acad Sci Czech Republic, Inst Physiol, Dept Funct Morphol, Prague, Czech Republic.	palecek@biomed.cas.cz	Mrózková, Petra/ABD-9871-2021; Spicarova, Diana/K-3069-2012; Palecek, Jiri/B-9614-2012	Spicarova, Diana/0000-0003-4268-2831; Palecek, Jiri/0000-0002-0609-8542; Mrozkova, Petra/0000-0001-9220-1819	GACR [15-11138S, P304/12/G069]; MSMT [LH15279]; GAUK [620312];  [CZ.1.05/1.1.00/02.0109];  [RVO67985823]	GACR(Grant Agency of the Czech Republic); MSMT(Ministry of Education, Youth & Sports - Czech Republic); GAUK; ; 	This work was supported by grants to JP from GACR 15-11138S, MSMT LH15279, GACR P304/12/G069, CZ.1.05/1.1.00/02.0109, RVO67985823, and to PM from GAUK 620312.	Alier KA, 2008, J PHARMACOL EXP THER, V324, P224, DOI 10.1124/jpet.107.129171; Amadesi S, 2004, J NEUROSCI, V24, P4300, DOI 10.1523/JNEUROSCI.5679-03.2004; Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; Amadesi S, 2009, J COMP NEUROL, V516, P141, DOI 10.1002/cne.22104; Bao YJ, 2015, INT J CANCER, V137, P1475, DOI 10.1002/ijc.29497; Bao Y, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-28; Bao YH, 2014, J MOL NEUROSCI; Bushell TJ, 2006, NEUROPHARMACOLOGY, V50, P714, DOI 10.1016/j.neuropharm.2005.11.024; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cenac N, 2013, CURR NEUROPHARMACOL, V11, P598, DOI 10.2174/1570159X113119990039; Chen K, 2015, J NEUROL SCI, V352, P62, DOI 10.1016/j.jns.2015.03.029; Chen Y, 2011, NEUROSCIENCE, V193, P440, DOI 10.1016/j.neuroscience.2011.06.085; Dai Y, 2004, J NEUROSCI, V24, P4293, DOI 10.1523/JNEUROSCI.0454-04.2004; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Ermolyuk YS, 2013, NAT NEUROSCI, V16, P1754, DOI 10.1038/nn.3563; Ferrini F, 2007, PAIN, V129, P195, DOI 10.1016/j.pain.2007.01.009; Fujita T, 2009, J NEUROPHYSIOL, V102, P312, DOI 10.1152/jn.91117.2008; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Gunthorpe MJ, 2004, NEUROPHARMACOLOGY, V46, P133, DOI 10.1016/S0028-3908(03)00305-8; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Hoogerwerf WA, 2001, J NEUROSCI, V21, P9036, DOI 10.1523/JNEUROSCI.21-22-09036.2001; Huang ZX, 2011, BRAIN RES, V1425, P20, DOI 10.1016/j.brainres.2011.09.058; Huang ZJ, 2012, PAIN, V153, P1426, DOI 10.1016/j.pain.2012.03.025; HUNG DT, 1992, J BIOL CHEM, V267, P20831; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Kawabata A, 2004, J PHARMACOL EXP THER, V309, P1098, DOI 10.1124/jpet.103.061010; Koetzner L, 2004, J PHARMACOL EXP THER, V311, P356, DOI 10.1124/jpet.104.069484; Liu L, 1997, J NEUROSCI, V17, P4101; Liu S, 2013, EUR J PAIN; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McDougall JJ, 2015, HANDB EXP PHARMACOL, V227, P239, DOI 10.1007/978-3-662-46450-2_12; Namer B, 2013, NAT NEUROSCI, V16, P117, DOI 10.1038/nn.3316; Noorbakhsh F, 2006, J EXP MED, V203, P425, DOI 10.1084/jem.20052148; Noorbakhsh F, 2003, NAT REV NEUROSCI, V4, P981, DOI 10.1038/nrn1255; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; NYSTEDT S, 1995, EUR J BIOCHEM, V232, P84, DOI 10.1111/j.1432-1033.1995.tb20784.x; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Poole DP, 2013, J BIOL CHEM, V288, P5790, DOI 10.1074/jbc.M112.438184; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1; SmithSwintosky VL, 1997, J NEUROCHEM, V69, P1890; Spicarova D, 2014, PHYSIOL RES, V63, pS225, DOI 10.33549/physiolres.932713; Spicarova D, 2008, PHYSIOL RES, V57, pS69, DOI 10.33549/physiolres.931601; Spicarova D, 2014, NEUROPHARMACOLOGY, V81, P75, DOI 10.1016/j.neuropharm.2014.01.041; Spicarova D, 2009, J NEUROPHYSIOL, V102, P234, DOI 10.1152/jn.00024.2009; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Striggow F, 2001, EUR J NEUROSCI, V14, P595, DOI 10.1046/j.0953-816x.2001.01676.x; Suen JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013809; Svensson CI, 2002, ANNU REV PHARMACOL, V42, P553, DOI 10.1146/annurev.pharmtox.42.092401.143905; Tillu DV, 2015, PAIN, V156, P859, DOI 10.1097/j.pain.0000000000000125; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tsai SH, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-97; Vergnolle N, 1999, BRIT J PHARMACOL, V127, P1083, DOI 10.1038/sj.bjp.0702634; Vergnolle N, 2000, ALIMENT PHARM THER, V14, P257; Vergnolle N, 2001, NAT MED, V7, P821, DOI 10.1038/89945; Vergnolle N, 2009, PHARMACOL THERAPEUT, V123, P292, DOI 10.1016/j.pharmthera.2009.05.004; Wei HT, 2016, PHYSIOL RES, V65, P145, DOI 10.33549/physiolres.933104; WEINSTEIN JR, 1995, J NEUROSCI, V15, P2906; Wu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078203; Wu ZZ, 2006, NEUROSCIENCE, V141, P407, DOI 10.1016/j.neuroscience.2006.03.023	63	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0163991	10.1371/journal.pone.0163991	http://dx.doi.org/10.1371/journal.pone.0163991			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755539	Green Submitted, Green Published, gold			2022-12-26	WOS:000386203800008
J	Neimanis, AS; Moraeus, C; Bergman, A; Bignert, A; Hoglund, J; Lundstrom, K; Stromberg, A; Backlin, BM				Neimanis, Aleksija S.; Moraeus, Charlotta; Bergman, Anders; Bignert, Anders; Hoglund, Johan; Lundstrom, Karl; Stromberg, Annika; Backlin, Britt-Marie			Emergence of the Zoonotic Biliary Trematode Pseudamphistomum truncatum in Grey Seals (Halichoerus grypus) in the Baltic Sea	PLOS ONE			English	Article							MINK MUSTELA-VISON; ROACH RUTILUS-RUTILUS; OTTERS LUTRA-LUTRA; BELORUSSIAN POLESIE; HELMINTH FAUNA; METACERCARIAE; POPULATIONS; LINNAEUS; MAMMALS; CASPICA	The biliary trematode Pseudamphistomum truncatum parasitizes a wide range of fish-eating mammals, including humans. Here we report the emergence of this parasite in grey seals (Halichoerus grypus) in the Baltic Sea. One hundred eighty-three of 1 554 grey seals (11.9%) examined from 2002-2013 had detectable hepatobiliary trematode infection. Parasite identification was confirmed as P. truncatum by sequencing the ITS2 region of a pool of five to 10 trematodes from each of ten seals collected off the coast of seven different Swedish counties. The proportion of seals parasitized by P. truncatum increased significantly over time and with increasing age of seals. Males were 3.1 times more likely to be parasitized than females and animals killed in fishery interactions were less likely to be parasitized than animals found dead or hunted. There was no significant difference in parasitism of seals examined from the Gulf of Bothnia versus those examined from the Baltic Proper. Although the majority of infections were mild, P. truncatum can cause severe hepatobiliary disease and resulted in liver failure in at least one seal. Because cyprinid fish are the second intermediate host for opisthorchiid trematodes, diets of grey seals from the Baltic Sea were analysed regarding presence of cyprinids. The proportion of gastrointestinal tracts containing cyprinid remains was ten times higher in seals examined from 2008 to 2013 (12.2%) than those examined from 2002 to 2007 (1.2%) and coincided with a general increase of trematode parasitism in the host population. The emergence and relatively common occurrence of P. truncatum in grey seals signals the presence of this parasite in the Baltic Sea ecosystem and demonstrates how aquatic mammals can serve as excellent sentinels of marine ecosystem change. Investigation of drivers behind P. truncatum emergence and infection risk for other mammals, including humans, is highly warranted.	[Neimanis, Aleksija S.] Natl Vet Inst, Dept Pathol & Wildlife Dis, Uppsala, Sweden; [Moraeus, Charlotta; Bergman, Anders; Bignert, Anders; Stromberg, Annika; Backlin, Britt-Marie] Swedish Museum Nat Hist, Dept Environm Res & Monitoring, Stockholm, Sweden; [Hoglund, Johan] Swedish Univ Agr Sci, Sect Parasitol, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Lundstrom, Karl] Swedish Univ Agr Sci, Dept Aquat Resources, Lysekil, Sweden	National Veterinary Institute SVA; Swedish Museum of Natural History; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Neimanis, AS (corresponding author), Natl Vet Inst, Dept Pathol & Wildlife Dis, Uppsala, Sweden.	aleksija.neimane@sva.se	Hoglund, Johan/F-6585-2013; Neimanis, Aleksija/E-4168-2016	Hoglund, Johan/0000-0002-1129-6615; Lundstrom, Karl/0000-0002-3758-0665; Neimanis, Aleksija/0000-0001-7747-2290	Swedish Environmental Protection Agency; INTERREG project ECOSEAL; Swedish Agency for Marine and Water Management	Swedish Environmental Protection Agency; INTERREG project ECOSEAL; Swedish Agency for Marine and Water Management	Funding support was provided by the Swedish Environmental Protection Agency (http//www.swedishepa.se/) and from the INTERREG project ECOSEAL (www.ecosealproject.eu). The Swedish Agency for Marine and Water Management (https://www.havochvatten.se/en/) provided funding support for the diet study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancroft JD, 1984, J PATH, V145, P355; Bergman A., 2007, THESIS, P131; Bignert A., 2013, PIA APPL STAT ANAL T; Cross Paul C., 2009, P9, DOI 10.1007/978-4-431-77134-0_2; Harding KC, 1999, AMBIO, V28, P619; Hawkins CJ, 2010, PARASITOL RES, V107, P993, DOI 10.1007/s00436-010-1951-6; Heckmann R, 2014, IRAN J PARASITOL, V9, P266; *HELCOM, 2005, BALT SEA ENV P; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Johnston DH, 1981, P WORLDWIDE FURBEARE, P407; KHAMIDULIN R I, 1991, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P60; King Sandie, 2001, Korean Journal of Parasitology, V39, P209, DOI 10.3347/kjp.2001.39.3.209; Krylov V.I., 1990, Finnish Game Research, V47, P32; Krylov VI, 1982, PSEUDAMPHISTOMUM TRU, P122; Kuiken T, 2006, VET PATHOL, V43, P321, DOI 10.1354/vp.43-3-321; Lundstrom K., 2007, NAMMCO Scientific Publications, V6, P177; Lundstrom K, 2010, ICES J MAR SCI, V67, P1230, DOI 10.1093/icesjms/fsq022; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Nyberg E, 2015, AMBIO, V44, pS484, DOI 10.1007/s13280-015-0673-5; Popov VN, 1985, VESTNIK ZOOLOGII, V2, P51; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; Saeed I, 2006, VET PARASITOL, V139, P168, DOI 10.1016/j.vetpar.2006.02.015; Schuster R, 2001, ARCH LEBENSMITTELHYG, V52, P102; Sherrard-Smith E, 2015, INT J PARASITOL, V45, P75, DOI 10.1016/j.ijpara.2014.09.004; Shimalov VV, 2000, PARASITOL RES, V86, P163, DOI 10.1007/s004360050026; Shimalov VV, 2001, PARASITOL RES, V87, P680, DOI 10.1007/s004360000373; Simpson VR, 2005, VET REC, V157, P49, DOI 10.1136/vr.157.2.49; Skov J, 2008, VET PARASITOL, V155, P209, DOI 10.1016/j.vetpar.2008.05.011; Swedish Environmental Protection Agency, 2014, PAT HOS GRAS VIK KNU; Torres J, 2008, J HELMINTHOL, V82, P349, DOI 10.1017/S0022149X08046920; Traldi G., 1986, Parassitologia, V28, P373; WHO (World Health Organization), EMERGING INFECT DIS; Woolhouse MEJ, 1998, PARASITOL TODAY, V14, P428, DOI 10.1016/S0169-4758(98)01318-0	34	9	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164782	10.1371/journal.pone.0164782	http://dx.doi.org/10.1371/journal.pone.0164782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755567	Green Published, Green Submitted, gold			2022-12-26	WOS:000386203800033
J	Sezen, UU; Barney, JN; Atwater, DZ; Pederson, GA; Pederson, JF; Chandler, JM; Cox, TS; Cox, S; Dotray, P; Kopec, D; Smith, SE; Schroeder, J; Wright, SD; Jiao, YN; Kong, WQ; Goff, V; Auckland, S; Rainville, LK; Pierce, GJ; Lemke, C; Compton, R; Phillips, C; Kerr, A; Mettler, M; Paterson, AH				Sezen, U. Uzay; Barney, Jacob N.; Atwater, Daniel Z.; Pederson, Gary A.; Pederson, Jeffrey F.; Chandler, J. Mike; Cox, T. Stan; Cox, Sheila; Dotray, Peter; Kopec, David; Smith, Steven E.; Schroeder, Jill; Wright, Steven D.; Jiao, Yuannian; Kong, Wenqian; Goff, Valorie; Auckland, Susan; Rainville, Lisa K.; Pierce, Gary J.; Lemke, Cornelia; Compton, Rosana; Phillips, Christine; Kerr, Alexandra; Mettler, Matthew; Paterson, Andrew H.			Multi-Phase US Spread and Habitat Switching of a Post-Columbian Invasive, Sorghum halepense	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; GENETIC-VARIATION; JOHNSONGRASS; RANGE; PROGRAM; PLANTS	Johnsongrass (Sorghum halepense) is a striking example of a post-Columbian founder event. This natural experiment within ecological time-scales provides a unique opportunity for understanding patterns of continent-wide genetic diversity following range expansion. Microsatellite markers were used for population genetic analyses including leaf-optimized Neighbor-Joining tree, pairwise FST, mismatch analysis, principle coordinate analysis, Tajima's D, Fu's F and Bayesian clusterings of population structure. Evidence indicates two geographically distant introductions of divergent genotypes, which spread across much of the US in <200 years. Based on geophylogeny, gene flow patterns can be inferred to have involved five phases. Centers of genetic diversity have shifted from two introduction sites separated by similar to 2000 miles toward the middle of the range, consistent with admixture between genotypes from the respective introductions. Genotyping provides evidence for a 'habitat switch' from agricultural to non-agricultural systems and may contribute to both Johnsongrass ubiquity and aggressiveness. Despite lower and more structured diversity at the invasion front, Johnsongrass continues to advance northward into cooler and drier habitats. Association genetic approaches may permit identification of alleles contributing to the habitat switch or other traits important to weed/invasive management and/or crop improvement.	[Sezen, U. Uzay; Kong, Wenqian; Goff, Valorie; Auckland, Susan; Rainville, Lisa K.; Pierce, Gary J.; Lemke, Cornelia; Compton, Rosana; Phillips, Christine; Kerr, Alexandra; Mettler, Matthew; Paterson, Andrew H.] Plant Genome Mapping Lab, Athens, GA 30602 USA; [Barney, Jacob N.; Atwater, Daniel Z.] Virginia Tech, Blacksburg, VA USA; [Pederson, Gary A.] ARS, USDA, PGRCU, Griffin, GA USA; [Pederson, Jeffrey F.] ARS, USDA, Lincoln, NE USA; [Pederson, Jeffrey F.] Univ Nebraska Lincoln, Lincoln, NE USA; [Chandler, J. Mike] Texas A&M Univ, College Stn, TX USA; [Cox, T. Stan; Cox, Sheila] Land Inst, Salina, KS USA; [Dotray, Peter] Texas Tech Univ, Lubbock, TX 79409 USA; [Kopec, David; Smith, Steven E.] Univ Arizona, Tucson, AZ USA; [Schroeder, Jill] New Mexico State Univ, Las Cruces, NM 88003 USA; [Wright, Steven D.] Univ Calif Davis, Davis, CA 95616 USA; [Jiao, Yuannian] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Virginia Polytechnic Institute & State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln; Texas A&M University System; Texas A&M University College Station; Texas Tech University System; Texas Tech University; University of Arizona; New Mexico State University; University of California System; University of California Davis; Chinese Academy of Sciences; Institute of Botany, CAS	Paterson, AH (corresponding author), Plant Genome Mapping Lab, Athens, GA 30602 USA.	paterson@uga.edu	Jiao, Yuannian/AAZ-7054-2021; Sezen, Uğur Uzay/V-1186-2019; Barney, Jacob/C-2412-2008	Jiao, Yuannian/0000-0002-8987-2782; Sezen, Uğur Uzay/0000-0002-2988-8790; Barney, Jacob/0000-0003-2949-5003	United States Department of Agriculture Biotechnology Risk Assessment Program [08-39211-19568, 2012-33522-19790]; United States Department of Agriculture Controlling Weedy and Invasive Plants program [2013-67013-21306]	United States Department of Agriculture Biotechnology Risk Assessment Program; United States Department of Agriculture Controlling Weedy and Invasive Plants program	Funding was provided by the United States Department of Agriculture Biotechnology Risk Assessment Program (08-39211-19568 to AHP, 2012-33522-19790 to AHP and TSC), and the United States Department of Agriculture Controlling Weedy and Invasive Plants program (2013-67013-21306 to JNB and AHP).	Aljanabi SM, 1999, PLANT MOL BIOL REP, V17, P281, DOI 10.1023/A:1007692929505; Atwater DZ, 2016, ECOGRAPHY, V39, P894, DOI 10.1111/ecog.02031; Baker H. G., 1965, The genetics of colonizing species., P147; Barney JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017222; Burke IC, 2006, WEED TECHNOL, V20, P571, DOI 10.1614/WT-05-110R.1; Casa AM, 2005, THEOR APPL GENET, V111, P23, DOI 10.1007/s00122-005-1952-5; CASAS AM, 1993, P NATL ACAD SCI USA, V90, P11212, DOI 10.1073/pnas.90.23.11212; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Fernandez L, 2013, ECOL EVOL, V3, P3388, DOI 10.1002/ece3.671; Gunn BF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021143; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Holm L, 1997, WORLD WEEDS NATURAL; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lavoie C, 2013, DIVERS DISTRIB, V19, P98, DOI 10.1111/ddi.12014; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu Y, 2011, WEED BIOL MANAG, V11, P160, DOI 10.1111/j.1445-6664.2011.00416.x; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; McDonald A, 2009, AGR ECOSYST ENVIRON, V130, P131, DOI 10.1016/j.agee.2008.12.007; MCWHORTER CG, 1971, WEED SCI, V19, P496, DOI 10.1017/S0043174500050517; MONAGHAN N, 1979, WEED RES, V19, P261, DOI 10.1111/j.1365-3180.1979.tb01536.x; Morrell PL, 2005, MOL ECOL, V14, P2143, DOI 10.1111/j.1365-294X.2005.02579.x; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Parks DH, 2009, 2009 17TH INTERNATIONAL CONFERENCE ON GEOINFORMATICS, VOLS 1 AND 2, P316; Parodi L. R., 1943, REV ARGENTINA AGRON, V10, P361; PATERSON AH, 1995, P NATL ACAD SCI USA, V92, P6127, DOI 10.1073/pnas.92.13.6127; Perrier X., 2006, DARWIN SOFTWARE; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Quinn LD, 2013, BIOSCIENCE, V63, P124, DOI 10.1525/bio.2013.63.2.8; RCore Team, 2020, R LANG ENV STAT COMP; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Roullier C, 2013, P NATL ACAD SCI USA, V110, P2205, DOI 10.1073/pnas.1211049110; Rout ME, 2009, PLANT SOIL, V315, P163, DOI 10.1007/s11104-008-9740-z; Stohlgren TJ, 2011, BIOL INVASIONS, V13, P1931, DOI 10.1007/s10530-011-0024-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tellman B, 1996, STOWAWAYS INVITED GU; WARWICK SI, 1986, WEED RES, V26, P381, DOI 10.1111/j.1365-3180.1986.tb00721.x; Yeh FC, 1997, POPGENE USER FRIENDL	46	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164584	10.1371/journal.pone.0164584	http://dx.doi.org/10.1371/journal.pone.0164584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755565	Green Published, Green Submitted, gold			2022-12-26	WOS:000386203800023
J	Adde, A; Roux, E; Mangeas, M; Dessay, N; Nacher, M; Dusfour, I; Girod, R; Briolant, S				Adde, Antoine; Roux, Emmanuel; Mangeas, Morgan; Dessay, Nadine; Nacher, Mathieu; Dusfour, Isabelle; Girod, Romain; Briolant, Sebastien			Dynamical Mapping of Anopheles darlingi Densities in a Residual Malaria Transmission Area of French Guiana by Using Remote Sensing and Meteorological Data	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; VECTOR CONTROL; CULICIDAE; DIPTERA; RISK; ROOT; MAP; INTERVENTIONS; HETEROGENEITY; PATTERNS	Local variation in the density of Anopheles mosquitoes and the risk of exposure to bites are essential to explain the spatial and temporal heterogeneities in the transmission of malaria. Vector distribution is driven by environmental factors. Based on variables derived from satellite imagery and meteorological observations, this study aimed to dynamically model and map the densities of Anopheles darlingi in the municipality of Saint-Georges de I'Oyapock (French Guiana). Longitudinal sampling sessions of An. darlingi densities were conducted between September 2012 and October 2014. Landscape and meteorological data were collected and processed to extract a panel of variables that were potentially related to An. darlingi ecology. Based on these data, a robust methodology was formed to estimate a statistical predictive model of the spatial-temporal variations in the densities of An. darlingi in Saint-Georges de l'Oyapock. The final cross-validated model integrated two landscape variables dense forest surface and built surface together with four meteorological variables related to rainfall, evapotranspiration, and the minimal and maximal temperatures. Extrapolation of the model allowed the generation of predictive weekly maps of An. darlingi densities at a resolution of 10-m. Our results supported the use of satellite imagery and meteorological data to predict malaria vector densities. Such fine-scale modeling approach might be a useful tool for health authorities to plan control strategies and social communication in a cost-effective, targeted, and timely manner.	[Adde, Antoine; Dusfour, Isabelle; Girod, Romain; Briolant, Sebastien] Inst Pasteur, Unite Entomol Med, Cayenne, French Guiana; [Roux, Emmanuel; Mangeas, Morgan; Dessay, Nadine] Inst Rech Dev, UMR ESPACE DEV, Montpellier, France; [Nacher, Mathieu] Ctr Hosp Andree Rosemon, Ctr Invest Clin & Epiderniol Clin Antilles Guyane, Cayenne, French Guiana; [Briolant, Sebastien] Direct Interarmees Serv Sante Guyane, Cayenne, French Guiana; [Briolant, Sebastien] Inst Rech Biomed Armees, Unite Parasitol & Entomol Med, Marseille, France; [Briolant, Sebastien] Fac Med La Timone, Unite Rech Malad Infect Trop Emergentes, Marseille, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite des Antilles; University of La Reunion; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Adde, A (corresponding author), Inst Pasteur, Unite Entomol Med, Cayenne, French Guiana.	adde.antoine@gmail.com	Dessay, Nadine/J-9856-2016; nacher, mathieu/AAH-4796-2021; mangeas, morgan/AAS-7995-2020; Dessay, Nadine/Y-1791-2019; ROUX, Emmanuel/G-9814-2011; Roux, Emmanuel/U-6942-2019; Mangeas, Morgan/J-5170-2016	Dessay, Nadine/0000-0003-0526-3531; nacher, mathieu/0000-0001-9397-3204; mangeas, morgan/0000-0003-4146-3784; Dessay, Nadine/0000-0003-0526-3531; Roux, Emmanuel/0000-0003-2266-8207; Mangeas, Morgan/0000-0003-4146-3784; Dusfour, Isabelle/0000-0002-5265-8432	CNES-DGA-MRIS scholarship; French army [LR607e]; Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-25-01]	CNES-DGA-MRIS scholarship; French army; Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR))	Financial support was made available by a CNES-DGA-MRIS scholarship and the French army (grant LR607e). This work has benefited from an "Investissement d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-25-01).	Achee NL, 2006, J MED ENTOMOL, V43, P382, DOI 10.1603/0022-2585(2006)043[0382:UORSAG]2.0.CO;2; Agresti A, 2001, INT STAT REV, V69, P345, DOI 10.2307/1403450; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alimi TO, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1052-1; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Ceccato P., 2005, Parassitologia (Rome), V47, P81; CHARLWOOD JD, 1989, ANN TROP MED PARASIT, V83, P569, DOI 10.1080/00034983.1989.11812389; Christian R., 2015, PHYS STATUS SOLIDI A, P1; Claustre J, 2001, B SOC PATHOL EXOT, V94, P353; de Santi VP, 2016, EMERG INFECT DIS, V22, P903, DOI 10.3201/eid2205.151957; de Santi VP, 2016, EMERG INFECT DIS, V22, P344, DOI 10.3201/eid2202.151292; de Santi VP, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1088-x; Dusfour I, 2012, MEM I OSWALDO CRUZ, V107, P429, DOI 10.1590/S0074-02762012000300021; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; FARAN M E, 1981, Mosquito Systematics, V13, P1; FLOCH H, 1955, Riv Malariol, V34, P57; Floch H., 1951, ARCH I PASTEUR GUYAN, V236, P1; Floch H, 1943, ARCH INST PASTEUR GU, V7, P1; Forattini, 1962, ENTOMOLOGIA MED; FORATTINI OP, 1987, REV SAUDE PUBL, V21, P291, DOI 10.1590/S0034-89101987000400002; Fouque F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-80; Girod R, 2011, ANN TROP MED PARASIT, V105, P107, DOI 10.1179/136485911X12899838683322; Girod R, 2008, MEM I OSWALDO CRUZ, V103, P702, DOI 10.1590/S0074-02762008000700013; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000209; Hemingway J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0431; Hiwat H, 2010, T ROY SOC TROP MED H, V104, P207, DOI 10.1016/j.trstmh.2009.07.007; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; HUDSON JE, 1984, B ENTOMOL RES, V74, P129, DOI 10.1017/S0007485300010002; Kar NP, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-265; Karunamoorthi K, 2011, CLIN MICROBIOL INFEC, V17, P1608, DOI 10.1111/j.1469-0691.2011.03664.x; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006; Laporta GZ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1038-4; Lounibos L. Philip, 2000, American Entomologist, V46, P238; Machault V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050674; Machault V, 2011, GEOSPATIAL HEALTH, V5, P151, DOI 10.4081/gh.2011.167; May JM, 1951, GEOGR REV, V41, P638, DOI 10.2307/210709; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; McGarigal K., FRAGSTATS V4 SPATIAL; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mnzava AP, 2014, T ROY SOC TROP MED H, V108, P550, DOI 10.1093/trstmh/tru101; Monteith J. L., 1964, S SOC EXP BIOL, V19, P205; Mouchet J, 2004, BIODIVERSITE A DU PA; Musset L, 2014, MEM I OSWALDO CRUZ, V109, P525, DOI 10.1590/0074-0276140031; PAJOT F-X, 1977, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V15, P15; Petit-Sinturel M, 2016, B VEILLE SANITAIRE A, V2, P6; Robert V, 1989, URBANISATION SANTE T, P181; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; Stefani A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-192; Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325; Takken W, 2009, TRENDS PARASITOL, V25, P101, DOI 10.1016/j.pt.2008.12.002; TANNER M, 1992, T ROY SOC TROP MED H, V86, P499, DOI 10.1016/0035-9203(92)90084-P; Tran A, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-9; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Vezenegho SB, 2015, ENVIRON ENTOMOL, V44, P454, DOI 10.1093/ee/nvv053; Vezenegho SB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-384; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; White G. B., 1989, GEOGRAPHICAL DISTRIB, P7; World Health Organization, 2015, WORLD MAL REP 2015; World Health Organization, 2012, HDB INT VECT MAN; Zeilhofer P, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-7; Zimmerman RH, 2006, J MED ENTOMOL, V43, P947, DOI 10.1603/0022-2585(2006)43[947:BHOASD]2.0.CO;2	67	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164685	10.1371/journal.pone.0164685	http://dx.doi.org/10.1371/journal.pone.0164685			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749938	Green Published, gold			2022-12-26	WOS:000386202300021
J	Liang, YK; Bian, LJ				Liang, Yin-Ku; Bian, Liu-jiao			Voltage- Dependent Anion Channel-1, a Possible Ligand of Plasminogen Kringle 5	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ATP-SYNTHASE; SRC FAMILY; ENDOSTATIN; CELLS; APOPTOSIS; ANGIOSTATIN; CAVEOLIN-1; KINASES	Kringle 5, the fifth fragment of plasminogen, is known to be important for inhibiting the proliferation and migration of vascular endothelial cell (VEC), while not having any effects on normal endothelial cells. Therefore, it may be a potential tumor therapy candidate. However, the ligand of the Kringle 5 in VEC has not yet been identified. In this study, the possible ligand of Kringle 5 in vitro was screened and validated using Ph.D.-7 phage display peptide library with molecular docking, along with surface plasma resonance (SPR). After four rounds of panning, the specific clones of Kringle 5 were confirmed using enzyme-linked immunosorbent assay (ELISA). The gene sequence analysis showed that they expressed the common amino sequence IGNSNTL. Then, using a NCBI BLAST, 103 matching sequences were found. Following the molecular docking evaluation and considering the acting function and pathway of the plasminogen Kringle 5 in the human body, the most promising candidate was determined to be voltage-dependent anion channel-1 (VDAC-1), which was able to bind to Kringle 5 at -822.65 J.mol(-1) of the binding energy at the residues of Lys12, Thr19, Ser57, Thr188, Arg139, Asn214, Ser240 and Lys274. A strong dose-dependent interaction occurred between the VDAC-1 and Kringle 5 (binding constant 2.43 x 10(3) L.mol(-1)) in SPR observation. Therefore, this study proposed that VDAC-1 was a potential ligand of plasminogen Kringle 5, and also demonstrated that the screening and validation of protein ligand using phage display peptide library with the molecular docking, along with SPR, was a practicable application.	[Liang, Yin-Ku; Bian, Liu-jiao] Northwest Univ, Coll Life Sci, Xian 710069, Peoples R China; [Liang, Yin-Ku] Shaanxi Univ Technol, Coll Biol Sci & Engn, Hanzhong 723000, Peoples R China; [Liang, Yin-Ku] Shaanxi Univ Technol, Shaanxi Prov Key Lab Bioresource, Hanzhong 723000, Peoples R China; [Liang, Yin-Ku] Shaanxi Univ Technol, Qinba Mt Bioresource Collaborat Innovat Ctr South, Hanzhong 723000, Peoples R China	Northwest University Xi'an; Shaanxi University of Technology; Shaanxi University of Technology; Shaanxi University of Technology	Bian, LJ (corresponding author), Northwest Univ, Coll Life Sci, Xian 710069, Peoples R China.	liangyinku26@163.com			National Basic Research Program of China [21075097]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (#21075097).	Cao Y, 2007, J BIOL CHEM, V272, P22924; Cao Y, 1966, J BIOL CHEM, V271, P22924; Chang Y, 1998, BIOCHEMISTRY-US, V37, P3258, DOI 10.1021/bi972284e; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; Dhanabal M, 1999, J BIOL CHEM, V274, P11721, DOI 10.1074/jbc.274.17.11721; Digtyar AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P235, DOI 10.1134/S0006297907030017; Gao GQ, 2002, J BIOL CHEM, V277, P9492, DOI 10.1074/jbc.M108004200; Gonzalez-Gronow M, 2003, J BIOL CHEM, V278, P27312, DOI 10.1074/jbc.M303172200; Jung KH, 2007, CANCER BIOTHER RADIO, V22, P704, DOI 10.1089/cbr.2007.369; Kim YM, 2002, J BIOL CHEM, V277, P27872, DOI 10.1074/jbc.M202771200; Kim YM, 2000, CANCER RES, V60, P5410; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lu H, 1999, BIOCHEM BIOPH RES CO, V258, P668, DOI 10.1006/bbrc.1999.0612; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Mundel TM, 2007, MICROVASC RES, V74, P85, DOI 10.1016/j.mvr.2007.05.005; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; Ortiz C, 2001, J EXP BOT, V52, P1711, DOI 10.1093/jexbot/52.361.1711; [彭永德 Peng Yongde], 2005, [生命科学研究, Life science research], V9, P15; Shichiri M, 2001, FASEB J, V15, P1044, DOI 10.1096/fj.99-1083com; Tatosyan AG, 2000, BIOCHEMISTRY-MOSCOW+, V65, P49; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Wang D., 2005, J HENAN U CHINESE ME, V20, P20; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wickstrom SA, 2002, CANCER RES, V62, P5580; Xiao J, 2010, ACTA AGR BOREALI OCC, V19, P21; Zhang D, 2001, DIABETOLOGIA, V44, P757, DOI 10.1007/s001250051685	27	4	5	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164834	10.1371/journal.pone.0164834	http://dx.doi.org/10.1371/journal.pone.0164834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749918	Green Published, gold, Green Submitted			2022-12-26	WOS:000386202300034
J	Bainbridge, M; Kraft, J				Bainbridge, Melissa; Kraft, Jana			Lipid Encapsulation Provides Insufficient Total-Tract Digestibility to Achieve an Optimal Transfer Efficiency of Fatty Acids to Milk Fat	PLOS ONE			English	Article							LACTATING DAIRY-COWS; RUMINAL FERMENTATION; STEARIDONIC ACID; ECHIUM-OIL; DIGESTION; FEED; BIOHYDROGENATION; SUPPLEMENTATION; METABOLISM; FRACTIONS	Transfer efficiencies of rumen-protected n-3 fatty acids (FA) to milk are low, thus we hypothesized that rumen-protection technologies allow for biohydrogenation and excretion of n-3 FA. The objectives of this study were to i) investigate the ruminal protection and post-ruminal release of the FA derived from the lipid-encapsulated echium oil (EEO), and ii) assess the bioavailability and metabolism of the EEO-derived FA through measuring the FA content in plasma lipid fractions, feces, and milk. The EEO was tested for rumen stability using the in situ nylon bag technique, then the apparent total-tract digestibility was assessed in vivo using six Holstein dairy cattle. Diets consisted of a control (no EEO); 1.5% of dry matter (DM) as EEO and 1.5% DM as encapsulation matrix; and 3% DM as EEO. The EEO was rumen-stable and had no effect on animal production. EEO-derived FA were incorporated into all plasma lipid fractions, with the highest proportion of n-3 FA observed in cholesterol esters. Fecal excretion of EEO-derived FA ranged from 7-14%. Biohydrogenation products increased in milk, plasma, and feces with EEO supplementation. In conclusion, lipid-encapsulation provides inadequate digestibility to achieve an optimal transfer efficiency of n-3 FA to milk.	[Bainbridge, Melissa; Kraft, Jana] Univ Vermont, Dept Anim & Vet Sci, 570 Main St, Burlington, VT 05405 USA	University of Vermont	Kraft, J (corresponding author), Univ Vermont, Dept Anim & Vet Sci, 570 Main St, Burlington, VT 05405 USA.	Jana.Kraft@uvm.edu			USDA NIFA-VT [VT-H01913]; Dairy Center of Excellence at the University of Vermont	USDA NIFA-VT; Dairy Center of Excellence at the University of Vermont	This project was funded by the USDA NIFA-VT (PROJ NO: VT-H01913) and Dairy Center of Excellence at the University of Vermont.	American Heart Association, 2015, DIET GUID ADV; [Anonymous], 2001, NUTR REQ DIAR CATTL; Association of Official Analytical Chemists, 2000, OFFICIAL METHODS ANA, Vseventeenth; Bainbridge ML, 2015, J AGR FOOD CHEM, V63, P4827, DOI 10.1021/acs.jafc.5b00857; Bauman DE, 2001, LIVEST PROD SCI, V70, P15, DOI 10.1016/S0301-6226(01)00195-6; Bernal-Santos G, 2010, J DAIRY SCI, V93, P32, DOI 10.3168/jds.2009-2711; BRUMBY PE, 1972, J DAIRY RES, V39, P167, DOI 10.1017/S0022029900013960; Chilliard Y, 2001, LIVEST PROD SCI, V70, P31, DOI 10.1016/S0301-6226(01)00196-8; Cortes C, 2010, J DAIRY SCI, V93, P3146, DOI 10.3168/jds.2009-2905; Demeyer D. I., 1991, Rumen microbial metabolism and ruminant digestion., P217; FIRKINS JL, 1994, J DAIRY SCI, V77, P2357, DOI 10.3168/jds.S0022-0302(94)77178-2; FOLCH J, 1957, J BIOL CHEM, V226, P497; Glasser F, 2008, ANIMAL, V2, P691, DOI 10.1017/S1751731108002036; Gressley TF, 2012, J DAIRY SCI, V95, P353; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Harfoot C, 1997, RUMEN MICROBIAL ECOS, P382; Hawkins A, 2013, J DAIRY SCI, V96, P3907, DOI 10.3168/jds.2012-6207; Jalc D, 2007, VET MED-CZECH, V52, P87, DOI 10.17221/2012-VETMED; JENKINS TC, 1993, J DAIRY SCI, V76, P3851, DOI 10.3168/jds.S0022-0302(93)77727-9; Jenkins TC, 2007, EUR J LIPID SCI TECH, V109, P778, DOI 10.1002/ejlt.200700022; Kitessa SM, 2011, ANIM FEED SCI TECH, V170, P35, DOI 10.1016/j.anifeedsci.2011.08.007; Kliem KE, MANIPULATION MILK FA, P1; Lanier JS, 2013, LIPIDS, V48, P469, DOI 10.1007/s11745-013-3782-6; MACGIBBON AKH, 2006, ADV DAIRY CHEM, V2, P1, DOI DOI 10.1007/0-387-28813-9; Maia MRG, 2012, J ANIM SCI, V90, P900, DOI 10.2527/jas.2011-4118; Nobel RC, 1978, PROG LIPID RES, V17, P55; Offer NW, 2001, ANIM SCI, V73, P523, DOI 10.1017/S1357729800058495; Palmquist D.L., 2006, ADV DAIRY CHEM, P43, DOI DOI 10.1007/0-387-28813-9; PALMQUIST DL, 1993, J DAIRY SCI, V76, P1753, DOI 10.3168/jds.S0022-0302(93)77508-6; Palmquist DL, 2007, EUR J LIPID SCI TECH, V109, P737, DOI 10.1002/ejlt.200700146; Pantoja J, 1996, J DAIRY SCI, V79, P429, DOI 10.3168/jds.S0022-0302(96)76382-8; Pappritz J, 2011, EUR J LIPID SCI TECH, V113, P1443, DOI 10.1002/ejlt.201100170; Stamey JA, 2012, J DAIRY SCI, V95, P5269, DOI 10.3168/jds.2012-5412; SUKHIJA PS, 1988, J AGR FOOD CHEM, V36, P1202, DOI 10.1021/jf00084a019; VANSOEST PJ, 1968, J DAIRY SCI, V51, P1644, DOI 10.3168/jds.S0022-0302(68)87246-7; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Weiss WP, 2004, J DAIRY SCI, V87, P1446, DOI 10.3168/jds.S0022-0302(04)73295-6; Whelan J, 2009, J NUTR, V139, P5, DOI 10.3945/jn.108.094268	38	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164700	10.1371/journal.pone.0164700	http://dx.doi.org/10.1371/journal.pone.0164700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741299	gold, Green Published, Green Submitted			2022-12-26	WOS:000385507000059
J	Harrod, A; Fulton, J; Nguyen, VTM; Periyasamy, M; Ramos-Garcia, L; Lai, CF; Metodieva, G; de Giorgio, A; Williams, RL; Santos, DB; Gomez, PJ; Lin, ML; Metodiev, MV; Stebbing, J; Castellano, L; Magnani, L; Coombes, RC; Buluwela, L; Ali, S				Harrod, A.; Fulton, J.; Nguyen, V. T. M.; Periyasamy, M.; Ramos-Garcia, L.; Lai, C-F; Metodieva, G.; de Giorgio, A.; Williams, R. L.; Santos, D. B.; Gomez, P. J.; Lin, M-L; Metodiev, M. V.; Stebbing, J.; Castellano, L.; Magnani, L.; Coombes, R. C.; Buluwela, L.; Ali, S.			Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; LIGAND-BINDING DOMAIN; ER-ALPHA; ENDOCRINE RESISTANCE; POSTMENOPAUSAL WOMEN; GENE-EXPRESSION; RETINOIC ACID; TYROSINE 537; PHOSPHORYLATION; TRANSCRIPTION	Drugs that inhibit estrogen receptor-a (ER) activity have been highly successful in treating and reducing breast cancer progression in ER-positive disease. However, resistance to these therapies presents a major clinical problem. Recent genetic studies have shown that mutations in the ER gene are found in > 20% of tumours that progress on endocrine therapies. Remarkably, the great majority of these mutations localize to just a few amino acids within or near the critical helix 12 region of the ER hormone binding domain, where they are likely to be single allele mutations. Understanding how these mutations impact on ER function is a prerequisite for identifying methods to treat breast cancer patients featuring such mutations. Towards this end, we used CRISPR-Cas9 genome editing to make a single allele knock-in of the most commonly mutated amino acid residue, tyrosine 537, in the estrogen-responsive MCF7 breast cancer cell line. Genomic analyses using RNA-seq and ER ChIP-seq demonstrated that the Y537S mutation promotes constitutive ER activity globally, resulting in estrogen-independent growth. MCF7-Y537S cells were resistant to the antiestrogen tamoxifen and fulvestrant. Further, we show that the basal transcription factor TFIIH is constitutively recruited by ER-Y537S, resulting in ligand-independent phosphorylation of Serine 118 (Ser118) by the TFIIH kinase, cyclin-dependent kinase (CDK)7. The CDK7 inhibitor, THZ1 prevented Ser118 phosphorylation and inhibited growth of MCF7-Y537S cells. These studies confirm the functional importance of ER mutations in endocrine resistance, demonstrate the utility of knock-in mutational models for investigating alternative therapeutic approaches and highlight CDK7 inhibition as a potential therapy for endocrine-resistant breast cancer mediated by ER mutations.	[Harrod, A.; Fulton, J.; Nguyen, V. T. M.; Periyasamy, M.; Ramos-Garcia, L.; Lai, C-F; de Giorgio, A.; Williams, R. L.; Santos, D. B.; Gomez, P. J.; Lin, M-L; Stebbing, J.; Castellano, L.; Magnani, L.; Coombes, R. C.; Buluwela, L.; Ali, S.] Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England; [Metodieva, G.; Metodiev, M. V.] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester, Essex, England	Imperial College London; University of Essex	Buluwela, L; Ali, S (corresponding author), Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	l.buluwela@imperial.ac.uk; simak.ali@imperial.ac.uk	periyasamy, manikandan/AAB-7924-2020; Castellano, Leandro/AAE-1366-2021; Periyasamy, Manikandan/AAL-6211-2020; Ali, Simak/M-6912-2018; magnani, luca/N-1094-2015	Ali, Simak/0000-0002-1320-0816; magnani, luca/0000-0002-7534-0785; Nguyen, Thuy Mai Van/0000-0002-5898-0043; Castellano, Leandro/0000-0002-3059-4829; Coombes, Raoul Charles/0000-0002-4811-1100; Harrod, Alison/0000-0002-3977-2791; Periyasamy, Manikandan/0000-0001-7626-2531; Stebbing, Justin/0000-0002-1117-6947	Breast Cancer Now [2014MayPR234]; Cancer Research UK [C37/A18784]; Cancer Research UK Imperial Centre; Cancer Research UK [12011, 14549, 18784] Funding Source: researchfish	Breast Cancer Now; Cancer Research UK(Cancer Research UK); Cancer Research UK Imperial Centre; Cancer Research UK(Cancer Research UK)	This work was funded by grants from Breast Cancer Now (2014MayPR234) and Cancer Research UK (C37/A18784). AH is supported by a PhD studentship from the Cancer Research UK Imperial Centre. We thank M Jones and L Game, MRC CSC Genomics Facility, Imperial College London. This study is dedicated to the memory of Professor Susan Malcolm.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Ali S, 2011, ANNU REV MED, V62, P217, DOI 10.1146/annurev-med-052209-100305; Ali S, 2009, CANCER RES, V69, P6208, DOI 10.1158/0008-5472.CAN-09-0301; Anghel SI, 2000, J BIOL CHEM, V275, P20867, DOI 10.1074/jbc.M002098200; Arnold SF, 1997, MOL ENDOCRINOL, V11, P48, DOI 10.1210/me.11.1.48; ARNOLD SF, 1995, J BIOL CHEM, V270, P30205; Chen DS, 2002, ONCOGENE, V21, P4921, DOI 10.1038/sj.onc.1205420; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Eng FCS, 1997, MOL CELL BIOL, V17, P4644, DOI 10.1128/MCB.17.8.4644; Eng FCS, 1998, J BIOL CHEM, V273, P28371, DOI 10.1074/jbc.273.43.28371; Fanning Sean W, 2016, Elife, V5, DOI 10.7554/eLife.12792; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Garner F, 2015, ANTI-CANCER DRUG, V26, P948, DOI 10.1097/CAD.0000000000000271; Guttery DS, 2015, CLIN CHEM, V61, P974, DOI 10.1373/clinchem.2015.238717; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herynk MH, 2004, ENDOCR REV, V25, P869, DOI 10.1210/er.2003-0010; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Jeselsohn R, 2014, CLIN CANCER RES, V20, P1757, DOI 10.1158/1078-0432.CCR-13-2332; Johnston SRD, 2003, NAT REV CANCER, V3, P821, DOI 10.1038/nrc1211; Jozwik KM, 2012, NAT REV CANCER, V12, P381, DOI 10.1038/nrc3263; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lai A, 2015, J MED CHEM, V58, P4888, DOI 10.1021/acs.jmedchem.5b00054; Lai CF, 2013, NUCLEIC ACIDS RES, V41, P10228, DOI 10.1093/nar/gkt827; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu YW, 2014, BIOINFORMATICS, V30, P301, DOI 10.1093/bioinformatics/btt688; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McCormack P, 2008, CLIN BREAST CANCER, V8, P347, DOI 10.3816/CBC.2008.n.040; Merenbakh-Lamin K, 2013, CANCER RES, V73, P6856, DOI 10.1158/0008-5472.CAN-13-1197; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; Nguyen VTM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10044; Oesterreich S, 2013, NAT GENET, V45, P1415, DOI 10.1038/ng.2831; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Periyasamy M, 2015, CELL REP, V13, P108, DOI 10.1016/j.celrep.2015.08.066; Piccart M., 2013, ANN ONCOL, V24, P25; Pritchard KI, 2010, BREAST CANCER RES TR, V123, P453, DOI 10.1007/s10549-010-1022-9; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Sarwar N, 2006, ENDOCR-RELAT CANCER, V13, P851, DOI 10.1677/erc.1.01123; Schiavon G, 2015, SCI TRANSL MED; Segal CV, 2014, CLIN CANCER RES, V20, P1724, DOI 10.1158/1078-0432.CCR-14-0067; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Skliris GP, 2010, ENDOCR-RELAT CANCER, V17, P589, DOI 10.1677/ERC-10-0030; Tharun IM, 2015, ACS CHEM BIOL, V10, P475, DOI 10.1021/cb5007097; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Wang PL, 2016, CLIN CANCER RES, V22, P1130, DOI 10.1158/1078-0432.CCR-15-1534; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Weir HM, 2016, CANCER RES, V76, P3307, DOI 10.1158/0008-5472.CAN-15-2357; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; White R, 1997, EMBO J, V16, P1427, DOI 10.1093/emboj/16.6.1427; Wittmann BM, 2007, CANCER RES, V67, P9549, DOI 10.1158/0008-5472.CAN-07-1590; Yudt MR, 1999, BIOCHEMISTRY-US, V38, P14146, DOI 10.1021/bi9911132; Zhang QX, 1997, CANCER RES, V57, P1244; Zhao CQ, 2003, J BIOL CHEM, V278, P27278, DOI 10.1074/jbc.M303840200	64	94	98	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 20	2017	36	16					2286	2296		10.1038/onc.2016.382	http://dx.doi.org/10.1038/onc.2016.382			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DM	27748765	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000399782700009
J	Song, X; Hao, J; Wang, J; Guo, C; Wang, Y; He, Q; Tang, H; Qin, X; Li, Y; Zhang, Y; Yin, Y				Song, X.; Hao, J.; Wang, J.; Guo, C.; Wang, Y.; He, Q.; Tang, H.; Qin, X.; Li, Y.; Zhang, Y.; Yin, Y.			The cancer/testis antigen MAGEC2 promotes amoeboid invasion of tumor cells by enhancing STAT3 signaling	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; IN-VIVO; MOLECULAR TARGETS; UBIQUITIN LIGASE; MELANOMA-CELLS; BREAST-CANCER; EXPRESSION; ACTIVATION; MOTILITY; DEGRADATION	The biological function of MAGEC2, a cancer/testis antigen highly expressed in various cancers, remains largely unknown. Here we demonstrate that expression of MAGEC2 induces rounded morphology and amoeboid-like movement of tumor cells in vitro and promotes tumor metastasis in vivo. The pro-metastasis effect of MAGEC2 was mediated by signal transducer and activator of transcription 3 (STAT3) activation. Mechanistically, MAGEC2 interacts with STAT3 and inhibits the polyubiquitination and proteasomal degradation of STAT3 in the nucleus of tumor cells, resulting in accumulation of phosphorylated STAT3 and enhanced transcriptional activity. Notably, expression levels of MAGEC2 and phosphorylated STAT3 are positively correlated and both are associated with incidence of metastasis in human hepatocellular carcinoma. This study not only reveals a previously unappreciated role of MAGEC2 in promoting tumor metastasis, but also identifies a new molecular mechanism by which MAGEC2 sustains hyperactivation of STAT3 in the nucleus of tumor cells. Thus, MAGEC2 may represent a new antitumor metastasis target for treatment of cancer.	[Song, X.; Hao, J.; Wang, J.; Guo, C.; Wang, Y.; Tang, H.; Qin, X.; Li, Y.; Zhang, Y.; Yin, Y.] Peking Univ, Sch Basic Med Sci, Dept Immunol, Key Lab Med Immunol,Minist Hlth,Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [He, Q.] Peking Univ, Hlth Sci Ctr, Ctr Med & Hlth Anal, Beijing, Peoples R China	Peking University; Peking University	Zhang, Y; Yin, Y (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Immunol, Key Lab Med Immunol,Minist Hlth,Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	zhangyu007@bjmu.edu.cn; yinyanhui@bjmu.edu.cn	Hao, Jiaqing/F-1266-2017	Hao, Jiaqing/0000-0002-2834-7255; Xiao, Song/0000-0002-3171-4300	National Natural Science Foundation of China [81472645]; Beijing Natural Science Foundation [7142087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	We thank Drs Xinmin Cao (National University of Singapore), Zhijie Chang (Tsinghua University) and Ning Guo (Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences) for providing vectors. This work was supported by grants from National Natural Science Foundation of China (no. 81472645) and Beijing Natural Science Foundation (7142087).	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Ayyoub M, 2014, J IMMUNOTHER, V37, P73, DOI 10.1097/CJI.0000000000000013; Bhatia N, 2013, J INVEST DERMATOL, V133, P759, DOI 10.1038/jid.2012.355; Brantley EC, 2008, CLIN CANCER RES, V14, P4694, DOI 10.1158/1078-0432.CCR-08-0618; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Buettner R, 2002, CLIN CANCER RES, V8, P945; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chomez P, 2001, CANCER RES, V61, P5544; Christoph DC, 2012, BRIT J CANCER, V107, P823, DOI 10.1038/bjc.2012.324; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Curioni-Fontecedro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021418; Devarajan E, 2009, CURR MOL MED, V9, P626, DOI 10.2174/156652409788488720; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Elson-Schwab I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013176; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Hao JQ, 2015, ONCOTARGET, V6, P42028, DOI 10.18632/oncotarget.5973; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Johnston PA, 2011, MOL INTERV, V11, P18, DOI 10.1124/mi.11.1.4; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Li B, 2003, LAB INVEST, V83, P1185, DOI 10.1097/01.LAB.0000080605.73839.96; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Marcar L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127713; Pabst C, 2010, EXP MOL PATHOL, V89, P175, DOI 10.1016/j.yexmp.2010.06.011; Pankova K, 2010, CELL MOL LIFE SCI, V67, P63, DOI 10.1007/s00018-009-0132-1; Parri M, 2009, CANCER RES, V69, P2072, DOI 10.1158/0008-5472.CAN-08-1845; Pineda CT, 2015, CELL, V160, P715, DOI 10.1016/j.cell.2015.01.034; Pinner S, 2008, J MICROSC-OXFORD, V231, P441, DOI 10.1111/j.1365-2818.2008.02056.x; Riener MO, 2009, INT J CANCER, V124, P352, DOI 10.1002/ijc.23966; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Su SF, 2013, J BIOL CHEM, V288, P24809, DOI 10.1074/jbc.M113.468579; Tanaka T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001637; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; von Boehmer L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021366; Wang YM, 2014, MOL CELL, V53, P752, DOI 10.1016/j.molcel.2014.01.020; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Weon JL, 2015, CURR OPIN CELL BIOL, V37, P1, DOI 10.1016/j.ceb.2015.08.002; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yang F, 2014, BREAST CANCER RES TR, V145, P23, DOI 10.1007/s10549-014-2915-9; Yin B, 2014, INT J CLIN EXP PATHO, V7, P2934; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhang Q, 2002, J IMMUNOL, V168, P466, DOI 10.4049/jimmunol.168.1.466; Zhang XD, 2007, P NATL ACAD SCI USA, V104, P4060, DOI 10.1073/pnas.0611665104; Zhuang Ran, 2006, Cancer Immun, V6, P7	56	18	18	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	11					1476	1486		10.1038/onc.2016.314	http://dx.doi.org/10.1038/onc.2016.314			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP5ZR	27775077				2022-12-26	WOS:000397458100003
J	Burgess, JL; Burgess, RA; Morales, Y; Bouvang, JM; Johnson, SJ; Dickenson, NE				Burgess, Jamie L.; Burgess, R. Alan; Morales, Yalemi; Bouvang, Jenna M.; Johnson, Sean J.; Dickenson, Nicholas E.			Structural and Biochemical Characterization of Spa47 Provides Mechanistic Insight into Type III Secretion System ATPase Activation and Shigella Virulence Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYMATIC CHARACTERIZATION; APPARATUS NEEDLE; PROTEIN EXPORT; FLII ATPASE; FLEXNERI; SALMONELLA; OLIGOMERIZATION; INVASION; IPAD; TIP	Like many Gram-negative pathogens, Shigella rely on a complex type III secretion system (T3SS) to inject effector proteins into host cells, take over host functions, and ultimately establish infection. Despite these critical roles, the energetics and regulatory mechanisms controlling the T3SS and pathogen virulence remain largely unclear. In this study, we present a series of high resolution crystal structures of Spa47 and use the structures to model an activated Spa47 oligomer, finding that ATP hydrolysis may be supported by specific side chain contributions from adjacent protomers within the complex. Follow-up mutagenesis experiments targeting the predicted active site residues validate the oligomeric model and determined that each of the tested residues are essential for Spa47 ATPase activity, although they are not directly responsible for stable oligomer formation. Although N-terminal domain truncation was necessary for crystal formation, it resulted in strictly monomeric Spa47 that is unable to hydrolyze ATP, despite maintaining the canonical ATPase core structure and active site residues. Coupled with studies of ATPase inactive full-length Spa47 point mutants, we find that Spa47 oligomerization and ATP hydrolysis are needed for complete T3SS apparatus formation, a proper translocator secretion profile, and Shigella virulence. This work represents the first structure-function characterization of Spa47, uniquely complementing the multitude of included Shigella T3SS phenotype assays and providing a more complete understanding of T3SS ATPase-mediated pathogen virulence. Additionally, these findings provide a strong platform for follow-up studies evaluating regulation of Spa47 oligomerization in vivo as a much needed means of treating and perhaps preventing shigellosis.	[Burgess, Jamie L.; Burgess, R. Alan; Morales, Yalemi; Bouvang, Jenna M.; Johnson, Sean J.; Dickenson, Nicholas E.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Dickenson, NE (corresponding author), Utah State Univ, Dept Chem & Biochem, 0300 Old Main Hill, Logan, UT 84321 USA.	nick.dickenson@usu.edu	Johnson, Sean/G-8191-2012	Johnson, Sean/0000-0001-7992-2494; Morales, Yalemi/0000-0001-9697-099X; Dickenson, Nicholas/0000-0003-1572-6077; Burgess, Robert/0000-0003-4487-0959	National Institutes of Health [1K22AI099086-01A1]; National Science Foundation MRI [1530862]; R. Gaurth Hansen endowment funds; Utah State University; U.S. Dept. of Energy [DE-AC02-76SF00515]; National Institutes of Health NIGMS [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI124108, K22AI099086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation MRI(National Science Foundation (NSF)); R. Gaurth Hansen endowment funds; Utah State University; U.S. Dept. of Energy(United States Department of Energy (DOE)); National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants 1K22AI099086-01A1, National Science Foundation MRI Grant 1530862, and R. Gaurth Hansen endowment funds (to N. E. D.) and by individual Utah State University Undergraduate Research and Creative Opportunity Grants (to J. L. B. and J. M. B.). The crystallographic data were collected at the Stanford Synchrotron Radiation Lightsource (Stanford University), which is supported by U.S. Dept. of Energy Contract DE-AC02-76SF00515 and National Institutes of Health NIGMS Grant P41GM103393. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akeda Y, 2004, J BACTERIOL, V186, P2402, DOI 10.1128/JB.186.8.2402-2412.2004; Allison SE, 2014, J BIOL CHEM, V289, P23734, DOI 10.1074/jbc.M114.578476; Andrade A, 2007, ARCH BIOCHEM BIOPHYS, V468, P121, DOI 10.1016/j.abb.2007.09.020; Ashida H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00219; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Bozue J, 2012, FEMS MICROBIOL LETT, V332, P113, DOI 10.1111/j.1574-6968.2012.02583.x; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Burgess JL, 2016, PROTEIN SCI, V25, P1037, DOI 10.1002/pro.2917; Carayol N, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a016717; Chatterjee S, 2013, BIOCHEMISTRY-US, V52, P2508, DOI 10.1021/bi400160a; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheung M, 2015, MOL MICROBIOL, V95, P31, DOI 10.1111/mmi.12843; Claret L, 2003, MOL MICROBIOL, V48, P1349, DOI 10.1046/j.1365-2958.2003.03506.x; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Dickenson NE, 2012, INT J MOL SCI, V13, P15137, DOI 10.3390/ijms131115137; Dickenson NE, 2011, BIOCHEMISTRY-US, V50, P172, DOI 10.1021/bi101365f; Diepold A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0020; Dutta S, 2003, J CLIN MICROBIOL, V41, P5833, DOI 10.1128/JCM.41.12.5833-5834.2003; EICHELBERG K, 1994, J BACTERIOL, V176, P4501, DOI 10.1128/JB.176.15.4501-4510.1994; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enninga J, 2005, NAT METHODS, V2, P959, DOI 10.1038/NMETH804; Epler CR, 2012, J MOL BIOL, V420, P29, DOI 10.1016/j.jmb.2012.03.025; Epler CR, 2009, INFECT IMMUN, V77, P2754, DOI 10.1128/IAI.00190-09; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Fan F, 1996, J BIOL CHEM, V271, P31981, DOI 10.1074/jbc.271.50.31981; FORMAL SB, 1958, J BACTERIOL, V75, P604, DOI 10.1128/JB.75.5.604-610.1958; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Gonzalez-Pedrajo B, 2002, MOL MICROBIOL, V45, P967, DOI 10.1046/j.1365-2958.2002.03047.x; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hu B, 2015, P NATL ACAD SCI USA, V112, P1047, DOI 10.1073/pnas.1411610112; Imada K, 2007, P NATL ACAD SCI USA, V104, P485, DOI 10.1073/pnas.0608090104; Jouihri N, 2003, MOL MICROBIOL, V49, P755, DOI 10.1046/j.1365-2958.2003.03590.x; Kato J, 2015, J BACTERIOL, V197, P3007, DOI 10.1128/JB.00434-15; Kazetani K, 2009, BIOCHEM BIOPH RES CO, V388, P323, DOI 10.1016/j.bbrc.2009.08.004; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; Komoriya Y, 2012, J BIOL CHEM, V287, P15134, DOI 10.1074/jbc.M111.328153; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Makino F, 2016, SCI REP-UK, V6, DOI 10.1038/srep33341; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MENARD R, 1993, J BACTERIOL, V175, P5899; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino T, 2006, J MOL BIOL, V360, P510, DOI 10.1016/j.jmb.2006.05.010; Minamino T, 2016, MICROBIOLOGYOPEN, V5, P424, DOI 10.1002/mbo3.340; Muller SA, 2006, MOL MICROBIOL, V61, P119, DOI 10.1111/j.1365-2958.2006.05219.x; NIESEL DW, 1985, J CLIN MICROBIOL, V22, P897, DOI 10.1128/JCM.22.6.897-902.1985; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARSOT C, 1995, MOL MICROBIOL, V16, P291, DOI 10.1111/j.1365-2958.1995.tb02301.x; Portaliou AG, 2016, TRENDS BIOCHEM SCI, V41, P175, DOI 10.1016/j.tibs.2015.09.005; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Schroeder GN, 2007, MICROBIOL-SGM, V153, P2862, DOI 10.1099/mic.0.2007/007427-0; Senior AE, 2000, J BIOENERG BIOMEMBR, V32, P523, DOI 10.1023/A:1005625326721; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Shiue SJ, 2006, EMBO J, V25, P1426, DOI 10.1038/sj.emboj.7601036; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stensrud KF, 2008, J BIOL CHEM, V283, P18646, DOI 10.1074/jbc.M802799200; Stone CB, 2008, J BACTERIOL, V190, P6580, DOI 10.1128/JB.00761-08; Venkatesan MM, 2001, INFECT IMMUN, V69, P3271, DOI 10.1128/IAI.69.5.3271-3285.2001; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; WHO,, 2017, DIARRH DIS; WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994; Yoshida Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094347; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196	75	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25837	25852		10.1074/jbc.M116.755256	http://dx.doi.org/10.1074/jbc.M116.755256			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27770024	Green Published, hybrid			2022-12-26	WOS:000390345200008
J	Hashido, T; Saito, S				Hashido, Takashi; Saito, Shigeyoshi			Quantitative T-1, T-2, and T-2 * Mapping and Semi-Quantitative Neuromelanin-Sensitive Magnetic Resonance Imaging of the Human Midbrain	PLOS ONE			English	Article							NORMAL HUMAN HEART; SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; TRANSFER CONTRAST; SPIN-ECHO; SEGMENTAL ARTIFACTS; RELAXATION-TIMES; BRAIN IRON; MRI; SUSCEPTIBILITY	Purpose Neuromelanin is a dark pigment granule present within certain catecholamine neurons of the human brain. Here, we aimed to clarify the relationship between contrast of neuromelanin-sensitive magnetic resonance imaging (MRI) and MR relaxation times using T-1, T-2, and T2 * mapping of the lower midbrain. Methods The subjects were 14 healthy volunteers (11 men and 3 women, mean age 29.9 +/- 6.9 years). Neuromelanin-sensitive MRI was acquired using an optimized T-1-weighted two-dimensional (2D)-turbo spin-echo sequence. To quantitatively evaluate the relaxation time, 2D-image data for the T-1, T-2, and T-2 * maps were also acquired. The regions of interest (substantia nigra pars compacta [SNc], superior cerebellar peduncles [SCP], cerebral peduncles [CP], and midbrain tegmentum [MT]) were manually drawn on neuromelanin-sensitive MRI to measure the contrast ratio (CR) and on relaxation maps to measure the relaxation times. Results The CR in the SNc was significantly higher than the CRs in the SCP and CP. Compared to the SCP and CP, the SNc had significantly higher T1 relaxation times. Moreover, the SNc had significantly lower T-2 and T-2 * relaxation times than the other three regions (SCP, CP, and MT). Correlation analyses showed no significant correlations between the CRs in the SNc, SCP, and CP and each relaxation time. Conclusions We demonstrated the relationship between the CR of neuromelanin-sensitive MRI and the relaxation times of quantitative maps of the human midbrain.	[Hashido, Takashi] Osaka Univ Hosp, Dept Med Technol, Div Radiol, Suita, Osaka, Japan; [Saito, Shigeyoshi] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Med Engn, Suita, Osaka, Japan	Osaka University; Osaka University	Saito, S (corresponding author), Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Med Engn, Suita, Osaka, Japan.	saito@sahs.med.osaka-u.ac.jp			Kakenhi from the Japan Society for the Promotion of Science (JSPS) [24300167, 16K09017]	Kakenhi from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (Kakenhi, No. 24300167 and No.16K09017) from the Japan Society for the Promotion of Science (JSPS).	Akhlaghpoor S, 2012, CLIN NEURORADIOL, V22, P211, DOI 10.1007/s00062-011-0108-z; Alecci M, 2001, MAGN RESON MED, V46, P379, DOI 10.1002/mrm.1201; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bilgic B, 2012, NEUROIMAGE, V59, P2625, DOI 10.1016/j.neuroimage.2011.08.077; Bolding MS, 2013, BIOL PSYCHIAT, V73, P289, DOI 10.1016/j.biopsych.2012.07.035; Bos C, 2005, MAGN RESON MED, V54, P1020, DOI 10.1002/mrm.20635; Chen XC, 2014, MAGN RESON IMAGING, V32, P1301, DOI 10.1016/j.mri.2014.07.003; Clare S, 2001, MAGNET RESON MED, V45, P630, DOI 10.1002/mrm.1085; CONSTABLE RT, 1992, MAGN RESON IMAGING, V10, P497, DOI 10.1016/0730-725X(92)90001-G; Cosottini M, 2015, AM J NEURORADIOL, V36, P461, DOI 10.3174/ajnr.A4158; Dall'Armellina E, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-15; Dawe RJ, 2014, NEUROBIOL AGING, V35, P1549, DOI 10.1016/j.neurobiolaging.2014.01.144; Deoni SCL, 2003, MAGNET RESON MED, V49, P515, DOI 10.1002/mrm.10407; DIXON WT, 1990, MAGN RESON IMAGING, V8, P417, DOI 10.1016/0730-725X(90)90050-C; DRAYER B, 1986, AM J ROENTGENOL, V147, P103, DOI 10.2214/ajr.147.1.103; Du G, 2016, MOVEMENT DISORD, V31, P317, DOI [10.1002/mds.26417, DOI 10.1002/MDS.26417]; Eapen M, 2011, AM J NEURORADIOL, V32, P688, DOI 10.3174/ajnr.A2355; Enochs WS, 1997, RADIOLOGY, V204, P417, DOI 10.1148/radiology.204.2.9240529; FINELLI DA, 1994, RADIOLOGY, V190, P553, DOI 10.1148/radiology.190.2.8284415; GIBB WRG, 1992, BRAIN RES, V581, P283, DOI 10.1016/0006-8993(92)90719-P; GORELL JM, 1995, NEUROLOGY, V45, P1138, DOI 10.1212/WNL.45.6.1138; HAACKE EM, 1989, RADIOLOGY, V170, P457, DOI 10.1148/radiology.170.2.2911669; Haselgrove J, 2000, JMRI-J MAGN RESON IM, V11, P360, DOI 10.1002/(SICI)1522-2586(200004)11:4<360::AID-JMRI3>3.0.CO;2-G; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hui C, 2013, NMR BIOMED, V26, P1420, DOI 10.1002/nbm.2969; Jezzard P, 1996, RADIOLOGY, V199, P773, DOI 10.1148/radiology.199.3.8638004; Kashihara K, 2011, J CLIN NEUROSCI, V18, P1093, DOI 10.1016/j.jocn.2010.08.043; KASTNER A, 1992, J NEUROCHEM, V59, P1080, DOI 10.1111/j.1471-4159.1992.tb08350.x; Kruit MC, 2009, CEPHALALGIA, V29, P351, DOI 10.1111/j.1468-2982.2008.01723.x; Langley J, 2015, NEUROIMAGE, V112, P7, DOI 10.1016/j.neuroimage.2015.02.045; Lehericy S, 2014, MOVEMENT DISORD, V29, P1574, DOI 10.1002/mds.26043; Lehericy S, 2012, MOVEMENT DISORD, V27, P822, DOI 10.1002/mds.25015; Luo ZR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076203; Menke RA, 2010, NEUROIMAGE, V52, P1175, DOI 10.1016/j.neuroimage.2010.05.086; Nakamura K, 2014, NEURAL REGEN RES, V9, P759, DOI 10.4103/1673-5374.131583; Nakane Toshiki, 2008, Magn Reson Med Sci, V7, P205; Nitz WR, 1999, EUR RADIOL, V9, P1032, DOI 10.1007/s003300050789; Ogisu K, 2013, NEURORADIOLOGY, V55, P719, DOI 10.1007/s00234-013-1171-8; Oikawa H, 2002, AM J NEURORADIOL, V23, P1747; Positano V, 2007, NMR BIOMED, V20, P578, DOI 10.1002/nbm.1121; RABEY JM, 1990, J NEURAL TRANSM-PARK, V2, P1, DOI 10.1007/BF02251241; Raman FS, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-64; Ramazzotti A, 2008, HEMOGLOBIN, V32, P97, DOI 10.1080/03630260701879514; Saito S, 2012, J MAGN RESON IMAGING, V36, P1483, DOI 10.1002/jmri.23726; Saito S, 2011, RADIAT RES, V175, P1, DOI 10.1667/RR2134.1; Sasaki M, 2006, NEUROREPORT, V17, P1215, DOI 10.1097/01.wnr.0000227984.84927.a7; Sasaki M, 2010, NEURORADIOLOGY, V52, P83, DOI 10.1007/s00234-009-0595-7; Sasaki M, 2008, NEUROREPORT, V19, P1649, DOI 10.1097/WNR.0b013e328315a637; Shah NJ, 2001, NEUROIMAGE, V14, P1175, DOI 10.1006/nimg.2001.0886; Shibata Eri, 2006, Magn Reson Med Sci, V5, P197, DOI 10.2463/mrms.5.197; Stikov N, 2015, MAGN RESON MED, V73, P514, DOI 10.1002/mrm.25135; Takatsu Y, 2015, ACTA RADIOL, V56, P997, DOI 10.1177/0284185114542367; TANTTU JI, 1992, J COMPUT ASSIST TOMO, V16, P19, DOI 10.1097/00004728-199201000-00004; Wade T, 2014, MAGN RESON MED, V71, P591, DOI 10.1002/mrm.24697; Watanabe A, 2007, J MAGN RESON IMAGING, V26, P109, DOI 10.1002/jmri.20962; Watanabe Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104619; WOLFF SD, 1991, RADIOLOGY, V179, P133, DOI 10.1148/radiology.179.1.2006263; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Zecca L, 2001, J CLIN PATHOL-MOL PA, V54, P414	59	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165160	10.1371/journal.pone.0165160	http://dx.doi.org/10.1371/journal.pone.0165160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768782	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400059
J	Mandlik, V; Patil, S; Bopanna, R; Basu, S; Singh, S				Mandlik, Vineetha; Patil, Sohan; Bopanna, Ramanamurthy; Basu, Sudipta; Singh, Shailza			Biological Activity of Coumarin Derivatives as Anti-Leishmanial Agents	PLOS ONE			English	Article							SESQUITERPENE COUMARINS; ANTIFUNGAL ACTIVITY; MOLECULAR DOCKING; LEISHMANIA-MAJOR; HYBRIDS DESIGN; PROMASTIGOTES; INHIBITION; DEATH	Cutaneous leishmaniasis affects nearly 0.7 to 1.3 million people annually. Treatment of this disease is difficult due to lack of appropriate medication and the growing problem of drug resistance. Natural compounds such as coumarins serve as complementary therapeutic agents in addition to the current treatment modalities. In this study, we have performed an in-silico screening of the coumarin derivatives and their anti-leishmanial properties has been explored both in-vitro and in-vivo. One of the compounds (compound 2) exhibited leishmanicidal activity and to further study its properties, nanoliposomal formulation of the compound was developed. Treatment of cutaneous lesions in BALB/c mice with compound 2 showed significantly reduced lesion size as compared to the untreated mice (p<0.05) suggesting that compound 2 may possess anti-leishmanial properties.	[Mandlik, Vineetha; Bopanna, Ramanamurthy; Singh, Shailza] Natl Ctr Cell Sci, NCCS Complex,SP Pune Univ Campus, Pune, Maharashtra, India; [Patil, Sohan; Basu, Sudipta] IISER, Dept Chem, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Indian Institute of Science Education & Research (IISER) Pune	Singh, S (corresponding author), Natl Ctr Cell Sci, NCCS Complex,SP Pune Univ Campus, Pune, Maharashtra, India.	singhs@nccs.res.in	Mandlik, Vineetha/AAH-7922-2021		Senior Research Fellow of Department of Biotechnology, Government of India; Department of Biotechnology, Government of India [BT/PR6037/GBD/27/372/2012]	Senior Research Fellow of Department of Biotechnology, Government of India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Vineetha Mandlik acknowledges the financial support as Senior Research Fellow of Department of Biotechnology, Government of India; and Shailza Singh received the funding BT/PR6037/GBD/27/372/2012, Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Vineetha Mandlik acknowledges the financial support as Senior Research Fellow of Department of Biotechnology, Government of India; and Shailza Singh received the funding BT/PR6037/GBD/27/372/2012, Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors would like to thank the Central Instrument facility at SP Pune University, Pune for carrying out the SEM imaging. Authors also acknowledge BHPCF(Bioinformatics & High Performance Computing Facility), FAGS and Animal house facilities of NCCS.	[Anonymous], 2014, FIELD BAS QSAR VERS; [Anonymous], ACD CHEMSK VERS 5 12; Bashir S, 2014, PHYTOCHEM LETT, V9, P46, DOI 10.1016/j.phytol.2014.04.009; Bravo JA, 1999, PHYTOCHEMISTRY, V50, P71, DOI 10.1016/S0031-9422(98)00497-X; Brenzan MA, 2008, BIOMED PHARMACOTHER, V62, P651, DOI 10.1016/j.biopha.2008.08.024; Croft SL, 2005, TRENDS PARASITOL, V21, P508, DOI 10.1016/j.pt.2005.08.026; Fournet Alain, 2002, Current Topics in Medicinal Chemistry, V2, P1215, DOI 10.2174/1568026023393011; Haldar A. K., 2011, MOL BIOL INT; Ibrar A, 2016, ARCH PHARM, V349, P553, DOI 10.1002/ardp.201500392; Iranshahi M, 2007, PHYTOCHEMISTRY, V68, P554, DOI 10.1016/j.phytochem.2006.11.002; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kermani EK, 2016, PHARMACOGN RES, V8, P1, DOI 10.4103/0974-8490.178650; Khademvatan S, 2011, KOREAN J PARASITOL, V49, P17, DOI 10.3347/kjp.2011.49.1.17; Lipinski CA, 2012, ADV DRUG DELIVER REV, V64, P4, DOI 10.1016/j.addr.2012.09.019; Mallick A, 2015, ACS APPL MATER INTER, V7, P7584, DOI 10.1021/am5090226; Mishra BB, 2009, FITOTERAPIA, V80, P81, DOI 10.1016/j.fitote.2008.10.009; Mogana R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/903529; Montagner C, 2008, Z NATURFORSCH C, V63, P21; Napolitano HB, 2004, BRAZ J MED BIOL RES, V37, P1847, DOI 10.1590/S0100-879X2004001200010; OketchRabah HA, 1997, J NAT PROD, V60, P458, DOI 10.1021/np970030o; Otero E, 2014, MOLECULES, V19, P13251, DOI 10.3390/molecules190913251; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; PILLER NB, 1978, BRIT J EXP PATHOL, V59, P93; Rasband W, IMAGE J VERSION 1 41; Sangshetti JN, 2016, BIOORG MED CHEM LETT, V26, P829, DOI 10.1016/j.bmcl.2015.12.085; Sardari S, 1999, BIOORGAN MED CHEM, V7, P1933, DOI 10.1016/S0968-0896(99)00138-8; Saudagar P, 2013, EUR J PHARM BIOPHARM, V85, P569, DOI 10.1016/j.ejpb.2013.08.014; Shukla AK, 2012, EUR J MED CHEM, V54, P49, DOI 10.1016/j.ejmech.2012.04.034; Sundar S, 2008, EXPERT OPIN INV DRUG, V17, P787, DOI [10.1517/13543784.17.5.787, 10.1517/13543784.17.5.787 ]; TASWELL C, 1981, J IMMUNOL, V126, P1614; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Yardley V, 1997, ANTIMICROB AGENTS CH, V41, P752, DOI 10.1128/AAC.41.4.752	32	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164585	10.1371/journal.pone.0164585	http://dx.doi.org/10.1371/journal.pone.0164585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768694	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400017
J	Wong, TC; Su, HY; Chen, YT; Wu, PY; Chen, HH; Chen, TH; Hsu, YH; Yang, SH				Wong, Te-Chih; Su, Hsiu-Yueh; Chen, Yu-Tong; Wu, Pei-Yu; Chen, Hsi-Hsien; Chen, Tso-Hsiao; Hsu, Yung-Ho; Yang, Shwu-Huey			Ratio of C-Reactive Protein to Albumin Predicts Muscle Mass in Adult Patients Undergoing Hemodialysis	PLOS ONE			English	Article							LEAN BODY-MASS; PROTEIN/ALBUMIN RATIO; CARDIOVASCULAR-DISEASE; SARCOPENIC OBESITY; INSULIN-RESISTANCE; DIALYSIS PATIENTS; PROGNOSTIC SCORE; INFLAMMATION; SURVIVAL; INDEX	Recent studies have indicated that the ratio of C-reactive protein to albumin (CRP-Alb ratio) is associated with clinical outcomes in patients with disease. We examined the predictive value of this ratio in patients undergoing hemodialysis (HD). In this cross-sectional study, 91 eligible adult HD patients were analyzed, and the correlation between the CRP-Alb ratio and skeletal muscle mass normalized for body weight (SMM/wt; estimated using a bioelectrical impedance analyzer) was investigated. The mean age of the study participants was 54.9 +/- 6.6 years (ranging from 27 to 64 years); 43 (47.2%) were men. The mean values for the SMM/wt were 39.1% +/- 5.4%. The CRP-Alb ratio was found to be negatively correlated with SMM/wt (r = -0.33, P = 0.002) and creatinine (r = -0.20, P = 0.056). All the uni-variate significant and nonsignificant relevant covariates were selected for multivariable stepwise regression analysis. We determined that the homeostasis model assessment-estimated insulin resistance and CRP-Alb ratio were independent risk determinants for SMM/wt (beta(HOMA-IR) = -0.18 and beta(CRP-Alb) ratio = -3.84, adjusted R-2 = 0.32). This study indicated that the CRP-Alb ratio may help clinicians in predicting muscle mass in adult patients undergoing HD.	[Wong, Te-Chih; Chen, Yu-Tong; Wu, Pei-Yu; Yang, Shwu-Huey] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan; [Su, Hsiu-Yueh] Taipei Med Univ Hosp, Dept Dietet, Taipei, Taiwan; [Chen, Hsi-Hsien] Taipei Med Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Chen, Tso-Hsiao] Taipei Med Univ, Wan Fang Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Hsu, Yung-Ho] Taipei Med Univ, Shuang Ho Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Yang, Shwu-Huey] Taipei Med Univ Hosp, Nutr Res Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University Hospital	Yang, SH (corresponding author), Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan.; Yang, SH (corresponding author), Taipei Med Univ Hosp, Nutr Res Ctr, Taipei, Taiwan.	sherry@tmu.edu.tw	Wong, Te-Chih/AAH-7667-2020	Wong, Te-Chih/0000-0002-5798-1060	Ministry of Science and Technology (Taiwan) [NSC-102-2320-B-038-026, MOST 105-2320-B-038-033-MY3]; Taipei Medical University Hospital [98TMU-TMUH-14]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan); Taipei Medical University Hospital	This work was supported by the Ministry of Science and Technology (Taiwan)-Grant Number: NSC-102-2320-B-038-026 & MOST 105-2320-B-038-033-MY3 (https://www.most.gov.tw/en/public): to TCW, YTC, PYW and YHH; Taipei Medical University Hospital-Grant Number: 98TMU-TMUH-14 (http://www.tmuh.org.tw/tmuh_en/index.php): to PYW and SHY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner RN, 1996, AM J CLIN NUTR, V64, P552, DOI 10.1093/ajcn/64.4.552; BIOLO G, 1993, BAILLIERE CLIN ENDOC, V7, P989, DOI 10.1016/S0950-351X(05)80242-3; Carrero JJ, 2010, SEMIN DIALYSIS, V23, P498, DOI 10.1111/j.1525-139X.2010.00784.x; Carrero JJ, 2009, SEMIN DIALYSIS, V22, P381, DOI 10.1111/j.1525-139X.2009.00585.x; Chiu YF, 2014, J RENAL NUTR, V24, P163, DOI 10.1053/j.jrn.2013.12.006; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Fairclough E, 2009, CLIN MED, V9, P30, DOI 10.7861/clinmedicine.9-1-30; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Hwang JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120266; Kakiya R, 2006, KIDNEY INT, V70, P549, DOI 10.1038/sj.ki.5000331; Kaysen GA, 2005, AM J CLIN NUTR, V82, P988, DOI 10.1093/ajcn/82.5.988; Kaysen GA, 2003, AM J KIDNEY DIS, V42, P1200, DOI 10.1053/j.ajkd.2003.08.021; Kim MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132109; Kim TN, 2013, CLIN ENDOCRINOL, V78, P525, DOI 10.1111/j.1365-2265.2012.04433.x; Kinoshita A, 2015, ANN SURG ONCOL, V22, P803, DOI 10.1245/s10434-014-4048-0; Kopple JD, 1997, AM J CLIN NUTR, V65, P1544, DOI 10.1093/ajcn/65.5.1544; Kopple JD, 2001, AM J KIDNEY DIS, V38, pS68, DOI 10.1053/ajkd.2001.27578; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Liao MT, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/691369; Liou Yiing Mei, 2008, J Nurs Res, V16, P252; Liu XC, 2015, TRANSL ONCOL, V8, P339, DOI 10.1016/j.tranon.2015.06.006; Teros MTL, 2015, CLIN NUTR, V34, P931, DOI 10.1016/j.clnu.2014.09.022; Mehrotra R, 2001, ANNU REV NUTR, V21, P343, DOI 10.1146/annurev.nutr.21.1.343; Menon V, 2003, AM J KIDNEY DIS, V42, P44, DOI 10.1016/S0272-6386(03)00407-4; Omae K, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2014.07.004; Pupim LB, 2005, KIDNEY INT, V68, P2368, DOI 10.1111/j.1523-1755.2005.00699.x; Ranzani OT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059321; Schrager MA, 2007, J APPL PHYSIOL, V102, P919, DOI 10.1152/japplphysiol.00627.2006; Shoji T, 2001, NEPHRON, V89, P348, DOI 10.1159/000046098; Shrivastava AK, 2015, EGYPT HEART J, V67, P89, DOI 10.1016/j.ehj.2014.11.005; Thage O., 1970, ACTA NEUROL SCAN S43, V46, P120; Wang JL, 2016, J RENAL NUTR, V26, P26, DOI 10.1053/j.jrn.2015.07.003; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; Wong TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140402; Wu PY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141917; Yamada K, 2008, AM J CLIN NUTR, V87, P106, DOI 10.1093/ajcn/87.1.106; Yang CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132908; Zhou T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10481; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x	39	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165403	10.1371/journal.pone.0165403	http://dx.doi.org/10.1371/journal.pone.0165403			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768746	Green Submitted, Green Published, gold			2022-12-26	WOS:000386205400083
J	Liu, XH; Ye, HH; Zhang, Q; Cai, X; Yu, WJ; Yu, SY; Wang, TY; Lu, WY; Li, X; Zhao, PQ				Liu, Xiaohong; Ye, Hehua; Zhang, Qi; Cai, Xuan; Yu, Wenjing; Yu, Siyi; Wang, Tianyu; Lu, Wuyi; Li, Xiang; Zhao, Peiquan			Association between Myopia, Biometry and Occludable Angle: The Jiangning Eye Study	PLOS ONE			English	Article							ANTERIOR-CHAMBER-DEPTH; OPTICAL COHERENCE TOMOGRAPHY; CLOSURE GLAUCOMA; REFRACTIVE ERROR; LIWAN EYE; PREVALENCE; POPULATION; PARAMETERS; CHINESE; GONIOSCOPY	Background Myopia subjects usually have long axial lengths and are predisposed to deep anterior chamber depths and open angles. Jiangning eye study is a randomized, population based study in Shanghai to determine whether myopia has an effect on the prevalence of occludable angles. Methods A total of 2478 residents aged 50 years and over were randomly selected, and 2044 (82.5%) individuals of them participated in ophthalmic examinations between November 2012 and February 2013. Eye examinations included autorefraction, noncontact tonometry, measurement of axial length, anterior chamber depth, lens thickness and spectral domain optical coherence tomography. Results The crude prevalences of iris trabecular meshwork contact in Jiangning Chinese individuals with myopia, emmetropia, and hyperopia are 1.25%, 6.44%, and 7.43%, respectively. There is also iris trabecular meshwork contact and shallow anterior chamber depth in myopia subjects even with long axial lengths. Conclusions The prevalence of iris trabecular meshwork contact in myopia subjects is lower than their emmetropia or hyperopia counterparts. Axial length is an important factor associate with occludable angle.	[Liu, Xiaohong; Ye, Hehua; Zhang, Qi; Cai, Xuan; Yu, Wenjing; Yu, Siyi; Wang, Tianyu; Lu, Wuyi; Li, Xiang; Zhao, Peiquan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Liu, Xiaohong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Ophthalmol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhao, PQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Ophthalmol, Shanghai, Peoples R China.	peiquanz@126.com		Cai, Xuan/0000-0003-4012-2726	foundation of Shanghai Jiao Tong University Affiliated Sixth People's Hospital [1651]; National Natural Science Foundation Project of China (Beijing, China) [81200682]	foundation of Shanghai Jiao Tong University Affiliated Sixth People's Hospital; National Natural Science Foundation Project of China (Beijing, China)	This work was supported by the foundation of Shanghai Jiao Tong University Affiliated Sixth People's Hospital (No.1651) (http://www.6thhosp.com/List/N), accepted by Xiaohong Liu; and the National Natural Science Foundation Project of China (81200682; Beijing, China) (http://www.nsfc.gov.cn/), accepted by Hehua Ye.; This study was supported by the foundation of Shanghai Jiao Tong University Affiliated Sixth People's Hospital (No.1651) and the National Natural Science Foundation Project of China (81200682; Beijing, China).	Barkana Y, 2006, OPHTHALMOLOGY, V113, P247, DOI 10.1016/j.ophtha.2005.10.006; Bonomi L, 2000, OPHTHALMOLOGY, V107, P998, DOI 10.1016/S0161-6420(00)00022-1; Chakravarti T, 2007, J GLAUCOMA, V16, P642, DOI 10.1097/IJG.0b013e318064c803; Dandona L, 2000, OPHTHALMOLOGY, V107, P1710, DOI 10.1016/S0161-6420(00)00274-8; George R, 2003, BRIT J OPHTHALMOL, V87, P399, DOI 10.1136/bjo.87.4.399; He MG, 2006, INVEST OPHTH VIS SCI, V47, P4772, DOI 10.1167/iovs.06-0309; He MG, 2009, INVEST OPHTH VIS SCI, V50, P5130, DOI 10.1167/iovs.09-3455; Hsieh YT, 2009, AM J OPHTHALMOL, V147, P1108, DOI 10.1016/j.ajo.2009.03.007; Jin GM, 2015, INVEST OPHTH VIS SCI, V56, P5714, DOI 10.1167/iovs.15-16914; Lavanya R, 2008, ARCH OPHTHALMOL-CHIC, V126, P686, DOI 10.1001/archopht.126.5.686; Liang YB, 2013, BRIT J OPHTHALMOL, V97, P765, DOI 10.1136/bjophthalmol-2012-302468; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Nolan WP, 2007, OPHTHALMOLOGY, V114, P33, DOI 10.1016/j.ophtha.2006.05.073; Park SH, 2010, OPHTHALMOLOGICA, V224, P188, DOI 10.1159/000252982; Quek DT, 2012, INVEST OPHTH VIS SCI, V53, P5131, DOI 10.1167/iovs.12-10132; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Sakata LM, 2008, OPHTHALMOLOGY, V115, P769, DOI 10.1016/j.ophtha.2007.06.030; Thapa SS, 2011, OPTOMETRY VISION SCI, V88, P150, DOI 10.1097/OPX.0b013e318205e320; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Ye HH, 2014, INVEST OPHTH VIS SCI, V55, P6374, DOI 10.1167/iovs.14-14899; Yong KL, 2014, OPHTHALMOLOGY, V121, P1566, DOI 10.1016/j.ophtha.2014.02.006	21	2	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165281	10.1371/journal.pone.0165281	http://dx.doi.org/10.1371/journal.pone.0165281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764227	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204500145
J	Rodrigues, HG; Vinolo, MAR; Sato, FT; Magdalon, J; Kuhl, CMC; Yamagata, AS; Pessoa, AFM; Malheiros, G; dos Santos, MF; Lima, C; Farsky, SH; Camara, NOS; Williner, MR; Bernal, CA; Calder, PC; Curi, R				Rodrigues, Hosana G.; Vinolo, Marco A. R.; Sato, Fabio T.; Magdalon, Juliana; Kuhl, Carolina M. C.; Yamagata, Ana S.; Pessoa, Ana Flavia M.; Malheiros, Gabriella; dos Santos, Marinilce F.; Lima, Camila; Farsky, Sandra H.; Camara, Niels O. S.; Williner, Maria R.; Bernal, Claudio A.; Calder, Philip C.; Curi, Rui			Oral Administration of Linoleic Acid Induces New Vessel Formation and Improves Skin Wound Healing in Diabetic Rats	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ENDOTHELIAL GROWTH-FACTOR; UP-REGULATION; ADRENIC ACID; EXPRESSION; ANGIOGENESIS; CELLS; MACROPHAGES; REPAIR; INFLAMMATION	Introduction Impaired wound healing has been widely reported in diabetes. Linoleic acid (LA) accelerates the skin wound healing process in non-diabetic rats. However, LA has not been tested in diabetic animals. Objectives We investigated whether oral administration of pure LA improves wound healing in streptozotocin- induced diabetic rats. Methods Dorsal wounds were induced in streptozotocin-induced type-1 diabetic rats treated or not with LA (0.22 g/kg b.w.) for 10 days. Wound closure was daily assessed for two weeks. Wound tissues were collected at specific time-points and used to measure fatty acid composition, and contents of cytokines, growth factors and eicosanoids. Histological and qPCR analyses were employed to examine the dynamics of cell migration during the healing process. Results LA reduced the wound area 14 days after wound induction. LA also increased the concentrations of cytokine-induced neutrophil chemotaxis (CINC-2 alpha beta), tumor necrosis factor-alpha (TNF-alpha) and leukotriene B-4 (LTB4), and reduced the expression of macrophage chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1 (MIP-1). These results together with the histological analysis, which showed accumulation of leukocytes in the wound early in the healing process, indicate that LA brought forward the inflammatory phase and improved wound healing in diabetic rats. Angiogenesis was induced by LA through elevation in tissue content of key mediators of this process: vascular-endothelial growth factor (VEGF) and angiopoietin-2 (ANGPT-2). Conclusions Oral administration of LA hastened wound closure in diabetic rats by improving the inflammatory phase and angiogenesis.	[Rodrigues, Hosana G.; Kuhl, Carolina M. C.] Univ Estadual Campinas, Sch Appl Sci, Limeira, Brazil; [Rodrigues, Hosana G.; Magdalon, Juliana; Yamagata, Ana S.; Curi, Rui] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Vinolo, Marco A. R.; Sato, Fabio T.] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Campinas, Brazil; [Pessoa, Ana Flavia M.; Malheiros, Gabriella; dos Santos, Marinilce F.] Univ Sao Paulo, Inst Biomed Sci, Cell & Dev Biol Dept, Sao Paulo, Brazil; [Lima, Camila; Farsky, Sandra H.] Univ Sao Paulo, Dept Clin & Toxicol Analyses, Sch Pharmaceut Sci, Sao Paulo, Brazil; [Camara, Niels O. S.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil; [Williner, Maria R.; Bernal, Claudio A.] Natl Univ Litoral, Sch Biochem & Biol Sci, Food Sci & Nutr, Santa Fe, Argentina; [Calder, Philip C.] Univ Southampton, Fac Med, Human Dev & Hlth Acad Unit, Southampton, Hants, England; [Calder, Philip C.] Univ Hosp Southampton NHS Fdn Trust, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Calder, Philip C.] Univ Southampton, Southampton, Hants, England	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; National University of the Littoral; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton	Rodrigues, HG (corresponding author), Univ Estadual Campinas, Sch Appl Sci, Limeira, Brazil.; Rodrigues, HG (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.	hosana.rodrigues@fca.unicamp.br	Camara, Niels OS/G-8336-2011; Magdalon, Juliana/G-8022-2015; Pessoa, Ana Flávia Marçal/ABA-5236-2020; Curi, Rui/AAT-7970-2021; camara, niels olsen saraiva/AAX-3269-2020; Santos, Marinilce F/G-9548-2011; Calder, Philip C/E-9739-2013; Farsky, Sandra HP/C-4044-2012; Sato, Fabio Takeo/AAS-6614-2020; Vinolo, Marco Aurélio R/K-3753-2012	Camara, Niels OS/0000-0001-5436-1248; Pessoa, Ana Flávia Marçal/0000-0003-3979-1607; Curi, Rui/0000-0001-5095-9154; camara, niels olsen saraiva/0000-0001-5436-1248; Santos, Marinilce F/0000-0002-3257-3327; Calder, Philip C/0000-0002-6038-710X; Yamagata, Ana Sayuri/0000-0002-6919-6369; Sato, Fabio Takeo/0000-0002-9863-4364; Rodrigues, Hosana/0000-0002-6122-0379; Vinolo, Marco Aurelio/0000-0003-1335-760X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/10653-9, 2013/06810-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq - 446562/2014-9]; Guggenheim Foundation	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Guggenheim Foundation	This research was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grants 2012/10653-9 and 2013/06810-4, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - 446562/2014-9), and Guggenheim Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altavilla D, 2001, DIABETES, V50, P667, DOI 10.2337/diabetes.50.3.667; Alzoghaibi MA, 2014, ASIAN J SURG, V37, P86, DOI 10.1016/j.asjsur.2013.07.016; Bakker K, 2012, DIABETES-METAB RES, V28, P116, DOI 10.1002/dmrr.2254; Bannon P, 2013, DIS MODEL MECH, V6, P1434, DOI 10.1242/dmm.012237; Beidler SK, 2009, J VASC SURG, V49, P1013, DOI 10.1016/j.jvs.2008.11.049; Acosta JB, 2008, INT WOUND J, V5, P530, DOI 10.1111/j.1742-481X.2008.00457.x; Bodnar RJ, 2015, ADV WOUND CARE, V4, P641, DOI 10.1089/wound.2014.0594; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRASKEN P, 1991, ACTA CHIR-EUR J SURG, P1; CAMPBELL WB, 1985, BIOCHIM BIOPHYS ACTA, V837, P67, DOI 10.1016/0005-2760(85)90086-4; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chin LC, 2011, BRIT J DERMATOL, V165, P1223, DOI 10.1111/j.1365-2133.2011.10599.x; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Costa PZ, 2013, LIFE SCI, V92, P1037, DOI 10.1016/j.lfs.2013.04.001; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Eming SA, 2010, J PROTEOME RES, V9, P4758, DOI 10.1021/pr100456d; Fang IM, 2014, MOL NUTR FOOD RES, V58, P2053, DOI 10.1002/mnfr.201400196; Fang Y, 2010, BRIT J DERMATOL, V162, P478, DOI 10.1111/j.1365-2133.2009.09528.x; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Gabbs M, 2015, ADV NUTR, V6, P513, DOI 10.3945/an.114.007732; Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com; Geng LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059918; Ghebremeskel K, 2004, LIPIDS, V39, P335, DOI 10.1007/s11745-004-1237-z; Harkewicz R, 2007, J BIOL CHEM, V282, P2899, DOI 10.1074/jbc.M610067200; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Huang FT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087897; Huang YS, 2011, MOL CELL BIOCHEM, V358, P85, DOI 10.1007/s11010-011-0924-0; Hutton DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107199; Kato N, 2009, EUR J PHARMACOL, V606, P187, DOI 10.1016/j.ejphar.2009.01.027; Kubo H, 2014, LEGAL MED-TOKYO, V16, P8, DOI 10.1016/j.legalmed.2013.10.002; Lima MHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036974; Liu Yimei, 2014, Zhonghua Yi Xue Za Zhi, V94, P296; Liu YJ, 2016, MOL MED REP, V13, P2101, DOI 10.3892/mmr.2016.4793; Luo XQ, 2016, MOL NUTR FOOD RES, V60, P871, DOI 10.1002/mnfr.201500714; Magdalon J, 2012, LIPIDS, V47, P803, DOI 10.1007/s11745-012-3687-9; Matesanz N, 2012, J NUTR BIOCHEM, V23, P685, DOI 10.1016/j.jnutbio.2011.03.020; Mirza RE, 2014, DIABETES, V63, P1103, DOI 10.2337/db13-0927; Naaldijk Y, 2015, EXP CELL RES, V338, P97, DOI 10.1016/j.yexcr.2015.08.019; Neub A, 2007, J INVEST DERMATOL, V127, P2453, DOI 10.1038/sj.jid.5700864; Nishioka N, 2011, BRIT J CANCER, V105, P1750, DOI 10.1038/bjc.2011.434; Noda K, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/279037; Ouahes N, 1998, DERMATOL SURG, V24, P1354, DOI 10.1111/j.1524-4725.1998.tb00014.x; Paraguassu GM, 2014, PHOTOMED LASER SURG, V32, P1; Qin ZP, 2014, AGE, V36, P353, DOI 10.1007/s11357-013-9565-4; Radziwon-Balicka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059281; Radziwon-Balicka A, 2013, VASC PHARMACOL, V58, P280, DOI 10.1016/j.vph.2012.11.003; Rodrigues HG, 2012, J INVEST DERMATOL, V132, P208, DOI 10.1038/jid.2011.265; Rodrigues HG, 2010, LIPIDS, V45, P809, DOI 10.1007/s11745-010-3461-9; Sain J, 2013, ANN NUTR METAB, V62, P240, DOI 10.1159/000339453; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Schumann T, 2015, ONCOTARGET, V6, P13416, DOI 10.18632/oncotarget.3826; Shook B, 2016, J INVEST DERMATOL, V136, P1885, DOI 10.1016/j.jid.2016.05.107; Spencer L, 2009, EUR J CANCER, V45, P2077, DOI 10.1016/j.ejca.2009.04.026; SPRECHER H, 1982, J BIOL CHEM, V257, P3912; Staton CA, 2010, BRIT J DERMATOL, V163, P920, DOI 10.1111/j.1365-2133.2010.09940.x; Thomas AC, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00479, 10.3389/fimmu.2014.00478]; Vijil C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088546; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Wicks K, 2014, SEMIN IMMUNOL, V26, P341, DOI 10.1016/j.smim.2014.04.006; Xi S, 2000, PROSTAG LEUKOTR ESS, V62, P13, DOI 10.1054/plef.1999.0119	62	29	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165115	10.1371/journal.pone.0165115	http://dx.doi.org/10.1371/journal.pone.0165115			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764229	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000386204500117
J	Chatterjee, S; Sarkar, A; Rao, KD				Chatterjee, Susmita; Sarkar, Anupam; Rao, Krishna D.			Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage - Do Costs Matter?	PLOS ONE			English	Article							MANAGEMENT	Background Postpartum heammorrhage (PPH), defined as blood loss greater than or equal to 500 ml within 24 hours after birth, is the leading cause of maternal deaths globally and in India. Misoprostol is an important option for PPH management in setting where oxytocin (the gold standard for PPH prevention and treatment) in not available or not feasible to use. For the substantial number of deliveries which take place at home or at lower level heatlh facilities in India, misoprostol pills can be adminstered to prevent PPH. The standard approach using misoprostol is to administer it prophylactically as primary prevention (600 mcg). An alternative strategy could be to administer misoprostol only to those who are at high risk of having PPH i.e. as secondary prevention. Methods This study reports on the relative cost per person of a strategy involving primary versus secondary prevention of PPH using misoprostol. It is based on a randomized cluster trial that was conducted in Bijapur district in Karnataka, India between December 2011 and March 2014 among pregnant women to compare two community-level strategies for the prevention of PPH: primary and secondary. The analysis was conducted from the government perspective using an ingredient approach. Results The cluster trial showed that there were no significant differences in clinical outcomes between the two study arms. However, the results of the cost analysis show that there is a difference of INR 6 (US$ 0.1) per birth for implementing the strategies primary versus secondary prevention. In India where 14.9 million births take place at sub-centres and at home, this additional cost of INR 6 per birth translates to an additional cost of INR 94 (US$ 1.6) million to the government to implement the primary prevention compared to the secondary prevention strategy. Conclusion As clinical outcomes did not differ significantly between the two arms in the trial, taking into account the difference in costs and potential issues with sustainability, secondary prevention might be a more strategic option.	[Chatterjee, Susmita; Sarkar, Anupam] Publ Hlth Fdn India, New Delhi, India; [Rao, Krishna D.] Johns Hopkins Univ, Baltimore, MD USA	Public Health Foundation of India; Johns Hopkins University	Chatterjee, S (corresponding author), Publ Hlth Fdn India, New Delhi, India.	susmita.c@phfi.org		Sarkar, Anupam/0000-0001-7445-2155	Gynuity Health Projects, USA; Gynuity Health projects	Gynuity Health Projects, USA; Gynuity Health projects	This work was supported by Gynuity Health Projects, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank Gynuity Health projects for providing funding support of this study. We are thankful to the partner institutes: University of Chicago, Illinois and University of California, San Francisco. We are grateful to KLE University, BLDE University and the ANMs of the sub-centres for their support and co-operation during field data collection.	Bellad MB, 2012, COMPREHENSIVE TXB PO, P275; Bradley SEK, 2007, INT J GYNECOL OBSTET, V97, P52, DOI 10.1016/j.ijgo.2006.12.005; Dabash R, 2012, COMPREHENSIVE TXB PO, P296; Derman RJ, 2006, LANCET, V368, P1248, DOI 10.1016/S0140-6736(06)69522-6; Drummond M.F., 2005, METHODS EC EVALUATIO, V3d, P55; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; Mobeen N, 2011, BJOG-INT J OBSTET GY, V118, P353, DOI 10.1111/j.1471-0528.2010.02807.x; Montgomery AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083331; Prata N, 2006, INT J GYNECOL OBSTET, V94, P149, DOI 10.1016/j.ijgo.2006.05.027; Raghavan S, 2016, BJOG-INT J OBSTET GY, V123, P120, DOI 10.1111/1471-0528.13540; Walker D, 2002, HEALTH POLICY PLANN, V17, P112, DOI 10.1093/heapol/17.1.112; Walraven G, 2005, BJOG-INT J OBSTET GY, V112, P1277, DOI 10.1111/j.1471-0528.2005.00711.x; World Health Organisation (WHO), 2009, WHO GUID MAN POSTP H, V1; World Health Organization WHO, 2012, RECOMMENDATIONS PREV	14	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164718	10.1371/journal.pone.0164718	http://dx.doi.org/10.1371/journal.pone.0164718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755601	Green Submitted, Green Published, gold			2022-12-26	WOS:000386203800029
J	Gordon, CS; Rajagopalan, N; Risseeuw, EP; Surpin, M; Ball, FJ; Barber, CJ; Buhrow, LM; Clark, SM; Page, JE; Todd, CD; Abrams, SR; Loewen, MC				Gordon, Cameron S.; Rajagopalan, Nandhakishore; Risseeuw, Eddy P.; Surpin, Marci; Ball, Fraser J.; Barber, Carla J.; Buhrow, Leann M.; Clark, Shawn M.; Page, Jonathan E.; Todd, Chris D.; Abrams, Suzanne R.; Loewen, Michele C.			Characterization of Triticum aestivum Abscisic Acid Receptors and a Possible Role for These in Mediating Fusairum Head Blight Susceptibility in Wheat	PLOS ONE			English	Article							GENE-EXPRESSION; ABA RECEPTORS; ARABIDOPSIS; RESISTANCE; IDENTIFICATION; DEFENSE; DISEASE; FAMILY; TRANSDUCTION; DISRUPTION	Abscisic acid (ABA) is a well-characterized plant hormone, known to mediate developmental aspects as well as both abiotic and biotic stress responses. Notably, the exogenous application of ABA has recently been shown to increase susceptibility to the fungal pathogen Fusarium graminearum, the causative agent of Fusarium head blight (FHB) in wheat and other cereals. However roles and mechanisms associated with ABA's modulation of pathogen responses remain enigmatic. Here the identification of putative ABA receptors from available genomic databases for Triticum aestivum (bread wheat) and Brachypodium distachyon (a model cereal) are reported. A number of these were cloned for recombinant expression and their functionality as ABA receptors confirmed by in vitro assays against protein phosphatases Type 2Cs. Ligand selectivity profiling of one of the wheat receptors (Ta_PYL2DS_FL) highlighted unique activities compared to Arabidopsis AtPYL5. Mutagenic analysis showed Ta_PYL2DS_FL amino acid D180 as being a critical contributor to this selectivity. Subsequently, a virus induced gene silencing (VIGS) approach was used to knockdown wheat Ta_PYL4AS_A (and similar) in planta, yielding plants with increased early stage resistance to FHB progression and decreased mycotoxin accumulation. Together these results confirm the existence of a family of ABA receptors in wheat and Brachypodium and present insight into factors modulating receptor function at the molecular level. That knockdown of Ta_PYL4AS_A (and similar) leads to early stage FHB resistance highlights novel targets for investigation in the future development of disease resistant crops.	[Gordon, Cameron S.; Loewen, Michele C.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Gordon, Cameron S.; Rajagopalan, Nandhakishore; Risseeuw, Eddy P.; Ball, Fraser J.; Barber, Carla J.; Buhrow, Leann M.; Clark, Shawn M.; Page, Jonathan E.; Abrams, Suzanne R.; Loewen, Michele C.] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada; [Surpin, Marci] Valent BioSci Corp, Libertyville, IL 60048 USA; [Todd, Chris D.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 5E2, Canada; [Abrams, Suzanne R.] Univ Saskatchewan, Dept Chem, Saskatoon, SK S7N 5C9, Canada	University of Saskatchewan; National Research Council Canada; University of Saskatchewan; University of Saskatchewan	Loewen, MC (corresponding author), Univ Saskatchewan, Dept Biochem, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	michele.loewen@nrc.ca		Todd, Christopher/0000-0003-1393-5211	National Research Council of Canada - Wheat Flagship, Canadian Wheat Alliance; Natural Sciences and Engineering Research Council of Canada [261683-2012]; Valent Biosciences Corporation (Libertyville, Illinois, United States of America)	National Research Council of Canada - Wheat Flagship, Canadian Wheat Alliance; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Valent Biosciences Corporation (Libertyville, Illinois, United States of America)	This work was funded by the National Research Council of Canada - Wheat Flagship, as part of the Canadian Wheat Alliance to MCL and JEP and provided support in the form of salaries for authors (MCL, CSG, NR, ER, FJB, CJB, LMB, SMC, JEP) and operating funds and contributed to the decision to publish, but did not have any additional role in the study design, data collection or analysis or preparation of the manuscript. This work was funded by the Natural Sciences and Engineering Research Council of Canada to MCL (grant # 261683-2012), and provided support in the form of salaries for one author (CSG), but did not have any additional role in the study design, data collection or analysis, preparation of the manuscript or decision to publish. This work was also funded by Valent Biosciences Corporation (Libertyville, Illinois, United States of America) who provided salary to MS and contributed to study design, data analysis and decision to publish, but not data collection.	Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Antoni R, 2013, PLANT PHYSIOL, V161, P931, DOI 10.1104/pp.112.208678; Asselbergh B, 2008, MOL PLANT MICROBE IN, V21, P709, DOI 10.1094/MPMI-21-6-0709; Bai G, 2013, PLANT MOL BIOL, V83, P651, DOI 10.1007/s11103-013-0114-4; Benson CL, 2015, PHYTOCHEMISTRY, V113, P96, DOI 10.1016/j.phytochem.2014.03.017; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Blumke A, 2015, MOL PLANT PATHOL, V16, P472, DOI 10.1111/mpp.12203; Boneh U, 2012, PLANT CELL REP, V31, P311, DOI 10.1007/s00299-011-1166-z; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buhrow LM, 2016, PHYTOPATHOLOGY, V106, P986, DOI 10.1094/PHYTO-01-16-0033-R; Buhrow LM, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0112-z; Cao FY, 2011, J PLANT RES, V124, P489, DOI 10.1007/s10265-011-0409-y; Chai YM, 2011, J EXP BOT, V62, P5079, DOI 10.1093/jxb/err207; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dorosh L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003114; Dupeux F, 2011, EMBO J, V30, P4171, DOI 10.1038/emboj.2011.294; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galka MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133033; Geiger D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001346; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Hao Q, 2011, MOL CELL, V42, P662, DOI 10.1016/j.molcel.2011.05.011; He Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095246; International Wheat Genome Sequencing, 2012, SCIENCE, V345; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Kang Z, 1999, PHYSIOL MOL PLANT P, V55, P275, DOI 10.1006/pmpp.1999.0233; Kharenko OA, 2013, J BIOCHEM, V154, P383, DOI 10.1093/jb/mvt067; Kharenko OA, 2011, BIOCHEM J, V437, P117, DOI 10.1042/BJ20101898; Kim H, 2012, J EXP BOT, V63, P1013, DOI 10.1093/jxb/err338; Koga H, 2004, PHYSIOL MOL PLANT P, V65, P3, DOI 10.1016/j.pmpp.2004.11.002; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lackman P, 2011, P NATL ACAD SCI USA, V108, P5891, DOI 10.1073/pnas.1103010108; Li CL, 2011, PLANT SIGNAL BEHAV, V6, P1950, DOI 10.4161/psb.6.12.18024; Li G, 2012, PLANT BIOLOGY, V14, P244, DOI 10.1111/j.1438-8677.2011.00504.x; Lim CW, 2014, PLANT CELL PHYSIOL, V55, P1691, DOI 10.1093/pcp/pcu100; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; McCormick S, 2003, FUSARIUM HEAD BLIGHT OF WHEAT & BARLEY, P165; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Mosquna A, 2011, P NATL ACAD SCI USA, V108, P20838, DOI 10.1073/pnas.1112838108; Nakamura S, 2007, THEOR APPL GENET, V114, P1129, DOI 10.1007/s00122-007-0502-8; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Okamoto M, 2013, P NATL ACAD SCI USA, V110, P12132, DOI 10.1073/pnas.1305919110; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pizzio GA, 2013, PLANT PHYSIOL, V163, P441, DOI 10.1104/pp.113.224162; Plattner RD, 2003, J AOAC INT, V86, P61; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Qi PF, 2016, PHYSIOL MOL PLANT P, V93, P39, DOI 10.1016/j.pmpp.2015.12.004; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Romero P, 2012, J EXP BOT, V63, P4931, DOI 10.1093/jxb/ers168; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 1989, MOLECULAR CLONING A; Sanchez-Vallet A, 2012, PLANT PHYSIOL, V160, P2109, DOI 10.1104/pp.112.200154; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Seiler C, 2014, PLANT PHYSIOL, V164, P1677, DOI 10.1104/pp.113.229062; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Szostkiewicz I, 2010, PLANT J, V61, P25, DOI 10.1111/j.1365-313X.2009.04025.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas CL, 2001, PLANT J, V25, P417, DOI 10.1046/j.1365-313x.2001.00976.x; Tian XJ, 2015, RICE, V8, DOI 10.1186/s12284-015-0061-6; Trusov Y, 2009, PLANT J, V58, P69, DOI 10.1111/j.1365-313X.2008.03755.x; Ulferts S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0409-x; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang YP, 2012, J PLANT PHYSIOL, V169, P1874, DOI 10.1016/j.jplph.2012.07.017; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Yuan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026468; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	72	32	32	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164996	10.1371/journal.pone.0164996	http://dx.doi.org/10.1371/journal.pone.0164996			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755583	Green Published, Green Submitted, gold			2022-12-26	WOS:000386203800046
J	Pornsukarom, S; Thakur, S				Pornsukarom, Suchawan; Thakur, Siddhartha			Assessing the Impact of Manure Application in Commercial Swine Farms on the Transmission of Antimicrobial Resistant Salmonella in the Environment	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI O157H7; ANTIBIOTIC-RESISTANCE; LAND APPLICATION; PRODUCTION SYSTEMS; AGRICULTURAL SOIL; FOOD ANIMALS; GENES ARGS; SURVIVAL; WATER	Land application of swine manure in commercial hog farms is an integral part of their waste management system which recycles the nutrients back to the soil. However, manure application can lead to the dissemination of bacterial pathogens in the environment and pose a serious public health threat. The aim of this study was to determine the dissemination of antimicrobial resistant Salmonella in the environment due to manure application in commercial swine farms in North Carolina (n = 6) and Iowa (n = 7), two leading pork producing states in the US. We collected manure and soil samples twice on day 0 (before and after manure application) from four distinct plots of lands (5 soil samples/plot) located at 20 feet away from each other in the field. Subsequent soil samples were collected again on days 7, 14, 21 from the same plots. A total of 1,300 soil samples (NC = 600; IA = 700) and 130 manure samples (NC = 60; IA = 70) were collected and analyzed in this study. The overall Salmonella prevalence was 13.22% (189/1,430), represented by 10.69% and 38.46% prevalence in soil and manure, respectively. The prevalence in NC (25.45%) was significantly higher than in IA (2.73%) (P< 0.001) and a consistent decrease in Salmonella prevalence was detected from Day 0-Day 21 in all the farms that tested positive. Salmonella serotypes detected in NC were not detected in IA, thereby highlighting serotype association based on manure storage and soil application method used in the two regions. Antimicrobial susceptibility testing was done by the broth microdilution method to a panel of 15 antimicrobial drugs. A high frequency of isolates (58.73%) were multidrug resistant (resistance to three or more class of antimicrobials) and the most frequent resistance was detected against streptomycin (88.36%), sulfisoxazole (67.2%), and tetracycline (57.67%). Genotypic characterization by pulse field gel electrophoresis revealed clonally related Salmonella in both manure and soil at multiple time points in the positive farms. Our study highlights the potential role of swine manure application in the dissemination and persistence of antimicrobial resistant Salmonella in the environment.	[Pornsukarom, Suchawan; Thakur, Siddhartha] North Carolina State Univ, Dept Populat Hlth & Pathobiol, Coll Vet Med, Raleigh, NC 27607 USA	University of North Carolina; North Carolina State University	Thakur, S (corresponding author), North Carolina State Univ, Dept Populat Hlth & Pathobiol, Coll Vet Med, Raleigh, NC 27607 USA.	sthakur@ncsu.edu	Pornsukarom, Suchawan/AAT-4280-2021	Pornsukarom, Suchawan/0000-0002-8449-4188; Thakur, Siddhartha/0000-0003-3787-9939	National Pork Board grant (NPB) [556678]; College of Veterinary Medicine, NC State University	National Pork Board grant (NPB); College of Veterinary Medicine, NC State University	This work was funded by a National Pork Board grant (NPB project number 556678), URL: http://www.pork.org/; and College of Veterinary Medicine, NC State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abley M, 2013, SAF 2013 P, P76; [Anonymous], 1998, ASAE STAND, P49085; Antunes P, 2011, J ANTIMICROB CHEMOTH, V66, P2028, DOI 10.1093/jac/dkr228; Baloda SB, 2001, APPL ENVIRON MICROB, V67, P2859, DOI 10.1128/AEM.67.6.2859-2862.2001; Barker J. C., 1985, Agricultural waste utilization and management. Proceedings of the 5th International Symposium on Agricultural Wastes, 16-17 December 1985, Chicago, Illinois, USA., P575; Barton MD, 2014, CURR OPIN MICROBIOL, V19, P9, DOI 10.1016/j.mib.2014.05.017; Bech TB, 2010, APPL ENVIRON MICROB, V76, P710, DOI 10.1128/AEM.00615-09; Boes J, 2005, PREV VET MED, V69, P213, DOI 10.1016/j.prevetmed.2005.02.007; Bolton DJ, 2013, INT J FOOD MICROBIOL, V160, P298, DOI 10.1016/j.ijfoodmicro.2012.11.001; Boonmar S, 2013, J GLOB ANTIMICROB RE, V1, P157, DOI 10.1016/j.jgar.2013.05.001; Brooks JP, 2009, J ENVIRON QUAL, V38, P2431, DOI 10.2134/jeq2008.0471; Centers for Disease Control and Prevention (CDC), 2013, NAT SALM SURV ANN RE; Centers for Disease Control and Prevention (CDC), 2004, STAND MOL SUBT FOODB, P1180, DOI [10.2134/jeq2005.0449, DOI 10.2134/JEQ2005.0449]; Chee-Sanford JC, 2009, J ENVIRON QUAL, V38, P1086, DOI 10.2134/jeq2008.0128; CLSI, 2013, M02A10 CLSI; Cole D, 2003, APPL ENVIRON MICROB, V69, P6507, DOI 10.1128/AEM.69.11.6507-6514.2003; Department of Agriculture (US), 2008, SWIN 2006 3; Dorn-In S, 2009, PREV VET MED, V88, P15, DOI 10.1016/j.prevetmed.2008.06.022; Erickson MC, 2014, J FOOD PROTECT, V77, P1512, DOI 10.4315/0362-028X.JFP-14-111; Flynn D., 2010, SALMONELLA RISSEN CA; Gebreyes WA, 2006, J FOOD PROTECT, V69, P743, DOI 10.4315/0362-028X-69.4.743; Haley BJ, 2009, APPL ENVIRON MICROB, V75, P1248, DOI 10.1128/AEM.01648-08; Hatfield J.L., 1998, AGR USES MUNICIPAL A, P78; He LY, 2016, ENVIRON INT, V92-93, P210, DOI 10.1016/j.envint.2016.03.023; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Higa J, 2011, UN INT INV M PRES Q; Holley R, 2008, J ENVIRON QUAL, V37, P2083, DOI 10.2134/jeq2007.0304; Holley RA, 2006, J ENVIRON QUAL, V35, P1170, DOI 10.2134/jeq2005.0449; Hutchison ML, 2004, APPL ENVIRON MICROB, V70, P5111, DOI 10.1128/AEM.70.9.5111-5118.2004; Islam M, 2004, APPL ENVIRON MICROB, V70, P2497, DOI 10.1128/AEM.70.4.2497-2502.2004; Jacobsen CS, 2012, FOOD RES INT, V45, P557, DOI 10.1016/j.foodres.2011.07.026; Jensen LS, 2013, ANIMAL MANURE RECYCLING: TREATMENT AND MANAGEMENT, P295; Jindal A, 2006, APPL ENVIRON MICROB, V72, P7813, DOI 10.1128/AEM.01087-06; Jokinen CC, 2010, J WATER HEALTH, V8, P374, DOI 10.2166/wh.2009.076; Joy SR, 2013, ENVIRON SCI TECHNOL, V47, P12081, DOI 10.1021/es4026358; Keelara S, 2013, APPL ENVIRON MICROB, V79, P5167, DOI 10.1128/AEM.01419-13; Kuo HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095772; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Millner P, 2014, WASTE MANAGE, V34, P1992, DOI 10.1016/j.wasman.2014.07.021; Minnesota Department of Agriculture, 1995, METH TIM MAN APPL; Minnesota Pollution Control Agency, 2012, MAN APPL RAT GUID, V1, P1; Moynihan EL, 2015, APPL SOIL ECOL, V89, P76, DOI 10.1016/j.apsoil.2015.01.011; National Antimicrobial Resistance Monitoring System (NARMS), 2009, EX REP; Nyberg KA, 2014, J SCI FOOD AGR, V94, P2541, DOI 10.1002/jsfa.6593; Oliveira SD, 2002, VET MICROBIOL, V87, P25, DOI 10.1016/S0378-1135(02)00028-7; Oliver MA, 2015, EUR J SOIL SCI, V66, P257, DOI 10.1111/ejss.12216; Ongeng D, 2011, J APPL MICROBIOL, V110, P1007, DOI 10.1111/j.1365-2672.2011.04956.x; Petersen SO, 2007, LIVEST SCI, V112, P180, DOI 10.1016/j.livsci.2007.09.001; Pornsukarom S, 2015, ZOONOSES PUBLIC HLTH, V62, P151, DOI 10.1111/zph.12144; Reid JH, 2015, United States patent, Patent No. [US 9,005,442, 9005442]; Sui QW, 2016, ENVIRON POLLUT, V213, P751, DOI 10.1016/j.envpol.2016.03.038; Tadee P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116581; Tamang MD, 2015, VET MICROBIOL, V178, P119, DOI 10.1016/j.vetmic.2015.05.005; Tang XJ, 2015, SOIL BIOL BIOCHEM, V90, P179, DOI 10.1016/j.soilbio.2015.07.027; Thakur S, 2007, VET MICROBIOL, V125, P362, DOI 10.1016/j.vetmic.2007.05.025; THOMASON BM, 1977, APPL ENVIRON MICROB, V34, P270, DOI 10.1128/AEM.34.3.270-273.1977; Tomer MD, 2010, J ENVIRON QUAL, V39, P882, DOI 10.2134/jeq2009.0289; United States Environmental Protection Agency, 2013, LIT REV CONT LIV POU; US EPA, 2007, CENS AGR; USDA, 2008, FY 2005 ANN REP MAN, V206; Van Huffel K, 2016, AGR ECOSYST ENVIRON, V218, P209, DOI 10.1016/j.agee.2015.11.020; Webb J, 2010, AGR ECOSYST ENVIRON, V137, P39, DOI 10.1016/j.agee.2010.01.001; You YW, 2006, APPL ENVIRON MICROB, V72, P5777, DOI 10.1128/AEM.00791-06	63	25	26	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164621	10.1371/journal.pone.0164621	http://dx.doi.org/10.1371/journal.pone.0164621			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755598	gold, Green Submitted, Green Published			2022-12-26	WOS:000386203800024
J	Schlossberg, S; Chase, MJ; Griffin, CR				Schlossberg, Scott; Chase, Michael J.; Griffin, Curtice R.			Testing the Accuracy of Aerial Surveys for Large Mammals: An Experiment with African Savanna Elephants (Loxodonta africana)	PLOS ONE			English	Article							IMPERFECT DETECTION; CAPTURE EXPERIMENTS; POPULATION; COUNTS; BIAS; CONSERVATION; PROBABILITY; INDEXES; TRENDS; SIZE	Accurate counts of animals are critical for prioritizing conservation efforts. Past research, however, suggests that observers on aerial surveys may fail to detect all individuals of the target species present in the survey area. Such errors could bias population estimates low and confound trend estimation. We used two approaches to assess the accuracy of aerial surveys for African savanna elephants (Loxodonta africana) in northern Botswana. First, we used double-observer sampling, in which two observers make observations on the same herds, to estimate detectability of elephants and determine what variables affect it. Second, we compared total counts, a complete survey of the entire study area, against sample counts, in which only a portion of the study area is sampled. Total counts are often considered a complete census, so comparing total counts against sample counts can help to determine if sample counts are underestimating elephant numbers. We estimated that observers detected only 76% +/- SE of 2% of elephant herds and 87 +/- 1% of individual elephants present in survey strips. Detectability increased strongly with elephant herd size. Out of the four observers used in total, one observer had a lower detection probability than the other three, and detectability was higher in the rear row of seats than the front. The habitat immediately adjacent to animals also affected detectability, with detection more likely in more open habitats. Total counts were not statistically distinguishable from sample counts. Because, however, the double-observer samples revealed that observers missed 13% of elephants, we conclude that total counts may be undercounting elephants as well. These results suggest that elephant population estimates from both sample and total counts are biased low. Because factors such as observer and habitat affected detectability of elephants, comparisons of elephant populations across time or space may be confounded. We encourage survey teams to incorporate detectability analysis in all aerial surveys for mammals.	[Schlossberg, Scott; Chase, Michael J.] Elephants Borders, Kasane, Botswana; [Griffin, Curtice R.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Schlossberg, S (corresponding author), Elephants Borders, POB 682, Kasane, Botswana.	xanthocephalus@gmail.com			Paul G. Allen as part of Great Elephant Census	Paul G. Allen as part of Great Elephant Census	The study was funded by Paul G. Allen as part of the Great Elephant Census. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archaux F, 2012, METHODS ECOL EVOL, V3, P188, DOI 10.1111/j.2041-210X.2011.00142.x; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Banks-Leite C, 2014, J APPL ECOL, V51, P849, DOI 10.1111/1365-2664.12272; BAYLISS P, 1989, J APPL ECOL, V26, P925, DOI 10.2307/2403702; Blanc Julian J., 2007, AFRICAN ELEPHANT STA; Buckland S. T., 2001, INTRODUCTION TO DIST; Burnham K. P., 2002, MODEL SELECTION AND; CAUGHLEY G, 1974, J WILDLIFE MANAGE, V38, P921, DOI 10.2307/3800067; CAUGHLEY G, 1976, J WILDLIFE MANAGE, V40, P290, DOI 10.2307/3800428; Chandler RB, 2009, AUK, V126, P186, DOI 10.1525/auk.2009.08083; Chase MJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2354; Chase MJ, 2007, HOME RANGES TRANSBOU; Cochran WG., 1963, SAMPLING TECHNIQUES; COOK RD, 1979, BIOMETRICS, V35, P735, DOI 10.2307/2530104; Craig G.C., 2012, AERIAL SURVEY STANDA; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; CRETE M, 1986, J APPL ECOL, V23, P751, DOI 10.2307/2403931; Foguekem D, 2010, AFR J ENVIRON SCI TE, V4, DOI [10.4314/ajest.v4i6.56378, DOI 10.4314/AJEST.V4I6.56378]; Frederick H., 2010, AERIAL PROCEDURES MA; Friess DA, 2011, ENVIRON CONSERV, V38, P1, DOI 10.1017/S0376892911000026; GRAHAM A, 1989, J WILDLIFE MANAGE, V53, P1009, DOI 10.2307/3809603; Guldemond R, 2008, J WILDLIFE MANAGE, V72, P892, DOI 10.2193/2007-072; Halterman MD., 2015, NATURAL HIST SUMMARY; HENDERSON D.C., 2009, OCCUPANCY SURVEY GUI; Hochachka WM, 2008, J ORNITHOL, V149, P375, DOI 10.1007/s10336-008-0282-1; Hoffmann M, 2011, PHILOS T R SOC B, V366, P2598, DOI 10.1098/rstb.2011.0116; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Jachmann H, 2002, J APPL ECOL, V39, P841, DOI 10.1046/j.1365-2664.2002.00752.x; Jachmann H., 2001, ESTIMATING ABUNDANCE, DOI 10.1007/978-1-4615-1381-0; Johnson DH, 2008, J WILDLIFE MANAGE, V72, P857, DOI 10.2193/2007-294; JOLLY G M, 1969, East African Agricultural and Forestry Journal, V34, P46; Kalies EL, 2012, ECOL APPL, V22, P204, DOI 10.1890/11-0758.1; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Koneff MD, 2008, J WILDLIFE MANAGE, V72, P1641, DOI 10.2193/2008-036; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; MAGNUSSON WE, 1978, J WILDLIFE MANAGE, V42, P174, DOI 10.2307/3800708; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; McConville A. J., 2009, Endangered Species Research, V6, P231, DOI 10.3354/esr00166; Newson SE, 2013, BIRD STUDY, V60, P384, DOI 10.1080/00063657.2013.805729; Norton-Griffiths M., 1978, COUNTING ANIMALS; Poole Joyce, 1996, P1; Ransom JI, 2012, J WILDLIFE MANAGE, V76, P299, DOI 10.1002/jwmg.204; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2009, BIOMETRICS, V65, P267, DOI 10.1111/j.1541-0420.2008.01038.x; Smith MJ, 2012, REC W AUST MUS, V40, P44; Tenan S, 2013, ECOL MODEL, V267, P39, DOI 10.1016/j.ecolmodel.2013.07.015; Tracey JP, 2005, WILDLIFE RES, V32, P245, DOI 10.1071/WR03126; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White GC, 2002, J APPL STAT, V29, P103, DOI 10.1080/02664760120108476; Whitehouse AM, 2001, AFR J ECOL, V39, P140, DOI 10.1046/j.1365-2028.2000.00285.x; Williams B., 2002, ANALYSIS AND MANAGEM	54	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164904	10.1371/journal.pone.0164904	http://dx.doi.org/10.1371/journal.pone.0164904			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755570	Green Published, gold, Green Submitted			2022-12-26	WOS:000386203800040
J	Wang, G; Pierangeli, SS; Willis, R; Gonzalez, EB; Petri, M; Khan, MF				Wang, Gangduo; Pierangeli, Silvia S.; Willis, Rohan; Gonzalez, Emilio B.; Petri, Michelle; Khan, M. Firoze			Significance of Lipid-Derived Reactive Aldehyde-Specific Immune Complexes in Systemic Lupus Erythematosus	PLOS ONE			English	Article							TRICHLOROETHENE-MEDIATED AUTOIMMUNITY; OXIDATIVE STRESS; DISEASE-ACTIVITY; PROTEIN ADDUCTS; TH17 CELLS; ANTIOXIDANT ENZYMES; T-CELLS; PEROXIDATION; CONTRIBUTE; DNA	Even though systemic lupus erythematosus (SLE) is associated with high morbidity and mortality rates among young and middle-aged women, the molecular mechanisms of disease pathogenesis are not fully understood. Previous studies from our laboratory suggested an association between oxidative stress and SLE disease activity (SLEDAI). To further assess the role of reactive oxygen species (ROS) in SLE, we examined the contribution of lipid-derived reactive aldehydes (LDRAs)-specific immune complexes in SLE. Sera from 60 SLE patients with varying SLEDAI and 32 age- and gender- matched healthy controls were analyzed for oxidative stress and related markers. Patients were divided into two groups based on their SLEDAI scores (<6 and >= 6). Both SLEDAI groups showed higher serum 4-hydroxynonenal (HNE)-/malondialdehyde (MDA)-protein adducts and their specific immune complexes (HNE-/MDA-specific ICs) together with IL-17 than the controls, but the levels were significantly greater in the high SLEDAI (>= 6) group. Moreover, the serum levels of anti-oxidant enzymes Cu/Zn superoxide dismutase (SOD) and catalase (CAT) were significantly reduced in both patient groups compared to controls. Remarkably, for the first time, our data show that increased HNE-/MDA-specific ICs are positively associated with SLEDAI and elevated circulating immune complexes (CICs), suggesting a possible causal relationship among oxidative stress, LDRA-specific ICs and the development of SLE. Our findings, apart from providing firm support to an association between oxidative stress and SLE, also suggest that these oxidative stress markers, especially the HNE-/ MDA-specific ICs, may be useful in evaluating the prognosis of SLE as well as in elucidating the mechanisms of disease pathogenesis.	[Wang, Gangduo; Khan, M. Firoze] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Pierangeli, Silvia S.; Willis, Rohan; Gonzalez, Emilio B.] Univ Texas Med Branch, Dept Internal Med, Div Rheumatol, Galveston, TX 77555 USA; [Petri, Michelle] Johns Hopkins Univ, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21205 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Johns Hopkins University	Khan, MF (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	mfkhan@utmb.edu			National Institute of Environmental Health Sciences (NIEHS), National Institute of Health (NIH), USA [ES016302]; NIH, USA [AR43727]	National Institute of Environmental Health Sciences (NIEHS), National Institute of Health (NIH), USA; NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Grant ES016302 (to Dr. Khan) from the National Institute of Environmental Health Sciences (NIEHS), National Institute of Health (NIH), USA and the Hopkins Lupus Cohort is supported by NIH AR43727 (to Dr. Petri), USA. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Akagawa M, 2006, P NATL ACAD SCI USA, V103, P6160, DOI 10.1073/pnas.0600865103; Al-Shobaili HA, 2013, IMMUNOL INVEST, V42, P191, DOI 10.3109/08820139.2012.751396; Alzolibani AA, 2013, CELL IMMUNOL, V284, P154, DOI 10.1016/j.cellimm.2013.07.011; Bagavant H, 2009, CURR OPIN RHEUMATOL, V21, P489, DOI 10.1097/BOR.0b013e32832efff1; Barrera G, 2015, ANTIOXID REDOX SIGN, V22, P1681, DOI 10.1089/ars.2014.6166; Chiaroni-Clarke RC, 2016, J AUTOIMMUN, V69, P12, DOI 10.1016/j.jaut.2016.02.011; Frostegard J, 2005, ARTHRITIS RHEUM-US, V52, P192, DOI 10.1002/art.20780; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Grune T, 1997, FREE RADICAL BIO MED, V23, P357, DOI 10.1016/S0891-5849(96)00586-2; Han L, 2015, FRONT MED-PRC, V9, P10, DOI 10.1007/s11684-015-0388-9; Hassan SZ, 2011, INT J RHEUM DIS, V14, P325, DOI 10.1111/j.1756-185X.2011.01630.x; Hayter SM, 2012, AUTOIMMUN REV, V11, P754, DOI 10.1016/j.autrev.2012.02.001; Khan MF, 2002, TOXICOLOGY, V173, P193; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kurien BT, 2008, AUTOIMMUN REV, V7, P567, DOI 10.1016/j.autrev.2008.04.019; Kurien BT, 2011, FREE RADICAL BIO MED, V50, P1222, DOI 10.1016/j.freeradbiomed.2010.10.687; Lai ZW, 2012, ARTHRITIS RHEUM-US, V64, P2937, DOI 10.1002/art.34502; Lee HT, 2014, CLIN EXP IMMUNOL, V176, P66, DOI 10.1111/cei.12256; Lopez-Pedrera C, 2016, RHEUMATOLOGY OXFORD; Nalbandian A, 2009, CLIN EXP IMMUNOL, V157, P209, DOI 10.1111/j.1365-2249.2009.03944.x; Nangaku Masaomi, 2005, Clin Exp Nephrol, V9, P183, DOI 10.1007/s10157-005-0357-8; Papp K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044824; Perl A, 2013, NAT REV RHEUMATOL, V9, P674, DOI 10.1038/nrrheum.2013.147; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Schmidt T, 2015, ARTHRITIS RHEUMATOL, V67, P475, DOI 10.1002/art.38955; Shin MS, 2011, CURR OPIN RHEUMATOL, V23, P444, DOI 10.1097/BOR.0b013e328349a255; Skaggs BJ, 2012, NAT REV RHEUMATOL, V8, P214, DOI 10.1038/nrrheum.2012.14; Talaat RM, 2015, CYTOKINE, V72, P146, DOI 10.1016/j.cyto.2014.12.027; Tewthanom K, 2008, J PHARM PHARM SCI, V11, P30, DOI 10.18433/J3C885; Toyoda K, 2007, J BIOL CHEM, V282, P25769, DOI 10.1074/jbc.M703039200; Wang GD, 2008, FREE RADICAL BIO MED, V44, P1475, DOI 10.1016/j.freeradbiomed.2008.01.012; Wang GD, 2013, TOXICOL APPL PHARM, V273, P189, DOI 10.1016/j.taap.2013.08.020; Wang GD, 2012, FREE RADICAL RES, V46, P1472, DOI 10.3109/10715762.2012.727209; Wang GD, 2012, TOXICOLOGY, V292, P113, DOI 10.1016/j.tox.2011.12.001; Wang GD, 2010, ARTHRITIS RHEUM-US, V62, P2064, DOI 10.1002/art.27442; Wuttge DM, 1999, IMMUNOLOGY, V98, P273; Zaieni SH, 2015, LUPUS, V24, P1400, DOI 10.1177/0961203315593170	38	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164739	10.1371/journal.pone.0164739	http://dx.doi.org/10.1371/journal.pone.0164739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749917	Green Submitted, Green Published, gold			2022-12-26	WOS:000386202300026
J	Zhang, YN; Wang, YJ; Zuo, QS; Wang, XY; Li, D; Tang, BB; Li, BC				Zhang, Yani; Wang, Yingjie; Zuo, Qisheng; Wang, Xiaoyan; Li, Dong; Tang, Beibei; Li, Bichun			Selection of the Inducer for the Differentiation of Chicken Embryonic Stem Cells into Male Germ Cells In Vitro	PLOS ONE			English	Article							TRANS-RETINOIC ACID; MEIOTIC INITIATION; EXPRESSION; GENES; MICE	Several inducers have been used to differentiate embryonic stem cells (ESCs) into male germ cells but the induction process has been inefficient. To solve the problem of low efficiency of inducer for ESCs differentiation into male germ cells, all-trans retinoic acid (ATRA), Am80(the retinoic acid receptor agonist), and estradiol (E2) was used to induce ESCs to differentiate into male germ cells in vitro. ESCs were cultured in media containing ATRA, Am80, or E2 respectively which can differentiate ESCs into a germ cell lineage. In process of ATRA and Am80 induction Group, germ cell-like cells can be observed in 10 days; but have no in E2 induction Group. The marker genes of germ cell: Dazl, Stra8, C-kit, Cvh, integrin alpha 6, and integrin beta 1 all showed a significant up-regulation in the expression level. The ATRA-induction group showed high expression of C-kit and Cvh around 4 days, and integrin alpha 6 and integrin beta 1 were activated on day 10, respectively, while the E2-, Am80-induction group showed a high expression of C-kit as early as 4 days immunocytochemistry results shown that, integrin alpha 6 and integrin beta 1 could be detected in the ATRA-, Am80-, and E2-induction group, Positive clones in the ATRA group were greater in number than those in the other two groups. we conclued that ATRA, Am80, and E2 can promote the expression of the corresponding genes of germ cells, and had different effect on the differentiation of ESCs into male germ cells. ATRA was the most effective inducer of germ cell differentiation.	[Zhang, Yani; Wang, Yingjie; Zuo, Qisheng; Wang, Xiaoyan; Li, Dong; Tang, Beibei; Li, Bichun] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China; [Zhang, Yani; Wang, Yingjie; Zuo, Qisheng; Wang, Xiaoyan; Li, Dong; Tang, Beibei; Li, Bichun] Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou 225009, Jiangsu, Peoples R China	Yangzhou University	Li, BC (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China.; Li, BC (corresponding author), Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou 225009, Jiangsu, Peoples R China.	yubcli@yzu.edu.cn			National Natural Science Foundation of China [31301959, 31272429, 31472087]; Specialized Research Fund for the Doctoral Program of Higher Education [20123250120009]; China Postdoctoral Science Foundation [2012M511326, 2014T70550]; Natural Science Foundation of Jiangsu Province [BK20161331]; science and technology projects fund of Yangzhou City [YZ2015105]; Priority Academic Program Development of Jiangsu Higher Education Institutions [2011-137]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); science and technology projects fund of Yangzhou City; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (31301959, 31272429,31472087), the Specialized Research Fund for the Doctoral Program of Higher Education (20123250120009), the China Postdoctoral Science Foundation (2012M511326, 2014T70550), the Natural Science Foundation of Jiangsu Province (BK20161331), the science and technology projects fund of Yangzhou City (YZ2015105) and the Priority Academic Program Development of Jiangsu Higher Education Institutions 2011-137 Dr. Yani Zhang.	[Anonymous], 2012, STUDY MALE GERM CELL; Brunstrom B, 2009, GEN COMP ENDOCR, V163, P97, DOI 10.1016/j.ygcen.2009.01.006; Ding WJ, 2013, STUDY EFFECT MECH RE; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Guo X, 2012, CELL BIOL INT, V36, P491, DOI 10.1042/CBI20110423; Jie M N, 2004, ZOOLOGICAL RES, V25, P4; Khillan JS, 2014, NUTRIENTS, V6, P1209, DOI 10.3390/nu6031209; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Mi M L, 2007, ACTA ACAD MED JIANGX, V47, P45; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Pan SH, 2010, STUDY EMBRONIC STEM; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Shi QQ, 2014, ANIM REPROD SCI, V147, P74, DOI 10.1016/j.anireprosci.2014.04.002; Shi QQ, 2013, ACTA VET ZOOTECHNICA, V44, P9; Silva C, 2009, MOL REPROD DEV, V76, P11, DOI 10.1002/mrd.20925; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Tan H, 2016, THERIOGENOLOGY, V85, P408, DOI 10.1016/j.theriogenology.2015.09.002; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Zhang L, 2015, INT J MOL SCI, V16, P6595, DOI 10.3390/ijms16036595; Zhang XH, 2009, MOL MECH AM80 REDUCE	22	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164664	10.1371/journal.pone.0164664	http://dx.doi.org/10.1371/journal.pone.0164664			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741318	Green Submitted, Green Published, gold			2022-12-26	WOS:000385507000054
J	Hwang, EY; Jeong, MS; Park, SK; Ha, SC; Yu, HS; Jang, SB				Hwang, Eun Young; Jeong, Mi Suk; Park, Sang Kyun; Ha, Sung Chul; Yu, Hak Sun; Jang, Se Bok			Structural Basis for Carbohydrate Recognition and Anti-inflammatory Modulation by Gastrointestinal Nematode Parasite Toxascaris leonina Galectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate; crystal structure; enzyme mutation; galectin; inflammation	T-CELL DEATH; MOLECULAR REPLACEMENT; PROTEIN AGGREGATION; DISEASE; DOMAINS; OLIGOSACCHARIDE; EXPRESSION; SEARCH; ACID	Toxascaris leonina galectin (Tl-gal) is a galectin-9 homologue protein isolated from an adult worm of the canine gastrointestinal nematode parasite, and Tl-gal-vaccinated challenge can inhibit inflammation in inflammatory bowel disease-induced mice. We determined the first X-ray structures of full-length Tl-gal complexes with carbohydrates (lactose, N-acetyllactosamine, lacto-N-tetraose, sialyllactose, and glucose). Bonds were formed on concave surfaces of both carbohydrate recognition domains (CRDs) in Tl-gal. All binding sites were found in the HXXXR and WGXEER motifs. Charged Arg(61)/Arg(196) and Glu(80)/Glu(215) on the conserved motif of Tl-gal N-terminal CRD and C-terminal CRD are critical amino acids for recognizing carbohydrate binding, and the residues can affect protein folding and structure. The polar amino acids His, Asn, and Trp are also important residues for the interaction with carbohydrates through hydrogen bonding. Hemagglutination activities of Tl-gal were inhibited by interactions with carbohydrates and mutations. We found that the mutation of Tl-gal (E80A/E215A) at the carbohydrate binding region induced protein aggregation and could be caused in many diseases. The short linker region between the N-terminal and C-terminal CRDs of Tl-gal was very stable against proteolysis and maintained its biological activity. This structural information is expected to elucidate the carbohydrate recognition mechanism of Tl-gal and improve our understanding of anti-inflammatory mediators and modulators of immune response.	[Hwang, Eun Young; Jeong, Mi Suk; Jang, Se Bok] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, 2,Busandaehak Ro 63beon Gil, Busan 46241, South Korea; [Ha, Sung Chul] Pohang Univ Sci & Technol, Pohang Accelerator Lab, 80,Jigok Ro 127 Beon Gil, Pohang Si 37673, Gyeongsangbuk D, South Korea; [Park, Sang Kyun; Yu, Hak Sun] Pusan Natl Univ, Sch Med, Dept Parasitol, 49 Busandaehak Ro, Yangsan Si 50612, Gyeongsangnam D, South Korea	Pusan National University; Pohang University of Science & Technology (POSTECH); Pusan National University	Jang, SB (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, 2,Busandaehak Ro 63beon Gil, Busan 46241, South Korea.	sbjang@pusan.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2015R1D1A1A01059594, 2016R1D1A1B02011142]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology	We thank Dr. Sung Chul Ha at the Pohang Light Source (PLS-7A), Republic of Korea, for assistance with the X-ray diffraction experiments. This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology, Grants 2015R1D1A1A01059594 (to S. B. J.) and 2016R1D1A1B02011142 (to J. M. S.).	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Bi S, 2008, J BIOL CHEM, V283, P12248, DOI 10.1074/jbc.M800523200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chabot S, 2002, GLYCOBIOLOGY, V12, P111, DOI 10.1093/glycob/12.2.111; Collins PM, 2014, J MOL BIOL, V426, P1439, DOI 10.1016/j.jmb.2013.12.004; De Felice FG, 2004, FASEB J, V18, P1099, DOI 10.1096/fj.03-1072fje; Heusschen R, 2013, BBA-REV CANCER, V1836, P177, DOI 10.1016/j.bbcan.2013.04.006; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Iglesias MM, 1998, EUR J BIOCHEM, V252, P400, DOI 10.1046/j.1432-1327.1998.2520400.x; Jeong MS, 2013, ACTA CRYSTALLOGR D, V69, P168, DOI 10.1107/S0907444912045106; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim JY, 2010, MOL BIOCHEM PARASIT, V174, P53, DOI 10.1016/j.molbiopara.2010.06.014; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Lee KH, 2008, VET PARASITOL, V156, P216, DOI 10.1016/j.vetpar.2008.06.016; Li YR, 2011, MOL IMMUNOL, V48, P670, DOI 10.1016/j.molimm.2010.11.011; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Matsushita N, 2000, J BIOL CHEM, V275, P8355, DOI 10.1074/jbc.275.12.8355; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reddy A, 2007, PARASITOL RES, V100, P921, DOI 10.1007/s00436-006-0416-4; Sato M, 2002, GLYCOBIOLOGY, V12, P191, DOI 10.1093/glycob/12.3.191; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thijssen VL, 2014, GLYCOBIOLOGY, V24, P915, DOI 10.1093/glycob/cwu048; Tureci O, 1997, J BIOL CHEM, V272, P6416, DOI 10.1074/jbc.272.10.6416; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wang J, 2007, VET PARASITOL, V148, P247, DOI 10.1016/j.vetpar.2007.06.024; Wiersma VR, 2013, MED RES REV, V33, pE102, DOI 10.1002/med.20249; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yoshida H, 2010, J BIOL CHEM, V285, P36969, DOI 10.1074/jbc.M110.163402	31	16	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25326	25338		10.1074/jbc.M116.743773	http://dx.doi.org/10.1074/jbc.M116.743773			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27742836	Green Published, hybrid			2022-12-26	WOS:000390095300005
J	Ramachandran, S; Osterhaus, SR; Parekh, KR; Jacobi, AM; Behlke, MA; McCray, PB				Ramachandran, Shyam; Osterhaus, Samantha R.; Parekh, Kalpaj R.; Jacobi, Ashley M.; Behlke, Mark A.; McCray, Paul B., Jr.			SYVN1, NEDD8, and FBXO2 Proteins Regulate F508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitin-mediated Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis; E3 ubiquitin ligase; endoplasmic-reticulum-associated protein degradation (ERAD); proteostasis; ubiquitylation (ubiquitination); airway epithelia; neddylation	SMALL-MOLECULE CORRECTORS; ENDOPLASMIC-RETICULUM; NEDD8-ACTIVATING ENZYME; CHLORIDE CHANNEL; QUALITY-CONTROL; PHARMACOLOGICAL CORRECTORS; CHEMICAL-MODIFICATION; AIRWAY EPITHELIA; GENETIC-ANALYSIS; CL-CONDUCTANCE	We previously reported that delivery of a microRNA-138 mimic or siRNA against SIN3A to cultured cystic fibrosis (F508/F508) airway epithelia partially restored F508-cystic fibrosis transmembrane conductance regulator (CFTR)-mediated cAMP-stimulated Cl- conductance. We hypothesized that dissecting this microRNA-138/SIN3A-regulated gene network would identify individual proteins contributing to the rescue of F508-CFTR function. Among the genes in the network, we rigorously validated candidates using functional CFTR maturation and electrolyte transport assays in polarized airway epithelia. We found that depletion of the ubiquitin ligase SYVN1, the ubiquitin/proteasome system regulator NEDD8, or the F-box protein FBXO2 partially restored F508-CFTR-mediated Cl- transport in primary cultures of human cystic fibrosis airway epithelia. Moreover, knockdown of SYVN1, NEDD8, or FBXO2 in combination with corrector compound 18 further potentiated rescue of F508-CFTR-mediated Cl- conductance. This study provides new knowledge of the CFTR biosynthetic pathway. It suggests that SYVN1 and FBXO2 represent two distinct multiprotein complexes that may degrade F508-CFTR in airway epithelia and identifies a new role for NEDD8 in regulating F508-CFTR ubiquitination.	[Ramachandran, Shyam; Osterhaus, Samantha R.; Parekh, Kalpaj R.; McCray, Paul B., Jr.] Univ Iowa, Pappajohn Biomed Inst, Dept Pediat, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Jacobi, Ashley M.; Behlke, Mark A.] Integrated DNA Technol, Coralville, IA 52241 USA	University of Iowa	McCray, PB (corresponding author), Univ Iowa, Dept Pediat, Carver Coll Med, 169 Newton Rd,6320 PBDB, Iowa City, IA 52242 USA.	paul-mccray@uiowa.edu	Parekh, Kalpaj/E-4966-2012	Parekh, Kalpaj/0000-0001-6869-5441; McCray, Paul/0000-0002-4067-577X; Behlke, Mark/0000-0002-4218-857X	National Institutes of Health [P01 HL091842, P30 DK54759]; Cystic Fibrosis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091842, P01HL051670, R21HL104337, R01HL118000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Rob Piper, Chris Adams, Lynda Ostedgaard, Patrick Sinn, Colleen Stein, and Carolyn Yrigollen for critical comments on the manuscript. We also thank Philip Karp, Sarah Ernst, Lynda Ostedgaard, and Christine Wohlford-Lenane for technical assistance. We also acknowledge the support of the In Vitro Models and Cell Culture Core, which is partly supported by National Institutes of Health Grants P01 HL091842 and P30 DK54759 and the Cystic Fibrosis Foundation.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; Ballar P, 2010, INT J BIOCHEM CELL B, V42, P167, DOI 10.1016/j.biocel.2009.10.005; Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Bulatov E, 2015, BIOCHEM J, V467, P365, DOI 10.1042/BJ20141450; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Collingwood MA, 2008, OLIGONUCLEOTIDES, V18, P187, DOI 10.1089/oli.2008.0123; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Esposito Speranza, 2016, Mol Cell Pediatr, V3, P13, DOI 10.1186/s40348-016-0040-z; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gnann A, 2004, MOL BIOL CELL, V15, P4125, DOI 10.1091/mbc.e04-01-0024; Godbersen JC, 2014, CLIN CANCER RES, V20, P1576, DOI 10.1158/1078-0432.CCR-13-0987; Gomes-Alves P, 2009, J PROTEOMICS, V73, P218, DOI 10.1016/j.jprot.2009.09.001; Grainger CI, 2006, PHARM RES, V23, P1482, DOI 10.1007/s11095-006-0255-0; HAWS C, 1994, AM J PHYSIOL, V266, pL502, DOI 10.1152/ajplung.1994.266.5.L502; Holleran JP, 2012, MOL MED, V18, P685, DOI 10.2119/molmed.2012.00001; Huang XD, 2016, CELL RES, V26, P484, DOI 10.1038/cr.2016.31; Hussain M, 2016, PHARMACOL RES, V111, P34, DOI 10.1016/j.phrs.2016.05.027; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Itani OA, 2011, P NATL ACAD SCI USA, V108, P10260, DOI 10.1073/pnas.1106695108; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; KUNZELMANN K, 1993, AM J RESP CELL MOL, V8, P522, DOI 10.1165/ajrcmb/8.5.522; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Nawrocki ST, 2012, EXPERT OPIN INV DRUG, V21, P1563, DOI 10.1517/13543784.2012.707192; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pesce E, 2016, J CYST FIBROS, V15, P425, DOI 10.1016/j.jcf.2016.02.009; Ramachandran S, 2013, AM J PHYSIOL-LUNG C, V305, pL23, DOI 10.1152/ajplung.00426.2012; Ramachandran S, 2012, P NATL ACAD SCI USA, V109, P13362, DOI 10.1073/pnas.1210906109; Ramachandran S, 2011, METHODS MOL BIOL, V742, P193, DOI 10.1007/978-1-61779-120-8_12; Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732; Roth DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001998; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Sondo E, 2011, AM J PHYSIOL-CELL PH, V301, pC872, DOI 10.1152/ajpcell.00507.2010; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Tsui Lap-Chee, 1992, Human Mutation, V1, P197, DOI 10.1002/humu.1380010304; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang DL, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00176; Zhang T, 2015, MOL BIOL CELL, V26, P4438, DOI 10.1091/mbc.E15-06-0354	66	23	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25489	25504		10.1074/jbc.M116.754283	http://dx.doi.org/10.1074/jbc.M116.754283			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27756846	hybrid, Green Published			2022-12-26	WOS:000390095300018
J	Mondelli, M; Farioli, A; Mattioli, S; Aretini, A; Ginanneschi, F; Greco, G; Curti, S				Mondelli, Mauro; Farioli, Andrea; Mattioli, Stefano; Aretini, Alessandro; Ginanneschi, Federica; Greco, Giuseppe; Curti, Stefania			Severity of Carpal Tunnel Syndrome and Diagnostic Accuracy of Hand and Body Anthropometric Measures	PLOS ONE			English	Article							CLINICAL-PREDICTION RULE; INDEPENDENT RISK-FACTORS; MASS INDEX; PROVOCATIVE TESTS; MEDIAN NERVE; WRIST RATIO; OBESITY; GENDER; AGE; CLASSIFICATION	Objective To study the diagnostic properties of hand/wrist and body measures according to validated clinical and electrophysiological carpal tunnel syndrome (CTS) severity scales. Methods We performed a prospective case-control study. For each case, two controls were enrolled. Two five-stage clinical and electrophysiological scales were used to evaluate CTS severity. Anthropometric measurements were collected and obesity indicators and hand/wrist ratios were calculated. Area under the receiver operating characteristic curves (AUC), sensitivity, specificity, and likelihood ratios were calculated separately by gender. Results We consecutively enrolled 370 cases and 747 controls. The wrist-palm ratio, waist-hip height ratio and waist-stature ratio showed the highest proportion of cases with abnormal values in the severe stages of CTS for clinical and electrophysiological severity scales in both genders. Accuracy tended to increase with CTS severity for females and males. In severe stage, most of the indexes presented moderate accuracy in both genders. Among subjects with severe CTS, the wrist-palm ratio presented the highest AUC for hand measures in the clinical and electrophysiological severity scales both in females (AUC 0.83 and 0.76, respectively) and males (AUC 0.91 and 0.82, respectively). Among subjects with severe CTS, the waist-stature ratio showed the highest AUC for body measures in the clinical and electrophysiological severity scales both in females (AUC 0.78 and 0.77, respectively) and males (AUC 0.84 and 0.76, respectively). The results of waist-hip-height ratio AUC were similar. Conclusions Wrist-palm ratio, waist-hip-height ratio and waist-stature ratio could contribute to support the diagnostic hypothesis of severe CTS that however has to be confirmed by nerve conduction study.	[Mondelli, Mauro; Aretini, Alessandro] EMG Serv, Local Hlth Unit 7, Siena, Italy; [Farioli, Andrea; Mattioli, Stefano; Curti, Stefania] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy; [Ginanneschi, Federica] Univ Siena, Dept Med Surg & Neurosci, Siena, Italy; [Greco, Giuseppe] Nottola Hosp, Local Hlth Unit 7, EMG Serv, Siena, Italy	University of Bologna; University of Siena	Mondelli, M (corresponding author), EMG Serv, Local Hlth Unit 7, Siena, Italy.	mauro.mondelli@uslsudest.toscana.it	Farioli, Andrea/K-9256-2016; Curti, Stefania/K-6407-2018	Farioli, Andrea/0000-0003-2001-2140; Curti, Stefania/0000-0003-4343-8873; Mattioli, Stefano/0000-0002-9639-7430				ALTROCCHI PH, 1993, NEUROLOGY, V43, P2406; Becker J, 2002, CLIN NEUROPHYSIOL, V113, P1429, DOI 10.1016/S1388-2457(02)00201-8; Bland JDP, 2005, MUSCLE NERVE, V32, P527, DOI 10.1002/mus.20408; Boz C, 2004, CLIN NEUROL NEUROSUR, V106, P294, DOI 10.1016/j.clineuro.2004.01.002; Burt S, 2013, OCCUP ENVIRON MED, V70, P568, DOI 10.1136/oemed-2012-101287; Chiotis K, 2013, ARCH PHYS MED REHAB, V94, P737, DOI 10.1016/j.apmr.2012.11.017; Chroni E, 2001, MUSCLE NERVE, V24, P1607, DOI 10.1002/mus.1195; D'Arcy CA, 2000, JAMA-J AM MED ASSOC, V283, P3110, DOI 10.1001/jama.283.23.3110; DEKROM MCTFM, 1990, LANCET, V335, P393, DOI 10.1016/0140-6736(90)90218-T; DEKROM MCTFM, 1990, AM J EPIDEMIOL, V132, P1102, DOI 10.1093/oxfordjournals.aje.a115753; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Farmer JE, 2008, J HAND SURG-EUR VOL, V33E, P445, DOI 10.1177/1753193408090142; Giannini F, 2002, CLIN NEUROPHYSIOL, V113, P71, DOI 10.1016/S1388-2457(01)00704-0; Harris-Adamson C, 2013, OCCUP ENVIRON MED, V70, P529, DOI 10.1136/oemed-2013-101365; JOHNSON EW, 1983, ARCH PHYS MED REHAB, V64, P556; Kamolz LP, 2004, J HAND SURG-BRIT EUR, V29B, P321, DOI 10.1016/j.jhsb.2003.09.010; Kouyoumdjian JA, 2000, ARQ NEURO-PSIQUIAT, V58, P625, DOI 10.1590/S0004-282X2000000400005; Kouyoumdjian JA, 2002, MUSCLE NERVE, V25, P93, DOI 10.1002/mus.10007; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Kurt S, 2008, EUR NEUROL, V59, P253, DOI 10.1159/000115639; Lim PG, 2008, J HAND SURG-EUR VOL, V33E, P645, DOI 10.1177/1753193408093326; MacDermid Joy C, 2004, J Hand Ther, V17, P309, DOI 10.1197/j.jht.2004.02.015; Mattioli S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-343; Moghtaderi A, 2005, ACTA NEUROL SCAND, V112, P375, DOI 10.1111/j.1600-0404.2005.00528.x; Mondelli M, 2001, CLIN NEUROL NEUROSUR, V103, P178, DOI 10.1016/S0303-8467(01)00140-8; Mondelli M, 2016, ARCH PHYS MED REHAB, V97, P1456, DOI 10.1016/j.apmr.2016.03.028; Mondelli M, 2015, ARTHRIT CARE RES, V67, P691, DOI 10.1002/acr.22465; Mondelli M, 2014, J NEUROL SCI, V338, P207, DOI 10.1016/j.jns.2014.01.012; NATHAN PA, 1992, J OCCUP ENVIRON MED, V34, P379; Padua L, 1997, ACTA NEUROL SCAND, V96, P211; RADECKI P, 1994, AM J PHYS MED REHAB, V73, P157, DOI 10.1097/00002060-199406000-00003; Rempel D, 1998, AM J PUBLIC HEALTH, V88, P1447, DOI 10.2105/AJPH.88.10.1447; Sharifi-Mollayousefi A., 2008, Folia Morphologica, V67, P36; Shiri R, 2015, OBES REV, V16, P1094, DOI 10.1111/obr.12324; Shiri R, 2015, MUSCLE NERVE, V52, P709, DOI 10.1002/mus.24761; Snoeker BAM, 2015, BRIT J GEN PRACT, V65, pE523, DOI 10.3399/bjgp15X686089; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM-US, V56, P433, DOI 10.1002/art.22380; Violante FS, 2007, J OCCUP ENVIRON MED, V49, P1189, DOI 10.1097/JOM.0b013e3181594873; Wainner RS, 2005, ARCH PHYS MED REHAB, V86, P609, DOI 10.1016/j.apmr.2004.11.008; WERNER RA, 1994, MUSCLE NERVE, V17, P632, DOI 10.1002/mus.880170610; World Health Organization, WAIST CIRC WAIST HIP	42	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164715	10.1371/journal.pone.0164715	http://dx.doi.org/10.1371/journal.pone.0164715			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768728	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400025
J	Gao, X; Deng, X; Wen, X; She, Y; Vinke, PC; Chen, H				Gao, Xiao; Deng, Xiao; Wen, Xin; She, Ying; Vinke, Petra Corianne; Chen, Hong			My Body Looks Like That Girl's: Body Mass Index Modulates Brain Activity during Body Image Self-Reflection among Young Women	PLOS ONE			English	Article							ANOREXIA-NERVOSA; BULIMIA-NERVOSA; EATING-DISORDERS; FUNCTIONAL NEUROANATOMY; DIETARY RESTRAINT; OWN BODY; FMRI; EMOTION; DISTORTION; CORTEX	Body image distress or body dissatisfaction is one of the most common consequences of obesity and overweight. We investigated the neural bases of body image processing in overweight and average weight young women to understand whether brain regions that were previously found to be involved in processing self-reflective, perspective and affective components of body image would show different activation between two groups. Thirteen overweight (O-W group, age = 20.31 +/- 1.70 years) and thirteen average weight (A-W group, age = 20.15 +/- 1.62 years) young women underwent functional magnetic resonance imaging while performing a body image self-reflection task. Among both groups, whole-brain analysis revealed activations of a brain network related to perceptive and affective components of body image processing. ROI analysis showed a main effect of group in ACC as well as a group by condition interaction within bilateral EBA, bilateral FBA, right IPL, bilateral DLPFC, left amygdala and left MPFC. For the A-W group, simple effect analysis revealed stronger activations in Thin-Control compared to Fat-Control condition within regions related to perceptive (including bilateral EBA, bilateral FBA, right IPL) and affective components of body image processing (including bilateral DLPFC, left amygdala), as well as self-reference (left MPFC). The O-W group only showed stronger activations in Fat-Control than in Thin-Control condition within regions related to the perceptive component of body image processing (including left EBA and left FBA). Path analysis showed that in the Fat-Thin contrast, body dissatisfaction completely mediated the group difference in brain response in left amygdala across the whole sample. Our data are the first to demonstrate differences in brain response to body pictures between average weight and overweight young females involved in a body image self-reflection task. These results provide insights for understanding the vulnerability to body image distress among overweight or obese young females.	[Gao, Xiao; Wen, Xin; She, Ying; Chen, Hong] Southwest Univ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Gao, Xiao; Wen, Xin; She, Ying; Chen, Hong] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Deng, Xiao] Chongqing Med Univ, Stomatol Hosp, Chongqing, Peoples R China; [Deng, Xiao] Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China; [Deng, Xiao] Chongqing Municipal Key Lab Oral Biomed Engn High, Chongqing, Peoples R China; [Vinke, Petra Corianne] Univ Groningen, Groningen Inst Evolutionary Life Sci, Dept Behav Neurosci, Groningen, Netherlands	Southwest University - China; Southwest University - China; Chongqing Medical University; University of Groningen	Gao, X (corresponding author), Southwest Univ, Key Lab Cognit & Personal, Chongqing, Peoples R China.; Gao, X (corresponding author), Southwest Univ, Fac Psychol, Chongqing, Peoples R China.	gaoxiaox@swu.edu.cn	Vinke, Petra/ABB-4330-2020		Chinese National Natural Science Foundation [31100758, 31170981]; Central Universities Fundamental Research Funds [SWU1409116]; Chongqing Health Bureau Foundation [2012-2-135]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Central Universities Fundamental Research Funds; Chongqing Health Bureau Foundation	This work was supported by: 1. Chinese National Natural Science Foundation (#31100758) to Xiao Gao, www.nsfc.gov.cn; 2. Central Universities Fundamental Research Funds (#SWU1409116) to Xiao Gao, www.swu.edu.cn; 3. Chongqing Health Bureau Foundation (#2012-2-135) to Xiao Deng, www.cqqjrk.gov.cn; and 4. Chinese National Natural Science Foundation (#31170981) to Hong Chen, www.nsfc.gov.cn.	Allison DB, 1992, PSYCHOL ASSESSMENT, V4, P391, DOI DOI 10.1037/1040-3590.4.3.391; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cash TF, 1997, INT J EAT DISORDER, V22, P107, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;107::AID-EAT1&gt;3.0.CO;2-J; Chen H, 2008, EUR EAT DISORD REV, V16, P375, DOI 10.1002/erv.837; Chen H, 2007, PERCEPT MOTOR SKILL, V105, P677, DOI 10.2466/PMS.105.2.677-680; Chen H, 2007, BEHAV RES THER, V45, P1345, DOI 10.1016/j.brat.2006.09.015; Chen Hong, 2006, Body Image, V3, P401, DOI 10.1016/j.bodyim.2006.07.005; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fitzsimmons-Craft EE, 2011, CLIN PSYCHOL REV, V31, P1224, DOI 10.1016/j.cpr.2011.07.011; Fossati P, 2003, AM J PSYCHIAT, V160, P1938, DOI 10.1176/appi.ajp.160.11.1938; Friederich HC, 2007, NEUROIMAGE, V37, P674, DOI 10.1016/j.neuroimage.2007.05.039; Friederich HC, 2010, NEUROPSYCHOLOGIA, V48, P2878, DOI 10.1016/j.neuropsychologia.2010.04.036; FRIEDMAN MA, 1995, PSYCHOL BULL, V117, P3, DOI 10.1037/0033-2909.117.1.3; Gaudio S, 2012, NEUROSCI BIOBEHAV R, V36, P1839, DOI 10.1016/j.neubiorev.2012.05.003; Gavin AR, 2010, J PSYCHOSOM RES, V69, P573, DOI 10.1016/j.jpsychores.2010.05.001; Goldin PR, 2009, BIOL PSYCHIAT, V66, P1091, DOI 10.1016/j.biopsych.2009.07.014; Heatherton TF, 2006, SOC COGN AFFECT NEUR, V1, P18, DOI 10.1093/scan/nsl001; Hodzic A, 2009, NEUROIMAGE, V45, P1264, DOI 10.1016/j.neuroimage.2009.01.027; Kurosaki M, 2006, BIOL PSYCHIAT, V59, P380, DOI 10.1016/j.biopsych.2005.06.039; Lemogne C, 2009, SOC COGN AFFECT NEUR, V4, P305, DOI 10.1093/scan/nsp008; Makara-Studzinska M, 2009, PSYCHIATR POL, V43, P109; Miyake Y, 2010, PSYCHIAT RES-NEUROIM, V181, P183, DOI 10.1016/j.pscychresns.2009.09.001; Miyake Y, 2010, NEUROIMAGE, V50, P1333, DOI 10.1016/j.neuroimage.2009.12.095; Mohr HM, 2011, NEUROIMAGE, V56, P1822, DOI 10.1016/j.neuroimage.2011.02.069; Mustillo SA, 2012, J HEALTH SOC BEHAV, V53, P2, DOI 10.1177/0022146511419205; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Owens TE, 2010, PERS INDIV DIFFER, V48, P849, DOI 10.1016/j.paid.2010.02.012; Paquette MC, 2004, SOC SCI MED, V59, P1047, DOI 10.1016/j.socscimed.2003.12.016; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pringle A, 2011, NEUROPSYCHOLOGIA, V49, P3272, DOI 10.1016/j.neuropsychologia.2011.07.032; Sachdev P, 2008, NEUROPSYCHOLOGIA, V46, P2161, DOI 10.1016/j.neuropsychologia.2008.02.031; Schwartz Marlene B, 2004, Body Image, V1, P43, DOI 10.1016/S1740-1445(03)00007-X; Seeger G, 2002, NEUROSCI LETT, V326, P25, DOI 10.1016/S0304-3940(02)00312-9; Smith RC, 1972, STUDY STATE TRAIT AN; Spangler DL, 2012, INT J EAT DISORDER, V45, P17, DOI 10.1002/eat.20899; Stice E, 2003, INT J EAT DISORDER, V34, P108, DOI 10.1002/eat.10171; Stice E, 1998, J SOC CLIN PSYCHOL, V17, P129, DOI 10.1521/jscp.1998.17.2.129; Stice E, 1998, BEHAV RES THER, V36, P931, DOI 10.1016/S0005-7967(98)00074-6; Strahan Erin J, 2006, Body Image, V3, P211, DOI 10.1016/j.bodyim.2006.07.004; Thompson J. K., 1991, BEHAV THERAPIST, V14, DOI DOI 10.1107/S0108768190010898; Uher R, 2005, BIOL PSYCHIAT, V58, P990, DOI 10.1016/j.biopsych.2005.06.001; van den Berg P, 2002, J PSYCHOSOM RES, V53, P1007, DOI 10.1016/S0022-3999(02)00499-3; van Strien T, 2006, PSYCHOL ASSESSMENT, V18, P89, DOI 10.1037/1040-3590.18.1.89; Van Strien T., 2005, NEDERLANDSE VRAGENLI; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; VITOUSEK KB, 1990, COGNITIVE THER RES, V14, P191, DOI 10.1007/BF01176209; Vocks S, 2011, PSYCHOL MED, V41, P1651, DOI 10.1017/S0033291710002382; Vocks S, 2010, COGN AFFECT BEHAV NE, V10, P422, DOI 10.3758/CABN.10.3.422; Vocks S, 2010, PSYCHIAT RES-NEUROIM, V183, P114, DOI 10.1016/j.pscychresns.2010.05.011; Vocks S, 2010, J PSYCHIATR NEUROSCI, V35, P163, DOI 10.1503/jpn.090048; Wagner A, 2003, NEUROREPORT, V14, P2193, DOI 10.1097/00001756-200312020-00012; Williamson DA, 2004, BEHAV MODIF, V28, P711, DOI 10.1177/0145445503259853; Yang J, 2014, SOC COGN AFFECT NEUR, V9, P1814, DOI 10.1093/scan/nst181; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	60	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164450	10.1371/journal.pone.0164450	http://dx.doi.org/10.1371/journal.pone.0164450			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9NZ	27764116	Green Published, gold			2022-12-26	WOS:000386204500034
J	Kabanywanyi, AM; Baiden, R; Ali, AM; Mahende, MK; Ogutu, BR; Oduro, A; Tinto, H; Gyapong, M; Sie, A; Sevene, E; Macete, E; Owusu-Agyei, S; Adjei, A; Compaore, G; Valea, I; Osei, I; Yawson, A; Adjuik, M; Akparibo, R; Kakolwa, MA; Abdulla, S; Binka, F				Kabanywanyi, Abdunoor M.; Baiden, Rita; Ali, Ali M.; Mahende, Muhidin K.; Ogutu, Bernhards R.; Oduro, Abraham; Tinto, Halidou; Gyapong, Margaret; Sie, Ali; Sevene, Esperanca; Macete, Eusebio; Owusu-Agyei, Seth; Adjei, Alex; Compaore, Guillaume; Valea, Innocent; Osei, Isaac; Yawson, Abena; Adjuik, Martin; Akparibo, Raymond; Kakolwa, Mwaka A.; Abdulla, Salim; Binka, Fred			Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with Electrocardiograms	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; PIPERAQUINE; EFFICACY; TRIAL	The antimalarial drug piperaquine is associated with delayed ventricular depolarization, causing prolonged QT interval (time taken for ventricular de-polarisation and re-polarisation). There is a lack of safety data regarding dihydroartemisinin/piperaquine (DHA/PPQ) for the treatment of uncomplicated malaria, which has limited its use. We created a platform where electrocardiograms (ECG) were performed in public hospitals for the safety assessment of DHA/PPQ, at baseline before the use of dihydroartemisinin/piperaquine (Eurartesim ((R))), and on day 3 (before and after administration of the final dose) and day 7 post-administration. Laboratory analyses included haematology and clinical chemistry. The main objective of the ECG assessment in this study was to evaluate the effect of administration of DHA/PPQ on QTc intervals and the association of QTc intervals with changes in blood biochemistry, full and differential blood count over time after the DHA/PPQ administration. A total of 1315 patients gave consent and were enrolled of which 1147 (87%) had complete information for analyses. Of the enrolled patients 488 (42%), 323 (28%), 213 (19%) and 123 (11%) were from Ghana, Burkina Faso, Tanzania and Mozambique, respectively. Median (lower-upper quartile) age was 8 (5-14) years and a quarter of the patients were children under five years of age (n = 287). Changes in blood biochemistry, full and differential blood count were temporal which remained within clinical thresholds and did not require any intervention. The mean QTcF values were significantly higher than on day 1 when measured on day 3 before and after administration of the treatment as well as on day 7, four days after completion of treatment (12, 22 and 4 higher, p < 0.001). In all age groups the values of QT, QTcF and QTcB were highest on day 3 after drug intake. The mean extreme QTcF prolongation from baseline was lowest on day 3 before drug intake (33 ms, SD = 19) and highest on day 3 after the last dose (60 ms, SD = 31). There were 79 (7%) events of extreme mean QTcF prolongation which were not clinically significant. Nearly a half of them (n = 37) were grade 3 and mainly among males (33/37). Patients in Burkina Faso, Mozambique and Tanzania had significantly lower mean QTcF than patients in Ghana by an average of 3, 4 and 11 ms, respectively. We found no evidence that Eurartesim((R)) administered in therapeutic doses in patients with uncomplicated malaria and no predisposing cardiac conditions in Africa was associated with adverse clinically significant QTc prolongation.	[Kabanywanyi, Abdunoor M.; Ali, Ali M.; Mahende, Muhidin K.; Kakolwa, Mwaka A.; Abdulla, Salim] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Baiden, Rita; Ogutu, Bernhards R.; Adjuik, Martin; Akparibo, Raymond] INDEPTH Network, Accra, Ghana; [Oduro, Abraham; Osei, Isaac] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Tinto, Halidou; Valea, Innocent] Nanoro Hlth Res Ctr, Nanoro, Burkina Faso; [Gyapong, Margaret; Adjei, Alex] Dodowa Hlth Res Ctr, Dodowa, Ghana; [Sie, Ali; Compaore, Guillaume] Nouna Hlth Res Ctr, Nouna, Burkina Faso; [Sevene, Esperanca; Macete, Eusebio] CISM, Manhica, Mozambique; [Owusu-Agyei, Seth; Yawson, Abena] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Binka, Fred] Univ Hlth & Allied Sci, Ho, Ghana	Ifakara Health Institute; INDEPTH Network; Navrongo Health Research Center; Centro de Investigacao em Saude de Manhica; Kintampo Health Research Centre	Kabanywanyi, AM (corresponding author), Ifakara Hlth Inst, Dar Es Salaam, Tanzania.	amulokozi@ihi.or.tz	Sevene, Esperança/AAI-3532-2020; Valea, Innocent/ABE-6694-2020; Kakolwa, Mwaka/GMX-2580-2022	Tinto, Halidou/0000-0002-0472-3586; Gyapong, Margaret/0000-0002-4818-3497; Valea, Innocent/0000-0002-3085-0490; ODURO, ABRAHAM/0000-0002-4191-7419; Owusu-Agyei, Seth/0000-0002-0807-1781; SIE, Ali/0000-0002-3959-2520	Bill and Melinda Gates Foundation [48363.01]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was funded by the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/), grant number 48363.01 to FB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by the Bill and Melinda Gates Foundation Grant number 48363.01. We are very grateful to all participants from Tanzania, Mozambique, Ghana and Burkina Faso who participated in the study. Researchers at the Nanoro research centre, "(Rouamba Toussaint, Tahita Marc Christian, and Sayouba Quedraogo)". The Nanoro team would like to recognize the head and staff of Nanoro hospital and all the health facilities in the district. The Nouna research centre team, "(Mamadou Bountogo, Mamadou Ouattara, Boubacar Coulibaly, Thierry Ouedrago, Tougri Gauthier, Nebie Eric and Cheik Bagagnan)". The Nouna team would like to recognize the Nouna District Officer and his personnel, Bourasso, Dara, Kamandena, Goni, Lekuy, and Koro health facilities). Rufiji research site, "(Mwaka Athman Kakolwa, Evans S. Ntilla, Zainab Lubiki, Muhidin Kassimu would like to thank Rufiji District council health management team (CHMT) and Mariam Msimbe, Dickson Tumka, Mgunda Sylus, Bakari Kisa, John Wigayi, Self Mu'ngombe, Fadhili Mwakitete, Gerry Pollo, Hilda Likonoka and Stephen Magasa)" and all staff at Ikwiriri and Kibiti Health Centres. Rufiji Researchers are also very grateful to Dr Joanna Schellenberg for her scientific advises, Dr Sarah Moore for her meticulous scientific revision including formatting the paper and Mr. Thabit Athman for designing figures and tables. The Manhica team would like to thank the study nurses from District Directorate and from CISM particularly Ana Ilda Biza, Joseline Rungo, Lidia Laco, all study microscopists, all laboratory technicians particularly Helder Bulo, Chenjerai Jairose, all field workers, all data manager particularly Alberto Chauque, the study drivers and those who assisted the study in logistic and administration). The Dodowa team (Alberta Amu, Solomon Narh-Bana, Richard Afedi, Alhasssan Iddrisu,Christian Niikoi) coveys special appreciation to the Health Directorate of Dangme East and West Districts). The Navrongo (Peter Wontuo, Slyvester Dassah, and Edward Y Sobe) would like to express their appreciation to Kassena Nankana East and West Health Directorate. Kintampo team (Kwaku Poku Asante, Anthony Kwarteng, David Dosoo, Elisha Adenji and Eliezer Lartey) is very grateful to the Kintampo North and South Health Directorate and all the health personnel in the district. The INDEPTH team would like to thank its partners: Governance Council, Scientific Advisory Panel, International Safety Panel, INDEPTH-Network Board of Management, INDEPTH-Network Secretariat, National Malaria Control Programmes in Tanzania, Ghana, Mozambique, Burkina Faso, The Ghanaian Food and Drugs Board (FDB), Tanzania Food and Drug Authority (TFDA), Drug boards in (Mozambique and Burkina Faso);School of Public Health, University of Ghana Legon; WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, Accra, Ghana; Swiss Tropical & Public Health Institute, Basel, Switzerland; Center for Disease Control, Atlanta, USA; Margan Contract research organization (CRO) team.	Baiden R, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0664-9; Bassat Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007871; Borsini F, 2012, ANTIMICROB AGENTS CH, V56, P3261, DOI 10.1128/AAC.05688-11; EMEA, 1997, CPMP HUMAN MEDICINES, V96, P1; EMEA, 2011, EMEAHC1199 CHMP; FDA, 2005, EST MAX SAF START DO; Lon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093138; Manning J, 2014, ANTIMICROB AGENTS CH, V58, P6056, DOI 10.1128/AAC.02667-14; Mayxay M, 2010, AM J TROP MED HYG, V83, P1221, DOI 10.4269/ajtmh.2010.10-0276; Molnar J, 1996, J AM COLL CARDIOL, V27, P76, DOI 10.1016/0735-1097(95)00426-2; Molnar J, 1996, AM J CARDIOL, V78, P920, DOI 10.1016/S0002-9149(96)00468-7; Moore BR, 2008, ANTIMICROB AGENTS CH, V52, P306, DOI 10.1128/AAC.00878-07; Mytton OT, 2007, AM J TROP MED HYG, V77, P447, DOI 10.4269/ajtmh.2007.77.447; Naing C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078819; Naing C, 2013, T ROY SOC TROP MED H, V107, P65, DOI 10.1093/trstmh/trs019; Ogutu BR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-33; Roche Diagnostics RG Basel Switzerlan, 2014, COBAS CHEM ANAL; Roggelin L, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-219; SAS C, 2007, SAS C; Sigma-Tau, 2011, EUR PROD INS, P55; Sigma-tau S, 2010, WHO MODEL LIST OF ES; Sim IK, 2005, ANTIMICROB AGENTS CH, V49, P2407, DOI 10.1128/AAC.49.6.2407-2411.2005; Sysmex, 2015, SYSM HAEM AN; Ubben D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-211; Valecha N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011880; Valecha N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-107; White NJ, 2007, LANCET INFECT DIS, V7, P549, DOI 10.1016/S1473-3099(07)70187-1	27	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e016485	10.1371/journal.pone.0164851	http://dx.doi.org/10.1371/journal.pone.0164851			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764178	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500071
J	Liu, WK; Chen, DH; Tan, WP; Xu, D; Qiu, SY; Zeng, ZQ; Li, X; Zhou, R				Liu, Wenkuan; Chen, Dehui; Tan, Weiping; Xu, Duo; Qiu, Shuyan; Zeng, Zhiqi; Li, Xiao; Zhou, Rong			Epidemiology and Clinical Presentations of Respiratory Syncytial Virus Subgroups A and B Detected with Multiplex Real-Time PCR	PLOS ONE			English	Article							DISEASE SEVERITY; HOSPITALIZED INFANTS; VIRAL-INFECTIONS; TRACT INFECTIONS; GROUP-A; CHILDREN; BRONCHIOLITIS; PNEUMONIA; LOAD; QUANTIFICATION	Respiratory syncytial virus (RSV) is one of the most important pathogenic infections of children and requires in-depth research worldwide, and especially in developing countries. We used a novel multiplex real-time PCR to test 5483 patients (<= 14 years old) hospitalized with respiratory illness in Guangzhou, China, over a 3-year period. Of these patients, 729 were positive for RSV-A (51.2%, 373/729) or RSV-B (48.8%, 356/729), but none was infected with both viruses. Two seasonal peaks in total RSV were detected at the changes from winter to spring and from summer to autumn. RSV-B was dominant in 2013 and RSVA in 2015, whereas RSV-A and RSV-B cocirculated in 2014. The clinical presentations of 645 RSV-positive patients were analyzed. Bronchiolitis, dyspnea, coryza, vomiting, poor appetite, and diarrhea occurred more frequently in RSV-A-positive than RSV-B-positive patients, whereas chill, headache, myalgia, debility, and rash etc. were more frequent in RSV-B-positive than RSV-A-positive patients, suggesting specific clinical characteristics for RSV-A and RSV-B. Coinfectons with other pathogens were common and diverse. Bronchiolitis, fever (>= 38 degrees C), and poor appetite were more frequent in patients with single RSV infections than in coinfected patients, suggesting the key pathogenic activity of RSV. Analysis of the relationships between the comparative viral load and clinical presentations showed significant differences in bronchiolitis, fever (>= 38 degrees C), and rash etc. among patients with different viral loads. This study provides a novel rapid method for detecting RSV subgroups, and provides new insights into the epidemiology and clinical implications of RSV.	[Liu, Wenkuan; Chen, Dehui; Xu, Duo; Qiu, Shuyan; Zeng, Zhiqi; Li, Xiao; Zhou, Rong] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Tan, Weiping] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Sun Yat Sen University	Zhou, R (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	zhourong@gird.cn		Liu, Wen-Kuan/0000-0003-3020-9158	Guangzhou Science and Technology Program key projects [201508020252, 201504010032]; National Natural Science Foundation of China [31500143]	Guangzhou Science and Technology Program key projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Guangzhou Science and Technology Program key projects (RZ) (201508020252) (http://www.gzsi.gov.cn/), Guangzhou Science and Technology Program key projects (XL) (201504010032) (http://www.gzsi.gov.cn/), National Natural Science Foundation of China (WKL) (31500143) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraha HY, 2015, EXPERT REV RESP MED, V9, P779, DOI 10.1586/17476348.2015.1098536; ABZUG MJ, 1990, PEDIATR INFECT DIS J, V9, P881, DOI 10.1097/00006454-199012000-00005; Borchers AT, 2013, CLIN REV ALLERG IMMU, V45, P331, DOI 10.1007/s12016-013-8368-9; Buckingham SC, 2000, PEDIATR INFECT DIS J, V19, P113, DOI 10.1097/00006454-200002000-00006; Caliendo AM, 2011, J CLIN MICROBIOL, V49, P2854, DOI 10.1128/JCM.00471-11; Calvo C, 2008, J CLIN VIROL, V42, P268, DOI 10.1016/j.jcv.2008.03.012; Cane PA, 2001, REV MED VIROL, V11, P103, DOI 10.1002/rmv.305; DeVincenzo JP, 2005, J INFECT DIS, V191, P1861, DOI 10.1086/430008; Tran DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045436; El Saleeby CM, 2011, J INFECT DIS, V204, P996, DOI 10.1093/infdis/jir494; Fodha I, 2007, J MED VIROL, V79, P1951, DOI 10.1002/jmv.21026; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Gilca R, 2006, J INFECT DIS, V193, P54, DOI 10.1086/498526; Gottschalk J, 1996, J CLIN MICROBIOL, V34, P41, DOI 10.1128/JCM.34.1.41-43.1996; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; HALL CB, 1981, INFECT IMMUN, V33, P779, DOI 10.1128/IAI.33.3.779-783.1981; HALL CB, 1990, J INFECT DIS, V162, P1283, DOI 10.1093/infdis/162.6.1283; Haynes AK, 2013, J INFECT DIS, V208, pS246, DOI 10.1093/infdis/jit515; HENDRY RM, 1985, J GEN VIROL, V66, P1705, DOI 10.1099/0022-1317-66-8-1705; HENDRY RM, 1986, J INFECT DIS, V153, P291, DOI 10.1093/infdis/153.2.291; Hirsh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090515; Hornsleth A, 1998, PEDIATR INFECT DIS J, V17, P1114, DOI 10.1097/00006454-199812000-00003; Imaz MS, 2000, J MED VIROL, V61, P76, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;76::AID-JMV12&gt;3.0.CO;2-P; Jafri HS, 2013, PEDIATR INFECT DIS J, V32, P335, DOI 10.1097/INF.0b013e318282603a; Jennings LC, 2004, PEDIATR INFECT DIS J, V23, P1003, DOI 10.1097/01.inf.0000143648.04673.6c; Legg JP, 2003, AM J RESP CRIT CARE, V168, P633, DOI 10.1164/rccm.200210-1148OC; Liu WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096674; Liu WK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-28; Mathisen M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-35; Mazur N, 2015, LANCET RESP MED, V3, P888, DOI 10.1016/S2213-2600(15)00255-6; MCCONNOCHIE KM, 1990, J PEDIATR-US, V117, P52, DOI 10.1016/S0022-3476(05)82443-6; MCINTOSH EDG, 1993, PEDIATR INFECT DIS J, V12, P815, DOI 10.1097/00006454-199310000-00004; Midulla F, 2010, ARCH DIS CHILD, V95, P35, DOI 10.1136/adc.2008.153361; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Papenburg J, 2010, REV MED VIROL, V20, P245, DOI 10.1002/rmv.651; Pavia AT, 2011, CLIN INFECT DIS, V52, pS284, DOI 10.1093/cid/cir043; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; RUSSI JC, 1989, LANCET, V2, P1039; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Salimi V, 2015, J INFECT PUBLIC HEAL, DOI [10.1016/j.jioh.2015.05.005, DOI 10.1016/J.JIOH.2015.05.005]; Semple MG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001038; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; TSUTSUMI H, 1988, J CLIN MICROBIOL, V26, P1171, DOI 10.1128/JCM.26.6.1171-1174.1988; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Wright PF, 2002, J INFECT DIS, V185, P1011, DOI 10.1086/339822	46	22	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165108	10.1371/journal.pone.0165108	http://dx.doi.org/10.1371/journal.pone.0165108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764220	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204500116
J	Zhang, MS; Houtman, JCD				Zhang, Michael S.; Houtman, Jon C. D.			Human Serum Albumin (HSA) Suppresses the Effects of Glycerol Monolaurate (GML) on Human T Cell Activation and Function	PLOS ONE			English	Article							SHOCK-SYNDROME TOXIN-1; FATTY-ACID-BINDING; IN-VITRO; STAPHYLOCOCCUS-AUREUS; RECEPTOR; SITES; DRUG; MICROCLUSTERS; SULFONAMIDES; PLC-GAMMA-1	Glycerol monolaurate (GML) is a monoglyceride with well characterized anti-microbial properties. Because of these properties, GML is widely used in food, cosmetics, and personal care products and currently being tested as a therapeutic for menstrual associated toxic shock syndrome, superficial wound infections, and HIV transmission. Recently, we have described that GML potently suppresses select T cell receptor (TCR)-induced signaling events, leading to reduced human T cell effector functions. However, how soluble host factors present in the blood and at sites of infection affect GML-mediated human T cell suppression is unknown. In this study, we have characterized how human serum albumin (HSA) affects GML-induced inhibition of human T cells. We found that HSA and other serum albumins bind to 12 carbon acyl side chain of GML at low micromolar affinities and restores the TCR-induced formation of LAT, PLC-gamma 1, and AKT microclusters at the plasma membrane. Additionally, HSA reverses GML mediated inhibition of AKT phosphorylation and partially restores cytokine production in GML treated cells. Our data reveal that HSA, one of the most abundant proteins in the human serum and at sites of infections, potently reverses the suppression of human T cells by GML. This suggests that GML-driven human T cell suppression depends upon the local tissue environment, with albumin concentration being a major determinant of GML function.	[Zhang, Michael S.; Houtman, Jon C. D.] Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa	Houtman, JCD (corresponding author), Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA.	Jon-houtman@uiowa.edu		Houtman, Jon/0000-0002-5307-9854; Zhang, Michael/0000-0003-1992-2550	National Cancer Institute at the US National Institutes of Health [R01 CA136729]; University of Iowa's Department of Microbiology, Office of Vice President of Research; Carver College of Medicine; Medical Scientist Training Program Training Grant from the National Institute of General Medical Sciences at the US National Institutes of Health [T32 GM007337]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Cancer Institute at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Iowa's Department of Microbiology, Office of Vice President of Research; Carver College of Medicine; Medical Scientist Training Program Training Grant from the National Institute of General Medical Sciences at the US National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Cancer Institute (www.cancer.gov) at the US National Institutes of Health (Grant Number R01 CA136729) and internal funding from the University of Iowa's Department of Microbiology, Office of Vice President of Research, and Carver College of Medicine (www.uiowa.edu) to JCDH. MSZ received funding from the Medical Scientist Training Program Training Grant from the National Institute of General Medical Sciences (www.nigms.nih.gov) at the US National Institutes of Health (Grant Number T32 GM007337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; ANTON AH, 1960, J PHARMACOL EXP THER, V129, P282; ANTON AH, 1973, ANN NY ACAD SCI, V226, P273, DOI 10.1111/j.1749-6632.1973.tb20490.x; Aubin E, 2011, VOX SANG, V101, P131, DOI 10.1111/j.1423-0410.2011.01475.x; Baek JE, 2010, KIDNEY BLOOD PRESS R, V33, P72, DOI 10.1159/000289576; Balagopalan L, 2015, J BIOL CHEM; Balagopalan L, 2013, J IMMUNOL, V190, P3849, DOI 10.4049/jimmunol.1202760; Bar-Or D, 2006, CRIT CARE MED, V34, P1707, DOI 10.1097/01.CCM.0000217923.53680.4C; BERSON SA, 1953, J CLIN INVEST, V32, P746, DOI 10.1172/JCI102789; Bilal MY, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00141; Blaszyk M, 1998, INT J FOOD MICROBIOL, V39, P175, DOI 10.1016/S0168-1605(97)00134-7; BRODIE BB, 1965, P ROY SOC MED, V58, P946, DOI 10.1177/003591576505811P202; Bruschi M, 2013, BBA-GEN SUBJECTS, V1830, P5503, DOI 10.1016/j.bbagen.2013.04.026; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Chapman NM, 2015, J LEUKOCYTE BIOL, V97, P285, DOI 10.1189/jlb.2A1013-568RRR; Clarke NM, 2000, J MED MICROBIOL, V49, P719, DOI 10.1099/0022-1317-49-8-719; Coussens NP, 2013, MOL CELL BIOL, V33, P4140, DOI 10.1128/MCB.00410-13; Cruz-Orcutt N, 2014, CELL SIGNAL, V26, P797, DOI 10.1016/j.cellsig.2013.12.022; Evans TW, 2002, ALIMENT PHARM THER, V16, P6, DOI 10.1046/j.1365-2036.16.s5.2.x; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Haase AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129465; HAMILTON JA, 1984, P NATL ACAD SCI-BIOL, V81, P3718, DOI 10.1073/pnas.81.12.3718; Hamilton JA, 2013, BBA-GEN SUBJECTS, V1830, P5418, DOI 10.1016/j.bbagen.2013.08.002; Hosainzadeh A, 2012, J BIOMOL STRUCT DYN, V29, P1013, DOI 10.1080/073911012010525029; James TJ, 2000, WOUND REPAIR REGEN, V8, P264, DOI 10.1046/j.1524-475x.2000.00264.x; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; KRAGHHANSEN U, 1988, MOL PHARMACOL, V34, P160; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lin YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007499; Manohar V, 2013, J MED FOOD, V16, P499, DOI 10.1089/jmf.2012.0066; Mignot I, 1996, CHIRALITY, V8, P271, DOI 10.1002/(SICI)1520-636X(1996)8:3<271::AID-CHIR7>3.0.CO;2-K; Moosavi-Movahedi AA, 2004, THERMOCHIM ACTA, V409, P137, DOI 10.1016/S0040-6031(03)00358-7; Mueller EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120280; Palareti G, 1996, CLIN PHARMACOKINET, V30, P300, DOI 10.2165/00003088-199630040-00003; Peters Jr. T., 1995, ALL ALBUMIN BIOCH GE; Peterson ML, 2006, BIOCHEMISTRY-US, V45, P2387, DOI 10.1021/bi051992u; Preuss HG, 2005, TOXICOL MECH METHOD, V15, P279, DOI 10.1080/15376520590968833; PROJAN SJ, 1994, J BACTERIOL, V176, P4204, DOI 10.1128/jb.176.14.4204-4209.1994; REED RG, 1975, BIOCHEMISTRY-US, V14, P4578, DOI 10.1021/bi00692a004; REYNOLDS J, 1968, BIOCHEMISTRY-US, V7, P1357, DOI 10.1021/bi00844a016; Schlievert PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040350; SCHLIEVERT PM, 1992, ANTIMICROB AGENTS CH, V36, P626, DOI 10.1128/AAC.36.3.626; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Shimonkevitz R, 2008, J TRAUMA, V64, P35, DOI 10.1097/TA.0b013e3181589ff9; Simard JR, 2005, P NATL ACAD SCI USA, V102, P17958, DOI 10.1073/pnas.0506440102; Strandberg KL, 2010, ANTIMICROB AGENTS CH, V54, P597, DOI 10.1128/AAC.01151-09; Strandberg KL, 2009, CLIN INFECT DIS, V49, P1711, DOI 10.1086/644614; Takamura N, 2005, DRUG METAB DISPOS, V33, P596, DOI 10.1124/dmd.104.002782; TILLEMENT JP, 1973, EUR J CLIN PHARMACOL, V6, P15, DOI 10.1007/BF00561795; Ulrich Hoppe UE, 1999, DEODORIZING ANTIMICR; Vahedian-Movahed H, 2011, J BIOMOL STRUCT DYN, V28, P483, DOI 10.1080/07391102.2011.10508590; VERBEECK RK, 1980, BIOCHEM PHARMACOL, V29, P571, DOI 10.1016/0006-2952(80)90378-0; Witcher KJ, 1996, CLIN DIAGN LAB IMMUN, V3, P10, DOI 10.1128/CDLI.3.1.10-13.1996; Yamasaki K, 1996, BBA-PROTEIN STRUCT M, V1295, P147, DOI 10.1016/0167-4838(96)00013-1; Yamasaki K, 2013, BBA-GEN SUBJECTS, V1830, P5435, DOI 10.1016/j.bbagen.2013.05.005; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zhang MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep30225	57	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165083	10.1371/journal.pone.0165083	http://dx.doi.org/10.1371/journal.pone.0165083			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764189	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500112
J	Lu, X; Kong, J; Luan, S; Dai, P; Meng, XH; Cao, BX; Luo, K				Lu, Xia; Kong, Jie; Luan, Sheng; Dai, Ping; Meng, Xianhong; Cao, Baoxiang; Luo, Kun			Transcriptome Analysis of the Hepatopancreas in the Pacific White Shrimp (Litopenaeus vannamei) under Acute Ammonia Stress	PLOS ONE			English	Article							SPOT-SYNDROME-VIRUS; C-TYPE LECTIN; DIFFERENTIALLY EXPRESSED GENES; SERINE PROTEINASE-INHIBITOR; IMMUNE-RESPONSE; ACUTE TOXICITY; PENAEUS-JAPONICUS; VIBRIO-PARAHAEMOLYTICUS; ANTIMICROBIAL ACTIVITY; FATTY-ACIDS	In the practical farming of Litopenaeus vannamei, the intensive culture system and environmental pollution usually results in a high concentration of ammonia, which usually brings large detrimental effects to shrimp, such as increasing the susceptibility to pathogens, reducing growth, decreasing osmoregulatory capacity, increasing the molting frequency, and even causing high mortality. However, little information is available on the molecular mechanisms of the detrimental effects of ammonia stress in shrimp. In this study, we performed comparative transcriptome analysis between ammonia-challenged and control groups from the same family of L. vannamei to identify the key genes and pathways response to ammonia stress. The comparative transcriptome analysis identified 136 significantly differentially expressed genes that have high homologies with the known proteins in aquatic species, among which 94 genes are reported potentially related to immune function, and the rest of the genes are involved in apoptosis, growth, molting, and osmoregulation. Fourteen GO terms and 6 KEGG pathways were identified to be significantly changed by ammonia stress. In these GO terms, 13 genes have been studied in aquatic species, and 11 of them were reported potentially involved in immune defense and two genes were related to molting. In the significantly changed KEGG pathways, all the 7 significantly changed genes have been reported in shrimp, and four of them were potentially involved in immune defense and the other three were related to molting, defending toxicity, and osmoregulation, respectively. In addition, majority of the significantly changed genes involved in nitrogen metabolisms that play an important role in reducing ammonia toxicity failed to perform the protection function. The present results have supplied molecular level support for the previous founding of the detrimental effects of ammonia stress in shrimp, which is a prerequisite for better understanding the molecular mechanism of the immunosuppression from ammonia stress.	[Lu, Xia; Kong, Jie; Luan, Sheng; Dai, Ping; Meng, Xianhong; Cao, Baoxiang; Luo, Kun] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Utilizat Marine Fisheries Res, Minist Agr, Qingdao 266071, Peoples R China; [Lu, Xia; Kong, Jie; Luan, Sheng; Dai, Ping; Meng, Xianhong; Cao, Baoxiang; Luo, Kun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao 266071, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Qingdao National Laboratory for Marine Science & Technology	Kong, J (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Utilizat Marine Fisheries Res, Minist Agr, Qingdao 266071, Peoples R China.; Kong, J (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao 266071, Peoples R China.	kongjie@ysfri.ac.cn			National Natural Science Foundation of China [31302179]; Taishan Scholar Program For Seed Industry; Introduction of International Advanced Agricultural Science and Technology Plan [2016-X39]; Shangdong Province Young and Middle Aged Scientists Research Awards Fund [BS2015NT010]; Special Fund for Basic Scientific Research Business of Central Public Research Institutes [2015604XK01]; Guangdong Province Aquaculture Improved Variety Establishment of System Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Program For Seed Industry; Introduction of International Advanced Agricultural Science and Technology Plan; Shangdong Province Young and Middle Aged Scientists Research Awards Fund; Special Fund for Basic Scientific Research Business of Central Public Research Institutes; Guangdong Province Aquaculture Improved Variety Establishment of System Project	This work was supported by the National Natural Science Foundation of China (31302179), the Taishan Scholar Program For Seed Industry, the Introduction of International Advanced Agricultural Science and Technology Plan (2016-X39), Shangdong Province Young and Middle Aged Scientists Research Awards Fund (BS2015NT010), the Special Fund for Basic Scientific Research Business of Central Public Research Institutes (2015604XK01), and the Guangdong Province Aquaculture Improved Variety Establishment of System Project.	Adachi Y, 2004, INFECT IMMUN, V72, P4159, DOI 10.1128/IAI.72.7.4159-4171.2004; Ai HS, 2008, FISH SHELLFISH IMMUN, V25, P28, DOI 10.1016/j.fsi.2007.12.002; Alagappan KM, 2010, CURR MICROBIOL, V61, P235, DOI 10.1007/s00284-010-9599-0; Antalis TM, 1998, J EXP MED, V187, P1799, DOI 10.1084/jem.187.11.1799; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Birukawa N, 2005, ZOOL SCI, V22, P1245, DOI 10.2108/zsj.22.1245; BUHLER DR, 1988, AQUAT TOXICOL, V11, P19, DOI 10.1016/0166-445X(88)90004-5; Chen DD, 2012, DEV COMP IMMUNOL; Chen J. C., 1989, ASIAN FISH SCI, V2, P233; CHEN J-C, 1990, Journal of the Fisheries Society of Taiwan, V17, P59; CHEN J-C, 1990, Journal of the World Aquaculture Society, V21, P300, DOI 10.1111/j.1749-7345.1990.tb00543.x; CHEN JC, 1992, AQUACULTURE, V104, P249, DOI 10.1016/0044-8486(92)90207-2; CHEN JC, 1992, J EXP MAR BIOL ECOL, V156, P139, DOI 10.1016/0022-0981(92)90021-2; CHEN JC, 1991, COMP BIOCHEM PHYS C, V100, P477; Chen JC, 1990, 2 AS FISH FOR, P61; Chen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131503; Cheng W, 2004, FISH SHELLFISH IMMUN, V17, P193, DOI 10.1016/j.fsi.2004.03.004; CHIEN YH, 1992, PROCEEDINGS OF THE SPECIAL SESSION ON SHRIMP FARMING, P144; Cohen JJ, 1993, HOSP PRACTICE, V28, P35; Colt J. E., 1981, Proceedings of the Bio-Engineering Symposium for Fish Culture, P34; Colt JE, 1981, P BIOENG S FISH CULT, P34; Cobo MD, 2014, AQUAC RES, V45, P470, DOI 10.1111/j.1365-2109.2012.03248.x; Destoumieux D, 1997, J BIOL CHEM, V272, P28398, DOI 10.1074/jbc.272.45.28398; Dhar AK, 2003, ARCH VIROL, V148, P2381, DOI 10.1007/s00705-003-0172-z; Dong CH, 2012, COMP BIOCHEM PHYS A, V161, P95, DOI 10.1016/j.cbpa.2011.09.006; Donpudsa S, 2009, DEV COMP IMMUNOL, V33, P481, DOI 10.1016/j.dci.2008.09.009; Eisenhaber B, 2000, TRENDS BIOCHEM SCI, V25, P340, DOI 10.1016/S0968-0004(00)01601-7; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; EMERSON K, 1975, J FISH RES BOARD CAN, V32, P2379, DOI 10.1139/f75-274; Fagutao F.F., 2011, DIS ASIAN AQUACULTUR, P171; Frye C A, 2009, Minerva Ginecol, V61, P541; Funder JW, 1997, RECENT PROG HORM RES, V52, P247; Gollas-Galvan T, 2003, COMP BIOCHEM PHYS C, V134, P431, DOI 10.1016/S1532-0456(03)00002-4; Goncalves-Soares D, 2012, COMP BIOCHEM PHYS D, V7, P73, DOI 10.1016/j.cbd.2011.11.002; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; Growth V., 2003, AQUACULTURE, V224, P105; Gupta BBP, 2002, CURR SCI INDIA, V83, P1103; Havanapan PO, 2009, J PROTEOME RES, V8, P2476, DOI 10.1021/pr801067e; Heath A.G, 1995, WATER POLLUTION FISH, P141, DOI [10.1201/9780203718896, DOI 10.1201/9780203718896]; Henry RP, 1996, ANNU REV PHYSIOL, V58, P523, DOI 10.1146/annurev.ph.58.030196.002515; Huang QS, 2010, FISH SHELLFISH IMMUN, V29, P75, DOI 10.1016/j.fsi.2010.02.014; Huang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113768; Hurvitz A, 1997, FISH SHELLFISH IMMUN, V7, P45, DOI 10.1006/fsim.1996.0062; James R, 2010, FISH SHELLFISH IMMUN, V29, P884, DOI 10.1016/j.fsi.2010.07.029; KANAZAWA A, 1977, B JPN SOC SCI FISH, V43, P1111; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim SK, 2014, AQUAC RES, V45, P362, DOI 10.1111/are.12319; Kir M, 2004, AQUACULTURE, V241, P479, DOI 10.1016/j.aquaculture.2004.05.003; KOU Y-Z, 1991, Aquaculture and Fisheries Management, V22, P259; Lei KY, 2008, DEV COMP IMMUNOL, V32, P808, DOI 10.1016/j.dci.2007.11.010; Leu JH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-120; Li WJ, 2016, CHIN J OCEANOL LIMN, V34, P1025, DOI 10.1007/s00343-016-5034-0; LIN HP, 1993, MAR BIOL, V117, P591, DOI 10.1007/BF00349770; Lin YC, 2001, J EXP MAR BIOL ECOL, V259, P109, DOI 10.1016/S0022-0981(01)00227-1; Lin YC, 2013, DEV COMP IMMUNOL, V40, P167, DOI 10.1016/j.dci.2013.01.001; Liu CH, 2004, FISH SHELLFISH IMMUN, V16, P321, DOI 10.1016/S1050-4648(03)00113-X; Loongyai W, 2007, MAR BIOTECHNOL, V9, P624, DOI 10.1007/s10126-007-9019-z; Lv JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082155; Ma THT, 2007, FISH SHELLFISH IMMUN, V23, P430, DOI 10.1016/j.fsi.2006.12.005; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Nadimpalli SK, 2015, LYSOSOMAL ENZYMES TH, V16, P49; NAN F-H, 1991, Journal of the Fisheries Society of Taiwan, V18, P41; O'Connell PJ, 2006, BLOOD, V107, P1010, DOI 10.1182/blood-2005-07-2903; Okumura T, 2007, FISH SHELLFISH IMMUN, V22, P68, DOI 10.1016/j.fsi.2006.03.013; OSTRENSKY A, 1995, AQUACULTURE, V132, P339, DOI 10.1016/0044-8486(94)00343-M; Pan D, 2005, DEV COMP IMMUNOL, V29, P103, DOI 10.1016/j.dci.2004.07.001; Pongsomboon S, 2011, FISH SHELLFISH IMMUN, V30, P439, DOI 10.1016/j.fsi.2010.10.015; Qiu De-Quan, 2008, Acta Hydrobiologica Sinica, V32, P455, DOI 10.3724/SP.J.1035.2008.00455; Racotta IS, 2000, COMP BIOCHEM PHYS A, V125, P437, DOI 10.1016/S1095-6433(00)00171-9; Ran XZ, 2013, J VIROL, V87, P12576, DOI 10.1128/JVI.01551-13; REIGH RC, 1989, AQUACULTURE, V77, P157, DOI 10.1016/0044-8486(89)90199-3; Renault T, 2011, DEV COMP IMMUNOL, V35, P725, DOI 10.1016/j.dci.2011.02.004; Smith S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-375; Song KK, 2010, FISH SHELLFISH IMMUN, V28, P596, DOI 10.1016/j.fsi.2009.12.015; Sotelo-Mundo RR, 2003, FISH SHELLFISH IMMUN, V15, P325, DOI 10.1016/S1050-4648(02)00176-6; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun GM, 2002, J AGUACULTURE, V1, P22; Supungul P, 2008, DEV COMP IMMUNOL, V32, P61, DOI 10.1016/j.dci.2007.04.004; Temple SJ, 1998, TRENDS PLANT SCI, V3, P51, DOI 10.1016/S1360-1385(97)01159-X; WAJSBROT N, 1990, ENVIRON TOXICOL CHEM, V9, P497, DOI 10.1002/etc.5620090413; Wang B, 2008, MAR BIOTECHNOL, V10, P664, DOI 10.1007/s10126-008-9105-x; Wang N, 2011, MOL BIOL REP, V38, P3055, DOI 10.1007/s11033-010-9972-x; Wang PH, 2013, ANTIVIR RES, V99, P270, DOI 10.1016/j.antiviral.2013.05.016; Wei XM, 2012, FISH SHELLFISH IMMUN, V32, P132, DOI 10.1016/j.fsi.2011.11.001; WICKINS JF, 1976, AQUACULTURE, V9, P19, DOI 10.1016/0044-8486(76)90045-4; Xia JH, 2013, DNA RES, V20, P449, DOI 10.1093/dnares/dst022; Xie SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144922; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059703; Zeng DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057515; Zhang KJ, 1993, J FISHERIES CHINA, V17, P52; Zhang QL, 2008, FISH SHELLFISH IMMUN, V24, P584, DOI 10.1016/j.fsi.2008.01.008; Zhang XB, 2004, ANTIVIR RES, V61, P93, DOI 10.1016/j.antiviral.2003.08.019; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038603; Zhao ZY, 2009, J VIROL, V83, P347, DOI 10.1128/JVI.00707-08	96	75	79	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164396	10.1371/journal.pone.0164396	http://dx.doi.org/10.1371/journal.pone.0164396			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760162	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204000034
J	Huang, J; Zhao, L; Yang, P; Chen, Z; Tang, N; Ruan, XZ; Chen, Y				Huang, Jian; Zhao, Lei; Yang, Ping; Chen, Zhen; Tang, Ni; Ruan, Xiong Z.; Chen, Yaxi			Genome-Wide Transcriptome Analysis of CD36 Overexpression in HepG2.2.15 Cells to Explore Its Regulatory Role in Metabolism and the Hepatitis B Virus Life Cycle	PLOS ONE			English	Article							SIGNALING PATHWAYS; HBX PROTEIN; CALCIUM; REPLICATION; ACTIVATION; INFECTION; APOBEC3B; RECEPTOR; CHANNEL; TARGETS	Hepatitis B virus (HBV) is a hepatocyte-specific DNA virus whose gene expression and replication are closely associated with hepatic metabolic processes. Thus, a potential anti-viral strategy is to target the host metabolic factors necessary for HBV gene expression and replication. Recent studies revealed that fatty acid translocase CD36 is involved in the replication, assembly, storage, and secretion of certain viruses, such as hepatitis C virus (HCV) and human immunodeficiency virus (HIV). However, the relationship between CD36 and the HBV life cycle remains unclear. Here, we showed, for the first time, that increased CD36 expression enhances HBV replication in HepG2.2.15 cells. To understand the underlying molecular basis, we performed genome-wide sequencing of the mRNA from HepG2.2.15-CD36 overexpression (CD36OE) cells and HepG2.2.15-vector cells using RNA Sequencing (RNA-seq) technology to analyze the differential transcriptomic profile. Our results identified 141 differentially expressed genes (DEGs) related to CD36 overexpression, including 79 upregulated genes and 62 downregulated genes. Gene ontology and KEGG pathway analysis revealed that some of the DEGs were involved in various metabolic processes and the HBV life cycle. The reliability of the RNA-Seq data was confirmed by qPCR analysis. Our findings provide clues to build a link between CD36, host metabolism and the HBV life cycle and identified areas that require further investigation.	[Huang, Jian; Zhao, Lei; Yang, Ping; Chen, Zhen; Tang, Ni; Ruan, Xiong Z.; Chen, Yaxi] Chongqing Med Univ, Ctr Lipid Res, Chongqing, Peoples R China; [Huang, Jian; Zhao, Lei; Yang, Ping; Chen, Zhen; Tang, Ni; Ruan, Xiong Z.; Chen, Yaxi] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Affiliated Hosp 2, Minist Educ,Inst Viral Hepatitis,Dept Infect Dis, Chongqing, Peoples R China; [Ruan, Xiong Z.] UCL, John Moorhead Res Lab, Ctr Nephrol, Sch Med, Royal Free Campus, London, England	Chongqing Medical University; Chongqing Medical University; University of London; University College London; UCL Medical School	Chen, Y (corresponding author), Chongqing Med Univ, Ctr Lipid Res, Chongqing, Peoples R China.; Chen, Y (corresponding author), Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Affiliated Hosp 2, Minist Educ,Inst Viral Hepatitis,Dept Infect Dis, Chongqing, Peoples R China.	chenyaxi@cqmu.edu.cn	Ruan, Xiong Zhong/GZA-5963-2022	Ruan, Xiong Zhong/0000-0001-5199-4971	National Natural Science Foundation of China [81570517, 81270789, 81390354]; Chongqing Research Program of Basic Research and Frontier Technology [cstc2015jcyjBX0044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Research Program of Basic Research and Frontier Technology	This work was supported by National Natural Science Foundation of China (81570517), http://www.nsfc.gov.cn/, YXC received the funding; National Natural Science Foundation of China (81270789, 81390354), http://www.nsfc.gov.cn/, XZR received the funding; Chongqing Research Program of Basic Research and Frontier Technology (No. cstc2015jcyjBX0044), http://www.cstc.gov.cn/, YXC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bar-Yishay I, 2011, LIVER INT, V31, P282, DOI 10.1111/j.1478-3231.2010.02423.x; Berre S, 2013, J EXP MED, V210, P2523, DOI 10.1084/jem.20130566; Bonvin M, 2007, J GEN VIROL, V88, P3270, DOI 10.1099/vir.0.83149-0; Bouchard MJ, 2003, J VIROL, V77, P7713, DOI 10.1128/JVI.77.14.7713-7719.2003; Bouchard MJ, 2001, SCIENCE, V294, P2376, DOI 10.1126/science.294.5550.2376; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Cheng JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21808; Choi YW, 2005, VIROLOGY, V332, P454, DOI 10.1016/j.virol.2004.11.019; Dong YY, 2015, SCIENCE, V347, P1256, DOI 10.1126/science.1261512; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Geng X, 2012, P NATL ACAD SCI USA, V109, P18471, DOI 10.1073/pnas.1204668109; Ghosh M, 2009, AM J REPROD IMMUNOL, V62, P60, DOI 10.1111/j.1600-0897.2009.00713.x; Guth CA, 2014, J VIROL, V88, P4612, DOI 10.1128/JVI.02945-13; Handberg A, 2010, J CLIN ENDOCR METAB, V95, P1939, DOI 10.1210/jc.2009-2002; Hoffman L, 2014, J BIOL CHEM, V289, P14644, DOI 10.1074/jbc.M114.560656; Jarcuska P, 2014, EUR J INTERN MED, V25, P286, DOI 10.1016/j.ejim.2014.01.006; Kuda O, 2011, J BIOL CHEM, V286, P17785, DOI 10.1074/jbc.M111.232975; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Lin ZW, 2014, TUMOR BIOL, V35, P10959, DOI 10.1007/s13277-014-2388-9; Lucifora J, 2016, J HEPATOL, V64, pS41, DOI 10.1016/j.jhep.2016.02.009; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nergiz-Unal R., 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P42, DOI 10.2174/187152511794182855; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Ouyang YY, 2016, FIBROGENESIS TISSUE, V9, DOI 10.1186/s13069-016-0039-z; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; Pepino MY, 2014, ANNU REV NUTR, V34, P281, DOI 10.1146/annurev-nutr-071812-161220; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Ren JH, 2014, J VIROL, V88, P2442, DOI 10.1128/JVI.02861-13; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Shlomai A, 2008, MED HYPOTHESES, V71, P53, DOI 10.1016/j.mehy.2007.08.032; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Yang B, 2012, J VIROL, V86, P313, DOI 10.1128/JVI.06442-11; Yoon SY, 2006, INT J ONCOL, V29, P315; Zhang CB, 2013, J BIOL CHEM, V288, P26135, DOI 10.1074/jbc.M113.478453; Zhang TW, 2013, HUM MOL GENET, V22, P1262, DOI 10.1093/hmg/dds513; Zhang Z, 2013, ARCH TOXICOL, V87, P1557, DOI 10.1007/s00204-013-1059-8; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	41	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164787	10.1371/journal.pone.0164787	http://dx.doi.org/10.1371/journal.pone.0164787			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749922	gold, Green Published, Green Submitted			2022-12-26	WOS:000386202300028
J	Ospina, JE; Orcau, A; Millet, JP; Ros, M; Gil, S; Cayla, JA				Ospina, Jesus E.; Orcau, Angels; Millet, Joan-Pau; Ros, Miriam; Gil, Sonia; Cayla, Joan A.		Barcelona TB Immigration Working G	Epidemiology of Tuberculosis in Immigrants in a Large City with Large-Scale Immigration (1991-2013)	PLOS ONE			English	Article							LARGE CITIES	Background The increase in immigration in Barcelona between 2000 and 2008 forced a reorganization of the control of tuberculosis (TB). TB clinical units (TBCU) were created and community health workers (CHW) were gradually included. Objective To understand trends in the incidence of TB among immigrants, their main characteristics and treatment compliance during the period 1991-2013. Design We conducted a cross-sectional population-based study of cases detected among immigrants by the Tuberculosis Program in Barcelona, Spain. Sociodemographic, clinical characteristics and risk factors were described. The annual incidence was calculated for various periods and geographical areas of origin. In the linear trend analysis, a p-value of <0.05 was considered statistically significant. Results We detected 3,284 cases. Incidence decreased from 144.8/100,000 inhabitants in 1991 to 53.4/100,000 in 2013. Individuals born in Pakistan-India-Bangladesh had the highest average annual incidence (675/100,000). In all, 2,156 cases (65.7%) were male. 2,272 (69.2%) had pulmonary TB, of which 48.2% were smear-positive. 33% of the cases (1,093) lived in the inner city. Contact tracing (CT) coverage in smear-positive individuals rose from 56.8% in 1991-1999 to 81.4% in 2000-2013 (p<0.01); this value was less than 50% in people from Africa and Eastern European countries. The case fatality rate was 3.6% overall and 9.8% among those born in high-income countries (p<0.01). The highest rate of treatment default (12.8%) was observed among cases from the Maghreb. The rate of successful treatment increased from 69.9% in 1991-1999 to 87.5% in 2000-2013 (p<0.01). Conclusion The incidence of TB in immigrants is decreasing in Barcelona. Organizational actions, such as incorporating CHWs and TBCUs, have been decisive for the observed improvements.	[Ospina, Jesus E.; Orcau, Angels; Millet, Joan-Pau; Ros, Miriam; Gil, Sonia; Cayla, Joan A.] Agencia Salud Publ Barcelona, Serv Epidemiol, Barcelona, Spain; [Ospina, Jesus E.] Univ Autonoma Barcelona, Dept Pediat Ginecol & Med Prevent, Barcelona, Spain; [Orcau, Angels; Millet, Joan-Pau; Cayla, Joan A.] CIBERESP, Barcelona, Spain	Public Health Agency of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Orcau, A (corresponding author), Agencia Salud Publ Barcelona, Serv Epidemiol, Barcelona, Spain.; Orcau, A (corresponding author), CIBERESP, Barcelona, Spain.			FORCADA PENA, NURIA/0000-0001-6249-4921; Molina Pinargote, Israel/0000-0002-9160-0284; Cayla, Joan A./0000-0003-3891-111X; Millet, Joan Pau/0000-0003-0200-2459				Ait Belghiti F., 2015, B EPIDEMIOL HEBD, V910, P164; Alcalde Campos R., 2014, MUJERES LATINOAMERIC, P7; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 2015, TUB LOND ANN REV 201; [Anonymous], WHOHTMTB20103; Ayuntamiento de Madrid, 2015, MADR DAT DEP EST POB; Burki T, 2010, LANCET, V376, P2055, DOI 10.1016/S0140-6736(10)62282-9; Cayla JA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-127; Centers for Disease Control and Prevention, 2012, MMWR-MORBID MORTAL W, V61, P181; Centro Nacional de Epidemiologia, 2014, INF EP SIT TUB ESP A; Cruz-Ferro E, 2013, INT J LUNG DIS  1011; Ospina JE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-158; European Centre for Disease Prevention and Control. ECDC, TB SIT EU EEA 2013; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2012, TUB SURV MON EUR 201; Gegia M, 2015, B WORLD HEALTH ORGAN, V93, P390, DOI 10.2471/BLT.14.147439; Gilbert RL, 2009, INT J TUBERC LUNG D, V13, P645; Health Protection Agency (UK), TUB UK ANN REP TUB S; Heldal E, 2008, INT J TUBERC LUNG D, V12, P878; Hladun O, 2013, J TRAVEL MED; Hollo V, 2009, EUROSURVEILLANCE, V14; Instituto Nacional de Estadistica, INE 2015; Long R, 1999, CAN MED ASSOC J, V160, P1185; Lozano Salazar JL, MEDISAN 2009, P13; Mitchell SL, 2010, THORAX, DOI 10.1136/thx.2010.148866; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; New York City Department of Health and Mental Hygiene, 2014, BUR TUB CONTR ANN SU; Orcau A, TUBERCULOSIS BARCELO; Rodrigo T, 2001, INT J TUBERC LUNG D, V5, P432; Salihu HM, 2001, EMERG INFECT DIS, V7, P570; UITB SEPAR GESIDA SEIMC SESP, 2003, MED CLIN-BARCELONA, V121, P549; van Hest NA, 2014, EUROSURVEILLANCE, V19; WHO, WHOHTMTB201501; *WHO, 2008, WHOHTMTB2008394; World Health Organization, GLOB TUB REP 2015; World Health Organization, 2014, WHOHTMTB201408; Yepes del Castillo I, INT J COLLECTIVE IDE, V2014; Zumla A, 2011, LANCET, V377, P10, DOI 10.1016/S0140-6736(10)62176-9	37	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164736	10.1371/journal.pone.0164736	http://dx.doi.org/10.1371/journal.pone.0164736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749904	Green Published, gold, Green Submitted			2022-12-26	WOS:000386202300025
J	Subedi, S; Kong, FR; Jelfs, P; Gray, TJ; Xiao, M; Sintchenko, V; Chen, SCA				Subedi, Shradha; Kong, Fanrong; Jelfs, Peter; Gray, Timothy J.; Xiao, Meng; Sintchenko, Vitali; Chen, Sharon C-A			16S-23S Internal Transcribed Spacer Region PCR and Sequencer-Based Capillary Gel Electrophoresis has Potential as an Alternative to High Performance Liquid Chromatography for Identification of Slowly Growing Nontuberculous Mycobacteria	PLOS ONE			English	Article							RIBOSOMAL-RNA; AVIUM COMPLEX; MOLECULAR EPIDEMIOLOGY; BURULI ULCER; SP-NOV; DIAGNOSIS; TUBERCULOSIS; INFECTIONS; GORDONAE; SENSITIVITY	Accurate identification of slowly growing nontuberculous mycobacteria (SG-NTM) of clinical significance remains problematic. This study evaluated a novel method of SG-NTM identification by amplification of the mycobacterial 16S-23S rRNA internal transcribed spacer (ITS) region followed by resolution of amplified fragments by sequencer-based capillary gel electrophoresis (SCGE). Fourteen American Type Culture Collection (ATCC) strains and 103 clinical/environmental isolates (total n = 24 species) of SG-NTM were included. Identification was compared with that achieved by high performance liquid chromatography (HPLC), in-house PCR and 16S/ITS sequencing. Isolates of all species yielded a SCGE profile comprising a single fragment length (or peak) except for M. scrofulaceum (two peaks). SCGE peaks of ATCC strains were distinct except for peak overlap between Mycobacterium kansasii and M. marinum. Of clinical/environmental strains, unique peaks were seen for 7/17 (41%) species (M. haemophilum, M. kubicae, M. lentiflavum, M. terrae, M. kansasii, M. asiaticum and M. triplex); 3/17 (18%) species were identified by HPLC. There were five SCGE fragment length types (I-V) each of M. avium, M. intracellulare and M. gordonae. Overlap of fragment lengths was seen between M. marinum and M. ulcerans; for M. gordonae SCGE type III and M. paragordonae; M. avium SCGE types III and IV, and M. intracellulare SCGE type I; M. chimaera, M. parascrofulaceum and M. intracellulare SCGE types III and IV; M. branderi and M. avium type V; and M. vulneris and M. intracellulare type V. The ITS-SCGE method was able to provide the first line rapid and reproducible species identification/screening of SG-NTM and was more discriminatory than HPLC.	[Subedi, Shradha; Kong, Fanrong; Jelfs, Peter; Sintchenko, Vitali; Chen, Sharon C-A] Westmead Hosp, ICPMR Pathol West, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW, Australia; [Jelfs, Peter; Sintchenko, Vitali; Chen, Sharon C-A] Westmead Hosp, Publ Hlth, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia; [Gray, Timothy J.] Concord Hosp, Dept Infect Dis & Microbiol, Concord, NSW, Australia; [Xiao, Meng] Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Sintchenko, Vitali; Chen, Sharon C-A] Univ Sydney, Ctr Infect Dis & Microbiol, Westmead Hosp, Sydney, NSW, Australia; [Sintchenko, Vitali; Chen, Sharon C-A] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia	University of Sydney; University of Sydney; Concord Repatriation General Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Sydney; University of Sydney	Subedi, S (corresponding author), Westmead Hosp, ICPMR Pathol West, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW, Australia.	subedi_82@yahoo.com	Xiao, Meng/J-6518-2017	Xiao, Meng/0000-0003-2103-7008; Sintchenko, Vitali/0000-0002-9261-3650				Baini R JP, 2008, IDENTIFICATION MYCOB; Behr MA, 2009, FUTURE MICROBIOL, V4, P1009, DOI [10.2217/fmb.09.75, 10.2217/FMB.09.75]; Behroozian AA, 2013, INFECT CONT HOSP EP, V34, P961, DOI 10.1086/671728; Ben Salah I, 2008, MICROBIOL-SGM, V154, P3715, DOI 10.1099/mic.0.2008/020164-0; Bertelli C, 2013, CLIN MICROBIOL INFEC, V19, P803, DOI 10.1111/1469-0691.12217; Brown-Elliott BA, 2012, CLIN MICROBIOL REV, V25, P545, DOI 10.1128/CMR.05030-11; Buckwalter SP, 2016, J CLIN MICROBIOL, V54, P376, DOI 10.1128/JCM.02128-15; Butler WR, 2001, CLIN MICROBIOL REV, V14, P704, DOI 10.1128/CMR.14.4.704-726.2001; de Zwaan R, 2014, J CLIN MICROBIOL, V52, P2544, DOI 10.1128/JCM.00233-14; Doig KD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-258; Fawley WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118150; Gauthier M, 2015, J CLIN MICROBIOL, V53, P498, DOI 10.1128/JCM.01611-14; Gray TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102290; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hoffmann M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-90; Itoh S, 2003, J CLIN MICROBIOL, V41, P1656, DOI 10.1128/JCM.41.4.1656-1663.2003; Jagielski T, 2016, CLIN MICROBIOL REV, V29, P239, DOI 10.1128/CMR.00055-15; Jorgensen JH, 2015, MANUAL CLIN MICROBIO; Kim BJ, 2014, INT J SYST EVOL MICR, V64, P39, DOI 10.1099/ijs.0.051540-0; KIRSCHNER P, 1992, J CLIN MICROBIOL, V30, P1049, DOI 10.1128/JCM.30.4.1049-1050.1992; Kodana M, 2016, J INFECT CHEMOTHER, V22, P32, DOI 10.1016/j.jiac.2015.09.006; Lindeboom JA, 2011, CLIN MICROBIOL REV, V24, P701, DOI 10.1128/CMR.00020-11; Mansfield ES, 1996, GENOME RES, V6, P893, DOI 10.1101/gr.6.9.893; Ngan GJY, 2011, LETT APPL MICROBIOL, V52, P546, DOI 10.1111/j.1472-765X.2011.03045.x; Phelippeau M, 2015, J CLIN MICROBIOL, V53, P3798, DOI 10.1128/JCM.01560-15; Phillips MS, 2001, CLIN INFECT DIS, V33, P1363, DOI 10.1086/323126; Phillips R, 2005, J CLIN MICROBIOL, V43, P3650, DOI 10.1128/JCM.43.8.3650-3656.2005; Roth A, 2000, J CLIN MICROBIOL, V38, P1094, DOI 10.1128/JCM.38.3.1094-1104.2000; Roth A, 1998, J CLIN MICROBIOL, V36, P139, DOI 10.1128/JCM.36.1.139-147.1998; Saleeb PG, 2011, J CLIN MICROBIOL, V49, P1790, DOI 10.1128/JCM.02135-10; Suomalainen S, 2001, J CLIN MICROBIOL, V39, P2668, DOI 10.1128/JCM.39.7.2668-2671.2001; Tortoli E, 2003, CLIN MICROBIOL REV, V16, P319, DOI 10.1128/CMR.16.2.319-354.2003; Tortoli E, 2004, INT J SYST EVOL MICR, V54, P1277, DOI 10.1099/ijs.0.02777-0; Tortoli E, 2014, CLIN MICROBIOL REV, V27, P727, DOI 10.1128/CMR.00035-14; Tortoli E, 2012, INFECT GENET EVOL, V12, P827, DOI 10.1016/j.meegid.2011.05.025; Turenne CY, 2006, J CLIN MICROBIOL, V44, P433, DOI 10.1128/JCM.44.2.433-440.2006; van Ingen J, 2009, INT J SYST EVOL MICR, V59, P2277, DOI 10.1099/ijs.0.008854-0; van Ingen J, 2015, CLIN CHEST MED, V36, P43, DOI 10.1016/j.ccm.2014.11.005; van Ingen J, 2010, INT J ANTIMICROB AG, V35, P169, DOI 10.1016/j.ijantimicag.2009.09.023; Wang J, 2015, GENOME BIOL EVOL, V7, P856, DOI 10.1093/gbe/evv035; Wehrhahn MC, 2012, J CLIN MICROBIOL, V50, P3478, DOI 10.1128/JCM.01311-12; Xiong LK, 2006, J CLIN MICROBIOL, V44, P3544, DOI 10.1128/JCM.00633-06	42	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164138	10.1371/journal.pone.0164138	http://dx.doi.org/10.1371/journal.pone.0164138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749897	Green Published, Green Submitted, gold			2022-12-26	WOS:000386202300008
J	Wu, M; Ingram, L; Tolosa, EJ; Vera, RE; Li, QJ; Kim, S; Ma, YJ; Spyropoulos, DD; Beharry, Z; Huang, JT; Fernandez-Zapico, ME; Cai, HJ				Wu, Meng; Ingram, Lishann; Tolosa, Ezequiel J.; Vera, Renzo E.; Li, Qianjin; Kim, Sungjin; Ma, Yongjie; Spyropoulos, Demetri D.; Beharry, Zanna; Huang, Jiaoti; Fernandez-Zapico, Martin E.; Cai, Houjian			Gli Transcription Factors Mediate the Oncogenic Transformation of Prostate Basal Cells Induced by a Kras-Androgen Receptor Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						androgen receptor; GTPase Kras (KRAS); Hedgehog signaling pathway; p63; prostate cancer	HEDGEHOG SIGNALING PATHWAY; STEM-CELLS; MURINE PROSTATE; CANCER; P63; EXPRESSION; OVEREXPRESSION; REARRANGEMENTS; ACTIVATION; SUPPORTS	Although the differentiation of oncogenically transformed basal progenitor cells is one of the key steps in prostate tumorigenesis, the mechanisms mediating this cellular process are still largely unknown. Here we demonstrate that an expanded p63(+) and CK5(+) basal/progenitor cell population, induced by the concomitant activation of oncogenic Kras(G12D) and androgen receptor (AR) signaling, underwent cell differentiation in vivo. The differentiation process led to suppression of p63-expressing cells with a decreased number of CK5(+) basal cells but an increase of CK8(+) luminal tumorigenic cells and revealed a hierarchal lineage pattern consisting of p63(+)/CK5(+) progenitor, CK5(+)/CK8(+) transitional progenitor, and CK8(+) differentiated luminal cells. Further analysis of the phenotype showed that Kras-AR axis-induced tumorigenesis was mediated by Gli transcription factors. Combined blocking of the activators of this family of proteins (Gli1 and Gli2) inhibited the proliferation of p63(+) and CK5(+) basal/progenitor cells and development of tumors. Finally, we identified that Gli1 and Gli2 exhibited different functions in the regulation of p63 expression or proliferation of p63(+) cells in Kras-AR driven tumors. Gli2, but not Gli1, transcriptionally regulated the expression levels of p63 and prostate sphere formation. Our study provides evidence of a novel mechanism mediating pathological dysregulation of basal/progenitor cells through the differential activation of the Gli transcription factors. Also, these findings define Gli proteins as new downstream mediators of the Kras-AR axis in prostate carcinogenesis and open a potential therapeutic avenue of targeting prostate cancer progression by inhibiting Gli signaling.	[Wu, Meng; Ingram, Lishann; Li, Qianjin; Kim, Sungjin; Ma, Yongjie; Cai, Houjian] Univ Georgia, Dept Pharmaceut & Biomed Sci, Coll Pharm, Athens, GA 30602 USA; [Tolosa, Ezequiel J.; Vera, Renzo E.; Fernandez-Zapico, Martin E.] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Spyropoulos, Demetri D.] Med Univ South Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Beharry, Zanna] Florida Gulf Coast Univ, Dept Chem & Phys, Ft Myers, FL 33965 USA; [Huang, Jiaoti] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27710 USA	University System of Georgia; University of Georgia; Mayo Clinic; Medical University of South Carolina; State University System of Florida; Florida Gulf Coast University; Duke University	Cai, HJ (corresponding author), Univ Georgia, Dept Pharmaceut & Biomed Sci, Coll Pharm, Athens, GA 30602 USA.	caihj@uga.edu	Tolosa, Ezequiel J/AAD-9799-2019; Cai, Houjian/AAJ-1290-2020; Wu, Meng/N-9345-2014	Tolosa, Ezequiel J/0000-0001-5167-0782; Huang, Jiaoti/0000-0003-1195-1998; Wu, Meng/0000-0001-8436-2209	National Institutes of Health [R01CA172495, CA136526]; DOD [W81XWH-15-1-0507]; NATIONAL CANCER INSTITUTE [R01CA172495, R01CA136526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01CA172495 (to H. C.) and CA136526 (to M. E. F. Z.) and DOD Grant W81XWH-15-1-0507 (to H. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Aberger F, 2012, VITAM HORM, V88, P25, DOI 10.1016/B978-0-12-394622-5.00002-X; Cai HJ, 2012, CANCER RES, V72, P4672, DOI 10.1158/0008-5472.CAN-12-0228; Cai HJ, 2011, CANCER RES, V71, P862, DOI 10.1158/0008-5472.CAN-10-1605; Caserta TM, 2006, MOL CANCER RES, V4, P759, DOI 10.1158/1541-7786.MCR-05-0149; Chari NS, 2013, CELL DEATH DIFFER, V20, P1080, DOI 10.1038/cdd.2013.41; Chen GC, 2011, BIOCHEM BIOPH RES CO, V404, P809, DOI 10.1016/j.bbrc.2010.12.065; Chen MQ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-89; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Fernandez-Zapico ME, 2008, PANCREATOLOGY, V8, P227, DOI 10.1159/000134271; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Graham L, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0759-3; Huang YQ, 2015, J BIOL CHEM, V290, P17745, DOI 10.1074/jbc.M115.661033; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; KONISHI N, 1992, CANCER-AM CANCER SOC, V69, P2293, DOI 10.1002/1097-0142(19920501)69:9<2293::AID-CNCR2820690915>3.0.CO;2-O; Kumar RMR, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-559; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Li N, 2014, PROSTATE, V74, P1400, DOI 10.1002/pros.22855; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Memmi EM, 2015, P NATL ACAD SCI USA, V112, P3499, DOI 10.1073/pnas.1500762112; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Ngalame NNO, 2016, CHEM RES TOXICOL, V29, P1458, DOI 10.1021/acs.chemrestox.6b00137; Ngalame NNO, 2014, TOXICOL SCI, V142, P489, DOI 10.1093/toxsci/kfu201; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Pandolfi S, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.3; Pignon JC, 2013, P NATL ACAD SCI USA, V110, P8105, DOI 10.1073/pnas.1221216110; Rajurkar M, 2012, P NATL ACAD SCI USA, V109, pE1038, DOI 10.1073/pnas.1114168109; Rimkus TK, 2016, CANCERS, V8, DOI 10.3390/cancers8020022; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Salm SN, 2002, PROSTATE, V51, P175, DOI 10.1002/pros.10075; Salmaninejad A, 2015, CLIN LAB, V61, P749, DOI 10.7754/Clin.Lab.2014.141210; Shigemura K, 2015, CURR DRUG TARGETS, V16, P258, DOI 10.2174/1389450115666141125122643; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang XS, 2011, CANCER DISCOV, V1, P35, DOI 10.1158/2159-8274.CD-10-0022; Wang XQ, 2001, J BIOL CHEM, V276, P1311, DOI 10.1074/jbc.M005191200; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Weber MJ, 2004, J CELL BIOCHEM, V91, P13, DOI 10.1002/jcb.10683; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Zheng DH, 2014, AM J RESP CELL MOL, V50, P595, DOI 10.1165/rcmb.2013-0327OC	49	14	14	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25749	25760		10.1074/jbc.M116.753129	http://dx.doi.org/10.1074/jbc.M116.753129			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27760825	Green Published, hybrid			2022-12-26	WOS:000390095300039
J	Andreu-Fernandez, V; Garcia-Murria, MJ; Bano-Polo, M; Martin, J; Monticelli, L; Orzaez, M; Mingarro, I				Andreu-Fernandez, Vicente; Garcia-Murria, Maria J.; Bano-Polo, Manuel; Martin, Juliette; Monticelli, Luca; Orzaez, Mar; Mingarro, Ismael			The C-terminal Domains of Apoptotic BH3-only Proteins Mediate Their Insertion into Distinct Biological Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE HELIX ASSOCIATION; OUTER MITOCHONDRIAL-MEMBRANE; PARTICLE MESH EWALD; ENDOPLASMIC-RETICULUM; BCL-2 FAMILY; CELL-DEATH; PAIR INTERACTIONS; SEC61 TRANSLOCON; PROLINE RESIDUES; FORCE-FIELD	Changes in the equilibrium of pro-and anti-apoptotic members of the B-cell lymphoma-2 (Bcl-2) protein family in the mitochondrial outer membrane (MOM) induce structural changes that commit cells to apoptosis. Bcl-2 homology-3 (BH3)-only proteins participate in this process by either activating pro-apoptotic effectors or inhibiting anti-apoptotic components and by promoting MOM permeabilization. The association of BH3-only proteins with MOMs is necessary for the activation and amplification of death signals; however, the nature of this association remains controversial, as these proteins lack a canonical transmembrane sequence. Here we used an in vitro expression system to study the insertion capacity of hydrophobic C-terminal regions of the BH3-only proteins Bik, Bim, Noxa, Bmf, and Puma into microsomal membranes. An Escherichia coli complementation assay was used to validate the results in a cellular context, and peptide insertions were modeled using molecular dynamics simulations. We also found that some of the C-terminal domains were sufficient to direct green fluorescent protein fusion proteins to specific membranes in human cells, but the domains did not activate apoptosis. Thus, the hydrophobic regions in the C termini of BH3-only members associated in distinct ways with various biological membranes, suggesting that a detailed investigation of the entire process of apoptosis should include studying the membranes as a setting for protein-protein and protein-membrane interactions.	[Andreu-Fernandez, Vicente; Garcia-Murria, Maria J.; Bano-Polo, Manuel; Mingarro, Ismael] Univ Valencia, Dept Bioquim & Biol Mol, ERI BioTecMed, E-46100 Burjassot, Spain; [Andreu-Fernandez, Vicente; Orzaez, Mar] Ctr Invest Principe Felipe, Lab Peptide & Prot Chem, E-46012 Valencia, Spain; [Martin, Juliette; Monticelli, Luca] CNRS, UMR 5086, BMSSI, 7 Passage Vercors, F-69007 Lyon, France	University of Valencia; Prince Felipe Research Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Mingarro, I (corresponding author), Univ Valencia, Dr Moliner 50, E-46100 Burjassot, Spain.	Ismael.Mingarro@uv.es	Garcia-Murria, Maria-Jesus/A-4855-2019; Polo, Manuel Bano/P-5346-2016; Orzaez, Mar/B-4992-2014; Monticelli, Luca/C-4608-2008; Martin, Juliette/T-9457-2019; Martin, Juliette/N-5545-2016; Mingarro, Ismael/B-4745-2014	Garcia-Murria, Maria-Jesus/0000-0002-8396-0335; Polo, Manuel Bano/0000-0002-4840-4480; Orzaez, Mar/0000-0003-3231-5835; Monticelli, Luca/0000-0002-6352-4595; Martin, Juliette/0000-0002-4787-0885; Martin, Juliette/0000-0002-4787-0885; Mingarro, Ismael/0000-0002-1910-1229; Andreu Fernandez, Vicente/0000-0001-7183-8706	Generalitat Valenciana [PROMETEOII/2014/061]; Spanish Ministry of Economy and Competitiveness [BFU2016-79487]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by Generalitat Valenciana Grant PROMETEOII/2014/061 and Spanish Ministry of Economy and Competitiveness Grant BFU2016-79487. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Andreu-Fernandez V, 2014, ACS CHEM BIOL, V9, P1799, DOI 10.1021/cb5002679; Aranovich A, 2012, MOL CELL, V45, P754, DOI 10.1016/j.molcel.2012.01.030; Baeza-Delgado C, 2016, SCI REP-UK, V6, DOI 10.1038/srep23397; Bano-Polo M, 2013, J MOL BIOL, V425, P830, DOI 10.1016/j.jmb.2012.12.001; Bano-Polo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044263; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen HC, 2015, NAT CELL BIOL, V17, P1270, DOI 10.1038/ncb3236; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Doerflinger M, 2015, FEBS J, V282, P1006, DOI 10.1111/febs.13190; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Germain M, 2002, J BIOL CHEM, V277, P18053, DOI 10.1074/jbc.M201235200; Gomez-Fernandez JC, 2014, CHEM PHYS LIPIDS, V183, P77, DOI 10.1016/j.chemphyslip.2014.05.003; Grespi F, 2010, CELL DEATH DIFFER, V17, P1672, DOI 10.1038/cdd.2010.97; Grimm S, 2012, BBA-MOL CELL RES, V1823, P327, DOI 10.1016/j.bbamcr.2011.11.018; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hill RB, 2015, J MOL BIOL, V427, P2257, DOI 10.1016/j.jmb.2015.04.005; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Jaud S, 2009, P NATL ACAD SCI USA, V106, P11588, DOI 10.1073/pnas.0900638106; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kvansakul M, 2014, METHOD ENZYMOL, V544, P49, DOI 10.1016/B978-0-12-417158-9.00003-0; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; LITHGOW T, 1994, CELL GROWTH DIFFER, V5, P411; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2013, CHEM SOC REV, V42, P6801, DOI 10.1039/c3cs60093a; Martinez-Gil L, 2008, BIOPHYS J, V95, pL36, DOI 10.1529/biophysj.108.138602; Martinez-Gil L, 2007, VIROLOGY, V367, P348, DOI 10.1016/j.virol.2007.06.006; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Orzaez M, 2004, J MOL BIOL, V335, P631, DOI 10.1016/j.jmb.2003.10.062; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; Pang XM, 2014, J BIOL CHEM, V289, P17802, DOI 10.1074/jbc.M114.548172; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Shamas-Din A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008714; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Tamborero S, 2011, J MOL BIOL, V406, P571, DOI 10.1016/j.jmb.2011.01.009; Tatulian SA, 2012, BIOCHEMISTRY-US, V51, P9406, DOI 10.1021/bi301195f; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; Wilfling F, 2012, CELL DEATH DIFFER, V19, P1328, DOI 10.1038/cdd.2012.9; WOOLFSON DN, 1990, FEBS LETT, V277, P185, DOI 10.1016/0014-5793(90)80839-B; Yao Y, 2015, J MOL BIOL, V427, P2262, DOI 10.1016/j.jmb.2015.02.019; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810; Zheng JY, 2008, BIOPHYS J, V94, P286, DOI 10.1529/biophysj.107.104323; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101	52	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25207	25216		10.1074/jbc.M116.733634	http://dx.doi.org/10.1074/jbc.M116.733634			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27758854	Green Published, hybrid			2022-12-26	WOS:000388880100034
J	Funakoshi, T; Aki, T; Tajiri, M; Unuma, K; Uemura, K				Funakoshi, Takeshi; Aki, Toshihiko; Tajiri, Masateru; Unuma, Kana; Uemura, Koichi			Necroptosis-like Neuronal Cell Death Caused by Cellular Cholesterol Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED NECROSIS; ANTIPSYCHOTIC-DRUGS; HOMEOSTASIS; DISEASE; PROTEIN; SREBP; EXPRESSION; BINDING; SCAP; C1	Aberrant cellular accumulation of cholesterol is associated with neuronal lysosomal storage disorders such as Niemann-Pick disease Type C (NPC). We have shown previously that L-norephedrine (L-Nor), a sympathomimetic amine, induces necrotic cell death associated with massive cytoplasmic vacuolation in SH-SY5Y human neuroblastoma cells. To reveal the molecular mechanism underling necrotic neuronal cell death caused by L-Nor, we examined alterations in the gene expression profile of cells during L-Nor exposure. DNA microarray analysis revealed that the gene levels for cholesterol transport (LDL receptor and NPC2) as well as cholesterol biosynthesis (mevalonate pathway enzymes) are increased after exposure to 3 mM L-Nor for similar to 6 h. Concomitant with this observation, the master transcriptional regulator of cholesterol homeostasis, SREBP-2, is activated by L-Nor. The increase in cholesterol uptake as well as biosynthesis is not accompanied by an increase in cholesterol in the plasma membrane, but rather by aberrant accumulation in cytoplasmic compartments. We also found that cell death by L-Nor can be suppressed by nec-1s, an inhibitor of a regulated form of necrosis, necroptosis. Abrogation of SREBP-2 activation by the small molecule inhibitor betulin or by overexpression of dominant-negative SREBP-2 efficiently reduces cell death by L-Nor. The mobilization of cellular cholesterol in the presence of cyclodextrin also suppresses cell death. These results were also observed in primary culture of striatum neurons. Taken together, our results indicate that the excessive uptake as well as synthesis of cholesterol should underlie neuronal cell death by L-Nor exposure, and suggest a possible link between lysosomal cholesterol storage disorders and the regulated form of necrosis in neuronal cells.	[Funakoshi, Takeshi; Aki, Toshihiko; Tajiri, Masateru; Unuma, Kana; Uemura, Koichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Forens Med, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU)	Aki, T (corresponding author), 1-5-45 Yushima,Bunkyo Ku, Tokyo 1138519, Japan.	aki.legm@tmd.ac.jp			Japan Society for the Promotion of Science [25860487]; MEXT [25460862]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant 25860487 (to T. F.) and MEXT KAKENHI Grant 25460862 (to T. A.). The authors declare no conflicts of interest with the contents of this article.	Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Appelqvist H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050262; Appelqvist H, 2011, AM J PATHOL, V178, P629, DOI 10.1016/j.ajpath.2010.10.030; Aqul A, 2011, J NEUROSCI, V31, P9404, DOI 10.1523/JNEUROSCI.1317-11.2011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo E. L., 1988, HYPERTENSION, V11, pII7; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Canfran-Duque A, 2013, J LIPID RES, V54, P310, DOI 10.1194/jlr.M026948; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Dwane Susan, 2013, BMC Res Notes, V6, P366, DOI 10.1186/1756-0500-6-366; Ferno J, 2005, PHARMACOGENOMICS J, V5, P298, DOI 10.1038/sj.tpj.6500323; Ferno J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-69; Funakoshi T, 2013, BRAIN RES, V1490, P9, DOI 10.1016/j.brainres.2012.10.056; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Kernan WN, 2000, NEW ENGL J MED, V343, P1826, DOI 10.1056/NEJM200012213432501; KRUTH HS, 1984, EXP MOL PATHOL, V40, P288, DOI 10.1016/0014-4800(84)90046-7; Lu FR, 2015, ELIFE, V4, DOI 10.7554/eLife.12177; Luu WN, 2016, ANNU REV PHARMACOL, V56, P447, DOI 10.1146/annurev-pharmtox-010715-103233; NORMAN AW, 1972, J BIOL CHEM, V247, P1918; Ordonez MP, 2012, HUM MOL GENET, V21, P2651, DOI 10.1093/hmg/dds090; Peake KB, 2012, J BIOL CHEM, V287, P9290, DOI 10.1074/jbc.M111.326405; PENTEL P, 1984, JAMA-J AM MED ASSOC, V252, P1898, DOI 10.1001/jama.252.14.1898; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Rishi V, 2004, J BIOL CHEM, V279, P11863, DOI 10.1074/jbc.M308000200; Robinet P, 2010, J LIPID RES, V51, P3364, DOI 10.1194/jlr.D007336; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Saraiva D, 2011, J CHROMATOGR B, V879, P3806, DOI 10.1016/j.jchromb.2011.10.021; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Tortelli B, 2014, HUM MOL GENET, V23, P6022, DOI 10.1093/hmg/ddu331; Vance JE, 2005, SEMIN CELL DEV BIOL, V16, P193, DOI 10.1016/j.semcdb.2005.01.005; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Vik-Mo Audun O., 2009, BMC Pharmacology, V9, P10, DOI 10.1186/1471-2210-9-10; Yamanaka K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.524; Yamanaka K, 2011, J BIOL CHEM, V286, P24666, DOI 10.1074/jbc.M111.236273; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yen M, 2012, J MED TOXICOL, V8, P145, DOI 10.1007/s13181-012-0213-7; Zhou W, 2014, SEMIN CELL DEV BIOL, V35, P14, DOI 10.1016/j.semcdb.2014.07.013	47	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25050	25065		10.1074/jbc.M116.727404	http://dx.doi.org/10.1074/jbc.M116.727404			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27756839	Green Published, hybrid			2022-12-26	WOS:000388880100021
J	Hinz, JM; Laughery, MF; Wyrick, JJ				Hinz, John M.; Laughery, Marian F.; Wyrick, John J.			Nucleosomes Selectively Inhibit Cas9 Off-target Activity at a Site Located at the Nucleosome Edge	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA CLEAVAGE; RNA; CRISPR-CAS9; SPECIFICITY; NUCLEASES; ENDONUCLEASE; ENABLES	Nucleosomes affect Cas9 binding and activity at on-target sites, but their impact at off-target sites is unknown. To investigate how nucleosomes affect Cas9 cleavage at off-target sites in vitro, we used a single guide RNA (sgRNA) that has been previously shown to efficiently direct Cas9 cleavage at the edge of the strongly positioned 601 nucleosome. Our data indicate that single mismatches between the sgRNA and DNA target have relatively little effect on Cas9 cleavage of naked DNA substrates, but strongly inhibit cleavage of nucleosome substrates, particularly when the mismatch is in the sgRNA "seed" region. These findings indicate that nucleosomes may enhance Cas9 specificity by inhibiting cleavage of off-target sites at the nucleosome edge.	Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University; Washington State University	Wyrick, JJ (corresponding author), Washington State Univ, Sch Mol Biosci, Biotechnol Life Sci 241, Pullman, WA 99164 USA.	jwyrick@vetmed.wsu.edu		Wyrick, John/0000-0002-7911-3803	National Institutes of Health from the NIEHS [ES002614]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002614, R01ES002614] Funding Source: NIH RePORTER	National Institutes of Health from the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant ES002614 (to J. J. W.) from the NIEHS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; DUNN K, 1980, NUCLEIC ACIDS RES, V8, P555, DOI 10.1093/nar/8.3.555; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hinz JM, 2015, BIOCHEMISTRY-US, V54, P7063, DOI 10.1021/acs.biochem.5b01108; Hodges AJ, 2015, GENETICS, V200, P795, DOI 10.1534/genetics.115.175885; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; HOVATTER KR, 1987, P NATL ACAD SCI USA, V84, P1162, DOI 10.1073/pnas.84.5.1162; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Singh R, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv575; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004	25	13	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24851	24856		10.1074/jbc.C116.758706	http://dx.doi.org/10.1074/jbc.C116.758706			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27756838	hybrid, Green Published			2022-12-26	WOS:000388880100005
J	Alcolea, PJ; Alonso, A; Garcia-Tabares, F; Mena, MC; Ciordia, S; Larraga, V				Alcolea, Pedro J.; Alonso, Ana; Garcia-Tabares, Francisco; Mena, Maria C.; Ciordia, Sergio; Larraga, Vicente			Increased Abundance of Proteins Involved in Resistance to Oxidative and Nitrosative Stress at the Last Stages of Growth and Development of Leishmania amazonensis Promastigotes Revealed by Proteome Analysis	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; ADENOSINE KINASE; NITRIC-OXIDE; IDENTIFICATION; INFANTUM; MEXICANA; ANTIGENS; TARGETS; GENOME; METACYCLOGENESIS	Leishmania amazonensis is one of the major etiological agents of the neglected, stigmatizing disease termed american cutaneous leishmaniasis (ACL). ACL is a zoonosis and rodents are the main reservoirs. Most cases of ACL are reported in Brazil, Bolivia, Colombia and Peru. The biological cycle of the parasite is digenetic because sand fly vectors transmit the motile promastigote stage to the mammalian host dermis during blood meal intakes. The amastigote stage survives within phagocytes of the mammalian host. The purpose of this study is detection and identification of changes in protein abundance by 2DE/ MALDI-TOF/TOF at the main growth phases of L. amazonensis promastigotes in axenic culture and the differentiation process that takes place simultaneously. The average number of proteins detected per gel is 202 and the non-redundant cumulative number is 339. Of those, 63 are differentially abundant throughout growth and simultaneous differentiation of L. amazonensis promastigotes. The main finding is that certain proteins involved in resistance to nitrosative and oxidative stress are more abundant at the last stages of growth and differentiation of cultured L. amazonensis promastigotes. These proteins are the arginase, a light variant of the tryparedoxin peroxidase, the iron superoxide dismutase, the regulatory subunit of the protein kinase A and a light HSP70 variant. These data taken together with the decrease of the stress-inducible protein 1 levels are additional evidence supporting the previously described pre-adaptative hypothesis, which consists of preparation in advance towards the amastigote stage.	[Alcolea, Pedro J.; Alonso, Ana; Garcia-Tabares, Francisco; Larraga, Vicente] CSIC, Ctr Invest Biol, Dept Microbiol Mol & Biol Infecc, Calle Ramiro de Maeztu 9, Madrid 28040, Spain; [Alcolea, Pedro J.; Alonso, Ana; Garcia-Tabares, Francisco; Larraga, Vicente] CSIC, Ctr Invest Biol, Serv Prote & Genom, Calle Ramiro de Maeztu 9, Madrid 28040, Spain; [Mena, Maria C.; Ciordia, Sergio] CSIC, Ctr Nacl Biotecnol, Unidad Prote, Calle Darwin 3, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Alcolea, PJ (corresponding author), CSIC, Ctr Invest Biol, Dept Microbiol Mol & Biol Infecc, Calle Ramiro de Maeztu 9, Madrid 28040, Spain.; Alcolea, PJ (corresponding author), CSIC, Ctr Invest Biol, Serv Prote & Genom, Calle Ramiro de Maeztu 9, Madrid 28040, Spain.	pjalcolea@cib.csic.es	Alcolea Alcolea, Pedro José/O-5654-2016	Alcolea Alcolea, Pedro José/0000-0002-0729-8941; Larraga, Vicente/0000-0003-1260-7400; Mena, Maria Carmen/0000-0002-6453-2132; Alonso Ayala, Ana Maria/0000-0002-1228-7331; Ciordia, Sergio/0000-0002-5726-853X	Spanish Ministry of Economy and Competitiveness [AGL2010-21806-C02-01]; Fundacion Ramon Areces [050204100014, 20100338]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacion Ramon Areces	This work was supported by AGL2010-21806-C02-01 (Spanish Ministry of Economy and Competitiveness, formerly Spanish Ministry of Science and Innovation); 050204100014, OTT code 20100338 (Fundacion Ramon Areces). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolea PJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004693; Alcolea PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113837; Alcolea PJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-849; Alcolea PJ, 2011, J EUKARYOT MICROBIOL, V58, P352, DOI 10.1111/j.1550-7408.2011.00549.x; Alcolea PJ, 2010, INT J PARASITOL, V40, P1497, DOI 10.1016/j.ijpara.2010.05.013; Alcolea Pedro J, 2010, BMC Genomics, V11, P31, DOI 10.1186/1471-2164-11-31; Alcolea PJ, 2009, GENOMICS, V93, P551, DOI 10.1016/j.ygeno.2009.01.007; Alcolea PJ, 2011, ANALISIS PERFILES EX; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Barrett MP, 1999, TRENDS MICROBIOL, V7, P82, DOI 10.1016/S0966-842X(98)01433-4; Bates PA, 2006, TRENDS PARASITOL, V22, P447, DOI 10.1016/j.pt.2006.08.003; Bhaskar, 2015, FEBS J, V282, P4607, DOI 10.1111/febs.13521; Bhattacharya A, 2012, MOL MICROBIOL, V83, P548, DOI 10.1111/j.1365-2958.2011.07950.x; Brandes N, 2007, MOL MICROBIOL, V66, P901, DOI 10.1111/j.1365-2958.2007.05964.x; Bras-Goncalves R, 2014, INFECT GENET EVOL, V24, P1, DOI 10.1016/j.meegid.2014.02.017; Brobey Reynolds K. B., 2006, Braz J Infect Dis, V10, P1, DOI 10.1590/S1413-86702006000100001; Brobey RKB, 2007, PROTEOMICS, V7, P116, DOI 10.1002/pmic.200600587; Brown GC, 1997, BIOCHEM SOC T, V25, P901, DOI 10.1042/bst0250901; Carrillo E, 2008, VACCINE, V26, P1902, DOI 10.1016/j.vaccine.2008.01.042; Castro H, 2002, FREE RADICAL BIO MED, V33, P1552, DOI 10.1016/S0891-5849(02)01089-4; Chakraborty A, 2004, BIOCHEMISTRY-US, V43, P11862, DOI 10.1021/bi049490o; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Convit J, 1946, REV PAT CLIN, V17, P153; COOMBS GH, 1982, MOL BIOCHEM PARASIT, V5, P199, DOI 10.1016/0166-6851(82)90021-4; Croft SL, 2002, CURR PHARM DESIGN, V8, P319, DOI 10.2174/1381612023396258; Davis AJ, 2004, J BIOL CHEM, V279, P12462, DOI 10.1074/jbc.M312365200; de Toledo Juliano S., 2010, Open Parasitology Journal, V4, P156; Depledge DP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000476; do Monte-Neto RL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001167; Dominguez M, 2001, PARASITE IMMUNOL, V23, P259, DOI 10.1046/j.1365-3024.2001.00380.x; Gaur U, 2007, J IMMUNOL, V179, P8446, DOI 10.4049/jimmunol.179.12.8446; Genestra M, 2004, CELL BIOCHEM FUNCT, V22, P315, DOI 10.1002/cbf.1107; Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096; Gonzalez-Aseguinolaza G, 1999, EUR J BIOCHEM, V259, P909, DOI 10.1046/j.1432-1327.1999.00122.x; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guerra DG, 2004, EUR J BIOCHEM, V271, P1798, DOI 10.1111/j.1432-1033.2004.04097.x; Gupta SK, 2007, PROTEOMICS, V7, P816, DOI 10.1002/pmic.200600725; Holzer TR, 2006, MOL BIOCHEM PARASIT, V146, P198, DOI 10.1016/j.molbiopara.2005.12.009; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kushawaha PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045766; Leifso K, 2007, MOL BIOCHEM PARASIT, V152, P35, DOI 10.1016/j.molbiopara.2006.11.009; Lynn MA, 2013, J PROTEOMICS, V82, P179, DOI 10.1016/j.jprot.2013.02.010; Magalhaes RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002764; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muleme HM, 2009, J IMMUNOL, V183, P8068, DOI 10.4049/jimmunol.0803979; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Pires SD, 2014, J PROTEOME RES, V13, P1860, DOI 10.1021/pr400923g; Ramos I, 2009, VACCINE, V27, P6695, DOI 10.1016/j.vaccine.2009.08.091; Rhee KY, 2005, P NATL ACAD SCI USA, V102, P467, DOI 10.1073/pnas.0406133102; Richardson AR, 2011, CELL HOST MICROBE, V10, P33, DOI 10.1016/j.chom.2011.06.004; Rosenzweig D, 2008, PROTEOMICS, V8, P1843, DOI 10.1002/pmic.200701043; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Sen B, 2007, BIOCHEMISTRY-US, V46, P7832, DOI 10.1021/bi602625h; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Tetaud E, 1998, MOL BIOCHEM PARASIT, V96, P111, DOI 10.1016/S0166-6851(98)00120-0; Verlinde CLM, 2001, DRUG RESIST UPDATE, V4, P50, DOI 10.1054/drup.2000.0177; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WHO, 2010, WHO TECH REP SER, V949, P1; WHO, 2015, LEISHM EP REP AM 201; Wiesgigl M, 2001, MED MICROBIOL IMMUN, V190, P27, DOI 10.1007/s004300100074; Yano M, 1997, FEBS LETT, V419, P244, DOI 10.1016/S0014-5793(97)01469-5; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	63	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164344	10.1371/journal.pone.0164344	http://dx.doi.org/10.1371/journal.pone.0164344			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776144	Green Published, Green Submitted, gold			2022-12-26	WOS:000389009200010
J	Kim, DW; Kim, EJ; Kim, EN; Sung, MW; Kwon, TK; Cho, YW; Kwon, SK				Kim, Dong Wook; Kim, Eun Ji; Kim, Eun Na; Sung, Myung Whun; Kwon, Tack-Kyun; Cho, Yong Woo; Kwon, Seong Keun			Human Adipose Tissue Derived Extracellular Matrix and Methylcellulose Hydrogels Augments and Regenerates the Paralyzed Vocal Fold	PLOS ONE			English	Article							FAT INJECTION LARYNGOPLASTY; TERM FOLLOW-UP; XENOGRAFT MODEL; CORD PARALYSIS; SCAFFOLD; TRANSPLANTATION; STRATEGIES; DELIVERY; SURGERY	Vocal fold paralysis results from various etiologies and can induce voice changes, swallowing complications, and issues with aspiration. Vocal fold paralysis is typically managed using injection laryngoplasty with fat or synthetic polymers. Injection with autologous fat has shown excellent biocompatibility. However, it has several disadvantages such as unpredictable resorption rate, morbidities associated with liposuction procedure which has to be done in operating room under general anesthesia. Human adipose-derived extracellular matrix (ECM) grafts have been reported to form new adipose tissue and have greater biostability than autologous fat graft. Here, we present an injectable hydrogel that is constructed from adipose tissue derived soluble extracellular matrix (sECM) and methylcellulose (MC) for use in vocal fold augmentation. Human sECM derived from adipose tissue was extracted using two major steps-ECM was isolated from human adipose tissue and was subsequently solubilized. Injectable sECM/MC hydrogels were prepared by blending of sECM and MC. Sustained vocal fold augmentation and symmetric vocal fold vibration were accomplished by the sECM/MC hydrogel in paralyzed vocal fold which were confirmed by laryngoscope, histology and a high-speed imaging system. There were increased number of collagen fibers and fatty granules at the injection site without significant inflammation or fibrosis. Overall, these results indicate that the sECM/MC hydrogel can enhance vocal function in paralyzed vocal folds without early resorption and has potential as a promising material for injection laryngoplasty for stable vocal fold augmentation which can overcome the shortcomings of autologous fat such as unpredictable duration and morbidity associated with the fat harvest.	[Kim, Dong Wook; Sung, Myung Whun; Kwon, Tack-Kyun; Kwon, Seong Keun] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul Natl Univ Hosp, Seoul, South Korea; [Kim, Eun Ji; Cho, Yong Woo] Hanyang Univ, Dept Chem Engn, Ansan 426791, Gyeonggi Do, South Korea; [Kim, Eun Na] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Hanyang University; University of Ulsan; Asan Medical Center	Kwon, SK (corresponding author), Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul Natl Univ Hosp, Seoul, South Korea.; Cho, YW (corresponding author), Hanyang Univ, Dept Chem Engn, Ansan 426791, Gyeonggi Do, South Korea.	ywcho77@gmail.com; otolarynx@snuh.org	Kim, Eun Na/GVU-5478-2022		National Research Foundation of Korea [NRF-2014R1A2A2A04003979]; Korea Health Industry Development Institute [HI14C1541, HI15C3049]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI))	This research was supported by National Research Foundation of Korea (https://www.nrf.re.kr) Grant # NRF-2014R1A2A2A04003979 to SKK, Korea Health Industry Development Institute (https://www.khidi.or.kr) Grant # HI14C1541 to SKK and the Korea Health Industry Development Institute HI15C3049 to SKK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad J, 2011, AESTHET SURG J, V31, P214, DOI 10.1177/1090820X10395508; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; CHAJCHIR A, 1989, PLAST RECONSTR SURG, V84, P921, DOI 10.1097/00006534-198912000-00009; Chen CZC, 2009, FIBROGENESIS TISSUE, V2, DOI 10.1186/1755-1536-2-7; Cho SW, 2005, BIOMATERIALS, V26, P3577, DOI 10.1016/j.biomaterials.2004.09.013; Choi JS, 2010, TISSUE ENG PART C-ME, V16, P387, DOI [10.1089/ten.tec.2009.0276, 10.1089/ten.TEC.2009.0276]; Choi JS, 2011, J BIOMED MATER RES A, V97A, P292, DOI 10.1002/jbm.a.33056; Choi JS, 2009, J CONTROL RELEASE, V139, P2, DOI 10.1016/j.jconrel.2009.05.034; Craft RO, 2009, J PLAST RECONSTR AES, V62, P235, DOI 10.1016/j.bjps.2007.11.017; DeFatta RA, 2012, J VOICE, V26, P614, DOI 10.1016/j.jvoice.2011.08.005; Fang TJ, 2010, ARCH OTOLARYNGOL, V136, P457, DOI 10.1001/archoto.2010.42; Fonseca-Alaniz MH, 2007, J PEDIAT-BRAZIL, V83, pS192, DOI [10.1590/S0021-75572007000700011, 10.2223/JPED.1709]; Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6; Han KD, 2012, AESTHET SURG J, V32, P745, DOI 10.1177/1090820X12452422; Havas TE, 2003, ANZ J SURG, V73, P938, DOI 10.1046/j.1445-2197.2003.02824.x; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Kim DY, 2003, ACTA OTO-LARYNGOL, V123, P1102, DOI 10.1080/00016480310001880; Kwon SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085512; Kwon SK, 2013, LARYNGOSCOPE, V123, P1694, DOI 10.1002/lary.23879; Kwon Tack-Kyun, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P538, DOI 10.1097/01.moo.0000144393.40874.98; Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269; McCulloch TM, 2002, LARYNGOSCOPE, V112, P1235, DOI 10.1097/00005537-200207000-00017; MIKUS JL, 1995, LARYNGOSCOPE, V105, P17, DOI 10.1288/00005537-199501000-00007; Mizuta M, 2013, LARYNGOSCOPE; NIECHAJEV I, 1994, PLAST RECONSTR SURG, V94, P496, DOI 10.1097/00006534-199409000-00012; O'Leary MA, 2006, OTOLARYNG CLIN N AM, V39, P43, DOI 10.1016/j.otc.2005.10.008; Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113; Philips BJ, 2013, PLAST RECONSTR SURG, V132, P845, DOI 10.1097/PRS.0b013e31829fe5b1; PINSKI KS, 1992, J DERMATOL SURG ONC, V18, P179, DOI 10.1111/j.1524-4725.1992.tb02795.x; Fraga MFP, 2008, J PLAST RECONSTR AES, V61, P1044, DOI 10.1016/j.bjps.2007.06.034; Umeno H, 2009, J LARYNGOL OTOL, V123, P35, DOI 10.1017/S0022215109005064; Umeno H, 2012, ANN OTO RHINOL LARYN, V121, P185, DOI 10.1177/000348941212100308; Veidal SS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-5	33	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165265	10.1371/journal.pone.0165265	http://dx.doi.org/10.1371/journal.pone.0165265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768757	gold, Green Submitted, Green Published			2022-12-26	WOS:000386205400074
J	Mathew, B; Hobrath, JV; Ross, L; Connelly, MC; Lofton, H; Rajagopalan, M; Guy, RK; Reynolds, RC				Mathew, Bini; Hobrath, Judith Varady; Ross, Larry; Connelly, Michele C.; Lofton, Hava; Rajagopalan, Malini; Guy, R. Kiplin; Reynolds, Robert C.			Screening and Development of New Inhibitors of FtsZ from M-Tuberculosis	PLOS ONE			English	Article							DIVISION PROTEIN FTSZ; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; FAMILIAL ADENOMATOUS POLYPOSIS; SMALL-MOLECULE INHIBITORS; COLON-CANCER CELLS; ANTIBACTERIAL ACTIVITY; SULINDAC DERIVATIVES; IN-VITRO; DISCOVERY; APOPTOSIS	A variety of commercial analogs and a newer series of Sulindac derivatives were screened for inhibition of M. tuberculosis (Mtb) in vitro and specifically as inhibitors of the essential mycobacterial tubulin homolog, FtsZ. Due to the ease of preparing diverse analogs and a favorable in vivo pharmacokinetic and toxicity profile of a representative analog, the Sulindac scaffold may be useful for further development against Mtb with respect to in vitro bacterial growth inhibition and selective activity for Mtb FtsZ versus mammalian tubulin. Further discovery efforts will require separating reported mammalian cell activity from both antibacterial activity and inhibition of Mtb FtsZ. Modeling studies suggest that these analogs bind in a specific region of the Mtb FtsZ polymer that differs from human tubulin and, in combination with a pharmacophore model presented herein, future hybrid analogs of the reported active molecules that more efficiently bind in this pocket may improve antibacterial activity while improving other drug characteristics.	[Reynolds, Robert C.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Reynolds, Robert C.] Univ Alabama Birmingham, Div Hematol & Oncol, Birmingham, AL 35294 USA; [Mathew, Bini; Ross, Larry] Southern Res Inst, Drug Discovery Div, 2000 Ninth Ave South, Birmingham, AL 35205 USA; [Hobrath, Judith Varady] Univ Dundee, Coll Life Sci, Drug Discovery Unit, Dundee DD1 5EH, Scotland; [Connelly, Michele C.; Guy, R. Kiplin] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Lofton, Hava; Rajagopalan, Malini] Univ Texas Tyler, Hlth Sci Ctr, Tyler, TX 75708 USA; [Lofton, Hava] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Dundee; St Jude Children's Research Hospital; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); Uppsala University	Reynolds, RC (corresponding author), Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA.; Reynolds, RC (corresponding author), Univ Alabama Birmingham, Div Hematol & Oncol, Birmingham, AL 35294 USA.	rcr12lkt@uab.edu			National Institutes of Health [1 R01 AI50470-01A1, R01 AI48417]; National Cancer Institute [1 R01 CA131378]; United States Department of Defense Era of Hope Idea Award [W81XWH-07-1-0463]; NIH TAACF Program [N01-AI-95364, N01-AI-15449, NO1 Al-95385]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital Memphis, TN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095364] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Defense Era of Hope Idea Award(United States Department of Defense); NIH TAACF Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital Memphis, TN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Primary support for this study was provided through the National Institutes of Health (http://www.nih.gov/) grants 1 R01 AI50470-01A1 (P.I.: RCR) and R01 AI48417 (P.I.: MR). This work was supported in part by the National Cancer Institute (http://www.cancer.gov) grant 1 R01 CA131378 (P.I.: RCR) and also by the United States Department of Defense (http://www.defense.gov) Era of Hope Idea Award W81XWH-07-1-0463 (P.I.: RCR) through supplying samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the NIH TAACF Program (Drs. Barbara Laughon and Robert Goldman, NIH Contract Officers), particularly contracts N01-AI-95364 (acquisition and data management contract), N01-AI-15449 (HTS contract) and contract NO1 Al-95385 [in vivo contract, Dr. Anne Lenaerts (P.I.), Colorado State University] for screening Zantrin Z2 in advanced screens. We gratefully acknowledge the University of Mississippi National Center for Natural Product Research for Sanguinarine and Pseudojatorrhizine. Totarol was a kind gift of Industrial Research Limited (New Zealand). We thank both Ms. E. Lucile White and Ms. Lynn Rasmussen for HTS services, and Dr. Kochurani Jacob for synthetic support. We thank Dr. William J. Suling for providing activity data of certain analogs against Mtb H<INF>37</INF>Ra and MAC NJ211. The M. avium strains were kindly provided by Dr. Leonid Heifets, National Jewish Center for Immunology and Respiratory Diseases, Denver, CO, USA. We would also like to acknowledge contributions by the High Throughput Biology Center in the Department of Chemical Biology and Therapeutics at St. Jude Children's Research Hospital in Memphis, TN. The screening at St. Jude Children's Hospital was supported in part by the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital Memphis, TN.	AbdelMagid AF, 1996, J ORG CHEM, V61, P3849, DOI 10.1021/jo960057x; Agarwal B, 1999, GASTROENTEROLOGY, V117, P838, DOI 10.1016/S0016-5085(99)70342-2; Al-Janabi AAHS, 2009, ASIAN J PHARM, V3, P148, DOI 10.4103/0973-8398.55054; Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Anderson DE, 2012, ACS CHEM BIOL, V7, P1918, DOI 10.1021/cb300340j; Bartzatt R, 2003, BIOTECHNOL APPL BIOC, V37, P273, DOI 10.1042/BA20020108; Beuria TK, 2005, BIOCHEMISTRY-US, V44, P16584, DOI 10.1021/bi050767+; Bhattacharya A, 2013, FEBS J, V280, P4585, DOI 10.1111/febs.12429; CARPINO LA, 1993, J AM CHEM SOC, V115, P4397, DOI 10.1021/ja00063a082; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Cheepsattayakorn Attapon, 2012, Recent Pat Antiinfect Drug Discov, V7, P141; Chennamaneni S, 2012, EUR J MED CHEM, V56, P17, DOI 10.1016/j.ejmech.2012.08.005; Chowdhury B, 1996, MED SCI RES, V24, P801; Domadia P, 2007, BIOCHEM PHARMACOL, V74, P831, DOI 10.1016/j.bcp.2007.06.029; DOURTOGLOU V, 1984, SYNTHESIS-STUTTGART, P572, DOI 10.1055/s-1984-30895; Duggirala S, 2014, APPL BIOCHEM BIOTECH, V174, P283, DOI 10.1007/s12010-014-1056-2; ERICKSON HP, 1995, CELL, V80, P367, DOI 10.1016/0092-8674(95)90486-7; Goldman R. C., 2007, Infectious Disorders - Drug Targets, V7, P92; Goldman RC, 2009, TUBERCULOSIS, V89, P331, DOI 10.1016/j.tube.2009.07.007; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Ito H, 2006, MICROBIOL IMMUNOL, V50, P759, DOI 10.1111/j.1348-0421.2006.tb03851.x; Jaiswal R, 2007, BIOCHEMISTRY-US, V46, P4211, DOI 10.1021/bi602573e; Keller JJ, 1999, GUT, V45, P822, DOI 10.1136/gut.45.6.822; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Kumar K, 2011, J MED CHEM, V54, P374, DOI 10.1021/jm1012006; Kumar K, 2010, FUTURE MED CHEM, V2, P1305, DOI [10.4155/fmc.10.220, 10.4155/FMC.10.220]; Ma S, 2012, CHEMMEDCHEM, V7, P1161, DOI 10.1002/cmdc.201200156; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Martin-Galiano AJ, 2010, J BIOL CHEM, V285, P22554, DOI 10.1074/jbc.M110.117127; Mathew B, 2013, TUBERCULOSIS, V93, P398, DOI 10.1016/j.tube.2013.04.002; Mathew B, 2011, BIOORGAN MED CHEM, V19, P7120, DOI 10.1016/j.bmc.2011.09.062; MIYAMOTO K, 1992, J AM CHEM SOC, V114, P6256, DOI 10.1021/ja00041a060; Nakka M, 2011, J CHEM PHARM RES, V3, P581; Panda P, 2015, BIOCHEM J, V471, P335, DOI 10.1042/BJ20150467; Piazza GA, 2010, PHARMACEUTICALS, V3, P1652, DOI 10.3390/ph3051652; Piazza GA, 2009, CANCER PREV RES, V2, P572, DOI 10.1158/1940-6207.CAPR-09-0001; Rahman MA, 2000, CANCER RES, V60, P2085; Ray S, 2015, FEBS J, V282, P4015, DOI 10.1111/febs.13403; Reynolds RC, 2004, BIOORG MED CHEM LETT, V14, P3161, DOI 10.1016/j.bmcl.2004.04.012; Schaffner-Barbero C, 2012, ACS CHEM BIOL, V7, P268, DOI 10.1021/cb2003626; Shirin H, 2006, J GASTROEN HEPATOL, V21, P1388, DOI 10.1111/j.1440-1746.2006.04194.x; Singh P, 2012, BIOCHEMISTRY-US, V51, P5434, DOI 10.1021/bi201813u; Sperl G, 2000, U. S. Patent, Patent No. [6028116 A 20000222, 20006028116]; Stokes NR, 2013, ANTIMICROB AGENTS CH, V57, P317, DOI 10.1128/AAC.01580-12; Stoner GD, 1999, ADV EXP MED BIOL, V470, P45; TEMPLE C, 1968, J MED CHEM, V11, P1216, DOI 10.1021/jm00312a024; Tsai CM, 1996, CANCER RES, V56, P1068; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; White EL, 2002, J ANTIMICROB CHEMOTH, V50, P111, DOI 10.1093/jac/dkf075; White EL, 2000, J BACTERIOL, V182, P4028, DOI 10.1128/JB.182.14.4028-4034.2000; World Health Organization, GLOB TUB REP 2015; Xiao D, 2006, MOL CANCER THER, V5, P60, DOI 10.1158/1535-7163.MCT-05-0260; Zarghi A, 2011, IRAN J PHARM RES, V10, P655; Zhang YQ, 2012, J MED CHEM, V55, P4205, DOI 10.1021/jm201642z	54	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164100	10.1371/journal.pone.0164100	http://dx.doi.org/10.1371/journal.pone.0164100			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768711	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400005
J	Wang, Y; Si, SY; Liu, JL; Wang, ZY; Jia, HY; Feng, K; Sun, LL; Song, SJ				Wang, Ying; Si, Shaoyan; Liu, Junli; Wang, Zongye; Jia, Haiying; Feng, Kai; Sun, Lili; Song, Shu Jun			The Associations of Serum Lipids with Vitamin D Status	PLOS ONE			English	Article							HEART-DISEASE RISK; PARATHYROID-HORMONE; ESTERIFICATION RATE; ATHEROGENIC INDEX; HDL-CHOLESTEROL; D DEFICIENCY; METAANALYSIS; PLASMA; PARAMETERS; CALCIUM	Aims Vitamin D deficiency has been associated with some disorders including cardiovascular diseases. Dyslipidemia is a major risk factor for cardiovascular diseases. However, data about the relationships between vitamin D and lipids are inconsistent. The relationship of vitamin D and Atherogenic Index of Plasma (AIP), as an excellent predictor of level of small and dense LDL, has not been reported. The objective of this study was to investigate the effects of vitamin D status on serum lipids in Chinese adults. Methods The study was carried out using 1475 participants from the Center for Physical Examination, 306 Hospital of PLA in Beijing, China. Fasting blood samples were collected and serum concentrations of 25(OH) D, total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C) were measured. AIP was calculated based on the formula: log [TG/HDL-C]. Multiple linear regression analysis was used to estimate the associations between serum 25(OH) D and lipids. The association between the occurrences of dyslipidemias and vitamin D levels was assessed by multiple logistic regression analysis. Confounding factors, age and BMI, were used for the adjustment. Results The median of serum 25(OH) D concentration was 47 (27-92.25) nmol/L in all subjects. The overall percentage of 25(OH)D <= 50 nmol/L was 58.5% (males 54.4%, females 63.7%). The serum 25(OH)D levels were inversely associated with TG (beta coefficient = -0.24, p < 0.001) and LDL-C (beta coefficient = -0.34, p < 0.001) and positively associated with TC (beta coefficient = 0.35, p < 0.002) in men. The associations between serum 25(OH)D and LDLC (beta coefficient = -0.25, p = 0.01) and TC (beta coefficient = 0.39, p = 0.001) also existed in women. The serum 25(OH)D concentrations were negatively associated with AIP in men (r = -0.111, p < 0.01) but not in women. In addition, vitamin D deficient men had higher AIP values than vitamin D sufficient men. Furthermore, the occurrences of dyslipidemias reduced HDL-C, elevated TG and elevated AIP) correlated with lower 25(OH)D levels in men, whereas the higher TC and LDL-C associated with higher 25(OH) D levels in women. Conclusion It seems that the serum 25(OH)D levels are closely associated with the serum lipids and AIP. Vitamin D deficiency may be associated with the increased risk of dyslipidemias, especially in men. The association between vitamin D status and serum lipids may differ by genders.	[Wang, Ying; Si, Shaoyan; Liu, Junli; Wang, Zongye; Feng, Kai; Song, Shu Jun] 306th Hosp PLA, Ctr Special Med & Expt Res, Beijing, Peoples R China; [Jia, Haiying; Sun, Lili] 306th Hosp PLA, Ctr Phys Examinat, Beijing, Peoples R China		Song, SJ (corresponding author), 306th Hosp PLA, Ctr Special Med & Expt Res, Beijing, Peoples R China.	shuj80@126.com	Sun, lili/GQH-2057-2022					Birtcher KK, 2004, CIRCULATION, V110, pE296, DOI 10.1161/01.CIR.0000141564.89465.4E; Bolland MJ, 2010, AM J CLIN NUTR, V91, P82, DOI 10.3945/ajcn.2009.28424; Burgaz A, 2011, J HYPERTENS, V29, P636, DOI 10.1097/HJH.0b013e32834320f9; Cho HJ, 2005, BIOL PHARM BULL, V28, P1418, DOI 10.1248/bpb.28.1418; Cho Y, 2015, ANN LAB MED, V35, P586, DOI 10.3343/alm.2015.35.6.586; Christensen R, 2009, OBES REV, V10, P475, DOI 10.1111/j.1467-789X.2009.00599.x; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Delvin E, 2014, CRIT REV CL LAB SCI, V51, P232, DOI 10.3109/10408363.2014.901291; Dobiasova M, 2006, Vnitr Lek, V52, P64; Dobiasova M, 2000, Vnitr Lek, V46, P152; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Dokic B, 2015, CENT EUR J PUBL HEAL, V23, P195; Enko D, 2015, BIOCHEM MEDICA, V25, P203, DOI 10.11613/BM.2015.020; Frohlich J, 2003, CLIN CHEM, V49, P1873, DOI 10.1373/clinchem.2003.022558; Gaddipati VC, 2011, J AM MED DIR ASSOC, V12, P58, DOI 10.1016/j.jamda.2010.02.006; Heidari B, 2015, AM HEART J, V170, P573, DOI 10.1016/j.ahj.2015.06.017; Holick MF, 2011, CURR DRUG TARGETS, V12, P4; Howard BV, 1999, AM J CARDIOL, V84, p28J; Jiang W, 2006, BIOCHEM BIOPH RES CO, V351, P176, DOI 10.1016/j.bbrc.2006.10.027; Jorde R, 2010, EUR J CLIN NUTR, V64, P1457, DOI 10.1038/ejcn.2010.176; Jungert A, 2015, PUBLIC HEALTH NUTR, V18, P1684, DOI 10.1017/S1368980014002286; Karhapaa P, 2010, J Intern Med, V268, P604, DOI 10.1111/j.1365-2796.2010.02279.x; Karnchanasorn R, 2012, PANCREAS, V41, P863, DOI 10.1097/MPA.0b013e31823c947c; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Lemieux I, 2001, ARCH INTERN MED, V161, P2685, DOI 10.1001/archinte.161.22.2685; Maghbooli Z, 2008, DIABETES-METAB RES, V24, P27, DOI 10.1002/dmrr.737; Mazidi M, 2015, PAK J MED SCI, V31, P1250, DOI 10.12669/pjms.315.7649; Nik MHS, 2014, INT J ENDOCRINOL MET, V12, DOI 10.5812/ijem.16967; Nsengiyumva V, 2015, ATHEROSCLEROSIS, V243, P645, DOI 10.1016/j.atherosclerosis.2015.10.011; Onat A, 2010, J CLIN LIPIDOL, V4, P89, DOI 10.1016/j.jacl.2010.02.005; Pirro M, 2012, J ATHEROSCLER THROMB, V19, P924, DOI 10.5551/jat.13128; Polkowska Agnieszka, 2015, Pediatr Endocrinol Diabetes Metab, V20, P47, DOI 10.18544/PEDM-20.02.0002; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; Rosen CJ, 2012, J CLIN ENDOCR METAB, V97, P1146, DOI 10.1210/jc.2011-2218; Rosenson RS, 2016, NAT REV CARDIOL, V13, P48, DOI 10.1038/nrcardio.2015.124; Schnatz PF, 2015, MENOPAUSE, V22, P554, DOI [10.1097/gme.0000000000000399, 10.1097/GME.0000000000000399]; Shen H, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0143-x; Skaaby T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057647; Skaaby T, 2012, CARDIOLOGY, V123, P62, DOI 10.1159/000341277; Song SJ, 2013, PUBLIC HEALTH NUTR, V16, P687, DOI 10.1017/S1368980012003084; Sun XM, 2015, J ATHEROSCLER THROMB, V22, P355, DOI 10.5551/jat.26070; Tai ES, 1999, DIABETES, V48, P1088, DOI 10.2337/diabetes.48.5.1088; Tuteja S, 2014, CLIN PHARMACOL THER, V96, P48, DOI 10.1038/clpt.2014.79; Vaskonen T, 2002, BRIT J NUTR, V87, P239, DOI 10.1079/BJN2001508; Vitezova A, 2015, EUR J ENDOCRINOL, V172, P327, DOI 10.1530/EJE-14-0580; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Yin X, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-68; Zhu XW, 2015, PRIM CARE DIABETES, V9, P60, DOI 10.1016/j.pcd.2014.03.007; Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004	51	55	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165157	10.1371/journal.pone.0165157	http://dx.doi.org/10.1371/journal.pone.0165157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768777	gold, Green Submitted, Green Published			2022-12-26	WOS:000386205400058
J	de Francesco, MC; Loy, A				de Francesco, Maria Carla; Loy, Anna			Intra- and Interspecific Interactions as Proximate Determinants of Sexual Dimorphism and Allometric Trajectories in the Bottlenose Dolphin Tursiops truncatus (Cetacea, Odontoceti, Delphinidae)	PLOS ONE			English	Article							PHOCOENA-PHOCOENA; SKULL SHAPE; HARBOR PORPOISES; MATING SYSTEMS; FOOD-HABITS; SIZE; EVOLUTION; ONTOGENY; MAMMALS; PATTERNS	Feeding adaptation, social behaviour, and interspecific interactions related to sexual dimorphism and allometric growth are particularly challenging to be investigated in the high sexual monomorphic Delphinidae. We used geometric morphometrics to extensively explore sexual dimorphism and ontogenetic allometry of different projections of the skull and the mandible of the bottlenose dolphin Tursiops truncatus. Two-dimensional landmarks were recorded on the dorsal, ventral, lateral, and occipital views of the skull, and on the lateral view of the left and the right mandible of 104 specimens from the Mediterranean and the North Seas, differing environmental condition and degree of interspecific associations. Landmark configurations were transformed, standardized and superimposed through a Generalized Procrustes Analysis. Size and shape differences between adult males and females were respectively evaluated through ANOVA on centroid size, Procrustes ANOVA on Procrustes distances, and MANOVA on Procrustes coordinates. Ontogenetic allometry was investigated by multivariate regression of shape coordinates on centroid size in the largest homogenous sample from the North Sea. Results evidenced sexual dimorphic asymmetric traits only detected in the adults of the North Sea bottlenose dolphins living in monospecific associations, with females bearing a marked incision of the cavity hosting the left tympanic bulla. These differences were related to a more refined echolocalization system that likely enhances the exploitation of local resources by philopatric females. Distinct shape in immature versus mature stages and asymmetric changes in postnatal allometry of dorsal and occipital traits, suggest that differences between males and females are established early during growth. Allometric growth trajectories differed between males and females for the ventral view of the skull. Allometric trajectories differed among projections of skull and mandible, and were related to dietary shifts experienced by subadults and adults.	[de Francesco, Maria Carla; Loy, Anna] Univ Molise, Dept Biosci & Terr, I-86090 Pesche, IS, Italy	University of Molise	de Francesco, MC (corresponding author), Univ Molise, Dept Biosci & Terr, I-86090 Pesche, IS, Italy.	maria.defrancesco@unimol.it			University of Molise; High Educational Ministry of Denmark in University of Aarhus; ERASMUS project at University of Vigo (Spain)	University of Molise; High Educational Ministry of Denmark in University of Aarhus; ERASMUS project at University of Vigo (Spain)	This study was supported by a PhD Project; funding institutions are: scholarship of University of Molise (internal); scholarship of High Educational Ministry of Denmark for 2 month in University of Aarhus (external); ERASMUS project at University of Vigo (Spain) for 4 months (external). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J., 2001, ANIMAL BEHAV EVOLUTI, V7th ed.; BARNES LG, 1985, MAR MAMMAL SCI, V1, P149, DOI 10.1111/j.1748-7692.1985.tb00003.x; Barnett J, 2009, VET REC, V165, P441, DOI 10.1136/vr.165.15.441; Barroso C, 2012, J MORPHOL, V273, P1021, DOI 10.1002/jmor.20040; Bearzi G, 2005, AQUAT CONSERV, V15, P243, DOI 10.1002/aqc.667; Bearzi G, 1997, MAR MAMMAL SCI, V13, P650, DOI 10.1111/j.1748-7692.1997.tb00089.x; Bearzi M, 2005, MAR BIOL RES, V1, P165, DOI 10.1080/17451000510019132; BEARZI M, 2005, SO CALIFORNIA ACAD S, V104, P113, DOI DOI 10.3160/0038-3872(2005)104[113:HPBTSO]2.0.CO;2; Bearzi M, 2003, THESIS; Bergmann G., 1965, BIOL SOC SCI FENN, p[28, 1]; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Cagnolaro L, 1983, NOTARBARTOLO SCIARA; Cardini A, 2005, ZOOMORPHOLOGY, V124, P189, DOI 10.1007/s00435-005-0008-3; Cardini A, 2008, J HUM EVOL, V54, P638, DOI 10.1016/j.jhevol.2007.09.023; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; CLUTTONBROCK TH, 1978, NATURE, V273, P191, DOI 10.1038/273191a0; Connor RC, 1996, BEHAVIOUR, V133, P37, DOI 10.1163/156853996X00026; Connor RC, 2000, CETACEAN SOCIETIES, P91; Connor RC, 1999, NATURE, V397, P571, DOI 10.1038/17501; CONNOR RC, 1992, P NATL ACAD SCI USA, V89, P987, DOI 10.1073/pnas.89.3.987; Cordero C, 2003, J EVOLUTION BIOL, V16, P1, DOI 10.1046/j.1420-9101.2003.00506.x; Darwin C., 1871, P423; de Stephanis R, 2008, ACTA ETHOL, V11, P81, DOI 10.1007/s10211-008-0045-2; Dementiev GP., 1951, BIRDS SOVIET UNION; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; Duggan ZPZ, 2009, J COMP PHYSIOL B, V179, P783, DOI 10.1007/s00360-009-0360-6; EARHART CM, 1970, CONDOR, V72, P251, DOI 10.2307/1366002; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FERRETTI S, 1998, EUROPEAN RES CETACEA, V12, P209; Frandsen MS, 2013, MAMM BIOL, V78, P153, DOI 10.1016/j.mambio.2012.04.005; Galatius A, 2005, J ANAT, V206, P141, DOI 10.1111/j.1469-7580.2005.00381.x; Galatius A, 2003, CAN J ZOOL, V81, P1851, DOI 10.1139/Z03-181; Garson GD., 2012, DISCRIMINANT FUNCTIO; GAUTIER-HION A, 1975, Mammalia, V39, P365, DOI 10.1515/mamm.1975.39.3.365; Gayon J, 2000, AM ZOOL, V40, P748, DOI 10.1668/0003-1569(2000)040[0748:HOTCOA]2.0.CO;2; GEIST V, 1974, BEHAVIOUR UNGULATES, P235; Gerstner GE, 2008, J MAMMAL, V89, P1020, DOI 10.1644/07-MAMM-A-188.1; Gould S.J, 1985, ONTOGENY PHYLOGENY; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Guidarelli G, 2014, ITAL J ZOOL, V81, P354, DOI 10.1080/11250003.2014.943685; Hanken J, 1993, FUNCTIONAL EVOLUTINA; Heide-Jorgensen MP, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P754; HERSH SL, 1990, MAR MAMMAL SCI, V6, P305, DOI 10.1111/j.1748-7692.1990.tb00360.x; Herzing D. L., 1997, Aquatic Mammals, V23, P85; HEYNING JE, 1984, CAN J ZOOL, V62, P1645, DOI 10.1139/z84-239; Hoglund NH, 1946, VILTREVY, V2, P271; Huxley J., 1932, PROBLEMS RELATIVE GR; Ichishima H, 2005, J VERTEBR PALEONTOL, V25, P655, DOI 10.1671/0272-4634(2005)025[0655:HTANEP]2.0.CO;2; Kakuda T, 2002, MEM NAT SCI MUS TOKY, V38, P258; Kemper CM, 2004, AUST J ZOOL, V52, P29, DOI 10.1071/ZO03026; Klingenberg CP, 2013, SYST BIOL, V62, P591, DOI 10.1093/sysbio/syt025; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 1996, NATO ADV SCI INST SE, V284, P23; Kraus C, 1971, INVESTIGATIONS CETAC, V3, P7; Krutzen M, 2004, MOL ECOL, V13, P1975, DOI 10.1111/j.1365-294X.2004.02192.x; Kurihara N, 2009, MAMM STUDY, V34, P19, DOI 10.3106/041.034.0104; Lambert O, 2010, J MAMMAL, V91, P19, DOI 10.1644/08-MAMM-A-388R1.1; Leatherwood S, 1990, BOTTLENOSE DOLPHIN; LEUTENEGGER W, 1977, Primates, V18, P117, DOI 10.1007/BF02382954; Levinton J. S., 1988, GENETICS PALEONTOLOG; Lindenfors P, 2002, J EVOLUTION BIOL, V15, P595, DOI 10.1046/j.1420-9101.2002.00422.x; Lindenfors Patrik, 2007, P16; LOWTHER PE, 1975, WILSON BULL, V87, P481; Loy A, 2004, ITAL J ZOOL, V71, P27, DOI 10.1080/11250000409356547; MacLeod CD, 2007, ANAT REC, V290, P539, DOI 10.1002/ar.20539; Mann J., 2000, CETACEAN SOC FIELD S; McLellan WA, 2002, J ZOOL, V257, P457, DOI 10.1017/S0952836902001061; Mead JG., 1995, IBI REPORTS, V5, P31; Mitteroecker P, 2013, HYSTRIX, V24, P59, DOI 10.4404/hystrix-24.1-6369; Orlosky F., 1973, THESIS; Perrin WF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1; Perrin WF., 1975, B SCRIPPS I OCEANOGR, V21; Piras P, 2013, SYST BIOL, V62, P878, DOI 10.1093/sysbio/syt053; POLACHECK T, 1987, MAR MAMMAL SCI, V3, P54, DOI 10.1111/j.1748-7692.1987.tb00151.x; Pough FH, 2002, VERTEBRATE LIFE; RALLS K, 1977, AM NAT, V111, P917, DOI 10.1086/283223; Ralls K, 2002, ENCY MARINE MAMMALS, P1071; Read A.J., 2002, ENCY MARINE MAMMALS, P982; Reyes JC, 1995, ASPECTS BIOL BURMEIS, P16; REYNOLDS PS, 1993, CAN J ZOOL, V71, P876, DOI 10.1139/z93-114; REYNOLDS RT, 1972, CONDOR, V74, P191, DOI 10.2307/1366283; Rohlf FJ, 2015, HYSTRIX, V26, P9, DOI 10.4404/hystrix-26.1-11264; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Ross HM, 1996, P ROY SOC B-BIOL SCI, V263, P283, DOI 10.1098/rspb.1996.0043; Ross JGB, 1990, BOTTLENOSE DOLPHIN, P101; Rossbach KA, 1999, CAN J ZOOL, V77, P581, DOI 10.1139/cjz-77-4-581; Sanger TJ, 2013, EVOLUTION, V67, P2180, DOI 10.1111/evo.12100; Scott MD, 1998, MAR MAMMAL SCI, V14, P401, DOI 10.1111/j.1748-7692.1998.tb00735.x; SELANDER RK, 1966, CONDOR, V68, P113, DOI 10.2307/1365712; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; STORER RW, 1966, AUK, V83, P423, DOI 10.2307/4083053; Tarnawski BA, 2014, CAN J ZOOL, V92, P19, DOI 10.1139/cjz-2013-0106; TOLLEY KA, 1995, J MAMMAL, V76, P1190, DOI 10.2307/1382611; Turner JP, 2003, J MAMMAL, V84, P665, DOI 10.1644/1545-1542(2003)084<0665:SMOBDT>2.0.CO;2; van Waerebeek K., 1990, P143; Viaud-Martinez KA, 2008, BIOL CONSERV, V141, P1600, DOI 10.1016/j.biocon.2008.04.004; Wang JY, 2000, J ZOOL, V252, P147, DOI 10.1017/S0952836900009894; Wells RS, 2008, ENCY MARINE MAMMALS, P249; Weston EM, 2003, BIOL J LINN SOC, V80, P625, DOI 10.1111/j.1095-8312.2003.00263.x; YOSHIDA H, 1994, MAR MAMMAL SCI, V10, P266, DOI 10.1111/j.1748-7692.1994.tb00482.x; YURICK DB, 1988, CAN J ZOOL, V66, P399, DOI 10.1139/z88-056; Zelditch ML, 2003, PALEOBIOLOGY, V29, P139, DOI 10.1666/0094-8373(2003)029<0139:TODOSD>2.0.CO;2	104	3	3	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164287	10.1371/journal.pone.0164287	http://dx.doi.org/10.1371/journal.pone.0164287			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764133	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204500025
J	Figueroa-Yanez, L; Pereira-Santana, A; Arroyo-Herrera, A; Rodriguez-Corona, U; Sanchez-Teyer, F; Espadas-Alcocer, J; Espadas-Gil, F; Barredo-Pool, F; Castano, E; Rodriguez-Zapata, LC				Figueroa-Yanez, Luis; Pereira-Santana, Alejandro; Arroyo-Herrera, Ana; Rodriguez-Corona, Ulises; Sanchez-Teyer, Felipe; Espadas-Alcocer, Jorge; Espadas-Gil, Francisco; Barredo-Pool, Felipe; Castano, Enrique; Carlos Rodriguez-Zapata, Luis			RAP2.4a Is Transported through the Phloem to Regulate Cold and Heat Tolerance in Papaya Tree (Carica papaya cv. Maradol): Implications for Protection Against Abiotic Stress	PLOS ONE			English	Article							LONG-DISTANCE TRANSPORT; GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTORS; GENE-EXPRESSION; MESSENGER-RNAS; CELL-FATE; ARABIDOPSIS; PLANT; DROUGHT; RESPONSES	Plants respond to stress through metabolic and morphological changes that increase their ability to survive and grow. To this end, several transcription factor families are responsible for transmitting the signals that are required for these changes. Here, we studied the transcription factor superfamily AP2/ERF, particularly, RAP2.4 from Carica papaya cv. Maradol. We isolated four genes (CpRap2.4a, CpRAap2.4b, CpRap2.1 and CpRap2.10), and an in silico analysis showed that the four genes encode proteins that contain a conserved APETALA2 (AP2) domain located within group I and II transcription factors of the AP2/ERF superfamily. Semiquantitative PCR experiments indicated that each CpRap2 gene is differentially expressed under stress conditions, such as extreme temperatures. Moreover, genetic transformants of tobacco plants overexpressing CpRap2.4a and CpRap2.4b genes show a high level of tolerance to cold and heat stress compared to non-transformed plants. Confocal microscopy analysis of tobacco transgenic plants showed that CpRAP2.4a and CpRAP2.4b proteins were mainly localized to the nuclei of cells from the leaves and roots and also in the sieve elements. Moreover, the movement of CpRap2.4a RNA in tobacco grafting was analyzed. Our results indicate that CpRap2.4a and CpRap2.4b RNA in the papaya tree have a functional role in the response to stress conditions such as exposure to extreme temperatures via direct translation outside the parental RNA cell.	[Figueroa-Yanez, Luis; Pereira-Santana, Alejandro; Sanchez-Teyer, Felipe; Espadas-Alcocer, Jorge; Espadas-Gil, Francisco; Barredo-Pool, Felipe; Carlos Rodriguez-Zapata, Luis] Ctr Invest Cient Yucatan, Unidad Biotecnol, Merida, Yucatan, Mexico; [Rodriguez-Corona, Ulises; Castano, Enrique] Ctr Invest Cient Yucatan, Unidad Bioquim & Biol Mol Plantas, Merida, Yucatan, Mexico; [Arroyo-Herrera, Ana] Univ Autonoma Yucatan, Fac Quim, Lab Farmacol, Merida, Yucatan, Mexico	Centro de Investigacion Cientifica de Yucatan; Centro de Investigacion Cientifica de Yucatan; Universidad Autonoma de Yucatan	Rodriguez-Zapata, LC (corresponding author), Ctr Invest Cient Yucatan, Unidad Biotecnol, Merida, Yucatan, Mexico.; Castano, E (corresponding author), Ctr Invest Cient Yucatan, Unidad Bioquim & Biol Mol Plantas, Merida, Yucatan, Mexico.	enriquec@cicy.mx; lcrz@cicy.mx	Figueroa, Luis/AAG-9549-2020; TEYER, LORENZO FELIPE F SANCHEZ/B-6375-2014; Pereira-Santana, Alejandro/F-7440-2019; TEYER, LORENZO FELIPE SÁNCHEZ/AAC-2433-2020; Rodriguez-Zapata, Luis/AAG-7569-2019	Figueroa, Luis/0000-0002-7283-8035; Pereira-Santana, Alejandro/0000-0001-7714-9485; TEYER, LORENZO FELIPE SÁNCHEZ/0000-0002-1714-0240; Rodriguez-Zapata, Luis/0000-0002-4872-8231; , Ulises/0000-0001-9286-0857; Castano, Enrique/0000-0003-2645-9541	SEP-CONACyT [59097, 153556, 221208]; FOMIX [247355]; CONACyT [35273, 240187, 271006]; Centro de Investigacion Cientifica de Yucatan, Mexico	SEP-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FOMIX; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Centro de Investigacion Cientifica de Yucatan, Mexico	This work received financial support from SEP-CONACyT (number: 59097 and 153556, and 221208); FOMIX 247355. LF received the financial support of a scholarship (# 35273) from CONACyT to obtain his PhD degree. APS received the financial support of a scholarship (# 240187) from CONACyT to obtain his PhD degree. JEA received the financial support of a scholarship (#271006) from CONACyT to obtain his PhD degree.; We thank the anonymous referees for their constructive comments and suggestions. The authors would also like to thank the Centro de Investigacion Cientifica de Yucatan, Mexico, for supporting this research. We are thankful to Angela Ku-Gonzalez and Wilma Gonzalez-Kan tun for their technical support with fluorescence microscopy and also Fernando Contreras Martin for his agronomical support of Carica papaya seedling.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; Asano T, 2002, PLANT J, V32, P401, DOI 10.1046/j.1365-313X.2002.01423.x; Ayadi M, 2014, PLANT PHYSIOL BIOCH, V79, P98, DOI 10.1016/j.plaphy.2014.02.018; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Banerjee AK, 2006, PLANT CELL, V18, P3443, DOI 10.1105/tpc.106.042473; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Byrne ME, 2003, DEVELOPMENT, V130, P3941, DOI 10.1242/dev.00620; CHAVES MM, 1991, J EXP BOT, V42, P1, DOI 10.1093/jxb/42.1.1; Clemente T, 2006, METH MOL B, V343, P143; Deeken R, 2008, PLANT J, V55, P746, DOI 10.1111/j.1365-313X.2008.03555.x; Dong CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-47; Duan CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-30; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engelhardt BE., 2007, PREDICTING PROTEINS; ERICKSON AH, 1983, METHOD ENZYMOL, V96, P38; Feng JX, 2005, PLANT MOL BIOL, V59, P853, DOI 10.1007/s11103-005-1511-0; Neto JRCF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083466; FITCH MMM, 1993, PLANT CELL TISS ORG, V32, P205, DOI 10.1007/BF00029844; Flexas J, 2006, PLANT J, V48, P427, DOI 10.1111/j.1365-313X.2006.02879.x; Gaupels F, 2008, J EXP BOT, V59, P3297, DOI 10.1093/jxb/ern181; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; Jiao YL, 2003, PLANT PHYSIOL, V133, P1480, DOI 10.1104/pp.103.029439; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kehr J, 2007, COMP BIOCHEM PHYS A, V146, pS240, DOI 10.1016/j.cbpa.2007.01.553; Kim JM, 2008, PLANT CELL PHYSIOL, V49, P1580, DOI 10.1093/pcp/pcn133; Kumar R, 2007, PLANT CELL, V19, P2719, DOI 10.1105/tpc.106.048769; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; LAUER MJ, 1992, PLANT PHYSIOL, V98, P1310, DOI 10.1104/pp.98.4.1310; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lin RC, 2008, MOL PLANT, V1, P42, DOI 10.1093/mp/ssm004; Lin T, 2013, PLANT PHYSIOL, V161, P760, DOI 10.1104/pp.112.209429; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Ma LG, 2003, DEVELOPMENT, V130, P969, DOI 10.1242/dev.00281; Ma LG, 2002, PLANT CELL, V14, P2383, DOI 10.1105/tpc.004416; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; NAGAO MA, 1986, HORTSCIENCE, V21, P1439; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Omid A, 2007, J EXP BOT, V58, P3645, DOI 10.1093/jxb/erm214; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Park J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/jmbi.1998.2221; Rae L, 2011, PLANTA, V234, P429, DOI 10.1007/s00425-011-1414-z; Ragni L, 2008, PLANT CELL, V20, P888, DOI 10.1105/tpc.108.058230; RAY A, 1994, P NATL ACAD SCI USA, V91, P5761, DOI 10.1073/pnas.91.13.5761; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rutjens B, 2009, PLANT J, V58, P641, DOI 10.1111/j.1365-313X.2009.03809.x; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sambrook J., 2006, CONDENSED PROTOCOLS; Shaikhali J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-48; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Solovyev VV., 2007, HDB STAT GENETICS, P1616, DOI DOI 10.1002/9780470061619.CH4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Szabala BM, 2014, PLANTA, V239, P847, DOI 10.1007/s00425-013-2018-6; Tepperman JM, 2001, P NATL ACAD SCI USA, V98, P9437, DOI 10.1073/pnas.161300998; Thieme CJ, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.25, 10.1038/nplants.2015.25]; Thornton JW, 2000, ANNU REV GENOM HUM G, V1, P41, DOI 10.1146/annurev.genom.1.1.41; Ursache R, 2014, J EXP BOT, V65, P1673, DOI 10.1093/jxb/ert462; Vilaine F, 2003, PLANT J, V36, P67, DOI 10.1046/j.1365-313X.2003.01855.x; Weber H, 2009, FEBS J, V276, P6624, DOI 10.1111/j.1742-4658.2009.07373.x; WISE RR, 1992, PLANT PHYSIOL, V100, P26, DOI 10.1104/pp.100.1.26; Yagisawa H, 1998, J BIOL CHEM, V273, P417, DOI 10.1074/jbc.273.1.417; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yordanov I., 2003, Bulgarian Journal of Plant Physiology, P187; Zhang L, 2014, PLANT PHYSIOL BIOCH, V78, P88, DOI 10.1016/j.plaphy.2014.02.019; Zlatev Z. S., 2004, Bulgarian Journal of Plant Physiology, V30, P3	72	14	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165030	10.1371/journal.pone.0165030	http://dx.doi.org/10.1371/journal.pone.0165030			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764197	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500105
J	Lescano, CH; de Oliveira, IP; Zaminelli, T; Baldivia, DD; da Silva, LR; Napolitano, M; Silverio, CBM; Lincopan, N; Sanjinez-Argandona, EJ				Lescano, Caroline Honaiser; de Oliveira, Ivan Pires; Zaminelli, Tiago; Baldivia, Debora da Silva; da Silva, Luan Ramos; Napolitano, Mauro; Mendes Silverio, Camila Bitencourt; Lincopan, Nilton; Sanjinez-Argandona, Eliana Janet			Campomanesia adamantium Peel Extract in Antidiarrheal Activity: The Ability of Inhibition of Heat-Stable Enterotoxin by Polyphenols	PLOS ONE			English	Article							ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; CYCLIC-NUCLEOTIDE; ANTIMICROBIAL ACTIVITY; ESSENTIAL OIL; IN-VITRO; O. BERG; ANTIOXIDANT; PLANTS; CELLS	Campomanesia adamantium (Myrtaceae) is a medicinal plant distributed in Brazilian Cerrado. Different parts of this plant are used in popular medicine for treatment of several diseases like fever, diarrhea, hypercholesterolemia and rheumatism. The aim of this work was to evaluate the inhibition of heat-stable enterotoxin type A (STa) by gallic acid present in the peel of C. adamantium fruit and assays to assess the antidiarrheal activity, anti-inflammatory and cytotoxic properties of peel extract using the T84 cell line model. The possible inhibition exerted by the gallic acid of the peel extract on the STa peptide was inferred by molecular dynamics simulations. The antidiarrheal effects were investigated measuring cGMP accumulation in cells after stimulation by STa toxin and antibacterial activity was assessed. The anti-inflammatory activity was assessed by inhibition of COX-1 and COX-2. MTT and LDH assays were used to evaluate any possible cytotoxic action while the CyQUANT test was used to investigate the effect on cell proliferation. A representation showing how the possible interactions between STa and the gallic acid of the extract might reduce the action of the enterotoxin is presented. C. adamantium peel extract significantly decreased the levels of cGMP in T84 cells. However, no effect on the species of microorganisms was observed. The extract also inhibited COX-1 (IC50 255.70 +/- 0.04 ng/mL) and COX-2 (IC50 569.50 +/- 0.11 ng/mL) enzymes. Cytotoxicity assay have shown significant changes in cells treated with the extract, which inhibited the cell proliferation until 72 hours of treatment. Direct interactions of phenolic compounds present in the extract with the STa toxin may limit its activity. Curative effect in the diarrhea treatment and its anti-inflammatory action is based on the pharmacological properties, mechanism of action of the C. adamantium peel extract, and no toxic effects of the peel extract presented on this work.	[Lescano, Caroline Honaiser; Zaminelli, Tiago; Mendes Silverio, Camila Bitencourt] Univ Estadual Campinas, Dept Pharmacol, Sao Paulo, Brazil; [de Oliveira, Ivan Pires] Univ Estadual Campinas, Inst Chem, Sao Paulo, Brazil; [Baldivia, Debora da Silva] Fed Univ Grande Dourados, Fac Biol & Environm Sci, Dourados, MS, Brazil; [da Silva, Luan Ramos; Sanjinez-Argandona, Eliana Janet] Fed Univ Grande Dourados, Fac Engn, Dourados, MS, Brazil; [Napolitano, Mauro; Lincopan, Nilton] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Federal da Grande Dourados; Universidade Federal da Grande Dourados; Universidade de Sao Paulo	Lescano, CH (corresponding author), Univ Estadual Campinas, Dept Pharmacol, Sao Paulo, Brazil.	carolinehonaiser@gmail.com	ZAMINELLI, TIAGO/S-8882-2017; Lincopan, Nilton/C-3818-2012; Ramos da Silva, Luan/R-2552-2018; Napolitano, Mauro/I-5263-2016; da Silva, Luan Ramos/P-1034-2019; Pires de Oliveira, Ivan/S-6023-2016; Argandoña, Eliana Janet EJSA Sanjinez/J-6524-2012; Lescano, Caroline C.H.L Honaiser/I-2108-2017; da Silva Baldivia, Débora/AAM-8601-2020; Silva Baldivia, Debora/P-9574-2017	ZAMINELLI, TIAGO/0000-0002-6122-891X; Lincopan, Nilton/0000-0003-0161-5800; Ramos da Silva, Luan/0000-0003-1150-6966; Napolitano, Mauro/0000-0001-7399-7276; da Silva, Luan Ramos/0000-0003-1150-6966; Pires de Oliveira, Ivan/0000-0003-1020-4376; Argandoña, Eliana Janet EJSA Sanjinez/0000-0001-9377-8839; Lescano, Caroline C.H.L Honaiser/0000-0003-4193-7361; Silva Baldivia, Debora/0000-0002-1122-8479	Sao Paulo Research Foundation FAPESP [2010/16947-9, 2013/05475-7, 2013/08293-7]; CNPq [470374/2013-6]	Sao Paulo Research Foundation FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was supported by Sao Paulo Research Foundation FAPESP (Nos. 2010/16947-9, 2013/05475-7 and 2013/08293-7) and CNPq (N.470374/2013-6).	Alves Andréa Regiani, 2003, Rev. esc. enferm. USP, V37, P85; Biavatti MW, 2004, J ETHNOPHARMACOL, V93, P385, DOI 10.1016/j.jep.2004.04.015; Bonilla A, 2005, PHYTOCHEMISTRY, V66, P1736, DOI 10.1016/j.phytochem.2005.05.025; Breda CA, 2012, FOOD CHEM, V135, P2960, DOI 10.1016/j.foodchem.2012.07.029; Chang CC, 2002, J FOOD DRUG ANAL, V10, P178; Chang R, 2011, LAT AM J PHARM, V30, P1843; Chen JC, 2006, J ETHNOPHARMACOL, V103, P385, DOI 10.1016/j.jep.2005.08.036; Bieski IGC, 2015, J ETHNOPHARMACOL, V173, P383, DOI 10.1016/j.jep.2015.07.025; Coutinho I. D., 2008, Ecletica Quimica, V33, P53, DOI 10.1590/S0100-46702008000400007; Coutinho ID, 2009, BRAZ J PHARM SCI, V45, P767, DOI 10.1590/S1984-82502009000400022; Crespy V, 2004, J NUTR, V134, p3431S, DOI 10.1093/jn/134.12.3431S; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; de Souza JC, 2014, NUTR NEUROSCI; Faried A, 2007, INT J ONCOL, V30, P605; Ferreira LC, 2013, J ETHNOPHARMACOL, V145, P100, DOI 10.1016/j.jep.2012.10.037; FIELD M, 1978, P NATL ACAD SCI USA, V75, P2800, DOI 10.1073/pnas.75.6.2800; Guerrant RL, 2002, ARCH MED RES, V33, P351, DOI 10.1016/S0188-4409(02)00379-X; Huang YY, 2013, J CHEM INF MODEL, V53, P3044, DOI 10.1021/ci400458z; HUGHES JM, 1978, NATURE, V271, P755, DOI 10.1038/271755a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jung YD, 2001, BRIT J CANCER, V84, P844, DOI 10.1054/bjoc.2000.1691; Klafke JZ, 2012, ANTIPLATELET ANTITHR; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Liang CZ, 2012, CANCER BIOTHER RADIO, V27, P701, DOI 10.1089/cbr.2012.1245; Cardoso CAL, 2010, J MED FOOD, V13, P1273, DOI 10.1089/jmf.2009.0047; Lin CS, 2002, INT J IMPOT RES, V14, P15, DOI 10.1038/sj.ijir.3900802; Lin CS, 2001, BIOCHEM BIOPH RES CO, V280, P693, DOI 10.1006/bbrc.2000.4221; Liu FF, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3453713; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; Mazzolin LP, 2013, J ETHNOPHARMACOL, V150, P1016, DOI 10.1016/j.jep.2013.10.006; Michel MCP, 2013, REV BRAS FARMACOGN, V23, P927, DOI 10.1590/S0102-695X2013000600010; Morris SS, 2003, INT J EPIDEMIOL, V32, P1041, DOI 10.1093/ije/dyg241; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moura-Costa GF, 2012, J ETHNOPHARMACOL, V143, P631, DOI 10.1016/j.jep.2012.07.016; Oliveira IP, 2016, PHYS CHEM CHEM PHYS, V18, P21797, DOI 10.1039/c6cp01789d; Pavan FRr, 2009, QUIM NOVA, V32; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polson JB, 1996, ANNU REV PHARMACOL, V36, P403, DOI 10.1146/annurev.pa.36.040196.002155; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Rao CV, 2008, J NAT MED-TOKYO, V62, P396, DOI 10.1007/s11418-008-0258-8; Read LT, 2014, INFECT IMMUN, V82, P5308, DOI 10.1128/IAI.02496-14; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Roessner A, 2008, PATHOL RES PRACT, V204, P511, DOI 10.1016/j.prp.2008.04.011; Scartezzini P, 2000, J ETHNOPHARMACOL, V71, P23, DOI 10.1016/S0378-8741(00)00213-0; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Souza-Moreira TM, 2011, J MED FOOD, V14, P528, DOI 10.1089/jmf.2009.0278; Tanifum EA, 2009, BIOORG MED CHEM LETT, V19, P3067, DOI 10.1016/j.bmcl.2009.04.024; Vaandrager AB, 2002, MOL CELL BIOCHEM, V230, P73, DOI 10.1023/A:1014231722696; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wardlaw T, 2010, LANCET, V375, P870, DOI 10.1016/S0140-6736(09)61798-0	53	19	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165208	10.1371/journal.pone.0165208	http://dx.doi.org/10.1371/journal.pone.0165208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764241	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204500134
J	Ulbrich, F; Kaufmann, KB; Meske, A; Lagreze, WA; Augustynik, M; Buerkle, H; Ramao, CC; Biermann, J; Goebel, U				Ulbrich, Felix; Kaufmann, Kai B.; Meske, Alexander; Lagreze, Wolf A.; Augustynik, Michael; Buerkle, Hartmut; Ramao, Carlos C.; Biermann, Julia; Goebel, Ulrich			The CORM ALF-186 Mediates Anti-Apoptotic Signaling via an Activation of the p38 MAPK after Ischemia and Reperfusion Injury in Retinal Ganglion Cells	PLOS ONE			English	Article							MONOXIDE-RELEASING MOLECULES; CARBON-MONOXIDE; ISCHEMIA/REPERFUSION INJURY; IN-VITRO; CEREBRAL-ISCHEMIA; HEME OXYGENASE-1; NEURONAL DEATH; NERVOUS-SYSTEM; BRAIN ISCHEMIA; PROTECTION	Purpose lschemia and reperfusion injury may induce apoptosis and lead to sustained tissue damage and loss of function, especially in neuronal organs. While carbon monoxide is known to exert protective effects after various harmful events, the mechanism of carbon monoxide releasing molecules in neuronal tissue has not been investigated yet. We hypothesize that the carbon monoxide releasing molecule (CORM) ALF-186, administered after neuronal ischemia-reperfusion injury (IRI), counteracts retinal apoptosis and its involved signaling pathways and consecutively reduces neuronal tissue damage. Methods IRI was performed in rat's retinae for 1 hour. The water-soluble CORM ALF-186 (10 mg/kg) was administered intravenously via a tail vein after reperfusion. After 24 and 48 hours, retinal tissue was harvested to analyze mRNA and protein expression of Bcl-2, Bax, Caspase-3, ERK1/2, p38 and JNK. Densities of fluorogold pre-labeled retinal ganglion cells (RGC) were analyzed 7 days after IRI. Immunohistochemistry was performed on retinal cross sections. Results ALF-186 significantly reduced IRI mediated loss of RGC. ALF-186 treatment differentially affected mitogen-activated protein kinases (MAPK) phosphorylation: ALF-186 activated p38 and suppressed ERK1/2 phosphorylation, while JNK remained unchanged. Furthermore, ALF-186 treatment affected mitochondrial apoptosis, decreasing pro-apoptotic Bax and Caspase-3-cleavage, but increasing anti-apoptotic Bcl-2. Inhibition of p38-MAPK using SB203580 reduced ALF-186 mediated anti-apoptotic effects. Conclusion In this study, ALF-186 mediated substantial neuroprotection, affecting intracellular apoptotic signaling, mainly via MAPK p38. CORMs may thus represent a promising therapeutic alternative treating neuronal IRI.	[Ulbrich, Felix; Kaufmann, Kai B.; Meske, Alexander; Buerkle, Hartmut; Goebel, Ulrich] Univ Freiburg, Dept Anesthesiol & Crit Care, Med Ctr, Fac Med, Freiburg, Germany; [Lagreze, Wolf A.; Augustynik, Michael; Biermann, Julia] Univ Freiburg, Ctr Eye, Med Ctr, Fac Med, Freiburg, Germany; [Ramao, Carlos C.] Univ Nova Lisboa, Inst Tecnol Quim Biol Antonio Xavier, Oeiras, Portugal; [Ramao, Carlos C.] Alfama Ltd, IBET, Oeiras, Portugal	University of Freiburg; University of Freiburg; Universidade Nova de Lisboa	Goebel, U (corresponding author), Univ Freiburg, Dept Anesthesiol & Crit Care, Med Ctr, Fac Med, Freiburg, Germany.	ulrich.goebel@uniklinik-freiburg.de	Goebel, Ulrich M./AGG-1495-2022; Göbel, Ulrich/Q-7613-2016	Göbel, Ulrich/0000-0002-9991-3226; Romao, Carlos C./0000-0001-5061-3743	German Research Foundation (DFG) [Go 2158/3-1, Bi 1567/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was conducted at the Department of Anesthesiology and Intensive Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany and granted by The German Research Foundation (DFG, Grants: Go 2158/3-1 and Bi 1567/2-1). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Alfama Ltd. provided support in the form of supplying Carlos C. Romao with the ALF-186 compound - which is not commercially available - but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ABE K, 1995, STROKE, V26, P1478, DOI 10.1161/01.STR.26.8.1478; Anilkumar U, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00281; Antoniou Xanthi, 2012, Front Biosci (Elite Ed), V4, P2110; Biermann J, 2011, MOL VIS, V17, P1275; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P3784, DOI 10.1167/iovs.09-4894; Cheng Y, 2014, ANESTH ANALG, V118, P1284, DOI 10.1213/ANE.0000000000000030; Choi BM, 2003, HEPATOLOGY, V37, P810, DOI 10.1053/jhep.2003.50114; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Fujimoto H, 2004, ARTERIOSCL THROM VAS, V24, P1848, DOI 10.1161/01.ATV.0000142364.85911.0e; Jasnos K, 2014, POSTEP HIG MED DOSW, V68, P101, DOI 10.5604/17322693.1087527; Jiang SY, 2012, MOL VIS, V18, P2096; Kaizu T, 2008, AM J PHYSIOL-GASTR L, V294, pG236, DOI 10.1152/ajpgi.00144.2007; Kim BJ, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0093-4; Kohmoto J, 2006, SURGERY, V140, P179, DOI 10.1016/j.surg.2006.03.004; Li Volti G, 2006, NEPHRON EXP NEPHROL, V104, pE135, DOI 10.1159/000094964; Li YY, 2013, TOXICOL APPL PHARM, V273, P53, DOI 10.1016/j.taap.2013.08.019; Liu XW, 2014, MOL MED REP, V10, P1942, DOI 10.3892/mmr.2014.2402; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Moretti A, 2015, PHARMACOL THERAPEUT, V146, P23, DOI 10.1016/j.pharmthera.2014.09.003; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Mortier E, 2000, ACTA NEUROL BELG, V100, P225; Motterlini R, 2005, EXPERT OPIN INV DRUG, V14, P1305, DOI 10.1517/13543784.14.11.1305; Motterlini R, 2003, CURR PHARM DESIGN, V9, P2525, DOI 10.2174/1381612033453785; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Nakao A, 2006, TRANSPLANTATION, V81, P220, DOI 10.1097/01.tp.0000188637.80695.7f; Nakao A, 2003, AM J PATHOL, V163, P1587, DOI 10.1016/S0002-9440(10)63515-8; Nakao A, 2008, J CLIN BIOCHEM NUTR, V42, P78, DOI 10.3164/jcbn.2008013; Neto JS, 2004, AM J PHYSIOL-RENAL, V287, pF979, DOI 10.1152/ajprenal.00158.2004; Nickells RW, 1996, J GLAUCOMA, V5, P345; Ning W, 2005, AM J PHYSIOL-LUNG C, V289, pL268, DOI 10.1152/ajplung.00168.2004; Otterbein LE, 1999, AM J PHYSIOL-LUNG C, V276, pL688; Ryter SW, 2004, BIOESSAYS, V26, P270, DOI 10.1002/bies.20005; Schallenberg M, 2009, EXP EYE RES, V89, P665, DOI 10.1016/j.exer.2009.06.008; Schallner N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046479; Schallner N, 2011, EUR J PHARMACOL, V670, P58, DOI 10.1016/j.ejphar.2011.08.028; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Schwer CI, 2010, MOL PHARMACOL, V77, P660, DOI 10.1124/mol.109.059519; Sethi JM, 2002, ANTIOXID REDOX SIGN, V4, P241, DOI 10.1089/152308602753666299; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Takeda K, 2002, GENES CELLS, V7, P1099, DOI 10.1046/j.1365-2443.2002.00591.x; VERMA D, 1993, MED HYPOTHESES, V41, P205, DOI 10.1016/0306-9877(93)90231-E; Wang B, 2011, STROKE, V42, P2605, DOI 10.1161/STROKEAHA.110.607101; Wang X, 2007, J BIOL CHEM, V282, P1718, DOI 10.1074/jbc.M607610200; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zeynalov E, 2009, NEUROTOX RES, V15, P133, DOI 10.1007/s12640-009-9014-4	47	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165182	10.1371/journal.pone.0165182	http://dx.doi.org/10.1371/journal.pone.0165182			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764224	gold, Green Submitted, Green Published			2022-12-26	WOS:000386204500129
J	Wiig, E; Reseland, JE; Ostbye, K; Haugen, HJ; Vollestad, LA				Wiig, Elisabeth; Reseland, Janne E.; Ostbye, Kjartan; Haugen, Havard J.; Vollestad, Leif A.			Variation in Lateral Plate Quality in Threespine Stickleback from Fresh, Brackish and Marine Water: A Micro-Computed Tomography Study	PLOS ONE			English	Article							GASTEROSTEUS-ACULEATUS POPULATIONS; 3-SPINED STICKLEBACK; PHENOTYPIC DIVERSITY; PARALLEL EVOLUTION; REDUCTION; SELECTION; ARMOR; CONVERGENCE; GENETICS; LOCUS	Introduction It is important to understand the drivers leading to adaptive phenotypic diversity within and among species. The threespine stickleback (Gasterosteus aculeatus) has become a model system for investigating the genetic and phenotypic responses during repeated colonization of fresh waters from the original marine habitat. During the freshwater colonization process there has been a recurrent and parallel reduction in the number of lateral bone plates, making it a suitable system for studying adaptability and parallel evolution. Objective The aim of this study was to investigate an alternative evolutionary path of lateral plate reduction, where lateral plates are reduced in size rather than number. Materials and Methods A total of 72 threespine stickleback individuals from freshwater (n = 54), brackish water (n = 27) and marine water (n = 9) were analysed using microcomputed tomography (mu CT) to determine variation in size, thickness and structure of the lateral plates. Furthermore, whole-body bone volume, and bone volume, bone surface and porosity of lateral plate number 4 were quantified in all specimens from each environment. Results The results showed a significant difference in plate size (area and volume) among populations, where threespine stickleback from polymorphic freshwater and brackish water populations displayed lateral plates reduced in size (area and volume) compared to marine stickleback Conclusions Reduction of lateral plates in threespine stickleback in fresh and brackish water occurs by both plate loss and reduction in plate size (area and volume).	[Wiig, Elisabeth; Ostbye, Kjartan; Vollestad, Leif A.] Univ Oslo, CEES, Dept Biosci, POB 1066, N-0316 Oslo, Norway; [Wiig, Elisabeth; Reseland, Janne E.; Haugen, Havard J.] Univ Oslo, Fac Dent, Dept Biomat, POB 1109, N-0317 Oslo, Norway; [Ostbye, Kjartan] Hedmark Univ Coll, Dept Forestry & Wildlife Management, Campus Evenstad, N-2418 Elverum, Norway	University of Oslo; University of Oslo; Inland Norway University of Applied Sciences	Wiig, E (corresponding author), Univ Oslo, CEES, Dept Biosci, POB 1066, N-0316 Oslo, Norway.; Wiig, E (corresponding author), Univ Oslo, Fac Dent, Dept Biomat, POB 1109, N-0317 Oslo, Norway.	Elisabeth.wiig@odont.uio.no	Haugen, Håvard J./H-3551-2014; Vøllestad, Leif Asbjørn/H-7305-2019	Haugen, Håvard J./0000-0002-6690-7233; Vøllestad, Leif Asbjørn/0000-0002-9389-7982	Norwegian Research Council [196639]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was supported by a grant from the Norwegian Research Council, RCN Project No. 196639. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Baker JA, 2010, BIOL CONSERV, V143, P1184, DOI 10.1016/j.biocon.2010.02.026; Barrett RDH, 2009, EVOLUTION, V63, P2831, DOI 10.1111/j.1558-5646.2009.00762.x; BELL MA, 1976, SYST ZOOL, V25, P211, DOI 10.2307/2412489; BELL MA, 1993, EVOLUTION, V47, P906, DOI 10.1111/j.1558-5646.1993.tb01243.x; Bell MA, 1995, BEHAVIOUR, V132, P1131, DOI 10.1163/156853995X00496; BELL MA, 1981, EVOLUTION, V35, P67, DOI 10.1111/j.1558-5646.1981.tb04859.x; Bergstrom CA, 2002, CAN J ZOOL, V80, P207, DOI 10.1139/Z01-226; Bjaerke O, 2010, ECOL FRESHW FISH, V19, P249, DOI 10.1111/j.1600-0633.2010.00409.x; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; BREDER C. M., 1960, ZOOLOGICA [NEW YORK], V45, P155; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Conte GL, 2012, P ROY SOC B-BIOL SCI, V279, P5039, DOI 10.1098/rspb.2012.2146; Cresko WA, 2008, SCIENCE, V322, P204, DOI 10.1126/science.1165663; Dalziel AC, 2012, EVOLUTION, V66, P1226, DOI 10.1111/j.1558-5646.2011.01498.x; GILES N, 1983, J ZOOL, V199, P535; GILES N, 1987, J FISH BIOL, V31, P37, DOI 10.1111/j.1095-8649.1987.tb05212.x; HAGEN DW, 1973, HEREDITY, V31, P75, DOI 10.1038/hdy.1973.59; HOOGLAND R., 1956, BEHAVIOUR, V10, P205, DOI 10.1163/156853956X00156; Indjeian VB, 2016, CELL, V164, P45, DOI 10.1016/j.cell.2015.12.007; Klepaker T, 2013, EVOL ECOL RES, V15, P413; Le Rouzic A, 2011, MOL ECOL, V20, P2483, DOI 10.1111/j.1365-294X.2011.05071.x; Lees J, 2012, ACTA ZOOL-STOCKHOLM, V93, P422, DOI 10.1111/j.1463-6395.2011.00517.x; Leinonen T, 2012, EVOLUTION, V66, P3866, DOI 10.1111/j.1558-5646.2012.01724.x; Marchinko KB, 2007, EVOLUTION, V61, P1084, DOI 10.1111/j.1558-5646.2007.00103.x; McCairns RJS, 2012, J EVOLUTION BIOL, V25, P1097, DOI 10.1111/j.1420-9101.2012.02496.x; Mills MG, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-5; MOODIE G E E, 1973, Canadian Field-Naturalist, V87, P173; Myhre F, 2009, J FISH BIOL, V75, P2062, DOI 10.1111/j.1095-8649.2009.02404.x; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Raeymaekers JAM, 2007, MOL ECOL, V16, P891, DOI 10.1111/j.1365-294X.2006.03190.x; REIMCHEN TE, 1983, EVOLUTION, V37, P931, DOI 10.1111/j.1558-5646.1983.tb05622.x; REIMCHEN TE, 1992, EVOLUTION, V46, P1224, DOI 10.1111/j.1558-5646.1992.tb00631.x; Rennison DJ, 2014, DRYAD DATA REPOSITOR; Roth F., 1920, Anatomischer Anzeiger, V52; Song JH, 2010, J STRUCT BIOL, V171, P318, DOI 10.1016/j.jsb.2010.04.009; Wootton R.J., 1976, BIOL STICKLEBACKS; Zeller M, 2012, EVOL ECOL RES, V14, P193	40	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164578	10.1371/journal.pone.0164578	http://dx.doi.org/10.1371/journal.pone.0164578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764140	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500044
J	Xu, Q; Sh, Y; Yu, T; Xu, XW; Yan, Y; Qi, XH; Chen, XH				Xu, Qiang; Sh, Yang; Yu, Ting; Xu, Xuewen; Yan, Yali; Qi, Xiaohua; Chen, Xuehao			Whole-Genome Resequencing of a Cucumber Chromosome Segment Substitution Line and Its Recurrent Parent to Identify Candidate Genes Governing Powdery Mildew Resistance	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; WIDE ANALYSIS; QTL; EVOLUTION; LOCI; IDENTIFICATION; PATHOGENS; SEQUENCE; DOMAIN; VIRUS	Cucumber is an economically important vegetable crop worldwide. Powdery mildew (PM) is one of the most severe diseases that can affect cucumber crops. There have been several research efforts to isolate PM resistance genes for breeding PM-resistant cucumber. In the present study, we used a chromosome segment substitution line, SSL508-28, which carried PM resistance genes from the donor parent, JIN5-508, through twelve generations of backcrossing with a PM-susceptible inbred line, D8. We performed whole-genome resequencing of SSL508-28 and D8 to identify single nucleotide polymorphisms (SNPs), and insertions and deletions (indels). When compared against the reference genome of the inbred cucumber line 9930, a total of 468,616 SNPs and 67,259 indels were identified in SSL508-28, and 537,352 SNPs and 91,698 indels were identified in D8. Of these, 3,014 non-synonymous SNPs and 226 frameshift indels in SSL508-28, and 3,104 non-synonymous SNPs and 251 frameshift indels in D8, were identified. Bioinformatics analysis of these variations revealed a total of 15,682 SNPs and 6,262 indels between SSL508-28 and D8, among which 120 non-synonymous SNPs and 30 frameshift indels in 94 genes were detected between SSL508-28 and D8. Finally, out of these 94 genes, five resistance genes with nucleotide-binding sites and leucine-rich repeat domains were selected for qRT-PCR analysis. This revealed an upregulation of two transcripts, Csa2M435460.1 and Csa5M579 560.1, in SSL508-28. Furthermore, the results of qRT-PCR analysis of these two genes in ten PM resistant and ten PM susceptible cucumber lines showed that when exposed to PM, Csa2M435460.1 and Csa5M579560.1 exhibited a higher expression level of resistant lines than susceptible lines. This indicates that Csa2M435460.1 and Csa5M579560.1 are candidate genes for PM resistance in cucumber. In addition, the non-synonymous SNPs in Csa2M435460.1 and Csa5M579560.1, identified in SSL508-28 and D8, might be the key to high PM-resistance in SSL508-28.	[Xu, Qiang; Sh, Yang; Yu, Ting; Xu, Xuewen; Yan, Yali; Qi, Xiaohua; Chen, Xuehao] Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China	Yangzhou University	Chen, XH (corresponding author), Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China.	xhchen@yzu.edu.cn			National Natural Science Foundation of China [31171978, 31672176]; National Key Basic Research Program of China [2012CB113900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	Funded by National Natural Science Foundation of China (CN) (31171978), National Key Basic Research Program of China (2012CB113900), and National Natural Science Foundation of China (CN)(31672176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 2005, INT J DEV BIOL, V49, P717, DOI 10.1387/ijdb.051994ca; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Coleman C, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-89; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Ruiter W, 2008, CUCURBITACEAE 2008: PROCEEDINGS OF THE IXTH EUCARPIA MEETING ON GENETICS AND BREEDING OF CUCURBITACEAE, P181; de Wit P J G M, 2007, Cell Mol Life Sci, V64, P2726; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Ellis J, 2000, CURR OPIN PLANT BIOL, V3, P278, DOI 10.1016/S1369-5266(00)00080-7; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; Fukino N, 2013, MOL BREEDING, V32, P267, DOI 10.1007/s11032-013-9867-3; Guo CJ, 2016, PLANT MOL BIOL, V90, P95, DOI 10.1007/s11103-015-0398-7; He XM, 2013, THEOR APPL GENET, V126, P2149, DOI 10.1007/s00122-013-2125-6; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Jordan T, 2011, PLANT J, V65, P610, DOI 10.1111/j.1365-313X.2010.04445.x; Kobayashi M, 2014, PLANT CELL PHYSIOL, V55, P445, DOI 10.1093/pcp/pct181; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lin XiaoJian, 2012, Acta Horticulturae Sinica, V39, P485; Liu LZ, 2008, J PHYTOPATHOL, V156, P691, DOI 10.1111/j.1439-0434.2008.01427.x; Mace E, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0253-z; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Mitchell AF, 2004, PEST MANAG SCI, V60, P126, DOI 10.1002/ps.795; Mondragon-Palomino M, 2005, MOL BIOL EVOL, V22, P2444, DOI 10.1093/molbev/msi241; Nie JT, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0206-8; Qi HH, 2013, THEOR APPL GENET, V126, P369, DOI 10.1007/s00122-012-1985-5; Rubio M, 2015, MOL PLANT PATHOL, V16, P164, DOI 10.1111/mpp.12169; Sakata Y, 2006, THEOR APPL GENET, V112, P243, DOI [10.1007/s00122-005-0121-1, 10.1007/s00122-005-0193-y]; Shen GJ, 2014, PLANT SCI, V215, P11, DOI 10.1016/j.plantsci.2013.10.004; Stirnweis D, 2014, MOL PLANT MICROBE IN, V27, P265, DOI 10.1094/MPMI-10-13-0297-FI; Takahashi H, 2012, MOL PLANT MICROBE IN, V25, P1171, DOI 10.1094/MPMI-04-12-0076-R; van der Biezen EA, 2000, P NATL ACAD SCI USA, V97, P3747, DOI 10.1073/pnas.060392397; Wei XY, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0287-4; Wulff BBH, 2009, MOL PLANT MICROBE IN, V22, P1191, DOI 10.1094/MPMI-22-10-1191; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu XW, 2016, THEOR APPL GENET, V129, P507, DOI 10.1007/s00122-015-2644-4; Yu Li, 2012, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V32, P1384; Zhang ShengPing, 2011, Scientia Agricultura Sinica, V44, P3584; Zheng LY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r114; Zhou B, 2007, MOL PLANT MICROBE IN, V20, P63, DOI 10.1094/MPMI-20-0063	45	16	16	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164469	10.1371/journal.pone.0164469	http://dx.doi.org/10.1371/journal.pone.0164469			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764118	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500036
J	Tanno, J; Gatate, Y; Kasai, T; Nakano, S; Senbonmatsu, T; Sato, O; Ichioka, S; Kuro-o, M; Nishimura, S				Tanno, Jun; Gatate, Yodo; Kasai, Takatoshi; Nakano, Shintaro; Senbonmatsu, Takaaki; Sato, Osamu; Ichioka, Shigeru; Kuro-o, Makoto; Nishimura, Shigeyuki			A Novel Index Using Ankle Hemodynamic Parameters to Assess the Severity of Peripheral Arterial Disease: A Pilot Study	PLOS ONE			English	Article							BRACHIAL INDEX	In peripheral arterial disease (PAD) of the lower extremities, the presence of flow-limiting stenoses can be objectively detected by the ankle-brachial index (ABI). However, the severity of ischemic symptoms is not necessarily associated with the ABI value. Atherosclerotic plaque in lower extremity PAD induces ankle arterial stiffness and reduces ankle vascular resistance, which may decrease ankle blood flow and cause ischemic symptoms. We hypothesized that the ankle hemodynamic index (AHI), defined as the ratio of ankle arterial stiffness to ankle vascular resistance, could be used to assess the blood supply deficiency in a diseased lower limb in patients with PAD. The 85 consecutive patients with PAD who were retrospectively analyzed in this study had Rutherford grade 1 to grade 6 ischemia diagnosed as PAD and significant stenotic lesions (>50% diameter stenosis) of the lower extremity on contrast angiography. The AHI was calculated as the product of the ankle pulse pressure and the ratio of heart rate to ankle mean arterial pressure (ankle pulse pressure x heart rate/ankle mean arterial pressure). The Rutherford grade was significantly correlated with the AHI (r = 0.50, P < 0.001), but not with the ABI (r = 0.07, P = 0.52). Multiple ordinal regression analysis showed that anemia (odds ratio 0.66, P = 0.002) and AHI (odds ratio 1.04, P = 0.02) were independently associated with Rutherford grade. Our study shows that AHI, a novel parameter based on the ABI measurement, is well correlated with ischemic symptoms, and may be a useful means to assess the arterial blood supply of the lower extremities of patients with PAD.	[Tanno, Jun; Gatate, Yodo; Nakano, Shintaro; Senbonmatsu, Takaaki; Nishimura, Shigeyuki] Saitama Med Univ, Int Med Ctr, Dept Cardiol, Saitama, Japan; [Kasai, Takatoshi] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Cardiovasc Resp Sleep Med, Tokyo, Japan; [Sato, Osamu] Saitama Med Univ, Saitama Med Ctr, Dept Vasc Surg, Saitama, Japan; [Ichioka, Shigeru] Saitama Med Univ, Dept Plast & Reconstruct Surg, Saitama, Japan; [Kuro-o, Makoto] Jichi Med Univ, Ctr Mol Med, Div Antiaging Med, Shimotsuke, Tochigi, Japan	Saitama Medical University; Juntendo University; Saitama Medical University; Saitama Medical University; Jichi Medical University	Tanno, J (corresponding author), Saitama Med Univ, Int Med Ctr, Dept Cardiol, Saitama, Japan.	j_tanno@saitama-med.ac.jp						Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Beckman JA, 2006, HYPERTENSION, V47, P35, DOI 10.1161/01.HYP.0000196686.85286.9c; Chirinos JA, 2010, HYPERTENSION, V56, P563, DOI 10.1161/HYPERTENSIONAHA.110.157339; Coutinho T, 2011, VASC MED, V16, P203, DOI 10.1177/1358863X11400935; Desormais I, 2014, EUR J VASC ENDOVASC, V48, P202, DOI 10.1016/j.ejvs.2014.04.005; Englund EK, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002673; Faxon DP, 2004, CIRCULATION, V109, P2617, DOI 10.1161/01.CIR.0000128520.37674.EF; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Franklin SS, 2008, J AM SOC HYPERTENS, V2, P140, DOI 10.1016/j.jash.2007.09.002; HARRIS LM, 1995, AM J CARDIOL, V76, P207, DOI 10.1016/S0002-9149(99)80066-6; Hiatt WR, 2008, CIRCULATION, V118, P2826, DOI 10.1161/CIRCULATIONAHA.108.191171; Hirsch AT, 2006, J AM COLL CARDIOL, V47, P1239, DOI 10.1016/j.jacc.2005.10.009; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Laughlin MH, 2012, COMPR PHYSIOL, V2, P321, DOI 10.1002/cphy.c100048; LIAO JK, 1991, CIRC RES, V68, P1027, DOI 10.1161/01.RES.68.4.1027; London G M, 1999, Am Heart J, V138, P220; Mahe G, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001277; Mahoney EM, 2010, CIRC-CARDIOVASC QUAL, V3, P642, DOI 10.1161/CIRCOUTCOMES.109.930735; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Richart T, 2009, HYPERTENS RES, V32, P884, DOI 10.1038/hr.2009.125; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Traupe T, 2013, CIRCULATION, V128, P737, DOI 10.1161/CIRCULATIONAHA.112.000516; Tzoulaki I, 2005, CIRCULATION, V112, P976, DOI 10.1161/CIRCULATIONAHA.104.513085	24	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164756	10.1371/journal.pone.0164756	http://dx.doi.org/10.1371/journal.pone.0164756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760183	gold, Green Published			2022-12-26	WOS:000386204000051
J	Zhao, XY; Li, L; Wang, XB; Fu, RJ; Lv, YP; Jin, W; Meng, C; Chen, GQ; Huang, L; Zhao, KW				Zhao, Xin-Yu; Li, Lei; Wang, Xiao-Bo; Fu, Rong-Jie; Lv, Ya-Ping; Jin, Wei; Meng, Chao; Chen, Guo-Qiang; Huang, Lei; Zhao, Ke-Wen			Inhibition of Snail Family Transcriptional Repressor 2 (SNAI2) Enhances Multidrug Resistance of Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NEURAL CREST DEVELOPMENT; SLUG SNAI2; STEM-CELL; E-CADHERIN; DOWN-REGULATION; BREAST-CANCER; EXPRESSION; METASTASIS; APOPTOSIS	China accounts for almost half of the total number of liver cancer cases and deaths worldwide, and hepatocellular carcinoma (HCC) is the most primary liver cancer. Snail family transcriptional repressor 2 (SNAI2) is known as an epithelial to mesenchymal transition inducing transcription factor that drives neoplastic epithelial cells into mesenchymal phenotype. However, the roles of endogenous SNAI2 remain controversial in different types of malignant tumors. Herein, we surprisingly identify that anchorage-independent growth, including the formation of tumor sphere and soft agar colony, is significantly increased when SNAI2 expression is inhibited by shRNAs in HCC cells. Suppression of SNAI2 suffices to up-regulate several cancer stem genes. Although unrelated to the metastatic ability, SNAI2 inhibition does increase the efflux of Hoechst 33342 and enhance multidrug resistance in vitro and in vivo. In agreement with this data, we demonstrate for the first time that decreasing SNAI2 level can transcriptionally upregulate several ATP binding cassette (ABC) transporter genes such as ABCB1. Moreover, ABC transporters' inhibitor verapamil can rescue the multidrug resistance induced by SNAI2 inhibition. Our results implicate that SNAI2 behaves as a tumor suppressor by inhibiting multidrug resistance via suppressing ABC transporter genes in HCC cells.	[Zhao, Xin-Yu; Li, Lei; Wang, Xiao-Bo; Lv, Ya-Ping; Jin, Wei; Chen, Guo-Qiang; Huang, Lei; Zhao, Ke-Wen] Shanghai Jiao Tong Univ, Sch Med, Key Lab Cell Differentiat & Apoptosis, Minist Educ China,Dept Pathophysiol, Shanghai, Peoples R China; [Fu, Rong-Jie] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Fu, Rong-Jie] SJTU SM, Shanghai, Peoples R China; [Meng, Chao] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Shanghai, Peoples R China	Ministry of Education, China; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, L; Zhao, KW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Key Lab Cell Differentiat & Apoptosis, Minist Educ China,Dept Pathophysiol, Shanghai, Peoples R China.	leihuang@shsmu.edu.cn; zkewen@shsmu.edu.cn	Wang, Xiaobo/F-8055-2018	Wang, Xiaobo/0000-0003-0397-919X; chen, guo qiang/0000-0003-4936-2363	National Basic Research Program of China (973 Program) [2012CB967003]; National Science Foundation of China [81171888, 81572692, 81272262]; Shanghai Science and Technology Committee [14PJ1406300]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by grant 2012CB967003 (to L. Huang) from National Basic Research Program of China (973 Program) (<http://most.gov.cn);/> http://www.most.gov.cn); grant 81171888 and 81572692 (to KW Zhao) and 81272262 (to L Huang) from National Science Foundation of China (<http//www.nsfc.gov.cn/);> http//www.nsfc.gov.cn/); 'Pu Jiang' project 14PJ1406300 (to C. Meng) from Shanghai Science and Technology Committee (<http://www.stcsm.gov.cn/).> http://www.stcsm.gov.cn/).	Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Perez-Mancera PA, 2007, HUM MOL GENET, V16, P2972, DOI 10.1093/hmg/ddm278; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Chang TH, 2011, AM J RESP CRIT CARE, V183, P1071, DOI 10.1164/rccm.201009-1440OC; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Fenouille N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040378; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hajra KM, 2002, CANCER RES, V62, P1613; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Huang W, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003069; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Jiang RL, 1998, DEV BIOL, V198, P277, DOI 10.1016/S0012-1606(98)80005-5; Kathawala RJ, 2015, DRUG RESIST UPDATE, V18, P1, DOI 10.1016/j.drup.2014.11.002; Kim H, 2014, DIGEST DIS, V32, P778, DOI 10.1159/000368021; Kim H, 2011, HEPATOLOGY, V54, P1707, DOI 10.1002/hep.24559; Langer EM, 2008, DEV CELL, V14, P424, DOI 10.1016/j.devcel.2008.01.005; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Liu J, 2010, PROSTATE, V70, P1768, DOI 10.1002/pros.21213; Mancini M, 2010, CELL SIGNAL, V22, P1247, DOI 10.1016/j.cellsig.2010.04.002; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Mei Z, 2014, SCI CHINA LIFE SCI, V57, P610, DOI 10.1007/s11427-014-4663-9; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Losada J, 2002, BLOOD, V100, P1274, DOI 10.1182/blood.V100.4.1274.h81602001274_1274_1286; Raguz S, 2004, CLIN CANCER RES, V10, P2776, DOI 10.1158/1078-0432.CCR-03-0517; Sanchez-Martin M, 2002, HUM MOL GENET, V11, P3231, DOI 10.1093/hmg/11.25.3231; Sanchez-Martin MS, 2003, AM J MED GENET A, V122A, P125, DOI 10.1002/ajmg.a.20345; Schatton T, 2010, J INVEST DERMATOL, V130, P1769, DOI 10.1038/jid.2010.135; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Takeichi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057829; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Uygur B, 2015, PROSTATE, V75, P907, DOI 10.1002/pros.22974; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Vitali R, 2008, CLIN CANCER RES, V14, P4622, DOI 10.1158/1078-0432.CCR-07-5210; Wang BS, 2006, MOL PHARMACOL, V70, P267, DOI 10.1124/mol.105.019810; Wang WL, 2015, ONCOGENE, V34, P1116, DOI 10.1038/onc.2014.58; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Zhao XY, 2010, CARCINOGENESIS, V31, P1367, DOI 10.1093/carcin/bgq116	48	9	10	12	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164752	10.1371/journal.pone.0164752	http://dx.doi.org/10.1371/journal.pone.0164752			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760172	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204000050
J	Jimenez-Lopez, JC; Lopez-Valverde, FJ; Robles-Bolivar, P; Lima-Cabello, E; Gachomo, EW; Kotchoni, SO				Jimenez-Lopez, Jose C.; Lopez-Valverde, Francisco J.; Robles-Bolivar, Paula; Lima-Cabello, Elena; Gachomo, Emma W.; Kotchoni, Simeon O.			Genome-Wide Identification and Functional Classification of Tomato (Solanum lycopersicum) Aldehyde Dehydrogenase (ALDH) Gene Superfamily	PLOS ONE			English	Article							RESPIRATORY BURST OXIDASE; ARABIDOPSIS-THALIANA; ABIOTIC STRESS; EXPRESSION; PLANTS; TOLERANCE; RICE; NOMENCLATURE; SPECIFICITY; EVOLUTION	Aldehyde dehydrogenases (ALDHs) is a protein superfamily that catalyzes the oxidation of aldehyde molecules into their corresponding non-toxic carboxylic acids, and responding to different environmental stresses, offering promising genetic approaches for improving plant adaptation. The aim of the current study is the functional analysis for systematic identification of S. lycopersicum ALDH gene superfamily. We performed genome-based ALDH genes identification and functional classification, phylogenetic relationship, structure and catalytic domains analysis, and microarray based gene expression. Twenty nine unique tomato ALDH sequences encoding 11 ALDH families were identified, including a unique member of the family 19 ALDH. Phylogenetic analysis revealed 13 groups, with a conserved relationship among ALDH families. Functional structure analysis of ALDH2 showed a catalytic mechanism involving Cys-Glu couple. However, the analysis of ALDH3 showed no functional gene duplication or potential neo-functionalities. Gene expression analysis reveals that particular ALDH genes might respond to wounding stress increasing the expression as ALDH2B7. Overall, this study reveals the complexity of S. lycopersicum ALDH gene superfamily and offers new insights into the structure-functional features and evolution of ALDH gene families in vascular plants. The functional characterization of ALDHs is valuable and promoting molecular breeding in tomato for the improvement of stress tolerance and signaling.	[Jimenez-Lopez, Jose C.; Lopez-Valverde, Francisco J.; Robles-Bolivar, Paula; Lima-Cabello, Elena] CSIC, Plant Reprod Biol Lab, Dept Biochem Cell & Mol Biol Plants, Estn Expt Zaidin, 1 Prof Albareda, E-18008 Granada, Spain; [Jimenez-Lopez, Jose C.] Univ Western Australia, UWA Inst Agr, 35 Stirling Highway, Perth, WA 6009, Australia; [Gachomo, Emma W.; Kotchoni, Simeon O.] Rutgers State Univ, Dept Biol, 315 Penn St, Camden, NJ 08102 USA; [Kotchoni, Simeon O.] Rutgers State Univ, Ctr Computat & Integrat Biol CCIB, 315 Penn St, Camden, NJ 08102 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); University of Western Australia; Rutgers State University Camden; Rutgers State University New Brunswick; Rutgers State University Camden; Rutgers State University New Brunswick	Jimenez-Lopez, JC (corresponding author), CSIC, Plant Reprod Biol Lab, Dept Biochem Cell & Mol Biol Plants, Estn Expt Zaidin, 1 Prof Albareda, E-18008 Granada, Spain.; Jimenez-Lopez, JC (corresponding author), Univ Western Australia, UWA Inst Agr, 35 Stirling Highway, Perth, WA 6009, Australia.	josecarlos.jimenez@eez.csic.es	Jimenez-Lopez, Jose C./H-5896-2011; Lima-Cabello, Elena/K-7955-2014	Jimenez-Lopez, Jose C./0000-0002-1470-360X; Lima-Cabello, Elena/0000-0002-5602-0620	European Research Program MARIE CURIE (FP7-PEOPLE-10F) [PIOF-GA-2011-301550]; Spanish Ministry of Economy and Competitiveness (Ramon y Cajal Research Program) [RYC-2014-16536]	European Research Program MARIE CURIE (FP7-PEOPLE-10F); Spanish Ministry of Economy and Competitiveness (Ramon y Cajal Research Program)	This research was supported by European Research Program MARIE CURIE (FP7-PEOPLE-2011-10F) - PIOF-GA-2011-301550, and by Spanish Ministry of Economy and Competitiveness (Ramon y Cajal Research Program) - RYC-2014-16536 to Dr. Jose C. Jimenez-Lopez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahvazi B, 2000, BIOCHEM J, V349, P853, DOI 10.1042/bj3490853; Aoki K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-210; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bartels D, 2001, TRENDS PLANT SCI, V6, P284, DOI 10.1016/S1360-1385(01)01983-5; Brocker C, 2013, PLANTA, V237, P189, DOI 10.1007/s00425-012-1749-0; Cheng CX, 2013, INT J MOL SCI, V14, P24169, DOI 10.3390/ijms141224169; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Frodin DG, 2004, TAXON, V53, P753, DOI 10.2307/4135449; Gao CX, 2009, GENE, V431, P86, DOI 10.1016/j.gene.2008.11.010; Gao ZG, 2000, PLANT PHYSIOL, V124, P321, DOI 10.1104/pp.124.1.321; GarciaRios M, 1997, P NATL ACAD SCI USA, V94, P8249, DOI 10.1073/pnas.94.15.8249; Hou QC, 2015, ANN BOT-LONDON, V115, P465, DOI 10.1093/aob/mcu152; ISHITANI M, 1995, PLANT MOL BIOL, V27, P307, DOI 10.1007/BF00020185; Itabashi E, 2011, PLANT J, V65, P359, DOI 10.1111/j.1365-313X.2010.04427.x; Jimenez-Lopez JC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-43; Kahraman A, 2007, J MOL BIOL, V368, P283, DOI 10.1016/j.jmb.2007.01.086; Keller MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5439; Keller MA, 2010, J LIPID RES, V51, P1554, DOI 10.1194/jlr.D002220; Kirch HH, 2005, PLANT MOL BIOL, V57, P315, DOI 10.1007/s11103-004-7796-6; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Koncitikova R, 2015, BIOCHEM J, V468, P109, DOI 10.1042/BJ20150009; Kopecny D, 2013, J BIOL CHEM, V288, P9491, DOI 10.1074/jbc.M112.443952; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Kotchoni SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011516; Kotchoni SO, 2012, GENE, V495, P128, DOI 10.1016/j.gene.2011.12.035; Kotchoni SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015906; Kriventseva EV, 2015, NUCLEIC ACIDS RES, V43, pD250, DOI 10.1093/nar/gku1220; Lehmann S, 2010, AMINO ACIDS, V39, P949, DOI 10.1007/s00726-010-0525-3; Li XQ, 2013, PLANT PHYSIOL BIOCH, V71, P268, DOI 10.1016/j.plaphy.2013.07.017; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Lloyd MD, 2007, J ENZYM INHIB MED CH, V22, P584, DOI 10.1080/14756360701425360; Missihoun TD, 2014, PLANTA, V239, P1281, DOI 10.1007/s00425-014-2051-0; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Ni FT, 2009, CURR GENOMICS, V10, P269, DOI 10.2174/138920209788488535; Pemberton TA, 2014, STRUCTURAL STUDIES Y; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Rejeb Ines Ben, 2014, Plants (Basel), V3, P458, DOI 10.3390/plants3040458; Rodrigues SM, 2006, J EXP BOT, V57, P1909, DOI 10.1093/jxb/erj132; Sagi M, 2004, PLANT CELL, V16, P616, DOI 10.1105/tpc.019398; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sobreira TJP, 2011, P NATL ACAD SCI USA, V108, P226, DOI 10.1073/pnas.1011223108; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Tian FX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124669; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Vandepoele K, 2003, PLANT CELL, V15, P2192, DOI 10.1105/tpc.014019; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; Wood AJ, 2009, BRYOLOGIST, V112, P1, DOI 10.1639/0007-2745-112.1.1; Xing WB, 2001, ENVIRON EXP BOT, V46, P21, DOI 10.1016/S0098-8472(01)00078-8; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038603	56	15	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164798	10.1371/journal.pone.0164798	http://dx.doi.org/10.1371/journal.pone.0164798			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755582	Green Published, gold, Green Submitted			2022-12-26	WOS:000386203800034
J	Popova, OV; Mikhailov, KV; Nikitin, MA; Logacheva, MD; Penin, AA; Muntyan, MS; Kedrova, OS; Petrov, NB; Panchin, YV; Aleoshin, VV				Popova, Olga V.; Mikhailov, Kirill V.; Nikitin, Mikhail A.; Logacheva, Maria D.; Penin, Aleksey A.; Muntyan, Maria S.; Kedrova, Olga S.; Petrov, Nikolai B.; Panchin, Yuri V.; Aleoshin, Vladimir V.			Mitochondrial Genomes of Kinorhyncha: trnM Duplication and New Gene Orders within Animals	PLOS ONE			English	Article							TRANSFER-RNA GENE; PHYLOGENETIC POSITION; EVOLUTION; SEQUENCE; REARRANGEMENTS; DNA; MITOGENOMICS; ARRANGEMENT; SELECTION; ALIGNMENT	Many features of mitochondrial genomes of animals, such as patterns of gene arrangement, nucleotide content and substitution rate variation are extensively used in evolutionary and phylogenetic studies. Nearly 6,000 mitochondrial genomes of animals have already been sequenced, covering the majority of animal phyla. One of the groups that escaped mitogenome sequencing is phylum Kinorhyncha-an isolated taxon of microscopic worm-like ecdysozoans. The kinorhynchs are thought to be one of the early-branching lineages of Ecdysozoa, and their mitochondrial genomes may be important for resolving evolutionary relations between major animal taxa. Here we present the results of sequencing and analysis of mitochondrial genomes from two members of Kinorhyncha, Echinoderes svetlanae (Cyclorhagida) and Pycnophyes kielensis (Allomalorhagida). Their mitochondrial genomes are circular molecules approximately 15 Kbp in size. The kinorhynch mitochondrial gene sequences are highly divergent, which precludes accurate phylogenetic inference. The mitogenomes of both species encode a typical metazoan complement of 37 genes, which are all positioned on the major strand, but the gene order is distinct and unique among Ecdysozoa or animals as a whole. We predict four types of start codons for protein-coding genes in E. svetlanae and five in P. kielensis with a consensus DTD in single letter code. The mitochondrial genomes of E. svetlanae and P. kielensis encode duplicated methionine tRNA genes that display compensatory nucleotide substitutions. Two distant species of Kinorhyncha demonstrate similar patterns of gene arrangements in their mitogenomes. Both genomes have duplicated methionine tRNA genes; the duplication predates the divergence of two species. The kinorhynchs share a few features pertaining to gene order that align them with Priapulida. Gene order analysis reveals that gene arrangement specific of Priapulida may be ancestral for Scalidophora, Ecdysozoa, and even Protostomia.	[Popova, Olga V.] Lomonosov Moscow State Univ, Fac Bioengn & Bioinformat, Leninskie Gory 1,Bldg 73, Moscow 119991, Russia; [Mikhailov, Kirill V.; Nikitin, Mikhail A.; Logacheva, Maria D.; Penin, Aleksey A.; Muntyan, Maria S.; Petrov, Nikolai B.; Panchin, Yuri V.; Aleoshin, Vladimir V.] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Leninskie Gory 1,Bldg 40, Moscow 119991, Russia; [Mikhailov, Kirill V.; Logacheva, Maria D.; Penin, Aleksey A.; Panchin, Yuri V.; Aleoshin, Vladimir V.] Russian Acad Sci, Inst Informat Transmiss Problems, Bolshoy Karetny Per 19,Bldg 1, Moscow 127994, Russia; [Logacheva, Maria D.] Kazan Fed Univ, Inst Fundamental Med & Biol, Extreme Biol Lab, 18 Kremlyovskaya Str, Kazan 420008, Russia; [Kedrova, Olga S.] Lomonosov Moscow State Univ, Fac Biol, Leninskie Gory 1,Bldg 12, Moscow 119991, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Kazan Federal University; Lomonosov Moscow State University	Aleoshin, VV (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Leninskie Gory 1,Bldg 40, Moscow 119991, Russia.; Aleoshin, VV (corresponding author), Russian Acad Sci, Inst Informat Transmiss Problems, Bolshoy Karetny Per 19,Bldg 1, Moscow 127994, Russia.	aleshin@genebee.msu.su	Logacheva, Maria/K-5217-2012; Aleoshin, Vladimir/AAE-9707-2022; Aleoshin, Vladimir/AFE-8409-2022; Penin, Aleksey/A-5477-2011; Muntyan, Maria/J-3377-2013; Petrov, Nikolai/K-6225-2013; Nikitin, Mikhail/K-3417-2013	Aleoshin, Vladimir/0000-0002-3299-9950; Muntyan, Maria/0000-0003-2332-5644; Mikhailov, Kirill/0000-0002-0457-9625; Nikitin, Mikhail/0000-0003-4855-8057; Penin, Aleksey/0000-0002-9057-3974	Russian Science Foundation [14-50-00150, 14-50-00029]; Russian Foundation for Basic Research [15-04-05841]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	Genome sequencing, assembly and annotation were supported by the Russian Science Foundation (Grant Number: 14-50-00150). Analyses of mtDNA structures was supported by the Russian Foundation for Basic Research (No. 15-04-05841). Phylogenetic analyses in this study were supported by the Russian Science Foundation (Grant Number: 14-50-00029).	Abascal F, 2006, NUCLEIC ACIDS RES, V34, pW389, DOI 10.1093/nar/gkl044; Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Abeel T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr995; Aleshin VV, 1998, J MOL EVOL, V47, P597, DOI 10.1007/PL00006416; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Beagley CT, 1999, GENETICS, V152, P641; Bergstrom CT, 1998, GENETICS, V149, P2135; Bernt M, 2008, LECT N BIOINFORMAT, V5267, P143, DOI 10.1007/978-3-540-87989-3_11; Bernt M, 2007, BIOINFORMATICS, V23, P2957, DOI 10.1093/bioinformatics/btm468; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P352, DOI 10.1016/j.ympev.2013.05.002; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Blanquart S, 2006, MOL BIOL EVOL, V23, P2058, DOI 10.1093/molbev/msl091; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2004, MOL BIOL EVOL, V21, P1492, DOI 10.1093/molbev/msh090; BOORE JL, 1995, NATURE, V376, P163, DOI 10.1038/376163a0; Borner J, 2014, MOL PHYLOGENET EVOL, V80, P79, DOI 10.1016/j.ympev.2014.08.001; Bourlat SJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-107; Braband A, 2010, MOL PHYLOGENET EVOL, V57, P285, DOI 10.1016/j.ympev.2010.05.011; CANTATORE P, 1987, INT REV CYTOL, V108, P149, DOI 10.1016/S0074-7696(08)61438-2; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cooper BS, 2015, G3-GENES GENOM GENET, V5, P2165, DOI 10.1534/g3.114.016493; Dinet A., 1979, Ambio Special Report, P75; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Dutilh BE, 2011, BIOINFORMATICS, V27, P1929, DOI 10.1093/bioinformatics/btr316; Gissi C, 2004, J MOL EVOL, V58, P376, DOI 10.1007/s00239-003-2559-6; Gissi C, 2010, MOL BIOL EVOL, V27, P211, DOI 10.1093/molbev/msp234; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Helfenbein KG, 2004, P NATL ACAD SCI USA, V101, P10639, DOI 10.1073/pnas.0400941101; HOFFMANN RJ, 1992, GENETICS, V131, P397; Hyman BC, 2011, GENETICA, V139, P611, DOI 10.1007/s10709-010-9531-3; Jang KH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-167; Jiang Y, 2016, MITOCHONDRIAL DNA A, V27, P2639, DOI 10.3109/19401736.2015.1041132; Juhling F, 2012, NUCLEIC ACIDS RES, V40, P2833, DOI 10.1093/nar/gkr1131; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kumazawa Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-930; Lartillot N, 2013, SYST BIOL, V62, P611, DOI 10.1093/sysbio/syt022; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lavrov DV, 2005, MOL BIOL EVOL, V22, P1231, DOI 10.1093/molbev/msi108; Lemburg Christian, 1995, Microfauna Marina, V10, P7; Lessinger AC, 2004, GENE, V339, P1, DOI 10.1016/j.gene.2004.06.041; Li MM, 2016, MITOCHONDRIAL DNA A, V27, P2147, DOI 10.3109/19401736.2014.982599; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Mwinyi A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-309; Mwinyi A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-27; Nesnidal MP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-572; Neuhaus B, 2012, HDB ZOOLOGY GASTROTR, V1, P181; Papillon D, 2004, MOL BIOL EVOL, V21, P2122, DOI 10.1093/molbev/msh229; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Petrov NB, 2005, MOL BIOL+, V39, P503, DOI 10.1007/s11008-005-0067-z; Phillips WS, 2015, GENOME BIOL EVOL, V7, P2023, DOI 10.1093/gbe/evv116; Podsiadlowski L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-364; Popadin KY, 2013, MOL BIOL EVOL, V30, P347, DOI 10.1093/molbev/mss219; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rota-Stabelli O, 2010, GENOME BIOL EVOL, V2, P425, DOI 10.1093/gbe/evq030; Rota-Stabelli O, 2009, MOL PHYLOGENET EVOL, V52, P268, DOI 10.1016/j.ympev.2009.01.011; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Segawa RD, 2005, GENE, V355, P28, DOI 10.1016/j.gene.2005.05.020; Shao R, 2004, INSECT MOL BIOL, V13, P219, DOI 10.1111/j.0962-1075.2004.00447.x; Shao RF, 2006, J MOL EVOL, V63, P251, DOI 10.1007/s00239-005-0196-y; Sherbakov DY., STEMS PROGRAM AUTOMA; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Singh TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-534; SMITH MJ, 1993, J MOL EVOL, V36, P545, DOI 10.1007/BF00556359; Sorensen MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133440; Stach T, 2010, MOL PHYLOGENET EVOL, V55, P860, DOI 10.1016/j.ympev.2010.03.011; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timmermans MJTN, 2012, MOL PHYLOGENET EVOL, V63, P299, DOI 10.1016/j.ympev.2011.12.021; Valles Y, 2006, INTEGR COMP BIOL, V46, P544, DOI 10.1093/icb/icj056; VANHOVE S, 1995, MAR ECOL PROG SER, V127, P65, DOI 10.3354/meps127065; Waeschenbach A, 2006, MOL PHYLOGENET EVOL, V40, P195, DOI 10.1016/j.ympev.2006.03.007; Wang XJ, 2011, GENE, V475, P22, DOI 10.1016/j.gene.2010.12.009; Webster BL, 2006, EVOL DEV, V8, P502, DOI 10.1111/j.1525-142X.2006.00123.x; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xu Y, 2016, MITOCHONDRIAL DNA A, V27, P2083, DOI 10.3109/19401736.2014.982567; Yamasaki H, 2014, ZOOL SCI, V31, P421, DOI 10.2108/zs140011; Yamasaki H, 2013, MOL PHYLOGENET EVOL, V67, P303, DOI 10.1016/j.ympev.2013.02.016; Yang HR, 2016, MITOCHONDRIAL DNA A, V27, P1674, DOI 10.3109/19401736.2014.958723; Yokobori S, 2003, J MOL EVOL, V57, P574, DOI 10.1007/s00239-003-2511-9; Zhang HQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16521; Zhuravlev AY, 2014, ZH OBSHCH BIOL, V75, P411	87	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0165072	10.1371/journal.pone.0165072	http://dx.doi.org/10.1371/journal.pone.0165072			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755612	Green Published, Green Submitted, gold			2022-12-26	WOS:000386203800054
J	Zhong, SF; Ma, LX; Fatima, SA; Yang, JZ; Chen, WQ; Liu, TG; Hu, YT; Li, Q; Guo, JW; Zhang, M; Lei, L; Li, X; Tang, SW; Luo, PG				Zhong, Shengfu; Ma, Lixia; Fatima, Syeda Akash; Yang, Jiezhi; Chen, Wanquan; Liu, Taiguo; Hu, Yuting; Li, Qing; Guo, Jingwei; Zhang, Min; Lei, Li; Li, Xin; Tang, Shengwen; Luo, Peigao			Collinearity Analysis and High-Density Genetic Mapping of the Wheat Powdery Mildew Resistance Gene Pm40 in PI 672538	PLOS ONE			English	Article							TURGIDUM VAR. DICOCCOIDES; COMMON WHEAT; CHROMOSOMAL LOCATION; THINOPYRUM-INTERMEDIUM; WILD EMMER; STRIPE RUST; LEAF RUST; MOLECULAR CHARACTERIZATION; DRAFT GENOME; BREAD WHEAT	The wheat powdery mildew resistance gene Pm40, which is located on chromosomal arm 7BS, is effective against nearly all prevalent races of Blumeria graminis f. sp tritici (Bgt) in China and is carried by the common wheat germplasm PI 672538. A set of the F-1, F-2 and F-2:3 populations from the cross of the resistant PI 672538 with the susceptible line L1034 were used to conduct genetic analysis of powdery mildew resistance and construct a high-density linkage map of the Pm40 gene. We constructed a high-density linkage genetic map with a total length of 6.18 cM and average spacing between markers of 0.48 cM. Pm40 is flanked by Xwmc335 and BF291338 at genetic distances of 0.58 cM and 0.26 cM, respectively, in deletion bin C-7BS-1-0.27. Comparative genomic analysis based on EST-STS markers established a high level of collinearity of the Pm40 genomic region with a 1.09-Mbp genomic region on Brachypodium chromosome 3, a 1.16-Mbp genomic region on rice chromosome 8, and a 1.62-Mbp genomic region on sorghum chromosome 7. We further anchored the Pm40 target intervals to the wheat genome sequence. A putative linear index of 85 wheat contigs containing 97 genes on 7BS was constructed. In total, 9 genes could be considered as candidates for the resistances to powdery mildew in the target genomic regions, which encoded proteins that were involved in the plant defense and response to pathogen attack. These results will facilitate the development of new markers for map-based cloning and marker-assisted selection of Pm40 in wheat breeding programs.	[Zhong, Shengfu; Ma, Lixia; Fatima, Syeda Akash; Yang, Jiezhi; Hu, Yuting; Li, Qing; Guo, Jingwei; Zhang, Min; Li, Xin; Tang, Shengwen; Luo, Peigao] Sichuan Agr Univ, State Key Lab Plant Breeding & Genet, Chengdu, Sichuan, Peoples R China; [Zhong, Shengfu; Chen, Wanquan; Liu, Taiguo; Luo, Peigao] Chinese Acad Agr Sci CAAS, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Li, Qing] Chongqing Ind & Trade Polytech Inst, Dept Biol & Chem, Fuling Dist Of Chongqing, Peoples R China; [Lei, Li] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA	Sichuan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of Minnesota System; University of Minnesota Twin Cities	Luo, PG (corresponding author), Sichuan Agr Univ, State Key Lab Plant Breeding & Genet, Chengdu, Sichuan, Peoples R China.	lpglab@sicau.edu.cn	Liu, Taiguo/EYP-0651-2022; Lei, Li/J-6122-2019; Fatima, Akash/ABH-9427-2020; Liu, Tai Guo/GYD-3049-2022	Lei, Li/0000-0001-5708-0118; Fatima, Akash/0000-0003-3660-7165; Liu, Tai Guo/0000-0001-7466-1811	National Natural Science Foundation of China [31571661]; Specific Foundation of Agronomy [nyhyzx3-15, 201303016]; Bureau of Science and Technology of Fuling of Chongqing [FLKJ-2015ABB1048]; Ministry of Science and Technology, China [2013CB127701]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specific Foundation of Agronomy(Ministry of Science and Technology, China); Bureau of Science and Technology of Fuling of Chongqing; Ministry of Science and Technology, China(Ministry of Science and Technology, China)	We are grateful for the financial support of the National Natural Science Foundation of China (No. 31571661), the Specific Foundation of Agronomy (No. nyhyzx3-15, 201303016), the Bureau of Science and Technology of Fuling of Chongqing (FLKJ-2015ABB1048), and the Ministry of Science and Technology, China (2013CB127701). The funders had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Blanco A, 2008, THEOR APPL GENET, V117, P135, DOI 10.1007/s00122-008-0760-0; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; Dobritsa AA, 2011, PLANT PHYSIOL, V157, P947, DOI 10.1104/pp.111.179523; Feuillet C, 2003, P NATL ACAD SCI USA, V100, P15253, DOI 10.1073/pnas.2435133100; FRIEBE B, 1994, CROP SCI, V34, P621, DOI 10.2135/cropsci1994.0011183X003400030003x; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Gao HD, 2012, THEOR APPL GENET, V125, P967, DOI 10.1007/s00122-012-1886-7; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; Green AJ, 2014, CROP PROT, V64, P177, DOI 10.1016/j.cropro.2014.06.023; Gupta PK, 2002, THEOR APPL GENET, V105, P413, DOI 10.1007/s00122-002-0865-9; Hao YF, 2008, THEOR APPL GENET, V117, P1205, DOI 10.1007/s00122-008-0827-y; Hao YF, 2015, THEOR APPL GENET, V128, P465, DOI 10.1007/s00122-014-2445-1; He RL, 2009, THEOR APPL GENET, V118, P1173, DOI 10.1007/s00122-009-0971-z; Holt BF, 2002, DEV CELL, V2, P807, DOI 10.1016/S1534-5807(02)00174-0; Hsam SLK, 1997, PLANT BREEDING, V116, P119, DOI 10.1111/j.1439-0523.1997.tb02164.x; Hsam SLK, 2001, THEOR APPL GENET, V102, P127, DOI 10.1007/s001220051627; Hsam SLK, 1998, THEOR APPL GENET, V96, P1129, DOI 10.1007/s001220050848; Hua W, 2009, THEOR APPL GENET, V119, P223, DOI 10.1007/s00122-009-1031-4; Huang Q, 2014, THEOR APPL GENET, V127, P843, DOI 10.1007/s00122-014-2261-7; Huang XQ, 2003, THEOR APPL GENET, V106, P1379, DOI 10.1007/s00122-002-1179-7; Huang X. Q., 2000, Journal of Genetics and Breeding, V54, P311; Huang XQ, 2002, HEREDITAS, V136, P212, DOI 10.1034/j.1601-5223.2002.1360306.x; Huh SU, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-75; Huh SU, 2013, P NATL ACAD SCI USA, V110, P779, DOI 10.1073/pnas.1214287110; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; LAW CN, 1966, CAN J GENET CYTOL, V8, P462, DOI 10.1139/g66-056; Lee SM, 2007, FEBS LETT, V581, P3943, DOI 10.1016/j.febslet.2007.07.023; Li GQ, 2009, THEOR APPL GENET, V119, P531, DOI 10.1007/s00122-009-1061-y; Li X, 2017, PHYTOPATHOLOGY, V107, P92, DOI 10.1094/PHYTO-04-16-0170-R; Li X, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/431476; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu ZH, 2015, J PLANT REGIST, V9, P121, DOI 10.3198/jpr2014.01.0003crg; Liu ZJ, 2012, THEOR APPL GENET, V124, P1041, DOI 10.1007/s00122-011-1767-5; Liu ZiJi, 2011, Acta Agronomica Sinica, V37, P1569, DOI 10.3724/SP.J.1006.2011.01569; Liu ZY, 2002, EUPHYTICA, V123, P21, DOI 10.1023/A:1014471113511; Luo PG, 2009, THEOR APPL GENET, V118, P1059, DOI 10.1007/s00122-009-0962-0; Luo PG, 2009, PHYTOPROTECTION, V90, P57, DOI 10.7202/044023ar; Ma LX, 2015, PHYSIOL MOL PLANT P, V90, P39, DOI 10.1016/j.pmpp.2015.02.005; Ma Qiang, 2007, Acta Agronomica Sinica, V33, P1; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Mohler V, 2013, J APPL GENET, V54, P259, DOI 10.1007/s13353-013-0158-9; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Qi YP, 2011, MOL PLANT PATHOL, V12, P702, DOI 10.1111/J.1364-3703.2010.00704.X; Qin B, 2011, THEOR APPL GENET, V123, P207, DOI 10.1007/s00122-011-1577-9; READER SM, 1991, EUPHYTICA, V53, P57, DOI 10.1007/BF00032033; Roder MS, 1998, GENETICS, V149, P2007; Rong JK, 2000, EUPHYTICA, V115, P121, DOI 10.1023/A:1003950431049; Shen XK, 2015, THEOR APPL GENET, V128, P517, DOI 10.1007/s00122-014-2449-x; Shi YaQian, 2009, Journal of Triticeae Crops, V29, P706; Silvar C., 2015, Plant Genome, V8, punpaginated; Silvar C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067336, 10.1371/j]; Silvar C, 2012, THEOR APPL GENET, V124, P49, DOI 10.1007/s00122-011-1686-5; Singrun C, 2003, THEOR APPL GENET, V106, P1420, DOI 10.1007/s00122-002-1187-7; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Tai T., 1990, PLANT MOL BIOL REP, V8, P297, DOI [10.1007/BF02668766, DOI 10.1007/BF02668766]; THE TT, 1979, AUST J BIOL SCI, V32, P115, DOI 10.1071/BI9790115; Xiao MG, 2013, THEOR APPL GENET, V126, P1397, DOI 10.1007/s00122-013-2060-6; Xie C, 2004, PLANT BREEDING, V123, P198, DOI 10.1046/j.1439-0523.2003.00940.x; Xue F, 2012, THEOR APPL GENET, V124, P1549, DOI 10.1007/s00122-012-1809-7; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Yang HJ, 2015, PLANT PHYSIOL, V167, P1604, DOI 10.1104/pp.114.255216; [杨立军 Yang Lijun], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P3354; [杨立军 Yang Lijun], 2009, [植物保护, Plant Protection], V35, P76; Zhang HT, 2010, THEOR APPL GENET, V121, P1613, DOI 10.1007/s00122-010-1414-6; Zhang Li, 2011, Acta Phytophylacica Sinica, V38, P569; Zhao ZH, 2013, THEOR APPL GENET, V126, P3081, DOI 10.1007/s00122-013-2194-6; Zhou RH, 2005, THEOR APPL GENET, V110, P640, DOI 10.1007/s00122-004-1889-0	73	7	7	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164815	10.1371/journal.pone.0164815	http://dx.doi.org/10.1371/journal.pone.0164815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755575	Green Published, gold, Green Submitted			2022-12-26	WOS:000386203800037
J	Julian, C; Lentjes, MAH; Huybrechts, I; Luben, R; Wareham, N; Moreno, LA; Khaw, KT				Julian, Cristina; Lentjes, Marleen A. H.; Huybrechts, Inge; Luben, Robert; Wareham, Nick; Moreno, Luis A.; Khaw, Kay-Tee			Fracture Risk in Relation to Serum 25-Hydroxyvitamin D and Physical Activity: Results from the EPIC-Norfolk Cohort Study	PLOS ONE			English	Article							INCIDENT CARDIOVASCULAR-DISEASE; BONE-MINERAL DENSITY; VITAMIN-D DEFICIENCY; ALL-CAUSE MORTALITY; OSTEOPOROTIC FRACTURES; OLDER-ADULTS; POSTMENOPAUSAL WOMEN; CONTROLLED-TRIAL; ADRENAL-GLAND; HIP FRACTURE	Vitamin D deficiency and physical inactivity have been associated with bone loss and fractures, but their combined effect has scarcely been studied either in younger or older adults. Therefore, we aimed to assess the associations between physical activity, age and 25-hydroxyvitamin D (25(OH)D) status separately and in combination with the incidence of fracture risk in the EPIC-Norfolk cohort study. Baseline (1993-1998) self-reported physical activity and serum 25(OH)D concentrations at follow-up (1998-2000) were collected in 14,624 men and women (aged 42-82 y between 1998 and 2000). Fracture incidence was ascertained up to March 2015. Cox proportional hazard model was used to determine HRs of fractures by plasma 25(OH)D (<30, 30 to <50, 50 to <70, 70 to <90, >90 nmol/L), age (<65 y and >65 y) and physical activity (inactive and active) categories, by follow-up time per 20 nmol/L increase in serum 25(OH)D and to explore age-25(OH)D and physical activity-25(OH)D interactions. The age-, sex-, and month-adjusted HRs (95% CIs) for all fractures (1183 fractures) by increasing vitamin D category were not significantly different. With additional adjustment for body mass index, smoking status, alcohol intake, supplement use and history of fractures, the fracture risk was 29% lower in those participants with 50 to 70 nmol/L compared with those in the lowest quintile (<30 nmol/L). Physical inactivity based on a single baseline assessment was not associated with fracture risk. Vitamin D status appeared inversely related to fractures in middle aged adults. In older adults, the relationship between vitamin D status and fracture risk was observed to be J-shaped. Clinical and public health practice in vitamin D supplementation could partially explain these findings, although definitive conclusions are difficult due to potential changes in exposure status over the long follow up period.	[Julian, Cristina; Lentjes, Marleen A. H.; Luben, Robert; Khaw, Kay-Tee] Univ Cambridge, Inst Publ Hlth, Sch Clin Med, Dept Publ Hlth & Primary Care, Cambridge, England; [Julian, Cristina; Moreno, Luis A.] Univ Zaragoza, IA2, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain; [Julian, Cristina; Moreno, Luis A.] Univ Zaragoza, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Zaragoza, Spain; [Huybrechts, Inge] Int Agcy Res Canc, Dietary Exposure Assessment Grp, Lyon, France; [Wareham, Nick] Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Med Res Council,Epidemiol Unit, Cambridge, England	University of Cambridge; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Zaragoza; World Health Organization; International Agency for Research on Cancer (IARC); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge	Julian, C (corresponding author), Univ Cambridge, Inst Publ Hlth, Sch Clin Med, Dept Publ Hlth & Primary Care, Cambridge, England.; Julian, C (corresponding author), Univ Zaragoza, IA2, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain.; Julian, C (corresponding author), Univ Zaragoza, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Zaragoza, Spain.	cjulian@unizar.es	Khaw, Kay-Tee/AAZ-3209-2021; Moreno, Luis/S-1780-2019; Luben, Robert N/H-5519-2015	Moreno, Luis/0000-0003-0454-653X; Luben, Robert N/0000-0002-5088-6343; Lentjes, Marleen/0000-0003-4713-907X; Julian Almarcegui, Cristina/0000-0002-8374-3410	Medical Research Council (MRC) [MKS/S16 (RG19715), G9502233]; Cancer Research UK (CRUK) [MKS/R07 (RG14230), SP2024/0201, MKS/T21 (RG23772), SP2024/0204]; Government of Spain "Ministerio de Educacion, Cultura y Deporte" [FPU13/00421]; Medical Research Council [G0401527, MR/N003284/1, MC_PC_13048, MC_U106179471, MC_UU_12015/1, G1000143] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114, NF-SI-0512-10135] Funding Source: researchfish; MRC [MC_UU_12015/1, MR/N003284/1] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK (CRUK)(Cancer Research UK); Government of Spain "Ministerio de Educacion, Cultura y Deporte"; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council (MRC) - MKS/S16 (RG19715) / Sponsor Funding Ref: G9502233; Cancer Research UK (CRUK) - MKS/R07 (RG14230) / Sponsor Funding Ref: SP2024/0201; and Cancer Research UK (CRUK) - MKS/T21 (RG23772) / Sponsor Funding Ref: SP2024/0204. CJA received a Grant FPU13/00421 from the Government of Spain "Ministerio de Educacion, Cultura y Deporte". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACSM, 2004, MED SCI SPORTS EX; Bleicher K, 2014, J BONE MINER RES, V29, P2024, DOI 10.1002/jbmr.2230; Bunout D, 2006, EXP GERONTOL, V41, P746, DOI 10.1016/j.exger.2006.05.001; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Curtis E, 2015, J CELL PHYSIOL, V230, P2618, DOI 10.1002/jcp.25001; Day N, 1999, BRIT J CANCER, V80, P95; Ebrahim S, 1997, AGE AGEING, V26, P253, DOI 10.1093/ageing/26.4.253; Ensrud KE, 2010, J CLIN ENDOCR METAB, V95, P5266, DOI 10.1210/jc.2010-2317; Feskanich D, 2002, JAMA-J AM MED ASSOC, V288, P2300, DOI 10.1001/jama.288.18.2300; Fritz J, 2016, OSTEOPOROSIS INT, V27, P915, DOI 10.1007/s00198-015-3311-y; Gardner MM, 2000, BRIT J SPORT MED, V34, P7, DOI 10.1136/bjsm.34.1.7; Garland CF, 2014, AM J PUBLIC HEALTH, V104, pE43, DOI 10.2105/AJPH.2014.302034; Garnero P, 2007, BONE, V40, P716, DOI 10.1016/j.bone.2006.09.026; Grant WB, 2016, DERM-ENDOCRINOL, V8, DOI 10.1080/19381980.2016.1187349; Gregg EW, 2000, J AM GERIATR SOC, V48, P883, DOI 10.1111/j.1532-5415.2000.tb06884.x; Health Canada, 2010, DIETARY REFERENCE IN; Hoidrup S, 2001, AM J EPIDEMIOL, V154, P60, DOI 10.1093/aje/154.1.60; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Jurutka PW, 2007, J BONE MINER RES, V22, pV2, DOI 10.1359/JBMR.07S216; Karlsson Magnus K, 2007, Med Sport Sci, V51, P121, DOI 10.1159/000103012; Kemmler W, 2013, OSTEOPOROSIS INT, V24, P1937, DOI 10.1007/s00198-012-2248-7; Khaw KT, 2006, INT J EPIDEMIOL, V35, P1034, DOI 10.1093/ije/dyl079; Khaw KT, 2014, AM J CLIN NUTR, V100, P1361, DOI 10.3945/ajcn.114.086413; Kotta S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007401; Looker AC, 2013, J BONE MINER RES, V28, P997, DOI 10.1002/jbmr.1828; Melhus H, 2010, J CLIN ENDOCR METAB, V95, P2637, DOI 10.1210/jc.2009-2699; Moayyeri A, 2009, J BONE MINER RES, V24, P1319, DOI [10.1359/jbmr.090212, 10.1359/JBMR.090212]; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Sanders KM, 2014, CURR OSTEOPOROS REP, V12, P74, DOI 10.1007/s11914-014-0193-4; Shohaimi S, 2004, EUR RESPIR J, V24, P157, DOI 10.1183/09031936.04.00088303; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2014, MOL CELL ENDOCRINOL, V383, P181, DOI 10.1016/j.mce.2013.12.012; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Snellman G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011555; Stevens JA, 1997, ANN EPIDEMIOL, V7, P54, DOI 10.1016/S1047-2797(96)00110-X; Svedbom A, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0137-0; Swanenburg J, 2007, CLIN REHABIL, V21, P523, DOI 10.1177/0269215507075206; Uusi-Rasi K, 2015, JAMA INTERN MED, V175, P703, DOI 10.1001/jamainternmed.2015.0225; van Schoor NM, 2008, BONE, V42, P260, DOI 10.1016/j.bone.2007.11.002; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Zhu K, 2015, CURR OSTEOPOROS REP, V13, P52, DOI 10.1007/s11914-014-0248-6	44	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164160	10.1371/journal.pone.0164160	http://dx.doi.org/10.1371/journal.pone.0164160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749911	Green Published, gold			2022-12-26	WOS:000386202300009
J	Spoerry, C; Hessle, P; Lewis, MJ; Paton, L; Woof, JM; von Pawel-Rammingen, U				Spoerry, Christian; Hessle, Pontus; Lewis, Melanie J.; Paton, Lois; Woof, Jenny M.; von Pawel-Rammingen, Ulrich			Novel IgG-Degrading Enzymes of the IgdE Protease Family Link Substrate Specificity to Host Tropism of Streptococcus Species	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; IMMUNOGLOBULIN-G; UNIQUE SPECIFICITY; IGA1 PROTEASES; PORCINE IGG; SUBCLASSES; CLEAVAGE; IDES; FC; IDENTIFICATION	Recently we have discovered an IgG degrading enzyme of the endemic pig pathogen S. suis designated IgdE that is highly specific for porcine IgG. This protease is the founding member of a novel cysteine protease family assigned C113 in the MEROPS peptidase database. Bioinformatical analyses revealed putative members of the IgdE protease family in eight other Streptococcus species. The genes of the putative IgdE family proteases of S. agalactiae, S. porcinus, S. pseudoporcinus and S. equi subsp. zooepidemicus were cloned for production of recombinant protein into expression vectors. Recombinant proteins of all four IgdE family proteases were proteolytically active against IgG of the respective Streptococcus species hosts, but not against IgG from other tested species or other classes of immunoglobulins, thereby linking the substrate specificity to the known host tropism. The novel IgdE family proteases of S. agalactiae, S. pseudoporcinus and S. equi showed IgG subtype specificity, i.e. IgdE from S. agalactiae and S. pseudoporcinus cleaved human IgG1, while IgdE from S. equi was subtype specific for equine IgG7. Porcine IgG subtype specificities of the IgdE family proteases of S. porcinus and S. pseudoporcinus remain to be determined. Cleavage of porcine IgG by IgdE of S. pseudoporcinus is suggested to be an evolutionary remaining activity reflecting ancestry of the human pathogen to the porcine pathogen S. porcinus. The IgG subtype specificity of bacterial proteases indicates the special importance of these IgG subtypes in counteracting infection or colonization and opportunistic streptococci neutralize such antibodies through expression of IgdE family proteases as putative immune evasion factors. We suggest that IgdE family proteases might be valid vaccine targets against streptococci of both human and veterinary medical concerns and could also be of therapeutic as well as biotechnological use.	[Spoerry, Christian; Hessle, Pontus; von Pawel-Rammingen, Ulrich] Umea Univ, Dept Mol Biol, Umea, Sweden; [Spoerry, Christian; Hessle, Pontus; von Pawel-Rammingen, Ulrich] Umea Univ, Umea Ctr Microbial Res, Umea, Sweden; [Lewis, Melanie J.; Paton, Lois; Woof, Jenny M.] Univ Dundee, Sch Life Sci, Cell Signalling & Immunol, Wellcome Trust Bldg, Dundee, Scotland	Umea University; Umea University; University of Dundee	von Pawel-Rammingen, U (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.; von Pawel-Rammingen, U (corresponding author), Umea Univ, Umea Ctr Microbial Res, Umea, Sweden.	ulrich.von-pawel@molbiol.umu.se		Spoerry, Christian/0000-0001-5763-6542	Carl Tryggers foundation [CTS13-514]; Umea University insamlingsstiftelse [2.1.12-1605-14]; Wellcome Trust [074863]; Kempestiftelsen; Medical research School Scotland; BILS (Bioinformatics Infrastructure for Life Sciences)	Carl Tryggers foundation; Umea University insamlingsstiftelse; Wellcome Trust(Wellcome TrustEuropean Commission); Kempestiftelsen; Medical research School Scotland; BILS (Bioinformatics Infrastructure for Life Sciences)	Financial support was provided by Carl Tryggers foundation (CTS13-514) (www.carltryggersstrftelse.sefindex.php?sida=rules&n=3) and Umea University insamlingsstiftelse (2.1.12-1605-14) (www.umu.se) to UPR, Wellcome Trust (074863) to JW, with support of Kempestiftelsen (CS) and the Medical research School Scotland (LP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Christoph G. Baums (College of Veterinary Medicine, University Leipzig, Leipzig, Germany) is acknowledged for kindly providing porcine plasma and S. porcinus and Asa Gylfe (Department of Clinical Microbiology, Umea University, Umea, Sweden) for S. agalactiae. Parts of this work were planned and performed by the Umea. Protein Expertise Platform. Support by BILS (Bioinformatics Infrastructure for Life Sciences) is gratefully acknowledged.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Abi-Rached L, 2007, J IMMUNOL, V178, P7943, DOI 10.4049/jimmunol.178.12.7943; An Y, 2014, MABS-AUSTIN, V6, P879, DOI 10.4161/mabs.28762; Bekal S, 2006, J CLIN MICROBIOL, V44, P2584, DOI 10.1128/JCM.02707-05; Bekker V, 2014, LANCET INFECT DIS, V14, P1083, DOI 10.1016/S1473-3099(14)70919-3; BINDON CI, 1988, J EXP MED, V168, P127, DOI 10.1084/jem.168.1.127; Bliss SJ, 2002, CLIN INFECT DIS, V34, P184, DOI 10.1086/338258; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Butler JE, 2009, IMMUNOGENETICS, V61, P209, DOI 10.1007/s00251-008-0336-9; Butler JE, 2006, J IMMUNOL, V177, P5480, DOI 10.4049/jimmunol.177.8.5480; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Chintalacharuvu KR, 2003, INFECT IMMUN, V71, P2563, DOI 10.1128/IAI.71.5.2563-2570.2003; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; ELLISON JW, 1982, NUCLEIC ACIDS RES, V10, P4071, DOI 10.1093/nar/10.13.4071; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guss B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000584; Hajtos I, 2002, MAGY ALLATORVOSOK, V124, P161; Hulting G, 2009, FEMS MICROBIOL LETT, V298, P44, DOI 10.1111/j.1574-6968.2009.01698.x; Ippolito DL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-336; Johansson BP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001692; JORM LR, 1994, RES VET SCI, V57, P292, DOI 10.1016/0034-5288(94)90120-1; Jutel M, 2011, ALLERGY, V66, P725, DOI 10.1111/j.1398-9995.2011.02589.x; KILIAN M, 1979, INFECT IMMUN, V26, P143, DOI 10.1128/IAI.26.1.143-149.1979; Lammler C, 1996, MED SCI RES, V24, P177; Lannergard J, 2006, FEMS MICROBIOL LETT, V262, P230, DOI 10.1111/j.1574-6968.2006.00404.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lewis MJ, 2008, MOL IMMUNOL, V45, P818, DOI 10.1016/j.molimm.2007.06.158; Markowska-Daniel I, 2010, POL J VET SCI, V13, P21; Nandakumar KS, 2007, ARTHRITIS RHEUM-US, V56, P3253, DOI 10.1002/art.22930; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Sullivan T, 2011, CAN J VET RES, V75, P106; Panda S, 2015, J IMMUNOL, V194, P13, DOI 10.4049/jimmunol.1400844; Pelkonen S, 2013, EMERG INFECT DIS, V19, P1041, DOI 10.3201/eid1907.121365; Pinheiro A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073934; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; REINHOLDT J, 1990, INFECT IMMUN, V58, P1186, DOI 10.1128/IAI.58.5.1186-1194.1990; SCHUMAKER VN, 1976, BIOCHEMISTRY-US, V15, P5175, DOI 10.1021/bi00668a035; SCHUR PH, 1988, MONOGR ALLERGY, V23, P1; Seele J, 2015, VACCINE, V33, P2207, DOI 10.1016/j.vaccine.2015.03.047; Seele J, 2013, J BACTERIOL, V195, P930, DOI 10.1128/JB.01875-12; Senior BW, 2006, J IMMUNOL, V177, P3913, DOI 10.4049/jimmunol.177.6.3913; Senior BW, 2005, J IMMUNOL, V174, P7792, DOI 10.4049/jimmunol.174.12.7792; Sheoran AS, 2000, AM J VET RES, V61, P1099, DOI 10.2460/ajvr.2000.61.1099; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simister NE, 1996, EUR J IMMUNOL, V26, P1527, DOI 10.1002/eji.1830260718; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Spoerry C, 2016, J BIOL CHEM, V291, P7915, DOI 10.1074/jbc.M115.711440; Stoner KA, 2011, J CLIN MICROBIOL, V49, P883, DOI 10.1128/JCM.01965-10; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P1177, DOI 10.1128/JCM.43.3.1177-1186.2005; Sunkara B, 2012, INT J INFECT DIS, V16, pE182, DOI 10.1016/j.ijid.2011.11.008; Takahashi R, 2015, SCI REP-UK, V5, DOI 10.1038/srep10809; TAO MH, 1993, J EXP MED, V178, P661, DOI 10.1084/jem.178.2.661; Timoney JF, 2004, VET RES, V35, P397, DOI 10.1051/vetres:2004025; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Wagner B, 2004, J IMMUNOL, V173, P3230, DOI 10.4049/jimmunol.173.5.3230; WANG AC, 1977, IMMUNOCHEMISTRY, V14, P197, DOI 10.1016/0019-2791(77)90194-X; Winstedt L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132011; Yang R, 2010, NEPHROL DIAL TRANSPL, V25, P2479, DOI 10.1093/ndt/gfq115; Yang Y.J., 2013, ABSTR APPL ANAL, V2013, P7, DOI DOI 10.1016/J.NEUR0SCIENCE.2013.07.009	61	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164809	10.1371/journal.pone.0164809	http://dx.doi.org/10.1371/journal.pone.0164809			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749921	gold, Green Published, Green Submitted			2022-12-26	WOS:000386202300031
J	Collinson-Pautz, MR; Slawin, KM; Levitt, JM; Spencer, DM				Collinson-Pautz, Matthew R.; Slawin, Kevin M.; Levitt, Jonathan M.; Spencer, David M.			MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity	PLOS ONE			English	Article							CD103(+) DENDRITIC CELLS; CD8(+) T-CELLS; IN-VIVO; CROSS-PRESENTATION; PLASMID ELECTROPORATION; IMMUNE-RESPONSES; PROSTATE-CANCER; TUMOR-ANTIGEN; SKIN-DISEASE; EXPRESSION	Therapeutic DNA-based vaccines aim to prime an adaptive host immune response against tumor-associated antigens, eliminating cancer cells primarily through CD8(+) cytotoxic T cell-mediated destruction. To be optimally effective, immunological adjuvants are required for the activation of tumor-specific CD8(+) T cells responses by DNA vaccination. Here, we describe enhanced anti-tumor efficacy of an in vivo electroporation-delivered DNA vaccine by inclusion of a genetically encoded chimeric MyD88/CD40 (MC) adjuvant, which integrates both innate and adaptive immune signaling pathways. When incorporated into a DNA vaccine, signaling by the MC adjuvant increased antigen-specific CD8(+) T cells and promoted elimination of pre-established tumors. Interestingly, MC-enhanced vaccine efficacy did not require direct-expression of either antigen or adjuvant by local antigen-presenting cells, but rather our data supports a key role for MC function in "atypical" antigen-presenting cells of skin. In particular, MC adjuvant-modified keratinocytes increased inflammatory cytokine secretion, upregulated surface MHC class I, and were able to increase in vitro and in vivo priming of antigen-specific CD8(+) T cells. Furthermore, in the absence of critical CD8 alpha(+)/CD103(+) cross-priming dendritic cells, MC was still able to promote immune priming in vivo, albeit at a reduced level. Altogether, our data support a mechanism by which MC signaling activates an inflammatory phenotype in atypical antigen-presenting cells within the cutaneous vaccination site, leading to an enhanced CD8(+) T cell response against DNA vaccine-encoded antigens, through both CD8 alpha(+)/CD103(+) dendritic cell-dependent and independent pathways.	[Collinson-Pautz, Matthew R.; Levitt, Jonathan M.] Baylor Coll Med, Interdepartmental Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Collinson-Pautz, Matthew R.; Levitt, Jonathan M.; Spencer, David M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Slawin, Kevin M.; Spencer, David M.] Bellicum Pharmaceut, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Levitt, JM (corresponding author), Baylor Coll Med, Interdepartmental Program Translat Biol & Mol Med, Houston, TX 77030 USA.; Levitt, JM; Spencer, DM (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.; Spencer, DM (corresponding author), Bellicum Pharmaceut, Houston, TX 77030 USA.	JLevitt@BCM.edu; DSpencer@Bellicum.com			Cancer Prevention and Research Institute of Texas [RP100728]; Bellicum Pharmaceuticals; National Institute of General Medical Sciences of the National Institutes of Health [T32GM088129]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; Bellicum Pharmaceuticals; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was in part supported by an award from the Cancer Prevention and Research Institute of Texas, grant number RP100728, awarded to DMS. Additionally, a gift to Baylor College of Medicine from Bellicum Pharmaceuticals partly funded this study. Lastly, research reported in this publication was supported in part by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number T32GM088129. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors [KS, DMS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amante DH, 2015, HUM GENE THER METHOD, V26, P134, DOI 10.1089/hgtb.2015.020; Antonarakis ES, 2010, CURR OPIN UROL, V20, P241, DOI 10.1097/MOU.0b013e3283381793; Azukizawa H, 2003, EUR J IMMUNOL, V33, P1879, DOI 10.1002/eji.200323630; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Black APB, 2007, EUR J IMMUNOL, V37, P1485, DOI 10.1002/eji.200636915; Bloy N, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1026531; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Butterfield LH, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h988; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; Desrichard A, 2016, CLIN CANCER RES, V22, P807, DOI 10.1158/1078-0432.CCR-14-3175; Di Meglio P, 2011, IMMUNITY, V35, P857, DOI 10.1016/j.immuni.2011.12.003; Didovic S, 2015, EUR J IMMUNOL, P1; Durward M, 2010, JOVE-J VIS EXP, P4; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; European Organisation of Research and Treatment of Cancer, 2016, PHAS 2 CLIN TRIAL CH; Fan L, 2003, P NATL ACAD SCI USA, V100, P3386, DOI 10.1073/pnas.0437899100; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Flingai S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00354; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gutowska-Owsiak D, 2012, J INVEST DERMATOL, V132, P940, DOI 10.1038/jid.2011.398; Hanks BA, 2005, NAT MED, V11, P130, DOI 10.1038/nm1183; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Juckem LK, 2008, J IMMUNOL, V180, P4965, DOI 10.4049/jimmunol.180.7.4965; Kalat M, 2002, CANCER RES, V62, P5489; Kemnade JO, 2012, MOL THER, V20, P1462, DOI 10.1038/mt.2012.48; Kim JJ, 1997, NAT BIOTECHNOL, V15, P641; Kim JJ, 2001, CLIN CANCER RES, V7, p882S; Kim JG, 2011, INT J SUSTAIN ENG, V4, P215, DOI 10.1080/19397038.2011.556757; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Klinman DM, 1997, J IMMUNOL, V158, P3635; Kutzler MA, 2016, MUCOSAL IMMUNOL, V9, P13, DOI 10.1038/mi.2015.31; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Li LJ, 2012, P NATL ACAD SCI USA, V109, P12716, DOI 10.1073/pnas.1203468109; Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111; Melief CJM, 2015, J CLIN INVEST, V125, P3401, DOI 10.1172/JCI80009; NAKAMURA K, 1995, J INVEST DERMATOL, V105, P635, DOI 10.1111/1523-1747.ep12324061; Narayanan P, 2011, J CLIN INVEST, V121, P1524, DOI 10.1172/JCI44327; Perales MA, 2008, MOL THER, V16, P2022, DOI 10.1038/mt.2008.196; Qu CF, 2009, J IMMUNOL, V182, P3650, DOI 10.4049/jimmunol.0801532; Roos AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007226; Shore ND, 2014, IMMUNOTHERAPY-UK, V6, P235, DOI 10.2217/imt.13.176; Smith TRF, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.54; Subang MC, 2015, CURR GENE THER, V15, P3; Tan ACL, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0093-x; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Villarreal DO, 2015, VACCINE, V33, P4313, DOI 10.1016/j.vaccine.2015.03.086; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Zhan YF, 2011, EUR J IMMUNOL, V41, P2585, DOI 10.1002/eji.201141540; Zhou QH, 2013, J IMMUNOL, V190, P6579, DOI 10.4049/jimmunol.1202993; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	53	2	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164547	10.1371/journal.pone.0164547	http://dx.doi.org/10.1371/journal.pone.0164547			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741278	Green Published, Green Submitted, gold			2022-12-26	WOS:000385507000042
J	Li, JG; Hao, CY; Ren, LL; Xiao, Y; Wang, JW; Qin, XM				Li, Jianguo; Hao, Chunyan; Ren, Lili; Xiao, Yan; Wang, Jianwei; Qin, Xuemei			Data Mining of Lung Microbiota in Cystic Fibrosis Patients	PLOS ONE			English	Article							GUT MICROBIOTA; DISEASE; METAANALYSES; PATHOGENESIS; INFLAMMATION; RESISTANCE; BACTERIA; HEALTHY; SAMPLES	The major therapeutic strategy used to treat exacerbated cystic fibrosis (CF) is antibiotic treatment. As this approach easily generates antibiotic-resistant strains of opportunistic bacteria, optimized antibiotic therapies are required to effectively control chronic and recurrent bacterial infections in CF patients. A promising future for the proper use of antibiotics is the management of lung microbiota. However, the impact of antibiotic treatments on CF microbiota and vice versa is not fully understood. This study analyzed 718 sputum samples from 18 previous studies to identify differences between CF and uninfected lung microbiota and to evaluate the effects of antibiotic treatments on exacerbated CF microbiota. A reference-based OTU (operational taxonomic unit) picking method was used to combine analyses of data generated using different protocols and platforms. Findings show that CF microbiota had greater richness and lower diversity in the community structure than uninfected control (NIC) microbiota. Specifically, CF microbiota showed higher levels of opportunistic bacteria and dramatically lower levels of commensal bacteria. Antibiotic treatment affected exacerbated CF microbiota notably but only transiently during the treatment period. Limited decrease of the dominant opportunistic bacteria and a dramatic decrease of commensal bacteria were observed during the antibiotic treatment for CF exacerbation. Simultaneously, low abundance opportunistic bacteria were thriving after the antibiotic treatment. The inefficiency of the current antibiotic treatment against major opportunistic bacteria and the detrimental effects on commensal bacteria indicate that the current empiric antibiotic treatment on CF exacerbation should be reevaluated and optimized.	[Li, Jianguo; Qin, Xuemei] Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Taiyuan 030006, Peoples R China; [Hao, Chunyan] Taiyuan Univ Sci Technol, Coll Chem & Biol Engn, Taiyuan 030021, Peoples R China; [Ren, Lili; Xiao, Yan; Wang, Jianwei] Chinese Acad Med Sci, MOH Key Lab Syst Pathogen Biol, Beijing 100730, Peoples R China; [Ren, Lili; Xiao, Yan; Wang, Jianwei] Chinese Acad Med Sci, Christophe Merieux Lab, IPB, CAMS Fdn Merieux, Beijing 100730, Peoples R China; [Ren, Lili; Xiao, Yan; Wang, Jianwei] Peking Union Med Coll, Beijing 100730, Peoples R China	Shanxi University; Taiyuan University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qin, XM (corresponding author), Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Taiyuan 030006, Peoples R China.	qinxm001@126.com	Wang, Jianwei/AAW-9499-2020; Li, Jianguo/T-3372-2019; Wang, Jianwei/W-5916-2019	Wang, Jianwei/0000-0002-1116-4559; Li, Jianguo/0000-0002-2251-8308; 	Youth Project of the National Natural Science Foundation of China [81301441]	Youth Project of the National Natural Science Foundation of China	This study was supported by the Youth Project of the National Natural Science Foundation of China (Project No. 81301441). (URL:http://www.nsfc.gov.cn/)	Ashish A, 2012, J CYST FIBROS, V11, P173, DOI 10.1016/j.jcf.2011.11.004; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Beck James M, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS3, DOI 10.1513/AnnalsATS.201306-188MG; Beck JM, 2012, TRANSL RES, V160, P258, DOI 10.1016/j.trsl.2012.02.005; Blainey PC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004458; Boutin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116029; Cantin AM, 2015, J CYST FIBROS, V14, P419, DOI 10.1016/j.jcf.2015.03.003; Cernadas M, 2011, AM J RESP CRIT CARE, V184, P149, DOI 10.1164/rccm.201105-0828ED; Conrad D, 2013, AM J RESP CELL MOL, V48, P150, DOI 10.1165/rcmb.2012-0059PS; Cuthbertson L, 2015, J CYST FIBROS, V14, P464, DOI 10.1016/j.jcf.2014.10.004; Cuthbertson L, 2014, J CLIN MICROBIOL, V52, P3011, DOI 10.1128/JCM.00764-14; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Field TR, 2010, ANAEROBE, V16, P337, DOI 10.1016/j.anaerobe.2010.04.002; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Flight WG, 2015, J CLIN MICROBIOL, V53, P2022, DOI 10.1128/JCM.00432-15; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; Hampton TH, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-14; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Hurley MN, 2012, PAEDIATR RESPIR REV, V13, P160, DOI 10.1016/j.prrv.2012.04.005; Jain K, 2012, EXPERT REV RESP MED, V6, P407, DOI [10.1586/ERS.12.39, 10.1586/ers.12.39]; Kosiewicz MM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00180; Kramer R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117436; Kreda SM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009589; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Lobo J, 2012, CLIN CHEST MED, V33, P307, DOI 10.1016/j.ccm.2012.02.006; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Maughan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045791; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Molyneaux PL, 2014, AM J RESP CRIT CARE, V190, P906, DOI 10.1164/rccm.201403-0541OC; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Narasimhan Mangala, 2011, Ther Adv Respir Dis, V5, P275, DOI 10.1177/1753465811398267; Nelson A, 2012, INNATE IMMUN-LONDON, V18, P774, DOI 10.1177/1753425912439910; Nguyen LDN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00089; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Pressler T, 2011, PEDIATR DRUGS, V13, P141, DOI 10.2165/11588150-000000000-00000; Price KE, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-27; Rabin HR, 2012, CURR OPIN PULM MED, V18, P622, DOI 10.1097/MCP.0b013e328358d49a; Rutebemberwa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111150; Saiman L, 2011, CURR OPIN INFECT DIS, V24, P390, DOI 10.1097/QCO.0b013e32834748ff; Segal Leopoldo N, 2014, Ann Am Thorac Soc, V11, P108, DOI 10.1513/AnnalsATS.201310-339FR; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sherrard LJ, 2014, LANCET, V384, P703, DOI 10.1016/S0140-6736(14)61137-5; Sloane PA, 2010, CURR OPIN PULM MED, V16, P591, DOI 10.1097/MCP.0b013e32833f1d00; Smith DJ, 2014, EUR RESPIR J, V44, P922, DOI 10.1183/09031936.00203013; Stenbit AE, 2011, CURR OPIN PULM MED, V17, P442, DOI 10.1097/MCP.0b013e32834b8c04; Tildy BE, 2015, PHARMACOLOGY, V95, P117, DOI 10.1159/000377638; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Willger SD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-40; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zemanick ET, 2011, CURR OPIN PEDIATR, V23, P319, DOI 10.1097/MOP.0b013e32834604f2; Zemanick ET, 2014, ANN AM THORAC SOC, V12, P221, DOI DOI 10.1513/ANNALSATS.2014073100C; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	57	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164510	10.1371/journal.pone.0164510	http://dx.doi.org/10.1371/journal.pone.0164510			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741283	Green Published, gold, Green Submitted			2022-12-26	WOS:000385507000039
J	Reilly, EC; Lambert-Emo, K; Topham, DJ				Reilly, Emma C.; Lambert-Emo, Kris; Topham, David J.			The Effects of Acute Neutrophil Depletion on Resolution of Acute Influenza Infection, Establishment of Tissue Resident Memory (T-RM), and Heterosubtypic Immunity	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR3; A VIRUS; LYMPHOCYTE EGRESS; CELL RESPONSES; E-CADHERIN; IN-VIVO; SKIN; PROTECTION; MIGRATION; EXPRESSION	After disease resolution, a small subset of influenza specific CD8(+) T cells can remain in the airways of the lung as a tissue resident memory population (T-RM). These cells are critical for protection from subsequent infections with heterosubtypic influenza viruses. Although it is well established that expression of the collagen IV binding integrin alpha 1 is necessary for the retention and maintenance of T-RM cells, other requirements allowing them to localize to the airways and persist are less well understood. We recently demonstrated that inhibition of neutrophils or neutrophil derived chemokine CXCL12 during acute influenza virus infection reduces the effector T cell response and affects the ability of these cells to localize to the airways. We therefore sought to determine whether the defects that occur in the absence of neutrophils would persist throughout resolution of the disease and impact the development of the T-RM population. Interestingly, the early alterations in the CD8(+) T cell response recover by two weeks post-infection, and mice form a protective population of T-RM cells. Overall, these observations show that acute neutrophil depletion results in a delay in the effector CD8(+) T cell response, but does not adversely impact the development of T-RM.	[Reilly, Emma C.; Lambert-Emo, Kris; Topham, David J.] Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA; [Reilly, Emma C.; Lambert-Emo, Kris; Topham, David J.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Topham, DJ (corresponding author), Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA.; Topham, DJ (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	david_topham@urmc.rochester.edu			National Institute of Allergy and Infectious Diseases [P01 Al102851 03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI102851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007026] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by National Institute of Allergy and Infectious Diseases P01 Al102851 03, to David J. Topham. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2015, NAT MED, V21, P1272, DOI 10.1038/nm.3962; Anderson KG, 2012, J IMMUNOL, V189, P2702, DOI 10.4049/jimmunol.1201682; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Bevan MJ, 2011, EUR J IMMUNOL, V41, P1192, DOI 10.1002/eji.201041377; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Furze RC, 2008, IMMUNOLOGY, V125, P281, DOI 10.1111/j.1365-2567.2008.02950.x; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Kohlmeier JE, 2011, J EXP MED, V208, P1621, DOI 10.1084/jem.20102110; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; Lambert-Emo K, 2016, PLOS PATHOG; Lee YT, 2011, J VIROL, V85, P4085, DOI 10.1128/JVI.02493-10; LIANG SH, 1994, J IMMUNOL, V152, P1653; Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352; Lu B, 1999, EUR J IMMUNOL, V29, P3804, DOI 10.1002/(SICI)1521-4141(199911)29:11<3804::AID-IMMU3804>3.0.CO;2-9; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McMaster SR, 2015, J IMMUNOL, V195, P203, DOI 10.4049/jimmunol.1402975; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Mrass P, 2008, IMMUNITY, V29, P971, DOI 10.1016/j.immuni.2008.10.015; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Powell TJ, 2004, CLIN IMMUNOL, V113, P89, DOI 10.1016/j.clim.2004.05.006; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Richter M, 2007, J IMMUNOL, V178, P4506, DOI 10.4049/jimmunol.178.7.4506; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Slutter B, 2013, IMMUNITY, V39, P939, DOI 10.1016/j.immuni.2013.09.013; Tate MD, 2012, IMMUNOL CELL BIOL, V90, P197, DOI 10.1038/icb.2011.26; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Topham DJ, 1997, J IMMUNOL, V159, P5197; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Webby RJ, 2003, P NATL ACAD SCI USA, V100, P7235, DOI 10.1073/pnas.1232449100; Wiley JA, 2001, J IMMUNOL, V167, P3293, DOI 10.4049/jimmunol.167.6.3293; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019	49	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164247	10.1371/journal.pone.0164247	http://dx.doi.org/10.1371/journal.pone.0164247			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741316	Green Published, gold, Green Submitted			2022-12-26	WOS:000385507000022
J	Sugawara, S; Maeno, M; Lee, C; Nagai, S; Kim, DM; Da Silva, J; Nagai, M; Kondo, H				Sugawara, Shiho; Maeno, Masahiko; Lee, Cliff; Nagai, Shigemi; Kim, David M.; Da Silva, John; Nagai, Masazumi; Kondo, Hisatomo			Establishment of Epithelial Attachment on Titanium Surface Coated with Platelet Activating Peptide	PLOS ONE			English	Article							PERI-IMPLANT; JUNCTIONAL EPITHELIUM; EXPRESSION PATTERN; DENTAL IMPLANT; LAMININ-5; ADHESION; CELLS; ROUGHNESS; GROWTH	The aim of this study was to produce epithelial attachment on a typical implant abutment surface of smooth titanium. A challenging complication that hinders the success of dental implants is peri-implantitis. A common cause of peri-implantitis may results from the lack of epithelial sealing at the peri-implant collar. Histologically, epithelial sealing is recognized as the attachment of the basement membrane (BM). BM-attachment is promoted by activated platelet aggregates at surgical wound sites. On the other hand, platelets did not aggregate on smooth titanium, the surface typical of the implant abutment. We then hypothesized that epithelial BM-attachment was produced when titanium surface was modified to allow platelet aggregation. Titanium surfaces were coated with a protease activated receptor 4-activating peptide (PAR4-AP). PAR4-AP coating yielded rapid aggregation of platelets on the titanium surface. Platelet aggregates released robust amount of epithelial chemoattractants (IGF-I, TGF-beta) and growth factors (EGF, VEGF) on the titanium surface. Human gingival epithelial cells, when they were co-cultured on the platelet aggregates, successfully attached to the PAR4-AP coated titanium surface with spread laminin5 positive BM and consecutive staining of the epithelial tight junction component ZO1, indicating the formation of complete epithelial sheet. These in-vitro results indicate the establishment of epithelial BM-attachment to the titanium surface.	[Sugawara, Shiho; Maeno, Masahiko; Lee, Cliff; Nagai, Shigemi; Da Silva, John] Harvard Sch Dent Med, Dept Restorat Dent & Biomat Sci, Boston, MA USA; [Kim, David M.; Nagai, Masazumi] Harvard Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Sugawara, Shiho; Kondo, Hisatomo] Iwate Med Univ, Sch Dent Med, Dept Prosthodont & Oral Implantol, Morioka, Iwate, Japan; [Maeno, Masahiko] Nippon Dent Univ Tokyo, Dept Adhes Dent, Chiyoda Ku, Tokyo, Japan	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard School of Dental Medicine; Iwate Medical University; Nippon Dental University	Nagai, M (corresponding author), Harvard Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA.	Masazumi_Nagai@hms.harvard.edu	Kondo, Hisatomo/AAA-9939-2021; Maeno, Masahiko/AAW-9849-2020; kim, david/AAA-4537-2020	Lee, Cliff/0000-0001-7987-3493				Almaguer-Flores A, 2010, J BIOMED MATER RES B, V92B, P196, DOI 10.1002/jbm.b.31506; Atsuta I, 2005, BIOMATERIALS, V26, P6280, DOI 10.1016/j.biomaterials.2005.03.046; Atsuta I, 2005, BIOMATERIALS, V26, P1751, DOI 10.1016/j.biomaterials.2004.05.033; Atsuta I, 2013, J BIOMED MATER RES A, V101, P2896, DOI 10.1002/jbm.a.34608; Atsuta I, 2012, CLIN ORAL IMPLAN RES, V23, P459, DOI 10.1111/j.1600-0501.2011.02163.x; Da Silva JD, 2014, J AM DENT ASSOC, V145, P704, DOI 10.14219/jada.2014.27; Dantas Andrea Abi Rached, 2012, J Contemp Dent Pract, V13, P332; de Waal YC, 2015, CLIN ORAL IMPLAN RES, V00, P1, DOI [10.1111/cir.12584, DOI 10.1111/CIR.12584]; Faruqi TR, 2000, J BIOL CHEM, V275, P19728, DOI 10.1074/jbc.M909960199; Fujiseki Masatsugu, 2003, Bull Tokyo Dent Coll, V44, P185, DOI 10.2209/tdcpublication.44.185; Fujita T, 2012, J PERIODONTAL RES, V47, P55, DOI 10.1111/j.1600-0765.2011.01404.x; Hatakeyama S, 2006, J PERIODONTAL RES, V41, P322, DOI 10.1111/j.1600-0765.2006.00875.x; Hosokawa I, 2006, CLIN EXP IMMUNOL, V146, P218, DOI 10.1111/j.1365-2249.2006.03200.x; Iglhaut G, 2014, J ESTHET RESTOR DENT, V26, P324, DOI 10.1111/jerd.12097; Ikeda H, 2002, CLIN ORAL IMPLAN RES, V13, P243, DOI 10.1034/j.1600-0501.2002.130303.x; Ikeda H, 2000, J PERIODONTOL, V71, P961, DOI 10.1902/jop.2000.71.6.961; Jiang Q, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-30; Kusumoto Y, 2004, J PERIODONTOL, V75, P370, DOI 10.1902/jop.2004.75.3.370; Larjava H, 2011, J DENT RES, V90, P1367, DOI 10.1177/0022034511402207; Lee HK, 2006, INVEST OPHTH VIS SCI, V47, P873, DOI 10.1167/iovs.05-0826; Lindhe J, 2008, J CLIN PERIODONTOL, V35, P282, DOI 10.1111/j.1600-051X.2008.01283.x; Linkevicius Tomas, 2008, Stomatologija, V10, P27; Mishra SK, 2016, J PROSTHODONT, V25, P185, DOI 10.1111/jopr.12310; Ofosu FA, 2009, BIOCHEMISTRY-US, V48, P1562, DOI 10.1021/bi801399c; Papaspyridakos P, 2012, J DENT RES, V91, P242, DOI 10.1177/0022034511431252; Sawada T, 1996, ANAT RECORD, V246, P317; Silva Aline Cristina, 2016, Braz. Dent. J., V27, P160, DOI 10.1590/0103-6440201600427; Taha M, 2016, ANGLE ORTHOD, V86, P285, DOI 10.2319/122814-947.1; Werner S, 2009, BIOMATERIALS, V30, P2291, DOI 10.1016/j.biomaterials.2009.01.004; Xiao Y, 2001, J PERIODONTOL, V72, P849, DOI 10.1902/jop.2001.72.7.849	30	17	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164693	10.1371/journal.pone.0164693	http://dx.doi.org/10.1371/journal.pone.0164693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741287	Green Published, gold, Green Submitted			2022-12-26	WOS:000385507000057
J	Kwon, SH; Oh, S; Nacke, M; Mostov, KE; Lipschutz, JH				Kwon, Sang-Ho; Oh, Sekyung; Nacke, Marisa; Mostov, Keith E.; Lipschutz, Joshua H.			Adaptor Protein CD2AP and L-type Lectin LMAN2 Regulate Exosome Cargo Protein Trafficking through the Golgi Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; extracellular vesicles; G protein-coupled receptor (GPCR); Golgi; membrane trafficking; CD2AP; exosomes; LMAN2; urinary proteins; multivesicular	CELL-SURFACE; RETROMER; SECRETION; BIOGENESIS; VESICLES; GPRC5B; VIP36; ACTIVATION; EXPRESSION; MATURATION	Exosomes, 40-150-nm extracellular vesicles, transport biological macromolecules that mediate intercellular communications. Although exosomes are known to originate from maturation of endosomes into multivesicular endosomes (also known as multivesicular bodies) with subsequent fusion of the multivesicular endosomes with the plasma membrane, it remains unclear how cargos are selected for exosomal release. Using an inducible expression system for the exosome cargo protein GPRC5B and following its trafficking trajectory, we show here that newly synthesized GPRC5B protein accumulates in the Golgi complex prior to its release into exosomes. The L-type lectin LMAN2 (also known as VIP36) appears to be specifically required for the accumulation of GPRC5B in the Golgi complex and restriction of GPRC5B transport along the exosomal pathway. This may occur due to interference with the adaptor protein GGA1-mediated trans Golgi network-to-endosome transport of GPRC5B. The adaptor protein CD2AP-mediated internalization following cell surface delivery appears to contribute to the Golgi accumulation of GPRC5B, possibly in parallel with biosynthetic/secretory trafficking from the endoplasmic reticulum. Our data thus reveal a Golgi-traversing pathway for exosomal release of the cargo protein GPRC5B in which CD2AP facilitates the entry and LMAN2 impedes the exit of the flux, respectively.	[Kwon, Sang-Ho; Lipschutz, Joshua H.] Med Univ South Carolina, Div Nephrol, Dept Med, Charleston, SC 29425 USA; [Oh, Sekyung] Stanford Univ, Sch Med, Dept Radiol, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Oh, Sekyung] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Nacke, Marisa; Mostov, Keith E.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Nacke, Marisa; Mostov, Keith E.] Univ Calif San Francisco, Dept Biochem Biophys, San Francisco, CA 94143 USA; [Lipschutz, Joshua H.] Ralph H Johnson Vet Affairs Med Ctr, Dept Med, Charleston, SC 29401 USA	Medical University of South Carolina; Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Kwon, SH (corresponding author), Med Univ South Carolina, Dept Med, 70 President St,Drug Discovery Bldg Rm 509, Charleston, SC 29425 USA.	kwonk@musc.edu	Oh, Sekyung/J-9331-2017	Oh, Sekyung/0000-0002-6880-5281; Kwon, Sang-Ho/0000-0001-9074-4641; mostov, keith/0000-0002-8123-6247	Medical University of South Carolina; American Society of Nephrology Gottschalk Research Scholar grant; National Institutes of Health [DK074398, DK091530, DK074038]; Veterans Affairs Merit Award [2I01BX000820]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074398, P30DK026743, P30DK074038, R01DK091530] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000820] Funding Source: NIH RePORTER	Medical University of South Carolina; American Society of Nephrology Gottschalk Research Scholar grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a start-up package from the Medical University of South Carolina and an American Society of Nephrology Gottschalk Research Scholar grant (to S.-H. K.), National Institutes of Health Grants DK074398 and DK091530 (to K. E. M.) and DK074038 (to J. H. L.), and Veterans Affairs Merit Award 2I01BX000820 (to J. H. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bai HD, 2004, J BIOL CHEM, V279, P17411, DOI 10.1074/jbc.M401158200; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Buschow SI, 2009, TRAFFIC, V10, P1528, DOI 10.1111/j.1600-0854.2009.00963.x; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Edwards M, 2014, NAT REV MOL CELL BIO, V15, P677, DOI 10.1038/nrm3869; Engelsberg A, 2003, J BIOL CHEM, V278, P22998, DOI 10.1074/jbc.M301361200; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fullekrug J, 1999, J CELL SCI, V112, P2813; Gallon M, 2015, BIOCHEM SOC T, V43, P33, DOI 10.1042/BST20140290; Geminard C, 2004, TRAFFIC, V5, P181, DOI 10.1111/j.1600-0854.2004.0167.x; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gokool S, 2007, TRAFFIC, V8, P1873, DOI 10.1111/j.1600-0854.2007.00652.x; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Gradilla AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6649; Gross JC, 2013, CURR OPIN GENET DEV, V23, P385, DOI 10.1016/j.gde.2013.02.017; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Hurley JH, 2015, EMBO J, V34, P2398, DOI 10.15252/embj.201592484; Kajimoto T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3712; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Keerthikumar S, 2015, ONCOTARGET, V6, P15375, DOI 10.18632/oncotarget.3801; Kim YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003149; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Kurabayashi N, 2013, DEVELOPMENT, V140, P4335, DOI 10.1242/dev.099754; Kwon SH, 2014, CURR BIOL, V24, P199, DOI 10.1016/j.cub.2013.12.010; Kwon SH, 2004, P NATL ACAD SCI USA, V101, P15237, DOI 10.1073/pnas.0404877101; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matusek T, 2014, NATURE, V516, P99, DOI 10.1038/nature13847; Mukadam AS, 2015, FEBS LETT, V589, P2620, DOI 10.1016/j.febslet.2015.05.052; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Oh S, 2016, ONCOTARGET, V7, P28169, DOI 10.18632/oncotarget.8612; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reinhardt TA, 2013, J PROTEOMICS, V82, P141, DOI 10.1016/j.jprot.2013.02.013; Reiterer V, 2010, TRAFFIC, V11, P1044, DOI 10.1111/j.1600-0854.2010.01078.x; Rouka E, 2015, J BIOL CHEM, V290, P25275, DOI 10.1074/jbc.M115.637207; Seaman MNJ, 2013, TRENDS CELL BIOL, V23, P522, DOI 10.1016/j.tcb.2013.04.010; Shirakabe K, 2011, J BIOL CHEM, V286, P43154, DOI 10.1074/jbc.M111.275586; Silhankova M, 2010, EMBO J, V29, P4094, DOI 10.1038/emboj.2010.278; Strauss K, 2010, J BIOL CHEM, V285, P26279, DOI 10.1074/jbc.M110.134775; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wakim LM, 2011, NATURE, V471, P629, DOI 10.1038/nature09863; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Zhang Jing, 2012, Cell Logist, V2, P161; Zhou H, 2006, KIDNEY INT, V70, P1847, DOI 10.1038/sj.ki.5001874	62	27	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25462	25475		10.1074/jbc.M116.729202	http://dx.doi.org/10.1074/jbc.M116.729202			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27765817	Green Published, hybrid			2022-12-26	WOS:000390095300016
J	Kumar, A; Sykorova, P; Demo, G; Dobes, P; Hyrsl, P; Wimmerova, M				Kumar, Atul; Sykorova, Petra; Demo, Gabriel; Dobes, Pavel; Hyrsl, Pavel; Wimmerova, Michaela			A Novel Fucose-binding Lectin from Photorhabdus luminescens (PLL) with an Unusual Heptabladed beta-Propeller Tetrameric Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETERORHABDITIS-BACTERIOPHORA; CRYSTAL-STRUCTURE; PROTEIN; PATHOGENICITY; CRYSTALLOGRAPHY; XENORHABDUS; RESISTANCE; RECEPTORS; INFECTION; SEQUENCE	Photorhabdus luminescens is known for its symbiosis with the entomopathogenic nematode Heterorhabditis bacteriophora and its pathogenicity toward insect larvae. Ahypothetical protein from P. luminescens was identified, purified from the native source, and characterized as an L-fucose-binding lectin, named P. luminescens lectin (PLL). Glycan array and biochemical characterization data revealed PLL to be specific toward L-fucose and the disaccharide glycan 3,6-O-Me-2-Glc beta 1-4(2,3-O-Me-2)Rha alpha-O-(p-C6H4)-OCH2CH2NH2. PLL was discovered to be a homotetramer with an intersubunit disulfide bridge. The crystal structures of native and recombinant PLL revealed a seven-bladed beta-propeller fold creating seven putative fucose-binding sites per monomer. The crystal structure of the recombinant PLL.L-fucose complex confirmed that at least three sites were fucose-binding. Moreover, the crystal structures indicated that some of the other sites are masked either by the tetrameric nature of the lectin or by incorporation of the C terminus of the lectin into one of these sites. PLL exhibited an ability to bind to insect hemocytes and the cuticular surface of a nematode, H. bacteriophora.	[Kumar, Atul; Sykorova, Petra; Demo, Gabriel; Wimmerova, Michaela] Masaryk Univ, Cent European Inst Technol CEITEC, Brno 62500, Czech Republic; [Sykorova, Petra; Wimmerova, Michaela] Masaryk Univ, Fac Sci, Dept Biochem, Brno 62500, Czech Republic; [Demo, Gabriel; Wimmerova, Michaela] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno 62500, Czech Republic; [Dobes, Pavel; Hyrsl, Pavel] Masaryk Univ, Inst Expt Biol, Dept Anim Physiol & Immunol, Brno 62500, Czech Republic; [Demo, Gabriel] Univ Massachusetts, Sch Med, RNA Therapeut Inst, 368 Plantat St, Worcester, MA 01605 USA	Masaryk University Brno; Masaryk University Brno; Masaryk University Brno; Masaryk University Brno; University of Massachusetts System; University of Massachusetts Worcester	Wimmerova, M (corresponding author), Masaryk Univ, Cent European Inst Technol, Kamenice 5, Brno 62500, Czech Republic.	michaw@chemi.muni.cz	Dobeš, Pavel/R-7150-2016; Wimmerova, Michaela/A-4114-2010; Hyrsl, Pavel/N-3371-2017; KUMAR, ATUL/W-1739-2018; Demo, Gabriel/D-7261-2012	Dobeš, Pavel/0000-0003-1699-0849; Wimmerova, Michaela/0000-0002-7108-4198; Hyrsl, Pavel/0000-0002-4266-5727; Demo, Gabriel/0000-0002-5472-9249	Czech Science Foundation [13-25401S]; Ministry of Education, Youth, and Sports of the Czech Republic [LQ1601]; project "Postdoc I" - European Social Fund [CZ.1.07/2.3.00/30.0009]; state budget of the Czech Republic	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); project "Postdoc I" - European Social Fund; state budget of the Czech Republic	This work was supported by Czech Science Foundation Project 13-25401S and by the Ministry of Education, Youth, and Sports of the Czech Republic under Project CEITEC 2020 (LQ1601). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the project "Postdoc I" (CZ.1.07/2.3.00/30.0009), co-financed by the European Social Fund and the state budget of the Czech Republic.	Amano K, 2012, BIOSCI BIOTECH BIOCH, V76, P967, DOI 10.1271/bbb.110982; Audfray A, 2012, J BIOL CHEM, V287, P4335, DOI 10.1074/jbc.M111.314831; Bandyopadhyay S, 2001, PLANT SCI, V161, P1025, DOI 10.1016/S0168-9452(01)00507-6; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Bleuler-Martinez S, 2011, MOL ECOL, V20, P3056, DOI 10.1111/j.1365-294X.2011.05093.x; BORREBAECK CAK, 1984, J BACTERIOL, V159, P53, DOI 10.1128/JB.159.1.53-56.1984; Browne N, 2013, VIRULENCE, V4, P597, DOI 10.4161/viru.25906; CAMPBELL LR, 1992, J NEMATOL, V24, P365; Cappello M, 2006, P NATL ACAD SCI USA, V103, P15154, DOI 10.1073/pnas.0607002103; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Ciche TA, 2008, APPL ENVIRON MICROB, V74, P2275, DOI 10.1128/AEM.02646-07; Cioci G, 2006, J MOL BIOL, V357, P1575, DOI 10.1016/j.jmb.2006.01.066; Cochran JR, 2001, TRENDS BIOCHEM SCI, V26, P304, DOI 10.1016/S0968-0004(01)01815-1; CONWAY EM, 1994, J CELL PHYSIOL, V158, P285, DOI 10.1002/jcp.1041580211; Dobes P, 2012, FLY, V6, P75, DOI 10.4161/fly.19553; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; EISEMANN CH, 1994, ENTOMOL EXP APPL, V72, P1, DOI 10.1007/BF02382409; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Forst S, 1996, MICROBIOL REV, V60, P21, DOI 10.1128/MMBR.60.1.21-43.1996; Frobius AC, 2000, EUR J BIOCHEM, V267, P2046, DOI 10.1046/j.1432-1327.2000.01207.x; Glatz R, 2004, J INSECT PHYSIOL, V50, P955, DOI 10.1016/j.jinsphys.2004.07.009; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Han RC, 2000, J INVERTEBR PATHOL, V75, P55, DOI 10.1006/jipa.1999.4900; Hao YJ, 2012, EXP PARASITOL, V130, P116, DOI 10.1016/j.exppara.2011.12.001; HAYDAK M. H., 1936, Journal of Economic Entomology, V29, pp, DOI 10.1093/jee/29.5.870; Heim C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1032-x; Houser J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083077; Hu Y, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000614; Hui F, 2012, BIOCHEMISTRY-US, V51, P9911, DOI 10.1021/bi301386q; HUNTER SW, 1982, J BIOL CHEM, V257, P5072; Joyce SA, 2006, CURR OPIN MICROBIOL, V9, P127, DOI 10.1016/j.mib.2006.01.004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kondakov NN, 2015, RUSS CHEM B+, V64, P1142, DOI 10.1007/s11172-015-0991-6; Kostlanova N, 2005, J BIOL CHEM, V280, P27839, DOI 10.1074/jbc.M505184200; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li YS, 2014, FEMS MICROBIOL LETT, V356, P23, DOI 10.1111/1574-6968.12474; Marchetti R, 2012, GLYCOBIOLOGY, V22, P1387, DOI 10.1093/glycob/cws105; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; NORDBRINGHERTZ B, 1979, NATURE, V281, P477, DOI 10.1038/281477a0; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Peters A, 1997, J INVERTEBR PATHOL, V70, P161, DOI 10.1006/jipa.1997.4681; de Oliveira CFR, 2011, PROCESS BIOCHEM, V46, P498, DOI 10.1016/j.procbio.2010.09.025; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; Sharon N, 2007, J BIOL CHEM, V282, P2753, DOI 10.1074/JBC.X600004200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Staudacher E, 2012, BIOL CHEM, V393, P675, DOI 10.1515/hsz-2012-0132; Stefanovska T, 2008, Commun Agric Appl Biol Sci, V73, P693; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vojtek L, 2014, EUR J ENTOMOL, V111, P335, DOI 10.14411/eje.2014.045; WEBER K, 1969, J BIOL CHEM, V244, P4406; Williamson VM, 2003, NAT BIOTECHNOL, V21, P1294, DOI 10.1038/nbt1103-1294; Wimmerova M, 2003, J BIOL CHEM, V278, P27059, DOI 10.1074/jbc.M302642200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wohlschlager T, 2014, P NATL ACAD SCI USA, V111, pE2787, DOI 10.1073/pnas.1401176111	64	16	16	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25032	25049		10.1074/jbc.M115.693473	http://dx.doi.org/10.1074/jbc.M115.693473			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27758853	hybrid, Green Published			2022-12-26	WOS:000388880100020
J	Petschow, C; Scheef, L; Pause, S; Zimmermann, N; Schild, HH; Klockgether, T; Boecker, H				Petschow, Christine; Scheef, Lukas; Pause, Sebastian; Zimmermann, Nadine; Schild, Hans H.; Klockgether, Thomas; Boecker, Henning			Central Pain Processing in Early-Stage Parkinson's Disease: A Laser Pain fMRI Study	PLOS ONE			English	Article							DEFAULT MODE NETWORK; COGNITIVE IMPAIRMENT; NONMOTOR SYMPTOMS; SOMATOSENSORY CORTICES; LEWY BODY; DEPRESSION; DYSFUNCTION; PERCEPTION; THRESHOLD; MOTOR	Background & Objective Pain is a common non-motor symptom in Parkinson's disease. As dopaminergic dysfunction is suggested to affect intrinsic nociceptive processing, this study was designed to characterize laser-induced pain processing in early-stage Parkinson's disease patients in the dopaminergic OFF state, using a multimodal experimental approach at behavioral, autonomic, imaging levels. Methods 13 right-handed early-stage Parkinson's disease patients without cognitive or sensory impairment were investigated OFF medication, along with 13 age-matched healthy control subjects. Measurements included warmth perception thresholds, heat pain thresholds, and central pain processing with event-related functional magnetic resonance imaging (erfMRI) during laser-induced pain stimulation at lower (E = 440 mJ) and higher (E = 640 mJ) target energies. Additionally, electrodermal activity was characterized during delivery of 60 randomized pain stimuli ranging from 440 mJ to 640 mJ, along with evaluation of subjective pain ratings on a visual analogue scale. Results No significant differences in warmth perception thresholds, heat pain thresholds, electrodermal activity and subjective pain ratings were found between Parkinson's disease patients and controls, and erfMRI revealed a generally comparable activation pattern induced by laser-pain stimuli in brain areas belonging to the central pain matrix. However, relatively reduced deactivation was found in Parkinson's disease patients in posterior regions of the default mode network, notably the precuneus and the posterior cingulate cortex. Conclusion Our data during pain processing extend previous findings suggesting default mode network dysfunction in Parkinson's disease. On the other hand, they argue against a genuine pain-specific processing abnormality in early-stage Parkinson's disease. Future studies are now required using similar multimodal experimental designs to examine pain processing in more advanced stages of Parkinson's disease.	[Petschow, Christine; Scheef, Lukas; Boecker, Henning] Univ Bonn, Dept Radiol, Funct Neuroimaging Grp, Bonn, Germany; [Pause, Sebastian; Zimmermann, Nadine; Klockgether, Thomas] Univ Bonn, Dept Neurol, Bonn, Germany; [Schild, Hans H.] Univ Bonn, Dept Radiol, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Boecker, H (corresponding author), Univ Bonn, Dept Radiol, Funct Neuroimaging Grp, Bonn, Germany.	henning.boecker@ukb.uni-bonn.de	Boecker, Henning/N-7172-2019	Boecker, Henning/0000-0003-2346-0598	BONFOR SciMed-Promotionsstipendium of the university of Bonn; Ipsen Pharma; Merz Pharmaceuticals; Allergan; Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung (BMBF); Deutsche Forschungsgemeinschaft (DFG); Robert Bosch Foundation; European Union (EU); ICON Clinical Research; National Paralympic Committee Germany and royalties from Springer, NY	BONFOR SciMed-Promotionsstipendium of the university of Bonn; Ipsen Pharma(Ipsen); Merz Pharmaceuticals; Allergan(AbbVieAllergan); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Robert Bosch Foundation; European Union (EU)(CGIAREuropean Commission); ICON Clinical Research; National Paralympic Committee Germany and royalties from Springer, NY	C. Petschow received research support from the BONFOR SciMed-Promotionsstipendium of the university of Bonn. L. Scheef has no relevant financial relationships with commercial interest to disclosure. S. Paus is an employer of the University Clinic of Bonn. He has received research grants from Ipsen Pharma and Merz Pharmaceuticals. He is a member of the Advisory Boards of Allergan, Ipsen Pharma and Merz Pharmaceuticals. He has received lecturer fees from Allergan, Ipsen Pharma and Merz Pharmaceuticals. N. Zimmermann has no relevant financial relationships with commercial interest to disclosure. H. Schild has received funding from the Deutsche Forschungsgemeinschaft and the Bundesministerium fur Bildung und Forschung (BMBF). T. Klockgether receives/has received research support from the Deutsche Forschungsgemeinschaft (DFG), the Bundesministerium fur Bildung und Forschung (BMBF), the Robert Bosch Foundation and the European Union (EU). He serves on the editorial board of The Cerebellum. He has received a consulting fee from ICON Clinical Research. H. Boecker receives/has received research support from the Deutsche Forschungsgemeinschaft (DFG) and the Bundesministerium fur Bildung und Forschung (BMBF). He has received a lecturer fee from the National Paralympic Committee Germany and royalties from Springer, NY.	Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Bar KJ, 2003, J PSYCHIATR RES, V37, P345, DOI 10.1016/S0022-3956(03)00051-7; Baumgartner U, 2010, J NEUROPHYSIOL, V104, P2863, DOI 10.1152/jn.00253.2010; Beiske AG, 2009, PAIN, V141, P173, DOI 10.1016/j.pain.2008.12.004; Beiske AG, 2008, MOVEMENT DISORD, V23, P1361, DOI [10.1002/mds.22142PMID:18546344, DOI 10.1002/MDS.22142]; Bernal-Pacheco O, 2012, NEUROLOGIST, V18, P1, DOI 10.1097/NRL.0b013e31823d7abb; Bingel U, 2004, CEREB CORTEX, V14, P1340, DOI 10.1093/cercor/bhh094; Bingel U, 2004, NEUROIMAGE, V23, P224, DOI 10.1016/j.neuroimage.2004.05.021; Boecker H, 1999, BRAIN, V122, P1651, DOI 10.1093/brain/122.9.1651; Borsook D, 2012, BRAIN, V135, P320, DOI 10.1093/brain/awr271; Breen DP, 2014, JAMA NEUROL, V71, P589, DOI 10.1001/jamaneurol.2014.65; Brefel-Courbon C, 2005, MOVEMENT DISORD, V20, P1557, DOI 10.1002/mds.20629; Brooks DJ, 2001, J NEURAL TRANSM, V108, P1283, DOI 10.1007/s007020100005; Brooks DJ, 1997, EUR NEUROL, V38, P26, DOI 10.1159/000113473; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carbon M, 2003, CURR OPIN NEUROL, V16, P475, DOI 10.1097/01.wco.0000084225.82329.3c; Ceballos-Baumann AO, 2003, J NEUROL, V250, P15, DOI 10.1007/s00415-003-1103-1; Chaudhuri KR, 2001, CURR OPIN NEUROL, V14, P505, DOI 10.1097/00019052-200108000-00012; Christopher L, 2013, J NEUROPSYCHOL, V7, P225, DOI 10.1111/jnp.12015; Davis KD, 2000, NEUROL RES, V22, P313; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; Defazio G, 2008, ARCH NEUROL-CHICAGO, V65, P1191, DOI 10.1001/archneurol.2008.2; Del Gratta C, 2002, NEUROIMAGE, V17, P1373, DOI 10.1006/nimg.2002.1253; Delaveau P, 2010, EUR NEUROPSYCHOPHARM, V20, P784, DOI 10.1016/j.euroneuro.2010.07.001; Djaldetti R, 2004, NEUROLOGY, V62, P2171, DOI 10.1212/01.WNL.0000130455.38550.9D; Duerden EG, 2013, HUM BRAIN MAPP, V34, P109, DOI 10.1002/hbm.21416; Duncan GW, 2013, MOVEMENT DISORD, V28, P425, DOI 10.1002/mds.25352; Ehrt U, 2009, AM J GERIAT PSYCHIAT, V17, P269, DOI 10.1097/JGP.0b013e31818af7ef; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ford B, 1998, CLIN NEUROSCI, V5, P63; FOWLES DC, 1981, PSYCHOPHYSIOLOGY, V18, P232, DOI 10.1111/j.1469-8986.1981.tb03024.x; Fukuda M, 2001, PARKINSONISM RELAT D, V8, P91, DOI 10.1016/S1353-8020(01)00022-0; Garcia-Ruiz PJ, 2014, J NEUROL SCI, V338, P30, DOI 10.1016/j.jns.2014.01.002; Gerdelat-Mas A, 2007, J NEUROL NEUROSUR PS, V78, P1140, DOI 10.1136/jnnp.2007.120212; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Giuffrida R, 2005, REV NEUROL-FRANCE, V161, P407, DOI 10.1016/S0035-3787(05)85070-2; Goldman JG, 2014, MOVEMENT DISORD, V29, P608, DOI 10.1002/mds.25866; Greenspan JD, 1999, PAIN, V81, P273, DOI 10.1016/S0304-3959(99)00021-4; GUIEU R, 1992, REV NEUROL, V148, P641; Heimchen C, 2008, HUM BRAIN MAPP, V29, P1080, DOI 10.1002/hbm.20447; HENDERSON R, 1992, J NEUROPSYCH CLIN N, V4, P257; Hoehn MM, 1998, NEUROLOGY, V50, P318, DOI 10.1212/WNL.50.2.318; Juri C, 2010, J NEUROL SCI, V289, P60, DOI 10.1016/j.jns.2009.08.018; Kalbe E, 2008, PARKINSONISM RELAT D, V14, P93, DOI 10.1016/j.parkreldis.2007.06.008; Lee MA, 2006, J PAIN SYMPTOM MANAG, V32, P462, DOI 10.1016/j.jpainsymman.2006.05.020; Leentjens AFG, 2000, MOVEMENT DISORD, V15, P1221, DOI 10.1002/1531-8257(200011)15:6<1221::AID-MDS1024>3.0.CO;2-H; Lima MMS, 2012, CNS NEUROL DISORD-DR, V11, P439; Marsala SZ, 2011, J NEUROL, V258, P627, DOI 10.1007/s00415-010-5812-0; Marsh L, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0409-5; Martinez-Martin P, 2007, MOVEMENT DISORD, V22, P1623, DOI 10.1002/mds.21586; Negre-Pages L, 2010, MOVEMENT DISORD, V25, P157, DOI 10.1002/mds.22760; Neikrug AB, 2014, SLEEP MED, V15, P959, DOI 10.1016/j.sleep.2014.04.009; Nolano M, 2008, BRAIN, V131, P1903, DOI 10.1093/brain/awn102; Nuti A, 2004, EUR J NEUROL, V11, P315, DOI 10.1111/j.1468-1331.2004.00781.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parkinson J, 1817, ESSAY SHAKING PALSY; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Rabinak CA, 2010, ARCH NEUROL-CHICAGO, V67, P58, DOI 10.1001/archneurol.2009.294; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rana AQ, 2013, CLIN NEUROL NEUROSUR, V115, P2313, DOI 10.1016/j.clineuro.2013.08.022; Richard Irene H, 2005, Adv Neurol, V96, P42; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; Rutten S, 2014, PARK RELAT DISORD, V21, P189; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Schestatsky P, 2007, NEUROLOGY, V69, P2162, DOI 10.1212/01.wnl.0000295669.12443.d3; Schmidt K-H, 1992, WST D WORTSCHATZTEST; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Simuni T, 2008, ANN NEUROL, V64, pS65, DOI 10.1002/ana.21472; Souques M., 1921, REV NEUROL, V37, P629; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stoessl AJ, 2009, PARKINSONISM RELAT D, V15, pS13, DOI 10.1016/S1353-8020(09)70771-0; Takeda A, 2010, J NEUROL SCI, V289, P36, DOI 10.1016/j.jns.2009.08.041; Tinazzi M, 2008, PAIN, V136, P117, DOI 10.1016/j.pain.2007.06.022; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; URAKAMI K, 1990, JPN J PSYCHIAT NEUR, V44, P589; van Eimeren T, 2009, ARCH NEUROL-CHICAGO, V66, P877, DOI 10.1001/archneurol.2009.97; Wagner G, 2009, NEUROPSYCHOLOGIA, V47, P980, DOI 10.1016/j.neuropsychologia.2008.10.021; Yamanishi T, 2013, INTERNAL MED, V52, P539, DOI 10.2169/internalmedicine.52.8617	83	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164607	10.1371/journal.pone.0164607	http://dx.doi.org/10.1371/journal.pone.0164607			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776130	Green Submitted, Green Published, gold			2022-12-26	WOS:000389009200015
J	Didier, A; Dietrich, R; Martlbauer, E				Didier, A.; Dietrich, R.; Martlbauer, E.			Antibody Binding Studies Reveal Conformational Flexibility of the Bacillus cereus Non-Hemolytic Enterotoxin (Nhe) A-Component	PLOS ONE			English	Article							RAY CRYSTAL-STRUCTURE; HEMOLYSIN BL; MONOCLONAL-ANTIBODIES; TOXIN; CLYA; CYTOTOXICITY; COMPLEX; PORES; SHEA; PCR	The non-hemolytic enterotoxin complex (Nhe) is supposed to be the main virulence factor of B. cereus causing a diarrheal outcome of food poisoning. This tripartite toxin consists of the single components NheA, -B and -C all of them being necessary for maximum toxicity. In the past, research activities aiming to elucidate the mode-of-action of Nhe were mostly focused on the B-and C-component. In this study the generation of novel monoclonal antibodies (mAb) and their thorough characterization enabled the determination of key features for NheA. By the means of immunoaffinity chromatography it could be shown that NheA does not interact with -B and -C in solution. Additionally, the establishment of a highly sensitive sandwich-EIA now enables the detection of NheA in B. cereus supernatants down to 20 pg ml(-1). Peptide-based epitope mapping in combination with partially deleted recombinant NheA fragments allowed the allocation of the binding regions for the three mAbs under study. Furthermore, by different EIA set-ups the conformational flexibility of NheA could be shown. For two of the antibodies under study different mechanisms of NheA neutralization were proven. Due to prevention of complete pore formation by one of the antibodies, NheA could be detected in an intermediate stage of the tripartite complex on the cell surface. Taken together, the results obtained in the present study allow a refinement of the mode-of-action for the Nhe toxin-complex.	[Didier, A.; Dietrich, R.; Martlbauer, E.] Univ Munich, Dept Vet Sci, Oberschleissheim, Germany	University of Munich	Didier, A (corresponding author), Univ Munich, Dept Vet Sci, Oberschleissheim, Germany.	a.didier@mh.vetmed.uni-muenchen.de	Märtlbauer, Erwin/I-2897-2016; Märtlbauer, Erwin/Y-8646-2019	Märtlbauer, Erwin/0000-0003-3390-8173; Märtlbauer, Erwin/0000-0003-3390-8173	AiF within the programme for promoting the Industrial Collective Research (IGF) of the German Ministry of Economics and Energy (BMWi) [18677 N]	AiF within the programme for promoting the Industrial Collective Research (IGF) of the German Ministry of Economics and Energy (BMWi)	The IGF Project AiF 18677 N of the FEI is supported via AiF within the programme for promoting the Industrial Collective Research (IGF) of the German Ministry of Economics and Energy (BMWi), based on a resolution of the German Parliament.	AGATA N, 1995, FEMS MICROBIOL LETT, V129, P17, DOI 10.1016/0378-1097(95)00119-P; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; BEECHER DJ, 1995, INFECT IMMUN, V63, P4423, DOI 10.1128/IAI.63.11.4423-4428.1995; Clavel T, 2004, J APPL MICROBIOL, V97, P214, DOI 10.1111/j.1365-2672.2004.02292.x; Phung D, 2012, ACTA CRYSTALLOGR F, V68, P1073, DOI 10.1107/S1744309112030813; Didier A, 2012, INFECT IMMUN, V80, P832, DOI 10.1128/IAI.05681-11; Dietrich R, 1997, ARCH LEBENSMITTELHYG, V48, P77; Dietrich R, 1999, APPL ENVIRON MICROB, V65, P4470; Dietrich R, 2005, APPL ENVIRON MICROB, V71, P8214, DOI 10.1128/AEM.71.12.8214-8220.2005; Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130; Fagerlund A, 2008, MICROBIOL-SGM, V154, P693, DOI 10.1099/mic.0.2007/014134-0; Fletcher P, 1999, LETT APPL MICROBIOL, V28, P394, DOI 10.1046/j.1365-2672.1999.00542.x; Ganash M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074748; Granum PE, 1999, FEMS MICROBIOL LETT, V177, P225, DOI 10.1111/j.1574-6968.1999.tb13736.x; Heilkenbrinker U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063104; Jessberger N, 2014, TOXICON, V77, P49, DOI 10.1016/j.toxicon.2013.10.028; Lindback T, 2004, MICROBIOL-SGM, V150, P3959, DOI 10.1099/mic.0.27359-0; Lindback T, 2010, INFECT IMMUN, V78, P3813, DOI 10.1128/IAI.00247-10; Lund T, 2000, MOL MICROBIOL, V38, P254, DOI 10.1046/j.1365-2958.2000.02147.x; Lund T, 1996, FEMS MICROBIOL LETT, V141, P151, DOI 10.1016/0378-1097(96)00208-X; Madegowda M, 2008, PROTEINS, V71, P534, DOI 10.1002/prot.21888; Mengistu M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004772; Moravek M, 2006, FEMS MICROBIOL LETT, V257, P293, DOI 10.1111/j.1574-6968.2006.00185.x; Ray K, 2014, J VIROL, V88, P1795, DOI 10.1128/JVI.03048-13; Saptarshi SR, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-26; Schoeni JL, 2005, J FOOD PROTECT, V68, P636, DOI 10.4315/0362-028X-68.3.636; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0; Wehrle E, 2010, MOL CELL PROBE, V24, P124, DOI 10.1016/j.mcp.2009.11.004; Wehrle E, 2009, J MICROBIOL METH, V78, P265, DOI 10.1016/j.mimet.2009.06.013; Zhu K, 2016, BIOCHEM BIOPH RES CO, V469, P613, DOI 10.1016/j.bbrc.2015.11.126	30	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165135	10.1371/journal.pone.0165135	http://dx.doi.org/10.1371/journal.pone.0165135			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768742	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400054
J	Cho, H; Ryu, S; Noh, J; Lee, J				Cho, Hyunju; Ryu, Seokjin; Noh, Jeeae; Lee, Jongsun			The Effectiveness of Daily Mindful Breathing Practices on Test Anxiety of Students	PLOS ONE			English	Article							STRESS REDUCTION; SOCIAL ANXIETY; REAPPRAISAL; VALIDATION; PROGRAM; HEALTH	The present study examined the effectiveness of daily mindful breathing practices on test anxiety of university students. A total of 36 participants were randomly assigned to one of three conditions: a training mindful breathing condition (n = 12), a training cognitive reappraisal condition (contrast group, n = 12), and a non-training condition (control group, n = 12). Each of the participants trained by themselves for 6 days after they had taken one session of education for mindful or cognitive reappraisal practices. They wrote their experiences on daily worksheets and sent it by mobile with taking pictures that were confirmed by the researcher. Before and after training, each of the participants completed a questionnaire to assess: test anxiety, positive thought, and positive affect. The results of the study showed that both mindful breathing practice and cognitive reappraisal practice yielded large effect sizes in reducing test anxiety. In addition, the mindful breathing condition scored significantly higher on positive thoughts than the cognitive reappraisal and control conditions. The findings of this study suggest that both daily mindful breathing and cognitive reappraisal practices were effective in reducing test anxiety; however, mindful breathing increased positive automatic thoughts to a greater extent than cognitive reappraisal.	[Cho, Hyunju; Ryu, Seokjin; Noh, Jeeae] Yeungnam Univ, Dept Psychol, Gyongsan, South Korea; [Lee, Jongsun] Kangwon Natl Univ, Dept Psychol, Chuncheon Si, South Korea	Yeungnam University; Kangwon National University	Cho, H (corresponding author), Yeungnam Univ, Dept Psychol, Gyongsan, South Korea.	itslife@ynu.ac.kr		Noh, Seunghye/0000-0002-8899-151X; Cho, Hyunju/0000-0001-8316-9626	Yeungnam University Research Grant	Yeungnam University Research Grant	This study was supported by the Yeungnam University Research Grant (http://www.yu.ac.kr/english/main/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PL, 1997, PSYCHOL BULL, V121, P219, DOI 10.1037/0033-2909.121.2.219; [Anonymous], 2005, PSYCHOL TESTING PRAC; Baer RA, 2003, CLIN PSYCHOL-SCI PR, V10, P125, DOI 10.1093/clipsy/bpg015; Benson J, 1994, STRUCT EQU MODELING, V1, P203, DOI 10.1080/10705519409539975; Burg JM, 2012, SWISS J PSYCHOL; Call D, 2014, MINDFULNESS, V5, P658, DOI 10.1007/s12671-013-0218-6; Carmody J, 2009, J CLIN PSYCHOL, V65, P613, DOI 10.1002/jclp.20579; Cassady J. C., 2010, ANXIETY SCH CAUSES C, V2; Cramer D., 2004, SAGE DISCTIONARY STA, DOI [10.4135/, DOI 10.4135/9780857020123, 10.4135/9780857020123]; Cramer D., 1998, FUNDAMENTAL STAT SOC; Doane DP, 2011, J STAT EDUC, V19, DOI 10.1080/10691898.2011.11889611; Ejei J, 2011, PROCD SOC BEHV, V30, DOI 10.1016/j.sbspro.2011.10.420; EYSENCK MW, 1992, COGNITION EMOTION, V6, P409, DOI 10.1080/02699939208409696; Garland E, 2009, EXPLORE-NY, V5, P37, DOI 10.1016/j.explore.2008.10.001; Greenberg J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036206; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Hayes SC, 2011, ANNU REV CLIN PSYCHO, V7, P141, DOI 10.1146/annurev-clinpsy-032210-104449; Hayes-Skelton S, 2013, BEHAV COGN PSYCHOTH, V41, P317, DOI 10.1017/S1352465812000902; Huberty T. J., 2009, PRINCIPAL LEADERSHIP, V10, P12; INGRAM RE, 1988, J CONSULT CLIN PSYCH, V56, P898, DOI 10.1037/0022-006X.56.6.898; Jha AP, 2007, COGN AFFECT BEHAV NE, V7, P109, DOI 10.3758/CABN.7.2.109; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; KABATZINN J, 1992, AM J PSYCHIAT, V149, P936; LIEBERT RM, 1967, PSYCHOL REP, V20, P975, DOI 10.2466/pr0.1967.20.3.975; Linda Graham M, 2013, BOUNCING BACK REWIRI; Linehan M. M., 1993, COGNITIVE BEHAV TREA; Martin W.E., 2012, QUANTITATIVE STAT RE; Nadinloyi KB, 2013, PROCD SOC BEHV, V84, P303, DOI 10.1016/j.sbspro.2013.06.556; Rana R.A., 2010, B ED RES, V32, P63; Safran J. D., 1990, INTERPERSONAL PROCES; Shapiro SL, 2007, TRAIN EDUC PROF PSYC, V1, P105, DOI 10.1037/1931-3918.1.2.105; Shi Z, 2014, LEARN INDIVID DIFFER, V32, P178, DOI 10.1016/j.lindif.2014.03.011; Shikatani B, 2014, J ANXIETY DISORD, V28, P570, DOI 10.1016/j.janxdis.2014.05.012; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zeidner, 2007, EMOTION ED, P165, DOI [DOI 10.1016/B978-012372545-5/50011-3, 10.1016/B978-012372545-5/50011-3]	35	25	26	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164822	10.1371/journal.pone.0164822	http://dx.doi.org/10.1371/journal.pone.0164822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9NZ	27764151	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204500068
J	Chung, JK; Brown, E; Crooker, B; Palmieri, KJ; McCauley, TG				Chung, Jou-Ku; Brown, Eilish; Crooker, Bob; Palmieri, Kathleen J.; McCauley, Thomas G.			Biodistribution of Idursulfase Formulated for Intrathecal Use (Idursulfase-IT) in Cynomolgus Monkeys after Intrathecal Lumbar Administration	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; HUNTER-SYNDROME; BRAIN; DIAGNOSIS; TRANSPORT; PROTEIN	Enzyme replacement therapy with intravenous idursulfase (recombinant iduronate-2-sulfatase) is approved for the treatment of Hunter syndrome. Intravenous administration does not, however, treat the neurological manifestations, due to its low central nervous system bioavailability. Using intrathecal-lumbar administration, iduronate-2-sulfatase is delivered directly to the central nervous system. This study investigates the central nervous system biodistribution of intrathecal-lumbar administered iduronate-2-sulfatase in cynomolgus monkeys. Twelve monkeys were administered iduronate-2-sulfatase in one 30 mg intrathecal-lumbar injection. Brain, spinal cord, liver, and kidneys were collected for iduronate-2-sulfatase concentration (measured by an enzyme linked immunosorbent assay) and enzyme activity measurement (via a method utilizing 4-methylumbelliferyl-alpha-iduronate-2sulfate) at 1, 2, 5, 12, 24, and 48 hours following administration. The tissue enzyme linked immunosorbent assay confirmed iduronate-2-sulfatase uptake to the brain, spinal cord, kidneys, and liver in a time-dependent manner. In spinal cord and brain, iduronate-2-sulfatase appeared as early as 1 hour following administration, and peak concentrations were observed at similar to 2 and similar to 5 hours. Iduronate-2-sulfatase appeared in liver and kidneys 1 hour post intrathecal-lumbar dose with peak concentrations between 5 and 24 hours. Liver iduronate-2-sulfatase concentration was approximately 10-fold higher than kidney. The iduronate-2-sulfatase localization and enzyme activity in the central nervous system, following intrathecal administration, demonstrates that intrathecal-lumbar treatment with iduronate-2-sulfatase may be considered for further investigation as a treatment for Hunter syndrome patients with neurocognitive impairment.	[Chung, Jou-Ku; Brown, Eilish; Crooker, Bob; Palmieri, Kathleen J.; McCauley, Thomas G.] Shire, Lexington, MA 02421 USA	Shire Pharmaceuticals Limited	Chung, JK (corresponding author), Shire, Lexington, MA 02421 USA.	jchung@shire.com			Shire	Shire	This study was funded and conducted by Shire (https://www.shire.com/). Editorial assistance was provided by Robin Smith, PhD, of The Curry Rockefeller Group, LLC, Tarrytown, New York and this assistance was funded by Shire. The funders had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	BACH G, 1973, P NATL ACAD SCI USA, V70, P2134, DOI 10.1073/pnas.70.7.2134; Begley DJ, 2008, CURR PHARM DESIGN, V14, P1566, DOI 10.2174/138161208784705504; Calias P, 2014, PHARMACOL THERAPEUT, V144, P114, DOI 10.1016/j.pharmthera.2014.05.009; Calias P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030341; Chen FT, 2006, MOL GENET METAB, V87, P349, DOI 10.1016/j.ymgme.2005.11.017; Felice BR, 2011, TOXICOL PATHOL, V39, P879, DOI 10.1177/0192623311409595; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Martin R, 2008, PEDIATRICS, V121, pE377, DOI 10.1542/peds.2007-1350; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; Muenzer J, 2016, GENET MED, V18, P73, DOI 10.1038/gim.2015.36; Muenzer J, 2012, EUR J PEDIATR, V171, P181, DOI 10.1007/s00431-011-1606-3; Muenzer J, 2011, GENET MED, V13, P95, DOI 10.1097/GIM.0b013e3181fea459; Muenzer J, 2009, PEDIATRICS, V124, pE1228, DOI 10.1542/peds.2008-0999; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Nielsen H. M., 2009, DELIVERY TECHNOLOGIE, P1; Passini MA, 2002, J NEUROSCI, V22, P6437; Tan ML, 2010, PEPTIDES, V31, P184, DOI 10.1016/j.peptides.2009.10.002; Voznyi YV, 2001, J INHERIT METAB DIS, V24, P675, DOI 10.1023/A:1012763026526; Xie HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122453; YOUNG ID, 1982, J MED GENET, V19, P408, DOI 10.1136/jmg.19.6.408	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164765	10.1371/journal.pone.0164765	http://dx.doi.org/10.1371/journal.pone.0164765			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764180	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500059
J	Silva, SV; Lima, MA; Cella, N; Jaeger, RG; Freitas, VM				Silva, Suely V.; Lima, Maira A.; Cella, Nathalie; Jaeger, Ruy G.; Freitas, Vanessa M.			ADAMTS-1 Is Found in the Nuclei of Normal and Tumoral Breast Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; IN-VITRO; METALLOPROTEINASES; EXPRESSION; PROTEIN; CANCER; LOCALIZATION; CARTILAGE; VERSICAN; MOTIFS	Proteins secreted in the extracellular matrix microenvironment (ECM) by tumor cells are involved in cell adhesion, motility, intercellular communication and invasion. The tumor microenvironment is expansively modified and remodeled by proteases, resulting in important changes in both cell-cell and cell-ECM interactions and in the generation of new signals from the cell surface. Metalloproteinases belonging to the ADAMTS (a disintegrin and metalloprotease with thrombospondin motifs) family have been implicated in tissue remodeling events observed in cancer development, growth and progression. Here we investigated the subcellular localization of ADAMTS-1 in normal-like (MCF10-A) and tumoral (MCF7 and MDA-MB-231) human breast cells. ADAMTS-1 is a secreted protease found in the extracellular matrix. However, in this study we show for the first time that ADAMTS-1 is also present in the nuclei and nucleoli of the three mammary cell lines studied here. Our findings indicate that ADAMTS-1 has proteolytic functions in the nucleus through its interaction with aggrecan substrate.	[Silva, Suely V.; Lima, Maira A.; Cella, Nathalie; Jaeger, Ruy G.; Freitas, Vanessa M.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil	Universidade de Sao Paulo	Freitas, VM (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.	vfreitas@usp.br	Jaeger, Ruy G/G-8230-2011; Cella, Nathalie/AAX-5494-2021; Freitas, Vanessa M/D-7897-2012	Jaeger, Ruy G/0000-0002-1564-0356; Cella, Nathalie/0000-0001-6060-1076; Freitas, Vanessa M/0000-0001-9613-8626	State of Sao Paulo Research Foundation; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/07699-1, 2015/02498-1]; FAPESP [2012/10053-1, 2013/01092-6];  [FAPESP 2015/09845-9];  [2015/19773-5]	State of Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ; 	This investigation was supported by The State of Sao Paulo Research Foundation, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grants 2010/07699-1 and 2015/02498-1, VMF). SVS and MAL are current recipients of Doctoral Graduate fellowships (FAPESP 2015/09845-9 and 2015/19773-5). SVS and MAL were former recipients of Masters fellowships from FAPESP (2012/10053-1 and 2013/01092-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bondeson J, 2008, CLIN EXP RHEUMATOL, V26, P139; Bukong TN, 2016, LAB INVEST, V96, P361, DOI 10.1038/labinvest.2015.152; Caterson B, 2000, MATRIX BIOL, V19, P333, DOI 10.1016/S0945-053X(00)00078-0; Chen TLL, 2001, EXP CELL RES, V263, P224, DOI 10.1006/excr.2000.5093; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; Freitas VM, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-2; Hellewell AL, 2016, BIOESSAYS, V38, P77, DOI 10.1002/bies.201500103; Kohrmann A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-188; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Kwan JA, 2004, FASEB J, V18, P690, DOI 10.1096/fj.02-1202fje; Lima MA, 2016, PATHOBIOLOGY, V83, P316, DOI 10.1159/000446244; Mannello F, 2012, PROG HISTOCHEM CYTO, V47, P27, DOI 10.1016/j.proghi.2011.12.002; Mannello F, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-95; Nakamura M, 2005, J HISTOCHEM CYTOCHEM, V53, P1553, DOI 10.1369/jhc.5A6669.2005; Obika M, 2014, J HISTOCHEM CYTOCHEM, V62, P34, DOI 10.1369/0022155413507727; Porter S, 2004, CLIN CANCER RES, V10, P2429, DOI 10.1158/1078-0432.CCR-0398-3; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Ravindran S, 2008, J BIOL CHEM, V283, P29658, DOI 10.1074/jbc.M800786200; Rocks N, 2008, BIOCHIMIE, V90, P369, DOI 10.1016/j.biochi.2007.08.008; Rocks N, 2008, CANCER RES, V68, P9541, DOI 10.1158/0008-5472.CAN-08-0548; Roughley PJ, 2001, ARTHRITIS RES, V3, P342, DOI 10.1186/ar326; Si-Tayeb K, 2006, AM J PATHOL, V169, P1390, DOI 10.2353/ajpath.2006.060005; Si-Yayeb K, 2003, J HEPATOLOGY; Sinha SK, 2014, AM J TRANSL RES, V6, P155; Stanton H, 2011, BBA-MOL BASIS DIS, V1812, P1616, DOI 10.1016/j.bbadis.2011.08.009; Tan ID, 2013, INT J CANCER, V133, P2263, DOI 10.1002/ijc.28127; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039446; Wen JD, 2006, J CLIN ENDOCR METAB, V91, P4825, DOI 10.1210/jc.2006-1567	29	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							0165061	10.1371/journal.pone.0165061	http://dx.doi.org/10.1371/journal.pone.0165061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764205	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500108
J	Luo, WW; Lieu, ZZ; Manser, E; Bershadsky, AD; Sheetz, MP				Luo, Weiwei; Lieu, Zi Zhao; Manser, Ed; Bershadsky, Alexander D.; Sheetz, Michael P.			Formin DAAM1 Organizes Actin Filaments in the Cytoplasmic Nodal Actin Network	PLOS ONE			English	Article							MORPHOGENESIS; PATHWAYS; PROTEINS; REQUIRES; MIM	A nodal cytoplasmic actin network underlies actin cytoplasm cohesion in the absence of stress fibers. We previously described such a network that forms upon Latrunculin A (LatA) treatment, in which formin DAAM1 was localized at these nodes. Knock down of DAAM1 reduced the mobility of actin nodes but the nodes remained. Here we have investigated DAAM1 containing nodes after LatA washout. DAAM1 was found to be distributed between the cytoplasm and the plasma membrane. The membrane binding likely occurs through an interaction with lipid rafts, but is not required for F-actin assembly. Interesting the forced interaction of DAAM1 with plasma membrane through a rapamycin-dependent linkage, enhanced F-actin assembly at the cell membrane (compared to the cytoplasm) after the LatA washout. However, immediately after addition of both rapamycin and LatA, the cytoplasmic actin nodes formed transiently, before DAAM1 moved to the membrane. This was consistent with the idea that DAAM1 was initially anchored to cytoplasmic actin nodes. Further, photoactivatable tracking of DAAM1 showed DAAM1 was immobilized at these actin nodes. Thus, we suggest that DAAM1 organizes actin filaments into a nodal complex, and such nodal complexes seed actin network recovery after actin depolymerization.	[Luo, Weiwei; Lieu, Zi Zhao; Bershadsky, Alexander D.; Sheetz, Michael P.] Natl Univ Singapore, Mechanobiol Inst, Singapore, Singapore; [Manser, Ed] Agcy Sci Technol & Res, Inst Mol & Cell Biol, SGSK Grp, Proteos Bldg,61 Biopolis Dr, Singapore 138673, Singapore; [Sheetz, Michael P.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Bershadsky, Alexander D.] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Luo, Weiwei] Duke NUS Med Sch, Signature Res Program Cardiovasc & Metab Disorder, Singapore, Singapore; [Lieu, Zi Zhao] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore, Singapore; [Lieu, Zi Zhao] Natl Univ Singapore, Fac Sci, Special Programme Sci, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Columbia University; Weizmann Institute of Science; National University of Singapore; National University of Singapore; National University of Singapore	Sheetz, MP (corresponding author), Natl Univ Singapore, Mechanobiol Inst, Singapore, Singapore.; Sheetz, MP (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ms2001@columbia.edu	Manser, Edward/ABD-2301-2020	Lieu, Zi Zhao/0000-0003-3053-9544	National Research Foundation (NRF), Singapore; Ministry of Education (MOE), Singapore	National Research Foundation (NRF), Singapore(National Research Foundation, Singapore); Ministry of Education (MOE), Singapore(Ministry of Education, Singapore)	This research was supported by the National Research Foundation (NRF), Singapore, and Ministry of Education (MOE), Singapore, and funding to the MBI, National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013064; Barko S, 2010, J BIOL CHEM, V285, P13154, DOI 10.1074/jbc.M109.093914; Cai YF, 2010, J CELL SCI, V123, P413, DOI 10.1242/jcs.058297; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Colombo A, 2013, DEVELOPMENT, V140, P3997, DOI 10.1242/dev.091934; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Filla MS, 2011, INVEST OPHTH VIS SCI, V52, P2952, DOI 10.1167/iovs.10-6618; Filla MS, 2009, INVEST OPHTH VIS SCI, V50, P5723, DOI 10.1167/iovs.08-3215; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gonzalez JM, 2014, CLIN EXP OPHTHALMOL, V42, P502, DOI 10.1111/ceo.12255; Gorelik R, 2011, MOL BIOL CELL, V22, P189, DOI 10.1091/mbc.E10-03-0256; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Holubcova Z, 2013, NAT CELL BIOL, V15, P937, DOI 10.1038/ncb2802; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jaiswal R, 2013, CURR BIOL, V23, P1373, DOI 10.1016/j.cub.2013.06.013; Kida Y, 2004, DEV BRAIN RES, V153, P143, DOI 10.1016/j.devbrainres.2004.07.014; Kida YS, 2007, P NATL ACAD SCI USA, V104, P6708, DOI 10.1073/pnas.0608946104; LAZARIDES E, 1979, SCI AM, V240, P100, DOI 10.1038/scientificamerican0579-100; Li DQ, 2011, DEVELOPMENT, V138, P303, DOI 10.1242/dev.055566; Liu W, 2011, DEVELOPMENT, V138, P2035, DOI 10.1242/dev.058800; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Luo WW, 2013, J CELL BIOL, V202, P1057, DOI 10.1083/jcb.201210123; Maddugoda MP, 2011, CELL HOST MICROBE, V10, P464, DOI 10.1016/j.chom.2011.09.014; Matsudaira Paul, 1994, Seminars in Cell Biology, V5, P165, DOI 10.1006/scel.1994.1021; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Paran Y, 2006, METHOD ENZYMOL, V414, P228, DOI 10.1016/S0076-6879(06)14013-6; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; Rosado M, 2014, MOL BIOL CELL, V25, P811, DOI 10.1091/mbc.E13-08-0443; Saengsawang W, 2013, J CELL SCI, V126, P2411, DOI 10.1242/jcs.117473; Salomon SN, 2008, NEUROSCI LETT, V447, P62, DOI 10.1016/j.neulet.2008.09.051; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Subach FV, 2010, J AM CHEM SOC, V132, P6481, DOI 10.1021/ja100906g; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Wagh D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120093; Werner M, 2007, CURR BIOL, V17, P1286, DOI 10.1016/j.cub.2007.06.070	39	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0163915	10.1371/journal.pone.0163915	http://dx.doi.org/10.1371/journal.pone.0163915			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760153	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000023
J	Malvisi, M; Palazzo, F; Morandi, N; Lazzari, B; Williams, JL; Pagnacco, G; Minozzi, G				Malvisi, Michela; Palazzo, Fiorentina; Morandi, Nicola; Lazzari, Barbara; Williams, John L.; Pagnacco, Giulio; Minozzi, Giulietta			Responses of Bovine Innate Immunity to Mycobacterium avium subsp paratuberculosis Infection Revealed by Changes in Gene Expression and Levels of MicroRNA	PLOS ONE			English	Article							CROHNS-DISEASE; CIRCULATING MICRORNAS; INDOLEAMINE 2,3-DIOXYGENASE; DIFFERENTIAL EXPRESSION; INFLAMMATORY CYTOKINES; TRYPTOPHAN CATABOLISM; ACTIVE TUBERCULOSIS; INTERFERON-GAMMA; JOHNES-DISEASE; T-CELLS	Paratuberculosis in cattle is a chronic granulomatous gastroenteritis caused by Mycobacterium avium subsp. paratubercolosis (MAP) which is endemic worldwide. In dairy herds, it is responsible for huge economic losses. However, current diagnostic methods do not detect subclinical infection making control of the disease difficult. The identification of MAP infected animals during the sub-clinical phase of infection would play a key role in preventing the dissemination of the pathogen and in reducing transmission. Gene expression and circulating microRNA (miRNA) signatures have been proposed as biomarkers of disease both in the human and veterinary medicine. In this paper, gene expression and related miRNA levels were investigated in cows positive for MAP, by ELISA and culture, in order to identify potential biomarkers to improve diagnosis of MAP infection. Three groups, each of 5 animals, were used to compare the results of gene expression from positive, exposed and negative cows. Overall 258 differentially expressed genes were identified between unexposed, exposed, but ELISA negative and positive groups which were involved in biological functions related to inflammatory response, lipid metabolism and small molecule biochemistry. Differentially expressed miRNA was also found among the three groups: 7 miRNAs were at a lower level and 2 at a higher level in positive animals vs unexposed animals, while 5 and 3 miRNAs were respectively reduced and increased in the exposed group compared to the unexposed group. Among the differentially expressed miRNAs 6 have been previously described as immune-response related and two were novel miRNAs. Analysis of the miRNA levels showed correlation with expression of their target genes, known to be involved in the immune process. This study suggests that miRNA expression is affected by MAP infection and play a key role in tuning the host response to infection. The miRNA and gene expression profiles may be biomarkers of infection and potential that no competing interests exist. diagnostic of MAP infection earlier than the current ELISA based diagnostic tests.	[Malvisi, Michela; Morandi, Nicola; Lazzari, Barbara; Williams, John L.] Parco Tecnol Padano, Lodi, Italy; [Malvisi, Michela; Pagnacco, Giulio; Minozzi, Giulietta] Univ Milan, Dept Vet Med, Milan, Italy; [Palazzo, Fiorentina] Univ Teramo, Fac Biosci & Technol Food Agr & Environm, Teramo, Italy; [Lazzari, Barbara] CNR, Inst Agr Biol & Biotechnol, Lodi, Italy; [Williams, John L.] Univ Adelaide, Sch Anim & Vet Sci, Roseworthy, SA, Australia	University of Milan; University of Teramo; Consiglio Nazionale delle Ricerche (CNR); University of Adelaide	Malvisi, M (corresponding author), Parco Tecnol Padano, Lodi, Italy.; Malvisi, M (corresponding author), Univ Milan, Dept Vet Med, Milan, Italy.	michela.malvisi@yahoo.com	Minozzi, Giulietta/K-8126-2017; Pagnacco, Giulio/K-8202-2017	Minozzi, Giulietta/0000-0002-0020-8798; Pagnacco, Giulio/0000-0002-5013-5179; Williams, John/0000-0001-5188-7957	Italian Ministry of Education University and Research [PON01_01841 PON EPISUD]	Italian Ministry of Education University and Research(Ministry of Education, Universities and Research (MIUR))	This work was carried out with the support of grant PON01_01841 PON EPISUD from the Italian Ministry of Education University and Research (www/istruzione.it) given to JLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Alter-Koltunoff M, 2008, J BIOL CHEM, V283, P2724, DOI 10.1074/jbc.M707704200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2002, VET Q, V24, P12, DOI [10.1080/01652176.2002.9695120, DOI 10.1080/01652176.2002.9695120]; Appelberg R, 1996, RES IMMUNOL, V147, P560, DOI 10.1016/S0923-2494(97)85222-4; Barbulescu K, 1998, J IMMUNOL, V160, P3642; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beard PM, 2001, J CLIN MICROBIOL, V39, P1517, DOI 10.1128/JCM.39.4.1517-1521.2001; Biet F, 2002, J MOL MED-JMM, V80, P147, DOI 10.1007/s00109-001-0307-1; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; Chaiyaroj SC, 2004, ACTA TROP, V89, P319, DOI 10.1016/j.actatropica.2003.10.010; Choi EJ, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0252-0; Clark DL, 2008, J DAIRY SCI, V91, P2620, DOI 10.3168/jds.2007-0902; Collins MT, 1996, VET CLIN N AM-FOOD A, V12, P357, DOI 10.1016/S0749-0720(15)30411-4; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Costoya Jose A., 2007, Briefings in Functional Genomics & Proteomics, V6, P8, DOI 10.1093/bfgp/elm002; Crossley BM, 2005, VET MICROBIOL, V107, P257, DOI 10.1016/j.vetmic.2005.01.017; David J, 2014, VET RES, V45, DOI 10.1186/s13567-014-0096-5; David J, 2014, VET IMMUNOL IMMUNOP, V160, P107, DOI 10.1016/j.vetimm.2014.04.006; De Rosa S, 2015, EXPERIENTIA SUPPL, V106, P139, DOI 10.1007/978-3-0348-0955-9_6; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duttagupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031241; Farr RJ, 2015, EXPERIENTIA SUPPL, V106, P215, DOI 10.1007/978-3-0348-0955-9_10; Farrell D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134310; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fu YR, 2014, J CELL MOL MED, V18, P503, DOI 10.1111/jcmm.12205; Garcia AB, 2015, J DAIRY SCI, V98, P5019, DOI 10.3168/jds.2014-9241; Ghadiali AH, 2004, J CLIN MICROBIOL, V42, P5345, DOI 10.1128/JCM.42.11.5345-5348.2004; Gilardoni LR, 2012, REV ARGENT MICROBIOL, V44, P201; Gossner AG, 2012, VET IMMUNOL IMMUNOP, V150, P118, DOI 10.1016/j.vetimm.2012.08.004; Grasso M, 2015, EXPERIENTIA SUPPL, V106, P151, DOI 10.1007/978-3-0348-0955-9_7; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Greig A, 1999, J CLIN MICROBIOL, V37, P1746, DOI 10.1128/JCM.37.6.1746-1751.1999; Gu JJ, 2003, MOL CELL BIOL, V23, P6702, DOI 10.1128/MCB.23.18.6702-6712.2003; Harrison RE, 2002, BIOCHEM CELL BIOL, V80, P509, DOI 10.1139/O02-142; Heegaard NHH, 2015, EXPERIENTIA SUPPL, V106, P171, DOI 10.1007/978-3-0348-0955-9_8; Hines ME, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00026; Huang LS, 2013, IMMUNOLOGY, V140, P314, DOI 10.1111/imm.12139; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Hussain KM, 2011, J BIOL CHEM, V286, P309, DOI 10.1074/jbc.M110.168468; Janeckova L, 2015, MOL CANCER RES, V13, P1139, DOI 10.1158/1541-7786.MCR-15-0033; Jha SS, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-100; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; Jonsson CA, 2002, CELL IMMUNOL, V216, P93, DOI 10.1016/S0008-8749(02)00502-6; Joshi AD, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-52; Khare S, 2009, VET PATHOL, V46, P717, DOI 10.1354/vp.08-VP-0187-G-FL; Kim K, 2012, MOL CANCER THER, V11, P1852, DOI 10.1158/1535-7163.MCT-12-0181; Knosp CA, 2011, J EXP MED, V208, P1523, DOI 10.1084/jem.20101167; Konishi H, 2016, METHODS MOL BIOL, V1368, P99, DOI 10.1007/978-1-4939-3136-1_8; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lawless N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057543; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li XQ, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0359-4; Liu SQ, 2014, J BIOL CHEM, V289, P12446, DOI 10.1074/jbc.M114.550723; Liu YH, 2011, MOL IMMUNOL, V48, P1084, DOI 10.1016/j.molimm.2011.02.001; Lui SL, 1998, TRANSPL IMMUNOL, V6, P23, DOI 10.1016/S0966-3274(98)80031-2; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Mannering SI, 2002, INFECT IMMUN, V70, P27, DOI 10.1128/IAI.70.1.27-35.2002; MCCLURE HM, 1987, J INFECT DIS, V155, P1011, DOI 10.1093/infdis/155.5.1011; Mendoza JL, 2009, WORLD J GASTROENTERO, V15, P417, DOI 10.3748/wjg.15.417; Middleton MK, 2009, INFECT IMMUN, V77, P5690, DOI 10.1128/IAI.00560-09; Minozzi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011117; Mitchell RM, 2012, EPIDEMIOL INFECT, V140, P231, DOI 10.1017/S0950268811000689; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Ouchida M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044095; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinedo PJ, 2009, PREV VET MED, V91, P189, DOI 10.1016/j.prevetmed.2009.05.020; Plain KM, 2011, INFECT IMMUN, V79, P3821, DOI 10.1128/IAI.05204-11; Rideout B., 2003, DIAGNOSIS CONTROL JO; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson TL, 2007, VET IMMUNOL IMMUNOP, V115, P160, DOI 10.1016/j.vetimm.2006.09.012; Roussey Jonathan A, 2014, Front Vet Sci, V1, P20, DOI 10.3389/fvets.2014.00020; Settles M, 2009, ANIM GENET, V40, P655, DOI 10.1111/j.1365-2052.2009.01896.x; Shin MK, 2015, J MICROBIOL BIOTECHN, V25, P255, DOI 10.4014/jmb.1408.08059; SOCKETT DC, 1992, J CLIN MICROBIOL, V30, P1134, DOI 10.1128/JCM.30.5.1134-1139.1992; Staedel C, 2013, CELL MICROBIOL, V15, P1496, DOI 10.1111/cmi.12159; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Tian GL, 2010, CYTOSKELETON, V67, P706, DOI 10.1002/cm.20480; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Tripathi P, 2006, CURR SCI INDIA, V90, P519; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Ueberberg Bianca, 2014, Mol Cell Pediatr, V1, P8, DOI 10.1186/s40348-014-0008-9; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vegh P, 2015, TUBERCULOSIS, V95, P60, DOI 10.1016/j.tube.2014.10.011; WATERS RV, 1993, ANN NY ACAD SCI, V696, P185; Wells SJ, 2006, CLIN VACCINE IMMUNOL, V13, P1125, DOI 10.1128/CVI.00236-06; Whitlock RH, 1996, VET CLIN N AM-FOOD A, V12, P345, DOI 10.1016/S0749-0720(15)30410-2; Whittington RJ, 2001, AUST VET J, V79, P267, DOI 10.1111/j.1751-0813.2001.tb11980.x; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267; Xu ZH, 2015, TUBERCULOSIS, V95, P395, DOI 10.1016/j.tube.2015.02.043; Yi ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043184; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081076; Zhu F, 2016, DEV COMP IMMUNOL, V55, P76, DOI 10.1016/j.dci.2015.10.012; Zwick LS, 2002, J VET DIAGN INVEST, V14, P326, DOI 10.1177/104063870201400409	100	31	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164461	10.1371/journal.pone.0164461	http://dx.doi.org/10.1371/journal.pone.0164461			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760169	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000037
J	Plumptre, AJ; Nixon, S; Kujirakwinja, DK; Vieilledent, G; Critchlow, R; Williamson, EA; Nishuli, R; Kirkby, AE; Hall, JS				Plumptre, Andrew J.; Nixon, Stuart; Kujirakwinja, Deo K.; Vieilledent, Ghislain; Critchlow, Rob; Williamson, Elizabeth A.; Nishuli, Radar; Kirkby, Andrew E.; Hall, Jefferson S.			Catastrophic Decline of World's Largest Primate: 80% Loss of Grauer's Gorilla (Gorilla beringei graueri) Population Justifies Critically Endangered Status	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BIEGA NATIONAL-PARK; SPATIAL AUTOCORRELATION; LOWLAND GORILLAS; DISTRIBUTIONS; CONSERVATION; IMPACTS; DESIGN; FOREST; CENSUS	Grauer's gorilla (Gorilla beringei graueri), the World's largest primate, is confined to eastern Democratic Republic of Congo (DRC) and is threatened by civil war and insecurity. During the war, armed groups in mining camps relied on hunting bushmeat, including gorillas. Insecurity and the presence of several militia groups across Grauer's gorilla's range made it very difficult to assess their population size. Here we use a novel method that enables rigorous assessment of local community and ranger-collected data on gorilla occupancy to evaluate the impacts of civil war on Grauer's gorilla, which prior to the war was estimated to number 16,900 individuals. We show that gorilla numbers in their stronghold of Kahuzi-Biega National Park have declined by 87%. Encounter rate data of gorilla nests at 10 sites across its range indicate declines of 82-100% at six of these sites. Spatial occupancy analysis identifies three key areas as the most critical sites for the remaining populations of this ape and that the range of this taxon is around 19,700 km(2). We estimate that only 3,800 Grauer's gorillas remain in the wild, a 77% decline in one generation, justifying its elevation to Critically Endangered status on the IUCN Red List of Threatened Species.	[Plumptre, Andrew J.; Kujirakwinja, Deo K.; Kirkby, Andrew E.] Wildlife Conservat Soc, 2300 Southern Blvd, Bronx, NY 10460 USA; [Plumptre, Andrew J.] Univ Cambridge, Dept Zool, Conservat Sci Grp, David Attenborough Bldg,Pembroke Rd, Cambridge, England; [Nixon, Stuart] Chester Zoo, North England Zool Soc, Upton By Chester CH2 1LH, Cheshire, England; [Vieilledent, Ghislain] CIRAD, UPR Forets & Soc, F-34398 Montpellier, France; [Critchlow, Rob] Univ York, Dept Biol, York, N Yorkshire, England; [Williamson, Elizabeth A.] Univ Stirling, Fac Nat Sci, Stirling, Scotland; [Nishuli, Radar] ICCN, Bukavu, DEM REP CONGO; [Hall, Jefferson S.] Smithsonian Trop Res Inst, Ave Roosevelt 401, Balboa, Ancon, Panama	Wildlife Conservation Society; University of Cambridge; CIRAD; University of York - UK; University of Stirling; Smithsonian Institution; Smithsonian Tropical Research Institute	Plumptre, AJ (corresponding author), Wildlife Conservat Soc, 2300 Southern Blvd, Bronx, NY 10460 USA.; Plumptre, AJ (corresponding author), Univ Cambridge, Dept Zool, Conservat Sci Grp, David Attenborough Bldg,Pembroke Rd, Cambridge, England.	aplumptre@wcs.org	Williamson, Elizabeth/E-4727-2016; Plumptre, Andrew J./X-3145-2019; Vieilledent, Ghislain/D-8323-2011; Williamson, Elizabeth/B-9090-2011; Williamson, Elizabeth/N-8958-2019	Williamson, Elizabeth/0000-0001-6848-9154; Plumptre, Andrew J./0000-0002-9333-4047; Vieilledent, Ghislain/0000-0002-1685-4997; Williamson, Elizabeth/0000-0001-6848-9154	Arcus Foundation through the Jane Goodall Institute (Arcus) [1202-03]; Critical Ecosystem Partnership Fund; Frankfurt Zoological Society; KfW; Rainforest Trust; UNESCO; USAID/CARPE; US Fish and Wildlife Service; World Bank	Arcus Foundation through the Jane Goodall Institute (Arcus); Critical Ecosystem Partnership Fund; Frankfurt Zoological Society; KfW; Rainforest Trust; UNESCO; USAID/CARPE(United States Agency for International Development (USAID)); US Fish and Wildlife Service(US Fish & Wildlife Service); World Bank(The World Bank India)	Support for this analysis was primarily provided by the generous support of the Arcus Foundation through the Jane Goodall Institute (Arcus 1202-03). The surveys referred to in the report were funded by other donors, notably Critical Ecosystem Partnership Fund, Frankfurt Zoological Society, KfW, Rainforest Trust, UNESCO, USAID/CARPE, US Fish and Wildlife Service and World Bank. We are also grateful to Wildlife Conservation Society for supporting Andrew Plumptre and Deo Kujirakwinja to compile and analyse the data; CIRAD, who supported Ghislain Vieilledent to help with the R-analyses, Chester Zoo, who supported Stuart Nixon's time during the writing of this report, and the University of York, who supported Rob Critchlow.	Buckland ST, 2010, INT J PRIMATOL, V31, P833, DOI 10.1007/s10764-010-9431-5; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Domisch S, 2016, ECOGRAPHY IN PRESS; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; EMLEN JOHN T., 1960, ZOOLOGICA [NEW YORK], V45, P41; Goodall A. G., 1977, P449; Gray M, 2013, BIOL CONSERV, V158, P230, DOI 10.1016/j.biocon.2012.09.018; Hall JS, 1998, INT J PRIMATOL, V19, P207, DOI 10.1023/A:1020375430965; Hall JS, 1998, ORYX, V32, P122, DOI 10.1046/j.1365-3008.1998.d01-22.x; Hart T, 1997, CONSERV BIOL, V11, P308, DOI 10.1046/j.1523-1739.1997.011002308.x; IUCN, 2014, GUID US RED LIST CAT; Kirkby A, 2015, INVESTIGATING UNPUB, DOI 10.13140/RG.2.1.3471.4963; Lahoz-Monfort JJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P504, DOI 10.1111/geb.12138; Latimer AM, 2006, ECOL APPL, V16, P33, DOI 10.1890/04-0609; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Liu CR, 2011, ECOGRAPHY, V34, P232, DOI 10.1111/j.1600-0587.2010.06354.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Maldonado O., 2012, GRAUERS GORILLAS CHI; Mehlman Patrick T., 2008, P3, DOI 10.1007/978-0-387-70721-1_1; Nackoney J, 2014, BIOL CONSERV, V170, P321, DOI 10.1016/j.biocon.2013.12.033; Nixon S, 2012, 24 C INT PRIM SOC CA; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Robbins M, 2008, IUCN RED LIST THREAT; Roy J, 2014, BIOL CONSERV, V180, P249, DOI 10.1016/j.biocon.2014.10.011; Spittaels S., 2010, COMPLEXITY RESOURCE; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; TUTIN CEG, 1995, INT J PRIMATOL, V16, P53, DOI 10.1007/BF02700153; VIEILLEDENT G, 2014, HSDM HIERARCHICAL BA; Wilson AM, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002415; Witness Global, 2009, FAC GUN WHAT CAN YOU; YAMAGIWA J, 1993, BIOL CONSERV, V64, P83, DOI 10.1016/0006-3207(93)90386-F; Yamagiwa J, 2012, ECOLOGICAL IMPACT LO, P385	33	43	44	2	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0162697	10.1371/journal.pone.0162697	http://dx.doi.org/10.1371/journal.pone.0162697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760201	Green Published, gold, Green Accepted			2022-12-26	WOS:000386204000003
J	Burton, LJ; Rivera, M; Hawsawi, O; Zou, J; Hudson, T; Wang, GD; Zhang, Q; Cubano, L; Boukli, N; Odero-Marah, V				Burton, Liza J.; Rivera, Mariela; Hawsawi, Ohuod; Zou, Jin; Hudson, Tamaro; Wang, Guangdi; Zhang, Qiang; Cubano, Luis; Boukli, Nawal; Odero-Marah, Valerie			Muscadine Grape Skin Extract Induces an Unfolded Protein Response-Mediated Autophagy in Prostate Cancer Cells: A TMT-Based Quantitative Proteomic Analysis	PLOS ONE			English	Article							ASTROCYTE-ELEVATED GENE-1; ANNEXIN-IV; OVARIAN CANCERS; ER STRESS; EXPRESSION; APOPTOSIS; DEATH; RESISTANCE; THERAPY; ADENOCARCINOMA	Muscadine grape skin extract (MSKE) is derived from muscadine grape (Vitis rotundifolia), a common red grape used to produce red wine. Endoplasmic reticulum (ER) stress activates the unfolded protein response (UPR) that serves as a survival mechanism to relieve ER stress and restore ER homeostasis. However, when persistent, ER stress can alter the cytoprotective functions of the UPR to promote autophagy and cell death. Although MSKE has been documented to induce apoptosis, it has not been linked to ER stress/ UPR/autophagy. We hypothesized that MSKE may induce a severe ER stress response-mediated autophagy leading to apoptosis. As a model, we treated C4-2 prostate cancer cells with MSKE and performed a quantitative Tandem Mass Tag Isobaric Labeling proteomic analysis. ER stress response, autophagy and apoptosis were analyzed by western blot, acridine orange and TUNEL/Annexin V staining, respectively. Quantitative proteomics analysis indicated that ER stress response proteins, such as GRP78 were greatly elevated following treatment with MSKE. The up-regulation of pro-apoptotic markers PARP, caspase-12, cleaved caspase-3, -7, BAX and down-regulation of anti-apoptotic marker BCL2 was confirmed by Western blot analysis and apoptosis was visualized by increased TUNEL/Annexin V staining upon MSKE treatment. Moreover, increased acridine orange, and LC3B staining was detected in MSKE-treated cells, suggesting an ER stress/autophagy response. Finally, MSKE-mediated autophagy and apoptosis was antagonized by co-treatment with chloroquine, an autophagy inhibitor. Our results indicate that MSKE can elicit an UPR that can eventually lead to apoptosis in prostate cancer cells.	[Burton, Liza J.; Hawsawi, Ohuod; Zou, Jin; Odero-Marah, Valerie] Clark Atlanta Univ, Dept Biol Sci, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA; [Rivera, Mariela; Cubano, Luis; Boukli, Nawal] Univ Cent Caribe, Sch Med, Dept Microbiol & Immunol, Bayamon, PR 00956 USA; [Hudson, Tamaro] Howard Univ, Dept Med, Washington, DC 20060 USA; [Wang, Guangdi; Zhang, Qiang] Xavier Univ, Dept Chem, New Orleans, LA 70125 USA	Clark Atlanta University; Howard University; Xavier University of Louisiana	Odero-Marah, V (corresponding author), Clark Atlanta Univ, Dept Biol Sci, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA.	vodero_marah@cau.edu		Rivera, Mariela/0000-0003-3085-5619	NIH [8G12MD007590, 5 G12RR003062, P20MD002285-01, G12MD007595]; NIH Research Centers in Minority Institutions (RCMI) Program and Biomedical Proteomics Facility [G12MD007583]; U.S. Department of Education [P031S130068]; National Institute on Minority Health and Health Disparities [G12MD007583, G12MD007595, G12MD007590] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Research Centers in Minority Institutions (RCMI) Program and Biomedical Proteomics Facility; U.S. Department of Education(US Department of Education); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	NIH grants 8G12MD007590 (formerly NIH/NCRR Grant Number 5 G12RR003062) (VOM), P20MD002285-01 (VOM), G12MD007595 (GW). This project was also supported by the NIH Research Centers in Minority Institutions (RCMI) Program and Biomedical Proteomics Facility Grant G12MD007583 (NMB) and Title V grant number P031S130068 from the U.S. Department of Education (LAC).	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Allahverdiyev A. M., 2012, BIOCH GENETICS MOL B; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Bair WB, 2010, MELANOMA RES, V20, P85, DOI 10.1097/CMR.0b013e3283364903; Bergmann A, 2007, CELL, V131, P1032, DOI 10.1016/j.cell.2007.11.027; Bhutia SK, 2010, P NATL ACAD SCI USA, V107, P22243, DOI 10.1073/pnas.1009479107; Boukli Nawal M, 2012, Clin Proteomics, V9, P11, DOI 10.1186/1559-0275-9-11; Boukli NM, 2010, ALCOHOL CLIN EXP RES, V34, P2081, DOI 10.1111/j.1530-0277.2010.01304.x; Burton LJ, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-97; Chen N, 2009, BBA-MOL CELL RES, V1793, P1516, DOI 10.1016/j.bbamcr.2008.12.013; Dean M, 2001, J LIPID RES, V42, P1007; Divisi Duilio, 2006, Acta Biomed, V77, P118; Dong YS, 2015, CELL DEATH DIFFER; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gomes IM, 2012, MOL CANCER RES, V10, P573, DOI 10.1158/1541-7786.MCR-11-0281; Gottlieb RA, 2015, CIRC RES, V116, P504, DOI 10.1161/CIRCRESAHA.116.303787; Han EKH, 2000, BRIT J CANCER, V83, P83; Heinonen IM, 1998, J AGR FOOD CHEM, V46, P25, DOI 10.1021/jf970489o; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hudson TS, 2007, CANCER RES, V67, P8396, DOI 10.1158/0008-5472.CAN-06-4069; Jeon YJ, 2010, CELL MOL LIFE SCI, V67, P2271, DOI 10.1007/s00018-010-0331-9; Joselin AP, 2006, J BIOL CHEM, V281, P12475, DOI 10.1074/jbc.M509859200; Ke ZF, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0383-9; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Kim A, 2010, EXPERT OPIN THER TAR, V14, P963, DOI 10.1517/14728222.2010.511180; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li J, 2009, ONCOGENE, V28, P3188, DOI 10.1038/onc.2009.171; Lin LL, 2008, PROTEOM CLIN APPL, V2, P619, DOI 10.1002/prca.200780088; Masuishi Y, 2011, FEBS J, V278, P1470, DOI 10.1111/j.1742-4658.2011.08059.x; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; Meiyanto E, 2012, ASIAN PAC J CANCER P, V13, P427, DOI 10.7314/APJCP.2012.13.2.427; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moreb JS, 2012, CHEM-BIOL INTERACT, V195, P52, DOI 10.1016/j.cbi.2011.10.007; Paglin S, 2001, CANCER RES, V61, P439; Paller CJ, 2015, PROSTATE, V75, P1518, DOI 10.1002/pros.23024; Rohozinski J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005064; Salazar M, 2011, METHOD ENZYMOL, V489, P297, DOI 10.1016/B978-0-12-385116-1.00017-0; Schwerk C, 2003, MOL CELL BIOL, V23, P2981, DOI 10.1128/MCB.23.8.2981-2990.2003; Shen JJ, 2004, CANCER RES, V64, P9018, DOI 10.1158/0008-5472.CAN-04-3262; Shi X, 2015, INT J CLIN EXP MED, V8, P4795; Shin DY, 2009, ANN NY ACAD SCI, V1171, P137, DOI 10.1111/j.1749-6632.2009.04689.x; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Thirkettle HJ, 2009, ONCOGENE, V28, P3663, DOI 10.1038/onc.2009.223; Toyama A, 2012, CANCER SCI, V103, P747, DOI 10.1111/j.1349-7006.2012.02224.x; Verfaillie T, 2010, INT J CELL BIOL, V2010; Wang K, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371591; Wang LS, 2008, CANCER LETT, V269, P281, DOI 10.1016/j.canlet.2008.05.020; Zhou CH, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3144; Zimmermann U, 2004, CANCER LETT, V209, P111, DOI 10.1016/j.canlet.2003.12.002	55	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164115	10.1371/journal.pone.0164115	http://dx.doi.org/10.1371/journal.pone.0164115			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755556	Green Published, Green Submitted, gold			2022-12-26	WOS:000386203800011
J	Svendsen, JB; Baslund, B; Cramer, EP; Rapin, N; Borregaard, N; Cowland, JB				Svendsen, Jesper Brink; Baslund, Bo; Cramer, Elisabeth Praestekjaer; Rapin, Nicolas; Borregaard, Niels; Cowland, Jack Bernard			MicroRNA-941 Expression in Polymorphonuclear Granulocytes Is Not Related to Granulomatosis with Polyangiitis	PLOS ONE			English	Article							GENE-EXPRESSION; UP-REGULATION; IN-VIVO; NEUTROPHIL; DIFFERENTIATION; PROTEINASE-3	Jumonji Domain-Containing Protein 3 (JMJD3)/lysine demethylase 6B (KDM6B) is an epigenetic modulator that removes repressive histone marks on genes. Expression of KDM6B mRNA is elevated in leukocytes from patients with ANCA-associated vasculitis (AAV) and has been suggested to be the reason for higher proteinase 3 (PR3) mRNA expression in these cells due to derepression of PRTN3 gene transcription. MicroRNA-941 (miR-941) has been shown to target KDM6B mRNA and inhibit JMJD3 production. We therefore investigated whether polymorphonuclear granulocytes (PMNs) from patients suffering from granulomatosis with polyangiitis (GPA) have lower expression of miR-941 than healthy control donors as a biological cause for higher JMJD3 levels. We found no significant difference in the degree of maturation of PMNs from GPA patients (n = 8) and healthy controls (n = 11) as determined from cell surface expression of the neutrophil maturation marker CD16 and gene expression profile of FCGR3B. The expression of PRTN3 and KDM6B mRNAs and miR-941 was not significantly different in GPA patients and healthy controls. Transfection of pre-miR-941 into the neutrophil promyelocyte cell line PLB-985 cells did not result in reduction of the KDM6B mRNA level as shown previously in a hepatocellular carcinoma cell line. The amount of PR3 in PMNs from GPA patients and healthy controls was comparable. In conclusion, we found that PRTN3 mRNA, KDM6B mRNA, and miR-941 expression levels in PMNs do not differ between GPA patients and healthy controls, and that miR-941 does not uniformly regulate KDM6B mRNA levels by inducing degradation of the transcript. Thus, decreased miR-941 expression in PMNs cannot be part of the pathogenesis of GPA.	[Svendsen, Jesper Brink; Cramer, Elisabeth Praestekjaer; Borregaard, Niels; Cowland, Jack Bernard] Natl Univ Hosp, Dept Hematol, Granulocyte Res Lab, Copenhagen, Denmark; [Baslund, Bo] Natl Univ Hosp, Dept Rheumatol, Copenhagen, Denmark; [Rapin, Nicolas] Natl Univ Hosp, Finsen Lab, Copenhagen, Denmark		Cowland, JB (corresponding author), Natl Univ Hosp, Dept Hematol, Granulocyte Res Lab, Copenhagen, Denmark.	jack.cowland@regionh.dk		Cowland, Jack Bernard/0000-0002-7429-5388; Rapin, Nicolas/0000-0001-5208-8874	Sundhed og Sygdom, Det Frie Forskningsrad [12-126802]; Novo Nordisk Fonden [NNF14CC0001]; Kraeftens Bekaempelse (The Danish Cancer Society) [R72-A4487-13-S2]; Lundbeck Foundation [R17-2007-1726] Funding Source: researchfish	Sundhed og Sygdom, Det Frie Forskningsrad; Novo Nordisk Fonden(Novo Nordisk Foundation); Kraeftens Bekaempelse (The Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden)	This work was supported by Sundhed og Sygdom, Det Frie Forskningsrad (12-126802) http://ufm.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad (JBC); Novo Nordisk Fonden (NNF14CC0001) http://www.novonordiskfonden.dk/da (JBC); and Kraeftens Bekaempelse (The Danish Cancer Society) (R72-A4487-13-S2) https://www.cancer.dk/ (JBC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Bagger FO, 2012, BLOOD, V119, P6394, DOI 10.1182/blood-2012-05-427310; Bjerregaard MD, 2003, BLOOD, V101, P4322, DOI 10.1182/blood-2002-03-0835; Ciavatta DJ, 2010, J CLIN INVEST, V120, P3209, DOI 10.1172/JCI40034; Cowland JB, 1999, J LEUKOCYTE BIOL, V66, P989, DOI 10.1002/jlb.66.6.989; Elghetany MT, 2002, BLOOD CELL MOL DIS, V28, P260, DOI 10.1006/bcmd.2002.0513; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Klausen P, 2004, J LEUKOCYTE BIOL, V75, P569, DOI 10.1189/jlb.1003474; Larsen MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058454; Rapin N, 2014, BLOOD, V123, P894, DOI 10.1182/blood-2013-02-485771; Rarok AA, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000028642.26222.00; Sinclair D, 2007, ANN CLIN BIOCHEM, V44, P432, DOI 10.1258/000456307781646049; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Witko-Sarsat V, 1999, J AM SOC NEPHROL, V10, P1224; Zhang PP, 2014, J BIOL CHEM, V289, P24724, DOI 10.1074/jbc.M114.567818	19	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164985	10.1371/journal.pone.0164985	http://dx.doi.org/10.1371/journal.pone.0164985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755585	Green Published, gold, Green Submitted			2022-12-26	WOS:000386203800044
J	Patel, R; Dwivedi, M; Mansuri, MS; Ansarullah; Laddha, NC; Thakker, A; Ramachandran, AV; Begum, R				Patel, Roma; Dwivedi, Mitesh; Mansuri, Mohmmad Shoab; Ansarullah; Laddha, Naresh C.; Thakker, Ami; Ramachandran, A. V.; Begum, Rasheedunnisa			Association of Neuropeptide-Y (NPY) and Interleukin-1beta (IL1B), Genotype-Phenotype Correlation and Plasma Lipids with Type-II Diabetes	PLOS ONE			English	Article							PROLINE 7 POLYMORPHISM; PREPRONEUROPEPTIDE-Y; SIGNAL PEPTIDE; SERUM-LIPIDS; LEU7PRO POLYMORPHISM; GENETIC ASSOCIATION; LEUCINE-7; HAPLOTYPE; SUSCEPTIBILITY; RETINOPATHY	Background Neuropeptide Y (NPY) is known to play a role in the regulation of satiety, energy balance, body weight, and insulin release. Interleukin-1beta (IL1B) has been associated with loss of beta-cell mass in type-II diabetes (TIID). Objectives The present study attempts to investigate the association of NPY exon2 + 1128 T/C (Leu7Pro; rs16139), NPY promoter -399 T/C (rs16147) and IL1B-511 C/T (rs16944) polymorphisms with TIID and their correlation with plasma lipid levels, BMI, and IL1B transcript levels. Methods PCR-RFLP was used for genotyping these polymorphisms in a case-control study involving 558 TIID patients and 1085 healthy age-matched controls from Gujarat. Linkage disequilibrium and haplotype analysis of the NPY polymorphic sites were performed to assess their association with TIID. IL1B transcript levels in PBMCs were also assessed in 108 controls and 101 patients using real-time PCR. Results Our results show significant association of both structural and promoter polymorphisms of NPY (p<0.0001 and p<0.0001 respectively) in patients with TIID. However, the IL1B C/T polymorphism did not show any association (p = 0.3797) with TIID patients. Haplotype analysis revealed more frequent association of CC and CT haplotypes (p = 3.34 x 10(-5), p = 6.04 x 10(-9)) in diabetics compared to controls and increased the risk of diabetes by 3.02 and 2.088 respectively. Transcript levels of IL1B were significantly higher (p<0.0001) in patients as compared to controls. Genotype-phenotype correlation of IL1B polymorphism did not show any association with its higher transcript levels. In addition, NPY +1128 T/C polymorphism was found to be associated with increased plasma LDL levels (p = 0.01). Conclusion The present study provides an evidence for a strong correlation between structural and promoter polymorphisms of NPY gene and upregulation of IL1B transcript levels with susceptibility to TIID and altering the lipid metabolism in Gujarat population.	[Patel, Roma; Dwivedi, Mitesh; Mansuri, Mohmmad Shoab; Laddha, Naresh C.; Thakker, Ami; Begum, Rasheedunnisa] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Vadodara, Gujarat, India; [Ansarullah; Ramachandran, A. V.] Maharaja Sayajirao Univ Baroda, Dept Zool, Fac Sci, Vadodara, Gujarat, India	Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda	Begum, R (corresponding author), Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Vadodara, Gujarat, India.	rasheedunnisab@yahoo.co.in	Begum, Rasheedunnisa/AAF-2981-2020; Dwivedi, Mitesh/Q-1276-2019; Ansarullah, ./CAH-0894-2022	Dwivedi, Mitesh/0000-0001-8497-0765; Patel, Roma/0000-0002-6037-0498; A. V., Ramachandran/0000-0002-2326-0994; , Ansarullah/0000-0002-3415-7319				Achyut BR, 2007, CLIN CHIM ACTA, V377, P163, DOI 10.1016/j.cca.2006.09.012; BAKER E, 1995, GENOMICS, V26, P163, DOI 10.1016/0888-7543(95)80098-7; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bhaskar LVKS, 2010, J HUM HYPERTENS, V24, P617, DOI 10.1038/jhh.2009.104; Camargo JF, 2004, GENES IMMUN, V5, P609, DOI 10.1038/sj.gene.6364133; Corleto VD, 2010, DIG LIVER DIS, V42, P179, DOI 10.1016/j.did.2009.06.016; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Dwivedi M, 2011, BRIT J DIAB VAS DIS, V11, P153, DOI DOI 10.1177/1474651411412662; Eckel RH, 2011, J CLIN ENDOCR METAB, V96, P1654, DOI 10.1210/jc.2011-0585; Erkkila AT, 2002, MOL GENET METAB, V75, P260, DOI 10.1006/mgme.2002.3302; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gericke MT, 2012, MOL CELL ENDOCRINOL, V348, P27, DOI 10.1016/j.mce.2011.07.028; Grimaldi LME, 2000, ANN NEUROL, V47, P361, DOI 10.1002/1531-8249(200003)47:3<361::AID-ANA12>3.3.CO;2-E; Ilhan A, 2010, NEUROPEPTIDES, V44, P485, DOI 10.1016/j.npep.2010.08.001; Imai Y, 2014, INFLAMMATORY PATHWAY, P1; Jaakkola U, 2005, J CLIN ENDOCR METAB, V90, P3646, DOI 10.1210/jc.2005-0153; Jaakkola U, 2010, MICROVASC RES, V80, P433, DOI 10.1016/j.mvr.2010.07.010; Kallio J, 2001, FASEB J, V15, P1242, DOI 10.1096/fj.00-0436fje; Kanemoto K, 2003, EPILEPSIA, V44, P796, DOI 10.1046/j.1528-1157.2003.43302.x; Karvonen MK, 1998, NAT MED, V4, P1434, DOI 10.1038/4027; Karvonen MK, 2001, ATHEROSCLEROSIS, V159, P145, DOI 10.1016/S0021-9150(01)00468-3; Karvonen MK, 2000, J CLIN ENDOCR METAB, V85, P1455, DOI 10.1210/jc.85.4.1455; Kauffman MA, 2008, GENET MED, V10, P83, DOI 10.1097/GIM.0b013e318161317c; Koulu M, 2004, ANN MED, V36, P232, DOI 10.1080/07853890410031236; Laddha NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107020; Liu YX, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-37; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Martinez-Carrillo DN, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-126; McCulley MC, 2004, AM J MED GENET B, V124B, P50, DOI 10.1002/ajmg.b.20086; MINTH CD, 1986, J BIOL CHEM, V261, P1974; Mu Y, 2010, ENDOCRINE, V37, P71, DOI 10.1007/s12020-009-9268-x; Niskanen L, 2000, EXP CLIN ENDOCR DIAB, V108, P235, DOI 10.1055/s-2000-7748; O'Neill CM, 2013, ENDOCRINOLOGY, V154, P3077, DOI 10.1210/en.2012-2138; Pettersson-Fernholm K, 2004, DIABETES CARE, V27, P503, DOI 10.2337/diacare.27.2.503; Rosmaninho-Salgado J, 2009, J NEUROCHEM, V109, P911, DOI 10.1111/j.1471-4159.2009.06023.x; Salminen M, 2008, PUBLIC HEALTH NUTR, V11, P1156, DOI 10.1017/S1368980008001717; Schwab US, 2002, EUR J CLIN NUTR, V56, P149, DOI 10.1038/sj.ejcn.1601297; Schwanstecher M, 2011, HDB EXPT PHARM, V203; Shah SH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000318; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Skarstrand H, 2013, J DIABETES COMPLICAT, V27, P609, DOI 10.1016/j.jdiacomp.2013.06.007; Sommer WH, 2010, HUM MUTAT, V31, pE1594, DOI 10.1002/humu.21299; Vasudevan R, 2008, J MED SCI, V8, P216; Wallerstedt SM, 2004, J HYPERTENS, V22, P1277, DOI 10.1097/01.hjh.0000125415.50839.7b; Wen YY, 2014, EUR J CANCER PREV, V23, P35, DOI 10.1097/CEJ.0b013e3283656380; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; Zhou ZF, 2008, NATURE, V452, P997, DOI 10.1038/nature06858	47	19	20	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164437	10.1371/journal.pone.0164437	http://dx.doi.org/10.1371/journal.pone.0164437			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749914	Green Submitted, Green Published, gold			2022-12-26	WOS:000386202300013
J	Wittenborn, EC; Jost, M; Wei, YF; Stubbe, J; Drennan, CL				Wittenborn, Elizabeth C.; Jost, Marco; Wei, Yifeng; Stubbe, JoAnne; Drennan, Catherine L.			Structure of the Catalytic Domain of the Class I Polyhydroxybutyrate Synthase from Cupriavidus necator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARRIER HYDROGEN-BOND; CHROMATIUM-VINOSUM; CRYSTAL-STRUCTURE; RALSTONIA-EUTROPHA; CHAIN TERMINATION; PHB SYNTHASE; PROTEIN-STRUCTURE; GASTRIC LIPASE; MECHANISM; BIOSYNTHESIS	Polyhydroxybutyrate synthase (PhaC) catalyzes the polymerization of 3-(R)-hydroxybutyryl-coenzyme A as a means of carbon storage in many bacteria. The resulting polymers can be used to make biodegradable materials with properties similar to those of thermoplastics and are an environmentally friendly alternative to traditional petroleum-based plastics. A full biochemical and mechanistic understanding of this process has been hindered in part by a lack of structural information on PhaC. Here we present the first structure of the catalytic domain (residues 201-589) of the class I PhaC from Cupriavidus necator (formerly Ralstonia eutropha) to 1.80 angstrom resolution. We observe a symmetrical dimeric architecture in which the active site of each monomer is separated from the other by similar to 33 angstrom across an extensive dimer interface, suggesting a mechanism in which polyhydroxybutyrate biosynthesis occurs at a single active site. The structure additionally highlights key side chain interactions within the active site that play likely roles in facilitating catalysis, leading to the proposal of a modified mechanistic scheme involving two distinct roles for the active site histidine. We also identify putative substrate entrance and product egress routes within the enzyme, which are discussed in the context of previously reported biochemical observations. Our structure lays a foundation for further biochemical and structural characterization of PhaC, which could assist in engineering efforts for the production of eco-friendly materials.	[Wittenborn, Elizabeth C.; Jost, Marco; Wei, Yifeng; Stubbe, JoAnne; Drennan, Catherine L.] MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Stubbe, JoAnne; Drennan, Catherine L.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Jost, Marco] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Wei, Yifeng] Agcy Sci Technol & Res, Metab Engn Res Lab, Inst Sci, Singapore 138669, Singapore; [Wei, Yifeng] Agcy Sci Technol & Res, Metab Engn Res Lab, Engn Inst, Singapore 138669, Singapore	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR)	Stubbe, J (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Stubbe, J (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	stubbe@mit.edu; cdrennan@mit.edu			National Institute of General Medical Sciences through National Institutes of Health [P41 GM103403]; National Institutes of Health-Office of Research Infrastructure Programs High End Instrumentation [S10RR029205]; Office of Science [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049171, P41GM103403, T32GM008334, R01GM069857] Funding Source: NIH RePORTER	National Institute of General Medical Sciences through National Institutes of Health; National Institutes of Health-Office of Research Infrastructure Programs High End Instrumentation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to Prof. Ping Li for providing an alignment of class I PhaC sequences. We additionally thank Tsehai Grell and David Born for helpful conversations. This work is based on research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences through National Institutes of Health Grant P41 GM103403. The Pilatus 6M detector on Beamline 24-ID-C is funded by National Institutes of Health-Office of Research Infrastructure Programs High End Instrumentation Grant S10RR029205. This research used resources of the Advanced Photon Source, a Department of Energy Office of Science User Facility operated for the Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2015, PYMOL MOL GRAPHICS S; Aschauer P, 2016, BBA-MOL CELL BIOL L, V1861, P462, DOI 10.1016/j.bbalip.2016.02.005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Buckley R. M., 2013, THESIS; Buckley RM, 2015, BIOCHEMISTRY-US, V54, P2117, DOI 10.1021/bi501405b; Buller AR, 2013, P NATL ACAD SCI USA, V110, pE653, DOI 10.1073/pnas.1221050110; Cassidy CS, 1997, BIOCHEMISTRY-US, V36, P4576, DOI 10.1021/bi962013o; Chen C, 2015, ACS CHEM BIOL, V10, P1330, DOI 10.1021/cb5009958; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YJ, 2014, ENZYME MICROB TECH, V56, P60, DOI 10.1016/j.enzmictec.2014.01.005; Cho M., 2012, THESIS; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FREY PA, 1994, SCIENCE, V264, P1927, DOI 10.1126/science.7661899; GERNGROSS TU, 1994, BIOCHEMISTRY-US, V33, P9311, DOI 10.1021/bi00197a035; GERNGROSS TU, 1995, P NATL ACAD SCI USA, V92, P6279, DOI 10.1073/pnas.92.14.6279; Goettig P, 2005, J BIOL CHEM, V280, P33387, DOI 10.1074/jbc.M505030200; Gog A, 2012, RENEW ENERG, V39, P10, DOI 10.1016/j.renene.2011.08.007; GRIEBEL R, 1968, BIOCHEMISTRY-US, V7, P3676, DOI 10.1021/bi00850a047; Hofmann B, 1998, J MOL BIOL, V279, P889, DOI 10.1006/jmbi.1998.1802; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Ishida T, 2006, BIOCHEMISTRY-US, V45, P5413, DOI 10.1021/bi051515b; Jia Y, 2000, BIOCHEMISTRY-US, V39, P3927, DOI 10.1021/bi9928086; Jia Y, 2001, BIOCHEMISTRY-US, V40, P1011, DOI 10.1021/bi002219w; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keshavarz T, 2010, CURR OPIN MICROBIOL, V13, P321, DOI 10.1016/j.mib.2010.02.006; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Labar G, 2010, CHEMBIOCHEM, V11, P218, DOI 10.1002/cbic.200900621; Lawrence AG, 2005, BIOMACROMOLECULES, V6, P2113, DOI 10.1021/bm0501048; Li P, 2009, BIOCHEMISTRY-US, V48, P9202, DOI 10.1021/bi901329b; LIEBERGESELL M, 1994, EUR J BIOCHEM, V226, P71, DOI 10.1111/j.1432-1033.1994.tb20027.x; LIEBERGESELL M, 1992, EUR J BIOCHEM, V209, P135, DOI 10.1111/j.1432-1033.1992.tb17270.x; Lin J, 1998, BIOCHEMISTRY-US, V37, P11940, DOI 10.1021/bi980278s; Madden LA, 1999, INT J BIOL MACROMOL, V25, P43, DOI 10.1016/S0141-8130(99)00014-8; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Moynihan PJ, 2014, BIOCHEMISTRY-US, V53, P6243, DOI 10.1021/bi501002d; Muh U, 1999, BIOCHEMISTRY-US, V38, P826, DOI 10.1021/bi9818319; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254; Rehm BHA, 2002, BBA-PROTEIN STRUCT M, V1594, P178, DOI 10.1016/S0167-4838(01)00299-0; Roussel A, 2002, J BIOL CHEM, V277, P2266, DOI 10.1074/jbc.M109484200; Roussel A, 1999, J BIOL CHEM, V274, P16995, DOI 10.1074/jbc.274.24.16995; Sayer C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25542; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O; Steinbuchel A, 2001, MACROMOL BIOSCI, V1, P1; STORER AC, 1994, METHOD ENZYMOL, V244, P486; Stubbe J, 2005, ANNU REV BIOCHEM, V74, P433, DOI 10.1146/annurev.biochem.74.082803.133013; Stubbe J, 2003, NAT PROD REP, V20, P445, DOI 10.1039/b209687k; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Tian J, 2005, BIOCHEMISTRY-US, V44, P1495, DOI 10.1021/bi047734z; Tian JM, 2005, BIOCHEMISTRY-US, V44, P8369, DOI 10.1021/bi050331u; Tian JM, 2005, J BACTERIOL, V187, P3825, DOI 10.1128/JB.187.11.3825-3832.2005; Ushimaru K, 2013, APPL MICROBIOL BIOT, V97, P1175, DOI 10.1007/s00253-012-4089-x; Wodzinska J, 1996, J AM CHEM SOC, V118, P6319, DOI 10.1021/ja961108a; Yahya ARM, 1998, ENZYME MICROB TECH, V23, P438, DOI 10.1016/S0141-0229(98)00065-9; Yuan W, 2001, ARCH BIOCHEM BIOPHYS, V394, P87, DOI 10.1006/abbi.2001.2522; Zhang SM, 2000, BIOMACROMOLECULES, V1, P244, DOI 10.1021/bm005513c; Zhao YH, 2003, J ORG CHEM, V68, P7368, DOI 10.1021/jo034808o	65	53	55	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25264	25277		10.1074/jbc.M116.756833	http://dx.doi.org/10.1074/jbc.M116.756833			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27742839	Green Published, hybrid			2022-12-26	WOS:000388880100040
J	Xie, N; Gong, H; Suhl, JA; Chopra, P; Wang, T; Warren, ST				Xie, Nina; Gong, He; Suhl, Joshua A.; Chopra, Pankaj; Wang, Tao; Warren, Stephen T.			Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome	PLOS ONE			English	Article							HISTONE MODIFICATIONS; TRINUCLEOTIDE REPEAT; GENE; CRISPR-CAS9; MECHANISM; SYSTEMS; REGION; CELLS	Fragile X syndrome (FXS) is a common cause of intellectual disability that is most often due to a CGG-repeat expansion mutation in the FMR1 gene that triggers epigenetic gene silencing. Epigenetic modifying drugs can only transiently and modestly induce FMR1 reactivation in the presence of the elongated CGG repeat. As a proof-of-principle, we excised the expanded CGG-repeat in both somatic cell hybrids containing the human fragile X chromosome and human FXS iPS cells using the CRISPR/Cas9 genome editing. We observed transcriptional reactivation in approximately 67% of the CRISPR cut hybrid colonies and in 20% of isolated human FXS iPSC colonies. The reactivated cells produced FMRP and exhibited a decline in DNA methylation at the FMR1 locus. These data demonstrate the excision of the expanded CGG-repeat from the fragile X chromosome can result in FMR1 reactivation.	[Xie, Nina; Gong, He; Suhl, Joshua A.; Chopra, Pankaj; Wang, Tao; Warren, Stephen T.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Xie, Nina] Cent S Univ, Xiangya Hosp, Dept Geriatr, Changsha, Hunan, Peoples R China; [Suhl, Joshua A.] Booz Allen Hamilton, Westborough, MA USA; [Wang, Tao] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Wang, Tao] Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA USA	Emory University; Emory University; Emory University; Central South University; Booz Allen Hamilton Holding Corporation; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Warren, ST (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.; Warren, ST (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.; Warren, ST (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.	swarren@emory.edu		Warren, Stephen/0000-0001-7748-4750	NIH award from the National Institute of Neurological Disorders and Stroke [NS091859]; Eunice Kennedy Shriver National Institute of Child Health & Human Development in support of the Emory National Fragile X Research Center; Emory Integrated Genomics Core (EIGC); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS091859] Funding Source: NIH RePORTER	NIH award from the National Institute of Neurological Disorders and Stroke; Eunice Kennedy Shriver National Institute of Child Health & Human Development in support of the Emory National Fragile X Research Center; Emory Integrated Genomics Core (EIGC); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH award NS091859 from the National Institute of Neurological Disorders and Stroke, the Eunice Kennedy Shriver National Institute of Child Health & Human Development in support of the Emory National Fragile X Research Center to STW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Nisha Raj for the advice of iPSC culture maintenance. We thank Ann F. Dodd for her support of the Southern blot experiments. We thank Oskar Laur for generating CRISPR plasmid constructs and Robert B. Isett for methylation profiling array, whose work was supported by the Emory Integrated Genomics Core (EIGC). This work was supported by: NIH award NS091859 from the National Institute of Neurological Disorders and Stroke, the Eunice Kennedy Shriver National Institute of Child Health & Human Development in support of the Emory National Fragile X Research Center to STW.	Alisch RS, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-18; Biacsi R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000017; Bulut-Karslioglu A, 2012, NAT STRUCT MOL BIOL, V19, P1023, DOI 10.1038/nsmb.2382; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Chiurazzi P, 1998, HUM MOL GENET, V7, P109, DOI 10.1093/hmg/7.1.109; Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Colak D, 2014, SCIENCE, V343, P1002, DOI 10.1126/science.1245831; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004630; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004318; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kumari D, 2010, HUM MOL GENET, V19, P4634, DOI 10.1093/hmg/ddq394; Ladd PD, 2007, HUM MOL GENET, V16, P3174, DOI 10.1093/hmg/ddm293; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pastori C, 2014, HUM GENET, V133, P59, DOI 10.1007/s00439-013-1356-6; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; SMITH SS, 1994, J MOL BIOL, V243, P143, DOI 10.1006/jmbi.1994.1640; Usdin K, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00226; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WARREN ST, 1987, SCIENCE, V237, P420, DOI 10.1126/science.3603029	27	46	48	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165499	10.1371/journal.pone.0165499	http://dx.doi.org/10.1371/journal.pone.0165499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768763	Green Submitted, Green Published, gold			2022-12-26	WOS:000386205400085
J	Aminnejad, M; Cogliati, M; Duan, SY; Arabatzis, M; Tintelnot, K; Castaneda, E; Lazera, M; Velegraki, A; Ellis, D; Sorrell, TC; Meyer, W				Aminnejad, Mojgan; Cogliati, Massimo; Duan, Shuyao; Arabatzis, Michael; Tintelnot, Kathrin; Castaneda, Elizabeth; Lazera, Marcia; Velegraki, Aristea; Ellis, David; Sorrell, Tania C.; Meyer, Wieland			Identification and Characterization of VNI/VNII and Novel VNII/VNIV Hybrids and Impact of Hybridization on Virulence and Antifungal Susceptibility Within the C-neoformans/C-gattii Species Complex	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; A MATA STRAIN; CRYPTOCOCCUS-NEOFORMANS; MATING-TYPE; SEROTYPE-A; VAR. GRUBII; GALLERIA-MELLONELLA; VANCOUVER-ISLAND; MOLECULAR EPIDEMIOLOGY; PHOSPHOLIPASE-ACTIVITY	Cryptococcus neoformans and C. gattii are pathogenic basidiomycetous yeasts and the commonest cause of fungal infection of the central nervous system. Cryptococci are typically haploid but several inter-species, inter-varietal and intra-varietal hybrids have been reported. It has a bipolar mating system with sexual reproduction occurring normally between two individuals with opposite mating types, a and a. This study set out to characterize hybrid isolates within the C. neoformans/C. gattii species complex: seven unisexual mating intra-varietal VNI/VNII (alpha AA alpha) and six novel inter-varietal VNII/VNIV (aAD alpha). The URA5-RFLP pattern for VNII/VNIV (aAD alpha) differs from the VNIII (alpha ADa) hybrids. Analysis of the allelic patterns of selected genes for AD hybrids showed 79% or more heterozygosis for the studied loci except for CBS132 (VNIII), which showed 50% of heterozygosity. MALDI-TOF MS was applied to hybrids belonging to different sero/mating type allelic patterns. All hybrid isolates were identified as belonging to the same hybrid group with identification scores ranging between 2.101 to 2.634. All hybrids were virulent when tested in the Galleria mellonella (wax moth) model, except for VNII/VNIV (aAD alpha) hybrids. VNI/VGII hybrids were the most virulent hybrids. Hybrids recovered from larvae manifested a significant increase in capsule and total cell size and produced a low proportion (5-10%) of giant cells compared with the haploid control strains. All strains expressed the major virulence factors-capsule, melanin and phospholipase B-and grew well at 37 degrees C. The minimal inhibitory concentration of nine drugs was measured by micro-broth dilution and compared with published data on haploid strains. MICs were similar amongst hybrids and haploid parental strains. This is the first study reporting natural same sex alpha AA alpha intra-varietal VNI/VNII hybrids and aAD alpha inter-varietal VNII/VNIV hybrids.	[Aminnejad, Mojgan; Duan, Shuyao; Sorrell, Tania C.; Meyer, Wieland] Univ Sydney, Westmead Inst Med Res, Mol Mycol Res Lab,Ctr Infect Dis & Microbiol, Sydney Med Sch,Westmead Hosp,Marie Bashir Inst In, Sydney, NSW, Australia; [Cogliati, Massimo] Univ Milan, Lab Micol Med, Dip Sci Biomed Salute, Milan, Italy; [Arabatzis, Michael; Velegraki, Aristea] Natl Kapodistrian Univ Athens, Sch Med, Dept Microbiol, Mycol Res Lab, Athens, Greece; [Tintelnot, Kathrin] Robert Koch Inst, Mycol Grp, Berlin, Germany; [Castaneda, Elizabeth] Inst Nacl Salud, Grp Microbiol, Bogota, Colombia; [Lazera, Marcia] Fundacao Oswaldo Cruz, Natl Inst Infect Dis, Mycol Lab, Rio De Janeiro, Brazil; [Ellis, David] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	University of Sydney; Westmead Institute for Medical Research; University of Milan; Athens Medical School; National & Kapodistrian University of Athens; Robert Koch Institute; Instituto Nacional de Salud (Colombia); Fundacao Oswaldo Cruz; University of Adelaide	Meyer, W (corresponding author), Univ Sydney, Westmead Inst Med Res, Mol Mycol Res Lab,Ctr Infect Dis & Microbiol, Sydney Med Sch,Westmead Hosp,Marie Bashir Inst In, Sydney, NSW, Australia.		Cogliati, Massimo/ABE-3586-2021; Velegraki, Aristea/AAG-6798-2019; Sorrell, Tania/AAZ-5286-2020	Cogliati, Massimo/0000-0002-6842-4817; Sorrell, Tania/0000-0001-9460-0960; Castaneda, Elizabeth/0000-0001-5970-1598	University of Sydney; CIDM Public Health scholarship; NH&MRC grant (Australia) [APP1031943]; Bodosakis Foundation; National Kapodistrian University of Athens [SARG70/3/6915]	University of Sydney(University of Sydney); CIDM Public Health scholarship; NH&MRC grant (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Bodosakis Foundation; National Kapodistrian University of Athens	M. Aminnejad was supported by a University of Sydney postgraduate award and a CIDM Public Health scholarship. This work was supported by an NH&MRC grant (Australia) #APP1031943 to WM, TS, and EC, and a grant from the Bodosakis Foundation and Research fund SARG70/3/6915 National Kapodistrian University of Athens to AV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminnejad M, 2012, MYCOPATHOLOGIA, V173, P337, DOI 10.1007/s11046-011-9491-x; Barchiesi F, 2005, J INFECTION, V51, P10, DOI 10.1016/j.jinf.2004.07.013; Bergin D, 2005, INFECT IMMUN, V73, P4161, DOI 10.1128/IAI.73.7.4161-4170.2005; Boekhout T, 2001, MICROBIOL-UK, V147, P891, DOI 10.1099/00221287-147-4-891; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; Bovers M, 2008, EMERG INFECT DIS, V14, P1105, DOI 10.3201/eid1407.080122; Bovers M, 2006, FEMS YEAST RES, V6, P599, DOI 10.1111/j.1567-1364.2006.00082.x; Brandt ME, 1996, J CLIN MICROBIOL, V34, P912, DOI 10.1128/JCM.34.4.912-917.1996; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Bui T, 2008, EUKARYOT CELL, V7, P1771, DOI 10.1128/EC.00097-08; CHASKES S, 1975, J CLIN MICROBIOL, V1, P509, DOI 10.1128/JCM.1.6.509-514.1975; Chaturvedi S, 2000, J CLIN MICROBIOL, V38, P2007, DOI 10.1128/JCM.38.5.2007-2009.2000; Chaturvedi V, 2002, INFECT IMMUN, V70, P5225, DOI 10.1128/IAI.70.9.5225-5235.2002; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Chen SCA, 1996, J INFECT DIS, V173, P754, DOI 10.1093/infdis/173.3.754; Chen SCA, 1997, J INFECT DIS, V175, P414, DOI 10.1093/infdis/175.2.414; Chong HS, 2010, J CLIN MICROBIOL, V48, P4115, DOI 10.1128/JCM.01271-10; CLSI, 1908, M27A3 CLSI; Cogliati M, 2012, MYCOPATHOLOGIA, V173, P347, DOI 10.1007/s11046-011-9467-x; Cogliati M, 2001, J CLIN MICROBIOL, V39, P3889, DOI 10.1128/JCM.39.11.3889-3894.2001; Cogliati M, 2006, FEMS YEAST RES, V6, P608, DOI 10.1111/j.1567-1364.2006.00085.x; Cogliati M, 2013, MED MYCOL, V51, P499, DOI 10.3109/13693786.2012.751642; Cotter G, 2000, FEMS IMMUNOL MED MIC, V27, P163, DOI 10.1111/j.1574-695X.2000.tb01427.x; CURRIE BP, 1994, CLIN INFECT DIS, V19, P1029, DOI 10.1093/clinids/19.6.1029; Diaz MR, 2005, J CLIN MICROBIOL, V43, P3662, DOI 10.1128/JCM.43.8.3662-3672.2005; Diaz MR, 2008, CURRENT PROTOCOLS CY, V44; DIEN BS, 1994, METHOD CELL BIOL, V42, P457; Eisentraut, 2009, SOP SAMPL PREP US FO, P1; Enache-Angoulvant A, 2007, J CLIN MICROBIOL, V45, P1261, DOI 10.1128/JCM.01839-06; Espinel-Ingroff A, 2012, ANTIMICROB AGENTS CH; Esposto MC, 2004, CLIN MICROBIOL INFEC, V10, P1092, DOI 10.1111/j.1469-0691.2004.00972.x; Feldmesser M, 2001, MICROBIOL-SGM, V147, P2355, DOI 10.1099/00221287-147-8-2355; Ferrer C, 2001, J CLIN MICROBIOL, V39, P2873, DOI 10.1128/JCM.39.8.2873-2879.2001; Firacative C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037566; Franzot SP, 1998, INFECT IMMUN, V66, P89, DOI 10.1128/IAI.66.1.89-97.1998; Franzot SP, 1999, J CLIN MICROBIOL, V37, P838, DOI 10.1128/JCM.37.3.838-840.1999; Franzot SP, 1997, J CLIN MICROBIOL, V35, P2243, DOI 10.1128/JCM.35.9.2243-2251.1997; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Garcia-Rodas R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024485; GRANGER DL, 1985, J CLIN INVEST, V76, P508, DOI 10.1172/JCI112000; Hagen F, 2010, ANTIMICROB AGENTS CH, V54, P5139, DOI 10.1128/AAC.00746-10; Hiremath SS, 2008, MICROBIOL-SGM, V154, P1513, DOI 10.1099/mic.0.2007/015594-0; Iqbal N, 2010, J CLIN MICROBIOL, V48, P539, DOI 10.1128/JCM.01505-09; Keller SM, 2003, MICROBIOL-SGM, V149, P131, DOI 10.1099/mic.0.25921-0; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kwon-Chung Kyung J., 2002, Taxon, V51, P804, DOI 10.2307/1555045; KWONCHUNG KJ, 1978, AM J EPIDEMIOL, V108, P337, DOI 10.1093/oxfordjournals.aje.a112628; KWONCHUNG KJ, 1984, AM J EPIDEMIOL, V120, P123, DOI 10.1093/oxfordjournals.aje.a113861; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Leger RJS, 2000, APPL ENVIRON MICROB, V66, P320, DOI 10.1128/AEM.66.1.320-324.2000; Lemmer K, 2004, MED MYCOL, V42, P135, DOI 10.1080/13693780310001624565; Lengeler KB, 2000, P NATL ACAD SCI USA, V97, P14455, DOI 10.1073/pnas.97.26.14455; Lengeler KB, 2001, INFECT IMMUN, V69, P115, DOI 10.1128/IAI.69.1.115-122.2001; Lin XR, 2008, INFECT IMMUN, V76, P2923, DOI 10.1128/IAI.00168-08; Lin X, 2007, PLOS GENET, V3, P1975, DOI 10.1371/journal.pgen.0030186; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Lin XR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000283; Litvintseva AP, 2007, PLOS PATHOG, V3, P1109, DOI 10.1371/journal.ppat.0030114; Litvintseva AP, 2006, GENETICS, V172, P2223, DOI 10.1534/genetics.105.046672; Litvintseva AP, 2005, J CLIN MICROBIOL, V43, P556, DOI 10.1128/JCM.43.2.556-564.2005; McTaggart LR, 2011, J CLIN MICROBIOL, V49, P3050, DOI 10.1128/JCM.00651-11; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Missall TA, 2005, EUKARYOT CELL, V4, P202, DOI 10.1128/EC.4.1.202-208.2005; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Ngamskulrungroj P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005862; Nishikawa MM, 2003, J CLIN MICROBIOL, V41, P73, DOI 10.1128/JCM.41.1.73-77.2003; Okagaki LH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000953; PERFECT JR, 1993, J CLIN MICROBIOL, V31, P3305, DOI 10.1128/JCM.31.12.3305-3309.1993; Posteraro B, 2012, J CLIN MICROBIOL, V50, P2472, DOI 10.1128/JCM.00737-12; PRICE MF, 1982, SABOURAUDIA, V20, P7; Pukkila-Worley R, 2008, EXPERT OPIN PHARMACO, V9, P551, DOI 10.1517/14656566.9.4.551; Reeves EP, 2004, MYCOPATHOLOGIA, V158, P73, DOI 10.1023/B:MYCO.0000038434.55764.16; Sanfelice F., 1894, ANN IG, V4, P463; Saul N, 2008, EUKARYOT CELL, V7, P727, DOI 10.1128/EC.00020-08; Shahid M, 2008, GENOME, V51, P272, DOI 10.1139/G08-004; Thompson GR, 2009, ANTIMICROB AGENTS CH, V53, P309, DOI 10.1128/AAC.01216-08; Trilles L, 2004, J CLIN MICROBIOL, V42, P4815, DOI 10.1128/JCM.42.10.4815-4817.2004; Trilles L, 2012, MED MYCOL, V50, P328, DOI 10.3109/13693786.2011.602126; Viviani MA, 1997, J MED VET MYCOL, V35, P355; Viviani MA, 2001, MED MYCOL, V39, P383, DOI 10.1080/mmy.39.5.383.386; Viviani MA, 2006, FEMS YEAST RES, V6, P614, DOI 10.1111/j.1567-1364.2006.00081.x; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; Xu JP, 2002, MICROBIOL-SGM, V148, P203, DOI 10.1099/00221287-148-1-203; Yan Z, 2002, J CLIN MICROBIOL, V40, P965, DOI 10.1128/JCM.40.3.965-972.2002; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003; Zaragoza O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000945	89	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0163955	10.1371/journal.pone.0163955	http://dx.doi.org/10.1371/journal.pone.0163955			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764108	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500012
J	Crivellenti, LZ; Silva, GEB; Borin-Crivellenti, S; Cianciolo, R; Adin, CA; Dantas, M; dos Anjos, DS; Tinucci-Costa, M; Santana, AE				Crivellenti, Leandro Z.; Silva, Gyl E. B.; Borin-Crivellenti, Sofia; Cianciolo, Rachel; Adin, Christopher A.; Dantas, Marcio; dos Anjos, Denner S.; Tinucci-Costa, Mirela; Santana, Aureo E.			Prevalence of Glomerulopathies in Canine Mammary Carcinoma	PLOS ONE			English	Article							GLOMERULAR-DISEASES; NEPHROTIC SYNDROME; PARANEOPLASTIC GLOMERULOPATHY; CANCER; DOGS; IMMUNOFLUORESCENCE; ASSOCIATION; CLASSIFICATION; TUMORS	The incidence and prevalence of paraneoplastic glomerulopathy, especially associated with carcinoma, are a matter of debate and the causal link between cancer and glomerular diseases remains unclear. The aim of this study was to evaluate renal biopsies of selected bitches with spontaneous mammary gland carcinoma. We hypothesized that dogs with mammary carcinomas would show histologic evidence of glomerular pathology. A prospective study was performed in dogs with naturally occurring mammary carcinoma that were undergoing tumor resection and ovariohysterectomy. We evaluated renal biopsies of 32 bitches with spontaneous mammary gland carcinoma and 11 control dogs without mammary gland neoplasia. Samples were obtained from the left kidney and the biopsy material was divided for light microscopy (LM), immunofluorescence (IF) and transmission electron microscopy (TEM). Light microscopy abnormalities were identified in 78.1% of dogs with mammary carcinoma (n = 25) and in none of the dogs in the control group. Focal glomerular mesangial matrix expansion was the most common alteration (n = 15, 60.0%), but mesangial cell proliferation (n = 9, 36.0%) and focal segmental glomerulosclerosis (n = 9, 36.0%), synechiae (n = 7, 28.0%), and globally sclerotic glomeruli (n = 6, 24.0%) were also frequent in dogs with malignancy. Immunofluorescence microscopy revealed strong IgM staining was demonstrated in 64.3% (n = 18) of carcinoma dogs. Transmission electron microscopy from dogs with carcinoma revealed slight changes, the most frequent of which was faint sub-endothelial and mesangial deposits of electron-dense material (78%). Mesangial cell interpositioning and segmental effacement of podocyte foot processes were identified in some specimens (45%). Changes in the glomerulus and proteinuria are common in dogs with naturally occurring mammary carcinoma and this condition appears to provide an excellent large animal model for cancer-associated glomerulopathy in humans.	[Crivellenti, Leandro Z.; dos Anjos, Denner S.] Franca Univ UNIFRAN, Dept Vet Clin & Surg, Franca, Brazil; [Crivellenti, Leandro Z.; Borin-Crivellenti, Sofia; Tinucci-Costa, Mirela; Santana, Aureo E.] Sao Paulo State Univ UNESP, Dept Vet Clin & Surg, Jaboticabal, Brazil; [Crivellenti, Leandro Z.; Silva, Gyl E. B.] Univ Estado Sao Paulo USP, Fac Med Ribeirao Preto, Dept Renal Pathol, Sao Paulo, Brazil; [Cianciolo, Rachel] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA; [Adin, Christopher A.] NC State Univ, Dept Clin Sci, Coll Vet Med, Raleigh, NC USA; [Dantas, Marcio] Univ Estado Sao Paulo USP, Fac Med Ribeirao Preto, Dept Internal Med, Div Nephrol, Sao Paulo, Brazil	Universidad de Franca; Universidade Estadual Paulista; University System of Ohio; Ohio State University; University of North Carolina; North Carolina State University	Crivellenti, LZ (corresponding author), Franca Univ UNIFRAN, Dept Vet Clin & Surg, Franca, Brazil.; Crivellenti, LZ (corresponding author), Sao Paulo State Univ UNESP, Dept Vet Clin & Surg, Jaboticabal, Brazil.; Crivellenti, LZ (corresponding author), Univ Estado Sao Paulo USP, Fac Med Ribeirao Preto, Dept Renal Pathol, Sao Paulo, Brazil.	crivelenti_lz@yahoo.com.br	dos Anjos, Denner Santos/Y-6730-2019; Silva, Gyl/ABE-3852-2021; Dantas, Marcio/B-9838-2013; Crivellenti, Leandro Zuccolotto/O-6619-2019; dos Anjos, Denner Santos/F-3412-2018	dos Anjos, Denner Santos/0000-0003-1804-475X; Dantas, Marcio/0000-0001-8515-6423; dos Anjos, Denner Santos/0000-0003-1804-475X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/08416-6, 2011/11355-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors would like to thank Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP process #2011/08416-6 and #2011/11355-9) for financial support. http://www.fapesp.br/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aresu L, 2008, VET REC, V163, P679; Bacchetta J, 2009, CRIT REV ONCOL HEMAT, V70, P39, DOI 10.1016/j.critrevonc.2008.08.003; Betjes MGH, 2009, AM J KIDNEY DIS, V53, P1059, DOI 10.1053/j.ajkd.2008.10.038; Brown C, 2011, NEPHROLOGY AND UROLOGY OF SMALL ANIMALS, P215; Cagnoli Leonardo, 2010, G Ital Nefrol, V27 Suppl 50, pS51; Cambier JF, 2012, CLIN J AM SOC NEPHRO, V7, P1701, DOI 10.2215/CJN.03770412; Campos LC, 2012, J VET INTERN MED, V26, P1383, DOI 10.1111/j.1939-1676.2012.01014.x; Cianciolo RE, 2016, VET PATHOL, V53, P113, DOI 10.1177/0300985815579996; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; Haas M, 2011, KIDNEY INT, V80, P701, DOI 10.1038/ki.2011.176; Heiene R, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-13; Jhaveri KD, 2013, KIDNEY INT, V84, P34, DOI [10.1038/ki.2012.484, 10.1038/ki.2013.50]; Lacombe J, 2013, INT J CANCER, V132, P1105, DOI 10.1002/ijc.27766; LEE JC, 1966, ANN INTERN MED, V64, P41, DOI 10.7326/0003-4819-64-1-41; Lefaucheur C, 2006, KIDNEY INT, V70, P1510, DOI 10.1038/sj.ki.5001790; Nangaku Masaomi, 2005, Clin Exp Nephrol, V9, P183, DOI 10.1007/s10157-005-0357-8; PASCAL RR, 1976, CANCER RES, V36, P43; Regierer AC, 2011, BREAST CARE, V6, P441, DOI 10.1159/000335201; Ronco PM, 1999, KIDNEY INT, V56, P355, DOI 10.1046/j.1523-1755.1999.00548.x; Sherman JL, 2010, J SURG ONCOL, V102, P704, DOI 10.1002/jso.21689; Silva GEB, 2013, CLIN NEPHROL, V79, P488, DOI 10.5414/CN107079; Spreitzer MV, 2014, PEDIATR NEPHROL, V29, P67, DOI 10.1007/s00467-013-2551-3; Swartz SJ, 2009, PEDIATR NEPHROL, V24, P1187, DOI 10.1007/s00467-009-1130-0; Takeda S, 2012, NEPHROL DIAL TRANSPL, V27, P1786, DOI 10.1093/ndt/gfr565; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Vaden SL, 2004, VET CLIN N AM-SMALL, V34, P887, DOI 10.1016/j.cvsm.2004.03.010; Yuste Claudia, 2015, World J Nephrol, V4, P185, DOI 10.5527/wjn.v4.i2.185; Zini E, 2004, AM J VET RES, V65, P964, DOI 10.2460/ajvr.2004.65.964	28	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164479	10.1371/journal.pone.0164479	http://dx.doi.org/10.1371/journal.pone.0164479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764139	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500037
J	Jiang, W; Dulaimi, E; Devarajan, K; Parsons, T; Wang, Q; Liao, L; Cho, EA; O'Neill, R; Solomides, C; Peiper, SC; Testa, JR; Uzzo, R; Yang, H				Jiang, Wei; Dulaimi, Essel; Devarajan, Karthik; Parsons, Theodore; Wang, Qiong; Liao, Lili; Cho, Eun-Ah; O'Neill, Raymond; Solomides, Charalambos; Peiper, Stephen C.; Testa, Joseph R.; Uzzo, Robert; Yang, Haifeng			Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							CANCER; EVOLUTIONARY; EXPRESSION; GROWTH; OVARY; BAP1	Recent studies have shown that intratumoral heterogeneity (ITH) is prevalent in clear cell renal cell carcinoma (ccRCC), based on DNA sequencing and chromosome aberration analysis of multiple regions from the same tumor. VHL mutations were found to be universal throughout individual tumors when it occurred (ubiquitous), while the mutations in other tumor suppressor genes tended to be detected only in parts of the tumors (subclonal). ITH has been studied mostly by DNA sequencing in limited numbers of samples, either by whole genome sequencing or by targeted sequencing. It is not known whether immunohistochemistry (IHC) can be used as a tool to study ITH. To address this question, we examined the protein expression of PBRM1, and PBRM1-related proteins such as ARID1A, SETD2, BRG1, and BRM. Altogether, 160 ccRCC (40 per stage) were used to generate a tissue microarray (TMA), with four foci from each tumor included. Loss of expression was defined as 0-5% of tumor cells with positive nuclear staining in an individual focus. We found that 49/160 (31%), 81/160 (51%), 23/160 (14%), 24/160 (15%), and 61/160 (38%) of ccRCC showed loss of expression of PBRM1, ARID1A, SETD2, BRG1, and BRM, respectively, and that IHC could successfully detect a high prevalence of ITH. Phylogenetic trees were constructed that reflected the ITH. Striking co-losses among proteins were also observed. For instance, ARID1A loss almost always accompanied PBRM1 loss, whereas BRM loss accompanied loss of BRG1, PBRM1 or ARID1A. SETD2 loss frequently occurred with loss of one or more of the other four proteins. Finally, in order to learn the impact of combined losses, we compared the tumor growth after cells acquired losses of ARID1A, PBRM1, or both in a xenograft model. The results suggest that ARID1A loss has a greater tumor-promoting effect than PBRM1 loss, indicating that xenograft analysis is a useful tool to investigate how these losses impact on tumor behavior, either alone or in combination.	[Jiang, Wei; Parsons, Theodore; Wang, Qiong; Liao, Lili; Cho, Eun-Ah; O'Neill, Raymond; Solomides, Charalambos; Peiper, Stephen C.; Yang, Haifeng] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Dulaimi, Essel] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Devarajan, Karthik] Fox Chase Canc Ctr, Biostat & Bioinformat Facil, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Testa, Joseph R.; Uzzo, Robert] Fox Chase Canc Ctr, Canc Biol Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Uzzo, Robert] Fox Chase Canc Ctr, Dept Surg Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA	Jefferson University; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center	Yang, H (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	haifeng.yang@jefferson.edu	Uzzo, Robert G./U-5238-2019		National Cancer Institute (US) [5R01CA155015, 5P30CA056036-14, 5R01CA175691', P30 CA06927]; NATIONAL CANCER INSTITUTE [P30CA006927, P30CA056036, R01CA155015] Funding Source: NIH RePORTER	National Cancer Institute (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Haifeng Yang is supported by 5R01CA155015 and 5P30CA056036-14; Joseph A. Testa is supported by 5R01CA175691; Karthik Devarajan is supported by P30 CA06927, all from National Cancer Institute (US). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Demetri GD, 2002, HEMATOL ONCOL CLIN N, V16, P1115, DOI 10.1016/S0889-8588(02)00052-7; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Joseph RW, 2016, J UROLOGY, V195, P180, DOI 10.1016/j.juro.2015.07.113; Joseph RW, 2014, CANCER-AM CANCER SOC, V120, P1059, DOI 10.1002/cncr.28521; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kahali B, 2014, ONCOTARGET, V5, P3316, DOI 10.18632/oncotarget.1945; Karnezis AN, 2016, J PATHOL, V238, P389, DOI 10.1002/path.4633; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Linehan WM, 2004, CLIN CANCER RES, V10, p6282S, DOI 10.1158/1078-0432.CCR-050013; Mauro MJ, 2001, ONCOLOGIST, V6, P233, DOI 10.1634/theoncologist.6-3-233; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Negrotto S, 2011, CANCER RES, V71, P1431, DOI 10.1158/0008-5472.CAN-10-2422; Niu X, 2012, ONCOGENE, V31, P776, DOI 10.1038/onc.2011.266; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Ramos P, 2014, NAT GENET, V46, P427, DOI 10.1038/ng.2928; Sankin A, 2014, CANCER MED-US, V3, P1485, DOI 10.1002/cam4.293; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Smalley KSM, 2010, CURR OPIN INVEST DR, V11, P699; Song SJ, 2014, MOL CANCER RES, V12, P560, DOI 10.1158/1541-7786.MCR-13-0427; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Thirlwell C, 2010, GASTROENTEROLOGY, V138, P1441, DOI 10.1053/j.gastro.2010.01.033; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639	35	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164554	10.1371/journal.pone.0164554	http://dx.doi.org/10.1371/journal.pone.0164554			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764136	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500043
J	Kim, JJ; Goldsberry, ME; Harmon, TC; Freeman, JH				Kim, Jangjin; Goldsberry, Mary E.; Harmon, Thomas C.; Freeman, John H.			Developmental Changes in Hippocampal CA1 Single Neuron Firing and Theta Activity during Associative Learning	PLOS ONE			English	Article							NICTITATING-MEMBRANE RESPONSE; RAT; ONTOGENY; SYSTEM; SEPTUM; DELAY; CONSOLIDATION; PLASTICITY; RABBITS; REGION	Hippocampal development is thought to play a crucial role in the emergence of many forms of learning and memory, but ontogenetic changes in hippocampal activity during learning have not been examined thoroughly. We examined the ontogeny of hippocampal function by recording theta and single neuron activity from the dorsal hippocampal CA1 area while rat pups were trained in associative learning. Three different age groups [postnatal days (P)17-19, P21-23, and P24-26] were trained over six sessions using a tone conditioned stimulus (CS) and a periorbital stimulation unconditioned stimulus (US). Learning increased as a function of age, with the P21-23 and P24-26 groups learning faster than the P17-19 group. Age- and learning-related changes in both theta and single neuron activity were observed. CA1 pyramidal cells in the older age groups showed greater task-related activity than the P17-19 group during CS-US paired sessions. The proportion of trials with a significant theta (4-10 Hz) power change, the theta/delta ratio, and theta peak frequency also increased in an age-dependent manner. Finally, spike/theta phase-locking during the CS showed an age-related increase. The findings indicate substantial developmental changes in dorsal hippocampal function that may play a role in the ontogeny of learning and memory.	[Kim, Jangjin; Goldsberry, Mary E.; Harmon, Thomas C.; Freeman, John H.] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA 52242 USA	University of Iowa	Kim, JJ; Freeman, JH (corresponding author), Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA 52242 USA.	kim.jangjin@gmail.com; john-freeman@uiowa.edu			National Institute of Neurological Disorders and Stroke [NS038890]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this work was provided by the National Institute of Neurological Disorders and Stroke (Grant NS038890 to JHF).	Hangya B, 2009, J NEUROSCI, V29, P8094, DOI 10.1523/JNEUROSCI.5665-08.2009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berens P., 2009, J STAT SOFTWARE, V31; BERGER TW, 1976, SCIENCE, V192, P483, DOI 10.1126/science.1257783; BERGER TW, 1980, BRAIN RES, V193, P229, DOI 10.1016/0006-8993(80)90960-9; BERGER TW, 1983, J NEUROPHYSIOL, V50, P1197, DOI 10.1152/jn.1983.50.5.1197; BERGER TW, 1978, BRAIN RES, V156, P293, DOI 10.1016/0006-8993(78)90510-3; BERRY SD, 1979, SCIENCE, V205, P209, DOI 10.1126/science.451592; BERRY SD, 1978, SCIENCE, V200, P1298, DOI 10.1126/science.663612; BRAGIN A, 1995, J NEUROPHYSIOL, V73, P1691, DOI 10.1152/jn.1995.73.4.1691; Brown KL, 2014, LEARN MEMORY, V21, P696, DOI 10.1101/lm.036103.114; Burke SN, 2011, HIPPOCAMPUS, V21, P783, DOI 10.1002/hipo.20929; FREEMAN JH, 1991, BEHAV NEUROSCI, V105, P386, DOI 10.1037/0735-7044.105.3.386; Freeman JH, 2011, LEARN MEMORY, V18, P666, DOI 10.1101/lm.2023011; Goldsberry ME, 2015, J NEUROSCI, V35, P4238, DOI 10.1523/JNEUROSCI.3145-14.2015; Goldsberry ME, 2014, DEV PSYCHOBIOL, V56, P1244, DOI 10.1002/dev.21204; Green JT, 2007, NEUROBIOL LEARN MEM, V87, P269, DOI 10.1016/j.nlm.2006.08.014; GREEN RJ, 1989, BEHAV NEUROSCI, V103, P98, DOI 10.1037/0735-7044.103.1.98; Harmon TC, 2015, DEV PSYCHOBIOL, V57, P168, DOI 10.1002/dev.21272; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Hoffmann LC, 2009, P NATL ACAD SCI USA, V106, P21371, DOI 10.1073/pnas.0908403106; Inui K, 2001, PSYCHIAT CLIN NEUROS, V55, P525, DOI 10.1046/j.1440-1819.2001.00900.x; Jablonski SA, 2012, DEV PSYCHOBIOL, V54, P714, DOI 10.1002/dev.20621; Kim JJ, 2011, J NEUROSCI, V31, P16991, DOI 10.1523/JNEUROSCI.2859-11.2011; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; Ng KH, 2012, J NEUROSCI, V32, P6841, DOI 10.1523/JNEUROSCI.0284-12.2012; Nokia MS, 2008, NEUROBIOL LEARN MEM, V90, P62, DOI 10.1016/j.nlm.2008.01.005; Nokia MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031375; Pugh CR, 1996, DEV PSYCHOBIOL, V29, P87, DOI 10.1002/(SICI)1098-2302(199603)29:2<87::AID-DEV1>3.0.CO;2-H; Rokers B, 2002, BEHAV NEUROSCI, V116, P48, DOI 10.1037//0735-7044.116.1.48; RUDY JW, 1993, BEHAV NEUROSCI, V107, P887, DOI 10.1037/0735-7044.107.5.887; RUDY JW, 1994, BEHAV NEUROSCI, V108, P227, DOI 10.1037/0735-7044.108.2.227; RUDY JW, 1987, BEHAV NEUROSCI, V101, P62, DOI 10.1037/0735-7044.101.1.62; SATO H, 1979, EXPERIENTIA, V35, P879, DOI 10.1007/BF01955125; Schiffino FL, 2011, NEUROBIOL LEARN MEM, V95, P190, DOI 10.1016/j.nlm.2010.11.011; Seager MA, 2002, P NATL ACAD SCI USA, V99, P1616, DOI 10.1073/pnas.032662099; SOLOMON PR, 1983, SCIENCE, V220, P329, DOI 10.1126/science.6836277; Stanton ME, 2000, BEHAV BRAIN RES, V110, P25, DOI 10.1016/S0166-4328(99)00182-5; STANTON ME, 1992, BEHAV NEUROSCI, V106, P657, DOI 10.1037/0735-7044.106.4.657; Stanton ME, 2009, OXFORD HDB DEV BEHAV, P501; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; TOTH K, 1993, J NEUROSCI, V13, P3712; Wikgren J, 2010, NEUROSCIENCE, V165, P1538, DOI 10.1016/j.neuroscience.2009.11.044; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224	47	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164781	10.1371/journal.pone.0164781	http://dx.doi.org/10.1371/journal.pone.0164781			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764172	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500061
J	Stango, A; Yazdandoost, KY; Negro, F; Farina, D				Stango, Antonietta; Yazdandoost, Kamya Yekeh; Negro, Francesco; Farina, Dario			Characterization of In-Body to On-Body Wireless Radio Frequency Link for Upper Limb Prostheses	PLOS ONE			English	Article							CHANNEL; SYSTEM	Wireless implanted devices can be used to interface patients with disabilities with the aim of restoring impaired motor functions. Implanted devices that record and transmit electromyographic (EMG) signals have been applied for the control of active prostheses. This simulation study investigates the propagation losses and the absorption rate of a wireless radio frequency link for in-to-on body communication in the medical implant communication service (MICS) frequency band to control myoelectric upper limb prostheses. The implanted antenna is selected and a suitable external antenna is designed. The characterization of both antennas is done by numerical simulations. A heterogeneous 3D body model and a 3D electromagnetic solver have been used to model the path loss and to characterize the specific absorption rate (SAR). The path loss parameters were extracted and the SAR was characterized, verifying the compliance with the guideline limits. The path loss model has been also used for a preliminary link budget analysis to determine the feasibility of such system compliant with the IEEE 802.15.6 standard. The resulting link margin of 11 dB confirms the feasibility of the system proposed.	[Stango, Antonietta; Farina, Dario] Univ Gottingen, Inst Neurorehabil Syst, Bernstein Focus Neurotechnol Goettingen, Bernstein Ctr Computat Neurosci,Univ Med Ctr Goet, D-37075 Gottingen, Germany; [Yazdandoost, Kamya Yekeh] Univ Oulu, Ctr Wireless Commun, Dept Commun Engn, POB 4500, Oulu 90014, Finland; [Negro, Francesco] Univ Brescia, Dept Clin & Expt Sci, I-25123 Brescia, Italy	University of Gottingen; University of Oulu; University of Brescia	Farina, D (corresponding author), Univ Gottingen, Inst Neurorehabil Syst, Bernstein Focus Neurotechnol Goettingen, Bernstein Ctr Computat Neurosci,Univ Med Ctr Goet, D-37075 Gottingen, Germany.	dario.farina@bccn.uni-goettingen.de	Yazdandoost, Kamya Yekeh/V-4755-2019; Stango, Antonietta/ABC-3225-2021; Farina, Dario/AAB-2648-2019; Negro, Francesco/H-4471-2019	Yazdandoost, Kamya Yekeh/0000-0001-9695-1342; Stango, Antonietta/0000-0003-1387-2150; Negro, Francesco/0000-0002-9094-8932	German Ministry for Education and Research (BMBF) via the Bernstein Focus Neurotechnology (BFNT) Gottingen [1GQ0810]	German Ministry for Education and Research (BMBF) via the Bernstein Focus Neurotechnology (BFNT) Gottingen(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Ministry for Education and Research (BMBF) via the Bernstein Focus Neurotechnology (BFNT) Gottingen under grant number 1GQ0810.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; Alomainy A, 2009, IEEE T ANTENN PROPAG, V57, P999, DOI 10.1109/TAP.2009.2014531; [Anonymous], 2009, 3018391 ETSI EN; [Anonymous], 1998, 13591 ITUR BT, P1; [Anonymous], 802156 IEEE; [Anonymous], 2013, PHOT PV MOD SAF QU 1, P1; Bazaka K, 2013, ELECTRONICS-SWITZ, V2, P1, DOI 10.3390/electronics2010001; Bergmeister KD, 2016, PLAST RECONSTR SURG, V137, P153, DOI 10.1097/PRS.0000000000001926; Chen M, 2011, MOBILE NETW APPL, V16, P171, DOI 10.1007/s11036-010-0260-8; Chow EY, 2013, IEEE MICROW MAG, V14, P64, DOI 10.1109/MMM.2013.2248586; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; DeMichele GA, 2014, IEEE ENG MED BIO, P3081, DOI 10.1109/EMBC.2014.6944274; Farrell TR, 2008, IEEE T BIO-MED ENG, V55, P2198, DOI 10.1109/TBME.2008.923917; Gabriel C, 1996, ENV HEAL; Hall P.S., 2006, ANTENNAS PROPAGATION; Houzen Tamotsu, 2008, 2008 IEEE International Workshop on Antenna Technology, P346, DOI 10.1109/IWAT.2008.4511351; IEEE, 2007, 802154A2007 IEEE; Jaehoon Choi, 2012, 2012 IEEE International Workshop on Antenna Technology "Small Antennas and Unconventional Applications" (iWAT), P213, DOI 10.1109/IWAT.2012.6178650; Kim J, 2004, IEEE T MICROW THEORY, V52, P1934, DOI 10.1109/TMTT.2004.832018; Kraus JD., 1988, ANTENNAS, V2nd ed.; Movassaghi S, 2014, IEEE COMMUN SURV TUT, V16, P1658, DOI 10.1109/SURV.2013.121313.00064; Oh J, 2010, IEEE T INF TECHNOL B, V14, P1464; Pasquina PF, 2015, J NEUROSCI METH, V244, P85, DOI 10.1016/j.jneumeth.2014.07.016; Prabhav N. R., 2009, 11th International Congress of the IUPESM. Medical Physics and Biomedical Engineering. World Congress 2009. Neuroengineering, Neural Systems, Rehabilitation and Prosthetics, P584, DOI 10.1007/978-3-642-03889-1_157; Reusens E, 2009, IEEE T INF TECHNOL B, V13, P933, DOI 10.1109/TITB.2009.2033054; Roman KLL, 2014, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2014-21; Sayrafian-Pour K, 2010, INT J WIREL INF NETW, V17, P105, DOI 10.1007/s10776-010-0124-y; Sayrafian-Pour K, 2009, 2009 IEEE 20TH INTERNATIONAL SYMPOSIUM ON PERSONAL, INDOOR AND MOBILE RADIO COMMUNICATIONS, P2995, DOI 10.1109/PIMRC.2009.5449869; Stango A, 2015, IEEE ENG MED BIO, P4085, DOI 10.1109/EMBC.2015.7319292; Weir REF, 2009, IEEE T BIO-MED ENG, V56, P159, DOI 10.1109/TBME.2008.2005942; World Health Organization (WHO), 2002, EST DIAL RISKS EL FI; Yazdandoost KY, 2007, 2007 EUROPEAN MICROWAVE CONFERENCE, VOLS 1-4, P968; Yu WH, 2011, ADVANCED FDTD METHODS: PARALLELIZATION, ACCELERATION, AND ENGINEERING APPLICATIONS, P1	33	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e1064987	10.1371/journal.pone.0164987	http://dx.doi.org/10.1371/journal.pone.0164987			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764182	Green Published, gold			2022-12-26	WOS:000386204500096
J	Abel, MK; Li, HC; Russo, FA; Schlaug, G; Loui, P				Abel, Mary Kathryn; Li, H. Charles; Russo, Frank A.; Schlaug, Gottfried; Loui, Psyche			Audiovisual Interval Size Estimation Is Associated with Early Musical Training	PLOS ONE			English	Article							TONE-DEAFNESS; FACIAL EXPRESSIONS; CONGENITAL AMUSIA; PITCH; PERCEPTION; DISCRIMINATION; PERFORMANCE; DEFICITS; MOTION; SOUND	Although pitch is a fundamental attribute of auditory perception, substantial individual differences exist in our ability to perceive differences in pitch. Little is known about how these individual differences in the auditory modality might affect crossmodal processes such as audiovisual perception. In this study, we asked whether individual differences in pitch perception might affect audiovisual perception, as it relates to age of onset and number of years of musical training. Fifty-seven subjects made subjective ratings of interval size when given point-light displays of audio, visual, and audiovisual stimuli of sung intervals. Audiovisual stimuli were divided into congruent and incongruent (audiovisual-mismatched) stimuli. Participants' ratings correlated strongly with interval size in audio-only, visual-only, and audiovisual-congruent conditions. In the audiovisual-incongruent condition, ratings correlated more with audio than with visual stimuli, particularly for subjects who had better pitch perception abilities and higher nonverbal IQ scores. To further investigate the effects of age of onset and length of musical training, subjects were divided into musically trained and untrained groups. Results showed that among subjects with musical training, the degree to which participants' ratings correlated with auditory interval size during incongruent audiovisual perception was correlated with both nonverbal IQ and age of onset of musical training. After partialing out nonverbal IQ, pitch discrimination thresholds were no longer associated with incongruent audio scores, whereas age of onset of musical training remained associated with incongruent audio scores. These findings invite future research on the developmental effects of musical training, particularly those relating to the process of audiovisual perception.	[Abel, Mary Kathryn] Harvard Univ, Cambridge, MA USA; [Abel, Mary Kathryn; Li, H. Charles; Schlaug, Gottfried; Loui, Psyche] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Abel, Mary Kathryn; Li, H. Charles; Schlaug, Gottfried; Loui, Psyche] Harvard Med Sch, Boston, MA 02115 USA; [Russo, Frank A.] Ryerson Univ, Toronto, ON, Canada; [Loui, Psyche] Wesleyan Univ, Middletown, CT 06459 USA	Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Toronto Metropolitan University; Wesleyan University	Loui, P (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.; Loui, P (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Loui, P (corresponding author), Wesleyan Univ, Middletown, CT 06459 USA.	ploui@wesleyan.edu	Russo, Frank A./H-3748-2019	Russo, Frank A./0000-0002-2939-6358; Loui, Psyche/0000-0001-7664-6092	National Institute of Deafness and Communication Disorders [R01 009823]; Harvard College Research Program; Grammy Foundation; Imagination Institute	National Institute of Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Harvard College Research Program; Grammy Foundation; Imagination Institute	This work was supported by National Institute of Deafness and Communication Disorders R01 009823 to GS and PL, Harvard College Research Program to MKA, and grants from Grammy Foundation and the Imagination Institute to PL.; Supported by National Institute of Deafness and Communication Disorders R01 009823 to GS and PL, Harvard College Research Program to MKA, and grants from Grammy Foundation and the Imagination Institute to PL. We also thank Stephen Handel and two anonymous reviewers for their invaluable comments on a previous version of this manuscript.	Bourquin NMP, 2013, BRAIN TOPOGR, V26, P152, DOI 10.1007/s10548-012-0260-z; Douglas KM, 2007, NAT NEUROSCI, V10, P915, DOI 10.1038/nn1925; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; Halwani GF, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00156; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Liu F, 2010, BRAIN, V133, P1682, DOI 10.1093/brain/awq089; Livingstone SR, 2009, MUSIC PERCEPT, V26, P475, DOI 10.1525/MP.2009.26.5.475; Loui P, 2008, CURR BIOL, V18, pR331, DOI 10.1016/j.cub.2008.02.045; Loui P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00111; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PAULSON MJ, 1970, J CLIN PSYCHOL, V26, P453, DOI 10.1002/1097-4679(197010)26:4<453::AID-JCLP2270260415>3.0.CO;2-V; Perrachione TK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073372; Pfordresher PQ, 2012, ANN NY ACAD SCI, V1252, P171, DOI 10.1111/j.1749-6632.2011.06408.x; Pfordresher PQ, 2009, ATTEN PERCEPT PSYCHO, V71, P1385, DOI 10.3758/APP.71.6.1385; RUSSO F. A., 2011, PSYCHOMUSICOLOGY MUS, V21, P98, DOI [10.1037/h0094007, DOI 10.1037/H0094007]; Russo FA, 2005, PSYCHON B REV, V12, P1068, DOI 10.3758/BF03206445; Semal C, 2006, J ACOUST SOC AM, V120, P3907, DOI 10.1121/1.2357708; Shipley WC, 1940, J PSYCHOL, V9, P371, DOI 10.1080/00223980.1940.9917704; Thompson WF, 2007, PSYCHOL SCI, V18, P756, DOI 10.1111/j.1467-9280.2007.01973.x; Thompson WF, 2010, PSYCHON B REV, V17, P317, DOI 10.3758/PBR.17.3.317; Tillmann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010173; Tsay CJ, 2013, P NATL ACAD SCI USA, V110, P14580, DOI 10.1073/pnas.1221454110; Tukey JW, 1977, EXPLORATORY DATA ANA; Williamson VJ, 2010, MEMORY, V18, P657, DOI 10.1080/09658211.2010.501339; Zicarelli D., 1998, P INT COMP MUS C U M	26	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0163589	10.1371/journal.pone.0163589	http://dx.doi.org/10.1371/journal.pone.0163589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9NW	27760134	gold, Green Submitted, Green Published			2022-12-26	WOS:000386204000016
J	de Meij, TGJ; de Groot, EFJ; Eck, A; Budding, AE; Kneepkens, CMF; Benninga, MA; van Bodegraven, AA; Savelkoul, PHM				de Meij, Tim G. J.; de Groot, Evelien F. J.; Eck, Anat; Budding, Andries E.; Kneepkens, C. M. Frank; Benninga, Marc A.; van Bodegraven, Adriaan A.; Savelkoul, Paul H. M.			Characterization of Microbiota in Children with Chronic Functional Constipation	PLOS ONE			English	Article							LACTOBACILLUS-REUTERI INGESTION; COLONIC TRANSIT; CHILDHOOD CONSTIPATION; ENTERIC MICROBIOTA; METHANE PRODUCTION; SYMPTOMS; MOTILITY; COMPLEX; FLORA	Objectives Disruption of the intestinal microbiota is considered an etiological factor in pediatric functional constipation. Scientifically based selection of potential beneficial probiotic strains in functional constipation therapy is not feasible due to insufficient knowledge of microbiota composition in affected subjects. The aim of this study was to describe microbial composition and diversity in children with functional constipation, compared to healthy controls. Study Design Fecal samples from 76 children diagnosed with functional constipation according to the Rome III criteria (median age 8.0 years; range 4.2-17.8) were analyzed by IS-pro, a PCR-based microbiota profiling method. Outcome was compared with intestinal microbiota profiles of 61 healthy children (median 8.6 years; range 4.1-17.9). Microbiota dissimilarity was depicted by principal coordinate analysis (PCoA), diversity was calculated by Shannon diversity index. To determine the most discriminative species, cross validated logistic ridge regression was performed. Results Applying total microbiota profiles (all phyla together) or per phylum analysis, no disease specific separation was observed by PCoA and by calculation of diversity indices. By ridge regression, however, functional constipation and controls could be discriminated with 82% accuracy. Most discriminative species were Bacteroides fragilis, Bacteroides ovatus, Bifidobacterium longum, Parabacteroides species (increased in functional constipation) and Alistipes finegoldii (decreased in functional constipation). Conclusions None of the commonly used unsupervised statistical methods allowed for microbiota-based discrimination of children with functional constipation and controls. By ridge regression, however, both groups could be discriminated with 82% accuracy. Optimization of micro biota-based interventions in constipated children warrants further characterization of microbial signatures linked to clinical subgroups of functional constipation.	[de Meij, Tim G. J.; Kneepkens, C. M. Frank] Vrije Univ Amsterdam Med Ctr, Dept Pediat Gastroenterol, Amsterdam, Netherlands; [de Groot, Evelien F. J.; van Bodegraven, Adriaan A.] Vrije Univ Amsterdam Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Eck, Anat; Budding, Andries E.; Savelkoul, Paul H. M.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Benninga, Marc A.] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Gastroenterol, Amsterdam, Netherlands; [van Bodegraven, Adriaan A.] Zuyderland Med Ctr, Dept Gastroenterol Geriatr Internal & Intens Care, Heerlen Sittard Geleen, Netherlands; [Savelkoul, Paul H. M.] Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	de Meij, TGJ (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pediat Gastroenterol, Amsterdam, Netherlands.	t.demeij@vumc.nl	van Bodegraven, Ad A/L-3180-2013; van Bodegraven, Ad/ABG-4367-2020	Budding, Andries/0000-0001-5128-5411				Attaluri A, 2010, AM J GASTROENTEROL, V105, P1407, DOI 10.1038/ajg.2009.655; Bar F, 2009, NEUROGASTROENT MOTIL, V21, P575, DOI 10.1111/j.1365-2982.2008.01258.x; Barbara G, 2005, AM J GASTROENTEROL, V100, P2560, DOI 10.1111/j.1572-0241.2005.00230.x; Benninga MA, 2004, J PEDIATR GASTR NUTR, V39, P448, DOI 10.1097/00005176-200411000-00002; Budding AE, 2010, FASEB J, V24, P4556, DOI 10.1096/fj.10-156190; Budding AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101344; CAENEPEEL P, 1989, DIGEST DIS SCI, V34, P1180, DOI 10.1007/BF01537265; Coccorullo P, 2010, J PEDIATR-US, V157, P598, DOI 10.1016/j.jpeds.2010.04.066; Daniels L, 2014, EUR J CLIN MICROBIOL, V33, P1927, DOI 10.1007/s10096-014-2162-3; de Meij TG, 2015, FASEB J; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Furnari M, 2012, J GASTROINTEST LIVER, V21, P157; Guarino MPL, 2008, J CLIN GASTROENTEROL, V42, pS185, DOI 10.1097/MCG.0b013e31817e1cac; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Husebye E, 2001, AM J PHYSIOL-GASTR L, V280, pG368, DOI 10.1152/ajpgi.2001.280.3.G368; Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047; Khalif IL, 2005, DIGEST LIVER DIS, V37, P838, DOI 10.1016/j.dld.2005.06.008; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Ma XL, 2009, AM J PHYSIOL-GASTR L, V296, pG868, DOI 10.1152/ajpgi.90511.2008; Mugie SM, 2011, NAT REV GASTRO HEPAT, V8, P502, DOI 10.1038/nrgastro.2011.130; Parthasarathy G, 2016, GASTROENTEROLOGY, V150, P367, DOI 10.1053/j.gastro.2015.10.005; Quigley EMM, 2011, BEST PRACT RES CL GA, V25, P119, DOI 10.1016/j.bpg.2011.01.003; Rajindrajith S, 2013, J PEDIATR-US, V163, P1069, DOI 10.1016/j.jpeds.2013.05.012; Rasquin A, 2006, GASTROENTEROLOGY, V130, P1527, DOI 10.1053/j.gastro.2005.08.063; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Sadeghzadeh M, 2014, INT J PEDIAT, V2014, DOI 10.1155/2014/937212; Soares ACF, 2005, J CLIN GASTROENTEROL, V39, P512, DOI 10.1097/01.mcg.0000165665.94777.bd; Tabbers MM, 2014, J PEDIATR GASTR NUTR, V58, P258, DOI 10.1097/MPG.0000000000000266; Tabbers MM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-19; Verdu EF, 2009, NEUROGASTROENT MOTIL, V21, P477, DOI 10.1111/j.1365-2982.2009.01297.x; Wang B, 2010, NEUROGASTROENT MOTIL, V22, P98, DOI 10.1111/j.1365-2982.2009.01384.x; Wang F, 2016, CELL REP, V14, P945, DOI 10.1016/j.celrep.2015.12.088; Zhu LX, 2014, PHYSIOL GENOMICS, V46, P679, DOI 10.1152/physiolgenomics.00082.2014; Zoppi G, 1998, ACTA PAEDIATR, V87, P836, DOI 10.1080/080352598750013590	36	55	58	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164731	10.1371/journal.pone.0164731	http://dx.doi.org/10.1371/journal.pone.0164731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760208	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204000047
J	Kametani, Y; Ohshima, S; Miyamoto, A; Shigenari, A; Takasu, M; Imaeda, N; Matsubara, T; Tanaka, M; Shiina, T; Kamiguchi, H; Suzuki, R; Kitagawa, H; Kulski, JK; Hirayama, N; Inoko, H; Ando, A				Kametani, Yoshie; Ohshima, Shino; Miyamoto, Asuka; Shigenari, Atsuko; Takasu, Masaki; Imaeda, Noriaki; Matsubara, Tatsuya; Tanaka, Masafumi; Shiina, Takashi; Kamiguchi, Hiroshi; Suzuki, Ryuji; Kitagawa, Hitoshi; Kulski, Jerzy K.; Hirayama, Noriaki; Inoko, Hidetoshi; Ando, Asako			Production of a Locus- and Allele-Specific Monoclonal Antibody for the Characterization of SLA-1*0401 mRNA and Protein Expression Levels in MHC-Defined Microminipigs	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; RESISTANT STAPHYLOCOCCUS-AUREUS; CLASS-I GENES; ANTIGEN PRESENTATION; RESPONSE ELEMENT; MINIATURE SWINE; MRSA CC398; TRANSACTIVATION; PIGS; MOLECULES	The class I major histocompatibility complex (MHC) presents self-developed peptides to specific T cells to induce cytotoxity against infection. The MHC proteins are encoded by multiple loci that express numerous alleles to preserve the variability of the antigen-presenting ability in each species. The mechanism regulating MHC mRNA and protein expression at each locus is difficult to analyze because of the structural and sequence similarities between alleles. In this study, we examined the correlation between the mRNA and surface protein expression of swine leukocyte antigen (SLA)-1*0401 after the stimulation of peripheral blood mononuclear cells (PBMCs) by Staphylococcus aureus superantigen toxic shock syndrome toxin-1 (TSST-1). We prepared a monoclonal antibody (mAb) against a domain composed of Y102, L103 and L109 in the alpha 2 domain. The Hp-16.0 haplotype swine possess only SLA-1*0401, which has the mAb epitope, while other haplotypes possess 0 to 3 SLA classical class I loci with the mAb epitopes. When PBMCs from SLA-1*0401 homozygous pigs were stimulated, the SLA-1*0401 mRNA expression level increased until 24 hrs and decreased at 48 hrs. The kinetics of the interferon regulatory transcription factor-1 (IRF-1) mRNA level were similar to those of the SLA-1*0401 mRNA. However, the surface protein expression level continued to increase until 72 hrs. Similar results were observed in the Hp-10.0 pigs with three mAb epitopes. These results suggest that TSST-1 stimulation induced both mRNA and surface protein expression of class I SLA in the swine PBMCs differentially and that the surface protein level was sustained independently of mRNA regulation.	[Kametani, Yoshie; Ohshima, Shino; Miyamoto, Asuka; Shigenari, Atsuko; Tanaka, Masafumi; Shiina, Takashi; Kulski, Jerzy K.; Inoko, Hidetoshi; Ando, Asako] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci, Isehara, Kanagawa, Japan; [Kametani, Yoshie] Tokai Univ, Inst Adv Biosci, Hiratsuka, Kanagawa 25912, Japan; [Takasu, Masaki; Imaeda, Noriaki; Matsubara, Tatsuya; Kitagawa, Hitoshi] Gifu Univ, Fac Appl Biol Sci, Dept Vet Med, Gifu, Gifu, Japan; [Kamiguchi, Hiroshi] Tokai Univ, Sch Med, Teaching & Res Support Ctr, Isehara, Kanagawa, Japan; [Suzuki, Ryuji] Natl Hosp Org, Dept Rheumatol & Clin Immunol, Clin Res Ctr Allergy & Rheumatol, Sagamihara Natl Hosp, Sagamihara, Kanagawa, Japan; [Kulski, Jerzy K.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Crawley, WA, Australia; [Hirayama, Noriaki] Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa, Japan	Tokai University; Tokai University; Gifu University; Tokai University; University of Western Australia; Tokai University	Kametani, Y (corresponding author), Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci, Isehara, Kanagawa, Japan.; Kametani, Y (corresponding author), Tokai Univ, Inst Adv Biosci, Hiratsuka, Kanagawa 25912, Japan.	y-kametn@is.icc.u-tokai.ac.jp	kulski, jerzy/V-2046-2019	kulski, jerzy/0000-0002-9789-245X; Shiina, Takashi/0000-0002-2067-6708	Japan Society for the Promotion of Science (JSPS) KAKENHI [23500502]; Tokai University grant Kametani; MEXT-Supported Program for the Strategic Research Foundation at Private Universities	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tokai University grant Kametani; MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 23500502, Tokai University grant Kametani (2015-2017) and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2012-2016).	Abud M, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.5.6; Alt K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-69; Amodio G, 2014, TISSUE ANTIGENS, V84, P255, DOI 10.1111/tan.12427; Ando A, 2005, XENOTRANSPLANTATION, V12, P121, DOI 10.1111/j.1399-3089.2005.00204.x; Ando A, 2014, ANIM GENET, V45, P791, DOI 10.1111/age.12199; Avsar M, 2016, AM J TRANSPLANT, V16, P1371, DOI 10.1111/ajt.13629; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Boost MV, 2012, VET REC, V171, P156, DOI 10.1136/vr.100779; Broens EM, 2011, PREV VET MED, V102, P41, DOI 10.1016/j.prevetmed.2011.06.005; Bukur J, 2012, SEMIN CANCER BIOL, V22, P350, DOI 10.1016/j.semcancer.2012.03.003; Cameron AM, 2016, AM J TRANSPLANT, V16, P2066, DOI 10.1111/ajt.13703; Cano F, 2013, MOL IMMUNOL, V55, P135, DOI 10.1016/j.molimm.2012.10.015; Carosella ED, 2015, ADV IMMUNOL, V127, P33, DOI 10.1016/bs.ai.2015.04.001; Crombe F, 2012, MICROB DRUG RESIST, V18, P125, DOI 10.1089/mdr.2011.0138; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Dellgren C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135385; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Fernandez-Rodriguez OM, 2016, CIR ESPAN, V94, P77, DOI 10.1016/j.ciresp.2015.09.007; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Gobin SJP, 2002, J BIOL CHEM, V277, P39525, DOI 10.1074/jbc.M112273200; Gobin SJP, 2001, J IMMUNOL, V167, P5175, DOI 10.4049/jimmunol.167.9.5175; Gobin SJP, 1999, J IMMUNOL, V163, P1428; Groothuis TAM, 2005, IMMUNOL REV, V207, P60, DOI 10.1111/j.0105-2896.2005.00305.x; Hake SB, 2000, MOL CELL BIOL, V20, P7716, DOI 10.1128/MCB.20.20.7716-7725.2000; Hansman GS, 2012, J VIROL, V86, P3635, DOI 10.1128/JVI.06868-11; Harris MR, 2001, INT IMMUNOL, V13, P1275, DOI 10.1093/intimm/13.10.1275; Ho CS, 2009, ANIM GENET, V40, P468, DOI 10.1111/j.1365-2052.2009.01860.x; Ho CS, 2009, TISSUE ANTIGENS, V73, P307, DOI 10.1111/j.1399-0039.2009.01213.x; Ito T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113833; Kametani Y, 2008, IMMUNOL LETT, V119, P97, DOI 10.1016/j.imlet.2008.05.006; Kametani Y, 2012, VET IMMUNOL IMMUNOP, V148, P252, DOI 10.1016/j.vetimm.2012.05.005; Krakauer T, 1999, IMMUNOL RES, V20, P163, DOI 10.1007/BF02786471; Kulhankova K, 2014, IMMUNOL RES, V59, P182, DOI 10.1007/s12026-014-8538-8; Lee K, 2014, P NATL ACAD SCI USA, V111, P7260, DOI 10.1073/pnas.1406376111; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Maier JKX, 2014, PROTEINS, V82, P1599, DOI 10.1002/prot.24576; Mizukami Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098319; Mizutani A, 2013, ANAL BIOCHEM, V443, P113, DOI 10.1016/j.ab.2013.08.009; Mulder A, 2010, MOL IMMUNOL, V47, P809, DOI 10.1016/j.molimm.2009.10.004; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Pratheek B M, 2014, Indian J Hum Genet, V20, P129, DOI 10.4103/0971-6866.142855; Renard C, 2006, GENOMICS, V88, P96, DOI 10.1016/j.ygeno.2006.01.004; Satta Yoko, 1998, Frontiers in Bioscience, V3, pD459; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Soe OK, 2008, XENOTRANSPLANTATION, V15, P390, DOI 10.1111/j.1399-3089.2008.00499.x; Sollid LM, 2014, CURR OPIN IMMUNOL, V31, P24, DOI 10.1016/j.coi.2014.08.005; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; Stach CS, 2014, IMMUNOL RES, V59, P177, DOI 10.1007/s12026-014-8539-7; Tanaka-Matsuda M, 2009, GENOMICS, V93, P261, DOI 10.1016/j.ygeno.2008.10.004; Thielens A, 2012, CURR OPIN IMMUNOL, V24, P239, DOI 10.1016/j.coi.2012.01.001; van den Elsen P, 2011, FRONT IMMUNOL, V2, P2; van den Elsen PJ, 2004, CURR OPIN IMMUNOL, V16, P67, DOI 10.1016/j.coi.2003.11.015; van den Elsen PJ, 1998, IMMUNOGENETICS, V48, P208, DOI 10.1007/s002510050425; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Zhang NZ, 2011, J VIROL, V85, P11709, DOI 10.1128/JVI.05040-11	59	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164995	10.1371/journal.pone.0164995	http://dx.doi.org/10.1371/journal.pone.0164995			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760184	gold, Green Submitted, Green Published			2022-12-26	WOS:000386204000073
J	Uratani, R; Toiyama, Y; Kitajima, T; Kawamura, M; Hiro, J; Kobayashi, M; Tanaka, K; Inoue, Y; Mohri, Y; Mori, T; Kato, T; Goel, A; Kusunoki, M				Uratani, Ryo; Toiyama, Yuji; Kitajima, Takahito; Kawamura, Mikio; Hiro, Junichiro; Kobayashi, Minako; Tanaka, Koji; Inoue, Yasuhiro; Mohri, Yasuhiko; Mori, Takao; Kato, Toshio; Goel, Ajay; Kusunoki, Masato			Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas	PLOS ONE			English	Article							FECAL OCCULT BLOOD; CIRCULATING MICRORNAS; CANCER; SERUM; BIOMARKERS; BIOGENESIS; MECHANISM; IMPACT	Background Although there is a growing interest in developing circulating microRNA ( miRNA) as nonin-vasive diagnostic biomarkers for the detection of high-risk colorectal adenomas and earlystage CRCs, but the comparative diagnostic significance of serum vs. exosomal miRNAs remains unexplored. Methods Based upon published literature, we performed an initial discovery step by investigating the expression of a miRNA panel in 20 normal colonic mucosa, 27 adenomas, and 19 CRC tissues. We performed subsequent validation by quantifying expression of candidate miRNAs in total serum and in exosomes from 26 adenoma patients and 47 healthy controls, and evaluated their clinical significance and potential diagnostic value in colorectal adenomas. Results We observed that the expression of four miRNAs, miR-21, miR-29a, miR-92a, and miR-135b, was significantly higher in colorectal adenomas vs. normal colonic mucosa. During validation, expression of miR-21, miR-29a and miR-92a in serum was significantly higher in adenomas vs. healthy controls, significantly correlated with adenoma size and total adenoma number within the colorectum, and significantly discriminated patients with advanced adenomas. In contrast, although exosomal miR-21 and miR-29a levels in adenoma patients were significantly higher than those of healthy volunteers, only exosomal miR-21 significantly correlated with adenoma size and total adenoma number, and could discriminate patients with high-risk adenomas. Conclusion Compared to exosomal miRNAs, serum levels of miR-21, miR-29a and miR-92a are superior diagnostic biomarkers in patients with high-risk adenomatous polyps.	[Uratani, Ryo; Toiyama, Yuji; Kitajima, Takahito; Kawamura, Mikio; Hiro, Junichiro; Kobayashi, Minako; Tanaka, Koji; Inoue, Yasuhiro; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Grad Sch Med, Inst Life Sci, Dept Gastrointestinal & Pediat Surg,Div Reparat M, Tsu, Mie 5148507, Japan; [Mori, Takao] Moriei Hosp, Kuwana City, Mie 5110038, Japan; [Kato, Toshio] Tohyama Hosp, Tsu, Mie 5140043, Japan; [Goel, Ajay] Baylor Univ, Med Ctr, Ctr Gastrointestinal Res, Dallas, TX 75246 USA; [Goel, Ajay] Baylor Univ, Med Ctr, Ctr Epigenet Canc Prevent & Canc Genom, Baylor Res Inst, Dallas, TX 75246 USA; [Goel, Ajay] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Dallas, TX 75246 USA	Mie University; Baylor University; Baylor University Medical Center; Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center	Toiyama, Y (corresponding author), Mie Univ, Grad Sch Med, Inst Life Sci, Dept Gastrointestinal & Pediat Surg,Div Reparat M, Tsu, Mie 5148507, Japan.	ytoi0725@clin.medic.mie-u.ac.jp; ajay.goel@bswHealth.org		Goel, Ajay/0000-0003-1396-6341	Ministry of Education, Culture, Sports, Science, and Technology, Japan [26293301]; National Cancer Institute, National Institutes of Health [R01 CA72851, CA184792]; Baylor Research Institute; Charles A. Sammons Cancer Center	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; Charles A. Sammons Cancer Center	This work was supported in part by a Grant-in-Aid for Scientific Research (26293301) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The present work was supported by grants R01 CA72851 and CA184792 from the National Cancer Institute, National Institutes of Health, funds from the Baylor Research Institute and a pilot grant from Charles A. Sammons Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baxter NN, 2011, GASTROENTEROLOGY, V140, P65, DOI 10.1053/j.gastro.2010.09.006; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Collins JF, 2005, ANN INTERN MED, V142, P81, DOI 10.7326/0003-4819-142-2-200501180-00006; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Fraser CG, 2006, LANCET ONCOL, V7, P127, DOI 10.1016/S1470-2045(05)70473-3; Gala M, 2011, SEMIN ONCOL, V38, P490, DOI 10.1053/j.seminoncol.2011.05.003; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Hur K, 2017, GUT, V66, P654, DOI 10.1136/gutjnl-2014-308737; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Lotvall J, 2007, CELL ADHES MIGR, V1, P156, DOI 10.4161/cam.1.3.5114; Matsumura T, 2015, BRIT J CANCER, V113, P275, DOI 10.1038/bjc.2015.201; Millan MS, 2008, DIS COLON RECTUM, V51, P1217, DOI 10.1007/s10350-008-9315-3; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nugent M, 2011, EJSO-EUR J SURG ONC, V37, P649, DOI 10.1016/j.ejso.2011.05.005; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Okugawa Y, 2014, EXPERT REV MOL DIAGN, V14, P999, DOI 10.1586/14737159.2014.946907; Palma J, 2012, NUCLEIC ACIDS RES, V40, P9125, DOI 10.1093/nar/gks656; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; Tanaka Y, 2013, CANCER-AM CANCER SOC, V119, P1159, DOI 10.1002/cncr.27895; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Toiyama Y, 2014, CURR COLORECTAL CANC; Toiyama Y, 2016, SURG TODAY, V46, P13, DOI 10.1007/s00595-015-1138-y; Toiyama Y, 2014, ANN SURG, V259, P735, DOI 10.1097/SLA.0b013e3182a6909d; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2012, CURR OPIN LIPIDOL, V23, P91, DOI 10.1097/MOL.0b013e328350a425; Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745; Wang QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044398; Xue W, 2014, P NATL ACAD SCI USA, V111, pE3553, DOI 10.1073/pnas.1412686111	42	65	66	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0160722	10.1371/journal.pone.0160722	http://dx.doi.org/10.1371/journal.pone.0160722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760147	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204000001
J	Fukai, K; Harada, S; Iida, M; Kurihara, A; Takeuchi, A; Kuwabara, K; Sugiyama, D; Okamura, T; Akiyama, M; Nishiwaki, Y; Oguma, Y; Suzuki, A; Suzuki, C; Hirayama, A; Sugimoto, M; Soga, T; Tomita, M; Takebayashi, T				Fukai, Kota; Harada, Sei; Iida, Miho; Kurihara, Ayako; Takeuchi, Ayano; Kuwabara, Kazuyo; Sugiyama, Daisuke; Okamura, Tomonori; Akiyama, Miki; Nishiwaki, Yuji; Oguma, Yuko; Suzuki, Asako; Suzuki, Chizuru; Hirayama, Akiyoshi; Sugimoto, Masahiro; Soga, Tomoyoshi; Tomita, Masaru; Takebayashi, Toru			Metabolic Profiling of Total Physical Activity and Sedentary Behavior in Community-Dwelling Men	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; DOSE-RESPONSE METAANALYSIS; CHAIN AMINO-ACIDS; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; HEALTH-BENEFITS; ACTIVITY LEVEL; RISK; JAPANESE; DISEASE	Objective Physical activity is known to be preventive against various non-communicable diseases. We investigated the relationship between daily physical activity level and plasma metabo-lites using a targeted metabolomics approach in a population-based study. Methods A total of 1,193 participants (male, aged 35 to 74 years) with fasting blood samples were selected from the baseline survey of a cohort study. Information on daily total physical activity, classified into four levels by quartile of metabolic equivalent scores, and sedentary behavior, defined as hours of sitting per day, was collected through a self-administered questionnaire. Plasma metabolite concentrations were quantified by capillary electrophoresis mass spectrometry method. We performed linear regression analysis models with multi-variable adjustment and corrected p-values for multiple testing in the original population (n = 808). The robustness of the results was confirmed by replication analysis in a separate population (n = 385) created by random allocation. Results Higher levels of total physical activity were associated with various metabolite concentrations, including lower concentrations of amino acids and their derivatives, and higher concentrations of pipecolate (FDR p <0.05 in original population). The findings persisted after adjustment for age, body mass index, smoking, alcohol intake, and energy intake.	[Fukai, Kota; Harada, Sei; Kurihara, Ayako; Takeuchi, Ayano; Kuwabara, Kazuyo; Sugiyama, Daisuke; Okamura, Tomonori; Takebayashi, Toru] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Fukai, Kota; Harada, Sei; Kurihara, Ayako; Akiyama, Miki; Suzuki, Asako; Suzuki, Chizuru; Hirayama, Akiyoshi; Sugimoto, Masahiro; Soga, Tomoyoshi; Tomita, Masaru; Takebayashi, Toru] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Iida, Miho] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan; [Akiyama, Miki; Soga, Tomoyoshi; Tomita, Masaru] Keio Univ, Fac Environm & Informat Studies, Fujisawa, Kanagawa, Japan; [Nishiwaki, Yuji] Toho Univ, Fac Med, Dept Social Med, Div Environm & Occupat Hlth, Tokyo, Japan; [Oguma, Yuko] Keio Univ, Sports Med Res Ctr, Yokohama, Kanagawa, Japan; [Oguma, Yuko; Takebayashi, Toru] Keio Univ, Grad Sch Hlth Management, Fujisawa, Kanagawa, Japan	Keio University; Keio University; Keio University; Keio University; Toho University; Keio University; Keio University	Takebayashi, T (corresponding author), Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan.; Takebayashi, T (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.; Takebayashi, T (corresponding author), Keio Univ, Grad Sch Hlth Management, Fujisawa, Kanagawa, Japan.	ttakebayashi@keio.jp	Takebayashi, Toru/K-7526-2013; Soga, Tomoyoshi/B-8105-2014; Okamura, Tomonori/L-1693-2013; Takebayashi, Toru/AAB-9356-2019; Sugiyama, Daisuke/L-4347-2013; Fukai, Kota/P-9046-2017; Harada, Sei/ABA-5975-2020; Takeuchi, Ayano/C-3130-2019	Takebayashi, Toru/0000-0002-8268-8026; Soga, Tomoyoshi/0000-0001-9502-2509; Okamura, Tomonori/0000-0003-0488-0351; Takebayashi, Toru/0000-0002-8268-8026; Sugiyama, Daisuke/0000-0002-6487-8934; Fukai, Kota/0000-0002-8319-8467; Harada, Sei/0000-0003-2666-4932; Takeuchi, Ayano/0000-0002-0908-1850; Sugimoto, Masahiro/0000-0003-3316-2543	Yamagata Prefectural Government; city of Tsuruoka; Japan Society for the Promotion of Science [24390168, 15H04778]	Yamagata Prefectural Government; city of Tsuruoka; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by research funds from the Yamagata Prefectural Government and the city of Tsuruoka and by the Grant-in-Aid for Scientific Research (grant numbers 24390168 and 15H04778) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Aune D, 2015, EUR J EPIDEMIOL, V30, P529, DOI 10.1007/s10654-015-0056-z; Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Benjamini Y, 2001, ANN STAT, V29, P1165; Berg A, 1997, Eur J Med Res, V2, P259; Berger MA, 2013, J EPIDEMIOL, V23, P411, DOI 10.2188/jea.JE20120151; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; CONSOLI A, 1990, J CLIN INVEST, V86, P2038, DOI 10.1172/JCI114940; FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Harada S, 2016, ENVIRON HEALTH PREV, V21, P18, DOI 10.1007/s12199-015-0494-y; Hirayama A, 2015, ELECTROPHORESIS, V36, P2148, DOI 10.1002/elps.201400600; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Hsiao G, 2011, AM J PHYSIOL-ENDOC M, V300, pE164, DOI 10.1152/ajpendo.00219.2010; Imaeda N, 2007, J EPIDEMIOL, V17, P100, DOI 10.2188/jea.17.100; Inoue M, 2008, AM J EPIDEMIOL, V168, P391, DOI 10.1093/aje/kwn146; Kaino W, 2013, ENDOCR J, V60, P617, DOI 10.1507/endocrj.EJ12-0351; Kim AM, 2010, NATURE, V465, P688, DOI 10.1038/465688a; Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leskinen T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012609; Lustgarten MS, 2014, J GERONTOL A-BIOL, V69, P717, DOI 10.1093/gerona/glt152; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; Mamas M, 2011, ARCH TOXICOL, V85, P5, DOI 10.1007/s00204-010-0609-6; Menni C, 2013, DIABETES, V62, P4270, DOI 10.2337/db13-0570; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ohkawara K, 2007, INT J OBESITY, V31, P1786, DOI 10.1038/sj.ijo.0803683; Oshima Y, 2010, GAIT POSTURE, V31, P370, DOI 10.1016/j.gaitpost.2010.01.005; Patel MJ, 2013, OMICS, V17, P627, DOI 10.1089/omi.2013.0031; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Qin LQ, 2011, J NUTR, V141, P249, DOI 10.3945/jn.110.128520; Ramautar R, 2013, CURR OPIN CHEM BIOL, V17, P841, DOI 10.1016/j.cbpa.2013.06.015; Roberts LD, 2014, LANCET DIABETES ENDO, V2, P65, DOI 10.1016/S2213-8587(13)70143-8; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; Shimomura Y, 2004, J NUTR, V134, p1583S, DOI 10.1093/jn/134.6.1583S; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Tokudome Y, 2005, J EPIDEMIOL, V15, P135, DOI 10.2188/jea.15.135; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; vanHall G, 1996, J PHYSIOL-LONDON, V494, P899, DOI 10.1113/jphysiol.1996.sp021542; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wientzek A, 2014, INT J SPORT NUTR EXE, V24, P215, DOI 10.1123/ijsnem.2013-0048	52	43	43	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e164877	10.1371/journal.pone.0164877	http://dx.doi.org/10.1371/journal.pone.0164877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741291	Green Published, gold, Green Submitted			2022-12-26	WOS:000385507000076
J	Singh, A; Varela, C; Bhatt, K; Veerapen, N; Lee, OYC; Wu, HHT; Besra, GS; Minnikin, DE; Fujiwara, N; Teramoto, K; Bhatt, A				Singh, Albel; Varela, Cristian; Bhatt, Kiranmai; Veerapen, Natacha; Lee, Oona Y. C.; Wu, Houdini H. T.; Besra, Gurdyal S.; Minnikin, David E.; Fujiwara, Nagatoshi; Teramoto, Kanae; Bhatt, Apoorva			Identification of a Desaturase Involved in Mycolic Acid Biosynthesis in Mycobacterium smegmatis	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CYCLOPROPANE SYNTHETASE; FATTY-ACID; BOVIS BCG; TUBERCULOSIS; SYNTHASE; CATALYZES; REDUCTASE; BACILLUS; LEADS	Mycolic acids are unique long chain fatty acids found in the cell walls of mycobacteria including the tubercle bacillus, Mycobacterium tuberculosis. The introduction of double bonds in mycolic acids remains poorly understood, however, genes encoding two potential aerobic desaturases have been proposed to be involved in this process. Here we show that one of these genes, desA1, is essential for growth of the saprophytic Mycobacterium smegmatis. Depletion of desA1 in a M. smegmatis conditional mutant led to reduction of mycolic acid biosynthesis and loss of viability. The DesA1-depleted cells exhibited two other phenotypes: using (14)[C]-labelling, we detected the accumulation of minor mycolic acid-related species that migrated faster in a silver TLC plate. Spiral Time of Flight Mass Spectroscopic analysis suggested the presence of species with sizes corresponding to what were likely monoenoic derivatives of alpha-mycolic acids. Additionally, conditional depletion led to the presence of free fatty acyl species of lengths similar to C-26-C-48 in the lysing cells. Cell viability could be rescued in the conditional mutant by Mycobacterium tuberculosis desA1, highlighting the potential of desA1 as a new drug target in pathogenic mycobacteria.	[Singh, Albel; Varela, Cristian; Veerapen, Natacha; Lee, Oona Y. C.; Wu, Houdini H. T.; Besra, Gurdyal S.; Minnikin, David E.; Bhatt, Apoorva] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Singh, Albel; Varela, Cristian; Veerapen, Natacha; Lee, Oona Y. C.; Wu, Houdini H. T.; Besra, Gurdyal S.; Minnikin, David E.; Bhatt, Apoorva] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England; [Bhatt, Kiranmai] Heart England NHS Trust, Birmingham, W Midlands, England; [Fujiwara, Nagatoshi] Tezukayama Gakuin Univ, Fac Contemporary Human Life Sci, Dept Food & Nutr, Nara, Nara 6318585, Japan; [Teramoto, Kanae] JEOL Ltd, Adv & Fundamental Technol Ctr, Akishima, Tokyo 1968558, Japan	University of Birmingham; University of Birmingham; Heart of England NHS Foundation Trust; Jeol Ltd; JEOL Japan	Bhatt, A (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.; Bhatt, A (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.	a.bhatt@bham.ac.uk		Besra, Gurdyal/0000-0002-5605-0395	Medical Research Council (UK); Biotechnology and Biological Sciences Research Council [BB/N01314X/1] Funding Source: researchfish; Medical Research Council [MR/K00042X/1, G0600105, MR/K012118/1] Funding Source: researchfish; BBSRC [BB/N01314X/1] Funding Source: UKRI; MRC [MR/K00042X/1, G0600105, MR/K012118/1] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	KT is an employee of Jeol Ltd. The funder provided support in the form of salaries for author KT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section. AB received grant funding from the Medical Research Council (UK). The funder provided support did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	ASSELINE.CP, 1970, EUR J BIOCHEM, V14, P406, DOI 10.1111/j.1432-1033.1970.tb00304.x; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bernut A, 2016, MOL MICROBIOL, V99, P866, DOI 10.1111/mmi.13283; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; Bhatt A, 2008, CHEM BIOL, V15, P930, DOI 10.1016/j.chembiol.2008.07.007; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Bhatt Apoorva, 2008, V465, P325, DOI 10.1007/978-1-59745-207-6_22; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dobson G., 1985, CHEM METHODS BACTERI, P237; Dubnau E, 1997, MOL MICROBIOL, V23, P313, DOI 10.1046/j.1365-2958.1997.2301589.x; Dyer DH, 2005, PROTEIN SCI, V14, P1508, DOI 10.1110/ps.041288005; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2001, J BIOL CHEM, V276, P2228, DOI 10.1074/jbc.C000652200; HAGEN SR, 1995, J CHROMATOGR A, V692, P167, DOI 10.1016/0021-9673(94)00743-S; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; Larsen Michelle H, 2007, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10a02s6; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Nataraj V, 2015, MOL MICROBIOL, V98, P7, DOI 10.1111/mmi.13101; Phetsuksiri B, 2003, J BIOL CHEM, V278, P53123, DOI 10.1074/jbc.M311209200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Slayden RA, 1996, ANTIMICROB AGENTS CH, V40, P2813, DOI 10.1128/AAC.40.12.2813; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Teramoto Kanae, 2015, Mass Spectrom (Tokyo), V4, pA0035, DOI 10.5702/massspectrometry.A0035; Teramoto K, 2013, J ANTIBIOT, V66, P713, DOI 10.1038/ja.2013.79; Watanabe M, 2002, MICROBIOL-SGM, V148, P1881, DOI 10.1099/00221287-148-6-1881; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200	33	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164253	10.1371/journal.pone.0164253	http://dx.doi.org/10.1371/journal.pone.0164253			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741286	Green Published, gold, Green Submitted			2022-12-26	WOS:000385507000023
J	Ambrogio, C; Barbacid, M; Santamaria, D				Ambrogio, C.; Barbacid, M.; Santamaria, D.			In vivo oncogenic conflict triggered by co-existing KRAS and EGFR activating mutations in lung adenocarcinoma	ONCOGENE			English	Article							GROWTH-FACTOR-RECEPTOR; K-RAS ONCOGENE; CANCER; MUTANT; INHIBITORS; INDUCTION; CARCINOMA; FEATURES; CELLS; GENE	Activating mutations in KRAS and EGFR, the two most frequent oncogenes in human lung adenocarcinoma, are mutually exclusive, a phenotype attributed to functional redundancy implying lack of positive selection. Employing a mouse model expressing EGFR(L858R) in advanced Kras(G12V)-driven tumors we show that their mutual exclusivity can be explained by detrimental effects of their co-expression in lung adenocarcinoma. In vivo, expression of EGFR(L858R) in Kras(G12V)-driven tumors triggers replicative stress and apoptosis, while the surviving cells enter a transient cytostatic state incompatible with tumor development that is fully reversible upon discontinued EGFR(L858R) expression. Eventually, sustained expression of both mutants induces attenuation of oncogenic signaling to levels compatible with proliferation and tumor growth resulting in high sensitivity to Mek inhibition. Our results indicate that the mutual exclusivity of KRAS and EGFR mutations occurs as a combination of cellular toxicity and signal adjustment resulting in lack of selective advantage for cells expressing both oncogenes.	[Ambrogio, C.; Barbacid, M.; Santamaria, D.] CNIO, Expt Oncol, Mol Oncol Programme, Melchor Fernandez Almagro 3, Madrid 28029, Spain; [Ambrogio, C.] Dana Farber Canc Inst, Med Oncol, 360 Longwood Ave,LC-4112, Boston, MA 02215 USA	Centro Nacional de Investigaciones Oncologicas (CNIO); Harvard University; Dana-Farber Cancer Institute	Ambrogio, C; Santamaria, D (corresponding author), CNIO, Expt Oncol, Mol Oncol Programme, Melchor Fernandez Almagro 3, Madrid 28029, Spain.	chiara_ambrogio@dfci.harvard.edu; dsantamaria@cnio.es	Santamaria, David/D-3930-2011	Santamaria, David/0000-0002-4711-3569	European Research Council [ERC-AG/250297-RAS AEAD]; EU [HEALTH-F2-2010-259770/LUNGTARGET, HEALTH-2010-260791/EUROCANPLATFORM]; Spanish Ministry of Economy and Competitiveness [SAF2011-30173]; Autonomous Community of Madrid [S2011/BDM-2470/ONCO-CYCLE]; Spanish Association Against Cancer (AECC)	European Research Council(European Research Council (ERC)European Commission); EU(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Autonomous Community of Madrid; Spanish Association Against Cancer (AECC)	We thank J. Haigh for providing Rosa26-LSLrtTA mice. This work was supported by the European Research Council (ERC-AG/250297-RAS AEAD), EU-Framework Programme (HEALTH-F2-2010-259770/LUNGTARGET and HEALTH-2010-260791/EUROCANPLATFORM), Spanish Ministry of Economy and Competitiveness (SAF2011-30173) and Autonomous Community of Madrid (S2011/BDM-2470/ONCO-CYCLE) to MB. CA is the recipient of a postdoctoral fellowship from the Spanish Association Against Cancer (AECC). We thank A. Ventura, O. Segatto and T. Cash for critical reading of the manuscript and S. Anton for constructive discussion.	Ambrogio C, 2015, BIOPROTOCOL, V5, pe1692; Ambrogio C, 2014, CANCER RES, V74, P5978, DOI 10.1158/0008-5472.CAN-14-1606; Anastasi S, 2016, SEMIN CELL DEV BIOL, V50, P115, DOI 10.1016/j.semcdb.2015.10.001; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Choughule A, 2014, BRIT J CANCER, V111, P2203, DOI 10.1038/bjc.2014.401; Cisowski J, 2015, ONCOGENE, V35, P1; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Guha U, 2008, P NATL ACAD SCI USA, V105, P14112, DOI 10.1073/pnas.0806158105; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Li S, 2014, BRIT J CANCER, V110, P2812, DOI 10.1038/bjc.2014.210; Maity TK, 2015, CANCER DISCOV, V5, P534, DOI 10.1158/2159-8290.CD-14-0750; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pikor LA, 2013, LUNG CANCER, V82, P179, DOI 10.1016/j.lungcan.2013.07.025; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Segatto O, 2011, J CELL SCI, V124, P1785, DOI 10.1242/jcs.083303; Sharifnia T, 2014, P NATL ACAD SCI USA, V111, P18661, DOI 10.1073/pnas.1412228112; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Sun C, 2014, TRENDS BIOCHEM SCI, V39, P465, DOI 10.1016/j.tibs.2014.08.010; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Tam IYS, 2006, CLIN CANCER RES, V12, P1647, DOI 10.1158/1078-0432.CCR-05-1981; Unni AM, 2015, ELIFE, V4, DOI 10.7554/eLife.06907; Xu AM, 2010, CANCER RES, V70, P3857, DOI 10.1158/0008-5472.CAN-10-0163	28	18	18	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 20	2017	36	16					2309	2318		10.1038/onc.2016.385	http://dx.doi.org/10.1038/onc.2016.385			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DM	27775074				2022-12-26	WOS:000399782700011
J	Zhang, F; Liu, GY; Wei, CJ; Gao, C; Hao, JW				Zhang, Fang; Liu, Guiyou; Wei, Changjuan; Gao, Chao; Hao, Junwei			Linc-MAF-4 regulates T(h)1/T(h)2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF	FASEB JOURNAL			English	Article						CD4(+) T cell; long noncoding RNAs; autoimmune diseases	CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LONG NONCODING RNAS; IMMUNE-SYSTEM; IFN-BETA; CELLS; EXPRESSION; RESPONSES	In this study, we strove to substantiate the ability of linc-MAF-4 to act as a regulator of pathogenesis during multiple sclerosis (MS). We recruited 34 patients who were diagnosed with MS according to the revised McDonald criteria. Six patients with MS and 5 healthy volunteers contributed peripheral blood mononuclear cells for microarray analysis. Subsequent knockdown and overexpression of linc-MAF-4 in naive CD4(+) T cells from the additional 28 patients with MS was performed to track changes in CD4+ T-cell subsets and their function, as well as to confirm results from the prior microarray analysis. Expression of linc-MAF-4 increased significantly in peripheral blood mononuclear cells of patients with MS compared with those of control participants. In addition, linc-MAF-4 regulated encephalitogenic T helper (Th) 1-cell differentiation in patients with MS. Transfection of synthetic linc-MAF-4 into naive CD4+ T cells facilitated T(h)1-cell differentiation and inhibited T(h)2-cell differentiation by directly inhibiting MAF, which is T(h)2-cell transcription factor. Linc-MAF-4 also promoted activation of CD4(+) Tcells from patients with MS. Expression level of linc-MAF-4 correlated with the annual relapse rate in patients with MS. Our results suggest that linc-MAF-4 is involved in the pathogenesis of MS, specifically via regulation of encephalitogenic T cells. Zhang, F., Liu, G., Wei, C., Gao, C., Hao, J. Linc-MAF-4 regulates T(h)1/T(h)2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF.	[Zhang, Fang; Wei, Changjuan; Gao, Chao; Hao, Junwei] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Anshan Rd, Tianjin 300052, Peoples R China; [Liu, Guiyou] Harbin Inst Technol, Sch Life Sci & Technol, Harbin, Peoples R China	Tianjin Medical University; Harbin Institute of Technology	Hao, JW (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Anshan Rd, Tianjin 300052, Peoples R China.	hjw@tmu.edu.cn		Liu, Guiyou/0000-0002-1126-2888; Hao, Junwei/0000-0002-3075-5434	National Natural Science Foundation of China [81571600, 81322018, 81273287, 81100887]; Youth Top-notch Talent Support Program; National Key Clinical Specialty Construction Project of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Top-notch Talent Support Program; National Key Clinical Specialty Construction Project of China	The authors thank their patients for participating in this study. This work supported by the National Natural Science Foundation of China (Grants 81571600, 81322018, 81273287, and 81100887; to J.H.), the Youth Top-notch Talent Support Program, and the National Key Clinical Specialty Construction Project of China. The authors declare no conflicts of interest.	Aharoni R, 2000, P NATL ACAD SCI USA, V97, P11472, DOI 10.1073/pnas.97.21.11472; Atianand MK, 2016, CELL, V165, P1672, DOI 10.1016/j.cell.2016.05.075; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Cao YH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8038; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Iaffaldano P, 2011, EXPERT REV NEUROTHER, V11, P1683, DOI [10.1586/ERN.11.154, 10.1586/ern.11.154]; Iiott NE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4979; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Kasper LH, 2010, NEUROLOGY, V74, pS2, DOI 10.1212/WNL.0b013e3181c97c8f; Kieseier BC, 2003, SEMIN NEUROL, V23, P133; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Meira M, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/897249; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093; Rasouli J, 2015, J IMMUNOL, V194, P5085, DOI 10.4049/jimmunol.1403243; Satpathy AT, 2015, IMMUNITY, V42, P792, DOI 10.1016/j.immuni.2015.05.004; Schmitt Nathalie, 2015, J Nat Sci, V1, pe139; Tao YZ, 2014, J IMMUNOL, V192, P5610, DOI 10.4049/jimmunol.1302580; Turner M, 2014, NAT IMMUNOL, V15, P484, DOI 10.1038/ni.2887; Wan GH, 2013, EMBO J, V32, P2833, DOI 10.1038/emboj.2013.221; Zhang F, 2016, CNS NEUROSCI THER, V22, P298, DOI 10.1111/cns.12498	23	60	67	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					519	525		10.1096/fj.201600838R	http://dx.doi.org/10.1096/fj.201600838R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27756768				2022-12-26	WOS:000394235400008
J	Tang, Y; Chen, AQ; Chen, Y; Guo, LX; Dai, HF; Huang, Y; Chen, QQ; Lin, C				Tang, Ying; Chen, Aiqin; Chen, Yu; Guo, Lixia; Dai, Hengfen; Huang, Yang; Chen, Qianqian; Lin, Chun			Zeta Inhibitory Peptide as a Novel Therapy to Control Chronic Visceral Hypersensitivity in a Rat Model	PLoS One			English	Article							IRRITABLE-BOWEL-SYNDROME; KINASE M-ZETA; LONG-TERM POTENTIATION; PERSISTENT NOCICEPTIVE SENSITIZATION; PKM-ZETA; NEUROPATHIC PAIN; PERIPHERAL INFLAMMATION; MAINTENANCE MECHANISM; NMDA RECEPTORS; ATYPICAL PKC	Background The pathogenesis of multiple chronic visceral pain syndromes, such as irritable bowel syndrome (IBS), is not well known, and as a result current therapies are ineffective. The objective of this study was to investigate the effect of spinal protein kinase M zeta (PKM zeta)on visceral pain sensitivity in rats with IBS to better understand the pathogenesis and investigate the effect of zeta inhibitory peptide (ZIP) as a therapy for chronic visceral pain. Methods Visceral hypersensitivity rats were produced by neonatal maternal separation (NMS). Visceral pain sensitivity was assessed by electromyographic (EMG) responses of abdominal muscles to colorectal distention (CRD). Spinal PKM zeta and phosphorylated PKM zeta(p-PKM zeta) were detected by western blot. Varying doses of ZIP were intrathecally administered to investigate the role of spinal PKM zeta in chronic visceral hypersensitivity. The open field test was used to determine if ZIP therapy causes spontaneous motor activity side effects. Results Graded CRD pressure significantly increased EMG responses in NMS rats compared to control rats (p< 0.05). p-PKM zeta expression increased in the thoracolumbar and lumbosacral spinal cord in the IBS-like rats with notable concomitant chronic visceral pain compared to control rats (p< 0.05). EMG data revealed that intrathecal ZIP injection (1, 5, and 10 mu g) dose-dependently attenuated visceral pain hypersensitivity in IBS-like rats. Conclusions Phosphorylated PKM zeta may be involved in the spinal central sensitization of chronic visceral hypersensitivity in IBS, and administration of ZIP could effectively treat chronic visceral pain with good outcomes in rat models.	[Tang, Ying; Chen, Aiqin; Chen, Yu; Dai, Hengfen; Huang, Yang; Chen, Qianqian; Lin, Chun] Fujian Med Univ, Basic Med Coll, Lab Pain Res,Neurosci Res Ctr, Key Lab Brain Aging & Neurodegenerat Dis, Fuzhou 350108, Fujian, Peoples R China; [Guo, Lixia] Pingxiang Peoples Hosp, Dept Pathol, Pingxiang 337000, Jiangxi, Peoples R China	Fujian Medical University	Lin, C (corresponding author), Fujian Med Univ, Basic Med Coll, Lab Pain Res,Neurosci Res Ctr, Key Lab Brain Aging & Neurodegenerat Dis, Fuzhou 350108, Fujian, Peoples R China.	chunlin77550@126.com			National Natural Science Foundation of China [81471138, 81500416]; Natural Science Foundation of Fujian Province [2014J01124, 2015J01315]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	The present work was supported by grants from the National Natural Science Foundation of China (81471138 and 81500416), and the Natural Science Foundation of Fujian Province (2014J01124 and 2015J01315).	Al-Chaer ED, 2002, PAIN, V96, P221, DOI 10.1016/S0304-3959(02)00046-5; Alstott J, 2009, BEHAV BRAIN RES, V196, P214, DOI 10.1016/j.bbr.2008.09.001; An K, 2015, EUR J PAIN, V19, P39, DOI 10.1002/ejp.517; Asiedu MN, 2011, J NEUROSCI, V31, P6646, DOI 10.1523/JNEUROSCI.6286-10.2011; Bellini M, 2014, WORLD J GASTROENTERO, V20, P8807, DOI 10.3748/wjg.v20.i27.8807; Chen AQ, 2015, J NEUROPHYSIOL, V113, P3047, DOI 10.1152/jn.00929.2014; Chen Y, 2014, BRAIN RES, V1570, P43, DOI 10.1016/j.brainres.2014.05.001; Coutinho S V, 2000, Prog Brain Res, V129, P375; Coutinho SV, 2002, AM J PHYSIOL-GASTR L, V282, pG307, DOI 10.1152/ajpgi.00240.2001; El-Salhy M, 2014, EXPERT REV GASTROENT, V8, P435, DOI 10.1586/17474124.2014.888952; Ford Alexander C, 2012, Gastroenterology, V143, P1683, DOI 10.1053/j.gastro.2012.10.006; Guerin Annie, 2014, J Med Econ, V17, P577, DOI 10.3111/13696998.2014.919926; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Ho SY, 2012, BIOL PSYCHIAT, V71, P706, DOI 10.1016/j.biopsych.2011.10.031; JANIG W, 1990, J AUTONOM NERV SYST, V30, pS89, DOI 10.1016/0165-1838(90)90108-U; Kannampalli P, 2014, NEUROGASTROENT MOTIL, V26, P1694, DOI 10.1111/nmo.12450; King T, 2012, PAIN, V153, P1263, DOI 10.1016/j.pain.2012.03.006; Laferriere A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-99; Lee AM, 2013, NATURE, V493, P416, DOI 10.1038/nature11803; Li XY, 2010, SCIENCE, V330, P1400, DOI 10.1126/science.1191792; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Luo XQ, 2014, BRAIN RES, V1542, P167, DOI 10.1016/j.brainres.2013.10.008; Maneerattanaporn Monthira, 2010, Gastroenterology, V139, P348, DOI 10.1053/j.gastro.2010.05.033; Marchand F, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-86; Melemedjian OK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-12; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; Parsons CG, 2001, EUR J PHARMACOL, V429, P71, DOI 10.1016/S0014-2999(01)01307-3; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Rafiei R, 2014, J RES MED SCI, V19, P913; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Shao CY, 2012, HIPPOCAMPUS, V22, P1501, DOI 10.1002/hipo.20996; Stuardi T, 2012, J ALTERN COMPLEM MED, V18, P1021, DOI 10.1089/acm.2011.0670; Tanaka T, 2011, AM J PHYSIOL-GASTR L, V300, pG418, DOI 10.1152/ajpgi.00456.2010; Traub RJ, 1999, PEPTIDES, V20, P267, DOI 10.1016/S0196-9781(98)00157-0; Wesselmann Ursula, 2009, Drug Discov Today Ther Strateg, V6, P89, DOI 10.1016/j.ddstr.2009.05.001; Yao YD, 2013, NEUROPHARMACOLOGY, V64, P37, DOI 10.1016/j.neuropharm.2012.07.018	37	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0163324	10.1371/journal.pone.0163324	http://dx.doi.org/10.1371/journal.pone.0163324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776136	Green Published, Green Submitted, gold			2022-12-26	WOS:000389009200004
J	de Carvalho, PR; Ropero, DR; Pinheiro, MM; Fernandes, PD; Boylan, F				de Carvalho, Patricia Ribeiro; Ropero, Denise Ricoy; Pinheiro, Mariana Martins; Fernandes, Patricia Dias; Boylan, Fabio			Quinoline Alkaloids Isolated from Choisya Aztec-Pearl and Their Contribution to the Overall Antinociceptive Activity of This Plant	PLOS ONE			English	Article							ZANTHOXYLUM-RHOIFOLIUM; ORBIGNYA-SPECIOSA; NICOTINIC RECEPTORS; ETHANOL EXTRACT; TERNATA KUNTH; IN-VITRO; PAIN; CLONIDINE; MECHANISM; LEAVES	Choisya 'Aztec-Pearl', a hybrid of Choisya ternata and Choisya dumosa var. arizonica, had the antinociceptive activity in the ethanol extract (EECA) of its leaves evaluated. Two quinoline alkaloids, anhydroevoxine (A) and choisyine (C), isolated from these leaves were also tested. The results obtained pointed out to a very high antinociceptive activity measured by the hot plate model for EECA (at doses of 10, 30 and 100 mg/kg) as well as for A and C (at doses of 1, 3 and 10 mg/kg). The magnitude of the activity was two-fold higher than the one observed for the morphine treated animals for the higher doses of extracts/compounds (30, 100 mg/kg and 3, 10 mg/kg respectively). The mechanism of action for this activity was also investigated and it seems that for EECA as well as A and C, the opiate system plays an important role. Results have also shown that the nitric oxide (NO) system also play a pivotal role in the case of EECA and A while for C it seems that the cholinergic system have some involvement. The acute toxicity was evaluated for EECA with results showing no important toxic effect.	[de Carvalho, Patricia Ribeiro; Pinheiro, Mariana Martins; Fernandes, Patricia Dias] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Dor & Inflamacao, Rio De Janeiro, Brazil; [Ropero, Denise Ricoy; Boylan, Fabio] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Pharm & Pharmaceut Sci, Dublin, Ireland	Universidade Federal do Rio de Janeiro; Trinity College Dublin	Boylan, F (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Pharm & Pharmaceut Sci, Dublin, Ireland.	Fabio.boylan@tcd.ie	Fernandes, Patricia Dias/W-1565-2019; Boylan, Fabio/K-9707-2015	Fernandes, Patricia Dias/0000-0001-6870-6745; Boylan, Fabio/0000-0001-5531-1787	SFI (Science Foundation Ireland); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior); FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); High Education Authority's Programme for Research in Third- Level Institutions Cycle 5; SFI programme ISCA-Brazil [SFI/13/ISCA/2843]; CAPES [BEX 5962 13-7]; FAPERJ [E26/203.018/2015]; CNPq [401683/2013-3]	SFI (Science Foundation Ireland)(Science Foundation Ireland); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); High Education Authority's Programme for Research in Third- Level Institutions Cycle 5; SFI programme ISCA-Brazil; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financed by the following granting agencies: SFI (Science Foundation Ireland), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior), FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), the High Education Authority's Programme for Research in Third- Level Institutions Cycle 5's funding support for TBSI. SFI programme ISCA-Brazil Grant no. SFI/13/ISCA/2843, CAPES Grant no BEX 5962 13-7, FAPERJ Grant no E26/203.018/2015, CNPq Grant no 401683/2013-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors from Brazil thank Mr. Alan Minho for technical assistance and the Instituto Vital Brazil for donations of animals used. They also want to acknowledge the grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The authors from Ireland wish to acknowledge the High Education Authority's Programme for Research in Third- Level Institutions Cycle 5's funding support for TBSI and to reinforce the importance of SFI programme ISCA-Brazil (Grant no. SFI/13/ISCA/2843) that contributed to the collaborative work between Brazil and Ireland.	Abdul-Wahab I.R., 2012, PLANTA MED, V78, P1597, DOI [10.1055/s-0032-1315044, DOI 10.1055/S-0032-1315044]; Abdul-Wahab IR, 2012, J ETHNOPHARMACOL, V144, P741, DOI 10.1016/j.jep.2012.10.029; Aceto MD, 1997, EUR J PHARMACOL, V338, P215, DOI 10.1016/S0014-2999(97)81924-3; Benson L, 1943, AM J BOT, V30, P630, DOI 10.2307/2437477; Bessonova I.A., 1982, KHIM PRIR SOEDIN, V4, P530; Boyd DR, 2007, ORG BIOMOL CHEM, V5, P2983, DOI 10.1039/b707576f; Boyd DR, 2002, CHEM COMMUN, P3070, DOI 10.1039/b208978e; Bruehl S, 2009, NEUROSCI BIOBEHAV R, V33, P475, DOI 10.1016/j.neubiorev.2008.12.003; Cragg GM, 1997, J NAT PROD, V60, P52, DOI 10.1021/np9604893; Cruz G.L., 1995, DICIONARIO PLANTAS U, V5, P436; Dayton W.A., 1931, IMPORTANT W BROWSE P, P1931; de Moura NF, 1997, PHYTOCHEMISTRY, V46, P1443, DOI 10.1016/S0031-9422(97)00498-6; Duflo F, 2003, ANESTHESIOLOGY, V98, P1237, DOI 10.1097/00000542-200305000-00028; Dussor GO, 2004, PAIN, V107, P22, DOI 10.1016/j.pain.2003.09.022; EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385; FROLOVA VI, 1963, ZH OBSHCH KHIM+, V33, P121; Ghelardini C, 2004, PHARMACOL RES, V50, P351, DOI 10.1016/j.phrs.2004.02.005; Pinheiro MMG, 2014, EUR J PHARMACOL, V727, P106, DOI 10.1016/j.ejphar.2013.12.042; Pinheiro MMG, 2012, LIFE SCI, V91, P293, DOI 10.1016/j.lfs.2012.06.013; Gonzaga WD, 2003, PLANTA MED, V69, P773, DOI 10.1055/s-2003-42783; GRUNDON MF, 1974, J CHEM SOC CHEM COMM, P51, DOI 10.1039/c39740000051; HOOD DD, 1995, ANESTHESIOLOGY, V82, P331, DOI 10.1097/00000542-199502000-00003; Ji RR, 2004, SCI STKE, V2004; JOHNS SR, 1967, AUST J CHEM, V20, P1975, DOI 10.1071/CH9671975; Jullian V, 2006, J ETHNOPHARMACOL, V106, P348, DOI 10.1016/j.jep.2006.01.011; Lancaster R, 1991, SHRUBS SEASONS; LORKE D, 1983, ARCH TOXICOL, V54, P275, DOI 10.1007/BF01234480; Martins FO, 2009, NAT PROD COMMUN, V4, P1693; Matheus ME, 2005, J ETHNOPHARMACOL, V102, P377, DOI 10.1016/j.jep.2005.06.033; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Moreira Déborah Luíza, 2009, Polibotánica, P159; MULLER CORNELIUS H., 1940, AMER MIDLAND NAT, V24, P729, DOI 10.2307/2420869; Niv D, 2001, Pain Pract, V1, P150, DOI 10.1046/j.1533-2500.2001.01016.x; Otuki MF, 2005, J PHARMACOL EXP THER, V313, P310, DOI 10.1124/jpet.104.071779; Pan HL, 1999, ANESTHESIOLOGY, V90, P509, DOI 10.1097/00000542-199902000-00027; Pinheiro MMG, 2013, J ETHNOPHARMACOL, V146, P324, DOI 10.1016/j.jep.2012.12.053; Pinheiro MMG, 2010, J ETHNOPHARMACOL, V127, P407, DOI 10.1016/j.jep.2009.10.025; Radulovic N, 2012, FOOD CHEM TOXICOL, V50, P274, DOI 10.1016/j.fct.2011.10.060; Radulovic NS, 2013, PHYTOTHER RES, V27, P1334, DOI 10.1002/ptr.4877; Radulovic NS, 2011, J ETHNOPHARMACOL, V135, P610, DOI 10.1016/j.jep.2011.03.035; de Souza PAVR, 2011, J ETHNOPHARMACOL, V135, P135, DOI 10.1016/j.jep.2011.03.003; Renno MN, 2008, AN ACAD BRAS CIENC, V80, P467, DOI 10.1590/S0001-37652008000300008; SAHLEY TL, 1979, PSYCHOPHARMACOLOGY, V65, P279, DOI 10.1007/BF00492216; Tabarelli Z, 2004, BRAZ J MED BIOL RES, V37, P1531, DOI 10.1590/S0100-879X2004001000013; TJOLSEN A, 1991, J PHARMACOL METHOD, V25, P241, DOI 10.1016/0160-5402(91)90014-V; Woodcock J, 2007, NAT REV DRUG DISCOV, V6, P703, DOI 10.1038/nrd2335; Xie YF, 2009, ACTA PHARMACOL SIN, V30, P31, DOI 10.1038/aps.2008.14; Xu ZM, 2000, BRAIN RES, V861, P390, DOI 10.1016/S0006-8993(00)02051-5; ZIMET PO, 1986, DRUG DEVELOP RES, V7, P277, DOI 10.1002/ddr.430070309	49	5	5	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164998	10.1371/journal.pone.0164998	http://dx.doi.org/10.1371/journal.pone.0164998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768733	Green Published, gold			2022-12-26	WOS:000386205400042
J	Kesely, KR; Pantaleo, A; Turrini, FM; Olupot-Olupot, P; Low, PS				Kesely, Kristina R.; Pantaleo, Antonella; Turrini, Francesco M.; Olupot-Olupot, Peter; Low, Philip S.			Inhibition of an Erythrocyte Tyrosine Kinase with Imatinib Prevents Plasmodium falciparum Egress and Terminates Parasitemia	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; N-DESMETHYL-IMATINIB; RED-BLOOD-CELLS; SYBR GREEN I; MOLECULAR-MECHANISM; INFECTED ERYTHROCYTES; TYR-PHOSPHORYLATION; MALARIA PARASITES; BAND-3 PROTEIN; MEMBRANE	With half of the world's population at risk for malaria infection and with drug resistance on the rise, the search for mutation-resistant therapies has intensified. We report here a therapy for Plasmodium falciparum malaria that acts by inhibiting the phosphorylation of erythrocyte membrane band 3 by an erythrocyte tyrosine kinase. Because tyrosine phosphorylation of band 3 causes a destabilization of the erythrocyte membrane required for parasite egress, inhibition of the erythrocyte tyrosine kinase leads to parasite entrapment and termination of the infection. Moreover, because one of the kinase inhibitors to demonstrate antimalarial activity is imatinib, i.e. an FDA-approved drug authorized for use in children, translation of the therapy into the clinic will be facilitated. At a time when drug resistant strains of P. falciparum are emerging, a strategy that targets a host enzyme that cannot be mutated by the parasite should constitute a therapeutic mechanism that will retard evolution of resistance.	[Kesely, Kristina R.; Low, Philip S.] Purdue Univ, Purdue Inst Drug Discovery, W Lafayette, IN 47907 USA; [Kesely, Kristina R.; Low, Philip S.] Purdue Univ, Purdue Dept Chem, W Lafayette, IN 47907 USA; [Pantaleo, Antonella] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Turrini, Francesco M.] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Olupot-Olupot, Peter] Mbale Reg Referral Hosp, Dept Paediat, Res Unit, Mbale, Uganda	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Sassari; University of Turin	Low, PS (corresponding author), Purdue Univ, Purdue Inst Drug Discovery, W Lafayette, IN 47907 USA.; Low, PS (corresponding author), Purdue Univ, Purdue Dept Chem, W Lafayette, IN 47907 USA.	plow@purdue.edu	Pantaleo, Antonella/ABA-5190-2020	Low, Philip/0000-0001-9042-5528	National Institutes of Health [5R01GM024417-35]; Mbale Regional Referral Hospital Department of Paediatrics and Hospital leadership;  [P30 CA023168]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mbale Regional Referral Hospital Department of Paediatrics and Hospital leadership; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported (in part) by research funding by a grant from the National Institutes of Health (5R01GM024417-35) and a gift from the Hurvis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Drs. Kasturi Haldar and Brian Grimberg for their help in establishing our initial malaria cultures. We would also like to acknowledge the help of Drs. Tom Williams and Kathryn Maitland in arranging the studies in Uganda. The authors thank Dr. Karson S. Putt for a critical proof reading of the manuscript figures and helpful discussion. Finally, we would like to thank Mbale Regional Referral Hospital Department of Paediatrics and Hospital leadership for their support. Flow cytometry data were acquired by the Purdue University Flow Cytometry and Cell Sorting Facility, supported by P30 CA023168. The following reagents were obtained through the MR4 as part of the BEI Resources Repository, NIAID, NIH: Plasmodium falciparum Dd2, MRA-156, deposited by TE Wellems; Plasmodium falciparum FUP UGANDA-PALO. The Journal cover showing entrapped malarial schizonts circulating among healthy erythrocytes was created by Michael E. Hoerter of the ITAP Envision Center at Purdue University. ALTO, MRA-915, deposited by T Sam-Yellowe. The journal cover showing erythrocytes with entrapped merozoites was created by Michael E. Hoerter of the ITAP Envision Center at Purdue University.	Alam MM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8285; Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; BENNETT V, 1980, J BIOL CHEM, V255, P6424; Bordin L, 2005, MOL MEMBR BIOL, V22, P411, DOI 10.1080/09687860500233679; Bordin L, 2005, BBA-MOL CELL RES, V1745, P20, DOI 10.1016/j.bbamcr.2004.12.010; Bornhauser M, 2005, J CLIN ONCOL, V23, P3855, DOI 10.1200/JCO.2005.05.246; Brizuela M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092411; Bruderer S, 2015, ANTIMICROB AGENTS CH, V59, P935, DOI 10.1128/AAC.04125-14; Brunati AM, 1996, EUR J BIOCHEM, V240, P394, DOI 10.1111/j.1432-1033.1996.0394h.x; Brunati AM, 2000, BLOOD, V96, P1550, DOI 10.1182/blood.V96.4.1550.h8001550_1550_1557; Champagne MA, 2004, BLOOD, V104, P2655, DOI 10.1182/blood-2003-09-3032; Chandramohanadas R, 2009, SCIENCE, V324, P794, DOI 10.1126/science.1171085; Chiou E, 2015, INT J BIOCHEM CELL B, V65, P40, DOI 10.1016/j.biocel.2015.05.013; CHISHTI AH, 1994, BLOOD, V83, P3339; Chu HY, 2008, BLOOD, V111, P932, DOI 10.1182/blood-2007-07-100180; Chu HY, 2006, BIOCHEM J, V400, P143, DOI 10.1042/BJ20060792; Combrinck JM, 2013, ACS CHEM BIOL, V8, P133, DOI 10.1021/cb300454t; Cyrklaff M, 2011, SCIENCE, V334, P1283, DOI 10.1126/science.1213775; DeFranceschi L, 1997, J CLIN INVEST, V99, P220, DOI 10.1172/JCI119150; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; Ferru E, 2011, BLOOD, V117, P5998, DOI 10.1182/blood-2010-11-317024; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Foley M, 1998, PHARMACOL THERAPEUT, V79, P55, DOI 10.1016/S0163-7258(98)00012-6; Gambacorti-Passerini C, 2011, JNCI-J NATL CANCER I, V103, P553, DOI 10.1093/jnci/djr060; Graciotti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085391; HARRISON ML, 1994, J BIOL CHEM, V269, P955; Izumiyama S, 2009, EXP PARASITOL, V121, P144, DOI 10.1016/j.exppara.2008.10.008; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; Kamau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071539; Klein EY, 2013, INT J ANTIMICROB AG, V41, P311, DOI 10.1016/j.ijantimicag.2012.12.007; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2012, MICROBES INFECT, V14, P811, DOI 10.1016/j.micinf.2012.04.008; le Coutre P, 2004, CANCER CHEMOTH PHARM, V53, P313, DOI 10.1007/s00280-003-0741-6; Le Nagard H, 2011, COMPUT METH PROG BIO, V104, P10, DOI 10.1016/j.cmpb.2010.08.003; Low HY, 2012, CELL MOL LIFE SCI, V69, P1523, DOI 10.1007/s00018-011-0888-y; LOW PS, 1987, J BIOL CHEM, V262, P4592; LOW PS, 1991, BLOOD, V77, P1581; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Manno S, 2005, J BIOL CHEM, V280, P7581, DOI 10.1074/jbc.M410650200; Marangon E, 2009, CANCER CHEMOTH PHARM, V63, P563, DOI 10.1007/s00280-008-0764-0; Mbengue A, 2015, NATURE, V520, P683, DOI 10.1038/nature14412; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Millholland MG, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010678-1, 10.1074/mcp.M111.010678]; Minetti G, 1998, BIOCHEM J, V335, P305, DOI 10.1042/bj3350305; Minetti G, 1996, BIOCHEM J, V320, P445, DOI 10.1042/bj3200445; Murphy SC, 2006, PLOS MED, V3, P2403, DOI 10.1371/journal.pmed.0030528; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Pantaleo A, 2012, FREE RADICAL BIO MED, V52, P527, DOI 10.1016/j.freeradbiomed.2011.11.008; Pantaleo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015847; Pantaleo A, 2010, PROTEOMICS, V10, P3469, DOI 10.1002/pmic.201000269; Pantaleo A, 2009, BIOCHEM J, V418, P359, DOI 10.1042/BJ20081557; Peng B, 2004, J CLIN ONCOL, V22, P935, DOI 10.1200/JCO.2004.03.050; RIVADENEIRA EM, 1983, J PROTOZOOL, V30, P367, DOI 10.1111/j.1550-7408.1983.tb02932.x; Rosenthal PJ, 2011, ADV EXP MED BIOL, V712, P30, DOI 10.1007/978-1-4419-8414-2_3; Sicard A, 2011, CELL MICROBIOL, V13, P836, DOI 10.1111/j.1462-5822.2011.01582.x; Skinner TS, 1996, INT J PARASITOL, V26, P519, DOI 10.1016/0020-7519(96)89380-5; Smith BD, 2011, JNCI-J NATL CANCER I, V103, P527, DOI 10.1093/jnci/djr073; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Sullivan DJ, 2013, P NATL ACAD SCI USA, V110, P4866, DOI 10.1073/pnas.1301607110; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vaid A, 2010, BLOOD, V115, P2500, DOI 10.1182/blood-2009-08-238972; van den Akker E, 2010, BLOOD CELL MOL DIS, V45, P1, DOI 10.1016/j.bcmd.2010.02.019; Verma R, 2013, HUM VACC IMMUNOTHER, V9, P1268, DOI 10.4161/hv.23950; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; WASSERMAN M, 1990, PARASITOL RES, V76, P681, DOI 10.1007/BF00931087; Wells TNC, 2015, NAT REV DRUG DISCOV, V14, P424, DOI 10.1038/nrd4573; White NJ, 2014, NEW ENGL J MED, V371, P403, DOI 10.1056/NEJMoa1315860; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2007, WORKING FOR HEALTH A	73	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164895	10.1371/journal.pone.0164895	http://dx.doi.org/10.1371/journal.pone.0164895			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768734	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400035
J	Lu, GQ; Xiong, Y; Ding, C; Wang, YP				Lu, Guangquan; Xiong, Ying; Ding, Chuan; Wang, Yunpeng			An Optimal Schedule for Urban Road Network Repair Based on the Greedy Algorithm	PLOS ONE			English	Article							TRANSPORTATION NETWORKS; EMERGENCY RESPONSE; LINKS; INFRASTRUCTURE; ACCESSIBILITY; VULNERABILITY; ROBUSTNESS; PROTECTION; DISASTERS; RESOURCE	The schedule of urban road network recovery caused by rainstorms, snow, and other bad weather conditions, traffic incidents, and other daily events is essential. However, limited studies have been conducted to investigate this problem. We fill this research gap by proposing an optimal schedule for urban road network repair with limited repair resources based on the greedy algorithm. Critical links will be given priority in repair according to the basic concept of the greedy algorithm. In this study, the link whose restoration produces the ratio of the system-wide travel time of the current network to the worst network is the minimum. We define such a link as the critical link for the current network. We will re-evaluate the importance of damaged links after each repair process is completed. That is, the critical link ranking will be changed along with the repair process because of the interaction among links. We repair the most critical link for the specific network state based on the greedy algorithm to obtain the optimal schedule. The algorithm can still quickly obtain an optimal schedule even if the scale of the road network is large because the greedy algorithm can reduce computational complexity. We prove that the problem can obtain the optimal solution using the greedy algorithm in theory. The algorithm is also demonstrated in the Sioux Falls network. The problem discussed in this paper is highly significant in dealing with urban road network restoration.	[Lu, Guangquan; Xiong, Ying; Ding, Chuan; Wang, Yunpeng] Beihang Univ, Beijing Key Lab Cooperat Vehicle Infrastruct Syst, Sch Transportat Sci & Engn, Beijing 100191, Peoples R China; [Lu, Guangquan; Xiong, Ying; Ding, Chuan; Wang, Yunpeng] Jiangsu Prov Collaborat Innovat Ctr Modern Urban, Si Pai Lou 2, Nanjing 210096, Jiangsu, Peoples R China	Beihang University	Ding, C (corresponding author), Beihang Univ, Beijing Key Lab Cooperat Vehicle Infrastruct Syst, Sch Transportat Sci & Engn, Beijing 100191, Peoples R China.; Ding, C (corresponding author), Jiangsu Prov Collaborat Innovat Ctr Modern Urban, Si Pai Lou 2, Nanjing 210096, Jiangsu, Peoples R China.	cding@buaa.edu.cn	Ding, Chuan/P-5105-2016	Ding, Chuan/0000-0001-9560-8585	National Natural Science Foundation of China [U1564212, 71503018]; Science and Technology Project on Transportation Construction by the Ministry of Transport of China [2015318221020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project on Transportation Construction by the Ministry of Transport of China	This work is partly supported by the National Natural Science Foundation of China (U1564212, 71503018) and the Science and Technology Project on Transportation Construction by the Ministry of Transport of China (2015318221020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is partly supported by the National Natural Science Foundation of China (U1564212, 71503018), and the Science and Technology Project on Transportation Construction by the Ministry of Transport of China (2015318221020).	Aksu DT, 2014, TRANSPORT RES E-LOG, V61, P56, DOI 10.1016/j.tre.2013.10.009; Aliakbarian N, 2015, COMPUT OPER RES, V64, P210, DOI 10.1016/j.cor.2015.05.016; [Anonymous], 2003, J 5 E ASIA SOC TRANS; Bonyuet MA, 2002, ENG OPTIMIZ, V34, P445, DOI 10.1080/03052150214015; Chang FS, 2014, EXPERT SYST APPL, V41, P2947, DOI 10.1016/j.eswa.2013.10.026; Chen YW, 1999, INT J FUZZY SYSTEMS; Corley H. W., 1982, Operations Research Letters, V1, P157, DOI 10.1016/0167-6377(82)90020-7; Duque PAM, 2015, EUROPEAN J OPERATION, V248; Fiedrich F, 2000, SAFETY SCI, V35, P41, DOI 10.1016/S0925-7535(00)00021-7; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; [侯立文 Hou Liwen], 2004, [系统工程理论方法应用, Systems engineering theory methodology applications], V13, P425; Hu F., 2016, SCI REPORTS, V6; Iyer S., 2013, PLOS ONE, V8; Li SL, 2014, J IND ENG ENG MANAGE, V28, P148; Matisziw TC, 2010, STRATEGIC NETWORK RE, V10; Matisziw TC, 2009, COMPUT OPER RES, V36, P16, DOI 10.1016/j.cor.2007.09.004; Matisziw TC, 2009, ANN REGIONAL SCI, V43, P307, DOI 10.1007/s00168-008-0235-x; Nardelli E, 1998, INFORM PROCESS LETT, V67, P51, DOI 10.1016/S0020-0190(98)00077-5; Oliveira ELD, 2014, DETERMINING CRITICAL, V162, P158; Ozdamar L, 2014, SOCIO-ECON PLAN SCI, V48, P249, DOI 10.1016/j.seps.2014.08.001; Rupi F, 2015, TRANSP RES PROC, V5, P221, DOI 10.1016/j.trpro.2015.01.003; Scaparra MP, 2008, COMPUT OPER RES, V35, P1905, DOI 10.1016/j.cor.2006.09.019; Scott DM, 2006, J TRANSP GEOGR, V14, P215, DOI 10.1016/j.jtrangeo.2005.10.003; Sohn J, 2006, TRANSPORT RES A-POL, V40, P491, DOI 10.1016/j.tra.2005.08.006; Sullivan JL, 2010, TRANSPORT RES A-POL, V44, P323, DOI 10.1016/j.tra.2010.02.003; Wardrop JG, 1952, P I I CIV ENG, P72; Ying KC, 2010, EXPERT SYST APPL, V37, P2848, DOI 10.1016/j.eswa.2009.09.006; Ying KC, 2009, EXPERT SYST APPL, V36, P7087, DOI 10.1016/j.eswa.2008.08.033; Zhang JH, 2012, EXPERT SYST APPL, V39, P11066, DOI 10.1016/j.eswa.2012.03.016	31	6	7	6	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164780	10.1371/journal.pone.0164780	http://dx.doi.org/10.1371/journal.pone.0164780			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768732	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400029
J	Naburi, H; Mujinja, P; Kilewo, C; Barnighausen, T; Orsini, N; Manji, K; Biberfeld, G; Sando, D; Geldsetzer, P; Chalamila, G; Ekstrom, AM				Naburi, Helga; Mujinja, Phares; Kilewo, Charles; Barnighausen, Till; Orsini, Nicola; Manji, Karim; Biberfeld, Gunnel; Sando, David; Geldsetzer, Pascal; Chalamila, Guerino; Ekstrom, Anna Mia			Predictors of Patient Dissatisfaction with Services for Prevention of Mother-To-Child Transmission of HIV in Dar es Salaam, Tanzania	PLOS ONE			English	Article							SATISFACTION; CARE; MALAWI	Background Mother-to-child transmission (MTCT) of HIV remains a major source of new HIV infections in children. Prevention of mother-to-child transmission of HIV (PMTCT) using lifelong anti-retroviral treatment (ART) for all pregnant and breastfeeding women living with HIV (Option B+) is the major strategy for eliminating paediatric HIV. Ensuring that patients are satisfied with PMTCT services is important for optimizing uptake, adherence and retention in treatment. Methods We conducted a facility based quantitative cross-sectional survey in Dar-es-Salaam, Tanzania, between March and April 2014, when the country was transitioning to the implementation of PMTCT Option B+. We interviewed 595 pregnant and breastfeeding women living with HIV, who received PMTCT care in 36 public health facilities. Predictors of overall dissatisfaction with PMTCT services were identified using a multiple logistic regression. Results Overall 8% of the patients expressed dissatisfaction with PMTCT services. Patients who perceived health care workers (HCW) communication skills as poor, had a 5-fold (OR 4.9, 95% CI 1.8-13.4) increased risk of dissatisfaction and those who perceived HCW capacity to understand client concerns as poor, had a 6-fold (OR 5.7, 95% CI 2.3-14.0) increased risk. Having a total visit time longer than two hours was associated with a 2-fold increased risk of being dissatisfied (OR 2.3, 95% CI 1.1-4.7). Every 30-minute increment in total visit time was associated with a 10% higher (OR 1.1, 95% CI 1.0-1.2) risk of being dissatisfied. The probability of being dissatisfied ranged from 4% (95% CI 2%-6%) in the presence of patient-perceived good communication, good understanding of patient concerns, and a total visit time below two hours, to 70% (95% CI 47%-86%) if HCW failed in all of these aspects. Conclusion Patient dissatisfaction with PMTCT services was generally low; reflecting that quality of care was maintained during Tanzania's transition to Option B+ strategy aiming to increase the number of women initiating life-long ART in PMTCT clinics. Improved HCW communication with clients, their understanding of patient concerns and a reduction of the total visit time would further optimize women's overall satisfaction with PMTCT services in Tanzania.	[Naburi, Helga; Manji, Karim] Muhimbili Univ Hlth & Allied Sci, Dept Pediat & Child Hlth, Dar Es Salaam, Tanzania; [Naburi, Helga; Orsini, Nicola; Biberfeld, Gunnel; Ekstrom, Anna Mia] Karolinska Inst, Dept Publ Hlth Sci, Global Hlth IHCAR, Stockholm, Sweden; [Mujinja, Phares] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth & Social Sci, Dar Es Salaam, Tanzania; [Kilewo, Charles] Muhimbili Univ Hlth & Allied Sci, Dept Obstet, Dar Es Salaam, Tanzania; [Kilewo, Charles] Muhimbili Univ Hlth & Allied Sci, Dept Gynaecol, Dar Es Salaam, Tanzania; [Barnighausen, Till; Sando, David; Geldsetzer, Pascal] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Barnighausen, Till] Africa Ctr Populat Hlth, Mtubatuba, South Africa; [Sando, David; Chalamila, Guerino] Management & Dev Hlth MDH Nongovt Org, Dar Es Salaam, Tanzania; [Ekstrom, Anna Mia] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden	Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Karolinska University Hospital	Naburi, H (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Pediat & Child Hlth, Dar Es Salaam, Tanzania.; Naburi, H (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Global Hlth IHCAR, Stockholm, Sweden.	hnaburi@muhas.ac.tz	Orsini, Nicola/A-3602-2012; Bärnighausen, Till/Y-2388-2019; Manji, Karim/S-9318-2019	Orsini, Nicola/0000-0002-2210-5634; Manji, Karim/0000-0002-7069-6408; Geldsetzer, Pascal/0000-0002-8878-5505; Naburi, Helga/0000-0003-1659-5224	Swedish International Development Cooperation Agency (Sida); management and development for health (MDH); MDH organization, Dar es Salaam	Swedish International Development Cooperation Agency (Sida); management and development for health (MDH); MDH organization, Dar es Salaam	This work was supported by: 1. Swedish International Development Cooperation Agency (Sida); and 2. The management and development for health (MDH).; We are grateful to the study participants, the Management and Development for Health (MDH) team, the health facility authorities and research assistants who made this study possible. We thank the Swedish International Development Cooperation Agency (Sida) and the MDH organization, Dar es Salaam, for funding.	Asadi-Lari Mohsen, 2004, Health Qual Life Outcomes, V2, P32, DOI 10.1186/1477-7525-2-32; Asefa A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-57; Ashipa T, 2014, J MED BIOMEDICAL RES, V12, P150; Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046680; Bargat K, 2011, NAT J COMMUNITY MED, V2, P241; Barker PM, 2011, JAIDS-J ACQ IMM DEF, V56, pE45, DOI 10.1097/QAI.0b013e3181fdbf20; Chinkonde JR, 2009, REPROD HEALTH MATTER, V17, P143, DOI 10.1016/S0968-8080(09)33440-0; Ciaranello AL, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001156; Dang BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054729; Dansereau E, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009700; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Deressa W, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-328; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Ekouevi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029823; Finseraas H., 2018, CARE CAREER MOTHERS; Gostin L, 2003, HUMAN RIGHTS ANAL; Gourlay A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106325; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Haas AD, 2016, CLIN INFECT DIS, DOI [10.1093/cid/ciw500, DOI 10.1093/CID/CIW500]; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149527; Kravitz R, 1998, J GEN INTERN MED, V13, P280, DOI 10.1046/j.1525-1497.1998.00084.x; Kumwenda A, 2011, EVALUATION QUALITY C; Lochman J E, 1983, J Community Health, V9, P91, DOI 10.1007/BF01349873; Lyatuu M B, 2008, East Afr J Public Health, V5, P174; Miller JS, 2014, AIDS CARE, V26, P1150, DOI 10.1080/09540121.2014.882487; Muchedzi A, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-38; Ngarina M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085310; Ngarina M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-450; Nwabueze S A, 2011, Niger J Med, V20, P144; Oche MO, 2013, J AIDS HIV RES, V5, P328, DOI [10.5897/JAHR2013.0247, DOI 10.5897/JAHR2013.0247]; Orsini N, 2011, STATA J, V11, P1; Pascoe G C, 1983, Eval Program Plann, V6, P185, DOI 10.1016/0149-7189(83)90002-2; Poles Gabriela, 2014, J Int Assoc Provid AIDS Care, V13, P78, DOI 10.1177/1545109712467068; PuliaM, 2011, AM ACAD EMERGENCY ME, V18, P18; Roberts M, 2006, B WHO, V84; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Schauffler HH, 1996, J FAM PRACTICE, V42, P62; Siegfried N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub3; Sprague C, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-10; Tanzania National Bureau of Statistics and ICF Macro, 2011, 2010 TANZ DEM HLTH S; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Thu AN, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-39; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2016, START FREE STAY FREE; WHO, 2016, WORLD HLTH STAT 2016; World Health Organisation, 2013, CONGUID UANT DRU; World Health Organisation, 2012, PROGR UPD US ANT DRU; World Health Organization, 2001, WORLD HLTH REP HLTH	48	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165121	10.1371/journal.pone.0165121	http://dx.doi.org/10.1371/journal.pone.0165121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768731	Green Submitted, gold, Green Published			2022-12-26	WOS:000386205400052
J	Srinivasan, M; Bayon, B; Chopra, N; Lahiri, DK				Srinivasan, Mythily; Bayon, Baindu; Chopra, Nipun; Lahiri, Debomoy K.			Novel Nuclear Factor-KappaB Targeting Peptide Suppresses beta-Amyloid Induced Inflammatory and Apoptotic Responses in Neuronal Cells	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TRANSACTIVATION DOMAIN; SECONDARY STRUCTURE; POLYPROLINE-II; PROTEIN INTERACTIONS; PRECURSOR PROTEIN; GLIAL ACTIVATION; BRAIN CULTURES; B PATHWAY; C-REL	In the central nervous system (CNS), activation of the transcription factor nuclear factor kappa B (NF-K beta) is associated with both neuronal survival and increased vulnerability to apoptosis. The mechanisms underlying these dichotomous effects are attributed to the composition of NF-kappa B dimers. In Alzheimer's disease (AD), beta-amyloid (A beta) and other aggregates upregulate activation of p65:p50 dimers in CNS cells and enhance transactivation of pathological mediators that cause neuroinflammation and neurodegeneration. Hence selective targeting of activated p65 is an attractive therapeutic strategy for AD. Here we report the design, structural and functional characterization of peptide analogs of a p65 interacting protein, the glucocorticoid induced leucine zipper (GILZ). By virtue of binding the transactivation domain of p65 exposed after release from the inhibitory IKB proteins in activated cells, the GILZ analogs can act as highly selective inhibitors of activated p65 with minimal potential for off-target effects.	[Srinivasan, Mythily] Indiana Univ Purdue Univ, Sch Dent, Indianapolis, IN 46202 USA; [Bayon, Baindu; Chopra, Nipun; Lahiri, Debomoy K.] Indiana Univ Purdue Univ, Inst Psychiat Res, Dept Psychiat & Med & Mol Genet, Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Srinivasan, M (corresponding author), Indiana Univ Purdue Univ, Sch Dent, Indianapolis, IN 46202 USA.	mysriniv@iu.edu	Bayon, Baindu/R-3097-2016; Lahiri, Debomoy/AAZ-3322-2020	Bayon, Baindu/0000-0001-7247-8378; 	Alzheimer's Association [IIRG-11-206418]; National Institute on Aging, NIH [5R21AG042804, 1R21AG047, 1R41AG053117-01]; Indiana CTSI; QR Pharma, Yuma Therapeutics, Entia Biosci-ences; International advisory board-Drug Discovery and Therapy World Congress; Baxter Healthcare; NATIONAL INSTITUTE ON AGING [R21AG042804, R41AG053117, R01AG051086] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Indiana CTSI; QR Pharma, Yuma Therapeutics, Entia Biosci-ences; International advisory board-Drug Discovery and Therapy World Congress; Baxter Healthcare; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We sincerely appreciate the grant support from the Alzheimer's Association (IIRG-11-206418) and the National Institute on Aging, NIH (5R21AG042804 and 1R21AG047) to DKL. We sincerely appreciate the grant supports from the Indiana CTSI to MS and DKL. Debomoy Lahiri received additional support from the following sources: Scientific advisory board- QR Pharma, Yuma Therapeutics, Entia Biosci-ences; International advisory board-Drug Discovery and Therapy World Congress; Stock options, QR Pharma; Patent involving AIT-082, memantine and pending on acamprosate; Editor in Chief, Current Alzheimer Research; Research Grant Support from Baxter Healthcare. Mythily Srinivasan: Co-Founder, Provaidya LLC., Indianapolis and patent involving GILZ analogs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely appreciate the grant support from the Alzheimer's Association (IIRG-11-206418) and the National Institute on Aging, NIH (5R21AG042804 and 1R21AG047) to DKL (1R41AG053117-01) to MS and DKL. We sincerely appreciate the grant supports from the Indiana CTSI to MS and DKL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; [Anonymous], 2015, LEUPR AC; Ascolani A, 2012, CURR ALZHEIMER RES, V9, P128, DOI 10.2174/156720512799015091; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Bailey JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021954; Bales KR, 1998, MOL BRAIN RES, V57, P63, DOI 10.1016/S0169-328X(98)00066-7; Bales KR, 2000, NEUROBIOL AGING, V21, P427, DOI 10.1016/S0197-4580(00)00143-3; Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Bhattacharyya R, 2003, J MOL BIOL, V331, P925, DOI 10.1016/S0022-2836(03)00759-9; BLAIR WS, 1994, MOL CELL BIOL, V14, P7226, DOI 10.1128/MCB.14.11.7226; Boissiere F, 1997, NEUROREPORT, V8, P2849, DOI 10.1097/00001756-199709080-00009; Buggia-Prevot V, 2008, J BIOL CHEM, V283, P10037, DOI 10.1074/jbc.M706579200; Byrne C, 2013, CHIRALITY, V25, P628, DOI 10.1002/chir.22188; Chami L, 2012, J BIOL CHEM, V287, P24573, DOI 10.1074/jbc.M111.333054; Chen CH, 2012, INT J NEUROPSYCHOPH, V15, P77, DOI 10.1017/S1461145711000149; Clement ME, 2006, BIOCHEM BIOPH RES CO, V342, P206, DOI 10.1016/j.bbrc.2006.01.137; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Coulson DTR, 2010, J ALZHEIMERS DIS, V22, P1111, DOI 10.3233/JAD-2010-101254; Creamer TP, 1998, PROTEINS, V33, P218, DOI 10.1002/(SICI)1097-0134(19981101)33:2<218::AID-PROT6>3.0.CO;2-E; Cubellis MV, 2005, PROTEINS, V58, P880, DOI 10.1002/prot.20327; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; Di Marco B, 2007, NUCLEIC ACIDS RES, V35, P517, DOI 10.1093/nar/gkl1080; Duclot F, 2010, NEUROSCIENCE, V167, P850, DOI 10.1016/j.neuroscience.2010.02.055; Dursun E, 2015, J NEUROIMMUNOL, V283, P50, DOI 10.1016/j.jneuroim.2015.04.014; Edwards PJ, 2011, PEPTIDE DRUG DISCOVERY AND DEVELOPMENT: TRANSLATIONAL RESEARCH IN ACADEMIA AND INDUSTRY, P3; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Grilli M, 1999, BIOCHEM PHARMACOL, V57, P1, DOI 10.1016/S0006-2952(98)00214-7; Groner B., 2009, PEPTIDES DRUGS DISCO; Heinrich L, 2010, J IMMUNOL METHODS, V352, P13, DOI 10.1016/j.jim.2009.10.002; Jang MH, 2005, NEUROSCI LETT, V380, P26, DOI 10.1016/j.neulet.2005.01.003; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; Kim HO, 2000, COMB CHEM HIGH T SCR, V3, P167; Kitamura Y, 1998, BRAIN RES, V780, P260, DOI 10.1016/S0006-8993(97)01202-X; Lahiri DK, 2014, CURR ALZHEIMER RES, V11, P645, DOI 10.2174/1567205011666140812113851; Long JM, 2012, J BIOL CHEM, V287, P31298, DOI 10.1074/jbc.M112.366336; Lu DC, 2003, J NEUROCHEM, V87, P733, DOI 10.1046/j.1471-4159.2003.02059.x; Lukiw WJ, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt150; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Ndinguri MW, 2012, MOLECULES, V17, P14230, DOI 10.3390/molecules171214230; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; O'Shea JM, 2008, BIOCHEM SOC T, V36, P603, DOI 10.1042/BST0360603; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Qin ZH, 2007, ACTA PHARMACOL SIN, V28, P1859, DOI 10.1111/j.1745-7254.2007.00741.x; Ray B, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0063-0; Riccardi C, 2010, Ann Ig, V22, P53; Sambamurti K, 2004, FASEB J, V18, P1034, DOI 10.1096/fj.03-1378fje; Sarnico I, 2009, J NEUROCHEM, V108, P475, DOI 10.1111/j.1471-4159.2008.05783.x; SCHMITZ ML, 1995, J BIOL CHEM, V270, P7219, DOI 10.1074/jbc.270.13.7219; SCHMITZ ML, 1994, J BIOL CHEM, V269, P25613; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Seidel G, 1997, J BIOL CHEM, V272, P30918, DOI 10.1074/jbc.272.49.30918; Spielmann H, 1999, ATLA-ALTERN LAB ANIM, V27, P957, DOI 10.1177/026119299902700609; Srinivasan M, 2005, J BIOL CHEM, V280, P10149, DOI 10.1074/jbc.M409521200; Srinivasan M, 2014, DRUG DES DE IN PRESS; Srinivasan M, 2015, EXPERT OPIN THER TAR, V19, P471, DOI 10.1517/14728222.2014.989834; Srinivasan Mythily, 2012, Int J Pept, V2012, P634769, DOI 10.1155/2012/634769; Srinivasan M, 2011, J BIOL CHEM, V286, P44799, DOI 10.1074/jbc.M111.279257; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; Stalmans S, 2014, PROTEIN PEPTIDE LETT, V21, P399, DOI 10.2174/09298665113206660110; Stein A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002524; Terai K, 1996, BRAIN RES, V735, P159; Teva Pharmaceuticals, 2011, COP PROD INF; Unal EB, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036014; Valerio A, 2006, EUR J NEUROSCI, V23, P1711, DOI 10.1111/j.1460-9568.2006.04722.x; Wang L, 2011, ACTA PHARMACOL SIN, V32, P991, DOI 10.1038/aps.2011.81; Wenzel S, 2010, BIOCHEM J, V425, P373, DOI 10.1042/BJ20091422	71	13	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0160314	10.1371/journal.pone.0160314	http://dx.doi.org/10.1371/journal.pone.0160314			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764084	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204500002
J	Du, H; Ran, F; Dong, HL; Wen, J; Li, JN; Liang, Z				Du, Hai; Ran, Feng; Dong, Hong-Li; Wen, Jing; Li, Jia-Na; Liang, Zhe			Genome-Wide Analysis, Classification, Evolution, and Expression Analysis of the Cytochrome P450 93 Family in Land Plants	PLOS ONE			English	Article							FLAVONE SYNTHASE II; ISOFLAVONE SYNTHASE; GLYCINE-MAX; FUNCTIONAL EXPRESSION; GENE-EXPRESSION; 2-HYDROXYISOFLAVANONE SYNTHASE; MOLECULAR CHARACTERIZATION; INDUCIBLE FLAVONE; AMINO-ACID; BIOSYNTHESIS	Cytochrome P450 93 family (CYP93) belonging to the cytochrome P450 superfamily plays important roles in diverse plant processes. However, no previous studies have investigated the evolution and expression of the members of this family. In this study, we performed comprehensive genome-wide analysis to identify CYP93 genes in 60 green plants. In all, 214 CYP93 proteins were identified; they were specifically found in flowering plants and could be classified into ten subfamilies-CYP93A-K, with the last two being identified first. CYP93A is the ancestor that was derived in flowering plants, and the remaining showed lineage-specific distribution-CYP93B and CYP93C are present in dicots; CYP93F is distributed only in Poaceae; CYP93G and CYP93J are monocot-specific; CYP93E is unique to legumes; CYP93H and CYP93K are only found in Aquilegia coerulea, and CYP93D is Brassicaceae-specific. Each subfamily generally has conserved gene numbers, structures, and characteristics, indicating functional conservation during evolution. Synonymous nucleotide substitution (dN/dS) analysis showed that CYP93 genes are under strong negative selection. Comparative expression analyses of CYP93 genes in dicots and monocots revealed that they are preferentially expressed in the roots and tend to be induced by biotic and/or abiotic stresses, in accordance with their well-known functions in plant secondary biosynthesis.	[Du, Hai; Ran, Feng; Dong, Hong-Li; Wen, Jing; Li, Jia-Na] Southwest Univ, Coll Agron & Biotechnol, Chongqing 400716, Peoples R China; [Liang, Zhe] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Southwest University - China; National University of Singapore	Li, JN (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing 400716, Peoples R China.; Liang, Z (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	ljn1950@swu.edu.cn; zhe.liang@nus.edu.sg	Du, Hai/AHD-1445-2022	Du, Hai/0000-0003-4274-5724	National Natural Science Foundation of China [31471528, 31671727]; National Program on Key Basic Research Project (973 Program) [2015CB150201]; Fundamental Research Funds for the Central Universities of China [XDJK20146035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by grants from National Natural Science Foundation of China (31471528 and 31671727), National Program on Key Basic Research Project (973 Program, 2015CB150201), and Fundamental Research Funds for the Central Universities of China (XDJK20146035).	Akashi T, 1999, PLANT PHYSIOL, V121, P821, DOI 10.1104/pp.121.3.821; Akashi T, 1998, FEBS LETT, V431, P287, DOI 10.1016/S0014-5793(98)00781-9; Bak Soren, 2011, Arabidopsis Book, V9, pe0144, DOI 10.1199/tab.0144; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; BRITSCH L, 1990, ARCH BIOCHEM BIOPHYS, V276, P348, DOI 10.1016/0003-9861(90)90731-D; Chang Z, 2010, PROTEIN EXPRES PURIF, DOI [10.1016/j.pep.2010.11.012, DOI 10.1016/J.PEP.2010.11.012]; Cooper LD, 2005, J EXP BOT, V56, P1229, DOI 10.1093/jxb/eri117; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; Dastmalchi M, 2016, PLANT J, V85, P689, DOI 10.1111/tpj.13137; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Domanski TL, 2001, CURR DRUG METAB, V2, P117, DOI 10.2174/1389200013338612; Du H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-106; Du H, 2010, APPL MICROBIOL BIOT, V86, P1293, DOI 10.1007/s00253-010-2512-8; Du YG, 2010, PLANT PHYSIOL, V154, P324, DOI 10.1104/pp.110.161042; Du YG, 2010, J EXP BOT, V61, P983, DOI 10.1093/jxb/erp364; Durst Francis, 1995, Drug Metabolism and Drug Interactions, V12, P189; Dutartre L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-64; Ehlting J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-47; Ferreyra MLF, 2013, J BIOL CHEM, V288, P31678, DOI 10.1074/jbc.M113.510040; FISHER RF, 1992, NATURE, V357, P655, DOI 10.1038/357655a0; Fliegmann J, 2010, PHYTOCHEMISTRY, V71, P508, DOI 10.1016/j.phytochem.2010.01.007; Franzmayr BK, 2012, ANN BOT-LONDON, V110, P1291, DOI 10.1093/aob/mcs168; Fukushima EO, 2013, PLANT CELL PHYSIOL, V54, P740, DOI 10.1093/pcp/pct015; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; GOTOH O, 1992, J BIOL CHEM, V267, P83; Graham SE, 1999, ARCH BIOCHEM BIOPHYS, V369, P24, DOI 10.1006/abbi.1999.1350; Guttikonda SK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-243; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; Jung W, 2000, NAT BIOTECHNOL, V18, P208, DOI 10.1038/72671; Katoh Kazutaka, 2010, Bioinformatics, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kitada C, 2001, PLANT CELL PHYSIOL, V42, P1338, DOI 10.1093/pcp/pce169; Lam PY, 2014, PLANT PHYSIOL, V165, P1315, DOI 10.1104/pp.114.239723; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Martens S, 1999, PLANT J, V20, P611, DOI 10.1046/j.1365-313X.1999.00636.x; Morohashi K, 2012, PLANT CELL, V24, P2745, DOI 10.1105/tpc.112.098004; Moses T, 2014, PHYTOCHEMISTRY, V108, P47, DOI 10.1016/j.phytochem.2014.10.002; Nakatsuka T, 2006, MOL BREEDING, V17, P91, DOI 10.1007/s11032-005-2520-z; Nelson D. R., 2008, Tropical Plant Biology, V1, P216, DOI 10.1007/s12042-008-9022-1; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Nelson David R, 2006, Methods Mol Biol, V320, P1; Nelson DR, 2013, TROP PLANT BIOL, V6, P138, DOI 10.1007/s12042-013-9119-z; Nelson David R., 2009, Human Genomics, V4, P59; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Overkamp S, 2000, PLANT SCI, V155, P101, DOI 10.1016/S0168-9452(00)00214-4; Paquette SM, 2000, DNA CELL BIOL, V19, P307, DOI 10.1089/10445490050021221; Picmanova M, 2013, BIOL PLANTARUM, V57, P635, DOI 10.1007/s10535-013-0344-y; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sawada Y, 2005, BIOCHEM BIOPH RES CO, V330, P907, DOI 10.1016/j.bbrc.2005.03.053; Sawada Y, 2002, PLANT J, V31, P555, DOI 10.1046/j.1365-313X.2002.01378.x; Schopfer CR, 1998, FEBS LETT, V432, P182, DOI 10.1016/S0014-5793(98)00866-7; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; Shimada N, 2000, PLANT SCI, V160, P37, DOI 10.1016/S0168-9452(00)00355-1; Simmonds MSJ, 2003, PHYTOCHEMISTRY, V64, P21, DOI 10.1016/S0031-9422(03)00293-0; Soriano IR, 2004, PHYTOPATHOLOGY, V94, P1207, DOI 10.1094/PHYTO.2004.94.11.1207; Sreevidya VS, 2006, J EXP BOT, V57, P1957, DOI 10.1093/jxb/erj143; Steele CL, 1999, ARCH BIOCHEM BIOPHYS, V367, P146, DOI 10.1006/abbi.1999.1238; Suzuki G, 1996, FEBS LETT, V383, P83, DOI 10.1016/0014-5793(96)00229-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Waki T, 2016, BIOCHEM BIOPH RES CO, V469, P546, DOI 10.1016/j.bbrc.2015.12.038; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Wu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19245; Xu WY, 2001, GENE, V272, P61, DOI 10.1016/S0378-1119(01)00516-9; Zhang JA, 2007, PLANT PHYSIOL, V144, P741, DOI 10.1104/pp.106.095018	70	21	21	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0165020	10.1371/journal.pone.0165020	http://dx.doi.org/10.1371/journal.pone.0165020			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760179	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204000076
J	Kovacs, KA; O'Neill, J; Schoenenberger, P; Penttonen, M; Guerrero, DKR; Csicsvari, J				Kovacs, Krisztian A.; O'Neill, Joseph; Schoenenberger, Philipp; Penttonen, Markku; Guerrero, Damaris K. Ranguel; Csicsvari, Jozsef			Optogenetically Blocking Sharp Wave Ripple Events in Sleep Does Not Interfere with the Formation of Stable Spatial Representation in the CA1 Area of the Hippocampus	PLOS ONE			English	Article							LONG-TERM STABILITY; REACTIVATION; MEMORY; PLASTICITY; PATTERNS; CELLS; MAPS	During hippocampal sharp wave/ripple (SWR) events, previously occurring, sensory input driven neuronal firing patterns are replayed. Such replay is thought to be important for plasticity-related processes and consolidation of memory traces. It has previously been shown that the electrical stimulation-induced disruption of SWR events interferes with learning in rodents in different experimental paradigms. On the other hand, the cognitive map theory posits that the plastic changes of the firing of hippocampal place cells constitute the electrophysiological counterpart of the spatial learning, observable at the behavioral level. Therefore, we tested whether intact SWR events occurring during the sleep/rest session after the first exploration of a novel environment are needed for the stabilization of the CA1 code, which process requires plasticity. We found that the newly-formed representation in the CA1 has the same level of stability with optogenetic SWR blockade as with a control manipulation that delivered the same amount of light into the brain. Therefore our results suggest that at least in the case of passive exploratory behavior, SWR-related plasticity is dispensable for the stability of CA1 ensembles.	[Kovacs, Krisztian A.; O'Neill, Joseph; Schoenenberger, Philipp; Guerrero, Damaris K. Ranguel; Csicsvari, Jozsef] IST Austria, Klosterneuburg, Austria; [Penttonen, Markku] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland; [Schoenenberger, Philipp] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Grenzacherstr 124, CH-4070 Basel, Switzerland	Institute of Science & Technology - Austria; University of Jyvaskyla; Roche Holding	Kovacs, KA; Csicsvari, J (corresponding author), IST Austria, Klosterneuburg, Austria.	Krisztian.Kovacs@ist.ac.at; Jozsef.Csicsvari@ist.ac.at	Penttonen, Markku/B-8348-2013	Penttonen, Markku/0000-0002-1033-7286; Kovacs, Krisztian/0000-0001-6251-1007	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA via the 1ST FELLOWSHIP [291734]; European Research Council [281511]	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA via the 1ST FELLOWSHIP; European Research Council(European Research Council (ERC)European Commission)	The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no [291734] via the 1ST FELLOWSHIP awarded to Dr. Krisztian A. Kovacs and the European Research Council starting grant (acronym: HIPECMEM Project reference: 281511) awarded to Dr. Jozsef Csicsvari.	Agnihotri NT, 2004, P NATL ACAD SCI USA, V101, P3656, DOI 10.1073/pnas.0400385101; Axmacher N, 2008, BRAIN, V131, P1806, DOI 10.1093/brain/awn103; Calton JL., 2003, J NEUROSCI; Chersi F, 2015, NEURON, V88, P64, DOI 10.1016/j.neuron.2015.09.021; Cutsuridis V, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00013; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Gillespie AK, 2016, NEURON, V90, P740, DOI 10.1016/j.neuron.2016.04.009; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Leao RN, 2012, NAT NEUROSCI, V15, P1524, DOI 10.1038/nn.3235; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Maingret N, 2016, NAT NEUROSCI, V19, P959, DOI 10.1038/nn.4304; McNamara CG, 2014, NAT NEUROSCI, V17, P1658, DOI 10.1038/nn.3843; Nicole O, 2016, SCI REP-UK, V6, DOI 10.1038/srep22728; Nokia MS, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00084; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; Olafsdottir HF, 2015, ELIFE, V4, DOI 10.7554/eLife.06063; Packard MG, 1997, NEUROBIOL LEARN MEM, V68, P42, DOI 10.1006/nlme.1996.3762; Ramirez-Villegas JF, 2015, P NATL ACAD SCI USA, V112, pE6379, DOI 10.1073/pnas.1518257112; Schoenenberger P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11824; Silva D, 2015, NAT NEUROSCI, V18, P1772, DOI 10.1038/nn.4151; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Witton J, 2016, J PHYSIOL-LONDON, V594, P4615, DOI 10.1113/jphysiol.2014.282889	28	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164675	10.1371/journal.pone.0164675	http://dx.doi.org/10.1371/journal.pone.0164675			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760158	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000386204000043
J	Albrecht, S; Hagemeier, K; Ehrlich, M; Kemming, C; Trotter, J; Kuhlmann, T				Albrecht, Stefanie; Hagemeier, Karin; Ehrlich, Marc; Kemming, Claudia; Trotter, Jacqueline; Kuhlmann, Tanja			Recovery from Toxic-Induced Demyelination Does Not Require the NG2 Proteoglycan	PLOS ONE			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PDGF ALPHA-RECEPTOR; SPINAL-CORD; NERVOUS-SYSTEM; NG2-EXPRESSING CELLS; MULTIPLE-SCLEROSIS; WHITE-MATTER; OPTIC-NERVE; NULL MOUSE		[Albrecht, Stefanie; Hagemeier, Karin; Ehrlich, Marc; Kemming, Claudia; Kuhlmann, Tanja] Univ Hosp Munster, Inst Neuropathol, Munster, Germany; [Trotter, Jacqueline] Univers Mainz, Dept Biol, Mol Cell Biol, Mainz, Germany	University of Munster; Johannes Gutenberg University of Mainz	Kuhlmann, T (corresponding author), Univ Hosp Munster, Inst Neuropathol, Munster, Germany.	tanja.kuhlmann@ukmuenster.de			German Research Foundation [SFB-TR128-B7]; Interdisciplinary Clinical Research Center, Munster [KuT3/012/15]; Hertie Foundation [P1130073]	German Research Foundation(German Research Foundation (DFG)); Interdisciplinary Clinical Research Center, Munster; Hertie Foundation	This work was funded by German Research Foundation (SFB-TR128-B7, http://www.dfg.de/) to TK and JT; Interdisciplinary Clinical Research Center, Munster (KuT3/012/15, http://campus.uni-muenster.de/izkf-start/) to TK; Hertie Foundation (P1130073, http://www.ghst.de/) to TK. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren S, 1996, ACTA NEUROPATHOL, V92, P49, DOI 10.1007/s004010050488; Bansal R, 1996, MOL CELL NEUROSCI, V7, P263, DOI 10.1006/mcne.1996.0020; Baracskay KL, 2007, GLIA, V55, P1001, DOI 10.1002/glia.20519; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; Biname F, 2014, MOL NEUROBIOL, V50, P482, DOI 10.1007/s12035-013-8610-8; Biname F, 2013, J NEUROSCI, V33, P10858, DOI 10.1523/JNEUROSCI.5010-12.2013; Boretius S, 2012, NEUROIMAGE, V59, P2678, DOI 10.1016/j.neuroimage.2011.08.051; Bribian A, 2006, MOL CELL NEUROSCI, V33, P2, DOI 10.1016/j.mcn.2006.05.009; Bu J, 2004, GLIA, V48, P51, DOI 10.1002/glia.20055; Burg MA, 1997, EXP CELL RES, V235, P254, DOI 10.1006/excr.1997.3674; Burg MA, 1998, J CELL PHYSIOL, V177, P299, DOI 10.1002/(SICI)1097-4652(199811)177:2<299::AID-JCP12>3.3.CO;2-0; Chekenya M, 1999, INT J DEV NEUROSCI, V17, P421, DOI 10.1016/S0736-5748(99)00019-2; Crawford AH, 2016, AM J PATHOL, V186, P511, DOI 10.1016/j.ajpath.2015.11.005; de Castro F, 2013, CELL MOL LIFE SCI, V70, P4355, DOI 10.1007/s00018-013-1365-6; Frost EE, 2003, J NEUROBIOL, V54, P457, DOI 10.1002/neu.10158; Frost EE, 2009, NEUROCHEM RES, V34, P169, DOI 10.1007/s11064-008-9748-z; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Grako KA, 1999, J CELL SCI, V112, P905; Huang C, 2015, GLIA; Huang WH, 2014, GLIA, V62, P896, DOI 10.1002/glia.22648; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Kadoya K, 2008, J HISTOCHEM CYTOCHEM, V56, P295, DOI 10.1369/jhc.7A7349.2007; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Karram K, 2005, J ANAT, V207, P735, DOI 10.1111/j.1469-7580.2005.00461.x; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Komitova M, 2011, GLIA, V59, P800, DOI 10.1002/glia.21152; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kucharova K, 2010, NEUROSCIENCE, V166, P185, DOI 10.1016/j.neuroscience.2009.12.014; Kucharova K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-158; Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Makagiansar IT, 2007, J CELL BIOL, V178, P155, DOI 10.1083/jcb.200612084; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Milner R, 1997, GLIA, V19, P85, DOI 10.1002/(SICI)1098-1136(199701)19:1<85::AID-GLIA9>3.0.CO;2-9; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; Moransard M, 2011, BRAIN, V134, P1315, DOI 10.1093/brain/awr070; Murfee WL, 2005, MICROCIRCULATION, V12, P151, DOI 10.1080/10739680590904955; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Nishiyama A., 2015, BRAIN RES; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Paez PM, 2009, J NEUROSCI, V29, P6663, DOI 10.1523/JNEUROSCI.5806-08.2009; Passlick S, 2016, CEREB CORTEX, V26, P51, DOI 10.1093/cercor/bhu171; Preisner A, 2015, ACTA NEUROPATHOL, V130, P247, DOI 10.1007/s00401-015-1426-z; Remington LT, 2007, AM J PATHOL, V170, P1713, DOI 10.2353/ajpath.2007.060783; Sakry D, 2015, BRAIN RES; Sakry D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127222; Sakry D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001993; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Simpson PB, 1999, GLIA, V26, P22, DOI 10.1002/(SICI)1098-1136(199903)26:1<22::AID-GLIA3>3.0.CO;2-M; STALLCUP WB, 1987, J NEUROSCI, V7, P2737; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Tsoa RW, 2014, P NATL ACAD SCI USA, V111, P7444, DOI 10.1073/pnas.1400422111; Vana AC, 2007, J NEUROPATH EXP NEUR, V66, P975, DOI 10.1097/NEN.0b013e3181587d46; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Wilson HC, 2006, J NEUROIMMUNOL, V176, P162, DOI 10.1016/j.jneuroim.2006.04.014; Xiao L, 2013, GLIA, V61, P2078, DOI 10.1002/glia.22578; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Zhu XQ, 2012, DEVELOPMENT, V139, P2299, DOI 10.1242/dev.078873; Zonouzi M, 2015, NAT NEUROSCI, V18, P674, DOI 10.1038/nn.3990	64	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0163841	10.1371/journal.pone.0163841	http://dx.doi.org/10.1371/journal.pone.0163841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755537	Green Published, Green Submitted, gold			2022-12-26	WOS:000386203800006
J	Fortenberry, YM; Brandal, SM; Carpentier, G; Hemani, M; Pathak, AP				Fortenberry, Yolanda M.; Brandal, Stephanie M.; Carpentier, Gilles; Hemani, Malvi; Pathak, Arvind P.			Intracellular Expression of PAI-1 Specific Aptamers Alters Breast Cancer Cell Migration, Invasion and Angiogenesis	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; RNA APTAMERS; TUMOR-GROWTH; IN-VIVO; CARCINOMA-CELLS; ADHESION; PROTEIN; SYSTEM; TYPE-1; SIRNA	Plasminogen activator inhibitor-1 (PAI-1) is elevated in various cancers, where it has been shown to effect cell migration and invasion and angiogenesis. While, PAI-1 is a secreted protein, its intercellular levels are increased in cancer cells. Consequently, intracellular PAI-1 could contribute to cancer progression. While various small molecule inhibitors of PAI-1 are currently being investigated, none specifically target intracellular PAI-1. A class of inhibitors, termed aptamers, has been used effectively in several clinical applications. We previously generated RNA aptamers that target PAI-1 and demonstrated their ability to inhibit extracellular PAI-1. In the current study we explored the effect of these aptamers on intracellular PAI-1. We transiently transfected the PAI-1 specific aptamers into both MDA-MB-231 human breast cancer cells, and human umbilical vein endothelial cells (HUVECs) and studied their effects on cell migration, invasion and angiogenesis. Aptamer expressing MDA-MB-231 cells exhibited a decrease in cell migration and invasion. Additionally, intracellular PAI-1 and urokinase plasminogen activator (uPA) protein levels decreased, while the PAI-1/uPA complex increased. Moreover, a significant decrease in endothelial tube formation in HUVECs transfected with the aptamers was observed. In contrast, conditioned media from aptamer transfected MDA-MB-231 cells displayed a slight pro-angiogenic effect. Collectively, our study shows that expressing functional aptamers inside breast and endothelial cells is feasible and may exhibit therapeutic potential.	[Fortenberry, Yolanda M.; Brandal, Stephanie M.] Johns Hopkins Univ, Sch Med, Dept Pediat Hematol, Baltimore, MD 21218 USA; [Fortenberry, Yolanda M.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Carpentier, Gilles] Univ Paris Est Creteil, Lab CRRET, Fac Sci & Technol, 61 Ave Gen De Gaulle, F-94010 Creteil, France; [Hemani, Malvi; Pathak, Arvind P.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Johns Hopkins University	Fortenberry, YM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat Hematol, Baltimore, MD 21218 USA.; Fortenberry, YM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	yforten1@jhmi.edu		Carpentier, Gilles/0000-0002-3730-7263	National Heart, Lung, and Blood Institutes [HL096407]; National Cancer Institute [5R21CA175784-02, 1R01CM 96701-01]; NATIONAL CANCER INSTITUTE [R21CA175784, R01CA196701] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL096407] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grants from the National Heart, Lung, and Blood Institutes to Y.M.F. (grant number: HL096407), and the National Cancer Institute to A.P.P. (grant numbers: 5R21CA175784-02, 1R01CM 96701-01).; This work was funded by grants from the National Heart, Lung, and Blood Institutes to Y.M.F (grant number: HL096407), and the National Cancer Institute to A.P.P (grant numbers: 5R21CA175784-02, 1R01CA196701-01).	Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Andreasen PA, 2007, CURR DRUG TARGETS, V8, P1030, DOI 10.2174/138945007781662346; Bajou K, 2001, J CELL BIOL, V152, P777, DOI 10.1083/jcb.152.4.777; Bajou K, 2004, ONCOGENE, V23, P6986, DOI 10.1038/sj.onc.1207859; Banerjee J, 2013, J MOL MED, V91, P1333, DOI 10.1007/s00109-013-1085-2; Beaulieu LM, 2007, BIOESSAYS, V29, P1029, DOI 10.1002/bies.20640; Binder BR, 2002, NEWS PHYSIOL SCI, V17, P56, DOI 10.1152/nips.01369.2001; Blake CM, 2009, OLIGONUCLEOTIDES, V19, P117, DOI 10.1089/oli.2008.0177; Blind M, 1999, P NATL ACAD SCI USA, V96, P3606, DOI 10.1073/pnas.96.7.3606; Brandal S, 2011, NUCLEIC ACID THER, V21, P373, DOI 10.1089/nat.2011.0320; Czekay Ralf-Peter, 2011, Int J Cell Biol, V2011, P562481, DOI 10.1155/2011/562481; Czekay RP, 2003, J CELL BIOL, V160, P781, DOI 10.1083/jcb.200208117; Dassie JP, 2013, THER DELIV, V4, P1527, DOI [10.4155/tde.13.118, 10.4155/TDE.13.118]; Dassie JP, 2009, NAT BIOTECHNOL, V27, P839, DOI 10.1038/nbt.1560; de Cremoux P, 2009, ANTICANCER RES, V29, P1475; Deng G, 2001, J CELL PHYSIOL, V189, P23, DOI 10.1002/jcp.1133; Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com; Duffy MJ, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0428-4; Duffy MJ, 2004, CLIN BIOCHEM, V37, P541, DOI 10.1016/j.clinbiochem.2004.05.013; Durand MK, 2004, THROMB HAEMOSTASIS, V91, P438, DOI 10.1160/TH03-12-0784; Famulok M, 2001, CHEM BIOL, V8, P931, DOI 10.1016/S1074-5521(01)00070-9; Fang H, 2012, JNCI-J NATL CANCER I, V104, P1470, DOI 10.1093/jnci/djs377; Ferroni P, 2014, ANTICANCER RES, V34, P1153; Fortenberry Y, 2015, BIOL CHEM, V396, P205, DOI 10.1515/hsz-2014-0254; Fortenberry YM, 2013, EXPERT OPIN THER PAT, V23, P801, DOI 10.1517/13543776.2013.782393; Gourronc FA, 2013, VIROLOGY, V446, P325, DOI 10.1016/j.virol.2013.08.015; Guo XD, 2014, BIOSENS BIOELECTRON, V56, P340, DOI 10.1016/j.bios.2014.01.045; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harbeck N, 2014, CANCER TREAT REV, V40, P434, DOI 10.1016/j.ctrv.2013.09.014; Hernandez LI, 2013, PHARMACEUTICALS, V6, P295, DOI 10.3390/ph6030295; Ishiguro A, 2011, ARTHRITIS RHEUM-US, V63, P455, DOI 10.1002/art.30108; Isogai C, 2001, CANCER RES, V61, P5587; Kang KN, 2013, ADV BIOCHEM ENG BIOT, V131, P153, DOI 10.1007/10_2012_136; Kaur G, 2008, EXPERT OPIN INV DRUG, V17, P43, DOI 10.1517/13543784.17.1.43; Kwaan HC, 2013, SEMIN THROMB HEMOST, V39, P382, DOI 10.1055/s-0033-1338127; Kwaan Hau C., 2009, V148, P43, DOI 10.1007/978-0-387-79962-9_4; Kwak H, 2009, MOL CANCER THER, V8, P2664, DOI 10.1158/1535-7163.MCT-09-0214; Lamy PJ, 2007, AM J CLIN PATHOL, V128, P404, DOI 10.1309/K4JAF2NMD5EJU67Y; Li N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020299; Li XL, 2014, ANAL CHEM, V86, P6596, DOI 10.1021/ac501205q; Lijnen HR, 2005, J THROMB HAEMOST, V3, P35, DOI 10.1111/j.1538-7836.2004.00827.x; Madsen JB, 2010, BIOCHEMISTRY-US, V49, P4103, DOI 10.1021/bi100066j; Mashiko S, 2015, CANCER BIOL THER, V16, P253, DOI 10.1080/15384047.2014.1001271; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; Meryet-Figuieres M, 2007, BIOCHIMIE, V89, P1228, DOI 10.1016/j.biochi.2007.03.017; Nishioka N, 2012, CANCER SCI, V103, P228, DOI 10.1111/j.1349-7006.2011.02155.x; Palmieri D, 2002, J BIOL CHEM, V277, P40950, DOI 10.1074/jbc.M202333200; Pathak AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063146; Pei Xiaoyu, 2014, Mol Clin Oncol, V2, P341; Placencio VR, 2015, CANCER RES, V75, P2969, DOI 10.1158/0008-5472.CAN-15-0876; Rouch A, 2015, EUR J MED CHEM, V92, P619, DOI 10.1016/j.ejmech.2015.01.010; Santosh B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/540451; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Senoo T, 2010, THORAX, V65, P334, DOI 10.1136/thx.2009.119974; Soff GA, 1995, J CLIN INVEST, V96, P2593, DOI 10.1172/JCI118323; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; Stefansson S, 2003, CURR PHARM DESIGN, V9, P1545, DOI 10.2174/1381612033454621; Stefansson S, 2001, J BIOL CHEM, V276, P8135, DOI 10.1074/jbc.M007609200; Thiel WH, 2015, METHODS MOL BIOL, V1218, P187, DOI 10.1007/978-1-4939-1538-5_11; Vaughan DE, 2007, CURR DRUG TARGETS, V8, P962, DOI 10.2174/138945007781662364; Whitley BR, 2004, EXP CELL RES, V296, P151, DOI 10.1016/j.yexer.2004.02.022; Wu JB, 2015, ARTERIOSCL THROM VAS, V35, P111, DOI 10.1161/ATVBAHA.114.304554; Xiang DX, 2015, THERANOSTICS, V5, P23, DOI 10.7150/thno.10202; Xiao ZY, 2008, CHEM-EUR J, V14, P1769, DOI 10.1002/chem.200701330; Zhang JD, 2012, AM J PHYSIOL-RENAL, V303, pF11, DOI 10.1152/ajprenal.00050.2012; Zhang KJ, 2012, CHEMMEDCHEM, V7, P79, DOI 10.1002/cmdc.201100457; Zhang ZW, 2014, INT J MOL MED, V34, P1423, DOI 10.3892/ijmm.2014.1908; Zueva E, 2011, INT J CANCER, V128, P797, DOI 10.1002/ijc.25401	69	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164288	10.1371/journal.pone.0164288	http://dx.doi.org/10.1371/journal.pone.0164288			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755560	gold, Green Published, Green Submitted			2022-12-26	WOS:000386203800014
J	Garg, M; Tsujimoto, H; Gupta, RK; Kumar, A; Kaur, N; Kumar, R; Chunduri, V; Sharma, NK; Chawla, M; Sharma, S; Mundey, JK				Garg, Monika; Tsujimoto, Hisashi; Gupta, Raj Kumar; Kumar, Aman; Kaur, Navneet; Kumar, Rohit; Chunduri, Venkatesh; Sharma, Nand Kishor; Chawla, Meenakshi; Sharma, Saloni; Mundey, Jaspreet Kaur			Chromosome Specific Substitution Lines of Aegilops geniculata Alter Parameters of Bread Making Quality of Wheat	PLOS ONE			English	Article							MOLECULAR-WEIGHT SUBUNITS; GLUTENIN SUBUNITS; PROTEIN-CONTENT; GRAIN PROTEIN; FLOUR QUALITY; STEM RUST; BREADMAKING; IDENTIFICATION; RESISTANCE; GLIADIN	Wheat cultivars with wide introgression have strongly impacted global wheat production. Aegilops geniculata ((MUg)-U-g) is an important wild relative with several useful traits that can be exploited for wheat improvement. Screening of Ae. geniculata addition lines indicated a negative effect of 1U(g) and the positive effect of 1M(g) chromosome on wheat dough strength. Negative effect of 1U(g) is probably associated with variation in number and position of the tripeptide repeat motif in the high molecular weight glutenin (HMW-G) gene. To utilize the positive potential of 1M(g) chromosome, three disomic substitution lines (DSLs) 1M(g) (1A), 1M(g) (1B) and 1M(g) (1D) were created. These lines were characterized for morphological, cytogenetic properties and biochemical signatures using FISH, 1D-, 2D-PAGE and RP-HPLC. Contribution of wheat 1A, 1B and 1D chromosomes towards dough mixing and baking parameters, chapatti quality, Fe/Zn content and glume color were identified. Observed order of variation in the dough mixing and baking parameters {1M(g) (1D) <= wheat <= 1M(g) (1B) <= 1M(g) (1A)} indicated that chromosome specific introgression is desirable for best utilization of wild species' potential.	[Garg, Monika; Kumar, Aman; Kaur, Navneet; Kumar, Rohit; Chunduri, Venkatesh; Sharma, Nand Kishor; Chawla, Meenakshi; Sharma, Saloni; Mundey, Jaspreet Kaur] Natl Agri Food Biotechnol Inst, Mohali 160071, Punjab, India; [Tsujimoto, Hisashi] Tottori Univ, United Grad Sch Agr, Tottori, Japan; [Gupta, Raj Kumar] Indian Inst Wheat & Barley Res, Karnal, Haryana, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Tottori University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research	Garg, M (corresponding author), Natl Agri Food Biotechnol Inst, Mohali 160071, Punjab, India.	mgarg100@yahoo.com	Tsujimoto, Hisashi/A-5914-2016; Kumar, Aman/AAY-3202-2020	Tsujimoto, Hisashi/0000-0003-0203-0759; Kumar, Aman/0000-0002-0904-0792; Garg, Monika/0000-0002-2297-1137; Venkatesh, Chunduri/0000-0002-1909-8867; Sharma, Saloni/0000-0003-4221-3277	Japan Society for the Promotion of Science [19380006, JSPS08094]; NABI, India	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NABI, India	Initial phase of this research was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (Nos. 19380006 and JSPS08094). Later part of this project was supported by NABI, India core grant 'Improvement of processing and nutritional quality of wheat'.	A. O. A. C. Association of Official Agriculture Chemists, 2000, OFFICIAL METHODS ANA, P19; AACC, 1990, APPROVED METHODS AME; Aghaee-Sarbarzeh M, 2002, EUPHYTICA, V127, P377, DOI 10.1023/A:1020334821122; BRANLARD G, 1985, J CEREAL SCI, V3, P345, DOI 10.1016/S0733-5210(85)80007-2; Campbell KG, 2001, CROP SCI, V41, P1275, DOI 10.2135/cropsci2001.4141275x; Feeney KA, 2003, BIOPOLYMERS, V72, P123, DOI 10.1002/bip.10298; FRIEBE B, 1989, THEOR APPL GENET, V78, P417, DOI 10.1007/BF00265306; Friebe BR, 1999, GENOME, V42, P374, DOI 10.1139/gen-42-3-374; Garg M, 2009, CEREAL CHEM, V86, P26, DOI 10.1094/CCHEM-86-1-0026; Gilbert SM, 2000, BBA-PROTEIN STRUCT M, V1479, P135, DOI 10.1016/S0167-4838(00)00059-5; Groos C, 2004, J CEREAL SCI, V40, P93, DOI 10.1016/j.jcs.2004.08.006; GUPTA RB, 1993, J CEREAL SCI, V18, P23, DOI 10.1006/jcrs.1993.1031; IRVINE GN, 1960, CEREAL CHEM, V37, P603; JACKSON EA, 1983, THEOR APPL GENET, V66, P29, DOI 10.1007/BF00281844; Juhasz A, 2003, P 8 GLUT WORKSH VIT, P57; Kamal AHM, 2009, J PLANT BIOL, V52, P533, DOI 10.1007/s12374-009-9069-z; KECK B, 1995, Z LEBENSM UNTERS FOR, V200, P432, DOI 10.1007/BF01193253; Khlestkina EK, 2009, CEREAL RES COMMUN, V37, P37, DOI 10.1556/CRC.37.2009.1.5; KIHARA H, 1954, CYTOLOGIA, V19, P336, DOI 10.1508/cytologia.19.336; KIMBER G, 1988, GENOME, V30, P218, DOI 10.1139/g88-037; Lemelin E, 2005, J CEREAL SCI, V42, P317, DOI 10.1016/j.jcs.2005.03.009; Medouri A, 2014, NOT BOT HORTI AGROBO, V42, P453, DOI 10.15835/nbha4229511; Mehta A, 2006, RES PUNJAB AGIC UNIV, V43, P263; Mejias JH, 2014, NUTRIENTS, V6, P1578, DOI 10.3390/nu6041578; Molnar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070844; NG PKW, 1988, CEREAL CHEM, V65, P408; Payne P. I., 1983, Cereal Research Communications, V11, P29; PAYNE PI, 1988, J CEREAL SCI, V7, P229, DOI [10.1016/S0733-5210(88)80004-3, 10.1006/jcrs.1998.0194]; PAYNE PI, 1979, PLANTA, V145, P83, DOI 10.1007/BF00379931; PAYNE PI, 1982, QUAL PLANT, V31, P229, DOI 10.1007/BF01108632; RAYBURN AL, 1986, J HERED, V77, P253, DOI 10.1093/oxfordjournals.jhered.a110231; Rouse MN, 2014, THEOR APPL GENET, V127, P1549, DOI 10.1007/s00122-014-2319-6; Sambrook J., 1989, MOLECULAR CLONING A; Sapirstein HD, 1998, CEREAL CHEM, V75, P500, DOI 10.1094/CCHEM.1998.75.4.500; Senerchia N, 2013, GENOME BIOL EVOL, V5, P1010, DOI 10.1093/gbe/evt064; SHEWRY PR, 1995, BIO-TECHNOL, V13, P1185, DOI 10.1038/nbt1195-1185; SHEWRY PR, 1992, J CEREAL SCI, V15, P105, DOI 10.1016/S0733-5210(09)80062-3; Shewry PR, 2002, PHILOS T R SOC B, V357, P133, DOI 10.1098/rstb.2001.1024; Singh A, 2013, THEOR APPL GENET, V126, P1951, DOI 10.1007/s00122-013-2109-6; SMITH D B, 1984, Journal of the National Institute of Agricultural Botany, V16, P487; Takata K, 1999, BREEDING SCI, V49, P221, DOI 10.1270/jsbbs.49.221; Tamas L, 2002, J CEREAL SCI, V36, P313, DOI 10.1006/jcrs.2001.0457; Tanaka H, 2012, EUPHYTICA, V186, P57, DOI 10.1007/s10681-011-0489-8; Turnbull KM, 2002, J CEREAL SCI, V36, P327, DOI 10.1006/jcrs.2002.0468; Uthayakumaran S, 1999, CEREAL CHEM, V76, P389, DOI 10.1094/CCHEM.1999.76.3.389; Wang Shufang, 2013, Biomed Res Int, V2013, P690491, DOI 10.1155/2013/690491; Weegels PL, 1996, J CEREAL SCI, V23, P103, DOI 10.1006/jcrs.1996.0010; Yanaka M, 2007, BREEDING SCI, V57, P243, DOI 10.1270/jsbbs.57.243; ZEMETRA RS, 1987, CROP SCI, V27, P677, DOI 10.2135/cropsci1987.0011183X002700040013x	49	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0162350	10.1371/journal.pone.0162350	http://dx.doi.org/10.1371/journal.pone.0162350			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755540	Green Submitted, Green Published, gold			2022-12-26	WOS:000386203800002
J	Mulla, SI; Sun, QA; Hu, AY; Wang, YW; Ashfaq, M; Eqani, SAMAS; Yu, CP				Mulla, Sikandar I.; Sun, Qian; Hu, Anyi; Wang, Yuwen; Ashfaq, Muhammad; Eqani, Syed Ali Musstjab Akber Shah; Yu, Chang-Ping			Evaluation of Sulfadiazine Degradation in Three Newly Isolated Pure Bacterial Cultures	PLOS ONE			English	Article							ANTIBIOTIC SULFADIAZINE; COMMUNITY STRUCTURE; CHEMOTAXIS; MANURE; SOIL; CHLORTETRACYCLINE; TRANSPORT; FATE; TRANSFORMATION; DISSIPATION	This study is aimed to assess the biodegradation of sulfadiazine (SDZ) and characterization of heavy metal resistance in three pure bacterial cultures and also their chemotactic response towards 2-aminopyrimidine. The bacterial cultures were isolated from pig manure, activated sludge and sediment samples, by enrichment technique on SDZ (6 mg L-1). Based on the 16S rRNA gene sequence analysis, the microorganisms were identified within the genera of Paracoccus, Methylobacterium and Kribbella, which were further designated as SDZ-PM2-BSH30, SDZ-W2-SJ40 and SDZ-3S-SCL47. The three identified pure bacterial strains degraded up to 50.0, 55.2 and 60.0% of SDZ (5 mg L-1), respectively within 290 h. On the basis of quadrupole time-of-flight mass spectrometry and high performance liquid chromatography, 2-aminopyrimidine and 4-hydroxy-2-aminopyrimidine were identified as the main intermediates of SDZ biodegradation. These bacteria were also able to degrade the metabolite, 2-aminopyrimidine, of the SDZ. Furthermore, SDZ-PM2-BSH30, SDZ-W2-SJ40 and SDZ-3S-SCL47 also showed resistance to various heavy metals like copper, cadmium, chromium, cobalt, lead, nickel and zinc. Additionally, all three bacteria exhibited positive chemotaxis towards 2-aminopyrimidine based on the drop plate method and capillary assay. The results of this study advanced our understanding about the microbial degradation of SDZ, which would be useful towards the future SDZ removal in the environment.	[Mulla, Sikandar I.; Sun, Qian; Hu, Anyi; Wang, Yuwen; Ashfaq, Muhammad] Chinese Acad Sci, Inst Urban Environm, CAS Key Lab Urban Pollutant Convers, Xiamen 361021, Peoples R China; [Eqani, Syed Ali Musstjab Akber Shah] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen 361021, Peoples R China; [Yu, Chang-Ping] Natl Taiwan Univ, Grad Inst Environm Engn, Taipei 106, Taiwan	Chinese Academy of Sciences; Institute of Urban Environment, CAS; Chinese Academy of Sciences; Institute of Urban Environment, CAS; National Taiwan University	Yu, CP (corresponding author), Natl Taiwan Univ, Grad Inst Environm Engn, Taipei 106, Taiwan.	cpyu@ntu.edu.tw	Mulla, Dr. Sikandar I./N-1228-2013; Hu, Anyi/E-6836-2018; SUN, Qian/AAF-3313-2021; CAS, KLUEH/T-5743-2019; Mulla, Sikandar I/I-8513-2019; CAS, KLUEH-Cooperation/E-1148-2017	Mulla, Dr. Sikandar I./0000-0002-3435-6457; Hu, Anyi/0000-0001-6226-2741; SUN, Qian/0000-0002-0774-1608; Mulla, Sikandar I/0000-0002-3435-6457; 	Hundred Talents Program of Fujian Province, China; National Natural Science Foundation of China [31370503, 31470539]; International Young Scientists by National Natural Science Foundation of China [31450110426]; Youth Innovation Promotion Association CAS; World Academy of Sciences-Chinese Academy of Sciences (TWAS-CAS) [2013FFZB0003]	Hundred Talents Program of Fujian Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Young Scientists by National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association CAS; World Academy of Sciences-Chinese Academy of Sciences (TWAS-CAS)	This research was supported by the Hundred Talents Program of Fujian Province, China, National Natural Science Foundation of China (31370503, 31470539), International Young Scientists by National Natural Science Foundation of China (31450110426), Youth Innovation Promotion Association CAS and the financial assistance from The World Academy of Sciences-Chinese Academy of Sciences (TWAS-CAS) under its Post-Doctoral fellowships for Young International Scientists (2013FFZB0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RZ, 2014, INT BIODETER BIODEGR, V88, P56, DOI 10.1016/j.ibiod.2013.11.017; Alboghobeish H, 2014, J ENVIRON HEALTH SCI, V12, DOI 10.1186/2052-336X-12-44; Altimira F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-193; Arikan OA, 2009, J HAZARD MATER, V164, P483, DOI 10.1016/j.jhazmat.2008.08.019; Arora PK, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0110-7; Arora PK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04475; Aust MO, 2010, WATER AIR SOIL POLL, V211, P143, DOI 10.1007/s11270-009-0288-1; Chu KH, 1998, APPL ENVIRON MICROB, V64, P3451; Engelhardt I, 2015, J CONTAM HYDROL, V177, P30, DOI 10.1016/j.jconhyd.2015.02.006; Fang H, 2014, CHEMOSPHERE, V96, P51, DOI 10.1016/j.chemosphere.2013.07.016; Feng CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113379; Gordillo F, 2007, FEMS MICROBIOL ECOL, V60, P322, DOI 10.1111/j.1574-6941.2007.00293.x; Grote M, 2004, FRESEN ENVIRON BULL, V13, P1216; Hammesfahr U, 2011, J PLANT NUTR SOIL SC, V174, P614, DOI 10.1002/jpln.201000322; Hamscher G, 2005, ENVIRON TOXICOL CHEM, V24, P861, DOI 10.1897/04-182R.1; HARWOOD CS, 1990, APPL ENVIRON MICROB, V56, P1501, DOI 10.1128/AEM.56.5.1501-1503.1990; Hawkins AC, 2002, APPL ENVIRON MICROB, V68, P968, DOI 10.1128/AEM.68.2.968-972.2002; Heuer H, 2011, APPL ENVIRON MICROB, V77, P2527, DOI 10.1128/AEM.02577-10; Holzel CS, 2012, ENVIRON RES, V113, P21, DOI 10.1016/j.envres.2012.01.002; Hoffmann T, 2011, ANAL BIOANAL CHEM, V399, P1859, DOI 10.1007/s00216-010-4575-x; Huang L, 2008, MAR POLLUT BULL, V56, P1714, DOI 10.1016/j.marpolbul.2008.07.007; Jorgensen SE, 2000, CHEMOSPHERE, V40, P691, DOI 10.1016/S0045-6535(99)00438-5; Kreuzig R, 2005, ENVIRON TOXICOL CHEM, V24, P771, DOI 10.1897/03-582R.1; Lamshoft M, 2007, ANAL BIOANAL CHEM, V388, P1733, DOI 10.1007/s00216-007-1368-y; Law AMJ, 2003, APPL ENVIRON MICROB, V69, P5968, DOI 10.1128/AEM.69.10.5968-5973.2003; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lv M, 2014, J HAZARD MATER, V280, P696, DOI 10.1016/j.jhazmat.2014.08.054; Mulla SI, 2016, CHEMOSPHERE, V144, P292, DOI 10.1016/j.chemosphere.2015.08.034; Nithya C, 2011, MAR ENVIRON RES, V71, P283, DOI 10.1016/j.marenvres.2011.02.003; Pailan S, 2015, PEERJ, V3, DOI 10.7717/peerj.1378; Pandey J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-19; Parales RE, 2004, APPL ENVIRON MICROB, V70, P285, DOI 10.1128/AEM.70.1.285-292.2004; Ricken B, 2013, APPL ENVIRON MICROB, V79, P5550, DOI 10.1128/AEM.00911-13; Selvam A, 2012, BIORESOURCE TECHNOL, V126, P412, DOI 10.1016/j.biortech.2011.12.073; Sharma SCD, 2016, MICROBES ENVIRON, V31, P213, DOI 10.1264/jsme2.ME15185; Sheng XF, 2008, ENVIRON POLLUT, V156, P1164, DOI 10.1016/j.envpol.2008.04.007; Sittig S, 2014, CHEMOSPHERE, V95, P470, DOI 10.1016/j.chemosphere.2013.09.100; Stoob K, 2007, ENVIRON SCI TECHNOL, V41, P7349, DOI 10.1021/es070840e; Sukul P, 2008, CHEMOSPHERE, V71, P717, DOI 10.1016/j.chemosphere.2007.10.045; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tappe W, 2015, BIODEGRADATION, V26, P139, DOI 10.1007/s10532-015-9722-9; Tappe W, 2013, APPL ENVIRON MICROB, V79, P2572, DOI 10.1128/AEM.03636-12; Unold M, 2009, VADOSE ZONE J, V8, P677, DOI 10.2136/vzj2008.0122; Wehrhan A, 2007, J CONTAM HYDROL, V89, P107, DOI 10.1016/j.jconhyd.2006.08.002; Zhang J, 2010, J ENVIRON SCI, V20, P1238, DOI DOI 10.1016/S1001-0742(08)62215-9	45	36	36	8	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0165013	10.1371/journal.pone.0165013	http://dx.doi.org/10.1371/journal.pone.0165013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755578	Green Published, gold, Green Submitted			2022-12-26	WOS:000386203800050
J	Tsenkova, VK; Karlamangla, A				Tsenkova, Vera K.; Karlamangla, Arun			Depression Amplifies the Influence of Central Obesity on 10-Year Incidence of Diabetes: Findings from MIDUS	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOSE-METABOLISM; TYPE-2; MECHANISMS; METAANALYSIS; ASSOCIATION; ADIPOSITY; SUBTYPE; DISEASE; STRESS	Background Central obesity is a major risk factor for diabetes but many obese individuals never develop diabetes, suggesting the presence of important effect modifiers. Depression has emerged as a key risk factor for poor glycemic control, but to our knowledge, no previous work has investigated whether depression amplifies the effect of central obesity on glucoregulation. Methods and Findings We used a national sample of adults without prevalent diabetes (MIDUS; N = 919) to test for synergy between central obesity and depression in the development of diabetes 10 years later. We found that depression amplified the association of waist-to-hip ratio (WHR) with incident diabetes adjusted for age, race, gender, education, physical activity, and sleep problems (p = 0.01 for test of interaction). The relative risk for incident diabetes per every 0.1 increment in WHR was 1.75 (95% CI: 1.31; 2.33) in those without depression and 3.78 in those with depression (95% CI: 2.14; 6.66). Conclusions These results confirm the role of depression as a robust risk factor for the development of diabetes and for the first time, demonstrate a synergy between depression and central obesity. Identifying and addressing depression could prove to be an effective approach to preventing diabetes in at risk individuals. Ultimately, elucidating the interplay among risk factors from different domains will be key to understanding multifactorial diseases such as diabetes and informing theory-based, patient-centered interventions aimed at reducing diabetes risk.	[Tsenkova, Vera K.] Univ Wisconsin, Inst Aging, Madison, WI 53706 USA; [Karlamangla, Arun] Univ Calif Los Angeles, Div Geriatr, Los Angeles, CA USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Los Angeles	Tsenkova, VK (corresponding author), Univ Wisconsin, Inst Aging, Madison, WI 53706 USA.	tsenkova@wisc.edu			National Institute on Aging [P01-AG020166, K01AG041179, P30AG028748]; John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development; General Clinical Research Centers Program [M01-RR023942, M01-RR00865]; Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, National Institutes of Health [1UL1RR025011]; NATIONAL INSTITUTE ON AGING [U19AG051426, P01AG020166] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development; General Clinical Research Centers Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the National Institute on Aging (P01-AG020166; Carol D. Ryff, Principal Investigator) to conduct a longitudinal follow-up of the MIDUS (Midlife in the United States) investigation. The original study was supported by the John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development. Data collection was supported by the following grants: M01-RR023942 (Georgetown), M01-RR00865 (UCLA) from the General Clinical Research Centers Program, and 1UL1RR025011 (UW) from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, National Institutes of Health. The first author (VT) of this study was supported by the National Institute on Aging (K01AG041179; https://www.nia.nih.gov/). The second author (AK) was also supported by the National Institute on Aging (P30AG028748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; American Psychiatric Association, 1987, DIAGNOSTIC AND STATI; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Attie AD, 2004, INT C SER, V1262, P220, DOI [10.1016/j.ics.2003.12.107, DOI 10.1016/J.ICS.2003.12.107]; Centers for Disease Control and Prevention, 2014, NATIONAL DIABETES ST; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Geer EB, 2014, ENDOCRIN METAB CLIN, V43, P75, DOI 10.1016/j.ecl.2013.10.005; Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751; Heraclides AM, 2012, OBESITY, V20, P428, DOI 10.1038/oby.2011.95; Holt RIG, 2014, DIABETES CARE, V37, P2067, DOI 10.2337/dc13-2134; Joseph JJ, 2015, PSYCHONEUROENDOCRINO, V62, P327, DOI 10.1016/j.psyneuen.2015.08.021; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kan C, 2013, DIABETES CARE, V36, P480, DOI 10.2337/dc12-1442; Kessler Rc, 2004, HOW HEALTHY ARE WE; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Lebovitz HE, 2005, DIABETES CARE, V28, P2322, DOI 10.2337/diacare.28.9.2322; Liu CS, 2014, CNS NEUROL DISORD-DR, V13, P1693; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Marazziti D, 2014, CNS SPECTRUMS, V19, P293, DOI 10.1017/S1092852913000667; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Nouwen A, 2011, DIABETES CARE, V34, P752, DOI 10.2337/dc10-1414; Ogden Cynthia L, 2010, NCHS Data Brief, P1; Qiao Q, 2010, EUR J CLIN NUTR, V64, P23, DOI 10.1038/ejcn.2009.92; Rosmond R, 2000, J INTERN MED, V247, P188, DOI 10.1046/j.1365-2796.2000.00603.x; Schmitz N., 2016, MOL PSYCHIAT; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; Sullivan MD, 2012, DIABETES CARE, V35, P1708, DOI 10.2337/dc11-1791; Surwit RS, 2010, OBESITY, V18, P1683, DOI 10.1038/oby.2010.43; SURWIT RS, 1984, DIABETES, V33, P616, DOI 10.2337/diabetes.33.7.616; Tsenkova VK, 2014, J BEHAV MED, V37, P37, DOI 10.1007/s10865-012-9460-y; Tsenkova VK, 2012, PSYCHOTHER PSYCHOSOM, V81, P327, DOI 10.1159/000337413; Tsenkova VK, 2011, ANN BEHAV MED, V41, P243, DOI 10.1007/s12160-010-9238-9; Vogelzangs N, 2011, J CLIN PSYCHIAT, V72, P598, DOI 10.4088/JCP.10m06559; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	35	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164802	10.1371/journal.pone.0164802	http://dx.doi.org/10.1371/journal.pone.0164802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9NV	27755576	Green Published, gold			2022-12-26	WOS:000386203800036
J	Santos, ASED; Silveira, EA; Falco, MD				Alves De Carvalho Santos, Annelisa Silva e; Silveira, Erika Aparecida; Falco, Marianne de Oliveira			Gastrointestinal Symptoms in HIV-Infected Patients: Female Sex and Smoking as Risk Factors in an Outpatient Cohort in Brazil	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; GASTROESOPHAGEAL-REFLUX DISEASE; ADVERSE EVENTS; MANAGEMENT; DISORDERS; DIARRHEA; EPIDEMIOLOGY; NICOTINE; COUNTS; HEALTH	This study aimed to estimate the incidence of gastrointestinal symptoms (GIS) and associated factors in an outpatient cohort of people living with HIV/AIDS (PLWHA) followed between October 2009 and July 2011. We evaluated nausea and/or vomiting, dyspepsia, heartburn, diarrhea, constipation, and flatulence. The outcome variable was the presence of three or more GIS. Sociodemographic (sex, skin color, age, income, years of schooling), lifestyle (smoking status, alcohol consumption, physical activity level), clinical (antiretroviral therapy, time of HIV infection, CD4 lymphocyte count, viral load), and anthropometric (nutritional status and waist circumference) variables were investigated. Data on sociodemographic and lifestyle variables were collected through a pre-tested and standardized questionnaire. CD4 count was determined by flow cytometry and viral load by branched DNA (bDNA) assays for HIV-1. All variables were analyzed at a p<0.05 significance level. Among 290 patients, the incidence of three or more GIS was 28.8% (95% CI 23.17 to 33.84) and 74.48% presented at least one symptom. Female gender (IR 2.29, 95% CI 1.63 to 3.22) and smoking status (IR 1.93, 95% CI 1.30 to 2.88) were risk factors for the presence of three or more GIS after multivariate Poisson regression. A high incidence of gastrointestinal symptoms was found among PLWHA, and it was significantly associated with female sex and tobacco use. Those results reinforce the relevance of investigating the presence of GIS in PLWHA as it may affect treatment adherence.	[Alves De Carvalho Santos, Annelisa Silva e; Silveira, Erika Aparecida; Falco, Marianne de Oliveira] Univ Fed Goias, Fac Med, Postgrad Program Hlth Sci, Goiania, Go, Brazil	Universidade Federal de Goias	Santos, ASED; Silveira, EA (corresponding author), Univ Fed Goias, Fac Med, Postgrad Program Hlth Sci, Goiania, Go, Brazil.	annelisa.nut@gmail.com; erikasil@terra.com.br	Silveira, Erika Aparecida/O-7585-2018	Silveira, Erika Aparecida/0000-0002-8839-4520; Santos, Annelisa/0000-0003-0045-6991	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [14/2008]; Fundacao de Amparo a Pesquisa do Estado de Goias - FAPEG [02/2009]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Goias - FAPEG(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (14/2008) and the Fundacao de Amparo a Pesquisa do Estado de Goias - FAPEG (02/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholi M, 2013, AIDS RES HUM RETROV, V29, P35, DOI [10.1089/aid.2012.0119, 10.1089/AID.2012.0119]; Al Anazi Awadh R, 2009, Saudi J Gastroenterol, V15, P95, DOI 10.4103/1319-3767.48965; Anastasi JK, 2006, J ASSOC NURSE AIDS C, V17, P47, DOI 10.1016/j.jana.2006.01.005; Anestesicas do Tabagismo, 2002, REV BRAS ANESTESIOL, V52, P354; [Anonymous], 2011, STAT STAT SOFTW REL; [Anonymous], 2013, GUID US ANT AG HIV 1; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Attili SVS, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-39; Brazilian Society of Cardiology Brazilian Society of Hypertension Brazilian Society of Nephrology, 2010, J BRAS NEFROL, V95, P1, DOI DOI 10.1590/S0066-782X2010001700001; Chu C, 2011, J URBAN HEALTH, V88, P556, DOI 10.1007/s11524-011-9552-y; Chu KM, 2013, CURR PHARM DESIGN, V19, P5; Chubineh S, 2008, INT J STD AIDS, V19, P723, DOI 10.1258/ijsa.2008.008244; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; El-Serag HB, 2007, CLIN GASTROENTEROL H, V5, P17, DOI 10.1016/j.cgh.2006.09.016; Freire AC, 2011, INT J PHARMACEUT, V415, P15, DOI 10.1016/j.ijpharm.2011.04.069; He M, 2011, CURR HIV RES, V9, P160, DOI 10.2174/157016211795945241; Heading RC, 1999, SCAND J GASTROENTERO, V34, P3, DOI 10.1080/003655299750025200; Hill A, 2009, AIDS REV, V11, P30; Knox TA, 2000, AM J GASTROENTEROL, V95, P3482, DOI 10.1111/j.1572-0241.2000.03365.x; Koloski NA, 2002, AM J GASTROENTEROL, V97, P2290; Le Pluart D, 2015, ALIMENT PHARM THER, V41, P758, DOI 10.1111/apt.13143; Lenzi L, 2013, INT J CLIN PHARM TH, V51, P141, DOI 10.5414/CP201818; Lohman T. G., 1998, ANTROPOMETRIC STANDA; MacArthur RD, 2012, CLIN INFECT DIS, V55, P860, DOI 10.1093/cid/cis544; Macintyre S, 1999, SOC SCI MED, V48, P89, DOI 10.1016/S0277-9536(98)00292-5; Maity P, 2003, MOL CELL BIOCHEM, V253, P329, DOI 10.1023/A:1026040723669; Margolis AM, 2014, J MED TOXICOL, V10, P26, DOI 10.1007/s13181-013-0325-8; Ministerio da Baude (Brazil) Secretaria de Vigilancia em baude. Programa Nacional de DBT e AIDS, 2006, MANUAL CLINICO DE AL; Ministerio da Saude, 2018, SECRETARIA VIGILANCI; [Ministrio da Saude (Brazil) Secretaria de Vigilancia em Saude Departamento de DST], 2013, MIN SAUD B EP AIDS D; Castro ADO, 2016, REV ASSOC MED BRAS, V62, P353, DOI 10.1590/1806-9282.62.04.353; Organizacion Panamericana de la Salud, 1997, PROT DIR CONJ ACC MU; Pavie J, 2012, INT J INFECT DIS, V16, pE677, DOI 10.1016/j.ijid.2012.05.1022; Reust CE, 2011, AM FAM PHYSICIAN, V83, P1443; RODGERS VD, 1987, WESTERN J MED, V146, P57; Santos ASAC, 2016, CLIN NUTR, VS0261-5614, P30135; Shacham E, 2015, INT J STD AIDS, V26, P243, DOI 10.1177/0956462414533318; Sherman DS, 2000, CLIN INFECT DIS, V30, P908, DOI 10.1086/313826; Tadesse WT, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-32; The International Physical Activity Questionnaires (IPAQ) Group, GUIDELINES DATA PROC; Thomas GAO, 2005, NAT CLIN PRACT GASTR, V2, P536, DOI 10.1038/ncpgasthep0316; VERBRUGGE LM, 1987, WOMEN HEALTH, V12, P103, DOI 10.1300/J013v12n02_07; WHO, 2010, ANT THER HIV INF AD; WHO, 1997, WHO TECHN REP SER	44	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164774	10.1371/journal.pone.0164774	http://dx.doi.org/10.1371/journal.pone.0164774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749931	gold, Green Published, Green Submitted			2022-12-26	WOS:000386202300027
J	Laxy, M; Knoll, G; Schunk, M; Meisinger, C; Huth, C; Holle, R				Laxy, Michael; Knoll, Gabriella; Schunk, Michaela; Meisinger, Christa; Huth, Cornelia; Holle, Rolf			Quality of Diabetes Care in Germany Improved from 2000 to 2007 to 2014, but Improvements Diminished since 2007. Evidence from the Population-Based KORA Studies	PLOS ONE			English	Article							DISEASE MANAGEMENT PROGRAMS; COST-EFFECTIVENESS; MULTIFACTORIAL INTERVENTION; GLUCOSE CONTROL; FOLLOW-UP; TYPE-2; INDIVIDUALS; MORTALITY; OUTCOMES; LIFE	Objective Little is known about the development of the quality of diabetes care in Germany. The aim of this study is to analyze time trends in patient self-management, physician-delivered care, medication, risk factor control, complications and quality of life from 2000 to 2014. Methods Analyses are based on data from individuals with type 2 diabetes of the population-based KORA S4 (1999-2001, n = 150), F4 (2006-2008, n = 203), FF4 (2013/14, n = 212) cohort study. Information on patient self-management, physician-delivered care, medication, risk factor control and quality of life were assessed in standardized questionnaires and examinations. The 10-year coronary heart disease (CHD) risk was calculated using the UKPDS risk engine. Time trends were analyzed using multivariable linear and logistic regression models adjusted for age, sex, education, diabetes duration, and history of cardiovascular disease. Results From 2000 to 2014 the proportion of participants with type 2 diabetes receiving oral antidiabetic/cardio-protective medication and of those reaching treatment goals for glycemic control (HbA1c<7%, 60% to 71%, p = 0.09), blood pressure (<140/80 mmHg, 25% to 69%, p<0.001) and LDL cholesterol (<2.6 mmol/l, 13% to 27%, p<0.001) increased significantly. However, improvements were generally smaller from 2007 to 2014 than from 2000 to 2007. Modeled 10-year CHD risk decreased from 30% in 2000 to 24% in 2007 to 19% in 2014 (p<0.01). From 2007 to 2014, the prevalence of microvascular complications decreased and quality of life increased, but no improvements were observed for the majority of indicators of self-management. Conclusion Despite improvements, medication and risk factor control has remained suboptimal. The flattening of improvements and deteriorations in quality of (self-) care since 2007 indicate that more effort is needed to improve quality of care and patient self-management. Due to selection or lead time bias an overestimation of quality of care improvements cannot be ruled out.	[Laxy, Michael; Knoll, Gabriella; Schunk, Michaela; Holle, Rolf] Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Laxy, Michael; Meisinger, Christa; Huth, Cornelia; Holle, Rolf] German Ctr Diabet Res DZD, Munich, Germany; [Knoll, Gabriella] Univ Munich, Inst Med Informat Biometr & Epidemiol, Munich, Germany; [Meisinger, Christa; Huth, Cornelia] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Laxy, M (corresponding author), Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany.; Laxy, M (corresponding author), German Ctr Diabet Res DZD, Munich, Germany.	michael.laxy@helmholtz-muenchen.de	Holle, Rolf/D-9333-2013; Huth, Cornelia/B-5350-2014; Meisinger, Christine/B-5358-2014	Holle, Rolf/0000-0001-5395-2695; Huth, Cornelia/0000-0003-2421-433X; Laxy, Michael/0000-0001-8775-7417; Schunk, Michaela/0000-0002-1200-1903	Helmholtz Zentrum Munchen - German Research Center for Environmental Health; German Federal Ministry of Education and Research; State of Bavaria; Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, LMU innovative	Helmholtz Zentrum Munchen - German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, LMU innovative	The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of the LMU innovative.	Ab E, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-24; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Busse R, 2004, HEALTH AFFAIR, V23, P56, DOI 10.1377/hlthaff.23.3.56; Costa J, 2006, BMJ-BRIT MED J, V332, P1115, DOI 10.1136/bmj.38793.468449.AE; Drabik A, 2012, DIABETES RES CLIN PR, V95, P194, DOI 10.1016/j.diabres.2011.09.015; Du Y, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2015-000135; Fuchs S, 2014, DTSCH ARZTEBL INT, V111, P453, DOI 10.3238/arztebl.2014.0453; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gray A, 2000, BMJ-BRIT MED J, V320, P1373, DOI 10.1136/bmj.320.7246.1373; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Hunger M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-1; Hunger M, 2012, J DIABETES COMPLICAT, V26, P413, DOI 10.1016/j.jdiacomp.2012.05.008; Hunger M, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-53; Ikonen TS, 2010, DIABETES CARE, V33, P2598, DOI 10.2337/dc10-0462; Knight K, 2005, AM J MANAG CARE, V11, P242; Koster I, 2014, EXP CLIN ENDOCR DIAB, V122, P510, DOI 10.1055/s-0034-1375675; Laxy M, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0065-9; Laxy M, 2014, DIABETES CARE, V37, P1604, DOI 10.2337/dc13-2533; Lazar LD, 2011, CIRCULATION, V124, P146, DOI 10.1161/CIRCULATIONAHA.110.986349; Li R, 2010, DIABETES CARE, V33, P1193, DOI 10.2337/dc09-1888; Meisinger C, 2010, DIABETIC MED, V27, P360, DOI 10.1111/j.1464-5491.2009.02905.x; Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Rueckert IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133493; Schunk M, 2012, DIABETIC MED, V29, P646, DOI 10.1111/j.1464-5491.2011.03465.x; Schunk M, 2011, BUNDESGESUNDHEITSBLA, V54, P1187, DOI 10.1007/s00103-011-1364-4; Schunk M, 2009, EXP CLIN ENDOCR DIAB, V117, P88, DOI 10.1055/s-2008-1078734; Schwarz PEH, 2008, EXP CLIN ENDOCR DIAB, V116, P167, DOI 10.1055/s-2007-992115; Stark RG, 2011, DIABETES-METAB RES, V27, P383, DOI 10.1002/dmrr.1186; Stearne MR, 1998, BMJ-BRIT MED J, V317, P720; Tamayo T, 2016, DTSCH ARZTEBL INT, V113, P177, DOI 10.3238/arztebl.2016.0177; Tamayo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099773; Tao LB, 2013, VALUE HEALTH, V16, P1074, DOI 10.1016/j.jval.2013.06.001; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; Vamos EP, 2010, DIABETES CARE, V33, P2592, DOI 10.2337/dc10-0989; van Hateren KJJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001387	41	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164704	10.1371/journal.pone.0164704	http://dx.doi.org/10.1371/journal.pone.0164704			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749939	Green Submitted, gold, Green Published			2022-12-26	WOS:000386202300022
J	Chiche, A; Moumen, M; Romagnoli, M; Petit, V; Lasla, H; Jezequel, P; de la Grange, P; Jonkers, J; Deugnier, MA; Glukhova, MA; Faraldo, MM				Chiche, A.; Moumen, M.; Romagnoli, M.; Petit, V.; Lasla, H.; Jezequel, P.; de la Grange, P.; Jonkers, J.; Deugnier, M-A; Glukhova, M. A.; Faraldo, M. M.			p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors	ONCOGENE			English	Article							MAMMARY EPITHELIAL-CELLS; SELF-RENEWAL; WNT/BETA-CATENIN; BASAL; MET; EXPRESSION; GLAND; TUMORIGENESIS; DISTINCT; PROGENITORS	Triple-negative breast cancer is a heterogeneous disease characterized by the expression of basal cell markers, no estrogen or progesterone receptor expression and a lack of HER2 overexpression. Triple-negative tumors often display activated Wnt/beta-catenin signaling and most have impaired p53 function. We studied the interplay between p53 loss and Wnt/beta-catenin signaling in stem cell function and tumorigenesis, by deleting p53 from the mammary epithelium of K5 Delta N beta cat mice displaying a constitutive activation of Wnt/beta-catenin signaling in basal cells. K5 Delta N beta cat transgenic mice present amplification of the basal stem cell pool and develop triple-negative mammary carcinomas. The loss of p53 in K5 Delta N beta cat mice led to an early expansion of mammary stem/progenitor cells and accelerated the formation of triple-negative tumors. In particular, p53-deficient tumors expressed high levels of integrins and extracellular matrix components and were enriched in cancer stem cells. They also overexpressed the tyrosine kinase receptor Met, a feature characteristic of human triple-negative breast tumors. The inhibition of Met kinase activity impaired tumorsphere formation, demonstrating the requirement of Met signaling for cancer stem cell growth in this model. Human basal-like breast cancers with predicted mutated p53 status had higher levels of MET expression than tumors with wild-type p53. These results connect p53 loss and beta-catenin activation to stem cell regulation and tumorigenesis in triple-negative cancer and highlight the role of Met signaling in maintaining cancer stem cell properties, revealing new cues for targeted therapies.	[Chiche, A.; Moumen, M.; Romagnoli, M.; Petit, V.; Deugnier, M-A; Glukhova, M. A.; Faraldo, M. M.] PSL Res Univ, CNRS, UMR144, Inst Curie, 26 Rue Ulm, F-75005 Paris, France; [Lasla, H.; Jezequel, P.] Inst Cancerol Ouest, St Herblain, France; [de la Grange, P.] Hop La Pitie Salpetriere, IPEPS ICM, GenoSplice Technol, Paris, France; [Jonkers, J.] Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [Jonkers, J.] Netherlands Canc Inst, Canc Genom Ctr Netherlands, Amsterdam, Netherlands; [Deugnier, M-A; Glukhova, M. A.; Faraldo, M. M.] Inst Natl Sante & Rech Med, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Netherlands Cancer Institute; Netherlands Cancer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm)	Faraldo, MM (corresponding author), PSL Res Univ, CNRS, UMR144, Inst Curie, 26 Rue Ulm, F-75005 Paris, France.	maria-luisa.martin-faraldo@curie.fr	Deugnier, Marie-Ange/AAF-5877-2021; Jonkers, Jos/AAG-3246-2019; Martin-Faraldo, Maria-Luisa/M-5811-2018; Deugnier, Marie-Ange/M-7556-2018	Deugnier, Marie-Ange/0000-0002-2199-1099; Jonkers, Jos/0000-0002-9264-9792; Faraldo, Marisa/0000-0001-9497-1171; PETIT, Valerie/0000-0003-1645-9396	La Ligue Nationale Contre le Cancer; Canceropole lle de France [2014-1-SEIN-01-ICR-1]; La Ligue Nationale Contre le Cancer Comites d'Ile de France; Association pour la Recherche sur le Cancer; Institut Curie and Servier Laboratories	La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Canceropole lle de France; La Ligue Nationale Contre le Cancer Comites d'Ile de France; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut Curie and Servier Laboratories	We are particularly grateful to A Di Cicco, D Gentien, A Rapinat and B Albaud for expert technical assistance, to Dr I Grandjean, S Jannet and the personnel of the animal facilities at Institut Curie for taking care of the mice and to Z Maciorowski, A Viguier and S Grondin for excellent assistance with flow cytometry. We also thank Dr JL Jorcano for providing mouse strains and Dr D Medina for valuable discussions. The work was supported by grants from La Ligue Nationale Contre le Cancer (Equipe Labelisee 2013), Canceropole lle de France (2014-1-SEIN-01-ICR-1) to MAG. and a grant from La Ligue Nationale Contre le Cancer Comites d'Ile de France to MMF. MM and AC received funding from Association pour la Recherche sur le Cancer; AC, from Institut Curie and Servier Laboratories; MAG. is Directeur de Recherche, MMF, MAD and AG are Charge de Recherche at the Institut National de la Sante et de la Recherche Medicale (INSERM).	Ali NA, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0437-3; Arcand SL, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0169-y; Ballard MS, 2015, CELL REP, V13, P290, DOI 10.1016/j.celrep.2015.09.006; Bertheau P, 2013, BREAST, V22, pS27, DOI 10.1016/j.breast.2013.07.005; Bertucci F, 2012, CURR MOL MED, V12, P96, DOI 10.2174/156652412798376134; Bonizzi G, 2012, TRENDS MOL MED, V18, P6, DOI 10.1016/j.molmed.2011.08.002; Cagnet S, 2014, ONCOGENE, V33, P4286, DOI 10.1038/onc.2013.391; Chang C, 2015, GENE DEV, V29, P1, DOI 10.1101/gad.253682.114; Chiche A, 2013, STEM CELLS, V31, P1857, DOI 10.1002/stem.1429; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Damalas A, 1999, EMBO J, V18, P3054, DOI 10.1093/emboj/18.11.3054; de la Grange P, 2005, NUCLEIC ACIDS RES, V33, P4276, DOI 10.1093/nar/gki738; Di-Cicco A, 2015, ELIFE, V4, DOI 10.7554/eLife.06104; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; Dumay A, 2013, INT J CANCER, V132, P1227, DOI 10.1002/ijc.27767; Faraldo MM, 2015, METHODS MOL BIOL, V1293, P161, DOI 10.1007/978-1-4939-2519-3_9; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Gastaldi S, 2013, ONCOGENE, V32, P1428, DOI 10.1038/onc.2012.154; Gastaldi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2617; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P373, DOI 10.1002/mc.20395; Graveel CR, 2009, P NATL ACAD SCI USA, V106, P12909, DOI 10.1073/pnas.0810403106; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Ho-Yen CM, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0547-6; Holland JD, 2013, CELL REP, V5, P1214, DOI 10.1016/j.celrep.2013.11.001; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jezequel P, 2013, DATABASE-OXFORD, DOI 10.1093/database/bas060; Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kataoka H, 2010, FEBS J, V277, P2230, DOI 10.1111/j.1742-4658.2010.07640.x; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Knight JF, 2013, P NATL ACAD SCI USA, V110, pE1301, DOI 10.1073/pnas.1210353110; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Liao JM, 2014, J MOL CELL BIOL, V6, P206, DOI 10.1093/jmcb/mju018; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lu X, 2013, ONCOGENE, V32, P2900, DOI 10.1038/onc.2012.299; Maroun CR, 2014, PHARMACOL THERAPEUT, V142, P316, DOI 10.1016/j.pharmthera.2013.12.014; Medina D, 2002, FASEB J, V16, P881, DOI 10.1096/fj.01-0885fje; Meniel V, 2005, CANCER RES, V65, P410; Meyer MJ, 2010, CANCER RES, V70, P4624, DOI 10.1158/0008-5472.CAN-09-3619; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Moumen M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-132; Moumen M, 2012, STEM CELLS, V30, P1246, DOI 10.1002/stem.1090; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Prater MD, 2014, NAT CELL BIOL, V16, P942, DOI 10.1038/ncb3025; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Ridgeway AG, 2006, ONCOGENE, V25, P3518, DOI 10.1038/sj.onc.1209391; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shi L, 2013, CIRC RES, V113, P1320, DOI 10.1161/CIRCRESAHA.113.301824; Skibinski A, 2015, ONCOGENE, V34, P5309, DOI 10.1038/onc.2014.475; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spike Benjamin T, 2011, Genes Cancer, V2, P404, DOI 10.1177/1947601911410224; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Tao LW, 2011, STEM CELLS, V29, P119, DOI 10.1002/stem.552; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; van Miltenburg MHAM, 2014, BRIT J CANCER, V110, P2747, DOI 10.1038/bjc.2014.219; Vieira AF, 2012, STEM CELLS, V30, P854, DOI 10.1002/stem.1075; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zoratti GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7776	72	15	16	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 27	2017	36	17					2355	2365		10.1038/onc.2016.396	http://dx.doi.org/10.1038/onc.2016.396			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET4QE	27775073				2022-12-26	WOS:000400268900003
J	Brunetti, J; Roscia, G; Lampronti, I; Gambari, R; Quercini, L; Falciani, C; Bracci, L; Pini, A				Brunetti, Jlenia; Roscia, Giulia; Lampronti, Ilaria; Gambari, Roberto; Quercini, Leila; Falciani, Chiara; Bracci, Luisa; Pini, Alessandro			Immunomodulatory and Anti-inflammatory Activity in Vitro and in Vivo of a Novel Antimicrobial Candidate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); drug discovery; infectious disease; inflammation; LPS; anti-inflammatory agents	HOST-DEFENSE PEPTIDES; CYSTIC-FIBROSIS; BRANCHED PEPTIDES; RESISTANCE; MECHANISM; SELECTION; TOXICITY; LUNGS; DRUG	The synthetic antimicrobial peptide SET-M33 has strong activity against bacterial infections caused by Gram-negative bacteria. It is currently in preclinical development as a new drug to treat lung infections caused by Gram-negative bacteria. Here we report its strong anti-inflammatory activity in terms of reduced expression of a number of cytokines, enzymes, and signal transduction factors involved in inflammation triggered by LPS from Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli. Sixteen cytokines and other major agents involved in inflammation were analyzed in macrophages and bronchial cells after stimulation with LPS and incubation with SET-M33. The bronchial cells were obtained from a cystic fibrosis patient. A number of these proteins showed up to 100% reduction in expression as measured by RT-PCR, Western blotting, or Luminex technology. LPS neutralization was also demonstrated in vivo by challenging bronchoalveolar lavage of SET-M33-treated mice with LPS, which led to a sharp reduction in TNF- with respect to non-SET-M33-treated animals. We also describe a strong activity of SET-M33 in stimulating cell migration of keratinocytes in wound healing experiments in vitro, demonstrating a powerful immunomodulatory action generally characteristic of molecules taking part in innate immunity.	[Brunetti, Jlenia; Roscia, Giulia; Quercini, Leila; Bracci, Luisa; Pini, Alessandro] Univ Siena, Dept Med Biotechnol, Via Aldo Moro 2, I-53100 Siena, Italy; [Lampronti, Ilaria; Gambari, Roberto] Univ Ferrara, Dept Life Sci & Biotechnol, Via Fossato Mortara 74, I-44121 Ferrara, Italy; [Falciani, Chiara] SetLance Srl, Via Fiorentina 1, I-53100 Siena, Italy	University of Siena; University of Ferrara	Pini, A (corresponding author), Univ Siena, Dept Med Biotechnol, Via Aldo Moro 2, I-53100 Siena, Italy.	pinia@unisi.it	Bracci, Luisa/V-9913-2018; Pini, Alessandro/R-1359-2018; Falciani, Chiara/R-1330-2018; Brunetti, Luisa/E-6464-2019	Bracci, Luisa/0000-0002-0738-5746; Pini, Alessandro/0000-0002-3832-8349; Falciani, Chiara/0000-0002-1027-8482; Brunetti, Luisa/0000-0001-8144-7186	European Community [604434]; Italian Foundation for Cystic Fibrosis [12/2013, 17/2016]	European Community(European Commission); Italian Foundation for Cystic Fibrosis(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation)	This work was supported by the European Community Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 604434 (PNEUMO-NP) and by the Italian Foundation for Cystic Fibrosis (Projects FFC# 12/2013 and FFC# 17/2016 to A. P.). The peptide SET-M33 is covered by three patents owned by or licensed to SetLance. C. F., A, P., and L. B. are partners of SetLance.	BALTIMORE RS, 1989, AM REV RESPIR DIS, V140, P1650, DOI 10.1164/ajrccm/140.6.1650; Bracci L, 2003, J BIOL CHEM, V278, P46590, DOI 10.1074/jbc.M308615200; Brunetti J., 2016, CURR TOP MED CHEM; Brunetti J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26077; Brunetti J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17736; Chmiel JF, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-8; Falciani C, 2007, MOL CANCER THER, V6, P2441, DOI 10.1158/1535-7163.MCT-07-0164; Falciani C, 2007, CHEM BIOL DRUG DES, V69, P216, DOI 10.1111/j.1747-0285.2007.00487.x; Falciani C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046259; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hulkower Keren I, 2011, Pharmaceutics, V3, P107, DOI 10.3390/pharmaceutics3010107; Lam SJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.162, 10.1038/NMICROBIOL.2016.162]; Lampronti I, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/960603; Lee TH, 2016, CURR TOP MED CHEM, V16, P25, DOI 10.2174/1568026615666150703121700; Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004; Pini A, 2005, ANTIMICROB AGENTS CH, V49, P2665, DOI 10.1128/AAC.49.7.2665-2672.2005; Pini A, 2008, CURR PROTEIN PEPT SC, V9, P468, DOI 10.2174/138920308785915227; Pini A, 2007, J PEPT SCI, V13, P393, DOI 10.1002/psc.858; Pini A, 2012, AMINO ACIDS, V43, P467, DOI 10.1007/s00726-011-1103-z; Pini A, 2010, FASEB J, V24, P1015, DOI 10.1096/fj.09-145474; Roscia G, 2013, CURR PROTEIN PEPT SC, V14, P641, DOI 10.2174/138920371408131227155308; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Tamanini A, 2011, AM J PHYSIOL-LUNG C, V300, pL380, DOI 10.1152/ajplung.00129.2010; Walter MNM, 2010, EXP CELL RES, V316, P1271, DOI 10.1016/j.yexcr.2010.02.026; Zhang PX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7221	27	33	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25742	25748		10.1074/jbc.M116.750257	http://dx.doi.org/10.1074/jbc.M116.750257			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27758868	Green Published, hybrid			2022-12-26	WOS:000390095300038
J	Boere, E; Kamperman, AM; van 't Hoog, AE; van den Broek, WW; Birkenhager, TK				Boere, Elvira; Kamperman, Astrid M.; van 't Hoog, Arianne E.; van den Broek, Walter W.; Birkenhager, Tom K.			Anterograde Amnesia during Electroconvulsive Therapy: A Prospective Pilot-Study in Patients with Major Depressive Disorder	PLOS ONE			English	Article							RETROGRADE-AMNESIA; ASSOCIATION; IMPAIRMENT; DEFICITS	Electroconvulsive therapy (ECT) is considered an effective treatment for major depression with melancholic features. However, neurocognitive side-effects such as anterograde amnesia still regularly occur. The present study aims to evaluate the severity and course of anterograde amnesia in severely depressed patients undergoing ECT. In a prospective naturalistic study, anterograde memory function was assessed among inpatients who underwent ECT (n = 11). Subjects met DSM-IV criteria for major depressive disorder. Recruitment took place between March 2010-March 2011 and March 2012-March 2013. Controls treated with antidepressants (n = 9) were matched for age, gender and depression severity. Primary outcome measure was immediate recall; secondary outcome measures were delayed recall, recognition, and visual association. Differences were tested using repeated measures ANOVA and paired t-tests. Correlations with hypothesized covariates were calculated. In patients with major depressive disorder, ECT had a significant effect on delayed memory function (p<0.01 with large effect sizes). Findings on immediate recall were less consistent. Four weeks after treatment discontinuation, these memory functions had recovered. Age was identified as a very important covariate. The main limitations of our study are its naturalistic design, possibly compromising internal validity, and its small sample size. However, if these findings can be reproduced in a more comprehensive study group, then the possible induction of anterograde amnesia is not a justifiable reason for clinicians to disregard ECT as a treatment option.	[Boere, Elvira; Kamperman, Astrid M.; van 't Hoog, Arianne E.; van den Broek, Walter W.; Birkenhager, Tom K.] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Boere, E (corresponding author), Erasmus MC, Dept Psychiat, Rotterdam, Netherlands.	e.boere@yahoo.com	Cardoner, Narcis/H-8436-2015; Birkenhager, Tom K/A-2816-2008; Boere, Elvira/AFL-9843-2022; Kamperman, Astrid/J-8046-2015; Boere, Elvira/AAH-2051-2022	Birkenhager, Tom K/0000-0002-6611-6597; Boere, Elvira/0000-0002-4881-0075; Kamperman, Astrid/0000-0003-4455-6492; Boere, Elvira/0000-0002-4881-0075				Abrams R., 2002, ELECTROCONVULSIVE TH; ANDRADE C, 1994, CONVULSIVE THER, V10, P59; Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200; Bodnar A, 2016, WORLD J BIOL PSYCHIA, V17, P159, DOI 10.3109/15622975.2015.1091501; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dotson VM, 2008, AM J GERIAT PSYCHIAT, V16, P318, DOI 10.1097/JGP.0b013e3181662a9c; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; FINK M, 1982, ARCH GEN PSYCHIAT, V39, P1189; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Heijnen WT, 2010, J CLIN PSYCHOPHARM, V30, P616, DOI 10.1097/JCP.0b013e3181ee0f5f; Hrobjartsson A, 2013, CAN MED ASSOC J, V185, pE201, DOI 10.1503/cmaj.120744; Ingram A, 2008, J ECT, V24, P3, DOI 10.1097/YCT.0b013e31815ef24a; Lezak MD., 2004, NEUROPSYCHOLOGICAL A, V(4th ed.), P429; Lindeboom J, 2002, J NEUROL NEUROSUR PS, V73, P126, DOI 10.1136/jnnp.73.2.126; Matthews JD, 2013, J ECT, V29, P170, DOI 10.1097/YCT.0b013e31828b3523; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; McClintock SM, 2010, CNS SPECTRUMS, V15, P304, DOI 10.1017/S109285290002753X; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; Meeter M, 2011, J AFFECT DISORDERS, V132, P216, DOI 10.1016/j.jad.2011.02.026; Nagane A, 2014, PSYCHIAT RES, V218, P101, DOI 10.1016/j.psychres.2014.04.013; O'Connor M, 2008, J ECT, V24, P146, DOI 10.1097/YCT.0b013e318158792f; Porter R, 2008, J ECT, V24, P35, DOI 10.1097/YCT.0b013e31816207f0; Porter RJ, 2008, J ECT, V24, P25, DOI 10.1097/YCT.0b013e31815d9627; Schmidt M., 1996, W PSYCHOL SERVICES; Schwarz KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130492; Semkovska M, 2016, AM J PSYCHIAT, V173, P408, DOI 10.1176/appi.ajp.2015.15030372; Semkovska M, 2010, BIOL PSYCHIAT, V68, P568, DOI 10.1016/j.biopsych.2010.06.009; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Van Der Elst W, 2005, J INT NEUROPSYCHOLOG, V11; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; Wingo AP, 2009, J CLIN PSYCHIAT, V70, P1588, DOI 10.4088/JCP.08r04972; Zaninotto L, 2015, J AFFECT DISORDERS, V174, P580, DOI 10.1016/j.jad.2014.11.027	32	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165392	10.1371/journal.pone.0165392	http://dx.doi.org/10.1371/journal.pone.0165392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768745	Green Submitted, Green Published, gold			2022-12-26	WOS:000386205400081
J	Kjaer, L; Cordua, S; Holmstrom, MO; Thomassen, M; Kruse, TA; Pallisgaard, N; Larsen, TS; de Stricker, K; Skov, V; Hasselbalch, HC				Kjaer, Lasse; Cordua, Sabrina; Holmstrom, Morten O.; Thomassen, Mads; Kruse, Torben A.; Pallisgaard, Niels; Larsen, Thomas S.; de Stricker, Karin; Skov, Vibe; Hasselbalch, Hans C.			Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment	PLOS ONE			English	Article							TYPE-2 CALRETICULIN MUTATIONS; POLYMERASE-CHAIN-REACTION; ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; JAK2 V617F; PRIMARY MYELOFIBROSIS; MOLECULAR RESPONSES; SOMATIC MUTATIONS; CRITERIA; DISEASE	Discovery of somatic mutations in the calreticulin gene (CALR) has identified a subgroup of Philadelphia-negative chronic myeloproliferative neoplasms (MPN) with separate haematological characteristics and prognosis. CALR mutations serve as novel markers both of diagnostic value and as targets for monitoring molecular responses during therapy. Interferon-alpha (IFN) selectively targets the malignant clone in a subset of MPN patients and can induce both haematological and molecular remissions in CALR mutated essential thrombocythemia (ET) patients. We investigated the response to IFN in a cohort of 21 CALR mutated MPN patients including ET, prefibrotic primary myelofibrosis (pre-PMF), and primary myelofibrosis (PMF) with a median follow-up of 31 months. For evaluation of a molecular response, we developed highly sensitive quantitative PCR (qPCR) assays for monitoring the mutant allele burden of the two most prevalent CALR mutations (type 1 and type 2). Thirteen patients (62%) experienced a decrease in the mutant allele burden with a median decline of 29% from baseline. However, only four patients, including patients with ET, pre-PMF, and PMF diagnosis, achieved molecular responder (MR) status with >50% reduction in mutant allele burden according to European LeukemiaNet (ELN) guidelines. MR patients displayed significant differences in the dynamics of the CALR mutant load with regard to time to response and dynamics in mutant allele burden after discontinuation of IFN treatment. Furthermore, we highlight the prognostic value of the CALR mutant allele burden by showing a close association with leucocyte-and platelet counts, hemoglobin concentration, in addition to plasma lactate dehydrogenase (LDH) irrespective of molecular response and treatment status.	[Kjaer, Lasse; Cordua, Sabrina; Holmstrom, Morten O.; Skov, Vibe; Hasselbalch, Hans C.] Zealand Univ Hosp, Dept Haematol, Roskilde, Denmark; [Thomassen, Mads; Kruse, Torben A.] Odense Univ Hosp, Dept Clin Genet, Odense, Denmark; [Pallisgaard, Niels] Zealand Univ Hosp, Dept Surg Pathol, Roskilde, Denmark; [Larsen, Thomas S.] Odense Univ Hosp, Dept Haematol, Odense, Denmark; [de Stricker, Karin] Odense Univ Hosp, Dept Pathol, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Kjaer, L (corresponding author), Zealand Univ Hosp, Dept Haematol, Roskilde, Denmark.	laskj@regionsjaelland.dk	Hasselbalch, Hans/H-2217-2017	Larsen, Thomas Stauffer/0000-0002-8418-6708; Pallisgaard, Niels/0000-0002-0749-0810; Hasselbalch, Hans/0000-0003-3936-8032; Holmstrom, Morten/0000-0002-3764-8578	The Danish Cancer Society [R90-A6143] Funding Source: researchfish	The Danish Cancer Society(Danish Cancer Society)		Andrikovics H, 2014, HAEMATOLOGICA, V99, P1184, DOI 10.3324/haematol.2014.107482; Barosi G, 2009, BLOOD, V113, P4829, DOI 10.1182/blood-2008-09-176818; Bench AJ, 2013, BRIT J HAEMATOL, V160, P25, DOI 10.1111/bjh.12075; Broseus J, 2014, LEUKEMIA, V28, P1374, DOI 10.1038/leu.2014.49; Broseus J, 2014, BLOOD, V124, P3964, DOI 10.1182/blood-2014-06-583161; Cabagnols X, 2015, LEUKEMIA, V29, P249, DOI 10.1038/leu.2014.270; Cabagnols X, 2015, NEW ENGL J MED, V372, P688, DOI 10.1056/NEJMc1413718; Cassinat B, 2014, NEW ENGL J MED, V371, P188, DOI 10.1056/NEJMc1401255; Guglielmelli P, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.90; Haslam K, 2014, BRIT J HAEMATOL, V166, P800, DOI 10.1111/bjh.12904; Hasselbalch HC, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/102476; Hermouet S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/145293; Jonesa AV, 2015, LEUKEMIA RES, V39, P82, DOI 10.1016/j.leukres.2014.11.019; Jovanovic JV, 2013, LEUKEMIA, V27, P2032, DOI 10.1038/leu.2013.219; Kiladjian JJ, 2008, BLOOD, V112, P3065, DOI 10.1182/blood-2008-03-143537; Kiladjian JJ, 2006, BLOOD, V108, P2037, DOI 10.1182/blood-2006-03-009860; Kittur J, 2007, CANCER-AM CANCER SOC, V109, P2279, DOI 10.1002/cncr.22663; Kjaer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033100; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Kristensen T, 2011, J MOL DIAGN, V13, P180, DOI 10.1016/j.jmoldx.2010.10.004; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; Langabeer SE, 2015, EUR J HAEMATOL, V95, P270, DOI 10.1111/ejh.12578; Larsen TS, 2007, EUR J HAEMATOL, V79, P508, DOI 10.1111/j.1600-0609.2007.00960.x; Larsen TS, 2007, BRIT J HAEMATOL, V136, P745, DOI 10.1111/j.1365-2141.2007.06497.x; Larsen TS, 2013, LEUKEMIA RES, V37, P1041, DOI 10.1016/j.leukres.2013.06.012; Lundberg P, 2014, BLOOD, V123, P2220, DOI 10.1182/blood-2013-11-537167; Mansier O, 2016, J MOL DIAGN, V18, P68, DOI 10.1016/j.jmoldx.2015.07.007; Marty C, 2013, LEUKEMIA, V27, P2187, DOI 10.1038/leu.2013.102; Marty C, 2016, BLOOD, V127, P1317, DOI 10.1182/blood-2015-11-679571; McGaffin G, 2014, BRIT J HAEMATOL, V167, P276, DOI 10.1111/bjh.12969; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Pietra D, 2016, LEUKEMIA, V30, P431, DOI 10.1038/leu.2015.277; Quintas-Cardama A, 2013, BLOOD, V122, P893, DOI 10.1182/blood-2012-07-442012; Quintas-Cardama A, 2009, J CLIN ONCOL, V27, P5418, DOI 10.1200/JCO.2009.23.6075; Rotunno G, 2014, BLOOD, V123, P1552, DOI 10.1182/blood-2013-11-538983; Rumi E, 2014, BLOOD, V124, P1062, DOI 10.1182/blood-2014-05-578435; SILVER RT, 1988, LANCET, V2, P403; Stadhouders R, 2010, J MOL DIAGN, V12, P109, DOI 10.2353/jmoldx.2010.090035; Tefferi A, 2014, LEUKEMIA, V28, P1568, DOI 10.1038/leu.2014.83; Tefferi A, 2014, LEUKEMIA, V28, P1407, DOI 10.1038/leu.2014.35; Tefferi A, 2014, BLOOD, V124, P2465, DOI 10.1182/blood-2014-07-588426; Tefferi A, 2014, AM J HEMATOL, V89, pE121, DOI 10.1002/ajh.23743; Tefferi A, 2013, BLOOD, V122, P1395, DOI 10.1182/blood-2013-03-488098; Verger E, 2015, BLOOD, V126, P2585, DOI 10.1182/blood-2015-07-659060	44	30	31	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165336	10.1371/journal.pone.0165336	http://dx.doi.org/10.1371/journal.pone.0165336			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764253	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500149
J	Polireddy, K; Dong, R; McDonald, PR; Wang, T; Luke, B; Chen, P; Broward, M; Roy, A; Chen, Q				Polireddy, Kishore; Dong, Ruochen; McDonald, Peter R.; Wang, Tao; Luke, Brendan; Chen, Ping; Broward, Melinda; Roy, Anuradha; Chen, Qi			Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation	PLOS ONE			English	Article							HISTONE-DEACETYLASE INHIBITORS; PHASE-III TRIAL; STEM-CELLS; E-CADHERIN; BREAST-CANCER; DRUG-RESISTANCE; PLUS GEMCITABINE; EMT; CHEMOTHERAPY; PROGRESSION	Background Pancreatic cancer has an enrichment of stem-like cancer cells (CSCs) that contribute to chemoresistant tumors prone to metastasis and recurrence. Drug screening assays based on cytotoxicity cannot identify specific CSC inhibitors, because CSCs comprise only a small portion of cancer cell population, and it is difficult to propagate stable CSC populations in vitro for high-throughput screening (HTS) assays. Based on the important role of cancer cell epithelial-to-mesenchymal transition (EMT) in promoting CSCs, we hypothesized that inhibition of EMT can be a useful strategy for inhibiting CSCs, and therefore a feasible approach for HTS can be built for identification of CSC inhibitors, based on assays detecting EMT inhibition. Methods An immunofluorescent assay was established and optimized for HTS to identify compounds that enhance E-cadherin expression, as a hallmark of inhibition of EMT. Four chemical libraries containing 41,472 compounds were screened in PANC-1 pancreatic cancer cell line. Positive hits were validated for EMT and CSC inhibition in vitro using sphere formation assay, western blotting, immune fluorescence, and scratch assay. Results Initial hits were refined to 73 compounds with a secondary screening, among which 17 exhibited concentration dependent induction of E-cadherin expression. Six compounds were selected for further study which belonged to 2 different chemical structural clusters. A novel compound 1-(benzylsulfonyl) indoline (BSI, Compound #38) significantly inhibited pancreatic cancer cell migration and invasion. BSI inhibited histone deacetylase, increased histone 4 acetylation preferably, resulting in E-cadherin up-regulation. BSI effectively inhibited tumor spheres formation. Six more analogues of BSI were tested for anti-migration and anti-CSC activities. Conclusion This study demonstrated a feasible approach for discovery of agents targeting EMT and CSCs using HTS, and identified a class of novel chemicals that could be developed as anti EMT and anti-CSC drug leads.	[Polireddy, Kishore; Dong, Ruochen; Wang, Tao; Luke, Brendan; Chen, Ping; Chen, Qi] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66103 USA; [McDonald, Peter R.; Broward, Melinda; Roy, Anuradha] Univ Kansas, Struct Biol Ctr, High Throughput Screening Core Facil, Lawrence, KS 66045 USA	University of Kansas; University of Kansas Medical Center; University of Kansas	Chen, Q (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66103 USA.	qchen@kumc.edu	Dong, Ruochen/ABC-9193-2020; Broward, Melinda/AAB-3293-2020	Wang, Tao/0000-0003-4832-1148; Roy, Anuradha/0000-0002-1057-1443	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [8P30GM103495]; State of Kansas [8P30GM103495-03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113117] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; State of Kansas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number 8P30GM103495 and the State of Kansas (https://projectreporter.nih.gov/project_info_description.cfrn?projectnumber=8P30GM103495-03). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; American Cancer Society, 2016, CANC FACTS FIGURES 2; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bayraktar S, 2010, MT SINAI J MED, V77, P606, DOI 10.1002/msj.20217; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Chetty R, 2009, PANCREAS, V38, P338, DOI 10.1097/MPA.0b013e318183d74a; Dahan L, 2010, GUT, V59, P1527, DOI 10.1136/gut.2010.216135; Dahlin JL, 2016, ASSAY DRUG DEV TECHN, V14, P168, DOI 10.1089/adt.2015.674; Dansranjavin T, 2006, ONCOL REP, V15, P1125; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Germain AR, 2012, BIOORG MED CHEM LETT, V22, P3571, DOI 10.1016/j.bmcl.2012.01.035; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gupta R, 2009, CELL STEM CELL, V5, P125, DOI 10.1016/j.stem.2009.07.006; Herzig M, 2007, ONCOGENE, V26, P2290, DOI 10.1038/sj.onc.1210029; Isayama H, 2011, ONCOLOGY-BASEL, V80, P97, DOI 10.1159/000328767; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Jordaan G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-88; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Karayiannakis AJ, 1998, ANTICANCER RES, V18, P4177; Kim R, 2011, LANCET ONCOL, V12, P8, DOI 10.1016/S1470-2045(10)70237-0; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lin YW, 2014, CURR PHARM DESIGN, V20, P1698, DOI 10.2174/13816128113199990512; Lively S, 2008, SERINE PROTEASE INHI; Lowenfels AB, 2004, JPN J CLIN ONCOL, V34, P238, DOI 10.1093/jjco/hyh045; Mahboobi S, 2007, J MED CHEM, V50, P4405, DOI 10.1021/jm0703136; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mathews LA, 2012, J BIOMOL SCREEN, V17, P1231, DOI 10.1177/1087057112458152; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nieto J, 2008, ONCOLOGIST, V13, P562, DOI 10.1634/theoncologist.2007-0181; Oberstein PE, 2011, J PANCREAS, V12, P96; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Renouf D, 2010, EXPERT REV ANTICANC, V10, P529, DOI 10.1586/ERA.10.21; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Singh SK, 2003, CANCER RES, V63, P5821; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tryndyak VP, 2010, INT J CANCER, V126, P2575, DOI 10.1002/ijc.24972; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang HG, 2013, INT J MOL MED, V31, P967, DOI 10.3892/ijmm.2013.1285; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104	63	15	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164811	10.1371/journal.pone.0164811	http://dx.doi.org/10.1371/journal.pone.0164811			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764163	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500067
J	Wu, JN; Wang, YM; Park, SY; Kim, SG; Yoo, JS; Park, S; Gupta, R; Kang, KY; Kim, ST				Wu, Jingni; Wang, Yiming; Park, Sook-Young; Kim, Sang Gon; Yoo, Ju Soon; Park, Sangryeol; Gupta, Ravi; Kang, Kyu Young; Kim, Sun Tae			Secreted Alpha-N-Arabinofuranosidase B Protein Is Required for the Full Virulence of Magnaporthe oryzae and Triggers Host Defences	PLOS ONE			English	Article							RICE BLAST FUNGUS; CELL-DEATH; INFECTION; IDENTIFICATION; REVEALS; KINASE; PLANTS; GRISEA; GENES; EXPRESSION	Rice blast disease caused by Magnaporthe oryzae is one of the most devastating fungal diseases of rice and results in a huge loss of rice productivity worldwide. During the infection process, M. oryzae secretes a large number of glycosyl hydrolase proteins into the host apoplast to digest the cell wall and facilitate fungal ingression into host tissues. In this study, we identified a novel arabinofuranosidase-B (MoAbfB) protein that is secreted by M. oryzae during fungal infection. Deletion of MoAbfB from M. oryzae resulted in reduced disease severity in rice. Biochemical assays revealed that the MoAbfB protein exhibited arabinofuranosidase activity and caused degradation of rice cell wall components. Interestingly, pre-treatment of rice with the MoAbfB protein inhibited fungal infection by priming defence gene expression. Our findings suggest that MoAbfB secretion affects M. oryzae pathogenicity by breaking down the host cell wall, releasing oligosaccharides that may be recognized by the host to trigger innate immune responses.	[Wu, Jingni; Kang, Kyu Young] Gyeongsang Natl Univ, Div Appl Life Sci, Program BK21, Jinju, South Korea; [Wu, Jingni; Wang, Yiming; Kim, Sang Gon; Kang, Kyu Young] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Jinju, South Korea; [Wang, Yiming] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany; [Park, Sook-Young] Sunchon Natl Univ, Korean Lichen Res Inst, Sunchon, South Korea; [Yoo, Ju Soon] Pusan Natl Univ, Dept Life Sci & Environm Biochem, Miryang, South Korea; [Park, Sangryeol] Rural Dev Adm, Mol Breeding Div, Natl Inst Agr Sci, Jeonju, South Korea; [Gupta, Ravi; Kim, Sun Tae] Pusan Natl Univ, Life & Ind Convergence Res Inst, Dept Plant Biosci, Miryang, South Korea	Gyeongsang National University; Gyeongsang National University; Max Planck Society; Sunchon National University; Pusan National University; National Institute of Agricultural Sciences; Rural Development Administration (RDA); Pusan National University	Kang, KY (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, Program BK21, Jinju, South Korea.; Kang, KY (corresponding author), Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Jinju, South Korea.; Kim, ST (corresponding author), Pusan Natl Univ, Life & Ind Convergence Res Inst, Dept Plant Biosci, Miryang, South Korea.	kykang@gnu.ac.kr; stkim71@pusan.ac.kr	Wang, Yiming/S-2538-2019; Gupta, Ravi/K-5977-2019	Wang, Yiming/0000-0003-0513-9039; Gupta, Ravi/0000-0001-5242-9528; gim, seontae/0000-0001-9705-6868	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2012RIA12040584]; Max-Planck Institute for Plant Breeding Research; Alexander-Bayer Fellowship from the Alexander von Humboldt Foundation; Bayer Science and Education Foundation; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural development Administration, Republic of Korea [PJ011038]	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Max-Planck Institute for Plant Breeding Research; Alexander-Bayer Fellowship from the Alexander von Humboldt Foundation; Bayer Science and Education Foundation; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural development Administration, Republic of Korea	This work was supported by grants from the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology [2012RIA12040584]. Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center, PJ011038), Rural development Administration, Republic of Korea. Y. W. was supported by the Max-Planck Institute for Plant Breeding Research, by an Alexander-Bayer Fellowship from the Alexander von Humboldt Foundation, and by the Bayer Science and Education Foundation.	Vu BA, 2012, MOL PLANT MICROBE IN, V25, P1135, DOI 10.1094/MPMI-02-12-0043-R; Battaglia E, 2013, FUNGAL GENET BIOL, V57, P76, DOI 10.1016/j.fgb.2013.06.005; Bhuiyan NH, 2009, PLANT SIGNAL BEHAV, V4, P158, DOI 10.4161/psb.4.2.7688; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bolouri Moghaddam MR, 2012, J EXP BOT, V63, P3989, DOI 10.1093/jxb/ers129; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Chen MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037654; Chen SB, 2013, MOL PLANT MICROBE IN, V26, P191, DOI 10.1094/MPMI-05-12-0117-R; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; D'Ovidio R, 2004, BBA-PROTEINS PROTEOM, V1696, P237, DOI 10.1016/j.bbapap.2003.08.012; FLIPPHI MJA, 1993, CURR GENET, V24, P525, DOI 10.1007/BF00351717; Gielkens M, 1999, MICROBIOL-UK, V145, P735, DOI 10.1099/13500872-145-3-735; Gupta R, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00352; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Kershaw MJ, 2009, P NATL ACAD SCI USA, V106, P15967, DOI 10.1073/pnas.0901477106; Kim SG, 2013, J PROTEOMICS, V78, P58, DOI 10.1016/j.jprot.2012.10.029; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000757; Kim ST, 2003, PROTEOMICS, V3, P2368, DOI 10.1002/pmic.200300577; Kim ST, 2001, ELECTROPHORESIS, V22, P2103, DOI 10.1002/1522-2683(200106)22:10&lt;2103::AID-ELPS2103&gt;3.0.CO;2-W; Kim ST, 2008, J PROTEOME RES, V7, P1750, DOI 10.1021/pr700878t; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Kwon Y, 2011, J PLANT RES, V124, P193, DOI 10.1007/s10265-010-0354-1; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lee J, 2003, MOL MICROBIOL, V50, P145, DOI 10.1046/j.1365-2958.2003.03694.x; LEVIN DA, 1976, ANNU REV ECOL SYST, V7, P121, DOI 10.1146/annurev.es.07.110176.001005; Li H, 2009, PLANT MOL BIOL, V69, P337, DOI 10.1007/s11103-008-9430-5; Liu WD, 2013, MOL PLANT, V6, P605, DOI 10.1093/mp/sst015; Ma ZC, 2015, PLANT CELL, V27, P2057, DOI 10.1105/tpc.15.00390; MargollesClark E, 1996, APPL ENVIRON MICROB, V62, P3840, DOI 10.1128/AEM.62.10.3840-3846.1996; MARTIN J. T., 1964, ANN REV PHYTO PATHOL, V2, P81, DOI 10.1146/annurev.py.02.090164.000501; Montes RAC, 2008, PLANT PHYSIOL, V147, P63, DOI 10.1104/pp.107.110023; Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228; Park SY, 2003, PHYTOPATHOLOGY, V93, P1378, DOI 10.1094/PHYTO.2003.93.11.1378; Peng DH, 2011, MOL PLANT MICROBE IN, V24, P1239, DOI 10.1094/MPMI-01-11-0003; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Qiu DW, 2009, PLANT CELL REP, V28, P925, DOI 10.1007/s00299-009-0698-y; Saitoh H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002711; Song WW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013193; Sumiyoshi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078269; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tamaoki D, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24260; Trouvelot S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00592; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Verica JA, 2003, PLANT PHYSIOL, V133, P1732, DOI 10.1104/pp.103.028530; Wang Y, 2016, MOL PLANT MICROBE IN, V29, P299, DOI 10.1094/MPMI-12-15-0266-R; Wang Y, 2014, METHODS MOL BIOL, V1072, P563, DOI 10.1007/978-1-62703-631-3_38; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Wu SC, 2006, APPL ENVIRON MICROB, V72, P986, DOI 10.1128/AEM.72.2.986-993.2006; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Yang XZ, 2015, APPL BIOCHEM BIOTECH, V175, P1960, DOI 10.1007/s12010-014-1416-y; Yang YN, 2004, PLANT J, V40, P909, DOI 10.1111/j.1365-313X.2004.02267.x; YUN SH, 1998, THESIS	55	14	15	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165149	10.1371/journal.pone.0165149	http://dx.doi.org/10.1371/journal.pone.0165149			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764242	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500124
J	Xiang, LX; Hu, LP; Xu, WN; Zhen, A; Zhang, L; Hu, XH				Xiang, Lixia; Hu, Lipan; Xu, Weinan; Zhen, Ai; Zhang, Liang; Hu, Xiaohui			Exogenous gamma-Aminobutyric Acid Improves the Structure and Function of Photosystem II in Muskmelon Seedlings Exposed to Salinity-Alkalinity Stress	PLOS ONE			English	Article							SALT STRESS; PHOTOSYNTHETIC APPARATUS; FLUORESCENCE TRANSIENT; GABA-METABOLISM; SPERMIDINE; GROWTH; ACCUMULATION; TOLERANCE; POLYAMINE; RESPONSES	Gamma-aminobutyric acid (GABA) is important in plant responses to environmental stresses. We wished to clarify the role of GABA in maintenance of photosynthesis in muskmelon seedlings (Cucumis melo L., cv. Yipintianxia) during saline-alkaline stress. To this end, we assessed the effect of GABA on the structure and function of the photosynthetic apparatus in muskmelon seedlings grown under saline-alkaline stress. These stresses in combination reduced net photosynthetic rate, gas-exchange, and inhibited photosystem II (PSII) electron transport as measured by the JIP-test. They also reduced the activity of chloroplast ATPases and disrupted the internal lamellar system of the thylakoids. Exogenous GABA alleviated the stress-induced reduction of net photosynthesis, the activity of chloroplast ATPases, and overcame some of the damaging effects of stress on the chloroplast structure. Based on interpretation of the JIP-test, we conclude that exogenous GABA alleviated stress-related damage on the acceptor side of PSII. It also restored energy distribution, the reaction center status, and enhanced the ability of PSII to repair reaction centers in stressed seedlings. GABA may play a crucial role in protecting the chloroplast structure and function of PSII against the deleterious effects of salinity-alkalinity stress.	[Xiang, Lixia; Hu, Lipan; Xu, Weinan; Zhen, Ai; Zhang, Liang; Hu, Xiaohui] Northwest Agr & Forest Univ, Coll Hort, Yangling 712100, Peoples R China; [Xiang, Lixia; Hu, Lipan; Xu, Weinan; Zhen, Ai; Zhang, Liang; Hu, Xiaohui] Minist Agr, Key Lab Protected Hort Engn Northwest, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs	Hu, XH (corresponding author), Northwest Agr & Forest Univ, Coll Hort, Yangling 712100, Peoples R China.; Hu, XH (corresponding author), Minist Agr, Key Lab Protected Hort Engn Northwest, Yangling 712100, Shaanxi, Peoples R China.	hxh1977@163.com			Science and Technology Planning Project of Shaanxi Province, China [2015KTTSNY03-03]	Science and Technology Planning Project of Shaanxi Province, China	We received funding for this manuscript from Science and Technology Planning Project of Shaanxi Province, China (No. 2015KTTSNY03-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay N, 2012, J PLANT PHYSIOL, V169, P452, DOI 10.1016/j.jplph.2011.11.006; Alcazar R, 2010, PLANTA, V231, P1237, DOI 10.1007/s00425-010-1130-0; Appenroth KJ, 2001, ENVIRON POLLUT, V115, P49, DOI 10.1016/S0269-7491(01)00091-4; Baum G, 1996, EMBO J, V15, P2988, DOI 10.1002/j.1460-2075.1996.tb00662.x; Bouchereau A, 1999, PLANT SCI, V140, P103, DOI 10.1016/S0168-9452(98)00218-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai J P, 1980, PLANT PHYSL COMMUN, V2, P33; Gao Jie, 2015, Yingyong Shengtai Xuebao, V26, P1391; Guo XY, 2015, HYDROL PROCESS, V29, P4703, DOI 10.1002/hyp.10495; Hu LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110855; Hu LP, 2016, PHYSIOL PLANTARUM, V156, P468, DOI 10.1111/ppl.12398; Hu XH, 2015, PLANT PHYSIOL BIOCH, V92, P1, DOI 10.1016/j.plaphy.2015.04.006; Hu XH, 2012, PLANT PHYSIOL BIOCH, V57, P200, DOI 10.1016/j.plaphy.2012.05.015; Jedmowski C, 2013, ACTA PHYSIOL PLANT, V35, P345, DOI 10.1007/s11738-012-1077-9; Kautsky H., 1931, NATURWISSENSCHAFTEN, V19, P964, DOI [DOI 10.1007/BF01516164, 10.1007/BF01516164]; Kinnersley AM, 2000, CRIT REV PLANT SCI, V19, P479, DOI 10.1016/S0735-2689(01)80006-X; Kukavica B, 2013, ARCH BIOL SCI, V65, P265, DOI 10.2298/ABS1301265K; Li RL, 2010, SOIL SCI PLANT NUTR, V56, P725, DOI 10.1111/j.1747-0765.2010.00506.x; Liu J, 2006, PLANT GROWTH REGUL, V49, P119, DOI 10.1007/s10725-006-9001-1; Liu ZX, 2012, PHOTOSYNTHETICA, V50, P152, DOI 10.1007/s11099-012-0007-9; Malekzadeh P, 2014, PHYSIOL MOL BIOL PLA, V20, P133, DOI 10.1007/s12298-013-0203-5; Mehta P, 2010, PLANT PHYSIOL BIOCH, V48, P16, DOI 10.1016/j.plaphy.2009.10.006; MIYAO M, 1994, BIOCHEMISTRY-US, V33, P9722, DOI 10.1021/bi00198a043; Miyashita Y, 2008, PLANT CELL PHYSIOL, V49, P92, DOI 10.1093/pcp/pcm171; Parida AK, 2003, PHOTOSYNTHETICA, V41, P191, DOI 10.1023/B:PHOT.0000011951.37231.69; ROBINSON C, 1988, PHYSIOL PLANTARUM, V72, P177, DOI 10.1111/j.1399-3054.1988.tb06640.x; Shi DC, 2005, ENVIRON EXP BOT, V54, P8, DOI 10.1016/j.envexpbot.2004.05.003; Shu S, 2014, AFRICAN J BIOTECHNOL, V11, P6064; Shu S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14390; Shu S, 2012, PHYSIOL PLANTARUM, V146, P285, DOI 10.1111/j.1399-3054.2012.01623.x; Song H, 2012, SOIL SCI SOC AM J, V76, P2074, DOI 10.2136/sssaj2011.0445; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; Strauss AJ, 2006, ENVIRON EXP BOT, V56, P147, DOI 10.1016/j.envexpbot.2005.01.011; Sun ZY, 2016, HYDROL PROCESS, V30, P1884, DOI 10.1002/hyp.10760; Xiang Li-xia, 2015, Yingyong Shengtai Xuebao, V26, P3746; Xing SG, 2007, PLANT PHYSIOL BIOCH, V45, P560, DOI 10.1016/j.plaphy.2007.05.007; Yang CW, 2008, PHOTOSYNTHETICA, V46, P107, DOI [10.1007/s11099-008-0018-8, 10.1007/s11099-008-0047-3]	39	37	39	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164847	10.1371/journal.pone.0164847	http://dx.doi.org/10.1371/journal.pone.0164847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764179	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500070
J	White, DAE; Anderson, ES; Pfeil, SK; Deering, LJ; Todorovic, T; Trivedi, TK				White, Douglas A. E.; Anderson, Erik S.; Pfeil, Sarah K.; Deering, Laura J.; Todorovic, Tamara; Trivedi, Tarak K.			Hepatitis C Virus Screening and Emergency Department Length of Stay	PLOS ONE			English	Article							IDENTIFICATION; INFECTION; PROGRAM	Background Recent studies demonstrate high rates of previously undiagnosed hepatitis C virus (HCV) infection among patients screened in urban emergency departments (ED). Experts caution, however, that public health interventions, such as screening for infectious diseases, must not interfere with the primary mission of EDs to provide timely acute care. Increases in ED length of stay (LOS) have been associated with decreased quality of ED care. Objective In this study, we assess the influence of an integrated HCV screening protocol on ED LOS. Methods This was a retrospective cohort study analyzing timestamp data for all discharged patients over a 1-year period. The primary outcome compared the median LOS in minutes between patients who completed HCV screening and those who did not. Further analysis compared LOS for HCV screening by whether or not complete blood count (CBC) testing was conducted. Results Of 69,639 visits, 2,864 (4%) had HCV screening tests completed and 272 (9.5%) were antibody positive. The median LOS for visits that included HCV screening was greater than visits that did not include screening (151 versus 119 minutes, P < 0.001). Among the subset of visits in which CBC testing was conducted, there was no significant difference in median LOS between visits that also included HCV screening and those that did not (240 versus 242 minutes, P = 0.68). Conclusion Integrated HCV screening modestly prolongs ED LOS. However, among patients undergoing other blood tests, screening had no effect on LOS. Programs may consider routinely offering HCV screening to patients who are undergoing laboratory testing.	[White, Douglas A. E.; Anderson, Erik S.; Pfeil, Sarah K.; Deering, Laura J.; Todorovic, Tamara; Trivedi, Tarak K.] Highland Hosp, Alameda Hlth Syst, Dept Emergency Med, Oakland, CA 94602 USA; [Anderson, Erik S.] Stanford Univ, Dept Emergency Med, Palo Alto, CA 94304 USA	Stanford University	Anderson, ES (corresponding author), Highland Hosp, Alameda Hlth Syst, Dept Emergency Med, Oakland, CA 94602 USA.; Anderson, ES (corresponding author), Stanford Univ, Dept Emergency Med, Palo Alto, CA 94304 USA.	esoremanderson@gmail.com	Todorović, Tamara R/P-8803-2016; Trivedi, Tarak/S-9107-2019	Todorović, Tamara R/0000-0002-7740-3639; Trivedi, Tarak/0000-0003-3357-9525	HIV FOCUS Grant from Gilead Sciences	HIV FOCUS Grant from Gilead Sciences	This study received support from the HIV FOCUS Grant from Gilead Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison WE, 2015, AM J EMERG IN PRESS; Anderson ES, 2016, AM J EMERG IN PRESS; Coeller N, 2011, ACAD EMERG MED, V18, P708, DOI 10.1111/j.1553-2712.2011.01100.x; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; Galbraith JW, 2016, ANN EMERG MED, V67, P129, DOI 10.1016/j.annemergmed.2015.08.002; Galbraith JW, 2015, HEPATOLOGY, V61, P776, DOI 10.1002/hep.27410; Geren KI, 2014, ANN EMERG MED, V64, P537, DOI 10.1016/j.annemergmed.2014.05.021; Herring A, 2009, ACAD EMERG MED, V16, P609, DOI 10.1111/j.1553-2712.2009.00428.x; Hollander JE, 2007, ANN EMERG MED, V50, P497, DOI 10.1016/j.annemergmed.2007.05.002; Kocher KE, 2012, ACAD EMERG MED, V19, P525, DOI 10.1111/j.1553-2712.2012.01353.x; Merchant Roland C, 2014, R I Med J (2013), V97, P35; Moran GJ, 2011, ANN EMERG MED, V58, pS172, DOI 10.1016/j.annemergmed.2011.03.044; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; White DAE, 2016, JAIDS-J ACQ IMM DEF, V71, pE82, DOI 10.1097/QAI.0000000000000887; White DAE, 2016, ANN EMERG MED, V67, P119, DOI 10.1016/j.annemergmed.2015.06.023	15	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164831	10.1371/journal.pone.0164831	http://dx.doi.org/10.1371/journal.pone.0164831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760176	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204000056
J	Zhou, D; Li, BH; Wang, J; Ding, YN; Dong, Y; Chen, YW; Fan, JG				Zhou, Da; Li, Bing-Hang; Wang, Jing; Ding, Yong-Nian; Dong, Yan; Chen, Yuan-Wen; Fan, Jian-Gao			Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line	PLOS ONE			English	Article							ENDOPEPTIDASE INHIBITOR; IN-VITRO; INFLAMMATION; S-17092; ACSDKP	Background Prolyl oligopeptidase (POP) is a serine endopeptidase that is widely distributed in vivo, particularly in the liver. Significant changes in functional mitochondrial proteins involved with mitochondrial oxidoreductases/transporters and nucleic acid binding proteins were observed after POP inhibition in the liver, which suggested a role of POP in regulating liver energy metabolism. Steatosis in nonalcoholic fatty liver disease (NAFLD) is associated with disturbances in lipid and energy metabolism in hepatocytes. Here, we aimed to study the effect of POP on hepatocyte steatosis. Methods The human liver cell line L02 was used to investigate the biological effects of POP. An in vitro cell model of steatosis was successfully induced with oleic acid and palmitic acid. L02 cells were also subjected to S17092 (a POP inhibitor) at different concentrations for 24 or 48 h. Ac-SDKP levels and POP activity were measured to assess the rate of inhibition of POP by S17092. The POP gene and protein expression levels were detected using real-time PCR and Western blots, respectively. Oil red O staining was performed and the triglyceride levels in the L02 cells were also measured. Cell proliferation and apoptosis were detected using CCK-8 and flow cytometry, respectively. The expression of genes involved in lipid metabolism was detected using real-time PCR. The effects of POP inhibition on LC3B II were detected by Western blot. Results Compared with the control, the POP mRNA levels increased by approximately 30%, and the POP protein levels increased by almost 60% in the steatotic L02 cells. After S17092 (0.026 similar to 130 mu M) incubation for 24 or 48 h, cell proliferation was significantly decreased in the free fatty acid (FFA)-treated cells at 26-130 mu M; however, S17092 did not affect the proliferation of L02 cells after 24 h of incubation with S17092 at 0.026-65 mu M without FFA treatment. S17092 treatment (13 and 26 mu M) also elicited no significant effect on apoptosis in normal L02 cells, but FFA treatment increased cell apoptosis, which was attenuated by S17092 incubation. S17092 treatment inhibited intracellular POP activity and decreased the AcSDKP level at the concentration of 0.026-26 mu M. After treatment with FFA for 24 h, oil red 0 staining revealed significant lipid accumulation in the cells in the model group compared with the controls; however, lipid accumulation was suppressed after the administration of S17092 (13 and 26 mu M). Accordingly, the triglyceride levels in the FFA-treated cells were approximately 5-fold greater than those of the controls and were decreased by approximately 25% and 45% after the administration of S17092 at 13 and 26 mu M, respectively. The mRNA levels of FASN, PPAR-gamma, and SREBP-1c were higher in the FFA-treated cells than in the normal controls, and all of these levels were significantly inhibited in the presence of S17092 at both 13 and 26 mu M. S17092 treatment did not affect LC3B II in the FFA-treated cells compared with FFA treatment alone. Conclusion The expression of POP increases with hepatocyte steatosis, and POP inhibitors can significantly reduce intracellular lipid accumulation, which might be related to the inhibition of genes involved in lipid synthesis.	[Zhou, Da; Li, Bing-Hang; Wang, Jing; Chen, Yuan-Wen; Fan, Jian-Gao] Shanghai Jiao Tong Univ, Sch Med, Dept Gastroenterol, Xinhua Hosp, Shanghai, Peoples R China; [Ding, Yong-Nian] Xinjiang Med Univ, Dept Gastroenterol, Affiliated Hosp 2, Urumqi, Peoples R China; [Dong, Yan] Shanghai Jiao Tong Univ, Sch Med, Dept Endocrinol, Xinhua Hosp, Shanghai, Peoples R China	Shanghai Jiao Tong University; Xinjiang Medical University; Shanghai Jiao Tong University	Chen, YW; Fan, JG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Gastroenterol, Xinhua Hosp, Shanghai, Peoples R China.	shsmus@263.net; fattyliver2004@126.com	Chen, Yuanwen/AAL-6421-2020		National Natural Science Foundation of China [81170410, 81260081, 81070322]; New Talented Young Medical Specialist Cultivating Program of Shanghai [XYQ2011010]; State Key Development Program for Basic Research of China [2012CB517501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Talented Young Medical Specialist Cultivating Program of Shanghai; State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China)	This work was supported by Grants No. 81170410 (for YW.C.), No. 81260081 (for YN.D.), and 81070322 (for JG.F.) from the National Natural Science Foundation of China (http//www.nsfc.gov.cn) and sponsored by New Talented Young Medical Specialist Cultivating Program of Shanghai No. XYQ2011010 (for YW.C.), and by the State Key Development Program for Basic Research of China No. 2012CB517501 (for JG.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Grant Nos. 81170410 (for YW.C.), 81260081(for YN.D.), 81070322 (for JG.F.) from the National Natural Science Foundation of China. This study was also sponsored by the New Talented Young Medical Specialist Cultivating Program of Shanghai Grant No. XYQ2011010 (for YW.C.), and by the State Key Development Program for Basic Research of China Grant No. 2012CB517501 (for JG.F.). We thank Emily F. at AJE for English language editing.	Agirregoitia N, 2007, REGUL PEPTIDES, V139, P52, DOI 10.1016/j.regpep.2006.10.004; Auger C, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00040; Barelli H, 1999, BIOCHEM BIOPH RES CO, V257, P657, DOI 10.1006/bbrc.1999.0366; Bellemere G, 2003, J NEUROCHEM, V84, P919, DOI 10.1046/j.1471-4159.2003.01536.x; Chen YW, 2010, J HEPATOL, V53, P528, DOI 10.1016/j.jhep.2010.03.027; Garcia-Horsman JA, 2007, NEUROPEPTIDES, V41, P1, DOI 10.1016/j.npep.2006.10.004; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Gomez-Lechon MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004; Hannula MJ, 2011, DEV NEUROSCI-BASEL, V33, P38, DOI 10.1159/000322082; Hu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079321; Iacono A, 2011, J NUTR BIOCHEM, V22, P699, DOI 10.1016/j.jnutbio.2010.10.002; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Lin CW, 2013, J HEPATOL, V58, P993, DOI 10.1016/j.jhep.2013.01.011; Liu JM, 2003, BLOOD, V101, P3014, DOI 10.1182/blood-2002-07-2315; Matsubara Y, 1998, EUR J BIOCHEM, V252, P178, DOI 10.1046/j.1432-1327.1998.2520178.x; Morain P, 2002, CNS DRUG REV, V8, P31; Myohanen TT, 2008, HISTOCHEM CELL BIOL, V130, P993, DOI 10.1007/s00418-008-0468-x; Myohanen TT, 2012, J HISTOCHEM CYTOCHEM, V60, P706, DOI 10.1369/0022155412453051; Myohanen TT, 2009, J HISTOCHEM CYTOCHEM, V57, P831, DOI 10.1369/jhc.2009.953711; Penttinen A, 2011, CNS NEUROL DISORD-DR, V10, P340, DOI 10.2174/187152711794653742; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Tenorio-Laranga J, 2012, BIOCHIMIE, V94, P1849, DOI 10.1016/j.biochi.2012.04.005; Tenorio-Laranga J, 2011, CNS NEUROL DISORD-DR, V10, P319, DOI 10.2174/187152711794653841; Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406; YAMAKAWA N, 1994, BBA-GEN SUBJECTS, V1199, P279, DOI 10.1016/0304-4165(94)90007-8; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4; Zhang XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133882; Zhao F, 2014, INT J MOL SCI, V15, P4019, DOI 10.3390/ijms15034019	28	13	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0165224	10.1371/journal.pone.0165224	http://dx.doi.org/10.1371/journal.pone.0165224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760195	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000091
J	Jorgensen, S; Coskun, M; Homburg, KM; Pedersen, OBV; Troelsen, JT				Jorgensen, Steffen; Coskun, Mehmet; Homburg, Keld Mikkelsen; Pedersen, Ole B. V.; Troelsen, Jesper T.			HOXB4 Gene Expression Is Regulated by CDX2 in Intestinal Epithelial Cells	PLOS ONE			English	Article							TIME RT-PCR; TRANSCRIPTION FACTORS; HOMEOBOX GENE; CANCER CELLS; COLON; DIFFERENTIATION; ADULT; OVEREXPRESSION; BINDING; MOUSE	The mammalian Caudal-related homeobox transcription factor 2 (CDX2) plays a key role in the homeobox regulatory network and is essential in regulating the expression of several homeobox (HOX) genes during embryonic development, particularly in the gut. Genome-wide CDX2 chromatin immunoprecipitation analysis and expression data from Caco2 cells also suggests a role for CDX2 in the regulation of HOXB4 gene expression in the intestinal epithelium. Thus, the aim of this study was to investigate whether HOXB4 gene expression is regulated by CDX2 in the intestinal epithelium. We demonstrated binding of CDX2 to four different CDX2 binding sites in an enhancer region located upstream of the HOXB4 transcription start site. Mutations in the CDX2 binding sites reduced HOXB4 gene activity, and knock down of endogenous CDX2 expression by shRNA reduced HOXB4 gene expression. This is the first report demonstrating the CDX2 regulation of HOXB4 gene expression in the developed intestinal epithelium, indicating a possible role for HOXB4 in intestinal homeostasis.	[Jorgensen, Steffen; Troelsen, Jesper T.] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark; [Jorgensen, Steffen; Homburg, Keld Mikkelsen; Pedersen, Ole B. V.] Naestved Hosp, Dept Clin Immunol, Naestved, Region Zealand, Denmark; [Coskun, Mehmet] Univ Copenhagen, Herlev Hosp, Med Sect, Dept Gastroenterol, Copenhagen, Denmark	Roskilde University; Naestved Hospital; University of Copenhagen; Herlev & Gentofte Hospital	Troelsen, JT (corresponding author), Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark.	troelsen@ruc.dk	Jørgensen, Steffen/AAR-6895-2021; Troelsen, Jesper Thorvald T/B-6264-2013; Pedersen, Ole Birger/W-8679-2019	Jørgensen, Steffen/0000-0002-7529-490X; Troelsen, Jesper Thorvald T/0000-0002-4177-3267; Pedersen, Ole Birger/0000-0003-2312-5976	Local Research Foundation, Hospital South, Naestved, Region Zealand; Regional Zealand Research Grant; Fonden til Laegevidenskabens Fremm; Danish Research Council (FSS)	Local Research Foundation, Hospital South, Naestved, Region Zealand; Regional Zealand Research Grant; Fonden til Laegevidenskabens Fremm; Danish Research Council (FSS)(Det Frie Forskningsrad (DFF)Danish Medical Research Council)	This work was funded by the Local Research Foundation, Hospital South, Naestved, Region Zealand; a Regional Zealand Research Grant; Fonden til Laegevidenskabens Fremm, and by the Danish Research Council (FSS).	Aparicio Oscar, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1707s23; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Barba-de la Rosa AP, 2012, J CANCER RES CLIN, V138, P293, DOI 10.1007/s00432-011-1081-2; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bhatlekar S, 2014, STEM CELLS DEV, V23, P167, DOI 10.1089/scd.2013.0039; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Boyd M, 2010, J BIOL CHEM, V285, P25115, DOI 10.1074/jbc.M109.089516; Cerda-Esteban N, 2014, DEV DYNAM, V243, P76, DOI 10.1002/dvdy.24075; Chan WC, 1997, BLOOD, V89, P3909; Charite J, 1998, DEVELOPMENT, V125, P4349; Coskun M, 2010, J CELL BIOCHEM, V109, P1118, DOI 10.1002/jcb.22490; Coskun M, 2012, BBA-MOL BASIS DIS, V1822, P843, DOI 10.1016/j.bbadis.2012.01.012; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Folberg A, 1999, DEV DYNAM, V215, P96, DOI 10.1002/(SICI)1097-0177(199906)215:2<96::AID-DVDY2>3.0.CO;2-T; Fujiwara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040959; Hamada J, 2001, INT J CANCER, V93, P516, DOI 10.1002/ijc.1357; Hryniuk A, 2012, DEV BIOL, V363, P426, DOI 10.1016/j.ydbio.2012.01.010; Kanai M, 2010, ONCOL REP, V23, P843, DOI 10.3892/or_00000706; Kikuyama M, 2012, CANCER LETT, V322, P204, DOI 10.1016/j.canlet.2012.03.016; Olsen AK, 2012, AM J PHYSIOL-GASTR L, V302, pG277, DOI 10.1152/ajpgi.00362.2011; Oshima M, 2011, BLOOD, V117, pE142, DOI 10.1182/blood-2010-12-323212; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Tabaries S, 2005, MOL CELL BIOL, V25, P1389, DOI 10.1128/MCB.25.4.1389-1401.2005; Takahashi Y, 2004, EXP CELL RES, V293, P144, DOI 10.1016/j.yexcr.2003.09.024; Verzi MP, 2011, MOL CELL BIOL, V31, P2026, DOI 10.1128/MCB.01250-10; Verzi MP, 2010, P NATL ACAD SCI USA, V107, P15157, DOI 10.1073/pnas.1003822107; Wang YX, 2001, INT J ONCOL, V18, P617; Yu YY, 2007, EJSO-EUR J SURG ONC, V33, P129, DOI 10.1016/j.ejso.2006.09.010	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164555	10.1371/journal.pone.0164555	http://dx.doi.org/10.1371/journal.pone.0164555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755609	Green Published, Green Submitted, gold			2022-12-26	WOS:000386203800021
J	Zadesenets, KS; Vizoso, DB; Schlatter, A; Konopatskaia, ID; Berezikov, E; Scharer, L; Rubtsov, NB				Zadesenets, Kira S.; Vizoso, Dita B.; Schlatter, Aline; Konopatskaia, Irina D.; Berezikov, Eugene; Scharer, Lukas; Rubtsov, Nikolay B.			Evidence for Karyotype Polymorphism in the Free-Living Flatworm, Macrostomum lignano, a Model Organism for Evolutionary and Developmental Biology	PLOS ONE			English	Article							STEM-CELLS; CHROMOSOMAL DUPLICATION; SEX ALLOCATION; REGENERATION; GENOME; PLATYHELMINTHES; ANEUPLOIDY; SPERMATOCYTES; CONSEQUENCES; EHRENBERGII	Over the past decade, the free-living flatworm Macrostomum lignano has been successfully used in many areas of biology, including embryology, stem cells, sexual selection, bioadhesion and aging. The increased use of this powerful laboratory model, including the establishment of genomic resources and tools, makes it essential to have a detailed description of the chromosome organization of this species, previously suggested to have a karyotype with 2n = 8 and one pair of large and three pairs of small metacentric chromosomes. We performed cytogenetic analyses for chromosomes of one commonly used inbred line of M. lignano (called DV1) and uncovered unexpected chromosome number variation in the form of aneuploidies of the largest chromosomes. These results prompted us to perform karyotypic studies in individual specimens of this and other lines of M. lignano reared under laboratory conditions, as well as in freshly field-collected specimens from different natural populations. Our analyses revealed a high frequency of aneuploids and in some cases other numerical and structural chromosome abnormalities in laboratory-reared lines of M. lignano, and some cases of aneuploidy were also found in freshly field-collected specimens. Moreover, karyological analyses were performed in specimens of three further species: Macrostomum sp. 8 (a close relative of M. lignano), M. spirale and M. hystrix. Macrostomum sp. 8 showed a karyotype that was similar to that of M. lignano, with tetrasomy for its largest chromosome being the most common karyotype, while the other two species showed a simpler karyotype that is more typical of the genus Macrostomum. These findings suggest that M. lignano and Macrostomum sp. 8 can be used as new models for studying processes of partial genome duplication in genome evolution.	[Zadesenets, Kira S.; Vizoso, Dita B.; Schlatter, Aline; Scharer, Lukas] Univ Basel, Inst Zool, Evolutionary Biol, Basel, Switzerland; [Zadesenets, Kira S.; Konopatskaia, Irina D.; Berezikov, Eugene; Rubtsov, Nikolay B.] Inst Cytol & Genet SB RAS, Novosibirsk, Russia; [Berezikov, Eugene] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands; [Rubtsov, Nikolay B.] Novosibirsk State Univ, Novosibirsk, Russia	University of Basel; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University of Groningen; Novosibirsk State University	Zadesenets, KS (corresponding author), Univ Basel, Inst Zool, Evolutionary Biol, Basel, Switzerland.; Zadesenets, KS (corresponding author), Inst Cytol & Genet SB RAS, Novosibirsk, Russia.	kira_z@bionet.nsc.ru	Rubtsov, Nikolay/L-2365-2017; Zadesenets, Kira/AAJ-1746-2020; Schärer, Lukas/B-4396-2008; Zadesenets, Kira/K-5500-2018; Berezikov, Eugene/D-3363-2013	Rubtsov, Nikolay/0000-0001-7406-8057; Zadesenets, Kira/0000-0001-7228-2973; Schärer, Lukas/0000-0002-0209-9871; Berezikov, Eugene/0000-0002-1145-2884	Russian Foundation for Basic Research (RFBR) [14-04-32007]; Swiss National Science Foundation (SNSF) [143732]; European Research Council (ERC) [310765]; Federal Agency for Science and Innovation [0324-2015-0003]; Russian Academy of Sciences	Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); European Research Council (ERC)(European Research Council (ERC)European Commission); Federal Agency for Science and Innovation(Federal Agency for Science & Innovations (FASI)); Russian Academy of Sciences(Russian Academy of Sciences)	The reported study was supported by: (1) the Russian Foundation for Basic Research (RFBR), http://www.rfbr.ru/rffi/eng, Project grant no.14-04-32007 (KZ); (2) Swiss National Science Foundation (SNSF), http://www.snf.ch/en/Pages/default.aspx, Grant no. 143732 (LS); (3) European Research Council (ERC), https://erc.europa.eu/, Starting Grant no. 310765 (EB); (4) Federal Agency for Science and Innovation, http://fano.gov.ru/en/, grant 0324-2015-0003, Russian Academy of Sciences, http://www.ras.ru/index.aspx (NBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Altug-Teber O, 2007, CYTOGENET GENOME RES, V119, P171, DOI 10.1159/000112058; Banaei-Moghaddam AM, 2015, BBA-GENE REGUL MECH, V1849, P64, DOI 10.1016/j.bbagrm.2014.11.007; Benazzi Lentati G, 1987, ATTI SOC TOSCANA S B, V94, P357; Benazzi Lentati G., 1970, INT REV CYTOL, V27, P101; Benazzi Lentati G, 1957, CARYOLOGIA, V10, P352; Beukeboom LW, 1998, HYDROBIOLOGIA, V383, P277, DOI 10.1023/A:1003460132521; Bi Ke, 2009, Current Zoology, V55, P145; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Blakeslee AF, 1920, SCIENCE, V52, P388, DOI 10.1126/science.52.1347.388; Chen GB, 2012, BIOESSAYS, V34, P893, DOI 10.1002/bies.201200069; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; CROFT JA, 1989, GENETICS, V121, P255; Danielak-Czech B., 2013, Annales Universitatis Mariae Curie-Sklodowska. Sectio EE Zootechnica, V31, P8; Demircan T., 2013, THESIS; Demircan T, 2013, STEM CELLS DEV, V22, P2174, DOI 10.1089/scd.2013.0006; DEVRIES EJ, 1986, HYDROBIOLOGIA, V132, P251, DOI 10.1007/BF00046257; Egger B, 2006, DEV GENES EVOL, V216, P565, DOI 10.1007/s00427-006-0069-4; Egger B, 2005, J ZOOL SYST EVOL RES, V43, P127, DOI 10.1111/j.1439-0469.2005.00300.x; Egger B, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-41; Ferraro-Gideon J, 2013, CELL BIOL INT, V37, P892, DOI 10.1002/cbin.10130; Graphodatsky AS, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-22; Hauffe HC, 1997, BIOL J LINN SOC, V62, P255, DOI 10.1006/bijl.1997.0153; Hernandez D, 1999, TRENDS GENET, V15, P241, DOI 10.1016/S0168-9525(99)01743-6; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; Jackson AP, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-432; JAMILENA M, 1990, GENOME, V33, P779, DOI 10.1139/g90-116; Janicke T, 2013, EVOLUTION, V67, P3233, DOI 10.1111/evo.12189; Janssen T, 2015, MOL PHYLOGENET EVOL, V92, P82, DOI 10.1016/j.ympev.2015.06.004; Kim ES, 2002, RUSS J GENET+, V38, P392, DOI 10.1023/A:1015250219322; Ladurner P, 2005, J ZOOL SYST EVOL RES, V43, P114, DOI 10.1111/j.1439-0469.2005.00299.x; Ladurner Peter, 2008, P75, DOI 10.1007/978-1-4020-8274-0_5; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Luthardt FW, 2001, ENCY LIFE SCI, DOI [10.1038/npg.els.0001446, DOI 10.1038/NPG.ELS.0001446]; Marie-Orleach L, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-148; Marschner S, 2007, GENOME, V50, P638, DOI 10.1139/G07-048; McGrath C.L., 2012, EVOLUTIONARY SIGNIFI, P1; Mouton S, 2009, EXP GERONTOL, V44, P243, DOI 10.1016/j.exger.2008.11.007; Niwa O, 2006, YEAST, V23, P937, DOI 10.1002/yea.1411; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Panzera Y, 2012, CYTOGENET GENOME RES, V138, P56, DOI 10.1159/000341888; Pebusque MJ, 1998, MOL BIOL EVOL, V15, P1145, DOI 10.1093/oxfordjournals.molbev.a026022; Pfister D, 2008, DEV BIOL, V319, P146, DOI 10.1016/j.ydbio.2008.02.045; Pfister D, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-9; Ramm SA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0660; Reeves A, 2001, GENOME, V44, P439, DOI 10.1139/gen-44-3-439; Rieger R, 1988, FORTSCHR ZOOL, V36, P525; Rubtsov NB, 2002, CYTOGENET GENOME RES, V99, P323, DOI 10.1159/000071611; Ruvinsky A, 2005, MAMMALIAN GENOMICS; Scharer L, 2007, MAR BIOL, V152, P1095, DOI 10.1007/s00227-007-0755-4; Scharer L, 2011, P NATL ACAD SCI USA, V108, P1490, DOI 10.1073/pnas.1013892108; Scharer L, 2003, P ROY SOC B-BIOL SCI, V270, P935, DOI 10.1098/rspb.2002.2323; Schneider MC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.8701; Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807; Simanov D, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/167265; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Wasik K, 2015, P NATL ACAD SCI USA, V112, P12462, DOI 10.1073/pnas.1516718112; Willems WR, 2006, ZOOL SCR, V35, P1, DOI 10.1111/j.1463-6409.2005.00216.x; Yamamoto M, 2010, J JPN SOC HORTIC SCI, V79, P23, DOI 10.2503/jjshs1.79.23; Yona AH, 2012, P NATL ACAD SCI USA, V109, P21010, DOI 10.1073/pnas.1211150109; Zadesenets KS, 2012, PARASITOL INT, V61, P84, DOI 10.1016/j.parint.2011.06.027	64	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164915	10.1371/journal.pone.0164915	http://dx.doi.org/10.1371/journal.pone.0164915			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755577	gold, Green Published, Green Submitted			2022-12-26	WOS:000386203800041
J	Ward, JD; Sutton, PC; Werner, AD; Costanza, R; Mohr, SH; Simmons, CT				Ward, James D.; Sutton, Paul C.; Werner, Adrian D.; Costanza, Robert; Mohr, Steve H.; Simmons, Craig T.			Is Decoupling GDP Growth from Environmental Impact Possible?	PLOS ONE			English	Article							ECONOMIC-GROWTH; SUSTAINABLE DEVELOPMENT; CLIMATE-CHANGE; RESOURCE USE; LIMITS; REALITY; ENERGY	The argument that human society can decouple economic growth D defined as growth in Gross Domestic Product (GDP) D from growth in environmental impacts is appealing. If such decoupling is possible, it means that GDP growth is a sustainable societal goal. Here we show that the decoupling concept can be interpreted using an easily understood model of economic growth and environmental impact. The simple model is compared to historical data and modelled projections to demonstrate that growth in GDP ultimately cannot be decoupled from growth in material and energy use. It is therefore misleading to develop growth-oriented policy around the expectation that decoupling is possible. We also note that GDP is increasingly seen as a poor proxy for societal wellbeing. GDP growth is therefore a questionable societal goal. Society can sustainably improve wellbeing, including the wellbeing of its natural assets, but only by discarding GDP growth as the goal in favor of more comprehensive measures of societal wellbeing.	[Ward, James D.] Univ South Australia, Sch Nat & Built Environm, GPO Box 2471, Adelaide, SA 5001, Australia; [Sutton, Paul C.] Univ Denver, Dept Geog, Denver, CO 80208 USA; [Werner, Adrian D.; Simmons, Craig T.] Flinders Univ S Australia, Sch Environm, GPO Box 2100, Adelaide, SA 5001, Australia; [Werner, Adrian D.; Simmons, Craig T.] Flinders Univ S Australia, Natl Ctr Groundwater Res & Training, GPO Box 2100, Adelaide, SA 5001, Australia; [Costanza, Robert] Australian Natl Univ, Crawford Sch Publ Policy, Acton, ACT 2601, Australia; [Mohr, Steve H.] Univ Technol Sydney, Inst Sustainable Futures, POB 123, Broadway, NSW 2007, Australia	University of South Australia; University of Denver; Flinders University South Australia; Flinders University South Australia; Australian National University; University of Technology Sydney	Ward, JD (corresponding author), Univ South Australia, Sch Nat & Built Environm, GPO Box 2471, Adelaide, SA 5001, Australia.	james.ward@unisa.edu.au	Sutton, Paul/K-9802-2019; Costanza, Robert/AAJ-3546-2021; Costanza, Robert/A-4912-2008; Hopeward, James David/GLS-9445-2022; Simmons, Craig T/H-7458-2015; Werner, Adrian/F-2222-2015	Sutton, Paul/0000-0002-4961-026X; Costanza, Robert/0000-0001-6348-8734; Hopeward, James David/0000-0003-4847-841X; Simmons, Craig T/0000-0001-5399-6292; Werner, Adrian/0000-0002-1190-1301; Sutton, Paul/0000-0001-6972-3256				Anderson K, 2015, NAT GEOSCI, V8, P898, DOI 10.1038/ngeo2559; [Anonymous], 2016, NEW YORK TIMES; Antal M, 2013, ENVIRON INNOV SOC TR, V6, P47, DOI 10.1016/j.eist.2013.01.002; Baker D., 2007, GAP PRODUCTIVITY WAG; Beckerman W., 1974, DEFENCE EC GROWTH SP, V7619, P19; Behrens A, 2007, ECOL ECON, V64, P444, DOI 10.1016/j.ecolecon.2007.02.034; Bringezu S, 2004, ECOL ECON, V51, P97, DOI 10.1016/j.ecolecon.2004.04.010; Chapin FS, 2009, NATURE, V461, P472, DOI [10.1038/461472a, DOI 10.1038/461472A]; Chertow MR, 2014, J IND ECOL, V4, P13; Commoner B, 1972, POPULATION RESOURCES, P339; Costanza R, 2016, SOLUTIONS, V7, P20; Costanza R, 2014, NATURE, V505, P283, DOI 10.1038/505283a; Csereklyei Z, 2015, ENERG ECON, V51, P633, DOI 10.1016/j.eneco.2015.08.029; Donella H, 1972, LIMITS GROWTH REPORT; Drews S, 2016, GLOBAL ENVIRON CHANG, V39, P1, DOI 10.1016/j.gloenvcha.2016.04.001; Eastin J, 2011, FUTURES, V43, P16, DOI 10.1016/j.futures.2010.03.001; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; Fischer-Kowalski M., 2011, DECOUPLING NATURAL R; Giljum Stefan, 2005, International Journal of Sustainable Development, V8, P31, DOI 10.1504/IJSD.2005.007373; Gupta S, 2015, INT J SUST DEV WORLD, V22, P510, DOI 10.1080/13504509.2015.1088485; Hatfield-Dodds S., 2015, AUSTR NATL OUTLOOK 2; Hatfield-Dodds S, 2015, NATURE, V527, P49, DOI 10.1038/nature16065; Klein Naomi, 2014, THIS CHANGES EVERYTH; Krautkramer J., 1995, HDB ENV EC, P139; Kubiszewski I, 2013, ECOL ECON, V93, P57, DOI 10.1016/j.ecolecon.2013.04.019; Looney B., 2020, STAT REV WORLD EN 20, V69; Lutter S, 2016, GLOBAL MAT FLOW DATA; Meadowcroft J, 2013, ENVIRON PLANN C, V31, P988, DOI 10.1068/c1338j; Meadows D., 2004, LIMITS GROWTH 30 YEA; Meadows D. H., 1992, LIMITS CONFRONTING G; Meyer Robinson, 2016, ATLANTIC; O'Rourke D, 2015, ANNU REV ENV RESOUR, V40, P233, DOI 10.1146/annurev-environ-102014-021224; Ockwell DG, 2008, ENERG POLICY, V36, P4600, DOI 10.1016/j.enpol.2008.09.005; OECD, 2011, OECD OBSER; OECD Secretariat, 2002, IND MEAS DEC ENV PRE, V1, P2002; PESSOA J. P, 2013, WAGE GROWTH PRODUCTI; Pulselli FM, 2015, GLOBAL ENVIRON CHANG, V35, P41, DOI 10.1016/j.gloenvcha.2015.08.002; Simon J. L, 1981, ULTIMATE RESOURCE; Smulders S, 2014, OXFORD REV ECON POL, V30, P423, DOI 10.1093/oxrep/gru027; Stern DI, 2011, ANN NY ACAD SCI, V1219, P6; Tol RSJ, 2009, J ECON PERSPECT, V23, P29, DOI 10.1257/jep.23.2.29; Turner GM, 2008, GLOBAL ENVIRON CHANG, V18, P397, DOI 10.1016/j.gloenvcha.2008.05.001; World Bank, 2020, WORLD BANK OPEN DATA; World Bank, 2012, WORLD BANK INCL GREE	44	198	199	6	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164733	10.1371/journal.pone.0164733	http://dx.doi.org/10.1371/journal.pone.0164733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741300	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000385507000062
J	Woodward, DF; Wang, JW; Ni, M; Bauer, A; Martos, JL; Carling, RW; Poloso, NJ				Woodward, David F.; Wang, Jenny W.; Ni, Ming; Bauer, Alex; Martos, Jose L.; Carling, Robert W.; Poloso, Neil J.			In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti- inflammatory effects	FASEB JOURNAL			English	Article						uveitis; retina; neovascularization; polypharmacology; antagonist	CHOROIDAL NEOVASCULARIZATION; S-ANTIGEN; AUTOIMMUNE UVEITIS; VASCULAR LEAKAGE; ANTAGONIST; ANGIOGENESIS; POTENT; KETOROLAC; NEPAFENAC; VEGF	The purpose of these studies was to test the hypothesis that a selected polypharmacological approach for treating the prostanoid-mediated component of inflammatory diseases would produce a therapeutic effect superior to global inhibition of prostaglandin (PG) biosynthesis by aspirin-like drugs. The compound studied was AGN 211377, which had been previously shown to produce a superior effect on cytokine release from human macrophages compared with cyclooxygenase (COX) inhibitors. AGN 211377 antagonizes prostanoid prostaglandin D-2 (DP)(1), DP2, prostaglandin E2 (EP)(1), EP4, prostaglandin F-2 alpha, and thromboxane A(2) receptors but not anti-inflammatory EP2, prostaglandin I-2, or EP3 receptors. Established rodent models of ocular inflammatory diseases were used to determine therapeutic effects in living animals. The drugs were administered systemically after predetermination of their blood levels to ensure bioavailability at an appropriate dose level. Whereas compounds selective for a single prostanoid receptor typically exhibited modest but statistically significant inhibition, AGN 211377 profoundly inhibited S-antigen-induced uveitis and laser-induced retinal neovascularization. Consistent with previous polypharmacological studies on chemokine/cytokine release from human macrophages, the prostanoid EP1 receptor played a permissive role in suppressing neovascularization and inflammation in vivo. Comparing AGN211377 with a close structural congener lacking EP1 antagonism(AGN 197727), AGN 197727 was much less active than AGN211377, but pronounced anti-inflammatory and angiostatic effects were achieved by adding the EP1 antagonist compound (SC51322) to AGN 197727 in the systemic dosing regimen. Further, AGN 211377 produced superior anti-inflammatory activity compared with the nonsteroidal anti-inflammatory agent ketorolac. These results indicate the value of using a polypharmacological approach in the design of novel therapeutic agents in preference to compounds targeting a single receptor or enzyme. A compound such as AGN 211377 may represent more effective therapy than COX inhibitors in treating uveitis and ocular diseases where neovascularization is a significant part of the pathology.-Woodward, D. F., Wang, J. W., Ni, M., Bauer, A., Martos, J. L., Carling, R. W., Poloso, N. J. In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti-inflammatory effects.	[Woodward, David F.; Wang, Jenny W.; Ni, Ming; Bauer, Alex; Poloso, Neil J.] Allergan PLC, Dept Biol Sci, Irvine, CA 92612 USA; [Martos, Jose L.; Carling, Robert W.] Selcia Ltd, Discovery Dept, Fyfield, England; [Woodward, David F.] Imperial Coll London, Dept Bioengn, London, England; [Wang, Jenny W.] JeviVision Inc, Irvine, CA USA; [Ni, Ming] Adverum Biotechnol Inc, Menlo Pk, CA USA	AbbVie; Allergan; Imperial College London	Poloso, NJ (corresponding author), Allergan PLC, Dept Biol Sci, Irvine, CA 92612 USA.	poloso_neil@allergan.com			intramural research program at Allergan	intramural research program at Allergan	This work was supported by the intramural research program at Allergan.	Adjunctive Diclofenac with Verteporfin (ADD-V) Study Group, 2007, Retina, V27, P693; af Forselles KJ, 2011, BRIT J PHARMACOL, V164, P1847, DOI 10.1111/j.1476-5381.2011.01495.x; Agarwal R.K., 2012, METHOD MOL BIOL, V2012, P900; Aguirre SA, 2009, TOXICOL PATHOL, V37, P911, DOI 10.1177/0192623309351724; Amrite AC, 2006, INVEST OPHTH VIS SCI, V47, P1149, DOI 10.1167/iovs.05-0531; Barnett JM, 2010, INVEST OPHTH VIS SCI, V51, P1136, DOI 10.1167/iovs.09-3691; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browning AC, 2012, BRIT J OPHTHALMOL, V96, P128, DOI 10.1136/bjophthalmol-2011-300572; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; CASPI RR, 1992, CURR EYE RES, V11, P81, DOI 10.3109/02713689208999515; CASPI RR, 1994, AUTOIMMUNE DIS MODEL, P57; Castro MR, 2004, EXP EYE RES, V79, P275, DOI 10.1016/j.exer.2004.04.008; Cillirio R., 2007, AM J OBSTET GYNECOL, V197, p54e; Cryan LM, 2009, PROSTAG LEUKOTR ESS, V81, P401, DOI 10.1016/j.plefa.2009.08.001; DONOSO LA, 1987, CURR EYE RES, V6, P1151, DOI 10.3109/02713688709034888; FLACH AJ, 1992, SURV OPHTHALMOL, V36, P259, DOI 10.1016/0039-6257(92)90095-B; Fujita I, 2012, J PHARM PHARMACOL, V64, P747, DOI 10.1111/j.2042-7158.2012.01468.x; Gery I., 1985, ADV IMMUNOLOGY IMMUN, P242; GILES H, 1989, BRIT J PHARMACOL, V96, P291, DOI 10.1111/j.1476-5381.1989.tb11816.x; GOH Y, 1987, BIOCHIM BIOPHYS ACTA, V921, P302; HALLINAN EA, 1994, BIOORG MED CHEM LETT, V4, P509, DOI 10.1016/0960-894X(94)80027-8; Heier JS, 2009, RETINA-J RET VIT DIS, V29, P1310, DOI 10.1097/IAE.0b013e3181b094e6; HIROSE S, 1990, JPN J OPHTHALMOL, V34, P298; Hoang KG, 2015, MICROVASC RES, V101, P127, DOI 10.1016/j.mvr.2015.07.004; Inada M, 2015, J BIOL CHEM, V290, P29781, DOI 10.1074/jbc.M115.669481; Ishizuka T, 2004, CARDIOVASC DRUG REV, V22, P71; Kim SJ, 2010, EXP EYE RES, V91, P537, DOI 10.1016/j.exer.2010.07.011; Kim SJ, 2010, ARCH OPHTHALMOL-CHIC, V128, P596, DOI 10.1001/archophthalmol.2010.69; Kuwano T, 2004, FASEB J, V18, P300, DOI 10.1096/fj.03-0473com; Mathiesen JM, 2006, MOL PHARMACOL, V69, P1441, DOI 10.1124/mol.105.017681; Nakanishi M, 2012, AM J RESP CELL MOL, V46, P217, DOI 10.1165/rcmb.2010-0115OC; NI M, 1992, GRAEF ARCH CLIN EXP, V230, P547, DOI 10.1007/BF00181777; OGLETREE ML, 1985, J PHARMACOL EXP THER, V234, P435; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Schoenberger SD, 2012, INVEST OPHTH VIS SCI, V53, P5906, DOI 10.1167/iovs.12-10410; SHINOHARA T, 1990, EXP EYE RES, V50, P751, DOI 10.1016/0014-4835(90)90125-E; Takahashi H, 2004, BIOCHEM BIOPH RES CO, V325, P461, DOI 10.1016/j.bbrc.2004.10.054; Takahashi K, 2003, INVEST OPHTH VIS SCI, V44, P409, DOI 10.1167/iovs.02-0346; Wang JW, 2016, FASEB J, V30, P394, DOI 10.1096/fj.15-275610; Wilson NM, 2016, PAIN RES TREAT, V2016, DOI 10.1155/2016/8364762; Wilson RJ, 2006, BRIT J PHARMACOL, V148, P326, DOI 10.1038/sj.bjp.0706726; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Wright WS, 2009, EXP EYE RES, V89, P532, DOI 10.1016/j.exer.2009.05.008; Yanni SE, 2010, BRAIN RES BULL, V81, P310, DOI 10.1016/j.brainresbull.2009.10.018; Yanni SE, 2009, INVEST OPHTH VIS SCI, V50, P5479, DOI 10.1167/iovs.09-3652	45	8	8	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					368	375		10.1096/fj.201600604R	http://dx.doi.org/10.1096/fj.201600604R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27770021				2022-12-26	WOS:000392177600034
J	Lisanti, S; Garlick, DS; Bryant, KG; Tavecchio, M; Mills, GB; Lu, YL; Kossenkov, AV; Showe, LC; Languino, LR; Altieri, DC				Lisanti, Sofia; Garlick, David S.; Bryant, Kelly G.; Tavecchio, Michele; Mills, Gordon B.; Lu, Yiling; Kossenkov, Andrew V.; Showe, Louise C.; Languino, Lucia R.; Altieri, Dario C.			Transgenic Expression of the Mitochondrial Chaperone TNFR-associated Protein 1 (TRAP1) Accelerates Prostate Cancer Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90; INHIBITOR; HOMEOSTASIS; NEOPLASIA; DYNAMICS; MUTATION; TARGETS; INDUCE; CELLS	Protein homeostasis, or proteostasis, is required for mitochondrial function, but its role in cancer is controversial. Here we show that transgenic mice expressing the mitochondrial chaperone TNFR-associated protein 1 (TRAP1) in the prostate develop epithelial hyperplasia and cellular atypia. When examined on a Pten(+/-) background, a common alteration in human prostate cancer, TRAP1 transgenic mice showed accelerated incidence of invasive prostatic adenocarcinoma, characterized by increased cell proliferation and reduced apoptosis, in situ. Conversely, homozygous deletion of TRAP1 delays prostatic tumorigenesis in Pten(+/-) mice without affecting hyperplasia or prostatic intraepithelial neoplasia. Global profiling of Pten(+/-) TRAP1 transgenic mice by RNA sequencing and reverse phase protein array reveals modulation of oncogenic networks of cell proliferation, apoptosis, cell motility, and DNA damage. Mechanistically, reconstitution of Pten(+/-) prostatic epithelial cells with TRAP1 increases cell proliferation, reduces apoptosis, and promotes cell invasion without changes in mitochondrial bioenergetics. Therefore, TRAP1 is a driver of prostate cancer in vivo and an "actionable" therapeutic target.	[Lisanti, Sofia; Garlick, David S.; Bryant, Kelly G.; Tavecchio, Michele; Languino, Lucia R.; Altieri, Dario C.] Wistar Inst Anat & Biol, Prostate Canc Discovery & Dev Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Lisanti, Sofia; Bryant, Kelly G.; Tavecchio, Michele; Altieri, Dario C.] Wistar Inst Anat & Biol, Tumor Microenvironm & Metastasis Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Kossenkov, Andrew V.; Showe, Louise C.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Showe, Louise C.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Mills, Gordon B.; Lu, Yiling] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Languino, Lucia R.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	The Wistar Institute; The Wistar Institute; The Wistar Institute; The Wistar Institute; University of Texas System; UTMD Anderson Cancer Center; Jefferson University	Altieri, DC (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	daltieri@wistar.org			Cancer Center Support Grants [CA010815, CA016672]; NATIONAL CANCER INSTITUTE [R01CA190027, P30CA016672, R01CA078810, R01CA089720, P30CA010815, P01CA140043, R50CA211199, T32CA009171] Funding Source: NIH RePORTER	Cancer Center Support Grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for the core facilities utilized in this study was provided by Cancer Center Support Grants CA010815 to The Wistar Institute and CA016672 to The University of Texas MD Anderson Cancer Center.	Agliarulo I, 2015, BBA-MOL CELL RES, V1853, P2570, DOI 10.1016/j.bbamcr.2015.05.034; Agorreta J, 2014, MOL CANCER RES, V12, P660, DOI 10.1158/1541-7786.MCR-13-0481; Altieri DC, 2012, BBA-MOL CELL RES, V1823, P767, DOI 10.1016/j.bbamcr.2011.08.007; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Cagin U, 2015, P NATL ACAD SCI USA, V112, pE6000, DOI 10.1073/pnas.1505036112; Caino MC, 2013, J CLIN INVEST, V123, P2907, DOI 10.1172/JCI67841; Chae YC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3139; Chae YC, 2012, CANCER CELL, V22, P331, DOI 10.1016/j.ccr.2012.07.015; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Goard CA, 2014, ONCOGENE, V33, P2690, DOI 10.1038/onc.2013.228; Hubner A, 2012, P NATL ACAD SCI USA, V109, P12046, DOI 10.1073/pnas.1209660109; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kang BH, 2010, CLIN CANCER RES, V16, P4779, DOI 10.1158/1078-0432.CCR-10-1818; Khacho M, 2016, CELL STEM CELL, V19, P232, DOI 10.1016/j.stem.2016.04.015; Kim H, 2016, J BIOL CHEM, V291, P1841, DOI 10.1074/jbc.M115.656934; Kleine T, 2016, BBA-BIOENERGETICS, V1857, P1313, DOI 10.1016/j.bbabio.2016.03.017; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lavery LA, 2014, MOL CELL, V53, P330, DOI 10.1016/j.molcel.2013.12.023; Leav I, 2010, AM J PATHOL, V176, P393, DOI 10.2353/ajpath.2010.090521; Lebedev I, 2016, J MOL BIOL, V428, P4154, DOI 10.1016/j.jmb.2016.08.001; Lee CW, 2015, J AM CHEM SOC, V137, P4358, DOI 10.1021/ja511893n; Lisanti S, 2014, CELL REP, V8, P671, DOI 10.1016/j.celrep.2014.06.061; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Sciacovelli M, 2013, CELL METAB, V17, P988, DOI 10.1016/j.cmet.2013.04.019; Sung N, 2016, P NATL ACAD SCI USA, V113, P2952, DOI 10.1073/pnas.1516167113; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Yan Y, 1997, PROSTATE, V32, P129; Yoshida S, 2013, P NATL ACAD SCI USA, V110, pE1604, DOI 10.1073/pnas.1220659110; Zhang B, 2015, ONCOTARGET, V6, P44495, DOI 10.18632/oncotarget.6252; Zhang G, 2016, J CLIN INVEST, V126, P1834, DOI 10.1172/JCI82661	36	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25247	25254		10.1074/jbc.M116.745950	http://dx.doi.org/10.1074/jbc.M116.745950			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27754870	Green Published, hybrid			2022-12-26	WOS:000388880100038
J	Chanmee, T; Ontong, P; Izumikawa, T; Higashide, M; Mochizuki, N; Chokchaitaweesuk, C; Khansai, M; Nakajima, K; Kakizaki, I; Kongtawelert, P; Taniguchi, N; Itano, N				Chanmee, Theerawut; Ontong, Pawared; Izumikawa, Tomomi; Higashide, Miho; Mochizuki, Nobutoshi; Chokchaitaweesuk, Chatchadawalai; Khansai, Manatsanan; Nakajima, Kazuki; Kakizaki, Ikuko; Kongtawelert, Prachya; Taniguchi, Naoyuki; Itano, Naoki			Hyaluronan Production Regulates Metabolic and Cancer Stem-like Properties of Breast Cancer Cells via Hexosamine Biosynthetic Pathway-coupled HIF-1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer stem cells; cell metabolism; glycolysis; hyaluronan; hypoxia-inducible factor (HIF); hexosamine biosynthetic pathway	C-MYC; GLUCOSE-METABOLISM; NUCLEOTIDE SUGARS; O-GLCNACYLATION; HYPOXIA; EXPRESSION; INVOLVEMENT; HIF-1-ALPHA; ACTIVATION; RESISTANCE	Cancer stem cells (CSCs) represent a small subpopulation of self-renewing oncogenic cells. As in many other stem cells, metabolic reprogramming has been implicated to be a key characteristic of CSCs. However, little is known about how the metabolic features of cancer cells are controlled to orchestrate their CSC-like properties. We recently demonstrated that hyaluronan (HA) overproduction allowed plastic cancer cells to revert to stem cell states. Here, we adopted stable isotope-assisted tracing and mass spectrometry profiling to elucidate the metabolic features of HA-overproducing breast cancer cells. These integrated approaches disclosed an acceleration of metabolic flux in the hexosamine biosynthetic pathway (HBP). A metabolic shift toward glycolysis was also evident by quantitative targeted metabolomics, which was validated by the expression profiles of key glycolytic enzymes. Forced expression of glutamine:fructose-6-phosphate amidotransferase 1 (GFAT1), an HBP rate-limiting enzyme, resembled the results of HA overproduction with regard to HIF-1 accumulation and glycolytic program, whereas GFAT1 inhibition significantly decreased HIF-1 protein level in HA-overproducing cancer cells. Moreover, inhibition of the HBP-HIF-1 axis abrogated HA-driven glycolytic enhancement and reduced the CSC-like subpopulation. Taken together, our results provide compelling evidence that HA production regulates the metabolic and CSC-like properties of breast cancer cells via HBP-coupled HIF-1 signaling.	[Chanmee, Theerawut; Izumikawa, Tomomi; Higashide, Miho; Mochizuki, Nobutoshi; Chokchaitaweesuk, Chatchadawalai; Khansai, Manatsanan; Itano, Naoki] Kyoto Sangyo Univ, Grad Sch Engn, Dept Mol Biosci, Fac Life Sci,Kita Ku, Kyoto 6038555, Japan; [Ontong, Pawared; Itano, Naoki] Kyoto Sangyo Univ, Grad Sch Engn, Div Engn Biotechnol, Kita Ku, Kyoto 6038555, Japan; [Khansai, Manatsanan; Kongtawelert, Prachya] Chiang Mai Univ, Dept Biochem, Thailand Excellence Ctr Tissue Engn & Stem Cells, Fac Med, Chiang Mai 50200, Thailand; [Nakajima, Kazuki] Fujita Hlth Univ Sch, Div Clin Res Promot, Toyoake, Aichi 4701192, Japan; [Nakajima, Kazuki] Fujita Hlth Univ Sch, Support Ctr Res Promot, Toyoake, Aichi 4701192, Japan; [Kakizaki, Ikuko] Hirosaki Univ, Dept Glycotechnol, Ctr Adv Med Res, Grad Sch Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan; [Taniguchi, Naoyuki] RIKEN, Max Planck Joint Res Ctr, Global Res Cluster, Dis Glyc Team,Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan	Kyoto Sangyo University; Kyoto Sangyo University; Chiang Mai University; Hirosaki University; RIKEN	Itano, N (corresponding author), Kyoto Sangyo Univ, Grad Sch Engn, Dept Mol Biosci, Fac Life Sci,Kita Ku, Kyoto 6038555, Japan.	itanon@cc.kyoto-su.ac.jp	Kakizaki, Ikuko/AAO-5489-2020; Taniguchi, Naoyuki/I-4182-2014; Taniguchi, Naoyuki/A-7086-2016	Kakizaki, Ikuko/0000-0002-6702-5830; Taniguchi, Naoyuki/0000-0001-5889-5968; Chanmee, Theerawut/0000-0001-6577-4216; kongtawelert, prachya/0000-0002-5963-2796	JSPS KAKENHI [26430125]; Tokyo Biochemical Research Foundation postdoctoral fellowships for Asian researchers in Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tokyo Biochemical Research Foundation postdoctoral fellowships for Asian researchers in Japan	This work was supported by JSPS KAKENHI Grant 26430125 (to N.I.) and Tokyo Biochemical Research Foundation postdoctoral fellowships for Asian researchers in Japan (to T.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Agani F, 2013, CURR CANCER DRUG TAR, V13, P245, DOI 10.2174/1568009611313030003; Alt J, 2015, ANAL BIOCHEM, V474, P28, DOI 10.1016/j.ab.2015.01.001; Bourguignon LYW, 2012, J BIOL CHEM, V287, P32800, DOI 10.1074/jbc.M111.308528; Calvani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038388; Chanmee T, 2014, J BIOL CHEM, V289, P26038, DOI 10.1074/jbc.M114.564120; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; HARTMAN SC, 1973, J BIOL CHEM, V248, P8506; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Jijiwa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024217; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Klopp AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012180; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Koyama H, 2008, AM J PATHOL, V172, P179, DOI 10.2353/ajpath.2008.070360; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Menendez JA, 2013, CELL CYCLE, V12, P1166, DOI 10.4161/cc.24479; Miletti-Gonzalez KE, 2012, J BIOL CHEM, V287, P18995, DOI 10.1074/jbc.M111.318774; Moon SO, 1998, EXP MOL MED, V30, P29, DOI 10.1038/emm.1998.4; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; Nakajima K, 2013, MOL CELL PROTEOMICS, V12, P2468, DOI 10.1074/mcp.M112.027151; Nakajima K, 2010, GLYCOBIOLOGY, V20, P865, DOI 10.1093/glycob/cwq044; Patten DA, 2010, MOL BIOL CELL, V21, P3247, DOI 10.1091/mbc.E10-01-0025; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Tamada M, 2012, CANCER RES, V72, P1438, DOI 10.1158/0008-5472.CAN-11-3024; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Vigetti D, 2012, J BIOL CHEM, V287, P35544, DOI 10.1074/jbc.M112.402347; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zhou J, 2003, MOL BIOL CELL, V14, P2216, DOI 10.1091/mbc.E02-09-0598; Zundel W, 2000, GENE DEV, V14, P391	45	48	50	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24105	24120		10.1074/jbc.M116.751263	http://dx.doi.org/10.1074/jbc.M116.751263			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27758869	hybrid, Green Published			2022-12-26	WOS:000388498100027
J	van den Brink, RL; Murphy, PR; Nieuwenhuis, S				van den Brink, Ruud L.; Murphy, Peter R.; Nieuwenhuis, Sander			Pupil Diameter Tracks Lapses of Attention	PLOS ONE			English	Article							LOCUS-COERULEUS; TASK DISENGAGEMENT; MENTAL FATIGUE; ADAPTIVE GAIN; PERFORMANCE; BRAIN; MODULATION; RESPONSES; SYSTEM; MEMORY	Our ability to sustain attention for prolonged periods of time is limited. Studies on the relationship between lapses of attention and psychophysiological markers of attentional state, such as pupil diameter, have yielded contradicting results. Here, we investigated the relationship between tonic fluctuations in pupil diameter and performance on a demanding sustained attention task. We found robust linear relationships between baseline pupil diameter and several measures of task performance, suggesting that attentional lapses tended to occur when pupil diameter was small. However, these observations were primarily driven by the joint effects of time-on-task on baseline pupil diameter and task performance. The linear relationships disappeared when we statistically controlled for time-on-task effects and were replaced by consistent inverted U-shaped relationships between baseline pupil diameter and each of the task performance measures, such that most false alarms and the longest and most variable response times occurred when pupil diameter was both relatively small and large. Finally, we observed strong linear relationships between the temporal derivative of pupil diameter and task performance measures, which were largely independent of time-on-task. Our results help to reconcile contradicting findings in the literature on pupil-linked changes in attentional state, and are consistent with the adaptive gain theory of locus coeruleus-norepinephrine function. Moreover, they suggest that the derivative of baseline pupil diameter is a potentially useful psychophysiological marker that could be used in the on-line prediction and prevention of attentional lapses.	[van den Brink, Ruud L.; Murphy, Peter R.; Nieuwenhuis, Sander] Leiden Univ, Inst Psychol, Leiden, Netherlands; [van den Brink, Ruud L.; Murphy, Peter R.; Nieuwenhuis, Sander] LIBC, Leiden, Netherlands; [Murphy, Peter R.] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany	Leiden University; Leiden University - Excl LUMC; University of Hamburg; University Medical Center Hamburg-Eppendorf	van den Brink, RL (corresponding author), Leiden Univ, Inst Psychol, Leiden, Netherlands.; van den Brink, RL (corresponding author), LIBC, Leiden, Netherlands.	r.l.van.den.brink@fsw.leidenuniv.nl		van den Brink, Ruud L./0000-0002-3142-7248; Murphy, Peter R/0000-0003-1963-185X	European Research Council [GA 283314-NOREPI]	European Research Council(European Research Council (ERC)European Commission)	This research was supported by a Consolidator Grant of the European Research Council (grant number GA 283314-NOREPI) (https://erc.europa.eu/).; We thank Michael Esterman for providing the behavioral task. This research was supported by a Consolidator Grant of the European Research Council.	Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Brown SBRE, 2015, BEHAV NEUROSCI, V129, P42, DOI 10.1037/bne0000030; Chamberlain SR, 2006, PSYCHOPHARMACOLOGY, V188, P397, DOI 10.1007/s00213-006-0391-6; COULL JT, 1995, PSYCHOPHARMACOLOGY, V120, P322, DOI 10.1007/BF02311180; Debettencourt MT, 2015, NAT NEUROSCI, V18, P470, DOI 10.1038/nn.3940; Esterman M, 2013, CEREB CORTEX, V23, P2712, DOI 10.1093/cercor/bhs261; Forstmann BU, 2016, ANNU REV PSYCHOL, V67, P641, DOI 10.1146/annurev-psych-122414-033645; Franklin MS, 2013, Q J EXP PSYCHOL, V66, P2289, DOI 10.1080/17470218.2013.858170; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Grandchamp R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00031; HOEKS B, 1993, BEHAV RES METH INSTR, V25, P16, DOI 10.3758/BF03204445; Hopstaken JF, 2015, BIOL PSYCHOL, V110, P100, DOI 10.1016/j.biopsycho.2015.06.013; Hopstaken JF, 2015, PSYCHOPHYSIOLOGY, V52, P305, DOI 10.1111/psyp.12339; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; Joshi S, 2016, NEURON, V89, P221, DOI 10.1016/j.neuron.2015.11.028; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; KAHNEMAN D, 1967, PERCEPT PSYCHOPHYS, V2, P101; Kang OE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102463; Kristjansson SD, 2009, APPL ERGON, V40, P978, DOI 10.1016/j.apergo.2009.04.007; MACKWORTH JF, 1968, PSYCHOL REV, V75, P308, DOI 10.1037/h0025896; Mackworth NH, 1948, Q J EXP PSYCHOL, V1, P6, DOI 10.1080/17470214808416738; Mathot S, 2015, J EXP PSYCHOL GEN, V144, P513, DOI 10.1037/a0039168; McGinley Matthew J, 2015, NEURON, V87, P179, DOI [10.1016/j.neuron.2015.05.038, DOI 10.1016/J.NEURON.2015.05.038]; Mittner M, 2014, J NEUROSCI, V34, P16286, DOI 10.1523/JNEUROSCI.2062-14.2014; Murphy PR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003854; Murphy PR, 2014, HUM BRAIN MAPP, V35, P4140, DOI 10.1002/hbm.22466; Murphy PR, 2011, PSYCHOPHYSIOLOGY, V48, P1531, DOI 10.1111/j.1469-8986.2011.01226.x; Nunez MD, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00018; Reimer J, 2014, NEURON, V84, P355, DOI 10.1016/j.neuron.2014.09.033; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Smallwood J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033706; Smallwood J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018298; Unsworth N, 2016, COGN AFFECT BEHAV NE; Van Orden KF, 2000, BIOL PSYCHOL, V52, P221, DOI 10.1016/S0301-0511(99)00043-5; Varazzani C, 2015, J NEUROSCI, V35, P7866, DOI 10.1523/JNEUROSCI.0454-15.2015; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	39	63	63	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165274	10.1371/journal.pone.0165274	http://dx.doi.org/10.1371/journal.pone.0165274			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9OE	27768778	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400076
J	Gilby, BL; Olds, AD; Connolly, RM; Stevens, T; Henderson, CJ; Maxwell, PS; Tibbetts, IR; Schoeman, DS; Rissik, D; Schlacher, TA				Gilby, Ben L.; Olds, Andrew D.; Connolly, Rod M.; Stevens, Tim; Henderson, Christopher J.; Maxwell, Paul S.; Tibbetts, Ian R.; Schoeman, David S.; Rissik, David; Schlacher, Thomas A.			Optimising Land-Sea Management for Inshore Coral Reefs	PLOS ONE			English	Article							MARINE PROTECTED AREAS; MORETON BAY; CONSERVATION; CONNECTIVITY; QUEENSLAND; ECOSYSTEMS; HABITATS; EROSION; STORMWATER; STRESSORS	Management authorities seldom have the capacity to comprehensively address the full suite of anthropogenic stressors, particularly in the coastal zone where numerous threats can act simultaneously to impact reefs and other ecosystems. This situation requires tools to prioritise management interventions that result in optimum ecological outcomes under a set of constraints. Here we develop one such tool, introducing a Bayesian Belief Network to model the ecological condition of inshore coral reefs in Moreton Bay (Australia) under a range of management actions. Empirical field data was used to model a suite of possible ecological responses of coral reef assemblages to five key management actions both in the sea (e.g. expansion of reserves, mangrove & seagrass restoration, fishing restrictions) and on land (e.g. lower inputs of sediment and sewage from treatment plants). Models show that expanding marine reserves (a 'marine action') and reducing sediment inputs from the catchments (a 'land action') were the most effective investments to achieve a better status of reefs in the Bay, with both having been included in >58% of scenarios with positive outcomes, and >98% of the most effective (5th percentile) scenarios. Heightened fishing restrictions, restoring habitats, and reducing nutrient discharges from wastewater treatment plants have additional, albeit smaller effects. There was no evidence that combining individual management actions would consistently produce sizeable synergistic until after maximum investment on both marine reserves (i.e. increasing reserve extent from 31 to 62% of reefs) and sediments (i.e. rehabilitating 6350 km of waterways within catchments to reduce sediment loads by 50%) were implemented. The method presented here provides a useful tool to prioritize environmental actions in situations where multiple competing management interventions exist for coral reefs and in other systems subjected to multiple stressor from the land and the sea.	[Gilby, Ben L.; Olds, Andrew D.; Schoeman, David S.; Schlacher, Thomas A.] Univ Sunshine Coast, Sch Sci & Engn, Maroochydore, Qld 4558, Australia; [Connolly, Rod M.; Stevens, Tim; Henderson, Christopher J.] Griffith Univ, Sch Environm, Australian Rivers Inst Coasts & Estuaries, Gold Coast, Qld 4222, Australia; [Maxwell, Paul S.] Univ Queensland, Sch Chem Engn, St Lucia, Qld 4072, Australia; [Maxwell, Paul S.] Hlth Waterways, Level 4,200 Creek St, Spring Hill, Qld 4004, Australia; [Tibbetts, Ian R.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Rissik, David] Griffith Univ, Natl Climate Change Adaptat Res Facil, Gold Coast, Qld 4222, Australia	University of the Sunshine Coast; Griffith University; University of Queensland; University of Queensland; Griffith University	Gilby, BL (corresponding author), Univ Sunshine Coast, Sch Sci & Engn, Maroochydore, Qld 4558, Australia.	bgilby@usc.edu.au	Rissik, David/I-3758-2017; Connolly, Rod M/C-4094-2008; Tibbetts, Ian/K-6191-2013; Schlacher, Thomas/J-4614-2016	Rissik, David/0000-0002-1976-5324; Connolly, Rod M/0000-0001-6223-1291; Tibbetts, Ian/0000-0002-1481-238X; Schlacher, Thomas/0000-0003-2184-9217; Schoeman, David/0000-0003-1258-0885; Olds, Andrew/0000-0002-8027-3599	Australian Rivers Institute; School of Environment at Griffith University	Australian Rivers Institute; School of Environment at Griffith University	Funded by Australian Rivers Institute and School of Environment at Griffith University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 1997, FRESHWATER BIOL, V37, P149, DOI 10.1046/j.1365-2427.1997.d01-546.x; Alvarez-Romero JG, ANNUAL REVIEW OF ECO, V42, P381; Australian Bureau of Statistics Canberra, QUEENSL POP GROWTH C; Bartley R, 2014, SCI TOTAL ENVIRON, V468, P1138, DOI 10.1016/j.scitotenv.2013.09.030; Beger M, 2010, BIOL CONSERV, V143, P565, DOI 10.1016/j.biocon.2009.11.006; Boersma PD, 1999, ECOL ECON, V31, P287, DOI 10.1016/S0921-8009(99)00085-3; Bratieres K, 2008, WATER RES, V42, P3930, DOI 10.1016/j.watres.2008.06.009; Brown CJ, 2015, P NATL ACAD SCI USA, V112, pE4342, DOI 10.1073/pnas.1509189112; Brown CJ, 2014, DIVERS DISTRIB, V20, P538, DOI 10.1111/ddi.12159; Campbell A.B., 2009, STOCK ASSESSMENT SUM; Carwardine J, 2010, CONSERV BIOL, V24, P1529, DOI 10.1111/j.1523-1739.2010.01535.x; Connolly RM, 2013, MAR POLLUT BULL, V71, P152, DOI 10.1016/j.marpolbul.2013.03.021; Cook MF, 2001, FISHERIES, V26, P19, DOI 10.1577/1548-8446(2001)026&lt;0019:CLIM&gt;2.0.CO;2; Costanzo SD, 2005, MAR POLLUT BULL, V51, P212, DOI 10.1016/j.marpolbul.2004.10.018; Dobbs K, 2008, OCEAN COAST MANAGE, V51, P368, DOI 10.1016/j.ocecoaman.2007.08.001; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Firn J, 2015, J APPL ECOL, V52, P1135, DOI 10.1111/1365-2664.12500; Gibbes B., 2014, ESTUARIES AUSTR 2050, P203, DOI DOI 10.1007/978-94-007-7019-5_12; Gilby BL, 2016, CORAL REEFS, V35, P979, DOI 10.1007/s00338-016-1449-5; Gilby BL, 2015, ECOSYSTEMS, V18, P1056, DOI 10.1007/s10021-015-9883-8; Gilby BL, 2016, MARINE FRES IN PRESS; Grinham A, 2011, J PALEOLIMNOL, V46, P511, DOI 10.1007/s10933-010-9407-7; Gupta VK, 2012, RSC ADV, V2, P6380, DOI 10.1039/c2ra20340e; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2009, CONSERV LETT, V2, P189, DOI 10.1111/j.1755-263X.2009.00060.x; Huijbers CM, 2015, CONSERV LETT, V8, P312, DOI 10.1111/conl.12128; Jensen FV, 2007, BAYESIAN NETWORKS DE; Johnson FA, 2015, ECOL SOC, V20, DOI 10.5751/ES-07986-200414; Jones KB, 2001, LANDSCAPE ECOL, V16, P301, DOI 10.1023/A:1011175013278; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Klein CJ, 2013, CONSERV LETT, V6, P324, DOI 10.1111/conl.12005; Klein CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012431; Leigh C, 2013, WATER-SUI, V5, P780, DOI 10.3390/w5020780; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lybolt M, 2011, FRONT ECOL ENVIRON, V9, P154, DOI 10.1890/090176; Makino A, 2013, BIOL CONSERV, V165, P35, DOI 10.1016/j.biocon.2013.05.027; Manson FJ, 2003, ESTUAR COAST SHELF S, V57, P653, DOI 10.1016/S0272-7714(02)00405-5; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Maxwell PS, 2015, ECOL APPL, V25, P573, DOI 10.1890/14-0395.1; Maxwell PS, 2014, J ECOL, V102, P54, DOI 10.1111/1365-2745.12167; McDole T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043233; Mitchell SB, 2015, ESTUAR COAST SHELF S, V156, P1, DOI 10.1016/j.ecss.2014.12.027; Nearing MA, 2005, CATENA, V61, P131, DOI 10.1016/j.catena.2005.03.007; Nicotra AB, 2015, CONSERV BIOL, V29, P1268, DOI 10.1111/cobi.12522; Olds AD, 2014, GLOBAL CHANGE BIOL, V20, P3050, DOI 10.1111/gcb.12606; Olds AD, 2012, J APPL ECOL, V49, P1195, DOI 10.1111/jpe.12002; Olds AD, 2012, MAR ECOL PROG SER, V462, P191, DOI 10.3354/meps09849; Olds AD, 2012, CONSERV LETT, V5, P56, DOI 10.1111/j.1755-263X.2011.00204.x; Olley J, 2015, HYDROL PROCESS, V29, P2290, DOI 10.1002/hyp.10369; Perring MP, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00121.1; Perry RI, 2003, FISH OCEANOGR, V12, P513; Pitt KA, 2009, MAR POLLUT BULL, V58, P573, DOI 10.1016/j.marpolbul.2008.11.016; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Radomski PJ, 2001, FISHERIES, V26, P7, DOI 10.1577/1548-8446(2001)026&lt;0007:VFRFR&gt;2.0.CO;2; Saeck EA, 2013, MAR FRESHWATER RES, V64, P655, DOI 10.1071/MF12227; Saunders MI, 2013, GLOBAL CHANGE BIOL, V19, P2569, DOI 10.1111/gcb.12218; Saxton NE, 2012, GEOMORPHOLOGY, V173, P80, DOI 10.1016/j.geomorph.2012.05.030; Scales IR, 2015, ORYX, V49, P226, DOI 10.1017/S0030605314000015; Software Norsys, 1997, NET US GUID; Stevens T, 2005, MAR FRESHWATER RES, V56, P111, DOI 10.1071/MF04233; Strain EMA, 2014, GLOBAL CHANGE BIOL, V20, P3300, DOI 10.1111/gcb.12619; Tetzlaff JC, 2013, B MAR SCI, V89, P483, DOI 10.5343/bms.2012.1025; Tibbetts I. R., 1998, MORETON BAY CATCHMEN; Tribbia J, 2008, ENVIRON SCI POLICY, V11, P315, DOI 10.1016/j.envsci.2008.01.003; van Poorten BT, 2013, FISHERIES MANAG ECOL, V20, P258, DOI 10.1111/j.1365-2400.2012.00872.x; Vaze J, 2004, J ENVIRON ENG-ASCE, V130, P391, DOI 10.1061/(ASCE)0733-9372(2004)130:4(391); Wallbrink PJ, 2004, J ENVIRON RADIOACTIV, V76, P67, DOI 10.1016/j.jenvrad.2004.03.019; Webley James, 2015, STATEWIDE RECREATION; World Parks Congress, 2014, STRAT INN APPR REC R; World Parks Congress, 2014, PROM SYDN; Yabsley NA, 2016, J ANIM ECOL, V85, P437, DOI 10.1111/1365-2656.12460	72	17	17	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164934	10.1371/journal.pone.0164934	http://dx.doi.org/10.1371/journal.pone.0164934			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764164	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500081
J	Russell, K; Hutchison, MG; Selci, E; Leiter, J; Chateau, D; Ellis, MJ				Russell, Kelly; Hutchison, Michael G.; Selci, Erin; Leiter, Jeff; Chateau, Daniel; Ellis, Michael J.			Academic Outcomes in High-School Students after a Concussion: A Retrospective Population-Based Analysis	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; 4TH INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; RECOVERY-TIME; SPORT HELD; CHILDREN; MANAGEMENT; SYMPTOMS; ZURICH; IMPACT	Background Many concussion symptoms, such as headaches, vision problems, or difficulty remembering or concentrating may deleteriously affect school functioning. Our objective was to determine if academic performance was lower in the academic calendar year that students sustain a concussion compared to the previous year when they did not sustain a concussion. Methods Using Manitoba Health and Manitoba Education data, we conducted a population-based, controlled before-after study from 2005-2006 to 2010-2011 academic years. Grade 9-12 students with an ICD9/10 code for concussion were matched to non-concussed controls. Overall changes in grade point average (GPA) were compared for the academic year prior to the concussion to the academic year the concussion occurred (or could have occurred among non-concussed matched students). Results Overall, 8240 students (1709 concussed, 6531 non-concussed students) were included. Both concussed and non-concussed students exhibited a lower overall GPA from one year to the next. Having sustained a concussion resulted in a -0.90% (95% CI: -1.88, 0.08) reduction in GPA. Over the same period, non-concussed matched students' GPA reduced by -0.57% (95% CI: -1.32, 0.19). Students who sustained a concussion during high school were just as likely to graduate within four years as their non-concussed peers (ORadj: 0.84; 95% CI: 0.73, 1.02). Conclusions We found that, at a population level, a concussion had minimal long-term effects on academic performance during high school. While academic accommodations and Return-to-Learn programs are an important component of pediatric concussion management, research is needed to identify risk factors for poor academic performance after a concussion and who should receive these programs.	[Russell, Kelly; Selci, Erin] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Russell, Kelly; Selci, Erin; Ellis, Michael J.] Childrens Hosp, Res Inst Manitoba, Winnipeg, MB, Canada; [Russell, Kelly; Leiter, Jeff; Ellis, Michael J.] Canada North Concuss Network, Winnipeg, MB, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON M5S 1A1, Canada; [Leiter, Jeff] Univ Manitoba, Dept Surg, Winnipeg, MB, Canada; [Chateau, Daniel] Univ Manitoba, Manitoba Ctr Hlth Policy, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Sect Neurosurg, Dept Surg, Winnipeg, MB, Canada; [Russell, Kelly] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Russell, K (corresponding author), Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada.; Russell, K (corresponding author), Childrens Hosp, Res Inst Manitoba, Winnipeg, MB, Canada.; Russell, K (corresponding author), Canada North Concuss Network, Winnipeg, MB, Canada.; Russell, K (corresponding author), Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada.	krussell@chrim.ca		chateau, Dan/0000-0002-2215-820X; Russell, Kelly/0000-0002-9159-9201	Manitoba Medical Services Foundation; Winnipeg Foundation; Population Health Research Data Repository [2014011, 2013/2014-56]	Manitoba Medical Services Foundation; Winnipeg Foundation; Population Health Research Data Repository	This study was funded by the Manitoba Medical Services Foundation (KR) and The Winnipeg Foundation (KR). The funders had no role in the study design, data collection, and analysis, decision to publish, or manuscript preparation.; We thank Mr Mingming (Milton) Hu (MSc in Statistics, Manitoba Center for Health Policy) for conducting the data analysis. He was paid for this work from the aforementioned funders. The authors acknowledge the Manitoba Centre for Health Policy for use of data contained in the Population Health Research Data Repository under project # 2014011 (HIPC# 2013/2014-56). The results and conclusions are those of the authors and no official endorsement by the Manitoba Centre for Health Policy, Manitoba Health, or other data providers is intended or should be inferred. Data used in this study are from the Population Health Research Data Repository housed at the Manitoba Centre for Health Policy, University of Manitoba and were derived from data provided by Manitoba Health and Manitoba Education.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cantu R., 2009, J ATHL TRAINING, V44, P434, DOI [DOI 10.4085/1062-6050-44.4.434, 10.4085/1062-6050-44.4.434]; Chouinard R, 2008, BRIT J EDUC PSYCHOL, V78, P31, DOI 10.1348/000709907X197993; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Ellis MJ, 2015, J NEUROSURG PEDIAT, P1; FARKAS G, 1990, AM EDUC RES J, V27, P807, DOI 10.2307/1163110; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hox J., 1998, P 21 ANN C GES KLASS, P147, DOI DOI 10.1007/978-3-642-72087-1_17; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Manitoba Education, 2015, GRADUATION REQUIREME; Manitoba Government, STUD REC SYST PROF S; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Patel DR, 2010, PEDIATR CLIN N AM, V57, P795, DOI 10.1016/j.pcl.2010.03.002; Purcell LK, 2014, PAED CHILD HEALT-CAN, V19, P153, DOI 10.1093/pch/19.3.153; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; SAS Institute Inc, 1976, SAS VERS 9 3 TS1M0; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Zemek R, 2013, ACAD EMERG MED, V20, P1041, DOI 10.1111/acem.12220	46	33	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165116	10.1371/journal.pone.0165116	http://dx.doi.org/10.1371/journal.pone.0165116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9NZ	27764223	gold, Green Submitted, Green Published			2022-12-26	WOS:000386204500118
J	Weinert, LS; Reichelt, AJ; Schmitt, LR; Boff, R; Oppermann, MLR; Camargo, JL; Silveiro, SP				Weinert, Leticia Schwerz; Reichelt, Angela Jacob; Schmitt, Leonardo Rauber; Boff, Roberta; Rocha Oppermann, Maria Lucia; Camargo, Joiza Lins; Silveiro, Sandra Pinho			Vitamin D Deficiency Increases the Risk of Adverse Neonatal Outcomes in Gestational Diabetes	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; HIGH PREVALENCE; CALCIUM STATUS; BIRTH-WEIGHT; PREGNANCY; FETAL; NEWBORN; AGE; MELLITUS	Background Gestational diabetes mellitus (GDM) and vitamin D deficiency have been associated with increased risk of adverse perinatal outcomes but the consequences of both conditions simultaneously present in pregnancy have not yet been evaluated. Our objective was to study the influence of vitamin D deficiency in neonatal outcomes of pregnancies with GDM. Methods 184 pregnant women with GDM referred to specialized prenatal monitoring were included in this cohort and had blood sampled for 25-hydroxyvitamin D measurement. Vitamin D was measured by chemiluminescence and deficiency was defined as < 20 ng/mL. Participants were followed until puerperium and adverse neonatal outcomes were evaluated. Results Newborns of women with vitamin D deficiency had higher incidences of hospitalization in intensive care units (ICU) (32 vs 19%, P = 0.048), of hypoglycemia (any, 17.3 vs 7.1%, P = 0.039 requiring ICU, 15.3 vs 3.6%, P = 0.008), and were more frequently small for gestational age (SGA) (17.3 vs 5.9%, P = 0.017). After adjustment, relative risk (RR) for hypoglycemia requiring ICU was 3.63 (95% CI 1.09-12.11) and for SGA was 4.32 (95% CI 1.75- 10.66). The incidence of prematurity, jaundice and shoulder dystocia was no statistically different between groups. Conclusions In this cohort of pregnant women with GDM, vitamin D deficiency was associated with a major increase in the incidence of adverse neonatal outcomes such as SGA newborns and neonatal hypoglycemia.	[Weinert, Leticia Schwerz; Boff, Roberta; Camargo, Joiza Lins; Silveiro, Sandra Pinho] Univ Fed Rio Grande do Sul, Postgrad Program Endocrinol, Porto Alegre, RS, Brazil; [Reichelt, Angela Jacob; Camargo, Joiza Lins; Silveiro, Sandra Pinho] Hosp Clin Porto Alegre, Div Endocrine, Porto Alegre, RS, Brazil; [Schmitt, Leonardo Rauber] Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil; [Rocha Oppermann, Maria Lucia] Hosp Clin Porto Alegre, Obstet Div, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Weinert, LS (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Program Endocrinol, Porto Alegre, RS, Brazil.	leticiasweinert@yahoo.com.br	Camargo, Joiza Lins/G-9301-2011; Silveiro, Sandra Pinho/V-7922-2019; de Azevedo Jacob Reichelt areichelt, Angela/AAQ-9556-2020	Camargo, Joiza Lins/0000-0001-8834-4075; Silveiro, Sandra Pinho/0000-0003-4891-4074; de Azevedo Jacob Reichelt, Angela/0000-0002-9393-3445	Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre; Universidade Federal do Rio Grande do Sul	Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre; Universidade Federal do Rio Grande do Sul	No author received personal fundings for the research. Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre AND Universidade Federal do Rio Grande do Sul are the funding institutions of our research. They have no grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, ou preparation of the manuscript.	ADA, 2011, DIABETES CARE S1, V34, pS1, DOI [10.2337/dc11-S001, DOI 10.2337/DC11-S001]; Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; [Anonymous], 2011, DIET REF INT CALC VI; Barrera D, 2007, J STEROID BIOCHEM, V103, P529, DOI 10.1016/j.jsbmb.2006.12.097; Barrera D, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-3; Bodnar LM, 2010, J NUTR, V140, P999, DOI 10.3945/jn.109.119636; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; BROOKE OG, 1980, BMJ-BRIT MED J, V280, P751, DOI 10.1136/bmj.280.6216.751; Burris HH, 2012, ANN EPIDEMIOL, V22, P581, DOI 10.1016/j.annepidem.2012.04.015; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2; Doi M, 2011, BRIT J NUTR, V106, P1398, DOI 10.1017/S0007114511001747; Gernand AD, 2013, J CLIN ENDOCR METAB, V98, P398, DOI 10.1210/jc.2012-3275; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Hossain N, 2011, INT J GYNECOL OBSTET, V112, P229, DOI 10.1016/j.ijgo.2010.09.017; Ioannou C, 2012, J CLIN ENDOCR METAB, V97, pE2070, DOI 10.1210/jc.2012-2538; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Kaijser M, 2008, CIRCULATION, V117, P405, DOI 10.1161/CIRCULATIONAHA.107.710715; Karras S, 2016, EUR J CLIN NUTR; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kovacs CS, 2011, ENDOCRIN METAB CLIN, V40, P795, DOI 10.1016/j.ecl.2011.08.002; Leffelaar ER, 2010, BRIT J NUTR, V104, P108, DOI 10.1017/S000711451000022X; MARYA RK, 1988, INDIAN J MED RES, V88, P488; McAree T, 2013, MATERN CHILD NUTR, V9, P23, DOI 10.1111/mcn.12014; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Morley R, 2006, J CLIN ENDOCR METAB, V91, P906, DOI 10.1210/jc.2005-1479; Nobles CJ, 2015, BRIT J NUTR, V114, P2116, DOI 10.1017/S0007114515003980; Pedreira CE, 2011, AN ACAD BRAS CIENC, V83, P619, DOI 10.1590/S0001-37652011005000008; Perez-Lopez FR, 2015, FERTIL STERIL, V103, P1278, DOI 10.1016/j.fertnstert.2015.02.019; Principi N, 2013, EUR J NUTR, V52, P859, DOI 10.1007/s00394-012-0476-4; Qin LL, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050301; Reichelt Angela J., 2002, Arq Bras Endocrinol Metab, V46, P574, DOI 10.1590/S0004-27302002000500012; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Waiters B, 1999, J AM COLL NUTR, V18, P122, DOI 10.1080/07315724.1999.10718839; Weinert LS, 2014, MATERN CHILD HLTH J	37	20	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164999	10.1371/journal.pone.0164999	http://dx.doi.org/10.1371/journal.pone.0164999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764194	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500099
J	Jo, YS; Park, JH; Lee, JK; Heo, EY; Chung, HS; Kim, DK				Jo, Yong Suk; Park, Ju-Hee; Lee, Jung Kyu; Heo, Eun Young; Chung, Hee Soon; Kim, Deog Kyeom			Discordance between MTB/RIF and Real-Time Tuberculosis-Specific Polymerase Chain Reaction Assay in Bronchial Washing Specimen and Its Clinical Implications	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; DIAGNOSTIC-ACCURACY; RAPID DIAGNOSIS; PCR; RESISTANCE; MICROSCOPY; COMPLEX	The prevalence and clinical implications of discordance between Xpert MTB/RIF assays and the AdvanSure TB/NTM real-time polymerase chain reaction (PCR) for bronchial washing specimens have not been studied in pulmonary TB (PTB) patients. The discordant proportion and its clinical impact were evaluated in 320 patients from the bronchoscopy registry whose bronchial washing specimens were tested simultaneously with Xpert MTB/RIF and the TB/NTM PCR assay for three years, and the accuracy of the assays, including the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), were studied. The clinical risk factors for discordance and false positivity of assays were also studied. Among 130 patients who were clinically diagnosed with PTB, 64 patients showed positive acid-fast bacilli culture results, 56 patients showed positive results in molecular methods and clinician diagnosed PTB without results of microbiology in 10 patients. The sensitivity, specificity, PPV, and NPV were 80.0%, 98.95%, 98.1%, and 87.9%, respectively, for Xpert MTB/RIF and 81.5%, 92.6%, 88.3%, and 88.0%, respectively, for TB/NTM PCR. The discordant proportion was 16.9% and was higher in culture negative PTB compared to culture-confirmed PTB (24.3% vs. 9.4%, p = 0.024). However, there were no significant differences in the clinical characteristics, regardless of the discordance. The diagnostic yield increased with an additional assay (7.7% for Xpert MTB/RIF and 9.2% for TB/NTM PCR). False positivity was less common in patients tested with Xpert MTB/RIF (1.05% vs. 7.37%, p = 0.0035). No host-related risk factor for false positivity was identified. The Xpert MTB/RIF and TB/NTM PCR assay in bronchial washing specimens can improve the diagnostic yields for PTB, although there were considerable discordant results without any patient-related risk factors.	[Jo, Yong Suk] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul, South Korea; [Park, Ju-Hee; Lee, Jung Kyu; Heo, Eun Young; Chung, Hee Soon; Kim, Deog Kyeom] Seoul Natl Univ, Div Pulm & Crit Care Med, Dept Internal Med, Seoul Metropolitan Govt,Boramae Med Ctr,Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, DK (corresponding author), Seoul Natl Univ, Div Pulm & Crit Care Med, Dept Internal Med, Seoul Metropolitan Govt,Boramae Med Ctr,Coll Med, Seoul, South Korea.	kimdkmd@gmail.com		Chung, Heesun/0000-0003-1298-2358; Kim, Deog Kyeom/0000-0001-9379-8098				Barnard DA, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0086-z; Bergmann JS, 1999, J CLIN MICROBIOL, V37, P1419, DOI 10.1128/JCM.37.5.1419-1425.1999; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Broccolo F, 2003, J CLIN MICROBIOL, V41, P4565, DOI 10.1128/JCM.41.10.4565-4572.2003; Chang HE, 2008, KOREAN J LAB MED, V28, P103, DOI 10.3343/kjlm.2008.28.2.103; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Cho SY, 2011, YONSEI MED J, V52, P301, DOI 10.3349/ymj.2011.52.2.301; Cho WH, 2015, ANN LAB MED, V35, P356, DOI 10.3343/alm.2015.35.3.356; Choudhary S, 2015, PANACEA J MED SCI, V5, P33; Foulds J, 1998, INT J TUBERC LUNG D, V2, P778; Janssens JP, 2008, EUR RESPIR J, V32, P1415, DOI 10.1183/09031936.00078708; Kim CH, 2014, J THORAC DIS, V6, P625, DOI 10.3978/j.issn.2072-1439.2014.04.12; Kim JH, 2015, EMERG INFECT DIS, V21, P1913, DOI 10.3201/eid2111.141894; Kim MJ, 2015, ANN CLIN LAB SCI, V45, P327; KIM TC, 1984, AM REV RESPIR DIS, V129, P264; Lee HY, 2013, INT J TUBERC LUNG D, V17, P917, DOI 10.5588/ijtld.12.0885; NARAIN R, 1971, AM REV RESPIR DIS, V103, P761; NOORDHOEK GT, 1994, J CLIN MICROBIOL, V32, P277, DOI 10.1128/JCM.32.2.277-284.1994; Ryu YJ, 2015, TUBERC RESPIR DIS, V78, P64, DOI 10.4046/trd.2015.78.2.64; SCHABERG T, 1995, EUR RESPIR J, V8, P1688, DOI 10.1183/09031936.95.08101688; Sharma SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141011; Steingart KR, 2007, EXPERT REV ANTI-INFE, V5, P327, DOI 10.1586/14787210.5.3.327; Theron G, 2016, CLIN INFECT DIS, V62, P995, DOI 10.1093/cid/civ1223; 황상선, 2011, Annals of Clinical Microbiology, V14, P55; Yuksekol I, 2002, TUBERKULOZ VE TORAKS, V51, P405	26	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164923	10.1371/journal.pone.0164923	http://dx.doi.org/10.1371/journal.pone.0164923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760181	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204000066
J	Kotiya, D; Jaiswal, B; Ghose, S; Kaul, R; Datta, K; Tyagi, RK				Kotiya, Deepak; Jaiswal, Bharti; Ghose, Sampa; Kaul, Rachna; Datta, Kasturi; Tyagi, Rakesh K.			Role of PXR in Hepatic Cancer: Its Influences on Liver Detoxification Capacity and Cancer Progression	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; XENOBIOTIC RECEPTOR; CELL-PROLIFERATION; DRUG-RESISTANCE; TRANSGENIC MICE; UP-REGULATION; EXPRESSION; ACTIVATION	The role of nuclear receptor PXR in detoxification and clearance of xenobiotics and endobiotics is well-established. However, its projected role in hepatic cancer is rather illusive where its expression is reported altered in different cancers depending on the tissue-type and micro-environment. The expression of PXR, its target genes and their biological or clinical significance have not been examined in hepatic cancer. In the present study, by generating DEN-induced hepatic cancer in mice, we report that the expression of PXR and its target genes CYP3A11 and GSTa2 are down-regulated implying impairment of hepatic detoxification capacity. A higher state of inflammation was observed in liver cancer tissues as evident from upregulation of inflammatory cytokines IL-6 and TNF-alpha along with NF-kappa B and STAT3. Our data in mouse model suggested a negative correlation between down-regulation of PXR and its target genes with that of higher expression of inflammatory proteins (like IL-6, TNF-alpha, NF-kappa B). In conjunction, our findings with relevant cell culture based assays showed that higher expression of PXR is involved in reduction of tumorigenic potential in hepatic cancer. Overall, the findings suggest that inflammation influences the expression of hepatic proteins important in drug metabolism while higher PXR level reduces tumorigenic potential in hepatic cancer.	[Kotiya, Deepak; Jaiswal, Bharti; Ghose, Sampa; Kaul, Rachna; Datta, Kasturi; Tyagi, Rakesh K.] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi, India; [Datta, Kasturi] Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Tyagi, RK (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi, India.	rktyagi@yahoo.com	Kotiya, Deepak/Z-3554-2019	Kotiya, Deepak/0000-0001-5794-8626	Department of Biotechnology (DBT); Council for Scientific and Industrial Research, India; UGC; UPE-II [25]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); UGC(University Grants Commission, India); UPE-II	DK and BJ acknowledge the Department of Biotechnology (DBT), and Council for Scientific and Industrial Research, India respectively for the award of doctoral research fellowship. The research work presented in this paper was financially supported by research grants from UGC (major project) and UPE-II (Project ID-25). Infrastructural facilities supported by UGC-SAP, ICMR-CAR, India and DST-PURSE to our centre are thankfully acknowledged.; We gratefully acknowledge Dr. Archana Rastogi and Dr. Chhagan Bihari from the Institute of Liver and Biliary Sciences (ILBS) for the help with histopathological evaluation of liver cancer samples and immunohistology of PXR. Dr. S.S. Majumdar and Dr. Abul from National Institute of Immunology (NII), New Delhi for helping in generation of transgenic mice at the institute's transgenic mice facility. The research work presented in this paper was financially supported by research grants from UGC (major project) and UPE-II (Project ID-25) to RKT. Infrastructural facilities supported by UGC-SAP, ICMR-CAR, India and DST-PURSE to our centre are thankfully acknowledged.	Bishayee A, 2014, ADV EXP MED BIOL, V816, P401, DOI 10.1007/978-3-0348-0837-8_16; Bohan A, 2003, J BIOL CHEM, V278, P36688, DOI 10.1074/jbc.M304011200; Braeuning A, 2014, TOXICOL SCI, V140, P259, DOI 10.1093/toxsci/kfu099; Chai J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120055; Chai J, 2012, HEPATOLOGY, V55, P1485, DOI 10.1002/hep.24801; Chen Y, 2007, CANCER RES, V67, P10361, DOI 10.1158/0008-5472.CAN-06-4758; Cheng J, 2014, J PHARMACOL EXP THER, V351, P559, DOI 10.1124/jpet.114.215913; Dhup S, 2008, NAT METHODS, V5, P601, DOI 10.1038/nmeth.1225; Fujimura T, 2012, CANCER SCI, V103, P176, DOI 10.1111/j.1349-7006.2011.02143.x; Gong HB, 2006, MOL ENDOCRINOL, V20, P279, DOI 10.1210/me.2005-0205; Gu XS, 2006, J BIOL CHEM, V281, P17882, DOI 10.1074/jbc.M601302200; Gupta D, 2008, CLIN CANCER RES, V14, P5332, DOI 10.1158/1078-0432.CCR-08-1033; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Ihunnah CA, 2011, BBA-MOL BASIS DIS, V1812, P956, DOI 10.1016/j.bbadis.2011.01.014; Jiang H, 2009, J GASTROINTEST SURG, V13, P1831, DOI 10.1007/s11605-009-0964-x; Kaul R, 2012, J BIOL CHEM, V287, P19750, DOI 10.1074/jbc.M111.266270; Masuyama H, 2003, J CLIN ENDOCR METAB, V88, P4446, DOI 10.1210/jc.2003-030203; Mensah-Osman EJ, 2007, CANCER-AM CANCER SOC, V109, P957, DOI 10.1002/cncr.22479; Morgan ET, 2008, DRUG METAB DISPOS, V36, P205, DOI 10.1124/dmd.107.018747; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; Niu YD, 2014, CANCER LETT, V347, P88, DOI 10.1016/j.canlet.2014.01.026; Ouyang N, 2010, BRIT J CANCER, V102, P1753, DOI 10.1038/sj.bjc.6605677; Pascussi JM, 2000, BIOCHEM BIOPH RES CO, V274, P707, DOI 10.1006/bbrc.2000.3219; Pondugula SR, 2013, CANCER LETT, V328, P1, DOI 10.1016/j.canlet.2012.08.030; Pondugula SR, 2009, EXPERT OPIN DRUG MET, V5, P861, DOI 10.1517/17425250903012360; Raynal C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-46; Saradhi M, 2005, BBA-MOL CELL RES, V1746, P85, DOI 10.1016/j.bbamcr.2005.10.004; Schwabedissen HEMZ, 2008, CANCER RES, V68, P9338, DOI 10.1158/0008-5472.CAN-08-0265; Teng S, 2005, J PHARMACOL EXP THER, V312, P841, DOI 10.1124/jpet.104.076141; Tinwell H, 2014, REGUL TOXICOL PHARM, V70, P648, DOI 10.1016/j.yrtph.2014.09.011; van de Winkel A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-108; Verma S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-3; Wang HW, 2011, J CLIN INVEST, V121, P3220, DOI 10.1172/JCI41514; Xie W, 2006, CELL METABOL; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283; Zhou J, 2008, MOL ENDOCRINOL, V22, P868, DOI 10.1210/me.2007-0197	37	13	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164087	10.1371/journal.pone.0164087	http://dx.doi.org/10.1371/journal.pone.0164087			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760163	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204000027
J	Feng, J; Shi, SL; Pei, LY; Lv, JP; Liu, Q; Xie, SL				Feng, Jia; Shi, Shengli; Pei, Liangyu; Lv, Junping; Liu, Qi; Xie, Shulian			Preparation of Activated Carbon From Polygonum orientale Linn. to Remove the Phenol in Aqueous Solutions	PLOS ONE			English	Article							WASTE-WATER; MALACHITE GREEN; METHYLENE-BLUE; ADSORPTION; 2,4-DICHLOROPHENOL; KINETICS; DYE; WOOD	Phenol components are major industry contaminants of aquatic environment. Among all practical methods for removing phenol substances from polluted water, activated carbon absorption is the most effective way. Here, we have produced low-cost activated carbon using Polygonum orientale Linn, a wide spreading species with large biomass. The phenol adsorption ability of this activated carbon was evaluated at different physico-chemical conditions. Average equilibrium time for adsorption was 120 min. The phenol adsorption ability of the P. orientale activated carbon was increased as the pH increases and reached to the max at pH 9.00. By contrast, the ionic strength had little effect on the phenol absorption. The optimum dose for phenol adsorption by the P. orientale activated carbon was 20.00 g/L. The dominant adsorption mechanism of the P. orientale activated carbon was chemisorption as its phenol adsorption kinetics matched with the pseudo-second-order kinetics. In addition, the equilibrium data were fit to the Langmuir model, with the negative standard free energy and the positive enthalpy, suggesting that adsorption was spontaneous and endothermic.	[Feng, Jia; Shi, Shengli; Pei, Liangyu; Lv, Junping; Liu, Qi; Xie, Shulian] Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China	Shanxi University	Xie, SL (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China.	xiesl@sxu.edu.cn			Social Development Foundation of Shanxi [201603D321001]	Social Development Foundation of Shanxi	The work was supported by Social Development Foundation of Shanxi (no. 201603D321001 to Jia Feng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 2003, APPL CATAL B-ENVIRON, V46, P229, DOI 10.1016/S0926-3373(03)00229-7; Ahluwalia SS, 2007, BIORESOURCE TECHNOL, V98, P2243, DOI 10.1016/j.biortech.2005.12.006; BANERJI SK, 1994, J HAZARD MATER, V39, P19, DOI 10.1016/0304-3894(94)00044-1; BOEHM HP, 1994, CARBON, V32, P759, DOI 10.1016/0008-6223(94)90031-0; Busca G, 2008, J HAZARD MATER, V160, P265, DOI 10.1016/j.jhazmat.2008.03.045; Chen CL, 2007, APPL GEOCHEM, V22, P436, DOI 10.1016/j.apgeochem.2006.11.010; Cheung WH, 2007, BIORESOURCE TECHNOL, V98, P2897, DOI 10.1016/j.biortech.2006.09.045; Coniglio MS, 2008, CHEMOSPHERE, V72, P1035, DOI 10.1016/j.chemosphere.2008.04.003; Dabrowski A, 2005, CHEMOSPHERE, V58, P1049, DOI 10.1016/j.chemosphere.2004.09.067; Das S, 2008, CHEM ENG J, V138, P215, DOI 10.1016/j.cej.2007.06.030; El-Hendawy ANA, 2003, CARBON, V41, P713, DOI 10.1016/S0008-6223(03)00029-0; Ferrero A, 1998, INT S CROP, V50, P833; Freundlich H, 1906, J PHYS CHEM, V40, P1361; Garg VK, 2004, DYES PIGMENTS, V62, P1, DOI 10.1016/j.dyepig.2003.10.016; Graham N, 2003, CHEMOSPHERE, V51, P237, DOI 10.1016/S0045-6535(02)00815-9; Guo J, 2003, MATER CHEM PHYS, V80, P114, DOI 10.1016/S0254-0584(02)00383-8; Gupta VK, 2004, SEP PURIF TECHNOL, V40, P87, DOI 10.1016/j.seppur.2004.01.008; HAUKOS DA, 1993, WILDLIFE SOC B, V21, P288; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Jha P, 2013, INT BIODETER BIODEGR, V77, P106, DOI 10.1016/j.ibiod.2012.11.001; Kalavathy MH, 2005, J COLLOID INTERF SCI, V292, P354, DOI 10.1016/j.jcis.2005.05.087; Kannan N, 2001, DYES PIGMENTS, V51, P25, DOI 10.1016/S0143-7208(01)00056-0; Karthikeyan T, 2005, J HAZARD MATER, V124, P192, DOI 10.1016/j.jhazmat.2005.05.003; Kavitha D, 2007, BIORESOURCE TECHNOL, V98, P14, DOI 10.1016/j.biortech.2005.12.008; Kulkarni Sunil J., 2013, INT J SCI RES PUBL, V3, P1; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Lim WC, 2010, J ANAL APPL PYROL, V88, P181, DOI 10.1016/j.jaap.2010.04.004; Lutzenkirchen J, 1997, J COLLOID INTERF SCI, V195, P149, DOI 10.1006/jcis.1997.5160; Mall ID, 2005, COLLOID SURFACE A, V264, P17, DOI 10.1016/j.colsurfa.2005.03.027; Moreno-Castilla C, 2004, CARBON, V42, P83, DOI 10.1016/j.carbon.2003.09.022; Nakbanpote W, 2000, MINER ENG, V13, P391, DOI 10.1016/S0892-6875(00)00021-2; Nath K, 2013, ENVIRON SCI POLLUT R, V20, P4030, DOI 10.1007/s11356-012-1325-y; Ozer A, 2006, DYES PIGMENTS, V71, P83, DOI 10.1016/j.dyepig.2005.06.004; Pavan FA, 2008, DYES PIGMENTS, V76, P64, DOI 10.1016/j.dyepig.2006.08.027; POOTS VJP, 1978, J WATER POLLUT CON F, V50, P926; Rajeshwarisivaraj, 2001, BIORESOURCE TECHNOL, V80, P233, DOI 10.1016/S0960-8524(00)00179-6; Rengaraj S, 2002, WASTE MANAGE, V22, P543, DOI 10.1016/S0956-053X(01)00016-2; Sathishkumar M, 2009, CHEM ENG J, V147, P265, DOI 10.1016/j.cej.2008.07.020; Sathishkumar M, 2007, BIORESOURCE TECHNOL, V98, P866, DOI 10.1016/j.biortech.2006.03.002; Vimonses V, 2009, CHEM ENG J, V148, P354, DOI 10.1016/j.cej.2008.09.009; Wang K, 2014, ENVIRON MONIT ASSESS, V186, P8667, DOI 10.1007/s10661-014-4034-9; Wang L, 2011, DESALINATION, V254, P68; Wang L, 2011, DESALINATION, V266, P175, DOI 10.1016/j.desal.2010.08.022; Wang L, 2010, BIORESOURCE TECHNOL, V101, P5808, DOI 10.1016/j.biortech.2010.02.099; WEBER TW, 1974, AICHE J, V20, P228, DOI 10.1002/aic.690200204; Weber W.J., 1963, J SANIT ENG DIV, V89, P31, DOI [10.1061/JSEDAI.0000430, DOI 10.1061/JSEDAI.0000430]; Wu FC, 2005, J COLLOID INTERF SCI, V283, P49, DOI 10.1016/j.jcis.2004.08.037; [杨志云 Yang Zhiyun], 2008, [中国野生植物资源, Chinese Wild Plant Resources], V27, P11	48	7	8	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164744	10.1371/journal.pone.0164744	http://dx.doi.org/10.1371/journal.pone.0164744			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741305	Green Submitted, Green Published, gold			2022-12-26	WOS:000385507000063
J	Kim, H; Park, CM; Lee, M; Park, SJ; Song, YS; Lee, JH; Hwang, EJ; Goo, JM				Kim, Hyungjin; Park, Chang Min; Lee, Myunghee; Park, Sang Joon; Song, Yong Sub; Lee, Jong Hyuk; Hwang, Eui Jin; Goo, Jin Mo			Impact of Reconstruction Algorithms on CT Radiomic Features of Pulmonary Tumors: Analysis of Intra- and Inter-Reader Variability and Inter-Reconstruction Algorithm Variability	PLOS ONE			English	Article							TEXTURE ANALYSIS; ITERATIVE RECONSTRUCTION; QUANTITATIVE FEATURES; LUNG; NODULES; HETEROGENEITY; REDUCTION; VOLUMETRY; COMPONENT; PHANTOM	Purpose To identify the impact of reconstruction algorithms on CT radiomic features of pulmonary tumors and to reveal and compare the intra- and inter-reader and inter-reconstruction algorithm variability of each feature. Methods Forty-two patients (M:F = 19: 23; mean age, 60.43 +/- 10.56 years) with 42 pulmonary tumors (22.56 +/- 8.51mm) underwent contrast-enhanced CT scans, which were reconstructed with filtered back projection and commercial iterative reconstruction algorithm (level 3 and 5). Two readers independently segmented the whole tumor volume. Fifteen radiomic features were extracted and compared among reconstruction algorithms. Intra-and inter-reader variability and inter-reconstruction algorithm variability were calculated using coefficients of variation (CVs) and then compared. Results Among the 15 features, 5 first-order tumor intensity features and 4 gray level co-occurrence matrix (GLCM)-based features showed significant differences (p<0.05) among reconstruction algorithms. As for the variability, effective diameter, sphericity, entropy, and GLCM entropy were the most robust features (CV <= 5%). Inter-reader variability was larger than intra-reader or inter-reconstruction algorithm variability in 9 features. However, for entropy, homogeneity, and 4 GLCM-based features, inter-reconstruction algorithm variability was significantly greater than inter-reader variability (p<0.013). Conclusions Most of the radiomic features were significantly affected by the reconstruction algorithms. Inter-reconstruction algorithm variability was greater than inter-reader variability for entropy, homogeneity, and GLCM-based features.	[Kim, Hyungjin; Park, Chang Min; Lee, Myunghee; Park, Sang Joon; Song, Yong Sub; Lee, Jong Hyuk; Hwang, Eui Jin; Goo, Jin Mo] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Park, Chang Min; Park, Sang Joon; Goo, Jin Mo] Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea; [Park, Chang Min; Park, Sang Joon; Goo, Jin Mo] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Park, CM (corresponding author), Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea.; Park, CM (corresponding author), Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea.; Park, CM (corresponding author), Seoul Natl Univ, Canc Res Inst, Seoul, South Korea.	cmpark.morphius@gmail.com	Hwang, Eui Jin/X-4415-2018	Hwang, Eui Jin/0000-0002-3697-5542; Lee, Jong Hyuk/0000-0002-9594-683X	Seoul National University Hospital (SNUH) Research Fund [05-2016-0050]	Seoul National University Hospital (SNUH) Research Fund	This study was supported by grant no. 05-2016-0050 from the Seoul National University Hospital (SNUH) Research Fund, www.snuh.org/pub/; CMP received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Ahn SY, 2015, INVEST RADIOL, V50, P719, DOI 10.1097/RLI.0000000000000174; Balagurunathan Y, 2014, TRANSL ONCOL, V7, P72, DOI 10.1593/tlo.13844; Chae HD, 2014, RADIOLOGY, V273, P285, DOI 10.1148/radiol.14132187; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Fletcher JG, 2012, J COMPUT ASSIST TOMO, V36, P560, DOI 10.1097/RCT.0b013e318263cc1b; Ganeshan B, 2012, EUR RADIOL, V22, P796, DOI 10.1007/s00330-011-2319-8; Goodman LR, 2006, AM J ROENTGENOL, V186, P989, DOI 10.2214/AJR.04.1821; Kim H, 2015, INVEST RADIOL, V50, P571, DOI 10.1097/RLI.0000000000000152; Lee KH, 2014, J THORAC ONCOL, V9, P74, DOI 10.1097/JTO.0000000000000019; Mackin D, 2015, INVEST RADIOL, V50, P757, DOI 10.1097/RLI.0000000000000180; Mattonen SA, 2014, J THORAC DIS, V6, P375, DOI 10.3978/j.issn.2072-1439.2013.11.09; McErlean Aoife, 2013, Radiology, V269, P451, DOI 10.1148/radiol.13122665; Ravanelli M, 2013, EUR RADIOL, V23, P3450, DOI 10.1007/s00330-013-2965-0; Sieren JP, 2014, MED PHYS, V41, DOI 10.1118/1.4893498; Solomon J, 2016, RADIOLOGY, V279, P185, DOI 10.1148/radiol.2015150892; Song YS, 2014, RADIOLOGY, V273, P276, DOI 10.1148/radiol.14132324; Wielputz MO, 2013, EUR J RADIOL, V82, P1577, DOI 10.1016/j.ejrad.2013.04.035; Willemink MJ, 2013, EUR RADIOL, V23, P1623, DOI 10.1007/s00330-012-2765-y; Willemink MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058053; Win T, 2013, CLIN CANCER RES, V19, P3591, DOI 10.1158/1078-0432.CCR-12-1307; Yan JH, 2015, J NUCL MED, V56, P1667, DOI 10.2967/jnumed.115.156927; Young S, 2015, MED PHYS, V42, P2679, DOI 10.1118/1.4918919; Zhao BS, 2014, TRANSL ONCOL, V7, P88, DOI 10.1593/tlo.13865	24	54	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164924	10.1371/journal.pone.0164924	http://dx.doi.org/10.1371/journal.pone.0164924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741289	Green Published, Green Submitted, gold			2022-12-26	WOS:000385507000083
J	Yang, HX; Seoighe, C				Yang, Haixuan; Seoighe, Cathal			Impact of the Choice of Normalization Method on Molecular Cancer Class Discovery Using Nonnegative Matrix Factorization	PLOS ONE			English	Article							CLASSIFICATION; PREDICTION; RISK	Nonnegative Matrix Factorization (NMF) has proved to be an effective method for unsupervised clustering analysis of gene expression data. By the nonnegativity constraint, NMF provides a decomposition of the data matrix into two matrices that have been used for clustering analysis. However, the decomposition is not unique. This allows different clustering results to be obtained, resulting in different interpretations of the decomposition. To alleviate this problem, some existing methods directly enforce uniqueness to some extent by adding regularization terms in the NMF objective function. Alternatively, various normalization methods have been applied to the factor matrices; however, the effects of the choice of normalization have not been carefully investigated. Here we investigate the performance of NMF for the task of cancer class discovery, under a wide range of normalization choices. After extensive evaluations, we observe that the maximum norm showed the best performance, although the maximum norm has not previously been used for NMF.	[Yang, Haixuan; Seoighe, Cathal] Natl Univ Ireland, Sch Math Stat & Appl Math, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	Yang, HX (corresponding author), Natl Univ Ireland, Sch Math Stat & Appl Math, Galway, Ireland.	haixuan.yang@nuigalway.ie		Seoighe, Cathal/0000-0003-0496-4029	Millennium Fund, National University of Ireland, Galway; Millennium Fund, NUI Galway	Millennium Fund, National University of Ireland, Galway; Millennium Fund, NUI Galway	This work was supported by the Millennium Fund, National University of Ireland, Galway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project is supported by the Millennium Fund, NUI Galway.	Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Chen X, 2013, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2013-10; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Fogel P, 2007, BIOINFORMATICS, V23, P44, DOI 10.1093/bioinformatics/btl550; Gao Y, 2005, BIOINFORMATICS, V21, P3970, DOI 10.1093/bioinformatics/bti653; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hastie T, 2009, ELEMENTS STAT LEARNI, DOI [10.1016/j.neunet.2009.04.005, DOI 10.1016/J.NEUNET.2009.04.005]; Kim H, 2007, BIOINFORMATICS, V23, P1495, DOI 10.1093/bioinformatics/btm134; Kim MH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S8; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kreike B, 2006, CLIN CANCER RES, V12, P5705, DOI 10.1158/1078-0432.CCR-06-0805; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Roepman P, 2014, INT J CANCER, V134, P552, DOI 10.1002/ijc.28387; Schlicker A, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-66; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Walters DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077065; Zheng CH, 2009, IEEE T INF TECHNOL B, V13, P599, DOI 10.1109/TITB.2009.2018115	21	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e164880	10.1371/journal.pone.0164880	http://dx.doi.org/10.1371/journal.pone.0164880			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741311	gold, Green Published			2022-12-26	WOS:000385507000077
J	Blomme, A; Costanza, B; de Tullio, P; Thiry, M; Van Simaeys, G; Boutry, S; Doumont, G; Di Valentin, E; Hirano, T; Yokobori, T; Gofflot, S; Peulen, O; Bellahcene, A; Sherer, F; Le Goff, C; Cavalier, E; Mouithys-Mickalad, A; Jouret, F; Cusumano, PG; Lifrange, E; Muller, RN; Goldman, S; Delvenne, P; De Pauw, E; Nishiyama, M; Castronovo, V; Turtoi, A				Blomme, A.; Costanza, B.; de Tullio, P.; Thiry, M.; Van Simaeys, G.; Boutry, S.; Doumont, G.; Di Valentin, E.; Hirano, T.; Yokobori, T.; Gofflot, S.; Peulen, O.; Bellahcene, A.; Sherer, F.; Le Goff, C.; Cavalier, E.; Mouithys-Mickalad, A.; Jouret, F.; Cusumano, P. G.; Lifrange, E.; Muller, R. N.; Goldman, S.; Delvenne, P.; De Pauw, E.; Nishiyama, M.; Castronovo, V.; Turtoi, A.			Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer	ONCOGENE			English	Article							TRAFFICKING; ENDOCYTOSIS; ENDOSOME; PROTEINS; CAVEOLAE; REVEALS; BIOLOGY; GROWTH; CELLS	Myoferlin is a multiple C2-domain-containing protein that regulates membrane repair, tyrosine kinase receptor function and endocytosis in myoblasts and endothelial cells. Recently it has been reported as overexpressed in several cancers and shown to contribute to proliferation, migration and invasion of cancer cells. We have previously demonstrated that myoferlin regulates epidermal growth factor receptor activity in breast cancer. In the current study, we report a consistent overexpression of myoferlin in triple-negative breast cancer cells (TNBC) over cells originating from other breast cancer subtypes. Using a combination of proteomics, metabolomics and electron microscopy, we demonstrate that myoferlin depletion results in marked alteration of endosomal system and metabolism. Mechanistically, myoferlin depletion caused impaired vesicle traffic that led to a misbalance of saturated/unsaturated fatty acids. This provoked mitochondrial dysfunction in TNBC cells. As a consequence of the major metabolic stress, TNBC cells rapidly triggered AMP activated protein kinase-mediated metabolic reprogramming to glycolysis. This reduced their ability to balance between oxidative phosphorylation and glycolysis, rendering TNBC cells metabolically inflexible, and more sensitive to metabolic drug targeting in vitro. In line with this, our in vivo findings demonstrated a significantly reduced capacity of myoferlin-deficient TNBC cells to metastasise to lungs. The significance of this observation was further supported by clinical data, showing that TNBC patients whose tumors overexpress myoferlin have worst distant metastasis-free and overall survivals. This novel insight into myoferlin function establishes an important link between vesicle traffic, cancer metabolism and progression, offering new diagnostic and therapeutic concepts to develop treatments for TNBC patients.	[Blomme, A.; Costanza, B.; Peulen, O.; Bellahcene, A.; Castronovo, V.; Turtoi, A.] Univ Liege, Metastasis Res Lab, GIGA Canc, Ave Hop 3,Tour Patho 4, B-4000 Liege, Belgium; [Costanza, B.; Yokobori, T.; Nishiyama, M.; Turtoi, A.] Gunma Univ, Dept Mol Pharmacol & Oncol, Grad Sch Med, Gunma, Japan; [de Tullio, P.] Univ Liege, CIRM, Liege, Belgium; [Thiry, M.] Univ Liege, Lab Cell Biol, Fac Sci, Liege, Belgium; [Van Simaeys, G.; Boutry, S.; Doumont, G.; Sherer, F.; Muller, R. N.; Goldman, S.] Ctr Microscopy & Mol Imaging, Charleroi, Belgium; [Van Simaeys, G.; Goldman, S.] Univ Libre Bruxelles, Dept Nucl Med, Hop Erasme, Brussels, Belgium; [Boutry, S.; Muller, R. N.] Univ Mons, Dept Gen Organ & Biomed Chem, NMR & Mol Imaging Lab, Mons, Belgium; [Di Valentin, E.] Univ Liege, GIGA Viral Vectors Platform, Liege, Belgium; [Hirano, T.] Gunma Univ, Dept Mol Pharmacol & Oncol, Grad Sch Med, Gunma, Japan; [Gofflot, S.] Univ Liege, BIOTHEQUE, Liege, Belgium; [Le Goff, C.; Cavalier, E.] Univ Liege, Univ Hosp, Dept Clin Chem, Liege, Belgium; [Mouithys-Mickalad, A.] Univ Liege, Ctr Oxygen Res & Dev, Liege, Belgium; [Jouret, F.] Univ Liege, GIGA Cardiovasc Sci, Liege, Belgium; [Cusumano, P. G.; Lifrange, E.] Univ Liege, Univ Hosp, Dept Senol, Liege, Belgium; [Delvenne, P.] Univ Liege, Univ Hosp, Dept Pathol, Liege, Belgium; [De Pauw, E.; Turtoi, A.] Univ Liege, Mass Spectrometry Lab, Liege, Belgium	University of Liege; Gunma University; University of Liege; University of Liege; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Mons; University of Liege; Gunma University; University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; University of Liege	Turtoi, A (corresponding author), Univ Liege, Metastasis Res Lab, GIGA Canc, Ave Hop 3,Tour Patho 4, B-4000 Liege, Belgium.	a.turtoi@ulg.ac.be	Cavalier, Etienne/E-8661-2011; Blomme, Arnaud/AAM-1440-2020; Peulen, Olivier/C-1250-2018; Blomme, Arnaud/AGO-7915-2022; Costanza, Brunella/AAB-6354-2022; De Tullio, Pascal/ABE-5585-2021; Turtoi, Andrei/ABD-1271-2021; Van Simaeys, Gaetan/AAR-8082-2020	Cavalier, Etienne/0000-0003-0947-2226; Peulen, Olivier/0000-0002-6933-0134; Blomme, Arnaud/0000-0003-4183-8726; Turtoi, Andrei/0000-0003-3813-6635; Van Simaeys, Gaetan/0000-0002-2678-542X; Costanza, Brunella/0000-0001-8279-805X; Di Valentin, Emmanuel/0000-0002-5287-7950; De Pauw, Edwin/0000-0003-3475-1315	University of Liege (Concerted Research Action Program (IDEA project)); National Fund for Scientific Research (FNRS); Fonds Erasme; Convention de Recherche Association Vincotte Nuclear-AVN; Gunma University (GIAR Research Program for Omics-Based Medical Science); European Regional Development Fund; Wallonia (FEDER)	University of Liege (Concerted Research Action Program (IDEA project)); National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds Erasme; Convention de Recherche Association Vincotte Nuclear-AVN; Gunma University (GIAR Research Program for Omics-Based Medical Science); European Regional Development Fund(European Commission); Wallonia (FEDER)	We acknowledge the experimental support of Dr Chantal Humblet and Mrs Alice Marquet (GIGA-histology platform, ULg), Dr Sandra Ormenese (GIGA-imaging platform, ULg), Mr Vincent Hennequiere and Mrs Naima Maloujahmoum (Metastasis Research Laboratory) for experimental support. We are also thankful to the institutional Biobank of the University Hospital Liege for providing patient material. Mr Mathieu Roch (CMMI) is thanked for his help in tumor volume measurements on MR images. We are grateful to Mrs Marie-Aline Laute and Mr Nicolas Passon, the Cyclotron team (Erasme Hospital, Brussels, Belgium) and Dr. Bolag Altan (Gunma University) for technical assistance. The results shown in this work are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/. This work was supported with grants from the University of Liege (Concerted Research Action Program (IDEA project)), National Fund for Scientific Research (FNRS), Fonds Erasme, Convention de Recherche Association Vincotte Nuclear-AVN and Gunma University (GIAR Research Program for Omics-Based Medical Science). Andrei Turtoi and Arnaud Blomme are post-doctoral research fellows (FNRS/Televie), Akeila Bellahcene and Pascal de Tullio are senior research associates (FNRS). The Center for Microscopy and Molecular Imaging (CMMI) as well as Gilles Doumont are supported by the European Regional Development Fund and Wallonia (FEDER). No funding bodies had any role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aisen P, 2001, INT J BIOCHEM CELL B, V33, P940, DOI 10.1016/S1357-2725(01)00063-2; Antonescu CN, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016964; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Bernatchez PN, 2009, AM J PHYSIOL-CELL PH, V297, pC484, DOI 10.1152/ajpcell.00498.2008; Chen JLY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000293; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Fahmy K, 2016, INT J CANCER, V138, P652, DOI 10.1002/ijc.29820; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Griguer CE, 2005, J NEURO-ONCOL, V74, P123, DOI 10.1007/s11060-004-6404-6; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Hullin-Matsuda F, 2014, SEMIN CELL DEV BIOL, V31, P48, DOI 10.1016/j.semcdb.2014.04.010; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kiss AL, 2012, ADV EXP MED BIOL, V729, P14, DOI 10.1007/978-1-4614-1222-9_2; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Leung C, 2013, AM J PATHOL, V182, P1900, DOI 10.1016/j.ajpath.2013.01.041; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Matheus N, 2014, PHYTOCHEM ANALYSIS, V25, P342, DOI 10.1002/pca.2498; Mayer IA, 2014, CLIN CANCER RES, V20, P782, DOI 10.1158/1078-0432.CCR-13-0583; Miccheli A, 2006, BIOCHIMIE, V88, P437, DOI 10.1016/j.biochi.2005.10.004; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Toole SA, 2013, J CLIN PATHOL, V66, P530, DOI 10.1136/jclinpath-2012-201361; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Penzo D, 2002, BBA-BIOENERGETICS, V1555, P160, DOI 10.1016/S0005-2728(02)00272-4; Pilch PF, 2011, TRENDS ENDOCRIN MET, V22, P318, DOI 10.1016/j.tem.2011.04.001; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Sachen KL, 2012, BLOOD, V120, P4182, DOI 10.1182/blood-2012-05-427534; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Turtoi A, 2013, CANCER RES, V73, P5438, DOI 10.1158/0008-5472.CAN-13-1142; Turtoi A, 2011, J PROTEOME RES, V10, P4302, DOI 10.1021/pr200527z; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Volakis LI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086110; Wang WS, 2013, J PROTEOMICS, V91, P453, DOI 10.1016/j.jprot.2013.06.032; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928	44	36	37	3	21	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 13	2017	36	15					2116	2130		10.1038/onc.2016.369	http://dx.doi.org/10.1038/onc.2016.369			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DK	27775075				2022-12-26	WOS:000399782500008
J	Feldbauer, K; Schlegel, J; Weissbecker, J; Sauer, F; Wood, PG; Bamberg, E; Terpitz, U				Feldbauer, Katrin; Schlegel, Jan; Weissbecker, Juliane; Sauer, Frank; Wood, Phillip G.; Bamberg, Ernst; Terpitz, Ulrich			Optochemokine Tandem for Light-Control of Intracellular Ca2+	PLOS ONE			English	Article							CHEMOKINE RECEPTOR 4; OPTOGENETIC CONTROL; MEMBRANE-PROTEINS; PROTON PUMP; IN-VIVO; CALCIUM; CXCR4; ACTIVATION; CHANNELRHODOPSIN-2; CHANNELS	An optochemokine tandem was developed to control the release of calcium from endosomes into the cytosol by light and to analyze the internalization kinetics of G-protein coupled receptors (GPCRs) by electrophysiology. A previously constructed rhodopsin tandem was re-engineered to combine the light-gated Ca2+-permeable cation channel Channelrho-dopsin-2(L132C), CatCh, with the chemokine receptor CXCR4 in a functional tandem protein tCXCR4/CatCh. The GPCR was used as a shuttle protein to displace CatCh from the plasma membrane into intracellular areas. As shown by patch-clamp measurements and confocal laser scanning microscopy, heterologously expressed tCXCR4/CatCh was internalized via the endocytic SDF1/CXCR4 signaling pathway. The kinetics of internalization could be followed electrophysiologically via the amplitude of the CatCh signal. The light-induced release of Ca2+ by tandem endosomes into the cytosol via CatCh was visualized using the Ca2+-sensitive dyes rhod2 and rhod2-AM showing an increase of intracellular Ca2+ in response to light.	[Feldbauer, Katrin; Weissbecker, Juliane; Wood, Phillip G.; Bamberg, Ernst] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany; [Schlegel, Jan; Sauer, Frank; Terpitz, Ulrich] Univ Wurzburg, Bioctr, Dept Biotechnol & Biophys, Wurzburg, Germany; [Bamberg, Ernst] Goethe Univ Frankfurt, Chem & Pharmaceut Sci Dept, Frankfurt, Germany; [Sauer, Frank] Univ Leipzig, Biol Phys Div, Inst Expt Phys 1, Leipzig, Germany	Max Planck Society; University of Wurzburg; Goethe University Frankfurt; Leipzig University	Terpitz, U (corresponding author), Univ Wurzburg, Bioctr, Dept Biotechnol & Biophys, Wurzburg, Germany.	ulrich.terpitz@uni-wuerzburg.de	Terpitz, Ulrich/F-5803-2012; Schlegel, Jan/M-2995-2018; Schlegel, Jan/R-6894-2019	Terpitz, Ulrich/0000-0003-3031-3422; Schlegel, Jan/0000-0003-3159-8079; Schlegel, Jan/0000-0003-3159-8079	German Research Foundation [SFB807]; Max-Planck-Society	German Research Foundation(German Research Foundation (DFG)); Max-Planck-Society(Max Planck Society)	Our work was supported by the German Research Foundation (http://www.dfg.de) (SFB807 to E.B.) and by the Max-Planck-Society (http://www.mpg.de) (E.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2011, PHYSIOLOGY, V26, P14, DOI 10.1152/physiol.00048.2010; Adamantidis A, 2015, NAT NEUROSCI, V18, P1202, DOI 10.1038/nn.4106; Aisen P, 2004, INT J BIOCHEM CELL B, V36, P2137, DOI 10.1016/j.biocel.2004.02.007; Albrecht T, 2015, CELL CALCIUM, V57, P263, DOI 10.1016/j.ceca.2015.01.008; ALMOHANNA FA, 1994, NATURE, V367, P745, DOI 10.1038/367745a0; Andersen CBF, 2014, TRENDS BIOCHEM SCI, V39, P82, DOI 10.1016/j.tibs.2013.12.003; Arnolds KL, 2014, INFECT GENET EVOL, V25, P146, DOI 10.1016/j.meegid.2014.04.018; Brini M, 2013, METAL IONS LIFE SCI, V12, P119, DOI 10.1007/978-94-007-5561-1_5; Busskamp V, 2012, GENE THER, V19, P169, DOI 10.1038/gt.2011.155; Chernet BT, 2016, ONCOTARGET, V7, P19575, DOI 10.18632/oncotarget.8036; Dawydow A, 2014, P NATL ACAD SCI USA, V111, P13972, DOI 10.1073/pnas.1408269111; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dupont Genevieve, 2016, F1000Res, V5, DOI 10.12688/f1000research.8438.1; Evans EL, 2010, BIOCHEM SOC T, V38, P1458, DOI 10.1042/BST0381458; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Garcia-Martinez J, 2015, SCI REP-UK, V5, DOI 10.1038/srep07798; Gascoyne PRC, 2013, ELECTROPHORESIS, V34, P1042, DOI 10.1002/elps.201200496; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; Gilabert JA, 2012, ADV EXP MED BIOL, V740, P483, DOI 10.1007/978-94-007-2888-2_20; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hesselgesser J, 1998, J IMMUNOL, V160, P877; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Ishii T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9021; Janowski M, 2009, CELL ADHES MIGR, V3, P243, DOI 10.4161/cam.3.3.8260; Kleinlogel S, 2011, NAT METHODS, V8, P1083, DOI [10.1038/NMETH.1766, 10.1038/nmeth.1766]; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kyung T, 2015, NAT BIOTECHNOL, V33, P1092, DOI 10.1038/nbt.3350; Li DD, 2012, J PHYSIOL-LONDON, V590, P855, DOI 10.1113/jphysiol.2011.219345; Li GY, 2010, BIOMED ENVIRON SCI, V23, P371, DOI 10.1016/S0895-3988(10)60078-5; Lundstrom K, 2009, METHODS MOL BIOL, V552, P51, DOI 10.1007/978-1-60327-317-6_4; Maghazachi AA, 1997, BIOCHEM BIOPH RES CO, V236, P270, DOI 10.1006/bbrc.1997.6937; Marchese A, 2014, CURR OPIN CELL BIOL, V27, P72, DOI 10.1016/j.ceb.2013.11.011; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Obukhov AG, 1996, EMBO J, V15, P5833, DOI 10.1002/j.1460-2075.1996.tb00970.x; Ronjat M, 2013, CHANNELS, V7, P119, DOI 10.4161/chan.23895; Rost BR, 2015, NAT NEUROSCI, V18, P1845, DOI 10.1038/nn.4161; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scholz F, 2012, BIOPHYS J, V102, P2649, DOI [10.1016/j.bpj.2012.04.034, 10.1016/j.bpj.2012.01.034]; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Swanson SJ, 2011, ANNU REV PLANT BIOL, V62, P273, DOI 10.1146/annurev-arplant-042110-103832; Telcher BA, 2010, CLIN CANCER RES, V16, P2927, DOI [10.1158/1078-0432.CCR-09-2329, DOI 10.1158/1078-0432.CCR-09-2329]; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Wescott MP, 2016, P NATL ACAD SCI USA, V113, P9928, DOI 10.1073/pnas.1601278113; Xu YX, 2014, P NATL ACAD SCI USA, V111, P6371, DOI 10.1073/pnas.1319296111; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zimmermann D, 2008, BIOCHEM BIOPH RES CO, V369, P1022, DOI 10.1016/j.bbrc.2008.02.153	48	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165344	10.1371/journal.pone.0165344	http://dx.doi.org/10.1371/journal.pone.0165344			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768773	Green Submitted, Green Published, gold			2022-12-26	WOS:000386205400080
J	Hwong, WY; Bots, ML; Selvarajah, S; Kappelle, LJ; Aziz, ZA; Sidek, NN; Vaartjes, I				Hwong, Wen Yea; Bots, Michiel L.; Selvarajah, Sharmini; Kappelle, L. Jaap; Aziz, Zariah Abdul; Sidek, Norsima Nazifah; Vaartjes, Ilonca			Use of a Diagnostic Score to Prioritize Computed Tomographic (CT) Imaging for Patients Suspected of Ischemic Stroke Who May Benefit from Thrombolytic Therapy	PLOS ONE			English	Article							CLINICAL-DIAGNOSIS; ACCURACY; SIRIRAJ; VALIDATION; PERFORMANCE; HEMORRHAGE; EMERGENCY; BEDSIDE; MODELS; BRAIN	Background A shortage of computed tomographic (CT) machines in low and middle income countries often results in delayed CT imaging for patients suspected of a stroke. Yet, time constraint is one of the most important aspects for patients with an ischemic stroke to benefit from thrombolytic therapy. We set out to assess whether application of the Siriraj Stroke Score is able to assist physicians in prioritizing patients with a high probability of having an ischemic stroke for urgent CT imaging. Methods From the Malaysian National Neurology Registry, we selected patients aged 18 years and over with clinical features suggesting of a stroke, who arrived in the hospital 4.5 hours or less from ictus. The prioritization of receiving CT imaging was left to the discretion of the treating physician. We applied the Siriraj Stroke Score to all patients, refitted the score and defined a cut-off value to best distinguish an ischemic stroke from a hemorrhagic stroke. Results Of the 2176 patients included, 73% had an ischemic stroke. Only 33% of the ischemic stroke patients had CT imaging within 4.5 hours. The median door-to-scan time for these patients was 4 hours (IQR: 1; 16). With the recalibrated score, it would have been possible to prioritize 95% (95% CI: 94%-96%) of patients with an ischemic stroke for urgent CT imaging. Conclusions In settings where CT imaging capacity is limited, we propose the use of the Siriraj Stroke Score to prioritize patients with a probable ischemic stroke for urgent CT imaging.	[Hwong, Wen Yea] Kuala Lumpur Gen Hosp, Natl Clin Res Ctr, Kuala Lumpur, Malaysia; [Hwong, Wen Yea; Bots, Michiel L.; Selvarajah, Sharmini; Vaartjes, Ilonca] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Kappelle, L. Jaap] Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Aziz, Zariah Abdul] Hosp Sultanah Nur Zahirah, Dept Neurol, Terengganu, Malaysia; [Sidek, Norsima Nazifah] Hosp Sultanah Nur Zahirah, Dept Pharm, Terengganu, Malaysia	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Vaartjes, I (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	c.h.vaartjes@umcutrecht.nl	SIDEK, NORSIMA NAZIFAH/AAG-4416-2021	SIDEK, NORSIMA NAZIFAH/0000-0003-1269-7661	Julius Center for Health Sciences and Primary Care; Dutch Heart Foundation; Ministry of Health Malaysia [NMRR 08-1631-3189]	Julius Center for Health Sciences and Primary Care; Dutch Heart Foundation(Netherlands Heart Foundation); Ministry of Health Malaysia	WYH is funded by Julius Center for Health Sciences and Primary Care under the Honors Track Programme. IV is funded by the Dutch Heart Foundation for project Facts and Figures. The Honors Track Committee and the Dutch Heart Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Malaysian National Neurology Registry is funded by Ministry of Health Malaysia (ID: NMRR 08-1631-3189). Ministry of Health Malaysia had no role in the study design, analysis and preparation of the manuscript.	Adeoye O, 2011, STROKE, V42, P1952, DOI 10.1161/STROKEAHA.110.612358; Allder SJ, 1999, LANCET, V354, P1523, DOI 10.1016/S0140-6736(99)04360-3; ALLEN CMC, 1983, Q J MED, V52, P515; [Anonymous], 2015, HLTH FACTS MAL; [Anonymous], 2013, STATA STAT SOFTW REL; [Anonymous], 2014, R LANG ENV STAT COMP; Arunah C, 2010, NATL HEALTHCARE ESTA, P73; Audebert HJ, 2014, NAT REV NEUROL, V10, P675, DOI 10.1038/nrneurol.2014.194; BESSON G, 1995, STROKE, V26, P1205, DOI 10.1161/01.STR.26.7.1205; CADIGAN RT, 1989, ANN EMERG MED, V18, P618, DOI 10.1016/S0196-0644(89)80514-1; CELANI MG, 1994, BRIT MED J, V308, P1674, DOI 10.1136/bmj.308.6945.1674; Connor MD, 2007, STROKE, V38, P62, DOI 10.1161/01.STR.0000251853.62387.68; Dorhout SM, 2012, STROKE, V43, P2126, DOI 10.1161/STROKEAHA.111.639690; Efstathiou SP, 2002, J INTERN MED, V252, P121, DOI 10.1046/j.1365-2796.2002.01013.x; Goswami Rudra Prosad, 2013, Indian J Med Sci, V67, P137; Hand PJ, 2006, STROKE, V37, P769, DOI 10.1161/01.STR.0000204041.13466.4c; Hui ACF, 2002, INTERN MED J, V32, P311, DOI 10.1046/j.1445-5994.2002.00228.x; Janssen KJM, 2008, J CLIN EPIDEMIOL, V61, P76, DOI 10.1016/j.jclinepi.2007.04.018; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kan CH, 2000, INT J CLIN PRACT, V54, P645; LIBMAN RB, 1995, ARCH NEUROL-CHICAGO, V52, P1119, DOI 10.1001/archneur.1995.00540350113023; Malaysian Society of Neurosciences Stroke Council, CLIN PRACT GUID MAN; McCleary L, 2002, NURS RES, V51, P339, DOI 10.1097/00006199-200209000-00012; Mwita CC, 2014, J NEUROSCI RURAL PRA, V5, P330, DOI 10.4103/0976-3147.139966; Nazifah S Norsima, 2012, Med J Malaysia, V67, P302; Nouira S, 2009, ANN EMERG MED, V53, P373, DOI 10.1016/j.annemergmed.2008.06.005; Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898; Ozeren A, 2006, EUR J NEUROL, V13, P611, DOI 10.1111/j.1468-1331.2006.01296.x; POUNGVARIN N, 1991, BRIT MED J, V302, P1565, DOI 10.1136/bmj.302.6792.1565; SANDERCOCK P, 1985, BRIT MED J, V290, P193, DOI 10.1136/bmj.290.6463.193; Sivasampu S, 2011, NATL HEALTHCARE ESTA, P5; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; WEIR CJ, 1994, LANCET, V344, P999, DOI 10.1016/S0140-6736(94)91648-9; Whitfield PC, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001697, DOI 10.1002/14651858.CD001697]	35	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165330	10.1371/journal.pone.0165330	http://dx.doi.org/10.1371/journal.pone.0165330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768752	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400079
J	Lu, Q; Wang, JH; Jiang, JS; Wang, SN; Jia, QL; Wang, Y; Li, WP; Zhou, Q; Lv, L; Li, QW				Lu, Qian; Wang, Jihong; Jiang, Junshu; Wang, Shengnan; Jia, Qilan; Wang, Yue; Li, Weiping; Zhou, Qin; Lv, Li; Li, Qingwei			rLj-RGD3, a Novel Recombinant Toxin Protein from Lampetra japonica, Protects against Cerebral Reperfusion Injury Following Middle Cerebral Artery Occlusion Involving the Integrin-PI3K/Akt Pathway in Rats	PLOS ONE			English	Article							FOCAL ADHESION; INTEGRIN; GROWTH; ACTIVATION; APOPTOSIS; CELLS; FIBRONECTIN; MOLECULES; PEPTIDES; PENUMBRA	Background The RGD-toxin protein Lj-RGD3 is a naturally occurring 118 amino acid peptide that can be obtained from the salivary gland of the Lampetra japonica fish. This unique peptide contains 3 RGD (Arg-Gly-Asp) motifs in its primary structure. Lj-RGD3 is available in recombinant form (rLj-RGD3) and can be produced in large quantities using DNA recombination techniques. The pharmacology of the three RGD motif-containing peptides has not been studied. This study investigated the protective effects of rLj-RGD3, a novel polypeptide, against ischemia/reperfusion-induced damage to the brain caused by middle cerebral artery occlusion (MCAO) in a rat stroke model. We also explored the mechanism by which rLj-RGD3 acts by measuring protein and mRNA expression levels, with an emphasis on the FAK and integrin-PI3K/Akt anti-apoptosis pathways. Methods rLj-RGD3 was obtained from the buccal secretions of Lampetra japonica using gene recombination technology. Sprague Dawley (SD) rats were randomly divided into the following seven groups: a sham group; a vehicle-treated (VT) group; 100.0 mu g.kg(-1), 50.0 mu g.kg(-1) and 25.0 mu g.kg(-1) dose rLj-RGD3 groups; and two positive controls, including 1.5 mg.kg(-1) Edaravone (ED) and 100.0 mu g.kg(-1) Eptifibatide (EP). MCAO was induced using a model consisting of 2 h of ischemia and 24 h of reperfusion. Behavioral changes were observed in the normal and operation groups after focal cerebral ischemia/reperfusion was applied. In addition, behavioral scores were evaluated at 4 and 24 h after reperfusion. Brain infarct volumes were determined based on 2,3,5-triphenyltetrazolium chloride (TTC) staining. Pathological changes in brain tissues were observed using hematoxylin and eosin (H&E) staining. Moreover, neuronal apoptosis was detected using terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling (TUNEL) assays. We determined the expression levels of focal adhesion kinase (FAK), phosphatidyl inositol 3-kinase (PI3K), protein kinase B (Akt, PKB), caspase-3 and Bcl-2 in the brain using western blot analysis and RT-PCR assays. The research protocol was approved by the Institutional Ethics Committee of Dalian Medical University. Results The behavioral scores and cerebral infarct volumes of the rLj-RGD3 groups were markedly lower at 4 and 24 h/RF. The rLj-RGD3 protein significantly ameliorated pathological changes in the brain and reduced the number of apoptotic neurons. Furthermore, the FAK and PI3K/Akt pathways were activated. rLj-RGD3 significantly increased the expression of FAK, p-FAK and Bcl-2 proteins. In contrast, caspase-3 expression was inhibited. Conclusion/Significance We conclude that recombinant Lampetra japonica RGD-peptide (rLj-RGD3) exerts a protective effect against cerebral ischemia/reperfusion injury in the brain. In addition, the mechanism of this protection is associated with the activation of the integrin-PI3K/Akt pathway. These results provide a theoretical foundation and an experimental basis for using RGD peptides as novel drugs for treating ischemic cerebral vascular diseases in addition to promoting the research and development of marine biotechnology drugs.	[Lu, Qian; Jiang, Junshu; Wang, Shengnan; Jia, Qilan; Wang, Yue; Li, Weiping; Zhou, Qin; Lv, Li] Dalian Med Univ, Dept Pharmacol, Dalian 116044, Liaoning Provin, Peoples R China; [Wang, Jihong; Lv, Li; Li, Qingwei] Liaoning Normal Univ, Sch Life Sci, Dalian 116029, Liaoning Provin, Peoples R China; [Wang, Jihong; Li, Qingwei] Key Lab Biotechnol & Drug Discovery Liaoning Prov, Dalian 116029, Liaoning Provin, Peoples R China; [Lu, Qian] Jilin Med Coll, Coll Basic Med, Jilin 132013, Jilin Province, Peoples R China	Dalian Medical University; Liaoning Normal University; Jilin Medical University	Lv, L (corresponding author), Dalian Med Univ, Dept Pharmacol, Dalian 116044, Liaoning Provin, Peoples R China.; Lv, L; Li, QW (corresponding author), Liaoning Normal Univ, Sch Life Sci, Dalian 116029, Liaoning Provin, Peoples R China.; Li, QW (corresponding author), Key Lab Biotechnol & Drug Discovery Liaoning Prov, Dalian 116029, Liaoning Provin, Peoples R China.	lv_li@126.com; liqw@263.net	Li, Weiming/D-9615-2013	Li, Weiming/0000-0001-5437-1518	Chinese National Natural Science Foundation [81173641, 81202455]; Chinese Marine Public Welfare Industry Special Research Project Foundation [201305016]; Liaoning Normal University	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Marine Public Welfare Industry Special Research Project Foundation; Liaoning Normal University	This work was supported by grants provided by the Chinese National Natural Science Foundation (No. 81173641 and 81202455), and by the Chinese Marine Public Welfare Industry Special Research Project Foundation (No. 201305016). The funders had no role in study design, data Collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the teachers and students at the Department of Pharmacology at Dalian Medical University for their assistance. In addition, we would like to thank Liaoning Normal University for its support.	BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Chen J, 1997, J CEREBR BLOOD F MET, V17, P2, DOI 10.1097/00004647-199701000-00002; Chopp M, 1996, J CEREBR BLOOD F MET, V16, P578, DOI 10.1097/00004647-199607000-00007; Courter D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009633; Edelman JM, 1995, PRINCIPLES CELL ADHE, P163; Fleming JC, 2008, EXP NEUROL, V214, P147, DOI 10.1016/j.expneurol.2008.04.024; Giannelli G, 2001, LAB INVEST, V81, P613, DOI 10.1038/labinvest.3780270; Hankey GJ, 1999, LANCET, V354, P1457, DOI 10.1016/S0140-6736(99)04407-4; HAYMAN EG, 1985, J CELL BIOL, V100, P1948, DOI 10.1083/jcb.100.6.1948; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Joo SJ, 2012, KOREAN CIRC J, V42, P295, DOI 10.4070/kcj.2012.42.5.295; KAY R, 1992, NEUROLOGY, V42, P985, DOI 10.1212/WNL.42.5.985; Kontos HA, 1985, CIRC RES, V57; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; Lemons ML, 2006, EXP NEUROL, V202, P324, DOI 10.1016/j.expneurol.2006.06.008; Lemons ML, 2008, EXP NEUROL, V209, P343, DOI 10.1016/j.expneurol.2007.05.027; Li N, 2011, NANOMED-NANOTECHNOL, V7, P403, DOI 10.1016/j.nano.2011.01.005; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lwrence Ms, 1996, NEUROSCIENCE, V6, P394; MEMEZAWA H, 1992, EXP BRAIN RES, V89, P67; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Namura S, 1998, J NEUROSCI, V18, P3659; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Schlomann U, 2009, J CELL SCI, V122, P2034, DOI 10.1242/jcs.038232; Tateishi U, 2012, CURR MED CHEM, V19, P3301, DOI 10.2174/092986712801215937; Wang JH, 2010, BIOCHIMIE, V92, P1387, DOI 10.1016/j.biochi.2010.07.001; William J, 1986, J NEUROSCI, V6, P3144; Woo S, 2009, J NEUROSCI, V29, P13981, DOI 10.1523/JNEUROSCI.4028-09.2009; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Zhou B, 2012, BIOSENS BIOELECTRON, V38, P389, DOI 10.1016/j.bios.2012.06.040	35	6	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165093	10.1371/journal.pone.0165093	http://dx.doi.org/10.1371/journal.pone.0165093			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768719	Green Submitted, Green Published, gold			2022-12-26	WOS:000386205400049
J	Rombaut, C; Faes, K; Goossens, E				Rombaut, Charlotte; Faes, Katrien; Goossens, Ellen			The Effect of a Unilateral Orchiectomy before Gonadotoxic Treatment on the Contralateral Testis in Adult and Prepubertal Rats	PLOS ONE			English	Article							GERM-CELL TRANSPLANTATION; SEMEN QUALITY; FERTILITY PRESERVATION; ENDOCRINE PARAMETERS; TESTICULAR TISSUE; CANCER; CHEMOTHERAPY; MEN; SPERMATOGENESIS; RECOVERY	Purpose Previous studies have shown that the removal of one testis leads to a compensatory mechanism in the contralateral one, but this was species and age dependent. The aim of this study was to check whether this compensation would still occur after the combination of a unilateral orchiectomy and gonadotoxic treatment, since this resembles the clinical situation of patients who have to undergo highly toxic cancer treatment and therefore choose to cryopreserve a testicular biopsy for fertility restoration purposes. Materials & Methods Sprague Dawley rats underwent either unilateral orchiectomy, gonadotoxic busulfan treatment, the combination of both or served as fertile control. A comparison of the compensatory effects was made between adult and prepubertal treated rats. Mating experiments were performed, testosterone levels were followed-up, testicular weight was recorded and histology was analysed. Results Adult treated rats were able to restore fertility spontaneously in all treatment groups. On the other hand, 30% of the rats that underwent a unilateral orchiectomy and gonadotoxic treatment at prepubertal age showed hampered spermatogenesis, low testosterone levels, decreased testicular weights and were not able to reproduce. Conclusion This study emphasizes the need of fertility preservation strategies in prepubertal patients before gonadotoxic interventions.	[Rombaut, Charlotte; Faes, Katrien; Goossens, Ellen] Vrije Univ Brussel, Res Lab Reprod Genet & Regenerat Med, Biol Testis, Brussels, Belgium	Vrije Universiteit Brussel	Rombaut, C (corresponding author), Vrije Univ Brussel, Res Lab Reprod Genet & Regenerat Med, Biol Testis, Brussels, Belgium.	charlotte.rombaut@vub.ac.be	Goossens, Ellen/N-8701-2015; Goossens, Ellen/K-8178-2019	Goossens, Ellen/0000-0001-7601-9689; 	Vrije Universiteit Brussel	Vrije Universiteit Brussel	This work was supported by funding obtained through research grants from Vrije Universiteit Brussel to E. Goossens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGEE J, 1988, ARCH ANDROLOGY, V20, P1; Amann R.P., 1970, TESTIS, V1, P433, DOI DOI 10.1016/B978-0-12-386601-1.50013-5; Apperley J, 2009, J NATL COMPR CANC NE, V7, P1050, DOI 10.6004/jnccn.2009.0069; Arkoun B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116660; ASH P, 1980, BRIT J RADIOL, V53, P271, DOI 10.1259/0007-1285-53-628-271; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Caires K, 2010, J ENDOCRINOL, V205, P133, DOI 10.1677/JOE-09-0275; Dere E, 2013, FERTIL STERIL, V100, P1192, DOI 10.1016/j.fertnstert.2013.09.017; Ginsberg J. P., 2012, ONCOFERTILITY MED PR, P15; Ginsberg JP, 2005, SURVIVORS CHILDHOOD, P215; HANSEN PV, 1993, EUR UROL, V23, P153; HUCKINS C, 1971, ANAT REC, V169, P533, DOI 10.1002/ar.1091690306; Irkilata HC, 2012, INT UROL NEPHROL, V44, P1617, DOI 10.1007/s11255-012-0256-3; Jacobsen KD, 2001, J UROLOGY, V165, P93, DOI 10.1097/00005392-200101000-00023; Jahnukainen K, 2012, CANCER RES, V72, P5174, DOI 10.1158/0008-5472.CAN-12-1317; Jahnukainen K, 2011, HUM REPROD, V26, P1945, DOI 10.1093/humrep/der160; Jahnukainen K, 2011, BEST PRACT RES CL EN, V25, P287, DOI 10.1016/j.beem.2010.09.007; Jiang FX, 1998, ANAT EMBRYOL, V198, P53, DOI 10.1007/s004290050164; LEE VWK, 1975, J REPROD FERTIL, V42, P121, DOI 10.1530/jrf.0.0420121; Lin WW, 1998, J UROLOGY, V159, P841, DOI 10.1016/S0022-5347(01)63748-0; Maselli J, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110759; NOLLER DW, 1977, FERTIL STERIL, V28, P168; Nurmio M, 2007, INT J ANDROL, V30, P366, DOI 10.1111/j.1365-2605.2007.00755.x; Nurmio Mirja, 2012, Spermatogenesis, V2, P79; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Ogawa T, 1999, TISSUE CELL, V31, P461, DOI 10.1054/tice.1999.0060; Petersen PM, 1999, J UROLOGY, V161, P822, DOI 10.1016/S0022-5347(01)61781-6; Sanefuji T, 1988, Hinyokika Kiyo, V34, P585; THOMPSON TL, 1993, BIOL REPROD, V48, P952, DOI 10.1095/biolreprod48.5.952; Van Saen D, 2009, FERTIL STERIL, V91, P2264, DOI 10.1016/j.fertnstert.2008.02.100; Wallace WHB, 2005, LANCET ONCOL, V6, P209, DOI 10.1016/S1470-2045(05)70092-9; Wen Yan-Lin, 2013, Zhonghua Nan Ke Xue, V19, P604; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Wyns C, 2010, FACTS VIEWS VIS OBGY, V2, P88	34	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164922	10.1371/journal.pone.0164922	http://dx.doi.org/10.1371/journal.pone.0164922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768736	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400038
J	Si, Y; Zhang, Y; Han, L; Chen, LH; Xu, YJ; Sun, F; Ji, MH; Yang, JJ; Bao, HG				Si, Yanna; Zhang, Yuan; Han, Liu; Chen, Lihai; Xu, Yajie; Sun, Fan; Ji, Muhuo; Yang, Jianjun; Bao, Hongguang			Dexmedetomidine Acts via the JAK2/STAT3 Pathway to Attenuate Isoflurane-Induced Neurocognitive Deficits in Senile Mice	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; NEUROTROPHIC FACTOR EXPRESSION; NITROUS OXIDE ANESTHESIA; TRAUMATIC BRAIN-INJURY; MEMORY IMPAIRMENT; MITOCHONDRIAL MECHANISMS; AMBULATORY ANESTHESIA; DESFLURANE ANESTHESIA; POSTNATAL MEMORY; MOUSE MODEL	Background Previous studies showed that isoflurane-induced cognitive deficits could be alleviated by dexmedetomidine in young animal subjects. In the current study, we examine whether dexmedetomidine could also alleviate isoflurane-induced cognitive deficits in senile animals. Methods Senile male C57BL/6 mice (20 months) received dexmedetomidine (50 mu g/kg, i.p.) or vehicle 30 minutes prior to isoflurane exposure (1.3% for 4 h). Cognitive function was assessed 19 days later using a 5-day testing regimen with Morris water maze. Some subjects also received pretreatment with alpha 2 adrenoreceptor antagonist atipamezole (250 mu g/kg, i.p.), JAK2 inhibitor AG490 (15 mg/kg i.p.) or STAT3 inhibitor WP1066 (40 mg/kg i.p.) 30 minutes prior to dexmedetomidine. Results Isoflurane exposure increased and reduced the time spent in the quadrant containing the target platform in training sessions. The number of crossings over the original target quadrant was also decreased. Dexmedotomidine attenuated such effects. Effects of dexmedotomidine were reduced by pretreatment with atipamezole, AG490 and WP1066. Increased phosphorylation of JAK2 and STAT3 in the hippocampus induced by isoflurane was augmented by dexmedetomidine. Effects of dexmedetomidine on JAK2/STAT3 phosphorylation were attenuated by atipamezole, AG490 and WP1066. Isoflurane promoted neuronal apoptosis and increased the expression of cleaved caspase-3 and BAD, and reduced Bcl-2 expression. Attenuation of such effects by dexmedotomidine was partially blocked by atipamezole, AG490 and WP1066. Conclusion Dexmedetomidine could protect against isoflurane-induced spatial learning and memory impairment in senile mice by stimulating the JAK2/STAT3 signaling pathway. Such findings encourage the use of dexmedetomidine in geriatric patients receiving isoflurane anesthesia.	[Si, Yanna; Zhang, Yuan; Han, Liu; Chen, Lihai; Xu, Yajie; Sun, Fan; Bao, Hongguang] Nanjing Med Univ, Nanjing Hosp 1, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China; [Ji, Muhuo; Yang, Jianjun] Southeast Univ, Sch Med, Zhongda Hosp, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China; [Ji, Muhuo; Yang, Jianjun] Xuzhou Med Coll, Coll Anesthesiol, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China; Xuzhou Medical University	Bao, HG (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China.	hongguang_bao@hotmail.com	Yang, Jianjun/AAN-4960-2021		Medical Development Project of Nanjing Science Committee [YKK12085]; National Natural Science Foundation of China [81401620]; Jiangsu Provincial Special Program of Medical Science [BL2014012]	Medical Development Project of Nanjing Science Committee; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Special Program of Medical Science	This work was supported by grants to YNS from the Medical Development Project of Nanjing Science Committee (YKK12085) and the National Natural Science Foundation of China (81401620), and grant to HGB from Jiangsu Provincial Special Program of Medical Science (BL2014012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants to YNS from the Medical Development Project of Nanjing Science Committee (YKK12085) and the National Natural Science Foundation of China (81401620), and grant to HGB from Jiangsu Provincial Special Program of Medical Science (BL2014012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R, 2013, BRIT J ANAESTH, V111, P703, DOI 10.1093/bja/aet194; Alonzi T, 2001, MOL CELL NEUROSCI, V18, P270, DOI 10.1006/mcne.2001.1018; BEDFORD PD, 1955, LANCET, V2, P259; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; Callaway JK, 2015, J ALZHEIMERS DIS, V44, P995, DOI 10.3233/JAD-132444; Cao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051431; Chen JJ, 2013, EXP THER MED, V5, P489, DOI 10.3892/etm.2012.811; Chen WJ, 2015, INT J CLIN EXP MED, V8, P4601; Chiba T, 2009, MOL PSYCHIATR, V14, P206, DOI 10.1038/mp.2008.105; Chiba T, 2009, EXPERT OPIN THER TAR, V13, P1155, DOI 10.1517/14728220903213426; Culley DJ, 2004, ANESTH ANALG, V99, P1393, DOI 10.1213/01.ANE.0000135408.14319.CC; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Darcet F, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00136; Engelhard K, 2003, ANESTH ANALG, V96, P524, DOI 10.1097/00000539-200302000-00041; Fiskum G, 2003, ANN NY ACAD SCI, V991, P111; Gerlai R, 2002, NEUROPHARMACOLOGY, V43, P235, DOI 10.1016/S0028-3908(02)00078-3; Guo ZH, 2008, J BIOL CHEM, V283, P1754, DOI 10.1074/jbc.M703753200; Hwang L, 2013, INT J MOL MED, V31, P1047, DOI 10.3892/ijmm.2013.1301; Izquierdo I, 1999, BEHAV BRAIN RES, V103, P1, DOI 10.1016/S0166-4328(99)00036-4; Kong FJ, 2012, BIOCHEM PHARMACOL, V84, P558, DOI 10.1016/j.bcp.2012.06.001; Kong FJ, 2011, EUR J PHARMACOL, V670, P168, DOI 10.1016/j.ejphar.2011.08.050; Lee B, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-338; Lee BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105340; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li XM, 2014, J MOL NEUROSCI, V52, P286, DOI 10.1007/s12031-013-0141-2; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Li YJ, 2013, NEUROSCI LETT, V545, P17, DOI 10.1016/j.neulet.2013.04.008; Liang G, 2008, ANESTH ANALG, V106, P492, DOI 10.1213/ane.0b013e3181605b71; Lin DW, 2012, BEHAV BRAIN RES, V228, P319, DOI 10.1016/j.bbr.2011.12.010; Lindqvist M, 2014, ACTA ANAESTH SCAND, V58, P1111, DOI 10.1111/aas.12381; Ma DQ, 2004, EUR J PHARMACOL, V502, P87, DOI 10.1016/j.ejphar.2004.08.044; Mahajan VA, 2007, EUR J ANAESTH, V24, P505, DOI 10.1017/S0265021506001980; Makkar JK, 2016, ANAESTHESIA, V71, P50, DOI 10.1111/anae.13230; Mason SE, 2010, J ALZHEIMERS DIS, V22, pS67, DOI 10.3233/JAD-2010-101086; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Negoro S, 2000, CARDIOVASC RES, V47, P797, DOI 10.1016/S0008-6363(00)00138-3; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Ren XY, 2016, J NEUROIMMUNE PHARM, V11, P238, DOI 10.1007/s11481-016-9658-9; Sanders RD, 2010, ACTA ANAESTH SCAND, V54, P710, DOI 10.1111/j.1399-6576.2009.02177.x; Sanders RD, 2009, ANESTHESIOLOGY, V110, P1077, DOI 10.1097/ALN.0b013e31819daedd; Shyu WC, 2008, J CLIN INVEST, V118, P133, DOI 10.1172/JCI32723; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Tramullas M, 2008, NEUROPHARMACOLOGY, V54, P640, DOI 10.1016/j.neuropharm.2007.11.018; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Uchimoto K, 2014, ANESTHESIOLOGY, V121, P302, DOI 10.1097/ALN.0000000000000269; Wang YJ, 2016, MOL MED REP, V14, P769, DOI 10.3892/mmr.2016.5321; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Yang H, 2008, ANESTHESIOLOGY, V109, P243, DOI 10.1097/ALN.0b013e31817f5c47; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Zhang F, 2014, EXP THER MED, V8, P471, DOI 10.3892/etm.2014.1769; Zhang Q, 2012, CHINESE MED J-PEKING, V125, P2455, DOI 10.3760/cma.j.issn.0366-6999.2012.14.011; Zhang Y, 2003, J NEUROCHEM, V87, P1184, DOI 10.1046/j.1471-4159.2003.02105.x; Zhang YY, 2012, ANN NEUROL, V71, P687, DOI 10.1002/ana.23536; Zhang ZH, 2014, BRAIN RES, V1563, P72, DOI 10.1016/j.brainres.2014.03.036; Zhao H, 2003, J NEUROCHEM, V85, P1026, DOI 10.1046/j.1471-4159.2003.01756.x; Zhou TF, 2013, J SURG RES, V183, P304, DOI 10.1016/j.jss.2012.11.035	58	21	22	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164763	10.1371/journal.pone.0164763	http://dx.doi.org/10.1371/journal.pone.0164763			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768775	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400027
J	Curtis, SA; Danda, N; Etzion, Z; Cohen, HW; Billett, HH				Curtis, Susanna A.; Danda, Neeraja; Etzion, Zipora; Cohen, Hillel W.; Billett, Henny H.			Longitudinal Analysis of Patient Specific Predictors for Mortality in Sickle Cell Disease	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; ALPHA-THALASSEMIA; IMPROVED SURVIVAL; GENE-THERAPY; ANEMIA; CHILDREN; HEMATOLOGY; COHORT; ADULTS; DEATH	Introduction White Blood Cell (WBC) count, %HbF, and serum creatinine (Cr), have been identified as markers for increased mortality in sickle cell anemia (SCA) but no studies have examined the significance of longitudinal rate of change in these or other biomarkers for SCA individuals. Methods Clinical, demographic and laboratory data from SCA patients seen in 2002 by our hospital system were obtained. Those who were still followed in 2012 (survival cohort) were compared to those who had died in the interim (mortality cohort). Patients lost to follow-up were excluded. Age adjusted multivariable Cox proportional hazards models were constructed to assess hazard ratios of mortality risk associated with the direction and degree of change for each variable. Results 359 SCA patients were identified. Baseline higher levels of WBC, serum creatinine and hospital admissions were associated with increased mortality, as were alkaline phosphatase and aspartate aminotransaminase levels. Lower baseline levels of %HbF were also associated with increased mortality. When longitudinal rates of change for individuals were assessed, increases in Hb or WBC over patient baseline values were associated with greater mortality risk (HR 1.54, p = 0.02 and HR 1.16, p = 0.01 with negative predictive values of 87.8 and 94.4 respectively), while increasing ED use was associated with decreased mortality (HR 0.84, p = 0.01). We did not detect any increased mortality risk for longitudinal changes in annual clinic visits or admissions, creatinine or %HbF. Conclusions Although initial steady state observations can help predict survival in SCA, the longitudinal course of a patient may give additional prognostic information.	[Curtis, Susanna A.] Yale New Haven Med Ctr, Dept Med Oncol & Hematol, New Haven, CT 06510 USA; [Danda, Neeraja; Etzion, Zipora; Billett, Henny H.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med & Oncol, Div Hematol, Bronx, NY 10467 USA; [Cohen, Hillel W.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	Yale University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Curtis, SA (corresponding author), Yale New Haven Med Ctr, Dept Med Oncol & Hematol, New Haven, CT 06510 USA.	Susanna.curtis@yale.edu		Curtis, Susanna/0000-0002-2281-0843	CTSA from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1 RR025750, KL2 RR025749, TL1 RR025748]; NIH roadmap for Medical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER	CTSA from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This publication was supported in part by the CTSA Grant UL1 RR025750, KL2 RR025749 and TL1 RR025748 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessary represent the official view of the NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anatonic L D., 1973, ANATONIC LESIONS SIC; Baldwin K, 2015, STEM CELLS, V33, P1532, DOI 10.1002/stem.1957; Darbari DS, 2006, AM J HEMATOL, V81, P858, DOI 10.1002/ajh.20685; Darbari DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079923; Duits AJ, 1996, CLIN IMMUNOL IMMUNOP, V81, P96, DOI 10.1006/clin.1996.0163; Elmariah H, 2014, AM J HEMATOL, V89, P530, DOI 10.1002/ajh.23683; EMBURY SH, 1982, NEW ENGL J MED, V306, P270, DOI 10.1056/NEJM198202043060504; Epstein K, 2006, J NATL MED ASSOC, V98, P1109; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Gladwin MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099489; Hankins J, 2007, PEDIATR BLOOD CANCER, V48, P705, DOI 10.1002/pbc.20903; HAYES RJ, 1985, BRIT J HAEMATOL, V59, P369, DOI 10.1111/j.1365-2141.1985.tb03002.x; Kato GJ, 2005, BRIT J HAEMATOL, V130, P943, DOI 10.1111/j.1365-2141.2005.05701.x; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Khoury R, 2011, EXPERT REV HEMATOL, V4, P343, DOI [10.1586/EHM.11.23, 10.1586/ehm.11.23]; Lee A, 1995, BRIT MED J, V311, P1600, DOI 10.1136/bmj.311.7020.1600; McKerrell TDH, 2004, AM J HEMATOL, V76, P101, DOI 10.1002/ajh.20075; MEARS JG, 1983, BLOOD, V62, P286; Mehari A, 2013, AM J RESP CRIT CARE, V187, P840, DOI 10.1164/rccm.201207-1222OC; MORRIS J, 1991, BRIT J HAEMATOL, V77, P382, DOI 10.1111/j.1365-2141.1991.tb08588.x; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; Quinn CT, 2010, BLOOD, V115, P3447, DOI 10.1182/blood-2009-07-233700; Serjeant GR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011783; Shankar SM, 2005, AM J HEMATOL, V80, P262, DOI 10.1002/ajh.20485; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; STEINBERG MH, 1995, BLOOD, V86, P3997, DOI 10.1182/blood.V86.10.3997.bloodjournal86103997; Williams SN, 2014, LUNG, V192, P385, DOI 10.1007/s00408-014-9572-y; Wun Ted, 2001, Hematology, V5, P403; Yusuf HR, 2010, AM J PREV MED, V38, pS536, DOI 10.1016/j.amepre.2010.01.001	31	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164743	10.1371/journal.pone.0164743	http://dx.doi.org/10.1371/journal.pone.0164743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764159	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500055
J	Schneidereit, D; Vass, H; Reischl, B; Allen, RJ; Friedrich, O				Schneidereit, D.; Vass, H.; Reischl, B.; Allen, R. J.; Friedrich, O.			Calcium Sensitive Fluorescent Dyes Fluo-4 and Fura Red under Pressure: Behaviour of Fluorescence and Buffer Properties under Hydrostatic Pressures up to 200 MPa	PLOS ONE			English	Article							PROTEIN STABILITY; SKELETAL-MUSCLE; LIVING CELLS; MICROSCOPY; IONIZATION; DEPENDENCE; CA2+	The fluorescent Ca2+ sensitive dyes Fura Red (ratiometric) and Fluo-4 (non-ratiometric) are widely utilized for the optical assessment of Ca2+ fluctuations in vitro as well as in situ. The fluorescent behavior of these dyes is strongly depends on temperature, pH, ionic strength and pressure. It is crucial to understand the response of these dyes to pressure when applying calcium imaging technologies in the field of high pressure bioscience. Therefore, we use an optically accessible pressure vessel to pressurize physiological Ca2+-buffered solutions at different fixed concentrations of free Ca2+ (1 nM to 25.6 mu M) and a specified dye concentration (12 mu M) to pressures of 200 MPa, and record dye fluorescence intensity. Our results show that Fluo-4 fluorescence intensity is reduced by 31% per 100 MPa, the intensity of Fura Red is reduced by 10% per 100 MPa. The mean reaction volume for the dissociation of calcium from the dye molecules Delta(d (v) over bar) is determined to -17.8 ml mol(-1) for Fluo-4 and -21.3 ml mol(-1) for Fura Red. Additionally, a model is presented that is used to correct for pressure-dependent changes in pH and binding affinity of Ca2+ to EGTA, as well as to determine the influence of these changes on dye fluorescence.	[Schneidereit, D.; Reischl, B.; Friedrich, O.] Univ Erlangen Nurnberg, Inst Med Biotechnol, D-91052 Erlangen, Bavaria, Germany; [Vass, H.; Allen, R. J.] Univ Edinburgh, Sch Phys & Astron, Edinburgh EH9 3FD, Midlothian, Scotland; [Schneidereit, D.; Friedrich, O.] Univ Erlangen Nurnberg, Erlangen Grad Sch Adv Opt Technol SAOT, D-91052 Erlangen, Bavaria, Germany	University of Erlangen Nuremberg; University of Edinburgh; University of Erlangen Nuremberg	Schneidereit, D (corresponding author), Univ Erlangen Nurnberg, Inst Med Biotechnol, D-91052 Erlangen, Bavaria, Germany.; Schneidereit, D (corresponding author), Univ Erlangen Nurnberg, Erlangen Grad Sch Adv Opt Technol SAOT, D-91052 Erlangen, Bavaria, Germany.	dominik.schneidereit@fau.de	Allen, Rosalind/M-5222-2017; Allen, Rosalind/M-5222-2017	Allen, Rosalind/0000-0003-4110-2962; Friedrich, Oliver/0000-0003-2238-2049; Allen, Rosalind/0000-0003-3163-6354	Deutsche Forschungsgemeinschaft [FR2993/16-1]; Royal Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Royal Society(Royal Society of London)	This work was funded by a grant from the Deutsche Forschungsgemeinschaft (FR2993/16-1) to OF who was involved in study design, decision to publish and preparation of the manuscript. A University Research Fellowship by the Royal Society has been granted to RJA who was involved in data collection and analysis, decision to publish and preparation of the manuscript.	Besch SR, 1996, UNDERSEA HYPERBAR M, V23, P175; Bootman Martin D, 2013, Cold Spring Harb Protoc, V2013, P83, DOI 10.1101/pdb.top066050; Bruton JD, 2012, ADV EXP MED BIOL, V740, P27, DOI 10.1007/978-94-007-2888-2_2; Crenshaw HC, 1996, EXP CELL RES, V227, P277, DOI 10.1006/excr.1996.0277; Friedrich O, 2006, UNDERSEA HYPERBAR M, V33, P181; Friedrich O, 2014, J CELL MOL MED, V18, P1851, DOI 10.1111/jcmm.12313; Friedrich O, 2010, COMP HIH PRESSURE BI; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; Hartmann M, 2004, CELL MOL BIOL, V50, P479; HASSELBACH W, 1987, Z NATURFORSCH C, V42, P641; JAENICKE R, 1991, EUR J BIOCHEM, V202, P715, DOI 10.1111/j.1432-1033.1991.tb16426.x; KITAMURA Y, 1987, J SOLUTION CHEM, V16, P715, DOI 10.1007/BF00652574; KUREBAYASHI N, 1993, BIOPHYS J, V64, P1934, DOI 10.1016/S0006-3495(93)81564-9; Lohr C, 2003, CELL CALCIUM, V34, P295, DOI 10.1016/S0143-4160(03)00105-2; Meersman F, 2006, BBA-PROTEINS PROTEOM, V1764, P346, DOI 10.1016/j.bbapap.2005.11.019; NEUMAN RC, 1973, J PHYS CHEM-US, V77, P2687, DOI 10.1021/j100640a025; Patton C, 1999, WINMAXC VERSION 2 0; Quinlan RJ, 2005, ANAL BIOCHEM, V341, P69, DOI 10.1016/j.ab.2005.03.002; Rohrbach P, 2005, J BIOL CHEM, V280, P27960, DOI 10.1074/jbc.M500777200; Ryan J, 2012, ANAL METHODS-UK, V4, P80, DOI 10.1039/c1ay05486d; Smith RM, 2003, NIST STANDARD REFERE; Taulier N, 2002, BBA-PROTEIN STRUCT M, V1595, P48, DOI 10.1016/S0167-4838(01)00334-X; Vass H, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802202; Vass H, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3427224; VERJOVSKIALMEIDA S, 1986, J BIOL CHEM, V261, P9872; Winter R, 2005, PHILOS T R SOC A, V363, P537, DOI 10.1098/rsta.2004.1507; Yu SP, 2001, CURR OPIN CELL BIOL, V13, P405, DOI 10.1016/S0955-0674(00)00228-3	27	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164509	10.1371/journal.pone.0164509	http://dx.doi.org/10.1371/journal.pone.0164509			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764134	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204500038
J	Shu, JJ; Teo, JBM; Chan, WK				Shu, Jian-Jun; Teo, Ji Bin Melvin; Chan, Weng Kong			A New Model for Temperature Jump at a Fluid-Solid Interface	PLOS ONE			English	Article								The problem presented involves the development of a new analytical model for the general fluid-solid temperature jump. To the best of our knowledge, there are no analytical models that provide the accurate predictions of the temperature jump for both gas and liquid systems. In this paper, a unified model for the fluid-solid temperature jump has been developed based on our adsorption model of the interfacial interactions. Results obtained from this model are validated with available results from the literature.	[Shu, Jian-Jun; Teo, Ji Bin Melvin; Chan, Weng Kong] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Shu, JJ (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.	mjjshu@ntu.edu.sg	Shu, Jian-Jun/A-3828-2011; Chan, Weng Kong/A-3825-2011					Acharya H, 2012, IND ENG CHEM RES, V51, P1767, DOI 10.1021/ie2010274; [Anonymous], 1959, J BASIC ENG-T ASME, DOI DOI 10.1115/1.4008375; Dadzie SK, 2005, PHYSICA A, V358, P328, DOI 10.1016/j.physa.2005.04.013; Deissler R., 1964, INT J HEAT MASS TRAN, V7, P681; Ge ZB, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.186101; HALL ROA, 1987, NUCL ENG DES, V101, P249, DOI 10.1016/0029-5493(87)90053-7; Hu M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3247882; Kapitza PL, 1941, J PHYS-USSR, V4, P181; Kennard EH, 1954, KINETIC THEORY GASES; Kim BH, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3001926; Lees L., 1960, KINETIC THEORY DESCR; Mazo RM, 1955, THEORETICAL STUDIES; Murad S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2905281; Oura K., 2003, SURFACE SCI INTRO; Shenogina N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.156101; Shu JJ, 2016, SOFT MATTER, V12, P8388, DOI 10.1039/c6sm01178k; Smoluchowski M. V., 1898, ANN PHYS-BERLIN, V300, P101; SWARTZ ET, 1989, REV MOD PHYS, V61, P605, DOI 10.1103/RevModPhys.61.605; Yamaguchi H, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4726059	19	5	5	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165175	10.1371/journal.pone.0165175	http://dx.doi.org/10.1371/journal.pone.0165175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764230	gold, Green Submitted, Green Published			2022-12-26	WOS:000386204500126
J	McGarty, AM; Penpraze, V; Melville, CA				McGarty, Arlene M.; Penpraze, Victoria; Melville, Craig A.			Calibration and Cross-Validation of the ActiGraph wGT3X+Accelerometer for the Estimation of Physical Activity Intensity in Children with Intellectual Disabilities	PLOS ONE			English	Article							ACTIVITY MONITORS; CEREBRAL-PALSY; ENERGY-COST; ACCELEROMETER; YOUTH; GT3X; ADOLESCENTS; GENERATIONS; CHILDHOOD; ADULTHOOD	Background Valid objective measurement is integral to increasing our understanding of physical activity and sedentary behaviours. However, no population-specific cut points have been calibrated for children with intellectual disabilities. Therefore, this study aimed to calibrate and cross validate the first population-specific accelerometer intensity cut points for children with intellectual disabilities. Methods Fifty children with intellectual disabilities were randomly assigned to the calibration (n=36; boys = 28, 9.53 +/- 1.08yrs) or cross-validation (n = 14; boys = 9, 9.57 +/- 1.16yrs) group. Participants completed a semi-structured school-based activity session, which included various activities ranging from sedentary to vigorous intensity. Direct observation (SOFIT tool) was used to calibrate the ActiGraph wGT3X+, which participants wore on the right hip. Receiver Operating Characteristic curve analyses determined the optimal cut points for sedentary, moderate, and vigorous intensity activity for the vertical axis and vector magnitude. Classification agreement was investigated using sensitivity, specificity, total agreement, and Cohen's kappa scores against the criterion measure of SOFIT. Results The optimal (AUC =.87-.94) vertical axis cut points (cpm) were <= 507 (sedentary), 1008-2300 (moderate), and >= 2301 (vigorous), which demonstrated high sensitivity (81-88%) and specificity (81-85%). The optimal (AUC =.86-.92) vector magnitude cut points (cpm) of <= 1863 (sedentary), 2610-4214 (moderate), and >= 4215 (vigorous) demonstrated comparable, albeit marginally lower, accuracy than the vertical axis cut points (sensitivity = 80-86%; specificity = 77-82%). Classification agreement ranged from moderate to almost perfect (kappa =.51-.85) with high sensitivity and specificity, and confirmed the trend that accuracy increased with intensity, and vertical axis cut points provide higher classification agreement than vector magnitude cut points. Conclusions This study provides the first valid methods of interpreting accelerometer output in children with intellectual disabilities. The calibrated physical activity cut points are notably higher than existing cut points, thus raising questions on the validity of previous low physical activity estimates in children with intellectual disabilities that were based on typically developing cut points.	[McGarty, Arlene M.; Melville, Craig A.] Univ Glasgow, Inst Hlth & Wellbeing, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Penpraze, Victoria] Univ Glasgow, Sch Life Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	McGarty, AM (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Arlene.McGarty@glasgow.ac.uk		Melville, Craig/0000-0001-7234-2382; McGarty, Arlene/0000-0003-4937-0574	Scottish Government [166372-01]	Scottish Government	Funded by Scottish Government (grant 166372-01; http://www.gov.scot/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2011, J PEDIATR PSYCHOL, V36, P385, DOI 10.1093/jpepsy/jsq107; Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Baynard T, 2008, MED SCI SPORT EXER, V40, P1984, DOI 10.1249/MSS.0b013e31817f19a1; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; De Decker E, 2013, MED SCI SPORT EXER, V45, P2002, DOI 10.1249/MSS.0b013e318292c575; de Vries SI, 2006, J CLIN EPIDEMIOL, V59, P670, DOI 10.1016/j.jclinepi.2005.11.020; Einarsson IT, 2015, MED SCI SPORT EXER, V47, P411, DOI 10.1249/MSS.0000000000000412; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Falson-Hodge J, 2004, ADAPT PHYS ACT Q, V21, P139, DOI 10.1123/apaq.21.2.139; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Frey GC, 2008, ADAPT PHYS ACT Q, V25, P95, DOI 10.1123/apaq.25.2.95; Hanggi JM, 2013, J SCI MED SPORT, V16, P40, DOI 10.1016/j.jsams.2012.05.012; Hinckson EA, 2013, RES DEV DISABIL, V34, P72, DOI 10.1016/j.ridd.2012.07.022; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Janssen X, 2013, J SCI MED SPORT, V15, pS66; Jimmy G., 2013, SCHWEIZERISCHE Z SPO, V61, P37, DOI [10.7892/boris.41860, DOI 10.7892/BORIS.41860]; Johnston TE, 2004, DEV MED CHILD NEUROL, V46, P34, DOI 10.1017/S0013162204000064; Kim Y, 2012, J SCI MED SPORT, V15, P311, DOI 10.1016/j.jsams.2011.12.001; Krzanowski WJ, 2009, MONOGR STAT APPL PRO, V111, P1; Lante K, 2010, RES DEV DISABIL, V31, P1380, DOI 10.1016/j.ridd.2010.06.022; Mackintosh KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036919; Maiano C, 2011, OBES REV, V12, P189, DOI 10.1111/j.1467-789X.2010.00744.x; Matthews C.E., 2002, PHYS ACTIVITY ASSESS, P107; Mattocks C, 2007, INT J PEDIATR OBES, V2, P218, DOI 10.1080/17477160701408809; McGarty AM, 2014, RES DEV DISABIL, V35, P973, DOI 10.1016/j.ridd.2014.02.009; MCKENZIE TL, 1992, J TEACH PHYS EDUC, V11, P195, DOI 10.1123/jtpe.11.2.195; McKenzie TL, 2009, SYSTEM OBSERVING FIT; Phillips AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028618; Pulsford RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021822; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Ridley K, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-45; Ried-Larsen M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-113; Robusto KM, 2012, J SPORT SCI, V30, P1429, DOI 10.1080/02640414.2012.710761; Romanzini M, 2014, EUR J SPORT SCI, V14, P91, DOI 10.1080/17461391.2012.732614; Rowe P, 2004, J TEACH PHYS EDUC, V23, P235, DOI 10.1123/jtpe.23.3.235; Rowe PJ, 1997, PEDIATR EXERC SCI, V9, P136, DOI 10.1123/pes.9.2.136; Rowlands AV, 2007, PEDIATR EXERC SCI, V19, P252, DOI 10.1123/pes.19.3.252; Sallis JF, 2000, ANN BEHAV MED, V22, P294, DOI 10.1007/BF02895665; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Sirard JR, 2001, SPORTS MED, V31, P439, DOI 10.2165/00007256-200131060-00004; Spruijt-Metz D, 2009, J AM DIET ASSOC, V109, P1058, DOI 10.1016/j.jada.2009.03.013; Staudenmayer J, 2012, MED SCI SPORT EXER, V44, pS61, DOI 10.1249/MSS.0b013e3182399e0f; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; Telama R, 2009, OBESITY FACTS, V2, P187, DOI 10.1159/000222244; Thomas SS, 2011, J PEDIATR REHAB MED, V4, P225, DOI 10.3233/PRM-2011-0178; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Tudor-Locke C, 2015, Int J Obes Suppl, V5, pS53, DOI 10.1038/ijosup.2015.20; Viera AJ, 2005, FAM MED, V37, P360; Welk GJ, 2005, MED SCI SPORT EXER, V37, pS501, DOI 10.1249/01.mss.0000185660.38335.de; ZWEIG MH, 1993, CLIN CHEM, V39, P561	54	22	22	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164928	10.1371/journal.pone.0164928	http://dx.doi.org/10.1371/journal.pone.0164928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760219	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000386204000067
J	Bassiouni, M; Dos Santos, A; Avci, HX; Lowenheim, H; Muller, M				Bassiouni, Mohamed; Dos Santos, Aurelie; Avci, Hasan X.; Loewenheim, Hubert; Mueller, Marcus			Bmi1 Loss in the Organ of Corti Results in p16(ink4a) Upregulation and Reduced Cell Proliferation of Otic Progenitors In Vitro	PLOS ONE			English	Article							MOUSE INNER-EAR; STEM-CELLS; SELF-RENEWAL; HAIR-CELLS; EXPRESSION; MICE; SENESCENCE; POLYCOMB; CYCLE; REGENERATION	The mature mammalian organ of Corti does not regenerate spontaneously after injury, mainly due to the absence of cell proliferation and the depletion of otic progenitors with age. The polycomb gene B lymphoma Mo-MLV insertion region 1 homolog (Bmi1) promotes proliferation and cell cycle progression in several stem cell populations. The cell cycle inhibitor p16(ink4a) has been previously identified as a downstream target of Bmi1. In this study, we show that Bmi1 is expressed in the developing inner ear. In the organ of Corti, Bmi1 expression is temporally regulated during embryonic and postnatal development. In contrast, p16(ink4a) expression is not detectable during the same period. Bmi1-deficient mice were used to investigate the role of Bmi1 in cochlear development and otosphere generation. In the absence of Bmi1, the postnatal organ of Corti displayed normal morphology at least until the end of the first postnatal week, suggesting that Bmi1 is not required for the embryonic or early postnatal development of the organ of Corti. However, Bmi1 loss resulted in the reduced sphere-forming capacity of the organ of Corti, accompanied by the decreased cell proliferation of otic progenitors in otosphere cultures. This reduced proliferative capacity was associated with the upregulation of p16(ink4a) in vitro. Viral vector-mediated overexpression of p16(ink4a) in wildtype otosphere cultures significantly reduced the number of generated otospheres in vitro. The findings strongly suggest a role for Bmi1 as a promoter of cell proliferation in otic progenitor cells, potentially through the repression of p16(ink4a).	[Bassiouni, Mohamed; Dos Santos, Aurelie; Avci, Hasan X.; Loewenheim, Hubert; Mueller, Marcus] Univ Tubingen, Dept Otolaryngol Head & Neck Surg, Tubingen Hearing Res Ctr, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Muller, M (corresponding author), Univ Tubingen, Dept Otolaryngol Head & Neck Surg, Tubingen Hearing Res Ctr, Tubingen, Germany.	marcus.mueller@uni-tuebingen.de	Löwenheim, Hubert/GPS-7207-2022	Löwenheim, Hubert/0000-0001-8200-8804; Avci, Hasan/0000-0002-6087-8355				Abdouh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031870; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bhattacharya R, 2015, GENES DIS, V2, P225, DOI 10.1016/j.gendis.2015.04.001; Biehs B, 2013, NAT CELL BIOL, V15, P846, DOI 10.1038/ncb2766; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010; Chatoo W, 2010, STEM CELLS, V28, P1412, DOI 10.1002/stem.462; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; Chen P, 2003, NAT CELL BIOL, V5, P422, DOI 10.1038/ncb976; Chen P, 1999, DEVELOPMENT, V126, P1581; Chen Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.549; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fukuda A, 2012, GASTROENTEROLOGY, V143, P821, DOI 10.1053/j.gastro.2012.05.009; GERDES J, 1984, J IMMUNOL, V133, P1710; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; Hasson T, 1997, CURR OPIN NEUROBIOL, V7, P615, DOI 10.1016/S0959-4388(97)80080-3; He S, 2009, DEV BIOL, V328, P257, DOI 10.1016/j.ydbio.2009.01.020; Hosen N, 2007, STEM CELLS, V25, P1635, DOI 10.1634/stemcells.2006-0229; Hume CR, 2007, GENE EXPR PATTERNS, V7, P798, DOI 10.1016/j.modgep.2007.05.002; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Juan G, 1998, CYTOMETRY, V32, P71, DOI 10.1002/(SICI)1097-0320(19980601)32:2<71::AID-CYTO1>3.0.CO;2-H; Kamijo T, 1997, CELL, P91; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Laine H, 2007, J NEUROSCI, V27, P1434, DOI 10.1523/JNEUROSCI.4956-06.2007; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; Lu XL, 2017, MOL NEUROBIOL, V54, P1326, DOI 10.1007/s12035-016-9686-8; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; QUELLE DE, 1995, ONCOGENE, V11, P635; ROBERSON DW, 1994, AM J OTOL, V15, P28; Ruben R.J., 1967, ACTA OTO-LARYNGOL, DOI DOI 10.3109/00016486709127790; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shen J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav071; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Waldhaus J, 2015, CELL REP, V11, P1385, DOI 10.1016/j.celrep.2015.04.062; Waldhaus J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036066; Warchol ME, 2011, HEARING RES, V273, P72, DOI 10.1016/j.heares.2010.05.004; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Yamasoba T, 2003, NEUROSCI LETT, V347, P171, DOI 10.1016/S0304-3940(03)00675-X; Zine A, 2014, STEM CELLS BIOL REG, P111, DOI 10.1007/978-1-4614-9569-7_6	55	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164579	10.1371/journal.pone.0164579	http://dx.doi.org/10.1371/journal.pone.0164579			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755610	Green Published, Green Submitted, gold			2022-12-26	WOS:000386203800022
J	Kalble, F; Damaske, J; Heide, D; Arnold, I; Richter, F; Maier, O; Eisel, U; Scheurich, P; Pfizenmaier, K; Zeier, M; Schwenger, V; Ranzinger, J				Kaelble, Florian; Damaske, Janine; Heide, Danijela; Arnold, Iris; Richter, Fabian; Maier, Olaf; Eisel, Ulrich; Scheurich, Peter; Pfizenmaier, Klaus; Zeier, Martin; Schwenger, Vedat; Ranzinger, Julia			Selective Blocking of TNF Receptor 1 Attenuates Peritoneal Dialysis Fluid Induced Inflammation of the Peritoneum in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MESOTHELIAL CELLS; HYALURONAN; RESPONSES; FIBROSIS; ANTIBODY; ALPHA	Chronic inflammatory conditions during peritoneal dialysis (PD)-treatment lead to the impairment of peritoneal tissue integrity. The resulting structural and functional reorganization of the peritoneal membrane diminishes ultrafiltration rate and thereby enhances mortality by limiting dialysis effectiveness over time. Tumour necrosis factor (TNF) and its receptors TNFR1 and TNFR2 are key players during inflammatory processes. To date, the role of TNFR1 in peritoneal tissue damage during PD-treatment is completely undefined. In this study, we used an acute PD-mouse model to investigate the role of TNFR1 on structural and morphological changes of the peritoneal membrane. TNFR1-mediated TNF signalling in transgenic mice expressing human TNFR1 was specifically blocked by applying a monoclonal antibody (H398) highly selective for human TNFR1 prior to PD-treatment. Cancer antigen-125 (CA125) plasma concentrations were measured by enzyme-linked immunosorbent assay (ELISA). Western blot analyses were applied to determine TNFR2 protein concentrations. Histological staining of peritoneal tissue sections was performed to assess granulocytes within the peritoneal membrane as well as the content of hyaluronic acid and collagen. We show for the first time that the number of granulocytes within the peritoneal membrane is significantly reduced in mice pre-treated with H398. Moreover, we demonstrate that blocking of TNFR1 not only influences CA125 values but also hyaluronic acid and collagen contents of the peritoneal tissue in these mice. These results strongly suggest that TNFR1 inhibition attenuates peritoneal damage caused by peritoneal dialysis fluid (PDF) and therefore may represent a new therapeutic approach in the treatment of PD-related side effects.	[Kaelble, Florian; Damaske, Janine; Heide, Danijela; Arnold, Iris; Zeier, Martin; Schwenger, Vedat; Ranzinger, Julia] Heidelberg Univ, Dept Nephrol, Heidelberg, Germany; [Richter, Fabian; Maier, Olaf; Scheurich, Peter; Pfizenmaier, Klaus] Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany; [Eisel, Ulrich] Univ Groningen, Groningen Inst Evolutionary Life Sci, Dept Mol Neurobiol, Groningen, Netherlands; [Schwenger, Vedat] Klinikum Stuttgart, Dept Nephrol, Stuttgart, Germany	Ruprecht Karls University Heidelberg; University of Stuttgart; University of Groningen; Klinikum Stuttgart	Ranzinger, J (corresponding author), Heidelberg Univ, Dept Nephrol, Heidelberg, Germany.	julia.ranzinger@gmx.de		Eisel, Ulrich/0000-0003-4178-0384				Cheema H, 2013, PERITON DIALYSIS INT, V33, P349, DOI 10.3747/pdi.2012.00320; Dong Y, 2016, P NATL ACAD SCI USA, V113, P12304, DOI 10.1073/pnas.1605195113; Duerrschmid C, 2013, J MOL CELL CARDIOL, V57, P59, DOI 10.1016/j.yjmcc.2013.01.006; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Grund EM, 2008, MOL PHARMACOL, V73, P1394, DOI 10.1124/mol.107.042176; GRUNFELD C, 1990, ENDOCRINOLOGY, V127, P46, DOI 10.1210/endo-127-1-46; Horiuchi T, 2003, KIDNEY INT, V64, P2280, DOI 10.1046/j.1523-1755.2003.00325.x; Kontermann RE, 2008, J IMMUNOTHER, V31, P225, DOI 10.1097/CJI.0b013e31816a88f9; Krediet RT, 2013, NAT REV NEPHROL, V9, P419, DOI 10.1038/nrneph.2013.99; Krediet RT, 2000, PERITON DIALYSIS INT, V20, pS22; McCann FE, 2014, ARTHRITIS RHEUMATOL, V66, P2728, DOI 10.1002/art.38755; Moosmayer D, 1995, Ther Immunol, V2, P31; Naude PJW, 2011, FEBS J, V278, P888, DOI 10.1111/j.1742-4658.2011.08017.x; Pletinck A, 2012, NAT REV NEPHROL, V8, P542, DOI 10.1038/nrneph.2012.144; Sampimon DE, 2010, PERITON DIALYSIS INT, V30, P163, DOI 10.3747/pdi.2009.00022; Sitter T, 2003, PERITON DIALYSIS INT, V23, P222; THOMA B, 1990, J EXP MED, V172, P1019, DOI 10.1084/jem.172.4.1019; Tomino Y, 2012, CLIN EXP NEPHROL, V16, P109, DOI 10.1007/s10157-011-0533-y; Vlahu CA, 2012, J AM SOC NEPHROL, V23, P1900, DOI 10.1681/ASN.2011121181; Williams SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090117; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Zettlitz KA, 2010, MABS-AUSTIN, V2, P639, DOI 10.4161/mabs.2.6.13583	22	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0163314	10.1371/journal.pone.0163314	http://dx.doi.org/10.1371/journal.pone.0163314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755542	Green Published, gold, Green Submitted			2022-12-26	WOS:000386203800005
J	Mahapatra, T; Chakraborty, K; Mahapatra, S; Mahapatra, U; Pandey, N; Thomson, PL; Musk, AW; Mitra, RN				Mahapatra, Tanmay; Chakraborty, Kaushik; Mahapatra, Sanchita; Mahapatra, Umakanta; Pandey, Naren; Thomson, Peter L.; Musk, Arthur W.; Mitra, Ramendra N.			Burden and Socio-Behavioral Correlates of Uncontrolled Abnormal Glucose Metabolism in an Urban Population of India	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; WAIST CIRCUMFERENCE; CIGARETTE-SMOKING; PORTAL THEORY; RISK-FACTORS; PREVALENCE; EPIDEMIOLOGY; TOLERANCE; HISTORY	Background Progressive burden of diabetes mellitus is a major concern in India. Data on the predictors of poor glycemic control among diabetics are scanty. A population-based cross-sectional study nested in an urban cohort was thus conducted in West Bengal, India to determine the burden and correlates of total and uncontrolled abnormalities in glucose metabolism (AGM) in a representative population. Methods From 9046 adult cohort-members, 269 randomly selected consenting subjects (non-response = 7.24%) were interviewed, examined [blood pressure (BP), anthropometry], tested for fasting plasma glucose (FPG) and glycosylated hemoglobin (HbA1C). Those having pre-diagnosed diabetes or FPG >= 126 or HbA1c >= 6.5 were defined as diabetic. Among non-diabetics, subjects with FPG (mg/dl) = 100-125 or HbA1C(%) = 5.7-6.4 were defined as pre-diabetic. Pre-diagnosed cases with current FPG >= 126 were defined as uncontrolled AGM. Descriptive and regression analyses were conducted using SAS-9.3.2. Results Among participants, 28.62% [95% Confidence Interval (95% CI) = 23.19-34.06)] were over-weight [body mass index(BMI) = (25-29.99) kg/meter(2)], 7.81% (4.58-11.03) were obese (BMI >= 30kg/meter(2)), 20.82% (15.93-25.70) were current smokers, 12.64% (8.64-16.64) were current alcohol-drinkers and 46.32% of responders (39.16-53.47) had family history of diabetes. 17.84% (13.24-22.45) had stage-I [140 <= average systolic BP (AvSBP in mm of mercury)< 160 or 90 <= average diastolic BP (AvDBP)< 100] and 12.64% (8.64-16.64) had stage-II (AvSBP >= 160 or AvDBP >= 160) hypertension. Based on FPG and HbA1c, 10.41% (6.74-14.08) were diabetic and 27.88% (22.49-33.27) were pre-diabetic. Overall prevalence of diabetes was 15.61% (11.25-19.98). Among pre-diagnosed cases, 46.43% (26.74-66.12) had uncontrolled AGM. With one year increase in age [Odds Ratio(OR) = 1.05(1.03-1.07)], retired subjects [OR = 9.14(1.72-48.66)], overweight[OR = 2.78(1.37-5.64)], ex-drinkers [OR = 4.66(1.35-16.12)] and hypertensives [ORStage I = 3.75(1.42-9.94); ORStage II = 4.69(1.67-13.17)] had higher odds of diabetes. Relatively older subjects [OR = 1.06(1.02-1.10)], unemployed [OR = 19.68(18.64-20.78)], business-owners [OR = 25.53(24.91-16.18)], retired [OR = 46.53(45.38-47.72)], ex-smokers [OR = 4.75(1.09-20.78)], ex-drinkers [OR = 22.43(4.62-108.81)] and hypertensives [ORStage II = 13.17 (1.29-134.03)] were more likely to have uncontrolled AGM. Conclusions Burden of uncontrolled AGM was high among participants. Efforts to curb the diabetes epidemic in urban India should include interventions targeting appropriate diabetic control among relatively older persons, unemployed, business-owners, retired, ex-smokers, exdrinkers and hypertensives.	[Mahapatra, Tanmay; Chakraborty, Kaushik; Mitra, Ramendra N.] Barrackpore Populat Hlth Res Fdn, Kolkata 700123, India; [Mahapatra, Tanmay; Mahapatra, Sanchita] Mission Arogya Hlth & Informat Technol Res Fdn, Kolkata 700010, India; [Mahapatra, Umakanta] Postgrad Inst Med Educ & Res, Dept Endocrinol & Metab, Kolkata 700020, India; [Pandey, Naren] Mediland Diagnost Inst, Kolkata 700014, India; [Thomson, Peter L.; Musk, Arthur W.; Mitra, Ramendra N.] Univ Western Australia, Sir Charles Gairdner Hosp, Nedlands, WA 6009, Australia; [Musk, Arthur W.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; University of Western Australia; University of Western Australia	Mahapatra, T (corresponding author), Barrackpore Populat Hlth Res Fdn, Kolkata 700123, India.; Mahapatra, T (corresponding author), Mission Arogya Hlth & Informat Technol Res Fdn, Kolkata 700010, India.	drtanmaymahapatra@yahoo.com			Australia-India Council, Department of Foreign Affairs & Trade (Australian Government); Barrackpore Health Study Fund	Australia-India Council, Department of Foreign Affairs & Trade (Australian Government); Barrackpore Health Study Fund	This work was supported by the Australia-India Council, Department of Foreign Affairs & Trade (Australian Government) and 'Barrackpore Health Study Fund'. RNM received the support as the Director of the Barrackpore Population Health Research Foundation, Kolkata, India. The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Ajay VS, 2008, DIABETIC MED, V25, P1187, DOI 10.1111/j.1464-5491.2008.02554.x; Anjana RM, 2011, DIABETOLOGIA, V54, P3022, DOI 10.1007/s00125-011-2291-5; Anjana RM, 2011, INDIAN J MED RES, V133, P369; Anjana RM, 2009, METABOLISM, V58, P344, DOI 10.1016/j.metabol.2008.10.006; [Anonymous], DIABETES FACT SHEETS; [Anonymous], 2009, HLTH ADM; [Anonymous], 2010, JMAJ; [Anonymous], IDF DIABETES ATLAS U; [Anonymous], THE SEVENTH REPORT O; [Anonymous], WAIST CIRCUMFERENCE; [Anonymous], EPI INFO VERSION 3 5; [Anonymous], STANDARDS OF MEDICAL; [Anonymous], DIAGNOSIS OF DIABETE; Anuradha R, 2012, J CLIN DIAGN RES, V6, P1510, DOI 10.7860/JCDR/2012/4379.2545; Bharati DR, 2011, DIABETES METAB SYND, V5, P12, DOI 10.1016/j.dsx.2010.05.008; Das Sutapa, 2005, J Indian Med Assoc, V103, P580; Deo S. S., 2006, International Journal of Diabetes in Developing Countries, V26, P19; Eliasson B, 2003, PROG CARDIOVASC DIS, V45, P405, DOI 10.1053/pcad.2003.00103; Eliasson M, 2004, J INTERN MED, V256, P101, DOI 10.1111/j.1365-2796.2004.01344.x; Feller S, 2010, DTSCH ARZTEBL INT, V107, P470, DOI 10.3238/arztebl.2010.0470; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Healthy Weight-it's not a diet its a lifestyle, DIVISION OF NUTRITIO; Hosmer Jr DW, 2013, APPLIED LOGISTIC REG; Joshi SR, 2012, DIABETES TECHNOL THE, V14, P8, DOI 10.1089/dia.2011.0243; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kumar Pranav, 2013, Indian J Public Health, V57, P24, DOI 10.4103/0019-557X.111364; Kwak C, 2002, NURS RES, V51, P406, DOI 10.1097/00006199-200211000-00009; Lee YH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-94; Menon VU, 2006, DIABETES RES CLIN PR, V74, P289, DOI 10.1016/j.diabres.2006.03.025; Misra P, 2011, DIABETES RES CLIN PR, V92, P303, DOI 10.1016/j.diabres.2011.02.032; Mohan V, 2007, INDIAN J MED RES, V125, P217; Mohan V, 2003, J Assoc Physicians India, V51, P771; Odetola L, 2013, COMPARISON OF DIETAR; Pradhan R, 2009, STUD ETHNO-MED, V3, P127, DOI 10.1080/09735070.2009.11886349; Ramachandran A, 2005, DIABETES RES CLIN PR, V70, P63, DOI 10.1016/j.diabres.2005.02.016; Ramachandran A, 2002, DIABETIC MED, V19, P130, DOI 10.1046/j.1464-5491.2002.00656.x; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Rao CR, 2010, INT J DIABETES DEV C, V30, P80, DOI 10.4103/0973-3930.62597; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; Rytka JM, 2011, DIABETES, V60, P56, DOI 10.2337/db10-0697; Sadikot SM, 2004, DIABETES RES CLIN PR, V66, P301, DOI 10.1016/j.diabres.2004.04.008; *SAS I INC, 1985, US GUID STAT VERS 5, P956; Scheen AJ, 2003, ACTA CLIN BELG, V58, P335, DOI 10.1179/acb.2003.58.6.001; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Starkweather J, MOSKE A MULTINOMIAL; Will JC, 2001, INT J EPIDEMIOL, V30, P540, DOI 10.1093/ije/30.3.540; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; World Health Organization, 2018, OBESITY AND OVERWEIG	49	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0163891	10.1371/journal.pone.0163891	http://dx.doi.org/10.1371/journal.pone.0163891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755543	Green Published, Green Submitted, gold			2022-12-26	WOS:000386203800007
J	Cha, SA; Yun, JS; Lim, TS; Min, K; Song, KH; Yoo, KD; Park, YM; Ahn, YB; Ko, SH				Cha, Seon-Ah; Yun, Jae-Seung; Lim, Tae-Seok; Min, Kyoungil; Song, Ki-Ho; Yoo, Ki-Dong; Park, Yong-Moon; Ahn, Yu-Bae; Ko, Seung-Hyun			Diabetic Cardiovascular Autonomic Neuropathy Predicts Recurrent Cardiovascular Diseases in Patients with Type 2 Diabetes	PLOS ONE			English	Article							SILENT-MYOCARDIAL-ISCHEMIA; MELLITUS; RISK; ASSOCIATION; MORTALITY; STROKE; EPIDEMIOLOGY; INFARCTION; STATEMENT; INDIVIDUALS	Cardiovascular autonomic neuropathy (CAN) is a risk factor for cardiovascular disease (CVD) and mortality in patients with type 2 diabetes. This study evaluated the relationship between CAN and recurrent CVD in type 2 diabetes. A total of 206 patients with type 2 diabetes who had a history of CVD within 3 years of enrollment were consecutively recruited from January 2001 to December 2009 and followed-up until December 2015. Cardiovascular autonomic function tests were performed using the following heart rate variability parameters: expiration-to-inspiration ratio, response to Valsalva maneuver and standing. We estimated the recurrence of CVD events during the follow-up period. A total of 159 (77.2%) of the 206 patients enrolled completed the follow up, and 78 (49.1%) patients had recurrent episodes of CVD, with an incidence rate of 75.6 per 1,000 patient-years. The mean age and diabetes duration were 62.5 +/- 8.7 and 9.2 +/- 6.9 years, respectively. Patients who developed recurrent CVD also exhibited hypertension (P = 0.004), diabetic nephropathy (P = 0.012), higher mean systolic blood pressure (P = 0.006), urinary albumin excretion (P = 0.015), and mean triglyceride level (P = 0.035) than did patients without recurrent CVD. Multivariable Cox hazard regression analysis revealed that definite CAN was significantly associated with an increased risk of recurrent CVD (hazard ratio [HR] 3.03; 95% confidence interval [CI] 1.39-6.60; P = 0.005). Definite CAN was an independent predictor for recurrent CVD in patients with type 2 diabetes who had a known prior CVD event.	[Cha, Seon-Ah; Yun, Jae-Seung; Lim, Tae-Seok; Min, Kyoungil; Song, Ki-Ho; Ahn, Yu-Bae; Ko, Seung-Hyun] Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, Coll Med, Seoul, South Korea; [Yoo, Ki-Dong] Catholic Univ Korea, Div Cardiol, Dept Internal Med, Coll Med, Seoul, South Korea; [Park, Yong-Moon] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA	Catholic University of Korea; Catholic University of Korea; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Ko, SH (corresponding author), Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, Coll Med, Seoul, South Korea.	kosh@catholic.ac.kr	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879; Cha, Seon-Ah/0000-0001-6533-3082; Ko, Seung-Hyun/0000-0003-3703-1479; MIN, KYOUNG IL/0000-0002-8089-3800				Adeghate E, 2006, ANN NY ACAD SCI, V1084, P1, DOI 10.1196/annals.1372.029; Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; Ahmed Amany H, 2007, Exp Clin Cardiol, V12, P189; [Anonymous], 1994, Diabetes Care, V17, P1357; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Buse JB, 2007, DIABETES CARE, V30, P162, DOI 10.2337/dc07-9917; Callahan A, 2011, ARCH NEUROL-CHICAGO, V68, P1245, DOI 10.1001/archneurol.2011.146; Chyun DA, 2015, SAGE OPEN MED, V3, DOI 10.1177/2050312114568476; Cohen JA, 2003, AUTON NEUROSCI-BASIC, V108, P73, DOI 10.1016/j.autneu.2003.07.001; EWING DJ, 1986, DIABETES CARE, V9, P648, DOI 10.2337/diacare.9.6.648; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Giorda CB, 2008, DIABETES CARE, V31, P2154, DOI 10.2337/dc08-1013; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Honda T, 2014, J CARDIOL, V63, P358, DOI 10.1016/j.jjcc.2013.10.007; Jung JH, 2015, DIABETES METAB J, V39, P307, DOI 10.4093/dmj.2015.39.4.307; Kim CS, 2014, DIABETES METAB J, V38, P35, DOI 10.4093/dmj.2014.38.1.35; Ko SH, 2008, DIABETIC MED, V25, P1171, DOI 10.1111/j.1464-5491.2008.02567.x; Ko SH, 2014, DIABETES METAB J, V38, P51, DOI 10.4093/dmj.2014.38.1.51; Korea Centers for Disease Control and Prevention, 2014, KOR HLTH STAT 2014 K; Korea Statistics, FACT SHEET CAUS DEAT; Korean Diabetes Association National Health Insurance Service, 2015, KOR DIAB FACT SHEET; Leiter LA, 2013, CAN J DIABETES, V37, P82, DOI 10.1016/j.jcjd.2013.02.055; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Maser RE, 2003, DIABETES CARE, V26, P1895, DOI 10.2337/diacare.26.6.1895; Orchard TJ, 1996, DIABETES RES CLIN PR, V34, pS165, DOI 10.1016/S0168-8227(96)01321-6; Pop-Busui R, 2010, DIABETES CARE, V33, P1578, DOI 10.2337/dc10-0125; Roh E, 2013, DIABETES METAB J, V37, P433, DOI 10.4093/dmj.2013.37.6.433; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Toyry JP, 1996, STROKE, V27, P1316, DOI 10.1161/01.STR.27.8.1316; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Valensi P, 2001, DIABETES CARE, V24, P339, DOI 10.2337/diacare.24.2.339; van der Heijden AAWA, 2013, DIABETES CARE, V36, P3498, DOI 10.2337/dc12-2691; Vincent JL, 2008, CRIT CARE, V12, DOI 10.1186/cc6975; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; Wackers FJT, 2004, DIABETES CARE, V27, P1954, DOI 10.2337/diacare.27.8.1954; Yun JS, 2016, J CLIN LIPIDOL, V10, P426, DOI 10.1016/j.jacl.2015.12.030; Yun JS, 2015, DIABETES METAB J, V39, P498, DOI 10.4093/dmj.2015.39.6.498; ZIEGLER D, 1993, DIABETES METAB, V19, P143	42	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164807	10.1371/journal.pone.0164807	http://dx.doi.org/10.1371/journal.pone.0164807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741306	Green Published, gold, Green Submitted			2022-12-26	WOS:000385507000068
J	Guo, X; Zhou, S; Wang, YW; Song, JL; Wang, HM; Kong, DL; Zhu, J; Dong, WW; He, MX; Hu, GQ; Ruan, ZY				Guo, Xiang; Zhou, Shan; Wang, Yanwei; Song, Jinlong; Wang, Huimin; Kong, Delong; Zhu, Jie; Dong, Weiwei; He, Mingxiong; Hu, Guoquan; Ruan, Zhiyong			Characterization of a Highly Thermostable and Organic Solvent-Tolerant Copper-Containing Polyphenol Oxidase with Dye-Decolorizing Ability from Kurthia huakuii LAM0618(T)	PLOS ONE			English	Article							PH-STABLE LACCASE; BIOCHEMICAL-CHARACTERIZATION; BACTERIAL LACCASE; BACILLUS-SUBTILIS; STREPTOMYCES-COELICOLOR; MULTICOPPER OXIDASE; BLUE LACCASE; PURIFICATION; EXPRESSION; CLONING	Laccases are green biocatalysts that possess attractive advantages for the treatment of resistant environmental pollutants and dye effluents. A putative laccase-like gene, laclK, encoding a protein of 29.3 kDa and belonging to the Cu-oxidase_4 superfamily, was cloned and overexpressed in Escherichia coli. The purified recombinant protein LaclK (LaclK) was able to oxidize typical laccase substrates such as 2,6-dimethoxyphenol and L-dopamine. The characteristic adsorption maximums of typical laccases at 330 nm and 610 nm were not detected for LaclK. Cu2+ was essential for substrate oxidation, but the ratio of copper atoms/molecule of LaclK was determined to only be 1: 1. Notably, the optimal temperature of LaclK was 85 degrees C with 2,6-dimethoxyphenol as substrates, and the half-life approximately 3 days at 80 degrees C. Furthermore, 10% (v/v) organic solvents (methanol, ethanol, isopropyl alcohol, butyl alcohol, Triton x-100 or dimethyl sulfoxide) could promote enzymatic activity. LaclK exhibited wide-spectrum decolorization ability towards triphenylmethane dyes, azo dyes and aromatic dyes, decolorizing 92% and 94% of Victoria Blue B (25 mu M) and Ethyl Violet (25 mu M), respectively, at a concentration of 60 U/L after 1 h of incubation at 60 degrees C. Overall, we characterized a novel thermostable and organic solvent-tolerant copper-containing polyphenol oxidase possessing dye-decolorizing ability. These unusual properties make LaclK an alternative for industrial applications, particularly processes that require high-temperature conditions.	[Guo, Xiang; Zhou, Shan; Wang, Huimin; Kong, Delong; Zhu, Jie; Dong, Weiwei; Ruan, Zhiyong] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China; [Guo, Xiang; Wang, Yanwei; He, Mingxiong; Hu, Guoquan] Minist Agr, Biogas Inst, Chengdu, Peoples R China; [Song, Jinlong] Chinese Acad Fishery Sci, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Chinese Academy of Agricultural Sciences; Biogas Institute of Ministry of Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences	Ruan, ZY (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China.; Hu, GQ (corresponding author), Minist Agr, Biogas Inst, Chengdu, Peoples R China.	huguoquan1@hotmail.com; ruanzhiyong@caas.cn	he, mingxiong/D-6683-2017; wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022	he, mingxiong/0000-0002-9780-6865; 	National Nonprofit Institute Research Grant of Chinese Academy of Agricultural Sciences [2014-30]; Special Fund for Agro-scientific Research in the Public Interest [201403019]; National Key Technology Research and Development Program of China [2013BAD05B04F02]; Major State Basic Research Development Program of China [2012CB417104]	National Nonprofit Institute Research Grant of Chinese Academy of Agricultural Sciences; Special Fund for Agro-scientific Research in the Public Interest; National Key Technology Research and Development Program of China(National Key Technology R&D Program); Major State Basic Research Development Program of China(National Basic Research Program of China)	This study was funded by National Nonprofit Institute Research Grant of Chinese Academy of Agricultural Sciences (No.2014-30, Funder: ZYR, http://www.iarrp.cn/sites/IARRP/), the Special Fund for Agro-scientific Research in the Public Interest (No.201403019, Funder: GQH, http://www.moa.gov.cn/), National Key Technology Research and Development Program of China (No.2013BAD05B04F02, Funder: ZYR, http.//www.most.gov.cn/) and the Major State Basic Research Development Program of China (No.2012CB417104, Funder: ZYR, http://www.most.gov.cn/). ZYR and GQH designed the study and helped write the manuscript; ZYR also contributed to analyzing the data and providing reagents/materials/analysis tools.	Ausec L, 2015, APPL MICROBIOL BIOT, V99, P9987, DOI 10.1007/s00253-015-6843-3; Ausec L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025724; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Beloqui A, 2006, J BIOL CHEM, V281, P22933, DOI 10.1074/jbc.M600577200; Brander S, 2015, J MOL CATAL B-ENZYM, V112, P59, DOI 10.1016/j.molcatb.2014.12.002; Chen B, 2015, INT J BIOL MACROMOL, V76, P39, DOI 10.1016/j.ijbiomac.2015.02.019; Chen CY, 2013, APPL MICROBIOL BIOT, V97, P8977, DOI 10.1007/s00253-013-4727-y; Claus H, 2004, MICRON, V35, P93, DOI 10.1016/j.micron.2003.10.029; Doukyu N, 2010, BIOCHEM ENG J, V48, P270, DOI 10.1016/j.bej.2009.09.009; Dube E, 2008, APPL MICROBIOL BIOT, V79, P597, DOI 10.1007/s00253-008-1475-5; Durao P, 2008, J BIOL INORG CHEM, V13, P183, DOI 10.1007/s00775-007-0312-0; Endo K, 2003, J BIOCHEM, V133, P671, DOI 10.1093/jb/mvg086; Fang ZM, 2012, BIORESOURCE TECHNOL, V111, P36, DOI 10.1016/j.biortech.2012.01.172; Fang Z, 2011, APPL MICROBIOL BIOT, V89, P1103, DOI 10.1007/s00253-010-2934-3; Feng CJ, 2008, COMP BIOCHEM PHYS B, V151, P139, DOI 10.1016/j.cbpb.2008.05.012; Forootanfar H, 2011, BIORESOURCE TECHNOL, V102, P1808, DOI 10.1016/j.biortech.2010.09.043; Guan ZB, 2014, APPL BIOCHEM BIOTECH, V172, P1147, DOI 10.1007/s12010-013-0614-3; Gunne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052360; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Hilden K, 2009, BIOTECHNOL LETT, V31, P1117, DOI 10.1007/s10529-009-9998-0; Ihssen J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10465; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Kunamneni Adinarayana, 2008, Recent Pat Biotechnol, V2, P10, DOI 10.2174/187220808783330965; Machczynski MC, 2004, PROTEIN SCI, V13, P2388, DOI 10.1110/ps.04759104; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Miyazaki K, 2005, EXTREMOPHILES, V9, P415, DOI 10.1007/s00792-005-0458-z; Mot AC, 2012, PROCESS BIOCHEM, V47, P968, DOI 10.1016/j.procbio.2012.03.006; Nakamura K, 2005, CELL MOL LIFE SCI, V62, P2050, DOI 10.1007/s00018-004-5076-x; Palmieri G, 1997, J BIOL CHEM, V272, P31301, DOI 10.1074/jbc.272.50.31301; Rasekh B, 2014, ENG LIFE SCI, V14, P442, DOI 10.1002/elsc.201300042; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; Ruan Z, 2014, GENOME ANNOUNC, V2; Ruan ZY, 2014, INT J SYST EVOL MICR, V64, P518, DOI 10.1099/ijs.0.056044-0; Ruan ZY, 2013, BIORESOURCE TECHNOL, V147, P477, DOI 10.1016/j.biortech.2013.08.017; Ryan S, 2003, ENZYME MICROB TECH, V33, P766, DOI 10.1016/S0141-0229(03)00162-5; Sani RK, 1999, ENZYME MICROB TECH, V24, P433, DOI 10.1016/S0141-0229(98)00159-8; Singh G, 2007, ENZYME MICROB TECH, V41, P794, DOI 10.1016/j.enzmictec.2007.07.001; Sondhi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096951; Suzuki T, 2003, BIOSCI BIOTECH BIOCH, V67, P2167, DOI 10.1271/bbb.67.2167; Tamayo-Ramos JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-165; Telke AA, 2010, BIOTECHNOL BIOPROC E, V15, P696, DOI 10.1007/s12257-009-3126-9; Wu J, 2010, J ENVIRON SCI-CHINA, V22, P635, DOI 10.1016/S1001-0742(09)60156-X; Ye M, 2010, APPL MICROBIOL BIOT, V87, P1023, DOI 10.1007/s00253-010-2507-5	44	27	28	7	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164810	10.1371/journal.pone.0164810	http://dx.doi.org/10.1371/journal.pone.0164810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741324	Green Published, gold, Green Submitted			2022-12-26	WOS:000385507000069
J	Urano, H; Iwatsuki, K; Yamamoto, M; Ohnisi, T; Kurimoto, S; Endo, N; Hirata, H				Urano, Hideki; Iwatsuki, Katsuyuki; Yamamoto, Michiro; Ohnisi, Tetsuro; Kurimoto, Shigeru; Endo, Nobuyuki; Hirata, Hitoshi			Novel Anti-Adhesive CMC-PE Hydrogel Significantly Enhanced Morphological and Physiological Recovery after Surgical Decompression in an Animal Model of Entrapment Neuropathy	PLOS ONE			English	Article							CHRONIC NERVE COMPRESSION; CARPAL-TUNNEL-SYNDROME; SCIATIC-NERVE; RAT MODEL; NEUROLYSIS; ADHESION; SCAR	We developed a novel hydrogel derived from sodium carboxymethylcellulose (CMC) in which phosphatidylethanolamine (PE) was introduced into the carboxyl groups of CMC to prevent perineural adhesions. This hydrogel has previously shown excellent anti-adhesive effects even after aggressive internal neurolysis in a rat model. Here, we confirmed the effects of the hydrogel on morphological and physiological recovery after nerve decompression. We prepared a rat model of chronic sciatic nerve compression using silicone tubing. Morphological and physiological recovery was confirmed at one, two, and three months after nerve decompression by assessing motor conduction velocity (MCV), the wet weight of the tibialis anterior muscle and morphometric evaluations of nerves. Electrophysiology showed significantly quicker recovery in the CMC-PE group than in the control group (24.0 +/- 3.1 vs. 21.0 +/- 2.1 m/s (p < 0.05) at one months and MCV continued to be significantly faster thereafter. Wet muscle weight at one month significantly differed between the CMC-PE (BW) and control groups (0.148 +/- 0.020 vs. 0.108 +/- 0.019% BW). The mean wet muscle weight was constantly higher in the CMC-PE group than in the control group throughout the experimental period. The axon area at one month was twice as large in the CMC-PE group compared with the control group (24.1 +/- 17.3 vs. 12.3 +/- 9 mu m(2)) due to the higher ratio of axons with a larger diameter. Although the trend continued throughout the experimental period, the difference decreased after two months and was not statistically significant at three months. Although anti-adhesives can reduce adhesion after nerve injury, their effects on morphological and physiological recovery after surgical decompression of chronic entrapment neuropathy have not been investigated in detail. The present study showed that the new anti-adhesive CMC-PE gel can accelerate morphological and physiological recovery of nerves after decompression surgery.	[Urano, Hideki] Yokkaichi Municipal Hosp, Dept Orthopaed Surg, 2-2-37 Shibata Cho, Yokaichi, Mie 5108567, Japan; [Urano, Hideki; Iwatsuki, Katsuyuki; Yamamoto, Michiro; Ohnisi, Tetsuro; Kurimoto, Shigeru; Hirata, Hitoshi] Nagoya Univ, Grad Sch Med, Dept Hand Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan; [Endo, Nobuyuki] Teijin Ltd, Healthcare Business Dev, 4-3-2 Asahigaoka Hino, Tokyo 1918512, Japan	Nagoya University; Teijin Limited	Urano, H (corresponding author), Yokkaichi Municipal Hosp, Dept Orthopaed Surg, 2-2-37 Shibata Cho, Yokaichi, Mie 5108567, Japan.; Urano, H (corresponding author), Nagoya Univ, Grad Sch Med, Dept Hand Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	jingarimituki@yahoo.co.jp			Teijin Limited; JSPS KAKENHI Grant [25861309]	Teijin Limited; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We received financial and/or technical supported from Teijin Limited and a grant in aid for Japan society for the promotion of science KAKENHI Grant Number 25861309. The funder provided support in the form of salaries for authors [N.E.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by JSPS KAKENHI Grant Number 25861309.	ABITBOL JJ, 1994, SPINE, V19, P1809, DOI 10.1097/00007632-199408150-00004; AGUAYO A, 1971, ARCH NEUROL-CHICAGO, V24, P358, DOI 10.1001/archneur.1971.00480340090010; Dam-Hieu Phong, 2005, Neurosurgery, V56, P425, DOI 10.1227/01.NEU.0000156845.41626.E9; Dumanian GA, 1999, J HAND SURG-AM, V24A, P30; Gupta R, 2004, EXP NEUROL, V187, P500, DOI 10.1016/j.expneurol.2004.02.009; Gupta R, 2012, MUSCLE NERVE, V45, P231, DOI 10.1002/mus.22276; Ikeda K, 2010, BR J PLAST SURG, V56, P342; Ikeda Kazuo, 2002, Hand Surg, V7, P11, DOI 10.1142/S0218810402000911; Isla A, 2003, J Neurosurg Sci, V47, P195; Iwatsuki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057721; Mackinnon SE, 2002, HAND CLIN, V18, P231, DOI 10.1016/S0749-0712(01)00012-9; MACKINNON SE, 1986, HAND CLIN, V2, P639; Mazal PR, 2005, ACT NEUR S, V92, P3; McCall TD, 2001, NEUROSURG CLIN N AM, V12, P329, DOI 10.1016/S1042-3680(18)30058-5; Miillesi H, 1990, ANN HNAD SURG, V9, P87; MILLESI H, 1993, MICROSURG, V14, P430, DOI 10.1002/micr.1920140703; Nishimura T, 2008, HISTOL HISTOPATHOL, V23, P157, DOI 10.14670/HH-23.157; OBRIEN JP, 1987, ANN PLAS SURG, V19, P430, DOI 10.1097/00000637-198711000-00008; Ohsumi H, 2005, PLAST RECONSTR SURG, V116, P823, DOI 10.1097/01.prs.0000176893.44656.8e; Okui N, 2012, MICROSURG, V32, P466, DOI 10.1002/micr.21998; Okui N, 2010, MUSCLE NERVE, V42, P570, DOI 10.1002/mus.21727; Petersen J, 1996, NEUROSURGERY, V38, P976, DOI 10.1097/00006123-199605000-00025; Pham K, 2009, NEUROSCI LETT, V465, P194, DOI 10.1016/j.neulet.2009.09.014; SUNDERLAND S, 1976, J NEUROL NEUROSUR PS, V39, P615, DOI 10.1136/jnnp.39.7.615; Watanabe M, 2001, J HAND SURG-AM, V26A, P663, DOI 10.1053/jhsu.2001.24142; Xu JM, 2000, J HAND SURG-AM, V25A, P93; Yamamoto M, 2010, J ORTHOP RES, V28, P284, DOI 10.1002/jor.21004; Yamamoto T, 2014, MICROSURG, V34, P145, DOI 10.1002/micr.22135; [No title captured]	29	6	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164572	10.1371/journal.pone.0164572	http://dx.doi.org/10.1371/journal.pone.0164572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741280	Green Submitted, Green Published, gold			2022-12-26	WOS:000385507000044
J	Garg, N; Bakhshinyan, D; Venugopal, C; Mahendram, S; Rosa, DA; Vijayakumar, T; Manoranjan, B; Hallett, R; McFarlane, N; Delaney, KH; Kwiecien, JM; Arpin, CC; Lai, PS; Gomez-Biagi, RF; Ali, AM; de Araujo, ED; Ajani, OA; Hassell, JA; Gunning, PT; Singh, SK				Garg, N.; Bakhshinyan, D.; Venugopal, C.; Mahendram, S.; Rosa, D. A.; Vijayakumar, T.; Manoranjan, B.; Hallett, R.; McFarlane, N.; Delaney, K. H.; Kwiecien, J. M.; Arpin, C. C.; Lai, P-S; Gomez-Biagi, R. F.; Ali, A. M.; de Araujo, E. D.; Ajani, O. A.; Hassell, J. A.; Gunning, P. T.; Singh, S. K.			CD133(+) brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence	ONCOGENE			English	Article							CANCER STEM-CELLS; SMALL-MOLECULE INHIBITOR; SUPPRESSES GROWTH; CYCLE ARREST; EXPRESSION; APOPTOSIS; PROLIFERATION; SUBGROUPS; PATHWAY; TARGET	Medulloblastoma (MB), the most common malignant paediatric brain tumor, is currently treated using a combination of surgery, craniospinal radiotherapy and chemotherapy. Owing to MB stem cells (MBSCs), a subset of MB patients remains untreatable despite standard therapy. CD133 is used to identify MBSCs although its functional role in tumorigenesis has yet to be determined. In this work, we showed enrichment of CD133 in Group 3 MB is associated with increased rate of metastasis and poor clinical outcome. The signal transducers and activators of transcription-3 (STAT3) pathway are selectively activated in CD133(+) MBSCs and promote tumorigenesis through regulation of c-MYC, a key genetic driver of Group 3 MB. We screened compound libraries for STAT3 inhibitors and treatment with the selected STAT3 inhibitors resulted in tumor size reduction in vivo. We propose that inhibition of STAT3 signaling in MBSCs may represent a potential therapeutic strategy to treat patients with recurrent MB.	[Garg, N.; Bakhshinyan, D.; Venugopal, C.; Mahendram, S.; Vijayakumar, T.; Manoranjan, B.; McFarlane, N.; Hassell, J. A.; Singh, S. K.] McMaster Stem Cell & Canc Res Inst, Hamilton, ON, Canada; [Garg, N.; Venugopal, C.; Mahendram, S.; Vijayakumar, T.; McFarlane, N.; Ajani, O. A.; Singh, S. K.] McMaster Univ, Dept Surg, Fac Hlth Sci, Hamilton, ON, Canada; [Bakhshinyan, D.; Vijayakumar, T.; Manoranjan, B.; Hassell, J. A.; Singh, S. K.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Rosa, D. A.; Arpin, C. C.; Lai, P-S; Gomez-Biagi, R. F.; de Araujo, E. D.; Gunning, P. T.] Univ Toronto, Dept Chem, Mississauga, ON, Canada; [Manoranjan, B.; Singh, S. K.] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada; [Hallett, R.; Hassell, J. A.] McMaster Univ, McMaster Ctr Funct Genom, Hamilton, ON, Canada; [Delaney, K. H.; Kwiecien, J. M.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Kwiecien, J. M.] Med Univ Lublin, Dept Neurosurg & Paediat Neurosurg, Lublin, Poland; [Ali, A. M.] Assiut Univ, Dept Med Chem, Fac Pharm, Assiut, Egypt; [Hassell, J. A.] McMaster Univ, Dept Pathol, Hamilton, ON, Canada; [Hassell, J. A.] McMaster Univ, Dept Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; University of Toronto; University Toronto Mississauga; McMaster University; McMaster University; McMaster University; Medical University of Lublin; Egyptian Knowledge Bank (EKB); Assiut University; McMaster University; McMaster University	Singh, SK (corresponding author), McMaster Univ, Stem Cell & Canc Res Inst, MDCL 5027,1280 Main St West, Hamilton, ON L8S 4K1, Canada.	ssingh@mcmaster.ca	Singh, Sheila K/W-2799-2018; Garg, Neha/AAG-5180-2020	Singh, Sheila K/0000-0003-1272-5300; Garg, Neha/0000-0003-2227-8292; Ali, Ahmed Magdy/0000-0001-7913-8544	Department of Surgery at McMaster University; Canada Research Chair award; Canadian Institutes of Health Research (CIHR) Operating Grant [RN193483-299211, MOP-142353]; Stem Cell Network Drug Discovery Grant; Ontario Institute for Cancer Research Cancer Stem Cell Program; Canadian Cancer Society Research Institute; Terry Fox Research Institute New Investigator Award; Alberta Innovates; Stem Cell Network; CIHR; ORF; CFI	Department of Surgery at McMaster University; Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes of Health Research (CIHR) Operating Grant(Canadian Institutes of Health Research (CIHR)); Stem Cell Network Drug Discovery Grant; Ontario Institute for Cancer Research Cancer Stem Cell Program; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Terry Fox Research Institute New Investigator Award; Alberta Innovates; Stem Cell Network; CIHR(Canadian Institutes of Health Research (CIHR)); ORF; CFI(Canada Foundation for Innovation)	Dr Sheila K Singh is supported by funds from the Department of Surgery at McMaster University, Canada Research Chair award, Canadian Institutes of Health Research (CIHR) Operating Grant #RN193483-299211, Stem Cell Network Drug Discovery Grant, Ontario Institute for Cancer Research Cancer Stem Cell Program, the Canadian Cancer Society Research Institute and Terry Fox Research Institute New Investigator Award. The Alberta Innovates, Stem Cell Network, CIHR, ORF and CFI fund Dr Patrick T. Gunning's research. Dr John A. Hassell is supported by the funds from CIHR Operating Grant # MOP-142353	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Ashizawa T, 2013, INT J ONCOL, V43, P219, DOI 10.3892/ijo.2013.1916; Bandopadhayay P, 2014, CLIN CANCER RES, V20, P912, DOI 10.1158/1078-0432.CCR-13-2281; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chang CJ, 2012, CHILD NERV SYST, V28, P363, DOI 10.1007/s00381-011-1672-x; Chen FX, 2010, J MOL NEUROSCI, V40, P353, DOI 10.1007/s12031-009-9323-3; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Cox CV, 2009, BLOOD, V113, P3287, DOI 10.1182/blood-2008-04-154187; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Eiring AM, 2015, LEUKEMIA, V29, P586, DOI 10.1038/leu.2014.245; FRIEDMAN HS, 1992, CANCER RES, V52, P5373; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Gu CY, 2011, ONCOL LETT, V2, P357, DOI 10.3892/ol.2011.235; Haftchenary S, 2013, ACS MED CHEM LETT, V4, P1102, DOI 10.1021/ml4003138; Haftchenary S, 2011, ANTI-CANCER DRUG, V22, P115, DOI 10.1097/CAD.0b013e328341185b; Holtick U, 2005, LEUKEMIA, V19, P936, DOI 10.1038/sj.leu.2403750; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Li GH, 2010, INT J ONCOL, V37, P103, DOI 10.3892/ijo_00000658; Lin L, 2011, BIOCHEM BIOPH RES CO, V416, P246, DOI 10.1016/j.bbrc.2011.10.112; Mabbott DJ, 2005, J CLIN ONCOL, V23, P2256, DOI 10.1200/JCO.2005.01.158; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Rahaman SO, 2002, ONCOGENE, V21, P8404, DOI 10.1038/sj.onc.1206047; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Sai K, 2012, J NEURO-ONCOL, V107, P487, DOI 10.1007/s11060-011-0786-z; Schaefer LK, 2002, ONCOGENE, V21, P2058, DOI 10.1038/sj.onc.1205263; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh M, 2015, ONCOTARGET, V6, P27461, DOI 10.18632/oncotarget.4742; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Stechishin OD, 2013, NEURO-ONCOLOGY, V15, P198, DOI 10.1093/neuonc/nos302; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Venugopal C, 2015, CLIN CANCER RES, V21, P5324, DOI 10.1158/1078-0432.CCR-14-3147; Venugopal C, 2012, JOVE-J VIS EXP, DOI 10.3791/4111; Wang XiaoLi, 2012, Agricultural Biotechnology, V1, P1; Won C, 2015, HEPATOLOGY, V62, P1160, DOI 10.1002/hep.27968; Xiao H, 2015, J BIOL CHEM, V290, P3418, DOI 10.1074/jbc.M114.616748; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zhao D, 2015, ONCOGENE, V34, P3107, DOI 10.1038/onc.2014.257	55	38	38	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 2	2017	36	5					606	617		10.1038/onc.2016.235	http://dx.doi.org/10.1038/onc.2016.235			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IS	27775079	Green Published, hybrid			2022-12-26	WOS:000394167700003
J	Xiong, XP; Li, X; Wen, YA; Gao, TY				Xiong, Xiaopeng; Li, Xin; Wen, Yang-An; Gao, Tianyan			Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; SIGNALING PATHWAYS; TUMOR PROGRESSION; CANCER; PHLPP; AKT; PKC; MORPHOGENESIS; PROLIFERATION; APOPTOSIS	The proper establishment of epithelial polarity allows cells to sense and respond to signals that arise from the microenvironment in a spatiotemporally controlled manner. Atypical PKCs (aPKCs) are implicated as key regulators of epithelial polarity. However, the molecular mechanism underlying the negative regulation of aPKCs remains largely unknown. In this study, we demonstrated that PH domain leucine-rich repeat protein phosphatase (PHLPP), a novel family of Ser/Thr protein phosphatases, plays an important role in regulating epithelial polarity by controlling the phosphorylation of both aPKC isoforms. Altered expression of PHLPP1 or PHLPP2 disrupted polarization of Caco2 cells grown in 3D cell cultures as indicated by the formation of aberrant multi-lumen structures. Overexpression of PHLPP resulted in a decrease in aPKC phosphorylation at both the activation loop and the turn motif sites; conversely, knockdown of PHLPP increased aPKC phosphorylation. Moreover, in vitro dephosphorylation experiments revealed that both aPKC isoforms were substrates of PHLPP. Interestingly, knockdown of PKC zeta, but not PKC iota, led to similar disruption of the polarized lumen structure, suggesting that PKC zeta likely controls the polarization process of Caco2 cells. Furthermore, knockdown of PHLPP altered the apical membrane localization of aPKCs and reduced the formation of aPKC-Par3 complex. Taken together, our results identify a novel role of PHLPP in regulating aPKC and cell polarity.	[Xiong, Xiaopeng; Li, Xin; Wen, Yang-An; Gao, Tianyan] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Gao, Tianyan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Gao, TY (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	tianyan.gao@uky.edu	xiong, xiaopeng/M-2120-2017	Gao, Tianyan/0000-0003-1159-3625	Biostatistics Shared Resources of the University of Kentucky Markey Cancer Center [P30CA177558]; NATIONAL CANCER INSTITUTE [R01CA133429, P30CA177558] Funding Source: NIH RePORTER	Biostatistics Shared Resources of the University of Kentucky Markey Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by the Biostatistics Shared Resources of the University of Kentucky Markey Cancer Center (Grant P30CA177558).	Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cai JC, 2013, CANCER RES, V73, P5402, DOI 10.1158/0008-5472.CAN-13-0297; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Chang RM, 2014, HEPATOLOGY, V60, P1251, DOI 10.1002/hep.27221; Chen J, 2013, EXP CELL RES, V319, P1357, DOI 10.1016/j.yexcr.2013.03.021; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Durgan J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174235; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Fleming TP, 2000, SEMIN CELL DEV BIOL, V11, P291, DOI 10.1006/scdb.2000.0179; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ivey RA, 2014, J BIOL CHEM, V289, P25021, DOI 10.1074/jbc.M114.565671; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Kemler R, 1992, Semin Cell Biol, V3, P149; Kumar CC, 2005, ONCOGENE, V24, P7493, DOI 10.1038/sj.onc.1209087; Li X, 2014, GASTROENTEROLOGY, V146, P1301, DOI 10.1053/j.gastro.2014.02.003; Li X, 2014, EMBO REP, V15, P191, DOI 10.1002/embr.201338119; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Linch M, 2014, CARCINOGENESIS, V35, P396, DOI 10.1093/carcin/bgt313; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Magudia K, 2012, J CELL BIOL, V198, P185, DOI 10.1083/jcb.201202108; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Masubuchi S, 2010, P NATL ACAD SCI USA, V107, P1642, DOI 10.1073/pnas.0910292107; McCaffrey LM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009654; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Murray NR, 2011, J CELL PHYSIOL, V226, P879, DOI 10.1002/jcp.22463; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nitsche C, 2012, GASTROENTEROLOGY, V142, P377, DOI 10.1053/j.gastro.2011.10.026; O'Neill AK, 2013, FEBS J, V280, P572, DOI 10.1111/j.1742-4658.2012.08537.x; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Takimura T, 2010, ACTA CRYSTALLOGR D, V66, P577, DOI 10.1107/S0907444910005639; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Wen YA, 2015, BBA-MOL BASIS DIS, V1852, P2013, DOI 10.1016/j.bbadis.2015.07.012; Wen YA, 2013, MOL CELL BIOL, V33, P4594, DOI 10.1128/MCB.00695-13; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433	49	7	7	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25167	25178		10.1074/jbc.M116.740639	http://dx.doi.org/10.1074/jbc.M116.740639			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27760826	Green Published, hybrid			2022-12-26	WOS:000388880100031
J	Kim, J; Farahmand, M; Dunn, C; Davies, Z; Frisbee, E; Milla, C; Wine, JJ				Kim, Jeeyeon; Farahmand, Miesha; Dunn, Colleen; Davies, Zoe; Frisbee, Eric; Milla, Carlos; Wine, Jeffrey J.			Evaporimeter and Bubble-Imaging Measures of Sweat Gland Secretion Rates	PLOS ONE			English	Article							CYSTIC-FIBROSIS; WATER-LOSS; IN-VIVO; MUTATION; GENE	Beta-adrenergically-stimulated sweat rates determined by evaporimetry or by sweat bubble imaging are useful for measuring CFTR function because they provide a near-linear read-out across almost the full range of CFTR function. They differentiate cystic fibrosis (CF) subjects from CF carriers and carriers from controls. However, evaporimetry, unlike bubble imaging, appears to be unable to detect improved levels of CFTR function in G551D subjects taking the CFTR modulator ivacaftor. Here, we quantify the sensitivity of evaporimetry and bubble imaging methods for assessing low levels of CFTR-dependent sweat rates. To establish sensitivity, we did dose-ranging studies using intradermally injected [cAMP](i)-elevating cocktails. We reduced isoproterenol/aminophylline levels while maintaining a high level of atropine to block muscarinic elevation of [Ca2+](i). We stimulated the same sets of glands for both assays and recorded responses for 20 min. In response to a 3-log dilution of the stimulating cocktail (0.1%), bubble responses were detected in 12/12 tests (100%), with 49% +/- 3% of glands secreting to produce an aggregate volume of 598 nl across the 12, 20-min tests. This was similar to 5% of the response to full cocktail. Evaporimetry detected responses in 3/12 (25%) tests with an aggregate secretion volume of 175 nl. After stimulation with a still more dilute cocktail (0.03%), bubble imaging detected 15 +/- 13% of glands secreting at a rate similar to 0.9% of the response to full cocktail, while zero responding was seen with evaporimetry. The bubble imaging method detected secretion down to aggregate rates of <0.2 nl/(cm(2).min), or similar to 1/30th of the average basal transepithelial water loss (TEWL) in the test subject of 4 g/m(2).hr or 6.7 nl/(cm(2).min). The increased sensitivity of bubble imaging may be required to detect small but physiologically important increases in secretion rates produced by CFTR modulators.	[Kim, Jeeyeon; Farahmand, Miesha; Frisbee, Eric; Wine, Jeffrey J.] Stanford Univ, Cyst Fibrosis Res Lab, Stanford, CA 94305 USA; [Dunn, Colleen; Davies, Zoe; Milla, Carlos; Wine, Jeffrey J.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Wine, Jeffrey J.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Wine, JJ (corresponding author), Stanford Univ, Cyst Fibrosis Res Lab, Stanford, CA 94305 USA.; Wine, JJ (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.; Wine, JJ (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	wine@stanford.edu		Milla, Carlos/0000-0001-5515-3053	Cystic Fibrosis Foundation Therapeutics [WINE14XX0]; CFFT	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); CFFT	Supported by Cystic Fibrosis Foundation Therapeutics, Grant WINE14XX0 to J.J.W. (http://www.cff.org/research/cfft/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the CFFT sweat gland consortium for valuable advice and discussions. Julie Desch and Nam Soo Joo provided technical assistance and conceptual discussions about cystic fibrosis and glandular function generally. Supported by CFFT.	Accurso FJ, 2014, J CYST FIBROS, V13, P139, DOI 10.1016/j.jcf.2013.09.007; Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; BEHM JK, 1987, PEDIATR RES, V22, P271, DOI 10.1203/00006450-198709000-00007; Char JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088564; Collaco JM, 2016, AM J RESP CRIT CARE, V194, P1375, DOI 10.1164/rccm.201603-0459OC; DESANTAGNESE PA, 1953, AMA AM J DIS CHILD, V86, P618; Kuno Y., 1956, HUMAN PERSPIRATION; PINNAGODA J, 1989, CONTACT DERMATITIS, V21, P16, DOI 10.1111/j.1600-0536.1989.tb04679.x; PINNAGODA J, 1990, CONTACT DERMATITIS, V22, P164, DOI 10.1111/j.1600-0536.1990.tb01553.x; Quinton P, 2012, AM J RESP CRIT CARE, V186, P732, DOI 10.1164/rccm.201205-0922OC; Quinton PM, 2007, PHYSIOLOGY, V22, P212, DOI 10.1152/physiol.00041.2006; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; REDDY MM, 1992, AM J PHYSIOL, V262, pC287, DOI 10.1152/ajpcell.1992.262.2.C287; RIORDAN JR, 1989, SCIENCE, V245, P1066; SATO K, 1984, J CLIN INVEST, V73, P1763, DOI 10.1172/JCI111385; Shamsuddin AKM, 2008, EXP PHYSIOL, V93, P969, DOI 10.1113/expphysiol.2008.042283; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Wilschanski M, 2006, AM J RESP CRIT CARE, V174, P787, DOI 10.1164/rccm.200509-1377OC; Wine JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077114	19	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165254	10.1371/journal.pone.0165254	http://dx.doi.org/10.1371/journal.pone.0165254			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768743	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400072
J	Baldow, C; Thielecke, L; Glauche, I				Baldow, Christoph; Thielecke, Lars; Glauche, Ingmar			Model Based Analysis of Clonal Developments Allows for Early Detection of Monoclonal Conversion and Leukemia	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; EVOLUTION; THERAPY	The availability of several methods to unambiguously mark individual cells has strongly fostered the understanding of clonal developments in hematopoiesis and other stem cell driven regenerative tissues. While cellular barcoding is the method of choice for experimental studies, patients that underwent gene therapy carry a unique insertional mark within the transplanted cells originating from the integration of the retroviral vector. Close monitoring of such patients allows accessing their clonal dynamics, however, the early detection of events that predict monoclonal conversion and potentially the onset of leukemia are beneficial for treatment. We developed a simple mathematical model of a self-stabilizing hematopoietic stem cell population to generate a wide range of possible clonal developments, reproducing typical, experimentally and clinically observed scenarios. We use the resulting model scenarios to suggest and test a set of statistical measures that should allow for an interpretation and classification of relevant clonal dynamics. Apart from the assessment of several established diversity indices we suggest a measure that quantifies the extension to which the increase in the size of one clone is attributed to the total loss in the size of all other clones. By evaluating the change in relative clone sizes between consecutive measurements, the suggested measure, referred to as maximum relative clonal expansion (mRCE), proves to be highly sensitive in the detection of rapidly expanding cell clones prior to their dominant manifestation. This predictive potential places the mRCE as a suitable means for the early recognition of leukemogenesis especially in gene therapy patients that are closely monitored. Our model based approach illustrates how simulation studies can actively support the design and evaluation of preclinical strategies for the analysis and risk evaluation of clonal developments.	[Baldow, Christoph; Thielecke, Lars; Glauche, Ingmar] Tech Univ Dresden, Carl Gustav Carus Fac Med, Inst Med Informat & Biometry, Dresden, Germany	Technische Universitat Dresden	Glauche, I (corresponding author), Tech Univ Dresden, Carl Gustav Carus Fac Med, Inst Med Informat & Biometry, Dresden, Germany.	ingmar.glauche@tu-dresden.de			German Federal Ministry of Research and Education [031A315]	German Federal Ministry of Research and Education	This work was supported by the German Federal Ministry of Research and Education, grant number 031A315 "MessAge".	Abe T, 2010, EXP HEMATOL, V38, P603, DOI 10.1016/j.exphem.2010.03.013; Abkowitz JL, 2002, BLOOD, V100, P2665, DOI 10.1182/blood-2002-03-0822; Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Biasco L, 2016, CELL STEM CELL; Braun CJ, 2014, RARE DIS, V2, DOI 10.4161/21675511.2014.947749; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Bystrykh LV, 2012, NAT METHODS, V9, P567, DOI [10.1038/NMETH.2043, 10.1038/nmeth.2043]; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chao A, 1984, SCANDINAVIAN J STAT, V11, P6; Desfarges S, 2010, VIRUSES-BASEL, V2, P111, DOI 10.3390/v2010111; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Giordano FA, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2014.61; Glauche I, 2013, BLOOD CELL MOL DIS, V50, P232, DOI 10.1016/j.bcmd.2013.01.007; Glauche I, 2011, AGING CELL, V10, P457, DOI 10.1111/j.1474-9726.2011.00692.x; Glauche I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000447; Gordon MY, 2002, BLOOD, V100, P4679, DOI 10.1182/blood-2002-08-2517; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grove CS, 2014, DIS MODEL MECH, V7, P941, DOI 10.1242/dmm.015974; Kent DG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001576; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; Paiva B, 2011, LEUKEMIA, V25, P697, DOI 10.1038/leu.2010.320; Roeder I, 2005, BLOOD, V105, P609, DOI 10.1182/blood-2004-01-0282; Scala S, 2016, CURR GENE THER; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048	29	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165129	10.1371/journal.pone.0165129	http://dx.doi.org/10.1371/journal.pone.0165129			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764218	Green Published, gold			2022-12-26	WOS:000386204500120
J	Monsarrat, P; Arcaute, B; Peters, OA; Maury, E; Telmon, N; Georgelin-Gurgel, M; Maret, D				Monsarrat, Paul; Arcaute, Bertrand; Peters, Ove A.; Maury, Elisabeth; Telmon, Norbert; Georgelin-Gurgel, Marie; Maret, Delphine			Interrelationships in the Variability of Root Canal Anatomy among the Permanent Teeth: A Full-Mouth Approach by Cone-Beam CT	PLOS ONE			English	Article							KOREAN POPULATION VARIATIONS; COMPUTED-TOMOGRAPHY; MAXILLARY 1ST; MESIOBUCCAL ROOT; 2ND MOLARS; MORPHOLOGY; CONFIGURATION; NUMBER	Objectives In endodontic practice, clinicians should be aware of possible root canal anatomic variations. The aim of this study was to assess using CBCT acquisitions regarding whether one root canal anatomy of a tooth is associated with a specific anatomy of another tooth. Methods A total of 106 CBCT acquisitions were obtained using a CBCT scanner with 200 mu m voxel size. Numbers of roots and canals of the entire dentition were described. Bivariate analyses and logistic regressions were conducted to explore root canal anatomy on one tooth according to age, gender, jaw, side and the others teeth. Multiple correspondence analysis (MCA) was performed to correlate the different numbers of canals profiles. Results A total of 2424 teeth were analyzed. Independently from the other variables, the presence of an additional root canal on a mandibular incisor increases the risk of having an additional root canal on a mandibular premolar (OR [95%] 3.7 [1.0;13.2]). The mandibular molar variability increases in women compared to men (OR [95%] 0.4 [0.1;0.9]). MCA showed correspondence between 2-canals maxillary incisor and canines and 5-canals maxillary molars, and some correlation between additional canal on maxillary and mandibular premolars. Conclusions Although CBCT examinations are conducted in the first intention of making a diagnosis or prognostic evaluation, medium FOV acquisitions could be used as an initial database thus furnishing preliminary evaluations and information. In endodontic practice, clinicians should be aware of possible root canal anatomic variations. The visualization of all canals is considered essential in endodontic therapy. The use of multi-correspondence analysis for statistics in endodontic research is a new approach as a prognostic tool.	[Monsarrat, Paul] Univ Toulouse 3, Toulouse Univ Hosp, Fac Dent, Dept Anat Sci & Radiol, Toulouse, France; [Monsarrat, Paul] Univ Toulouse, STROMALab, CNRS, ERL 5311,EFS,INP,ENVT,Inserm,U1031,UPS, Toulouse, France; [Arcaute, Bertrand; Maury, Elisabeth; Georgelin-Gurgel, Marie; Maret, Delphine] Univ Toulouse 3, Toulouse Univ Hosp, Fac Dent, Dept Dept Conservat Dent & Endodont, Toulouse, France; [Arcaute, Bertrand; Telmon, Norbert; Maret, Delphine] Univ Toulouse, CNRS, AMIS Lab, UMR 5288,UPS, Toulouse, France; [Peters, Ove A.] Univ Pacific, Arthur A Dugoni Sch Dent, Dept Endodont, San Francisco, CA USA; [Telmon, Norbert] Ctr Hosp Univ Rangueil, Serv Med Legale, Ave Prof Jean Poulhes, F-31059 Toulouse 9, France	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of the Pacific; CHU de Toulouse	Maret, D (corresponding author), Univ Toulouse 3, Toulouse Univ Hosp, Fac Dent, Dept Dept Conservat Dent & Endodont, Toulouse, France.; Maret, D (corresponding author), Univ Toulouse, CNRS, AMIS Lab, UMR 5288,UPS, Toulouse, France.	delphine_maret@yahoo.fr	Peters, Ove/AAU-7644-2020; Maret, Delphine/AFT-1061-2022; Monsarrat, Paul/A-8232-2010	Peters, Ove/0000-0001-5222-8718; Monsarrat, Paul/0000-0002-5473-6035				Al-Ghananeem MMF, 2014, INT J DENT, V2014, DOI 10.1155/2014/797692; Atieh Momen A, 2008, J Contemp Dent Pract, V9, P46; Baratto F, 2009, J ENDODONT, V35, P337, DOI 10.1016/j.joen.2008.11.022; Bilfeld MF, 2015, J FORENSIC SCI, V60, P1121, DOI 10.1111/1556-4029.12761; Bulut Duygu Goller, 2015, Eur J Dent, V9, P551, DOI 10.4103/1305-7456.172624; Celikten B, 2016, CLIN ORAL INVEST, V20, P2221, DOI 10.1007/s00784-016-1742-2; Cleghorn BM, 2007, J ENDODONT, V33, P1031, DOI 10.1016/j.joen.2007.03.020; Cleghorn BM, 2007, J ENDODONT, V33, P509, DOI 10.1016/j.joen.2006.12.004; Gulabivala K, 2001, INT ENDOD J, V34, P359, DOI 10.1046/j.1365-2591.2001.00399.x; Guo J, 2014, J ENDODONT, V40, P635, DOI 10.1016/j.joen.2014.02.002; Hoen MM, 2002, J ENDODONT, V28, P834, DOI 10.1097/00004770-200212000-00010; Kartal N, 1998, J ENDODONT, V24, P417, DOI 10.1016/S0099-2399(98)80024-1; Kim SY, 2013, J ENDODONT, V39, P1516, DOI 10.1016/j.joen.2013.08.015; Kim Y, 2012, J ENDODONT, V38, P1063, DOI 10.1016/j.joen.2012.04.025; Kottoor Jojo, 2013, Anat Res Int, V2013, P254250, DOI 10.1155/2013/254250; Lee JH, 2011, ORAL SURG ORAL MED O, V111, P785, DOI 10.1016/j.tripleo.2010.11.026; Leoni GB, 2014, J ENDODONT, V40, P710, DOI 10.1016/j.joen.2013.09.003; MADEIRA MC, 1973, ORAL SURG ORAL MED O, V36, P589, DOI 10.1016/0030-4220(73)90318-6; Neelakantan P, 2010, J ENDODONT, V36, P1622, DOI 10.1016/j.joen.2010.07.006; Neelakantan P, 2010, J ENDODONT, V36, P1547, DOI 10.1016/j.joen.2010.05.008; Ng YL, 2001, INT ENDOD J, V34, P620, DOI 10.1046/j.1365-2591.2001.00438.x; Silva EJNL, 2014, J ENDODONT, V40, P173, DOI 10.1016/j.joen.2013.10.002; Park Jun-Beom, 2013, Eur J Dent, V7, P94; Pattanshetti N, 2008, INT ENDOD J, V41, P755, DOI 10.1111/j.1365-2591.2008.01427.x; Plotino G, 2013, J ENDODONT, V39, P1545, DOI 10.1016/j.joen.2013.09.012; Sert S, 2004, J ENDODONT, V30, P391, DOI 10.1097/00004770-200406000-00004; Song JS, 2009, ORAL SURG ORAL MED O, V107, pE56, DOI 10.1016/j.tripleo.2008.09.004; VERTUCCI FJ, 1984, ORAL SURG ORAL MED O, V58, P589, DOI 10.1016/0030-4220(84)90085-9; Vertucci FJ, 2005, ENDODONTIC TOPICS, V10, P3, DOI [DOI 10.1111/J.1601-1546.2005.00129.X, 10.1111/j.1601-1546.2005.00129.x]; Weine FS, 2012, J ENDODONT, V38, P1305, DOI 10.1016/j.joen.2012.08.005; Yang L, 2014, J ENDODONT, V40, P630, DOI 10.1016/j.joen.2014.01.007; Zheng QH, 2010, J ENDODONT, V36, P1480, DOI 10.1016/j.joen.2010.06.018	32	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165329	10.1371/journal.pone.0165329	http://dx.doi.org/10.1371/journal.pone.0165329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764246	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500148
J	Bueno, CG; Williamson, SN; Barrio, IC; Helgadottir, A; Hik, DS				Bueno, C. Guillermo; Williamson, Scott N.; Barrio, Isabel C.; Helgadottir, Agusta; Hik, David S.			Moss Mediates the Influence of Shrub Species on Soil Properties and Processes in Alpine Tundra	PLOS ONE			English	Article							LITTER DECOMPOSITION RATES; ARCTIC TUNDRA; NITROGEN-FIXATION; BOREAL; VEGETATION; SNOW; TEMPERATURE; BRYOPHYTE; EXPANSION; FOREST	In tundra ecosystems, bryophytes influence soil processes directly and indirectly through interactions with overstory shrub species. We experimentally manipulated moss cover and measured seasonal soil properties and processes under two species of deciduous shrubs with contrasting canopy structures, Salix planifolia pulchra and Betula glandulosa-nana complex. Soil properties (seasonal temperature, moisture and C:N ratios) and processes (seasonal litter decomposition and soil respiration) were measured over twelve months. Shrub species identity had the largest influence on summer soil temperatures and soil respiration rates, which were higher under Salix canopies. Mosses were associated with lower soil moisture irrespective of shrub identity, but modulated the effects of shrubs on winter soil temperatures and soil C:N ratios so that moss cover reduced differences in soil winter temperatures between shrub species and reduced C:N ratios under Betula but not under Salix canopies. Our results suggest a central role of mosses in mediating soil properties and processes, with their influence depending on shrub species identity. Such species-dependent effects need to be accounted for when forecasting vegetation dynamics under ongoing environmental changes.	[Bueno, C. Guillermo] Univ Tartu, Inst Ecol & Earth Sci, Dept Bot, Lai 40, EE-51005 Tartu, Estonia; [Bueno, C. Guillermo] Pyrenean Inst Ecol CSIC, Avda Nuestra Senora de la Victoria S-N, Jaca 22700, Spain; [Bueno, C. Guillermo; Williamson, Scott N.; Barrio, Isabel C.; Hik, David S.] Univ Alberta, Dept Biol Sci, Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada; [Barrio, Isabel C.; Helgadottir, Agusta] Univ Iceland, Dept Life & Environm Sci, Sturlugata 7, IS-101 Reykjavik, Iceland; [Helgadottir, Agusta] Soil Conservat Serv Iceland, IS-851 Gunnarsholt, Hella, Iceland	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); University of Alberta; University of Iceland	Bueno, CG (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Dept Bot, Lai 40, EE-51005 Tartu, Estonia.; Bueno, CG (corresponding author), Pyrenean Inst Ecol CSIC, Avda Nuestra Senora de la Victoria S-N, Jaca 22700, Spain.; Bueno, CG (corresponding author), Univ Alberta, Dept Biol Sci, Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.	cgbuenog@gmail.com	Bueno, C. Guillermo/F-8563-2010; Hik, David S/B-3462-2009; Barrio, Isabel C/F-8566-2010	Bueno, C. Guillermo/0000-0002-7288-2271; Hik, David S/0000-0002-8994-9305; Barrio, Isabel C/0000-0002-8120-5248	AXA Research Fund [PDOC_2011_W2]; NSERC Discovery Grant [RGPIN 179647-2010]	AXA Research Fund(AXA Research Fund); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	CGB and soil analyses were funded by AXA Research Fund PDOC_2011_W2 (https://www.axa-research.org/en/page/post-doctoral-fellowships). Fieldwork and material were funded by NSERC Discovery Grant: RGPIN 179647-2010 (http://www.nserc-crsng.gc.ca/index_eng.asp) with DSH as principal investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blok D, 2011, ECOSYSTEMS, V14, P1055, DOI 10.1007/s10021-011-9463-5; Buckeridge KM, 2010, PLANT SOIL, V330, P407, DOI 10.1007/s11104-009-0214-8; Cahoon SMP, 2012, ECOL LETT, V15, P1415, DOI 10.1111/j.1461-0248.2012.01865.x; Cornelissen JHC, 2007, ECOL LETT, V10, P619, DOI 10.1111/j.1461-0248.2007.01051.x; Danby RK, 2007, GLOBAL CHANGE BIOL, V13, P437, DOI 10.1111/j.1365-2486.2006.01302.x; Danby RK, 2011, AMBIO, V40, P660, DOI 10.1007/s13280-011-0172-2; DeLuca TH, 2002, NATURE, V419, P917, DOI 10.1038/nature01051; DeMarco J, 2014, ECOLOGY, V95, P1861, DOI 10.1890/13-2221.1; DeMarco J, 2011, ECOSYSTEMS, V14, P804, DOI 10.1007/s10021-011-9447-5; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; Flo D, 2013, ARCT ANTARCT ALP RES, V45, P481, DOI 10.1657/1938-4246-45.4.481; Frost GV, 2014, GLOBAL CHANGE BIOL, V20, P1264, DOI 10.1111/gcb.12406; Gauthier S, 2015, SCIENCE, V349, P819, DOI 10.1126/science.aaa9092; Gavazov KS, 2010, PLANT SOIL, V333, P507, DOI 10.1007/s11104-010-0374-6; Gornall JL, 2007, OECOLOGIA, V153, P931, DOI 10.1007/s00442-007-0785-0; Gornall JL, 2011, OECOLOGIA, V166, P769, DOI 10.1007/s00442-011-1911-6; Gornall JL, 2009, OECOLOGIA, V161, P747, DOI 10.1007/s00442-009-1427-5; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; IPPC, 2014, CLIMATE CHANGE 2014; Korner C, 2012, ALPINE TREELINES FUN, DOI 10.1007/978-3-0348-0396-0; Lang SI, 2009, J ECOL, V97, P886, DOI 10.1111/j.1365-2745.2009.01538.x; Lewkowicz AG, 2008, PERMAFROST PERIGLAC, V19, P323, DOI 10.1002/ppp.625; Liston GE, 2002, GLOBAL CHANGE BIOL, V8, P17, DOI 10.1046/j.1354-1013.2001.00416.x; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Melissa P, 2016, ENVIRON RES LETT, V11; Myers-Smith IH, 2013, ECOL EVOL, V3, P3683, DOI 10.1002/ece3.710; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Pajunen AM, 2011, J VEG SCI, V22, P837, DOI 10.1111/j.1654-1103.2011.01285.x; Pajunen A, 2012, OIKOS, V121, P1544, DOI 10.1111/j.1600-0706.2011.20115.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Rousk K, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00150; Rousk K, 2013, SOIL BIOL BIOCHEM, V61, P86, DOI 10.1016/j.soilbio.2013.02.011; Saccone P, 2013, PLANT SOIL, V363, P215, DOI 10.1007/s11104-012-1307-3; Safriel U., 2005, ECOSYSTEMS HUMAN WEL, P623; Schimel JP, 2004, SOIL BIOL BIOCHEM, V36, P217, DOI 10.1016/j.soilbio.2003.09.008; Segal AD, 2014, BIOGEOCHEMISTRY, V121, P489, DOI 10.1007/s10533-014-0017-8; Semenchuk PR, 2015, BIOGEOCHEMISTRY, V124, P81, DOI 10.1007/s10533-015-0082-7; Solheim B, 2004, SYMBIOSIS, V37, P169; Soudzilovskaia NA, 2013, FUNCT ECOL, V27, P1442, DOI 10.1111/1365-2435.12127; Soudzilovskaia NA, 2011, NEW PHYTOL, V190, P1019, DOI 10.1111/j.1469-8137.2011.03644.x; Sturm M, 2005, BIOSCIENCE, V55, P17, DOI 10.1641/0006-3568(2005)055[0017:WBPCHC]2.0.CO;2; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Sturm M, 2001, J CLIMATE, V14, P336, DOI 10.1175/1520-0442(2001)014<0336:SSIIAT>2.0.CO;2; Sturm M, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000013; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Turetsky MR, 2012, NEW PHYTOL, V196, P49, DOI 10.1111/j.1469-8137.2012.04254.x; Turetsky MR, 2010, CAN J FOREST RES, V40, P1237, DOI 10.1139/X10-072; Turetsky MR, 2003, BRYOLOGIST, V106, P395, DOI 10.1639/05; Williamson SN, 2016, GLOBAL CHANGE BIOL, V22, P3621, DOI 10.1111/gcb.13297; Williamson SN., 2015, ELEVATION DEPENDENT; Zuur Alain F., 2009, P1	52	9	9	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164143	10.1371/journal.pone.0164143	http://dx.doi.org/10.1371/journal.pone.0164143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760156	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204000030
J	Bian, SN; Zhang, YQ; Zhang, LF; Shi, XC; Liu, XQ				Bian, Sainan; Zhang, Yueqiu; Zhang, Lifan; Shi, Xiaochun; Liu, Xiaoqing			Diagnostic Value of Interferon-gamma Release Assays on Pericardial Effusion for Diagnosis of Tuberculous Pericarditis	PLOS ONE			English	Article							ELISPOT ASSAY; DISEASES; PERFORMANCE; PREDICTORS; INFECTION; FLUID; CELLS	Diagnosis of tuberculous pericarditis remains a challenge. We aimed in this study to evaluate the diagnostic value of T-SPOT. TB on pericardial effusion for diagnosis of tuberculous pericarditis. Patients with suspected tuberculous pericarditis were enrolled consecutively between August 2011 and December 2015. T-SPOT. TB was performed on both pericardial effusion mononuclear cells (PEMCs) and peripheral blood mononuclear cells (PBMCs). Sensitivity, specificity, predictive value (PV), and likelihood ratio (LR) of T-SPOT. TB on PEMCs and PBMCs were analyzed. Among the 75 patients enrolled, 24 patients (32%) were diagnosed with tuberculous pericarditis, 38 patients (51%) with nontuberculous pericarditis, and 13 patients (17%) were clinically indeterminate and were excluded from the final analysis. The sensitivity, specificity, positive PV (PPV), negative PV (NPV), positive LR (LR+), and negative LR (LR-) of T-SPOT. TB on PEMCs was 92%, 92%, 88%, 95%, 11.61, and 0.09, respectively, compared to 83%, 95%, 91%, 90%, 15.83, and 0.18, respectively of T-SPOT. TB on PBMCs. In patients with tuberculous pericarditis, the median frequencies of spot-forming cells (SFCs) of T-SPOT. TB on PEMCs and PBMCs was 172SFCs/10(6) MCs (IQR 39 similar to 486), and 66 SFCs/10(6) MCs (IQR 24 similar to 526), respectively, but the difference was not statistically significant (P = 0.183). T-SPOT. TB on PEMCs appeared to be a valuable and rapid diagnostic method for diagnosis of tuberculous pericarditis with high sensitivity and specificity.	[Bian, Sainan; Zhang, Yueqiu; Zhang, Lifan; Shi, Xiaochun; Liu, Xiaoqing] Chinese Acad Med Sci, Dept Infect Dis, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Bian, Sainan; Zhang, Yueqiu; Zhang, Lifan; Shi, Xiaochun; Liu, Xiaoqing] Peking Union Med Coll, Beijing, Peoples R China; [Zhang, Lifan; Liu, Xiaoqing] Peking Union Med Coll, Int Clin Epidemiol Network, Clin Epidemiol Unit, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, XQ (corresponding author), Chinese Acad Med Sci, Dept Infect Dis, Peking Union Med Coll Hosp, Beijing, Peoples R China.; Liu, XQ (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	liuxq@pumch.cn			Ministry of Science and Technology of the People's Republic of China [2014ZX10003003]; National Health and Family Planning Commission of the People's Republic of China [201402001]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Health and Family Planning Commission of the People's Republic of China	This work was supported by Ministry of Science and Technology of the People's Republic of China (grant number 2014ZX10003003, http://www.most.gov.cn/), and National Health and Family Planning Commission of the People's Republic of China (grant number 201402001, http://www.nhfpc.gov.cn/). The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Adler Y, 2015, EUR HEART J, V36, P2873, DOI 10.1093/eurheartj/ehv479; Bathoorn E, 2011, CLIN VACCINE IMMUNOL, V18, P874, DOI 10.1128/CVI.00031-11; Biglino A, 2008, INFECTION, V36, P601, DOI 10.1007/s15010-008-7402-y; Burgess LJ, 2002, CHEST, V122, P900, DOI 10.1378/chest.122.3.900; Cho OH, 2011, J INFECTION, V63, P362, DOI 10.1016/j.jinf.2011.06.010; Gao L, 2015, LANCET INFECT DIS, V15, P310, DOI 10.1016/S1473-3099(14)71085-0; Jung HJ, 2014, RHEUMATOL INT, V34, P1711, DOI 10.1007/s00296-014-3033-z; Kobashi Y, 2010, SCAND J INFECT DIS, V42, P712, DOI 10.3109/00365541003705768; Komiya K, 2010, INTERNAL MED, V49, P1849, DOI 10.2169/internalmedicine.49.3659; Ma W, 2012, HERZ, V37, P183, DOI 10.1007/s00059-011-3428-5; Macaskill P, 2002, STAT MED, V21, P2527, DOI 10.1002/sim.1227; Mayosi BM, 2005, CIRCULATION, V112, P3608, DOI 10.1161/CIRCULATIONAHA.105.543066; Mayosi BM, 2008, SAMJ S AFR MED J, V98, P36; Om SY, 2014, J AM COLL CARDIOL, V64, P1966, DOI 10.1016/j.jacc.2014.07.983; Papay P, 2011, EUR J CLIN INVEST, V41, P1071, DOI 10.1111/j.1365-2362.2011.02502.x; Qin L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141814; Wilkinson KA, 2005, CLIN INFECT DIS, V40, P184, DOI 10.1086/426139; World Health Organization, 2015, GLOB TUB REP 2015; Zhang LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086970	19	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0165008	10.1371/journal.pone.0165008	http://dx.doi.org/10.1371/journal.pone.0165008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755587	gold, Green Published, Green Submitted			2022-12-26	WOS:000386203800049
J	Pogson, M				Pogson, Mark			Simulation of Invertebrate Aggregation Shows the Importance of Stable Personality over Diversity in Consensus Decision-Making	PLOS ONE			English	Article							TERRESTRIAL ISOPODS ISOPODA; WOODLICE; EVOLUTIONARY; ONISCIDEA; LITTER; SWARM	Aggregation of many species of invertebrate is an example of a consensus decision, the success of which is central to survival. Personality is a stable form of behavioural diversity which has been observed in the aggregation process, but neither the reasons for its stability nor its effects on consensus decisions are well understood. By using an agent-based model of invertebrate aggregation, it is found that diverse personalities have only limited benefits to the experimental consensus decision-making process, but may have a more valuable role in natural settings. Importantly, although certain personalities may ostensibly have potential drawbacks at the individual level, such as choosing to rest in unfavourable places, all individuals are likely to benefit from maintaining a constant personality, which promotes group stability. These findings help to improve understanding of consensus decision-making and the prevalence of stable personality.	[Pogson, Mark] Liverpool John Moores Univ, Dept Appl Math, James Parsons Bldg,Byrom St, Liverpool L3 3AF, Merseyside, England	Liverpool John Moores University	Pogson, M (corresponding author), Liverpool John Moores Univ, Dept Appl Math, James Parsons Bldg,Byrom St, Liverpool L3 3AF, Merseyside, England.	m.a.pogson@ljmu.ac.uk	Pogson, Mark/D-9558-2016	Pogson, Mark/0000-0002-2116-7200				Allee WC, 1926, J EXP ZOOL, V45, P255, DOI 10.1002/jez.1400450108; Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; Anselme P, 2015, LEARN MOTIV, V50, P48, DOI 10.1016/j.lmot.2014.09.002; Broly P, 2013, INSECT SOC, V60, P419, DOI 10.1007/s00040-013-0313-7; Broly P, 2012, ZOOKEYS, P133, DOI 10.3897/zookeys.176.2258; Canonge S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019748; Canonge S, 2009, J INSECT PHYSIOL, V55, P976, DOI 10.1016/j.jinsphys.2009.06.011; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2013, AM NAT, V182, P592, DOI 10.1086/673253; Correll N, 2011, INT J ROBOT RES, V30, P615, DOI 10.1177/0278364911403017; Czaczkes TJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2723; Dammhahn M, 2012, P ROY SOC B-BIOL SCI, V279, P2645, DOI 10.1098/rspb.2012.0212; Devigne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017389; Dingemanse NJ, 2014, QUANTITATIVE GENETICS IN THE WILD, P54; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Godet JP, 2011, ECOTOX ENVIRON SAFE, V74, P451, DOI 10.1016/j.ecoenv.2010.09.007; HASSALL M, 1987, OECOLOGIA, V72, P597, DOI 10.1007/BF00378988; Holcombe M, 2012, INTEGR BIOL-UK, V4, P53, DOI 10.1039/c1ib00042j; Hong L, 2004, P NATL ACAD SCI USA, V101, P16385, DOI 10.1073/pnas.0403723101; Jeanson R, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00121; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; Luan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031043; Michelena P, 2010, P ROY SOC B-BIOL SCI, V277, P1093, DOI 10.1098/rspb.2009.1926; Planas-Sitja I, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2515; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; Zimmer M, 2005, FUNCT ECOL, V19, P7, DOI 10.1111/j.0269-8463.2005.00926.x; Zimmer M, 2002, BIOL REV, V77, P455, DOI 10.1017/S1464793102005912; Zimmer M, 2001, ANIM BEHAV, V62, P815, DOI 10.1006/anbe.2001.1845	35	7	7	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0165082	10.1371/journal.pone.0165082	http://dx.doi.org/10.1371/journal.pone.0165082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755591	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000386203800055
J	Lukovsky-Akhsanov, N; Keating, MK; Spivey, P; Lathrop, GW; Powell, N; Levine, ML				Lukovsky-Akhsanov, Nicole; Keating, M. Kelly; Spivey, Pamela; Lathrop, George W., Jr.; Powell, Nathaniel; Levine, Michael L.			Assessment of Domestic Goats as Models for Experimental and Natural Infection with the North American Isolate of Rickettsia slovaca	PLOS ONE			English	Article							DERMACENTOR-MARGINATUS TICKS; MOUNTAIN-SPOTTED-FEVER; BORNE RICKETTSIOSES; NORTHEASTERN SPAIN; VARIABILIS; RAOULTII	Rickettsia slovaca is a tick-borne human pathogen that is associated with scalp eschars and neck lymphadenopathy known as tick-borne lymphadenopathy (TIBOLA) or Dermacentor-borne necrosis erythema and lymphadenopathy (DEBONEL). Originally, R. slovaca was described in Eastern Europe, but since recognition of its pathogenicity, human cases have been reported throughout Europe. European vertebrate reservoirs of R. slovaca remain unknown, but feral swine and domestic goats have been found infected or seropositive for this pathogen. Recently, a rickettsial pathogen identical to R. slovaca was identified in, and isolated from, the American dog tick, Dermacentor variabilis. In previous experimental studies, this organism was found infectious to guinea pigs and transovarially transmissible in ticks. In this study, domestic goats (Capra hircus) were experimentally inoculated with the North American isolate of this R. slovaca-like agent to assess their reservoir competence-the ability to acquire the pathogens and maintain transmission between infected and uninfected ticks. Goats were susceptible to infection as demonstrated by detection of the pathogen in skin biopsies and multiple internal tissues, but the only clinical sign of illness was transient fever noted in three out of four goats, and reactive lymphoid hyperplasia. On average, less than 5% of uninfected ticks acquired the pathogen while feeding upon infected goats. Although domestic goats are susceptible to the newly described North American isolate of R. slovaca, they are likely to play a minor role in the natural transmission cycle of this pathogen. Our results suggest that goats do not propagate the North American isolate of R. slovaca in peridomestic environments and clinical diagnosis of infection could be difficult due to the brevity and mildness of clinical signs. Further research is needed to elucidate the natural transmission cycle of R. slovaca both in Europe and North America, as well as to identify a more suitable laboratory model.	[Lukovsky-Akhsanov, Nicole; Lathrop, George W., Jr.; Powell, Nathaniel] Ctr Dis Control & Prevent, Comparat Med Branch, Div Sci Resources, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Levine, Michael L.] Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Div Viral & Rickettsia! Dis, Natl Ctr Infect Dis, Atlanta, GA USA; [Keating, M. Kelly; Spivey, Pamela] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Lukovsky-Akhsanov, N (corresponding author), Ctr Dis Control & Prevent, Comparat Med Branch, Div Sci Resources, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	YJN2@cdc.gov						BREZINA R, 1969, ACTA VIROL, V13, P142; de Sousa R, 2013, EMERG INFECT DIS, V19, P1627, DOI 10.3201/eid1910.130376; ehuYek J., 1984, ACTA SCI NAT BRNO, V18, P1; Eremeeva ME, 2003, J CLIN MICROBIOL, V41, P5466, DOI 10.1128/JCM.41.12.5466-5472.2003; Instuite for Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; Killmaster LF, 2016, VECTOR BORN IN PRESS; Killmaster LF, 2016, VECTOR-BORNE ZOONOT, V16, P61, DOI 10.1089/vbz.2015.1860; Lennette EH, 1995, DIAGNOSTIC PROCEDURE, P633; Levin ML, 2016, TICKS TICK IN PRESS; Masala G, 2012, TICKS TICK-BORNE DIS, V3, P392, DOI 10.1016/j.ttbdis.2012.10.007; Ortuno A, 2007, VECTOR-BORNE ZOONOT, V7, P59, DOI 10.1089/vbz.2006.0576; Ortuno A, 2012, VECTOR-BORNE ZOONOT, V12, P1019, DOI 10.1089/vbz.2012.0972; Oteo JA, 2012, TICKS TICK-BORNE DIS, V3, P270, DOI 10.1016/j.ttbdis.2012.10.035; Paddock CD, 2008, CLIN INFECT DIS, V47, P1188, DOI 10.1086/592254; Parola P, 2009, EMERG INFECT DIS, V15, P1105, DOI 10.3201/eid1507.081449; Raoult D, 2002, CLIN INFECT DIS, V34, P1331, DOI 10.1086/340100; Raoult D, 1997, LANCET, V350, P112, DOI 10.1016/S0140-6736(05)61814-4; Selmi M, 2009, J MED ENTOMOL, V46, P1490, DOI 10.1603/033.046.0636; Spitalska E, 2012, EXP APPL ACAROL, V57, P189, DOI 10.1007/s10493-012-9539-8; Talley J., 2019, EXTERNAL PARASITES G; Troughton DR, 2007, J MED ENTOMOL, V44, P732, DOI 10.1603/0022-2585(2007)44[732:LCOSIT]2.0.CO;2; Zemtsova GE, 2016, VECTOR-BORNE ZOONOT, V16, P77, DOI 10.1089/vbz.2015.1844	22	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0165007	10.1371/journal.pone.0165007	http://dx.doi.org/10.1371/journal.pone.0165007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741322	Green Published, gold, Green Submitted			2022-12-26	WOS:000385507000087
J	Sugi, Y; Takahashi, K; Kurihara, K; Nakata, K; Narabayashi, H; Hamamoto, Y; Suzuki, M; Tsuda, M; Hanazawa, S; Hosono, A; Kaminogawa, S				Sugi, Yutaka; Takahashi, Kyoko; Kurihara, Kenta; Nakata, Kazuaki; Narabayashi, Hikari; Hamamoto, Yuji; Suzuki, Makoto; Tsuda, Masato; Hanazawa, Shigemasa; Hosono, Akira; Kaminogawa, Shuichi			Post-Transcriptional Regulation of Toll-Interacting Protein in the Intestinal Epithelium	PLOS ONE			English	Article							INTRACELLULAR TRAFFICKING; CELLS; HOST; GUT; MICROBIOTA; AUTOPHAGY; DIFFERENTIATION; SUSCEPTIBILITY; EXPRESSION; RECEPTORS	Immune responses against gut microbiota should be minimized to avoid unnecessary inflammation at mucosal surface. In this study, we analyzed the expression patterns of Toll-interacting protein (Tollip), an inhibitor of TLRs and IL-1 family cytokine-related intracellular signaling, in intestinal epithelial cells (IECs). Comparable mRNA expression was observed in murine small and large IECs (S-IECs and L-IECs). However, Tollip protein was only detected in L-IECs, but not in S-IECs. Similar results were obtained in germ-free mice, indicating that L-IEC-specific TOLLIP expression does not depend on bacterial colonization. Next, to understand the mechanisms underlying the post-transcriptional repression of Tollip, 3'-UTR-mediated translational regulation was evaluated. The region +1876/+2398 was responsible for the repression of Tollip expression. This region included the target sequence of miR-31. The inhibition of miR-31 restored the 3'-UTR-meditaed translational repression. In addition, miR-31 expression was significantly higher in S-IECs than in L-IECs, suggesting that miR-31 represses the translation of Tollip mRNA in S-IECs. Collectively, we conclude that the translation of Tollip is inhibited in S-IECs, at least in part, by miR-31 to yield L-IEC-specific high-level expression of the Tollip protein, which may contribute to the maintenance of intestinal homeostasis.	[Sugi, Yutaka; Takahashi, Kyoko; Kurihara, Kenta; Nakata, Kazuaki; Hamamoto, Yuji; Suzuki, Makoto; Tsuda, Masato; Hosono, Akira; Kaminogawa, Shuichi] Nihon Univ, Coll Bioresource Sci, Dept Food Biochem & Biotechnol, Kanagawa, Japan; [Takahashi, Kyoko; Nakata, Kazuaki; Narabayashi, Hikari; Hanazawa, Shigemasa] Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, Kanagawa, Japan	Nihon University; Nihon University	Takahashi, K (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Food Biochem & Biotechnol, Kanagawa, Japan.; Takahashi, K (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, Kanagawa, Japan.	ktaka@brs.nihon-u.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [26450165]; Institute for Fermentation, Osaka; Strategic Research Base Development Program, "International joint research and training of young researchers for zoonosis control in a globalized world"; Ministry of Education, Culture, Sports, Science and Technology of Japan [S0991023, S1491007]; Grants-in-Aid for Scientific Research [26292065] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); Strategic Research Base Development Program, "International joint research and training of young researchers for zoonosis control in a globalized world"; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants from the Japan Society for the Promotion of Science (KAKENHI 26450165, to K.T.) and the Institute for Fermentation, Osaka (K.T.). This work was also supported by the Strategic Research Base Development Program, "International joint research and training of young researchers for zoonosis control in a globalized world", and a matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S0991023 and S1491007).	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Amr KS, 2016, RHEUMATOL INT, V36, P1617, DOI 10.1007/s00296-016-3550-z; Asada R, 2012, J BIOL CHEM, V287, P8144, DOI 10.1074/jbc.M111.332593; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benjamin JL, 2013, CELL HOST MICROBE, V13, P723, DOI 10.1016/j.chom.2013.05.004; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Blanco FF, 2014, MOL CELL BIOL, V34, P180, DOI 10.1128/MCB.01020-13; Brandao I, 2015, GUT MICROBES, V6, P202, DOI 10.1080/19490976.2015.1034417; Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Cao SS, 2013, GASTROENTEROLOGY, V144, P989, DOI 10.1053/j.gastro.2013.01.023; Carames C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060878; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Fuke H, 2008, NUCLEIC ACIDS RES, V36, P1037, DOI 10.1093/nar/gkm1120; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Hino K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088048; Hormann N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113080; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Inoue J, 2012, ARCH BIOCHEM BIOPHYS, V521, P95, DOI 10.1016/j.abb.2012.03.019; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lee J, 2015, SCI REP-UK, V5, DOI 10.1038/srep18174; Liu SR, 2016, CELL HOST MICROBE, V19, P32, DOI 10.1016/j.chom.2015.12.005; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782; Maillard MH, 2014, INFLAMM BOWEL DIS, V20, P660, DOI 10.1097/MIB.0000000000000006; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Melmed G, 2003, J IMMUNOLOGY BALTIM, P170; Mlcochova J, 2015, ONCOTARGET, V6, P38695, DOI 10.18632/oncotarget.5735; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakato G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150379; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Podolsky DK, 2009, GASTROENTEROLOGY, V137, P209, DOI 10.1053/j.gastro.2009.03.007; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ramasamy S, 2011, INFLAMM BOWEL DIS, V17, P532, DOI 10.1002/ibd.21377; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schaefer JS, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0069-0; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Shifrin DA, 2012, CURR BIOL, V22, P627, DOI 10.1016/j.cub.2012.02.022; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588, DOI 10.4049/jimmunol.180.4.2588; Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007; Sugi Y, 2011, BIOCHEM BIOPH RES CO, V412, P704, DOI 10.1016/j.bbrc.2011.08.035; Takahashi K, 2011, J BIOL CHEM, V286, P35755, DOI 10.1074/jbc.M111.271007; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; Tateishi Y, 2015, PATHOL INT, V65, P513, DOI 10.1111/pin.12334; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311; Weilner S, 2016, AGING CELL, V15, P744, DOI 10.1111/acel.12484; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Yan S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8652; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010; Zhang LY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8639; Zhu L, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388009	69	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e164858	10.1371/journal.pone.0164858	http://dx.doi.org/10.1371/journal.pone.0164858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741296	Green Submitted, Green Published, gold			2022-12-26	WOS:000385507000075
J	Chandramouli, B; Bernacchioni, C; Di Maio, D; Turano, P; Brancato, G				Chandramouli, Balasubramanian; Bernacchioni, Caterina; Di Maio, Danilo; Turano, Paola; Brancato, Giuseppe			Electrostatic and Structural Bases of Fe2+ Translocation through Ferritin Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ferritin; ion channel; iron; molecular dynamics; translocation; ferritin channels; iron uptake; multi-ion mechanism; structure	PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; PROTEIN NANOCAGES; BINDING SITES; IRON-BINDING; ION CHANNELS; SUBSTRATE; RESIDUES; STORAGE; MECHANISM	Ferritin molecular cages are marvelous 24-mer supramolecular architectures that enable massive iron storage (>2000 iron atoms) within their inner cavity. This cavity is connected to the outer environment by two channels at C3 and C4 symmetry axes of the assembly. Ferritins can also be exploited as carriers for in vivo imaging and therapeutic applications, owing to their capability to effectively protect synthetic non-endogenous agents within the cage cavity and deliver them to targeted tissue cells without stimulating adverse immune responses. Recently, X-ray crystal structures of Fe2+-loaded ferritins provided important information on the pathways followed by iron ions toward the ferritin cavity and the catalytic centers within the protein. However, the specific mechanisms enabling Fe2+ uptake through wild-type and mutant ferritin channels is largely unknown. To shed light on this question, we report extensive molecular dynamics simulations, site-directed mutagenesis, and kinetic measurements that characterize the transport properties and translocation mechanism of Fe2+ through the two ferritin channels, using the wild-type bullfrog Rana catesbeiana H protein and some of its variants as case studies. We describe the structural features that determine Fe2+ translocation with atomistic detail, and we propose a putative mechanism for Fe2+ transport through the channel at the C3 symmetry axis, which is the only iron-permeable channel in vertebrate ferritins. Our findings have important implications for understanding how ion permeation occurs, and further how it may be controlled via purposely engineered channels for novel biomedical applications based on ferritin.	[Chandramouli, Balasubramanian; Di Maio, Danilo; Brancato, Giuseppe] Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56126 Pisa, Italy; [Chandramouli, Balasubramanian; Di Maio, Danilo; Brancato, Giuseppe] INFN, Sez Pisa, Largo Bruno Pontecorvo 3, I-56127 Pisa, Italy; [Bernacchioni, Caterina; Turano, Paola] Univ Florence, Magnet Resonance Ctr CERM, Via L Sacconi 6, I-50019 Sesto Fiorentino, Italy; [Chandramouli, Balasubramanian; Turano, Paola] Univ Florence, Dept Chem, Via L Sacconi 6, I-50019 Sesto Fiorentino, Italy	Scuola Normale Superiore di Pisa; Istituto Nazionale di Fisica Nucleare (INFN); University of Florence; University of Florence	Chandramouli, B; Brancato, G (corresponding author), Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56126 Pisa, Italy.	bala.chandramouli@sns.it; giuseppe.brancato@sns.it	Brancato, Giuseppe/A-4346-2010; CHANDRAMOULI, BALASUBRAMANIAN/L-9556-2018; Brancato, Giuseppe/U-7083-2019; Turano, Paola/F-9089-2011	CHANDRAMOULI, BALASUBRAMANIAN/0000-0002-6837-4709; Brancato, Giuseppe/0000-0001-8059-2517; Turano, Paola/0000-0002-7683-8614; Bernacchioni, Caterina/0000-0002-1023-0067	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) through the PRIN program [2012SK7ASN]; Scuola Normale Superiore Young Researchers Grant [2015/58]	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) through the PRIN program; Scuola Normale Superiore Young Researchers Grant	This work was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) through the PRIN program (Contract 2012SK7ASN). This work was also supported by a Scuola Normale Superiore Young Researchers Grant (2015/58) (to B.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aime S, 2002, ANGEW CHEM INT EDIT, V41, P1017, DOI 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO;2-P; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Arosio P, 2015, BIOCHEM J, V472, P1, DOI 10.1042/BJ20150787; Aryal P, 2015, J MOL BIOL, V427, P121, DOI 10.1016/j.jmb.2014.07.030; Banghart MR, 2006, BIOCHEMISTRY-US, V45, P15129, DOI 10.1021/bi0618058; Beckstein O, 2004, PHYS BIOL, V1, P42, DOI 10.1088/1478-3967/1/1/005; Behera RK, 2015, J BIOL INORG CHEM, V20, P957, DOI 10.1007/s00775-015-1279-x; Behera RK, 2014, P NATL ACAD SCI USA, V111, P7925, DOI 10.1073/pnas.1318417111; Bernacchioni C, 2016, RSC ADV, V6, P21219, DOI 10.1039/c5ra25056k; Bernacchioni C, 2016, CHEM-EUR J, V22, P16213, DOI 10.1002/chem.201602842; Bernacchioni C, 2015, BBA-PROTEINS PROTEOM, V1854, P1118, DOI 10.1016/j.bbapap.2015.02.011; Bernacchioni C, 2014, ACS CHEM BIOL, V9, P2517, DOI 10.1021/cb500431r; Bertini I, 2012, J AM CHEM SOC, V134, P6169, DOI 10.1021/ja210084n; Bou-Abdallah F, 2010, BBA-GEN SUBJECTS, V1800, P719, DOI 10.1016/j.bbagen.2010.03.021; Chandramouli B, 2016, BBA-BIOMEMBRANES, V1858, P689, DOI 10.1016/j.bbamem.2015.12.030; Chandramouli B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120196; Chasteen ND, 1998, MET IONS BIOL SYST, V35, P479; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; Darve E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829861; Di Maio D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140258; Ebrahimi KH, 2015, CHEM REV, V115, P295, DOI 10.1021/cr5004908; Haldar S, 2011, J BIOL CHEM, V286, P25620, DOI 10.1074/jbc.M110.205278; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Heger Z, 2014, NANOMEDICINE-UK, V9, P2233, DOI [10.2217/NNM.14.119, 10.2217/nnm.14.119]; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Hwang J, 2000, SCIENCE, V287, P122, DOI 10.1126/science.287.5450.122; Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996; Jutz G, 2015, CHEM REV, V115, P1653, DOI 10.1021/cr400011b; Laghaei R, 2013, PROTEINS, V81, P1042, DOI 10.1002/prot.24251; Levi S, 1996, BIOCHEM J, V317, P467, DOI 10.1042/bj3170467; Li PF, 2013, J CHEM THEORY COMPUT, V9, P2733, DOI 10.1021/ct400146w; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pozzi C, 2015, ACTA CRYSTALLOGR D, V71, P1909, DOI 10.1107/S1399004715013073; Pozzi C, 2015, ACTA CRYSTALLOGR D, V71, P941, DOI 10.1107/S1399004715002333; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Takahashi T, 2003, BIOPHYS J, V84, P2256, DOI 10.1016/S0006-3495(03)75031-0; Theil EC, 2000, INORG CHIM ACTA, V297, P242, DOI 10.1016/S0020-1693(99)00375-8; Theil EC, 2016, ACCOUNTS CHEM RES, V49, P784, DOI 10.1021/ar500469e; Theil EC, 2014, J BIOL INORG CHEM, V19, P615, DOI 10.1007/s00775-014-1103-z; Vasalatiy O, 2006, CONTRAST MEDIA MOL I, V1, P10, DOI 10.1002/cmmi.93	45	29	30	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25617	25628		10.1074/jbc.M116.748046	http://dx.doi.org/10.1074/jbc.M116.748046			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27756844	hybrid, Green Published			2022-12-26	WOS:000390095300028
J	Hosoi, A; Su, Y; Torikai, M; Jono, H; Ishikawa, D; Soejima, K; Higuchi, H; Guo, J; Ueda, M; Suenaga, G; Motokawa, H; Ikeda, T; Senju, S; Nakashima, T; Ando, Y				Hosoi, Akihiko; Su, Yu; Torikai, Masaharu; Jono, Hirofumi; Ishikawa, Daisuke; Soejima, Kenji; Higuchi, Hirofumi; Guo, Jianying; Ueda, Mitsuharu; Suenaga, Genki; Motokawa, Hiroaki; Ikeda, Tokunori; Senju, Satoru; Nakashima, Toshihiro; Ando, Yukio			Novel Antibody for the Treatment of Transthyretin Amyloidosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYPTIC EPITOPES; IN-VIVO; POLYNEUROPATHY; INHIBITION; EXPRESSION; DEPOSITION; MECHANISM; PROGRESS; PLASMA; TISSUE	Familial amyloidotic polyneuropathy (FAP) is a systemic amyloidosis mainly caused by amyloidogenic transthyretin (ATTR). This incurable disease causes death similar to 10 years after onset. Although it has been widely accepted that conformational change of the monomeric form of transthyretin (TTR) is very important for amyloid formation and deposition in the organs, no effective therapy targeting this step is available. In this study, we generated a mouse monoclonal antibody, T24, that recognized the cryptic epitope of conformationally changed TTR. T24 inhibited TTR accumulation in FAP model rats, which expressed human ATTR V30M in various tissues and exhibited non-fibrillar deposits of ATTR in the gastrointestinal tracts. Additionally, humanized T24 (RT24) inhibited TTR fibrillation and promoted macrophage phagocytosis of aggregated TTR. This antibody did not recognize normal serum TTR functioning properly in the blood. These results demonstrate that RT24 would be an effective novel therapeutic antibody for FAP.	[Hosoi, Akihiko; Torikai, Masaharu; Ishikawa, Daisuke; Soejima, Kenji; Higuchi, Hirofumi; Nakashima, Toshihiro] Chemoserotherapeut Res Inst KAKETSUKEN, 1314-1 Kyokushi Kawabe Kikuchi, Kumamoto 8691298, Japan; [Su, Yu; Guo, Jianying; Ueda, Mitsuharu; Suenaga, Genki; Motokawa, Hiroaki; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Ikeda, Tokunori; Senju, Satoru] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Jono, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmaceut Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Jono, Hirofumi] Kumamoto Univ Hosp, Dept Pharm, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Kumamoto University	Nakashima, T (corresponding author), Chemoserotherapeut Res Inst KAKETSUKEN, 1314-1 Kyokushi Kawabe Kikuchi, Kumamoto 8691298, Japan.; Ando, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	nakashima-to@kaketsuken.or.jp; andoy709@kumamoto-u.ac.jp	Ikeda, Tokunori/S-6043-2019; Ueda, Mitsuharu/Q-8595-2019	Ando, Yukio/0000-0001-7115-9105	Adaptable and Seamless Technology Transfer Program through Target-driven RAMP;D, Japan Science and Technology Agency [AS2311336G]; Surveys and Research on Specific Disease, the Ministry of Health and Welfare of Japan; Ministry of Education, Sports, Science and Technology of Japan [24249036, 15H04841, 15K15195, 15K15006]	Adaptable and Seamless Technology Transfer Program through Target-driven RAMP;D, Japan Science and Technology Agency; Surveys and Research on Specific Disease, the Ministry of Health and Welfare of Japan; Ministry of Education, Sports, Science and Technology of Japan(Core Research for Evolutional Science and Technology (CREST)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency, (AS2311336G), grants from the Surveys and Research on Specific Disease, the Ministry of Health and Welfare of Japan, Grants-in-Aid for Scientific Research from the Ministry of Education, Sports, Science and Technology of Japan: (A) 24249036 and (B) 15H04841, and Challenging Exploratory Research 15K15195 (to Y. A.) and 15K15006 (to H. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Ando Y, 2005, ARCH NEUROL-CHICAGO, V62, P1057, DOI 10.1001/archneur.62.7.1057; Ando Y, 1996, TRANSPLANTATION, V62, P1037, DOI 10.1097/00007890-199610150-00028; Araki S, 2010, P JPN ACAD B-PHYS, V86, P694, DOI 10.2183/pjab.86.694; Arsequell G, 2012, CURR MED CHEM, V19, P2343, DOI 10.2174/092986712800269281; Bergstrom J, 2006, BIOCHEM BIOPH RES CO, V348, P532, DOI 10.1016/j.bbrc.2006.07.140; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Eneqvist T, 2002, BIOCHEMISTRY-US, V41, P13143, DOI 10.1021/bi025800w; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; Falk RH, 2010, PROG CARDIOVASC DIS, V52, P347, DOI 10.1016/j.pcad.2009.11.007; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Foss TR, 2005, J MOL BIOL, V347, P841, DOI 10.1016/j.jmb.2005.01.050; GLENNER GG, 1980, NEW ENGL J MED, V302, P1333, DOI 10.1056/NEJM198006123022403; Goldsteins G, 1999, P NATL ACAD SCI USA, V96, P3108, DOI 10.1073/pnas.96.6.3108; GUSTAVSSON A, 1994, AM J PATHOL, V144, P1301; Haruta M, 2013, GENE THER, V20, P504, DOI 10.1038/gt.2012.59; Hou X, 2007, FEBS J, V274, P1637, DOI 10.1111/j.1742-4658.2007.05712.x; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kohno K, 1997, AM J PATHOL, V150, P1497; Lannfelt L, 2014, J INTERN MED, V275, P284, DOI 10.1111/joim.12168; Matsubara K, 2003, PROTEIN EXPRES PURIF, V30, P55, DOI 10.1016/S1046-5928(03)00069-X; Phay M, 2014, REJUV RES, V17, P97, DOI 10.1089/rej.2013.1524; Said G, 2012, NAT REV DRUG DISCOV, V11, P185, DOI 10.1038/nrd3675; Su Y, 2012, AMYLOID, V19, P45, DOI 10.3109/13506129.2012.674075; Terazaki H, 2006, LAB INVEST, V86, P23, DOI 10.1038/labinvest.3700365; Ueda M, 2007, BIOCHEM BIOPH RES CO, V352, P299, DOI 10.1016/j.bbrc.2006.11.045; Ueda M, 2006, J RHEUMATOL, V33, P2260; Ueda M, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-19; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0; Wisniewski T, 2015, NEURON, V85, P1162, DOI 10.1016/j.neuron.2014.12.064; Yonemura H, 2004, J BIOCHEM, V135, P577, DOI 10.1093/jb/mvh070	33	29	38	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25096	25105		10.1074/jbc.M116.738138	http://dx.doi.org/10.1074/jbc.M116.738138			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27758856	Green Published, hybrid			2022-12-26	WOS:000388880100025
J	Suzuki, Y; Ohya, S; Yamamura, H; Giles, WR; Imaizumi, Y				Suzuki, Yoshiaki; Ohya, Susumu; Yamamura, Hisao; Giles, Wayne R.; Imaizumi, Yuji			A New Splice Variant of Large Conductance Ca2+-activated K+ (BK) Channel Subunit Alters Human Chondrocyte Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; chondrocyte; fluorescence resonance energy transfer (FRET); molecular imaging; patch clamp; potassium channel; single molecule biophysics	POTASSIUM CHANNELS; CA2+ CHANNELS; EXPRESSION; TRAFFICKING; ACTIVATION; HISTAMINE; COMPLEX; STOICHIOMETRY; SURFACE; STRESS	Large conductance Ca2+-activated K+ (BK) channels play essential roles in both excitable and non-excitable cells. For example, in chondrocytes, agonist-induced Ca2+ release from intracellular store activates BK channels, and this hyperpolarizes these cells, augments Ca2+ entry, and forms a positive feed-back mechanism for Ca2+ signaling and stimulation-secretion coupling. In the present study, functional roles of a newly identified splice variant in the BK channel subunit (BKe2) were examined in a human chondrocyte cell line, OUMS-27, and in a HEK293 expression system. Although BKe2 lacks exon2, which codes the intracellular S0-S1 linker (Glu-127-Leu-180), significant expression was detected in several tissues from humans and mice. Molecular image analyses revealed that BKe2 channels are not expressed on plasma membrane but can traffic to the plasma membrane after forming hetero-tetramer units with wild-type BK (BKWT). Single-channel current analyses demonstrated that BK hetero-tetramers containing one, two, or three BKe2 subunits are functional. These hetero-tetramers have a smaller single channel conductance and exhibit lower trafficking efficiency than BKWT homo-tetramers in a stoichiometry-dependent manner. Site-directed mutagenesis of residues in exon2 identified Helix2 and the linker to S1 (Trp-158-Leu-180, particularly Arg-178) as an essential segment for channel function including voltage dependence and trafficking. BKe2 knockdown in OUMS-27 chondrocytes increased BK current density and augmented the responsiveness to histamine assayed as cyclooxygenase-2 gene expression. These findings provide significant new evidence that BKe2 can modulate cellular responses to physiological stimuli in human chondrocyte and contribute under pathophysiological conditions, such as osteoarthritis.	[Suzuki, Yoshiaki; Ohya, Susumu; Yamamura, Hisao; Imaizumi, Yuji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Mizuho Ku, 3-1 Tanabedori, Nagoya, Aichi 4678603, Japan; [Ohya, Susumu] Kyoto Pharmaceut Univ, Div Pathol Sci, Dept Pharmacol, Kyoto 6078414, Japan; [Giles, Wayne R.] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada; [Giles, Wayne R.] Univ Calgary, Fac Med, Calgary, AB T2N 1N4, Canada	Nagoya City University; Kyoto Pharmaceutical University; University of Calgary; University of Calgary	Imaizumi, Y (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Mizuho Ku, 3-1 Tanabedori, Nagoya, Aichi 4678603, Japan.	yimaizum@phar.nagoya-cu.ac.jp	Ohya, Susumu/AAB-3618-2020; Suzuki, Yoshiaki/ABH-5320-2020; Imaizumi, Yuji/AAF-6585-2020	Ohya, Susumu/0000-0002-5765-0667; Suzuki, Yoshiaki/0000-0002-7879-6059; 	Japan Society for the Promotion of Science [26293021, 15H01408, 26860059, 16H06215, 16K15127, 16K08278]; Takeda Science Foundation; Salt Science Research Foundation [1637]; Grants-in-Aid for Scientific Research [16K15127, 16K08278, 15H01408, 26293021] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Salt Science Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 26293021 and 15H01408 (to Y.I.), 26860059, 16H06215, and 16K15127 (to Y.S.), and 16K08278 (to H.Y.). This work was also supported by a grant-in-aid from Takeda Science Foundation (to Y.S.) and Salt Science Research Foundation Grant 1637 (to Y.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Barrett-Jolley R, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00135; Bharill S, 2014, P NATL ACAD SCI USA, V111, P6491, DOI 10.1073/pnas.1400248111; Braun AP, 2001, J PHYSIOL-LONDON, V533, P681, DOI 10.1111/j.1469-7793.2001.00681.x; Chen L, 2010, J BIOL CHEM, V285, P23263, DOI 10.1074/jbc.M110.139758; Contreras GF, 2013, CHANNELS, V7, P442, DOI 10.4161/chan.26242; Dabertrand F, 2006, CELL CALCIUM, V40, P11, DOI 10.1016/j.ceca.2006.03.008; Ding J, 2006, J BIOL CHEM, V281, P24405, DOI 10.1074/jbc.M600751200; Funabashi K, 2010, AM J PHYSIOL-CELL PH, V298, pC786, DOI 10.1152/ajpcell.00469.2009; Grumbach Y, 2014, AM J PHYSIOL-CELL PH, V307, pC701, DOI 10.1152/ajpcell.00134.2014; Gueguinou M, 2014, BBA-MOL CELL RES, V1843, P2322, DOI 10.1016/j.bbamcr.2014.02.019; Inayama M, 2015, CELL CALCIUM, V57, P337, DOI 10.1016/j.ceca.2015.02.005; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kitazawa M, 2014, J BIOL CHEM, V289, P17597, DOI 10.1074/jbc.M114.563452; Kurita T, 2015, MOL PHARMACOL, V88, P113, DOI 10.1124/mol.115.098160; Kwon SH, 2004, P NATL ACAD SCI USA, V101, P15237, DOI 10.1073/pnas.0404877101; Lewis R, 2013, CHANNELS, V7, P459, DOI 10.4161/chan.26071; Lewis R, 2011, CELL PHYSIOL BIOCHEM, V28, P1111, DOI 10.1159/000335847; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Mobasheri A, 2010, J CELL PHYSIOL, V223, P511, DOI 10.1002/jcp.22075; Niu XW, 2002, P NATL ACAD SCI USA, V99, P11441, DOI 10.1073/pnas.172254699; Shi P, 2013, BIOCHEM BIOPH RES CO, V437, P408, DOI 10.1016/j.bbrc.2013.06.091; Sugita S, 2015, P NATL ACAD SCI USA, V112, P3080, DOI 10.1073/pnas.1419699112; Suzuki Y, 2013, J BIOL CHEM, V288, P36750, DOI 10.1074/jbc.M113.511485; Suzuki Y, 2013, BIOCHEM BIOPH RES CO, V430, P1169, DOI 10.1016/j.bbrc.2012.12.015; Tetlow LC, 2005, RHEUMATOL INT, V26, P173, DOI 10.1007/s00296-005-0622-x; Tetlow LC, 2002, ANN RHEUM DIS, V61, P737, DOI 10.1136/ard.61.8.737; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Yamamura H, 2012, AM J PHYSIOL-CELL PH, V302, pC1257, DOI 10.1152/ajpcell.00191.2011; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101	30	18	19	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24247	24260		10.1074/jbc.M116.743302	http://dx.doi.org/10.1074/jbc.M116.743302			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27758860	hybrid, Green Published			2022-12-26	WOS:000388498100037
J	Fisher, JB; Horst, A; Wan, T; Kim, MS; Auchampach, J; Lough, J				Fisher, Joseph B.; Horst, Audrey; Wan, Tina; Kim, Min-Su; Auchampach, John; Lough, John			Depletion of Tip60 from In Vivo Cardiomyocytes Increases Myocyte Density, Followed by Cardiac Dysfunction, Myocyte Fallout and Lethality	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; CELL-CYCLE ARREST; HOMOZYGOUS DISRUPTION; HEART REGENERATION; ATRIAL FUNCTION; MOUSE; ACETYLATION; P53; ACTIVATION; EXPRESSION	Tat-interactive protein 60 (Tip60), encoded by the Kat5 gene, is a member of the MYST family of acetyltransferases. Cancer biology studies have shown that Tip60 induces the DNA damage response, apoptosis, and cell-cycle inhibition. Although Tip60 is expressed in the myocardium, its role in cardiomyocytes (CMs) is unclear. Earlier studies here showed that application of cardiac stress to globally targeted Kat5(+/-) haploinsufficient mice resulted in inhibition of apoptosis and activation of the CM cell-cycle, despite only modest reduction of Tip60 protein levels. It was therefore of interest to ascertain the effects of specifically and substantially depleting Tip60 from CMs using Kat5(LoxP/-;Myh6-Cre) mice in the absence of stress. We report initial findings using this model, in which the effects of specifically depleting Tip60 protein from ventricular CMs, beginning at early neonatal stages, were assessed in 2-12 week-old mice. Although 5'-bromodeoxyuridine immunostaining indicated that CM proliferation was not altered at any of these stages, CM density was increased in 2 week-old ventricles, which persisted in 4 week-old hearts when TUNEL staining revealed inhibition of apoptosis. By week 4, levels of connexin-43 were depleted, and its patterning was dysmorphic, concomitant with an increase in cardiac hypertrophy marker expression and interstitial fibrosis. This was followed by systolic dysfunction at 8 weeks, after which extensive apoptosis and CM fallout occurred, followed by lethality as mice approached 12 weeks of age. In summary, chronic depletion of Tip60 from the ventricular myocardium beginning at early stages of neonatal heart development causes CM death after 8 weeks; hence, Tip60 protein has a crucial function in the heart.	[Fisher, Joseph B.; Horst, Audrey; Kim, Min-Su; Lough, John] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Fisher, Joseph B.; Horst, Audrey; Wan, Tina; Kim, Min-Su; Auchampach, John; Lough, John] Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA; [Wan, Tina; Auchampach, John] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Horst, Audrey] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Boston University	Lough, J (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.; Lough, J (corresponding author), Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA.	jlough@mcw.edu			National Institutes of Health (U.S.) [HL089471, HL111392]	National Institutes of Health (U.S.)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by National Institutes of Health (U.S.) grants HL089471 (JL) and HL111392 (JA).	Ahuja P, 2004, J CELL SCI, V117, P3295, DOI 10.1242/jcs.01159; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; D'Uva G, 2015, NAT CELL BIOL, V17, P627, DOI 10.1038/ncb3149; Davis J, 2012, CIRC RES, V111, P761, DOI 10.1161/CIRCRESAHA.111.262717; Fisher JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031569; Gogna R, 2013, EMBO MOL MED, V5, P1662, DOI 10.1002/emmm.201202055; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Heallen T, 2013, DEVELOPMENT, V140, P4683, DOI 10.1242/dev.102798; Hu YF, 2009, DEV DYNAM, V238, P2912, DOI 10.1002/dvdy.22110; Huang CQ, 2003, DEVELOPMENT, V130, P6111, DOI 10.1242/dev.00831; Jeyaraman MM, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00090; Kardami E, 2007, PROG BIOPHYS MOL BIO, V94, P245, DOI 10.1016/j.pbiomolbio.2007.03.009; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Lough JW, 2002, DEV DYNAM, V223, P419, DOI 10.1002/dvdy.10058; Mahmoud AI, 2014, CELL CYCLE, V13, P1057, DOI 10.4161/cc.28379; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; NG WA, 1991, CIRC RES, V68, P1742, DOI 10.1161/01.RES.68.6.1742; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Sdek P, 2011, J CELL BIOL, V194, P407, DOI 10.1083/jcb.201012049; Severs NJ, 2004, CARDIOVASC RES, V62, P368, DOI 10.1016/j.cardiores.2003.12.007; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Szibor M, 2014, CELL MOL LIFE SCI, V71, P1907, DOI 10.1007/s00018-013-1535-6; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Tyteca S, 2006, MOL CELL, V24, P807, DOI 10.1016/j.molcel.2006.12.005; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; van Berlo JH, 2014, NAT MED, V20, P1386, DOI 10.1038/nm.3764; Xiao GS, 2001, CIRC RES, V89, P1122, DOI 10.1161/hh2401.100742; Xu YX, 2014, ONCOTARGET, V5, P12555, DOI 10.18632/oncotarget.2717	38	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164855	10.1371/journal.pone.0164855	http://dx.doi.org/10.1371/journal.pone.0164855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768769	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400032
J	Kancherla, S; Kohler, WJ; van der Merwe, Y; Chan, KC				Kancherla, Swarupa; Kohler, William J.; van der Merwe, Yolandi; Chan, Kevin C.			In Vivo Evaluation of the Visual Pathway in Streptozotocin-Induced Diabetes by Diffusion Tensor MRI and Contrast Enhanced MRI	PLOS ONE			English	Article							RAT OPTIC-NERVE; WHITE-MATTER; INTRAVITREAL INJECTION; AXONAL-TRANSPORT; IMAGING DETECTS; MULTIMODAL MRI; DAVUNETIDE NAP; MOUSE MODEL; RETINOPATHY; RETINA	Visual function has been shown to deteriorate prior to the onset of retinopathy in some diabetic patients and experimental animal models. This suggests the involvement of the brain's visual system in the early stages of diabetes. In this study, we tested this hypothesis by examining the integrity of the visual pathway in a diabetic rat model using in vivo multi-modal magnetic resonance imaging (MRI). Ten-week-old Sprague-Dawley rats were divided into an experimental diabetic group by intraperitoneal injection of 65 mg/kg streptozotocin in 0.01 M citric acid, and a sham control group by intraperitoneal injection of citric acid only. One month later, diffusion tensor MRI (DTI) was performed to examine the white matter integrity in the brain, followed by chromium-enhanced MRI of retinal integrity and manganese-enhanced MRI of anterograde manganese transport along the visual pathway. Prior to MRI experiments, the streptozotocin-induced diabetic rats showed significantly smaller weight gain and higher blood glucose level than the control rats. DTI revealed significantly lower fractional anisotropy and higher radial diffusivity in the prechiasmatic optic nerve of the diabetic rats compared to the control rats. No apparent difference was observed in the axial diffusivity of the optic nerve, the chromium enhancement in the retina, or the manganese enhancement in the lateral geniculate nucleus and superior colliculus between groups. Our results suggest that streptozotocin-induced diabetes leads to early injury in the optic nerve when no substantial change in retinal integrity or anterograde transport along the visual pathways was observed in MRI using contrast agent enhancement. DTI may be a useful tool for detecting and monitoring early pathophysiological changes in the visual system of experimental diabetes non-invasively.	[Kancherla, Swarupa; Kohler, William J.; van der Merwe, Yolandi; Chan, Kevin C.] Univ Pittsburgh, Neurolmaging Lab, Pittsburgh, PA 15260 USA; [Kancherla, Swarupa; Kohler, William J.; van der Merwe, Yolandi; Chan, Kevin C.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, UPMC Eye Ctr,Ophthalmol & Visual Sci Res Ctr, Pittsburgh, PA 15261 USA; [van der Merwe, Yolandi; Chan, Kevin C.] Univ Pittsburgh, Dept Bioengn, Swanson Sch Engn, Pittsburgh, PA 15260 USA; [van der Merwe, Yolandi; Chan, Kevin C.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA; [van der Merwe, Yolandi; Chan, Kevin C.] Univ Pittsburgh, Louis J Fox Ctr Vis Restorat, Pittsburgh, PA 15260 USA; [Chan, Kevin C.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA; [Chan, Kevin C.] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Chan, Kevin C.] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; University of Hong Kong	Chan, KC (corresponding author), Univ Pittsburgh, Neurolmaging Lab, Pittsburgh, PA 15260 USA.; Chan, KC (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, UPMC Eye Ctr,Ophthalmol & Visual Sci Res Ctr, Pittsburgh, PA 15261 USA.; Chan, KC (corresponding author), Univ Pittsburgh, Dept Bioengn, Swanson Sch Engn, Pittsburgh, PA 15260 USA.; Chan, KC (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.; Chan, KC (corresponding author), Univ Pittsburgh, Louis J Fox Ctr Vis Restorat, Pittsburgh, PA 15260 USA.; Chan, KC (corresponding author), Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA.; Chan, KC (corresponding author), Carnegie Mellon Univ, Pittsburgh, PA 15213 USA.; Chan, KC (corresponding author), Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China.	chuenwing.chan@fulbrightmail.org	Chan, Kevin C/AAK-7665-2020; Kancherla, Swarupa/AAM-3996-2020	Chan, Kevin C/0000-0003-4012-7084; 	National Institutes of Health (Bethesda, Maryland) [P30-EY008098, UL1-TR000005]; BrightFocus Foundation (Clarksburg, Maryland) [G2013077]; Alcon Research Institute Young Investigator Grant (Fort Worth, Texas); Eye and Ear Foundation (Pittsburgh, Pennsylvania); Research to Prevent Blindness (New York, New York)	National Institutes of Health (Bethesda, Maryland)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BrightFocus Foundation (Clarksburg, Maryland)(BrightFocus Foundation); Alcon Research Institute Young Investigator Grant (Fort Worth, Texas); Eye and Ear Foundation (Pittsburgh, Pennsylvania); Research to Prevent Blindness (New York, New York)(Research to Prevent Blindness (RPB))	This work was supported by the National Institutes of Health Contracts P30-EY008098, and UL1-TR000005 (Bethesda, Maryland); BrightFocus Foundation G2013077 (Clarksburg, Maryland); Alcon Research Institute Young Investigator Grant (Fort Worth, Texas); Eye and Ear Foundation (Pittsburgh, Pennsylvania); and Research to Prevent Blindness (New York, New York) (All to KC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2000, METABOLISM, V49, P990, DOI 10.1053/meta.2000.7729; Aleman R, 2016, Arch Soc Esp Oftalmol, V91, P170, DOI 10.1016/j.oftal.2015.12.017; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; BELL RC, 1994, ENDOCRINOLOGY, V135, P2681, DOI 10.1210/en.135.6.2681; Berkowitz Bruce A, 2013, Expert Opin Med Diagn, V7, P393, DOI 10.1517/17530059.2013.814639; Berkowitz BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029619; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P2351, DOI 10.1167/iovs.08-2918; BRADBURY MWB, 1991, EXP PHYSIOL, V76, P887, DOI 10.1113/expphysiol.1991.sp003551; Bui BV, 2009, EXP EYE RES, V88, P1076, DOI 10.1016/j.exer.2009.01.009; BUSIK JV, 2009, METH MOL B 1, V579, P33, DOI DOI 10.1007/978-1-60761-322-0_; Chan KC, 2008, NEUROIMAGE, V40, P1166, DOI 10.1016/j.neuroimage.2008.01.002; Chan KC, 2015, INVEST OPHTH VIS SCI, V56, P1, DOI 10.1167/iovs.14-14287; Chan KC, 2014, NEUROIMAGE, V90, P235, DOI 10.1016/j.neuroimage.2013.12.056; Chan KC, 2012, MAGN RESON MED, V68, P1202, DOI 10.1002/mrm.24123; Chan KC, 2012, NEUROIMAGE, V59, P2274, DOI 10.1016/j.neuroimage.2011.09.055; Chan KC, 2011, NEUROIMAGE, V54, P389, DOI 10.1016/j.neuroimage.2010.07.015; Chan KC, 2009, INT J DEV NEUROSCI, V27, P607, DOI 10.1016/j.ijdevneu.2009.05.012; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; Chiang CW, 2014, NEUROIMAGE, V101, P310, DOI 10.1016/j.neuroimage.2014.06.064; Colantuoni A, 2002, DIABETOLOGIA, V45, P121, DOI 10.1007/s125-002-8252-0; Cortright RN, 1996, PHYSIOL BEHAV, V60, P1233, DOI 10.1016/S0031-9384(96)00222-3; Deeds MC, 2011, LAB ANIM-UK, V45, P131, DOI 10.1258/la.2010.010090; DILEO MAS, 1992, DIABETES CARE, V15, P620, DOI 10.2337/diacare.15.5.620; Dorfman D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136637; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Ewing FME, 1998, ENDOCR REV, V19, P462, DOI 10.1210/er.19.4.462; FALSINI B, 1989, DOC OPHTHALMOL, V73, P193, DOI 10.1007/BF00155037; Fernandez DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051966; Fernandez DC, 2012, AM J PATHOL, V180, P303, DOI 10.1016/j.ajpath.2011.09.018; FORRESTER J, 1967, NATURE, V214, P245, DOI 10.1038/214245a0; GHAFOUR IM, 1982, BRIT J OPHTHALMOL, V66, P492, DOI 10.1136/bjo.66.8.492; Ghita A M, 2013, J Med Life, V6, P340; Heravian Javad, 2012, J Ophthalmic Vis Res, V7, P225; Ho LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep32080; Ho LC, 2015, INVEST OPHTH VIS SCI, V56, P3788, DOI 10.1167/iovs.14-15552; Hori M, 2012, MAGN RESON MED SCI, V11, P221, DOI 10.2463/mrms.11.221; Huang MM, 2012, NEUROIMAGE-CLIN, V1, P57, DOI 10.1016/j.nicl.2012.09.004; Idan-Feldman A, 2011, NEUROBIOL DIS, V44, P327, DOI 10.1016/j.nbd.2011.06.020; Ino-ue M, 2000, INVEST OPHTH VIS SCI, V41, P4055; Karlica D, 2010, COLLEGIUM ANTROPOL, V34, P525; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kodl CT, 2008, DIABETES, V57, P3083, DOI 10.2337/db08-0724; Kohzaki K, 2008, INVEST OPHTH VIS SCI, V49, P3595, DOI 10.1167/iovs.08-1679; Kusari J, 2007, INVEST OPHTH VIS SCI, V48, P5152, DOI 10.1167/iovs.07-0427; LEITER EH, 1982, P NATL ACAD SCI-BIOL, V79, P630, DOI 10.1073/pnas.79.2.630; MEDORI R, 1985, P NATL ACAD SCI USA, V82, P7716, DOI 10.1073/pnas.82.22.7716; MOSS SE, 1988, OPHTHALMOLOGY, V95, P1340; Muir ER, 2015, INVEST OPHTH VIS SCI, V56, P4006, DOI 10.1167/iovs.14-16128; Muir ER, 2012, INVEST OPHTH VIS SCI, V53, P6488, DOI 10.1167/iovs.12-9758; O'Connell CM, 2016, NEUROREPORT IN PRESS; Obrosova IG, 2006, DIABETOLOGIA, V49, P2525, DOI 10.1007/s00125-006-0356-7; Obrosova IG, 2000, EUR J PHARMACOL, V398, P139, DOI 10.1016/S0014-2999(00)00286-7; Olsen O, 2008, J MAGN RESON IMAGING, V27, P34, DOI 10.1002/jmri.21234; Ozawa Y, 2011, EXP DIABETES RES, DOI 10.1155/2011/108328; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Paxinos G., 2007, THE RAT BRAIN IN STE; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Roy S, 2016, EXP EYE RES, V142, P71, DOI 10.1016/j.exer.2015.04.004; Sase K, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00425; SCOTT TM, 1986, J ANAT, V144, P145; Scuderi S, 2014, J MOL NEUROSCI, V54, P395, DOI 10.1007/s12031-014-0244-4; Seigel GM, 2006, J DIABETES COMPLICAT, V20, P196, DOI 10.1016/j.jdiacomp.2005.06.007; Sharma R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013463; Simo R, 2014, TRENDS ENDOCRIN MET, V25, P23, DOI 10.1016/j.tem.2013.09.005; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Szabadfi K, 2014, NEUROCHEM INT, V64, P84, DOI 10.1016/j.neuint.2013.11.005; Thuen M, 2008, J MAGN RESON IMAGING, V28, P855, DOI 10.1002/jmri.21504; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Trick GL, 2008, NMR BIOMED, V21, P1003, DOI 10.1002/nbm.1314; TRICK GL, 1988, DOC OPHTHALMOL, V70, P19, DOI 10.1007/BF00154732; Wang XJ, 2014, NMR BIOMED, V27, P843, DOI 10.1002/nbm.3129; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Watanabe T, 2006, MAGN RESON MED, V56, P1, DOI 10.1002/mrm.20930; Wolff BE, 2010, DOC OPHTHALMOL, V121, P189, DOI 10.1007/s10633-010-9245-y; Yau PL, 2009, PSYCHIAT RES-NEUROIM, V174, P223, DOI 10.1016/j.pscychresns.2009.04.016; Zhang JF, 2008, INVEST OPHTH VIS SCI, V49, P732, DOI 10.1167/iovs.07-0721; Zhang XY, 2013, INT J BIOCHEM CELL B, V45, P1525, DOI 10.1016/j.biocel.2013.03.002	79	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165169	10.1371/journal.pone.0165169	http://dx.doi.org/10.1371/journal.pone.0165169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768755	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400061
J	Kesselheim, AS; Eddings, W; Raj, T; Campbell, EG; Franklin, JM; Ross, KM; Fulchino, LA; Avorn, J; Gagne, JJ				Kesselheim, Aaron S.; Eddings, Wesley; Raj, Tara; Campbell, Eric G.; Franklin, Jessica M.; Ross, Kathryn M.; Fulchino, Lisa A.; Avorn, Jerry; Gagne, Joshua J.			Physicians' Trust in the FDA's Use of Product-Specific Pathways for Generic Drug Approval	PLOS ONE			English	Article							BRAND-NAME DRUGS; SCIENTIFIC CONSIDERATIONS; CARDIOVASCULAR-DISEASE; PERCEPTIONS; TACROLIMUS; MEDICINES	Background Generic drugs are cost-effective versions of brand-name drugs approved by the Food and Drug Administration (FDA) following proof of pharmaceutical equivalence and bioequivalence. Generic drugs are widely prescribed by physicians, although there is disagreement over the clinical comparability of generic drugs to brand-name drugs within the physician community. The objective of this survey was to assess physicians' perceptions of generic drugs and the generic drug approval process. Methods and Findings A survey was administered to a national sample of primary care internists and specialists between August 2014 and January 2015. In total, 1,152 physicians comprising of internists with no reported specialty certification and those with specialty certification in hematology, infectious diseases, and endocrinology were surveyed. The survey assessed physicians' perceptions of the FDA's generic drug approval process, as well as their experiences prescribing six generic drugs approved between 2008 and 2012 using product-specific approval pathways and selected comparator drugs. Among 718 respondents (62% response rate), a majority were comfortable with the FDA's process in ensuring the safety and effectiveness of generic drugs overall (91%) and with letting the FDA determine which tests were necessary to determine bioequivalence in a particular drug (92%). A minority (13-26%) still reported being uncomfortable prescribing generic drugs approved using product-specific pathways. Overall, few physicians heard reports of concerns about generic versions of the study drugs or their comparators, with no differences between the two groups. Physicians tended to hear about concerns about the safety or effectiveness of generic drugs from patients, pharmacists, and physician colleagues. Conclusions Physicians hold largely positive views of the FDA's generic drug approval process even when some questioned the performance of certain generic drugs in comparison to brand-name drugs. Better education about the generic drug approval process and standards may alleviate concerns among the physician community and support the delivery of cost-effective health care.	[Kesselheim, Aaron S.; Eddings, Wesley; Raj, Tara; Franklin, Jessica M.; Fulchino, Lisa A.; Avorn, Jerry; Gagne, Joshua J.] Brigham & Womens Hosp, Dept Med, PORTAL, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Kesselheim, Aaron S.; Eddings, Wesley; Raj, Tara; Franklin, Jessica M.; Fulchino, Lisa A.; Avorn, Jerry; Gagne, Joshua J.] Harvard Med Sch, Boston, MA 02115 USA; [Campbell, Eric G.] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; [Ross, Kathryn M.] Amer Board Internal Med, Philadelphia, PA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; American Board of Internal Medicine	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, PORTAL, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.; Kesselheim, AS (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	akesselheim@partners.org			FDA Office of Generic Drugs	FDA Office of Generic Drugs	This study was funded by a grant from the FDA Office of Generic Drugs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell L, 2003, CITIZENS PETITION; Berg MJ, 2007, NEUROLOGY, V68, P1245, DOI 10.1212/01.wnl.0000262876.37269.8b; Bloom RD, 2013, CLIN TRANSPLANT, V27, pE685, DOI 10.1111/ctr.12256; Buono D, 2008, COBALT DISMISSES GEN; Corrao G, 2014, EUR J CLIN INVEST, V44, P933, DOI 10.1111/eci.12326; Department of Justice, 2013, GEN DRUG MAN RANB PL; Dmyterko K, 2010, SNOFI SLAPS FDA LAWS; Dunne SS, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0415-3; Dunne SS, 2014, FAM PRACT, V31, P467, DOI 10.1093/fampra/cmu024; Edlin M, 2010, MODERN MED; Food and Drug Administration, 2012, FACT SHEET NEW US FE; Food and Drug Administration, 2008, GUID VANC H IN PRESS; Food and Drug Administration, 2010, GUID IND BIOEQ REC S; Food and Drug Administration, 2013, RFAFD13022; Gagne JJ, 2016, PHARMACOEPIDEM DR S, V25, P944, DOI 10.1002/pds.4009; Gagne JJ, 2014, ANN INTERN MED, V161, P400, DOI 10.7326/M13-2942; Garattini L, 2000, HEALTH POLICY, V51, P149, DOI 10.1016/S0168-8510(00)00061-0; Gothe H, 2015, APPL HEALTH ECON HEA, V13, pS21, DOI 10.1007/s40258-014-0147-0; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; Hakonsen H, 2009, HEALTH POLICY, V90, P277, DOI 10.1016/j.healthpol.2008.09.018; Kanavos P, 1999, PHARMACOECONOMICS, V15, P519, DOI 10.2165/00019053-199915060-00001; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Kesselheim AS, 2012, NEW ENGL J MED, V367, P1119, DOI 10.1056/NEJMsa1202397; Lee S, 2013, NAT BIOTECHNOL, V31, P220, DOI 10.1038/nbt.2528; Lee SL, 2011, AAPS J, V13, P14, DOI 10.1208/s12248-010-9242-9; McManus P, 2001, PHARMACOEPIDEM DR S, V10, P295, DOI 10.1002/pds.603; Rakoczy WA, 2007, CITIZENS PETITION; Regulatory Affairs Professional Society, 2014, PUBL VIEW FDA CONT I; Shrank WH, 2011, ANN PHARMACOTHER, V45, P31, DOI 10.1345/aph.1P389; Simoens Steven, 2008, Expert Rev Clin Pharmacol, V1, P497, DOI 10.1586/17512433.1.4.497; Taube D, 2014, CLIN TRANSPLANT, V28, P623, DOI 10.1111/ctr.12336; US Food and Drug Administration, OR BOOK PREF; Weng W GB, 2010, RACIAL DISPARITY QUA; Yu LX, 2015, CLIN PHARMACOL THER, V97, P286, DOI 10.1002/cpt.28; Zajac A, 2013, VIROPHARMA SUIT FDA; Zhang Y GR, 2011, LONGITUDINAL ANAL CE	36	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0163339	10.1371/journal.pone.0163339	http://dx.doi.org/10.1371/journal.pone.0163339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768700	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400003
J	de Lima, FF; Menegati, SELT; Traesel, GK; de Araujo, FHS; Lescano, CH; Peixoto, SM; Silva, FAM; Vieira, SCH; Vieira, MD; Oesterreich, SA				de Lima, Fernando Freitas; Lima Tolouei Menegati, Sara Emilia; Traesel, Giseli Karenina; Souza de Araujo, Flavio Henrique; Lescano, Caroline Honaiser; Peixoto, Sara Moraes; Mao Silva, Felipe Ariel; Heredia Vieira, Silvia Cristina; Vieira, Maria do Carmo; Oesterreich, Silvia Aparecida			Study on the Cytotoxic, Genotoxic and Clastogenic Potential of Attalea phalerata Mart. ex Spreng. Oil Pulp In Vitro and In Vivo Experimental Models	PLOS ONE			English	Article							COMET ASSAY; MICRONUCLEUS; ARTHRITIS; BIOASSAY; EXTRACT; FRUITS; CELLS	Attalea phalerata Mart. ex Spreng. (Arecaceae), popularly known as "bacuri", is used in Brazilian folk medicine. Its oil is used orally to relieve pulmonary congestion and joint pain. In topical applications, it is applied as an effective hair tonic and anti-dandruff. The in natura pulp and its nuts are used as food because of its nutritional value. Despite its use in folk medicine, there is a lack of data regarding its in vivo/in vitro cytotoxic/genotoxic and clastogenic effects. Therefore, in this study, we evaluated the cytotoxic, genotoxic and clastogenic effects of Attalea phalerata Mart. ex Spreng. oil (APMO) in vitro and in vivo. For the analysis of cytotoxic potential, the Artemia salina and MTT (3-(4,5-dimethizzol-zyl)-2,5-diphenyltetrazolium bromide) assays were performed. Possible cytotoxic, genotoxic and clastogenic effects of APMO intake were determined by performing the comet and micronucleus assays. Male and female Wistar rats were orally treated with doses of 125, 250, 500 or 1000 mg.kg(-1) of the APMO daily for 28 consecutive days (four weeks). The results showed that the APMO did not induce cell death in the experiments of Artemia salina and MTT, indicating that it has no cytotoxicity. The APMO did not cause significant damage to the DNA of the rats in the four doses used when compared to the negative control group (saline + Tween (R) 80). The APMO did not present any significant increase in micronucleated polychromatic erythrocytes (MNPCEs) for the four tested doses. When compared to the positive control group, all groups (comet and micronucleus tests) were statistically different. These data suggest that the administration of Attalea phalerata Mart oil. ex Spreng does not cause cytotoxicity, genotoxicity and clastogenicity in experimental models in vitro and in vivo following oral administration in this study.	[de Lima, Fernando Freitas; Traesel, Giseli Karenina; Peixoto, Sara Moraes; Mao Silva, Felipe Ariel; Oesterreich, Silvia Aparecida] Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, Brazil; [Lima Tolouei Menegati, Sara Emilia] Fed Univ Grande Dourados, Fac Biol & Environm Sci, Dourados, Brazil; [Vieira, Maria do Carmo] Fed Univ Grande Dourados, Fac Agr Sci, Dourados, Brazil; [Heredia Vieira, Silvia Cristina] Univ Estadual Mato Grosso do Sul, Biodivers Ctr, Dourados, Brazil; [Souza de Araujo, Flavio Henrique] Univ Fed Mato Grosso do Sul, Ctr Biol & Hlth Sci, Campo Grande, Brazil; [Lescano, Caroline Honaiser] Univ Estadual Campinas, Fac Med Sci, Campinas, Brazil	Universidade Federal da Grande Dourados; Universidade Federal da Grande Dourados; Universidade Federal da Grande Dourados; Universidade Estadual de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Universidade Estadual de Campinas	de Lima, FF (corresponding author), Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, Brazil.	flfernando_@hotmail.com	Heredia, Silvia/AAF-7602-2019; de Lima, Fernando Freitas/E-6661-2017; Lescano, Caroline C.H.L Honaiser/I-2108-2017; de Araújo, Flávio Henrique Souza/AAM-6252-2020; Vieira, Maria do Carmo MCV/D-4860-2016	de Lima, Fernando Freitas/0000-0001-5889-8165; Lescano, Caroline C.H.L Honaiser/0000-0003-4193-7361; de Araújo, Flávio Henrique Souza/0000-0003-1282-3162; Lima Tolouei, Sara Emilia/0000-0002-5147-6434	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	To the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for the financial support.	Al-Okbi SY, 2014, TOXICOL IND HEALTH, V30, P738, DOI 10.1177/0748233712462468; Araldi RP, 2015, BIOMED PHARMACOTHER, V72, P74, DOI 10.1016/j.biopha.2015.04.004; Balslev H, 1989, AAU REPORTS, P1; de Oliveira FFB, 2015, J ETHNOPHARMACOL, V174, P452, DOI 10.1016/j.jep.2015.08.017; Negrelle RRB, 2015, CIENC FLOREST, V25, P1061, DOI 10.5902/1980509820669; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; da Silva CJ, 2010, HUM EXP TOXICOL, V29, P187, DOI 10.1177/0960327109358732; Gomes FdS, 2007, REV NUTR, V20, P537; Hall AH, 1998, TOXICOL LETT, V103, P623; Hartmann A, 2003, MUTAGENESIS, V18, P45, DOI 10.1093/mutage/18.1.45; Kaulmann A, 2014, NUTR RES, V34, P907, DOI 10.1016/j.nutres.2014.07.010; Lescano CH, 2015, J MED FOOD, V18, P656, DOI 10.1089/jmf.2014.0077; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Malta LG, 2012, FOOD RES INT, V49, P604, DOI 10.1016/j.foodres.2012.07.055; Martins MD, 2014, J ETHNOPHARMACOL, V151, P485, DOI 10.1016/j.jep.2013.10.063; MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236; Munari CC, 2012, FOOD CHEM TOXICOL, V50, P3696, DOI 10.1016/j.fct.2012.07.028; OECD, TEST NO 489 IN VIV M; OECD, TEST NO 474 MAMM FRY; Organization for Economic Co- operation and Development, TEST NO 407 REP DOS; Quassinti L, 2013, NAT PROD RES, V27, P862, DOI 10.1080/14786419.2012.677044; Ribnicky DM, 2008, AM J CLIN NUTR, V87, p472S, DOI 10.1093/ajcn/87.2.472S; Rodriguez-Amaya DB, 2010, J FOOD COMPOS ANAL, V23, P726, DOI 10.1016/j.jfca.2010.03.008; Sadeghi I, 2013, IRAN RED CRESCENT ME, V15, P70, DOI 10.5812/ircmj.4989; Samanta S, 2012, DIAGN CYTOPATHOL, V40, P84, DOI 10.1002/dc.21592; Sharififar F, 2009, PAK J PHARM SCI, V22, P317; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Vinod V, 2011, J ETHNOPHARMACOL, V134, P931, DOI 10.1016/j.jep.2011.02.003	28	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165258	10.1371/journal.pone.0165258	http://dx.doi.org/10.1371/journal.pone.0165258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764219	gold, Green Submitted, Green Published			2022-12-26	WOS:000386204500142
J	Nathalang, O; Panichrum, P; Intharanut, K; Thattanon, P; Nathalang, S				Nathalang, Oytip; Panichrum, Puangpaka; Intharanut, Kamphon; Thattanon, Phatchira; Nathalang, Siriporn			Distribution of DI*A and DI*B Allele Frequencies and Comparisons among Central Thai and Other Populations	PLOS ONE			English	Article							HEMOLYTIC-DISEASE; CELL ANTIGENS; RED-CELL; NEWBORN; BAND-3; SYSTEM; DUFFY; KIDD	Alloantibodies to the Diego (DI) blood group system, anti-Di(a) and anti-Di(b) are clinically significant in causing hemolytic transfusion reactions (HTRs) and hemolytic disease of the fetus and newborn (HDFN), especially in Asian populations with Mongolian ancestry. This study aimed to report the frequency of the DI*A and DI*B alleles in a Central Thai population and to compare them with those of other populations previously published. Altogether, 1,011 blood samples from unrelated healthy blood donors at the National Blood Centre, Thai Red Cross Society, Bangkok were included. Only 391 samples were tested with anti-Di(a) by conventional tube technique. All samples were genotyped for DI*A and DI*B alleles using an in-house polymerase chain reaction with sequence-specific primer (PCR-SSP) technique. The DI phenotyping and genotyping results were in 100% concordance. The DI*A and DI*8 allele frequencies among 1,011 Central Thais were 0.0183 (37/2,022) and 0.9817 (1,985/2,022), respectively. Allele frequencies were compared between Central Thai and other populations. Our data shows that DI*A and DI* B allele frequencies are similar to Southeast Asian, Brazilian, Southern Brazilian and American Native populations; whereas, these frequencies significantly differ from those reported in East Asian, Italian, Alaska Native/Aleut, Hawaiian/Pacific Islander and Filipino populations (P<0.05), corresponding to the results of a matrix of geometric genetic distances. This study confirms that the prevalence of DI*A and DI*8 alleles among Central Thais is similar to Southeast Asians and different to others populations of the world. A PCR-based identification of DI genotyping should overcome some of the serological limitations in transfusion medicine and provides a complementary tool for further population-genetic studies.	[Nathalang, Oytip; Panichrum, Puangpaka] Thammasat Univ, Fac Allied Hlth Sci, Grad Program Med Technol, Pathum Thani, Thailand; [Intharanut, Kamphon; Thattanon, Phatchira] Thammasat Univ, Fac Allied Hlth Sci, Grad Program Biomed Sci, Pathum Thani, Thailand; [Nathalang, Siriporn] Thai Red Cross Soc, Natl Blood Ctr, Bangkok, Thailand	Thammasat University; Thammasat University; Thai Red Cross Society	Nathalang, O (corresponding author), Thammasat Univ, Fac Allied Hlth Sci, Grad Program Med Technol, Pathum Thani, Thailand.	oytipntl@hotmail.com		Intharanut, Kamphon/0000-0002-2978-1432	National Research Council of Thailand; National Research University Project of Thailand, Office of Higher Education Commission; Office of Higher Education Commission	National Research Council of Thailand(National Research Council of Thailand (NRCT)); National Research University Project of Thailand, Office of Higher Education Commission; Office of Higher Education Commission(Office of Higher Education Commission (OHEC))	This work was supported by grants of the National Research Council of Thailand and the National Research University Project of Thailand, Office of Higher Education Commission.; This work was supported by grants of the National Research Council of Thailand and the National Research University Project of Thailand, Office of Higher Education Commission. We thank Mr. Morakot Emthip, Histocompatibility and Immunogenetics Laboratory, National Blood Centre, Thai Red Cross Society for providing DNA controls.	Begat C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132211; Belsito A, 2015, TRANSFUS APHER SCI, V52, P72, DOI 10.1016/j.transci.2014.12.006; BRUCE LJ, 1994, J BIOL CHEM, V269, P16155; Chen C C, 1993, Zhonghua Yi Xue Za Zhi (Taipei), V52, P262; Costa Daiane Cobianchi, 2016, Rev. Bras. Hematol. Hemoter., V38, P199, DOI 10.1016/j.bjhh.2016.04.005; Daniels G., 2013, HUMAN BLOOD GROUPS; Delaney M, 2015, TRANSFUSION, V55, P2369, DOI 10.1111/trf.13163; Delfin F, 2014, EUR J HUM GENET, V22, P228, DOI 10.1038/ejhg.2013.122; DELIMA LMA, 1982, TRANSFUSION, V22, P246; Felsenstein J., 2013, PHYLIP PHYLOGENY INF; Figueroa Dolores, 2013, Immunohematology, V29, P73; Fongsarun J, 2002, THAI J HEMATOL TRANS, V12, P277; Gong Tianxiang, 2014, Immunohematology, V30, P161; Issitt, 1998, APPL BLOOD GROUP SER; Jones Gavin W., 2011, Rev. bras. estud. popul., V28, P267, DOI 10.1590/S0102-30982011000200002; Jungbauer C, 2012, VOX SANG, V102, P234, DOI 10.1111/j.1423-0410.2011.01542.x; Junqueira Pedro C., 2002, Rev. Bras. Hematol. Hemoter., V24, P15, DOI 10.1590/S1516-84842002000100004; Kim DA, 1999, KOREAN J CLIN PATHOL, V19, P246; Kupatawintu P, 2010, J HEMATOL T MED, V20, P255; KUSNIERZALEJSKA G, 1992, VOX SANG, V62, P124; Flores MALR, 2014, TRANSFUS APHER SCI, V50, P123, DOI 10.1016/j.transci.2013.09.014; NEI M, 1993, MOL BIOL EVOL, V10, P927; Novaretti M C Z, 2010, Immunohematology, V26, P66; Poole J, 2000, BLOOD REV, V14, P31, DOI 10.1054/blre.1999.0124; Reid ME, 2012, BLOOD GROUP ANTIGEN; Ribeiro ML, 2000, BLOOD, V96, P1602; Tanaka M, 2011, LEGAL MED-TOKYO, V13, P1, DOI 10.1016/j.legalmed.2010.08.004; THOMPSON PR, 1967, VOX SANG, V13, P314, DOI 10.1111/j.1423-0410.1967.tb03114.x; Ting J. Y., 2004, Hong Kong Medical Journal, V10, P347; UCHIKAWA M, 1982, VOX SANG, V42, P91; Wu GG, 2002, TRANSFUSION, V42, P1553, DOI 10.1046/j.1537-2995.2002.00248.x; Ye LY, 2015, BLOOD TRANSFUS-ITALY, V13, P690, DOI 10.2450/2015.0?301-14; Yung C H, 1995, Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi, V28, P146	33	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165134	10.1371/journal.pone.0165134	http://dx.doi.org/10.1371/journal.pone.0165134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764238	gold, Green Submitted, Green Published			2022-12-26	WOS:000386204500123
J	Park, KT; ElNaggar, MM; Abdellrazeq, GS; Bannantine, JP; Mack, V; Fry, LM; Davis, WC				Park, Kun Taek; ElNaggar, Mahmoud M.; Abdellrazeq, Gaber S.; Bannantine, John P.; Mack, Victoria; Fry, Lindsay M.; Davis, William C.			Phenotype and Function of CD209(+) Bovine Blood Dendritic Cells, Monocyte-Derived-Dendritic Cells and Monocyte-Derived Macrophages	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; RESPIRATORY SYNCYTIAL VIRUS; DC-SIGN; IMMUNE-RESPONSES; IDENTIFICATION; SUBPOPULATIONS; PATHOGENESIS; RECEPTOR; MUTANTS; ANTIGEN	Phylogenic comparisons of the mononuclear phagocyte system (MPS) of humans and mice demonstrate phenotypic divergence of dendritic cell (DC) subsets that play similar roles in innate and adaptive immunity. Although differing in phenotype, DC can be classified into four groups according to ontogeny and function: conventional DC (cDC1 and cDC2), plasmacytoid DC (pDC), and monocyte derived DC (MoDC). DC of Artiodactyla (pigs and ruminants) can also be sub-classified using this system, allowing direct functional and phenotypic comparison of MoDC and other DC subsets trafficking in blood (bDC). Because of the high volume of blood collections required to study DC, cattle offer the best opportunity to further our understanding of bDC and MoDC function in an outbred large animal species. As reported here, phenotyping DC using a monoclonal antibody (mAb) to CD209 revealed CD209 is expressed on the major myeloid population of DC present in blood and MoDC, providing a phenotypic link between these two subsets. Additionally, the present study demonstrates that CD209 is also expressed on monocyte derived macrophages (MoF). Functional analysis revealed each of these populations can take up and process antigens (Ags), present them to CD4 and CD8 T cells, and elicit a T-cell recall response. Thus, bDC, MoDC, and MoF pulsed with pathogens or candidate vaccine antigens can be used to study factors that modulate DC-driven T-cell priming and differentiation ex vivo.	[Park, Kun Taek; ElNaggar, Mahmoud M.; Abdellrazeq, Gaber S.; Mack, Victoria; Fry, Lindsay M.; Davis, William C.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Park, Kun Taek] Seoul Natl Univ, Dept Vet Microbiol, Coll Vet Med, Seoul 151742, South Korea; [ElNaggar, Mahmoud M.; Abdellrazeq, Gaber S.] Univ Alexandria, Fac Vet Med, Dept Microbiol, Alexandria, Egypt; [Bannantine, John P.] ARS, USDA, Natl Anim Dis Ctr, Ames, IA USA; [Fry, Lindsay M.] ARS, USDA, Anim Dis Res Unit, Pullman, WA 99164 USA	Washington State University; Seoul National University (SNU); Egyptian Knowledge Bank (EKB); Alexandria University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Davis, WC (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	davisw@vetmed.wsu.edu	Abdellrazeq, Gaber S/C-7667-2015; Abdellrazeq, Gaber/AAA-8255-2021	Abdellrazeq, Gaber S/0000-0002-8677-911X; Abdellrazeq, Gaber/0000-0002-8677-911X; Park, Kun Taek/0000-0001-6177-0373; Bannantine, John/0000-0002-5692-7898; Fry, Lindsay/0000-0003-0938-9254; Elnaggar, Mahmoud/0000-0003-4501-7722	Washington State University Monoclonal Antibody Center; Egyptian government; USAID	Washington State University Monoclonal Antibody Center; Egyptian government; USAID(United States Agency for International Development (USAID))	This study was supported by the Washington State University Monoclonal Antibody Center (http://vmp.vetmed.wsu.edu/resources/ monoclonal-antibody center). Mahmoud M. ElNaggar was supported in part by a fellowship from the Egyptian government. Gaber S. Abdellrazeq was supported by a fellowship from the USAID.	Allen AJ, 2009, CLIN VACCINE IMMUNOL, V16, P453, DOI 10.1128/CVI.00347-08; Bannantine John P., 2006, V345, P185; Bannantine JP, 2003, MICROBIOL-SGM, V149, P2061, DOI 10.1099/mic.0.26323-0; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Davis WC, 2015, WORLD J GASTROENTERO, V21, P13411, DOI 10.3748/wjg.v21.i48.13411; Elnaggar MM, 2016, VET IMMUNOL IMMUNOP, V178, P57, DOI 10.1016/j.vetimm.2016.06.010; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Facci MR, 2010, IMMUNOLOGY, V129, P396, DOI 10.1111/j.1365-2567.2009.03192.x; Fry LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156004; Geijtenbeek TBH, 2002, J BIOL CHEM, V277, P11314, DOI 10.1074/jbc.M111532200; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gonzalez-Cano P, 2014, DEV COMP IMMUNOL, V44, P378, DOI 10.1016/j.dci.2014.01.014; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Koo HC, 2004, INFECT IMMUN, V72, P6870, DOI 10.1128/IAI.72.12.6870-6883.2004; Miyazawa K, 2006, RES VET SCI, V81, P40, DOI 10.1016/j.rvsc.2005.09.003; Park KT, 2014, ADV AN VET SCI, V2, P2; Park KT, 2008, APPL ENVIRON MICROB, V74, P1687, DOI 10.1128/AEM.01208-07; Park KT, 2015, VET IMMUNOL IMMUNOP, V163, P216, DOI 10.1016/j.vetimm.2014.12.008; Park KT, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00064; Park KT, 2011, VACCINE, V29, P4709, DOI 10.1016/j.vaccine.2011.04.090; Saalmuller A, 2005, CELL IMMUNOL, V236, P51, DOI 10.1016/j.cellimm.2005.08.009; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sallusto F, 2010, CELL, V143, P339, DOI 10.1016/j.cell.2010.10.022; Sei JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109273; Singh S. V., 2014, Journal of Public Health and Epidemiology, V6, P20; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Summerfield A, 2015, ANNU REV ANIM BIOSCI, V3, P533, DOI 10.1146/annurev-animal-022114-111009; Werling D, 2002, J LEUKOCYTE BIOL, V72, P297; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Yamakawa Y, 2008, J LEUKOCYTE BIOL, V83, P1396, DOI 10.1189/jlb.0807523	33	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165247	10.1371/journal.pone.0165247	http://dx.doi.org/10.1371/journal.pone.0165247			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764236	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500140
J	Pochechueva, T; Chinarev, A; Schoetzau, A; Fedier, A; Bovin, NV; Hacker, NF; Jacob, F; Heinzelmann-Schwarz, V				Pochechueva, Tatiana; Chinarev, Alexander; Schoetzau, Andreas; Fedier, Andre; Bovin, Nicolai V.; Hacker, Neville F.; Jacob, Francis; Heinzelmann-Schwarz, Viola			Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients	PLOS ONE			English	Article							ABERRANT GLYCOSYLATION; NATURAL ANTIBODIES; SERUM BIOMARKERS; TUMOR-MARKERS; SIALIC ACIDS; IN-VIVO; AUTOANTIBODIES; CA125; HE-4; IDENTIFICATION	Altered levels of naturally occurring anti-glycan antibodies (AGA) circulating in human blood plasma are found in different pathologies including cancer. Here the levels of AGA directed against 22 negatively charged (sialylated and sulfated) glycans were assessed in high-grade serous ovarian cancer (HGSOC, n = 22) patients and benign controls (n = 31) using our previously developed suspension glycan array (SGA). Specifically, the ability of AGA to differentiate between controls and HGSOC, the most common and aggressive type of ovarian cancer with a poor outcome was determined. Results were compared to CA125, the commonly used ovarian cancer biomarker. AGA to seven glycans that significantly (P<0.05) differentiated between HGSOC and control were identified: AGA to top candidates SiaT(n) and 6-OSulfo-TF (both IgM) differentiated comparably to CA125. The area under the curve (AUC) of a panel of AGA to 5 glycans (SiaTn(,) 6-OSulfo-TF, 6-OSulfo-LN, SiaLe(a), and GM(2)) (0.878) was comparable to CA125 (0.864), but it markedly increased (0.985) when combined with CA125. AGA to SiaTn and 6-OSulfo-TF were also valuable predictors for HGSOC when CA125 values appeared inconclusive, i.e. were below a certain threshold. AGA-glycan binding was in some cases isotype-dependent and sensitive to glycosidic linkage switch (alpha 2-6 vs. alpha 2-3), to sialylation, and to sulfation of the glycans. In conclusion, plasma-derived AGA to sialylated and sulfated glycans including SiaTn and 6-OSulfo-TF detected by SGA present a valuable alternative to CA125 for differentiating controls from HGSOC patients and for predicting the likelihood of HGSOC, and may be potential HGSOC tumor markers.	[Pochechueva, Tatiana; Schoetzau, Andreas; Fedier, Andre; Jacob, Francis; Heinzelmann-Schwarz, Viola] Univ Basel Hosp, Dept Biomed, Ovarian Canc Res, Hebelstr 20, CH-4031 Basel, Switzerland; [Pochechueva, Tatiana; Schoetzau, Andreas; Fedier, Andre; Jacob, Francis; Heinzelmann-Schwarz, Viola] Univ Basel, Hebelstr 20, CH-4031 Basel, Switzerland; [Chinarev, Alexander; Bovin, Nicolai V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Mlklukho Maklaya 16-10, Moscow 117997, Russia; [Hacker, Neville F.] Univ New South Wales, Royal Hosp Women, Gynecol Canc Ctr, Sch Womens & Childrens Hlth, Sydney, NSW 2031, Australia; [Jacob, Francis] Univ Basel Hosp, Dept Biomed, Ovarian Canc Res, Glycooncol, Hebelstr 20, CH-4031 Basel, Switzerland; [Heinzelmann-Schwarz, Viola] Univ Basel Hosp, Dept Gynecol & Gynecol Oncol, Hosp Women, Spitalstr 21, CH-4021 Basel, Switzerland; [Heinzelmann-Schwarz, Viola] Univ Basel, Spitalstr 21, CH-4021 Basel, Switzerland	University of Basel; University of Basel; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; University of New South Wales Sydney; University of Basel; University of Basel; University of Basel	Heinzelmann-Schwarz, V (corresponding author), Univ Basel Hosp, Dept Biomed, Ovarian Canc Res, Hebelstr 20, CH-4031 Basel, Switzerland.; Heinzelmann-Schwarz, V (corresponding author), Univ Basel, Hebelstr 20, CH-4031 Basel, Switzerland.; Heinzelmann-Schwarz, V (corresponding author), Univ Basel Hosp, Dept Gynecol & Gynecol Oncol, Hosp Women, Spitalstr 21, CH-4021 Basel, Switzerland.; Heinzelmann-Schwarz, V (corresponding author), Univ Basel, Spitalstr 21, CH-4021 Basel, Switzerland.	viola.heinzelmann@usb.ch	Jacob, Francis/C-7910-2009; Bovin, Nicolai/P-2948-2017; Chinarev, Alexander/GRS-5784-2022; Chinarev, Alexander/T-1368-2018	Jacob, Francis/0000-0002-0446-1942; Bovin, Nicolai/0000-0001-8669-4477; Chinarev, Alexander/0000-0001-6088-9751; Heinzelmann-Schwarz, Viola/0000-0002-4056-3225; Hacker, Neville/0000-0002-1445-2302	Cancer Institute NSW [09/CRF/2-02]; RANZCOG Research Foundation; William Maxwell Trust; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung [310030-156982, 310030_143619, 310030_143632]; Oncosuisse [KFS_3013-08-2012]; Krebsliga Beider Basel [06-2013]; Russian Science Foundation [14-50-00131]	Cancer Institute NSW; RANZCOG Research Foundation; William Maxwell Trust; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Oncosuisse; Krebsliga Beider Basel; Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Cancer Institute NSW, 09/CRF/2-02; RANZCOG Research Foundation; William Maxwell Trust; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung, 310030-156982; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung, 310030_143619; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung, 310030_143632; Oncosuisse, KFS_3013-08-2012; Krebsliga Beider Basel, 06-2013; and Russian Science Foundation, 14-50-00131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2010, PROTEOMICS, V10, P470, DOI 10.1002/pmic.200900537; Adamczyk B, 2012, BBA-GEN SUBJECTS, V1820, P1347, DOI 10.1016/j.bbagen.2011.12.001; Bast RC, 2005, INT J GYNECOL CANCER, V15, P274, DOI 10.1111/j.1525-1438.2005.00441.x; Blixt O, 2010, J PROTEOME RES, V9, P5250, DOI 10.1021/pr1005229; Bovin NV, 2013, BIOCHEMISTRY-MOSCOW+, V78, P786, DOI 10.1134/S0006297913070109; Bovin N, 2012, BBA-GEN SUBJECTS, V1820, P1373, DOI 10.1016/j.bbagen.2012.02.005; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chinarev AA, 2010, METHODS MOL BIOL, V600, P67, DOI 10.1007/978-1-60761-454-8_5; Christiansen MN, 2014, PROTEOMICS, V14, P525, DOI 10.1002/pmic.201300387; Cohen Joshua G, 2014, World J Biol Chem, V5, P286, DOI 10.4331/wjbc.v5.i3.286; Cooper DKC, 1998, XENOTRANSPLANTATION, V5, P6, DOI 10.1111/j.1399-3089.1998.tb00003.x; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gronwall C, 2014, J CLIN IMMUNOL, V34, pS12, DOI 10.1007/s10875-014-0025-4; Hakomori S, 1996, CANCER RES, V56, P5309; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Huflejt ME, 2009, MOL IMMUNOL, V46, P3037, DOI 10.1016/j.molimm.2009.06.010; Huflejt ME, 2008, 28 ANN SAN ANT BREAS; Jacob F, 2014, BRIT J CANCER, V111, P1634, DOI 10.1038/bjc.2014.455; Jacob F, 2011, GLYCOBIOLOGY, V21, P1519; Jacob F, 2011, GYNECOL ONCOL, V121, P487, DOI 10.1016/j.ygyno.2011.02.022; Jacob F, 2012, INT J CANCER, V130, P138, DOI 10.1002/ijc.26002; Jacob F, 2009, BIOMARK MED, V3, P743, DOI 10.2217/BMM.09.48; JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Kuhn K, 2016, CARET CLASSIFICATION; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Menon U, 2014, GYNECOL ONCOL, V132, P490, DOI 10.1016/j.ygyno.2013.11.030; Milland J, 2006, TISSUE ANTIGENS, V68, P459, DOI 10.1111/j.1399-0039.2006.00721.x; Mirkin BL, 2002, CELL PROLIFERAT, V35, P105, DOI 10.1046/j.1365-2184.2002.00228.x; Moore RG, 2009, GYNECOL ONCOL, V112, P40, DOI 10.1016/j.ygyno.2008.08.031; Nolen BM, 2013, MOL DIAGN THER, V17, P139, DOI 10.1007/s40291-013-0027-6; Ozols RF, 2006, ANN ONCOL, V17, pV181, DOI 10.1093/annonc/mdj978; Padler-Karavani V, 2014, CANCER LETT, V352, P102, DOI 10.1016/j.canlet.2013.10.005; Padler-Karavani V, 2011, CANCER RES, V71, P3352, DOI 10.1158/0008-5472.CAN-10-4102; Pedersen JW, 2014, INT J CANCER, V134, P2180, DOI 10.1002/ijc.28538; Pedersen JW, 2011, INT J CANCER, V128, P1860, DOI 10.1002/ijc.25778; Pochechueva T, 2014, J IMMUNOL METHODS, V412, P42, DOI 10.1016/j.jim.2014.06.015; Pochechueva T, 2011, GLYCOCONJUGATE J, V28, P507, DOI 10.1007/s10719-011-9349-y; Pochechueva T, 2011, ANALYST, V136, P560, DOI 10.1039/c0an00758g; Schneider C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010524; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Schwartz-Albiez R, 2012, ADV EXP MED BIOL, V750, P27, DOI 10.1007/978-1-4614-3461-0_3; Shah CA, 2009, CANCER EPIDEM BIOMAR, V18, P1365, DOI 10.1158/1055-9965.EPI-08-1034; Shankar G, 2008, J PHARMACEUT BIOMED, V48, P1267, DOI 10.1016/j.jpba.2008.09.020; Shilova N, 2012, GLYCOCONJUGATE J, V29, P87, DOI 10.1007/s10719-011-9368-8; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Urban Nicole, 2011, J Natl Cancer Inst, V103, P1630, DOI 10.1093/jnci/djr359; Ushakova NA, 2005, BIOCHEMISTRY-MOSCOW+, V70, P432, DOI 10.1007/s10541-005-0133-0; van Buuren S, 2011, J STAT SOFTW, V45, P1; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Venables WN., 2002, MODERN APPL STAT S 4; Vollmers HP, 2009, IMMUNOTHERAPY-UK, V1, P241, DOI 10.2217/1750743X.1.2.241; Vollmers HP, 2009, NEW BIOTECHNOL, V25, P294, DOI 10.1016/j.nbt.2009.03.016; Wandall HH, 2010, CANCER RES, V70, P1306, DOI 10.1158/0008-5472.CAN-09-2893; Wang CC, 2008, P NATL ACAD SCI USA, V105, P11661, DOI 10.1073/pnas.0804923105; Webb TJ, 2012, CANCER RES, V72, P3744, DOI 10.1158/0008-5472.CAN-11-2695; West MB, 2010, J BIOL CHEM, V285, P29511, DOI 10.1074/jbc.M110.145938; YOUNG WW, 1979, J IMMUNOL, V123, P92	60	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164230	10.1371/journal.pone.0164230	http://dx.doi.org/10.1371/journal.pone.0164230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764122	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500022
J	Sramko, M; Wichterle, D; Kautzner, J				Sramko, Marek; Wichterle, Dan; Kautzner, Josef			Feasibility of In-Vivo Simulation of Acute Hemodynamics in Human Atrial Fibrillation	PLOS ONE			English	Article							NORMAL SINUS RHYTHM; VENTRICULAR RHYTHM; IRREGULARITY; FLOW	This study evaluated hemodynamic feasibility and reproducibility of a new method for in vivo simulation of human atrial fibrillation (AF). The method was tested during sinus rhythm in 10 patients undergoing catheter ablation for AF. A simple electronic device was assembled that allowed triggering a cardiac stimulator by predefined series of RR intervals. Irregular RR interval sequences with a mean heart rate of 90/min and 130/min were obtained from ECG recordings of another patients with AF. Simultaneous atrioventricular pacing was delivered by catheters placed inside the coronary sinus and at the His bundle region. Hemodynamic effect of the simulated AF was assessed by invasive measurement of the left ventricular (LV) pressure, dP/dt, and Tau. Compared to regular pacing at the same mean heart rate, the simulated AF significantly impaired the LV both systolic and diastolic function. Repeated AF pacing in the same patients generated similar LV hemodynamics. The proposed method provides a realistic and reproducible in-vivo model of AF. It can be exploited for investigation of the hemodynamic consequences of AF in various patient populations.	[Sramko, Marek; Wichterle, Dan; Kautzner, Josef] Inst Clin & Expt Med IKEM, Dept Cardiol, Prague, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM)	Sramko, M (corresponding author), Inst Clin & Expt Med IKEM, Dept Cardiol, Prague, Czech Republic.	marek.sramko@ikem.cz	Wichterle, Dan/G-7611-2017	Wichterle, Dan/0000-0002-0448-5143	Ministry of the Health of the Czech Republic Conceptual development of research organization ("Institute for Clinical and Experimental Medicine - IKEM) [IN 00023001]	Ministry of the Health of the Czech Republic Conceptual development of research organization ("Institute for Clinical and Experimental Medicine - IKEM)	This study was supported by the research grant of the Ministry of the Health of the Czech Republic Conceptual development of research organization ("Institute for Clinical and Experimental Medicine - IKEM, IN 00023001"), which was received by JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clark DM, 1997, J AM COLL CARDIOL, V30, P1039, DOI 10.1016/S0735-1097(97)00254-4; Daoud EG, 1996, AM J CARDIOL, V78, P1433, DOI 10.1016/S0002-9149(97)89297-1; FALSETTI HL, 1974, CIRCULATION, V49, P165, DOI 10.1161/01.CIR.49.1.165; FRIEDMAN H S, 1987, Canadian Journal of Cardiology, V3, P240; GLANTZ SA, 1979, AM J PHYSIOL, V236, pH376, DOI 10.1152/ajpheart.1979.236.2.H376; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; HOLM S, 1979, SCAND J STAT, V6, P65; LAVY S, 1980, STROKE, V11, P35, DOI 10.1161/01.STR.11.1.35; Lieberman R, 2006, J AM COLL CARDIOL, V48, P1634, DOI 10.1016/j.jacc.2006.04.099; MABO P, 1995, PACE, V18, P1894, DOI 10.1111/j.1540-8159.1995.tb03838.x; Melenovsky V, 2005, EUR HEART J, V26, P705, DOI 10.1093/eurheartj/ehi066; NAITO M, 1983, AM HEART J, V106, P284, DOI 10.1016/0002-8703(83)90194-1; Obel OA, 2005, HEART, V91, P764, DOI 10.1136/hrt.2003.030940; ORLANDO JR, 1979, CHEST, V76, P521, DOI 10.1378/chest.76.5.521; Segerson NM, 2007, HEART RHYTHM, V4, P20, DOI 10.1016/j.hrthm.2006.09.017; SHAPIRO W, 1968, CIRCULATION, V38, P1074, DOI 10.1161/01.CIR.38.6.1074; Sramko M, 2014, J CARDIOVASC ELECTR, V25, P349, DOI 10.1111/jce.12325	17	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165241	10.1371/journal.pone.0165241	http://dx.doi.org/10.1371/journal.pone.0165241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764240	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500138
J	Coelho, CH; Costa, AO; Silva, ACC; Pucci, MM; Serufo, AV; Busatti, HGNO; Durigan, M; Perales, J; Chapeaurouge, A; Silva, DADSE; Gomes, MA; Toledo, JS; Singer, SM; Silva-Pereira, RA; Fernandes, AP				Coelho, Camila Henriques; Costa, Adriana Oliveira; Carvalho Silva, Ana Carolina; Pucci, Maira Mazzoni; Serufo, Angela Vieira; Nogueira Oliveira Busatti, Haendel Goncalves; Durigan, Mauricio; Perales, Jonas; Chapeaurouge, Alex; da Silva e Silva, Daniel Almeida; Gomes, Maria Aparecida; Toledo, Juliano Simoes; Singer, Steven M.; Silva-Pereira, Rosiane A.; Fernandes, Ana Paula			Genotyping and Descriptive Proteomics of a Potential Zoonotic Canine Strain of Giardia duodenalis, Infective to Mice	PLOS ONE			English	Article							PHOSPHOLIPASE A(1); LAMBLIA; VIRULENCE; IDENTIFICATION; PROTEINS; HOST; DOGS; EPIDEMIOLOGY; PATHWAYS; A(2)	The zoonotic potential of giardiasis, as proposed by WHO since the late 70's, has been largely confirmed in this century. The genetic assemblages A and B of Giardia duodenalis are frequently isolated from human and canine hosts. Most of the assemblage A strains are not infective to adult mice, which can limit the range of studies regarding to biology of G. duodenalis, including virulence factors and the interaction with host immune system. This study aimed to determine the infectivity in mice of an assemblage A Giardia duodenalis strain (BHFC1) isolated from a dog and to classify the strain in sub-assemblages (Al, All, AIII) through the phylogenetic analysis of beta-giardin (bg), triose phosphate isomerase (tpi) and glutamate dehydrogenase (gdh) genes. In addition, the proteomic profile of soluble and insoluble protein fractions of trophozoites was analyzed by 2D-electrophoresis. Accordingly, trophozoites of BHFC1 were highly infective to Swiss mice. The phylogenetic analysis of tpi and gdh revealed that BHFC1 clustered to sub-assemblage Al. The proteomic map of soluble and insoluble protein fractions led to the identification of 187 proteins of G. duodenalis, 27 of them corresponding to hypothetical proteins. Considering both soluble and soluble fractions, the vast majority of the identified proteins (n = 82) were classified as metabolic proteins, mainly associated with carbon and lipid metabolism, including 53 proteins with catalytic activity. Some of the identified proteins correspond to antigens while others can be correlated with virulence. Besides a significant complementation to the proteomic data of G. duodenalis, these data provide an important source of information for future studies on various aspects of the biology of this parasite, such as virulence factors and host and pathogen interactions.	[Coelho, Camila Henriques; Costa, Adriana Oliveira; Carvalho Silva, Ana Carolina; Serufo, Angela Vieira; Nogueira Oliveira Busatti, Haendel Goncalves; Toledo, Juliano Simoes; Fernandes, Ana Paula] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil; [Pucci, Maira Mazzoni; Silva-Pereira, Rosiane A.] FIOCRUZ MG, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Durigan, Mauricio] Univ Estadual Campinas, CBMEG, Campinas, SP, Brazil; [Perales, Jonas; Chapeaurouge, Alex] FIOCRUZ RJ, Inst Oswaldo Cruz, Lab Toxinol, Rio De Janeiro, Brazil; [da Silva e Silva, Daniel Almeida] Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Gomes, Maria Aparecida] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil; [Singer, Steven M.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Estadual de Campinas; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Georgetown University	Fernandes, AP (corresponding author), Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil.	apfernandes.ufmg@gmail.com	Coelho, Camila/I-4946-2019; Singer, Steven/V-7778-2019; Costa, Adriana Oliveira/AAD-3037-2020; Durigan, Mauricio/GLU-4564-2022	Singer, Steven/0000-0001-5719-7535; Coelho, Camila/0000-0002-7885-9996; Oliveira Costa, Adriana/0000-0002-1793-3013	CNPq (Brazilian National Council for Scientific and Technological Development); FAPEMIG (State Funding Agency of Minas Gerais (FAPEMIG)); INCTV (National Institute of Science and Technology in Vaccines); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI109591] Funding Source: NIH RePORTER	CNPq (Brazilian National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (State Funding Agency of Minas Gerais (FAPEMIG))(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); INCTV (National Institute of Science and Technology in Vaccines); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by CNPq (Brazilian National Council for Scientific and Technological Development); FAPEMIG (State Funding Agency of Minas Gerais (FAPEMIG); INCTV (National Institute of Science and Technology in Vaccines).	Bekal S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145601; BYRD LG, 1994, INFECT IMMUN, V62, P3583, DOI 10.1128/IAI.62.8.3583-3585.1994; Caccio SM, 2010, EXP PARASITOL, V124, P107, DOI 10.1016/j.exppara.2009.02.007; Dawson SC, 2007, EUKARYOT CELL, V6, P2354, DOI 10.1128/EC.00128-07; de Lucio A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143981; Dyballa N, 2009, JOVE-J VIS EXP, DOI [10.3791/1431, DOI 10.3791/1431PMID:19684561]; Emery SJ, 2015, DATA BRIEF, V5, P23, DOI 10.1016/j.dib.2015.08.003; Emery SJ, 2015, MOL BIOCHEM PARASIT, V201, P47, DOI 10.1016/j.molbiopara.2015.05.007; Emery SJ, 2015, PROTEOMICS, V15, P2281, DOI 10.1002/pmic.201400434; Emery SJ, 2014, PROTEOMICS, V14, P2523, DOI 10.1002/pmic.201400144; Esch KJ, 2013, CLIN MICROBIOL REV, V26, P58, DOI 10.1128/CMR.00067-12; Escobedo AA, 2015, J INFECT DEV COUNTR, V9, P76, DOI 10.3855/jidc.5785; FARTHING MJG, 1989, Q J MED, V70, P191; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Geurden T, 2009, J ZOO WILDLIFE MED, V40, P126, DOI 10.1638/2008-0152.1; Gomes KB, 2011, REV SOC BRAS MED TRO, V44, P508, DOI 10.1590/S0037-86822011000400021; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Itoh N, 2011, VET PARASITOL, V176, P74, DOI 10.1016/j.vetpar.2010.10.048; Johansen KM, 2014, PARASITOL RES, V113, P387, DOI 10.1007/s00436-013-3666-y; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Magalhaes RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002764; Obata F, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00030; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paoletti B, 2008, ANN NY ACAD SCI, V1149, P371, DOI 10.1196/annals.1428.005; Peck J, 2002, FEBS LETT, V528, P27, DOI 10.1016/S0014-5793(02)03331-8; Ramirez MA, 2007, EUKARYOT CELL, V6, P280, DOI 10.1128/EC.00372-06; Rodriguez A, 1996, J CELL BIOL, V134, P349, DOI 10.1083/jcb.134.2.349; Paz-Maldonado MT, 2013, INFECT GENET EVOL, V15, P10, DOI 10.1016/j.meegid.2012.08.021; Upjohn M, 2010, VET PARASITOL, V172, P341, DOI 10.1016/j.vetpar.2010.05.010; Vargas-Villarreal J, 2005, J PARASITOL, V91, P5, DOI 10.1645/GE-3338; Vargas-Villarreal J, 2007, J PARASITOL, V93, P979, DOI 10.1645/GE-1038R3.1; VARGASVILLARREAL J, 1995, PARASITOL RES, V81, P320, DOI 10.1007/BF00931538; Volotao AC, 2007, ACTA TROP, V102, P10, DOI 10.1016/j.actatropica.2007.02.010; Waligora EA, 2014, INFECT IMMUN, V82, P2746, DOI 10.1128/IAI.01575-13; Wampfler PB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094089; Wesolowski J, 2010, VIRULENCE, V1, P319, DOI 10.4161/viru.1.4.12195; Williamson AL, 2000, INT J PARASITOL, V30, P129, DOI 10.1016/S0020-7519(99)00181-2; YANZEKONTCHOU C, 1994, APPL ENVIRON MICROB, V60, P4297, DOI 10.1128/AEM.60.12.4297-4302.1994; Yichoy M, 2009, MOL BIOCHEM PARASIT, V165, P67, DOI 10.1016/j.molbiopara.2009.01.004	40	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164946	10.1371/journal.pone.0164946	http://dx.doi.org/10.1371/journal.pone.0164946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760188	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204000069
J	Thiriet, PD; Di Franco, A; Cheminee, A; Guidetti, P; Bianchimani, O; Basthard-Bogain, S; Cottalorda, JM; Arceo, H; Moranta, J; Lejeune, P; Francour, P; Mangialajo, L				Thiriet, Pierre D.; Di Franco, Antonio; Cheminee, Adrien; Guidetti, Paolo; Bianchimani, Olivier; Basthard-Bogain, SolSne; Cottalorda, Jean-Michel; Arceo, Hazel; Moranta, Joan; Lejeune, Pierre; Francour, Patrice; Mangialajo, Luisa			Abundance and Diversity of Crypto- and Necto-BenthicCoastal Fish Are Higher in Marine Forests than in Structurally Less Complex Macroalgal Assemblages	PLOS ONE			English	Article							WESTERN MEDITERRANEAN SEA; CRYPTOBENTHIC FISHES; REEF FISHES; COMMUNITY STRUCTURE; HABITAT COMPLEXITY; SEAGRASS BEDS; ADRIATIC SEA; BIODIVERSITY; ECOSYSTEMS; FUTURE	In Mediterranean subtidal rocky reefs, Cystoseira spp. (Phaeophyceae) form dense canopies up to 1 m high. Such habitats, called 'Cystoseira forests', are regressing across the entire Mediterranean Sea due to multiple anthropogenic stressors, as are other large brown algae forests worldwide. Cystoseira forests are being replaced by structurally less complex habitats, but little information is available regarding the potential difference in the structure and composition of fish assemblages between these habitats. To fill this void, we compared necto-benthic (NB) and crypto-benthic (CB) fish assemblage structures between Cystoseira forests and two habitats usually replacing the forests (turf and barren), in two sampling regions (Corsica and Menorca). We sampled NB fish using Underwater Visual Census (UVC) and CB fish using Enclosed Anaesthetic Station Vacuuming (EASV), since UVC is known to underestimate the diversity and density of the 'hard to spot' CB fish. We found that both taxonomic diversity and total density of NB and CB fish were highest in Cystoseira forests and lowest in barrens, while turfs, that could be sampled only at Menorca, showed intermediate values. Conversely, total biomass of NB and CB fish did not differ between habitats because the larger average size of fish in barrens (and turfs) compensated for their lower densities. The NB families Labridae and Serranidae, and the CB families Blenniidae, Cliniidae, Gobiidae, Trypterigiidae and Scorpaenidae, were more abundant in forests. The NB taxa Diplodus spp. and Thalassoma pavo were more abundant in barrens. Our study highlights the importance of using EASV for sampling CB fish, and shows that Cystoseira forests support rich and diversified fish assemblages. This evidence suggests that the ongoing loss of Cystoseira forests may impair coastal fish assemblages and related goods and services to humans, and stresses the need to implement strategies for the successful conservation and/or recovery of marine forests.	[Thiriet, Pierre D.; Di Franco, Antonio; Cheminee, Adrien; Guidetti, Paolo; Cottalorda, Jean-Michel; Arceo, Hazel; Francour, Patrice; Mangialajo, Luisa] Univ Nice Sophia Antipolis, CNRS, FRE ECOMERS 3729, Parc Valrose 28, Nice, France; [Thiriet, Pierre D.] Museum Natl Hist Nat, Stn Marine Dinard, UMR BOREA 7208, CRESCO, Dinard, France; [Di Franco, Antonio] UPVD, EPHE, CNRS, CRIOBE,USR 3278, Perpignan, France; [Cheminee, Adrien] Univ Perpignan Via Domitia, CEFREM, CNRS, UMR 5110, Perpignan, France; [Bianchimani, Olivier; Basthard-Bogain, SolSne] Septentr Environm, Marseille, France; [Arceo, Hazel] Univ Philippines, Inst Marine Sci, Quezon City, Philippines; [Moranta, Joan] Estn Invest Jaume Ferrer, Menorca, Illes Balears, Spain; [Moranta, Joan] Ctr Oceanog Balears, IEO, Moll Ponent S-N, Palma De Mallorca, Spain; [Lejeune, Pierre] Stn Rech Oceanog & Sous Marines, STARESO, Calvi, France; [Mangialajo, Luisa] Univ Paris 06, Sorbonne Univ, CNRS, INSU,Lab Oceanog Villefranche,UMR 7093, Villefranche Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite Perpignan Via Domitia; University of the Philippines System; University of the Philippines Diliman; Spanish Institute of Oceanography; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Thiriet, PD (corresponding author), Univ Nice Sophia Antipolis, CNRS, FRE ECOMERS 3729, Parc Valrose 28, Nice, France.; Thiriet, PD (corresponding author), Museum Natl Hist Nat, Stn Marine Dinard, UMR BOREA 7208, CRESCO, Dinard, France.	pierre.d.thiriet@gmail.com	Moranta, Joan/B-5522-2008; Cheminée, Adrien/K-5846-2017; Di Franco, Antonio/A-8796-2010	Moranta, Joan/0000-0002-9814-0735; Cheminée, Adrien/0000-0002-2982-2142; Di Franco, Antonio/0000-0003-3411-7015; Mangialajo, Luisa/0000-0002-0225-8625; THIRIET, Pierre, Daniel/0000-0002-5254-5948	University Nice Sophia Antipolis; Coconet European project [287844]; Total Foundation	University Nice Sophia Antipolis; Coconet European project; Total Foundation(Total SA)	PT Phd thesis was funded by the University Nice Sophia Antipolis; the work was partially realized in the framework of (and funded by) the Coconet European project (grant number 287844) and FOREFISH project funded by Total Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; BALLESTEROS E, 1990, Scientia Marina, V54, P155; Ballesteros E, 1998, EUR J PHYCOL, V33, P121, DOI 10.1080/09670269810001736613; Ballesteros E, 2009, ESTUAR COAST SHELF S, V82, P477, DOI 10.1016/j.ecss.2009.02.013; Beck MW, 2000, J EXP MAR BIOL ECOL, V249, P29, DOI 10.1016/S0022-0981(00)00171-4; Beldade R, 2006, J MAR BIOL ASSOC UK, V86, P1221, DOI 10.1017/S0025315406014226; Bianchi CN, 2014, MEDITERR MAR SCI, V15, P482, DOI 10.12681/mms.678; Bonaca MO, 2005, MAR ECOL-EVOL PERSP, V26, P42, DOI 10.1111/j.1439-0485.2005.00037.x; Bostrom C, 2006, ESTUAR COAST SHELF S, V68, P383, DOI 10.1016/j.ecss.2006.01.026; Bozec YM, 2011, MAR BIOL, V158, P969, DOI 10.1007/s00227-011-1623-9; Brodie J, 2014, ECOL EVOL, V4, P2787, DOI 10.1002/ece3.1105; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cardona L, 2013, ESTUAR COAST SHELF S, V133, P88, DOI 10.1016/j.ecss.2013.08.020; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chemello R, 2002, MAR BIOL, V140, P981, DOI 10.1007/s00227-002-0777-x; Cheminee A., 2012, ECOLOGICAL FUNCTIONS; Cheminee A, 2013, J EXP MAR BIOL ECOL, V442, P70, DOI 10.1016/j.jembe.2013.02.003; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Claudet J, 2010, BIOL CONSERV, V143, P2195, DOI 10.1016/j.biocon.2010.06.004; Connell SD, 2014, MAR ECOL PROG SER, V495, P299, DOI 10.3354/meps10513; Consoli P, 2008, J MAR BIOL ASSOC UK, V88, P401, DOI 10.1017/S0025315408000489; Depczynski M, 2003, MAR ECOL PROG SER, V256, P183, DOI 10.3354/meps256183; Felix-Hackradt FC, 2013, ESTUAR COAST SHELF S, V129, P59, DOI 10.1016/j.ecss.2013.05.029; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Giakoumi S, 2013, MEDITERR MAR SCI, V14, P58, DOI 10.12681/mms.318; Giakoumi S, 2012, ESTUAR COAST SHELF S, V109, P1, DOI 10.1016/j.ecss.2011.06.004; Gianni Fabrizio, 2014, Advances in Oceanography and Limnology, V4, P83, DOI 10.1080/19475721.2013.845604; Gorley C.K., 2006, GETTING STARTED PRIM; Gozler AM, 2010, AFR J BIOTECHNOL, V9, P8852; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; Guidetti P, 2000, ESTUAR COAST SHELF S, V50, P515, DOI 10.1006/ecss.1999.0584; Guidetti P, 2004, CONSERV BIOL, V18, P1417, DOI 10.1111/j.1523-1739.2004.00343.x; Guidetti P, 2002, AQUAT CONSERV, V12, P619, DOI 10.1002/aqc.514; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Harmelin-Vivien ML, 1985, EVALUATION VISUELLE; HARMELINVIVIEN ML, 1989, J FISH BIOL, V34, P715, DOI 10.1111/j.1095-8649.1989.tb03352.x; Hereu B, 2008, ECOLOGY, V89, P3423, DOI 10.1890/07-0613.1; HOFFMANN L, 1992, MAR ECOL PROG SER, V80, P249, DOI 10.3354/meps080249; Holmlund CM, 1999, ECOL ECON, V29, P253, DOI 10.1016/S0921-8009(99)00015-4; Horinouchi M, 2009, MAR ECOL PROG SER, V377, P43, DOI 10.3354/meps07869; Jackson EL, 2015, CONSERV BIOL, V29, P899, DOI 10.1111/cobi.12436; JONES GP, 1984, J EXP MAR BIOL ECOL, V75, P277, DOI 10.1016/0022-0981(84)90170-9; Jordan F, 1997, T AM FISH SOC, V126, P1012, DOI 10.1577/1548-8659(1997)126<1012:SFIVHE>2.3.CO;2; Keith DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062111; Kovacic M, 2012, MAR BIOL, V159, P2731, DOI 10.1007/s00227-012-2030-6; La Mesa G, 2006, MAR BIOL, V149, P149, DOI 10.1007/s00227-005-0194-z; La Mesa G, 2004, MAR BIOL, V145, P233, DOI 10.1007/s00227-004-1315-9; Laegdsgaard P, 2001, J EXP MAR BIOL ECOL, V257, P229, DOI 10.1016/S0022-0981(00)00331-2; Lejeune P., 1985, CAH ETHOL APPL, V5, P1; Letourneur Y, 2003, J MAR BIOL ASSOC UK, V83, P193, DOI 10.1017/S0025315403006970h; Mangialajo L, 2008, MAR ECOL PROG SER, V358, P63, DOI 10.3354/meps07400; Mangialajo L, 2012, J EXP MAR BIOL ECOL, V412, P72, DOI 10.1016/j.jembe.2011.10.031; Manson FJ, 2005, OCEANOGR MAR BIOL, V43, P483; Morey G, 2003, FISH RES, V62, P89, DOI 10.1016/S0165-7836(02)00250-3; Murtaugh PA, 2007, ECOLOGY, V88, P56, DOI 10.1890/0012-9658(2007)88[56:SACIED]2.0.CO;2; Nanjo K, 2011, J EXP MAR BIOL ECOL, V405, P53, DOI 10.1016/j.jembe.2011.05.016; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Patzner RA, 1999, ENVIRON BIOL FISH, V55, P207, DOI 10.1023/A:1007535808710; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Raventos N, 2005, ESTUAR COAST SHELF S, V63, P479, DOI 10.1016/j.ecss.2004.11.018; Ruitton S, 2000, ESTUAR COAST SHELF S, V50, P217, DOI 10.1006/ecss.1999.0546; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Schultz ST, 2009, MAR ECOL PROG SER, V374, P85, DOI 10.3354/meps07779; Schultz ST, 2010, HYDROBIOLOGIA, V649, P25, DOI 10.1007/s10750-010-0256-1; Smale DA, 2013, ECOL EVOL, V3, P4016, DOI 10.1002/ece3.774; Smith-Vaniz WF, 2006, B MAR SCI, V79, P17; Somerfield PJ, 2013, J EXP MAR BIOL ECOL, V449, P261, DOI 10.1016/j.jembe.2013.10.002; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Stergiou KI, 2001, REV FISH BIOL FISHER, V11, P217, DOI 10.1023/A:1020556722822; Strain EMA, 2014, GLOBAL CHANGE BIOL, V20, P3300, DOI 10.1111/gcb.12619; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Thibaut T, 2015, MEDITERR MAR SCI, V16, P206, DOI 10.12681/mms.1032; Thiriet P., 2014, UNDERWATER SEASCAPES, DOI 10.1007/978-3-319-03440-9_12; Thiriet P., 2014, THESIS; Tsiamis K, 2013, MAR ECOL PROG SER, V472, P73, DOI 10.3354/meps10060; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willis TJ, 2001, J FISH BIOL, V59, P1408, DOI 10.1006/jfbi.2001.1721	81	39	39	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164121	10.1371/journal.pone.0164121	http://dx.doi.org/10.1371/journal.pone.0164121			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760168	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204000029
J	Gaiotto, T; Hufton, SE				Gaiotto, Tiziano; Hufton, Simon E.			Cross-Neutralising Nanobodies Bind to a Conserved Pocket in the Hemagglutinin Stem Region Identified Using Yeast Display and Deep Mutational Scanning	PLOS ONE			English	Article							A VIRUS HEMAGGLUTININ; CELL-SURFACE DISPLAY; INFLUENZA-VIRUS; MONOCLONAL-ANTIBODIES; ESCAPE MUTANTS; AFFINITY MATURATION; ESCHERICHIA-COLI; PEPTIDE ARRAYS; FUSION DOMAIN; EPITOPE	Cross-neutralising monoclonal antibodies against influenza hemagglutinin (HA) are of considerable interest as both therapeutics and diagnostic tools. We have recently described five different single domain antibodies (nanobodies) which share this cross-neutralising activity and suggest their small size, high stability, and cleft binding properties may present distinct advantages over equivalent conventional antibodies. We have used yeast display in combination with deep mutational scanning to give residue level resolution of positions in the antibody-HA interface which are crucial for binding. In addition, we have mapped positions within HA predicted to have minimal effect on antibody binding when mutated. Our cross-neutralising nanobodies were shown to bind to a highly conserved pocket in the HA2 domain of A(H1N1) pdm09 influenza virus overlapping with the fusion peptide suggesting their mechanism of action is through the inhibition of viral membrane fusion. We also note that the epitope overlaps with that of CR6261 and F10 which are human monoclonal antibodies in clinical development as immunotherapeutics. Although all five nanobodies mapped to the same highly conserved binding pocket we observed differences in the size of the epitope footprint which has implications in comparing the relative genetic barrier each nanobody presents to a rapidly evolving influenza virus. To further refine our epitope map, we have re-created naturally occurring mutations within this HA stem epitope and tested their effect on binding using yeast display. We have shown that a D46N mutation in the HA2 stem domain uniquely interferes with binding of R2b-E8. Further testing of this substitution in the context of full length purified HA from 1918 H1N1 pandemic (Spanish flu), 2009 H1N1 pandemic (swine flu) and highly pathogenic avian influenza H5N1 demonstrated binding which correlated with D46 whereas binding to seasonal H1N1 strains carrying N46 was absent. In addition, our deep sequence analysis predicted that binding to the emerging H1N1 strain (A/Christchurch/16/2010) carrying the HA2-E47K mutation would not affect binding was confirmed experimentally. This demonstrates yeast display, in combination with deep sequencing, may be able to predict antibody reactivity to emerging influenza strains so assisting in the preparation for future influenza pandemics.	[Gaiotto, Tiziano; Hufton, Simon E.] Natl Inst Biol Stand & Controls, Biotherapeut Grp, Blanche Lane, Potters Bar EN6 3QG, Herts, England	National Institute for Biological Standards & Control	Hufton, SE (corresponding author), Natl Inst Biol Stand & Controls, Biotherapeut Grp, Blanche Lane, Potters Bar EN6 3QG, Herts, England.	simon.hufton@nibsc.org	Hufton, Simon E/E-3949-2013; hufton, simon/AAA-8245-2019	hufton, simon/0000-0003-1756-0306				[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Balazs AB, 2013, NAT BIOTECHNOL, V31, P647, DOI 10.1038/nbt.2618; Blaise L, 2004, GENE, V342, P211, DOI 10.1016/j.gene.2004.08.014; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Bodle J, 2013, INFLUENZA OTHER RESP, V7, P191, DOI 10.1111/j.1750-2659.2012.00375.x; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Burritt JB, 2001, J BIOL CHEM, V276, P2053, DOI 10.1074/jbc.M006236200; Carnell GW, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00161; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chao G, 2004, J MOL BIOL, V342, P539, DOI 10.1016/j.jmb.2004.07.053; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen J, 1995, P NATL ACAD SCI USA, V92, P12205, DOI 10.1073/pnas.92.26.12205; Christmann A, 2001, J IMMUNOL METHODS, V257, P163, DOI 10.1016/S0022-1759(01)00461-6; Chun S, 2008, VACCINE, V26, P6068, DOI 10.1016/j.vaccine.2008.09.015; Clementi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028001; Cochran JR, 2004, J IMMUNOL METHODS, V287, P147, DOI 10.1016/j.jim.2004.01.024; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Doolan KM, 2015, J MOL BIOL, V427, P328, DOI 10.1016/j.jmb.2014.10.024; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fennell BJ, 2010, J MOL BIOL, V400, P155, DOI 10.1016/j.jmb.2010.04.061; Ferreira HL, 2010, AVIAN DIS, V54, P565, DOI 10.1637/8750-033009-ResNote.1; Finlay WJ, 2009, J MOL BIOL, V388, P541, DOI 10.1016/j.jmb.2009.03.019; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Han T, 2011, BIOCHEM BIOPH RES CO, V409, P253, DOI 10.1016/j.bbrc.2011.04.139; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Huang J, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-7; Hufton SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103294; Ibanez LI, 2011, J INFECT DIS, V203, P1063, DOI 10.1093/infdis/jiq168; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Li J, 2009, EUR J IMMUNOL, V39, P3498, DOI 10.1002/eji.200939532; Lorieau JL, 2010, P NATL ACAD SCI USA, V107, P11341, DOI 10.1073/pnas.1006142107; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marasco WA, 2007, NAT BIOTECHNOL, V25, DOI 10.1038/nbt1363; Mata-Fink J, 2013, J MOL BIOL, V425, P444, DOI 10.1016/j.jmb.2012.11.010; Matsuzaki Y, 2014, J VIROL, V88, P12364, DOI 10.1128/JVI.01381-14; Maurer-Stroh Sebastian, 2010, PLoS Curr, V2, pRRN1162; Minor PD, 2015, VACCINES-BASEL, V3, P90, DOI 10.3390/vaccines3010090; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Nakamura G, 2013, CELL HOST MICROBE, V14, P93, DOI 10.1016/j.chom.2013.06.004; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005672; Reineke U, 2001, CURR OPIN BIOTECH, V12, P59, DOI 10.1016/S0958-1669(00)00178-6; Rudneva I, 2012, VIRUS RES, V166, P61, DOI 10.1016/j.virusres.2012.03.003; Schmeisser F, 2014, INFLUENZA OTHER RESP, V8, P587, DOI 10.1111/irv.12272; Shembekar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055516; Shen JQ, 2006, J BIOL CHEM, V281, P10706, DOI 10.1074/jbc.M513415200; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sriwilaijaroen N, 2012, P JPN ACAD B-PHYS, V88, P226, DOI 10.2183/pjab.88.226; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sutherland JN, 2009, BIOCHEMISTRY-US, V48, P11982, DOI 10.1021/bi901532z; Tan GS, 2014, J VIROL, V88, P13580, DOI 10.1128/JVI.02289-14; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Treanor J, 2004, NEW ENGL J MED, V350, P218, DOI 10.1056/NEJMp038238; Vajdos FF, 2002, J MOL BIOL, V320, P415, DOI 10.1016/S0022-2836(02)00264-4; Van Blarcom T, 2015, J MOL BIOL, V427, P1513, DOI 10.1016/j.jmb.2014.09.020; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wyrzucki A, 2014, J VIROL, V88, P7083, DOI 10.1128/JVI.00178-14; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10	75	16	16	1	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164296	10.1371/journal.pone.0164296	http://dx.doi.org/10.1371/journal.pone.0164296			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741319	Green Submitted, Green Published, gold			2022-12-26	WOS:000385507000025
J	Burgess, M; Mapp, S; Mazzieri, R; Cheung, C; Chambers, L; Mattarollo, SR; Mollee, P; Gill, D; Saunders, NA				Burgess, M.; Mapp, S.; Mazzieri, R.; Cheung, C.; Chambers, L.; Mattarollo, S. R.; Mollee, P.; Gill, D.; Saunders, N. A.			Increased Fc gamma RIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients	ONCOGENE			English	Article							NURSE-LIKE CELLS; IN-VITRO; MACROPHAGES; RITUXIMAB; EXPRESSION; IDELALISIB; IBRUTINIB; CANCER; CLL; STRATEGIES	Resistance to therapeutic antibodies in chronic lymphocytic leukaemia (CLL) is common. In this study, we show that therapeutic antibodies against CD62L (CD62L-Ab) or CD20 (obinutuzumab) were able to induce antibody-dependent cell-mediated cytotoxicity (ADCC) and phagocytosis (ADP) in primary cultures of CLL cells. CLL cells derived from patients with active disease requiring treatment displayed resistance to these antibodies, whereas patients with stable disease were sensitive. Using enrichment strategies and transcriptomic analyses, we show that antibody-dependent tumour cell killing was Fc gamma R-dependent and mediated by macrophages. Moreover, we show that resistance cannot be attributed to total numbers or established subtypes of monocytes/macrophages, or the efficiency with which they bind an immune complex. Rather, ADCC/ADP resistance was due to reduced signalling activity through the activating Fc gamma Rs resulting in the transfer of dominance to the inhibitory Fc gamma RIIb within macrophages. Most significantly, we show that resistance is an actionable event that could be reversed using inhibitors of Fc gamma RIIb signalling in primary cultures of CLL cells that were previously insensitive to obinutuzumab or CD62L-Ab.	[Burgess, M.; Mazzieri, R.; Mattarollo, S. R.; Gill, D.; Saunders, N. A.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Burgess, M.; Mapp, S.; Cheung, C.; Chambers, L.; Mollee, P.; Gill, D.] Princess Alexandra Hosp, Dept Haematol, Canc Serv, Ipswich Rd, Woolloongabba, Qld 4102, Australia; [Mollee, P.] Univ Queensland, Sch Med, Translat Res Inst, Woolloongabba, Qld, Australia	University of Queensland; University of Queensland	Gill, D (corresponding author), Princess Alexandra Hosp, Dept Haematol, Canc Serv, Ipswich Rd, Woolloongabba, Qld 4102, Australia.; Saunders, NA (corresponding author), Univ Queensland, Diamantina Inst, Translat Res Inst, Ipswich Rd, Woolloongabba, Qld 4102, Australia.	Devinder.gill@health.qld.gov.au; nsaunders@uq.edu.au	saunders, nicholas/AAJ-6101-2020; Mollee, Peter/A-6677-2012; Mazzieri, Roberta/C-9773-2015	saunders, nicholas/0000-0002-2478-3420; Mollee, Peter/0000-0002-8537-1198; Mazzieri, Roberta/0000-0002-5172-0927	Australian NHMRC [APP1049182]; Cancer Council Queensland [APP1025479]; Senior Research Fellowship - Cancer Council Queensland	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); Senior Research Fellowship - Cancer Council Queensland(Cancer Council Queensland)	We gratefully acknowledge the patients who donated samples for this study. We also gratefully acknowledge the constructive comments of Professor Maher Gandhi before submission. NS is supported by grants from the Australian NHMRC (#APP1049182) and the Cancer Council Queensland (#APP1025479). NS is supported by a Senior Research Fellowship awarded by the Cancer Council Queensland.	ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Awan FT, 2014, CLIN CANCER RES, V20, P5869, DOI 10.1158/1078-0432.CCR-14-1889; Bhattacharya N, 2011, BRIT J HAEMATOL, V154, P349, DOI 10.1111/j.1365-2141.2011.08747.x; Boissard F, 2015, LEUKEMIA LYMPHOMA, V56, P1570, DOI 10.3109/10428194.2014.991731; Bournazos S, 2009, CLIN EXP IMMUNOL, V157, P244, DOI 10.1111/j.1365-2249.2009.03980.x; Burger JA, 2000, BLOOD, V96, P2655; Burger JA, 2014, LANCET ONCOL, V15, P1090, DOI 10.1016/S1470-2045(14)70335-3; Burger JA, 2014, NAT REV CLIN ONCOL, V11, P184, DOI 10.1038/nrclinonc.2014.42; Burgess M, 2016, GENOM DATA, V7, P4, DOI 10.1016/j.gdata.2015.11.010; Burgess M, 2013, CLIN CANCER RES, V19, P5675, DOI 10.1158/1078-0432.CCR-13-1037; Burgess M, 2012, LEUKEMIA LYMPHOMA, V53, P1988, DOI 10.3109/10428194.2012.672735; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; DiLillo DJ, 2015, CELL, V161, P1035, DOI 10.1016/j.cell.2015.04.016; Filip AA, 2013, BLOOD CELL MOL DIS, V50, P263, DOI 10.1016/j.bcmd.2012.12.003; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Giannoni P, 2014, HAEMATOLOGICA, V99, P1078, DOI 10.3324/haematol.2013.091405; Gu  B, 2001, LEUKEMIA LYMPHOMA, V42, P5, DOI 10.3109/10428190109097671; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hallek M, 2013, BLOOD, V122, P3723, DOI 10.1182/blood-2013-05-498287; Herter S, 2014, J IMMUNOL, V192, P2252, DOI 10.4049/jimmunol.1301249; Jaglowski SM, 2015, BLOOD, V126, P842, DOI 10.1182/blood-2014-12-617522; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mellor JD, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-1; Morabito F, 2015, LEUKEMIA LYMPHOMA, V56, P3250, DOI 10.3109/10428194.2015.1061193; Nimmerjahn F, 2007, CURR OPIN IMMUNOL, V19, P239, DOI 10.1016/j.coi.2007.01.005; Pallasch CP, 2014, CELL, V156, P590, DOI 10.1016/j.cell.2013.12.041; Patz M, 2011, BRIT J HAEMATOL, V152, P295, DOI 10.1111/j.1365-2141.2010.08428.x; Robak T, 2014, EXPERT REV HEMATOL, V7, P841, DOI 10.1586/17474086.2014.963048; Roghanian A, 2015, CANCER CELL, V27, P473, DOI 10.1016/j.ccell.2015.03.005; Tsukada N, 2002, BLOOD, V99, P1030, DOI 10.1182/blood.V99.3.1030; Ysebaert L, 2011, LEUKEMIA LYMPHOMA, V52, P1404, DOI 10.3109/10428194.2011.568078	32	9	9	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 27	2017	36	17					2366	2376		10.1038/onc.2016.387	http://dx.doi.org/10.1038/onc.2016.387			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET4QE	27748757				2022-12-26	WOS:000400268900004
J	Zhong, T; Men, Y; Lu, L; Geng, T; Zhou, J; Mitsuhashi, A; Shozu, M; Maihle, NJ; Carmichael, GG; Taylor, HS; Huang, Y				Zhong, T.; Men, Y.; Lu, L.; Geng, T.; Zhou, J.; Mitsuhashi, A.; Shozu, M.; Maihle, N. J.; Carmichael, G. G.; Taylor, H. S.; Huang, Y.			Metformin alters DNA methylation genome-wide via the H19/SAHH axis	ONCOGENE			English	Article							LONG NONCODING RNA; GENE-EXPRESSION; PROSTATE-CANCER; CELLS; DRUG; CONTRIBUTES; METASTASIS; METABOLISM; MICRORNAS; PROMOTES	The molecular mechanisms underlying the antineoplastic properties of metformin, a first-line drug for type 2 diabetes, remain elusive. Here we report that metformin induces genome-wide alterations in DNA methylation by modulating the activity of S-adenosylhomocysteine hydrolase (SAHH). Exposing cancer cells to metformin leads to hypermethylation of tumor-promoting pathway genes and concomitant inhibition of cell proliferation. Metformin acts by upregulating microRNA let-7 through AMPK activation, leading to degradation of H19 long noncoding RNA, which normally binds to and inactivates SAHH. H19 knockdown activates SAHH, enabling DNA methyltransferase 3B to methylate a subset of genes. This metformin-induced H19 repression and alteration of gene methylation are recapitulated in endometrial cancer tissue samples obtained from patients treated with antidiabetic doses of metformin. Our findings unveil a novel mechanism of action for the drug metformin with implications for the molecular basis of epigenetic dysregulation in cancer. This novel mechanism of action also may be occurring in normal cells.	Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; Gannan Med Univ, Affiliated Hosp 1, Dept Lab Med, Ganzhou, Jiangxi, Peoples R China; Sichuan Univ, West China Hosp Stomatol, Dept Head & Neck Surg, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; Yale Univ, Sch Med, Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, 310 Cedar St,LSOG 205C, New Haven, CT 06510 USA; Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Endocrinol, Xian, Shaanxi, Peoples R China; Zhejiang Univ, Sch Med, Affiliated Sir Run Run Shaw Hosp, Dept Surg Oncol, Hangzhou, Zhejiang, Peoples R China; Chiba Univ, Grad Sch Med, Dept Reprod Med, Chiba, Japan; Med Coll Georgia, Georgia Canc Ctr, Augusta, GA 30912 USA; Univ Connecticut, Farmington, CT USA	Yale University; Gannan Medical University; Sichuan University; Yale University; Xi'an Jiaotong University; Zhejiang University; Chiba University; University System of Georgia; Augusta University; University of Connecticut		Yingqun.huang@yale.edu	Zhou, Jichun/Q-8646-2019; Zhong, Tianyu/HCG-8326-2022	Zhou, Jichun/0000-0002-0727-4034; Zhong, Tianyu/0000-0003-1934-0032	Bennack-Polan Foundation; NIGMS [R01 HD072418]; national Natural Science Foundation of China [81602471]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072418] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Bennack-Polan Foundation; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); national Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank Alessandro Santin for the gift of ARK2 cells. This work was supported by grants from Bennack-Polan Foundation and Discover to Cure to YH, R01 HD072418 from the NIGMS to GGC and national Natural Science Foundation of China (No. 81602471) to JZ.	Albitar L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-166; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Fernandez AF, 2012, GENOME RES, V22, P407, DOI 10.1101/gr.119867.110; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Gao Y, 2014, NUCLEIC ACIDS RES, V42, P13799, DOI 10.1093/nar/gku1160; Graham JR, 2010, MOL CELL BIOL, V30, P5295, DOI 10.1128/MCB.00303-10; Gravina GL, 2011, ENDOCRINOLOGY, V152, P4550, DOI 10.1210/en.2011-1056; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Jin BL, 2012, CELL REP, V2, P1411, DOI 10.1016/j.celrep.2012.10.017; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; Matouk IJ, 2016, ONCOTARGET, V7, P3748, DOI 10.18632/oncotarget.6387; Merry CR, 2015, HUM MOL GENET, V24, P6240, DOI 10.1093/hmg/ddv343; Milinkovic V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082108; Mitsuhashi A, 2014, CANCER-AM CANCER SOC, V120, P2986, DOI 10.1002/cncr.28853; Oliveras-Ferraros C, 2011, CELL CYCLE, V10, P1144, DOI 10.4161/cc.10.7.15210; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pollak M, 2013, J CLIN INVEST, V123, P3693, DOI 10.1172/JCI67232; Poulain M, 2014, MOL HUM REPROD, V20, P960, DOI 10.1093/molehr/gau058; Pryor R, 2015, BIOCHEM J, V471, P307, DOI 10.1042/BJ20150497; Raveh E, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0458-2; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Su B, 2015, HEPATOLOGY, V61, P585, DOI 10.1002/hep.27551; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Tsang WP, 2010, CARCINOGENESIS, V31, P350, DOI 10.1093/carcin/bgp181; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Wang GC, 2013, NAT GENET, V45, P739, DOI 10.1038/ng.2654; Xu WJ, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0425-6; Yan L, 2015, ONCOGENE, V34, P3076, DOI 10.1038/onc.2014.236; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10221	32	81	86	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 27	2017	36	17					2345	2354		10.1038/onc.2016.391	http://dx.doi.org/10.1038/onc.2016.391			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET4QE	27775072	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000400268900002
J	Deering-Rice, CE; Stockmann, C; Romero, EG; Lu, ZY; Shapiro, D; Stone, BL; Fassl, B; Nkoy, F; Uchida, DA; Ward, RM; Veranth, JM; Reilly, CA				Deering-Rice, Cassandra E.; Stockmann, Chris; Romero, Erin G.; Lu, Zhenyu; Shapiro, Darien; Stone, Bryan L.; Fassl, Bernhard; Nkoy, Flory; Uchida, Derek A.; Ward, Robert M.; Veranth, John M.; Reilly, Christopher A.			Characterization of Transient Receptor Potential Vanilloid-1 (TRPV1) Variant Activation by Coal Fly Ash Particles and Associations with Altered Transient Receptor Potential Ankyrin-1 (TRPA1) Expression and Asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ENDOPLASMIC-RETICULUM STRESS; AIR-POLLUTION; CELL-DEATH; SENSORY NEURONS; PARTICULATE MATERIAL; EPITHELIAL-CELLS; LUNG-CELLS; CAPSAICIN RESPONSIVENESS; ENVIRONMENTAL PARTICLES	Transient receptor potential (TRP) channels are activated by environmental particulate materials. We hypothesized that polymorphic variants of transient receptor potential vanilloid-1 (TRPV1) would be uniquely responsive to insoluble coal fly ash compared with the prototypical soluble agonist capsaicin. Furthermore, these changes would manifest as differences in lung cell responses to these agonists and perhaps correlate with changes in asthma symptom control. The TRPV1-I315M and -T469I variants were more responsive to capsaicin and coal fly ash. The I585V variant was less responsive to coal fly ash particles due to reduced translation of protein and an apparent role for Ile-585 in activation by particles. In HEK-293 cells, I585V had an inhibitory effect on wild-type TRPV1 expression, activation, and internalization/agonist-induced desensitization. In normal human bronchial epithelial cells, IL-8 secretion in response to coal fly ash treatment was reduced for cells heterozygous for TRPV1-I585V. Finally, both the I315M and I585V variants were associated with worse asthma symptom control with the effects of I315M manifesting in mild asthma and those of the I585V variant manifesting in severe, steroid-insensitive individuals. This effect may be due in part to increased transient receptor potential ankyrin-1 (TRPA1) expression by lung epithelial cells expressing the TRPV1-I585V variant. These findings suggest that specific molecular interactions control TRPV1 activation by particles, differential activation, and desensitization of TRPV1 by particles and/or other agonists, and cellular changes in the expression of TRPA1 as a result of I585V expression could contribute to variations in asthma symptom control.	[Deering-Rice, Cassandra E.; Stockmann, Chris; Romero, Erin G.; Lu, Zhenyu; Shapiro, Darien; Veranth, John M.; Reilly, Christopher A.] Univ Utah, Dept Pharmacol & Toxicol, 30 South 2000 East,201 Skaggs Hall, Salt Lake City, UT 84112 USA; [Stone, Bryan L.; Fassl, Bernhard; Nkoy, Flory; Uchida, Derek A.; Ward, Robert M.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Reilly, CA (corresponding author), Univ Utah, Dept Pharmacol & Toxicol, 30 South 2000 East,201 Skaggs Hall, Salt Lake City, UT 84112 USA.	Chris.Reilly@pharm.utah.edu	Sherwin, Catherine Mary Turner/B-2888-2012	Sherwin, Catherine Mary Turner/0000-0002-0844-3207	National Center for Research Resources NCRR Shared Equipment Grant [1S10RR024761-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060559] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017431] Funding Source: NIH RePORTER	National Center for Research Resources NCRR Shared Equipment Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Imaging was performed at the Fluorescence Microscopy Core Facility, a part of the Health Sciences Cores at the University of Utah. Microscopy equipment was purchased using National Center for Research Resources NCRR Shared Equipment Grant 1S10RR024761-01.	Agopyan N, 2003, TOXICOL APPL PHARM, V186, P63, DOI 10.1016/S0041-008X(02)00013-3; Aguilera I, 2009, ENVIRON HEALTH PERSP, V117, P1322, DOI 10.1289/ehp.0800256; Akopian AN, 2008, J NEUROSCI, V28, P1064, DOI 10.1523/JNEUROSCI.1565-06.2008; Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Allen RW, 2008, INHAL TOXICOL, V20, P423, DOI 10.1080/08958370801903826 ; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Cantero-Recasens G, 2010, J BIOL CHEM, V285, P27532, DOI 10.1074/jbc.C110.159491; Chen CL, 2015, ALLERGY ASTHMA PROC, V36, pE29, DOI 10.2500/aap.2015.36.3828; Deering-Rice CE, 2015, AM J RESP CELL MOL, V53, P893, DOI 10.1165/rcmb.2015-0086OC; Deering-Rice CE, 2012, MOL PHARMACOL, V81, P411, DOI 10.1124/mol.111.076067; Deering-Rice CE, 2011, CHEM RES TOXICOL, V24, P950, DOI 10.1021/tx200123z; Dicpinigaitis PV, 2001, THORAX, V56, P162; Doherty MJ, 2000, THORAX, V55, P643, DOI 10.1136/thorax.55.8.643; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Epton MJ, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-16; Fujimura M, 1998, Respirology, V3, P267, DOI 10.1111/j.1440-1843.1998.tb00133.x; Groneberg DA, 2004, AM J RESP CRIT CARE, V170, P1276, DOI 10.1164/rccm.200402-174OC; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Iskandar A, 2012, THORAX, V67, P252, DOI 10.1136/thoraxjnl-2011-200324; Jacquemin B, 2009, EUR RESPIR J, V34, P834, DOI 10.1183/09031936.00138208; Johansen ME, 2006, TOXICOL SCI, V89, P278, DOI 10.1093/toxsci/kfi292; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Lee LY, 2009, CURR OPIN PHARMACOL, V9, P243, DOI 10.1016/j.coph.2009.02.002; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McConnell R, 2010, ENVIRON HEALTH PERSP, V118, P1021, DOI 10.1289/ehp.0901232; McGarvey LP, 2014, J ALLERGY CLIN IMMUN, V133, P704, DOI 10.1016/j.jaci.2013.09.016; Meseguer V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4125; Nassini R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042454; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Nieto L, 2003, RESP MED, V97, P393, DOI 10.1053/rmed.2002.1460; Nkoy FL, 2013, PEDIATRICS, V132, pE1554, DOI 10.1542/peds.2013-1389; Nkoy Flory L, 2012, AMIA Annu Symp Proc, V2012, P663; Oortgiesen M, 2000, AM J PHYSIOL-LUNG C, V278, pL683, DOI 10.1152/ajplung.2000.278.4.L683; Portnov BA, 2012, INT J ENVIRON HEAL R, V22, P249, DOI 10.1080/09603123.2011.634387; Rehman R, 2013, INT IMMUNOPHARMACOL, V15, P597, DOI 10.1016/j.intimp.2013.02.010; Reilly CA, 2005, J BIOCHEM MOL TOXIC, V19, P266, DOI 10.1002/jbt.20084; Reilly CA, 2003, TOXICOL SCI, V73, P170, DOI 10.1093/toxsci/kfg044; Ren YF, 2015, PEDIATR RES, V77, P506, DOI 10.1038/pr.2015.11; Sanz-Salvador L, 2012, J BIOL CHEM, V287, P19462, DOI 10.1074/jbc.M111.289751; Schembari A, 2014, ENVIRON HEALTH PERSP, V122, P317, DOI 10.1289/ehp.1306802; Shapiro D, 2013, CHEM RES TOXICOL, V26, P750, DOI 10.1021/tx400024h; Smit LAM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-26; Smith KR, 2006, TOXICOL SCI, V93, P390, DOI 10.1093/toxsci/kfl062; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Stockmann C, 2015, J ALLERGY CLIN IMMUN, V136, P505, DOI 10.1016/j.jaci.2015.02.009; Stockmann C, 2013, J PEDIATR-US, V162, P1222, DOI 10.1016/j.jpeds.2012.11.031; Thomas KC, 2007, J PHARMACOL EXP THER, V321, P830, DOI 10.1124/jpet.107.119412; Thomas KC, 2012, AM J PHYSIOL-LUNG C, V302, pL111, DOI 10.1152/ajplung.00231.2011; Veranth JM, 2004, TOXICOL SCI, V82, P88, DOI 10.1093/toxsci/kfh248; Veranth JM, 2008, TOXICOL IN VITRO, V22, P498, DOI 10.1016/j.tiv.2007.10.011; Veronesi B, 2003, NEUROTOXICOLOGY, V24, P463, DOI 10.1016/S0161-813X(03)00022-6; Veronesi B, 1999, NEUROPEPTIDES, V33, P447, DOI 10.1054/npep.1999.0761; Xu H, 2007, AM J PHYSIOL-RENAL, V293, pF1865, DOI 10.1152/ajprenal.00347.2007	56	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24866	24879		10.1074/jbc.M116.746156	http://dx.doi.org/10.1074/jbc.M116.746156			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27758864	Green Published, hybrid			2022-12-26	WOS:000388880100007
J	Fukui, N; Araki, K; Hongo, K; Mizobata, T; Kawata, Y				Fukui, Naoya; Araki, Kiho; Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi			Modulating the Effects of the Bacterial Chaperonin GroEL on Fibrillogenic Polypeptides through Modification of Domain Hinge Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; BETA-AMYLOID FIBRILS; ALZHEIMERS-DISEASE; APICAL DOMAIN; PROTEINS; AGGREGATION; SYNUCLEIN; TOXICITY; HSP70; BINDING	The isolated apical domain of the Escherichia coli GroEL subunit displays the ability to suppress the irreversible fibrillation of numerous amyloid-forming polypeptides. In previous experiments, we have shown that mutating Gly-192 (located at hinge II that connects the apical domain and the intermediate domain) to a tryptophan results in an inactive chaperonin whose apical domain is disoriented. In this study, we have utilized this disruptive effect of Gly-192 mutation to our advantage, by substituting this residue with amino acid residues of varying van der Waals volumes with the intent to modulate the affinity of GroEL toward fibrillogenic peptides. The affinities of GroEL toward fibrillogenic polypeptides such as A beta(1-40) (amyloid-beta(1-40)) peptide and alpha-synuclein increased in accordance to the larger van der Waals volume of the substituent amino acid side chain in the G192X mutants. When we compared the effects of wildtype GroEL and selected GroEL G192X mutants on alpha-synuclein fibril formation, we found that the effects of the chaperonin on alpha-synuclein fibrillation were different; the wild-type chaperonin caused changes in both the initial lag phase and the rate of fibril extension, whereas the effects of the G192X mutants were more specific toward the nucleus-forming lag phase. The chaperonins also displayed differential effects on alpha-synuclein fibril morphology, suggesting that through mutation of Gly-192, we may induce changes to the intermolecular affinities between GroEL and alpha-synuclein, leading to more efficient fibril suppression, and in specific cases, modulation of fibril morphology.	[Fukui, Naoya; Araki, Kiho; Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan; [Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Tottori 6808552, Japan	Tottori University; Tottori University	Kawata, Y (corresponding author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan.	kawata@bio.tottori-u.ac.jp	Kawata, Yasushi/ABA-9608-2021; Mizobata, Tomohiro/V-6672-2019	Mizobata, Tomohiro/0000-0002-7808-2099; Kawata, Yasushi/0000-0002-2744-1506	Japan Society for the Promotion of Science (JSPS) [25440027]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [2411376]; Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development (AMED)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by Grant-in-Aid for Scientific Research (C) 25440027 from the Japan Society for the Promotion of Science (JSPS) and Grant-in-Aid for Scientific Research on Innovative Areas 2411376 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). This research was also partially supported by the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development (AMED). The authors declare that they have no conflicts of interest with the contents of this article.	Chaudhuri TK, 2009, PROG BIOPHYS MOL BIO, V99, P42, DOI 10.1016/j.pbiomolbio.2008.10.007; Darby N. J., 1993, PROTEIN STRUCTURE FO; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hayer-Hartl M, 2016, TRENDS BIOCHEM SCI, V41, P62, DOI 10.1016/j.tibs.2015.07.009; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; Jacobson D R, 1991, Adv Hum Genet, V20, P69; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Knight SD, 2013, BIOCHEMISTRY-US, V52, P7523, DOI 10.1021/bi400908x; KUBO T, 1993, J BIOL CHEM, V268, P19346; Kulig M, 2012, BIOCHEM J, V448, P343, DOI 10.1042/BJ20121187; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Machida K, 2009, BBA-PROTEINS PROTEOM, V1794, P1344, DOI 10.1016/j.bbapap.2008.12.003; Mainz A, 2015, NAT STRUCT MOL BIOL, V22, P898, DOI 10.1038/nsmb.3108; Nishida N, 2013, J BIOSCI BIOENG, V116, P160, DOI 10.1016/j.jbiosc.2013.02.012; Noi K., 2012, AM J MOL BIOL, V2, P265, DOI [10.4236/ajmb.2012.23028, DOI 10.4236/AJMB.2012.23028]; Ohi T, 2004, J NEUROL SCI, V225, P19, DOI 10.1016/j.jns.2004.06.008; Ojha B, 2016, SCI REP-UK, V6, DOI 10.1038/srep31041; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; Sakane I, 2007, J MOL BIOL, V367, P1171, DOI 10.1016/j.jmb.2007.01.037; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Shahmoradian SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00710; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Uversky VN, 2008, CURR ALZHEIMER RES, V5, P260, DOI 10.2174/156720508784533312; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Yagi-Utsumi M, 2013, FEBS LETT, V587, P1605, DOI 10.1016/j.febslet.2013.04.007	36	11	11	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25217	25226		10.1074/jbc.M116.751925	http://dx.doi.org/10.1074/jbc.M116.751925			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27742838	hybrid, Green Published			2022-12-26	WOS:000388880100035
J	Ly, K; Essalmani, R; Desjardins, R; Seidah, NG; Day, R				Ly, Kevin; Essalmani, Rachid; Desjardins, Roxane; Seidah, Nabil G.; Day, Robert			An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; FAMILIAL HYPERCHOLESTEROLEMIA; INTRACELLULAR DEGRADATION; LIVER-REGENERATION; ANNEXIN A2; PROTEIN; PATHWAY; BINDING; CHOLESTEROL; ENDOCYTOSIS	The mechanism of LDL receptor (LDLR) degradation mediated by the proprotein convertase subtilisin/kexin type 9 (PCSK9) has been extensively studied; however, many steps within this process remain unclear and still require characterization. Recent studies have shown that PCSK9 lacking its Cys/His-rich domain can still promote LDLR internalization, but the complex does not reach the lysosome suggesting the presence of an additional interaction partner(s). In this study we carried out an unbiased screening approach to identify PCSK9-interacting proteins in the HepG2 cells' secretome using co-immunoprecipitation combined with mass spectrometry analyses. Several interacting proteins were identified, including glypican-3 (GPC3), phospholipid transfer protein, matrilin-3, tissue factor pathway inhibitor, fibrinogen-like 1, and plasminogen activator inhibitor-1. We then validated these interactions by co-immunoprecipitation and Western blotting. Furthermore, functional validation was examined by silencing each candidate protein in HepG2 cells using short hairpin RNAs to determine their effect on LDL, uptake and LDLR levels. Only GPC3 and phospholipid transfer protein silencing in HepG2 cells significantly increased LDI, uptake in these cells and displayed higher total LDLR protein levels compared with control cells. Moreover, our study provides the first evidence that GPC3 can modulate the PCSK9 extracellular activity as a competitive binding partner to the LDLR in HepG2 cells.	[Ly, Kevin; Desjardins, Roxane; Day, Robert] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Fac Med & Sci Sante, Dept Surg,Urol Div, Sherbrooke, PQ J1H 5N4, Canada; [Essalmani, Rachid; Seidah, Nabil G.] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	University of Sherbrooke; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Day, R (corresponding author), Univ Sherbrooke, Inst Pharmacol Sherbrooke, Fac Med & Sci Sante, 3001 12e Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	robert.day@usherbrooke.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342	Fondation Leducq [13 CVD 03]; Canada Research Chair [126684]; Pfizer ASPIRE CV IIR Grant; Fonds de Recherche du Quebec-Sante (FRQS)	Fondation Leducq(Leducq Foundation); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Pfizer ASPIRE CV IIR Grant; Fonds de Recherche du Quebec-Sante (FRQS)	This work was supported in part by Fondation Leducq Grant 13 CVD 03 (to R. D. and N.G. S.), by Canada Research Chair 126684 (to N.G. S.), and in part by a Pfizer ASPIRE CV IIR Grant (to N.G. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of studentship support from the Fonds de Recherche du Quebec-Sante (FRQS).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2012, J BIOL CHEM, V287, P33745, DOI 10.1074/jbc.M112.399725; Butkinaree C, 2015, J BIOL CHEM, V290, P18609, DOI 10.1074/jbc.M115.647180; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Capurro M, 2003, GASTROENTEROLOGY, V125, P89, DOI 10.1016/S0016-5085(03)00689-9; Capurro M, 2014, J CELL SCI, V127, P1565, DOI 10.1242/jcs.140871; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Capurro MI, 2012, J CELL SCI, V125, P3380, DOI 10.1242/jcs.098889; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Cortese K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003730; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Dashty M, 2014, THROMB HAEMOSTASIS, V111, P518, DOI 10.1160/TH13-02-0178; De Cat B, 2003, J CELL BIOL, V163, P625, DOI 10.1083/jcb.200302152; Demchev V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058084; Denis N, 2011, J PROTEOME RES, V10, P2011, DOI 10.1021/pr2000072; Filmus J, 2001, J CLIN INVEST, V108, P497, DOI 10.1172/JCI13712; Filmus J, 2013, FEBS J, V280, P2471, DOI 10.1111/febs.12126; Fu SJ, 2013, SURGERY, V154, P536, DOI 10.1016/j.surg.2013.02.014; Gao Wei, 2011, Cancer Rep, V1, P14; Hamik A, 1999, J BIOL CHEM, V274, P4962, DOI 10.1074/jbc.274.8.4962; Haruyama Y, 2016, WORLD J GASTROENTERO, V22, P275, DOI 10.3748/wjg.v22.i1.275; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Holla OL, 2010, MOL GENET METAB, V99, P149, DOI 10.1016/j.ymgme.2009.09.012; Hsu HC, 1997, CANCER RES, V57, P5179; Iglesias BV, 2008, HISTOL HISTOPATHOL, V23, P1333, DOI 10.14670/HH-23.1333; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Leren TP, 2014, ATHEROSCLEROSIS, V237, P76, DOI 10.1016/j.atherosclerosis.2014.08.038; Llorente-Cortes V, 2004, CIRCULATION, V110, P452, DOI 10.1161/01.CIR.0000136032.40666.3D; Ly K, 2014, J BIOL CHEM, V289, P17732, DOI 10.1074/jbc.M113.541094; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Murdoch SJ, 2002, J LIPID RES, V43, P1256, DOI 10.1194/jlr.M100373-JLR200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Norman D, 1999, J CLIN INVEST, V104, P619, DOI 10.1172/JCI6677; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2015, CELL REP, V13, P2064, DOI 10.1016/j.celrep.2015.11.006; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041865; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Strickland DK, 2014, ARTERIOSCL THROM VAS, V34, P487, DOI 10.1161/ATVBAHA.113.301924; Strom TB, 2010, MOL GENET METAB, V101, P76, DOI 10.1016/j.ymgme.2010.05.003; Sun H, 2012, ARTERIOSCL THROM VAS, V32, P1585, DOI 10.1161/ATVBAHA.112.250043; Traister A, 2008, BIOCHEM J, V410, P503, DOI 10.1042/BJ20070511; Tveten K, 2012, HUM MOL GENET, V21, P1402, DOI 10.1093/hmg/ddr578; Weider E, 2016, J BIOL CHEM, V291, P16659, DOI 10.1074/jbc.M116.717736; Xu WM, 2012, MOLECULES, V17, P12086, DOI 10.3390/molecules171012086; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105	52	7	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24676	24687		10.1074/jbc.M116.746883	http://dx.doi.org/10.1074/jbc.M116.746883			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27758865	hybrid, Green Published			2022-12-26	WOS:000388875500027
J	Sharma, AK; Arora, D; Singh, LK; Gangwal, A; Sajid, A; Molle, V; Singh, Y; Nandicoori, VK				Sharma, Aditya K.; Arora, Divya; Singh, Lalit K.; Gangwal, Aakriti; Sajid, Andaleeb; Molle, Virginie; Singh, Yogendra; Nandicoori, Vinay Kumar			Serine/Threonine Protein Phosphatase PstP of Mycobacterium tuberculosis Is Necessary for Accurate Cell Division and Survival of Pathogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell division; cell signaling; mycobacteria; Mycobacterium tuberculosis; phosphatase; phosphorylation; protein serine; threonine phosphatase (PSP); PstP; cell division	VACUOLAR-H+-ATPASE; TYROSINE PHOSPHATASES; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; KINASES PKNA; IN-VITRO; PHOSPHORYLATION; THREONINE; SERINE; GROWTH	Protein phosphatases play vital roles in phosphorylation-mediated cellular signaling. Although there are 11 serine/threonine protein kinases in Mycobacterium tuberculosis, only one serine/threonine phosphatase, PstP, has been identified. Although PstP has been biochemically characterized and multiple in vitro substrates have been identified, its physiological role has not yet been elucidated. In this study, we have investigated the impact of PstP on cell growth and survival of the pathogen in the host. Overexpression of PstP led to elongated cells and partially compromised survival. We find that depletion of PstP is detrimental to cell survival, eventually leading to cell death. PstP depletion results in elongated multiseptate cells, suggesting a role for PstP in regulating cell division events. Complementation experiments performed with PstP deletion mutants revealed marginally compromised survival, suggesting that all of the domains, including the extracellular domain, are necessary for complete rescue. On the other hand, the catalytic activity of PstP is absolutely essential for the in vitro growth. Mice infection experiments establish a definitive role for PstP in pathogen survival within the host. Depletion of PstP from established infections causes pathogen clearance, indicating that the continued presence of PstP is necessary for pathogen survival. Taken together, our data suggest an important role for PstP in establishing and maintaining infection, possibly via the modulation of cell division events.	[Arora, Divya; Nandicoori, Vinay Kumar] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India; [Sharma, Aditya K.; Singh, Lalit K.; Sajid, Andaleeb; Singh, Yogendra] CSIR Inst Genom & Integrat Biol, Mall Rd, Delhi 110007, India; [Gangwal, Aakriti; Singh, Yogendra] Univ Delhi, Dept Zool, Delhi 110007, India; [Molle, Virginie] Univ Montpellier 2, CNRS, Lab Dynam Interact Membranaires Normales & Pathol, UMR 5235, Montpellier, France; [Sharma, Aditya K.] CSIR IGIB, Acad Sci & Innovat Res AcSIR, Delhi 110025, India; [Sajid, Andaleeb] NIAID, NIH, Bethesda, MD 20814 USA	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.; Singh, Y (corresponding author), CSIR Inst Genom & Integrat Biol, Mall Rd, Delhi 110007, India.; Singh, Y (corresponding author), Univ Delhi, Dept Zool, Delhi 110007, India.	ysingh@igib.res.in; vinaykn@nii.ac.in	Sajid, Andaleeb/AAI-2960-2020; MOLLE, Virginie/D-4050-2019	Sajid, Andaleeb/0000-0001-6248-4985; MOLLE, Virginie/0000-0002-6573-3411; Nandicoori, Vinay/0000-0002-5682-4178; Sharma, Aditya Kumar/0000-0002-1085-5665	Indo French Centre for the Promotion of Advanced Research Grant [5303-1, BSC0104]	Indo French Centre for the Promotion of Advanced Research Grant	This work was supported by Indo French Centre for the Promotion of Advanced Research Grant 5303-1 (to V.K.N., Y.S., and V.M.) and BSC0104 (CSIR) (to Y.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Arora G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010772; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Bohmer F, 2013, FEBS J, V280, P413, DOI 10.1111/j.1742-4658.2012.08655.x; Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x; BOTTA GA, 1981, ANTIMICROB AGENTS CH, V19, P891, DOI 10.1128/AAC.19.5.891; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P113, DOI 10.1016/j.mib.2010.02.003; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Chakraborti PK, 2011, TUBERCULOSIS, V91, P432, DOI 10.1016/j.tube.2011.04.005; Chawla Y, 2014, J BIOL CHEM, V289, P13858, DOI 10.1074/jbc.M114.563536; Chiaradia LD, 2012, J MED CHEM, V55, P390, DOI 10.1021/jm2012062; Chopra P, 2003, BIOCHEM BIOPH RES CO, V311, P112, DOI 10.1016/j.bbrc.2003.09.173; Clarke M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008585; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; Dhiman A, 2014, FEBS OPEN BIO, V4, P65, DOI 10.1016/j.fob.2013.12.005; Fay A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004516; Fortuin S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00006; Galinier A, 1998, P NATL ACAD SCI USA, V95, P1823, DOI 10.1073/pnas.95.4.1823; Gopalaswamy R, 2004, PROTEIN EXPRES PURIF, V36, P82, DOI 10.1016/j.pep.2004.03.011; Grundner C, 2008, FEMS MICROBIOL LETT, V287, P181, DOI 10.1111/j.1574-6968.2008.01309.x; Hatzios SK, 2013, P NATL ACAD SCI USA, V110, pE5069, DOI 10.1073/pnas.1321205110; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; Jain P, 2014, MBIO, V5, DOI 10.1128/mBio.01245-14; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kaur K, 2016, FEBS J, V283, P2949, DOI 10.1111/febs.13787; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Koul A, 2000, J BACTERIOL, V182, P5425, DOI 10.1128/JB.182.19.5425-5432.2000; Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200; Lakshminarayan H, 2008, PROTEIN EXPRES PURIF, V58, P309, DOI 10.1016/j.pep.2007.12.012; LAPORTE DC, 1985, J BIOL CHEM, V260, P5291; Mascarello A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077081; Mir M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002182; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2003, BIOCHEM BIOPH RES CO, V308, P820, DOI 10.1016/S0006-291X(03)01476-1; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Nagarajan SN, 2015, J BIOL CHEM, V290, P9626, DOI 10.1074/jbc.M114.611822; Nakedi KC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00237; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; Osaki M, 2009, J BACTERIOL, V191, P4943, DOI 10.1128/JB.00196-09; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Parikh A, 2013, APPL ENVIRON MICROB, V79, P1718, DOI 10.1128/AEM.03695-12; Peirs P, 2000, FEMS MICROBIOL LETT, V188, P135; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Prisic S, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0006-2013; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Pullen KE, 2004, STRUCTURE, V12, P1947, DOI 10.1016/j.str.2004.09.008; Sajid A, 2015, ANNU REV MICROBIOL, V69, P527, DOI 10.1146/annurev-micro-020415-111342; Sajid A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017871; Shi L, 2004, FRONT BIOSCI-LANDMRK, V9, P1382, DOI 10.2741/1318; Shi L, 1998, FEMS MICROBIOL REV, V22, P229, DOI 10.1016/S0168-6445(98)00015-1; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sieger B, 2013, MOL MICROBIOL, V90, P966, DOI 10.1111/mmi.12411; Singh LK, 2015, ENVIRON MICROBIOL, V17, P855, DOI 10.1111/1462-2920.12548; Singh R, 2003, MOL MICROBIOL, V50, P751, DOI 10.1046/j.1365-2958.2003.03712.x; Soni V, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005235; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Wehenkel A, 2007, J MOL BIOL, V374, P890, DOI 10.1016/j.jmb.2007.09.076; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108; WEIDEL W, 1964, ADV ENZYMOL REL S BI, V26, P193; Wong D, 2013, TRENDS MICROBIOL, V21, P100, DOI 10.1016/j.tim.2012.09.002; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Zheng JH, 2015, J PROTEOMICS, V126, P189, DOI 10.1016/j.jprot.2015.06.003; Zhou B, 2010, P NATL ACAD SCI USA, V107, P4573, DOI 10.1073/pnas.0909133107	68	31	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24215	24230		10.1074/jbc.M116.754531	http://dx.doi.org/10.1074/jbc.M116.754531			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27758870	Green Published, hybrid			2022-12-26	WOS:000388498100035
J	Lien, PTK; Izumikawa, K; Muroi, K; Irie, K; Suda, Y; Irie, K				Pham Thi Kim Lien; Izumikawa, Keiichi; Muroi, Kei; Irie, Kaoru; Suda, Yasuyuki; Irie, Kenji			Analysis of the Physiological Activities of Scd6 through Its Interaction with Hmt1	PLoS One			English	Article							PROTEIN ARGININE METHYLATION; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL REPRESSION; BOX PROTEIN; P-BODIES; IN-VIVO; YEAST; DEGRADATION; RECRUITMENT	Scd6, a yeast homologue of human RAP55, is a component of messenger ribonucleoproteins (mRNPs) that repress translation by binding to translation initiation factors, and also is a decapping activator along with the binding partners Edc3 and Dhh1. Herein, we report that Scd6 is a substrate of the intrinsic protein arginine methyltransferase, Hmt1, in budding yeast Saccharomyces cerevisiae. Mass spectrometric analysis revealed that several arginine residues within the Scd6 RGG motif, which is important for mRNA binding, were methylated in Hmt1 dependent manner. Under stress conditions such as glucose starvation, Scd6 localized to cytoplasmic processing bodies (P-bodies) wherein translationally repressed mRNPs and untranslated mRNAs accumulate. Localization of Scd6 to P-bodies was impaired in hmt1 deletion mutant and in the presence of methylation-deficient substitution of Scd6. In addition, deletion of scd6 and dhh1 led to severe synthetic growth defect at high temperature. Methylation-deficient mutation of Scd6 suppressed the phenotypic defects of scd6 dhh1 double mutant, whereas methylation-mimic mutation did not, suggesting that the arginine methylation might negatively regulate Scd6 function relating to Dhh1. Therefore, the present data suggest that Hmt1-based arginine methylation is required for Scd6 localization and function.	[Pham Thi Kim Lien; Muroi, Kei; Irie, Kaoru; Suda, Yasuyuki; Irie, Kenji] Univ Tsukuba, Dept Mol Cell Biol, Fac Med, Tsukuba, Ibaraki, Japan; [Izumikawa, Keiichi] Tokyo Univ Agr & Technol, Global Innovat Res Org, Fuchu, Tokyo, Japan; [Suda, Yasuyuki] RIKEN Ctr Adv Photon, Live Cell Super Resolut Imaging Res Team, Wako, Saitama, Japan	University of Tsukuba; Tokyo University of Agriculture & Technology; RIKEN	Suda, Y (corresponding author), Univ Tsukuba, Dept Mol Cell Biol, Fac Med, Tsukuba, Ibaraki, Japan.; Suda, Y (corresponding author), RIKEN Ctr Adv Photon, Live Cell Super Resolut Imaging Res Team, Wako, Saitama, Japan.	ysuda@md.tsukuba.ac.jp	Suda, Yasuyuki/AAH-5065-2020; Izumikawa, Keiichi/H-4156-2016; Suda, Yasuyuki/D-3870-2017	Suda, Yasuyuki/0000-0001-8725-8001; Izumikawa, Keiichi/0000-0001-7262-5403; Suda, Yasuyuki/0000-0001-8725-8001	Ministry of Education, Culture, Sports, Science and Technology of Japan [24570192, 15K06944]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (grant numbers 24570192 and 15K06944) to Kenji Irie from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Grants-in-Aid for Scientific Research (grant number 24570192 to K.I. from the Ministry of Education, Culture, Sports, Science and Technology of Japan). We thank members of Molecular Cell Biology Laboratory for valuable discussions.	Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Balagopal V, 2009, GENETICS, V181, P93, DOI 10.1534/genetics.108.092601; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bikkavilli RK, 2011, J CELL SCI, V124, P2310, DOI 10.1242/jcs.084046; Buchan JR, 2010, METHOD ENZYMOL, V470, P619, DOI 10.1016/S0076-6879(10)70025-2; Burke D., 2000, METHODS YEAST GENETI; Chen YC, 2010, MOL CELL BIOL, V30, P5245, DOI 10.1128/MCB.00359-10; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Erce MA, 2012, PROTEOMICS, V12, P564, DOI 10.1002/pmic.201100397; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Fromm SA, 2012, EMBO J, V31, P279, DOI 10.1038/emboj.2011.408; Hieronymus H, 2004, GENE DEV, V18, P2845, DOI 10.1101/gad.1256904; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Huang KM, 1997, J CELL SCI, V110, P899; Jackson CA, 2012, PROTEOMICS, V12, P3304, DOI 10.1002/pmic.201200132; Kerr SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018302; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Low JKK, 2012, FEBS J, V279, P4423, DOI 10.1111/febs.12039; Luke B, 2007, NUCLEIC ACIDS RES, V35, P7688, DOI 10.1093/nar/gkm912; Marnef A, 2009, INT J BIOCHEM CELL B, V41, P977, DOI 10.1016/j.biocel.2008.06.015; Matsumoto K, 2012, RNA BIOL, V9, P610, DOI 10.4161/rna.19527; Messier V, 2013, CELL, V153, P1080, DOI 10.1016/j.cell.2013.04.035; Muhlrad D, 1999, RNA, V5, P1299, DOI 10.1017/S1355838299990829; Nissan T, 2010, MOL CELL, V39, P773, DOI 10.1016/j.molcel.2010.08.025; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Rajyaguru P, 2012, MOL CELL, V45, P244, DOI 10.1016/j.molcel.2011.11.026; Sakumoto N, 2002, YEAST, V19, P587, DOI 10.1002/yea.860; Segal SP, 2006, MOL CELL BIOL, V26, P5120, DOI 10.1128/MCB.01913-05; Snijders APL, 2010, J AM SOC MASS SPECTR, V21, P88, DOI 10.1016/j.jasms.2009.09.010; Steiger M, 2003, RNA, V9, P231, DOI 10.1261/rna.2151403; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Tritschler F, 2009, MOL CELL, V33, P661, DOI 10.1016/j.molcel.2009.02.014; Tudisca V, 2010, EUR J CELL BIOL, V89, P339, DOI 10.1016/j.ejcb.2009.08.005; Wong CM, 2010, NUCLEIC ACIDS RES, V38, P2217, DOI 10.1093/nar/gkp1133; Xu C, 2003, RNA, V9, P746, DOI 10.1261/rna.5020803; Yoshikawa H, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006148; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204	39	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164773	10.1371/journal.pone.0164773	http://dx.doi.org/10.1371/journal.pone.0164773			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776129	Green Published, Green Submitted, gold			2022-12-26	WOS:000389009200021
J	Chien, HT; Cheng, SD; Chuang, WY; Liao, CT; Wang, HM; Huang, SF				Chien, Huei-Tzu; Cheng, Sou-De; Chuang, Wen-Yu; Liao, Chun-Ta; Wang, Hung-Ming; Huang, Shiang-Fu			Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; DEATH DOMAIN; 11Q13 AMPLIFICATION; CCND1 AMPLIFICATION; COPY NUMBER; EXPRESSION; CANCER; HEAD; NECK; FAS	Amplification of 11q13.3 is a frequent event in human cancers, including head and neck squamous cell carcinoma. This chromosome region contains several genes that are potentially cancer drivers, including FADD (Fas associated via death domain), an apoptotic effector that was previously identified as a novel oncogene in laryngeal/pharyngeal cancer. This study was designed to explore the role of FADD in oral squamous cell carcinomas (OSCCs) samples from Taiwanese patients, by assessing copy number variations (CNVs) and protein expression and the clinical implications of these factors in 339 male OSCCs. The intensity of FADD protein expression, as determined by immunohistochemistry, was strongly correlated with gene copy number amplification, as analyzed using a TaqMan CNV assay. Both FADD gene copy number amplification and high protein expression were significantly associated with lymph node metastasis (P < 0.001). Patients with both FADD copy number amplification and high protein expression had the shortest disease-free survival (DFS; P = 0.074 and P = 0.002) and overall survival (OS; P = 0.011 and P = 0.027). After adjusting for primary tumor status, tumor differentiation, lymph node metastasis and age at diagnosis, DFS was still significantly lower in patients with either copy number amplification or high protein expression (hazard ratio [H.R.] = 1.483; 95% confidence interval [C.I.], 1.044-2.106). In conclusion, our data reveal that FADD gene copy number and protein expression can be considered potential prognostic markers and are closely associated with lymph node metastasis in patients with OSCC in Taiwan.	[Chien, Huei-Tzu; Huang, Shiang-Fu] Chang Gung Univ, Dept Publ Hlth, Taoyuan, Taiwan; [Cheng, Sou-De] Chang Gung Univ, Dept Anat, Taoyuan, Taiwan; [Chuang, Wen-Yu] Chang Gung Mem Hosp, Dept Pathol, Taoyuan, Taiwan; [Liao, Chun-Ta; Huang, Shiang-Fu] Chang Gung Mem, Dept Otolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Wang, Hung-Ming] Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Taoyuan, Taiwan; [Liao, Chun-Ta; Wang, Hung-Ming; Huang, Shiang-Fu] Taipei CGMH Head & Neck Oncol Grp, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Huang, SF (corresponding author), Chang Gung Univ, Dept Publ Hlth, Taoyuan, Taiwan.; Huang, SF (corresponding author), Chang Gung Mem, Dept Otolaryngol Head & Neck Surg, Taoyuan, Taiwan.; Huang, SF (corresponding author), Taipei CGMH Head & Neck Oncol Grp, Taoyuan, Taiwan.	shiangfu.huang@gmail.com	Chuang, Wen-Yu/I-8013-2019	Chuang, Wen-Yu/0000-0002-3729-073X	Chang Gung Memorial Hospital [CMRPG3F0671, CMRPB53]; National Science Council, Executive Yuan, Taiwan, ROC [NSC 102-2314-B-182A-081, NSC 101-2314-B-182-048-MY3, MOST 103-2314-B-182A-057-MY2]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council, Executive Yuan, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was supported by Grants CMRPG3F0671 (SFH) and CMRPB53 (SFH) from Chang Gung Memorial Hospital and by Grants NSC 102-2314-B-182A-081 (SFH), NSC 101-2314-B-182-048-MY3 (SFH) and MOST 103-2314-B-182A-057-MY2 (SFH) from the National Science Council, Executive Yuan, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen GA, 2005, P NATL ACAD SCI USA, V102, P12507, DOI 10.1073/pnas.0500397102; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; CORDONCARDO C, 1994, CANCER RES, V54, P794; Fan SQ, 2013, CANCER BIOL THER, V14, P365, DOI 10.4161/cbt.23636; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; Gibcus JH, 2007, CLIN CANCER RES, V13, P6257, DOI 10.1158/1078-0432.CCR-07-1247; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Hanken H, 2014, CLIN ORAL INVEST, V18, P269, DOI 10.1007/s00784-013-0967-6; Hsieh LL, 2001, CARCINOGENESIS, V22, P1497, DOI 10.1093/carcin/22.9.1497; Huang SF, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-40; Huang SF, 2012, ORAL ONCOL, V48, P67, DOI 10.1016/j.oraloncology.2011.06.511; Kim H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4351; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; MULLER D, 1994, ORAL ONCOL, V30B, P113; Pattje WJ, 2013, HISTOPATHOLOGY, V63, P263, DOI 10.1111/his.12174; Ponder BAJ, 2001, NATURE, V411, P336, DOI 10.1038/35077207; Prapinjumrune C, 2010, J ORAL PATHOL MED, V39, P525, DOI 10.1111/j.1600-0714.2009.00847.x; Reis JS, 2006, MODERN PATHOL, V19, P999, DOI 10.1038/modpathol.3800621; Rothsschild BL, 2006, CANCER RES, V66, P8017, DOI 10.1158/0008-5472.CAN-05-4490; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Seiler R, 2014, MODERN PATHOL, V27, P87, DOI 10.1038/modpathol.2013.125; Sugahara K, 2011, INT J ONCOL, V39, P761, DOI 10.3892/ijo.2011.1094; Surgical P, 2000, MODPATHOL, V13, P1038; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Wang K, 2013, HEPATOLOGY, V58, P706, DOI 10.1002/hep.26402; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Werner MH, 2006, CELL CYCLE, V5, P2332, DOI 10.4161/cc.5.20.3385; Wilkerson PM, 2013, GENE CHROMOSOME CANC, V52, P333, DOI 10.1002/gcc.22037	30	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164870	10.1371/journal.pone.0164870	http://dx.doi.org/10.1371/journal.pone.0164870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764170	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204500075
J	Rouleau, N; Karbowski, LM; Persinger, MA				Rouleau, Nicolas; Karbowski, Lukasz M.; Persinger, Michael A.			Experimental Evidence of Classical Conditioning and Microscopic Engrams in an Electroconductive Material	PLOS ONE			English	Article								Synthetic experimental substrates are indispensable tools which can allow researchers to model biological processes non-invasively in three-dimensional space. In this study, we investigated the capacities of an electroconductive material whose properties converge upon those of the brain. An electrically conductive material composed of carbohydrates, proteins, fats, ions, water, and trace amounts of other organic compounds and minerals was classically conditioned as inferred by electrophysiological measurements. Spectral densities evoked during the display of a conditioned stimulus (CS) probe were strongly congruent with those displayed during the conditioned-unconditioned stimulus pairing (CS-UCS). The neutral stimulus consisted of the pulsed light from a LED. The unconditioned stimulus was an alternating current. Interstimulus intervals > 130 ms did not result in conditioned responses. Microscopic analysis of the chemically-fixed substratum revealed 10-200 mu m wide 'vessel structures' within samples exposed to a stimulus. Greater complexity (increased fractal dimensions) was clearly discernable by light microscopy for stained sections of fixed samples that had been conditioned compared to various controls. The denser pixels indicated greater concentration of stain and increased canalization. Implications for learning and memory formation are discussed.	[Rouleau, Nicolas; Karbowski, Lukasz M.; Persinger, Michael A.] Laurentian Univ, Biomol Sci Program, Sudbury, ON, Canada; [Rouleau, Nicolas; Karbowski, Lukasz M.; Persinger, Michael A.] Laurentian Univ, Behav Neurosci Programs, Sudbury, ON, Canada	Laurentian University; Laurentian University	Rouleau, N (corresponding author), Laurentian Univ, Biomol Sci Program, Sudbury, ON, Canada.; Rouleau, N (corresponding author), Laurentian Univ, Behav Neurosci Programs, Sudbury, ON, Canada.	ny_rouleau@laurentian.ca						Beylin AV, 2001, NEUROBIOL LEARN MEM, V76, P447, DOI 10.1006/nlme.2001.4039; BURKHARDT PE, 1978, ANIM LEARN BEHAV, V6, P225, DOI 10.3758/BF03209605; CRAGG BG, 1955, BRAIN, V78, P304, DOI 10.1093/brain/78.2.304; EPSTEIN JB, 1992, J ORAL PATHOL MED, V21, P160, DOI 10.1111/j.1600-0714.1992.tb00094.x; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; GAMBARDELLA A, 1995, EPILEPSIA, V36, P122, DOI 10.1111/j.1528-1157.1995.tb00970.x; GORMEZANO I, 1983, PROG PSYCHOB PHYSIOL, V10, P197; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Pavlov I.P., 1927, CONDITIONED REFLEXES; Rouleau N, 2014, J SIGNAL INFORM PROC, V5, P143; Skinner B.F, 1938, BEHAV ORGANISMS EXPT; Sridharan Gokul, 2012, J Oral Maxillofac Pathol, V16, P251, DOI 10.4103/0973-029X.99081	13	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165269	10.1371/journal.pone.0165269	http://dx.doi.org/10.1371/journal.pone.0165269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764215	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500144
J	Carneiro, MS; Campos, CCF; Beijo, LA; Ramos, FN				Carneiro, Magda Silva; Furtado Campos, Caroline Cambraia; Beijo, Luiz Alberto; Ramos, Flavio Nunes			Anthropogenic Matrices Favor Homogenization of Tree Reproductive Functions in a Highly Fragmented Landscape	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; FOREST FRAGMENTS; BETA-DIVERSITY; CONSERVATION; EROSION; ALPHA	Species homogenization or floristic differentiation are two possible consequences of the fragmentation process in plant communities. Despite the few studies, it seems clear that fragments with low forest cover inserted in anthropogenic matrices are more likely to experience floristic homogenization. However, the homogenization process has two other components, genetic and functional, which have not been investigated. The purpose of this study was to verify whether there was homogenization of tree reproductive functions in a fragmented landscape and, if found, to determine how the process was influenced by landscape composition. The study was conducted in eight fragments in southwest Brazil. The study was conducted in eight fragments in southwestern Brazil. In each fragment, all individual trees were sampled that had a diameter at breast height >= 3 cm, in ten plots (0.2 ha) and, classified within 26 reproductive functional types (RFTs). The process of functional homogenization was evaluated using additive partitioning of diversity. Additionally, the effect of landscape composition on functional diversity and on the number of individuals within each RFT was evaluated using a generalized linear mixed model. appeared to be in a process of functional homogenization (dominance of RFTs, alpha diversity lower than expected by chance and and low beta diversity). More than 50% of the RFTs and the functional diversity were affected by the landscape parameters. In general, the percentage of forest cover has a positive effect on RFTs while the percentage of coffee matrix has a negative one. The process of functional homogenization has serious consequences for biodiversity conservation because some functions may disappear that, in the long term, would threaten the fragments. This study contributes to a better understanding of how landscape changes affect the functional diversity, abundance of individuals in RFTs and the process of functional homogenization, as well as how to manage fragmented landscapes.	[Carneiro, Magda Silva] Univ Estadual Campinas UNICAMP SP, Inst Biol, BR-13083970 Campinas, SP, Brazil; [Furtado Campos, Caroline Cambraia; Ramos, Flavio Nunes] Univ Fed Alfenas UNIFAL MG, Inst Ciencias Nat, Rua Gabriel Monteiro da Silva 700, BR-37130000 Alfenas, MG, Brazil; [Beijo, Luiz Alberto] Univ Fed Alfenas UNIFAL MG, Inst Ciencias Exatas, Rua Gabriel Monteiro da Silva 700, BR-37130000 Alfenas, MG, Brazil	Universidade Estadual de Campinas; Universidade Federal de Alfenas; Universidade Federal de Alfenas	Ramos, FN (corresponding author), Univ Fed Alfenas UNIFAL MG, Inst Ciencias Nat, Rua Gabriel Monteiro da Silva 700, BR-37130000 Alfenas, MG, Brazil.	fnramos@gmail.com	Ramos, Flavio N/D-6268-2013; Beijo, Luiz/V-6461-2019	Ramos, Flavio N/0000-0001-6689-3575; Beijo, Luiz/0000-0002-3286-5602	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CRA- RDP-00104-10]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [472250/2010-8]; Vale SA [472250/2010-8]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Vale SA	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) to MSC and CCFC, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br): Grant number: CRA- RDP-00104-10. The project, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (www.fapemig.br). Grant number: 472250/2010-8. The project, Vale SA (www.vale.com). Grant number: 472250/2010-8. The project, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer NJ., 1991, ECOLOGY TEMPERATE CE, P304; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Arroyo-Rodriguez V, 2013, J ECOL, V101, P1449, DOI 10.1111/1365-2745.12153; Aslan CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066993; Barragan F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017976; Baselga A, 2015, METHODS ECOL EVOL, V6, P1069, DOI 10.1111/2041-210X.12388; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Carvalho FP, 2006, ENVIRON SCI POLICY, V9, P685, DOI 10.1016/j.envsci.2006.08.002; Castilho FFA, 2009, REV HIST EC EC REGIO, V4, P1; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; da Silva JMC, 2000, NATURE, V404, P72, DOI 10.1038/35003563; Solar RRD, 2015, ECOL LETT, V18, P1108, DOI 10.1111/ele.12494; Deconchat M, 2009, FOREST ECOL MANAG, V258, pS196, DOI 10.1016/j.foreco.2009.08.003; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Gardner TA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0166; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Girao LC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000908; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Groeneveld J, 2008, J APPL ECOL, V45, P1477, DOI 10.1111/j.1365-2664.2008.01539.x; Hernandez-Ruedas MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098931; Joly CA, 2014, NEW PHYTOL, V204, P459, DOI 10.1111/nph.12989; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Klimek S, 2007, BIOL CONSERV, V134, P559, DOI 10.1016/j.biocon.2006.09.007; Laurance WF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001017; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lehtonen M, 2009, BIOMASS BIOENERG, V1, P10; Li W.M., 2015, CHINESE RURAL EC, V2015, P4, DOI DOI 10.1186/S12943-014-0285-X; Lindborg R, 2014, BIOL CONSERV, V169, P206, DOI 10.1016/j.biocon.2013.11.015; Lopes AV, 2009, BIOL CONSERV, V142, P1154, DOI 10.1016/j.biocon.2009.01.007; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; Louzada J, 2010, BIOL CONSERV, V143, P1102, DOI 10.1016/j.biocon.2010.02.003; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Maues Marcia Motta, 2010, Oecologia Australis, V14, P238; McGarigal K., 1995, SPATIAL PATTERN ANAL; Mesquita RCG, 1999, BIOL CONSERV, V91, P129, DOI 10.1016/S0006-3207(99)00086-5; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Olivetti D, 2015, CIENC AGROTEC, V39, P58, DOI 10.1590/S1413-70542015000100007; Gomez JP, 2010, J ANIM ECOL, V79, P1181, DOI 10.1111/j.1365-2656.2010.01725.x; Paini DR, 2004, AUSTRAL ECOL, V29, P399, DOI 10.1111/j.1442-9993.2004.01376.x; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, P ROY SOC LONDON, V269, P1721; Petchey OL, 2007, OIKOS, V116, P1422, DOI 10.1111/j.2007.0030-1299.15894.x; Pillar VD, 1999, ECOLOGY, V80, P2508; Podani J, 2006, OIKOS, V115, P179, DOI 10.1111/j.2006.0030-1299.15048.x; Pointereau P., 2010, JRC SCI TECHNICAL RE; Price OF, 2004, AUSTRAL ECOL, V29, P137, DOI 10.1111/j.1442-9993.2004.01331.x; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Rabello Ananza, 2010, Biota Neotrop., V10, P47, DOI 10.1590/S1676-06032010000100004; Ramos FN, ANN BOT FENICC UNPUB; RAW A, 1989, Revista Brasileira de Entomologia, V33, P103; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; Schleuning M, 2015, ECOGRAPHY, V38, P380, DOI 10.1111/ecog.00983; Soininen J, 2007, ECOLOGY, V88, P2830, DOI 10.1890/06-1730.1; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; Tybirk K, 2001, P ANN IALE C, DOI [2001.10.1016/j.biocon.2006.10.053., DOI 10.1016/J.BIOCON.2006.10.053]; Weber M, 2007, BIOTA NEOTROP, V72, P293; Wilms W, 1997, APIDOLOGIE, V28, P339, DOI 10.1051/apido:19970602; Zechmeister HG, 2003, BIOL CONSERV, V114, P165, DOI 10.1016/S0006-3207(03)00020-X	66	6	6	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164814	10.1371/journal.pone.0164814	http://dx.doi.org/10.1371/journal.pone.0164814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760218	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000053
J	Li, XQ; Zhang, ZL; Tan, WF; Sun, XJ; Ma, H				Li, Xiao-Qian; Zhang, Zai-Li; Tan, Wen-Fei; Sun, Xi-Jia; Ma, Hong			Down-Regulation of CXCL12/CXCR4 Expression Alleviates Ischemia-Reperfusion-Induced Inflammatory Pain via Inhibiting Glial TLR4 Activation in the Spinal Cord	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NEUROPATHIC PAIN; NERVE INJURY; RATS; ASTROCYTES; MODEL; CONTRIBUTES; MICE; ISCHEMIA/REPERFUSION; HYPERSENSITIVITY	Toll-like receptor 4 (TLR4) is important for the pathogenesis of inflammatory reactions and the promotion of pain processing after ischemia/reperfusion (IR) in spinal cord. Recently, C-X-C chemokine ligand 12 (CXCL12) and its receptor, C-X-C chemokine receptor 4 (CXCR4), were demonstrated to be simultaneously critical for inflammatory reactions, thereby facilitating glial activation. However, whether CXCL12/CXCR4 expression can contribute to IR-induced inflammatory pain via spinal TLR4 remained unclear. A rat model was established by 8 min of aortic arch occlusion. The effects of CXCL12/CXCR4 expression and TLR4 activation on inflammatory hyperalgesia were investigated by pretreatments with CXCL12-neutralizing antibody, CXCR4 antagonist (AMD3100) and TLR4 antagonist (TAK-242) for 5 consecutive days before surgery. The results indicated that IR induced significant and sustained inflammatory pain, observed as decreases in paw withdrawal threshold (PWT) and paw withdrawal latency (PWL), throughout the post-injury period. The increased levels of TLR4 and proinflammatory chemokine CXCL12, as well as its receptor, CXCR4, were closely correlated with the PWT and PWL trends. Double immunostaining further suggested that TLR4, which is mainly expressed on astrocytes and microglia, was closely co-localized with CXCL12 and CXCR4 in spinal dorsal horn. As expected, intrathecal pretreatment with the TLR4 antagonist, TAK-242 markedly ameliorated pain by inhibiting astrocytic and microglial activation, as shown by decreases in TLR4 immunoreactivity and the percentage of double-labeled cells. These protective effects were likely due in part to the reduced production of the downstream cytokines IL-1 beta and TNF-alpha, as well as for the recruitment of CXCL12 and CXCR4. Additionally, intrathecal pretreatment with CXCL12-neutralizing antibody and AMD3100 resulted in similar analgesic and anti-inflammatory effects as those receiving TAK-242 pretreatment. These results suggest that intrathecal blockade of CXCL12/CXCR4 expression may attenuate IR-induced pain sensation and the release of inflammatory cytokines by limiting glial TLR4 activation in spinal cord.	[Li, Xiao-Qian; Zhang, Zai-Li; Tan, Wen-Fei; Sun, Xi-Jia; Ma, Hong] China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang 110001, Liaoning, Peoples R China	China Medical University	Ma, H (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang 110001, Liaoning, Peoples R China.	mahong5466@yahoo.com		Li, Xiao-Qian/0000-0001-6676-735X	Doctoral Fund of the Ministry of Education of China [20092104110009]; Science and Technology Program of Liaoning [2012408002]; Natural Science Foundation of Liaoning Province [2014021035]; National Natural Science Foundation of China [81601053]	Doctoral Fund of the Ministry of Education of China(Ministry of Education, China); Science and Technology Program of Liaoning; Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for this project was provided by the Doctoral Fund of the Ministry of Education of China, (No. 20092104110009), the Science and Technology Program of Liaoning (No. 2012408002), Natural Science Foundation of Liaoning Province (Grant No. 2014021035) and National Natural Science Foundation of China (Grant No. 81601053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was provided by the Doctoral Fund of the Ministry of Education of China, (No. 20092104110009), the Science and Technology Program of Liaoning (No. 2012408002), Natural Science Foundation of Liaoning Province (Grant No. 2014021035) and National Natural Science Foundation of China (Grant No. 81601053).	Bettoni I, 2008, GLIA, V56, P1312, DOI 10.1002/glia.20699; Blazevski J, 2015, IMMUNOBIOLOGY, V220, P845, DOI 10.1016/j.imbio.2015.01.007; Cali C, 2008, J NEUROIMMUNOL, V198, P82, DOI 10.1016/j.jneuroim.2008.04.015; Han YL, 2001, J CLIN INVEST, V108, P425, DOI 10.1172/JCI12629; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Heiman A, 2014, BRAIN BEHAV IMMUN, V42, P232, DOI 10.1016/j.bbi.2014.06.203; Hernangomez M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0508-8; Knerlich-Lukoschus F, 2011, J NEUROSURG-SPINE, V14, P583, DOI 10.3171/2010.12.SPINE10480; Lang-Lazdunski L, 2000, EUR J CARDIO-THORAC, V18, P174, DOI 10.1016/S1010-7940(00)00430-9; Li C, 2015, J ACUPUNCT MERIDIAN, V8, P236, DOI 10.1016/j.jams.2015.01.001; Li XQ, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0069-7; Li XQ, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-28; Liu T, 2012, NEUROSCI BULL, V28, P131, DOI 10.1007/s12264-012-1219-5; Lu DY, 2009, EUR J PHARMACOL, V613, P146, DOI 10.1016/j.ejphar.2009.03.001; Shen W, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-75; Shu RC, 2015, ANESTHESIOLOGY, V122, P908, DOI 10.1097/ALN.0000000000000562; Stokes JA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-148; Virgintino D, 2013, J INHERIT METAB DIS, V36, P455, DOI 10.1007/s10545-012-9574-y; Wang MH, 2012, J NEUROSCI, V32, P17948, DOI 10.1523/JNEUROSCI.1860-12.2012; Wang YS, 2015, PAIN PHYSICIAN, V18, pE615; White FA, 2007, P NATL ACAD SCI USA, V104, P20151, DOI 10.1073/pnas.0709250104; White FA, 2008, CURR OPIN ANESTHESIO, V21, P580, DOI 10.1097/ACO.0b013e32830eb69d; Yang F, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0441-2; Yu CZ, 2014, EUR J PAIN, V18, P76, DOI 10.1002/j.1532-2149.2013.00390.x; Yu Q, 2015, BIOCHEM BIOPH RES CO, V464, P447, DOI 10.1016/j.bbrc.2015.06.135; Yu Q, 2015, CELL J, V16, P440; Zhang J, 2013, INT J BIOCHEM CELL B, V45, P1911, DOI 10.1016/j.biocel.2013.06.005; Zhang YK, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-112; Zhao Y, 2015, INT J CLIN EXP MED, V8, P11202; ZHU P, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/701970	30	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0163807	10.1371/journal.pone.0163807	http://dx.doi.org/10.1371/journal.pone.0163807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760212	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204000020
J	Sztacho, M; Segeletz, S; Sanchez-Fernandez, MA; Czupalla, C; Niehage, C; Hoflack, B				Sztacho, Martin; Segeletz, Sandra; Sanchez-Fernandez, Maria Arantzazu; Czupalla, Cornelia; Niehage, Christian; Hoflack, Bernard			BAR Proteins PSTPIP1/2 Regulate Podosome Dynamics and the Resorption Activity of Osteoclasts	PLOS ONE			English	Article							MEMBRANE CURVATURE; SHP-1; MICE; CYTOSKELETON; MACROPHAGES; DEFICIENCY; ADHESIONS; MUTATION	Bone resorption in vertebrates relies on the ability of osteoclasts to assemble F-actin-rich podosomes that condense into podosomal belts, forming sealing zones. Sealing zones segregate bone-facing ruffled membranes from other membrane domains, and disassemble when osteoclasts migrate to new areas. How podosome/sealing zone dynamics is regulated remains unknown. We illustrate the essential role of the membrane scaffolding F-BAR-Proline-Serine-Threonine Phosphatase Interacting Proteins (PSTPIP) 1 and 2 in this process. Whereas PSTPIP2 regulates podosome assembly, PSTPIP1 regulates their disassembly. PSTPIP1 recruits, through its F-BAR domain, the protein tyrosine phosphatase non-receptor type 6 (PTPN6) that de-phosphophorylates the phosphatidylinositol 5-phosphatases SHIP1/2 bound to the SH3 domain of PSTPIP1. Depletion of any component of this complex prevents sealing zone disassembly and increases osteoclast activity. Thus, our results illustrate the importance of BAR domain proteins in podosome structure and dynamics, and identify a new PSTPIP1/PTPN6/SHIP1/2-dependent negative feedback mechanism that counterbalances Src and PI(3,4,5) P3 signalling to control osteoclast cell polarity and activity during bone resorption.	[Sztacho, Martin; Segeletz, Sandra; Sanchez-Fernandez, Maria Arantzazu; Czupalla, Cornelia; Niehage, Christian; Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, Tatzberg 47-51, D-01307 Dresden, Germany	Technische Universitat Dresden	Hoflack, B (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Tatzberg 47-51, D-01307 Dresden, Germany.	bernard.hoflack@biotec.tu-dresden.de	HOFLACK, Bernard/AAZ-6668-2020	Sztacho, Martin/0000-0002-8496-1364	Deutsche Forschungsgemeinschaft [TRR 13/2-08, TRR13/2-2013, HO 2584/2-1, HO 2584/1-1, HO 2584/6-1, HO 2584/8-1]; TU-Dresden (Support-the-best); Marie Curie Initial Training Network (Euroclast, FP7-People- ITN) [607447]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TU-Dresden (Support-the-best); Marie Curie Initial Training Network (Euroclast, FP7-People- ITN)	This work was supported in part by grants from Deutsche Forschungsgemeinschaft (TRR 13/2-08, TRR13/2-2013, HO 2584/2-1, HO 2584/1-1, HO 2584/6-1, HO 2584/8-1) and TU-Dresden (Support-the-best). SS was supported by the Marie Curie Initial Training Network (Euroclast, FP7-People- 2013-ITN: #607447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the different lab members for their helpful discussions and critical comments. Dorothee Thiel and Theresia Pursche kindly provided their technical assistance. This work was supported in part by grants from DFG (TRR 13/2-08, TRR13/2-2013, HO 2584/2-1, HO 2584/1-1, HO 2584/6-1, HO 2584/8-1) and TU-Dresden (Support-the-best). SS was supported by the Marie Curie Initial Training Network (Euroclast, FP7-People- 2013-ITN: #607447).	Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Chitu V, 2012, BLOOD, V120, P3126, DOI 10.1182/blood-2012-04-425595; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; Cox S, 2012, NAT METHODS, V9, P195, DOI [10.1038/NMETH.1812, 10.1038/nmeth.1812]; Daumke O, 2014, CELL, V156, P882, DOI 10.1016/j.cell.2014.02.017; Ferguson PJ, 2006, BONE, V38, P41, DOI 10.1016/j.bone.2005.07.009; Futterer K, 2007, CELL, V129, P655, DOI 10.1016/j.cell.2007.05.006; Grosse J, 2006, BLOOD, V107, P3350, DOI 10.1182/blood-2005-09-3556; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heckel T, 2009, P NATL ACAD SCI USA, V106, P1451, DOI 10.1073/pnas.0804464106; Kruger J, 2000, J IMMUNOL, V165, P5847, DOI 10.4049/jimmunol.165.10.5847; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Luxenburg C, 2006, EUR J CELL BIOL, V85, P203, DOI 10.1016/j.ejcb.2005.11.002; Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mim C, 2012, TRENDS BIOCHEM SCI, V37, P526, DOI 10.1016/j.tibs.2012.09.001; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; NITSCH L, 1989, CELL BIOL INT REP, V13, P919, DOI 10.1016/0309-1651(89)90074-X; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Poole AW, 2005, CELL SIGNAL, V17, P1323, DOI 10.1016/j.cellsig.2005.05.016; Roach TIA, 1998, CURR BIOL, V8, P1035, DOI 10.1016/S0960-9822(07)00426-5; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Sanchez-Fernandez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037592; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P3068, DOI 10.1073/pnas.93.7.3068; Starnes TW, 2014, BLOOD, V123, P2703, DOI 10.1182/blood-2013-07-516948; Steenblock C, 2014, J BIOL CHEM, V289, P18347, DOI 10.1074/jbc.M113.504894; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Tsujita K, 2013, J CELL SCI, V126, P2267, DOI 10.1242/jcs.122515; Vives V, 2011, J BONE MINER RES, V26, P1099, DOI 10.1002/jbmr.282; Yu CH, 2013, CELL REP, V5, P1456, DOI 10.1016/j.celrep.2013.10.040; Zou W, 2013, MOL CELL BIOL, V33, P830, DOI 10.1128/MCB.00790-12	36	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164829	10.1371/journal.pone.0164829	http://dx.doi.org/10.1371/journal.pone.0164829			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760174	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000055
J	Xia, YP; Zhao, GQ; Lin, J; Li, C; Cong, L; Jiang, N; Xu, Q; Wang, Q				Xia, Yiping; Zhao, Guiqiu; Lin, Jing; Li, Cui; Cong, Lin; Jiang, Nan; Xu, Qiang; Wang, Qian			1,25(OH)(2)D-3 and VDR Signaling Pathways Regulate the Inhibition of Dectin-1 Caused by Cyclosporine A in Response to Aspergillus Fumigatus in Human Corneal Epithelial Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; VITAMIN-D; CYTOCHROME P450SCC; IN-VIVO; FUNGAL KERATITIS; METABOLISM; PERSPECTIVE; ACTIVATION; D-3; TRANSPLANTATION	Background The objective of this study is to observe whether cyclosporine A (CsA) inhibits the expression of dectin-1 in human corneal epithelial cells infected with Aspergillus fumigatus (A. fumigatus) and to investigate the molecular mechanisms of the inhibition. Methods Immortalized human corneal epithelial cells (HCECs) were pretreated with 1,25(OH)(2)D-3 and VDR inhibitor for 1 h, and then they were pretreated with CsA for 12h. After these pre-treatments, the HCECs were stimulated with A. fumigatus and curdlan respectively, and the expression of dectin-1 and proinflammatory cytokines (IL-1 beta and TNF-alpha) were detected by RT-PCR, western blot and ELISA. Results Dectin-1 mRNA and dectin-1 protein expression increased when HCECs were stimulated with A. fumigatus or curdlan, and CsA inhibited the dectin-1 expression both in mRNA and protein levels specifically. Dectin-1 and proinflammatory cytokine expression levels were higher when HCECs were pretreated with VDR inhibitor and CsA compared to pretreatment with CsA alone, while dectin-1 and proinflammatory cytokine levels were lower when HCECs were pretreated with 1,25(OH) 2D3 and CsA compared to pretreatment with CsA alone. Conclusions These data provide evidence that CsA can inhibit the expression of dectin-1 and proinflammatory cytokines through dectin-1 when HCECs are stimulated by A. fumigatus or curdlan. The active form of vitamin D, 1,25(OH)(2)D-3, and VDR signaling pathway regulate the inhibition of CsA. The inhibition is enhanced by 1,25(OH)(2)D-3, and the VDR inhibitor suppresses the inhibition.	[Xia, Yiping; Zhao, Guiqiu; Lin, Jing; Li, Cui; Jiang, Nan; Xu, Qiang; Wang, Qian] Qingdao Univ, Dept Ophthalmol, Affiliated Hosp, Qingdao, Shandong, Peoples R China; [Cong, Lin] Shandong Eye Inst, Qingdao, Shandong, Peoples R China	Qingdao University; Shandong First Medical University & Shandong Academy of Medical Sciences	Zhao, GQ (corresponding author), Qingdao Univ, Dept Ophthalmol, Affiliated Hosp, Qingdao, Shandong, Peoples R China.	zhaoguiqiu_good@126.com			National Natural Science Foundation of China [81170825, 81470609]; Youth Project of Natural Science Foundation of Shandong Province [ZR2013HQ007]; Specialized Research Fund for the Doctoral Program of Higher Education [20123706110003]; Key Project of Natural Science Foundation of Shandong Province [ZR2012FZ001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Project of Natural Science Foundation of Shandong Province; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Project of Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by: 1. National Natural Science Foundation of China NO.81170825 (Role of Dectin-1 in the innate immune inflammation of Fungal Keratitis); 2. National Natural Science Foundation of China No.81470609 (Mechanism of LOX-1 in anti-fungal innate immune of fungal keratitis; 3. The Youth Project of Natural Science Foundation of Shandong Province No. ZR2013HQ007 (Role of Interlein33/ST2 signaling in the immune inflammation of Fungal Keratitis); 4. The Specialized Research Fund for the Doctoral Program of Higher Education No.20123706110003 (Role of Mincle in the innate immune inflammation of Fungal Keratitis); 5. The Key Project of Natural Science Foundation of Shandong Province No. ZR2012FZ001 (The influence of AQP1 on a Crystal protein and the study of targeted therapy in the pathogenesis of senile cataract).	Apetrei Natalia Simona, 2010, Roum Arch Microbiol Immunol, V69, P61; Bikle DD, 2011, EXP DERMATOL, V20, P7, DOI 10.1111/j.1600-0625.2010.01202.x; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Cantorna MT, 2015, NUTRIENTS, V7, P3011, DOI 10.3390/nu7043011; Che CY, 2013, INT J OPHTHALMOL-CHI, V6, P30, DOI 10.3980/j.issn.2222-3959.2013.01.06; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; Erdinest N, 2014, CURR OPIN ALLERGY CL, V14, P457, DOI 10.1097/ACI.0000000000000089; Grenet O, 2000, BIOCHEM PHARMACOL, V59, P267, DOI 10.1016/S0006-2952(99)00321-4; Guryev O, 2003, P NATL ACAD SCI USA, V100, P14754, DOI 10.1073/pnas.2336107100; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2012, JPEN-PARENTER ENTER, V36, p9S, DOI 10.1177/0148607111430189; Hossein-nezhad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058725; Hossein-nezhad A, 2012, CURR OPIN CLIN NUTR, V15, P567, DOI 10.1097/MCO.0b013e3283594978; Howell J, 2013, LIVER TRANSPLANT, V19, P1099, DOI 10.1002/lt.23712; Jiang J, 2007, TRANSPLANTATION, V84, P1158, DOI 10.1097/01.tp.0000286099.50532.b0; Jurkunas U, 2009, CORNEA, V28, P638, DOI 10.1097/ICO.0b013e318191695b; Li Na, 2011, Zhonghua Yan Ke Za Zhi, V47, P378; Lim SW, 2005, TRANSPLANTATION, V80, P691, DOI 10.1097/01.tp.0000173594.69089.a0; Meier A, 2003, CELL MICROBIOL, V5, P561, DOI 10.1046/j.1462-5822.2003.00301.x; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Neoh CF, 2014, INT J ANTIMICROB AG, V44, P96, DOI 10.1016/j.ijantimicag.2014.04.008; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Slominski A, 2005, FEBS J, V272, P4080, DOI 10.1111/j.1742-4658.2005.04819.x; Slominski A, 2013, J CLIN ENDOCR METAB, V98, pE298, DOI 10.1210/jc.2012-3074; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2014, J STEROID BIOCHEM, V144, P28, DOI 10.1016/j.jsbmb.2013.10.012; Slominski AT, 2014, MOL CELL ENDOCRINOL, V383, P181, DOI 10.1016/j.mce.2013.12.012; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Slominski AT, 2011, AM J PHYSIOL-CELL PH, V300, pC526, DOI 10.1152/ajpcell.00203.2010; Slominski AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009907; Syed BA, 2014, CURR OPIN ALLERGY CL, V14, P485, DOI 10.1097/ACI.0000000000000097; Tuckey RC, 2008, FEBS J, V275, P2585, DOI 10.1111/j.1742-4658.2008.06406.x; Verma R, 2014, J STEROID BIOCHEM, V141, P1, DOI 10.1016/j.jsbmb.2013.12.012; Wang J, 2012, ANTICANCER RES, V32, P739; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Yin ZH, 2011, INVEST OPHTH VIS SCI, V52, P7359, DOI 10.1167/iovs.11-7605; Zhao J, 2009, INNATE IMMUN-LONDON, V15, P155, DOI 10.1177/1753425908101521; Ziaei M, 2015, CORNEA, V34, P110, DOI 10.1097/ICO.0000000000000291	42	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164717	10.1371/journal.pone.0164717	http://dx.doi.org/10.1371/journal.pone.0164717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755569	Green Published, Green Submitted, gold			2022-12-26	WOS:000386203800028
J	Tang, HL; Wu, ZY; Mao, YR; Cepeda, J; Morano, J				Tang, Houlin; Wu, Zunyou; Mao, Yurong; Cepeda, Javier; Morano, Jamie			Risk Factor Associated with Negative Spouse HIV Seroconversion among Sero-Different Couples: A Nested Case-Control Retrospective Survey Study in 30 Counties in Rural China	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DISCORDANT COUPLES; VIRAL LOAD; SERODISCORDANT COUPLES; TRANSMISSION; PREVENTION; INFECTION; CHALLENGES	Background Antiretroviral therapy (ART) and condom use have been proven to reduce the risk of sexual transmission of human immunodeficiency virus (HIV) among HIV sero-different couples, but its full implementation remains a challenge. This study aims to assess HIV seroconversion rate of HIV-negative spouse and its associated risk factors among HIV sero-different couples in rural China. Methods An open cohort of HIV sero-different couples enrolled in 30 counties in China between October 1, 2010, and September 30, 2012, and followed-up to December 31, 2012, was constructed retrospectively. A nested case-control study of risk factors of HIV seroconversion among sero-different couples was conducted in April and May of 2013, based on the open cohort. Sero-different couples with the HIV-negative spouse seroconverting at least 3 months after the previous negative diagnosis during cohort observation period were labeled as "case couples". The "control couples" were selected randomly from the same cohort that did not have the HIV-negative spouse seroconversion during the same period. The "case couples" and "control couples" were matched on gender, age, and region of residence. Sexual behaviors among HIV sero-different couples before and after the index spouses notifying their HIV infection status to their HIV-negative spouses were collected via face-to-face interview. Univariate and multivariate logistic regression models were used to assess factors associated with HIV seroconversion among HIV sero-different couples. Results Of 4481 HIV sero-different couples, a total of 53 seroconversions were observed within 5218 person-years of follow-up. The incidence rate was 1.02 (95% CI: 0.76-1.33) per 100 person-years. Forty "case couples" confirmed HIV-negative spouse seroconversions infected via marital sexual transmission, were matched to 80 "control couples". Of the 120 couples, 81(67.5%) were receiving ART, and 70 (58.3%) reported consistently used condoms during intercourse after the index spouse was diagnosed HIV infection. Multivariate conditional logistic regression analysis showed that the desire to conceive a child (OR = 5.18, 95% CI: 1.19-22.58) significantly increased the odds of HIV seroconversion. Protective factors of spousal HIV seroconversion were currently receiving ART (OR = 0.09, 95% CI: 0.01-0.67) and consistent condom use (OR = 0.05, 95% CI: 0.01-0.28). Conclusions Intention to conceive a child is the most important risk factor for HIV seroconversion among sero-different couples. Specific efforts on scientific use of ART to assist sero-different couples to achieve their wish to conceive a healthy child are needed to minimize the risk of HIV transmission.	[Tang, Houlin; Mao, Yurong] Chinese Ctr Dis Control & Prevent, Div Integrat & Evaluat, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Cepeda, Javier] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Morano, Jamie] Univ S Florida, Div Infect Dis & Int Med, Morsani Coll Med, Tampa, FL USA	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; State University System of Florida; University of South Florida	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wuzy@263.net	tang, houlin/HGA-1502-2022		National Health and Family Planning Commission of the People's Republic of China [2012ZX10001-007]	National Health and Family Planning Commission of the People's Republic of China	National Health and Family Planning Commission of the People's Republic of China supported the project (2012ZX10001-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglemyer A, 2013, JAMA-J AM MED ASSOC, V310, P1619, DOI [10.1001/jama.2013.278328, 10.1002/14651858.CD009153.pub3]; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Barreiro P, 2007, HUM REPROD, V22, P2353, DOI 10.1093/humrep/dem226; Barreiro P, 2006, JAIDS-J ACQ IMM DEF, V43, P324, DOI 10.1097/01.qai.0000243091.40490.fd; Bavinton BR, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-917; Brubaker SG, 2011, HIV MED, V12, P316, DOI 10.1111/j.1468-1293.2010.00884.x; Bunnell RE, 2005, AIDS CARE, V17, P999, DOI 10.1080/09540120500100718; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Chen JL, 2001, FAM PLANN PERSPECT, V33, P144, DOI 10.2307/2673717; Chu X, 2009, CHINESE J DIS CONTRO, V13, P256; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Curran K, 2012, CURR HIV-AIDS REP, V9, P160, DOI 10.1007/s11904-012-0114-z; Del Romero J, 2010, BMJ-BRIT MED J, P340; Demeter LM, 2001, ANN INTERN MED, V135, P954, DOI 10.7326/0003-4819-135-11-200112040-00007; Duan Song, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P997; Dybul Mark, 2002, MMWR Recomm Rep, V51, P1; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; He N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077981; Heard I, 2007, AIDS, V21, pS77, DOI 10.1097/01.aids.0000255089.44297.6f; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; Kumarasamy N, 2010, HIV MED, V11, P178, DOI 10.1111/j.1468-1293.2009.00760.x; LI H, 2008, CHINESE J AIDS STD, V14, P39; Liu HX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0111175, 10.1371/journal.pone.0110887]; Loutfy MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055747; Mao YR, 2010, INT J EPIDEMIOL, V39, pII79, DOI 10.1093/ije/dyq213; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Matthews LT, 2010, AIDS, V24, P1975, DOI 10.1097/QAD.0b013e32833bedeb; Mehendale SM, 2006, JAIDS-J ACQ IMM DEF, V41, P371, DOI 10.1097/01.qai.0000209905.35620.48; Mmeje O, 2012, INFECT DIS OBSTET GY, P2012; Pan X, 2010, CHINESE J PREVENTIVE, V45, P1023; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Supervie V, 2014, CLIN INFECT DIS, V59, P115, DOI 10.1093/cid/ciu223; Tang CSK, 2001, AIDS EDUC PREV, V13, P329, DOI 10.1521/aeap.13.4.329.21426; Tang H, 2012, CHINESE J PREVENTIVE, V46, P4; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Wang L, 2010, JAIDS-J ACQ IMM DEF, V55, P232, DOI 10.1097/QAI.0b013e3181e9b6b7; Zhuang K, 2002, FOREIGN MED INT J EP, V29, P321	40	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164761	10.1371/journal.pone.0164761	http://dx.doi.org/10.1371/journal.pone.0164761			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741292	gold, Green Published, Green Submitted			2022-12-26	WOS:000385507000066
J	Wu, SY; Zou, P; Fuller, AW; Mishra, S; Wang, Z; Schey, KL; Mchaourab, HS				Wu, Shu-Yu; Zou, Ping; Fuller, Alexandra W.; Mishra, Sanjay; Wang, Zhen; Schey, Kevin L.; Mchaourab, Hassane S.			Expression of Cataract-linked -Crystallin Variants in Zebrafish Reveals a Proteostasis Network That Senses Protein Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aggregation; cataract; chaperone; crystallin; lens; proteostasis; small heat shock protein (sHsp); zebrafish	HEAT-SHOCK PROTEINS; ALPHA-A-CRYSTALLIN; GAMMA-D-CRYSTALLIN; FIBER CELL DENUCLEATION; MOUSE EYE LENS; CHAPERONE FUNCTION; NUCLEAR CATARACT; GENE-EXPRESSION; 2-DIMENSIONAL ELECTROPHORESIS; MOLECULAR CHAPERONE	The refractivity and transparency of the ocular lens is dependent on the stability and solubility of the crystallins in the fiber cells. A number of mutations of lens crystallins have been associated with dominant cataracts in humans and mice. Of particular interest were B- and D-crystallin mutants linked to dominant cataracts in mouse models. Although thermodynamically destabilized and aggregation-prone, these mutants were found to have weak affinity to the resident chaperone -crystallin in vitro. To better understand the mechanism of the cataract phenotype, we transgenically expressed different D-crystallin mutants in the zebrafish lens and observed a range of lens defects that arise primarily from the aggregation of the mutant proteins. Unlike mouse models, a strong correlation was observed between the severity and penetrance of the phenotype and the level of destabilization of the mutant. We interpret this result to reflect the presence of a proteostasis network that can sense protein stability. In the more destabilized mutants, the capacity of this network is overwhelmed, leading to the observed increase in phenotypic penetrance. Overexpression of A-crystallin had no significant effects on the penetrance of lens defects, suggesting that its chaperone capacity is not limiting. Although consistent with the prevailing hypothesis that a chaperone network is required for lens transparency, our results suggest that A-crystallin may not be efficient to inhibit aggregation of lens -crystallin. Furthermore, our work implicates additional inputs/factors in this underlying proteostasis network and demonstrates the utility of zebrafish as a platform to delineate mechanisms of cataract.	[Wu, Shu-Yu; Zou, Ping; Fuller, Alexandra W.; Mishra, Sanjay; Mchaourab, Hassane S.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Wang, Zhen; Schey, Kevin L.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Wang, Zhen; Schey, Kevin L.] Vanderbilt Univ, Sch Med, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Mchaourab, HS (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	hassane.mchaourab@vanderbilt.edu	Mishra, Sanjay/ABF-9252-2021	Mishra, Sanjay/0000-0002-7775-9600	National Institutes of Health [R01 EY12018, R01 EY13462, P30 EY008126]; Vanderbilt University Proteomics Facility in the Mass Spectrometry Research Center; Vanderbilt University Medical Center Cell Imaging Shared Resource; NATIONAL EYE INSTITUTE [R01EY013462, R01EY012018, P30EY008126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Proteomics Facility in the Mass Spectrometry Research Center; Vanderbilt University Medical Center Cell Imaging Shared Resource; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants R01 EY12018 (to H. S. M.), R01 EY13462 (to K. L. S.), and P30 EY008126 (to H. S. M. and K. L. S.) and by the Vanderbilt University Proteomics Facility in the Mass Spectrometry Research Center and Vanderbilt University Medical Center Cell Imaging Shared Resource. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee PR, 2011, P NATL ACAD SCI USA, V108, P574, DOI 10.1073/pnas.1014653107; Bassnett S, 1997, INVEST OPHTH VIS SCI, V38, P1678; Beebe DC, 2001, INVEST OPHTH VIS SCI, V42, P727; BENEDEK GB, 1971, APPL OPTICS, V10, P459, DOI 10.1364/AO.10.000459; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; De Maria A, 2007, INVEST OPHTH VIS SCI, V48, P5638, DOI 10.1167/iovs.07-0782; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Firtina Z, 2009, J BIOL CHEM, V284, P35872, DOI 10.1074/jbc.M109.060384; Goishi K, 2006, DEVELOPMENT, V133, P2585, DOI 10.1242/dev.02424; Hanson SRA, 1998, EXP EYE RES, V67, P301, DOI 10.1006/exer.1998.0530; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; Harocopos GJ, 1998, INVEST OPHTH VIS SCI, V39, P2696; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hayes JM, 2012, MOL BIOL CELL, V23, P4725, DOI 10.1091/mbc.E12-09-0672; Hill EG, 2008, J PROTEOME RES, V7, P3091, DOI 10.1021/pr070520u; Hinaux H, 2015, DEV NEUROBIOL, V75, P505, DOI 10.1002/dneu.22239; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; JAENISCH R, 1981, CELL, V24, P519, DOI 10.1016/0092-8674(81)90343-3; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Koteiche HA, 2003, J BIOL CHEM, V278, P10361, DOI 10.1074/jbc.M211851200; Koteiche HA, 2015, BIOCHEMISTRY-US, V54, P5949, DOI 10.1021/acs.biochem.5b00678; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; Lampi KJ, 2006, BIOCHEMISTRY-US, V45, P3146, DOI 10.1021/bi052051k; Lampi KJ, 2002, MOL VIS, V8, P359; Lampi KJ, 2002, INVEST OPHTH VIS SCI, V43, P216; LI WC, 1995, J CELL BIOL, V130, P169, DOI 10.1083/jcb.130.1.169; Liu HQ, 2005, J BIOL CHEM, V280, P25071, DOI 10.1074/jbc.M502490200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Mchaourab HS, 2002, J BIOL CHEM, V277, P40557, DOI 10.1074/jbc.M206250200; Meehan S, 2004, J BIOL CHEM, V279, P3413, DOI 10.1074/jbc.M308203200; Michiel M, 2010, EXP EYE RES, V90, P688, DOI 10.1016/j.exer.2010.02.007; Mishra S, 2012, FEBS LETT, V586, P330, DOI 10.1016/j.febslet.2012.01.019; Moreau KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037256; Nakahara M, 2007, FEBS J, V274, P3055, DOI 10.1111/j.1742-4658.2007.05836.x; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Nuckels R. J., 2007, CSH PROTOC; Okamura Nobuaki, 2002, Medical Electron Microscopy, V35, P234, DOI 10.1007/s007950200027; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Rossant J, 2011, P NATL ACAD SCI USA, V108, P7659, DOI 10.1073/pnas.1104844108; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Sharma KK, 1997, BIOCHEM BIOPH RES CO, V239, P217, DOI 10.1006/bbrc.1997.7460; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; TARDIEU A, 1988, ANNU REV BIOPHYS BIO, V17, P47; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Uribe R. A, 2007, CSH PROTOC; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Wang K, 2007, INVEST OPHTH VIS SCI, V48, P3719, DOI 10.1167/iovs.06-1487; Wang Z, 2015, INVEST OPHTH VIS SCI, V56, P8349, DOI 10.1167/iovs.15-18273; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cellbio.6.1.679; Yan Q, 2006, DIFFERENTIATION, V74, P195, DOI 10.1111/j.1432-0436.2006.00068.x; Zhang L, 2010, CURR MOL MED, V10, P864, DOI 10.2174/156652410793937741; Zhang LY, 2007, MOL VIS, V13, P2096; Zou P, 2015, EXP EYE RES, V138, P104, DOI 10.1016/j.exer.2015.07.001	65	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25387	25397		10.1074/jbc.M116.749606	http://dx.doi.org/10.1074/jbc.M116.749606			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27770023	Green Published, hybrid			2022-12-26	WOS:000390095300010
J	Lope, V; de Larrea, NF; Perez-Gomez, B; Martin, V; Moreno, V; Costas, L; Longo, F; Jimenez-Moleon, JJ; Llorca, J; Ascunce, N; Peiro-Perez, R; Altzibar, JM; Tardon, A; Alguacil, J; Navarro, C; Sierra, A; Vega, AB; Villafane, A; Castano-Vinyals, G; Kogevinas, M; Pollan, M; Aragones, N				Lope, Virginia; Fernandez de Larrea, Nerea; Perez-Gomez, Beatriz; Martin, Vicente; Moreno, Victor; Costas, Laura; Longo, Federico; Juan Jimenez-Moleon, Jose; Llorca, Javier; Ascunce, Nieves; Peiro-Perez, Rosana; Altzibar, Jone M.; Tardon, Adonina; Alguacil, Juan; Navarro, Carmen; Sierra, Angeles; Belen Vega, Ana; Villafane, Amaya; Castano-Vinyals, Gemma; Kogevinas, Manolis; Pollan, Marina; Aragones, Nuria			Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain	PLOS ONE			English	Article							POSTMENOPAUSAL HORMONE-THERAPY; ORAL-CONTRACEPTIVES; ESTROGEN; WOMEN; HISTORY; METAANALYSIS; SUBSITE; PARITY	Background Sex hormones play a role in gastric cancer and colorectal cancer etiology, however, epidemiological evidence is inconsistent. This study examines the influence of menstrual and reproductive factors over the risk of both tumors. Methods In this case-control study 128 women with gastric cancer and 1293 controls, as well as 562 female and colorectal cancer cases and 1605 controls were recruited in 9 and 11 Spanish provinces, respectively. Population controls were frequency matched to cases by age and province. Demographic and reproductive data were directly surveyed by trained staff. The association with gastric, colon and rectal cancer was assessed using logistic and multinomial mixed regression models. Results Our results show an inverse association of age at first birth with gastric cancer risk (five-year trend: OR = 0.69; p-value = 0.006). Ever users of hormonal contraception presented a decreased risk of gastric (OR = 0.42; 95% CI = 0.26-0.69), colon (OR = 0.64; 95% CI = 0.48-0.86) and rectal cancer (OR = 0.61; 95% CI = 0.43-0.88). Postmenopausal women who used hormone replacement therapy showed a decreased risk of colon and rectal tumors. A significant interaction of educational level with parity and months of first child lactation was also observed. Conclusion These findings suggest a protective role of exogenous hormones in gastric and colorectal cancer risk. The role of endogenous hormones remains unclear.	[Lope, Virginia; Fernandez de Larrea, Nerea; Perez-Gomez, Beatriz; Sierra, Angeles; Pollan, Marina; Aragones, Nuria] Carlos III Inst Hlth, Canc & Environm Epidemiol Unit, Natl Ctr Epidemiol, Madrid 28029, Spain; [Lope, Virginia; Fernandez de Larrea, Nerea; Perez-Gomez, Beatriz; Martin, Vicente; Moreno, Victor; Costas, Laura; Juan Jimenez-Moleon, Jose; Llorca, Javier; Ascunce, Nieves; Peiro-Perez, Rosana; Altzibar, Jone M.; Tardon, Adonina; Alguacil, Juan; Navarro, Carmen; Sierra, Angeles; Castano-Vinyals, Gemma; Kogevinas, Manolis; Pollan, Marina; Aragones, Nuria] CIBERESP, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid 28029, Spain; [Lope, Virginia; Perez-Gomez, Beatriz; Sierra, Angeles; Pollan, Marina; Aragones, Nuria] IIS Puerta Hierro IDIPHIM, Oncol & Hematol Area, Canc Epidemiol Res Grp, Madrid 28222, Spain; [Martin, Vicente] Univ Leon, Grp Invest Interacc Gen Ambiente & Salud, E-24071 Leon, Spain; [Moreno, Victor] IDIBELL Catalan Inst Oncol, Barcelona 08907, Spain; [Moreno, Victor] Univ Barcelona, Dept Clin Sci, Fac Med, Barcelona 08907, Spain; [Costas, Laura] Catalan Inst Oncol, IDIBELL, Unit Infect & Canc, Canc Epidemiol Res Programme, Barcelona 08907, Spain; [Costas, Laura] Univ Barcelona, Dept Med, Barcelona 08907, Spain; [Longo, Federico] Hosp Univ Ramon y Cajal, Dept Med Oncol, Madrid 28034, Spain; [Juan Jimenez-Moleon, Jose] Granada Hlth Res Inst Ibs GRANADA, Inst Invest Biosanitaria Granada Ibs GRANADA, Granada 18012, Spain; [Juan Jimenez-Moleon, Jose] Univ Granada, Dept Prevent Med & Publ Hlth, Granada 18016, Spain; [Llorca, Javier] Univ Cantabria, IDIVAL, Santander 39011, Spain; [Ascunce, Nieves] Inst Publ Hlth, Navarra Breast Canc Screening Programme, Pamplona 31003, Spain; [Peiro-Perez, Rosana] Fdn Fomento Invest Sanitaria & Biomed FISABIO, Canc & Publ Hlth Area, Valencia 46020, Spain; [Altzibar, Jone M.] Publ Hlth Div Gipuzkoa, San Sebastian 20013, Spain; [Altzibar, Jone M.] Biodonostia Res Inst, San Sebastian 20014, Spain; [Tardon, Adonina] Univ Oviedo, Inst Univ Oncol, E-33006 Oviedo, Asturias, Spain; [Alguacil, Juan] Univ Huelva, Ctr Invest Salud & Medio Ambiente CYSMA, Huelva 21071, Spain; [Navarro, Carmen] Murcia Reg Hlth Council, Dept Epidemiol, IMIB Arrixaca, Murcia 30008, Spain; [Navarro, Carmen] Univ Murcia, Dept Hlth & Social Sci, Murcia 30003, Spain; [Belen Vega, Ana] Hosp Viladecans, Gastroenterol, Barcelona 08840, Spain; [Villafane, Amaya] Complejo Asistencial Univ Leon, Serv Cirugia, Leon 24071, Spain; [Castano-Vinyals, Gemma; Kogevinas, Manolis] Ctr Res Environm Epidemiol CREAL, Barcelona 08003, Spain; [Castano-Vinyals, Gemma; Kogevinas, Manolis] Hosp Mar, Med Res Inst, IMIM, Barcelona 08003, Spain; [Castano-Vinyals, Gemma; Kogevinas, Manolis] Univ Pompeu Fabra, Barcelona 08003, Spain	Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad de Leon; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Barcelona; Hospital Universitario Ramon y Cajal; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Universidad de Cantabria; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Universidad de Huelva; Hospital Clinico Universitario Virgen de la Arrixaca; Murcia Regional Health Council; University of Murcia; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Valdecans; Universidad de Leon; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University	Lope, V (corresponding author), Carlos III Inst Hlth, Canc & Environm Epidemiol Unit, Natl Ctr Epidemiol, Madrid 28029, Spain.; Lope, V (corresponding author), CIBERESP, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid 28029, Spain.; Lope, V (corresponding author), IIS Puerta Hierro IDIPHIM, Oncol & Hematol Area, Canc Epidemiol Res Grp, Madrid 28222, Spain.	vicarvajal@isciii.es	Pollan, Marina/M-3259-2014; TARDON, ADONINA/B-6563-2014; Alguacil, Juan J/D-4463-2019; Martin, Vicente/GRE-8306-2022; Perez-Gomez, Beatriz/C-4715-2012; Kogevinas, Manolis/C-3918-2017; Llorca, Javier/F-7371-2011; Martin, Vicente/A-1597-2008; Jimenez-Moleon, Jose J/O-2519-2016; LOPE, VIRGINIA/S-4774-2016; Castaño-Vinyals, Gemma/N-3885-2019; Moreno, Victor/A-1697-2010; Aragones, Nuria/O-5962-2015; Castaño-Vinyals, Gemma/H-7021-2017; Martin, Vicente/ABF-2276-2021	Pollan, Marina/0000-0002-4328-1565; TARDON, ADONINA/0000-0001-5150-1209; Alguacil, Juan J/0000-0003-2703-9725; Martin, Vicente/0000-0003-0552-2804; Perez-Gomez, Beatriz/0000-0002-4299-8214; Kogevinas, Manolis/0000-0002-9605-0461; Llorca, Javier/0000-0001-8569-861X; Martin, Vicente/0000-0003-0552-2804; Jimenez-Moleon, Jose J/0000-0001-7917-6145; LOPE, VIRGINIA/0000-0002-6986-4021; Castaño-Vinyals, Gemma/0000-0003-4468-1816; Moreno, Victor/0000-0002-2818-5487; Aragones, Nuria/0000-0003-0983-2156; Castaño-Vinyals, Gemma/0000-0003-4468-1816; Costas, Laura/0000-0003-2755-302X; Peiro Perez, Rosana/0000-0003-1525-4030; ALTZIBAR, JONE MIREN/0000-0001-7037-7944; Navarro, Carmen/0000-0001-8896-7483; Sierra, Maria Angeles/0000-0003-1765-8733	Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP); Institute de Salud Carlos III [PI08/1770, PI09/0773, PI09/1286, PI09/1903, PI09/1662, PI11/01403]; Institute de Salud Carlos III; FEDER funds [PI08-1359, PI14-0613]; European Commission [FOOD-CT-2006-036224-HIWATE]; Catalan Government DURSI [2014SGR647]; Fundacion Marques de Valdecilla grant [API 10/09]; Junta de Castilla y Leon [LE22A10-2]; Consejeria de Salud of the Junta de Andalucia [2009-SO143]; Conselleria de Sanitat of the Generalitat Valenciana grant [AP061/10]	Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP); Institute de Salud Carlos III(Instituto de Salud Carlos III); Institute de Salud Carlos III(Instituto de Salud Carlos III); FEDER funds(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Catalan Government DURSI; Fundacion Marques de Valdecilla grant; Junta de Castilla y Leon(Junta de Castilla y Leon); Consejeria de Salud of the Junta de Andalucia(Junta de Andalucia); Conselleria de Sanitat of the Generalitat Valenciana grant	The study was supported by the Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), by the "Accion Transversal del Cancer," approved on the Spanish Ministry Council on the 11th October 2007, by the Institute de Salud Carlos III grants PI08/1770 (to M. Kogevinas), PI09/0773 (to J. LLorca), PI09/1286 (to V. Martin), PI09/1903 (to R. Peiro), PI09/1662 (to J.J. Jimenez-Moleon), PI11/01403 (to N. Aragones), by the Institute de Salud Carlos III, co-funded by FEDER funds a way to build Europe - PI08-1359, PI14-0613 (to V. Moreno), by the European Commission grants FOOD-CT-2006-036224-HIWATE (to V. Moreno), by the Catalan Government DURSI grant 2014SGR647 (to V. Moreno), by the Fundacion Marques de Valdecilla grant API 10/09 (to J. Llorca), by the Junta de Castilla y Leon grant LE22A10-2 (to V. Martin), by the Consejeria de Salud of the Junta de Andalucia grant 2009-SO143 (to J. Alguacil), and by the Conselleria de Sanitat of the Generalitat Valenciana grant AP061/10 (to R. Peiro). The funders had no role in the study design and data analysis.	Akhter M, 2008, EUR J CANCER PREV, V17, P515, DOI 10.1097/CEJ.0b013e3282f521f8; [Anonymous], 2013, COL CRC LARG BOW CAN; [Anonymous], 2016, MORT CANC OTR CAUS 2; [Anonymous], 2016, INT EP INF SYST ARIA; Bahmanyar S, 2008, BRIT J CANCER, V98, P1295, DOI 10.1038/sj.bjc.6604283; Barzi A, 2013, CLIN CANCER RES, V19, P5842, DOI 10.1158/1078-0432.CCR-13-0325; Bosetti C, 2001, J CLIN EPIDEMIOL, V54, P902, DOI 10.1016/S0895-4356(01)00362-6; Bosetti C, 2009, HUM REPROD UPDATE, V15, P489, DOI 10.1093/humupd/dmp017; Cairns BJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-7; Camargo MC, 2012, CANCER EPIDEM BIOMAR, V21, P20, DOI 10.1158/1055-9965.EPI-11-0834; Castano-Vinyals G, 2015, GAC SANIT, V29, P308, DOI 10.1016/j.gaceta.2014.12.003; Chandanos E, 2008, GASTRIC CANCER, V11, P168, DOI 10.1007/s10120-008-0475-6; Chandanos E, 2008, EUR J CANCER, V44, P2397, DOI 10.1016/j.ejca.2008.07.031; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep18766; Costas L, 2015, MENOPAUSE, V22, P1138, DOI 10.1097/GME.0000000000000487; Duell EJ, 2010, AM J EPIDEMIOL, V172, P1384, DOI 10.1093/aje/kwq321; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fernandez E, 2001, BRIT J CANCER, V84, P722, DOI 10.1054/bjoc.2000.1622; Foster PA, 2013, INT J COLORECTAL DIS, V28, P737, DOI 10.1007/s00384-012-1628-y; Freedman ND, 2007, GUT, V56, P1671, DOI 10.1136/gut.2007.129411; Freedman ND, 2010, CANCER-AM CANCER SOC, V116, P1572, DOI 10.1002/cncr.24880; Frise S, 2006, ANN EPIDEMIOL, V16, P908, DOI 10.1016/j.annepidem.2006.03.001; Galceran J, 2014, ESTIMACIONES INCIDEN; Garcia-Arenzana N, 2012, MENOPAUSE, V19, P1121, DOI 10.1097/gme.0b013e3182544925; Green J, 2012, INT J CANCER, V130, P2387, DOI 10.1002/ijc.26236; Grodstein F, 1999, AM J MED, V106, P574, DOI 10.1016/S0002-9343(99)00063-7; Guan HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075279; Inoue M, 2002, INT J CANCER, V97, P833, DOI 10.1002/ijc.10149; JACOBSEN BK, 1995, J CLIN EPIDEMIOL, V48, P1119, DOI 10.1016/0895-4356(95)00009-S; LAVECCHIA C, 1991, CANCER CAUSE CONTROL, V2, P193, DOI 10.1007/BF00056213; Lin KJ, 2012, INT J CANCER, V130, P419, DOI 10.1002/ijc.26026; Lo AC, 2010, DIS COLON RECTUM, V53, P830, DOI 10.1007/DCR.0b013e3181d320b1; Lope V, 2012, BREAST CANCER RES TR, V132, P1137, DOI 10.1007/s10549-011-1936-x; Lopez-Abente G, 2010, ANN ONCOL, V21, piii76, DOI 10.1093/annonc/mdq091; Luan NN, 2015, CANCER CAUSE CONTROL, V26, P65, DOI 10.1007/s10552-014-0483-2; Peiro-Perez R, 2015, EUR J PUBLIC HEALTH, V25, P857, DOI 10.1093/eurpub/cku248; Tsilidis KK, 2010, BRIT J CANCER, V103, P1755, DOI 10.1038/sj.bjc.6605965; Zervoudakis A, 2011, J NATL CANCER I, V103, P826, DOI 10.1093/jnci/djr101	38	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164620	10.1371/journal.pone.0164620	http://dx.doi.org/10.1371/journal.pone.0164620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776142	Green Published, gold			2022-12-26	WOS:000389009200016
J	Liu, XY; Feng, DF; Liu, DM; Wang, SY; Yu, XX; Dai, EY; Wang, J; Wang, LH; Jiang, W				Liu, Xinyi; Feng, Dongfei; Liu, Dianming; Wang, Shuyuan; Yu, Xuexin; Dai, Enyu; Wang, Jing; Wang, Lihong; Jiang, Wei			Dissecting the Origin of Breast Cancer Subtype Stem Cell and the Potential Mechanism of Malignant Transformation	PLOS ONE			English	Article							DIFFERENTIATION; RECEPTOR; THERAPY; PATHWAY; DISPLAY; TOOL	Background Breast cancer is the most common incident form of cancer in women including different subtypes. Cancer stem cells (CSCs) have been confirmed to exist in breast cancer. But the research on the origin of breast cancer subtype stem cells (BCSSCs) is still inadequate. Methods We identified the putative origin cells of BCSSCs through comparing gene signatures between BCSSCs and normal mammary cells from multiple perspectives: common signature, expression consistency, functional similarity and shortest path length. First, the potential origin cells were ranked according to these measures separately. Then Q statistic was employed to combine all rank lists into a unique list for each subtype, to prioritize the origin cells for each BCSSC. Next, we identified origin-related gene modules through integrating functional interaction network with differentially expressed genes. Finally, transcription factors of significant gene modules were predicted by Match TM. Results The results showed that Luminal A CSC was most relevant to luminal progenitor cell or mature luminal cell; luminal B and HER2 CSC were most relevant to bipotent-enriched progenitor cell; basal-like CSC was most relevant to bipotent-enriched progenitor cell or mature luminal cell. Network modules analysis revealed genes related to mitochondrial respiratory chain (MRC) were significantly dysregulated during the origin of luminal B CSC. In addition, SOX10 emerged as a key regulator of MRC. Conclusions Our study supports substantive evidence for the possible origin of four kinds of BCSSCs. Dysfunction of MRC may contribute to the origin of luminal B CSC. These findings may have important implications to treat and prevent breast cancer.	[Liu, Xinyi; Feng, Dongfei; Liu, Dianming; Wang, Shuyuan; Yu, Xuexin; Dai, Enyu; Wang, Jing; Jiang, Wei] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Feng, Dongfei] Harbin Childrens Hosp, Dept Stomatol, Harbin, Peoples R China; [Wang, Lihong] Harbin Med Univ, Inst Canc Prevent & Treatment, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Jiang, W (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.; Wang, LH (corresponding author), Harbin Med Univ, Inst Canc Prevent & Treatment, Harbin, Peoples R China.	lw2247@gmail.com; jiangwei@hrbmu.eclu.cn	liu, xinyi/GWZ-8739-2022		Foundation for the National Natural Science Foundation of China [61571169]; Natural Science Foundation of Heilongjiang Province of China [QC2014C017]; University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province [UNPYSCT-2015037]	Foundation for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province	This work was supported by the Foundation for the National Natural Science Foundation of China [61571169] and the Natural Science Foundation of Heilongjiang Province of China [QC2014C017], and the University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province [UNPYSCT-2015037].	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Amin R, 2016, MOL ONCOL, V10, P575, DOI 10.1016/j.molonc.2015.11.009; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Boyle P, 2012, ANN ONCOL, V23, P7, DOI 10.1093/annonc/mds187; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Czarnecka AM, 2010, ONCOL REP, V23, P531, DOI 10.3892/or_00000666; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Dormeyer W, 2008, J PROTEOME RES, V7, P2936, DOI 10.1021/pr800056j; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Grillet F, 2016, GUT; Ivanov SV, 2013, BRIT J CANCER, V109, P444, DOI 10.1038/bjc.2013.326; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Kagawa Y, 1999, BIOCHEM BIOPH RES CO, V266, P662, DOI 10.1006/bbrc.1999.1884; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li BQ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/267375; Li LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144441; Lottaz C, 2010, CANCER RES, V70, P2030, DOI 10.1158/0008-5472.CAN-09-1707; Ma JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064912; Mazandu GK, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/292063; Melchor L, 2008, CARCINOGENESIS, V29, P1475, DOI 10.1093/carcin/bgn157; Miyahara K, 2011, J PEDIATR SURG, V46, P2305, DOI 10.1016/j.jpedsurg.2011.09.020; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Mou ZM, 2009, J BIOL CHEM, V284, P13629, DOI 10.1074/jbc.M901177200; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Putignani L, 2008, BREAST CANCER RES TR, V110, P439, DOI 10.1007/s10549-007-9738-x; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Ringner Markus, 2013, Methods Mol Biol, V973, P279, DOI 10.1007/978-1-62703-281-0_18; Seshie B, 2015, BMC CLIN PATHOL, V15, DOI 10.1186/s12907-015-0014-4; Simon R, 2007, CANCER INFORM, V3, P11; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Swartz HM, 2003, ADV EXP MED BIOL, V530, P1; Turner-Ivey B, 2014, NEOPLASIA, V16, P644, DOI 10.1016/j.neo.2014.07.007; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang J, 2012, BRIEF BIOINFORM, V13, P216, DOI 10.1093/bib/bbr041; Wijaya L, 2011, CURR PHARM BIOTECHNO, V12, P189, DOI 10.2174/138920111794295819; Witkiewicz AK, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3652; Wu GM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r112; Yang Z, 2016, EUROPEAN UROLOGY; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Zhang J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/523415; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	53	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165001	10.1371/journal.pone.0165001	http://dx.doi.org/10.1371/journal.pone.0165001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768723	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400043
J	Mahor, D; Priyanka, A; Prasad, GS; Thakur, KG				Mahor, Durga; Priyanka, Anu; Prasad, Gandham S.; Thakur, Krishan Gopal			Functional and Structural Characterization of Purine Nucleoside Phosphorylase from Kluyveromyces lactis and Its Potential Applications in Reducing Purine Content in Food	PLOS ONE			English	Article							EVIDENCE BASED RECOMMENDATIONS; URIC-ACID LEVEL; CRYSTAL-STRUCTURE; CARDIOVASCULAR-DISEASE; HEALTH-PROFESSIONALS; RISK-FACTOR; TASK-FORCE; GOUT; HYPERURICEMIA; MANAGEMENT	Consumption of foods and beverages with high purine content increases the risk of hyper-uricemia, which causes gout and can lead to cardiovascular, renal, and other metabolic disorders. As patients often find dietary restrictions challenging, enzymatically lowering purine content in popular foods and beverages offers a safe and attractive strategy to control hyperuricemia. Here, we report structurally and functionally characterized purine nucleoside phosphorylase (PNP) from Kluyveromyces lactis (KlacPNP), a key enzyme involved in the purine degradation pathway. We report a 1.97 angstrom resolution crystal structure of homotrimeric KlacPNP with an intrinsically bound hypoxanthine in the active site. KlacPNP belongs to the nucleoside phosphorylase-I (NP-I) family, and it specifically utilizes 6-oxopurine substrates in the following order: inosine > guanosine > xanthosine, but is inactive towards adenosine. To engineer enzymes with broad substrate specificity, we created two point variants, KlacPNP(N256D) and KlacPNP(N256E),by replacing the catalytically active Asn256 with Asp and Glu, respectively, based on structural and comparative sequence analysis. KlacPNP(N256D) not only displayed broad substrate specificity by utilizing both 6-oxopurines and 6-aminopurines in the order adenosine > inosine > xanthosine > guanosine, but also displayed reversal of substrate specificity. In contrast, KlacPNP(N256E) was highly specific to inosine and could not utilize other tested substrates. Beer consumption is associated with increased risk of developing gout, owing to its high purine content. Here, we demonstrate that KlacPNP and KlacPNP(N256D) could be used to catalyze a key reaction involved in lowering beer purine content. Biochemical properties of these enzymes such as activity across a wide pH range, optimum activity at about 25 degrees C, and stability for months at about 8 degrees C, make them suitable candidates for food and beverage industries. Since KlacPNP(N256D) has broad substrate specificity, a combination of engineered KlacPNP and other enzymes involved in purine degradation could effectively lower the purine content in foods and beverages.	[Mahor, Durga; Prasad, Gandham S.] CSIR Inst Microbial Technol, Microbial Type Culture Collect & Gene Bank, Chandigarh, India; [Priyanka, Anu; Thakur, Krishan Gopal] CSIR Inst Microbial Technol, GN Ramachandran Prot Ctr, Struct Biol Lab, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Prasad, GS (corresponding author), CSIR Inst Microbial Technol, Microbial Type Culture Collect & Gene Bank, Chandigarh, India.; Thakur, KG (corresponding author), CSIR Inst Microbial Technol, GN Ramachandran Prot Ctr, Struct Biol Lab, Chandigarh, India.	prasad@imtech.res.in; krishang@imtech.res.in		Priyanka, Anu/0000-0002-0098-9790; Thakur, Krishan/0000-0003-4500-2133; Prasad, Gandham S/0000-0002-8557-8789	Council of Scientific and Industrial Research, India; Innovative Young Biotechnologist Award, Department of Biotechnology, Ministry of Science and Technology, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Innovative Young Biotechnologist Award, Department of Biotechnology, Ministry of Science and Technology, India	This work was supported by Council of Scientific and Industrial Research, India grants to KGT and GSP. KGT is a recipient of Innovative Young Biotechnologist Award-2011, Department of Biotechnology, Ministry of Science and Technology, India. DM and AP are senior research fellows, University Grants Commission, India.	Alderman M, 2004, CURR MED RES OPIN, V20, P369, DOI 10.1185/030079904125002982; Annemans L, 2008, ANN RHEUM DIS, V67, P960, DOI 10.1136/ard.2007.076232; [Anonymous], 2014, GLOB BEER CONS COUNT; Ar'ev A L, 2012, Adv Gerontol, V25, P540; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker JF, 2010, INT J CLIN PRACT, V64, P371, DOI 10.1111/j.1742-1241.2009.02188.x; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Belenky P, 2009, J BIOL CHEM, V284, P158, DOI 10.1074/jbc.M807976200; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Bzowska A, 2000, PHARMACOL THERAPEUT, V88, P349, DOI 10.1016/S0163-7258(00)00097-8; BZOWSKA A, 1990, Z NATURFORSCH C, V45, P59; Bzowska A, 1996, EUR J BIOCHEM, V239, P229, DOI 10.1111/j.1432-1033.1996.0229u.x; Bzowska Agnieszka, 2015, Postepy Biochem, V61, P260; Cammalleri Lisa, 2007, Int J Med Sci, V4, P83; Canduri F, 2004, BIOCHEM BIOPH RES CO, V313, P907, DOI 10.1016/j.bbrc.2003.11.179; Caspi D, 2000, ARTHRITIS RHEUM-US, V43, P103, DOI 10.1002/1529-0131(200001)43:1<103::AID-ANR13>3.0.CO;2-C; Chang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061450; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Choi HK, 2004, ARTHRIT RHEUM-ARTHR, V51, P1023, DOI 10.1002/art.20821; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Choi HK, 2010, CURR OPIN RHEUMATOL, V22, P165, DOI 10.1097/BOR.0b013e328335ef38; Colen L, 2016, J AGR ECON, V67, P186, DOI 10.1111/1477-9552.12128; DADDONA PE, 1986, J BIOL CHEM, V261, P1667; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Dessanti P, 2012, ACTA CRYSTALLOGR D, V68, P239, DOI 10.1107/S090744491200073X; EALICK SE, 1990, J BIOL CHEM, V265, P1812; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; Eggebeen AT, 2007, AM FAM PHYSICIAN, V76, P801; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erion MD, 1997, BIOCHEMISTRY-US, V36, P11725, DOI 10.1021/bi961969w; Erion MD, 1997, BIOCHEMISTRY-US, V36, P11735, DOI 10.1021/bi961970v; Fam AG, 2002, J RHEUMATOL, V29, P1350; Fang JI, 2014, ATHEROSCLEROSIS, V236, P389, DOI 10.1016/j.atherosclerosis.2014.07.024; Feig DI, 2003, HYPERTENSION, V42, P247, DOI 10.1161/01.HYP.0000085858.66548.59; Fukuuchi T, 2013, ANAL SCI, V29, P511, DOI 10.2116/analsci.29.511; Gaffo AL, 2008, AM J KIDNEY DIS, V52, P994, DOI 10.1053/j.ajkd.2008.07.035; Galen, CLAUD GAL OP OMN; Grahane R, 2003, GOUT YOUR FINGERTIPS; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Jankowska DA, 2015, BIOENGINEERED, V6, P20, DOI 10.4161/21655979.2014.991667; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; KALCKAR HM, 1947, J BIOL CHEM, V167, P461; Kim C, 2004, AM J PREV MED, V27, P1, DOI 10.1016/j.amepre.2004.03.008; Koellner G, 1997, J MOL BIOL, V265, P202, DOI 10.1006/jmbi.1996.0730; Kuo CF, 2015, NAT REV RHEUMATOL, V11, P649, DOI 10.1038/nrrheum.2015.91; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lecoq K, 2001, J BACTERIOL, V183, P4910, DOI 10.1128/JB.183.16.4910-4913.2001; Levinson W, 2001, ANN INTERN MED, V135, P386, DOI 10.7326/0003-4819-135-5-200109040-00027; Luk AJ, 2005, AM J MANAG CARE, V11, pS435; MacFarlane LA, 2014, RHEUM DIS CLIN N AM, V40, P581, DOI 10.1016/j.rdc.2014.07.002; Masseoud D, 2005, CURR PHARM DESIGN, V11, P4117, DOI 10.2174/138161205774913318; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Pereira HM, 2007, FEBS LETT, V581, P5082, DOI 10.1016/j.febslet.2007.09.051; Perez-Ruiz F, 1998, ANN RHEUM DIS, V57, P545, DOI 10.1136/ard.57.9.545; Pogosian L. H., 2013, Biomeditsinskaya Khimiya, V59, P483; Pugmire MJ, 2002, BIOCHEM J, V361, P1, DOI 10.1042/0264-6021:3610001; Rathmann W, 1998, ANN EPIDEMIOL, V8, P250, DOI 10.1016/S1047-2797(97)00204-4; Richette P, 2006, NAT CLIN PRACT RHEUM, V2, P338, DOI 10.1038/ncprheum0214; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sherman MR, 2008, ADV DRUG DELIVER REV, V60, P59, DOI 10.1016/j.addr.2007.06.011; Silva RG, 2005, ARCH BIOCHEM BIOPHYS, V442, P49, DOI 10.1016/j.abb.2005.07.021; Smith EUR, 2010, BEST PRACT RES CL RH, V24, P811, DOI 10.1016/j.berh.2010.10.004; Stack AG, 2013, QJM-INT J MED, V106, P647, DOI 10.1093/qjmed/hct083; Steiner T., 2003, CRYSTALLOGR REV, V9, P177, DOI [10.1080/08893110310001621772, DOI 10.1080/08893110310001621772]; Stoeckler JD, 1997, BIOCHEMISTRY-US, V36, P11749, DOI 10.1021/bi961971n; Tahirov TH, 2004, J MOL BIOL, V337, P1149, DOI 10.1016/j.jmb.2004.02.016; Takano Y, 2005, LIFE SCI, V76, P1835, DOI 10.1016/j.lfs.2004.10.031; Tausche AK, 2009, DTSCH ARZTEBL INT, V106, P549, DOI 10.3238/arztebl.2009.0549; Terkeltaub R, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2738; Trautwein-Schult A, 2014, J MOL MICROB BIOTECH, V24, P67, DOI 10.1159/000357674; TYKARSKI A, 1991, NEPHRON, V59, P364, DOI 10.1159/000186593; Vanltallie TB, 2010, METABOLISM, V59, pS32, DOI 10.1016/j.metabol.2010.07.009; Visser DF, 2010, EXTREMOPHILES, V14, P185, DOI 10.1007/s00792-009-0297-4; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Weissgerber TL, 2015, MAYO CLIN PROC, V90, P1207, DOI 10.1016/j.mayocp.2015.05.020; Yamamoto T, 2002, METABOLISM, V51, P1317, DOI 10.1053/meta.2002.34041; Yamamoto T, 2009, BEER HLTH DIS PREVEN; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269; Zhang W, 2006, ANN RHEUM DIS, V65, P1301, DOI 10.1136/ard.2006.055251	81	11	12	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164279	10.1371/journal.pone.0164279	http://dx.doi.org/10.1371/journal.pone.0164279			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768715	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400007
J	Singh, D; Upadhyay, G; Sengupta, A; Biplob, MA; Chakyayil, S; George, T; Saleque, S				Singh, Divya; Upadhyay, Ghanshyam; Sengupta, Ananya; Biplob, Mohammed A.; Chakyayil, Shaleen; George, Tiji; Saleque, Shireen			Cooperative Stimulation of Megakaryocytic Differentiation by Gfi1b Gene Targets Kindlin3 and Talin1	PLOS ONE			English	Article							MEGAKARYOBLASTIC CELL-LINE; INTEGRIN ACTIVATION; TRANSCRIPTIONAL REPRESSION; ERYTHROID-DIFFERENTIATION; PLATELET-AGGREGATION; GFI-1B; EXPRESSION; MOUSE; HEMATOPOIESIS; RECRUITMENT	Understanding the production and differentiation of megakaryocytes from progenitors is crucial for realizing the biology and functions of these vital cells. Previous gene ablation studies demonstrated the essential role of the transcriptional repressor Gfi1b (growth factor independence 1b) in the generation of both erythroid and megakaryocytic cells. However, our recent work has demonstrated the down-regulation of this factor during megakaryocytic differentiation. In this study we identify two new gene targets of Gfi1b, the cytoskeletal proteins Kindlin3 and Talin1, and demonstrate the inverse expression and functions of these cytoskeletal targets relative to Gfi1b, during megakaryocytic differentiation. Both kindlin3 and talin1 promoters exhibit dose dependent Gfi1b and LSD1 (lysine specific demethylase 1; a Gfi1b cofactor) enrichment in megakaryocytes and repression in non-hematopoietic cells. Accordingly the expression of these genes is elevated in gfi1b mutant and LSD1 inhibited hematopoietic cells, while during megakaryocytic differentiation, declining Gfi1b levels fostered the reciprocal upregulation of these cytoskeletal factors. Concordantly, manipulation of Kindlin3 and Talin1 expression demonstrated positive correlation with megakaryocytic differentiation with over-expression stimulating, and inhibition diminishing, this process. Co-operativity between these factors and integrins in promoting differentiation was further underscored by physical interactions between them and integrin beta 3/CD61 and by stimulation of differentiation by the Talin1 head domain, which is necessary and sufficient for integrin activation. Therefore this study demonstrates the significance of Gfi1b regulated Kindlin3-Talin1 expression in driving megakaryocytic differentiation and highlights the contribution of cytoskeletal agents in the developmental progression of these platelet progenitors.	[Saleque, Shireen] CUNY City Coll, Dept Biol, 160 Convent Ave, New York, NY 10031 USA; CUNY, Grad Ctr, 160 Convent Ave, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Saleque, S (corresponding author), CUNY City Coll, Dept Biol, 160 Convent Ave, New York, NY 10031 USA.	ssaleque@ccny.cuny.edu		Chakyayil, Shaleen/0000-0003-0928-3986	National Institute on Minority Health and Health Disparities Research Centers in Minority Institutions [G12RR03060-26A1, 8G12MD007603-27]; National Heart, Lung, and Blood Institute grant [5SC1HL104638]	National Institute on Minority Health and Health Disparities Research Centers in Minority Institutions; National Heart, Lung, and Blood Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute on Minority Health and Health Disparities Research Centers in Minority Institutions [grant numbers G12RR03060-26A1 and 8G12MD007603-27 to The City University of New York]; and by the National Heart, Lung, and Blood Institute grant [grant number 5SC1HL104638 to S.S.].	ALITALO R, 1990, LEUKEMIA RES, V14, P501, DOI 10.1016/0145-2126(90)90002-Q; ANDERSSON LC, 1979, NATURE, V278, P364, DOI 10.1038/278364a0; Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Beaty BT, 2014, J CELL BIOL, V205, P737, DOI 10.1083/jcb.201312046; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Chowdhury AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053666; Cornejo MG, 2011, BLOOD, V118, P1264, DOI 10.1182/blood-2011-01-328567; Doan LL, 2004, NUCLEIC ACIDS RES, V32, P2508, DOI 10.1093/nar/gkh570; Duan ZJ, 2005, MOL CELL BIOL, V25, P10338, DOI 10.1128/MCB.25.23.10338-10351.2005; Elmaagacli AH, 2007, BRIT J HAEMATOL, V136, P212, DOI 10.1111/j.1365-2141.2006.06407.x; Foudi A, 2014, J EXP MED, V211, P909, DOI 10.1084/jem.20131065; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Horton M A, 1983, Prog Clin Biol Res, V134, P305; ISHIDA Y, 1993, EXP HEMATOL, V21, P289; Kanamori H, 2011, ONCOLOGY-BASEL, V80, P406, DOI 10.1159/000330734; Khandanpour C, 2012, BLOOD, V120, P4006, DOI 10.1182/blood-2011-02-334722; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Monkley SJ, 2000, DEV DYNAM, V219, P560, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y; Monteferrario D, 2014, NEW ENGL J MED, V370, P245, DOI 10.1056/NEJMoa1308130; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Nakazawa T, 2013, EXP HEMATOL, V41, P79, DOI 10.1016/j.exphem.2012.09.011; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Niu HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047356; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulz D, 2012, J EXP MED, V209, P187, DOI 10.1084/jem.20110645; Sengupta A, 2016, J CELL SCI, V129, P145, DOI 10.1242/jcs.177519; Tong B, 1998, MOL CELL BIOL, V18, P2462, DOI 10.1128/MCB.18.5.2462; Tzivion G, 2012, BIOCHIM BIOPHYS ACTA, V1813, P1938; Upadhyay G, 2014, P NATL ACAD SCI US; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; Vassen L, 2005, NUCLEIC ACIDS RES, V33, P987, DOI 10.1093/nar/gki243; Vassen L, 2007, BLOOD, V109, P2356, DOI 10.1182/blood-2006-06-030031; Vassen L, 2006, EMBO J, V25, P2409, DOI 10.1038/sj.emboj.7601124; Vassen L, 2009, INT J HEMATOL, V89, P422, DOI 10.1007/s12185-009-0286-5; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; Whalen AM, 1997, MOL CELL BIOL, V17, P1947, DOI 10.1128/MCB.17.4.1947; Ye F, 2014, FRONT MED-PRC, V8, P6, DOI 10.1007/s11684-014-0317-3; Ye F, 2011, CURR OPIN HEMATOL, V18, P356, DOI 10.1097/MOH.0b013e3283497f09; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	45	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164506	10.1371/journal.pone.0164506	http://dx.doi.org/10.1371/journal.pone.0164506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768697	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400015
J	Zhang, JC; Hu, QS; Xu, CB; Liu, SX; Li, CF				Zhang, Jiachao; Hu, Qisong; Xu, Chuanbiao; Liu, Sixin; Li, Congfa			Key Microbiota Identification Using Functional Gene Analysis during Pepper (Piper nigrum L.) Peeling	PLOS ONE			English	Article							GUT MICROBIOTA; BIODEGRADATION; BACTERIUM; SEQUENCES; ASSAY	Pepper pericarp microbiota plays an important role in the pepper peeling process for the production of white pepper. We collected pepper samples at different peeling time points from Hainan Province, China, and used a metagenomic approach to identify changes in the pericarp microbiota based on functional gene analysis. UniFrac distance-based principal coordinates analysis revealed significant changes in the pericarp microbiota structure during peeling, which were attributed to increases in bacteria from the genera Selenomonas and Prevotella. We identified 28 core operational taxonomic units at each time point, mainly belonging to Selenomonas, Prevotella, Megasphaera, Anaerovibrio, and Clostridium genera. The results were confirmed by quantitative polymerase chain reaction. At the functional level, we observed significant increases in microbial features related to acetyl xylan esterase and pectinesterase for pericarp degradation during peeling. These findings offer a new insight into biodegradation for pepper peeling and will promote the development of the white pepper industry.	[Zhang, Jiachao; Hu, Qisong; Xu, Chuanbiao; Li, Congfa] Hainan Univ, Coll Food Sci & Technol, Haikou 570228, Peoples R China; [Liu, Sixin] Hainan Univ, Coll Mat & Chem Engn, Haikou 570228, Peoples R China	Hainan University; Hainan University	Li, CF (corresponding author), Hainan Univ, Coll Food Sci & Technol, Haikou 570228, Peoples R China.; Liu, SX (corresponding author), Hainan Univ, Coll Mat & Chem Engn, Haikou 570228, Peoples R China.	sixinliu@126.com; congfa@vip.163.com	xu, chuanbiao/GVU-7982-2022; Zhang, jiachao/L-1332-2013	Zhang, jiachao/0000-0001-8099-6749; Zhang, Jiachao/0000-0002-3339-7345	National Natural Science Foundation of China [31160339]; Natural Science Foundation of Hainan province [20163042]; Scientific Research Foundation of Hainan University [KYQD1548]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hainan province; Scientific Research Foundation of Hainan University	This research was supported by the National Natural Science Foundation of China (no. 31160339), Natural Science Foundation of Hainan province (no. 20163042) and Scientific Research Foundation of Hainan University (no. KYQD1548).	Abbasi BH, 2016, TOXICOL IND HEALTH, V32, P98, DOI 10.1177/0748233713498450; Ahn J, 2014, J FOOD PROTECT, V77, P948, DOI 10.4315/0362-028X.JFP-13-535; Birch L, 1996, FRESEN J ANAL CHEM, V354, P760; BRUHLMANN F, 1995, APPL ENVIRON MICROB, V61, P3580; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chiriac AP, 2013, INT J PHARMACEUT, V456, P21, DOI 10.1016/j.ijpharm.2013.07.073; Clements GR, 2012, INTEGR ZOOL, V7, P400, DOI 10.1111/j.1749-4877.2012.00314.x; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cruz P, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0071-1; Dailey R, 2013, CHEMOSPHERE, V93, P1023, DOI 10.1016/j.chemosphere.2013.05.072; Darshan S, 2004, PHYTOTHER RES, V18, P343, DOI 10.1002/ptr.1475; Delcourt A, 1994, Boll Chim Farm, V133, P235; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Felsberg J, 2014, J APPL MICROBIOL, V117, P1328, DOI 10.1111/jam.12610; Guo M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0512-7; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hall MB, 2016, J DAIRY SCI, V99, P245, DOI 10.3168/jds.2015-10417; Hector RE, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-84; Hu J, 2013, PHYTOPATHOLOGY, V103, P920, DOI 10.1094/PHYTO-01-13-0016-R; Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001; Kunioka M, 2009, INT J MOL SCI, V10, P4267, DOI 10.3390/ijms10104267; Lai LH, 2012, ACTA PHARMACOL SIN, V33, P523, DOI 10.1038/aps.2011.209; Le Roes-Hill M, 2011, ANTON LEEUW INT J G, V100, P589, DOI 10.1007/s10482-011-9614-x; Liu Y, 2014, LIFE SCI, V94, P99, DOI 10.1016/j.lfs.2013.10.024; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Toledo-Martin EM, 2016, J SCI FOOD AGR, V96, P3114, DOI 10.1002/jsfa.7488; McGregor N, 2016, J BIOL CHEM, V291, P1175, DOI 10.1074/jbc.M115.691659; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Nathani NM, 2015, J MOL MICROB BIOTECH, V25, P292, DOI 10.1159/000437265; Navickiene HMD, 2000, PHYTOCHEMISTRY, V55, P621, DOI 10.1016/S0031-9422(00)00226-0; Ozler A, 2008, PREP BIOCHEM BIOTECH, V38, P358, DOI 10.1080/10826060802325469; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ricke SC, 1996, CRIT REV MICROBIOL, V22, P27, DOI 10.3109/10408419609106455; Tanaka S, 2009, FEMS IMMUNOL MED MIC, V56, P80, DOI 10.1111/j.1574-695X.2009.00553.x; Ueki A, 2007, INT J SYST EVOL MICR, V57, P1803, DOI 10.1099/ijs.0.64914-0; Vinod V, 2014, J APPL MICROBIOL, V116, P890, DOI 10.1111/jam.12431; Zhang J, 2015, ISME J, V9, P1979, DOI 10.1038/ismej.2015.11	40	0	0	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165206	10.1371/journal.pone.0165206	http://dx.doi.org/10.1371/journal.pone.0165206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768750	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400067
J	Bogner, DM; Kaemingk, MA; Wuellner, MR				Bogner, David M.; Kaemingk, Mark A.; Wuellner, Melissa R.			Consequences of Hatch Phenology on Stages of Fish Recruitment	PLOS ONE			English	Article							PERCH PERCA-FLAVESCENS; BLUEGILL LEPOMIS-MACROCHIRUS; LARVAL YELLOW PERCH; EARLY-LIFE-HISTORY; CLIMATE-CHANGE; TEMPORAL DIMENSION; GREAT-PLAINS; GROWTH; MORTALITY; SIZE	Little is known about how hatch phenology (e.g., the start, peak, and duration of hatching) could influence subsequent recruitment of freshwater fishes into a population. We used two commonly sympatric fish species that exhibit different hatching phenologies to examine recruitment across multiple life stages. Nine yellow perch (Perca flavescens) and bluegill (Lepomis macrochirus) annual cohorts were sampled from 2004 through 2013 across larval, age-0, age-1, and age-2 life stages in a Nebraska (U.S.A.) Sandhill lake. Yellow perch hatched earlier in the season and displayed a more truncated hatch duration compared to bluegill. The timing of hatch influenced recruitment dynamics for both species but important hatching metrics were not similar between species across life stages. A longer hatch duration resulted in greater larval yellow perch abundance but greater age-1 bluegill abundance. In contrast, bluegill larval and age-0 abundances were greater during years when hatching duration was shorter and commenced earlier, whereas age-0 yellow perch abundance was greater when hatching occurred earlier. As a result of hatch phenology, yellow perch recruitment variability was minimized sooner (age-0 life stage) than bluegill (age-1 life stage). Collectively, hatch phenology influenced recruitment dynamics across multiple life stages but was unique for each species. Understanding the complexities of when progeny enter an environment and how this influences eventual recruitment into a population will be critical in the face of ongoing climate change.	[Bogner, David M.] Illinois Nat Hist Survey, Kaskaskia Biol Stn, Sullivan, IL 61951 USA; [Kaemingk, Mark A.] Univ Nebraska, Sch Nat Resources, Lincoln, NE 68583 USA; [Wuellner, Melissa R.] South Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA	Illinois Natural History Survey; University of Nebraska System; University of Nebraska Lincoln; South Dakota State University	Kaemingk, MA (corresponding author), Univ Nebraska, Sch Nat Resources, Lincoln, NE 68583 USA.	mkaemingk2@unl.edu	Kaemingk, Mark/Q-2191-2019	Kaemingk, Mark/0000-0001-9588-4563	Nebraska Game and Parks Commission through the Federal Aid in Sport Fish Restoration Project [F-118-R]	Nebraska Game and Parks Commission through the Federal Aid in Sport Fish Restoration Project	Funding for this project was provided by the Nebraska Game and Parks Commission through the Federal Aid in Sport Fish Restoration Project F-118-R. The funders had a limited role in study design but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Marcy R., 1998, North American Journal of Fisheries Management, V18, P989, DOI 10.1577/1548-8675(1998)018<0989:RBLAJY>2.0.CO;2; Auer N.A., 1982, IDENTIFICATION LARVA, V82, P471; Beverton RJ, 2012, DYNAMICS EXPLOITED F, V11th; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Brown ML, 2002, FISHERIES MANAG ECOL, V9, P225, DOI 10.1046/j.1365-2400.2002.00299.x; Burnham K P, 2003, MODEL SELECT MULTIMO; Cargnelli LM, 1996, CAN J FISH AQUAT SCI, V53, P360, DOI 10.1139/cjfas-53-2-360; Chambers R.C., 2012, EARLY LIFE HIST RECR; Clapp DF, 2004, FISHERIES, V29, P11, DOI 10.1577/1548-8446(2004)29[11:YPRAMI]2.0.CO;2; Cushing D.H, 1975, CUP Archive; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; DeBoer JA, 2013, ECOL FRESHW FISH, V22, P43, DOI 10.1111/eff.12000; Dembkowski DJ, 2016, CAN J FISH AQUAT SCI, V73, P1567, DOI 10.1139/cjfas-2015-0310; Divino JN, 2007, ECOL FRESHW FISH, V16, P165, DOI 10.1111/j.1600-0633.2006.00208.x; Doi H, 2008, BIOL LETTERS, V4, P388, DOI 10.1098/rsbl.2008.0234; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Falke JA, 2010, CAN J FISH AQUAT SCI, V67, P1942, DOI 10.1139/F10-109; Garvey JE, 2002, ECOL APPL, V12, P194, DOI 10.1890/1051-0761(2002)012[0194:PRISTT]2.0.CO;2; HILBORN R, 1992; Hjort J., 1914, P RAPPORTS PROCRS VE; Holland-Bartels L.E., 1990, GUIDE LARVAL FISHES; Honsey AE, 2016, FISH RES, V181, P214, DOI 10.1016/j.fishres.2016.04.021; Houde E.D., 1987, FISH EARLY LIFE DYNA; Houde ED, 1997, J FISH BIOL, V51, P52, DOI 10.1111/j.1095-8649.1997.tb06093.x; Houde Edward D., 2009, Journal of Northwest Atlantic Fishery Science, V41, P53; Isermann DA, 2008, FISHERIES MANAG ECOL, V15, P259, DOI 10.1111/j.1365-2400.2008.00610.x; Jolley Jeffrey C., 2013, Open Fish Science Journal, V6, P58; Jolley JC, 2009, J FRESHWATER ECOL, V24, P29, DOI 10.1080/02705060.2009.9664262; Kaemingk MA, 2011, J FISH BIOL, V78, P1132, DOI 10.1111/j.1095-8649.2011.02924.x; Kaemingk MA, 2014, T AM FISH SOC, V143, P845, DOI 10.1080/00028487.2014.886622; Kaemingk MA, 2014, CAN J FISH AQUAT SCI, V71, P93, DOI 10.1139/cjfas-2013-0282; Kaemingk MA, 2012, AQUAT ECOL, V46, P353, DOI 10.1007/s10452-012-9406-z; Kaemingk MA, 2012, FRESHWATER BIOL, V57, P654, DOI 10.1111/j.1365-2427.2011.02728.x; Koenig WD, 2002, ECOGRAPHY, V25, P283, DOI 10.1034/j.1600-0587.2002.250304.x; Ludsin SA, 1997, ECOL APPL, V7, P1024; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; NIELSEN LA, 1980, CAN J FISH AQUAT SCI, V37, P11, DOI 10.1139/f80-002; Pankhurst NW, 2011, MAR FRESHWATER RES, V62, P1015, DOI 10.1071/MF10269; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Paukert CP, 2002, N AM J FISH MANAGE, V22, P1306, DOI 10.1577/1548-8675(2002)022<1306:EAAOBL>2.0.CO;2; Quinn TP, 2000, EVOLUTION, V54, P1372, DOI 10.1111/j.0014-3820.2000.tb00569.x; Quist MC, 2007, N AM J FISH MANAGE, V27, P30, DOI 10.1577/M06-100.1; RICE JA, 1993, CAN J FISH AQUAT SCI, V50, P133, DOI 10.1139/f93-015; Sammons Steve M., 1998, North American Journal of Fisheries Management, V18, P137, DOI 10.1577/1548-8675(1998)018<0137:LSAAFM>2.0.CO;2; Santucci VJ, 2003, T AM FISH SOC, V132, P346, DOI 10.1577/1548-8659(2003)132<0346:TEOGPA>2.0.CO;2; Shima JS, 2010, J ANIM ECOL, V79, P1308, DOI 10.1111/j.1365-2656.2010.01733.x; Shima JS, 2009, ECOLOGY, V90, P1255, DOI 10.1890/08-0029.1; Sogard SM, 1997, B MAR SCI, V60, P1129; Todd BD, 2010, P ROY SOC LOND B BIO; Tomcko CM, 2005, N AM J FISH MANAGE, V25, P171, DOI 10.1577/M04-054.1; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; WHITESIDE MC, 1985, ENVIRON BIOL FISH, V12, P47, DOI 10.1007/BF00007709; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055; Wright PJ, 1996, MAR BIOL, V126, P143, DOI 10.1007/BF00571386	56	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164980	10.1371/journal.pone.0164980	http://dx.doi.org/10.1371/journal.pone.0164980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764216	Green Published, gold			2022-12-26	WOS:000386204500092
J	Mayaphi, SH; Martin, DJ; Quinn, TC; Laeyendecker, O; Olorunju, SAS; Tintinger, GR; Stoltz, AC				Mayaphi, Simnikiwe H.; Martin, Desmond J.; Quinn, Thomas C.; Laeyendecker, Oliver; Olorunju, Steve A. S.; Tintinger, Gregory R.; Stoltz, Anton C.			Detection of Acute and Early HIV-1 Infections in an HIV Hyper-Endemic Area with Limited Resources	PLOS ONE			English	Article							CIRCULATING IMMUNE-COMPLEXES; MOTHER-TO-CHILD; SOUTH-AFRICA; PREGNANT-WOMEN; VIRAL-LOAD; TRANSMISSION; ASSAY; CARE; SENSITIVITY; DIAGNOSIS	Background Two thirds of the world's new HIV infections are in sub-Saharan Africa. Acute HIV infection (AHI) is the time of virus acquisition until the appearance of HIV antibodies. Early HIV infection, which includes AHI, is the interval between virus acquisition and establishment of viral load set-point. This study aimed to detect acute and early HIV infections in a hyper-endemic setting. Methods This was a cross-sectional diagnostic study that enrolled individuals who had negative rapid HIV results in five clinics in South Africa. Pooled nucleic acid amplification testing (NAAT) was performed, followed by individual sample testing in positive pools. NAAT-positive participants were recalled to the clinics for confirmatory testing and appropriate management. HIV antibody, p24 antigen, Western Blot and avidity tests were performed for characterization of NAAT-positive samples. Results The study enrolled 6910 individuals with negative rapid HIV results. Median age was 27 years (interquartile range {IQR}: 23-31). NAAT was positive in 55 samples, resulting in 0.8% newly diagnosed HIV-infected individuals (95% confidence interval {CI}: 0.6-1.0). The negative predictive value for rapid HIV testing was 99.2% (95% CI: 99.0-99.4). Characterization of NAAT-positive samples revealed that 0.04% (95% CI: 0.000-0.001) had AHI, 0.3% (95% CI: 0.1-0.4) had early HIV infection, and 0.5% (95% CI: 0.5-0.7) had chronic HIV infection. Forty-seven (86%) of NAAT-positive participants returned for follow-up at a median of 4 weeks (IQR: 2-8). Follow-up rapid tests were positive in 96% of these participants. Conclusions NAAT demonstrated that a substantial number of HIV-infected individuals are misdiagnosed at South African points-of-care. Follow-up rapid tests done within a 4 week interval detected early and chronic HIV infections initially missed by rapid HIV testing. This may be a practical and affordable strategy for earlier detection of these infections in resource-constrained settings. Newer molecular tests that can be used at the points-of-care should be evaluated for routine diagnosis of HIV in hyper-endemic settings.	[Mayaphi, Simnikiwe H.; Martin, Desmond J.] Univ Pretoria, Dept Med Virol, City Of Tshwane, South Africa; [Mayaphi, Simnikiwe H.] Natl Hlth Lab Serv, Tshwane Acad Div NHLS TAD, City Of Tshwane, South Africa; [Martin, Desmond J.] Toga Labs, Johannesburg, South Africa; [Quinn, Thomas C.; Laeyendecker, Oliver] NIAID, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Quinn, Thomas C.; Laeyendecker, Oliver] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Olorunju, Steve A. S.] MRC, Biostat Unit, City Of Tshwane, South Africa; [Tintinger, Gregory R.; Stoltz, Anton C.] Univ Pretoria, Dept Internal Med, City Of Tshwane, South Africa	University of Pretoria; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; University of Pretoria	Mayaphi, SH (corresponding author), Univ Pretoria, Dept Med Virol, City Of Tshwane, South Africa.; Mayaphi, SH (corresponding author), Natl Hlth Lab Serv, Tshwane Acad Div NHLS TAD, City Of Tshwane, South Africa.	sim.mayaphi@up.ac.za		Mayaphi, Simnikiwe/0000-0002-5453-4353; Laeyendecker, Oliver/0000-0002-6429-4760	National Health Laboratory Service Research Trust (NHLS-RT); Federation of Infectious Diseases Societies of Southern Africa and GlaxoSmithKline (FIDSSA-GSK); University of Pretoria research; South African Medical Research Council Self Initiated Research (MRC-SIR); Toga Laboratories; GlaxoSmithKline; National Institute for Communicable Diseases (NICD) HIV Sero-Molecular Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361] Funding Source: NIH RePORTER	National Health Laboratory Service Research Trust (NHLS-RT); Federation of Infectious Diseases Societies of Southern Africa and GlaxoSmithKline (FIDSSA-GSK); University of Pretoria research; South African Medical Research Council Self Initiated Research (MRC-SIR); Toga Laboratories; GlaxoSmithKline(GlaxoSmithKline); National Institute for Communicable Diseases (NICD) HIV Sero-Molecular Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	1. National Health Laboratory Service Research Trust (NHLS-RT) grant (www.nhls.ac.za), SHM and DJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2. Federation of Infectious Diseases Societies of Southern Africa and GlaxoSmithKline (FIDSSA-GSK) grant (www.fidssa.co.za), SHM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 3. University of Pretoria research assistant grant (www.up.ac.za), SHM. The funders had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript. 4. South African Medical Research Council Self Initiated Research (MRC-SIR) grant (www.mrc.ac.za), SHM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 5. Discovery Foundation (www.tshikululu.org.za), SHM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 6. Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (www.nih.gov), TCQ and OL; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. DJM is an employee of a commercial company, Toga Laboratories. The Toga Laboratories provided support in the form of salaries for [DJM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. SHM received are search grant from a commercial funder, GlaxoSmithKline. GlaxoSmithKline did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all the funders for supporting this study, all study participants, National Institute for Communicable Diseases (NICD) HIV Sero-Molecular Laboratory staff for assisting with 3rd generation HIV ELISA and limiting antigen avidity testing, and special thanks to our research assistants for recruiting and enrolling study participants.	Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec; [Anonymous], 2010, S AFR PMTCT GUID CLI; [Anonymous], 2007, WHO HIV TEST GUID GU; [Anonymous], 2014, MIDWIFERY, V30; [Anonymous], 2015, WHO HIV TEST GUID CO; [Anonymous], 2010, S AFR ART GUID CLIN; [Anonymous], 2015, S AFR ART GUID NAT C; [Anonymous], 2010, THE NATIONAL HIV COU; [Anonymous], 2012, BOTSW NAT HIV AIDS T; [Anonymous], 2013, S AFR ART GUID S AFR; Bailey GP, 2010, J INFECT DIS, V201, P1811, DOI 10.1086/652785; Bassett IV, 2011, HIV MED, V12, P46, DOI 10.1111/j.1468-1293.2010.00850.x; Bekker LG, 2014, ANTIVIR THER, V19, P105, DOI 10.3851/IMP2905; Black V, 2009, BJOG-INT J OBSTET GY, V116, P1805, DOI 10.1111/j.1471-0528.2009.02357.x; Branson BM, 2010, JAIDS-J ACQ IMM DEF, V55, pS102, DOI 10.1097/QAI.0b013e3181fbca44; Brauer M, 2013, J VIROL METHODS, V189, P180, DOI 10.1016/j.jviromet.2013.01.017; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Emerson B, 2013, J CLIN VIROL, V58, pE48, DOI 10.1016/j.jcv.2013.08.005; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Galiwango RM, 2013, J VIROL METHODS, V192, P25, DOI 10.1016/j.jviromet.2013.04.003; Goga AE, 2015, J EPIDEMIOL COMMUN H, V69, P240, DOI 10.1136/jech-2014-204535; Kassutto S, 2004, CLIN INFECT DIS, V38, P1452, DOI 10.1086/420745; KESTENS L, 1991, J VIROL METHODS, V31, P67, DOI 10.1016/0166-0934(91)90145-P; Kharsany ABM, 2010, HIV MED, V11, P661, DOI 10.1111/j.1468-1293.2010.00838.x; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Luzuriaga K, 2016, NEW ENGL J MED, V374, P761, DOI 10.1056/NEJMra1505256; Martin EG, 2011, J CLIN VIROL, V52, pS11, DOI 10.1016/j.jcv.2011.09.014; Mlisana K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062928; Moshgabadi N, 2015, J CLIN VIROL, V71, P67, DOI 10.1016/j.jcv.2015.08.005; Pavie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011581; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Riolexus AA., 2014, ATIC NEWSLETTER, V11, P1; Ritchie AV, 2014, J CLIN MICROBIOL, V52, P3377, DOI 10.1128/JCM.00593-14; Sanders EJ, 2014, AIDS, V28, P1357, DOI 10.1097/QAD.0000000000000245; Serna-Bolea C, 2010, AIDS, V24, P603, DOI 10.1097/QAD.0b013e328335cda3; Setty MKHG, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/497046; Shisana O, 2014, S AFRICAN NATL HIV P; Stanojevic M, 1996, BIOMED PHARMACOTHER, V50, P488, DOI 10.1016/S0753-3322(97)89279-7; Strode A, 2010, SAMJ S AFR MED J, V100, P247, DOI 10.7196/SAMJ.3609; Taha TE, 2011, AIDS, V25, P1357, DOI 10.1097/QAD.0b013e3283489d45; Viani RM, 2013, AIDS RES HUM RETROV, V29, P429, DOI [10.1089/aid.2012.0190, 10.1089/AID.2012.0190]; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wilkinson D, 1997, AIDS, V11, P377, DOI 10.1097/00002030-199703110-00016; Wolpaw BJ, 2011, SEX TRANSM INFECT, V87, P71, DOI 10.1136/sti.2009.041475	46	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164943	10.1371/journal.pone.0164943	http://dx.doi.org/10.1371/journal.pone.0164943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764165	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500082
J	Zeng, Z; Yu, R; Zuo, FL; Zhang, B; Peng, DJ; Ma, HQ; Chen, SW				Zeng, Zhu; Yu, Rui; Zuo, Fanglei; Zhang, Bo; Peng, Deju; Ma, Huiqin; Chen, Shangwu			Heterologous Expression and Delivery of Biologically Active Exendin-4 by Lactobacillus paracasei L14	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; LACTIC-ACID BACTERIA; ORAL DELIVERY; GLYCEMIC CONTROL; INSULIN SENSITIVITY; EXENATIDE EXENDIN-4; RECEPTOR AGONISTS; DRUG ABSORPTION; PROTEIN; GLUCOSE	Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, is an excellent therapeutic peptide drug for type 2 diabetes due to longer lasting biological activity compared to GLP-1. This study explored the feasibility of using probiotic Lactobacillus paracasei as an oral vector for recombinant exendin-4 peptide delivery, an alternative to costly chemical synthesis and inconvenient administration by injection. L. paracasei transformed with a plasmid encoding the exendin-4 gene (L. paracasei L14/pMG76e-exendin-4) with a constitutive promotor was successfully constructed and showed efficient secretion of exendin-4. The secreted exendin-4 significantly enhanced insulin secretion of INS-1 beta-cells, along with an increment in their proliferation and inhibition of their apoptosis, corresponding to the effect of GLP-1 on these cells. The transcription level of the pancreatic duodenal homeobox-1 gene (PDX-1), a key transcription factor for cellular insulin synthesis and secretion, was upregulated by the treatment with secreted exendin-4, paralleling the upregulation of insulin gene expression. Caco-2 cell monolayer permeability assay showed a 34-fold increase in the transport of exendin-4 delivered by L. paracasei vs. that of free exendin-4 (control), suggesting effective facilitation of exendin-4 transport across the intestinal barrier by this delivery system. This study demonstrates that the probiotic Lactobacillus can be engineered to secrete bioactive exendin-4 and facilitate its transport through the intestinal barrier, providing a novel strategy for oral exendin-4 delivery using this lactic acid bacterium.	[Zeng, Zhu; Yu, Rui; Zhang, Bo; Chen, Shangwu] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing, Peoples R China; [Zeng, Zhu; Yu, Rui; Zuo, Fanglei; Zhang, Bo; Chen, Shangwu] China Agr Univ, Dept Food Sci & Engn, Coll Food Sci & Nutr Engn, Key Lab Funct Dairy, Beijing, Peoples R China; [Peng, Deju] Yangling St Agcy, Yangling Zhongyang Joint Ranch Co Ltd, Beiyang Breeding Area, Xian, Peoples R China; [Ma, Huiqin] China Agr Univ, Coll Agr & Biotechnol, Beijing, Peoples R China	China Agricultural University; China Agricultural University; China Agricultural University	Chen, SW (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing, Peoples R China.; Chen, SW (corresponding author), China Agr Univ, Dept Food Sci & Engn, Coll Food Sci & Nutr Engn, Key Lab Funct Dairy, Beijing, Peoples R China.	swchen@cau.edu.cn	Zuo, Fanglei/Z-4079-2019	Zuo, Fanglei/0000-0002-4545-1265	National Science and Technology Support Program of the People's Republic of China [2011BAD09B03]	National Science and Technology Support Program of the People's Republic of China	This work was supported by the National Science and Technology Support Program of the People's Republic of China (2011BAD09B03). The funder Yangling Zhongyang Joint Ranch Co., Ltd. provided study materials forus, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Agarwal P, 2014, PHARM RES-DORDR, V31, P3404, DOI 10.1007/s11095-014-1430-3; [Anonymous], 2015, J MICROBIOL BIOTECHN, DOI DOI 10.4014/JMB.1412.12030; [Anonymous], 2014, BYD EX EXT REL INJ S; Baboota RK, 2013, J FUNCT FOODS, V5, P997, DOI 10.1016/j.jff.2013.04.014; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Bouttefeux O, 2016, CURR PHARM DESIGN, V22, P1161, DOI 10.2174/1381612822666151216150238; Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cano-Garrido O, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0313-6; Castro PM, 2015, J CONTROL RELEASE, V211, P63, DOI 10.1016/j.jconrel.2015.05.258; Charman WN, 1997, J PHARM SCI-US, V86, P269, DOI 10.1021/js960085v; Chepurny OG, 2002, ENDOCRINOLOGY, V143, P2303, DOI 10.1210/en.143.6.2303; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Drucker DJ, 1998, DIABETES, V47, P159, DOI 10.2337/diabetes.47.2.159; Duan FF, 2015, DIABETES, V64, P1794, DOI 10.2337/db14-0635; Edwards CMB, 2001, AM J PHYSIOL-ENDOC M, V281, pE155, DOI 10.1152/ajpendo.2001.281.1.E155; ENG J, 1992, J BIOL CHEM, V267, P7402; Fonte P, 2015, BIOTECHNOL ADV, V33, P1342, DOI 10.1016/j.biotechadv.2015.02.010; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Gupta V, 2016, ANN BIOMED ENG, V44, P1993, DOI 10.1007/s10439-016-1558-x; Habener JF, 1998, P ASSOC AM PHYSICIAN, V110, P12; Hartstra AV, 2015, DIABETES CARE, V38, P159, DOI 10.2337/dc14-0769; Hirayama K, 1999, ANTON LEEUW INT J G, V76, P391; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Holst JJ, 1998, DIABETES, V47, P1663, DOI 10.2337/diabetes.47.11.1663; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Kaushal G, 2006, INT J PHARMACEUT, V313, P29, DOI 10.1016/j.ijpharm.2006.01.013; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Khokhlova EV, 2010, ARCH MICROBIOL, V192, P769, DOI 10.1007/s00203-010-0606-4; Le Loir Y, 2001, APPL ENVIRON MICROB, V67, P4119, DOI 10.1128/AEM.67.9.4119-4127.2001; Lopes M, 2015, THER DELIV, V6, P973, DOI 10.4155/TDE.15.47; Ma YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105701; Mest HJ, 2005, DIABETOLOGIA, V48, P616, DOI 10.1007/s00125-005-1707-5; Miyoshi M, 2014, EUR J NUTR, V53, P599, DOI 10.1007/s00394-013-0568-9; Nami Y, 2014, ANAEROBE, V28, P29, DOI 10.1016/j.anaerobe.2014.04.012; Nauck MA, 1996, DIABETOLOGIA, V39, P1546, DOI 10.1007/s001250050613; Neumiller JJ, 2015, MED CLIN N AM, V99, P107, DOI 10.1016/j.mcna.2014.08.013; Ng DTW, 2011, BIOTECHNOL BIOENG, V108, P1987, DOI 10.1002/bit.23130; Ouwehand AC, 1999, INT DAIRY J, V9, P623, DOI 10.1016/S0958-6946(99)00132-6; PINTO M, 1983, BIOL CELL, V47, P323; Rekha MR, 2013, INT J PHARMACEUT, V440, P48, DOI 10.1016/j.ijpharm.2012.03.056; Robert S, 2014, DIABETES, V63, P2876, DOI 10.2337/db13-1236; Sanchez-Navarro M, 2016, ADV DRUG DELIV REV; Sarkar G, 2014, DIABETES CARE, V37, P666, DOI 10.2337/dc13-1473; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schotte L, 2000, ENZYME MICROB TECH, V27, P761, DOI 10.1016/S0141-0229(00)00297-0; Shaji J, 2008, INDIAN J PHARM SCI, V70, P269, DOI 10.4103/0250-474X.42967; Shao J, 2004, INT J PHARMACEUT, V286, P117, DOI 10.1016/j.ijpharm.2004.08.004; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Thum A, 2002, EXP CLIN ENDOCR DIAB, V110, P113, DOI 10.1055/s-2002-29087; Thuret G, 2003, BRIT J OPHTHALMOL, V87, P346, DOI 10.1136/bjo.87.3.346; VANDEGUCHTE M, 1989, APPL ENVIRON MICROB, V55, P224, DOI 10.1128/AEM.55.1.224-228.1989; Verspohl EJ, 2009, PHARMACOL THERAPEUT, V124, P113, DOI 10.1016/j.pharmthera.2009.06.002; Wang M, 2016, APPL MICROBIOL BIOT, V100, P5691, DOI 10.1007/s00253-016-7557-x; Wang Q, 2004, DIABETOLOGIA, V47, P478, DOI 10.1007/s00125-004-1327-5; Wang XL, 2001, ENDOCRINOLOGY, V142, P1820, DOI 10.1210/en.142.5.1820; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Willms B, 1996, J CLIN ENDOCR METAB, V81, P327, DOI 10.1210/jc.81.1.327; Wyszynska A, 2015, APPL MICROBIOL BIOT, V99, P2967, DOI [10.1007/s00253-015-6498-0, 10.1007/s00253-015-6569-2]; Xu G, 2006, DIABETES RES CLIN PR, V73, P107, DOI 10.1016/j.diabres.2005.11.007; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7; Zeng Z, 2016, J FUNCT FOODS, V20, P486, DOI 10.1016/j.jff.2015.11.030; Zhang B, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0506-7	65	10	10	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165130	10.1371/journal.pone.0165130	http://dx.doi.org/10.1371/journal.pone.0165130			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764251	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500121
J	Bertrand, YJK; Johansson, M; Norberg, P				Bertrand, Yann J. K.; Johansson, Magnus; Norberg, Peter			Revisiting Recombination Signal in the Tick-Borne Encephalitis Virus: A Simulation Approach	PLOS ONE			English	Article							DETECTING RECOMBINATION; EVOLUTION; FLAVIVIRUSES; DISPERSAL; MODEL	The hypothesis of wide spread reticulate evolution in Tick-Borne Encephalitis virus (TBEV) has recently gained momentum with several publications describing past recombination events involving various TBEV clades. Despite a large body of work, no consensus has yet emerged on TBEV evolutionary dynamics. Understanding the occurrence and frequency of recombination in TBEV bears significant impact on epidemiology, evolution, and vaccination with live vaccines. In this study, we investigated the possibility of detecting recombination events in TBEV by simulating recombinations at several locations on the virus' phylogenetic tree and for different lengths of recombining fragments. We derived estimations of rates of true and false positive for the detection of past recombination events for seven recombination detection algorithms. Our analytical framework can be applied to any investigation dealing with the difficult task of distinguishing genuine recombination signal from background noise. Our results suggest that the problem of false positives associated with low detection P-values in TBEV, is more insidious than generally acknowledged. We reappraised the recombination signals present in the empirical data, and showed that reliable signals could only be obtained in a few cases when highly genetically divergent strains were involved, whereas false positives were common among genetically similar strains. We thus conclude that recombination among wild-type TBEV strains may occur, which has potential implications for vaccination with live vaccines, but that these events are surprisingly rare.	[Bertrand, Yann J. K.] Sci & Hist Invest Evolut Lab Duba, Duba, Czech Republic; [Johansson, Magnus] Univ Orebro, Sch Med Sci, Orebro, Sweden; [Johansson, Magnus] Sodertorn Univ, Sch Nat Sci Technol & Environm Studies, Huddinge, Sweden; [Johansson, Magnus] Univ Orebro, Fac Med & Hlth, IRiSC, Orebro, Sweden; [Norberg, Peter] Sahlgrenska Univ, Dept Clin Microbiol, Gothenburg, Sweden	Orebro University; Sodertorn University; Orebro University	Bertrand, YJK (corresponding author), Sci & Hist Invest Evolut Lab Duba, Duba, Czech Republic.	yjk_bertrand@ybertrand.org	Bertrand, Yann/R-5850-2018	Bertrand, Yann/0000-0001-6593-6959	Foundation for Baltic and East European Studies [1330/42/2010]; Knowledge Foundation [20150201]	Foundation for Baltic and East European Studies; Knowledge Foundation	This work was supported by grants to M. J. by The Foundation for Baltic and East European Studies (Dnr 1330/42/2010) and The Knowledge Foundation (Dnr 20150201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aaskov J, 2007, J GEN VIROL, V88, P3334, DOI 10.1099/vir.0.83122-0; AbuBakar S, 2002, J GEN VIROL, V83, P2437, DOI 10.1099/0022-1317-83-10-2437; [Anonymous], 2014, TRACER V1 6; Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498; Baele G, 2013, BIOINFORMATICS, V29, P1970, DOI 10.1093/bioinformatics/btt340; Baillie GJ, 2008, MOL PHYLOGENET EVOL, V47, P717, DOI 10.1016/j.ympev.2008.02.015; Bertrand Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031981; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chan CX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-412; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Craig S, 2003, J VIROL, V77, P4463, DOI 10.1128/JVI.77.7.4463-4467.2003; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179; EDWARDS AWF, 1994, BIOL REV, V69, P443, DOI 10.1111/j.1469-185X.1994.tb01247.x; Fajs L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048420; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; FELSENSTEIN J, 1976, GENETICS, V83, P845; Fisher RA, 1930, GENETICAL THEORY NAT; Gao GF, 1997, ACTA VIROL, V41, P259; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Golovljova I, 2004, J MED VIROL, V74, P580, DOI 10.1002/jmv.20224; Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686; Gould EA, 2004, ARCH VIROL, P65; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heinze DM, 2012, J VIROL, V86, P8663, DOI 10.1128/JVI.01013-12; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keightley PD, 2006, NATURE, V443, P89, DOI 10.1038/nature05049; Kovalev SY, 2009, J GEN VIROL, V90, P2884, DOI 10.1099/vir.0.012419-0; MARIN MS, 1995, RES VET SCI, V58, P11, DOI 10.1016/0034-5288(95)90081-0; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; May FJ, 2008, J GEN VIROL, V89, P1901, DOI 10.1099/vir.0.2008/000190-0; McGuire K, 1998, J GEN VIROL, V79, P981, DOI 10.1099/0022-1317-79-5-981; Norberg P, 2013, VIROLOGY, V440, P105, DOI 10.1016/j.virol.2013.02.017; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pickett BE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-165; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SMITH JM, 1992, J MOL EVOL, V34, P126; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Twiddy SS, 2003, J GEN VIROL, V84, P429, DOI 10.1099/vir.0.18660-0; Uzcategui NY, 2012, J GEN VIROL, V93, P786, DOI 10.1099/vir.0.035766-0; Weidmann M, 2011, J GEN VIROL, V92, P1906, DOI 10.1099/vir.0.032417-0; Weidmann M, 2013, J GEN VIROL, V94, P2129, DOI 10.1099/vir.0.054478-0; Yun SM, 2011, VIRUS GENES, V42, P307, DOI 10.1007/s11262-011-0575-y; ZANOTTO PMD, 1995, VIROLOGY, V210, P152, DOI 10.1006/viro.1995.1326; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548	57	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164435	10.1371/journal.pone.0164435	http://dx.doi.org/10.1371/journal.pone.0164435			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760182	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204000036
J	Hertlein, G; Seiffert, M; Gensel, S; Garcia-Gonzalez, E; Ebeling, J; Skobalj, R; Kuthning, A; Sussmuth, RD; Genersch, E				Hertlein, Gillian; Seiffert, Marlene; Gensel, Sebastian; Garcia-Gonzalez, Eva; Ebeling, Julia; Skobalj, Ranko; Kuthning, Anja; Suessmuth, Roderich D.; Genersch, Elke			Biological Role of Paenilarvins, Iturin-Like Lipopeptide Secondary Metabolites Produced by the Honey Bee Pathogen Paenibacillus larvae	PLOS ONE			English	Article							AMERICAN FOULBROOD; ETIOLOGIC AGENT; CAUSATIVE AGENT; SUBSP LARVAE; BACTERIAL PATHOGEN; BACILLUS-LARVAE; APIS-MELLIFERA; VIRULENCE; GENOTYPES; RECLASSIFICATION	The Gram-positive bacterium Paenibacillus larvae (P. larvae) is the causative agent of a deadly honey bee brood disease called American Foulbrood (AFB). AFB is a notifiable epizootic in most countries and, hence, P. larvae is of considerable relevance for veterinarians and apiculturists alike. Over the last decade, much progress has been made in the understanding of the (patho)biology of P. larvae. Recently, several non-ribosomally produced peptides (NRP) and peptide/polyketide (NRP/PK) hybrids produced by P. larvae were identified. Among these NRPs were iturin-like lipopeptides, the paenilarvins A-C. Iturins are known to exhibit strong anti-fungal activity; for some iturins, cytotoxic activity towards mammalian erythrocytes and human cancer cell lines are described. We here present our results on the analysis of the natural function of the paenilarvins during pathogenesis of P. larvae infections. We demonstrated production of paenilarvins in infected larvae. However, we could neither demonstrate cytotoxicity of paenilarvins towards cultured insect cells nor towards larvae in feeding assays. Accordingly, exposure bioassays performed with larvae infected by wild-type P. larvae and a knockout mutant of P. larvae lacking production of paenilarvins did not substantiate a role for the paenilarvins as virulence factor. Further experiments are necessary to analyze the relevance of the paenilarvins' anti-fungal activity for P. larvae infections in the presence of fungal competitors in the larval midgut or cadaver.	[Hertlein, Gillian; Seiffert, Marlene; Garcia-Gonzalez, Eva; Ebeling, Julia; Genersch, Elke] Inst Bee Res, Dept Mol Microbiol & Bee Dis, Hohen Neuendorf, Germany; [Gensel, Sebastian; Skobalj, Ranko; Kuthning, Anja; Suessmuth, Roderich D.] Tech Univ Berlin, Inst Chem, Berlin, Germany; [Genersch, Elke] Free Univ Berlin, Inst Mikrobiol & Tierseuchen, Fachbereich Vet Med, Berlin, Germany	Technical University of Berlin; Free University of Berlin	Genersch, E (corresponding author), Inst Bee Res, Dept Mol Microbiol & Bee Dis, Hohen Neuendorf, Germany.; Genersch, E (corresponding author), Free Univ Berlin, Inst Mikrobiol & Tierseuchen, Fachbereich Vet Med, Berlin, Germany.	elke.genersch@fu-berlin.de	Ebeling, Julia/AAG-4931-2021	Ebeling, Julia/0000-0001-6575-7803; Sussmuth, Roderich/0000-0001-7027-2069; Genersch, Elke/0000-0001-7906-4530	Ministry for Agriculture from Brandenburg, Germany; German Research Foundation [1121, GE 1365/1-2, SU 239/21-1]; Ministry for Agriculture from Sachsen-Anhalt, Germany	Ministry for Agriculture from Brandenburg, Germany; German Research Foundation(German Research Foundation (DFG)); Ministry for Agriculture from Sachsen-Anhalt, Germany	EG and MS were supported by grants from the Ministries for Agriculture from Brandenburg and Sachsen-Anhalt, Germany. GH, EG-G, and JE were supported through the German Research Foundation (Graduate School 1121 and grant GE 1365/1-2; both granted to EG). SG and AK were supported by the German Research Foundation (grant SU 239/21-1; granted to RDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda FJ, 2005, BBA-BIOMEMBRANES, V1713, P51, DOI 10.1016/j.bbamem.2005.05.003; Ashiralieva A, 2006, APIDOLOGIE, V37, P411, DOI 10.1051/apido:2006028; BESSON F, 1984, J ANTIBIOT, V37, P172, DOI 10.7164/antibiotics.37.172; Cochrane SA, 2016, MED RES REV, V36, P4, DOI 10.1002/med.21321; Crailsheim K, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.05; Dey G, 2015, SCI REP-UK, V5, DOI 10.1038/srep10316; DINGMAN DW, 1983, APPL ENVIRON MICROB, V46, P860, DOI 10.1128/AEM.46.4.860-869.1983; Djukic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090914; Fontana R, 2004, PEPTIDES, V25, P919, DOI 10.1016/j.peptides.2004.03.016; Funfhaus A, 2013, ENVIRON MICROBIOL, V15, P2951, DOI 10.1111/1462-2920.12229; Funfhaus A, 2012, ENV MICROBIOL REP, V4, P194, DOI 10.1111/j.1758-2229.2011.00320.x; Funfhaus A, 2009, ENV MICROBIOL REP, V1, P240, DOI 10.1111/j.1758-2229.2009.00039.x; Fukuda H., 1968, Researches on Population Ecology Kyoto University, V10, P31, DOI 10.1007/BF02514731; Garcia-Gonzalez E, 2014, MICROBIOLOGYOPEN, V3, P642, DOI 10.1002/mbo3.195; Garcia-Gonzalez E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004284; Garcia-Gonzalez E, 2014, ENVIRON MICROBIOL, V16, P1297, DOI 10.1111/1462-2920.12417; Garcia-Gonzalez E, 2013, ENVIRON MICROBIOL, V15, P2894, DOI 10.1111/1462-2920.12167; Genersch E, 2006, INT J SYST EVOL MICR, V56, P501, DOI 10.1099/ijs.0.63928-0; Genersch E, 2005, APPL ENVIRON MICROB, V71, P7551, DOI 10.1128/AEM.71.11.7551-7555.2005; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Hertlein G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108272; Jensen AB, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.13; Krska D, 2015, J BIOL CHEM, V290, P1639, DOI 10.1074/jbc.M114.589846; MAGETDANA R, 1985, BIOCHIM BIOPHYS ACTA, V815, P405, DOI 10.1016/0005-2736(85)90367-0; MAGETDANA R, 1994, TOXICOLOGY, V87, P151, DOI 10.1016/0300-483X(94)90159-7; Muller S, 2015, NAT PROD REP, V32, P765, DOI 10.1039/c4np00158c; Muller S., 2014, ANGEW CHEM INT ENGL, V53, P10547, DOI [10.1002/anie.201406846, DOI 10.1002/ANIE.201406846]; Neuendorf S, 2004, MICROBIOL-SGM, V150, P2381, DOI 10.1099/mic.0.27125-0; Poppinga L, 2012, J APPL MICROBIOL, V112, P430, DOI 10.1111/j.1365-2672.2011.05214.x; Poppinga L, 2015, CURR OPIN INSECT SCI, V10, P29, DOI 10.1016/j.cois.2015.04.013; Poppinga L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002716; QUENTIN MJ, 1982, BIOCHIM BIOPHYS ACTA, V684, P207, DOI 10.1016/0005-2736(82)90007-4; Rauch S, 2009, APPL ENVIRON MICROB, V75, P3344, DOI 10.1128/AEM.02839-08; Son S, 2016, MAR DRUGS, V14, DOI 10.3390/md14040072; Sood S, 2014, CHEMBIOCHEM, V15, P1947, DOI 10.1002/cbic.201402139; Tarr HLA, 1937, ANN APPL BIOL, V24, P377, DOI 10.1111/j.1744-7348.1937.tb05040.x; THIMON L, 1995, FEMS MICROBIOL LETT, V128, P101, DOI 10.1111/j.1574-6968.1995.tb07507.x; Yue D, 2008, ENVIRON MICROBIOL, V10, P1612, DOI 10.1111/j.1462-2920.2008.01579.x; Zarschler K, 2009, APPL ENVIRON MICROB, V75, P3077, DOI 10.1128/AEM.00087-09	39	14	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164656	10.1371/journal.pone.0164656	http://dx.doi.org/10.1371/journal.pone.0164656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760211	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204000042
J	Li, SP; Yao, PY; Li, JF; Ferguson, DK; Min, LR; Chi, ZQ; Wang, Y; Yao, JX; Sha, JG				Li, Su-Ping; Yao, Pei-Yi; Li, Jin-Feng; Ferguson, David Kay; Min, Long-Rui; Chi, Zhen-Qing; Wang, Yong; Yao, Jian-Xin; Sha, Jin-Geng			Freshwater Fossil Pearls from the Nihewan Basin, Early Early Pleistocene	PLOS ONE			English	Article							NORTH CHINA; SECRETION; BIVALVIA; MOLLUSKS; SITES; NACRE; JAPAN; SHELL	Fossil blister pearls attached to the shells of an Anodonta mollusk from China, early Early Pleistocene, are reported here for the first time. The pearls were investigated in detail using a variety of methods. Micro-CT scanning of the fossil pearls was carried out to discover the inner structure and the pearl nucleus. Using CTAn software, changes in the gray levels of the biggest pearl, which reflect the changing density of the material, were investigated. The results provide us with some clues on how these pearls were formed. Sand grains, shell debris or material with a similar density could have stimulated the development of these pearls. X-ray diffraction analysis of one fossil pearl and the shell to which it was attached reveals that only aragonite exists in both samples. The internal structures of our fossil shells and pearls were investigated using a Scanning Electron Microscope. These investigations throw some light on pearl development in the past.	[Li, Su-Ping; Yao, Pei-Yi; Min, Long-Rui; Chi, Zhen-Qing; Wang, Yong; Yao, Jian-Xin] Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China; [Li, Su-Ping; Yao, Jian-Xin] Minist Land & Resources China, Key Lab Stratig & Paleontol, Beijing, Peoples R China; [Li, Jin-Feng] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolut, Beijing, Peoples R China; [Ferguson, David Kay] Univ Vienna, Inst Palaeontol, Vienna, Austria; [Sha, Jin-Geng] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Geological Sciences; Ministry of Natural Resources of the People's Republic of China; Chinese Academy of Sciences; Institute of Botany, CAS; University of Vienna; Chinese Academy of Sciences	Li, SP (corresponding author), Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China.; Li, SP (corresponding author), Minist Land & Resources China, Key Lab Stratig & Paleontol, Beijing, Peoples R China.	lisuping@cags.ac.cn	li, jinfeng/GVS-5425-2022		Ministry of Science and Technology of the People's Republic of China [2015FY310100]; National Natural Science Foundation of China [41172150, 31500183, 41472030, 31300186]; Ministry of Land and Resources of China [201211005-1]; China Geological Survey [DD20160120-04, DD20160345, 121201140 26701]; Basic Research Fund of the Chinese Academy of Geological Sciences [YYWF201501]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Land and Resources of China; China Geological Survey(China Geological Survey); Basic Research Fund of the Chinese Academy of Geological Sciences	This research was supported by the Ministry of Science and Technology of the People's Republic of China (No. 2015FY310100), the National Natural Science Foundation of China (Nos. 41172150, 31500183, 41472030, 31300186), the Ministry of Land and Resources of China (No. 201211005-1), the China Geological Survey (Nos. DD20160120-04, DD20160345, 121201140 26701) and the Basic Research Fund of the Chinese Academy of Geological Sciences (No. YYWF201501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 2014, NAUTILUS, V128, P9; Ao H, 2010, QUATERN INT, V223, P472, DOI 10.1016/j.quaint.2010.02.002; Arajirou K, 1960, THE STUDY OF PEARLS; BACHMAYER F, 1967, Annalen des Naturhistorischen Museums in Wien, V71, P1; Barthelat F, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/3/035001; BERRY CHARLES T., 1936, AMER MIDLAND NAT, V17, P464, DOI 10.2307/2419973; Boucot A.J., 2010, FOSSIL BEHAV COMPEND; Brown Roland W., 1946, JOUR WASHINGTON ACAD SCI, V36, P75; BROWN ROLAND W., 1940, JOUR WASHINGTON ACAD SCI, V30, P365; BUCHARDT B, 1981, SEDIMENTOLOGY, V28, P423, DOI 10.1111/j.1365-3091.1981.tb01691.x; Che LM, 2001, OCEANOL ACTA, V24, pS37; Chen XQ, 2015, J ASIAN EARTH SCI, V114, P242, DOI 10.1016/j.jseaes.2015.06.020; Comps M, 2000, AQUAT LIVING RESOUR, V13, P49, DOI 10.1016/S0990-7440(00)00134-0; De Baets K, 2011, ACTA PALAEONTOL POL, V56, P159, DOI 10.4202/app.2010.0044; Deng CL, 2008, QUATERNARY RES, V69, P77, DOI 10.1016/j.yqres.2007.10.006; Foote M, 2007, SCIENCE, V318, P1131, DOI 10.1126/science.1146303; Freer A, 2010, CRYST GROWTH DES, V10, P344, DOI 10.1021/cg901265x; GDNU (Geology Department of Nanjing University), 1980, PHAS AN XRAY POWD DI; Harper EM, 2009, ACTA ZOOL-STOCKHOLM, V90, P132, DOI 10.1111/j.1463-6395.2008.00338.x; Huang BY, 1982, B NANJING I GEOLOGY, V5, P231; Isaji Shinji, 2011, Venus (Tokyo), V69, P195; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Jackson JF, 1926, P ISLE WIGHT NAT HIS, V1, P466; Jackson JW, 1909, J MOLLUS STUD, V8, P318; John Woodward, 1723, ESSAY NATURAL HIST E; Keates SG, 2010, QUATERN INT, V223, P408, DOI 10.1016/j.quaint.2010.01.017; Kusworo A, 2015, PALAIOS, V30, P116, DOI 10.2110/palo.2013.124; Kutassy E., 1937, Matematikai es Termeszettudomanyi Ertesito (Budapest), V55, P1005; Liljedahl L, 1994, FOSSILS STRATA, V33, P89; Lin AYM, 2008, ACTA BIOMATER, V4, P131, DOI 10.1016/j.actbio.2007.05.005; Liu XQ, 2014, J PALEOLIMNOL, V51, P211, DOI 10.1007/s10933-013-9716-8; Liu Y, 2013, QUATERN INT, V295, P215, DOI 10.1016/j.quaint.2012.09.024; Lopes-Lima M, 2010, J SHELLFISH RES, V29, P969, DOI 10.2983/035.029.0431; Lucas J., 2011, PEARL OYSTER; Marwick J., 1922, New Zealand Journal of Science and Technology, V5, P202; Min Long-rui, 2006, Journal of Stratigraphy, V30, P103; Mu HS, 2015, QUATERN INT, V374, P76, DOI 10.1016/j.quaint.2015.02.019; Newton RB, 1908, J MOLLUS STUD, V8, P128; Qiao L, 2007, J CRYST GROWTH, V304, P253, DOI 10.1016/j.jcrysgro.2007.02.001; Qiu Z.X., 2000, QUATERNARY SCI, V20, P142; Robertson DI, 1883, T GEOLOGICAL SOC GLA, V7, P1, DOI [10.1144/transglas.7.1.1, DOI 10.1144/TRANSGLAS.7.1.1]; Russell RD, 1929, AM J SCI, V18, P416; Taylor J., 2008, PEARL PRODUCTION; TAYLOR J D, 1972, Palaeontology (Oxford), V15, P73; Tong HW, 2016, QUATERN INT, V406, P57, DOI 10.1016/j.quaint.2015.02.026; VOKES H. E., 1955, JOUR WASHINGTON ACAD SCI, V45, P260; Wagner FJ, 1957, T ROY SOC CAN SECT 3, VII, P5; Wang HQ, 2005, QUATERNARY RES, V64, P1, DOI 10.1016/j.yqres.2005.04.001; Yan J, 2013, S CHINA FISHERIES SC, V9, P49; Zhu RX, 2004, NATURE, V431, P559, DOI 10.1038/nature02829; Zilch A., 1936, Archiv fuer Molluskenkunde, V68, P238	51	0	0	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164083	10.1371/journal.pone.0164083	http://dx.doi.org/10.1371/journal.pone.0164083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760154	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000026
J	Ma, YC; Wang, ZX; Jin, SJ; Zhang, YX; Hu, GQ; Cui, DT; Wang, JS; Wang, M; Wang, FQ; Zhao, ZJ				Ma, Yong-Chao; Wang, Zhi-Xin; Jin, Shao-Ju; Zhang, Yan-Xin; Hu, Guo-Qiang; Cui, Dong-Tao; Wang, Jiang-Shuan; Wang, Min; Wang, Fu-Qing; Zhao, Zhi-Jun			Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells	PLOS ONE			English	Article							RESISTANCE; APOPTOSIS; ARREST	Both tyrosine kinase and topoisomerase II (TopII) are important anticancer targets, and their respective inhibitors are widely used in cancer therapy. However, some combinations of anticancer drugs could exhibit mutually antagonistic actions and drug resistance, which further limit their therapeutic efficacy. Here, we report that HMNE3, a novel bis-fluoroquinolonechalcone-like derivative that targets both tyrosine kinase and TopII, induces tumor cell proliferation and growth inhibition. The viabilities of 6 different cancer cell lines treated with a range of HMNE3 doses were detected using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cellular apoptosis was determined using Hoechst 33258 fluorescence staining and the terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling (TUNEL) assay. The expression of activated Caspase-3 was examined by immunocytochemistry. The tyrosine kinase activity was measured with a human receptor tyrosine kinase (RTK) detection kit using a horseradish peroxidase (HRP)-conjugated phosphotyrosine (pY20) antibody as the substrate. The topoisomerase II activity was measured using agarose gel electrophoresis with the DNA plasmid pBR322 as the substrate. The expression levels of the P53, Bax, Bcl-2, Caspase-3, -8, -9, p-cSrc, c-Src and topoisomerase II proteins were detected by western blot analysis. The proliferation of five of the six cancer cell lines was significantly inhibited by HMNE3 at 0.312 to 10 mu mol/L in a time-and dose-dependent manner. Treatment of the Capan-1 and Panc-1 cells with 1.6 to 3.2 mu M HMNE3 for 48 h significantly increased the percentage of apoptotic cells (P<0.05), and this effect was accompanied by a decrease in tyrosine kinase activity. HMNE3 potentially inhibited tyrosine kinase activity in vitro with an IC50 value of 0.64 +/- 0.34 mu mol/L in Capan-1 cells and 3.1 +/- 0.86 mu mol/L in Panc-1 cells. The activity of c-Src was significantly inhibited by HMNE3 in a dose-and time-dependent manner in different cellular contexts.Compared with the control group, HMNE3 induced increased expression of cellular apoptosis-related proteins. Consistent with cellular apoptosis data, a significant decrease in topoisomerase II beta activity was noted following treatment with HMNE3 for 24 h. Our data suggest that HMNE3 induced apoptosis in Capan-1 and Panc-1 cells by inhibiting the activity of both tyrosine kinases and topoisomerase II.	[Ma, Yong-Chao; Cui, Dong-Tao; Wang, Min; Zhao, Zhi-Jun] Luohe Med Coll, Clin Med Inst, Luohe, Henan, Peoples R China; [Ma, Yong-Chao] Luohe Med Coll, Affiliated Hosp 1, Luohe, Henan, Peoples R China; [Ma, Yong-Chao] Tumor Occurrence & Prevent Res Innovat Team Luohe, Luohe, Henan, Peoples R China; [Wang, Zhi-Xin] Zhengzhou Univ, Basic Med Inst, Zhengzhou, Henan, Peoples R China; [Jin, Shao-Ju] Luohe Med Coll, Inst Pharmacol, Luohe, Henan, Peoples R China; [Zhang, Yan-Xin; Wang, Jiang-Shuan; Wang, Fu-Qing] Luohe Med Coll, Basic Med Inst, Luohe, Henan, Peoples R China; [Hu, Guo-Qiang] Henan Univ, Inst Chem & Biol, Kaifeng, Henan, Peoples R China	Zhengzhou University; Henan University	Zhao, ZJ (corresponding author), Luohe Med Coll, Clin Med Inst, Luohe, Henan, Peoples R China.; Wang, FQ (corresponding author), Luohe Med Coll, Basic Med Inst, Luohe, Henan, Peoples R China.	lhyzxswyh@163.com; 13839527381@163.com	wang, zhixin/GZH-2500-2022		Plan of Science and Technology of Henan Province [142102310465, 132102310111]	Plan of Science and Technology of Henan Province	This work is supported by the Plan of Science and Technology of Henan Province (142102310465 and 132102310111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashour A, 2014, BIOORGAN MED CHEM, V22, P211, DOI 10.1016/j.bmc.2013.11.034; Bau JT, 2014, BIOCHEM PHARMACOL, V89, P464, DOI 10.1016/j.bcp.2014.03.011; Chamani E, 2014, SPECTROCHIM ACTA A, V133, P292, DOI 10.1016/j.saa.2014.05.068; Chang LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144506; Engelman JA, 2008, CURR OPIN GENET DEV, V18, P73, DOI 10.1016/j.gde.2008.01.004; Faivre S, 2006, SEMIN ONCOL, V33, P407, DOI 10.1053/j.seminoncol.2006.04.005; Gilbert AM, 2014, PHARM PAT ANAL, V3, P375, DOI 10.4155/ppa.14.24; Hu GQ, 2012, YAO XUE XUE BAO, V8, P1017; Kan JY, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/159786; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Li DH, 2015, AM J CANCER RES, V5, P3260; Ma Y., 2012, MOL IMPR, V1, P3, DOI [10.2478/molim-2012-0002, DOI 10.2478/MOLIM-2012-0002]; Norton KA, 2014, ONCOTARGETS THER, V7, P1571, DOI 10.2147/OTT.S65055; Perucca P, 2014, J PHOTOCH PHOTOBIO B, V140, P57, DOI 10.1016/j.jphotobiol.2014.07.006; Rajulu GG, 2014, CHEM PHARM BULL, V62, P168, DOI 10.1248/cpb.c13-00797; Shen Y, 2014, MED CHEM, V10, P533, DOI 10.2174/15734064113096660048; Sudan S, 2014, ANTICANCER RES, V34, P1691; Sun C, 2014, TRENDS BIOCHEM SCI, V39, P465, DOI 10.1016/j.tibs.2014.08.010; Telesco SE, 2011, MOL BIOSYST, V7, P2066, DOI 10.1039/c0mb00345j; Valle JW, 2014, CANCER TREAT REV, V40, P1230, DOI 10.1016/j.ctrv.2014.09.001; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; von Manstein V, 2013, CURR SIGNAL TRANSD T, V8, P193; Wang MH, 2013, J BIOMED RES, V27, P345, DOI 10.7555/JBR.27.20130038; Yang F, 2010, MOL CANCER RES, V8, P35, DOI 10.1158/1541-7786.MCR-09-0220	24	8	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0162821	10.1371/journal.pone.0162821	http://dx.doi.org/10.1371/journal.pone.0162821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760157	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204000004
J	Van Damme, E; Thys, K; Tuefferd, M; Van Hove, C; Aerssens, J; Van Loock, M				Van Damme, Ellen; Thys, Kim; Tuefferd, Marianne; Van Hove, Carl; Aerssens, Jeroen; Van Loock, Marnix			HCMV Displays a Unique Transcriptome of Immunomodulatory Genes in Primary Monocyte-Derived Cell Types	PLOS ONE			English	Article							HUMAN CYTOMEGALOVIRUS-INFECTION; LATENT HUMAN CYTOMEGALOVIRUS; MHC CLASS-I; HEMATOPOIETIC PROGENITOR CELLS; DENDRITIC CELLS; MACROPHAGE DIFFERENTIATION; ENDOPLASMIC-RETICULUM; MONOCLONAL-ANTIBODY; CD14(+) MONOCYTES; RNA-SYNTHESIS	Human cytomegalovirus (HCMV) is a betaherpesvirus which rarely presents problems in healthy individuals, yet may result in severe morbidity in immunocompromised patients and in immune-naive neonates. HCMV has a large 235 kb genome with a coding capacity of at least 165 open reading frames (ORFs). This large genome allows complex gene regulation resulting in different sets of transcripts during lytic and latent infection. While latent virus mainly resides within monocytes and CD34(+) progenitor cells, reactivation to lytic infection is driven by differentiation towards terminally differentiated myeloid dendritic cells and macrophages. Consequently, it has been suggested that macrophages and dendritic cells contribute to viral spread in vivo. Thus far only limited knowledge is available on the expression of HCMV genes in terminally differentiated myeloid primary cells and whether or not the virus exhibits a different set of lytic genes in primary cells compared with lytic infection in NHDF fibroblasts. To address these questions, we used Illumina next generation sequencing to determine the HCMV transcriptome in macrophages and dendritic cells during lytic infection and compared it to the transcriptome in NHDF fibroblasts. Here, we demonstrate unique expression profiles in macrophages and dendritic cells which significantly differ from the transcriptome in fibroblasts mainly by modulating the expression of viral transcripts involved in immune modulation, cell tropism and viral spread. In a head to head comparison between macrophages and dendritic cells, we observed that factors involved in viral spread and virion composition are differentially regulated suggesting that the plasticity of the virion facilitates the infection of surrounding cells. Taken together, this study provides the full transcript expression analysis of lytic HCMV genes in monocyte-derived type 1 and type 2 macrophages as well as in monocyte-derived dendritic cells. Thereby underlining the potential of HCMV to adapt to or influence different cellular environments to promote its own survival.	[Van Damme, Ellen; Thys, Kim; Tuefferd, Marianne; Aerssens, Jeroen; Van Loock, Marnix] Janssen Pharmaceut NV, Infect Dis, Beerse, Belgium; [Van Hove, Carl] Janssen Pharmaceut NV, Discovery Sci, Beerse, Belgium	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals	Van Loock, M (corresponding author), Janssen Pharmaceut NV, Infect Dis, Beerse, Belgium.	mvloock@its.jnj.com		Aerssens, Jeroen/0000-0002-9254-4800	Janssen Phamaceutica NV	Janssen Phamaceutica NV	All authors work for Janssen Phamaceutica NV and receive a salary. The work was funded by internal resources without grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arnolds KL, 2013, VIROLOGY, V439, P122, DOI 10.1016/j.virol.2013.02.006; Arrode G, 2003, CURR TOP MICROBIOL, V276, P277; Avdic S, 2011, J VIROL, V85, P7465, DOI 10.1128/JVI.00088-11; Bayer C, 2013, J VIROL, V87, P67, DOI 10.1128/JVI.01585-12; Bego M, 2005, J VIROL, V79, P11022, DOI 10.1128/JVI.79.17.11022-11034.2005; Bego MG, 2011, ARCH VIROL, V156, P1847, DOI 10.1007/s00705-011-1027-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bresnahan WA, 2000, SCIENCE, V288, P2373, DOI 10.1126/science.288.5475.2373; Bullwinkel J, 2011, EPIGENETICS-US, V6, P45, DOI 10.4161/epi.6.1.13314; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Chambers J, 1999, J VIROL, V73, P5757, DOI 10.1128/JVI.73.7.5757-5766.1999; Chan G, 2012, J VIROL, V86, P10714, DOI 10.1128/JVI.07129-11; Cheung AKL, 2006, BLOOD, V108, P3691, DOI 10.1182/blood-2005-12-026682; CHOU SW, 1988, J CLIN MICROBIOL, V26, P504, DOI 10.1128/JCM.26.3.504-507.1988; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; de Saint-Vis B, 1998, J IMMUNOL, V160, P1666; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0; Dugan GE, 2008, J VIROL, V82, P3271, DOI 10.1128/JVI.01705-07; DuRose JB, 2012, J VIROL, V86, P13745, DOI 10.1128/JVI.02244-12; Eligini S, 2015, J PROTEOMICS, V124, P112, DOI 10.1016/j.jprot.2015.03.026; Eligini S, 2013, J CELL PHYSIOL, V228, P1464, DOI 10.1002/jcp.24301; Elkord E, 2005, IMMUNOLOGY, V114, P204, DOI 10.1111/j.1365-2567.2004.02076.x; Furman MH, 2002, J VIROL, V76, P11753, DOI 10.1128/JVI.76.22.11753-11756.2002; Gatherer D, 2011, P NATL ACAD SCI USA, V108, P19755, DOI 10.1073/pnas.1115861108; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson W, 2008, CURR TOP MICROBIOL, V325, P187; Goodrum F, 2004, BLOOD, V104, P687, DOI 10.1182/blood-2003-12-4344; Goodrum FD, 2002, P NATL ACAD SCI USA, V99, P16255, DOI 10.1073/pnas.252630899; Goodrum F, 2007, BLOOD, V110, P937, DOI 10.1182/blood-2007-01-070078; Gurczynski SJ, 2014, J VIROL, V88, P2168, DOI 10.1128/JVI.02704-13; Hahn G, 1998, P NATL ACAD SCI USA, V95, P3937, DOI 10.1073/pnas.95.7.3937; Hargett D, 2010, P NATL ACAD SCI USA, V107, P20039, DOI 10.1073/pnas.1014509107; Hesse J, 2013, J GEN VIROL, V94, P376, DOI 10.1099/vir.0.045682-0; Hook L, 2014, CURR OPIN VIROL, V7, P40, DOI 10.1016/j.coviro.2014.03.015; Huang MM, 2012, J VIROL, V86, P8507, DOI 10.1128/JVI.00598-12; Keyes LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052827; Kim ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103308; Kim Y, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000123; Kondo K, 1995, SCAND J INFECT DIS, P63; KONDO K, 1994, P NATL ACAD SCI USA, V91, P11879, DOI 10.1073/pnas.91.25.11879; Kreklywich CN, 2014, METHODS MOL BIOL, V1119, P217, DOI 10.1007/978-1-62703-788-4_13; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mezger M, 2009, VIRAL IMMUNOL, V22, P343, DOI 10.1089/vim.2009.0011; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Murphy E, 2008, CURR TOP MICROBIOL, V325, P1; Noriega VM, 2012, MOL IMMUNOL, V51, P245, DOI 10.1016/j.molimm.2012.03.024; O'Connor CM, 2012, J VIROL, V86, P11425, DOI 10.1128/JVI.05900-11; Ohradanova-Repic A, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2015.39; Oresic K, 2008, J GEN VIROL, V89, P1122, DOI 10.1099/vir.0.83516-0; Oresic K, 2006, J BIOL CHEM, V281, P19395, DOI 10.1074/jbc.M601026200; Park B, 2010, J EXP MED, V207, P2033, DOI 10.1084/jem.20091793; Petrucelli A, 2009, J VIROL, V83, P5615, DOI 10.1128/JVI.01989-08; Poole E, 2013, J VIROL, V87, P4261, DOI 10.1128/JVI.03497-12; Raftery MJ, 2009, J GEN VIROL, V90, P2221, DOI 10.1099/vir.0.010538-0; Raghavan N, 2006, J COMPUT BIOL, V13, P798, DOI 10.1089/cmb.2006.13.798; Reeves Matthew, 2005, Discov Med, V5, P170; Reeves MB, 2005, J GEN VIROL, V86, P2949, DOI 10.1099/vir.0.81161-0; Reeves MB, 2005, P NATL ACAD SCI USA, V102, P4140, DOI 10.1073/pnas.0408994102; Renneson J, 2009, EUR J IMMUNOL, V39, P2789, DOI 10.1002/eji.200939414; Riegler S, 2000, J GEN VIROL, V81, P393, DOI 10.1099/0022-1317-81-2-393; Rossetto CC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003366; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schmittel A, 1995, SCAND J IMMUNOL, V42, P701, DOI 10.1111/j.1365-3083.1995.tb03714.x; Seidel E, 2015, CELL REP, V10, P968, DOI 10.1016/j.celrep.2015.01.029; Sinzger C, 1999, J INFECT DIS, V180, P976, DOI 10.1086/315032; Sinzger C, 2008, J GEN VIROL, V89, P359, DOI 10.1099/vir.0.83286-0; Sissons JGP, 2002, J INFECTION, V44, P73, DOI 10.1053/jinf.2001.0948; Slobedman B, 1999, J VIROL, V73, P4806, DOI 10.1128/JVI.73.6.4806-4812.1999; Smith MS, 2004, J LEUKOCYTE BIOL, V76, P65, DOI 10.1189/jlb.1203621; Snaar SP, 1999, J HISTOCHEM CYTOCHEM, V47, P245, DOI 10.1177/002215549904700213; Soderberg-Naucler C, 2001, J VIROL, V75, P7543, DOI 10.1128/JVI.75.16.7543-7554.2001; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Springer KL, 2004, J ANTIMICROB CHEMOTH, V54, P582, DOI 10.1093/jac/dkh396; Steinbach F, 1998, RES IMMUNOL, V149, P627, DOI 10.1016/S0923-2494(99)80028-5; STENBERG RM, 1985, J VIROL, V56, P665, DOI 10.1128/JVI.56.3.665-675.1985; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Stevenson EV, 2014, VIRUSES-BASEL, V6, P782, DOI 10.3390/v6020782; STINSKI MF, 1983, J VIROL, V46, P1; Streblow DN, 2007, J VIROL, V81, P3816, DOI 10.1128/JVI.02425-06; Stropes MP, 2009, J VIROL, V83, P10016, DOI 10.1128/JVI.00354-09; Tirabassi R, 2011, J VIROL, V85, P11938, DOI 10.1128/JVI.05443-11; Tirabassi RS, 2002, J VIROL, V76, P6832, DOI 10.1128/JVI.76.13.6832-6835.2002; Tirosh B, 2005, J VIROL, V79, P2768, DOI 10.1128/JVI.79.5.2768-2779.2005; Towler JC, 2012, J GEN VIROL, V93, P1046, DOI 10.1099/vir.0.038083-0; Tugal D, 2013, ARTERIOSCL THROM VAS, V33, P1135, DOI 10.1161/ATVBAHA.113.301453; Van Damme E, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00218; van den Boomen DJH, 2015, MOL IMMUNOL, V68, P106, DOI 10.1016/j.molimm.2015.07.005; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Vogt G, 2011, J CLIN INVEST, V121, P3889, DOI 10.1172/JCI57235; WATHEN MW, 1982, J VIROL, V41, P462, DOI 10.1128/JVI.41.2.462-477.1982; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Zhu H, 1997, P NATL ACAD SCI USA, V94, P13985, DOI 10.1073/pnas.94.25.13985; Zhuravskaya T, 1997, BLOOD, V90, P2482, DOI 10.1182/blood.V90.6.2482.2482_2482_2491	99	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164843	10.1371/journal.pone.0164843	http://dx.doi.org/10.1371/journal.pone.0164843			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760232	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000060
J	Bielby, J; Vial, F; Woodroffe, R; Donnelly, CA				Bielby, Jon; Vial, Flavie; Woodroffe, Rosie; Donnelly, Christl A.			Localised Badger Culling Increases Risk of Herd Breakdown on Nearby, Not Focal, Land	PLOS ONE			English	Article							BOVINE TUBERCULOSIS; CATTLE	Bovine tuberculosis is an important disease affecting the UK livestock industry. Controlling bovine tuberculosis (TB) is made more complex by the presence of a wildlife host, the Eurasian badger, Meles meles. Repeated large-scale badger culls implemented in the Randomised Badger Culling Trial (RBCT) were associated with decreased cattle risks inside the culling area, but also with increased cattle risks up to the 2km outside the culling area. Intermediate reductions in badger density, as achieved by localised reactive culling in the RBCT, significantly increased cattle TB. Using a matched-pairs case-control study design (n = 221 pairs of cattle herds), we investigated the spatial scale over which localised badger culling had its biggest impact. We found that reactive badger culling had a significant positive association with the risk of cattle TB at distances of 1-3km and 3-5km, and that no such association existed over shorter distances (<1km). These findings indicate that localised badger culls had significant negative effects, not on the land on which culling took place, but, perhaps more importantly, on adjoining lands and farms.	[Bielby, Jon; Woodroffe, Rosie] Inst Zool, Regents Pk, London NW1 4RY, England; [Vial, Flavie] Epi Connect, Djupdalsvagen 7, S-14251 Skogas, Sweden; [Donnelly, Christl A.] Imperial Coll, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England	Imperial College London	Donnelly, CA (corresponding author), Imperial Coll, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England.	c.donnelly@imperial.ac.uk		Vial, Flavie/0000-0003-3603-4694; Bielby, Jon/0000-0003-4586-0429	Defra; MRC; Institute of Zoology Research Fellowship; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish	Defra(Department for Environment, Food & Rural Affairs (DEFRA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Zoology Research Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was funded by Defra. C.A. D. thanks the MRC for Centre funding. J.B. was funded by an Institute of Zoology Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The RBCT was designed by the Independent Scientific Group on Cattle TB (including C.A.D and R.W.) and implemented by Defra and its associated agencies. We thank the farmers and landholders in trial areas. This research was funded by Defra. C.A.D. thanks the MRC for Centre funding. J.B. was funded by an Institute of Zoology Research Fellowship.	Bourne J., 2007, BOVINE TB SCI EVIDEN; Department for Environment Food and Rural Affairs, 2006, SE3110 DEP ENV FOOD; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Donnelly CA, 2012, BIOL LETT, V8; Krebs J., 1997, PB3423 HMSO; Pope LC, 2007, MOL ECOLOGY, V16; Tuyttens FAM, 2000, J ANIM ECOL, V69, P815, DOI 10.1046/j.1365-2656.2000.00437.x; Vial F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018058; Woodroffe R, 2008, J ZOOL, V274, P28, DOI 10.1111/j.1469-7998.2007.00353.x; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; Woodroffe R, 2009, J WILDLIFE DIS, V45, P128, DOI 10.7589/0090-3558-45.1.128	12	6	7	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164618	10.1371/journal.pone.0164618	http://dx.doi.org/10.1371/journal.pone.0164618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749934	Green Published, gold, Green Submitted			2022-12-26	WOS:000386202300019
J	Wu, WF; Deng, Q; Shi, PB; Yang, JH; Hu, ZY; Zhang, MF				Wu, Weifang; Deng, Qin; Shi, Pibiao; Yang, Jinghua; Hu, Zhongyuan; Zhang, Mingfang			Identification of Appropriate Reference Genes for Normalization of miRNA Expression in Grafted Watermelon Plants under Different Nutrient Stresses	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SUITABLE REFERENCE GENES; QUANTITATIVE RT-PCR; REAL-TIME PCR; PHOSPHATE STARVATION RESPONSES; RELIABLE REFERENCE GENES; MICRORNA EXPRESSION; INTERNAL CONTROL; SELECTION; ARABIDOPSIS	Watermelon (Citrullus lanatus) is a globally important crop belonging to the family Cucurbitaceae. The grafting technique is commonly used to improve its tolerance to stress, as well as to enhance its nutrient uptake and utilization. It is believed that miRNA is most likely involved in its nutrient-starvation response as a graft-transportable signal. The quantitative real-time reverse transcriptase polymerase chain reaction is the preferred method for miRNA functional analysis, in which reliable reference genes for normalization are crucial to ensure the accuracy. The purpose of this study was to select appropriate reference genes in scion (watermelon) and rootstocks (squash and bottle gourd) of grafted watermelon plants under normal growth conditions and nutrient stresses (nitrogen and phosphorus starvation). Under nutrient starvation, geNorm identified miR167c and miR167f as two most stable genes in both watermelon leaves and squash roots. miR166b was recommended by both geNorm and NormFinder as the best reference in bottle gourd roots under nutrient limitation. Expression of a new Cucurbitaceae miRNA, miR85, was used to validate the reliability of candidate reference genes under nutrient starvation. Moreover, by comparing several target genes expression in qRT-PCR analysis with those in RNA-seq data, miR166b and miR167c were proved to be the most suitable reference genes to normalize miRNA expression under normal growth condition in scion and rootstock tissues, respectively. This study represents the first comprehensive survey of the stability of miRNA reference genes in Cucurbitaceae and provides valuable information for investigating more accurate miRNA expression involving grafted watermelon plants.	[Wu, Weifang; Deng, Qin; Shi, Pibiao; Yang, Jinghua; Hu, Zhongyuan; Zhang, Mingfang] Zhejiang Univ, Inst Vegetable Sci, Lab Germplasm Innovat & Mol Breeding, Hangzhou, Zhejiang, Peoples R China; [Yang, Jinghua; Hu, Zhongyuan; Zhang, Mingfang] Minist Agr, Key Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou, Zhejiang, Peoples R China; [Yang, Jinghua; Hu, Zhongyuan; Zhang, Mingfang] Zhejiang Prov Key Lab Hort Plant Integrat Biol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University	Hu, ZY (corresponding author), Zhejiang Univ, Inst Vegetable Sci, Lab Germplasm Innovat & Mol Breeding, Hangzhou, Zhejiang, Peoples R China.; Hu, ZY (corresponding author), Minist Agr, Key Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou, Zhejiang, Peoples R China.; Hu, ZY (corresponding author), Zhejiang Prov Key Lab Hort Plant Integrat Biol, Hangzhou, Zhejiang, Peoples R China.	huzhongyuan@zju.edu.cn	Yang, Jinghua/G-9164-2016		National Natural Science Foundation of China [31372077, 31501782]; earmarked fund for Modern Agro-Industry Technology Research System of China [CARS-26-17]; Zhejiang Provincial Natural Science Foundation of China [LQ16C150002]; Key Science and Technology Foundation of Zhejiang Province [2012C129031-2-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for Modern Agro-Industry Technology Research System of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Key Science and Technology Foundation of Zhejiang Province	This work was supported by National Natural Science Foundation of China (31372077;31501782), the earmarked fund for Modern Agro-Industry Technology Research System of China (CARS-26-17), Zhejiang Provincial Natural Science Foundation of China (LQ16C150002), and Key Science and Technology Foundation of Zhejiang Province (2012C129031-2-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CS, 2011, PLANT CELL, V23, P185, DOI 10.1105/tpc.110.074005; Baek D, 2013, PLANT PHYSIOL, V161, P362, DOI 10.1104/pp.112.205922; Borowski JM, 2014, PLANTA, V239, P1187, DOI 10.1007/s00425-014-2041-2; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Davis AR, 2008, CRIT REV PLANT SCI, V27, P50, DOI 10.1080/07352680802053940; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Feng H, 2012, PLANT PHYSIOL BIOCH, V51, P116, DOI 10.1016/j.plaphy.2011.10.010; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Hoagland D. R., 1950, CALIF AES C, V347, P357; Hu B, 2011, PLANT PHYSIOL, V156, P1101, DOI 10.1104/pp.110.170209; Hu JH, 2014, BIOCHIMIE, V102, P137, DOI 10.1016/j.biochi.2014.03.002; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Kong W, 2009, J CELL PHYSIOL, V218, P22, DOI 10.1002/jcp.21577; Kou SJ, 2012, PLANT CELL REP, V31, P2151, DOI 10.1007/s00299-012-1325-x; Kulcheski FR, 2010, ANAL BIOCHEM, V406, P185, DOI 10.1016/j.ab.2010.07.020; Lin YL, 2013, PLANT PHYSIOL BIOCH, V66, P20, DOI 10.1016/j.plaphy.2013.02.002; Liu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057359; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machado RD, 2015, PLANT CELL REP, V34, P1139, DOI 10.1007/s00299-015-1773-1; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; McAllister CH, 2012, PLANT BIOTECHNOL J, V10, P1011, DOI 10.1111/j.1467-7652.2012.00700.x; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Obrero A, 2011, J AGR FOOD CHEM, V59, P5402, DOI 10.1021/jf200689r; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Sato N., 1930, NOGYO SEKAI, V25, P24; Sestili S, 2013, J PLANT BIOCHEM BIOT, V3, P1; Sun ZB, 2015, J MICROBIOL METH, V114, P62, DOI 10.1016/j.mimet.2015.05.009; Tateishi K, 1927, J JPN HORTIC, V39, P5; THEODOROU ME, 1993, PLANT PHYSIOL, V101, P339, DOI 10.1104/pp.101.2.339; Timoneda O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044413; Toegel S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-13; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Wang T, 2014, SCI HORTIC-AMSTERDAM, V169, P130, DOI 10.1016/j.scienta.2014.02.006; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Warzybok A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072887; Xiang MQ, 2014, BIOCHEM BIOPH RES CO, V454, P210, DOI 10.1016/j.bbrc.2014.10.064; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; Xu YY, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1784-0; Cesare P, 2015, PHYTOCHEMISTRY, V116, P78, DOI 10.1016/j.phytochem.2015.02.024; Zhao M, 2011, NEW PHYTOL, V190, P906, DOI 10.1111/j.1469-8137.2011.03647.x; 2004, CANCER RES, V64, P5245, DOI DOI 10.1158/0008-5472	56	10	10	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164725	10.1371/journal.pone.0164725	http://dx.doi.org/10.1371/journal.pone.0164725			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749935	Green Published, Green Submitted, gold			2022-12-26	WOS:000386202300023
J	Wu, J; Liu, W; Williams, JP; Ratner, N				Wu, J.; Liu, W.; Williams, J. P.; Ratner, N.			EGFR-Stat3 signalling in nerve glial cells modifies neurofibroma initiation	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; SCHWANN-CELLS; SHEATH TUMORS; TYPE-1 NF1; EGFR; INHIBITION; EXPRESSION; PHENOTYPE; PLEXIFORM; ORIGIN	Neurofibromatosis type 1 (NF1) is an inherited disease in which affected patients are predisposed to develop benign Schwann cell (SC) tumours called neurofibromas. In the mouse, loss of Nf1 in the SC lineage causes neurofibroma formation. The tyrosine kinase receptor EGFR is expressed in Schwann cell precursors (SCP), which have been implicated in plexiform neurofibroma initiation. To test if EGFR activity affects neurofibroma initiation, size, and/or number, we studied mice expressing human EGFR in SCs and SCP in the context of mice that form neurofibromas. Neurofibroma number increased in homozygous CNP-hEGFR mice versus heterozygous littermates, and neurofibroma number and size increased when CNP-hEGFR was crossed to Nf1(fl/fl); DhhCre mice. Conversely, diminished EGFR signalling in Nf1(fl/fl); DhhCre; Wa2/+ mice decreased neurofibroma number. In vivo transplantation verified the correlation between EGFR activity and neurofibroma formation. Mechanistically, expression of CNP-hEGFR increased SCP/neurofibroma-initiating cell self-renewal, a surrogate for tumour initiation, and activated P-Stat3. Further, Il-6 reinforced Jak2/ Stat3 activation in SCPs and SCs. These gain-and loss-of function assays show that levels of tyrosine kinase expression in SCPs modify neurofibroma initiation.	[Wu, J.; Liu, W.; Williams, J. P.; Ratner, N.] Univ Cincinnati, Cincinnati Childrens Hosp, Cincinnati Childrens Hosp Res Fdn, Canc & Blood Dis Inst,Div Expt Hematol & Canc Bio, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Liu, W.] Shandong Univ, Dept Pediat Surg, Prov Hosp Affiliated, Jinan, Peoples R China; [Williams, J. P.] San Antonio Mil Med Ctr Neurol, JBSA, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Cincinnati; Shandong University; San Antonio Military Medical Center	Ratner, N (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp, Cincinnati Childrens Hosp Res Fdn, Canc & Blood Dis Inst,Div Expt Hematol & Canc Bio, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	nancy.ratner@cchmc.org	Williams, Jon/AAP-2761-2020	RATNER, NANCY/0000-0001-5030-9354	DAMD New Investigator Award [W81XWH-11-1-0259]; NIH [R01 NS28840]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028840, R01NS086219] Funding Source: NIH RePORTER	DAMD New Investigator Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr Luis F Parada (Memorial Sloan Kettering, NY) for Nf1<SUP>fl/fl</SUP> mice and Dr Anat O Stemmer-Rachamimov (Massachusetts General Hospital) for assistance with mouse pathology. We thank Dr Adam Lane (CCHMC) for consultation on statistical analysis. This work was supported by a DAMD New Investigator Award (W81XWH-11-1-0259) (Jianqiang Wu) and NIH R01 NS28840 (Nancy Ratner).	Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boyd KP, 2009, J AM ACAD DERMATOL, V61, P1, DOI 10.1016/j.jaad.2008.12.051; Carroll SL, 2008, GLIA, V56, P1590, DOI 10.1002/glia.20776; Chen SZ, 2003, NAT NEUROSCI, V6, P1186, DOI 10.1038/nn1139; Chen ZG, 2014, CANCER CELL, V26, P695, DOI 10.1016/j.ccell.2014.09.009; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; de Bruin EC, 2014, CANCER DISCOV, V4, P606, DOI 10.1158/2159-8290.CD-13-0741; DeClue JE, 2000, J CLIN INVEST, V105, P1233, DOI 10.1172/JCI7610; EASTON DF, 1993, AM J HUM GENET, V53, P305; Gomez-Sanchez JA, 2009, J NEUROSCI, V29, P11304, DOI 10.1523/JNEUROSCI.1753-09.2009; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Holtkamp N, 2008, NEURO-ONCOLOGY, V10, P946, DOI 10.1215/15228517-2008-053; Huijbregts RPH, 2003, J NEUROSCI, V23, P7269; Jessen WJ, 2013, J CLIN INVEST, V123, P340, DOI 10.1172/JCI60578; Joseph NM, 2008, CANCER CELL, V13, P129, DOI 10.1016/j.ccr.2008.01.003; Kazmi SJ, 2013, AM J PATHOL, V182, P646, DOI 10.1016/j.ajpath.2012.11.017; Le LQ, 2011, CANCER RES, V71, P4686, DOI 10.1158/0008-5472.CAN-10-4577; Leppig KA, 1997, AM J MED GENET, V73, P197, DOI 10.1002/(SICI)1096-8628(1997)73:2<197::AID-AJMG17>3.0.CO;2-P; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li H, 2016, ONCOGENE, V35, P1468, DOI 10.1038/onc.2015.207; Li HZ, 2002, CANCER RES, V62, P4507; Ling BC, 2005, CANCER CELL, V7, P65, DOI 10.1016/j.ccr.2004.10.016; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Mautner VF, 2010, J MED GENET, V47, P623, DOI 10.1136/jmg.2009.075937; Mayes DA, 2011, CANCER RES, V71, P4675, DOI 10.1158/0008-5472.CAN-10-4558; Ratner N, 2006, METHOD ENZYMOL, V407, P22, DOI 10.1016/S0076-6879(05)07003-5; Ribeiro S, 2013, CELL REP, V5, P126, DOI 10.1016/j.celrep.2013.08.033; Rieley MB, 2011, AM J MED GENET A, V155A, P478, DOI 10.1002/ajmg.a.33851; Rizvi TA, 2002, J NEUROSCI, V22, P9831; Ryan MA, 2010, NAT MED, V16, P1141, DOI 10.1038/nm.2217; Stemmer-Rachamimov AO, 2004, CANCER RES, V64, P3718, DOI 10.1158/0008-5472.CAN-03-4079; Upadhyaya M, 2007, AM J HUM GENET, V80, P140, DOI 10.1086/510781; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; Walrath JC, 2009, MAMM GENOME, V20, P214, DOI 10.1007/s00335-009-9179-4; Wang L, 2009, NEUROREPORT, V20, P663, DOI 10.1097/WNR.0b013e32832a09f8; Williams JP, 2008, CELL STEM CELL, V3, P658, DOI 10.1016/j.stem.2008.10.003; Wu J, 2014, ONCOGENE, V33, P173, DOI 10.1038/onc.2012.579; Wu JQ, 2008, CANCER CELL, V13, P105, DOI 10.1016/j.ccr.2007.12.027; Wu JQ, 2016, CELL REP, V14, P1979, DOI 10.1016/j.celrep.2016.01.074; Wu JQ, 2006, AM J PATHOL, V168, P1686, DOI 10.2353/ajpath.2006.050859; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zheng H, 2008, CANCER CELL, V13, P117, DOI 10.1016/j.ccr.2008.01.002; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	44	16	16	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	12					1669	1677		10.1038/onc.2016.386	http://dx.doi.org/10.1038/onc.2016.386			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP6AP	27748759	Green Accepted			2022-12-26	WOS:000397460600006
J	Li, CJ; Tan, BK; Zhao, JS; Guan, ZQ				Li, Chijun; Tan, Brandon K.; Zhao, Jinshi; Guan, Ziqiang			In Vivo and in Vitro Synthesis of Phosphatidylglycerol by an Escherichia coli Cardiolipin Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PGSA NULL MUTANT; MASS-SPECTROMETRY; LACKING PHOSPHATIDYLGLYCEROL; ANIONIC PHOSPHOLIPIDS; BACILLUS-MEGATERIUM; PHOSPHATIDYLETHANOLAMINE; IDENTIFICATION; BIOSYNTHESIS; LIPIDS; IONIZATION	Phosphatidylglycerol (PG) makes up 5-20% of the phospholipids of Escherichia coli and is essential for growth in wild-type cells. PG is synthesized from the dephosphorylation of its immediate precursor, phosphatidylglycerol phosphate (PGP) whose synthase in E. coli is PgsA. Using genetic, biochemical, and highly sensitive mass spectrometric approaches, we identified an alternative mechanism for PG synthesis in E. coli that is PgsA independent. The reaction of synthesis involves the conversion of phosphatidylethanolamine and glycerol into PG and is catalyzed by ClsB, a phospholipase D-type cardiolipin synthase. This enzymatic reaction is demonstrated herein both in vivo and in vitro as well as by using the purified ClsB protein. When the growth medium was supplemented with glycerol, the expression of E. coli ClsB significantly increased PG and cardiolipin levels, with the growth deficiency of pgsA null strain also being complemented under such conditions. Identification of this alternative mechanism for PG synthesis not only expands our knowledge of bacterial anionic phospholipid biosynthesis, but also sheds light on the biochemical functions of the cls gene redundancy in E. coli and other bacteria. Finally, the PGP-independent PG synthesis in E. coli may also have important implications for the understanding of PG biosynthesis in eukaryotes that remains incomplete.	[Li, Chijun; Tan, Brandon K.; Zhao, Jinshi; Guan, Ziqiang] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Guan, ZQ (corresponding author), POB 3711, Durham, NC 27710 USA.	ziqiang.guan@duke.edu	Guan, Ziqiang/AAE-5110-2019		National Institutes of Health [GM069338, EY023666]; NATIONAL EYE INSTITUTE [R01EY023666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Lipid Maps Collaborative Grant GM069338 and EY023666 from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; Dowhan W, 2013, BBA-MOL CELL BIOL L, V1831, P471, DOI 10.1016/j.bbalip.2012.08.007; Dowhan W, 2009, J LIPID RES, V50, pS305, DOI 10.1194/jlr.R800041-JLR200; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Guan ZQ, 2007, BIOCHEMISTRY-US, V46, P14500, DOI 10.1021/bi701907g; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P800, DOI 10.1016/j.bbalip.2011.04.009; Guan ZQ, 2005, ANAL BIOCHEM, V345, P336, DOI 10.1016/j.ab.2005.07.002; Guo DG, 2000, BBA-MOL CELL BIOL L, V1483, P263, DOI 10.1016/S1388-1981(99)00193-6; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Han XL, 2003, J LIPID RES, V44, P1071, DOI 10.1194/jlr.R300004-JLR200; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HIRSCHBERG CB, 1972, P NATL ACAD SCI USA, V69, P648, DOI 10.1073/pnas.69.3.648; Kanipes MI, 2001, J BIOL CHEM, V276, P1156, DOI 10.1074/jbc.M009019200; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Kawai F, 2004, J BACTERIOL, V186, P1475, DOI 10.1128/JB.186.5.1475-1483.2004; Kikuchi S, 2000, J BACTERIOL, V182, P371, DOI 10.1128/JB.182.2.371-376.2000; Koprivnjak T, 2011, J BACTERIOL, V193, P4134, DOI 10.1128/JB.00288-11; LOMBARDI FJ, 1980, J BACTERIOL, V141, P618, DOI 10.1128/JB.141.2.618-625.1980; LOMBARDI FJ, 1980, J BACTERIOL, V141, P626, DOI 10.1128/JB.141.2.626-634.1980; Lu YH, 2011, J BIOL CHEM, V286, P5506, DOI 10.1074/jbc.M110.199265; Matsumoto K, 2001, MOL MICROBIOL, V39, P1427, DOI 10.1046/j.1365-2958.2001.02320.x; Mileykovskaya E, 2005, CURR OPIN MICROBIOL, V8, P135, DOI 10.1016/j.mib.2005.02.012; Mileykovskaya E, 2009, J BIOL CHEM, V284, P2990, DOI 10.1074/jbc.M805189200; Murphy RC, 2001, CHEM REV, V101, P479, DOI 10.1021/cr9900883; Nagahama H, 2006, J GEN APPL MICROBIOL, V52, P91, DOI 10.2323/jgam.52.91; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Shiba Y, 2004, J BACTERIOL, V186, P6526, DOI 10.1128/jb.186.19.6526-6535.2004; Suzuki M, 2002, J BACTERIOL, V184, P5418, DOI 10.1128/JB.184.19.5418-5425.2002; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; WALTON PA, 1987, J BIOL CHEM, V262, P10355; Ward WC, 2007, J LIPID RES, V48, P1457, DOI 10.1194/jlr.C700008-JLR200; XIA WM, 1995, P NATL ACAD SCI USA, V92, P783, DOI 10.1073/pnas.92.3.783; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007	40	26	26	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25144	25153		10.1074/jbc.M116.762070	http://dx.doi.org/10.1074/jbc.M116.762070			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27760827	Green Published, hybrid			2022-12-26	WOS:000388880100029
J	Tran, TT; Adams-Bedford, J; Yiengprugsawan, V; Seubsman, SA; Sleigh, A				Thanh Tam Tran; Adams-Bedford, Joel; Yiengprugsawan, Vasoontara; Seubsman, Sam-Ang; Sleigh, Adrian			Psychological Distress following Injury in a Large Cohort of Thai Adults	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; MENTAL-HEALTH; RISK-FACTORS; POPULATION; TRAUMA; CONSEQUENCES	Introduction Injury and psychological distress are public health priorities because of their high occurrence in the population. This study examines the longitudinal effects of injury characteristics on psychological distress. Methods Study participants were enrolled distance learning Thai adults (N = 42,785 at 2013 followup) residing nationwide. We analysed 2009 and 2013 data. Injury questions included injury prevalence, causes and levels of severity. Distress was measured using the standard Kessler-6. To assess the risk for post-injury distress, we used multinomial logistic regression investigating psychological distress in 2013 as an outcome including injury categories in both 2009 and 2013 as predictors, adjusted for sociodemographic factors. Results Overall injury was predictive of psychological distress. Both types of injury (traffic and non-traffic) associated with increasing psychological distress. Those that had experienced both types of injuries in the previous year had higher odds of developing psychological distress compared to those who experienced just one type. In 2013, adjusted psychological distress odds ratios were 1.46 [95% Confidence Interval 1.14-1.87] for traffic injury only; 1.26 [1.13-1.40] for non-traffic injury only; and 2.71 [2.19-3.35] for both traffic and non-traffic injuries. Increasing frequency of injury and increasing injury severity were also linked to elevated psychological distress among our Thai cohort members. Conclusions Our results revealed a significantly high risk of psychological distress following injury. With increasing occurrence of injury, especially traffic injuries in low and middle income countries such as Thailand, future policies should not only focus on physical care but also address psychological distress as an important consequence of injury.	[Thanh Tam Tran; Sleigh, Adrian] Australian Natl Univ, ANU Coll Med Biol & Environm, Res Sch Populat Hlth, Dept Global Hlth, Canberra, ACT, Australia; [Thanh Tam Tran; Sleigh, Adrian] Australian Natl Univ, ANU Coll Med Biol & Environm, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Adams-Bedford, Joel] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Yiengprugsawan, Vasoontara] Australian Natl Univ, Ctr Res Ageing Hlth & Wellbeing, Res Sch Populat Hlth, ANU Coll Med Biol & Environm, Canberra, ACT, Australia; [Seubsman, Sam-Ang] Sukhothai Thammathirat Open Univ, Sch Human Ecol, Nonthaburi, Thailand	Australian National University; Australian National University; Australian National University; Australian National University; Sukhothai Thammathirat Open University	Tran, TT (corresponding author), Australian Natl Univ, ANU Coll Med Biol & Environm, Res Sch Populat Hlth, Dept Global Hlth, Canberra, ACT, Australia.; Tran, TT (corresponding author), Australian Natl Univ, ANU Coll Med Biol & Environm, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	tarntran@anu.edu.au	Yiengprugsawan, Vas Sbirakos/G-3176-2011; sleigh, adrian/J-4540-2019	Yiengprugsawan, Vas Sbirakos/0000-0001-9101-4704; sleigh, adrian/0000-0001-8443-7864	International Collaborative Research Grants Scheme; Wellcome Trust UK [GR071587MA]; Australian National Health and Medical Research Council [268055]; National Health and Medical Research Council [585426]	International Collaborative Research Grants Scheme; Wellcome Trust UK(Wellcome Trust); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the International Collaborative Research Grants Scheme with joint grants from the Wellcome Trust UK (GR071587MA) and the Australian National Health and Medical Research Council (268055), and as a global health grant from the National Health and Medical Research Council (585426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, GLOBAL BURDEN DIS ST, DOI DOI 10.2147/DDDT.S164565; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Cameron CM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-114; Haagsma JA, 2011, INJURY PREV, V17, P21, DOI 10.1136/ip.2010.026419; Hepp U, 2008, BRIT J PSYCHIAT, V192, P376, DOI 10.1192/bjp.bp.106.030569; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Laursen B, 2012, DAN MED J, V59; Lin KH, 2013, J OCCUP REHABIL, V23, P55, DOI 10.1007/s10926-012-9381-1; Lyons R, 2010, INJURY PREV, V16, P145, DOI 10.1136/ip.2009.025833; Mason S, 2006, BRIT J CLIN PSYCHOL, V45, P217, DOI 10.1348/014466505X50158; Mills KL, 2006, AM J PSYCHIAT, V163, P652, DOI 10.1176/appi.ajp.163.4.652; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-783; Sareen J, 2013, DEPRESS ANXIETY, V30, P321, DOI 10.1002/da.22077; Seubsman Sam-Ang, 2011, BMC Res Notes, V4, P166, DOI 10.1186/1756-0500-4-166; Sleigh AC, 2008, INT J EPIDEMIOL, V37, P266, DOI 10.1093/ije/dym161; ter Smitten MH, 2011, BURNS, V37, P753, DOI 10.1016/j.burns.2010.12.018; Toft AMH, 2010, J TRAUMA, V69, P26, DOI 10.1097/TA.0b013e3181d3cbf2; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Weisell RC, 2002, ASIA PAC J CLIN NUTR, V11, pS681, DOI 10.1046/j.1440-6047.11.s8.5.x; Wesson HKH, 2014, HEALTH POLICY PLANN, V29, P795, DOI 10.1093/heapol/czt064; Wiesenthal N, 2013, TRANSPORT RES F-TRAF, V21, P1, DOI 10.1016/j.trf.2013.08.004; Wrenger M, 2008, EUR PSYCHIAT, V23, P434, DOI 10.1016/j.eurpsy.2008.02.001; Yiengprugsawan V, 2012, ASEAN J OPEN DISTANC, V4, P1; Yiengprugsawan V, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004668; Yiengprugsawan V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088903; Zatzick DF, 2002, AM J PSYCHIAT, V159, P941, DOI 10.1176/appi.ajp.159.6.941	29	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164767	10.1371/journal.pone.0164767	http://dx.doi.org/10.1371/journal.pone.0164767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED7AX	27776133	gold, Green Published			2022-12-26	WOS:000389009200020
J	Hernandez, SM; Welch, CN; Peters, VE; Lipp, EK; Curry, S; Yabsley, MJ; Sanchez, S; Presotto, A; Gerner-Smidt, P; Hise, KB; Hammond, E; Kistler, WM; Madden, M; Conway, AL; Kwan, T; Maurer, JJ				Hernandez, Sonia M.; Welch, Catharine N.; Peters, Valerie E.; Lipp, Erin K.; Curry, Shannon; Yabsley, Michael J.; Sanchez, Susan; Presotto, Andrea; Gerner-Smidt, Peter; Hise, Kelley B.; Hammond, Elizabeth; Kistler, Whitney M.; Madden, Marguerite; Conway, April L.; Kwan, Tiffany; Maurer, John J.			Urbanized White Ibises (Eudocimus albus) as Carriers of Salmonella enterica of Significance to Public Health and Wildlife	PLOS ONE			English	Article							SPARROWS PASSER-MONTANUS; UNITED-STATES; AVIAN WILDLIFE; MOLECULAR EPIDEMIOLOGY; TYPHIMURIUM INFECTION; MULTISTATE OUTBREAK; SUBSP ENTERICA; GULLS LARUS; SEROVAR; HUMANS	Worldwide, Salmonella spp. is a significant cause of disease for both humans and wildlife, with wild birds adapted to urban environments having different opportunities for pathogen exposure, infection, and transmission compared to their natural conspecifics. Food provisioning by people may influence these factors, especially when high-density mixed species flocks aggregate. White Ibises (Eudocimus albus), an iconic Everglades species in decline in Florida, are becoming increasingly common in urbanized areas of south Florida where most are hand-fed. We examined the prevalence of Salmonella shedding by ibises to determine the role of landscape characteristics where ibis forage and their behavior, on shedding rates. We also compared Salmonella isolated from ibises to human isolates to better understand non-foodborne human salmonellosis. From 2010-2013, 13% (n = 261) adult/subadult ibises and 35% (n = 72) nestlings sampled were shedding Salmonella. The prevalence of Salmonella shedding by ibises significantly decreased as the percent of Palustrine emergent wetlands and herbaceous grasslands increased, and increased as the proportion of open-developed land types (e.g. parks, lawns, golf courses) increased, suggesting that natural ecosystem land cover types supported birds with a lower prevalence of infection. A high diversity of Salmonella serotypes (n = 24) and strain types (43 PFGE types) were shed by ibises, of which 33% of the serotypes ranked in the top 20 of high significance for people in the years of the study. Importantly, 44% of the Salmonella Pulsed-Field Gel Electrophoresis patterns for ibis isolates (n = 43) matched profiles in the CDC PulseNet USA database. Of these, 20% came from Florida in the same three years we sampled ibis. Importantly, there was a negative relationship between the amount of Palustrine emergent wetland and the number of Salmonella isolates from ibises that matched human cases in the PulseNet database (p = 0.056). Together, our results indicate that ibises are good indicators of salmonellae strains circulating in their environment and they have both the potential and opportunity to transmit salmonellae to people. Finally, they may act as salmonellae carriers to natural environments where other more highly-susceptible groups (nestlings) may be detrimentally affected.	[Hernandez, Sonia M.; Welch, Catharine N.; Curry, Shannon; Yabsley, Michael J.; Conway, April L.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Hernandez, Sonia M.; Yabsley, Michael J.; Kistler, Whitney M.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Peters, Valerie E.] Miami Univ, Dept Zool, Inst Environm & Sustainabil, Columbia, OH USA; [Lipp, Erin K.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA; [Sanchez, Susan] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA; [Presotto, Andrea; Madden, Marguerite] Univ Georgia, Dept Geog, Athens, GA 30602 USA; [Gerner-Smidt, Peter; Hise, Kelley B.] Ctr Dis Control & Prevent, US Dept Hlth & Human Serv, Atlanta, GA USA; [Hammond, Elizabeth] Lion Country Safari Pk, Loxahatchee, FL USA; [Kwan, Tiffany; Maurer, John J.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Poultry Diagnost & Res Ctr, Athens, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Ohio; Miami University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia	Hernandez, SM (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.; Hernandez, SM (corresponding author), Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA.	shernz@uga.edu		Kwan, Tiffany/0000-0001-5575-7498; Lipp, Erin/0000-0002-8066-0636; Yabsley, Michael/0000-0003-2452-5015	National Institutes of Health [1R15A1089565-01]; American Association of Zoo Veterinarians; University of Georgia; National Science Foundation [EEID 1518611]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association of Zoo Veterinarians; University of Georgia; National Science Foundation(National Science Foundation (NSF))	This research was funded by National Institutes of Health 1R15A1089565-01 to Erin K Lipp; American Association of Zoo Veterinarians to Dr Sonia M. Hernandez; University of Georgia to Dr Sonia Maria Hernandez; and National Science Foundation EEID 1518611 to Dr. Sonia M. Hernandez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley MR, 2002, NEW ZEAL VET J, V50, P170; [Anonymous], 1984, WETLANDS US CURRENT; Barton K, 2016, MODEL SELECTION MODE; Bates D., 2015, LINEAR MIXED EFFECTS; Bidol S. A., 2007, Morbidity and Mortality Weekly Report, V56, P909; BILDSTEIN KL, 1990, WILSON BULL, V102, P84; Bivand R, 2016, SPATIAL DEPENDENCE W; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; CDC, 2006, SALM ANN SUMM 2006; CDC, 2002, MMWR-MORBID MORTAL W, V51, P1044; CDC, 2014, NAT SALM SURV ANN RE; CDC, 2004, OUTBR SALM SER ENT I, P484; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P392; CIZEK A, 1994, J VET MED B, V41, P320, DOI 10.1111/j.1439-0450.1994.tb00234.x; Daoust Pierre-Yves, 2007, P270, DOI 10.1002/9780470344668.ch13; Daoust PY, 2000, CAN VET J, V41, P54; Dorn NJ, 2011, IBIS, V153, P323, DOI 10.1111/j.1474-919X.2011.01101.x; Epstein JH, 2006, ECOHEALTH, V3, P290, DOI 10.1007/s10393-006-0064-2; Friend M, 1999, ITR1999001 BIOL RES; Fukui D, 2014, J WILDLIFE DIS, V50, P484, DOI 10.7589/2012-12-321; Fukui Daisuke, 2013, Japanese Journal of Zoo and Wildlife Medicine, V18, P41; Gawlik DE, 2002, ECOL MONOGR, V72, P329, DOI 10.1890/0012-9615(2002)072[0329:TEOPAO]2.0.CO;2; Gerner-Smidt P, 2006, FOODBORNE PATHOG DIS, V3, P9, DOI 10.1089/fpd.2006.3.9; GIRDWOOD RWA, 1985, J HYG-CAMBRIDGE, V95, P229, DOI 10.1017/S0022172400062665; Greene SK, 2008, EPIDEMIOL INFECT, V136, P157, DOI 10.1017/S095026880700859X; Haley BJ, 2009, APPL ENVIRON MICROB, V75, P1248, DOI 10.1128/AEM.01648-08; Hall AJ, 2008, J WILDLIFE DIS, V44, P585, DOI 10.7589/0090-3558-44.3.585; Hauser E, 2009, BERL MUNCH TIERARZTL, V122, P169, DOI 10.2376/0005-9366-122-169; Hedberg CW, 1999, EPIDEMIOL INFECT, V122, P385, DOI 10.1017/S0950268899002393; Hernandez SM, 2012, APPL ENVIRON MICROB, V78, P7290, DOI 10.1128/AEM.01408-12; Kapperud G, 1998, AM J EPIDEMIOL, V147, P774, DOI 10.1093/oxfordjournals.aje.a009522; KUSHLAN JA, 1979, CONDOR, V81, P376, DOI 10.2307/1366963; Kushlan JA, 2011, SUPPLEMENTAL INFORM, P3; Lawson B, 2010, ECOHEALTH, V7, P294, DOI 10.1007/s10393-010-0349-3; Lawson B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088968; Liljebjelke KA, 2005, FOODBORNE PATHOG DIS, V2, P90, DOI 10.1089/fpd.2005.2.90; LOCKE L N, 1974, Journal of Wildlife Diseases, V10, P143; Lynch Michael, 2006, Morbidity and Mortality Weekly Report, V55, P1; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Martin JM, 2011, LANDSCAPE URBAN PLAN, V102, P65, DOI 10.1016/j.landurbplan.2011.03.010; Matyas B., 2010, Morbidity and Mortality Weekly Report, V59, P418; Maurer JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128937; Meinersmann RJ, 2008, MICROB ECOL, V55, P444, DOI 10.1007/s00248-007-9290-6; Miller S, 2015, J WILDLIFE DIS, V51, P60, DOI 10.7589/2014-02-046; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Mohle-Boetani JC, 2009, EPIDEMIOL INFECT, V137, P357, DOI 10.1017/S0950268808000411; Nesse LL, 2005, EPIDEMIOL INFECT, V133, P53, DOI 10.1017/S0950268804003279; Oksanen J., COMMUNITY ECOLOGY PA; Oliver AJ, 2011, LANDSCAPE URBAN PLAN, V102, P215, DOI 10.1016/j.landurbplan.2011.04.007; Olsen SJ, 2001, J INFECT DIS, V183, P753, DOI 10.1086/318832; Palmgren H, 2006, EPIDEMIOL INFECT, V134, P635, DOI 10.1017/S0950268805005261; Pedersen K, 2006, J WILDLIFE DIS, V42, P46, DOI 10.7589/0090-3558-42.1.46; PENFOLD JB, 1979, BRIT MED J, V2, P802; Pennycott TW, 2006, VET REC, V158, P817, DOI 10.1136/vr.158.24.817; Phalen DN, 2010, J WILDLIFE DIS, V46, P379, DOI 10.7589/0090-3558-46.2.379; Proctor ME, 2001, J CLIN MICROBIOL, V39, P3461, DOI 10.1128/JCM.39.10.3461-3465.2001; R Core Team, 2016, R LANG ENV STAT COMP; Reche MP, 2003, J VET MED B, V50, P42, DOI 10.1046/j.1439-0450.2003.00623.x; Refsum T, 2003, J WILDLIFE DIS, V39, P64, DOI 10.7589/0090-3558-39.1.64; Refsum T, 2002, APPL ENVIRON MICROB, V68, P5600, DOI 10.1128/AEM.68.11.5600-5606.2002; Safranek T., 2009, Morbidity and Mortality Weekly Report, V58, P500; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Tauni MA, 2000, J SMALL ANIM PRACT, V41, P339, DOI 10.1111/j.1748-5827.2000.tb03214.x; Thorns CJ, 2000, REV SCI TECH OIE, V19, P226, DOI 10.20506/rst.19.1.1219; Tizard I, 2004, SEMIN AVIAN EXOT PET, V13, P50, DOI 10.1053/j.saep.2004.01.008; Une Y, 2008, JPN J INFECT DIS, V61, P166; Velarde R, 2012, J WILDLIFE DIS, V48, P113, DOI 10.7589/0090-3558-48.1.113; Wales A, 2013, SALMONELLA IN DOMESTIC ANIMALS, 2ND EDITION, P399, DOI 10.1079/9781845939021.0399; Zamperini K, 2007, AVIAN DIS, V51, P958, DOI 10.1637/7944-021507-REGR.1	69	20	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164402	10.1371/journal.pone.0164402	http://dx.doi.org/10.1371/journal.pone.0164402			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768705	gold, Green Published, Green Submitted			2022-12-26	WOS:000386205400013
J	Ai, CQ; Ma, N; Zhang, QX; Wang, G; Liu, XM; Tian, FW; Chen, P; Chen, W				Ai, Chunqing; Ma, Na; Zhang, Qiuxiang; Wang, Gang; Liu, Xiaoming; Tian, Fengwei; Chen, Pei; Chen, Wei			Immunomodulatory Effects of Different Lactic Acid Bacteria on Allergic Response and Its Relationship with In Vitro Properties	PLOS ONE			English	Article							REGULATORY T-CELLS; ATOPIC-DERMATITIS; MURINE MODEL; IFN-GAMMA; PROBIOTICS; SENSITIZATION; SUPPLEMENTATION; ANAPHYLAXIS; MICROBIOTA; EXPRESSION	Some studies reported that probiotic could relieve allergy-induced damage to the host, but how to get a useful probiotic is still a challenge. In this study, the protective effects of three lactic acid bacteria (La, Lp and Lc) were evaluated in a mouse model, and its relationship with the in vitro properties was analyzed. The in vitro results indicated that La with the capacity to inhibit IL-4 production could have a better anti-allergy effect in vivo than two others. However, the animal trials showed that all LAB strains could alleviate allergen-induced airway inflammation. Among them, LAB strain Lp had a better effect in inhibiting allergic response through a modulation of Th1/Th2 balance and an increase of regulatory T cells. This difference could be explained by that different LAB strains have a strain-specific effect on gut microbiota closely associated with host immune responses. Finally, this study did not only obtain an effective anti-allergy probiotic strain via animal study, but also indicate that probiotic-induced effect on intestinal microbiota should be considered as an important screening index, apart from its inherent characteristics.	[Ai, Chunqing; Ma, Na] Dalian Polytech Univ, Sch Food Sci & Technol, Natl Engn Res Ctr Seafood, Dalian 116034, Peoples R China; [Ai, Chunqing; Zhang, Qiuxiang; Wang, Gang; Liu, Xiaoming; Tian, Fengwei; Chen, Wei] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China; [Chen, Pei] Shaanxi Univ Technol, Sch Biol Sci & Engn, Hanzhong 723001, Peoples R China; [Chen, Pei] Shanxi Radio & TV Univ, Xian 710119, Peoples R China	Dalian Polytechnic University; Jiangnan University; Shaanxi University of Technology	Zhang, QX; Chen, W (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China.	zhangqx@jiangnan.edu.cn; chenwei66@jiangnan.edu.cn	Chen, Wei/GZK-7348-2022; Wang, Gang/AEO-7822-2022	Wang, Gang/0000-0003-2007-2143	National Natural Science Foundation of China [31200691]; National Science Fund for Distinguished Young Scholars [31125021]; National Science and Technology Pillar Program [2013BAD18B01]; Agricultural Science and Technology Innovation Projects of Shaanxi Province [2015NY025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Science and Technology Pillar Program; Agricultural Science and Technology Innovation Projects of Shaanxi Province	This work was supported by the National Natural Science Foundation of China (No. 31200691; QXZ), the National Science Fund for Distinguished Young Scholars (No. 31125021; WC), the National Science and Technology Pillar Program (2013BAD18B01; WC) and the Agricultural Science and Technology Innovation Projects of Shaanxi Province (2015NY025; PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai CQ, 2015, FOOD CONTROL, V50, P283, DOI 10.1016/j.foodcont.2014.08.040; Ando H, 2008, J ALLERGY CLIN IMMUN, V122, P583, DOI 10.1016/j.jaci.2008.06.016; Barnes PJ, 2001, RESPIR RES, V2, P64, DOI 10.1186/rr39; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Earle KE, 2005, CLIN IMMUNOL, V115, P3, DOI 10.1016/j.clim.2005.02.017; Elazab N, 2013, PEDIATRICS, V132, pE666, DOI 10.1542/peds.2013-0246; Feleszko W, 2007, CLIN EXP ALLERGY, V37, P498, DOI 10.1111/j.1365-2222.2006.02629.x; Fujiwara D, 2004, INT ARCH ALLERGY IMM, V135, P205, DOI 10.1159/000081305; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Hougee S, 2010, INT ARCH ALLERGY IMM, V151, P107, DOI 10.1159/000236000; Jacquet A, 2011, TRENDS MOL MED, V17, P604, DOI 10.1016/j.molmed.2011.05.014; Kim H, 2005, FEMS IMMUNOL MED MIC, V45, P259, DOI 10.1016/j.femsim.2005.05.005; Krug N, 1996, AM J RESP CELL MOL, V14, P319, DOI 10.1165/ajrcmb.14.4.8600935; Lee CC, 2011, CELL MOL IMMUNOL, V8, P404, DOI 10.1038/cmi.2011.13; Matasar MJ, 2003, CURR ALLERGY ASTHM R, V3, P30, DOI 10.1007/s11882-003-0007-8; Meijerink M, 2012, FEMS IMMUNOL MED MIC, V65, P488, DOI 10.1111/j.1574-695X.2012.00981.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neau E, 2015, 17 INT C MUC IMM ICM; Niemi RM, 2001, J MICROBIOL METH, V45, P155, DOI 10.1016/S0167-7012(01)00253-6; Niers LEM, 2005, CLIN EXP ALLERGY, V35, P1481, DOI 10.1111/j.1365-2222.2005.02375.x; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Ongol MP, 2008, BIOSCI BIOTECH BIOCH, V72, P2847, DOI 10.1271/bbb.80307; Pelucchi C, 2012, EPIDEMIOLOGY, V23, P402, DOI 10.1097/EDE.0b013e31824d5da2; Pohjavuori E, 2004, J ALLERGY CLIN IMMUN, V114, P131, DOI 10.1016/j.jaci.2004.03.036; Rigaux P, 2009, ALLERGY, V64, P406, DOI 10.1111/j.1398-9995.2008.01825.x; Rinne M, 2005, J PEDIATR-US, V147, P186, DOI 10.1016/j.jpeds.2005.03.053; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Salminen S., 2004, LACTIC ACID BACTERIA, DOI [10.1201/9780824752033, DOI 10.1201/9780824752033]; Schaafsma G., 1996, IDF Nutrition Newsletter, P23; Schiavi E, 2011, ALLERGY, V66, P499, DOI 10.1111/j.1398-9995.2010.02501.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Taylor AL, 2007, J ALLERGY CLIN IMMUN, V119, P184, DOI 10.1016/j.jaci.2006.08.036; Toh ZQ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00171; Tsuji NM, 2008, TRENDS IMMUNOL, V29, P532, DOI 10.1016/j.it.2008.09.002; Wang JJ, 2015, ISME J, V9, P1, DOI 10.1038/ismej.2014.99; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Xiao JZ, 2006, J INVEST ALLERG CLIN, V16, P273; Zhang Q, 2015, J APPL MICROBIOL, V119, P809, DOI 10.1111/jam.12885	40	23	23	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164697	10.1371/journal.pone.0164697	http://dx.doi.org/10.1371/journal.pone.0164697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764153	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500051
J	Cox, CV; Diamanti, P; Moppett, JP; Blair, A				Cox, Charlotte V.; Diamanti, Paraskevi; Moppett, John P.; Blair, Allison			Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							MINIMAL RESIDUAL DISEASE; RANDOMIZED CONTROLLED-TRIAL; FLOW-CYTOMETRIC DETECTION; UKALL 2003; B-ALL; THERAPY; POPULATIONS; RISK; INDUCTION; REMISSION	A significant number of children with T-lineage acute lymphoblastic leukemia (T-ALL) fail to respond to therapy and experience early relapse. CD99 has been shown to be overexpressed on T-ALL cells and is considered to be a reliable detector of the disease. However, the relevance of CD99 overexpression in ALL has not been investigated in a functional context. The aim of this study was to investigate the functional capacity of CD99(+) cells in childhood ALL and determine the suitability of CD99 as a therapeutic target. Flow cytometric analyses confirmed higher expression of CD99 in ALL blasts (81.5 +/- 22.7%) compared to normal hemopoietic stem cells (27.5 +/- 21.9%) and T cells (3.1 +/- 5.2%, P <= 0.004). When ALL cells were sorted and assessed in functional assays, all 4 subpopulations (CD34(+)/CD99(+), CD34(+)/CD99(-), CD34(-)/CD99(+) and CD34(-)/CD99(-)) could proliferate in vitro and establish leukemia in NSG mice. Leukemia propagating cell frequencies ranged from 1 in 300 to 1 in 7.4x10(4) but were highest in the CD34(+)/CD99(-) subpopulation. In addition, all four subpopulations had self-renewal ability in secondary NSG mice. Cells in each subpopulation contained patient specific TCR rearrangements and karyotypic changes that were preserved with passage through serial NSG transplants. Despite high levels of CD99 antigen on the majority of blast cells, leukemia initiating capacity in vivo was not restricted to cells that express this protein. Consequently, targeting CD99 alone would not eliminate all T-ALL cells with the ability to maintain the disease. The challenge remains to develop therapeutic strategies that can eliminate all leukemia cells with self-renewal capacity in vivo.	[Cox, Charlotte V.; Diamanti, Paraskevi; Blair, Allison] NHS Blood & Transplant, Bristol Inst Transfus Sci, Bristol, Avon, England; [Cox, Charlotte V.; Diamanti, Paraskevi; Moppett, John P.; Blair, Allison] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Moppett, John P.] Bristol Royal Hosp Children, Bristol, Avon, England	University of Bristol; Bristol Royal Hospital For Children	Blair, A (corresponding author), NHS Blood & Transplant, Bristol Inst Transfus Sci, Bristol, Avon, England.; Blair, A (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.	allison.blair@bristol.ac.uk	Blair, Allison/O-5440-2019	Blair, Allison/0000-0002-9759-5156; Moppett, John/0000-0003-1844-3531	National Institute for Health Research (NIHR) under its Programme Grants scheme [RP-PG-0310-1003]; National Institute for Health Research [RP-PG-0310-1003] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Grants scheme; National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research commissioned by the National Institute for Health Research (NIHR www.nihr.ac.uk/) under its Programme Grants scheme (RP-PG-0310-1003) and the Department of Health (UK). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Basso G, 2009, J CLIN ONCOL, V27, P5168, DOI 10.1200/JCO.2008.20.8934; Borowitz MJ, 2015, BLOOD, V126, P964, DOI 10.1182/blood-2015-03-633685; Chiu PPL, 2010, BLOOD, V116, P5268, DOI 10.1182/blood-2010-06-292300; Cox CV, 2007, BLOOD, V109, P674, DOI 10.1182/blood-2006-06-030445; Denys B, 2013, LEUKEMIA, V27, P635, DOI 10.1038/leu.2012.231; Diamanti P, 2012, LEUKEMIA, V26, P376, DOI 10.1038/leu.2011.212; Diamanti P, 2013, BLOOD, V121, P1384, DOI 10.1182/blood-2012-08-448852; DWORZAK MN, 1994, BLOOD, V83, P415, DOI 10.1182/blood.V83.2.415.bloodjournal832415; Dworzak MN, 2004, LEUKEMIA, V18, P703, DOI 10.1038/sj.leu.2403303; Gardner R, 2016, BLOOD, V127, P2406, DOI 10.1182/blood-2015-08-665547; Gerby B, 2011, LEUKEMIA, V25, P1249, DOI 10.1038/leu.2011.93; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Handgretinger R, 2011, LEUKEMIA, V25, P181, DOI 10.1038/leu.2010.239; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Morisot S, 2010, LEUKEMIA, V24, P1859, DOI 10.1038/leu.2010.184; Patrick K, 2015, CURR OPIN PEDIATR, V27, P44, DOI 10.1097/MOP.0000000000000171; Pui CH, 2015, LANCET ONCOL, V16, P465, DOI 10.1016/S1470-2045(15)70082-3; Rehe K, 2013, EMBO MOL MED, V5, P38, DOI 10.1002/emmm.201201703; Roshal M, 2010, CYTOM PART B-CLIN CY, V78B, P139, DOI 10.1002/cyto.b.20511; Schlegel P, 2014, HAEMATOLOGICA, V99, P1212, DOI 10.3324/haematol.2013.100073; Schrappe M, 2012, NEW ENGL J MED, V366, P1371, DOI 10.1056/NEJMoa1110169; Stow P, 2010, BLOOD, V115, P4657, DOI 10.1182/blood-2009-11-253435; Szczepanski T, 2011, J CLIN ONCOL, V29, P1643, DOI 10.1200/JCO.2010.30.2877; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; van Dongen JJM, 2015, BLOOD, V125, P3996, DOI 10.1182/blood-2015-03-580027; Vora A, 2014, LANCET ONCOL, V15, P809, DOI 10.1016/S1470-2045(14)70243-8; Vora A, 2013, LANCET ONCOL, V14, P199, DOI 10.1016/S1470-2045(12)70600-9	28	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165210	10.1371/journal.pone.0165210	http://dx.doi.org/10.1371/journal.pone.0165210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764235	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500135
J	Gardiner, J; Gunarathne, N; Howard, D; Kenney, L				Gardiner, James; Gunarathne, Nuwan; Howard, David; Kenney, Laurence			Crowd-Sourced Amputee Gait Data: A Feasibility Study Using YouTube Videos of Unilateral Trans-Femoral Gait	PLOS ONE			English	Article							TRANSFEMORAL AMPUTEES; TRANSTIBIAL AMPUTEES; WALKING; ASYMMETRY; KNEE	Collecting large datasets of amputee gait data is notoriously difficult. Additionally, collecting data on less prevalent amputations or on gait activities other than level walking and running on hard surfaces is rarely attempted. However, with the wealth of user-generated content on the Internet, the scope for collecting amputee gait data from alternative sources other than traditional gait labs is intriguing. Here we investigate the potential of YouTube videos to provide gait data on amputee walking. We use an example dataset of trans-femoral amputees level walking at self-selected speeds to collect temporal gait parameters and calculate gait asymmetry. We compare our YouTube data with typical literature values, and show that our methodology produces results that are highly comparable to data collected in a traditional manner. The similarity between the results of our novel methodology and literature values lends confidence to our technique. Nevertheless, clear challenges with the collection and interpretation of crowd-sourced gait data remain, including long term access to datasets, and a lack of validity and reliability studies in this area.	[Gardiner, James; Howard, David] Univ Salford, Sch Comp Sci & Engn, Salford, Lancs, England; [Gunarathne, Nuwan; Kenney, Laurence] Univ Salford, Sch Hlth Sci, Salford, Lancs, England	University of Salford; University of Salford	Gardiner, J (corresponding author), Univ Salford, Sch Comp Sci & Engn, Salford, Lancs, England.	j.d.gardiner@salford.ac.uk		Kenney, Laurence/0000-0003-2164-3892; Gardiner, James/0000-0003-1902-3416	EPSRC [EP/K019759/1]; EPSRC [EP/I003223/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I003223/1, EP/K019759/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was funded by an EPSRC grant: EP/K019759/1. The funding body had no role in the design, in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Ache KA, 2008, AM J PREV MED, V35, P389, DOI 10.1016/j.amepre.2008.06.029; Albert MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065340; BECKER HP, 1995, CLIN ORTHOP RELAT R, P262; Beurskens R, 2014, J BIOMECH, V47, P3072, DOI 10.1016/j.jbiomech.2014.06.041; Boonstra AM, 1996, ARCH PHYS MED REHAB, V77, P515, DOI 10.1016/S0003-9993(96)90044-1; Castelli A, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/186780; Ceseracciu E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087640; Fletcher DD, 2001, ARCH PHYS MED REHAB, V82, P776, DOI 10.1053/apmr.2001.21856; Hak L, 2013, ARCH PHYS MED REHAB, V94, P2186, DOI 10.1016/j.apmr.2013.07.020; Hand E, 2010, NATURE, V466, P685, DOI 10.1038/466685a; Hofstad Cheriel J, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD003978.PUB2]; LeMoyne R., 2016, ADV PROSHETIC TECHNO, P127; Murugiah K, 2011, RESUSCITATION, V82, P332, DOI 10.1016/j.resuscitation.2010.11.015; Nolan L, 2003, GAIT POSTURE, V17, P142, DOI 10.1016/S0966-6362(02)00066-8; Paysant J, 2006, J REHABIL RES DEV, V43, P153, DOI 10.1682/JRRD.2005.02.0043; Sandau M, 2014, MED ENG PHYS, V36, P1168, DOI 10.1016/j.medengphy.2014.07.007; Schaarschmidt M, 2012, HUM MOVEMENT SCI, V31, P907, DOI 10.1016/j.humov.2011.09.004; Shorter KA, 2008, CLIN BIOMECH, V23, P459, DOI 10.1016/j.clinbiomech.2007.11.009; Sood A, 2011, UROLOGY, V77, P558, DOI 10.1016/j.urology.2010.07.536; Starholm IM, 2010, PROSTHET ORTHOT INT, V34, P184, DOI 10.3109/03093640903585016; Sup F, 2011, IEEE T NEUR SYS REH, V19, P71, DOI 10.1109/TNSRE.2010.2087360; van der Linden ML, 1999, J BIOMECH, V32, P877, DOI 10.1016/S0021-9290(99)00086-X	22	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165287	10.1371/journal.pone.0165287	http://dx.doi.org/10.1371/journal.pone.0165287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764226	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500146
J	Venables, E; Edwards, JK; Baert, S; Etienne, W; Khabala, K; Bygrave, H				Venables, Emilie; Edwards, Jeffrey K.; Baert, Saar; Etienne, William; Khabala, Kelly; Bygrave, Helen			"They just come, pick and go." The Acceptability of Integrated Medication Adherence Clubs for HIV and Non Communicable Disease (NCD) Patients in Kibera, Kenya	PLOS ONE			English	Article							CARE; PREVALENCE; NAIROBI; PEOPLE	Introduction The number of people on antiretroviral therapy (ART) for the long-term management of HIV in low-and middle-income countries (LMICs) is continuing to increase, along with the prevalence of Non-Communicable Diseases (NCDs). The need to provide large volumes of HIV patients with ART has led to significant adaptations in how medication is delivered, but access to NCD care remains limited in many contexts. Medication Adherence Clubs (MACs) were established in Kibera, Kenya to address the large numbers of patients requiring chronic HIV and/or NCD care. Stable NCD and HIV patients can now collect their chronic medication every three months through a club, rather than through individual clinic appointments. Methodology We conducted a qualitative research study to assess patient and health-care worker perceptions and experiences of MACs in the urban informal settlement of Kibera, Kenya. A total of 106 patients (with HIV and/or other NCDs) and health-care workers were purposively sampled and included in the study. Ten focus groups and 19 in-depth interviews were conducted and 15 sessions of participant observation were carried out at the clinic where the MACs took place. Thematic data analysis was conducted using NVivo software, and coding focussed on people's experiences of MACs, the challenges they faced and their perceptions about models of care for chronic conditions. Results MACs were considered acceptable to patients and health-care workers because they saved time, prevented unnecessary queues in the clinic and provided people with health education and group support whilst they collected their medication. Some patients and health-care workers felt that MACs reduced stigma for HIV positive patients by treating HIV as any other chronic condition. Staff and patients reported challenges recruiting patients into MACs, including patients not fully understanding the eligibility criteria for the clubs. There were also some practical challenges during the implementation of the clubs, but MACs have shown that it is possible to learn from ART provision and enable stable HIV and NCD patients to collect chronic medication together in a group. Conclusions Extending models of care previously only offered to HIV-positive cohorts to NCD patients can help to de-stigmatise HIV, allow for the efficient clinical management of co-morbidities and enable patients to benefit from peer support. Through MACs, we have demonstrated that an integrated approach to providing medication for chronic diseases including HIV can be implemented in resource-poor settings and could thus be rolled out in other similar contexts.	[Venables, Emilie; Baert, Saar; Bygrave, Helen] Med Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa; [Venables, Emilie] Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Cape Town, South Africa; [Edwards, Jeffrey K.; Etienne, William] Med Sans Frontieres Belgium, Operat Ctr Brussels, Dept Med, Brussels, Belgium; [Khabala, Kelly] Med Sans Frontieres, Nairobi, Kenya	University of Cape Town	Venables, E (corresponding author), Med Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa.; Venables, E (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Cape Town, South Africa.	emilie.venables@brussels.msf.org		Baert, Saar/0000-0002-9822-148X				[Anonymous], 2012, NVIVO COMP PROGR; Ayah R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-371; Belue R, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-10; Bemelmans M, 2014, TROP MED INT HEALTH, V19, P968, DOI 10.1111/tmi.12332; Council on Foreign Relations, 2014, EM GLOB CRIS NONC DI; Dalal W, 2013, JAIDS-J ACQ IMM DEF, V62, pE47, DOI 10.1097/QAI.0b013e318276bea0; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Desgroppes A, 2011, CAHIERS AFRIQUE EST, P23; Duncombe C, 2015, TROP MED INT HEALTH, V20, P430, DOI 10.1111/tmi.12460; Edwards JK, 2015, T ROY SOC TROP MED H, V109, P440, DOI 10.1093/trstmh/trv038; Fedele F, 2011, AIDS REV, V13, P119; Kalra S, 2013, CURR DIABETES REP, V13, P419, DOI 10.1007/s11892-013-0369-9; Kenyan Ministry of Health, 2014, KEN HLTH POL 2014 20; Khabala KB, 2015, TROP MED INT HEALTH, V20, P1265, DOI 10.1111/tmi.12539; Narayan KMV, 2014, JAIDS-J ACQ IMM DEF, V67, pS2, DOI 10.1097/QAI.0000000000000267; National Institute of Allergy and Infectious Diseases (NIAID), 2015, START ANT TREATM EAR; Opwora A, 2015, HEALTH POLICY PLANN, V30, P508, DOI 10.1093/heapol/czu026; Rabkin M, 2011, GLOB PUBLIC HEALTH, V6, P247, DOI 10.1080/17441692.2011.552068; UNAIDS, 2014, 90 90 90 AMB TREATM, P40; UNAIDS and Medecins sans Frontieres, 2015, COMM BAS ANT THER DE; van de Vijver SJM, 2013, J HYPERTENS, V31, P1018, DOI 10.1097/HJH.0b013e32835e3a56; Wilkinson LS, 2013, S AFR J HIV MED, V14, P48, DOI [10.7196/SAJHIVMED.924, 10.7196/sajhivmed.924]; World Health Organization, 2015, GUID START ANT THER	23	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164634	10.1371/journal.pone.0164634	http://dx.doi.org/10.1371/journal.pone.0164634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764128	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500048
J	Lei, XM; Chen, CS; Chen, CH; He, QH; Moyzis, RK; Xue, G; Dong, Q				Lei, Xuemei; Chen, Chuansheng; Chen, Chunhui; He, Qinghua; Moyzis, Robert K.; Xue, Gui; Dong, Qi			Striatum-Centered Fiber Connectivity Is Associated with the Personality Trait of Cooperativeness	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; LATERAL PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; VENTRAL STRIATUM; DIFFUSION TRACTOGRAPHY; SOCIAL COOPERATION; DECISION-MAKING; MOTIVATION; REWARD; BRAIN	Cooperativeness is an essential behavioral trait evolved to facilitate group living. Social and cognitive mechanisms involved in cooperation (e.g., motivation, reward encoding, action evaluation, and executive functions) are sub-served by the striatal-projected circuits, whose physical existence has been confirmed by animal studies, human postmortem studies, and in vivo human brain studies. The current study investigated the associations between Cooperativeness and fiber connectivities from the striatum to nine subcortical and cortical regions, including the amygdala, hippocampus, medial orbitofrontal cortex, lateral orbitofrontal cortex, ventrolateral prefrontal cortex, dorsolateral prefrontal cortex, posterior cingulate cortex/retrosplenial cortex, dorsal cingulate cortex, and rostral cingulate cortex. Results showed that Cooperativeness was negatively correlated with fiber connectivity for the cognitive control system (from the dorsal caudate to the rostral cingulate cortex and ventrolateral prefrontal cortex), but not with fiber connectivity for the social cognitive system (e.g., connectivity with the medial prefrontal cortex and amygdala). These results partially supported Declerck et al.' s (2013) cognitive neural model of the role of cognitive control and social cognition in cooperation.	[Lei, Xuemei] Beijing Normal Univ, Sch Psychol, Beijing, Peoples R China; [Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA 92697 USA; [Chen, Chunhui; Xue, Gui; Dong, Qi] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [He, Qinghua] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Moyzis, Robert K.] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92717 USA	Beijing Normal University; University of California System; University of California Irvine; Beijing Normal University; Southwest University - China; University of California System; University of California Irvine	Chen, CS (corresponding author), Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA 92697 USA.; Dong, Q (corresponding author), Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China.	chuansheng.chen@uci.edu; dongqi@bnu.edu.cn	He, Qinghua/B-2573-2008; Xue, Gui/A-1762-2009	He, Qinghua/0000-0001-6396-6273; Xue, Gui/0000-0001-7891-8151; Chen, Chuansheng/0000-0002-8224-1005	111 Project of the Ministry of Education of China [B07008]; New Teacher Research Funds of Beijing Normal University [SKXJS2014024]; Natural Science Foundation of China [31521023]	111 Project of the Ministry of Education of China(Ministry of Education, China - 111 Project); New Teacher Research Funds of Beijing Normal University; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the 111 Project of the Ministry of Education of China (B07008), the New Teacher Research Funds of Beijing Normal University (SKXJS2014024), and the Natural Science Foundation of China (31521023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemori K, 2015, J NEUROSCI, V35, P1939, DOI 10.1523/JNEUROSCI.1731-14.2015; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bohanna I, 2011, NEUROBIOL DIS, V42, P475, DOI 10.1016/j.nbd.2011.02.010; Burnham TC, 2007, HUM NATURE-INT BIOS, V18, P88, DOI 10.1007/s12110-007-9012-2; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cloninger CR, 1998, THE DEVELOPMENT OF P, P1; Cloninger CR, 1999, THE TEMPERAMENT AND; Cohen MX, 2011, CURR BIOL, V21, P1900, DOI 10.1016/j.cub.2011.09.036; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; De Pisapia N, 2007, CEREB CORTEX, V17, P993, DOI 10.1093/cercor/bhl010; Declerck CH, 2013, BRAIN COGNITION, V81, P95, DOI 10.1016/j.bandc.2012.09.009; Diekhof EK, 2012, NEUROPSYCHOLOGIA, V50, P1252, DOI 10.1016/j.neuropsychologia.2012.02.007; Dixon ML, 2014, NEUROSCI BIOBEHAV R, V45, P9, DOI 10.1016/j.neubiorev.2014.04.011; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Dyrby TB, 2014, NEUROIMAGE, V103, P202, DOI 10.1016/j.neuroimage.2014.09.005; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Emonds G, 2012, SOC NEUROSCI-UK, V7, P494, DOI 10.1080/17470919.2012.655426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Goncalves DM, 2010, J AFFECT DISORDERS, V124, P126, DOI 10.1016/j.jad.2009.11.007; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Haroush K, 2015, CELL, V160, P1233, DOI 10.1016/j.cell.2015.01.045; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; HOM HL, 1994, J GENET PSYCHOL, V155, P87, DOI 10.1080/00221325.1994.9914761; Immordino-Yang MH, 2013, HUM BRAIN MAPP, V34, P945, DOI 10.1002/hbm.21485; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Izuma K, 2010, J COGNITIVE NEUROSCI, V22, P621, DOI 10.1162/jocn.2009.21228; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Johansen-Berg H, 2009, ANNU REV NEUROSCI, V32, P75, DOI 10.1146/annurev.neuro.051508.135735; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Lei XM, 2014, NEUROIMAGE, V89, P226, DOI 10.1016/j.neuroimage.2013.04.043; Liljeholm M, 2012, TRENDS COGN SCI, V16, P467, DOI 10.1016/j.tics.2012.07.007; Lockwood PL, 2015, J NEUROSCI, V35, P13720, DOI 10.1523/JNEUROSCI.1703-15.2015; Martin A, 2015, PERSPECT PSYCHOL SCI, V10, P159, DOI 10.1177/1745691615568998; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rilling JK, 2007, BIOL PSYCHIAT, V61, P1260, DOI 10.1016/j.biopsych.2006.07.021; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sanfey AG, 2015, TRENDS COGN SCI, V19, P364, DOI 10.1016/j.tics.2015.05.009; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stalnaker TA, 2015, NAT NEUROSCI, V18, P620, DOI 10.1038/nn.3982; Stevens JR, 2005, ANNU REV ECOL EVOL S, V36, P499, DOI 10.1146/annurev.ecolsys.36.113004.083814; Sutterlin S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00173; Tziortzi AC, 2014, CEREB CORTEX, V24, P1165, DOI 10.1093/cercor/bhs397; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yamasue H, 2008, CEREB CORTEX, V18, P2331, DOI 10.1093/cercor/bhm254; Yap PT, 2014, NEUROIMAGE, V84, P939, DOI 10.1016/j.neuroimage.2013.09.016; Yuan K, 2017, ADDICT BIOL, V22, P813, DOI 10.1111/adb.12348	61	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0162160	10.1371/journal.pone.0162160	http://dx.doi.org/10.1371/journal.pone.0162160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9NV	27755551	Green Published, gold			2022-12-26	WOS:000386203800001
J	Brandt, AU; Meinert-Bohn, E; Rinnenthal, JL; Zimmermann, H; Mikolajczak, J; Oberwahrenbrock, T; Papazoglou, S; Pfuller, CF; Schinzel, J; Tackenberg, B; Paul, F; Hahn, K; Bellmann-Strobl, J				Brandt, Alexander U.; Meinert-Bohn, Elena; Rinnenthal, Jan Leo; Zimmermann, Hanna; Mikolajczak, Janine; Oberwahrenbrock, Timm; Papazoglou, Sebastian; Pfuller, Caspar F.; Schinzel, Johann; Tackenberg, Bjorn; Paul, Friedemann; Hahn, Katrin; Bellmann-Strobl, Judith			Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MARIE-TOOTH-DISEASE; PERIPHERAL MYELIN; MULTIPLE-SCLEROSIS; BRAIN; INVOLVEMENT; LESIONS; FAMILY; HNPP; ASSOCIATION	Background The PMP22 gene encodes a protein integral to peripheral myelin. Its deletion leads to hereditary neuropathy with liability to pressure palsies (HNPP). PMP22 is not expressed in the adult central nervous system, but previous studies suggest a role in CNS myelin development. The objective of this study was to identify potential structural and functional alterations in the afferent visual system in HNPP patients. Methods Twenty HNPP patients and 18 matched healthy controls (HC) were recruited in a cross-sectional study. Participants underwent neurological examination including visual acuity, visual evoked potential (VEP) examination, optical coherence tomography (OCT), and magnetic resonance imaging with calculation of brain atrophy, regarding grey and white matter, and voxel based morphometry (VBM), in addition answered the National Eye Institute's 39-item Visual Functioning Questionnaire (NEI-VFQ). Thirteen patients and 6 HC were additionally examined with magnetic resonance spectroscopy (MRS). Results All patients had normal visual acuity, but reported reduced peripheral vision in comparison to HC in the NEI-VFQ (p = 0.036). VEP latency was prolonged in patients (P-100 = 103.7 +/- 5.7 ms) in comparison to healthy subjects (P100 = 99.7 +/- 4.2 ms, p = 0.007). In OCT, peripapillary retinal nerve fiber layer thickness RNFL was decreased in the nasal sector (90.0 +/- 15.5 vs. 101.8 +/- 16.5, p = 0.013), and lower nasal sector RNFL correlated with prolonged VEP latency (Rho = -0.405, p = 0.012). MRS revealed reduced tNAA (731.4 +/- 45.4 vs. 814.9 +/- 62.1, p = 0.017) and tCr (373.8 +/- 22.2 vs. 418.7 +/- 31.1, p = 0.002) in the visual cortex in patients vs. HC. Whole brain volume, grey and white matter volume, VBM and metabolites in a MRS sensory cortex control voxel did not differ significantly between patients and HC. Conclusion PMP22 deletion leads to functional, metabolic and macro-structural alterations in the afferent visual system of HNPP patients. Our data suggest a functional relevance of these changes for peripheral vision, which warrants further investigation and confirmation.	[Brandt, Alexander U.; Meinert-Bohn, Elena; Zimmermann, Hanna; Mikolajczak, Janine; Oberwahrenbrock, Timm; Papazoglou, Sebastian; Pfuller, Caspar F.; Schinzel, Johann; Paul, Friedemann; Bellmann-Strobl, Judith] Charite, NeuroCure Clin Res Ctr, Berlin, Germany; [Rinnenthal, Jan Leo] Charite, Inst Neuropathol, Berlin, Germany; [Tackenberg, Bjorn] Univ Giessen Marburg, Dept Neurol, Marburg, Germany; [Paul, Friedemann; Hahn, Katrin] Charite, Dept Neurol, Berlin, Germany; [Paul, Friedemann; Bellmann-Strobl, Judith] Max Delbrueck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany; [Paul, Friedemann; Bellmann-Strobl, Judith] Charite, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Brandt, AU (corresponding author), Charite, NeuroCure Clin Res Ctr, Berlin, Germany.	alexander.brandt@charite.de	Paul, Friedemann/ABF-9415-2020	Bellmann-Strobl, Judith/0000-0003-2615-1643; paul, friedemann/0000-0002-6378-0070; Zimmermann, Hanna/0000-0002-0276-8051; Hahn, Katrin/0000-0002-6013-0072	German Research Foundation (DFG Exc) [257]	German Research Foundation (DFG Exc)	This work was supported by the German Research Foundation (DFG Exc 257 to FP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the German Research Foundation (DFG Exc 257 to FP).	Amato AA, 1996, MUSCLE NERVE, V19, P770; Boerkoel CF, 2002, ANN NEUROL, V51, P190, DOI 10.1002/ana.10089; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Chanson JB, 2013, J NEUROL NEUROSUR PS, V84, P392, DOI 10.1136/jnnp-2012-303725; Dackovic J, 2001, EUR J NEUROL, V8, P689, DOI 10.1046/j.1468-1331.2001.00306.x; De Gasperi R, 2010, TRANSL NEUROSCI, V1, P282, DOI 10.2478/v10134-010-0038-3; De Stefano N, 2002, ARCH NEUROL-CHICAGO, V59, P1565, DOI 10.1001/archneur.59.10.1565; FitzGibbon T, 1996, J COMP NEUROL, V375, P238; Foley C, 2012, J NEUROL NEUROSUR PS, V83, P573, DOI 10.1136/jnnp-2011-300285; Franke GH, 1998, Z MED PSYCHOL, P178; Guo JS, 2014, ANN NEUROL, V75, P255, DOI 10.1002/ana.24086; HAASE A, 1985, PHYS MED BIOL, V30, P341, DOI 10.1088/0031-9155/30/4/008; Hagedorn L, 1999, DEVELOPMENT, V126, P3781; Knopp M, 2014, ACTA NEUROL SCAND, V130, P53, DOI 10.1111/ane.12226; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McAuliffe MJ, 2001, COMP MED SY, P381; Meretoja P, 1997, NEUROMUSCULAR DISORD, V7, P529, DOI 10.1016/S0960-8966(97)00100-4; MOFFETT JR, 1993, J HISTOCHEM CYTOCHEM, V41, P559, DOI 10.1177/41.4.8450195; Mouton P, 1999, NEUROLOGY, V52, P1440, DOI 10.1212/WNL.52.7.1440; Muneuchi J, 2000, PEDIATR NEUROL, V22, P302, DOI 10.1016/S0887-8994(99)00146-0; Oberwahrenbrock T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137316; Parmantier E, 1997, J COMP NEUROL, V378, P159; PARMANTIER E, 1995, EUR J NEUROSCI, V7, P1080, DOI 10.1111/j.1460-9568.1995.tb01095.x; POPTANI H, 1995, AM J NEURORADIOL, V16, P1593; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; Russo M, 2011, NEUROMUSCULAR DISORD, V21, P106, DOI 10.1016/j.nmd.2010.11.011; Sacco S, 2004, EUR NEUROL, V51, P168, DOI 10.1159/000077664; Sanahuja J, 2005, ARCH NEUROL-CHICAGO, V62, P1911, DOI 10.1001/archneur.62.12.1911; Schinzel J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-31; Schneider C, 2000, J NEUROL, V247, P222, DOI 10.1007/s004150050569; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; Tackenberg B, 2006, NEUROLOGY, V67, P2250, DOI 10.1212/01.wnl.0000249185.78359.06; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; van Paassen BW, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-38; Wang WW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001909; Wulf P, 1999, J NEUROSCI RES, V57, P467, DOI 10.1002/(SICI)1097-4547(19990815)57:4<467::AID-JNR6>3.3.CO;2-V; Zimmermann H, 2014, DEGENER NEUROL NEURO, V4, P153, DOI 10.2147/DNND.S73506	40	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164617	10.1371/journal.pone.0164617	http://dx.doi.org/10.1371/journal.pone.0164617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749933	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000386202300018
J	Vincent, D; Elkins, A; Condina, MR; Ezernieks, V; Rochfort, S				Vincent, Delphine; Elkins, Aaron; Condina, Mark R.; Ezernieks, Vilnis; Rochfort, Simone			Quantitation and Identification of Intact Major Milk Proteins for High-Throughput LC-ESI-Q-TOF MS Analyses	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; CASEIN MICELLE SIZE; BOVINE-MILK; MASS-SPECTROMETRY; GENETIC-VARIANTS; QUANTIFICATION; PHOSPHORYLATION; SEPARATION; HOLSTEIN; JERSEY	Cow's milk is an important source of proteins in human nutrition. On average, cow's milk contains 3.5% protein. The most abundant proteins in bovine milk are caseins and some of the whey proteins, namely beta-lactoglobulin, alpha-lactalbumin, and serum albumin. A number of allelic variants and post-translationally modified forms of these proteins have been identified. Their occurrence varies with breed, individuality, stage of lactation, and health and nutritional status of the animal. It is therefore essential to have reliable methods of detection and quantitation of these proteins. Traditionally, major milk proteins are quantified using liquid chromatography (LC) and ultra violet detection method. However, as these protein variants co-elute to some degree, another dimension of separation is beneficial to accurately measure their amounts. Mass spectrometry (MS) offers such a tool. In this study, we tested several RP-HPLC and MS parameters to optimise the analysis of intact bovine proteins from milk. From our tests, we developed an optimum method that includes a 20-28-40% phase B gradient with 0.02% TFA in both mobile phases, at 0.2 mL/min flow rate, using 75 degrees C for the C8 column temperature, scanning every 3 sec over a 600-3000 m/z window. The optimisations were performed using external standards commercially purchased for which ionisation efficiency, linearity of calibration, LOD, LOQ, sensitivity, selectivity, precision, reproducibility, and mass accuracy were demonstrated. From the MS analysis, we can use extracted ion chromatograms (EICs) of specific ion series of known proteins and integrate peaks at defined retention time (RT) window for quantitation purposes. This optimum quantitative method was successfully applied to two bulk milk samples from different breeds, Holstein-Friesian and Jersey, to assess differences in protein variant levels.	[Vincent, Delphine; Elkins, Aaron; Ezernieks, Vilnis; Rochfort, Simone] AgriBio Ctr, Dept Econ Dev Jobs Transport & Resources, 5 Ring Rd, Bundoora, Vic 3083, Australia; [Condina, Mark R.] Bruker Pty Ltd, Preston, Vic, Australia; [Rochfort, Simone] La Trobe Univ, Bundoora, Vic 3083, Australia	La Trobe University	Vincent, D (corresponding author), AgriBio Ctr, Dept Econ Dev Jobs Transport & Resources, 5 Ring Rd, Bundoora, Vic 3083, Australia.	delphine.vincent@ecodev.vic.gov.au	Condina, Mark/F-5366-2017; Condina, Mark/T-6256-2019	Condina, Mark/0000-0002-1375-9820; Condina, Mark/0000-0002-1375-9820; Vincent, Delphine/0000-0002-9083-015X	DEDJTR	DEDJTR	This work was funded by DEDJTR. The funder provided support in the form of salaries for authors DV, AE, VE, SR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. At the time of the study MRC was employed by Bruker Pty. Ltd and provided DEDJTR with technical support with MS instrumentation and analytical software. Bruker Pty. Ltd provided support in the form of salary for author MRC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ENCY DAIRY SCI; Ardo Y, 2011, THE ENCYCLOPEDIA OF, P169; Bailey KW, 2005, J DAIRY SCI, V88, P2269, DOI 10.3168/jds.S0022-0302(05)72903-9; Bijl E, 2014, J DAIRY SCI, V97, P7240, DOI 10.3168/jds.2014-8061; Bijl E, 2014, INT DAIRY J, V34, P135, DOI 10.1016/j.idairyj.2013.08.001; Bobe G, 1998, J AGR FOOD CHEM, V46, P458, DOI 10.1021/jf970499p; Bonfatti V, 2008, J CHROMATOGR A, V1195, P101, DOI 10.1016/j.chroma.2008.04.075; Bonizzi I, 2009, J CHROMATOGR A, V1216, P165, DOI 10.1016/j.chroma.2008.11.045; Bordin G, 2001, J CHROMATOGR A, V928, P63, DOI 10.1016/S0021-9673(01)01097-4; Brew K., 2011, ENCY DAIRY SCI, V2, P780; Capper JL, 2012, J DAIRY SCI, V95, P165, DOI 10.3168/jds.2011-4360; Caroli AM, 2009, J DAIRY SCI, V92, P5335, DOI 10.3168/jds.2009-2461; Day L, 2015, J DAIRY SCI, V98, P3633, DOI 10.3168/jds.2014-9285; Farrell HM, 2004, J DAIRY SCI, V87, P1641, DOI 10.3168/jds.S0022-0302(04)73319-6; Fox PF., 2011, ENCY DAIRY SCI, P478, DOI [10.1016/B978-0-12-374407-4.00312-5, DOI 10.1016/B978-0-12-374407-4.00312-5]; Frederiksen PD, 2011, J DAIRY SCI, V94, P4787, DOI 10.3168/jds.2011-4343; Givens I, 2013, FOOD CHEM, V139, P549, DOI 10.1016/j.foodchem.2013.01.115; Heck JML, 2008, INT DAIRY J, V18, P548, DOI 10.1016/j.idairyj.2007.11.004; Holland JW, 2006, PROTEOMICS, V6, P3087, DOI 10.1002/pmic.200500780; Holland JW, 2004, PROTEOMICS, V4, P743, DOI 10.1002/pmic.200300613; Jensen HB, 2012, J DAIRY SCI, V95, P6905, DOI 10.3168/jds.2012-5675; MAHONEY WC, 1980, J BIOL CHEM, V255, P1199; Ng-Kwai-Hang K. F., 2011, ENCY DAIRY SCI, V3, P751; Page JS, 2007, J AM SOC MASS SPECTR, V18, P1582, DOI 10.1016/j.jasms.2007.05.018; Page JS, 2009, J AM SOC MASS SPECTR, V20, P2265, DOI 10.1016/j.jasms.2009.08.018; Pierri G, 2013, J CHROMATOGR A, V1313, P259, DOI 10.1016/j.chroma.2013.08.083; Poulsen NA, 2016, J DAIRY SCI, V99, P3325, DOI 10.3168/jds.2015-10226; Poulsen NA, 2013, J DAIRY SCI, V96, P4830, DOI 10.3168/jds.2012-6422; Ramirez-Palomino P, 2014, FOOD CHEM, V142, P249, DOI 10.1016/j.foodchem.2013.07.046; Sargaeva N, 2014, LC MS STUDY CASEIN P; Singh H., 2011, ENCY DAIRY SCI, V2, P887, DOI DOI 10.1016/B978-0-12-381422-7.10004-5; Slangen CJ, 1999, J AGR FOOD CHEM, V47, P4549, DOI 10.1021/jf990212j; Stelwagen K., 2011, ENCYCL DAIRY SCI, V2, P359, DOI [10.1016/B978-0-12-374407-4.00293-4, DOI 10.1016/B978-0-12-374407-4.00293-4]; Vincent D, 2016, FRONT GENET, V6, DOI 10.3389/fgene.2015.00360; Wiley AS, 2012, AM J HUM BIOL, V24, P130, DOI 10.1002/ajhb.22201; Young NL, 2011, RSC CHROMATOGR MONOG, P38, DOI 10.1039/9781849733144-00038	36	35	37	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0163471	10.1371/journal.pone.0163471	http://dx.doi.org/10.1371/journal.pone.0163471			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749892	Green Submitted, Green Published, gold			2022-12-26	WOS:000386202300006
J	Eskikand, PZ; Kameneva, T; Ibbotson, MR; Burkitt, AN; Grayden, DB				Eskikand, Parvin Zarei; Kameneva, Tatiana; Ibbotson, Michael R.; Burkitt, Anthony N.; Grayden, David B.			A Possible Role for End-Stopped V1 Neurons in the Perception of Motion: A Computational Model	PLOS ONE			English	Article							VISUAL AREA MT; SURROUND SUPPRESSION; RESPONSE VARIABILITY; RECEPTIVE-FIELDS; CORTICAL-NEURONS; APERTURE PROBLEM; NEURAL DYNAMICS; INTEGRATION; SEGMENTATION; SIGNALS	We present a model of the early stages of processing in the visual cortex, in particular V1 and MT, to investigate the potential role of end-stopped V1 neurons in solving the aperture problem. A hierarchical network is used in which the incoming motion signals provided by complex V1 neurons and end-stopped V1 neurons proceed to MT neurons at the next stage. MT neurons are categorized into two types based on their function: integration and segmentation. The role of integration neurons is to propagate unambiguous motion signals arriving from those V1 neurons that emphasize object terminators (e. g. corners). Segmentation neurons detect the discontinuities in the input stimulus to control the activity of integration neurons. Although the activity of the complex V1 neurons at the terminators of the object accurately represents the direction of the motion, their level of activity is less than the activity of the neurons along the edges. Therefore, a model incorporating end-stopped neurons is essential to suppress ambiguous motion signals along the edges of the stimulus. It is shown that the unambiguous motion signals at terminators propagate over the rest of the object to achieve an accurate representation of motion.	[Eskikand, Parvin Zarei; Kameneva, Tatiana; Burkitt, Anthony N.; Grayden, David B.] Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Parkville, Vic 3010, Australia; [Eskikand, Parvin Zarei] NICTA Victorian Res Lab, Parkville, Vic 3010, Australia; [Ibbotson, Michael R.] Australian Coll Optometry, Natl Vis Res Inst, Carlton, Vic 3053, Australia; [Grayden, David B.] Univ Melbourne, Ctr Neural Engn, Parkville, Vic 3030, Australia	University of Melbourne; University of Melbourne	Eskikand, PZ (corresponding author), Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Parkville, Vic 3010, Australia.; Eskikand, PZ (corresponding author), NICTA Victorian Res Lab, Parkville, Vic 3010, Australia.	parvinz@student.unimelb.edu.au	Grayden, David B/L-5782-2018; ibbotson, michael/F-9030-2011	Grayden, David B/0000-0002-5497-7234; Zarei Eskikand, Parvin/0000-0002-1424-6445; ibbotson, michael/0000-0002-3803-6653	Australian Research Council (ARC) [DP140104533]; Centre of Excellence for Integrative Brain Function (ARC) [CE140100007]; Discovery Early Career Researcher Award (ARC) [DE120102210]; National ICT Australia	Australian Research Council (ARC)(Australian Research Council); Centre of Excellence for Integrative Brain Function (ARC); Discovery Early Career Researcher Award (ARC)(Australian Research Council); National ICT Australia	This work was supported by the Discovery Project grant from Australian Research Council (ARC), DP140104533, (http://www.arc.gov.au/) to ANB and TK, Centre of Excellence for Integrative Brain Function (ARC), CE140100007, (http://www.cibf.edu.au/) to MIR, Discovery Early Career Researcher Award (ARC), DE120102210, (http://www.arc.gov.au/) to TK and the National ICT Australia to PZE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Back T, 1993, EVOL COMPUT, V1, P1, DOI 10.1162/evco.1993.1.1.1; Bayerl P, 2004, NEURAL COMPUT, V16, P2041, DOI 10.1162/0899766041732404; Beck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021254; Berzhanskaya J, 2007, SPATIAL VISION, V20, P337, DOI 10.1163/156856807780919000; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Born RT, 2002, PROG BRAIN RES, V140, P225; Bradley DC, 2008, NAT REV NEUROSCI, V9, P686, DOI 10.1038/nrn2472; Chey J, 1997, J OPT SOC AM A, V14, P2570, DOI 10.1364/JOSAA.14.002570; Goldberg D.E., 1989, GENETIC ALGORITHMS S; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grossberg S, 2001, VISION RES, V41, P2521, DOI 10.1016/S0042-6989(01)00131-6; Grossberg S, 2015, FRONT PSYCHOL, P6; Gur M, 1997, J NEUROSCI, V17, P2914; Hildreth EC, 1982, MEASUREMENT VISUAL M; HORN BKP, 1981, P SOC PHOTO-OPT INST, V281, P319; Huang X, 2007, NEURON, V53, P761, DOI 10.1016/j.neuron.2007.01.032; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Koechlin E, 1999, BIOL CYBERN, V80, P25, DOI 10.1007/s004220050502; Liden L, 1999, VISION RES, V39, P3301, DOI 10.1016/S0042-6989(99)00055-3; Majaj NJ, 2007, J NEUROSCI, V27, P366, DOI 10.1523/JNEUROSCI.3183-06.2007; Mingolla E, 2003, NEURAL NETWORKS, V16, P939, DOI 10.1016/S0893-6080(03)00099-6; Movshon JA, 1996, J NEUROSCI, V16, P7733; Movshon JA, 1985, STUDY GROUP PATTERN, P117, DOI [DOI 10.1007/978-3-662-09224-8_7., DOI 10.1007/978-3-662-09224-8_]; NOWLAN SJ, 1995, J NEUROSCI, V15, P1195; Pack CC, 2004, J NEUROSCI, V24, P3268, DOI 10.1523/JNEUROSCI.4387-03.2004; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; RAIGUEL S, 1995, EUR J NEUROSCI, V7, P2064, DOI 10.1111/j.1460-9568.1995.tb00629.x; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Tsui JMG, 2010, J NEUROPHYSIOL, V103, P3123, DOI 10.1152/jn.00654.2009; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386	38	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164813	10.1371/journal.pone.0164813	http://dx.doi.org/10.1371/journal.pone.0164813			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741307	Green Published, gold			2022-12-26	WOS:000385507000071
J	Fischer, K; Guensch, DP; Shie, N; Lebel, J; Friedrich, MG				Fischer, Kady; Guensch, Dominik P.; Shie, Nancy; Lebel, Julie; Friedrich, Matthias G.			Breathing Maneuvers as a Vasoactive Stimulus for Detecting Inducible Myocardial Ischemia - An Experimental Cardiovascular Magnetic Resonance Study	PLOS ONE			English	Article							CORONARY-ARTERY; BLOOD; OXYGENATION	Background Breathing maneuvers can elicit a similar vascular response as vasodilatory agents like adenosine; yet, their potential diagnostic utility in the presence of coronary artery stenosis is unknown. The objective of the study is to investigate if breathing maneuvers can non-invasively detect inducible ischemia in an experimental animal model when the myocardium is imaged with oxygenation-sensitive cardiovascular magnetic resonance (OS-CMR). Methods and Findings In 11 anesthetised swine with experimentally induced significant stenosis (fractional flow reserve < 0.75) of the left anterior descending coronary artery (LAD) and 9 control animals, OS-CMR at 3T was performed during two different breathing maneuvers, a long breath-hold; and a combined maneuver of 60s of hyperventilation followed by a long breath-hold. The resulting change of myocardial oxygenation was compared to the invasive measurements of coronary blood flow, blood gases, and oxygen extraction. In control animals, all breathing maneuvers could significantly alter coronary blood flow as hyperventilation decreased coronary blood flow by 34 +/- 23%. A long breath-hold alone led to an increase of 97 +/- 88%, while the increase was 346 +/- 327% (p< 0.001), when the long breath-hold was performed after hyperventilation. In stenosis animals, the coronary blood flow response was attenuated after both hyperventilation and the following breath-hold. This was matched by the observed oxygenation response as breath-holds following hyperventilation consistently yielded a significant difference in the signal of the MRI images between the perfusion territory of the stenosis LAD and remote myocardium. There was no difference between the coronary territories during the other breathing maneuvers or in the control group at any point. Conclusion In an experimental animal model, the response to a combined breathing maneuver of hyperventilation with subsequent breath-holding is blunted in myocardium subject to significant coronary artery stenosis. This maneuver may allow for detecting severe coronary artery stenosis and have a significant clinical potential as a non-pharmacological method for diagnostic testing in patients with suspected coronary artery disease.	[Fischer, Kady; Guensch, Dominik P.; Shie, Nancy; Lebel, Julie; Friedrich, Matthias G.] Univ Montreal, Montreal Heart Inst, Philippa & Marvin Carsley CMR Ctr, Montreal, PQ, Canada; [Fischer, Kady; Guensch, Dominik P.] Univ Bern, Inselspital, Univ Hosp Bern, Dept Anaesthesiol & Pain Therapy, Bern, Switzerland; [Fischer, Kady; Guensch, Dominik P.] Univ Bern, Inselspital, Univ Hosp Bern, Inst Diagnost Intervent & Paediat Radiol, Bern, Switzerland; [Lebel, Julie] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Friedrich, Matthias G.] Univ Montreal, Dept Radiol, Montreal, PQ, Canada; [Friedrich, Matthias G.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Friedrich, Matthias G.] McGill Univ, Dept Diagnost Radiol, Montreal, PQ, Canada; [Friedrich, Matthias G.] Univ Heidelberg Hosp, Dept Cardiol, Heidelberg, Germany; [Friedrich, Matthias G.] Univ Calgary, Dept Cardiac Sci, Calgary, AB, Canada; [Friedrich, Matthias G.] Univ Calgary, Dept Radiol, Calgary, AB, Canada	Universite de Montreal; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; McGill University; Universite de Montreal; McGill University; McGill University; Ruprecht Karls University Heidelberg; University of Calgary; University of Calgary	Friedrich, MG (corresponding author), Univ Montreal, Montreal Heart Inst, Philippa & Marvin Carsley CMR Ctr, Montreal, PQ, Canada.; Friedrich, MG (corresponding author), Univ Montreal, Dept Radiol, Montreal, PQ, Canada.; Friedrich, MG (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.; Friedrich, MG (corresponding author), McGill Univ, Dept Diagnost Radiol, Montreal, PQ, Canada.; Friedrich, MG (corresponding author), Univ Heidelberg Hosp, Dept Cardiol, Heidelberg, Germany.; Friedrich, MG (corresponding author), Univ Calgary, Dept Cardiac Sci, Calgary, AB, Canada.; Friedrich, MG (corresponding author), Univ Calgary, Dept Radiol, Calgary, AB, Canada.	mgwfriedrich@gmail.com	Friedrich, Matthias/H-8474-2015	Friedrich, Matthias/0000-0003-1204-5647; Gunsch, Dominik/0000-0003-4127-4086; Fischer, Kady/0000-0002-7765-4550	Montreal Heart Institute Foundation; Canadian Foundation for Innovation; Fonds de Recherche du Quebec	Montreal Heart Institute Foundation; Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de Recherche du Quebec	Funding was provided by the Montreal Heart Institute Foundation, the Canadian Foundation for Innovation (https://www.innovation.ca.) and the Fonds de Recherche du Quebec (http://www.frq.gouv.qc.ca/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony R, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-57; Arnold JR, 2012, J AM COLL CARDIOL, V59, P1954, DOI 10.1016/j.jacc.2012.01.055; Breskovic T, 2012, RESP PHYSIOL NEUROBI, V181, P228, DOI 10.1016/j.resp.2012.03.007; BROTEN TP, 1991, CIRC RES, V68, P531, DOI 10.1161/01.RES.68.2.531; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Chareonthaitawee P, 2001, CARDIOVASC RES, V50, P151, DOI 10.1016/S0008-6363(01)00202-4; Donato P, 2012, SURG RADIOL ANAT, V34, P805, DOI 10.1007/s00276-012-0976-1; Fischer K, 2015, EUR HEART J-CARD IMG, V16, P395, DOI 10.1093/ehjci/jeu202; Friedrich MG, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-43; Friedrich MG, 2003, CIRCULATION, V108, P2219, DOI 10.1161/01.CIR.0000095271.08248.EA; Guensch DP, 2014, CURR CARDIOVASC IMAG, V7, DOI 10.1007/s12410-014-9261-5; Guensch DP, 2014, EUR HEART J-CARD IMG, V15, P409, DOI 10.1093/ehjci/jet171; Guensch DP, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.98; Guensch DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053282; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Kahn CM, 2010, MERCK VET MANUAL, V9; Kastrup A, 1998, STROKE, V29, P2641, DOI 10.1161/01.STR.29.12.2641; KLOCKE FJ, 1959, J APPL PHYSIOL, V14, P689, DOI 10.1152/jappl.1959.14.5.689; NEILL WA, 1975, CIRCULATION, V52, P854, DOI 10.1161/01.CIR.52.5.854; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Parkes MJ, 2006, EXP PHYSIOL, V91, P1, DOI 10.1113/expphysiol.2005.031625; Roubille F, 2016, J CARDIOL; Sasse SA, 1996, CHEST, V110, P958, DOI 10.1378/chest.110.4.958; Seiler C, 1997, CIRCULATION, V96, P4261; Stalder AF, 2015, MAGN RESON MED, V73, P577, DOI 10.1002/mrm.25164; Tanguay JF, 2003, J ENDOVASC THER, V10, P968, DOI 10.1583/1545-1550(2003)010<0968:CPANAA>2.0.CO;2; Teixeira T, 2016, J MAGN RESON IMAGING; Wacker CM, 2003, J AM COLL CARDIOL, V41, P834, DOI 10.1016/S0735-1097(02)02931-5; WILSON RF, 1990, CIRCULATION, V82, P1595, DOI 10.1161/01.CIR.82.5.1595; Yang HJ, 2014, RADIOLOGY, V272, P397, DOI 10.1148/radiol.14132549	30	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164524	10.1371/journal.pone.0164524	http://dx.doi.org/10.1371/journal.pone.0164524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741282	Green Published, gold			2022-12-26	WOS:000385507000040
J	Kalous, KS; Wynia-Smith, SL; Olp, MD; Smith, BC				Kalous, Kelsey S.; Wynia-Smith, Sarah L.; Olp, Michael D.; Smith, Brian C.			Mechanism of Sirt1 NAD(+)-dependent Protein Deacetylase Inhibition by Cysteine S-Nitrosation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; allosteric regulation; enzyme inactivation; inhibition mechanism; nicotinamide adenine dinucleotide (NAD); nitric oxide; nitrosylation; sirtuin 1 (SIRT1); zinc; nitrosation	NITRIC-OXIDE SYNTHASE; SECONDARY STRUCTURE ANALYSES; DRUG-LIKE MOLECULES; REDOX REGULATION; ACETYL-LYSINE; RAT-LIVER; NITROSYLATION; GLUTATHIONE; STRESS; GAPDH	The sirtuin family of proteins catalyze the NAD(+)-dependent deacylation of acyl-lysine residues. Humans encode seven sirtuins (Sirt1-7), and recent studies have suggested that post-translational modification of Sirt1 by cysteine S-nitrosation correlates with increased acetylation of Sirt1 deacetylase substrates. However, the mechanism of Sirt1 inhibition by S-nitrosation was unknown. Here, we show that Sirt1 is transnitrosated and inhibited by the physiologically relevant nitrosothiol S-nitrosoglutathione. Steady-state kinetic analyses and binding assays were consistent with Sirt1 S-nitrosation inhibiting binding of both the NAD(+) and acetyl-lysine substrates. Sirt1 S-nitrosation correlated with Zn2+ release from the conserved sirtuin Zn2+-tetrathiolate and a loss of -helical structure without overall thermal destabilization of the enzyme. Molecular dynamics simulations suggested that Zn2+ loss due to Sirt1 S-nitrosation results in repositioning of the tetrathiolate subdomain away from the rest of the catalytic domain, thereby disrupting the NAD(+) and acetyl-lysine-binding sites. Sirt1 S-nitrosation was reversed upon exposure to the thiol-based reducing agents, including physiologically relevant concentrations of the cellular reducing agent glutathione. Reversal of S-nitrosation resulted in full restoration of Sirt1 activity only in the presence of Zn2+, consistent with S-nitrosation of the Zn2+-tetrathiolate as the primary source of Sirt1 inhibition upon S-nitrosoglutathione treatment.	[Kalous, Kelsey S.; Wynia-Smith, Sarah L.; Olp, Michael D.; Smith, Brian C.] Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Smith, BC (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	brismith@mcw.edu	Smith, Brian C/D-9949-2013	Smith, Brian C/0000-0001-6330-2768; Wynia-Smith, Sarah/0000-0003-0985-2843; Olp, Michael/0000-0002-3821-435X	American Heart Association Scientist Development [15SDG25830057]; Medical College of Wisconsin Research Affairs Committee; American Cancer Society [14-247-29-IRG, 86-004-26-IRG]; Advancing a Healthier Wisconsin Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080202] Funding Source: NIH RePORTER	American Heart Association Scientist Development(American Heart Association); Medical College of Wisconsin Research Affairs Committee; American Cancer Society(American Cancer Society); Advancing a Healthier Wisconsin Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by American Heart Association Scientist Development Grant 15SDG25830057 (to B. C. S.), the Medical College of Wisconsin Research Affairs Committee (to B. C. S.), Institutional Research Grants 14-247-29-IRG and 86-004-26-IRG from the American Cancer Society (to B. C. S.), and the Advancing a Healthier Wisconsin Endowment (to B. C. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anand P, 2014, P NATL ACAD SCI USA, V111, P18572, DOI 10.1073/pnas.1417816112; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Broniowska KA, 2006, J BIOL CHEM, V281, P33835, DOI 10.1074/jbc.M603248200; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Cao DF, 2015, GENE DEV, V29, P1316, DOI 10.1101/gad.265462.115; Chen W. C., 2000, FMOC SOLID PHASE PEP, P9; Dai H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8645; Davenport AM, 2014, J MOL BIOL, V426, P526, DOI 10.1016/j.jmb.2013.10.009; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Ghisays F, 2015, CELL REP, V10, P1665, DOI 10.1016/j.celrep.2015.02.036; Ginnan R, 2008, FREE RADICAL BIO MED, V44, P1232, DOI 10.1016/j.freeradbiomed.2007.12.025; Giustarini D, 2008, NITRIC OXIDE-BIOL CH, V19, P252, DOI 10.1016/j.niox.2008.07.003; Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1; Hothersall JS, 1997, BIOCHEM J, V322, P477, DOI 10.1042/bj3220477; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Jung SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065415; KELLER GA, 1985, ARCH SURG-CHICAGO, V120, P941; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; MCKELVEY TG, 1988, AM J PHYSIOL, V254, pG753, DOI 10.1152/ajpgi.1988.254.5.G753; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Monteiro G, 2007, P NATL ACAD SCI USA, V104, P4886, DOI 10.1073/pnas.0700481104; OKABE H, 1994, J SURG RES, V57, P416, DOI 10.1006/jsre.1994.1163; Pan M, 2012, J BIOL CHEM, V287, P2468, DOI 10.1074/jbc.M111.285031; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Peralta D, 2015, NAT CHEM BIOL, V11, P156, DOI [10.1038/NCHEMBIO.1720, 10.1038/nchembio.1720]; Rodriguez-Ortigosa CM, 2014, GASTROENTEROLOGY, V147, P1084, DOI 10.1053/j.gastro.2014.07.030; Santos L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9831825; Schultheisz HL, 2009, J AM CHEM SOC, V131, P14571, DOI 10.1021/ja903155s; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; Seneviratne U, 2013, J AM CHEM SOC, V135, P7693, DOI 10.1021/ja401565w; Shao D, 2014, J BIOL CHEM, V289, P7293, DOI 10.1074/jbc.M113.520403; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Shinozaki S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005375; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; Smith BC, 2007, J BIOL CHEM, V282, P37256, DOI 10.1074/jbc.M707878200; Smith BC, 2007, BIOCHEMISTRY-US, V46, P14478, DOI 10.1021/bi7013294; Smith BC, 2007, J AM CHEM SOC, V129, P5802, DOI 10.1021/ja070162w; Smith BC, 2012, CURR OPIN CHEM BIOL, V16, P498, DOI 10.1016/j.cbpa.2012.10.016; Smith BC, 2012, BIOCHEMISTRY-US, V51, P1028, DOI 10.1021/bi201818c; Smith BC, 2011, ACS CHEM BIOL, V6, P146, DOI 10.1021/cb100218d; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; Truong T. H., 2012, CURR PROTOC CHEM BIO, DOI [10.1002/9780470559277.ch110219, DOI 10.1002/9780470559277]; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yi JJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1684, DOI 10.1016/j.bbapap.2010.05.002; Zee RS, 2010, ANTIOXID REDOX SIGN, V13, P1023, DOI 10.1089/ars.2010.3251	52	31	31	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25398	25410		10.1074/jbc.M116.754655	http://dx.doi.org/10.1074/jbc.M116.754655			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27756843	hybrid, Green Published			2022-12-26	WOS:000390095300011
J	Lovereide, L; Hagell, P				Lovereide, Lise; Hagell, Peter			Measuring Life Satisfaction in Parkinson's Disease and Healthy Controls Using the Satisfaction With Life Scale	PLOS ONE			English	Article								The 5-item Satisfaction With Life Scale (SWLS) was designed to measure general life satisfaction (LS). Here we examined the psychometric properties of the SWLS in a cohort of persons with Parkinson's disease (PwPD) and age and gender matched individuals without PD. The SWLS was administered to PwPD and controls from the Norwegian ParkWest study at 5 and 7 years after the time of diagnosis. Data were analysed according to classical test theory (CTT) and Rasch measurement theory. CTT scaling assumptions for computation of a SWLS total score were met (corrected item-total correlations >0.58). The SWLS was reasonably well targeted to the sample and had good reliability (ordinal alpha, 0.92). The scale exhibited good fit to the Rasch model and successfully separated between 5 statistically distinct strata of people (levels of SWLS). The seven response categories did not work as intended and the scale may benefit from reduction to five response categories. There was no clinically significant differential item functioning. Separate analyses in PwPD and controls yielded very similar results to those from the pooled analysis. This study supports the SWLS as a valid instrument for measuring LS in PD and controls. However, Rasch analyses provided new insights into the performance and validity of the SWLS and identified areas for future revisions in order to further improve the scale.	[Lovereide, Lise] Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, Stavanger, Norway; [Hagell, Peter] Kristianstad Univ, Sch Hlth & Soc, PRO CARE Grp, Kristianstad, Sweden	Stavanger University Hospital; Kristianstad University	Lovereide, L (corresponding author), Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, Stavanger, Norway.	liselo@sus.no			Norwegian Parkinson's Disease Association; Kristianstad University, Kristianstad, Sweden	Norwegian Parkinson's Disease Association; Kristianstad University, Kristianstad, Sweden	LL received research support from the Norwegian Parkinson's Disease Association (http://parkinsonfondet.no/). PH was supported by Kristianstad University, Kristianstad, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves G, 2009, J NEUROL NEUROSUR PS, V80, P851, DOI 10.1136/jnnp.2008.168211; ANDRICH D, 1995, PSYCHOMETRIKA, V60, P7, DOI 10.1007/BF02294426; Andrich D., 2013, INTERPRETING RUMM203; Andrich D, 1982, ED RES PERSPECTIVES, V9, P95; Andrich D., 1988, SAGE PUBLICATIONS; Andrich D, 1997, RUMM2030 RASCH UNIDI; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Clench-Aas J, 2011, QUAL LIFE RES, V20, P1307, DOI 10.1007/s11136-011-9859-x; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener EP, 2008, J POSIT PSYCHOL, V3, P137, DOI DOI 10.1080/17439760701756946; Gadermann AM, 2012, PRACTICAL ASSESSMENT, V17; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Hagell P, 2015, 4 INT OUTC MEAS C CH; Hagquist C, 2009, INT J NURS STUD, V46, P380, DOI 10.1016/j.ijnurstu.2008.10.007; Hobart J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13120; Hobart JC, 2007, LANCET NEUROL, V6, P1094, DOI 10.1016/S1474-4422(07)70290-9; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Kubinger KD, 2009, PSYCHOL SCI Q, V51, P370; Kulczycka L, 2010, CLIN RHEUMATOL, V29, P991, DOI 10.1007/s10067-010-1509-0; Kyngdon A., 2011, RASCH MEASUREMENT T, V25, P1324; Lucas-Carrasco R, 2014, SCI WORLD J, DOI 10.1155/2014/680659; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Post MW, 2012, ARCH PHYS MED REHAB, V93, P1832, DOI 10.1016/j.apmr.2012.03.025; Rasch G., 1960, PROBABILISTIC MODELS; Rosengren L, 2015, ACTA NEUROL SCAND, V132, P164, DOI 10.1111/ane.12380; Soundy A, 2014, SCI WORLD J; Timmerman ME, 2011, PSYCHOL METHODS, V16, P209, DOI 10.1037/a0023353; WARD CD, 1990, ADV NEUROL, V53, P245; Wright BD, 1982, RATING SCALE ANAL	29	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0163931	10.1371/journal.pone.0163931	http://dx.doi.org/10.1371/journal.pone.0163931			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776131	Green Published, Green Submitted, gold			2022-12-26	WOS:000389009200007
J	Alam, K; Mahal, A				Alam, Khurshid; Mahal, Ajay			The Economic Burden of Road Traffic Injuries on Households in South Asia	PLOS ONE			English	Article							OUT-OF-POCKET; LIFE-YEARS DALYS; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; HEALTH-CARE; PROPENSITY SCORE; DISEASE; EXPENDITURE; CONSUMPTION; DEPRESSION	Globally, road traffic injuries accounted for about 1.36 million deaths in 2015 and are projected to become the fourth leading cause of disability-adjusted life years (DALYs) lost by 2030. One-fifth of these deaths occurred in South Asia where road traffic injuries are projected to increase by 144% by 2020. Despite this rapidly increasing disease burden there is limited evidence on the economic burden of road traffic injuries on households in South Asia. We applied a novel coarsened exact matching method to assess the household economic burden of road traffic injuries using nationally representative World Health Survey data from five South Asian countries-Bangladesh, India, Nepal, Pakistan and Sri Lanka collected during 2002-2003. We examined the impact of road traffic injuries on household out-of-pocket (OOP) health spending, household non-medical consumption expenditure and the employment status of the traffic injury-affected respondent. We exactly matched a household (after 'coarsening') where a respondent reported being involved in a road traffic injury to households where the respondent did not report a road traffic injury on each of multiple observed household characteristics. Our analysis found that road traffic injury-affected households had significantly higher levels of OOP health spending per member (I$0.75, p<0.01), higher OOP spending on drugs per member (I$0.30, p = 0.03), and higher OOP hospital spending per member (I$0.29, p<0.01) in the four weeks preceding the survey. Indicators of "catastrophic spending" were also significantly higher in road traffic injury-affected households: 6.45% (p<0.01) for a threshold of OOP health spending to total household spending ratio of 20%, and 7.40% (p<0.01) for a threshold of OOP health spending to household 'capacity to pay' ratio of 40%. However, no statistically significant effects were observed for household non-medical consumption expenditure, and employment status of the road traffic injury-affected individual. Our analysis points to the need for financial risk protection against the road traffic injury-related OOP health expenditure and a focus on prevention.	[Alam, Khurshid] Murdoch Childrens Res Inst, 50 Flemington Rd, Parkville, Vic 3052, Australia; [Alam, Khurshid] Univ Melbourne, Dept Pediat, 50 Flemington Rd,Victoria, Parkville, Vic 3052, Australia; [Mahal, Ajay] Univ Melbourne, Nossal Inst Global Hlth, 161 Barry St,4th Floor, Carlton, Vic 3053, Australia; [Mahal, Ajay] Monash Univ, Dept Epidemiol & Prevent Med, Alfred Ctr, Level 6,99 Commercial Rd, Melbourne, Vic 3004, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Monash University	Alam, K (corresponding author), Murdoch Childrens Res Inst, 50 Flemington Rd, Parkville, Vic 3052, Australia.; Alam, K (corresponding author), Univ Melbourne, Dept Pediat, 50 Flemington Rd,Victoria, Parkville, Vic 3052, Australia.	khurshid.alam@mcri.edu.au		Alam, Khurshid/0000-0002-7402-7519	Australian Postgraduate Award; Alan AMP; Elizabeth Finkel Chair in Global Health of Monash University; Australian Postgraduate Award; Alan AMP; Elizabeth Finkel Chair in Global Health of Monash University	Australian Postgraduate Award(Australian Government); Alan AMP; Elizabeth Finkel Chair in Global Health of Monash University; Australian Postgraduate Award(Australian Government); Alan AMP; Elizabeth Finkel Chair in Global Health of Monash University	This work was supported by an Australian Postgraduate Award (PhD scholarship).r KA acknowledges funding support from the Australian Postgraduate Award. AM acknowledges funding support from the Alan & Elizabeth Finkel Chair in Global Health of Monash University.	Aeron-Thomas A, 2004, INVOLVEMENT IMPACT R; ANAND S, 1994, AM ECON REV, V84, P226; [Anonymous], 2002, WORLD HLTH SURV HOUS; [Anonymous], 2008, ANAL HLTH EQUITY USI; Blackwell M, 2009, STATA J, V9, P524, DOI 10.1177/1536867X0900900402; BROOME J, 1978, J PUBLIC ECON, V9, P91, DOI 10.1016/0047-2727(78)90029-4; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Crichlow RJ, 2006, J BONE JOINT SURG AM, V88A, P1927, DOI 10.2106/JBJS.D.02604; Fan VYM, 2011, J DEV EFFECT, V3, P340, DOI 10.1080/19439342.2011.596941; Gertler P, 2002, AM ECON REV, V92, P51, DOI 10.1257/000282802760015603; Ghaffar A, 2004, PUBLIC HEALTH, V118, P211, DOI 10.1016/j.puhe.2003.05.003; Global Burden of Disease, 2013, GLOB HLTH EST 2013 D; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Kopits E, 2005, ACCIDENT ANAL PREV, V37, P169, DOI 10.1016/j.aap.2004.04.006; Kruk ME, 2009, HEALTH AFFAIR, V28, P1056, DOI 10.1377/hlthaff.28.4.1056; Kulakkal GS, 2007, FINANCIAL BURDEN TRE; Kumar GA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-285; Kumar JS, 2010, INJURY PREV, V16, pA2, DOI 10.1136/ip.2010.029215.5; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; Mashreky SR, 2010, PUBLIC HEALTH, V124, P185, DOI 10.1016/j.puhe.2010.01.004; Mathers C, 2009, GLOB HLTH RISKS MORT; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mohanan M, 2013, REV ECON STAT, V95, P673, DOI 10.1162/REST_a_00262; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nannicini T., 2007, STATA J, V7, P334, DOI DOI 10.1177/1536867X0700700303; Nithershini P, 2012, INJURY PREVENTION S1, V18; Peden M., 2004, WORLD REPORT ROAD TR; Prinja S, 2015, LANCET, V385, P57, DOI 10.1016/S0140-6736(15)60852-2; Razzak JA, 2011, INT J INJ CONTROL SA, V18, P199, DOI 10.1080/17457300.2011.551942; Reddy G M M, 2009, Indian J Med Sci, V63, P549; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Silcok BR, 2003, GUIDELINES ESTIMATIN; The World Health Survey, 2002, IND QUEST; The World Health Survey, 2002, SAMPL GUID PART COUN; VISARIA P, 1980, POPUL DEV REV, V6, P189, DOI 10.2307/1972728; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Wang CH, 2005, J ADV NURS, V52, P22, DOI 10.1111/j.1365-2648.2005.03560.x; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wesson HK, 2013, HLTH POLICY PLANNING; World Health Organisation, 2018, NONC DIS COUNTR PROF; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2009, HEALTH POLICY, V91, P297, DOI 10.1016/j.healthpol.2009.01.002	45	14	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164362	10.1371/journal.pone.0164362	http://dx.doi.org/10.1371/journal.pone.0164362			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9OE	27768701	Green Published, gold			2022-12-26	WOS:000386205400011
J	Boddu, S; Dinkin, M; Suurna, M; Hannsgen, K; Bui, X; Patsalides, A				Boddu, Srikanth; Dinkin, Marc; Suurna, Maria; Hannsgen, Kelly; Bui, Xem; Patsalides, Athos			Resolution of Pulsatile Tinnitus after Venous Sinus Stenting in Patients with Idiopathic Intracranial Hypertension	PLOS ONE			English	Article							ENDOVASCULAR TREATMENT; PRESSURE; PREVALENCE	Objective Evaluate the role of venous sinus stenting in the treatment of pulsatile tinnitus among patients with Idiopathic Intracranial Hypertension (IIH) and significant venous sinus stenosis. Subjects and Methods A written informed consent approved by the Weill Cornell institutional review board was signed and obtained from the study participants. Thirty-seven consecutive patients with IIH and venous sinus stenosis who were treated with venous sinus stenting between Jan. 2012-Jan. 2016 were prospectively evaluated. Patients without pulsatile tinnitus were excluded. Tinnitus severity was categorized based on "Tinnitus Handicap Inventory" (THI) at pre-stent, day-0, 1-month, 3-month, 6-month, 12-month, 18-month and 2-year follow-up. Demographics, body-mass index (BMI), pre and post VSS trans-stenotic pressure gradient were documented. Statistical analysis performed using Pearson's correlation, Chi-square analysis and Fischer's exact test. Results 29 patients with a mean age of 29.5 +/- 8.5 years M:F = 1:28. Median (mean) THI pre and post stenting were: 4 (3.7) and 1 (1) respectively. Median time of tinnitus resolution post VSS was 0-days. There was significant improvement of THI (Delta Mean: 2.7 THI [95% CI: 2.3-3.1 THI], p<0.001) and transverse-distal sigmoid sinus gradient (Delta Mean:-15.3 mm Hg [95% CI: 12.7-18 mm Hg], p<0.001) post-stenting. Mean follow-up duration of 26.4 +/- 9.8 months (3-44 months). VSS was feasible in 100% patients with no procedural complications. Three-patients (10%) had recurrent sinus stenosis and tinnitus at mean follow-up of 12 months (6-30 months). Conclusion Venous sinus stenting is an effective treatment for pulsatile tinnitus in patients with IIH and venous sinus stenosis.	[Boddu, Srikanth; Hannsgen, Kelly; Bui, Xem; Patsalides, Athos] New York Presbyterian Hosp, Weill Cornell Med Ctr, Div Intervent Neuroradiol, Dept Neurol Surg, New York, NY 10016 USA; [Dinkin, Marc] New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Ophthalmol, New York, NY USA; [Suurna, Maria] New York Presbyterian Hosp, Dept Otolaryngol, Weill Cornell Med Ctr, New York, NY USA	Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital	Boddu, S; Patsalides, A (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Ctr, Div Intervent Neuroradiol, Dept Neurol Surg, New York, NY 10016 USA.	sboddu6@gmail.com; atp9002@med.cornell.edu		Dinkin, Marc/0000-0003-1277-1016; Boddu, Srikanth/0000-0003-2863-5094				Ahmed RM, 2011, AM J NEURORADIOL, V32, P1408, DOI 10.3174/ajnr.A2575; Albuquerque FC, 2011, WORLD NEUROSURG, V75, P648, DOI 10.1016/j.wneu.2010.11.012; Binder DK, 2004, NEUROSURGERY, V54, P538, DOI 10.1227/01.NEU.0000109042.87246.3C; Boddu SR, 2014, AJNR AM J NEURORADIO; Bono F, 2005, NEUROLOGY, V65, P1090, DOI 10.1212/01.wnl.0000178889.63571.e5; Bussiere M, 2010, AM J NEURORADIOL, V31, P645, DOI 10.3174/ajnr.A1890; Cho IK, 2012, ACTA OTO-LARYNGOL, V132, P285, DOI 10.3109/00016489.2011.631190; Dandy WE, 1937, ANN SURG, V106, P492, DOI 10.1097/00000658-193710000-00002; De Simone R, 2010, NEUROL SCI, V31, P33, DOI 10.1007/s10072-010-0271-z; Digre KB, 2001, NEUROLOGIST, V7, P2, DOI 10.1097/00127893-200107010-00002; Dong C, 2015, CHINESE MED J-PEKING, V128, P581, DOI 10.4103/0366-6999.151648; Donnet A, 2008, NEUROLOGY, V70, P641, DOI 10.1212/01.wnl.0000299894.30700.d2; Farb RI, 2007, NEURORADIOLOGY, V49, P727, DOI 10.1007/s00234-007-0250-0; Fields JD, 2013, J NEUROINTERV SURG, V5, P62, DOI 10.1136/neurintsurg-2011-010156; Friedman DI, 2006, J NEURO-OPHTHALMOL, V26, P61, DOI 10.1097/01.wno.0000204663.33559.1e; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); Higgins JNP, 2003, J NEUROL NEUROSUR PS, V74, P1662, DOI 10.1136/jnnp.74.12.1662; Jindal M, 2009, EUR ARCH OTO-RHINO-L, V266, P803, DOI 10.1007/s00405-009-0973-0; Kim BJ, 2014, CLIN EXP OTORHINOLAR, V7, P87, DOI 10.3342/ceo.2014.7.2.87; Krishnan A, 2006, AM J NEURORADIOL, V27, P1635; Kumpe DA, 2012, J NEUROSURG, V116, P538, DOI 10.3171/2011.10.JNS101410; Li BM, 2014, OTOL NEUROTOL, V35, P366, DOI 10.1097/MAO.0b013e3182990d52; Mathis JM, 1997, SKULL BASE SURG, V7, P145, DOI 10.1055/s-2008-1058606; McCombe A, 2001, CLIN OTOLARYNGOL, V26, P388, DOI 10.1046/j.1365-2273.2001.00490.x; Newman C W, 1998, J Am Acad Audiol, V9, P153; Owler BK, 2003, J NEUROSURG, V98, P1045, DOI 10.3171/jns.2003.98.5.1045; Puffer RC, 2013, J NEUROINTERV SURG, V5, P483, DOI 10.1136/neurintsurg-2012-010468; Radvany MG, 2013, J NEURO-OPHTHALMOL, V33, P117, DOI 10.1097/WNO.0b013e31827f18eb; Riggeal BD, 2013, NEUROLOGY, V80, P289, DOI 10.1212/WNL.0b013e31827debd6; Russell, 1995, Int Tinnitus J, V1, P127; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; SISMANIS A, 1990, LARYNGOSCOPE, V100, P33; Sismanis A, 2003, OTOLARYNG CLIN N AM, V36, P389, DOI 10.1016/S0030-6665(02)00169-X; Sismanis A, 2003, OTOLARYNG CLIN N AM, V36, pXI, DOI 10.1016/S0030-6665(02)00158-5; Sismanis A, 1998, AM J OTOL, V19, P472; SMITH JL, 1985, J CLIN NEURO-OPHTHAL, V5, P55	36	34	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164466	10.1371/journal.pone.0164466	http://dx.doi.org/10.1371/journal.pone.0164466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768690	Green Submitted, Green Published, gold			2022-12-26	WOS:000386205400014
J	Chai, SL; Zhang, J; Nixon, A; Nielsen, S				Chai, Shauna-Lee; Zhang, Jian; Nixon, Amy; Nielsen, Scott			Using Risk Assessment and Habitat Suitability Models to Prioritise Invasive Species for Management in a Changing Climate	PLOS ONE			English	Article							ALIEN PLANT; PREDICTION; FUTURE; SHIFT; FACE; TOOL	Accounting for climate change in invasive species risk assessments improves our understanding of potential future impacts and enhances our preparedness for the arrival of new non-native species. We combined traditional risk assessment for invasive species with habitat suitability modeling to assess risk to biodiversity based on climate change. We demonstrate our method by assessing the risk for 15 potentially new invasive plant species to Alberta, Canada, an area where climate change is expected to facilitate the poleward expansion of invasive species ranges. Of the 15 species assessed, the three terrestrial invasive plant species that could pose the greatest threat to Alberta's biodiversity are giant knotweed (Fallopia sachalinensis), tamarisk (Tamarix chinensis), and alkali swainsonpea (Sphaerophysa salsula). We characterise giant knotweed as 'extremely invasive', with 21 times the suitable habitat between baseline and future projected climate. Tamarisk is 'extremely invasive' with a 64% increase in suitable habitat, and alkali swainsonpea is 'highly invasive' with a 21% increase in suitable habitat. Our methodology can be used to predict and prioritise potentially new invasive species for their impact on biodiversity in the context of climate change.	[Chai, Shauna-Lee] Alberta Innovates Technol Futures, Ecosyst Management, Vegreville, AB, Canada; [Zhang, Jian; Nielsen, Scott] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Nixon, Amy] Univ Alberta, Alberta Biodivers Monitoring Inst, Edmonton, AB, Canada	Alberta Innovates; University of Alberta; University of Alberta	Chai, SL (corresponding author), Alberta Innovates Technol Futures, Ecosyst Management, Vegreville, AB, Canada.	shaunachai@yahoo.com	Zhang, Jian/A-7878-2008; Nielsen, Scott/O-7482-2019	Zhang, Jian/0000-0003-0589-6267; Nielsen, Scott/0000-0002-9754-0630	Climate Change and Emissions Management Corporation; Alberta Innovates-Technology Futures	Climate Change and Emissions Management Corporation; Alberta Innovates-Technology Futures	This research was funded by the Climate Change and Emissions Management Corporation and Alberta Innovates-Technology Futures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shauna-Lee Chai, Amy Nixon, Jian Zhang and Scott Nielsen were funded by the Climate Change and Emissions Management Corporation. Shauna-Lee Chai received additional funding from Alberta Innovates-Technology Futures.	[Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Batjes H, 2000, GLOBAL DATA SET DERI; Beaumont LJ, 2014, DIVERS DISTRIB, V20, P613, DOI 10.1111/ddi.12190; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Carlson M.L., 2008, INVASIVENESS RANKING; Crossman ND, 2011, ECOL INDIC, V11, P183, DOI 10.1016/j.ecolind.2008.10.011; Dukes JS, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P345; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Global Biodiversity Information Facility, 2013, FREE OP ACC BIOD DAT; Heffernan K, 2001, 0113 NAT HER; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill MP, 2012, DIVERS DISTRIB, V18, P191, DOI 10.1111/j.1472-4642.2011.00844.x; Ibanez I, 2014, ECOL APPL, V24, P25, DOI 10.1890/13-0776.1; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; Leishman MR, 2015, DIVERS DISTRIB, V21, P848, DOI 10.1111/ddi.12338; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Lu S., 2004, INVASIVE SPECIES ASS; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Mooney H.A., 2000, INVASIVE SPECIES CHA; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; PORTER JH, 1991, AGR FOREST METEOROL, V57, P221, DOI 10.1016/0168-1923(91)90088-8; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Roger E, 2015, J ENVIRON MANAGE, V159, P121, DOI 10.1016/j.jenvman.2015.05.039; Schneider R.R., 2013, ALBERTAS NATURAL SUB; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Sutherst R W, 2007, CLIMEX VERSION 3 USE; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thomas CD, 2011, TRENDS ECOL EVOL, V26, P216, DOI 10.1016/j.tree.2011.02.006; Tu M, 2009, PROTECTED AREA QUICK, P40; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Zhang J, 2015, DIVERS DISTRIB, V21, P1441, DOI 10.1111/ddi.12365	47	10	10	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165292	10.1371/journal.pone.0165292	http://dx.doi.org/10.1371/journal.pone.0165292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768758	Green Submitted, Green Published, gold			2022-12-26	WOS:000386205400077
J	Krinsky, N; Kaduri, M; Shainsky-Roitman, J; Goldfeder, M; Ivanir, E; Benhar, I; Shoham, Y; Schroeder, A				Krinsky, Nitzan; Kaduri, Maya; Shainsky-Roitman, Janna; Goldfeder, Mor; Ivanir, Eran; Benhar, Itai; Shoham, Yuval; Schroeder, Avi			A Simple and Rapid Method for Preparing a Cell-Free Bacterial Lysate for Protein Synthesis	PLOS ONE			English	Article							SYNTHESIS SYSTEM; EXTRACT PREPARATION; COLI; TEMPERATURE; POLYPEPTIDES; ROBUST	Cell-free protein synthesis (CFPS) systems are important laboratory tools that are used for various synthetic biology applications. Here, we present a simple and inexpensive laboratory-scale method for preparing a CFPS system from E. coli. The procedure uses basic lab equipment, a minimal set of reagents, and requires less than one hour to process the bacterial cell mass into a functional S30-T7 extract. BL21(DE3) and MRE600 E. coli strains were used to prepare the S30-T7 extract. The CFPS system was used to produce a set of fluorescent and therapeutic proteins of different molecular weights (up to 66 kDa). This system was able to produce 40-150 mu g-protein/ml, with variations depending on the plasmid type, expressed protein and E. coli strain. Interestingly, the BL21-based CFPS exhibited stability and increased activity at 40 and 45 degrees C. To the best of our knowledge, this is the most rapid and affordable lab-scale protocol for preparing a cell-free protein synthesis system, with high thermal stability and efficacy in producing therapeutic proteins.	[Krinsky, Nitzan; Kaduri, Maya; Shainsky-Roitman, Janna; Goldfeder, Mor; Schroeder, Avi] Technion Israel Inst Technol, Dept Chem Engn, Lab Targeted Drug Delivery & Personalized Med Tec, Haifa, Israel; [Krinsky, Nitzan] Technion Israel Inst Technol, Interdisciplinary Program Biotechnol, Haifa, Israel; [Ivanir, Eran; Shoham, Yuval] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, Haifa, Israel; [Benhar, Itai] Tel Aviv Univ, Georg S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Tel Aviv, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Tel Aviv University	Schroeder, A (corresponding author), Technion Israel Inst Technol, Dept Chem Engn, Lab Targeted Drug Delivery & Personalized Med Tec, Haifa, Israel.	avids@technion.ac.il	Shoham, Yuval/M-4409-2013	Benhar, Itai/0000-0002-0824-7177; Schroeder, Avi/0000-0003-2571-5937	EU-FP7 Marie Curie Program - Israel Science Foundation [333797, 1778/13]; Israel Cancer Association [20150116]; Israel Ministry of Economy [52752]; Israel Ministry of Science, Technology and Space [311878]; GIF [1-2328-1139. 10/20]; ERC [2015-STG-680242]; Mallat Family Foundation; Russell Berrie Nanotechnology Institute (RBNI) at the Technion - Lorry Lokey Interdisciplinary Center for Life Sciences & Engineering at the Technion - Alon Fellowship from the Council For Higher Education; Taub Foundation Fellowships; "Baroness Ariane de Rothschild Women Doctoral Program" from the Rothschild Caesarea Foundation; Interdisciplinary Program for Biotechnology at the Technion	EU-FP7 Marie Curie Program - Israel Science Foundation; Israel Cancer Association; Israel Ministry of Economy; Israel Ministry of Science, Technology and Space(Ministry of Science, Technology and Space (MOST), Israel); GIF(German-Israeli Foundation for Scientific Research and Development); ERC(European Research Council (ERC)European Commission); Mallat Family Foundation; Russell Berrie Nanotechnology Institute (RBNI) at the Technion - Lorry Lokey Interdisciplinary Center for Life Sciences & Engineering at the Technion - Alon Fellowship from the Council For Higher Education; Taub Foundation Fellowships; "Baroness Ariane de Rothschild Women Doctoral Program" from the Rothschild Caesarea Foundation; Interdisciplinary Program for Biotechnology at the Technion	This work was supported by the EU-FP7 Marie Curie Program (No. 333797) - Dr. Avi Schroeder, Israel Science Foundation (No. 1778/13), Israel Cancer Association (No. 20150116), Israel Ministry of Economy (No. 52752), Israel Ministry of Science, Technology and Space (311878), GIF (No. 1-2328-1139. 10/20), ERC (2015-STG-680242), Mallat Family Foundation, The Russell Berrie Nanotechnology Institute (RBNI) at the Technion - Dr. Avi Schroeder, The Lorry Lokey Interdisciplinary Center for Life Sciences & Engineering at the Technion - Dr. Avi Schroeder, the Alon Fellowship from the Council For Higher Education and Taub Foundation Fellowships to A.S, and the "Baroness Ariane de Rothschild Women Doctoral Program" from the Rothschild Caesarea Foundation, and The Interdisciplinary Program for Biotechnology at the Technion (Mrs. Nitan Krinsky). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENHAR I, 1994, J BIOL CHEM, V269, P13398; Bouvet OMM, 1999, APPL ENVIRON MICROB, V65, P4245; Carlson ED, 2012, BIOTECHNOL ADV, V30, P1185, DOI 10.1016/j.biotechadv.2011.09.016; EHRLICH R, 1970, APPL MICROBIOL, V19, P245, DOI 10.1128/AEM.19.2.245-249.1970; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; FitzGerald D J, 1988, Cancer Treat Res, V37, P161; Fujiwara K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154614; Gagoski D, 2016, BIOTECHNOL BIOENG, V113, P292, DOI 10.1002/bit.25814; Goerke AR, 2008, BIOTECHNOL BIOENG, V99, P351, DOI 10.1002/bit.21567; Hasan CMM, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-35; He MY, 2011, PROCESS BIOCHEM, V46, P615, DOI 10.1016/j.procbio.2010.11.003; ITO K, 1983, CELL, V32, P789, DOI 10.1016/0092-8674(83)90065-X; Ivanir E, 2009, DEV EFFICIENT CELL F; Jackson Alison M., 2004, Briefings in Functional Genomics & Proteomics, V2, P308, DOI 10.1093/bfgp/2.4.308; KIGAWA T, 1995, J BIOMOL NMR, V6, P129, DOI 10.1007/BF00211776; Kim TW, 2007, J BIOTECHNOL, V130, P389, DOI 10.1016/j.jbiotec.2007.05.002; Kim TW, 2006, J BIOTECHNOL, V126, P554, DOI 10.1016/j.jbiotec.2006.05.014; Kim TW, 2006, J BIOTECHNOL, V124, P373, DOI 10.1016/j.jbiotec.2005.12.030; Kwon YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08663; LEMAUX PG, 1978, CELL, V13, P427, DOI 10.1016/0092-8674(78)90317-3; Liu DV, 2005, BIOTECHNOL PROGR, V21, P460, DOI 10.1021/bp049789y; Martemyanov KA, 2001, PROTEIN EXPRES PURIF, V21, P456, DOI 10.1006/prep.2001.1400; NEVIN DE, 1991, FEBS LETT, V291, P259, DOI 10.1016/0014-5793(91)81297-L; Nguyen TA, 2010, J MOL MICROB BIOTECH, V18, P85, DOI 10.1159/000283512; NIRENBERG M, 1961, P NATL ACAD SCI USA, V47, P1588, DOI 10.1073/pnas.47.10.1588; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pisal DS, 2010, J PHARM SCI-US, V99, P2557, DOI 10.1002/jps.22054; Pratt J.M., 1984, TRANSCRIPTION TRANSL, P179; Rosenblum G, 2014, FEBS LETT, V588, P261, DOI 10.1016/j.febslet.2013.10.016; Salehi ASM, 2016, BIOTECHNOL J, V11, P274, DOI 10.1002/biot.201500237; Shapira A, 2010, TOXINS, V2, P2519, DOI 10.3390/toxins2112519; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shrestha P, 2012, BIOTECHNIQUES, V53, P163, DOI 10.2144/0000113924; Shuster V, 2009, J MOL MICROB BIOTECH, V17, P188, DOI 10.1159/000233506; Yang WC, 2012, BIOTECHNOL PROGR, V28, P413, DOI 10.1002/btpr.1509; ZUBAY G, 1973, ANNU REV GENET, V7, P267, DOI 10.1146/annurev.ge.07.120173.001411	36	27	27	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165137	10.1371/journal.pone.0165137	http://dx.doi.org/10.1371/journal.pone.0165137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768741	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400055
J	Chong, SY; Rohrle, O				Chong, Sook-Yee; Rohrle, Oliver			Exploring the Use of Non-Image-Based Ultrasound to Detect the Position of the Residual Femur within a Stump	PLOS ONE			English	Article							TRANS-FEMORAL SOCKET; PROSTHETIC SOCKET; PTB PROSTHESIS; KNEE AMPUTEES; MOTION; CALIBRATION; MODE; GAIT; LIMB	A satisfactorily fitted socket interacts dynamically with the stump in order to support body weight, transmit load effectively, enhance dynamic stability, and enable the control and stabilization of the residual limb. The internal dynamics occurring within a socket is important in determining optimal fit. Many measurement and imaging techniques, such as X-rays, have been utilized to investigate the movement of the residual femur within the stump during gait. However, due to associated health risks and costs, none of the current techniques have been extended to clinical prosthetics. The use of B-mode ultrasound has been suggested as a safe and cheap alternative, and has been utilized in previous studies to monitor the motion of the femur. However, the need to create a duplicate socket and time-consuming analysis of the images were obstacles to the system being applied clinically. This study aims to gauge the effectiveness of a non-image based ultrasound system. Here, we determined errors expected from the measurements. Accuracy errors of 2.9 mm to 8.4 mm and reproducibility measurements within a standard deviation of 3.9 mm are reported. We also estimated errors up to 14.4 mm in in-vivo measurements. We think there is potential in developing this technique, and we hope to reduce some technical difficulties such that it can, one day, be easily incorporated into prosthetic fitting.	[Chong, Sook-Yee; Rohrle, Oliver] Univ Stuttgart, Inst Appl Mech, Stuttgart, Germany; [Rohrle, Oliver] Fraunhofer IPA, Biomechatron Syst, Stuttgart, Germany	University of Stuttgart	Chong, SY (corresponding author), Univ Stuttgart, Inst Appl Mech, Stuttgart, Germany.	sy.chong@wwu.de	Chong, Sook Yee/T-2947-2018	Chong, Sook Yee/0000-0002-9761-3991; Rohrle, Oliver/0000-0002-1934-6525	European Research Council (ERC) under the European Union's Seventh Framework Program (FP7) [306757]	European Research Council (ERC) under the European Union's Seventh Framework Program (FP7)	Support was provided by the European Research Council (ERC) under the European Union's Seventh Framework Program (FP7/2007-2013) ERC grant agreement no 306757. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boone DA., 2006, J PROSTHET ORTHOT, V18, P68, DOI DOI 10.1097/00008526-200601001-00008; Convery P, 2000, PROSTHET ORTHOT INT, V24, P226, DOI 10.1080/03093640008726552; Douglas TS, 2002, IEEE T NEUR SYS REH, V10, P11, DOI 10.1109/TNSRE.2002.1021582; ERIKSON U, 1973, UPSALA J MED SCI, V78, P203, DOI 10.3109/03009737309178629; ERIKSON U, 1969, ACTA ORTHOP SCAND, V40, P520, DOI 10.3109/17453676909046537; GREVSTEN S, 1975, UPSALA J MED SCI, V80, P49, DOI 10.3109/03009737509178991; He P, 1996, IEEE Trans Rehabil Eng, V4, P114, DOI 10.1109/86.506408; LILJA M, 1993, PROSTHET ORTHOT INT, V17, P21, DOI 10.3109/03093649309164351; Long IA., 1985, CLIN PROSTHET ORTHOT, V9, P9; Mast T. D., 2000, Acoustics Research Letters Online, V1, P37, DOI 10.1121/1.1336896; Mayfield GW, 1977, ORTHOP T, V1, P95; Metwally K, 2016, ULTRASONICS, V65, P10, DOI 10.1016/j.ultras.2015.09.006; Mozes A, 2010, INT J MED ROBOT COMP, V6, P91, DOI 10.1002/rcs.294; Murray KD, 2000, PROSTHET ORTHOT INT, V24, P55, DOI 10.1080/03093640008726522; Oppenheim Alan V., 1999, DISCRETE TIME SIGNAL; Pinkerton JMM., 1949, P PHYS SOC B, V62, P129, DOI [10.1088/0370-1301/62/2/307, DOI 10.1088/0370-1301/62/2/307]; Richards JG, 1999, HUM MOVEMENT SCI, V18, P589, DOI 10.1016/S0167-9457(99)00023-8; Sabolich J., 1985, CLIN PROSTH ORTHOS, V9, P15; SAUNDERS JBDM, 1953, J BONE JOINT SURG AM, V35-A, P543, DOI 10.2106/00004623-195335030-00003; Shen C, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041033; Zhang M, 1998, P ANN INT IEEE EMBS, V20, P2741, DOI 10.1109/IEMBS.1998.745244; Zheng YP, 2001, J REHABIL RES DEV, V38, P487	22	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164583	10.1371/journal.pone.0164583	http://dx.doi.org/10.1371/journal.pone.0164583			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764120	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204500045
J	Kim, HS; Shin, JS; Lee, J; Lee, YJ; Kim, MR; Bae, YH; Park, KB; Lee, EJ; Kim, JH; Ha, IH				Kim, Ho Sun; Shin, Joon-Shik; Lee, Jinho; Lee, Yoon Jae; Kim, Me-Riong; Bae, Young-Hyeon; Park, Ki Byung; Lee, Eun-Jung; Kim, Joo-Hee; Ha, In-Hyuk			Association between Knee Osteoarthritis, Cardiovascular Risk Factors, and the Framingham Risk Score in South Koreans: A Cross-Sectional Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PREVALENCE; WOMEN; ATHEROSCLEROSIS; EPIDEMIOLOGY; HYPERTENSION; MORTALITY; ARTHRITIS	Background Osteoarthritis is a significant burden on personal health and for social cost, and its prevalence is rising. Recent research has revealed an association between osteoarthritis and cardiovascular disease, and this study uses the Framingham risk score (FRS), which is widely used as a composite index of cardiovascular risk factors, to investigate the association between osteoarthritis and various cardiovascular risk factors. Methods A total 9,514 participants aged 50 years or older who received knee X-ray diagnosis of the 5th Korean National Health and Nutrition Examination Survey (total surveyees = 24,173) released by the Korean Centers for Disease Control and Prevention was included for analysis. Knee osteoarthritis patients were defined as participants with K-L grade >= 2 on knee Xray regardless of knee pain. The association between major cardiovascular risk factors (blood pressure, diabetes, cholesterol, and smoking habits), FRS, and knee osteoarthritis was analyzed, adjusting for various covariates. Results Prevalence of knee osteoarthritis in Koreans aged >= 50 years was 36.6%, and higher in women (men: 24.9%, women: 45.4%). Prevalence of knee osteoarthritis in participants with hypertension was significantly higher than those without hypertension (fully adjusted odds ratio (OR) 1.26; 95% confidence interval (CI) 1.08-1.48). Knee osteoarthritis prevalence was also higher in participants with impaired fasting glucose or diabetes than those without (age, sex adjusted OR 1.19; 95% CI 1.00-1.41). Also, OR values increased statistically significantly with FRS as a continuous variable (fully adjusted OR 1.007; 95% CI 1.00-1.01). Conclusions Prevalence of knee osteoarthritis was associated with hypertension and diabetes, which are major cardiovascular risk factors, and the FRS. Further studies on FRS pertaining to its relationship with osteoarthritis are warranted.	[Kim, Ho Sun; Shin, Joon-Shik; Lee, Jinho; Lee, Yoon Jae; Kim, Me-Riong; Bae, Young-Hyeon; Park, Ki Byung; Ha, In-Hyuk] Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea; [Lee, Eun-Jung] Dae Jeon Univ, Coll Korean Med, Dept Korean Rehabil Med, Daejeon, South Korea; [Kim, Joo-Hee] Korea Inst Oriental Med, Div Med Res, Daejeon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Ha, IH (corresponding author), Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea.	hanihata@gmail.com	Lee, Yoon Jae/ABA-8808-2020	Lee, Yoon Jae/0000-0002-1532-0942; Shin, Joon-Shik/0000-0001-5488-3273; Lee, Jinho/0000-0003-0672-6892; HA, IN-HYUK/0000-0002-5020-6723				CERHAN JR, 1995, AM J EPIDEMIOL, V141, P225, DOI 10.1093/oxfordjournals.aje.a117424; CIMMINO MA, 1990, CLIN EXP RHEUMATOL, V8, P251; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; DAWBER TR, 1966, CIRCULATION, V34, P553, DOI 10.1161/01.CIR.34.4.553; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Fernandes GS, 2015, EUR J CLIN INVEST, V45, P405, DOI 10.1111/eci.12413; Findlay DM, 2007, RHEUMATOLOGY, V46, P1763, DOI 10.1093/rheumatology/kem191; Ha IH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093671; Haara MM, 2003, ANN RHEUM DIS, V62, P151, DOI 10.1136/ard.62.2.151; HARRISON MHM, 1953, J BONE JOINT SURG BR, V35, P598, DOI 10.1302/0301-620X.35B4.598; HART DJ, 1995, J RHEUMATOL, V22, P1118; Hochberg MC., 2004, OSTEOARTHR CARTIL, V12, P45, DOI [10.1016/j.joca.2003.09.008, DOI 10.1016/J.JOCA.2003.09.008]; Kadam UT, 2004, ANN RHEUM DIS, V63, P408, DOI 10.1136/ard.2003.007526; Kang K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010062; Karasik D, 2006, CALCIFIED TISSUE INT, V78, P1, DOI 10.1007/s00223-005-0054-3; KELLGREN JH, 1961, BMJ-BRIT MED J, V2, P1, DOI 10.1136/bmj.2.5243.1; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kerkhof HJM, 2010, ARTHRITIS RHEUM-US, V62, P499, DOI 10.1002/art.27184; Kim Hye-Ryoung, 2013, Journal of korean biological nursing science, V15, P219, DOI 10.7586/jkbns.2013.15.4.219; Kurunlahti M, 1999, SPINE, V24, P2080, DOI 10.1097/00007632-199910150-00003; Lee MY, 2006, J LEUKOCYTE BIOL, V80, P922, DOI 10.1189/jlb.0306160; Marks Ray, 2002, Med Sci Monit, V8, pCR305; MONSON RR, 1976, J CHRON DIS, V29, P459, DOI 10.1016/0021-9681(76)90086-2; Rosa SC, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2713; Sharma L, 2007, OSTEOARTHRITIS DIAGN; Singh G, 2002, AM J MANAG CARE, V8, pS383; Sowers M, 2009, ARTHRIT CARE RES, V61, P1328, DOI 10.1002/art.24739; Sturmer T, 1998, J RHEUMATOL, V25, P1827; VANSAASE JLCM, 1988, J RHEUMATOL, V15, P1152; Wen CY, 2013, OSTEOARTHR CARTILAGE, V21, P1716, DOI 10.1016/j.joca.2013.06.027; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yoshimura N, 2012, OSTEOARTHR CARTILAGE, V20, P1217, DOI 10.1016/j.joca.2012.06.006; Zhang YQ, 2010, CLIN GERIATR MED, V26, P355, DOI [10.1016/j.cger.2010.03.001, 10.1016/j.rdc.2012.10.004]; Zhou S, 2003, OSTEOARTHR CARTILAGE, V11, pS20	35	21	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165325	10.1371/journal.pone.0165325	http://dx.doi.org/10.1371/journal.pone.0165325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764239	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500147
J	O'Hara, CB; Keyes, A; Renwick, B; Giel, KE; Campbell, IC; Schmidt, U				O'Hara, Caitlin B.; Keyes, Alexandra; Renwick, Bethany; Giel, Katrin E.; Campbell, Iain C.; Schmidt, Ulrike			Evidence that Illness-Compatible Cues Are Rewarding in Women Recovered from Anorexia Nervosa: A Study of the Effects of Dopamine Depletion on Eye-Blink Startle Responses	PLOS ONE			English	Article							ACUTE PHENYLALANINE/TYROSINE DEPLETION; AMINO-ACID MIXTURE; ALTERED INSULA RESPONSE; TYROSINE DEPLETION; PHYSICAL-ACTIVITY; BULIMIA-NERVOSA; FOOD; MOOD; MOTIVATION; EXERCISE	In anorexia nervosa (AN), motivational salience is attributed to illness-compatible cues (e.g., underweight and active female bodies) and this is hypothesised to involve dopaminergic reward circuitry. We investigated the effects of reducing dopamine (DA) transmission on the motivational processing of AN-compatible cues in women recovered from AN (AN REC, n = 17) and healthy controls (HC, n = 15). This involved the acute phenylalanine and tyrosine depletion (APTD) procedure and a startle eye-blink modulation (SEM) task. In a balanced amino acid state, AN REC showed an increased appetitive response (decreased startle potentiation) to illness-compatible cues (underweight and active female body pictures (relative to neutral and non-active cues, respectively)). The HC had an aversive response (increased startle potentiation) to the same illness-compatible stimuli (relative to neutral cues). Importantly, these effects, which may be taken to resemble symptoms observed in the acute stage of illness and healthy behaviour respectively, were not present when DA was depleted. Thus, AN REC implicitly appraised underweight and exercise cues as more rewarding than did HC and the process may, in part, be DA-dependent. It is proposed that the positive motivational salience attributed to cues of emaciation and physical activity is, in part, mediated by dopaminergic reward processes and this contributes to illness pathology. These observations are consistent with the proposal that, in AN, aberrant reward-based learning contributes to the development of habituation of AN-compatible behaviours.	[O'Hara, Caitlin B.; Keyes, Alexandra; Renwick, Bethany; Campbell, Iain C.; Schmidt, Ulrike] Kings Coll London, Inst Psychiat Psychol & Neurosci, Sect Eating Disorders, Dept Psychol Med, London, England; [Giel, Katrin E.] Med Univ Hosp Tubingen, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany	University of London; King's College London; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	O'Hara, CB (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Sect Eating Disorders, Dept Psychol Med, London, England.	caitlin.b.o'hara@kcl.ac.uk			Swiss Anorexia Foundation [10-11]; NIHR Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust; King's College London; BRC; Ministry of Science Baden-Wuerttemberg; European Social Fund; Athene programme; Excellence Initiative of the German federal and state governments	Swiss Anorexia Foundation; NIHR Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust; King's College London; BRC; Ministry of Science Baden-Wuerttemberg; European Social Fund(European Social Fund (ESF)); Athene programme; Excellence Initiative of the German federal and state governments	This study was supported by the Swiss Anorexia Foundation (project no. 10-11) and by the NIHR Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. IC and US receive salary support from the BRC. KEG receives funding from the Ministry of Science Baden-Wuerttemberg and the European Social Fund and is partly supported by the Athene programme, a project of the Excellence Initiative of the German federal and state governments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett SP, 2008, EUR NEUROPSYCHOPHARM, V18, P439, DOI 10.1016/j.euroneuro.2008.01.008; Barrett SP, 2004, PRIM PSYCHIAT, V11, P36; Berridge KC, 2015, NEURON, V86, P646, DOI 10.1016/j.neuron.2015.02.018; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; BIGGIO G, 1976, J NEUROCHEM, V26, P1253, DOI 10.1111/j.1471-4159.1976.tb07014.x; Blechert J, 2010, J ABNORM PSYCHOL, V119, P575, DOI 10.1037/a0019531; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Carr K, 2009, PSYCHOPHARMACOLOGY, V202, P731, DOI 10.1007/s00213-008-1355-9; Cawley EI, 2013, J PSYCHIATR NEUROSCI, V38, P388, DOI 10.1503/jpn.120181; Cowdrey FA, 2013, AM J CLIN NUTR, V97, P463, DOI 10.3945/ajcn.112.046011; Cowdrey FA, 2011, BIOL PSYCHIAT, V70, P736, DOI 10.1016/j.biopsych.2011.05.028; Crisp A, 2006, EUR EAT DISORD REV, V14, P153, DOI 10.1002/erv.701; Davis C, 2002, COMPR PSYCHIAT, V43, P189, DOI 10.1053/comp.2002.32356; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fladung AK, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.88; Fladung AK, 2010, AM J PSYCHIAT, V167, P206, DOI 10.1176/appi.ajp.2009.09010071; Frank GK, 2005, BIOL PSYCHIAT, V58, P908, DOI 10.1016/j.biopsych.2005.05.003; Frank GKW, 2015, CNS SPECTRUMS, V20, P391, DOI 10.1017/S1092852915000012; Frank Guido K W, 2014, Front Nutr, V1, P19, DOI 10.3389/fnut.2014.00019; Friederich HC, 2006, PSYCHOL MED, V36, P1327, DOI 10.1017/S0033291706008129; Gelegen C, 2008, GENES BRAIN BEHAV, V7, P552, DOI 10.1111/j.1601-183X.2008.00394.x; Giel KE, 2013, BIOL PSYCHOL, V94, P575, DOI 10.1016/j.biopsycho.2013.10.004; Giel KE, 2011, BIOL PSYCHIAT, V69, P661, DOI 10.1016/j.biopsych.2010.09.047; Graybiel AM, 2014, SCI AM, V310, P38, DOI 10.1038/scientificamerican0614-38; Harmer CJ, 2001, PSYCHOPHARMACOLOGY, V154, P105, DOI 10.1007/s002130000613; Holsen LM, 2012, J PSYCHIATR NEUROSCI, V37, P322, DOI 10.1503/jpn.110156; Holtkamp K, 2006, BIOL PSYCHIAT, V60, P311, DOI 10.1016/j.biopsych.2005.11.001; Jansen A, 2005, BEHAV RES THER, V43, P183, DOI 10.1016/j.brat.2004.01.003; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; Keyes A, 2015, INT J EAT DISORDER, V48, P46, DOI 10.1002/eat.22354; Keys A, 1950, BIOL HUMAN STARVATIO; Klein DA, 2010, INT J EAT DISORDER, V43, P611, DOI 10.1002/eat.20758; Klenotich SJ, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.109; Kullmann S, 2014, SOC COGN AFFECT NEUR, V9, P917, DOI 10.1093/scan/nst070; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Le Masurier M, 2004, PSYCHOPHARMACOLOGY, V171, P435, DOI 10.1007/s00213-003-1607-7; Le Masurier M, 2014, J PSYCHOPHARMACOL, V28, P561, DOI 10.1177/0269881113507642; Leyton M, 2004, NEUROPSYCHOPHARMACOL, V29, P427, DOI 10.1038/sj.npp.1300328; Leyton M, 2000, NEUROPSYCHOPHARMACOL, V22, P52, DOI 10.1016/S0893-133X(99)00086-X; Leyton M, 2007, J PSYCHIATR NEUROSCI, V32, P129; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; McTavish SFB, 2001, BRIT J PSYCHIAT, V179, P356, DOI 10.1192/bjp.179.4.356; McTavish SFB, 1999, PSYCHOPHARMACOLOGY, V141, P182, DOI 10.1007/s002130050823; Moja EA, 1996, LIFE SCI, V58, P2389, DOI 10.1016/0024-3205(96)00242-1; O'Hara CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145894; O'Hara CB, 2015, NEUROSCI BIOBEHAV R, V52, P131, DOI 10.1016/j.neubiorev.2015.02.012; Oberndorfer TA, 2013, AM J PSYCHIAT, V170, P1143, DOI 10.1176/appi.ajp.2013.11111745; Palmour RM, 1998, PSYCHOPHARMACOLOGY, V136, P1, DOI 10.1007/s002130050532; Park RJ, 2014, BEHAV RES THER, V62, P47, DOI 10.1016/j.brat.2014.07.007; Robinson OJ, 2010, NEUROIMAGE, V51, P1459, DOI 10.1016/j.neuroimage.2010.03.036; Roiser JP, 2005, NEUROPSYCHOPHARMACOL, V30, P775, DOI 10.1038/sj.npp.1300659; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Sanders N, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00046; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Shafran R, 2007, INT J EAT DISORDER, V40, P369, DOI 10.1002/eat.20375; Sheehan BD, 1996, J PSYCHOPHARMACOL, V10, P231, DOI 10.1177/026988119601000309; SILBERSTEIN LR, 1988, SEX ROLES, V19, P219, DOI 10.1007/BF00290156; Soussignan R, 2011, BIOL PSYCHOL, V86, P265, DOI 10.1016/j.biopsycho.2010.12.007; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; van den Eynde F, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-302; Venugopalan VV, 2011, NEUROPSYCHOPHARMACOL, V36, P2469, DOI 10.1038/npp.2011.135; Verhagen LAW, 2009, EUR NEUROPSYCHOPHARM, V19, P153, DOI 10.1016/j.euroneuro.2008.09.005; Wagner A, 2008, NEUROPSYCHOPHARMACOL, V33, P513, DOI 10.1038/sj.npp.1301443; Wagner A, 2007, AM J PSYCHIAT, V164, P1842, DOI 10.1176/appi.ajp.2007.07040575; Walsh BT, 2013, AM J PSYCHIAT, V170, P477, DOI 10.1176/appi.ajp.2012.12081074; YOUNG SN, 1985, PSYCHOPHARMACOLOGY, V87, P173, DOI 10.1007/BF00431803; Zipfel S, 2015, LANCET PSYCHIAT, V2, P1099, DOI 10.1016/S2215-0366(15)00356-9	71	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165104	10.1371/journal.pone.0165104	http://dx.doi.org/10.1371/journal.pone.0165104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9NZ	27764214	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500115
J	Wang, JW; Hsu, CN; Tai, WC; Ku, MK; Hung, TH; Tseng, KL; Yuan, LT; Nguang, SH; Liang, CM; Yang, SC; Wu, CK; Hsu, PI; Wu, DC; Chuah, SK				Wang, Jiunn-Wei; Hsu, Chien-Ning; Tai, Wei-Chen; Ku, Ming-Kun; Hung, Tsung-Hsing; Tseng, Kuo-Lun; Yuan, Lan-Ting; Nguang, Seng-Howe; Liang, Chih-Ming; Yang, Shih-Cheng; Wu, Cheng-Kun; Hsu, Pin-I; Wu, Deng-Chyang; Chuah, Seng-Kee			The Association of Helicobacter pylori Eradication with the Occurrences of Chronic Kidney Diseases in Patients with Peptic Ulcer Diseases	PLOS ONE			English	Article							STAGE RENAL-DISEASE; ENDOTHELIAL DYSFUNCTION; INFECTION; RISK	The association of Helicobacter pylori eradication with the occurrence of renal dysfunction in patients with peptic ulcer diseases is still unclear. This study aimed to clarify the relevance of H. pylori eradication to the occurrence of chronic kidney diseases in patients with peptic ulcer diseases. Data that were available from 2000-2011 were extracted from the National Health Insurance Research Database in Taiwan, and all patients with peptic ulcer diseases (n = 208 196) were screened for eligibility. We divided randomly selected patients into an H. pylori eradication cohort (cohort A, n = 3593) and matched them by age and sex to a without H. pylori eradication cohort (cohort B, n = 3593). Subgroup analysis was further performed for H. pylori eradication within <= 90 days of the diagnosis date (early eradication, n = 2837) and within 91-365 days (non-early eradication, n = 756). Cox proportional hazards regression analysis was used to estimate the association of H. pylori eradication with the risk of developing chronic kidney diseases and mortality. We observed that there were more patients suffering from chronic kidney disease in cohort B than in the early eradication subgroup of cohort A (8.49% vs. 6.70%, respectively, p = 0.0075); the mortality rate was also higher in cohort B (4.76% vs. 3.70%, respectively, p= 0.0376). Old age, pulmonary disease, connective tissue disorders, and diabetes were risk factors for chronic kidney diseases but early H. pylori eradication was a protective factor against chronic kidney diseases (hazard ratio: 0.68, 95% confidence interval: 0.52-0.88, p= 0.0030), and death (hazard ratio: 0.69, 95% confidence interval: 0.49-0.96, p= 0.0297). In conclusion, our findings have important implications suggesting that early H. pylori eradication is mandatory since it is associated with a protective role against the occurrence of chronic kidney diseases.	[Wang, Jiunn-Wei; Tseng, Kuo-Lun; Wu, Deng-Chyang] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan; [Wang, Jiunn-Wei; Tseng, Kuo-Lun; Wu, Deng-Chyang] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Hsu, Chien-Ning] Kaohsiung Chang Gung Mem Hosp, Dept Pharm, Kaohsiung, Taiwan; [Hsu, Chien-Ning] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan; [Tai, Wei-Chen; Liang, Chih-Ming; Yang, Shih-Cheng; Wu, Cheng-Kun; Chuah, Seng-Kee] Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Tai, Wei-Chen; Liang, Chih-Ming; Yang, Shih-Cheng; Wu, Cheng-Kun; Chuah, Seng-Kee] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Tai, Wei-Chen; Chuah, Seng-Kee] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Ku, Ming-Kun] FooYin Univ Hosp, Div Gastroenterol, Pingtung, Taiwan; [Ku, Ming-Kun] FooYin Univ Hosp, Pingtung, Taiwan; [Hung, Tsung-Hsing] Buddist Tzu Chi Gen Hosp, Dalin Branch, Div Hepatogastroenterol, Taipei, Taiwan; [Hung, Tsung-Hsing] Buddist Tzu Chi Gen Hosp, Dalin Branch, Dept Internal Med, Taipei, Taiwan; [Yuan, Lan-Ting] Yuan Gen Hosp, Div Gastroenterol, Kaohsiung, Taiwan; [Nguang, Seng-Howe] Pin Tung Christian Hosp, Div Gastroenterol, Pingtung, Taiwan; [Nguang, Seng-Howe] Pin Tung Christian Hosp, Pingtung, Taiwan; [Hsu, Pin-I] Natl Yang Ming Univ, Kaohsiung Vet Gen Hosp, Div Gastroenterol, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Chang Gung Memorial Hospital; Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Buddhist Tzu Chi General Hospital; Buddhist Tzu Chi General Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University	Wu, DC (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan.; Wu, DC (corresponding author), Kaohsiung Med Univ, Kaohsiung, Taiwan.; Chuah, SK (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Kaohsiung, Taiwan.; Chuah, SK (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan.; Chuah, SK (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	dechwu@yahoo.com; Chuahsk@seed.net.tw	Hsu, Chien-Ning/GLS-4014-2022	Hsu, Chien-Ning/0000-0001-7470-528X; Wang, Jiunn-Wei/0000-0003-2534-438X	Kaohsiung Medical University "Aim for the Top Universities Grant" [KMU-TP104G00, KMU-TP104G04]; Kaohsiung Medical University Hospital [KMUH103-3R01]; Kaohsiung Municipal Ta-Tung Hospital [KMTTH-104-012]	Kaohsiung Medical University "Aim for the Top Universities Grant"; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital	This study was supported by grants from Kaohsiung Medical University "Aim for the Top Universities Grant, grant No. KMU-TP104G00, KMU-TP104G04, Kaohsiung Medical University Hospital (KMUH103-3R01), Kaohsiung Municipal Ta-Tung Hospital (KMTTH-104-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Professor Yi-Hsin Yang and center for medical informatics and statistics for their suggestions and help on data analysis, Kaohsiung Medical University. This study was supported by grants from Kaohsiung Medical University "Aim for the Top Universities Grant, grant No. KMU-TP104G00, KMU-TP104G04, Kaohsiung Medical University Hospital (KMUH103-3R01), Kaohsiung Municipal Ta-Tung Hospital (KMTTH-104-012)	Annibale B, 1999, ANN INTERN MED, V131, P668, DOI 10.7326/0003-4819-131-9-199911020-00006; Chen CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25855; Chiu HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136508; Chuah SK, 2011, WORLD J GASTROENTERO, V17, P3971, DOI 10.3748/wjg.v17.i35.3971; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Franceschi F, 2014, NAT REV GASTRO HEPAT, V11, P234, DOI 10.1038/nrgastro.2013.243; Gasbarrini A, 1998, LANCET, V352, P878, DOI 10.1016/S0140-6736(05)60004-9; Grabczewska Z, 2006, EUR J INTERN MED, V17, P339, DOI 10.1016/j.ejim.2006.02.005; Hiew C, 2012, INTERN MED J, V42, P289, DOI 10.1111/j.1445-5994.2010.02260.x; Hsu PI, 2005, AM J GASTROENTEROL, V100, P2387, DOI 10.1111/j.1572-0241.2005.00264.x; Khedmat H, 2009, SAUDI J KIDNEY DIS T, V20, P969; Kurata JH, 1997, J CLIN GASTROENTEROL, V24, P2, DOI 10.1097/00004836-199701000-00002; Lin SY, 2015, INT J CLIN PRACT, V69, P604, DOI 10.1111/ijcp.12602; Liou JM, 2016, J GASTROEN HEPATOL, V31, P1918, DOI 10.1111/jgh.13418; Marra M, 2005, HELICOBACTER, V10, P609, DOI 10.1111/j.1523-5378.2005.00359.x; MARSHALL BJ, 1984, LANCET, V1, P1311; Mihout F, 2011, J PATHOL, V223, P37, DOI 10.1002/path.2769; NHRI, NAT HLTH INS RES DAT; Niccoli G, 2010, CORONARY ARTERY DIS, V21, P217, DOI 10.1097/MCA.0b013e3283399f36; Nozaki K, 2003, CANCER SCI, V94, P235, DOI 10.1111/j.1349-7006.2003.tb01426.x; Oshima T, 2005, J AM COLL CARDIOL, V45, P1219, DOI 10.1016/j.jacc.2005.01.019; PEREZPEREZ GI, 1990, J INFECT DIS, V161, P1237, DOI 10.1093/infdis/161.6.1237; ROCHA GA, 1992, BRAZ J MED BIOL RES, V25, P683; Satoh M, 2012, CLIN EXP NEPHROL, V16, P518, DOI 10.1007/s10157-012-0646-y; Shih HY, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/390967; Sugimoto M, 2011, THER APHER DIAL, V15, P1, DOI 10.1111/j.1744-9987.2010.00851.x; Tai WC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/623732; Tebbe B, 1996, J AM ACAD DERMATOL, V34, P685, DOI 10.1016/S0190-9622(96)80086-7; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wu CY, 2009, GASTROENTEROLOGY, V137, P1641, DOI 10.1053/j.gastro.2009.07.060	30	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164824	10.1371/journal.pone.0164824	http://dx.doi.org/10.1371/journal.pone.0164824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764171	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500069
J	Wamsley, EJ; Hamilton, K; Graveline, Y; Manceor, S; Parr, E				Wamsley, Erin J.; Hamilton, Kelly; Graveline, Yvette; Manceor, Stephanie; Parr, Elaine			Test Expectation Enhances Memory Consolidation across Both Sleep and Wake	PLOS ONE			English	Article							EMOTIONAL MEMORY; MOTOR SKILL; REM-SLEEP; REPRESENTATION; PERFORMANCE; INTENTIONS; ACTIVATION; PLASTICITY; FUTURE; SCENES	Memory consolidation benefits from post-training sleep. However, recent studies suggest that sleep does not uniformly benefit all memory, but instead prioritizes information that is important to the individual. Here, we examined the effect of test expectation on memory consolidation across sleep and wakefulness. Following reports that information with strong "future relevance" is preferentially consolidated during sleep, we hypothesized that test expectation would enhance memory consolidation across a period of sleep, but not across wakefulness. To the contrary, we found that expectation of a future test enhanced memory for both spatial and motor learning, but that this effect was equivalent across both wake and sleep retention intervals. These observations differ from those of least two prior studies, and fail to support the hypothesis that the "future relevance" of learned material moderates its consolidation selectively during sleep.	[Wamsley, Erin J.; Hamilton, Kelly; Graveline, Yvette; Manceor, Stephanie; Parr, Elaine] Furman Univ, Dept Psychol, Greenville, SC 29613 USA; [Wamsley, Erin J.; Hamilton, Kelly; Graveline, Yvette; Manceor, Stephanie; Parr, Elaine] Furman Univ, Program Neurosci, Greenville, SC 29613 USA; [Graveline, Yvette] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	Wamsley, EJ (corresponding author), Furman Univ, Dept Psychol, Greenville, SC 29613 USA.; Wamsley, EJ (corresponding author), Furman Univ, Program Neurosci, Greenville, SC 29613 USA.	erin.wamsley@furman.edu		Wamsley, Erin/0000-0003-4465-3890	Bursaries award from BIAL Foundation, Portugal [83/12]; NIMH [R01-MH48832]	Bursaries award from BIAL Foundation, Portugal(Bial Foundation); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a Bursaries award (83/12) from the BIAL Foundation, Portugal (https://www.bial.com.en/bial_foundation.11/foundation.15/bial_foundation.a36.html), as well as R01-MH48832 from the NIMH (https://www.nimh.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badets A, 2006, J EXP PSYCHOL LEARN, V32, P491, DOI 10.1037/0278-7393.32.3.491; Barakat M, 2011, BEHAV BRAIN RES, V217, P117, DOI 10.1016/j.bbr.2010.10.019; Baran B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075326; Baran B, 2012, J NEUROSCI, V32, P1035, DOI 10.1523/JNEUROSCI.2532-11.2012; Born J, 2012, PSYCHOL RES-PSYCH FO, V76, P192, DOI 10.1007/s00426-011-0335-6; Chesson Jr A. L., 2007, THE AASM MANUAL FOR; Cunningham TJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00862; DEKONINCK J, 1990, PSYCHIAT J U OTTAWA, V15, P91; Djonlagic I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034106; Fischer S, 2009, J EXP PSYCHOL LEARN, V35, P1586, DOI 10.1037/a0017256; Fiss H., 1977, SLEEP RES, V6, P122; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; GOSCHKE T, 1993, J EXP PSYCHOL LEARN, V19, P1211, DOI 10.1037/0278-7393.19.5.1211; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kiryu T, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-34; Lehmann M., 2016, SOMNOLOGIE, P1, DOI DOI 10.1007/S11818-015-0034-4; Lewis PA, 2011, NEUROPSYCHOLOGIA, V49, P2619, DOI 10.1016/j.neuropsychologia.2011.05.009; Marsh RL, 1998, J EXP PSYCHOL LEARN, V24, P350, DOI 10.1037/0278-7393.24.2.350; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Nguyen ND, 2013, SLEEP, V36, P1051, DOI 10.5665/sleep.2808; Nishida M, 2009, CEREB CORTEX, V19, P1158, DOI 10.1093/cercor/bhn155; Oudiette D, 2013, J NEUROSCI, V33, P6672, DOI 10.1523/JNEUROSCI.5497-12.2013; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Payne JD, 2015, EMOTION, V15, P176, DOI 10.1037/a0038683; Payne JD, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00108; Payne JD, 2010, CURR DIR PSYCHOL SCI, V19, P290, DOI 10.1177/0963721410383978; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Stamm AW, 2014, LEARN MEMORY, V21, P591, DOI 10.1101/lm.035196.114; Stanley DJ, 2014, PERSPECT PSYCHOL SCI, V9, P305, DOI 10.1177/1745691614528518; Stickgold R, 2000, SCIENCE, V290, P350, DOI 10.1126/science.290.5490.350; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; Tucker MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021737; van Dongen EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043426; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; Wagner U, 2006, BIOL PSYCHIAT, V60, P788, DOI 10.1016/j.biopsych.2006.03.061; Walker MP, 2005, NEUROSCIENCE, V133, P911, DOI 10.1016/j.neuroscience.2005.04.007; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wamsley EJ, 2012, BIOL PSYCHIAT, V71, P154, DOI 10.1016/j.biopsych.2011.08.008; Wamsley EJ, 2010, LEARN MEMORY, V17, P332, DOI 10.1101/lm.1828310; Wamsley EJ, 2010, CURR BIOL, V20, P850, DOI 10.1016/j.cub.2010.03.027; Wamsley EJ, 2010, SLEEP, V33, P59, DOI 10.1093/sleep/33.1.59; Warby SC, 2014, NAT METHODS, V11, P385, DOI [10.1038/nmeth.2855, 10.1038/NMETH.2855]; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; Witt K, 2010, NEUROSCIENCE, V171, P227, DOI 10.1016/j.neuroscience.2010.07.062	49	19	19	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0165141	10.1371/journal.pone.0165141	http://dx.doi.org/10.1371/journal.pone.0165141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9NW	27760193	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000088
J	Omi, T; Nakazawa, S; Udagawa, C; Tada, N; Ochiai, K; Chong, YH; Kato, Y; Mitsui, H; Gin, A; Oda, H; Azakami, D; Tamura, K; Sako, T; Inagaki, T; Sakamoto, A; Tsutsui, T; Bonkobara, M; Tsuchida, S; Ikemoto, S				Omi, Toshinori; Nakazawa, Shota; Udagawa, Chihiro; Tada, Naomi; Ochiai, Kazuhiko; Chong, Yong Hwa; Kato, Yuiko; Mitsui, Hiroko; Gin, Azusa; Oda, Hitomi; Azakami, Daigo; Tamura, Kyoichi; Sako, Toshinori; Inagaki, Takeshi; Sakamoto, Atsushi; Tsutsui, Toshihiko; Bonkobara, Makoto; Tsuchida, Shuichi; Ikemoto, Shigenori			Molecular Characterization of the Cytidine Monophosphate-N-Acetylneuraminic Acid Hydroxylase (CMAH) Gene Associated with the Feline AB Blood Group System	PLOS ONE			English	Article							PEDIGREE DOMESTIC CATS; GLYCOLYLNEURAMINIC ACID; INDIVIDUAL-DIFFERENCES; TRANSFUSION PURPOSES; VIRUS RECEPTORS; UNITED-STATES; FREQUENCIES; ANTIBODIES; UK; PREVALENCE	Cat's AB blood group system (blood types A, B, and AB) is of major importance in feline transfusion medicine. Type A and type B antigens are Neu5Gc and Neu5Ac, respectively, and the enzyme CMAH participating in the synthesis of Neu5Gc from Neu5Ac is associated with this cat blood group system. Rare type AB erythrocytes express both Neu5Gc and Neu5Ac. Cat serum contains naturally occurring antibodies against antigens occurring in the other blood types. To understand the molecular genetic basis of this blood group system, we investigated the distribution of AB blood group antigens, CMAH gene structure, mutation, diplotypes, and haplotypes of the cat CMAH genes. Blood-typing revealed that 734 of the cats analyzed type A (95.1%), 38 cats were type B (4.9%), and none were type AB. A family of three Ragdoll cats including two type AB cats and one type A was also used in this study. CMAH sequence analyses showed that the CMAH protein was generated from two mRNA isoforms differing in exon 1. Analyses of the nucleotide sequences of the 16 exons including the coding region of CMAH examined in the 34 type B cats and in the family of type AB cats carried the CMAH variants, and revealed multiple novel diplotypes comprising several polymorphisms. Haplotype inference, which was focused on non-synonymous SNPs revealed that eight haplotypes carried one to four mutations in CMAH, and all cats with type B (n = 34) and AB (n = 2) blood carried two alleles derived from the mutated CMAH gene. These results suggested that double haploids selected from multiple recessive alleles in the cat CMAH loci were highly associated with the expression of the Neu5Ac on erythrocyte membrane in types B and AB of the feline AB blood group system.	[Omi, Toshinori; Nakazawa, Shota; Udagawa, Chihiro; Ochiai, Kazuhiko; Chong, Yong Hwa; Kato, Yuiko] Nippon Vet & Life Sci Univ, Dept Basic Sci, Sch Vet Nursing & Technol, Fac Vet Sci, Tokyo, Japan; [Tada, Naomi; Mitsui, Hiroko; Tsutsui, Toshihiko] AHB Inc, Int Inst Small Anim Med Bio Plus, Tokyo, Japan; [Gin, Azusa; Oda, Hitomi; Azakami, Daigo; Sako, Toshinori] Nippon Vet & Life Sci Univ, Dept Vet Nursing, Sch Vet Nursing & Technol, Fac Vet Sci, Tokyo, Japan; [Tamura, Kyoichi; Bonkobara, Makoto] Nippon Vet & Life Sci Univ, Sch Vet Med, Dept Vet Clin Pathol, Fac Vet Sci, Tokyo, Japan; [Inagaki, Takeshi; Sakamoto, Atsushi] Jichi Med Univ, Dept Legal Med, Shimotsuke, Tochigi, Japan; [Tsuchida, Shuichi] Nippon Vet & Life Sci Univ, Lab Comparat Cellular Biol, Sch Vet Med, Tokyo, Japan; [Ikemoto, Shigenori] Nippon Vet & Life Sci Univ, Sch Vet Med, Fac Vet Sci, Tokyo, Japan; [Udagawa, Chihiro] Natl Canc Ctr, Div Genet, Tokyo, Japan	Nippon Veterinary & Life Science University; Nippon Veterinary & Life Science University; Nippon Veterinary & Life Science University; Jichi Medical University; Nippon Veterinary & Life Science University; Nippon Veterinary & Life Science University; National Cancer Center - Japan	Omi, T (corresponding author), Nippon Vet & Life Sci Univ, Dept Basic Sci, Sch Vet Nursing & Technol, Fac Vet Sci, Tokyo, Japan.	toshinoriomi@gmail.com	Azakami, Daigo/M-8873-2019; INAGAKI, Takeshi/N-2247-2016	Azakami, Daigo/0000-0002-4512-8599; INAGAKI, Takeshi/0000-0002-8720-2654; OCHIAI, Kazuhiko/0000-0002-5736-0598	JSPS KAKENHI [25450454, 16K08062]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 25450454 and 16K08062.	ANDREWS GA, 1992, BLOOD, V79, P2485; Arikan S, 2003, J VET MED A, V50, P303, DOI 10.1046/j.1439-0442.2003.00536.x; AUER L, 1983, RES VET SCI, V35, P145, DOI 10.1016/S0034-5288(18)32171-4; Axner E, 2014, J FELINE MED SURG, V16, P781, DOI 10.1177/1098612X13518937; Bagdi N, 2001, ACTA VET HUNG, V49, P369, DOI 10.1556/AVet.49.2001.4.1; Bighignoli B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-27; Cattin RP, 2016, NEW ZEAL VET J, V64, P154, DOI 10.1080/00480169.2015.1112313; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; EJIMA H, 1986, JPN J VET SCI, V48, P971; EYQUEM A, 1962, ANN NY ACAD SCI, V97, P320, DOI 10.1111/j.1749-6632.1962.tb34646.x; Forcada Y, 2007, J SMALL ANIM PRACT, V48, P570, DOI 10.1111/j.1748-5827.2007.00325.x; FURUKAWA K, 1988, J BIOL CHEM, V263, P14939; Gandolfi B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154973; GIGER U, 1991, J HERED, V82, P15, DOI 10.1093/jhered/82.1.15; GIGER U, 1989, J AM VET MED ASSOC, V195, P1230; Giger U, 1997, J REPROD FERTIL, P313; Giger U, 1992, P INT SOC AN GEN S1, V23, P17; GRIOTWENK M, 1993, ANIM GENET, V24, P401, DOI 10.1111/j.1365-2052.1993.tb00352.x; GRIOTWENK ME, 1995, VET CLIN N AM-SMALL, V25, P1305, DOI 10.1016/S0195-5616(95)50156-1; GriotWenk ME, 1996, AM J VET RES, V57, P1438; Gunn-Moore DA, 2009, J FELINE MED SURG, V11, P826, DOI 10.1016/j.jfms.2009.03.008; Gurkan M, 2005, J FELINE MED SURG, V7, P301, DOI 10.1016/j.jfms.2005.03.003; HAARER M, 1993, KLEINTIERPRAXIS, V38, P195; Hohenhaus AE, 2004, TRANSFUS MED REV, V18, P117, DOI 10.1016/j.tmrv.2003.12.003; HOLMES R, 1950, J PHYSL, V111, P61; HUBLER M, 1993, SCHWEIZ ARCH TIERH, V135, P231; IKEMOTO S, 1981, JPN J VET SCI, V43, P433; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; JENSEN AL, 1994, ACTA VET SCAND, V35, P121; Juvet F, 2011, VET REC, V168, P352, DOI 10.1136/vr.c6879; Karadjole T, 2016, VET ARHIV, V86, P209; Kelm S, 1996, GLYCOCONJUGATE J, V13, P913, DOI 10.1007/BF01053186; Knottenbelt CM, 1999, J SMALL ANIM PRACT, V40, P115, DOI 10.1111/j.1748-5827.1999.tb03051.x; Landsteiner K, 1927, P SOC EXP BIOL MED, V24, P941; Landsteiner K, 1931, SCIENCE, V73, P403, DOI 10.1126/science.73.1894.403; Lofling J, 2013, VIROLOGY, V440, P89, DOI 10.1016/j.virol.2013.02.009; Malik R, 2005, AUST VET J, V83, P38, DOI 10.1111/j.1751-0813.2005.tb12190.x; Marques C, 2011, VET CLIN PATH, V40, P185, DOI 10.1111/j.1939-165X.2011.00303.x; Merbl Y, 2011, ISR J VET MED, V66, P21; Ng PSK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6750; Omi T, 2014, 34 ISAG C, P128; Proverbio D, 2013, VET CLIN PATH, V42, P157, DOI 10.1111/vcp.12048; Proverbio D, 2011, VET CLIN PATH, V40, P32, DOI 10.1111/j.1939-165X.2011.00286.x; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; Seth M, 2011, AM J VET RES, V72, P203, DOI 10.2460/ajvr.72.2.203; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Silvestre-Ferreira AC, 2004, VET CLIN PATH, V33, P240, DOI 10.1111/j.1939-165X.2004.tb00380.x; SPADA E, 2014, VET MED INT, V2014, DOI DOI 10.1155/2014/704836; Tasker S, 2014, J SMALL ANIM PRACT, V55, P185, DOI 10.1111/jsap.12180; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; YOUNG LE, 1951, T NEW YORK ACAD SCI, V13, P209, DOI 10.1111/j.2164-0947.1951.tb00041.x; Zheng L, 2011, VET CLIN PATH, V40, P513, DOI 10.1111/j.1939-165X.2011.00371.x	54	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0165000	10.1371/journal.pone.0165000	http://dx.doi.org/10.1371/journal.pone.0165000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755584	Green Submitted, Green Published, gold			2022-12-26	WOS:000386203800047
J	Surowiec, I; Arlestig, L; Rantapaa-Dahlqvist, S; Trygg, J				Surowiec, Izabella; Arlestig, Lisbeth; Rantapaa-Dahlqvist, Solbritt; Trygg, Johan			Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; MALDI-TOF MS; LYSOPHOSPHOLIPID RECEPTORS; SERIAL MEASUREMENTS; BLOOD-DONORS; TRYPTOPHAN; INFLAMMATION; LYSOPHOSPHATIDYLCHOLINE; XANTHINE; DISEASE	Objective The early diagnosis of rheumatoid arthritis (RA) is desirable to install treatment to prevent disease progression and joint destruction. Autoantibodies and immunological markers predate the onset of symptoms by years albeit not all patients will present these factors, even at disease onset. Additional biomarkers would be of high value to improve early diagnosis and understanding of the process, leading to disease development. Methods Plasma samples donated before the onset of RA were identified in the Biobank of Northern Sweden, a collection within national health survey programs. Thirty samples from pre-symptomatic individuals and nineteen from controls were subjected to liquid chromatogra-phy-mass spectrometry (LCMS) metabolite and lipid profiling. Lipid and metabolite profiles discriminating samples from pre-symptomatic individuals from controls were identified after univariate and multivariate OPLS-DA based analyses. Results The OPLS-DA models including pre-symptomatic individuals and controls identified profiles differentiating between the groups that was characterized by lower levels of acyl-carnitines and fatty acids, with higher levels of lysophospatidylcholines (LPCs) and metabolites from tryptophan metabolism in pre-symptomatic individuals compared with controls. Lipid profiling showed that the majority of phospholipids and sphingomyelins were at higher levels in pre-symptomatic individuals in comparison with controls. Conclusions Our LCMS based approach demonstrated that there are changes in small molecule and lipid profiles detectable in plasma samples collected from the pre-symptomatic individuals who subsequently developed RA, which point to an up-regulation of levels of lysophospati-dylcholines, and of tryptophan metabolism, perturbation of fatty acid beta-oxidation and increased oxidative stress in pre-symptomatic individuals' years before onset of symptoms.	[Surowiec, Izabella; Trygg, Johan] Umea Univ, Dept Chem, Computat Life Sci Cluster CLiC, Umea, Sweden; [Arlestig, Lisbeth; Rantapaa-Dahlqvist, Solbritt] Umea Univ Hosp, Dept Publ Hlth & Clin Med, Rheumatol, Umea, Sweden	Umea University; Umea University	Trygg, J (corresponding author), Umea Univ, Dept Chem, Computat Life Sci Cluster CLiC, Umea, Sweden.	johan.trygg@umu.se		Rantapaa Dahlqvist, Solbritt/0000-0001-8259-3863	King Gustaf V's 80-Year Fund; Swedish Rheumatism Association; Swedish Research Council [K2013-52X-20307-07-3, 621-2011-6044]; Vasterbotten county council (ALF); Swedish Foundation for Strategic Research, Sweden	King Gustaf V's 80-Year Fund; Swedish Rheumatism Association; Swedish Research Council(Swedish Research CouncilEuropean Commission); Vasterbotten county council (ALF); Swedish Foundation for Strategic Research, Sweden	This research was supported by grants from King Gustaf V's 80-Year Fund, the Swedish Rheumatism Association, the Swedish Research Council (K2013-52X-20307-07-3 and 621-2011-6044), Vasterbotten county council (ALF) and the Swedish Foundation for Strategic Research, Sweden. These funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AcureOmics AB did not provide support in the form of the salary for author JT, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar N, 2007, MOL CELL BIOCHEM, V295, P113, DOI 10.1007/s11010-006-9280-x; Angelini R, 2014, CHEM PHYS LIPIDS, V183, P169, DOI 10.1016/j.chemphyslip.2014.07.001; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Battelli MG, 2014, BBA-MOL BASIS DIS, V1842, P1502, DOI 10.1016/j.bbadis.2014.05.022; Birgbauer E, 2006, CELL MOL LIFE SCI, V63, P2695, DOI 10.1007/s00018-006-6155-y; Borba EF, 2000, ARTHRITIS RHEUM, V43, P1033, DOI 10.1002/1529-0131(200005)43:5<1033::AID-ANR11>3.0.CO;2-B; Cimen MYB, 2000, CLIN RHEUMATOL, V19, P275, DOI 10.1007/PL00011172; Criado G, 2009, ARTHRITIS RHEUM-US, V60, P1342, DOI 10.1002/art.24446; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Egan J.P., 1975, SIGNAL DETECTION THE; Forrest CM, 2003, ADV EXP MED BIOL, V527, P287; Fuchs B, 2005, CLIN BIOCHEM, V38, P925, DOI 10.1016/j.clinbiochem.2005.06.006; Fukushima N, 2001, ANNU REV PHARMACOL, V41, P507, DOI 10.1146/annurev.pharmtox.41.1.507; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; GUDBJORNSSON B, 1991, ANN RHEUM DIS, V50, P669, DOI 10.1136/ard.50.10.669; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Jackson SK, 2008, PHARMACOL THERAPEUT, V119, P104, DOI 10.1016/j.pharmthera.2008.04.001; Kabarowski JH, 2009, PROSTAG OTH LIPID M, V89, P73, DOI 10.1016/j.prostaglandins.2009.04.007; Kapoor SR, 2013, ARTHRITIS RHEUM-US, V65, P1448, DOI 10.1002/art.37921; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097501; Klareskog L, 2006, NAT CLIN PRACT RHEUM, V2, P425, DOI 10.1038/ncprheum0249; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Kouglas P, 2006, MED SCI MONITOR, V12, pRA5; Lauridsen MB, 2010, J PROTEOME RES, V9, P4545, DOI 10.1021/pr1002774; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Madsen R, 2012, J PROTEOME RES, V11, P3796, DOI 10.1021/pr300296v; Madsen RK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3243; Mankia K, 2016, ARTHRITIS RHEUMATOL, V68, P779, DOI 10.1002/art.39603; MIESEL R, 1993, INFLAMMATION, V17, P551, DOI 10.1007/BF00914193; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; Nielen MMJ, 2006, ANN RHEUM DIS, V65, P535, DOI 10.1136/ard.2005.040659; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Nurmohamed MT, 2015, NAT REV RHEUMATOL, V11, P693, DOI 10.1038/nrrheum.2015.112; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; SAUGSTAD OD, 1975, PEDIATR RES, V9, P158, DOI 10.1203/00006450-197504000-00002; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Schonfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Schroecksnadel K, 2006, CLIN RHEUMATOL, V25, P334, DOI 10.1007/s10067-005-0056-6; Schroecksnadel K, 2003, J RHEUMATOL, V30, P1935; Szanto S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2205; Torkhovskaya TI, 2007, BIOCHEMISTRY-MOSCOW+, V72, P125, DOI 10.1134/S0006297907020010; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; van Halm VP, 2007, ANN RHEUM DIS, V66, P184, DOI 10.1136/ard.2006.051672; Williams RO, 2013, INT J TRYPTOPHAN RES, P67, DOI 10.4137/IJTR.S11737; Xu Yan, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P23, DOI 10.2174/1568008033340414; Yan JJ, 2004, NAT MED, V10, P161, DOI 10.1038/nm989; Young SP, 2013, ARTHRITIS RHEUM-US, V65, P2015, DOI 10.1002/art.38021; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	51	30	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164196	10.1371/journal.pone.0164196	http://dx.doi.org/10.1371/journal.pone.0164196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755546	gold, Green Published, Green Submitted			2022-12-26	WOS:000386203800012
J	Jensen, CJ; Demol, F; Bauwens, R; Kooijman, R; Massie, A; Villers, A; Ris, L; De Keyser, J				Jensen, Cathy Joanna; Demol, Frauke; Bauwens, Romy; Kooijman, Ron; Massie, Ann; Villers, Agnes; Ris, Laurence; De Keyser, Jacques			Astrocytic beta 2 Adrenergic Receptor Gene Deletion Affects Memory in Aged Mice	PLOS ONE			English	Article							MOUSE WHITE-MATTER; GLUCOSE-CONCENTRATION; GLYCOGEN-METABOLISM; BRAIN; LACTATE; CORTEX; INHIBITION; STRIATUM; NEURONS; TASK	In vitro and in vivo studies suggest that the astrocytic adrenergic signalling enhances glycogenolysis which provides energy to be transported to nearby cells and in the form of lactate. This energy source is important for motor and cognitive functioning. While it is suspected that the beta 2-adrenergic receptor on astrocytes might contribute to this energy balance, it has not yet been shown conclusively in vivo. Inducible astrocyte specific beta 2-adrenergic receptor knock-out mice were generated by crossing homozygous beta 2-adrenergic receptor floxed mice (Adrb2(flox)) and mice with heterozygous tamoxifen-inducible Cre recombinase-expression driven by the astrocyte specific L-glutamate/L-aspartate transporter promoter (GLAST-CreERT2). Assessments using the modified SHIRPA (SmithKline/Harwell/Imperial College/Royal Hospital/Phenotype Assessment) test battery, swimming ability test, and accelerating rotarod test, performed at 1, 2 and 4 weeks, 6 and 12 months after tamoxifen (or vehicle) administration did not reveal any differences in physical health or motor functions between the knock-out mice and controls. However deficits were found in the cognitive ability of aged, but not young adult mice, reflected in impaired learning in the Morris Water Maze. Similarly, long-term potentiation (LTP) was impaired in hippocampal brain slices of aged knock-out mice maintained in low glucose media. Using microdialysis in cerebellar white matter we found no significant differences in extracellular lactate or glucose between the young adult knock-out mice and controls, although trends were detected. Our results suggest that beta 2-adrenergic receptor expression on astrocytes in mice may be important for maintaining cognitive health at advanced age, but is dispensable for motor function.	[Jensen, Cathy Joanna; Demol, Frauke; De Keyser, Jacques] Vrije Univ Brussel, Univ Hosp Brussels, Dept Neurol, Brussels, Belgium; [Jensen, Cathy Joanna; Demol, Frauke; Bauwens, Romy; Kooijman, Ron; Massie, Ann] Vrije Univ Brussel, Ctr Neurosci, Brussels, Belgium; [Jensen, Cathy Joanna] Vlaams Inst Biotechnol, Dept Neurobiol, Leuven, Belgium; [Villers, Agnes; Ris, Laurence] Univ Mons, Dept Neurosci, Hlth, Mons, Belgium; [De Keyser, Jacques] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	University Hospital Brussels; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); University of Mons; University of Groningen	Jensen, CJ (corresponding author), Vrije Univ Brussel, Univ Hosp Brussels, Dept Neurol, Brussels, Belgium.; Jensen, CJ (corresponding author), Vrije Univ Brussel, Ctr Neurosci, Brussels, Belgium.; Jensen, CJ (corresponding author), Vlaams Inst Biotechnol, Dept Neurobiol, Leuven, Belgium.	cathyjen@hotmail.com	De Keyser, Jacques/AAA-8721-2021; Kooijman, Ron/D-7040-2013; Massie, Ann/F-1039-2013; De Keyser, Jacques/D-3725-2013; VILLERS, Arnauld/K-6629-2016	De Keyser, Jacques/0000-0002-3394-7757; Kooijman, Ron/0000-0002-3676-477X; De Keyser, Jacques/0000-0002-3394-7757; Massie, Ann/0000-0002-8418-5879; VILLERS, Arnauld/0000-0002-6298-7758	Fonds Wetenschappelijk Onderzoek grant [G.A.100.11. N.10]; Charcot Foundation Belgium; Willy Gepts Fonds	Fonds Wetenschappelijk Onderzoek grant; Charcot Foundation Belgium; Willy Gepts Fonds	This work was supported by Fonds Wetenschappelijk Onderzoek grant (G.A.100.11. N.10) (httpa/www.fwo.be/en/) to JDK, Charcot Foundation Belgium (http://www.fondation-charcot.org/) to JDK and Willy Gepts Fonds. UZ Brussel to JDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benarroch EE, 2010, NEUROLOGY, V74, P919, DOI 10.1212/WNL.0b013e3181d3e44b; Berger UV, 2006, ANAT EMBRYOL, V211, P595, DOI 10.1007/s00429-006-0109-x; Brown AM, 2003, J PHYSIOL-LONDON, V549, P501, DOI 10.1113/jphysiol.2003.042416; BRUCKNER G, 1981, J NEUROCYTOL, V10, P749, DOI 10.1007/BF01262651; Canal CE, 2005, LEARN MEMORY, V12, P367, DOI 10.1101/lm.88205; Carnevale D., 2007, CNS & Neurological Disorders-Drug Targets, V6, P388; Chuquet J, 2010, J NEUROSCI, V30, P15298, DOI 10.1523/JNEUROSCI.0762-10.2010; Cohen Z, 1997, J CEREBR BLOOD F MET, V17, P894, DOI 10.1097/00004647-199708000-00008; De Keyser J, 2010, NEUROCHEM INT, V57, P446, DOI 10.1016/j.neuint.2010.02.012; Dong JH, 2012, J MOL NEUROSCI, V48, P456, DOI 10.1007/s12031-012-9742-4; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Gold PE, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00116; Hertz L, 2010, NEUROCHEM INT, V57, P411, DOI 10.1016/j.neuint.2010.03.019; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Ji JZ, 2003, BEHAV NEUROSCI, V117, P1378, DOI 10.1037/0735-7044.117.6.1378; Kemp A, 2008, CEREB CORTEX, V18, P1326, DOI 10.1093/cercor/bhm164; Laureys G, 2014, NEUROSCIENCE, V277, P367, DOI 10.1016/j.neuroscience.2014.07.022; Laureys G, 2010, PROG NEUROBIOL, V91, P189, DOI 10.1016/j.pneurobio.2010.01.011; Masuya H, 2005, MAMM GENOME, V16, P829, DOI 10.1007/s00335-005-2430-8; McNay EC, 2001, NEUROBIOL LEARN MEM, V75, P325, DOI 10.1006/nlme.2000.3976; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; Messier C, 2004, EUR J PHARMACOL, V490, P33, DOI 10.1016/j.ejphar.2004.02.043; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Newman LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028427; O'Donnell J, 2012, NEUROCHEM RES, V37, P2496, DOI 10.1007/s11064-012-0818-x; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107; Sandusky LA, 2013, BEHAV BRAIN RES, V245, P83, DOI 10.1016/j.bbr.2013.02.006; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; SWANSON RA, 1992, CAN J PHYSIOL PHARM, V70, pS138, DOI 10.1139/y92-255; Walls AB, 2009, NEUROSCIENCE, V158, P284, DOI 10.1016/j.neuroscience.2008.09.058; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Zhang XR, 2013, BRAIN RES, V1507, P28, DOI 10.1016/j.brainres.2013.02.033	34	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164721	10.1371/journal.pone.0164721	http://dx.doi.org/10.1371/journal.pone.0164721			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776147	Green Published, Green Submitted, gold			2022-12-26	WOS:000389009200019
J	Gu, DN; Mao, YR; Tang, ZZ; Montaner, J; Shen, ZY; Zhu, QY; Detels, R; Jin, X; Xiong, R; Xu, J; Ling, W; Erinoff, L; Lindblad, R; Liu, D; Van Veldhuisen, P; Hasson, A; Wu, ZY				Gu, Diane; Mao, Yurong; Tang, Zhenzhu; Montaner, Julio; Shen, Zhiyong; Zhu, Qiuying; Detels, Roger; Jin, Xia; Xiong, Ran; Xu, Juan; Ling, Walter; Erinoff, Lynda; Lindblad, Robert; Liu, David; Van Veldhuisen, Paul; Hasson, Albert; Wu, Zunyou			Loss to Follow-Up from HIV Screening to ART Initiation in Rural China	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; INFECTION; CARE; RETENTION; DIAGNOSIS; COUNTRIES; PROGRAM	Background Patients who are newly screened HIV positive by EIA are lost to follow-up due to complicated HIV testing procedures. Because this is the first step in care, it affects the entire continuum of care. This is a particular concern in rural China. Objective(s) To assess the routine HIV testing completeness and treatment initiation rates at 18 county-level general hospitals in rural Guangxi. Methods We reviewed original hospital HIV screening records. Investigators also engaged with hospital leaders and key personnel involved in HIV prevention activities to characterize in detail the routine care practices in place at each county. Results 699 newly screened HIV-positive patients between January 1 and June 30, 2013 across the 18 hospitals were included in the study. The proportion of confirmatory testing across the 18 hospitals ranged from 14% to 87% (mean of 43%), and the proportion of newly diagnosed individuals successfully initiated antiretroviral treatment across the hospitals ranged from 3% to 67% (mean of 23%). The average interval within hospitals for individuals to receive the Western Blot (WB) and CD4 test results from HIV positive screening (i.e. achieving testing completion) ranged from 14-116 days (mean of 41.7 days) across the hospitals. The shortest interval from receiving a positive EIA screening test result to receiving WB and CD4 testing and counseling was 0 day and the longest was 260 days. Conclusion The proportion of patients newly screened HIV positive that completed the necessary testing procedures for HIV confirmation and received ART was very low. Interventions are urgently needed to remove barriers so that HIV patients can have timely access to HIV/AIDS treatment and care in rural China.	[Gu, Diane; Mao, Yurong; Jin, Xia; Xiong, Ran; Xu, Juan; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 102206, Peoples R China; [Tang, Zhenzhu; Shen, Zhiyong; Zhu, Qiuying] Guangxi Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China; [Montaner, Julio] Univ British Columbia, BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Detels, Roger] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Ling, Walter; Hasson, Albert] Univ Calif Los Angeles, David Geffen Sch Med, Integrated Subst Abuse Programs, Los Angeles, CA 90095 USA; [Erinoff, Lynda; Liu, David] NIDA, NIH, Bethesda, MD 20892 USA; [Lindblad, Robert; Van Veldhuisen, Paul] EMMES Corp, Rockville, MD USA	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Emmes Corporation	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 102206, Peoples R China.	wuzy@263.net		, Walter/0000-0003-0664-5099	National Institute on Drug Abuse (NIDA) of National Institutes of Health (NIH), USA; National Health and Family Planning Commission of the People's Republic of China	National Institute on Drug Abuse (NIDA) of National Institutes of Health (NIH), USA; National Health and Family Planning Commission of the People's Republic of China	The funders, National Institute on Drug Abuse (NIDA) of National Institutes of Health (NIH), USA, and the National Health and Family Planning Commission of the People's Republic of China, provided support in the form of salaries for authors: DG, YM, ZT, ZS, QZ, XJ, RX, JX, WL, RL, PV, AH and ZW, and supported study activities, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The EMMES Corporation, USA (https://secure.emmes.com/emmesweb/about) provided support in the data collection and interpretation to authors RL and PV. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinese Ministry of Health, 1989, CLASS CHIN HOSP; Department of Health and Human Services (DHHS), 2014, GUIDELINES USE ANTIR; Fleishman JA, 2012, JAIDS-J ACQ IMM DEF, V60, P249, DOI 10.1097/QAI.0b013e318258c696; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Global Hospital Management Survey, 2013, GLOB HOSP MAN SURV C; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Hoffmann CJ, 2013, JAIDS-J ACQ IMM DEF, V63, P105, DOI 10.1097/QAI.0b013e3182893fb4; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Laanani M, 2015, CLIN INFECT DIS, V60, P1715, DOI 10.1093/cid/civ171; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Nash D, 2011, AIDS, V25, P1523, DOI 10.1097/QAD.0b013e32834811b2; National Center for AIDS/ STD Control and Prevention, 2012, 2011 ANN REP NAT AID; National HIV/AIDS Prevention Committee, 2013, NAT HIV AIDS TEST CO; NCAIDS, 2009, NAT GUID HIV AIDS DE; NCAIDS. China CDC, 2012, AN HIV AIDS TEST TRE; Tang H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096098, DOI 10.1371/JOURNAL.PONE.0096098]; Thanawuth N, 2008, AIDS CARE, V20, P43, DOI 10.1080/09540120701439303; UNAIDS, 2014, BRICS HLTH MIN AD UN; UNAIDS, 2013, REP GLOB AIDS EP AD; UNAIDS, 2014, 90 90 90 AMB TREATM; Volkow ND, 2010, JAMA-J AM MED ASSOC, V303, P1423, DOI 10.1001/jama.2010.421; Yip WCM, 2010, LANCET, V375, P1120, DOI 10.1016/S0140-6736(10)60063-3; Zhang F, 2011, LANCET INFECT DIS	26	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164346	10.1371/journal.pone.0164346	http://dx.doi.org/10.1371/journal.pone.0164346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768710	gold, Green Published, Green Submitted			2022-12-26	WOS:000386205400010
J	Sidorov, IS; Romashko, RV; Koval, VT; Giniatullin, R; Kamshilin, AA				Sidorov, Igor S.; Romashko, Roman V.; Koval, Vasily T.; Giniatullin, Rashid; Kamshilin, Alexei A.			Origin of Infrared Light Modulation in Reflectance-Mode Photoplethysmography	PLOS ONE			English	Article							OPTICAL-PROPERTIES; ADVANCEMENTS; SKIN	We recently pointed out the important role of dermis deformation by pulsating arterial pressure in the formation of a photoplethysmographic signal at green light. The aim of this study was to explore the role of this novel finding in near-infrared (NIR) light. A light-emitting diode (LED)-based imaging photoplethysmography (IPPG) system was used to detect spatial distribution of blood pulsations under frame-to-frame switching green and NIR illumination in the palms of 34 healthy individuals. We observed a significant increase of light-intensity modulation at the heartbeat frequency for both illuminating wavelengths after a palm was contacted with a glass plate. Strong positive correlation between data measured at green and NIR light was found, suggesting that the same signal was read independently from the depth of penetration. Analysis of the data shows that an essential part of remitted NIR light is modulated in time as a result of elastic deformations of dermis caused by variable blood pressure in the arteries. Our observations suggest that in contrast with the classical model, photoplethysmographic waveform originates from the modulation of the density of capillaries caused by the variable pressure applied to the skin from large blood vessels. Particularly, beat-to-beat transmural pressure in arteries compresses/decompresses the dermis and deforms its connective-tissue components, thus affecting the distance between the capillaries, which results in the modulation of absorption and scattering coefficients of both green and NIR light. These findings are important for the correct interpretation of this widely used medical technique, which may have novel applications in diagnosis and treatment monitoring of aging and skin diseases.	[Sidorov, Igor S.] ITMO Univ, R&D Ctr Laser Phys, St Petersburg 197101, Russia; [Romashko, Roman V.] FEB RAS, Precis Opt Measurement Tech Dept, Inst Automat & Control Proc, 5 Radio St, Vladivostok 690041, Russia; [Romashko, Roman V.] Far Eastern Fed Univ, 8 Sukhanova St, Vladivostok 690900, Russia; [Koval, Vasily T.] Fed State Inst 1477 Navy Clin Hosp, Vladivostok 690005, Russia; [Giniatullin, Rashid] Univ Eastern Finland, Dept Neurobiol, Kuopio 70210, Finland; [Giniatullin, Rashid] Kazan Fed Univ, Neurobiol Lab, Kazan 420000, Russia; [Giniatullin, Rashid; Kamshilin, Alexei A.] ITMO Univ, Dept Comp Photon & Videomat, St Petersburg 197101, Russia	ITMO University; Russian Academy of Sciences; Institute of Automation & Control Processes, Far East Branch of the Russian Academy of Sciences; Far Eastern Federal University; University of Eastern Finland; Kazan Federal University; ITMO University	Kamshilin, AA (corresponding author), ITMO Univ, Dept Comp Photon & Videomat, St Petersburg 197101, Russia.	alexei.kamshilin@yandex.ru	Kamshilin, Alexei A./Q-9775-2016; Romashko, Roman/E-5707-2014; Giniatullin, Rashid/Y-9687-2018; Koval, Vasily/AAV-1414-2020	Kamshilin, Alexei A./0000-0003-2506-9736; Romashko, Roman/0000-0003-0869-0993; 	Russian Science Foundation [15-15-20012]	Russian Science Foundation(Russian Science Foundation (RSF))	The study was funded by Russian Science Foundation (grant 15-15-20012). Website: http://www.rscf.ru/en/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R., 1982, SCI PHOTOMEDICINE, P147; Bashkatov AN, 2005, J PHYS D APPL PHYS, V38, P2543, DOI 10.1088/0022-3727/38/15/004; Chan EK, 1996, IEEE J SEL TOP QUANT, V2, P943, DOI 10.1109/2944.577320; Daly SM, 2013, J BIOPHOTONICS, V6, P217, DOI 10.1002/jbio.201200071; FUNG YC, 1966, CIRC RES, V19, P441, DOI 10.1161/01.RES.19.2.441; Gray H., 2008, ANATOMY HUMAN BODY; Humphreys K, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2724789; Kamshilin AA, 2015, BIOMED OPT EXPRESS, V6, P4326, DOI 10.1364/BOE.6.004326; Kamshilin AA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10494; Kamshilin AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057117; Kamshilin AA, 2011, BIOMED OPT EXPRESS, V2, P996, DOI 10.1364/BOE.2.000996; Maeda Y, 2011, J MED SYST, V35, P829, DOI 10.1007/s10916-010-9506-z; Mannheimer PD, 2007, ANESTH ANALG, V105, pS10, DOI 10.1213/01.ane.0000269522.84942.54; Nitzan M, 2013, SENSORS-BASEL, V13, P14797, DOI 10.3390/s131114797; Poh MZ, 2011, IEEE T BIO-MED ENG, V58, P7, DOI 10.1109/TBME.2010.2086456; Sun Y, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.037005; Tamura T, 2014, ELECTRONICS-SWITZ, V3, P282, DOI 10.3390/electronics3020282; Teplov V, 2014, BIOMED OPT EXPRESS, V5, P3123, DOI 10.1364/BOE.5.003123; Wieringa FP, 2005, ANN BIOMED ENG, V33, P1034, DOI 10.1007/s10439-005-5763-2; Zaproudina N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080189	21	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165413	10.1371/journal.pone.0165413	http://dx.doi.org/10.1371/journal.pone.0165413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768753	gold, Green Submitted, Green Published			2022-12-26	WOS:000386205400084
J	Hasan, A; Luo, L; Yan, C; Zhang, TX; Urata, Y; Goto, S; Mangoura, SA; Abdel-Raheem, MH; Zhang, SH; Li, TS				Hasan, Al Shaimaa; Luo, Lan; Yan, Chen; Zhang, Tian-Xia; Urata, Yoshishige; Goto, Shinji; Mangoura, Safwat A.; Abdel-Raheem, Mahmoud H.; Zhang, Shouhua; Li, Tao-Sheng			Cardiosphere-Derived Cells Facilitate Heart Repair by Modulating M1/M2 Macrophage Polarization and Neutrophil Recruitment	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; ALTERNATIVELY ACTIVATED MACROPHAGES; MYOCARDIAL-INFARCTION; MONOCYTE; EFFICACY; THERAPY; MICE; DIFFERENTIATION; SUBPOPULATIONS; HETEROGENEITY	Cardiosphere-derived cells (CDCs), one of the promising stem cell sources for myocardial repair, have been tested in clinical trials and resulted in beneficial effects; however, the relevant mechanisms are not fully understood. In this study, we examined the hypothesis that CDCs favor heart repair by switching the macrophages from a pro-inflammatory phenotype (M1) into a regulatory anti-inflammatory phenotype (M2). Macrophages from mice were cultured with CDCs-conditioned medium or with fibroblasts-conditioned medium as a control. Immunostaining showed that CDCs-conditioned medium significantly enhanced the expression of CD206 (a marker for M2 macrophages), but decreased the expression of CD86 (a marker for M1 macrophages) 3 days after culture. For animal studies, we used an acute myocardial infarction model of mice. We injected CDCs, fibroblasts, or saline only into the border zone of infarction. Then we collected the heart tissues for histological analysis 5 and 14 days after treatment. Compared with control animals, CDCs treatment significantly decreased M1 macrophages and neutrophils but increased M2 macrophages in the infarcted heart. Furthermore, CDCs-treated mice had reduced infarct size and fewer apoptotic cells compared to the controls. Our data suggest that CDCs facilitate heart repair by modulating M1/M2 macrophage polarization and neutrophil recruitment, which may provide a new insight into the mechanisms of stem cell-based myocardial repair.	[Hasan, Al Shaimaa; Luo, Lan; Yan, Chen; Zhang, Tian-Xia; Urata, Yoshishige; Goto, Shinji; Li, Tao-Sheng] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Inst, Dept Stem Cell Biol, Nagasaki, Japan; [Hasan, Al Shaimaa; Mangoura, Safwat A.; Abdel-Raheem, Mahmoud H.] South Valley Univ, Qena Fac Med, Dept Med Pharmacol, Qena, Egypt; [Zhang, Shouhua] Jiangxi Prov Childrens Hosp, Dept Gen Surg, Nanchang, Jiangxi, Peoples R China	Nagasaki University; Egyptian Knowledge Bank (EKB); South Valley University Egypt	Li, TS (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Inst, Dept Stem Cell Biol, Nagasaki, Japan.	litaoshe@nagasaki-u.ac.jp	yan, chen/ACO-6451-2022	Li, Tao-Sheng/0000-0002-7653-8873; Luo, Lan/0000-0001-7549-9852; yan, chen/0000-0003-3808-1259	Ministry of Education, Science, Sports, Culture and Technology, Japan; Ministry of Higher Education, Egypt; National Natural Science Foundation of China [81460118]	Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Higher Education, Egypt(Ministry of Higher Education & Scientific Research (MHESR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was partially supported by a Grant-in-Aid from the Ministry of Education, Science, Sports, Culture and Technology, Japan, the Ministry of Higher Education, Egypt and partially supported by the National Natural Science Foundation of China (81460118-Dr. Al Shaimaa Hasan). The funder played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adutler-Lieber S, 2013, J CARDIOVASC PHARM T, V18, P78, DOI 10.1177/1074248412453875; Aminzadeh MA, 2015, EUR HEART J, V36, P751, DOI 10.1093/eurheartj/ehu196; Ben-Mordechai T, 2013, J AM COLL CARDIOL, V62, P1890, DOI 10.1016/j.jacc.2013.07.057; Cheng K, 2014, JACC-HEART FAIL, V2, P49, DOI 10.1016/j.jchf.2013.08.008; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; de Jager SCA, 2013, ARTERIOSCL THROM VAS, V33, pE75, DOI 10.1161/ATVBAHA.112.300857; Ertl G, 2005, CARDIOVASC RES, V66, P22, DOI 10.1016/j.cardiores.2005.01.011; Francois M, 2012, MOL THER, V20, P187, DOI 10.1038/mt.2011.189; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Fujiu K, 2014, CARDIOVASC RES, V102, P232, DOI 10.1093/cvr/cvu059; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hu YL, 2011, BASIC RES CARDIOL, V106, P1311, DOI 10.1007/s00395-011-0204-x; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2014, J AM COLL CARDIOL, V63, P110, DOI 10.1016/j.jacc.2013.08.724; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Malliaras K, 2011, BRIT MED BULL, V98, P161, DOI 10.1093/bmb/ldr018; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2013, CIRC RES, V112, P1624, DOI 10.1161/CIRCRESAHA.113.300890; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Panizzi P, 2010, J AM COLL CARDIOL, V55, P1629, DOI 10.1016/j.jacc.2009.08.089; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Shen DL, 2012, J CELL MOL MED, V16, P2112, DOI 10.1111/j.1582-4934.2011.01512.x; Shiraishi M, 2016, J CLIN INVEST, V126, P2151, DOI 10.1172/JCI85782; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Takeuch O, 2011, EUR J IMMUNOL, V41, P2490, DOI 10.1002/eji.201141792; Tsujita K, 2007, CIRCULATION, V115, P1904, DOI 10.1161/CIRCULATIONAHA.106.671198; Wu JX, 2011, BASIC RES CARDIOL, V106, P317, DOI 10.1007/s00395-011-0168-x; Zhang QZ, 2010, STEM CELLS, V28, P1856, DOI 10.1002/stem.503; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077	45	25	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165255	10.1371/journal.pone.0165255	http://dx.doi.org/10.1371/journal.pone.0165255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764217	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500141
J	Liu, R; Khalil, H; Lin, SCJ; Sargent, MA; York, AJ; Molkentin, JD				Liu, Ruijie; Khalil, Hadi; Lin, Suh-Chin J.; Sargent, Michelle A.; York, Allen J.; Molkentin, Jeffery D.			Nemo-Like Kinase (NLK) Is a Pathological Signaling Effector in the Mouse Heart	PLOS ONE			English	Article							GENETIC INHIBITION; INDUCED APOPTOSIS; DROSOPHILA NEMO; CANCER CELLS; IN-VIVO; PATHWAY; HYPERTROPHY; PROTEIN; ACTIVATION; EXPRESSION	Nemo-like kinase (NLK) is an evolutionary conserved serine/threonine protein kinase implicated in development, proliferation and apoptosis regulation. Here we identified NLK as a gene product induced in the hearts of mice subjected to pressure overload or myocardial infarction injury, suggesting a potential regulatory role with pathological stimulation to this organ. To examine the potential functional consequences of increased NLK levels, cardiac-specific transgenic mice with inducible expression of this gene product were generated, as well as cardiac-specific Nlk gene-deleted mice. NLK transgenic mice demonstrated baseline cardiac hypertrophy, dilation, interstitial fibrosis, apoptosis and progression towards heart failure in response to two surgery-induced cardiac disease models. In contrast, cardiac-specific deletion of Nlk from the heart, achieved by crossing a Nlk-loxP allele containing mouse with either a mouse containing a beta-myosin heavy chain promoter driven Cre transgene or a tamoxifen inducible a-myosin heavy chain promoter containing transgene driving a MerCreMer cDNA, protected the mice from cardiac dysfunction following pathological stimuli. Mechanistically, NLK interacted with multiple proteins including the transcription factor Stat1, which was significantly increased in the hearts of NLK transgenic mice. These results indicate that NLK is a pathological effector in the heart.	[Liu, Ruijie; Khalil, Hadi; Lin, Suh-Chin J.; Sargent, Michelle A.; York, Allen J.; Molkentin, Jeffery D.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45220 USA; [Molkentin, Jeffery D.] Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute	Molkentin, JD (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45220 USA.; Molkentin, JD (corresponding author), Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH 45229 USA.	Jeff.Molkentin@cchmc.org		Molkentin, Jeffery/0000-0002-3558-6529; liu, ruijie/0000-0002-2468-0579; Khalil, Hadi/0000-0003-3860-5331	National Institutes of Health [R37HL60562]; Howard Hughes Medical Institute; National Heart Lung and Blood Institute of the NIH [T32HL125204]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL060562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Heart Lung and Blood Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health to JDM (R37HL60562). JDM was also supported by the Howard Hughes Medical Institute. RL was supported by a training grant from the National Heart Lung and Blood Institute of the NIH (T32HL125204).	Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; Braid LR, 2008, GENETICS, V180, P283, DOI 10.1534/genetics.108.092155; Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; Cheng XW, 2012, FEBS LETT, V586, P1497, DOI 10.1016/j.febslet.2012.04.005; De Windt LJ, 2000, J BIOL CHEM, V275, P13571, DOI 10.1074/jbc.275.18.13571; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Emami KH, 2009, PROSTATE, V69, P1481, DOI 10.1002/pros.20998; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Ishitani S, 2011, MOL BIOL CELL, V22, P266, DOI 10.1091/mbc.E10-07-0605; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Ishitani T, 2013, CELL SIGNAL, V25, P190, DOI 10.1016/j.cellsig.2012.09.017; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Ke HN, 2016, SCI REP-UK, V6, DOI 10.1038/srep23987; Kim S, 2010, J BIOL CHEM, V285, P8122, DOI 10.1074/jbc.M110.101824; Kortenjann M, 2001, EUR J IMMUNOL, V31, P3580, DOI 10.1002/1521-4141(200112)31:12<3580::AID-IMMU3580>3.0.CO;2-N; Lorell BH, 2000, CIRCULATION, V102, P470; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; McCormick J, 2012, J CELL MOL MED, V16, P386, DOI 10.1111/j.1582-4934.2011.01323.x; Mirkovic I, 2002, MECH DEVELOP, V119, P9, DOI 10.1016/S0925-4773(02)00289-7; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Ota S, 2012, EMBO J, V31, P1904, DOI 10.1038/emboj.2012.46; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Satoh K, 2007, MOL CELL BIOL, V27, P7623, DOI 10.1128/MCB.01481-07; Shaw-Hallgren G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096506; Stephanou A, 2003, INT J EXP PATHOL, V84, P239, DOI 10.1111/j.0959-9673.2003.00363.x; Stephanou A, 2000, J BIOL CHEM, V275, P10002, DOI 10.1074/jbc.275.14.10002; Wan CK, 2015, P NATL ACAD SCI USA, V112, P9394, DOI 10.1073/pnas.1511711112; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wu L, 2007, BIOCHEM BIOPH RES CO, V358, P449, DOI 10.1016/j.bbrc.2007.04.119; Yasuda J, 2003, BIOCHEM BIOPH RES CO, V308, P227, DOI 10.1016/S0006-291X(03)01343-3	35	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							0164897	10.1371/journal.pone.0164897	http://dx.doi.org/10.1371/journal.pone.0164897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764156	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500078
J	Martinez-Alcantara, B; Martinez-Cuenca, MR; Bermejo, A; Legaz, F; Quinones, A				Martinez-Alcantara, Belen; Martinez-Cuenca, Mary-Rus; Bermejo, Almudena; Legaz, Francisco; Quinones, Ana			Liquid Organic Fertilizers for Sustainable Agriculture: Nutrient Uptake of Organic versus Mineral Fertilizers in Citrus Trees	PLOS ONE			English	Article							NITROGEN USE EFFICIENCY; LEACHING LOSSES; SOIL QUALITY; SHEEP MANURE; NITRATE; COMPOST; MANAGEMENT; AVAILABILITY; AMENDMENTS; COMPONENTS	The main objective of this study was to compare the performance of two liquid organic fertilizers, an animal and a plant-based fertilizer, with mineral fertilization on citrus trees. The source of the fertilizer (mineral or organic) had significant effect in the nutritional status of the organic and conventionally managed mandarins. Nutrient uptake, vegetative growth, carbohydrate synthesis and soil characteristics were analyzed. Results showed that plants fertilized with animal based liquid fertilizers exhibited higher total biomass with a more profuse development of new developing organs (leaves and fibrous roots). Liquid organic fertilization resulted in an increased uptake of macro and micronutrients compared to mineral fertilized trees. Moreover, organic fertilization positively affected the carbohydrate content (fructose, glucose and sucrose) mainly in summer flush leaves. Liquid organic fertilization also resulted in an increase of soil organic matter content. Animal-based fertilizer, due to intrinsic composition, increased total tree biomass and carbohydrate leaves content, and led to lower soil nitrate concentration and higher P and Mg exchangeable in soil extract compared to vegetal-based fertilizer. Therefore, liquid organic fertilizers could be used as an alternative to traditional mineral fertilization in drip irrigated citrus trees.	[Martinez-Alcantara, Belen; Martinez-Cuenca, Mary-Rus; Bermejo, Almudena; Legaz, Francisco; Quinones, Ana] Inst Valenciano Invest Agr, Dept Citriculture & Vegetal Prod, Valencia, Spain	Instituto Valenciano de Investigaciones Agrarias (IVIA)	Quinones, A (corresponding author), Inst Valenciano Invest Agr, Dept Citriculture & Vegetal Prod, Valencia, Spain.	quinones_ana@gva.es	Martinez-Cuenca, Mary-Rus/K-7710-2015; Quinones, Ana/E-6229-2014; MARTINEZ ALCANTARA, BELEN/AGF-5074-2022; Bermejo, Almudena/C-3180-2008	Martinez-Cuenca, Mary-Rus/0000-0002-9017-2951; Quinones, Ana/0000-0002-6096-734X; MARTINEZ ALCANTARA, BELEN/0000-0002-7816-4115; Bermejo, Almudena/0000-0003-4030-6007	National Institute of Research and Agrarian and Food Technology [RTA2008-00071-00-00]; European Regional Development Funds	National Institute of Research and Agrarian and Food Technology; European Regional Development Funds(European Commission)	This work was funded by the National Institute of Research and Agrarian and Food Technology (RTA2008-00071-00-00) and the European Regional Development Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Alla MH, 1999, J APPL BOT-ANGEW BOT, V73, P69; Aminifard M. H., 2013, Journal of Central European Agriculture, V14, P47; Asami DK, 2003, J AGR FOOD CHEM, V51, P1237, DOI 10.1021/jf020635c; Baldi E, 2013, PLANT SOIL ENVIRON, V59, P221, DOI 10.17221/857/2012-PSE; Baldi E, 2010, TREE PHYSIOL, V30, P1373, DOI 10.1093/treephys/tpq078; Baldi E, 2010, SOIL USE MANAGE, V26, P346, DOI 10.1111/j.1475-2743.2010.00286.x; Baldi E, 2014, SCI HORTIC-AMSTERDAM, V179, P174, DOI 10.1016/j.scienta.2014.09.029; Baldi E, 2010, J PLANT NUTR, V33, P2050, DOI 10.1080/01904167.2010.519080; Barakat MR, 2012, J HORTICULT SCI ORNA, V4, P18; Berry PM, 2003, SOIL USE MANAGE, V19, P112, DOI 10.1079/SUM2003176; BINGHAM FT, 1971, SOIL SCI, V112, P410, DOI 10.1097/00010694-197112000-00005; Bosshard C, 2009, NUTR CYCL AGROECOSYS, V83, P271, DOI 10.1007/s10705-008-9218-7; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Burkart MR, 2002, WATER SCI TECHNOL, V45, P19, DOI 10.2166/wst.2002.0195; CACCO G, 1984, CAN J SOIL SCI, V64, P225, DOI 10.4141/cjss84-023; Campbell CR, 1998, HANDBOOK OF REFERENCE METHODS FOR PLANT ANALYSIS, P37; Canali S, 2009, SOIL USE MANAGE, V25, P34, DOI 10.1111/j.1475-2743.2008.00191.x; Canali S, 2004, BIOL FERT SOILS, V40, P206, DOI 10.1007/s00374-004-0759-x; Canali S., 2012, ADV CITRUS NUTR, P353; Chapman H.D., 1968, U CALIF DIV AGR SCI, V2, P127; Cusick PR, 2006, J ENVIRON QUAL, V35, P2170, DOI 10.2134/jeq2005.0287; DAVIDSON EA, 1991, J SOIL SCI, V42, P335, DOI 10.1111/j.1365-2389.1991.tb00413.x; de Paz JM, 2004, AGR ECOSYST ENVIRON, V103, P59, DOI 10.1016/j.agee.2003.10.006; Diacono M, 2015, AGRICULTURE-BASEL, V5, P221, DOI 10.3390/agriculture5020221; Diacono M, 2010, AGRON SUSTAIN DEV, V30, P401, DOI 10.1051/agro/2009040; Dumas Y, 2003, J SCI FOOD AGR, V83, P369, DOI 10.1002/jsfa.1370; FAOSTAT, 2012, FAOS STAT YB; Favoino E, 2008, WASTE MANAGE RES, V26, P61, DOI 10.1177/0734242X08088584; Gamal A. M., 2003, Assiut Journal of Agricultural Sciences, V34, P253; Gosling P, 2005, AGR ECOSYST ENVIRON, V105, P425, DOI 10.1016/j.agee.2004.03.007; Hakkinen SH, 2000, FOOD RES INT, V33, P517, DOI 10.1016/S0963-9969(00)00086-7; Hardarson G, 1990, TRAINING COURSE SERI; Hassan HSA, 2010, NATURE SCI, V8, P59; Helail BM, 2003, J APPL SCI, V18, P270; IAEA International Atomic Energy Agency, 1983, INT AT EN AG GUID US; Ibrahim MH, 2013, MOLECULES, V18, P10973, DOI 10.3390/molecules180910973; Intrigliolo F, 2000, 10 INT C OPT PLANT N, P106; Isaac RA, 1998, HANDBOOK OF REFERENCE METHODS FOR PLANT ANALYSIS, P165; Kato T, 1986, HORTICULTURAL REV, V8, P81; Kilcher L., 2005, CUADERNO RESUMENES, P22; Lea-Cox JD, 2001, J AM SOC HORTIC SCI, V126, P242, DOI 10.21273/JASHS.126.2.242; Martinez-Alcantara B, 2016, PLOS ONE; Martinez-Alcantara B, 2012, SOIL SCI PLANT NUTR, V58, P659, DOI 10.1080/00380768.2012.733678; Martinez-Alcantara B, 2011, PLANT SOIL, V342, P433, DOI 10.1007/s11104-010-0707-5; Munoz GR, 2003, SOIL SCI SOC AM J, V67, P817, DOI 10.2136/sssaj2003.0817; Parsons LR, 1989, MANAGEMENT MICROIRRI; Polat E, 2010, SCI AGR, V67, P424, DOI 10.1590/S0103-90162010000400008; Quinones A, 2005, PLANT SOIL, V268, P367, DOI 10.1007/s11104-004-0337-x; Quinones A, 2012, ADV CITRUS NUTR, P353; RAIGON MD, 1992, ANALUSIS, V20, P483; Ramos C, 2002, ENVIRON POLLUT, V118, P215, DOI 10.1016/S0269-7491(01)00314-1; Rapisarda P, 2005, J AGR FOOD CHEM, V53, P2664, DOI 10.1021/jf048733g; Rivas F, 2006, J HORTIC SCI BIOTECH, V81, P289, DOI 10.1080/14620316.2006.11512064; Rosen CJ, 2005, USING MANURE COMPOST; SERNA MD, 1992, PLANT SOIL, V147, P13, DOI 10.1007/BF00009366; SHIRALIPOUR A, 1992, BIOMASS BIOENERG, V3, P261, DOI 10.1016/0961-9534(92)90030-T; Smajstrala AG, 1987, BULL, V208; SORENSEN P, 1994, PLANT SOIL, V162, P39, DOI 10.1007/BF01416088; Stockmann U, 2013, AGR ECOSYST ENVIRON, V164, P80, DOI 10.1016/j.agee.2012.10.001; Thomsen IK, 1997, PLANT SOIL, V197, P233, DOI 10.1023/A:1004224615075; Weibel FP, 2000, ACTA HORTIC, P417, DOI 10.17660/ActaHortic.2000.517.53; Wild A., 1992, RUSELLS SOIL CONDITI; Willer H., 2011, FIBL IFOAM REPORT; World Health Organization, 2004, NITR NITR DRINK WAT; Yang J., 2013, ADV J FOOD SCI TECHN, V5, P588, DOI [DOI 10.19026/AJFST.5.3132, 10.19026/ajfst.5.3132]; Zahoor, 2014, International Journal of Agriculture and Forestry, V4, P201; Zekri M, 2013, MAGNESIUM MG CITRUS, pSL380	67	14	19	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0161619	10.1371/journal.pone.0161619	http://dx.doi.org/10.1371/journal.pone.0161619			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764099	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500003
J	Brommesson, P; Wennergren, U; Lindstrom, T				Brommesson, Peter; Wennergren, Uno; Lindstrom, Tom			Spatiotemporal Variation in Distance Dependent Animal Movement Contacts: One Size Doesn't Fit All	PLOS ONE			English	Article							CATTLE MOVEMENTS; 2001 FOOT; BOVINE TUBERCULOSIS; SIMULATION-MODEL; MOUTH EPIDEMIC; SPREAD; DISEASE; TRANSMISSION; KERNEL	The structure of contacts that mediate transmission has a pronounced effect on the outbreak dynamics of infectious disease and simulation models are powerful tools to inform policy decisions. Most simulation models of livestock disease spread rely to some degree on predictions of animal movement between holdings. Typically, movements are more common between nearby farms than between those located far away from each other. Here, we assessed spatiotemporal variation in such distance dependence of animal movement contacts from an epidemiological perspective. We evaluated and compared nine statistical models, applied to Swedish movement data from 2008. The models differed in at what level ( if at all), they accounted for regional and/or seasonal heterogeneities in the distance dependence of the contacts. Using a kernel approach to describe how probability of contacts between farms changes with distance, we developed a hierarchical Bayesian framework and estimated parameters by using Markov Chain Monte Carlo techniques. We evaluated models by three different approaches of model selection. First, we used Deviance Information Criterion to evaluate their performance relative to each other. Secondly, we estimated the log predictive posterior distribution, this was also used to evaluate their relative performance. Thirdly, we performed posterior predictive checks by simulating movements with each of the parameterized models and evaluated their ability to recapture relevant summary statistics. Independent of selection criteria, we found that accounting for regional heterogeneity improved model accuracy. We also found that accounting for seasonal heterogeneity was beneficial, in terms of model accuracy, according to two of three methods used for model selection. Our results have important implications for livestock disease spread models where movement is an important risk factor for between farm transmission. We argue that modelers should refrain from using methods to simulate animal movements that assume the same pattern across all regions and seasons without explicitly testing for spatiotemporal variation.	[Brommesson, Peter; Wennergren, Uno; Lindstrom, Tom] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden	Linkoping University	Lindstrom, T (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden.	tomli@ifm.liu.se	Lindström, Tom/AAX-6492-2020		Foreign Animal Disease Modeling Program, Science and Technology Directorate, U.S. Department of Homeland Security [HSHQDC-13-C-B0028]; European research area: animal health and welfare (ANIHWA) [ANR-13-ANWA-0007-03]	Foreign Animal Disease Modeling Program, Science and Technology Directorate, U.S. Department of Homeland Security; European research area: animal health and welfare (ANIHWA)	Funding was provided by the Foreign Animal Disease Modeling Program, Science and Technology Directorate, U.S. Department of Homeland Security (Grant HSHQDC-13-C-B0028); and European research area: animal health and welfare (ANIHWA; https://www.anihwa.eu) No. ANR-13-ANWA-0007-03 (LIVEepi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson I., FOOT MOUTH DIS INQUI; Brooks-Pollock E, 2014, NATURE, V511, P228, DOI 10.1038/nature13529; Buhnerkempe MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091724; Carslake D, 2011, PHILOS T R SOC B, V366, P1975, DOI 10.1098/rstb.2010.0396; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Durand B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070000; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Gamerman D, 2006, MARKOV CHAIN MONTE C; Garthwaite P.H., 2010, ARXIV10063690; Gates MC, 2013, PREV VET MED, V112, P285, DOI 10.1016/j.prevetmed.2013.07.017; Gelman A., 2003, BAYESIAN DATA ANAL; Gelman A, 2014, STAT COMPUT, V24, P997, DOI 10.1007/s11222-013-9416-2; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Harvey N, 2007, PREV VET MED, V82, P176, DOI 10.1016/j.prevetmed.2007.05.019; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Leslie EEC, 2015, PREV VET MED, V118, P293, DOI 10.1016/j.prevetmed.2014.12.002; Lindstrom T, 2008, ECOLOGY, V89, P1784, DOI 10.1890/07-1363.1; Lindstrom T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004187; Lindstrom T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053432; Lindstrom T, 2012, J R SOC INTERFACE, V9, P1287, DOI 10.1098/rsif.2011.0625; Lindstrom T, 2011, P ROY SOC B-BIOL SCI, V278, P1564, DOI 10.1098/rspb.2010.1902; Lindstrom T, 2011, PREV VET MED, V98, P230, DOI 10.1016/j.prevetmed.2010.11.005; Lindstrom T, 2009, PREV VET MED, V91, P85, DOI 10.1016/j.prevetmed.2009.05.022; Meuwissen MPM, 1999, PREV VET MED, V42, P249, DOI 10.1016/S0167-5877(99)00079-3; MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283; Nigsch A, 2013, PREV VET MED, V108, P262, DOI 10.1016/j.prevetmed.2012.11.003; Noremark M, 2011, PREV VET MED, V99, P78, DOI 10.1016/j.prevetmed.2010.12.009; Noremark M, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-37; Roberts GO, 1997, ANN APPL PROBAB, V7, P110, DOI 10.1214/aoap/1034625254; Robinson SE, 2007, PREV VET MED, V81, P21, DOI 10.1016/j.prevetmed.2007.04.011; Roche SE, 2015, EPIDEMIOL INFECT, V143, P1256, DOI 10.1017/S0950268814001927; Sanson RL, 2005, NEW ZEAL VET J, V53, P223, DOI 10.1080/00480169.2005.36550; Siembieda J. L., 2011, Animal Health Research Reviews, V12, P95, DOI 10.1017/S1466252311000041; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Ster IC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000502; Stevenson MA, 2013, PREV VET MED, V109, P10, DOI 10.1016/j.prevetmed.2012.08.015; Tildesley MJ, 2008, P ROY SOC B-BIOL SCI, V275, P1459, DOI 10.1098/rspb.2008.0006; Tildesley MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3239, DOI 10.1098/rspb.2009.0427; Vernon MC, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-31; Wang T, 2015, AM J AGR ECON, V97, P435, DOI 10.1093/ajae/aau119; Westfall PH, 2014, AM STAT, V68, P191, DOI 10.1080/00031305.2014.917055; Woolhouse M, 2011, PHILOS T R SOC B, V366, P2045, DOI 10.1098/rstb.2010.0387	45	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164008	10.1371/journal.pone.0164008	http://dx.doi.org/10.1371/journal.pone.0164008			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760155	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000024
J	Parlesak, A; Tetens, I; Jensen, JD; Smed, S; Blenkus, MG; Rayner, M; Darmon, N; Robertson, A				Parlesak, Alexandr; Tetens, Inge; Jensen, Jorgen Dejgard; Smed, Sinne; Blenkus, Mojca Gabrijelcic; Rayner, Mike; Darmon, Nicole; Robertson, Aileen			Use of Linear Programming to Develop Cost-Minimized Nutritionally Adequate Health Promoting Food Baskets	PLOS ONE			English	Article							NUTRIENT DENSITY; VITAMIN-D; DIET; AFFORDABILITY; PREVENTION; VARIETY; WEIGHT; INDEX; PRICE	Background Food-Based Dietary Guidelines (FBDGs) are developed to promote healthier eating patterns, but increasing food prices may make healthy eating less affordable. The aim of this study was to design a range of cost-minimized nutritionally adequate health-promoting food baskets (FBs) that help prevent both micronutrient inadequacy and diet-related non-communicable diseases at lowest cost. Methods Average prices for 312 foods were collected within the Greater Copenhagen area. The cost and nutrient content of five different cost-minimized FBs for a family of four were calculated per day using linear programming. The FBs were defined using five different constraints: cultural acceptability (CA), or dietary guidelines (DG), or nutrient recommendations (N), or cultural acceptability and nutrient recommendations (CAN), or dietary guidelines and nutrient recommendations (DGN). The variety and number of foods in each of the resulting five baskets was increased through limiting the relative share of individual foods. Results The one-day version of N contained only 12 foods at the minimum cost of DKK 27 ((sic)3.6). The CA, DG, and DGN were about twice of this and the CAN cost similar to DKK 81 ((sic)10.8). The baskets with the greater variety of foods contained from 70 (CAN) to 134 (DGN) foods and cost between DKK 60 ((sic)8.1, N) and DKK 125 ((sic)16.8, DGN). Ensuring that the food baskets cover both dietary guidelines and nutrient recommendations doubled the cost while cultural acceptability (CAN) tripled it. Conclusion Use of linear programming facilitates the generation of low-cost food baskets that are nutritionally adequate, health promoting, and culturally acceptable.	[Parlesak, Alexandr; Robertson, Aileen] Metropolitan Univ Coll, WHO Collaborating Ctr Global Nutr & Hlth, Copenhagen, Denmark; [Tetens, Inge] Tech Univ Denmark, Natl Food Inst, Res Grp Risk Benefit, Soborg, Denmark; [Jensen, Jorgen Dejgard; Smed, Sinne] Univ Copenhagen, Dept Food & Resource Econ, Sect Consumpt Bioeth & Governance, Copenhagen, Denmark; [Blenkus, Mojca Gabrijelcic] NIJZ, Ljubljana, Slovenia; [Rayner, Mike] Univ Oxford, Nuffield Dept Populat Hlth, British Heart Fdn, Ctr Populat Approaches Noncommunicable Dis Preven, Oxford, England; [Darmon, Nicole] Aix Marseille Univ, Inst Natl Rech Agron INRA 1260, Inst Natl Sante & Rech Med INSERM 1062, UMR Nutr Obes & Risk Thrombosis, Marseille, France	Technical University of Denmark; University of Copenhagen; University of Oxford; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Parlesak, A (corresponding author), Metropolitan Univ Coll, WHO Collaborating Ctr Global Nutr & Hlth, Copenhagen, Denmark.	alpa@phmetropol.dk	Parlesak, Alexandr/K-6310-2013; Smed, Sinne/AFK-6410-2022	Parlesak, Alexandr/0000-0002-8973-3467; Smed, Sinne/0000-0002-3897-4439				Aggarwal A, 2011, EUR J CLIN NUTR, V65, P1059, DOI 10.1038/ejcn.2011.72; Barosh L, 2014, AUST NZ J PUBL HEAL, V38, P7, DOI 10.1111/1753-6405.12158; Beck TK, 2015, APPETITE, V91, P366, DOI 10.1016/j.appet.2015.04.060; Bernstein MA, 2002, J AM DIET ASSOC, V102, P1096, DOI 10.1016/S0002-8223(02)90246-4; Brough L, 2010, BRIT J NUTR, V104, P437, DOI 10.1017/S0007114510000747; Carlson A.C., 2007, CNPP19 USDA; Center for Nutrition Policy and Promotion United States Department of Agriculture, 2015, USDA FOOD PLANS COST; Dantzig G.B., 1951, ACTIVITY ANAL PRODUC, P339; Darmon N, 2002, J NUTR, V132, P3764, DOI 10.1093/jn/132.12.3764; Darmon N, 2002, AM J CLIN NUTR, V75, P245, DOI 10.1093/ajcn/75.2.245; Davis GC, 2011, FOOD POLICY, V36, P101, DOI 10.1016/j.foodpol.2010.09.001; Denmarks Statistik, 2015, FAM44N FAMILIER 1 JA; Denmarks Statistik, 2015, FU51 HUSSTANDENES HU; Denmarks Statistik, 2015, LONS20 EARNINGS BY O; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Dubuisson C, 2010, BRIT J NUTR, V103, P1035, DOI 10.1017/S0007114509992625; Eden Alvin N, 2005, Paediatr Drugs, V7, P347, DOI 10.2165/00148581-200507060-00003; Ferguson EL, 2004, J NUTR, V134, P951, DOI 10.1093/jn/134.4.951; Friel S, 2006, J EPIDEMIOL COMMUN H, V60, P1013, DOI 10.1136/jech.2005.041335; Gille MB, 2008, UNDERSOGELSE AT MERU; Hakansson A, 2008, DANISH FOOD COMPOSIT; Hakansson A, 2015, FOOD NUTR RES, V59, DOI [10.3402/fnr.v59.26932, 10.3402/fnr.v59.27601]; Hatloy A, 1998, EUR J CLIN NUTR, V52, P891, DOI 10.1038/sj.ejcn.1600662; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jones NRV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109343; Knudsen VK, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.17129; Lamberg-Allardt C, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.22671; Landin-Wilhelmsen K, 1995, EUR J CLIN NUTR; Leather S., 1992, Your food: whose choice?., P72; Lee A, 2013, OBES REV, V14, P82, DOI 10.1111/obr.12078; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Magnusson M, 2014, CURR OBES REP, V3, P1, DOI 10.1007/s13679-013-0087-2; Maillot M, 2011, BRIT J NUTR, V105, P1133, DOI 10.1017/S0007114510004800; Maillot M, 2010, PUBLIC HEALTH NUTR, V13, P1178, DOI 10.1017/S1368980009993028; Mason AJ., 2011, RESEARCH PROCEEDINGS; Miller R, 2016, NUTR BULL, V41, P14, DOI 10.1111/nbu.12187; Ministry of Food, 2014, AGRICULTURE AND FISH; Monsivais P, 2014, AM J PREV MED, V47, P796, DOI 10.1016/j.amepre.2014.07.033; Newell FD, 2014, CAN J PUBLIC HEALTH, V105, pE158, DOI 10.17269/cjph.105.4322; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Nordic Council of Ministers, 2014, INTEGRATING NUTRITIO; Ontario Ministry of Health Promotion, 2010, NUTRITIOUS FOOD BASK; Parlesak A, 2014, FOOD NUTR BULL, V35, P191, DOI 10.1177/156482651403500205; Pedersen AN, 2014, DANSKERNES KOSTVANER; Prusse U, 2004, MITTLERE GEWICHTE EI; Robertson A, 2007, CONTRACT REPORT SANC; SMITH VE, 1959, J FARM ECON, V41, P272, DOI 10.2307/1235154; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Toft U, 2015, EUR J PUBLIC HEALTH, V25, P273, DOI 10.1093/eurpub/cku175; Troesch B, 2015, NUTRIENTS, V7, P6016, DOI 10.3390/nu7075266; United States Department of Agriculture, 2014, THE USDA NATIONAL NU; Virtanen JK, 2011, EUR J NUTR, V50, P305, DOI 10.1007/s00394-010-0138-3; Ward PR, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/968078; Webber L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004787; Williams P, 2010, NUTRIENTS, V2, P1132, DOI 10.3390/nu2111132; World Health Organization, 2018, OBESITY AND OVERWEIG	56	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0163411	10.1371/journal.pone.0163411	http://dx.doi.org/10.1371/journal.pone.0163411			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9NW	27760131	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204000011
J	Zhang, J; Pang, H; Ma, MX; Bu, YF; Shao, W; Huang, WJ; Ji, QL; Yao, YC				Zhang, Jie; Pang, Hui; Ma, Mengxia; Bu, Yufen; Shao, Wei; Huang, Weijing; Ji, Qianlong; Yao, Yuncong			An Apple Fruit Fermentation (AFF) Treatment Improves the Composition of the Rhizosphere Microbial Community and Growth of Strawberry (Fragaria x ananassa Duch 'Benihoppe') Seedlings	PLOS ONE			English	Article							SOIL; DIVERSITY; BIODIVERSITY; BIOSORPTION; RESISTANCE; INDUCTION; PROMOTION; CADMIUM; COPPER; PLANTS	Plant growth can be promoted by the application of apple fruit fermentation (AFF), despite unclear of the underlying mechanisms, the effects involved in AFF on rhizosphere microorganisms have been hypothesized. We investigated the consequences of applying AFF alone or in combination with Bacillus licheniformis to strawberry tissue culture seedlings in vitro, the analyses of Denaturing Gradient Gel Electrophoresis (DGGE) and 16S rDNA were performed to determine AFF effects on rhizosphere. Moreover, the growth index and antioxidant enzyme activities were determined 30 days after treatments. We identified five dominant bacteria in AFF: Coprinus atramentarius, Bacillus megaterium, Bacillus licheniformis, Weissella and B. subtilis. The greatest number of bacterial species were observed in the rhizosphere of control matrix (water treated), and the lowest diversity appeared in the rhizosphere soil treated with 10(8) cfu/mL B. licheniformis alone. Combining AFF plus B. licheniformis in one treatment resulted in the largest leaf area, plant height, root length, plant weight, and the markedly higher activities of antioxidant enzymes. We conclude that a combination of AFF plus B. licheniformis treatment to matrix can increase antioxidant enzymes activities in strawberry seedlings, optimize the status of rhizosphere microbial, and promote plant growth.	[Zhang, Jie; Pang, Hui; Ma, Mengxia; Bu, Yufen; Shao, Wei; Huang, Weijing; Yao, Yuncong] Beijing Agr Univ, Dept Plant Sci & Technol, Beijing 102206, Peoples R China; [Zhang, Jie; Pang, Hui; Ma, Mengxia; Bu, Yufen; Yao, Yuncong] Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Beijing 102206, Peoples R China; [Ji, Qianlong] Beijing Agr Univ, Coll Biol Sci & Engn, Beijing 102206, Peoples R China	Beijing University of Agriculture; Beijing University of Agriculture	Yao, YC (corresponding author), Beijing Agr Univ, Dept Plant Sci & Technol, Beijing 102206, Peoples R China.; Yao, YC (corresponding author), Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Beijing 102206, Peoples R China.; Ji, QL (corresponding author), Beijing Agr Univ, Coll Biol Sci & Engn, Beijing 102206, Peoples R China.	13693344293@163.com; yaoyc_20@126.com			Beijing Collaborative Innovation Center for Eco-Environmental Improvement with Forestry and Fruit Trees; National Key Research Program [2016YFD0201116]; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under Beijing Municipality [IDHT20150503]; Beijing Municipal Agricultural Work Committee of Agricultural Science and Technology Project [20140136]; Project of Beijing Municipal Science & Technology Commission [ZL201607412003]	Beijing Collaborative Innovation Center for Eco-Environmental Improvement with Forestry and Fruit Trees; National Key Research Program; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under Beijing Municipality; Beijing Municipal Agricultural Work Committee of Agricultural Science and Technology Project; Project of Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	Financial support was provided by the Beijing Collaborative Innovation Center for Eco-Environmental Improvement with Forestry and Fruit Trees, the National Key Research Program (2016YFD0201116), the Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under the Beijing Municipality (Project No. IDHT20150503), Beijing Municipal Agricultural Work Committee of Agricultural Science and Technology Project (20140136), and the Project of Beijing Municipal Science & Technology Commission (ZL201607412003).	Andren O, 1999, APPL SOIL ECOL, V13, P105, DOI 10.1016/S0929-1393(99)00025-6; [Anonymous], THESIS; Bharti N, 2015, MICROB ECOL, V70, P196, DOI 10.1007/s00248-014-0557-4; Chakraborty U, 2006, J BASIC MICROB, V46, P186, DOI 10.1002/jobm.200510050; Chen SM, 2001, ACTA BOT BOREALI-OCC, V21, P1182; Coats VC, 2014, MOL ECOL, V23, P1318, DOI 10.1111/mec.12544; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Donnison LM, 2000, SOIL BIOL BIOCHEM, V32, P253, DOI 10.1016/S0038-0717(99)00159-5; Fei HM, 2003, PLANTA, V216, P467, DOI 10.1007/s00425-002-0873-7; Freeman S, 1997, PLANT DIS, V81, P749, DOI 10.1094/PDIS.1997.81.7.749; [高菲 Gao Fei], 2012, [广东农业科学, Guangdong Agricultural Sciences], V39, P4; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; Goswami D, 2014, MICROBIOL RES, V169, P66, DOI 10.1016/j.micres.2013.07.004; Heldno SA, 2014, FOOD FUNCT, V10, P2521, DOI [10.1039/C4FO00490, DOI 10.1039/C4FO00490]; Li XiaoMeng, 2012, Scientia Agricultura Sinica, V45, P489; Liu M., 2008, THESIS; Liu SQ, 2014, FOOD SCI, V35, P173; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lu WB, 2006, J HAZARD MATER, V134, P80, DOI 10.1016/j.jhazmat.2005.10.036; Palys T, 1997, INT J SYST BACTERIOL, V47, P1145, DOI 10.1099/00207713-47-4-1145; Pan RC., 1998, PLANT PHYSL; Pardo R, 2003, ANAL BIOANAL CHEM, V376, P26, DOI 10.1007/s00216-003-1843-z; Peng MS, 2008, J EXP BOT, V59, P2933, DOI 10.1093/jxb/ern148; Qi Y., 2010, THESIS; [乔爱香 QIAO Ai-xiang], 2010, [岩矿测试, Rock and Mineral Analysis], V29, P29; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Reiter B, 2002, APPL ENVIRON MICROB, V68, P2261, DOI 10.1128/AEM.68.5.2261-2268.2002; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Shao W., 2014, THESIS; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Su JQ, 2015, MOL ECOL, V24, P136, DOI 10.1111/mec.13010; Sukumar P, 2013, PLANT CELL ENVIRON, V36, P909, DOI 10.1111/pce.12036; Talboys PJ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-51; [唐娟 TANG Juan], 2008, [湖北农业科学, Hubei Agricultural Sciences], V47, P351; Ton J, 2002, MOL PLANT MICROBE IN, V15, P27, DOI 10.1094/MPMI.2002.15.1.27; Wang QiuJu, 2014, Chinese Journal of Animal Nutrition, V26, P504; [王荣娟 Wang Rongjuan], 2012, [生态学报, Acta Ecologica Sinica], V32, P2239; Xia F, 2012, THESIS; Xue K, 2013, APPL ENVIRON MICROB, V79, P1284, DOI 10.1128/AEM.03393-12; Yeates GW, 2003, AUST J SOIL RES, V41, P613, DOI 10.1071/SR02113; Zhalnina K, 2015, MICROB ECOL, V69, P395, DOI 10.1007/s00248-014-0530-2; Zhang H.Q., 2009, MACHINERY DESIGN MAN, V4, P4, DOI DOI 10.1021/PR900002F.PUBMED; Zhang J, 2015, PAK J BOT, V47, P279; Zhang L, 2005, CHINESE AGR SCI B, V21, P40, DOI [DOI 10.3969/J.ISSN.1000-6850.2005.07.013, 10.3969/j.issn.1000-6850.2005.07.013]; Zhao CL, 2013, J BEIJING U AGR, V28, P18, DOI [10.3969/j.issn.1002-3186.2013.00.006, DOI 10.3969/J.ISSN.1002-3186.2013.00.006]; Zhao LingLing, 2011, Scientia Agricultura Sinica, V44, P2504; [周鸣 Zhou Ming], 2006, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V12, P84	47	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164776	10.1371/journal.pone.0164776	http://dx.doi.org/10.1371/journal.pone.0164776			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755580	Green Published, Green Submitted, gold			2022-12-26	WOS:000386203800032
J	Shiratori, H; Feinweber, C; Knothe, C; Lotsch, J; Thomas, D; Geisslinger, G; Parnham, MJ; Resch, E				Shiratori, Hiromi; Feinweber, Carmen; Knothe, Claudia; Loetsch, Joern; Thomas, Dominique; Geisslinger, Gerd; Parnham, Michael J.; Resch, Eduard			High-Throughput Analysis of Global DNA Methylation Using Methyl-Sensitive Digestion	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER; 5-METHYLCYTOSINE; EPIGENOMICS; EPIGENETICS; CELLS	DNA methylation is a major regulatory process of gene transcription, and aberrant DNA methylation is associated with various diseases including cancer. Many compounds have been reported to modify DNA methylation states. Despite increasing interest in the clinical application of drugs with epigenetic effects, and the use of diagnostic markers for genomewide hypomethylation in cancer, large-scale screening systems to measure the effects of drugs on DNA methylation are limited. In this study, we improved the previously established fluorescence polarization-based global DNA methylation assay so that it is more suitable for application to human genomic DNA. Our methyl-sensitive fluorescence polarization (MSFP) assay was highly repeatable (inter-assay coefficient of variation = 1.5%) and accurate (r(2) = 0.99). According to signal linearity, only 50-80 ng human genomic DNA per reaction was necessary for the 384-well format. MSFP is a simple, rapid approach as all biochemical reactions and final detection can be performed in one well in a 384-well plate without purification steps in less than 3.5 hours. Furthermore, we demonstrated a significant correlation between MSFP and the LINE-1 pyrosequencing assay, a widely used global DNA methylation assay. MSFP can be applied for the pre-screening of compounds that influence global DNA methylation states and also for the diagnosis of certain types of cancer.	[Shiratori, Hiromi; Feinweber, Carmen; Loetsch, Joern; Geisslinger, Gerd; Parnham, Michael J.; Resch, Eduard] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Frankfurt, Germany; [Knothe, Claudia; Loetsch, Joern; Thomas, Dominique; Geisslinger, Gerd] Goethe Univ Frankfurt, Inst Clin Pharmacol, Frankfurt, Germany	Fraunhofer Gesellschaft; Goethe University Frankfurt	Shiratori, H (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Frankfurt, Germany.	hiromi.shiratori@ime.fraunhofer.de	Parnham, Michael J/D-8733-2014	Parnham, Michael J/0000-0002-7098-8451; Resch, Eduard/0000-0002-7685-6388; Lotsch, Jorn/0000-0002-5818-6958	Landesoffensive zur Entwicklung wissenschaftlich-okonomischer Exzellenz (LOEWE); LOEWE-Zentrum fur Translationale Medizin und Pharmakologie; Nakajima Foundation; Else Kroner-Fresenius Foundation Research Training Group Translational Research Innovation-Pharma (TRIP); European Union Seventh Framework Programme (FP7) [602919]; Deutsche Forschungsgemeinschaft Excellence Cluster 147 Cardiopulmonary Systems (ECCPS)	Landesoffensive zur Entwicklung wissenschaftlich-okonomischer Exzellenz (LOEWE); LOEWE-Zentrum fur Translationale Medizin und Pharmakologie; Nakajima Foundation; Else Kroner-Fresenius Foundation Research Training Group Translational Research Innovation-Pharma (TRIP); European Union Seventh Framework Programme (FP7); Deutsche Forschungsgemeinschaft Excellence Cluster 147 Cardiopulmonary Systems (ECCPS)(German Research Foundation (DFG))	This work was supported by Landesoffensive zur Entwicklung wissenschaftlich-okonomischer Exzellenz (LOEWE), LOEWE-Zentrum fur Translationale Medizin und Pharmakologie - recipients (GG, JL, MJP), http://www.proloewe.de/en/loewe-research-initiatives/loewe-researchinitiatives/pharmaceutical-research.html; Deutsche Forschungsgemeinschaft Excellence Cluster 147 Cardiopulmonary Systems (ECCPS; GG), http://www.dfg.de/en/research_funding/programmes/list/projectdetails/index.jsp?id=24676099& Nakajima Foundation (HS), http://www.nakajimafound.or.jp/; Else Kroner-Fresenius Foundation Research Training Group Translational Research Innovation-Pharma (TRIP) - recipients (GG, JL), http://www.ekfs.de/de/. Additional support of the analytical environment was gained from the European Union Seventh Framework Programme (FP7/2007 - 2013) under grant agreement no. 602919 ("GLORIA"; JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achille NJ, 2016, LEUKEMIA RES, V42, P68, DOI 10.1016/j.leukres.2016.01.004; Anisowicz Anthony, 2008, BMC Cancer, V8, P222, DOI 10.1186/1471-2407-8-222; Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Barchitta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109478; Beck S, 2010, NAT BIOTECHNOL, V28, P1026, DOI 10.1038/nbt1010-1026; Chen XN, 1999, GENOME RES, V9, P492; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Day JJ, 2015, ANNU REV PHARMACOL, V55, P591, DOI 10.1146/annurev-pharmtox-010814-124527; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; Delgado-Cruzata L, 2014, EPIGENETICS-US, V9, P1504, DOI 10.4161/15592294.2014.983364; Doehring A, 2013, PAIN, V154, P15, DOI 10.1016/j.pain.2012.06.011; Doo NW, 2016, EPIGENOMICS-UK, V8, P55, DOI 10.2217/epi.15.97; EICK D, 1983, ANAL BIOCHEM, V135, P165, DOI 10.1016/0003-2697(83)90746-7; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Foulks JM, 2012, J BIOMOL SCREEN, V17, P2, DOI 10.1177/1087057111421212; Fulnecek J, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-2; Gnyszka A, 2013, ANTICANCER RES, V33, P2989; Hackett JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0328; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Havlis J, 2002, J CHROMATOGR B, V781, P373, DOI 10.1016/S1570-0232(02)00499-3; Hirasawa R, 2010, ESSAYS BIOCHEM, V48, P187, DOI [10.1042/bse0480187, 10.1042/BSE0480187]; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jameson DM, 2010, CHEM REV, V110, P2685, DOI 10.1021/cr900267p; Jorda M, 2010, MUTAT RES-FUND MOL M, V693, P84, DOI 10.1016/j.mrfmmm.2010.06.010; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Kirchner H, 2013, TRENDS CELL BIOL, V23, P203, DOI 10.1016/j.tcb.2012.11.008; Knothe C, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0227-0; Knothe C, 2016, EPIGENOMICS-UK, V8, P167, DOI 10.2217/epi.15.78; Kurdyukov Sergey, 2016, Biology-Basel, V5, DOI 10.3390/biology5010003; Labrie V, 2012, TRENDS GENET, V28, P427, DOI 10.1016/j.tig.2012.04.002; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Langie SAS, 2015, CARCINOGENESIS, V36, pS61, DOI 10.1093/carcin/bgv031; Lea WA, 2011, EXPERT OPIN DRUG DIS, V6, P17, DOI 10.1517/17460441.2011.537322; Leeb M, 2012, CHROMOSOMA, V121, P251, DOI 10.1007/s00412-012-0365-x; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Lisanti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079044; Liu F, 2010, ONCOGENE, V29, P3650, DOI 10.1038/onc.2010.129; Liyanage Vichithra R B, 2014, Biology (Basel), V3, P670, DOI 10.3390/biology3040670; Lotsch J, 2013, TRENDS MOL MED, V19, P742, DOI 10.1016/j.molmed.2013.08.006; Luna-Zurita L, 2013, CURR OPIN GENET DEV, V23, P556, DOI 10.1016/j.gde.2013.07.002; Martinez-Arguelles Daniel B, 2014, BMC Res Notes, V7, P534, DOI 10.1186/1756-0500-7-534; MASSER DR, 2015, JOVE-J VIS EXP, V96, DOI DOI 10.3791/52488; Moerke Nathan J, 2009, Curr Protoc Chem Biol, V1, P1, DOI 10.1002/9780470559277.ch090102; O'Dwyer K, 2008, EXPERT OPIN PHARMACO, V9, P1981, DOI 10.1517/14656566.9.11.1981 ; Paradis A, 2014, INT J MED SCI, V11, P373, DOI 10.7150/ijms.7802; Reardon ES, 2015, ANN THORAC SURG, V100, P1839, DOI 10.1016/j.athoracsur.2015.05.089; Riganti C, 2013, NEURO-ONCOLOGY, V15, P1502, DOI 10.1093/neuonc/not104; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Sanchez-Mut J, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00347; Schiano C, 2015, TRENDS PHARMACOL SCI, V36, P226, DOI 10.1016/j.tips.2015.02.005; SINGER MF, 1982, CELL, V28, P433, DOI 10.1016/0092-8674(82)90194-5; TardyPlanechaud S, 1997, NUCLEIC ACIDS RES, V25, P553, DOI 10.1093/nar/25.3.553; Thomas EA, 2016, NEUROSCI LETT, V625, P34, DOI 10.1016/j.neulet.2015.10.060; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Udali S, 2015, HEPATOLOGY, V62, P496, DOI 10.1002/hep.27823; WAALWIJK C, 1978, NUCLEIC ACIDS RES, V5, P3231, DOI 10.1093/nar/5.9.3231; Wang JJ, 2013, INT J MODEL SIMUL SC, V4, DOI 10.1142/S1793962313500098; Zelic R, 2016, CLIN CANCER RES, V22, P984, DOI 10.1158/1078-0432.CCR-15-0606; Zhao CY, 2012, EPIGENETICS-US, V7, P335, DOI 10.4161/epi.19376; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	63	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0163184	10.1371/journal.pone.0163184	http://dx.doi.org/10.1371/journal.pone.0163184			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749902	Green Published, gold, Green Submitted			2022-12-26	WOS:000386202300004
J	Sui, FY; Zang, SY; Fan, YW; Ye, HX				Sui, Fengyang; Zang, Shuying; Fan, Yawen; Ye, Huaxiang			Effects of Different Saline-Alkaline Conditions on the Characteristics of Phytoplankton Communities in the Lakes of Songnen Plain, China	PLOS ONE			English	Article							BIOCHEMICAL-COMPOSITION; NANNOCHLOROPSIS-OCULATA; MARINE MICROALGAE; BALTIC SEA; BIOMASS; GROWTH; DYNAMICS; ZONE	Many lakes located in the Songnen Plain of China exhibit a high saline-alkaline level. 25 lakes in the Songnen Plain were selected as research objects in this study. Water samples in these lakes were collected from June to August in 2008. Total Dissolved Solids (TDS) and Total Alkalinity (TA) were measured to assess the saline-alkaline level, and partial canonical correspondence analysis (CCA) was conducted as well. The results show that the majority of these lakes in the study area could be categorized into HCO3--Na+-I type. According to the TDS assessment, of the total 25 lakes, there are 14 for freshwater, 7 for brackish water and 4 for saltwater; and the respective range of TA was from 0.98 to 40.52. The relationship between TA and TDS indicated significant linear relationship (R-2 = 0.9292) in the HCO3--Na+-I type lakes in the Songnen Plain. There was a general trend that cell density, genera richness and taxonomic diversity decreased with the increase of saline alkaline gradient, whereas a contrary trend was observed for the proportion of dominant species. When the TDS values were above 3x10(3)mg/L and the TA values were above 15mg/L, there was a significant reduction in cell density, genera richness and biodiversity, and their corresponding values were respectively below 10x10(6) (ind/L), 15 and approximately 2.5. Through the partial canonical correspondence analysis (CCA), 10.7% of the genera variation was explained by pure saline-alkaline variables. Cyclotella meneghiniana, Melosira ambigua and Melosira granulate were found to become the dominant species in most of these lakes, which indicated that there may be rather wide saline-alkaline niches for common dominant species. About one-quarters of the genera which have certain tolerance to salinity and alkalinity preferred to live in the regions with relatively higher saline alkaline levels in this study.	[Sui, Fengyang; Zang, Shuying; Ye, Huaxiang] Harbin Normal Univ, Key Lab Remote Sensing Monitoring Geog Environm, Coll Heilongjiang Prov, Harbin, Heilongjiang, Peoples R China; [Fan, Yawen] Harbin Normal Univ, Key Lab Bot, Harbin, Heilongjiang, Peoples R China	Harbin Normal University; Harbin Normal University	Zang, SY (corresponding author), Harbin Normal Univ, Key Lab Remote Sensing Monitoring Geog Environm, Coll Heilongjiang Prov, Harbin, Heilongjiang, Peoples R China.; Fan, YW (corresponding author), Harbin Normal Univ, Key Lab Bot, Harbin, Heilongjiang, Peoples R China.	zsy6311@163.com; fanyaw@163.com			Innovation research Projects of Doctoral candidates of Harbin Normal University [HSDBSCX2015-13]; Key Projects of Natural Science Foundation of Heilongjiang Province [ZD201308]; National Natural Science Foundation of China [31270250, 31470308, 41501547]	Innovation research Projects of Doctoral candidates of Harbin Normal University; Key Projects of Natural Science Foundation of Heilongjiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by: HSDBSCX2015-13, http://yjsxy.hrbnu.edu.cn/index.htm, Innovation research Projects of Doctoral candidates of Harbin Normal University, FS; the funder had a role in decision to publish. ZD201308, http://219.147.168.104/Kjpt/platform/login.htm, Key Projects of Natural Science Foundation of Heilongjiang Province, SZ; the funder had a role in study design. 31270250, https://isisn.nsfc.gov.cn/egrantweb/index:jsessionid=bipIXBidIZT00jrLX6jOGuXyWtTEkoHT3OQLE3rzYS0ZaQven367y!-883794514, National Natural Science Foundation of China, YE; the funder had a role in data collection and analysis. 31470308, https://isisn.nsfc.gov.cn/egrantweb/index:jsessionid=bipIXBidZT00jrLX6jOGuXyWtTEkoHT3OQLE3rzYS0ZaQven367y!-883794514, National Natural Science Foundation of China, YE; the funder had a role in data collection and analysis. 41501547, https://isisn.nsfc.gov.cn/egrantweb/index:jsessionid=bipIXBidZT00jrLX6jOGuXyWtTEkoHT3OQLE3rzYS0ZaQven367y!-883794514, National Natural Science Foundation of China, HY; the funder had a role in preparation of the manuscript.	[白军红 BAI JunHong], 2008, [湿地科学, Wetland Science], V6, P1; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; CHEN JS, 1999, ACTA SCI CIRCUMSTANT, V19, P500; D'ors A, 2016, ESTUAR COAST SHELF S, V175, P169, DOI 10.1016/j.ecss.2016.04.004; Ettl H., 1997, SUSSWASSERFLORA MITT; Gasiunaite ZR, 2005, ESTUAR COAST SHELF S, V65, P239, DOI 10.1016/j.ecss.2005.05.018; Gu N, 2012, ENG LIFE SCI, V12, P631, DOI 10.1002/elsc.201100204; Gu N, 2012, J WORLD AQUACULT SOC, V43, P97, DOI 10.1111/j.1749-7345.2011.00538.x; Hu H., 2006, FRESHWATER ALGAE CHI; Huang C, 2000, J LAKE SCI, V12, P63; Kies Ludwig, 1997, Limnologica, V27, P55; KIRST GO, 1990, ANNU REV PLANT PHYS, V41, P21, DOI 10.1146/annurev.pp.41.060190.000321; Kostamo K, 2012, MAR BIOL, V159, P561, DOI 10.1007/s00227-011-1835-z; Krammer K., 2004, SUSSWASSERFLORA MITT; Krammer K, 2003, SUSSWASSERFLORA MITT, V2/4; Lehman PW, 2000, ESTUARIES, V23, P216, DOI 10.2307/1352829; Li JD, 1997, AMENDMENT SALINE ALK; Li Rui, 2013, Research of Environmental Sciences, V26, P1072; Li YP, 2001, WATER RESOURCES HYDR, V11, P39; Luo XZ, 2000, SCI GEOGRAPHICA SINI, V20, P483; Lv JF, 2000, J NE NORMAL U, V32, P99; Masmoudi S, 2015, AQUAT ECOL, V49, P1, DOI 10.1007/s10452-014-9500-5; Morais P, 2003, ACTA OECOL, V24, pS87, DOI 10.1016/S1146-609X(03)00008-0; Muylaert K, 1999, J MARINE SYST, V22, P133, DOI 10.1016/S0924-7963(99)00037-8; NAKANBHI MASAMI, 1965, J FAC SCI UNIV TOKYO SECT III BOT, V9, P19; Ogato T, 2016, MAR FRESHWATER RES, V67, P483, DOI 10.1071/MF14426; Redden AM, 2008, HYDROBIOLOGIA, V608, P87, DOI 10.1007/s10750-008-9376-2; RENAUD SM, 1994, J APPL PHYCOL, V6, P347, DOI 10.1007/BF02181949; Richmond A, 1986, HDB MICROALGAL MASS, P89; RIJSTENBIL JW, 1987, NETH J SEA RES, V21, P113, DOI 10.1016/0077-7579(87)90027-5; Rodriguez-Gallego L, 2015, ESTUAR COAST, V38, P451, DOI 10.1007/s12237-014-9842-1; Sampathkumar P, 2015, ADV CLIM CHANG RES, V6, P36, DOI 10.1016/j.accre.2015.09.005; Schubert H, 2011, MAR POLLUT BULL, V62, P1948, DOI 10.1016/j.marpolbul.2011.06.033; Semcheski MR, 2016, WETLANDS, V36, P483, DOI 10.1007/s13157-016-0756-5; Shi YC, 1991, MONITORING FORECAST, P21; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Sui FY, 2010, PRELIMINARY STUDIES; Takagi M, 2006, J BIOSCI BIOENG, V101, P223, DOI 10.1263/jbb.101.223; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Wang CM, 1992, J CHANGCHUN GEOLOGY, V22, P30; Wang L, 2009, PADDY WATER ENVIRON, V7, P259, DOI 10.1007/s10333-009-0166-x; Wei D., 2001, J GEOGR SCI, V11, P217, DOI [10.1007/BF02888693, DOI 10.1007/BF02888693]; [肖海丰 XIAO HaiFeng], 2011, [湿地科学, Wetland Science], V9, P120; Xu JY, 2001, WATER RESOURCES HYDR, V19, P42; Yang JC, 2010, CHINESE GEOGR SCI, V20, P159, DOI 10.1007/s11769-010-0159-0; [姚书春 Yao Shuchun], 2010, [湿地科学, Wetland Science], V8, P169; Zhang B, 2007, ENVIRON MONIT ASSESS, V133, P379, DOI 10.1007/s10661-006-9592-z; Zhang XL, 1996, STUDY ECOTONE W NE C, P58; Zhang YH, 2001, J ARID LAND RESOURCE, V15, P31; Zhila NO, 2011, J APPL PHYCOL, V23, P47, DOI 10.1007/s10811-010-9532-8	51	7	9	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164734	10.1371/journal.pone.0164734	http://dx.doi.org/10.1371/journal.pone.0164734			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749936	gold, Green Published, Green Submitted			2022-12-26	WOS:000386202300024
J	de Salas, F; Pardo, I; Salavagione, HJ; Aza, P; Amougi, E; Vind, J; Martinez, AT; Camarero, S				de Salas, Felipe; Pardo, Isabel; Salavagione, Horacio J.; Aza, Pablo; Amougi, Eleni; Vind, Jesper; Martinez, Angel T.; Camarero, Susana			Advanced Synthesis of Conductive Polyaniline Using Laccase as Biocatalyst	PLOS ONE			English	Article							CRITICAL MICELLE CONCENTRATION; CATALYZED SYNTHESIS; ANILINE; POLYMERIZATION; NANOCOMPOSITES; ELECTROPOLYMERIZATION; COMPOSITES; NANOFIBERS; MORPHOLOGY; EVOLUTION	Polyaniline is a conductive polymer with distinctive optical and electrical properties. Its enzymatic synthesis is an environmentally friendly alternative to the use of harsh oxidants and extremely acidic conditions. 7D5L, a high-redox potential laccase developed in our lab, is the biocatalyst of choice for the synthesis of green polyaniline (emeraldine salt) due to its superior ability to oxidize aniline and kinetic stability at the required polymerization conditions (pH 3 and presence of anionic surfactants) as compared with other fungal laccases. Doses as low as 7.6 nM of 7D5L catalyze the polymerization of 15 mM aniline (in 24 h, room temperature, 7% yield) in the presence of different anionic surfactants used as doping templates to provide linear and water-soluble polymers. Aniline polymerization was monitored by the increase of the polaron absorption band at 800 nm (typical for emeraldine salt). Best polymerization results were obtained with 5 mM sodium dodecylbenzenesulfonate (SDBS) as template. At fixed conditions (15 mM aniline and 5mM SDBS), polymerization rates obtained with 7D5L were 2.5-fold the rates obtained with commercial Trametes villosa laccase. Moreover, polyaniline yield was notably boosted to 75% by rising 7D5L amount to 0.15 mu M, obtaining 1g of green polyaniline in 1L-reaction volume. The green polymer obtained with the selected system (7D5L/SDBS) holds excellent electrochemical and electro-conductive properties displayed in water-dispersible nanofibers, which is advantageous for the nanomaterial to be readily cast into uniform films for different applications.	[de Salas, Felipe; Pardo, Isabel; Aza, Pablo; Martinez, Angel T.; Camarero, Susana] CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain; [Salavagione, Horacio J.] CSIC, Inst Ciencia & Tecnol Polimeros, Juan de la Cierva 3, E-28006 Madrid, Spain; [Amougi, Eleni; Vind, Jesper] Novozymes AS, Krogshoejvej 36, DK-2880 Bagsvaerd, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia & Tecnologia de Polimeros (ICTP); Novozymes	Camarero, S (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	susanacam@cib.csic.es	SALAVAGIONE, HORACIO J/J-7194-2016; de Salas, Felipe/GON-5080-2022; Martínez, Angel T/G-7284-2017; Pardo, Isabel/GLT-6378-2022; Camarero, Susana/K-3172-2014	SALAVAGIONE, HORACIO J/0000-0001-9588-7879; de Salas, Felipe/0000-0002-0057-0180; Martínez, Angel T/0000-0002-1584-2863; Pardo, Isabel/0000-0002-8568-1559; Camarero, Susana/0000-0002-2812-895X	INDOX European project [KBBE-2013-7-613549]; NOESIS Spanish national project [BIO2014-56388-R]; company Novozymes NS (Denmark)	INDOX European project; NOESIS Spanish national project; company Novozymes NS (Denmark)	This work was funded by INDOX (KBBE-2013-7-613549) European project and NOESIS (BIO2014-56388-R) Spanish national project. Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The company Novozymes NS (Denmark) provided support in the form of salaries for EA and JV and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.r This work was funded by the INDOX European project (KBBE-2013-7-613549) and NOESIS Spanish national project (BIO2014-56388-R). The authors thank David Gomez from ICTP, CSIC for SEM analyses.	Alcalde M, DIR ENZYM EVOL, P193, DOI [10.1385/1-59259-396-8:193, DOI 10.1385/1-59259-396-8:193]; BAYNTON KJ, 1994, BBA-PROTEIN STRUCT M, V1206, P272, DOI 10.1016/0167-4838(94)90218-6; Blinova NV, 2007, EUR POLYM J, V43, P2331, DOI 10.1016/j.eurpolymj.2007.03.045; Camarero S, 2012, APPL ENVIRON MICROB, V78, P1370, DOI 10.1128/AEM.07530-11; Chauhan S, 2014, J CHEM THERMODYN, V71, P205, DOI 10.1016/j.jct.2013.12.019; Cruz-Silva R, 2005, EUR POLYM J, V41, P1129, DOI 10.1016/j.eurpolymj.2004.11.012; Guo CG, 2013, POLYM POLYM COMPOS, V21, P449, DOI 10.1177/096739111302100706; Hino T, 2006, SYNTHETIC MET, V156, P1327, DOI 10.1016/j.synthmet.2006.10.001; Huang JX, 2003, J AM CHEM SOC, V125, P314, DOI 10.1021/ja028371y; Huang JX, 2006, CHEM COMMUN, P367, DOI 10.1039/b510956f; Junker K, 2014, ENZYME MICROB TECH, V55, P72, DOI 10.1016/j.enzmictec.2013.12.008; Karamyshev AV, 2003, ENZYME MICROB TECH, V33, P556, DOI 10.1016/S0141-0229(03)00163-7; Lin CE, 2004, J CHROMATOGR A, V1037, P467, DOI 10.1016/j.chroma.2003.11.059; Liu W, 1999, J AM CHEM SOC, V121, P71, DOI 10.1021/ja982270b; Martinez MV, 2015, POLYMER, V78, P94, DOI 10.1016/j.polymer.2015.09.054; Mate DM, 2013, BIOCATAL BIOTRANSFOR, V31, P8, DOI 10.3109/10242422.2012.749463; Matsui T, 2016, WO, Patent No. [2016026938 A1 Patent 2016, 2016026938]; Pardo I, 2012, BIOTECHNOL BIOENG, V109, P2978, DOI 10.1002/bit.24588; Sapurina I, 2008, POLYM INT, V57, P1295, DOI 10.1002/pi.2476; Shumakovich GP, 2010, J APPL POLYM SCI, V117, P1544, DOI 10.1002/app.32008; Shumakovich G, 2011, J MOL CATAL B-ENZYM, V69, P83, DOI 10.1016/j.molcatb.2011.01.016; Stejskal J, 2002, PURE APPL CHEM, P74; Stejskal J, 2008, MACROMOLECULES, V41, P3530, DOI 10.1021/ma702601q; Streltsov AV, 2008, APPL BIOCHEM MICRO+, V44, P264, DOI 10.1134/S000368380803006X; Tran HD, 2011, J MATER CHEM, V21, P3534, DOI 10.1039/c0jm02699a; Trchova M, 2011, PURE APPL CHEM, V83, P1803, DOI 10.1351/PAC-REP-10-02-01; Vasil'eva IS, 2007, SYNTHETIC MET, V157, P684, DOI 10.1016/j.synthmet.2007.07.018; Vasil'eva I S, 2009, Prikl Biokhim Mikrobiol, V45, P33; Wang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03568; Wang YM, 2014, SYNTHETIC MET, V198, P293, DOI 10.1016/j.synthmet.2014.10.038; Wen T, 2012, J NANOSCI NANOTECHNO, V12, P91, DOI 10.1166/jnn.2012.5143; Wu Q, 2010, ACS NANO, V4, P1963, DOI 10.1021/nn1000035; WUDL F, 1987, J AM CHEM SOC, V109, P3677, DOI 10.1021/ja00246a026; YANG HJ, 1992, J ELECTROANAL CHEM, V339, P423, DOI 10.1016/0022-0728(92)80466-H; Yang LYO, 2007, J AM CHEM SOC, V129, P8076, DOI 10.1021/ja072201+; Zhang HM, 2011, POLYMER, V52, P3059, DOI 10.1016/j.polymer.2011.02.031; Zhang J, 2014, COLLOID POLYM SCI, V292, P2549, DOI 10.1007/s00396-014-3301-1; Zhang K, 2010, CHEM MATER, V22, P1392, DOI 10.1021/cm902876u; Zhang WC, 2009, LANGMUIR, V25, P2363, DOI 10.1021/la803240x; Zhang XJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085007, 10.1186/1748-717X-9-64]; Zhang Y, 2014, APPL BIOCHEM BIOTECH, V174, P820, DOI 10.1007/s12010-014-1094-9	41	26	27	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164958	10.1371/journal.pone.0164958	http://dx.doi.org/10.1371/journal.pone.0164958			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741301	Green Published, gold, Green Submitted			2022-12-26	WOS:000385507000085
J	Fu, X; Lindgren, T; Wieslander, G; Janson, C; Norback, D				Fu, Xi; Lindgren, Torsten; Wieslander, Gunilla; Janson, Christer; Norback, Dan			Respiratory Illness and Allergy Related to Work and Home Environment among Commercial Pilots	PLOS ONE			English	Article							INFLUENZA A(H1N1)PDM09; AIR-QUALITY; SYMPTOMS; ASTHMA; INDOOR; RISK; TRANSMISSION; QUESTIONNAIRE; PREVALENCE; SMOKING	The aim was to study associations between work and home environment and prevalence and incidence of respiratory health and a history of atopy in a 3-y cohort of commercial pilots. A questionnaire was mailed in 1997 to all pilots in a Scandinavian airline company (N = 622); 577 (93%) participated. The same questionnaire was sent to the participants 3 years later, 436 participated (76%). There were questions on asthma, respiratory symptoms and infections, allergies, the cabin environment, psychosocial environment and the home environment. Associations were analyzed by multiple logistic regression, calculating odds ratios (OR) with 95% confidence intervals (95% CI). The incidence of doctors' diagnosed asthma and atopy were 2.4 and 16.6 per 1000 person years, respectively. Pilots changing type of flight during follow-up got more airway infections (OR = 11.27; 95% CI 2.39-53.14). Those reporting decreased work control (OR = 1.85; 95% CI 1.03-3.31 for 1 unit change) and those with environmental tobacco smoke (ETS) at home (OR = 3.73; 95% CI 1.09-12.83) had a higher incidence of atopy during follow up. Dampness or mould at home was associated with a higher prevalence of asthma symptoms (OR = 3.55; 95% CI 1.43-8.82) and airway infections (OR = 3.12 95% CI 1.27-7.68). Window pane condensation in winter at home, reported at baseline, was associated with increased incidence of asthma symptoms (OR = 4.14; 95% CI 1.32-12.97) and pilots living in newer buildings at baseline had a higher incidence of airway infections (OR = 5.23; 95% CI 1.43-19.10). In conclusion, lack of work control and ETS at home can be a risk factors for development of allergic symptoms in pilots. Window pane condensation at home can be a risk factor for incidence of asthma symptoms. Dampness and mould at home can be a risk factor for prevalence of asthma symptoms and airway infections and living in newer buildings can be a risk factor for incidence of airway infections.	[Fu, Xi; Lindgren, Torsten; Wieslander, Gunilla; Norback, Dan] Uppsala Univ, Univ Hosp, Dept Med Sci, Occupat & Environm Med, Uppsala, Sweden; [Janson, Christer] Uppsala Univ, Univ Hosp, Dept Med Sci, Resp Allergy & Sleep Res, Uppsala, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital	Fu, X (corresponding author), Uppsala Univ, Univ Hosp, Dept Med Sci, Occupat & Environm Med, Uppsala, Sweden.	xi.fu@medsci.uu.se		Fu, Xi/0000-0001-9530-8478	Chinese Scholarship Council [201307930011]	Chinese Scholarship Council(China Scholarship Council)	FAS: DNR 2001-0260 The Swedish Council for Worklife Research,www.fas.se and State Scholarship Fund: No.201307930011 Chinese Scholarship Council www.csc.edu.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Scandinavian Airlines System and all participants in this study. This work was supported by the Chinese Scholarship Council.	Andersson K, 1998, INDOOR AIR, P32; [Anonymous], 1992, CAA ASTHM CLASS 1 2; Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P167, DOI 10.1289/ehp.0900994; Emenius G, 2004, INDOOR AIR, V14, P34, DOI 10.1046/j.1600-0668.2003.00207.x; Emenius G, 2000, CLIN EXP ALLERGY, V30, P418; Feleszko W, 2014, ARCH DIS CHILD, V99, P985, DOI 10.1136/archdischild-2013-305444; Forey BA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-36; FRYE RE, 1990, JAMA-J AM MED ASSOC, V263, P1233, DOI 10.1001/jama.263.9.1233; Fu X, 2015, AEROSP MED HUM PERF, V86, P458, DOI 10.3357/AMHP.4216.2015; Fu X, 2013, ENVIRON SCI-PROC IMP, V15, P1228, DOI 10.1039/c3em30928b; Gustafson P, 2005, J EXPO ANAL ENV EPID, V15, P252, DOI 10.1038/sj.jea.7500399; Hammer GP, 2009, RADIAT PROT DOSIM, V136, P232, DOI 10.1093/rpd/ncp125; Heinrich J, 2011, INT J HYG ENVIR HEAL, V214, P3, DOI 10.1016/j.ijheh.2010.08.009; IRVINE D, 1992, AVIAT SPACE ENVIR MD, V63, P276; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Kwon JW, 2011, ALLERGY ASTHMA IMMUN, V3, P27, DOI 10.4168/aair.2011.3.1.27; Lakwijk N, 1998, CLIN EXP ALLERGY, V28, P454; Lindgren T, 2002, INDOOR AIR, V12, P263, DOI 10.1034/j.1600-0668.2002.01121.x; Lindgren T, 2006, AVIAT SPACE ENVIR MD, V77, P832; Linneberg A, 2001, RESP MED, V95, P258, DOI 10.1053/rmed.2001.1031; LUNDHOLM M, 1990, ARCH ENVIRON HEALTH, V45, P135, DOI 10.1080/00039896.1990.9936706; Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8; Martinez I., 2015, AIRCRAFT ENV CONTROL; McCarty DJ, 2000, CLIN EXP OPHTHALMOL, V28, P169, DOI 10.1046/j.1442-9071.2000.00294.x; Mendell MJ, 2011, ENVIRON HEALTH PERSP, V119, P748, DOI 10.1289/ehp.1002410; Neatherlin J, 2013, TRAVEL MED INFECT DI, V11, P110, DOI 10.1016/j.tmaid.2013.02.004; Norback D, 1999, INT J TUBERC LUNG D, V3, P368; NORBACK D, 1991, BRIT J IND MED, V48, P451; Norback D, 2006, SCAND J WORK ENV HEA, V32, P138, DOI 10.5271/sjweh.989; Norback D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112960; Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349; Organization WH, 2009, WHO GUID IND AIR QUA; Repace J, 2004, TOB CONTROL, V13, P8, DOI 10.1136/tc.2003.003111; Rosenkvist L, 2008, AVIAT SPACE ENVIR MD, V79, P960, DOI 10.3357/ASEM.2287.2008; Runeson R, 2011, AM J IND MED, V54, P545, DOI 10.1002/ajim.20943; Runeson-Broberg R, 2014, INT ARCH OCC ENV HEA, V87, P685, DOI 10.1007/s00420-013-0911-8; Runeson-Broberg R, 2014, PSYCHOL REP, V114, P377, DOI 10.2466/15.14.PR0.114k20w3; Sahlberg B, 2009, INT ARCH OCC ENV HEA, V82, P1211, DOI 10.1007/s00420-009-0444-3; Sanne B, 2005, SCAND J PUBLIC HEALT, V33, P166, DOI 10.1080/14034940410019217; Sykes AJ, 2012, AVIAT SPACE ENVIR MD, V83, P1001, DOI 10.3357/ASEM.3380.2012; Takaoka M, 2011, INDOOR BUILT ENVIRON, V20, P369, DOI 10.1177/1420326X11403194; TOREN K, 1993, CHEST, V104, P600, DOI 10.1378/chest.104.2.600; Toren K, 1999, INT J TUBERC LUNG D, V3, P192; Toren K, 2004, EUR RESPIR J, V24, P942, DOI 10.1183/09031936.04.00044804; Ulanovski D, 2008, AM J RHINOL, V22, P122, DOI 10.2500/ajr.2008.22.3158; Vellappally Sajith, 2007, Acta Medica (Hradec Kralove), V50, P161; Vogt TM, 2006, J TRAVEL MED, V13, P268, DOI 10.1111/j.1708-8305.2006.00048.x; Wang X.D., 2014, J APPL MATH, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0105125; Weisel C, 2013, ENVIRON SCI TECHNOL, V47, P4711, DOI 10.1021/es3046795; Whelan EA, 2003, OCCUP ENVIRON MED, V60, P929, DOI 10.1136/oem.60.12.929; WICKMAN M, 1994, CLIN EXP ALLERGY, V24, P109, DOI 10.1111/j.1365-2222.1994.tb00205.x; Wieslander G, 1997, J OCCUP HEALTH, V39, P331, DOI 10.1539/joh.39.331; Wirawan IMA, 2012, AVIAT SPACE ENVIR MD, V83, P465, DOI 10.3357/ASEM.3222.2012; Young N, 2014, INFLUENZA OTHER RESP, V8, P66, DOI 10.1111/irv.12181	54	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164954	10.1371/journal.pone.0164954	http://dx.doi.org/10.1371/journal.pone.0164954			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741314	gold, Green Published, Green Submitted			2022-12-26	WOS:000385507000084
J	Qi, DL; Cobrinik, D				Qi, D-L; Cobrinik, D.			MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation	ONCOGENE			English	Article							TUMOR SUPPRESSION; GENE-EXPRESSION; P53 ACTIVATION; CANCER-THERAPY; DNA-DAMAGE; RB; P14(ARF); NEUROBLASTOMA; PATHWAYS; MICE	Retinoblastomas can arise from cone photoreceptor precursors in response to the loss of pRB function. Cone precursor-specific circuitry cooperates with pRB loss to initiate this process and subsequently contributes to the malignancy. Intrinsic high-level MDM2 expression is a key component of the cone precursor circuitry and is thought to inactivate p53-mediated tumor surveillance, which could otherwise be induced in response to pRB loss. However, the MDM2-related MDM4 has also been proposed to abrogate p53-mediated tumor surveillance in the absence of detectable MDM2 in retinoblastoma cells, bringing into question the importance of high-level MDM2 versus MDM4 expression. Here we report that high-level MDM2 but not MDM4 has a consistent critical role in retinoblastoma cell proliferation in vitro, as well as in orthotopic xenografts. Reduction of either MDM2 or MDM4 weakly induced p53, yet reduction of MDM2 but not MDM4 severely impaired proliferation and survival through a p53-independent mechanism. Specifically, MDM2 upregulated the mRNA expression and translation of another component of the cone circuitry, MYCN, in retinoblastoma cells. Moreover, MYCN was essential to retinoblastoma cell growth and tumor formation, and ectopic MYCN partially reversed the effects of MDM2 depletion, indicating that MYCN is an important MDM2 target. These findings indicate that high-level MDM2 expression is needed in order to perform a critical p53-independent function and may obviate the need for genomic alterations to the p53 pathway during retinoblastoma tumorigenesis.	[Qi, D-L; Cobrinik, D.] Childrens Hosp Los Angeles, Dept Surg, Div Ophthalmol, Vis Ctr, Los Angeles, CA 90027 USA; [Qi, D-L; Cobrinik, D.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Cobrinik, D.] Univ Southern Calif, Keck Sch Med, USC Roski Eye Inst, Los Angeles, CA USA; [Cobrinik, D.] Univ Southern Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA USA; [Cobrinik, D.] Univ Southern Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA USA; [Cobrinik, D.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Cobrinik, D (corresponding author), Childrens Hosp Los Angeles, 4650 Sunset Blvd,MS 163, Los Angeles, CA 90027 USA.	dcobrinik@chla.usc.edu			NIH [1R01CA137124, P30CA014089]; Saban Research Institute Research Career Development Fellowship; Research to Prevent Blindness (New York, New York); Larry & Celia Moh Foundation; NATIONAL CANCER INSTITUTE [P30CA014089, R01CA137124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saban Research Institute Research Career Development Fellowship; Research to Prevent Blindness (New York, New York)(Research to Prevent Blindness (RPB)); Larry & Celia Moh Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	D-L Qi and D Cobrinik designed the study. D-L Qi conducted all the experiments. D-L Qi and D Cobrinik wrote the manuscript. We thank Xiaoliang Leon Xu for early passage retinoblastoma cell preparations, Narine Harutyunyan and Jennifer Aparicio for CHLAVC-RB43, Pat Reynolds and A Linn Murphree for CHLA-RB215 cells, and the Saban Research Institute Research Imaging Core for assistance. This study was supported by NIH grants 1R01CA137124 and P30CA014089, by a Saban Research Institute Research Career Development Fellowship to D-L Qi, by Research to Prevent Blindness (New York, New York), by the Larry & Celia Moh Foundation and by the charitable support of the Nautica Malibu Triathlon event produced by MESP, Inc.	Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Brennan RC, 2011, CANCER RES, V71, P4205, DOI 10.1158/0008-5472.CAN-11-0058; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Carr-Wilkinson J, 2010, CLIN CANCER RES, V16, P1108, DOI 10.1158/1078-0432.CCR-09-1865; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Cobrinik D, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-72; Cobrinik D, 2015, EBIOMEDICINE, V2, P623, DOI 10.1016/j.ebiom.2015.07.023; Cobrinik D, 2013, GENE CHROMOSOME CANC, V52, P1150, DOI 10.1002/gcc.22110; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; DIMARAS H, 2015, NAT REV DIS PRIMERS, V1, P1, DOI DOI 10.1038/NRDP.2015.21.ACCESSED; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Elison JR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1269, DOI 10.1001/archopht.124.9.1269; Embade N, 2012, HEPATOLOGY, V55, P1237, DOI 10.1002/hep.24795; Evans L, 2015, CANCER LETT, V363, P37, DOI 10.1016/j.canlet.2015.03.044; Gratias S, 2005, INT J CANCER, V116, P555, DOI 10.1002/ijc.21051; Gu L, 2012, ONCOGENE, V31, P1342, DOI 10.1038/onc.2011.343; Guo Y, 2008, BIOCHEM BIOPH RES CO, V375, P1, DOI 10.1016/j.bbrc.2008.07.055; Harbour JW, 2002, ARCH OPHTHALMOL-CHIC, V120, P1341, DOI 10.1001/archopht.120.10.1341; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Huang M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014415; Kato MV, 1996, CANCER LETT, V106, P75, DOI 10.1016/0304-3835(96)04305-4; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Komori H, 2005, EMBO J, V24, P3724, DOI 10.1038/sj.emboj.7600836; Kooi IE, 2015, EBIOMEDICINE, V2, P660, DOI 10.1016/j.ebiom.2015.06.022; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lee TC, 2006, INVEST OPHTH VIS SCI, V47, P5590, DOI 10.1167/iovs.06-0063; Li Q, 2013, CLIN CANCER RES, V19, P34, DOI 10.1158/1078-0432.CCR-12-0053; Liu DP, 2010, ONCOGENE, V29, P949, DOI 10.1038/onc.2009.376; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; McEvoy J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042739; McEvoy J, 2011, CANCER CELL, V20, P260, DOI 10.1016/j.ccr.2011.07.005; Miles WO, 2014, EMBO J, V33, P2201, DOI 10.15252/embj.201488057; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sohn D, 2009, CELL DEATH DIFFER, V16, P869, DOI 10.1038/cdd.2009.17; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Theriault BL, 2014, CLIN EXP OPHTHALMOL, V42, P33, DOI 10.1111/ceo.12132; To KH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-69; Viatour P, 2011, DIS MODEL MECH, V4, P581, DOI 10.1242/dmm.008060; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Xu XLL, 2014, NATURE, V514, P385, DOI 10.1038/nature13813; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051	53	30	30	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 30	2017	36	13					1760	1769		10.1038/onc.2016.350	http://dx.doi.org/10.1038/onc.2016.350			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EQ5NF	27748758	Green Accepted			2022-12-26	WOS:000398128900002
J	Matsui, Y; Shindo, K; Nagata, K; Yoshinaga, N; Shirakawa, K; Kobayashi, M; Takaori-Kondo, A				Matsui, Yusuke; Shindo, Keisuke; Nagata, Kayoko; Yoshinaga, Noriyoshi; Shirakawa, Kotaro; Kobayashi, Masayuki; Takaori-Kondo, Akifumi			Core Binding Factor beta Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIF-INDUCED DEGRADATION; CBF-BETA; UBIQUITIN LIGASE; T-LYMPHOCYTES; E3 LIGASE; APOBEC3G; MDM2; P53; RESTRICTION	HIV, type 1 overcomes host restriction factor apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APO-BEC3) proteins by organizing an E3 ubiquitin ligase complex together with viral infectivity factor (Vif) and a host transcription cofactor core binding factor beta (CBF beta). CBF beta is essential for Vif to counteract APOBEC3 by enabling the recruitment of cullin 5 to the complex and increasing the steady-state level of Vif protein; however, the mechanisms by which CBF beta up-regulates Vif protein remains unclear. Because we have reported previously that mouse double minute 2 homolog (MDM2) is an E3 ligase for Vif, we hypothesized that CBF beta might protect Vif from MDM2-mediated degradation. Co-immunoprecipitation analyses showed that Vif mutants that do not bind to CBF beta preferentially interact with MDM2 and that overexpression of CBF beta disrupts the interaction between MDM2 and Vif. Knockdown of CBF beta reduced the steady-state level of Vif in MDM2-proficient cells but not in MDM2-null cells. Cycloheximide chase analyses revealed that Vif E88A/W89A, which does not interact with CBF beta, degraded faster than wild-type Vif in MDM2-proficient cells but not in MDM2-null cells, suggesting that Vif stabilization by CBF beta is mainly caused by impairing MDM2-mediated degradation. We identified Vif R93E as a Vif variant that does not bind to MDM2, and the virus with this substitution mutation was more resistant to APOBEC3G than the parental virus. Combinatory substitution of Vif residues required for CBF beta binding and MDM2 binding showed full recovery of Vif steady-state levels, supporting our hypothesis. Our data provide new insights into the mechanism of Vif augmentation by CBF beta	[Matsui, Yusuke; Shindo, Keisuke; Nagata, Kayoko; Yoshinaga, Noriyoshi; Shirakawa, Kotaro; Kobayashi, Masayuki; Takaori-Kondo, Akifumi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto 6068507, Japan	Kyoto University	Shindo, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Sakyo Ku, 54 Shogoin Kawaracho, Kyoto 6068507, Japan.	shind009@kuhp.kyoto-u.ac.jp		Shindo, Keisuke/0000-0001-8793-8189	Ministry of Education, Culture, Sports, Science, and Technology [JP24115004]; Japan Society for the Promotion of Science [JP16K08807]; Ministry of Health, Labor, and Welfare in Japan	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan)	Twhis study was partly supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI #JP24115004), Japan Society for the Promotion of Science (KAKENHI #JP16K08807), and the Ministry of Health, Labor, and Welfare in Japan. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Dussart S, 2004, BIOCHEM BIOPH RES CO, V315, P66, DOI 10.1016/j.bbrc.2004.01.023; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fribourgh JL, 2014, J VIROL, V88, P3309, DOI 10.1128/JVI.03824-13; Fujita M, 2004, MICROBES INFECT, V6, P791, DOI 10.1016/j.micinf.2004.04.011; Fujita M, 2003, J VIROL, V77, P1626, DOI 10.1128/JVI.77.2.1626-1632.2003; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; GABUZDA DH, 1994, J ACQ IMMUN DEF SYND, V7, P908; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; Hache G, 2008, CURR BIOL, V18, P819, DOI 10.1016/j.cub.2008.04.073; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107; Izumi T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-1; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kim DY, 2013, MOL CELL, V49, P632, DOI 10.1016/j.molcel.2012.12.012; Kobayashi M, 2004, J VIROL, V78, P8238, DOI 10.1128/JVI.78.15.8238-8244.2004; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lohrum MAE, 2000, NAT CELL BIOL, V2, P179, DOI 10.1038/35004057; LUNA RMD, 1995, NATURE, V378, P203; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Malbec M, 2010, VIROLOGY, V405, P414, DOI 10.1016/j.virol.2010.06.021; Matsui M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-122; Matsui Y, 2014, VIROLOGY, V449, P82, DOI 10.1016/j.virol.2013.11.004; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Miyagi E, 2014, J VIROL, V88, P4839, DOI 10.1128/JVI.03359-13; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Salter JD, 2014, TRENDS BIOCHEM SCI, V39, P373, DOI 10.1016/j.tibs.2014.07.001; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718	39	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24892	24899		10.1074/jbc.M116.734673	http://dx.doi.org/10.1074/jbc.M116.734673			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27758855	Green Published, hybrid			2022-12-26	WOS:000388880100009
J	Sato, K; Kimura, M; Sugiyama, K; Nishikawa, M; Okano, Y; Nagaoka, H; Nagase, T; Kitade, Y; Ueda, H				Sato, Katsuya; Kimura, Masashi; Sugiyama, Kazue; Nishikawa, Masashi; Okano, Yukio; Nagaoka, Hitoshi; Nagase, Takahiro; Kitade, Yukio; Ueda, Hiroshi			Four-and-a-half LIM Domains 1 (FHL1) Protein Interacts with the Rho Guanine Nucleotide Exchange Factor PLEKHG2/FLJ00018 and Regulates Cell Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; ONLY PROTEIN; NEURO-2A CELLS; FAMILY; CYTOSKELETON; ACTIVATION; NUCLEUS; GTPASES; IDENTIFICATION; LOCALIZATION	PLEKHG2/FLJ00018 is a G beta gamma-dependent guanine nucleotide exchange factor for the small GTPases Rac and Cdc42 and has been shown to mediate the signaling pathways leading to actin cytoskeleton reorganization. Here we showed that the zinc finger domain-containing protein four-and-a-half LIM domains 1 (FHL1) acts as a novel interaction partner of PLEKHG2 by the yeast two-hybrid system. Among the isoforms of FHL1 (i.e. FHL1A, FHL1B, and FHL1C), FHL1A and FHL1B interacted with PLEKHG2. We found that there was an FHL1-binding region at amino acids 58-150 of PLEKHG2. The overexpression of FHL1A but not FHL1B enhanced the PLEKHG2-induced serum response element-dependent gene transcription. The co-expression of FHL1A and G beta gamma synergistically enhanced the PLEKHG2-induced serum response element-dependent gene transcription. Increased transcription activity was decreased by FHL1A knock-out with the CRISPR/Cas9 system. Compared with PLEKHG2-expressing cells, the number and length of finger-like protrusions were increased in PLEKHG2-, G beta gamma-, and FHL1A-expressing cells. Our results provide evidence that FHL1A interacts with PLEKHG2 and regulates cell morphological change through the activity of PLEKHG2.	[Sato, Katsuya; Sugiyama, Kazue; Nishikawa, Masashi; Kitade, Yukio; Ueda, Hiroshi] Gifu Univ, Grad Sch Med, United Grad Sch Drug Discovery & Med Informat Sci, Yanagido 1-1, Gifu 5011193, Japan; [Sato, Katsuya; Kimura, Masashi; Okano, Yukio; Nagaoka, Hitoshi] Gifu Univ, Grad Sch Med, Dept Mol Pathobiochem, Yanagido 1-1, Gifu 5011193, Japan; [Nagase, Takahiro] Kazusa DNA Res Inst, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 2920818, Japan; [Kitade, Yukio; Ueda, Hiroshi] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Yanagido 1-1, Gifu 5011193, Japan; [Kimura, Masashi] Gifu Univ, Grad Sch Med, Dept Cell Signaling, Yanagido 1-1, Gifu 5011193, Japan	Gifu University; Gifu University; Kazusa DNA Research Institute; Gifu University; Gifu University	Ueda, H (corresponding author), Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Yanagido 1-1, Gifu 5011193, Japan.	hueda@gifu-u.ac.jp		Nishikawa, Masashi/0000-0003-2542-8057; Sato, Katsuya/0000-0002-5573-746X	JSPS [23590073, 15K07927]; Division of Genomic Research at the Life Science Research Center at Gifu University	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Division of Genomic Research at the Life Science Research Center at Gifu University	This study was supported by JSPS KAKENHI Grants 23590073 and 15K07927. The DNA sequence analysis was supported by the Division of Genomic Research at the Life Science Research Center at Gifu University. The authors declare that they have no conflicts of interest with the contents of this article.	Brown S, 1999, J BIOL CHEM, V274, P27083, DOI 10.1074/jbc.274.38.27083; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Lee SMY, 1999, GENE, V237, P253, DOI 10.1016/S0378-1119(99)00251-6; Li HY, 2001, CELL MOTIL CYTOSKEL, V48, P11, DOI 10.1002/1097-0169(200101)48:1<11::AID-CM2>3.0.CO;2-I; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Nagae R, 2011, BIOCHEM BIOPH RES CO, V415, P168, DOI 10.1016/j.bbrc.2011.10.047; Pen AE, 2015, EUR J MED GENET, V58, P222, DOI 10.1016/j.ejmg.2015.02.003; Purcell NH, 2004, MOL CELL BIOL, V24, P1081, DOI 10.1128/MCB.24.3.1081-1095.2004; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Runne C, 2013, MOL CELL BIOL, V33, P4294, DOI 10.1128/MCB.00879-13; Sato K, 2014, J BIOL CHEM, V289, P10045, DOI 10.1074/jbc.M113.521880; Sato K, 2014, CELL SIGNAL, V26, P691, DOI 10.1016/j.cellsig.2013.12.006; Sato K, 2013, CELL SIGNAL, V25, P41, DOI 10.1016/j.cellsig.2012.09.015; Schessl J, 2009, BRAIN, V132, P452, DOI 10.1093/brain/awn325; Ueda H, 2008, J BIOL CHEM, V283, P1946, DOI 10.1074/jbc.M707037200; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wixler V, 2000, J BIOL CHEM, V275, P33669, DOI 10.1074/jbc.M002519200; Wong CH, 2010, FEBS LETT, V584, P4511, DOI 10.1016/j.febslet.2010.10.022; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	27	7	8	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25227	25238		10.1074/jbc.M116.759571	http://dx.doi.org/10.1074/jbc.M116.759571			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27765816	Green Published, hybrid			2022-12-26	WOS:000388880100036
J	Chauhan, J; Cardinale, S; Fang, L; Huang, J; Kwasny, SM; Pennington, MR; Basi, K; diTargiani, R; Capacio, BR; MacKerell, AD; Opperman, TJ; Fletcher, S; de Leeuw, EPH				Chauhan, Jamal; Cardinale, Steven; Fang, Lei; Huang, Jing; Kwasny, Steven M.; Pennington, M. Ross; Basi, Kelly; diTargiani, Robert; Capacio, Benedict R.; MacKerell, Alexander D., Jr.; Opperman, Timothy J.; Fletcher, Steven; de Leeuw, Erik P. H.			Towards Development of Small Molecule Lipid II Inhibitors as Novel Antibiotics	PLOS ONE			English	Article							GENERAL FORCE-FIELD; RESISTANT STAPHYLOCOCCUS-AUREUS; PEPTIDOGLYCAN-BIOSYNTHESIS; FUNGAL DEFENSIN; CHARMM; INFECTIONS; TARGETS; ENTEROCOCCUS; ORITAVANCIN; AUTOMATION	Recently we described a novel di-benzene-pyrylium-indolene (BAS00127538) inhibitor of Lipid II. BAS00127538 (1-Methyl-2,4-diphenyl-6-((1E, 3E)-3-(1,3,3-trimethylindolin-2-ylidene) prop-1-en-1-yl) pyryl-1-ium) tetrafluoroborate is the first small molecule Lipid II inhibitor and is structurally distinct from natural agents that bind Lipid II, such as vancomycin. Here, we describe the synthesis and biological evaluation of 50 new analogs of BAS001 27538 designed to explore the structure-activity relationships of the scaffold. The results of this study indicate an activity map of the scaffold, identifying regions that are critical to cytotoxicity, Lipid II binding and range of anti-bacterial action. One compound, 6jc48-1, showed significantly enhanced drug-like properties compared to BAS00127538. 6jc48-1 has reduced cytotoxicity, while retaining specific Lipid II binding and activity against Enterococcus spp. in vitro and in vivo. Further, this compound showed a markedly improved pharmacokinetic profile with a half-life of over 13 hours upon intravenous and oral administration and was stable in plasma. These results suggest that scaffolds like that of 6jc48-1 can be developed into small molecule antibiotic drugs that target Lipid II.	[Chauhan, Jamal; Fang, Lei; Huang, Jing; MacKerell, Alexander D., Jr.; Fletcher, Steven] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Fang, Lei; Huang, Jing; MacKerell, Alexander D., Jr.] Univ Maryland, Sch Pharm, Comp Aided Drug Design Ctr, Baltimore, MD 21201 USA; [Chauhan, Jamal; Fang, Lei] Univ Maryland, Sch Med, Ctr Biomol Therapeut, Baltimore, MD 21201 USA; [Cardinale, Steven; Kwasny, Steven M.; Opperman, Timothy J.] Microbiotix Inc, One Innovat Dr, Worcester, MA USA; [Pennington, M. Ross; Basi, Kelly; diTargiani, Robert; Capacio, Benedict R.] US Army Med Res Inst Chem Def, Aberdeen Proving Ground, MD USA; [de Leeuw, Erik P. H.] Univ Maryland, Inst Human Virol, Baltimore Sch Med, Baltimore, MD 21201 USA; [de Leeuw, Erik P. H.] Univ Maryland, Dept Biochem & Mol Biol, Baltimore Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; United States Department of Defense; United States Army; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	de Leeuw, EPH (corresponding author), Univ Maryland, Inst Human Virol, Baltimore Sch Med, Baltimore, MD 21201 USA.; de Leeuw, EPH (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Baltimore Sch Med, Baltimore, MD 21201 USA.	edeleeuw@som.umaryland.edu	MacKerell, Alex/AAA-2560-2020; Huang, Jing/G-5320-2011	Huang, Jing/0000-0001-9639-2907	NIH [A1092033]; CBT [PR155EDL1]; Maryland Innovation Initiative; UM Ventures seed grant; University of Maryland Computer Aided Drug Design Center and School of Pharmacy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070855] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CBT; Maryland Innovation Initiative; UM Ventures seed grant; University of Maryland Computer Aided Drug Design Center and School of Pharmacy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant A1092033 (www.nih.gov), CBT grant PR155EDL1 (www.medschool.umaryland.edu/cbt/), a Maryland Innovation Initiative (http://tedco.md/program/the-maryland-innovation-initiative-mii/) award and a UM Ventures seed grant (www.umventures.org) to EdL. Further support was provided through the University of Maryland Computer Aided Drug Design Center and School of Pharmacy. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Microbiotix Inc. provided support in the form of salaries for authors [SC, SK and TO], but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen NE, 1996, ANTIMICROB AGENTS CH, V40, P2356, DOI 10.1128/AAC.40.10.2356; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Belley A, 2009, ANTIMICROB AGENTS CH, V53, P800, DOI 10.1128/AAC.00603-08; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Butler MM, 2007, ANTIMICROB AGENTS CH, V51, P119, DOI 10.1128/AAC.01311-05; Cardona AF, 2015, CLIN INFECT DIS, V61, pS69, DOI 10.1093/cid/civ528; Clinical and Laboratory Standards Institute (CLSI), 2009, METH DIL ANT SUSC TE; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; de Leeuw EPH, 2014, DRUG DES DEV THER, V8, P1061, DOI 10.2147/DDDT.S68020; den Blaauwen T, 2014, BIOORG CHEM, V55, P27, DOI 10.1016/j.bioorg.2014.03.007; Essig A, 2014, J BIOL CHEM, V289, P34953, DOI 10.1074/jbc.M114.599878; Fletcher S, 2015, DRUG DES DEV THER, V9, P2383, DOI 10.2147/DDDT.S79504; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Hanaki H, 1998, J ANTIMICROB CHEMOTH, V42, P315, DOI 10.1093/jac/42.3.315; Holland TL, 2014, JAMA-J AM MED ASSOC, V312, P1330, DOI 10.1001/jama.2014.9743; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; JORGENSEN WL, 1981, J AM CHEM SOC, V103, P335, DOI 10.1021/ja00392a016; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Munch D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002509; Munita JM, 2014, INT J ANTIMICROB AG, V44, P387, DOI 10.1016/j.ijantimicag.2014.08.002; O'Driscoll T, 2015, INFECT DRUG RESIST, V8, P217, DOI 10.2147/IDR.S54125; Oeemig JS, 2012, J BIOL CHEM, V287, P42361, DOI 10.1074/jbc.M112.382028; Oppedijk SF, 2016, BBA-BIOMEMBRANES, V1858, P947, DOI 10.1016/j.bbamem.2015.10.024; Paradise E., 2007, CURR PROTOC PHARM, DOI DOI 10.1002/0471141755.S79504; Roberts KD, 2015, PHARMACOTHERAPY, V35, P935, DOI 10.1002/phar.1641; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schneider T, 2010, CURR OPIN INVEST DR, V11, P157; Tran TT, 2015, ANN NY ACAD SCI, V1354, P32, DOI 10.1111/nyas.12948; van Heijenoort J, 2007, MICROBIOL MOL BIOL R, V71, P620, DOI 10.1128/MMBR.00016-07; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Varney KM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003732	42	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164515	10.1371/journal.pone.0164515	http://dx.doi.org/10.1371/journal.pone.0164515			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776124	Green Submitted, gold, Green Published			2022-12-26	WOS:000389009200012
J	Yeh, DY; Kuo, HC; Yang, YH; Ho, PS				Yeh, Ding-Yu; Kuo, Hsiao-Ching; Yang, Yi-Hsin; Ho, Pei-Shan			The Responsiveness of Patients' Quality of Life to Dental Caries Treatment - A Prospective Study	PLOS ONE			English	Article							ORAL-HEALTH-STATUS; 3RD MOLAR SURGERY; IMPACT; EXPERIENCE; CHILDREN; THERAPY; DISEASE; TRIAL; AGE	The objective of this study was to determine the responsiveness of oral health-related quality of life (OHRQoL) (oral health impact profile [OHIP] and oral impact on daily performance [OIDP]) and health-related quality of life (HRQoL) (World Health Organization quality of life scale, brief [WHOQOL-BREF]) in dental caries restoration treatment. The study also aimed to assess the influence of treatment on the responsiveness of patients' quality of life (QoL). A total of 126 patients (aged 16-40 years) received dental caries restoration treatment with a 2-week follow-up and pre-and posttreatment interviews by questionnaire. Patients were assessed for their perceptions of OHRQoL and HRQoL by using the OHIP, OIDP, and WHOQOL-BREF measures. The responsiveness of all outcome measurements was assessed by effect size (ES). Stepwise multiple regression analysis was used to examine the association with the responsiveness of all outcome measurements. Significant differences were found between OIDP (ES = 0.39), OHIP (ES = 0.54), and WHOQOL-BREF (ES = 0.13) with regard to pretreatment and posttreatment (p-values: < 0.0001, < 0.0001, and 0.0120, respectively). Sex and dental caries status at baseline were significantly associated with responsiveness by all measurements. This study suggests that dental caries treatment moderately improves OHRQoL, but is less related to HRQoL. Furthermore, the number of dental caries and restoration are important factors affecting the improvement of patients' perceived OHRQoL.	[Yeh, Ding-Yu] Kaohsiung Armed Forces Gen Hosp, Dept Dent, Kaohsiung, Taiwan; [Kuo, Hsiao-Ching] Kaohsiung Med Univ, Coll Dent Med, Sch Dent, Kaohsiung, Taiwan; [Yang, Yi-Hsin] Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan; [Ho, Pei-Shan] Kaohsiung Med Univ, Dept Oral Hyg, Kaohsiung, Taiwan; [Ho, Pei-Shan] Kaohsiung Med Univ, Dept Oral Hyg, Coll Dent Med, 100 Shih Chuan 1st Rd, Kaohsiung 807, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Ho, PS (corresponding author), Kaohsiung Med Univ, Dept Oral Hyg, Kaohsiung, Taiwan.; Ho, PS (corresponding author), Kaohsiung Med Univ, Dept Oral Hyg, Coll Dent Med, 100 Shih Chuan 1st Rd, Kaohsiung 807, Taiwan.	psho@kmu.edu.tw	Yang, Yi-Hsin/D-6471-2012	Yang, Yi-Hsin/0000-0002-9581-2778				Adulyanon S, 1996, COMMUNITY DENT ORAL, V24, P385, DOI 10.1111/j.1600-0528.1996.tb00884.x; Allen PF, 2006, J DENT RES, V85, P547, DOI 10.1177/154405910608500613; Alm A, 2012, COMMUNITY DENT ORAL, V40, P125, DOI 10.1111/j.1600-0528.2011.00647.x; [Anonymous], 1992, NORD J PSYCHIAT, V46, P85; Awad MA, 2003, INT J PROSTHODONT, V16, P390; Awad MA, 2000, J DENT RES, V79, P1659, DOI 10.1177/00220345000790090401; Barbosa TS, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-32; Berg Joel H, 2006, BMC Oral Health, V6 Suppl 1, pS6, DOI 10.1186/1472-6831-6-S1-S6; Berretin-Felix G, 2008, CLIN ORAL IMPLAN RES, V19, P704, DOI 10.1111/j.1600-0501.2007.01451.x; Biazevic Maria Gabriela Haye, 2008, Braz. oral res., V22, P36, DOI 10.1590/S1806-83242008000100007; Broadbent JM, 2008, J DENT RES, V87, P69, DOI 10.1177/154405910808700112; Broder HL, 2000, J PUBLIC HEALTH DENT, V60, P189, DOI 10.1111/j.1752-7325.2000.tb03326.x; Chen M, 2010, ANGLE ORTHOD, V80, P49, DOI 10.2319/010509-9.1; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen-Carneiro F, 2010, CAD SAUDE PUBLICA, V26, P1122, DOI 10.1590/S0102-311X2010000600006; Dahl KE, 2012, INT J DENT HYG, V10, P15, DOI 10.1111/j.1601-5037.2011.00533.x; Dahl KE, 2011, INT J DENT HYG, V9, P87, DOI 10.1111/j.1601-5037.2010.00445.x; Davies GM, 2011, COMMUNITY DENT HLTH, V28, P5, DOI 10.1922/CDH_2765Davies07; de Oliveira C M, 2004, J Orthod, V31, P20; Dye Bruce A, 2007, Vital Health Stat 11, P1; Espinoza I, 2013, COMMUNITY DENT ORAL, V41, P242, DOI 10.1111/cdoe.12001; FAZEKAS JF, 1952, PUBLIC HEALTH REP, V67, P421, DOI 10.2307/4588097; Hansmeier U, 2010, INT J DENT, V2010, DOI 10.1155/2010/252303; Heydecke G, 2003, COMMUNITY DENT ORAL, V31, P161, DOI 10.1034/j.1600-0528.2003.00029.x; Hopcraft MS, 2006, COMMUNITY DENT ORAL, V34, P174, DOI 10.1111/j.1600-0528.2006.00270.x; John MT, 2004, COMMUNITY DENT ORAL, V32, P125, DOI 10.1111/j.0301-5661.2004.00144.x; Kuo HC, 2009, J ORAL REHABIL, V36, P217, DOI 10.1111/j.1365-2842.2008.01929.x; Kuo HC, 2012, QUAL LIFE RES; Kuo HC, 2011, QUAL LIFE RES, V20, P1707, DOI 10.1007/s11136-011-9901-z; Lee IC, 2012, GERODONTOLOGY, V29, pE1067, DOI 10.1111/j.1741-2358.2012.00614.x; Locker D, 2004, COMMUNITY DENT ORAL, V32, P10, DOI 10.1111/j.1600-0528.2004.00114.x; LOCKER D, 1994, COMMUNITY DENT ORAL, V22, P425, DOI 10.1111/j.1600-0528.1994.tb00791.x; Locker D, 1994, Gerodontology, V11, P108, DOI 10.1111/j.1741-2358.1994.tb00116.x; Mashoto KO, 2010, EUR J ORAL SCI, V118, P626, DOI 10.1111/j.1600-0722.2010.00776.x; McGrath C, 2003, Community Dent Health, V20, P241; McGrath C, 2003, BRIT DENT J, V194, P265, DOI 10.1038/sj.bdj.4809930; Mendonca Juliano Sartori, 2010, J Contemp Dent Pract, V11, P025; Oliveira DC, 2015, ORAL HLTH PREV DENT, V13, P417, DOI 10.3290/j.ohpd.a33922; Oscarson N, 2007, CARIES RES, V41, P85, DOI 10.1159/000098040; Ozhayat EB, 2012, J ORAL REHABIL, V39, P28, DOI 10.1111/j.1365-2842.2011.02245.x; PARMENTER TR, 1994, SOC INDIC RES, V33, P9, DOI 10.1007/BF01078957; REISINE S, 1985, SOC SCI MED, V21, P1309, DOI 10.1016/0277-9536(85)90433-2; Saito A, 2010, J PERIODONTOL, V81, P1001, DOI 10.1902/jop.2010.090663; Slade GD, 1997, COMMUNITY DENT ORAL, V25, P284, DOI 10.1111/j.1600-0528.1997.tb00941.x; Sorensen T, 1996, NORD J PSYCHIAT, V50, P29, DOI 10.3109/08039489609099728; Steele JG, 2004, COMMUNITY DENT ORAL, V32, P107, DOI 10.1111/j.0301-5661.2004.00131.x; Tsakos G, 2010, J CLIN PERIODONTOL, V37, P903, DOI 10.1111/j.1600-051X.2010.01583.x; van Wijk A, 2009, J ORAL MAXIL SURG, V67, P1026, DOI 10.1016/j.joms.2008.12.041; Yao G, 2002, J FORMOS MED ASSOC, V101, P342	49	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164707	10.1371/journal.pone.0164707	http://dx.doi.org/10.1371/journal.pone.0164707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED7AX	27776148	gold, Green Published, Green Submitted			2022-12-26	WOS:000389009200018
J	Bayraktar, O; Oral, O; Kocaturk, NM; Akkoc, Y; Eberhart, K; Kosar, A; Gozuacik, D				Bayraktar, Oznur; Oral, Ozlem; Kocaturk, Nur Mehpare; Akkoc, Yunus; Eberhart, Karin; Kosar, Ali; Gozuacik, Devrim			IBMPFD Disease-Causing Mutant VCP/p97 Proteins Are Targets of Autophagic-Lysosomal Degradation	PLOS ONE			English	Article							INCLUSION-BODY MYOPATHY; VALOSIN-CONTAINING PROTEIN; RETICULUM-ASSOCIATED DEGRADATION; MITOCHONDRIAL QUALITY-CONTROL; FRONTOTEMPORAL DEMENTIA; PAGET-DISEASE; VCP MUTATIONS; CELL-DEATH; FAMILY; BONE	The ubiquitin-proteasome system (UPS) degrades soluble proteins and small aggregates, whereas macroautophagy (autophagy herein) eliminates larger protein aggregates, tangles and even whole organelles in a lysosome-dependent manner. VCP/p97 was implicated in both pathways. VCP/p97 mutations cause a rare multisystem disease called IBMPFD (Inclusion Body Myopathy with Paget's Disease and Frontotemporal Dementia). Here, we studied the role IBMPFD-related mutants of VCP/p97 in autophagy. In contrast with the wild-type VCP/p97 protein or R155C or R191Q mutants, the P137L mutant was aggregate-prone. We showed that, unlike commonly studied R155C or R191Q mutants, the P137L mutant protein stimulated both autophagosome and autolysosome formation. Moreover, P137L mutant protein itself was a substrate of autophagy. Starvation- and mTOR inhibition-induced autophagy led to the degradation of the P137L mutant protein, while preserving the wild-type and functional VCP/p97. Strikingly, similar to the P137L mutant, other IBMPFD- related VCP/p97 mutants, namely R93C and G157R mutants induced autophagosome and autolysosome formation; and G157R mutant formed aggregates that could be cleared by autophagy. Therefore, cellular phenotypes caused by P137L mutant expression were not isolated observations, and some other IBMPFD disease-related VCP/p97 mutations could lead to similar outcomes. Our results indicate that cellular mechanisms leading to IBMPFD disease may be various, and underline the importance of studying different disease-associated mutations in order to better understand human pathologies and tailor mutation-specific treatment strategies.	[Bayraktar, Oznur; Kocaturk, Nur Mehpare; Akkoc, Yunus; Eberhart, Karin; Gozuacik, Devrim] Sabanci Univ, Fac Engn & Nat Sci, Mol Biol Genet & Bioengn Program, TR-34956 Istanbul, Turkey; [Oral, Ozlem] Sabanci Univ, Nanotechnol Res & Applicat Ctr, TR-34956 Istanbul, Turkey; [Kosar, Ali] Sabanci Univ, Fac Engn & Nat Sci, Mechatron Engn Program, TR-34956 Istanbul, Turkey; [Kosar, Ali; Gozuacik, Devrim] Sabanci Univ, Ctr Excellence Funct Surfaces & Interfaces Nano D, TR-34956 Istanbul, Turkey	Sabanci University; Sabanci University; Sabanci University; Sabanci University	Gozuacik, D (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Mol Biol Genet & Bioengn Program, TR-34956 Istanbul, Turkey.; Gozuacik, D (corresponding author), Sabanci Univ, Ctr Excellence Funct Surfaces & Interfaces Nano D, TR-34956 Istanbul, Turkey.	dgozuacik@sabanciuniv.edu	bayraktar ekmekcigil, oznur/GRO-1353-2022; Kosar, Ali/F-5827-2014; bayraktar ekmekcigil, oznur/GOG-8239-2022; AKKOC, Yunus/AAK-8853-2020; Kocaturk, Nur/V-3125-2018; Devrim, Gozuacik/C-3330-2008	bayraktar ekmekcigil, oznur/0000-0002-4824-9943; Kosar, Ali/0000-0001-6283-6717; AKKOC, Yunus/0000-0001-5379-6151; Kocaturk, Nur/0000-0002-4452-9913; Devrim, Gozuacik/0000-0001-7739-2346	Scientific and Technological Research Council of Turkey (TUBITAK) 1001 [110T405]; Sabanci University; TUBITAK-BIDEB PHD scholarships [2211A]; TUBITAK [2216]; Turkish Academy of Sciences (TUBA) GEBIP Award; EMBO Strategical Development and Installation Grant (EMBO-SDIG); IKU Prof. Dr Onder Oztunah Science Award; TGC Sedat Simavi Award; TUBITAK Incentive Award	Scientific and Technological Research Council of Turkey (TUBITAK) 1001(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Sabanci University(Sabanci University); TUBITAK-BIDEB PHD scholarships; TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Turkish Academy of Sciences (TUBA) GEBIP Award(Turkish Academy of Sciences); EMBO Strategical Development and Installation Grant (EMBO-SDIG); IKU Prof. Dr Onder Oztunah Science Award; TGC Sedat Simavi Award; TUBITAK Incentive Award(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) 1001 Grant Project Number 110T405 and Sabanci University. OB, NMK and YA are recipients of TUBITAK-BIDEB 2211A PHD scholarships. KE was supported by a TUBITAK 2216 postdoctoral grant.; The authors declare that there is no conflict of interest. This work was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) 1001 Grant Project Number 110T405 and Sabanci University. Mutant VCP/p97 plasmids were kindly provided by Petek Ballar-Kirmizibayrak. GFP-LC3 and GFP and RFP tandemly tagged LC3 (tfLC3) plasmids were kindly provided by Tomatsu Yoshimori. D.G. and A.K. are recipients the Turkish Academy of Sciences (TUBA) GEBIP Award. D.G. is a recipient of the EMBO Strategical Development and Installation Grant (EMBO-SDIG), IKU Prof. Dr Onder Oztunah Science Award and TGC Sedat Simavi Award. A.K. is a recipient of the TUBITAK Incentive Award. O.B., N.M.K. and Y.A. are recipients of TUBITAK-BIDEB PhD Scholarships. K.E. was supported by a TUBITAK 2216 postdoctoral grant.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arhzaouy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046879; Auner HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074415; Ching JK, 2013, HUM MOL GENET, V22, P1167, DOI 10.1093/hmg/dds524; Choi K, 2014, FEBS J, V281, P3048, DOI 10.1111/febs.12841; Djamshidian A, 2009, MUSCLE NERVE, V39, P389, DOI 10.1002/mus.21225; Erzurumlu Y, 2013, INT J BIOCHEM CELL B, V45, P773, DOI 10.1016/j.biocel.2013.01.006; Fang L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00016; Fanganiello RD, 2011, BRAZ J MED BIOL RES, V44, P374, DOI 10.1590/S0100-879X2011007500028; Franz A, 2014, BBA-MOL CELL RES, V1843, P205, DOI 10.1016/j.bbamcr.2013.03.031; Gidaro T, 2008, MUSCLE NERVE, V37, P111, DOI 10.1002/mus.20890; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hubbers CU, 2007, BRAIN, V130, P381, DOI 10.1093/brain/awl238; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029; Kimonis VE, 2008, BBA-MOL BASIS DIS, V1782, P744, DOI 10.1016/j.bbadis.2008.09.003; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Kimura Y, 2013, GENES CELLS, V18, P1131, DOI 10.1111/gtc.12103; Liu S, 2013, BBA-PROTEINS PROTEOM, V1834, P2672, DOI 10.1016/j.bbapap.2013.09.021; Mizuno Y, 2003, NEUROPATHOLOGY, V23, P282, DOI 10.1046/j.1440-1789.2003.00514.x; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nalbandian A, 2015, MITOCHONDRION, V22, P1, DOI 10.1016/j.mito.2015.02.004; Nan L, 2005, EXP MOL PATHOL, V78, P1, DOI 10.1016/j.yexmp.2004.08.006; Nowis D, 2006, EXP CELL RES, V312, P2921, DOI 10.1016/j.yexcr.2006.05.013; Oral O, 2012, APOPTOSIS, V17, P810, DOI 10.1007/s10495-012-0735-0; Palmio J, 2011, NEUROMUSCULAR DISORD, V21, P551, DOI 10.1016/j.nmd.2011.05.008; Schroder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407; Sherer NM, CARTOGRAPHERS VISUAL; Springer ML, 2002, GENE DELIVERY MUSCLE, DOI [10.1002/0471142905.hg1304s31, DOI 10.1002/0471142905.HG1304S31]; Stojkovic T, 2009, NEUROMUSCULAR DISORD, V19, P316, DOI 10.1016/j.nmd.2009.02.012; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Wang YL, 2013, BIOTECHNOL LETT, V35, P1983, DOI 10.1007/s10529-013-1295-2; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Watts GDJ, 2003, NEUROMUSCULAR DISORD, V13, P559, DOI 10.1016/S0960-8966(03)00070-1; Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Yang FC, 2013, J BIOL CHEM, V288, P33861, DOI 10.1074/jbc.M113.492199	44	25	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164864	10.1371/journal.pone.0164864	http://dx.doi.org/10.1371/journal.pone.0164864			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768726	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400033
J	Kreuger, J; O'Callaghan, P				Kreuger, Johan; O'Callaghan, Paul			Failure to Genotype: A Cautionary Note on an Elusive loxP Sequence	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; EXPRESSION; ALLELES; PREDICTION; REPORTER; MICE	Here we report on a technical difficulty we encountered while optimizing genotyping strategies to identify mice derived from Exoc3l2(tm1a( KOMP)Wtsi) embryonic stem cells obtained from the Knockout Mouse Project Repository. The Exoc3l2(tm1a(KOMP)Wtsi) construct encodes a "knockout-first" design with loxP sites that confer conditional potential (KO1st). We designed primers that targeted wild-type sequences flanking the most downstream element of the construct, an 80 base pair synthetic loxP region, which BLAST alignment analysis reveals is an element common to over 10,000 conditional gene-targeting mouse models. As PCR products amplified from KO1st and wild-type templates would have different lengths (and different mobility in an agarose gel) this strategy was designed to determine the zygosity of individual mice from a single PCR. In parallel we performed PCR with a primer specifically targeting the synthetic loxP sequence. Unexpectedly, while the latter strategy detected the synthetic loxP region and correctly genotyped KO1st chimeric mice, the same individuals were genotyped as wild-type when using the primers that flanked the synthetic loxP region. We discuss the possibility that secondary DNA structures, formed due to the palindromic nature of the synthetic loxP region, may have caused the KO1st template to elude the PCR when using primers that flanked this region. This brief report aims to raise awareness regarding this potential source of false-negative genotype results, particularly for those who are devising genotyping strategies for similarly engineered animal models.	[Kreuger, Johan; O'Callaghan, Paul] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Uppsala University	O'Callaghan, P (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	paul.ocallaghan@mcb.uu.se	O'Callaghan, Paul/T-5308-2018; Kreuger, Johan/HDM-1503-2022	O'Callaghan, Paul/0000-0003-3117-5367; 	Cancer Foundation (Cancerfonden) [CAN 2014/820]; Swedish Research Council (Vetenskapsradet) [2010-3968]; NIH [U01HG004085]; CSD Consortium [U01HG004080]; CHORI [U42RR024244]	Cancer Foundation (Cancerfonden); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSD Consortium; CHORI	This study was funded by grants awarded to JK from the Cancer Foundation (Cancerfonden: www.cancerfonden.se), grant number CAN 2014/820 and the Swedish Research Council (Vetenskapsradet: www.vr.se), grant number 2010-3968. The ES cells used for this research project were generated by the trans-NIH Knock-Out Mouse Project (KOMP) and obtained from the KOMP Repository (www.komp.org). NIH grants to Velocigene at Regeneron Inc (U01HG004085) and the CSD Consortium (U01HG004080) funded the generation of gene-targeted ES cells for 8500 genes in the KOMP Program and archived and distributed by the KOMP Repository at UC Davis and CHORI (U42RR024244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellaousov S, 2013, NUCLEIC ACIDS RES, V41, pW471, DOI 10.1093/nar/gkt290; de Lange WJ, 2008, PHYSIOL GENOMICS, V35, P1, DOI 10.1152/physiolgenomics.90284.2008; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Mantamadiotis T, 1998, BIOTECHNIQUES, V25, P968, DOI 10.2144/98256bm07; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Nanda N, 2001, J BIOL CHEM, V276, P20673, DOI 10.1074/jbc.M010846200; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Rattray AJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh143; Schulz TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001013; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	13	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165012	10.1371/journal.pone.0165012	http://dx.doi.org/10.1371/journal.pone.0165012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768725	gold, Green Submitted, Green Published			2022-12-26	WOS:000386205400044
J	Flynn, JA; Durr, E; Swoyer, R; Cejas, PJ; Horton, MS; Galli, JD; Cosmi, SA; Espeseth, AS; Bett, AJ; Zhang, L				Flynn, Jessica A.; Durr, Eberhard; Swoyer, Ryan; Cejas, Pedro J.; Horton, Melanie S.; Galli, Jennifer D.; Cosmi, Scott A.; Espeseth, Amy S.; Bett, Andrew J.; Zhang, Lan			Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein	PLOS ONE			English	Article							DIFFERENTIAL SCANNING FLUOROMETRY; F-GLYCOPROTEIN; STRUCTURAL BASIS; RSV F; PROTEIN; NEUTRALIZATION; ANTIBODIES; FLUORESCENCE; GENERATION; INFECTION	Infection with Respiratory Syncytial Virus (RSV) causes both upper and lower respiratory tract disease in humans, leading to significant morbidity and mortality in both young children and older adults. Currently, there is no licensed vaccine available, and therapeutic options are limited. During the infection process, the type I viral fusion (F) glycoprotein on the surface of the RSV particle rearranges from a metastable prefusion conformation to a highly stable postfusion form. In people naturally infected with RSV, most potent neutralizing antibodies are directed to the prefusion form of the F protein. Therefore, an engineered RSV F protein stabilized in the prefusion conformation (DS-Cavl) is an attractive vaccine candidate. Long-term stability at 4 degrees C or higher is a desirable attribute for a commercial subunit vaccine antigen. To assess the stability of DS-Cavl, we developed assays using D25, an antibody which recognizes the prefusion F-specific antigenic site 0, and a novel antibody 4D7, which was found to bind antigenic site I on the postfusion form of RSV F. Biophysical analysis indicated that, upon long-term storage at 4 degrees C, DS-Cavl undergoes a conformational change, adopting alternate structures that concomitantly lose the site 0 epitope and gain the ability to bind 4D7.	[Flynn, Jessica A.; Durr, Eberhard; Swoyer, Ryan; Cejas, Pedro J.; Horton, Melanie S.; Galli, Jennifer D.; Espeseth, Amy S.; Bett, Andrew J.; Zhang, Lan] Merck & Co Inc, MRL, Kenilworth, NJ 07033 USA; [Cosmi, Scott A.] Eurofins Lancaster Labs, Profess Sci Serv, Lancaster, PA USA	Merck & Company	Zhang, L (corresponding author), Merck & Co Inc, MRL, Kenilworth, NJ 07033 USA.	lan_zhang2@merck.com		Horton, Melanie/0000-0003-4996-9042; Galli, Jennifer/0000-0001-8577-4790	Merck and Co., Inc.	Merck and Co., Inc.(Merck & Company)	The research was fully funded by Merck and Co., Inc. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ARBIZA J, 1992, J GEN VIROL, V73, P2225, DOI 10.1099/0022-1317-73-9-2225; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Chen ZF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156798; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fong RH, 2014, J VIROL, V88, P14364, DOI 10.1128/JVI.01943-14; Gilman MSA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005035; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Higgins D, VACCINE; Homaira Nusrat, 2014, Int J Pediatr, V2014, P571609, DOI 10.1155/2014/571609; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Krarup A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9143; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LOPEZ JA, 1990, J VIROL, V64, P927; Lopez JA, 1998, J VIROL, V72, P6922; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; Magro M, 2010, J VIROL, V84, P7970, DOI 10.1128/JVI.00447-10; Mallick SP, 2005, ULTRAMICROSCOPY, V104, P8, DOI 10.1016/j.ultramic.2005.02.004; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Sastre P, 2005, J MED VIROL, V76, P248, DOI 10.1002/jmv.20349; Simeonov A, 2013, EXPERT OPIN DRUG DIS, V8, P1071, DOI 10.1517/17460441.2013.806479; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Whimbey E, 2000, CURR CLIN TOPICS INF, V20, P232; Widjaja I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130829; Zhu Q, 2011, J INFECT DIS, V203, P674, DOI 10.1093/infdis/jiq100	41	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164789	10.1371/journal.pone.0164789	http://dx.doi.org/10.1371/journal.pone.0164789			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764150	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500064
J	Gao, R; Zhang, GJ; Chen, XQ; Yang, AM; Smith, G; Wong, DF; Zhou, Y				Gao, Rui; Zhang, Guangjian; Chen, Xueqi; Yang, Aimin; Smith, Gwenn; Wong, Dean F.; Zhou, Yun			CSF Biomarkers and Its Associations with F-18-AV133 Cerebral VMAT2 Binding in Parkinson's Disease-A Preliminary Report	PLOS ONE			English	Article							CEREBROSPINAL-FLUID BIOMARKERS; MILD COGNITIVE IMPAIRMENT; ALPHA-SYNUCLEIN LEVELS; EARLY-ONSET PD; ALZHEIMERS-DISEASE; AMYLOID-BETA; PHOSPHO-TAU; MOLECULAR-MECHANISMS; DEMENTIA; PET	Objective Cerebrospinal fluid (CSF) biomarkers, such as alpha-synuclein (alpha-syn), amyloid beta peptide 1-42 (A beta(1-42)), phosphorylated tau (181P) (p-tau), and total tau (t-tau), have long been associated with the development of Parkinson disease (PD) and other neurodegenerative diseases. In this investigation, we reported the assessment of CSF biomarkers and their correlations with vesicular monoamine transporter 2 (VMAT2) bindings measured with F-18-9-fluoropropyl-(+)-dihydrotetrabenazine (F-18-AV133) that is being developed as a bio-marker for PD. We test the hypothesis that monoaminergic degeneration was correlated with CSF biomarker levels in untreated PD patients. Methods The available online data from the Parkinson's Progression Markers Initiative study (PPMI) project were collected and analyzed, which include demographic information, clinical evaluations, CSF biomarkers (alpha-syn, A beta 1-42, p-tau, and t-tau), F-18-AV133 brain PET, and T1 weighted MRIs. Region of interest (ROI) and voxel-wise Pearson correlation between standardized uptake value ratio (SUVR) and CSF biomarkers were calculated. Results Our major findings are: 1) Compared with controls, CSF alpha-syn and tau levels decreased significantly in PD; 2) alpha-syn was closely correlated with A beta(1-42) and tau in PD, especially in early-onset patients; and 3) hypothesis-driven ROI analysis found a significant negative correlation between CSF A beta(1-42) levels and VMAT2 densities in post cingulate, left caudate,left anterior putamen, and left ventral striatum in PDs. CSF t-tau and p-tau levels were significantly negatively related to VMAT2 SUVRs in substantia nigra and left ventral striatum, respectively. Voxel-wise analysis showed that left caudate, parahippocampal gyrus, insula and temporal lobe were negatively correlated with A beta(1-42). In addition, superior frontal gyrus and transverse temporal gyrus were negatively correlated with CSF p-tau levels. Conclusion These results suggest that monoaminergic degeneration in PD is correlated with CSF biomarkers associated with cognitive impairment in neurodegenerative diseases including Alzheimer's disease. The association between loss of dopamine synaptic function and pathologic protein accumulations in PD indicates an important role of CSF biomarkers in PD development.	[Gao, Rui; Yang, Aimin] Xi An Jiao Tong Univ, Dept Nucl Med, Affiliated Hosp 1, Xian 710061, Shaanxi, Peoples R China; [Gao, Rui; Chen, Xueqi; Wong, Dean F.; Zhou, Yun] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA; [Zhang, Guangjian] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Surg, Xian 710061, Shaanxi, Peoples R China; [Chen, Xueqi] Peking Univ, Hosp 1, Dept Nucl Med, Beijing 100034, Peoples R China; [Smith, Gwenn] Johns Hopkins Bayview Med Ctr, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD 21287 USA; [Wong, Dean F.] Johns Hopkins Univ, Dept Psychiat, Baltimore, MD 21205 USA; [Wong, Dean F.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA; [Wong, Dean F.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA	Xi'an Jiaotong University; Johns Hopkins University; Xi'an Jiaotong University; Peking University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Gao, R (corresponding author), Xi An Jiao Tong Univ, Dept Nucl Med, Affiliated Hosp 1, Xian 710061, Shaanxi, Peoples R China.; Gao, R; Zhou, Y (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA.	jacky_mg@163.com; yunzhou@jhmi.edu		Zhang, Guangjian/0000-0003-0888-5723	Michael J. Fox Foundation for Parkinson's Research (MJFF); Industry Scientific Advisory Board (ISAB); Project of Natural Science Foundation Research Project of Shaanxi Province [2016JM8056]; Abbott; Avid; Biogen Idec; Covalence; Elan; GlaxoSmithKline; Lilly; Merck; UCB; F. Hoffman-La Roche Ltd.; GE Healthcare; Genentech; Pfizer Inc.	Michael J. Fox Foundation for Parkinson's Research (MJFF); Industry Scientific Advisory Board (ISAB); Project of Natural Science Foundation Research Project of Shaanxi Province; Abbott(Abbott Laboratories); Avid; Biogen Idec(Biogen); Covalence; Elan; GlaxoSmithKline(GlaxoSmithKline); Lilly(Eli Lilly); Merck(Merck & Company); UCB(UCB Pharma SA); F. Hoffman-La Roche Ltd.; GE Healthcare(General ElectricGE Healthcare); Genentech(Roche HoldingGenentech); Pfizer Inc.(Pfizer)	As mentioned in the manuscript, data used in the preparation of this article were obtained from the PPMI database (www.ppmi-info.org/data). PPMI is sponsored and partially funded by The Michael J. Fox Foundation for Parkinson's Research (MJFF). Other funding partners include a consortium of industry players, non-profit organizations and private individuals, including Abbott, Avid, Biogen Idec, Covalence, Elan, GlaxoSmithKline, Lilly, Merck, UCB, F. Hoffman-La Roche Ltd., GE Healthcare, Genentech, and Pfizer Inc. Industry partners are contributing to PPMI through financial and in-kind donations and are playing a lead role in providing feedback on study parameters through the Industry Scientific Advisory Board (ISAB). For up-to-date information on the study, visit www.ppmi-info.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work of the author was in part supported by the Project of Natural Science Foundation Research Project of Shaanxi Province (No. 2016JM8056).; Data used in the preparation of this article were obtained from the PPMI database (www.ppmi-info.org/data). PPMI is sponsored and partially funded by The Michael J. Fox Foundation for Parkinson's Research (MJFF). Other funding partners include a consortium of industry players, non-profit organizations and private individuals, including Abbott, Avid, Biogen Idec, Covance, Elan, GlaxoSmithKline, Lilly, Merck, UCB, F. Hoffman-La Roche Ltd., GE Healthcare, Genentech, and Pfizer Inc. Industry partners are contributing to PPMI through financial and in-kind donations and are playing a lead role in providing feedback on study parameters through the Industry Scientific Advisory Board (ISAB). For up-to-date information on the study, visit www.ppmi-info.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin RL, 2003, NEUROLOGY, V61, P310, DOI 10.1212/01.WNL.0000076181.39162.FC; Alcalay RN, 2012, NEUROLOGY, V78, P1434, DOI 10.1212/WNL.0b013e318253d54b; Alves G, 2014, NEUROLOGY, V82, P1784, DOI 10.1212/WNL.0000000000000425; Alves G, 2013, J NEUROL NEUROSUR PS, V84, P537, DOI 10.1136/jnnp-2012-303808; Arlt S, 2009, EUR J NUCL MED MOL I, V36, P1090, DOI 10.1007/s00259-009-1063-7; Badiola N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026609; Bouwman FH, 2007, NEUROLOGY, V69, P1006, DOI 10.1212/01.wnl.0000271375.37131.04; Buddhala C, 2015, NEUROBIOL AGING, V36, P476, DOI 10.1016/j.neurobiolaging.2014.07.043; Cerasa A, 2013, PARKINSONISM RELAT D, V19, P883, DOI 10.1016/j.parkreldis.2013.05.015; Ceravolo R, 2008, BRAIN RES BULL, V76, P80, DOI 10.1016/j.brainresbull.2008.01.010; Chao KT, 2012, SYNAPSE, V66, P823, DOI 10.1002/syn.21572; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Compta Y, 2012, PARKINSONISM RELAT D, V18, P941, DOI 10.1016/j.parkreldis.2012.04.028; Compta Y, 2009, MOVEMENT DISORD, V24, P2203, DOI 10.1002/mds.22594; Constantinescu R, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00187; DIAMOND SG, 1989, NEUROLOGY, V39, P1187, DOI 10.1212/WNL.39.9.1187; Fellgiebel A, 2004, BIOL PSYCHIAT, V56, P279, DOI 10.1016/j.biopsych.2004.05.014; Fellgiebel A, 2007, PSYCHIAT RES-NEUROIM, V155, P167, DOI 10.1016/j.pscychresns.2006.12.002; Gao R, 2016, J NEUROIMAGING PSYCH, V1, P20; Gaser C, 2014, VOXEL BASED MORPHOME; Gendreau KL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00160; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Guillot TS, 2009, MOL NEUROBIOL, V39, P149, DOI 10.1007/s12035-009-8059-y; Hall S, 2015, NEUROLOGY, V84, P57, DOI 10.1212/WNL.0000000000001098; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Hoops S, 2009, NEUROLOGY, V73, P1738, DOI 10.1212/WNL.0b013e3181c34b47; Hsiao IT, 2014, NUCL MED BIOL, V41, P322, DOI 10.1016/j.nucmedbio.2013.12.017; Jellinger KA, 2012, J NEURAL TRANSM, V119, P455, DOI 10.1007/s00702-011-0736-0; Kandiah N, 2014, PARKINSONISM RELAT D, V20, P1145, DOI 10.1016/j.parkreldis.2014.08.002; Kang JH, 2013, JAMA NEUROL, V70, P1277, DOI 10.1001/jamaneurol.2013.3861; Kayed R, 2013, J ALZHEIMERS DIS, V33, pS67, DOI 10.3233/JAD-2012-129001; Lin KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075952; Lohmann E, 2009, NEUROLOGY, V72, P110, DOI 10.1212/01.wnl.0000327098.86861.d4; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Marek K, 2011, PROG NEUROBIOL, V95, P629, DOI 10.1016/j.pneurobio.2011.09.005; Martinez-Martin P, 2015, PARKINSONISM RELAT D, V21, P50, DOI 10.1016/j.parkreldis.2014.10.026; Mattsson N, 2015, BRAIN, V138, P772, DOI 10.1093/brain/awu367; Mollenhauer B, 2007, J NEURAL TRANSM, V114, P919, DOI 10.1007/s00702-007-0629-4; Mollenhauer B, 2013, NEUROSCI LETT, V532, P44, DOI 10.1016/j.neulet.2012.11.004; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Parnetti L, 2008, BIOL PSYCHIAT, V64, P850, DOI 10.1016/j.biopsych.2008.02.016; Schapira AHV, 2009, NEUROL CLIN, V27, P583, DOI 10.1016/j.ncl.2009.04.004; Shah N, 2016, MOVEMENT DISORD, V31, P111, DOI 10.1002/mds.26369; Shi M, 2011, ANN NEUROL, V69, P570, DOI 10.1002/ana.22311; Siderowf A, 2010, NEUROLOGY, V75, P1055, DOI 10.1212/WNL.0b013e3181f39a78; Siderowf A, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-79; Skogseth RE, 2015, J PARKINSON DIS, V5, P783, DOI 10.3233/JPD-150682; TISON F, 1995, NEUROLOGY, V45, P705, DOI 10.1212/WNL.45.4.705; Toledo JB, 2015, JAMA NEUROL, V72, P571, DOI 10.1001/jamaneurol.2014.4829; Toledo JB, 2013, ACTA NEUROPATHOL, V126, P683, DOI 10.1007/s00401-013-1148-z; van Dijk KD, 2014, EUR J NEUROL, V21, P388, DOI 10.1111/ene.12176; Wang J, 2007, J NEUROL, V254, P185, DOI 10.1007/s00415-006-0322-9; Zhang J, 2013, ACTA NEUROPATHOL, V126, P671, DOI 10.1007/s00401-013-1121-x	53	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164762	10.1371/journal.pone.0164762	http://dx.doi.org/10.1371/journal.pone.0164762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764160	gold, Green Submitted, Green Published			2022-12-26	WOS:000386204500058
J	Li, BN; Wang, LX; Kaseke, KF; Li, L; Seely, MK				Li, Bonan; Wang, Lixin; Kaseke, Kudzai F.; Li, Lin; Seely, Mary K.			The Impact of Rainfall on Soil Moisture Dynamics in a Foggy Desert	PLOS ONE			English	Article							NAMIB DESERT; WATER; PATTERNS; GRASSLANDS; FEEDBACK; STRESS; PLANTS; STATES; AGE	Soil moisture is a key variable in dryland ecosystems since it determines the occurrence and duration of vegetation water stress and affects the development of weather patterns including rainfall. However, the lack of ground observations of soil moisture and rainfall dynamics in many drylands has long been a major obstacle in understanding ecohydrological processes in these ecosystems. It is also uncertain to what extent rainfall controls soil moisture dynamics in fog dominated dryland systems. To this end, in this study, twelve to nineteen months' continuous daily records of rainfall and soil moisture (from January 2014 to August 2015) obtained from three sites (one sand dune site and two gravel plain sites) in the Namib Desert are reported. A process-based model simulating the stochastic soil moisture dynamics in water-limited systems was used to study the relationships between soil moisture and rainfall dynamics. Model sensitivity in response to different soil and vegetation parameters under diverse soil textures was also investigated. Our field observations showed that surface soil moisture dynamics generally follow rainfall patterns at the two gravel plain sites, whereas soil moisture dynamics in the sand dune site did not show a significant relationship with rainfall pattern. The modeling results suggested that most of the soil moisture dynamics can be simulated except the daily fluctuations, which may require a modification of the model structure to include non-rainfall components. Sensitivity analyses suggested that soil hygroscopic point (s(h)) and field capacity (s(fc)) were two main parameters controlling soil moisture output, though permanent wilting point (s(w)) was also very sensitive under the parameter setting of sand dune (Gobabeb) and gravel plain (Kleinberg). Overall, the modeling results were not sensitive to the parameters in non-bounded group (e.g., soil hydraulic conductivity (K-s) and soil porosity (n)). Field observations, stochastic modeling results as well as sensitivity analyses provide soil moisture baseline information for future monitoring and the prediction of soil moisture patterns in the Namib Desert.	[Li, Bonan; Wang, Lixin; Kaseke, Kudzai F.; Li, Lin] Indiana Univ Purdue Univ, Dept Earth Sci, Indianapolis, IN 46202 USA; [Seely, Mary K.] Desert Res Fdn Namibia, Windhoek, Namibia	Indiana University System; Indiana University-Purdue University Indianapolis	Wang, LX (corresponding author), Indiana Univ Purdue Univ, Dept Earth Sci, Indianapolis, IN 46202 USA.	lxwang@iupui.edu	Wang, Lixin/A-2572-2008; Kaseke, Kudzai Farai/AAH-3182-2019; Zorger, Bianca/O-1015-2018; Seely, Mary Kathryn/AAI-1072-2019	Wang, Lixin/0000-0003-0968-1247; Kaseke, Kudzai Farai/0000-0002-3856-0711; 	United States National Science Foundation [IIA-1427642, EAR-1554894]; U.S. National Science Foundation [IIA-1427642, EAR-1554894]; Division Of Earth Sciences [1554894] Funding Source: National Science Foundation; Office Of The Director [1427642] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); U.S. National Science Foundation(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	United States National Science Foundation (IIA-1427642) https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=12815. United States National Science Foundation (EAR-1554894) http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503214. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge support from the U.S. National Science Foundation (IIA-1427642 and CAREER award EAR-1554894) to LW. We thank Dr. Sujith Ravi for the assistance in field data collection. We thank the comments from two anonymous reviewers, which significantly improved the quality and readability of this manuscript.	Agam N, 2006, J ARID ENVIRON, V65, P572, DOI 10.1016/j.jaridenv.2005.09.004; Albergel C, 2012, REMOTE SENS ENVIRON, V118, P215, DOI 10.1016/j.rse.2011.11.017; Alfieri L, 2008, J HYDROMETEOROL, V9, P280, DOI 10.1175/2007JHM863.1; BERNDTSSON R, 1994, J ARID ENVIRON, V27, P127, DOI 10.1006/jare.1994.1053; Berndtsson R, 1996, J HYDROL, V185, P221, DOI 10.1016/0022-1694(95)02987-7; Bristow CS, 2007, GEOLOGY, V35, P555, DOI 10.1130/G23369A.1; D'Odorico P, 2000, WATER RESOUR RES, V36, P2209, DOI 10.1029/2000WR900103; D'Odorico P, 2003, ADV WATER RESOUR, V26, P59, DOI 10.1016/S0309-1708(02)00095-7; D'Odorico P, 2013, ADV WATER RESOUR, V51, P326, DOI 10.1016/j.advwatres.2012.01.013; D'Odorico P, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000379; Devitt DA, 2002, J ARID ENVIRON, V50, P99, DOI 10.1006/jare.2001.0853; DOdorico P., 2006, DRYLAND ECOHYDROLOGY; Eckardt FD, 2013, J ARID ENVIRON, V93, P7, DOI 10.1016/j.jaridenv.2012.01.011; Eltahir EAB, 1998, WATER RESOUR RES, V34, P765, DOI 10.1029/97WR03499; Fan JL, 2015, J HYDROL, V523, P475, DOI 10.1016/j.jhydrol.2015.01.064; Fischer DT, 2009, J BIOGEOGR, V36, P783, DOI 10.1111/j.1365-2699.2008.02025.x; Gao L, 2012, CATENA, V95, P24, DOI 10.1016/j.catena.2012.02.020; Grayson RB, 1997, WATER RESOUR RES, V33, P2897, DOI 10.1029/97WR02174; Hachfeld B, 2000, PHYTOCOENOLOGIA, V30, P567; HENNESSY JT, 1983, J RANGE MANAGE, V36, P723, DOI 10.2307/3898195; Henschel JR, 2008, ATMOS RES, V87, P362, DOI 10.1016/j.atmosres.2007.11.015; Hiatt C., 2012, Atmospheric and Climate Sciences, V2, P525, DOI 10.4236/acs.2012.24047; HOLLINGER SE, 1994, J CLIMATE, V7, P822, DOI 10.1175/1520-0442(1994)007<0822:ASMCOI>2.0.CO;2; Hu W, 2010, GEODERMA, V158, P181, DOI 10.1016/j.geoderma.2010.04.030; Jacobson K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126977; Kaseke KF, 2012, PURE APPL GEOPHYS, V169, P2217, DOI 10.1007/s00024-012-0469-5; Kaseke KF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154598; Kimura K., 2005, AFRIC STUDY MONOGR S, P57; Laio F, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004502; Laio F, 2001, ADV WATER RESOUR, V24, P707, DOI 10.1016/S0309-1708(01)00005-7; LANCASTER J, 1984, Madoqua, V14, P5; Paige GB, 2008, J AM WATER RESOUR AS, V44, P121, DOI 10.1111/j.1752-1688.2007.00142.x; Pan FF, 2015, J HYDROL, V524, P296, DOI 10.1016/j.jhydrol.2015.02.044; Ravi S, 2008, OECOLOGIA, V158, P545, DOI 10.1007/s00442-008-1164-1; Ravi S, 2009, ECOSYSTEMS, V12, P434, DOI 10.1007/s10021-009-9233-9; Robock A, 2000, B AM METEOROL SOC, V81, P1281, DOI [10.1175/1520-0477(2000)081<1281:TGSMDB>2.3.CO;2, 10.1175/1520-0477(2000)081&lt;1281:TGSMDB&gt;2.3.CO;2]; Roth-Nebelsick A, 2012, J R SOC INTERFACE, V9, P1965, DOI 10.1098/rsif.2011.0847; Scholz H., 1972, MADOQUA, V1972, P33; SEELY MK, 1979, OECOLOGIA, V42, P213, DOI 10.1007/BF00344858; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Stone AEC, 2013, J AFR EARTH SCI, V82, P70, DOI 10.1016/j.jafrearsci.2013.02.003; Wang L, 2012, HYDROL EARTH SYST SC, V16, P2585, DOI 10.5194/hess-16-2585-2012; Wang LX, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00122.1; Wang LX, 2010, PLANT SOIL, V328, P95, DOI 10.1007/s11104-009-0085-z; Wang LX, 2009, CLIMATIC CHANGE, V94, P63, DOI 10.1007/s10584-009-9548-8; Wang LX, 2016, WIRES WATER IN PRESS; Yamagata K, 2005, LANDFORM DEV MIDDLE; Yu KL, 2014, J GEOPHYS RES-BIOGEO, V119, P192, DOI 10.1002/2013JG002577; Zhang X, 2016, CATENA, V145, P56, DOI 10.1016/j.catena.2016.05.022	49	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164982	10.1371/journal.pone.0164982	http://dx.doi.org/10.1371/journal.pone.0164982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764203	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204500094
J	Liu, XB; Wei, XJ; Sheng, ZH; Jiao, G; Tang, SQ; Luo, J; Hu, PS				Liu, Xianbo; Wei, Xiangjin; Sheng, Zhonghua; Jiao, Guiai; Tang, Shaoqing; Luo, Ju; Hu, Peisong			Polycomb Protein OsFIE2 Affects Plant Height and Grain Yield in Rice	PLOS ONE			English	Article							ORYZA-SATIVA L.; NATURAL VARIATION; TRYPTOPHAN AMINOTRANSFERASE; ARABIDOPSIS-THALIANA; GREEN-REVOLUTION; SEED DEVELOPMENT; GENE-EXPRESSION; SIZE; GIBBERELLIN; ENCODES	Polycomb group (PcG) proteins have been shown to affect growth and development in plants. To further elucidate their role in these processes in rice, we isolated and characterized a rice mutant which exhibits dwarfism, reduced seed setting rate, defective floral organ, and small grains. Map-based cloning revealed that abnormal phenotypes were attributed to a mutation of the Fertilization Independent Endosperm 2 (OsFIE2) protein, which belongs to the PcG protein family. So we named the mutant as osfie2-1. Histological analysis revealed that the number of longitudinal cells in the internodes decreased in osfie2-1, and that lateral cell layer of the internodes was markedly thinner than wild-type. In addition, compared to wild-type, the number of large and small vascular bundles decreased in osfie2-1, as well as cell number and cell size in spikelet hulls. OsFIE2 is expressed in most tissues and the coded protein localizes in both nucleus and cytoplasm. Yeast two hybrid and bimolecular fluorescence complementation assays demonstrated that OsFIE2 interacts with OsiEZ1 which encodes an enhancer of zeste protein previously identified as a histone methylation enzyme. RNA sequencing-based transcriptome profiling and qRT-PCR analysis revealed that some homeotic genes and genes involved in endosperm starch synthesis, cell division/expansion and hormone synthesis and signaling are differentially expressed between osfie2-1 and wild-type. In addition, the contents of IAA, GA(3), ABA, JA and SA in osfie2-1 are significantly different from those in wild-type. Taken together, these results indicate that OsFIE2 plays an important role in the regulation of plant height and grain yield in rice.	[Liu, Xianbo; Wei, Xiangjin; Sheng, Zhonghua; Jiao, Guiai; Tang, Shaoqing; Luo, Ju; Hu, Peisong] China Natl Rice Res Inst, State Key Lab Rice Biol, Key Lab Rice Biol & Breeding, Minist Agr, Hangzhou 310006, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Luo, J; Hu, PS (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Key Lab Rice Biol & Breeding, Minist Agr, Hangzhou 310006, Zhejiang, Peoples R China.	luojurice@126.com; peisonghu@126.com		Wei, Xiangjin/0000-0002-1190-5222	National Natural Science Foundation of China [31161140348, 31501285, 31301303, 31521064]; National Science and Technology Major Project [2016ZX08001006]; Natural Science Foundation of China [31161140348, 31501285, 31301303, 31521064]; National S&T Major Project of china [2016ZX08001006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Project of china	This work was supported by National Natural Science Foundation of China, grants No. 31161140348 (PH), 31501285 (ZS), 31301303 (GJ), 31521064 (ST); National Science and Technology Major Project grants No. 2016ZX08001006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the financial support given by the Natural Science Foundation of China (grants No. 31161140348, 31501285, 31301303, 31521064) and by the National S&T Major Project of china (2016ZX08001006)	Abu-Zaitoon YM, 2012, PHYSIOL PLANTARUM, V146, P487, DOI 10.1111/j.1399-3054.2012.01649.x; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Che LX, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004405; Chen J, 2015, PLANT J, V83, P427, DOI 10.1111/tpj.12895; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Ding ZJ, 2001, SEX PLANT REPROD, V13, P285, DOI 10.1007/s004970100065; Duan YL, 2012, PLANT J, V72, P829, DOI 10.1111/j.1365-313X.2012.05126.x; HARGROVE TR, 1979, BIOSCIENCE, V29, P731, DOI 10.2307/1307667; He CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002911; Hu Y, 2015, MOL PLANT, V8, P1366, DOI 10.1016/j.molp.2015.04.009; Huang DB, 2015, PLANT CELL, V27, P1681, DOI 10.1105/tpc.15.00015; Ishimaru K, 2013, NAT GENET, V45, P707, DOI 10.1038/ng.2612; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Katz A, 2004, PLANT J, V37, P707, DOI 10.1111/j.1365-313X.2003.01996.x; Khush GS, 1999, GENOME, V42, P646, DOI 10.1139/gen-42-4-646; Kim EH, 2009, PLANT PHYSIOL, V149, P1751, DOI 10.1104/pp.108.134684; Kim GT, 1998, PLANTA, V206, P175, DOI 10.1007/s004250050389; Kim MC, 2007, J PLANT PHYSIOL, V164, P665, DOI 10.1016/j.jplph.2006.08.003; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kohler C, 2008, TRENDS CELL BIOL, V18, P236, DOI 10.1016/j.tcb.2008.02.005; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; La HG, 2006, MOL GENET GENOMICS, V275, P374, DOI 10.1007/s00438-005-0093-5; Lafos M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002040; Lewis E. B., 1978, GENES DEV CANC, P205, DOI DOI 10.1007/978-1-4419-8981-9_13; Li SS, 2014, NEW PHYTOL, V201, P66, DOI 10.1111/nph.12472; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Luo M, 2000, P NATL ACAD SCI USA, V97, P10637, DOI 10.1073/pnas.170292997; Luo M, 2009, MOL PLANT, V2, P711, DOI 10.1093/mp/ssp036; Magome H, 2013, P NATL ACAD SCI USA, V110, P1947, DOI 10.1073/pnas.1215788110; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Martinez AM, 2006, GENE DEV, V20, P501, DOI 10.1101/gad.357106; Nallamilli BRR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003322; Nekrasov M, 2005, EMBO REP, V6, P348, DOI 10.1038/sj.embor.7400376; Ohad N, 1999, PLANT CELL, V11, P407, DOI 10.1105/tpc.11.3.407; Oikawa T, 2004, PLANT MOL BIOL, V55, P687, DOI 10.1007/s11103-004-1692-y; Pien S, 2007, BBA-GENE STRUCT EXPR, V1769, P375, DOI 10.1016/j.bbaexp.2007.01.010; Qi P, 2012, CELL RES, V22, P1666, DOI 10.1038/cr.2012.151; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Sakamoto T, 2008, CURR OPIN PLANT BIOL, V11, P209, DOI 10.1016/j.pbi.2008.01.009; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Si LZ, 2016, NAT GENET, V48, P447, DOI 10.1038/ng.3518; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Spillane C, 2000, CURR BIOL, V10, P1535, DOI 10.1016/S0960-9822(00)00839-3; Suzaki T, 2004, DEVELOPMENT, V131, P5649, DOI 10.1242/dev.01441; Tong HN, 2014, PLANT CELL, V26, P4376, DOI 10.1105/tpc.114.132092; Trapp MA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00417; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang YX, 2015, NAT GENET, V47, P944, DOI 10.1038/ng.3346; Wei XJ, 2013, GENET MOL RES, V12, P3845, DOI 10.4238/2013.September.23.2; Wei XJ, 2010, PLANT PHYSIOL, V153, P1747, DOI 10.1104/pp.110.156943; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Wu YZ, 2016, PLANT BIOTECHNOL J, V14, P377, DOI 10.1111/pbi.12391; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yadegari R, 2000, PLANT CELL, V12, P2367, DOI 10.1105/tpc.12.12.2367; Ye N, 2014, PLANT CELL PHYSL; Yoshikawa T, 2014, PLANT J, V78, P927, DOI 10.1111/tpj.12517; Zhang LG, 2012, PLANT CELL, V24, P4407, DOI 10.1105/tpc.112.102269; ZHANG QF, 1994, P NATL ACAD SCI USA, V91, P8675, DOI 10.1073/pnas.91.18.8675; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878; Zhu GH, 2009, PLANT CELL PHYSIOL, V50, P644, DOI 10.1093/pcp/pcp022; Zuo JR, 2014, ANNU REV GENET, V48, P99, DOI 10.1146/annurev-genet-120213-092138	71	12	16	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164748	10.1371/journal.pone.0164748	http://dx.doi.org/10.1371/journal.pone.0164748			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764161	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500056
J	Meloni, ST; Chang, CA; Eisen, G; Jolayemi, T; Banigbe, B; Okonkwo, PI; Kanki, PJ				Meloni, Seema T.; Chang, Charlotte A.; Eisen, Geoffrey; Jolayemi, Toyin; Banigbe, Bolanle; Okonkwo, Prosper I.; Kanki, Phyllis J.			Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria	PLOS ONE			English	Article							SAMPLING-BASED APPROACH; RESOURCE-LIMITED SETTINGS; HIV-INFECTED PATIENTS; FOLLOW-UP; PATIENTS LOST; VIROLOGICAL FAILURE; MULTICENTER COHORT; ADHERENCE; AFRICA; INITIATION	Background While there has been a rapid global scale-up of antiretroviral therapy programs over the past decade, there are limited data on long-term outcomes from large cohorts in resource-constrained settings. Our objective in this evaluation was to measure multiple outcomes during first-line antiretroviral therapy in a large treatment program in Nigeria. Methods We conducted a retrospective multi-site program evaluation of adult patients (age >= 15 years) initiating antiretroviral therapy between June 2004 and February 2012 in Nigeria. The baseline characteristics of patients were described and longitudinal analyses using primary endpoints of immunologic recovery, virologic rebound, treatment failure and long-term adherence patterns were conducted. Results Of 70,002 patients, 65.2% were female and median age was 35 (IQR: 29-41) years; 54.7% were started on a zidovudine-containing and 40% on a tenofovir-containing first-line regimen. Median CD4+ cell counts for the cohort started at 149 cells/mm(3) (IQR: 78-220) and increased over duration of ART. Of the 70,002 patients, 1.8% were reported as having died, 30.1% were lost to follow-up, and 0.1% withdrew from treatment. Overall, of those patients retained and with viral load data, 85.4% achieved viral suppression, with 69.3% achieving suppression by month 6. Of 30,792 patients evaluated for virologic failure, 24.4% met criteria for failure and of 45,130 evaluated for immunologic failure, 34.0% met criteria for immunologic failure, with immunologic criteria poorly predicting virologic failure. In adjusted analyses, older age, ART regimen, lower CD4+ cell count, higher viral load, and inadequate adherence were all predictors of virologic failure. Predictors of immunologic failure differed slightly, with age no longer predictive, but female sex as protective; additionally, higher baseline CD4+ cell count was also predictive of failure. Evaluation of long-term adherence patterns revealed that the majority of patients retained through 84 months maintained >= 95% adherence. Conclusion While improved access to HIV care and treatment remains a challenge in Nigeria, our study shows that a high quality of care was achieved as evidenced by strong long-term clinical, immunologic and virologic outcomes.	[Meloni, Seema T.; Chang, Charlotte A.; Kanki, Phyllis J.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Eisen, Geoffrey] Northwestern Univ, Feinberg Sch Med, Ctr Global Hlth, Chicago, IL 60611 USA; [Jolayemi, Toyin; Banigbe, Bolanle; Okonkwo, Prosper I.] AIDS Prevent Initiat Nigeria Ltd Guarantee, Abuja, Federal Capital, Nigeria	Harvard University; Harvard T.H. Chan School of Public Health; Northwestern University; Feinberg School of Medicine	Kanki, PJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	pkanki@hsph.harvard.edu			U.S. Department of Health and Human Services, Health Resources and Services Administration [U51HA0252]; Centers for Disease Control and Prevention (CDC) through AIDS Prevention Initiative in Nigeria (APIN) [PS 001058]	U.S. Department of Health and Human Services, Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Centers for Disease Control and Prevention (CDC) through AIDS Prevention Initiative in Nigeria (APIN)	This research used data collected as part of routine care and treatment services that were supported by the U.S. Department of Health and Human Services, Health Resources and Services Administration [U51HA0252] and the Centers for Disease Control and Prevention (CDC) through a cooperative agreement with the AIDS Prevention Initiative in Nigeria (APIN) [PS 001058]. The funders were not involved in the design of the study or the writing of the report.	Assefa Y, 2015, J ACQ IMMUN DEF SYND, V70, P414, DOI [10.1097/QAI.0000000000000753, DOI 10.1097/QAI.0000000000000753]; Boender TS, 2015, CLIN INFECT DIS, V61, P1453, DOI 10.1093/cid/civ556; Boulle C, 2015, JAIDS-J ACQ IMM DEF, V69, P355, DOI 10.1097/QAI.0000000000000604; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Castelnuovo B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142722; Chang CA, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv154; Chaplin B, 2015, INT J MED INFORM, V84, P58, DOI 10.1016/j.ijmedinf.2014.09.006; Colasanti J, 2015, CLIN INFECT DIS; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; De Beaudrap P, 2013, JAIDS-J ACQ IMM DEF, V62, P381, DOI 10.1097/QAI.0b013e31827a2a7a; Farahani M, 2014, LANCET GLOB HEALTH, V2, pE44, DOI 10.1016/S2214-109X(13)70149-9; Federal Ministry of Health Nigeria, 2010, NAT GUID HIV AIDS TR; Federal Ministry of Health Nigeria, 2007, NAT GUID HIV AIDS TR; Federal Republic of Nigeria National Agency for the Control of AIDS, 2014, GLOB AIDS RESP COUNT; Federal Republic of Nigeria National Agency for the Control of AIDS, 2015, GLOB AIDS RESP COUNT; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Geng EH, 2015, LANCET HIV, V2, pE107, DOI 10.1016/S2352-3018(15)00002-8; Geng EH, 2010, TROP MED INT HEALTH, V15, P63, DOI 10.1111/j.1365-3156.2010.02507.x; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Goldman JD, 2008, AIDS RES HUM RETROV, V24, P1031, DOI 10.1089/aid.2008.0035; Grimsrud A, 2016, J EPIDEMIOL COMMUN H, V70, P549, DOI 10.1136/jech-2015-206629; Grimsrud A, 2014, JAIDS-J ACQ IMM DEF, V67, pE55, DOI 10.1097/QAI.0000000000000268; Grossberg Robert, 2007, Curr HIV/AIDS Rep, V4, P187, DOI 10.1007/s11904-007-0027-4; Gutierrez F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000089; Hamel DJ, 2015, AFR J LAB MED, V4, DOI [10.4102/AJLM.V4I1.190, 10.4102/ajlm.v4i1.190]; Holmes CB, 2010, JAMA-J AM MED ASSOC, V304, P313, DOI 10.1001/jama.2010.993; Huang JS, 2011, J PEDIATR-US, V159, P994, DOI 10.1016/j.jpeds.2011.05.038; Huang P, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007508; Lee MP, 2015, AIDS PATIENT CARE ST, V29, P229, DOI 10.1089/apc.2014.0232; Lima VD, 2015, AIDS, V29, P1871, DOI 10.1097/QAD.0000000000000790; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P360; Meloni ST, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu055; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Novak RM, 2015, JAIDS-J ACQ IMM DEF, V70, P23, DOI 10.1097/QAI.0000000000000652; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Sangeda RZ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1035; Sanne IM, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-38; Scarsi KK, 2016, CLIN INFECT DIS, V62, P512, DOI 10.1093/cid/civ928; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; UNAIDS, 2014, THE GAP REP; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2003, SCAL ANT THER RES LI; World Health Organization, 2006, ANT THER HIV INF AD	47	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164030	10.1371/journal.pone.0164030	http://dx.doi.org/10.1371/journal.pone.0164030			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764094	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204500017
J	Nazari, V; Schmidt, BC; Prosser, S; Hebert, PDN				Nazari, Vazrick; Schmidt, B. Christian; Prosser, Sean; Hebert, Paul D. N.			Century-Old DNA Barcodes Reveal Phylogenetic Placement of the Extinct Jamaican Sunset Moth, Urania sloanus Cramer (Lepidoptera: Uraniidae)	PLOS ONE			English	Article							HISTORY; FLIGHT; MIGRATION; PATTERNS	Analysis of the DNA barcode region of the cytochrome c oxidase 1 gene from a specimen of the extinct Jamaican sunset moth, Urania sloanus, places this species as a sister to the Central American U. fulgens. We found that all Urania F. species were closely related (<2.8% maximum divergence at COI), with the Cuban endemic U. boisduvalii appearing as sister to the rest. The low divergence in DNA barcodes and genitalic structures indicate that the Cuban U. poeyi and eastern Brazilian U. brasiliensis are geographic segregates of U. fulgens and U. leilus respectively, so the former two taxa are accordingly recognized as subspecies.	[Nazari, Vazrick; Schmidt, B. Christian] Agr & Agri Food Canada, Canadian Natl Collect Insects Arachnids & Nematod, Ottawa Res & Dev Ctr, Ottawa, ON, Canada; [Prosser, Sean; Hebert, Paul D. N.] Univ Guelph, Ctr Biodivers Genom, Biodivers Inst Ontario, Guelph, ON, Canada	Agriculture & Agri Food Canada; University of Guelph	Nazari, V (corresponding author), Agr & Agri Food Canada, Canadian Natl Collect Insects Arachnids & Nematod, Ottawa Res & Dev Ctr, Ottawa, ON, Canada.	nazariv@agr.gc.ca	Schmidt, Christian/AAE-3069-2019; Nazari, Vazrick/AAF-2777-2019	Nazari, Vazrick/0000-0001-9064-8959; Schmidt, Christian/0000-0003-4160-7629	Natural Sciences and Engineering Research Council of Canada (NSERC); Government of Canada through Genome Canada; Ontario Genomics Institute in support of the International Barcode of Life Project	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute in support of the International Barcode of Life Project	This study was supported by grants to Paul D.N. Hebert (PDNH) from Natural Sciences and Engineering Research Council of Canada (NSERC) and from the Government of Canada through Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life Project.	Adams CD., 1971, FLOWERING PLANTS JAM, V7, P109; Barro A, 2009, FUNCTIONAL SURFACES IN BIOLOGY, VOL 1, P189, DOI 10.1007/978-1-4020-6697-9_11; BUSKIRK RE, 1985, J BIOGEOGR, V12, P445, DOI 10.2307/2844953; Catala R, 1940, THESIS, V17; Cramer P, 1775, UITLANDSCHE KAPELLEN; Domgata P, 2015, SHILAP-REV LEPIDOPT, V43, P455; DRAKE VA, 1988, ANNU REV ENTOMOL, V33, P183, DOI 10.1146/annurev.en.33.010188.001151; Dudley R, 2002, BIOTROPICA, V34, P452, DOI 10.1111/j.1744-7429.2002.tb00560.x; Emmel T.C., 1974, Journal Lepid Soc, V28, P292; Gaede M, 1930, MACROLEPIDOPTERA WOR, V6, P820; Gosse P., 1851, NATURALISTS SOJOURN; Gosse PH, 1881, ENTOMOLOGIST, V14, P241; Gosse PH, 1880, ENTOMOLOGIST, V13, P133; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; Griveaud P., 1959, Naturaliste Malgache Tananarive, V11, P107; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heikkila M, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0520-0; Hemsley WB, 1885, REPORTS BOT J FERNAN; Holloway J. D., 1998, Malayan Nature Journal, V52, P1; Kendall RO, 1978, J LEPID SOC, V32, P307; Kirby WF, 1897, HDB ORDER LEPIDOPTER, VIII; Kite GC, 1997, J CHEM ECOL, V23, P119, DOI 10.1023/B:JOEC.0000006349.84075.f0; Lafontaine J. Donald, 2004, P1; LEES D C, 1991, Journal of the Lepidopterists' Society, V45, P296; Lees DC, 2010, ZOOL SCR, V39, P642, DOI 10.1111/j.1463-6409.2010.00447.x; LEES DC, 1992, ZOOL J LINN SOC-LOND, V106, P163, DOI 10.1111/j.1096-3642.1992.tb01245.x; Leussler RA, 1918, ENTOMOL NEWS, V29, P149; Lewis CB, 1944, NAT HIST SOC JAMAICA, V2, P133; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; Montes C, 2015, SCIENCE, V348, P226, DOI 10.1126/science.aaa2815; MURILLO-HILLER Luis Ricardo, 2008, Acta Zool. Mex, V24, P239; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Perez Alvarez M, 2014, REV CUBANA CIENCIAS, V3, P81; Perkins L, 1944, NAT HIST SOC JAMAICA, V2, P144; Prosser SWJ, 2016, MOL ECOL RESOUR, V16, P487, DOI 10.1111/1755-0998.12474; Ronquist F., 1996, DIVA DISPERSAL VICAR; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sane SP, 2010, BIOL LETTERS, V6, P406, DOI 10.1098/rsbl.2009.1073; Sloane H, 1725, VOYAGE ISLANDS MADER, V2, P157; Smith Neal G., 1992, P576; SMITH NG, 1983, FLA ENTOMOL, V66, P76, DOI 10.2307/3494552; Srygley RB, 2008, INTEGR COMP BIOL, V48, P119, DOI 10.1093/icb/icn011; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1995, GENETICS, V140, P767; Townsend CHT, 1893, J I JAMAICA, V1, P379; van der Heyden Torsten, 2006, Nachrichten des Entomologischen Vereins Apollo, V27, P55; viette P, 1972, B MENS SOC LINN LYON, V41, P189; Vinciguerra R, 2009, SHILAP-REV. LEPIDOPT, V37, P307; Wahlberg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080875	50	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164405	10.1371/journal.pone.0164405	http://dx.doi.org/10.1371/journal.pone.0164405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764148	gold, Green Published			2022-12-26	WOS:000386204500031
J	Poulos, M				Poulos, Marios			Determining the Stationarity Distance via a Reversible Stochastic Process	PLOS ONE			English	Article							COMPLEX NETWORK ANALYSIS; TIME-SERIES; FLOW	The problem of controlling stationarity involves an important aspect of forecasting, in which a time series is analyzed in terms of levels or differences. In the literature, non-parametric stationary tests, such as the Kwiatkowski-Phillips-Schmidt-Shin (KPSS) tests, have been shown to be very important; however, they are affected by problems with the reliability of lag and sample size selection. To date, no theoretical criterion has been proposed for the lag-length selection for tests of the null hypothesis of stationarity. Their use should be avoided, even for the purpose of so-called 'confirmation'. The aim of this study is to introduce a new method that measures the distance by obtaining each numerical series from its own time-reversed series. This distance is based on a novel stationary ergodic process, in which the stationary series has reversible symmetric features, and is calculated using the Dynamic Time-warping (DTW) algorithm in a self-correlation procedure. Furthermore, to establish a stronger statistical foundation for this method, the F-test is used as a statistical control and is a suggestion for future statistical research on resolving the problem of a sample of limited size being introduced. Finally, as described in the theoretical and experimental documentation, this distance indicates the degree of non-stationarity of the times series.	[Poulos, Marios] Ionian Univ, Fac Informat Sci & Informat, Informat Technol Lab, Corfu, Greece	Ionian University	Poulos, M (corresponding author), Ionian Univ, Fac Informat Sci & Informat, Informat Technol Lab, Corfu, Greece.	mpoulos@ionio.gr						Aach J, 2001, BIOINFORMATICS, V17, P495, DOI 10.1093/bioinformatics/17.6.495; Cassisi C., 2012, ADV DATA MINING KNOW, P71, DOI [10.5772/49941, DOI 10.5772/49941]; Cortez P, 2012, EXPERT SYST, V29, P143, DOI 10.1111/j.1468-0394.2010.00568.x; Dahlhaus R, 2012, HANDB STAT, V30, P351, DOI 10.1016/B978-0-444-53858-1.00013-2; ERMENTROUT GB, 1979, BIOL CYBERN, V34, P137, DOI 10.1007/BF00336965; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20052; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gao ZK, 2016, IEEE T INSTRUM MEAS, V65, P1690, DOI 10.1109/TIM.2016.2540862; Giorgino T, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i07; Harvey AC, 1990, FORECASTING STRUCTUR; Hobijn B, 2004, STAT NEERL, V58, P483, DOI 10.1111/j.1467-9574.2004.00272.x; Hyndman R.J, TIME SERIES DATA LIB; Hyndman RobJ., 2018, FORECASTING PRINCIPL; Kang KJ, 2003, P NATL ACAD SCI USA, V100, P2848, DOI 10.1073/pnas.0138051100; Keogh E, 2003, DATA MIN KNOWL DISC, V7, P349, DOI 10.1023/A:1024988512476; Kumar A., 2004, COMMUNICATION NETWOR; Kuo BS, 2005, 50 HELS CTR EC RES; Leite MCA, 2012, NONLINEAR ANAL-REAL, V13, P497, DOI 10.1016/j.nonrwa.2011.02.025; Perng C.-S., 2000, Proceedings of 16th International Conference on Data Engineering (Cat. No.00CB37073), P33, DOI 10.1109/ICDE.2000.839385; Rabiner L., 1993, FUNDAMENTALS SPEECH; SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055; Serra Joan, 2012, Case-Based Reasoning Research and Development. Proceedings of the 20th International Conference, ICCBR 2012, P414, DOI 10.1007/978-3-642-32986-9_31; Sharifdoost M, 2009, APPL MATH SCI, V52, P2563; Syczewska EM, 2010, EMPIRICAL POWER KWIA; Virmani V, 2004, UNIT ROOT TESTS RESU; Wang Q, 2008, INFORM SYST, V33, P115, DOI 10.1016/j.is.2007.07.002; Wang XY, 2013, DATA MIN KNOWL DISC, V26, P275, DOI 10.1007/s10618-012-0250-5; WEISS G, 1975, J APPL PROBAB, V12, P831, DOI 10.2307/3212735; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhang Z, 2006, INT C PATT RECOG, P1135	32	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164110	10.1371/journal.pone.0164110	http://dx.doi.org/10.1371/journal.pone.0164110			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764103	gold, Green Submitted, Green Published			2022-12-26	WOS:000386204500018
J	Van Nieuland, S; Baetens, JM; De Baets, B				Van Nieuland, Steffie; Baetens, Jan M.; De Baets, Bernard			Spatially Explicit Modelling of the Belgian Major Endurance Event 'The 100 km Dodentocht'	PLOS ONE			English	Article							DISTANCE	'The 100 km Dodentocht', which takes place annually and has its start in Bornem, Belgium, is a long distance march where participants have to cover a 100 km trail in at most 24 hours. The approximately 11 000 marchers per edition are tracked by making use of passive radio-frequency-identification (RFID). These tracking data were analyzed to build a spatially explicit marching model that gives insights into the dynamics of the event and allows to evaluate the effect of changes in the starting procedure of the event. For building the model, the empirical distribution functions (edf) of the marching speeds at every section of the trail in between two consecutive checkpoints and of the checkpoints where marchers retire, are determined, taking into account age, gender, and marching speeds at previous sections. These distribution functions are then used to sample the consecutive speeds and retirement, and as such to simulate the times when individual marchers pass by the consecutive checkpoints. We concluded that the data-driven model simulates the event reliably. Furthermore, we tested three scenarios to reduce the crowdiness along the first part of the trail and in this way were able to conclude that either the start should be moved to a location outside the town center where the streets are at least 25% wider, or that the marchers should start in two groups at two different locations, and that these groups should ideally merge at about 20 km after the start. The crowdiness at the start might also be reduced by installing a bottleneck at the start in order to limit the number of marchers that can pass per unit of time. Consequently, the operating hours of the consecutive checkpoints would be longer. The developed framework can likewise be used to analyze and improve the operation of other endurance events if sufficient tracking data are available.	[Van Nieuland, Steffie; Baetens, Jan M.; De Baets, Bernard] Univ Ghent, Dept Math Modelling Stat & Bioinformat, KERMIT, Coupure Links 653, B-9000 Ghent, Belgium	Ghent University	Van Nieuland, S (corresponding author), Univ Ghent, Dept Math Modelling Stat & Bioinformat, KERMIT, Coupure Links 653, B-9000 Ghent, Belgium.	steffie.vannieuland@ugent.be	De Baets, Bernard/E-8877-2010	De Baets, Bernard/0000-0002-3876-620X; Baetens, Jan/0000-0003-4084-9992				[Anonymous], 2014, RUNN US ANN MAR REP; Baca A, 2009, J SPORT SCI, V27, P1335, DOI 10.1080/02640410903277427; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; BRESLOW NE, 1975, INT STAT REV, V43, P45, DOI 10.2307/1402659; Chatfield C., 2004, CHAPMAN HALL CRC TEX; Cheng RCH, 1998, HDB SIMULATION PRINC; Cox D. R., 1984, ANAL SURVIVAL DATA; Frank J, 1951, J AM STAT ASSOC, V46, P68, DOI DOI 10.1080/01621459.1951.10500769; Frank M.J., 1979, AEQUATIONES MATH, V19, P194, DOI DOI 10.1007/BF02189866; Grillmayer L, 2013, INNOVATIVE INTERNET, V25, P25; Harris J.W., 1998, HDB MATH COMPUTATION; Hoogendoorn S.P., 2006, P TRANSPORTATION RES, P1; Malkinson T, 2009, IEEE TIC-STH 09: 2009 IEEE TORONTO INTERNATIONAL CONFERENCE: SCIENCE AND TECHNOLOGY FOR HUMANITY, P581, DOI 10.1109/TIC-STH.2009.5444434; Nelsen RB, 1998, INTRO COPULAS; Rubner Y, 2000, INT J COMPUT VISION, V40, P99, DOI 10.1023/A:1026543900054; Sargent RG, 2011, WINT SIMUL C PROC, P183, DOI 10.1109/WSC.2011.6147750; Sittard Kennedy-Mars, OV ALL TIJD; Sklar M., 1959, FONCTIONS REPARTITIO, V8, P229; Vananderoye S., 2014, ANTWERP 10 MILES IS; Venuti F, 2007, CR MECANIQUE, V335, P194, DOI 10.1016/j.crme.2007.03.008; Weidmann U, 1993, 90 IVT ETH ZUR; WERMAN M, 1985, COMPUT VISION GRAPH, V32, P328, DOI 10.1016/0734-189X(85)90055-6	22	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164981	10.1371/journal.pone.0164981	http://dx.doi.org/10.1371/journal.pone.0164981			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764202	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204500093
J	Barhorst-Cates, EM; Rand, KM; Creem-Regehr, SH				Barhorst-Cates, Erica M.; Rand, Kristina M.; Creem-Regehr, Sarah H.			The Effects of Restricted Peripheral Field-of-View on Spatial Learning while Navigating	PLOS ONE			English	Article							MOBILITY PERFORMANCE; HUMAN LOCOMOTION; WORKING-MEMORY; COGNITIVE LOAD; SELF-MOTION; OPTIC FLOW; VISION; ORIENTATION; REPRESENTATIONS; ACQUISITION	Recent work with simulated reductions in visual acuity and contrast sensitivity has found decrements in survey spatial learning as well as increased attentional demands when navigating, compared to performance with normal vision. Given these findings, and previous work showing that peripheral field loss has been associated with impaired mobility and spatial memory for room-sized spaces, we investigated the role of peripheral vision during navigation using a large-scale spatial learning paradigm. First, we aimed to establish the magnitude of spatial memory errors at different levels of field restriction. Second, we tested the hypothesis that navigation under these different levels of restriction would use additional attentional resources. Normally sighted participants walked on novel real-world paths wearing goggles that restricted the field-of-view (FOV) to severe (15 degrees, 10 degrees, 4 degrees, or 0 degrees) or mild angles (60 degrees) and then pointed to remembered target locations using a verbal reporting measure. They completed a concurrent auditory reaction time task throughout each path to measure cognitive load. Only the most severe restrictions (4 degrees and blindfolded) showed impairment in pointing error compared to the mild restriction (within-subjects). The 10 degrees and 4 degrees conditions also showed an increase in reaction time on the secondary attention task, suggesting that navigating with these extreme peripheral field restrictions demands the use of limited cognitive resources. This comparison of different levels of field restriction suggests that although peripheral field loss requires the actor to use more attentional resources while navigating starting at a less extreme level (10 degrees), spatial memory is not negatively affected until the restriction is very severe (4 degrees). These results have implications for understanding of the mechanisms underlying spatial learning during navigation and the approaches that may be taken to develop assistance for navigation with visual impairment.	[Barhorst-Cates, Erica M.; Rand, Kristina M.; Creem-Regehr, Sarah H.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Barhorst-Cates, EM (corresponding author), Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA.	erica.barhorst@psych.utah.edu			National Eye Institute of the National Institutes of Health [R01EY017835]; NATIONAL EYE INSTITUTE [R01EY017835] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research is supported by the National Eye Institute of the National Institutes of Health under award number R01EY017835. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert W. S., 1999, Spatial Cognition and Computation, V1, P131, DOI 10.1023/A:1010096408311; ANDERSEN GJ, 1985, J EXP PSYCHOL HUMAN, V11, P122, DOI 10.1037/0096-1523.11.2.122; Blasch, 2010, FDN ORIENTATION MOBI, P45; BRANDT T, 1973, EXP BRAIN RES, V16, P476, DOI 10.1007/BF00234474; Bremner JD, 1998, J TRAUMA STRESS, V11, P125, DOI 10.1023/A:1024465317902; Bruggeman H, 2007, CURR BIOL, V17, P2035, DOI 10.1016/j.cub.2007.10.059; Brunken R, 2003, EDUC PSYCHOL-US, V38, P53, DOI 10.1207/S15326985EP3801_7; Chrastil ER, 2012, PSYCHON B REV, V19, P1, DOI 10.3758/s13423-011-0182-x; DAVIDSON HA, 1991, APPL COGNITIVE PSYCH, V5, P423, DOI 10.1002/acp.2350050504; Farrell MJ, 1998, Q J EXP PSYCHOL-A, V51, P637; Fortenbaugh FC, 2008, INVEST OPHTH VIS SCI, V49, P2765, DOI 10.1167/iovs.07-1021; Fortenbaugh FC, 2007, VISION RES, V47, P2506, DOI 10.1016/j.visres.2007.06.012; Frenz H, 2005, VISION RES, V45, P1679, DOI 10.1016/j.visres.2004.12.019; Furman AJ, 2014, COGN AFFECT BEHAV NE, V14, P1375, DOI 10.3758/s13415-014-0279-6; Gardony AL, 2013, SPAT COGN COMPUT, V13, P319, DOI 10.1080/13875868.2013.792821; Hassan SE, 2007, VISION RES, V47, P2115, DOI 10.1016/j.visres.2007.03.012; Hegarty M, 2002, INTELLIGENCE, V30, P425, DOI 10.1016/S0160-2896(02)00116-2; Hegarty M, 2005, HANDBOOK OF HIGHER L; HELD R, 1975, VISION RES, V15, P357, DOI 10.1016/0042-6989(75)90083-8; Jansen SEM, 2011, EXP BRAIN RES, V212, P449, DOI 10.1007/s00221-011-2757-1; Jansen SEM, 2011, J MOTOR BEHAV, V43, P55, DOI 10.1080/00222895.2010.533593; Klatzky RL, 1998, PSYCHOL SCI, V9, P293, DOI 10.1111/1467-9280.00058; Klatzky RL, 2006, J EXP PSYCHOL-APPL, V12, P223, DOI 10.1037/1076-898X.12.4.223; Legge GE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150708; LINDBERG E, 1982, SCAND J PSYCHOL, V23, P207, DOI 10.1111/j.1467-9450.1982.tb00434.x; Marchette SA, 2011, J NEUROSCI, V31, P15264, DOI 10.1523/JNEUROSCI.3634-11.2011; MARRON JA, 1982, AM J OPTOM PHYS OPT, V59, P413; Meisinger P, 2016, ANN M PSYCH SOC BOST; Meneghetti C, 2011, BRIT J PSYCHOL, V102, P499, DOI 10.1111/j.2044-8295.2010.02007.x; Millodot M., 2014, DICTIONARY OF OPTOME; Pelli DG, 1987, VISUAL REQUIREMENTS, DOI [10.1007/978-1-4612-4780-7_11BF00234474, DOI 10.1007/978-1-4612-4780-7_11]; Philbeck J, 2008, PERCEPTION, V37, P511, DOI 10.1068/p5839; Rand KM, 2015, J EXP PSYCHOL HUMAN, V41, P649, DOI 10.1037/xhp0000040; RIESER JJ, 1992, J EXP PSYCHOL GEN, V121, P210, DOI 10.1037/0096-3445.121.2.210; RIESER JJ, 1995, J EXP PSYCHOL HUMAN, V21, P480, DOI 10.1037/0096-1523.21.3.480; Sun HJ, 2004, EXP BRAIN RES, V154, P246, DOI 10.1007/s00221-003-1652-9; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Turano KA, 2004, OPTOMETRY VISION SCI, V81, P298, DOI 10.1097/01.opx.0000134903.13651.8e; van Asselen M, 2006, BRAIN RES, V1067, P229, DOI 10.1016/j.brainres.2005.10.048; Varner KM, 2016, INT J AGING HUM DEV, V82, P188, DOI 10.1177/0091415015626551; Verwey WB, 1996, J EXP PSYCHOL-APPL, V2, P270, DOI 10.1037/1076-898X.2.3.270; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; Wen W, 2011, APPL COGNITIVE PSYCH, V25, P654, DOI 10.1002/acp.1737; Yamamoto N, 2013, MEM COGNITION, V41, P109, DOI 10.3758/s13421-012-0240-2	44	17	17	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0163785	10.1371/journal.pone.0163785	http://dx.doi.org/10.1371/journal.pone.0163785			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9NW	27760150	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204000019
J	Liu, TR; Xiao, ZW; Xu, HN; Long, Z; Wei, FQ; Zhuang, SM; Sun, XM; Xie, LE; Mu, JS; Yang, AK; Zhang, GP; Fan, Y				Liu, Tian-Run; Xiao, Zhi-Wen; Xu, Hai-Neng; Long, Zhen; Wei, Fan-Qin; Zhuang, Shi-Min; Sun, Xiao-Mei; Xie, Liang-En; Mu, Jia-Sheng; Yang, An-Kui; Zhang, Guan-Ping; Fan, Yi			Treatment and Prognosis of Anaplastic Thyroid Carcinoma: A Clinical Study of 50 Cases	PLOS ONE			English	Article							SINGLE INSTITUTION; SURVIVAL; CANCER; RADIOTHERAPY; OUTCOMES; SURGERY; DISEASE	Introduction Although anaplastic thyroid carcinoma (ATC) is rare, it is one of the most aggressive human cancers. The optimal multimodal therapy policy of ATC is still debated, and a standardized treatment strategy remains to be established. This study aimed to evaluate the management aspect and prognosis of ATC. Materials and Methods The data were analyzed retrospectively for 50 patients with ATC to evaluate the clinical characters, management and factors influencing survival. Survival analysis was performed by Kaplan-Merier method and log-rank test, and multivariate analysis was performed using Cox proportional hazard model. Results The 1-year and 2-year overall survival rates (OS) were 48.0% and 26.0% respectively in all patients, with the 2-year OS of 40.0% and 31.0% and 6.3% for stage IVA, IVB and IVC respectively (P <0.05). In stage IVA and IVB patients, combined surgery with radiotherapy improved overall survival, and the 2-year OS were 50.0% and 35.7% respectively in the group with combined surgery with radiotherapy and the group with surgery with only (P< 0.05). Postoperative radiotherapy improved local control rate in stage IVA and IVB patients (P <0.05). However, surgery, radiotherapy or chemotherapy could not improve the survival of stage IVC patients. Multivariate analysis showed that distant metastases, surgery, radiotherapy and tumor residue could predict the prognosis. Conclusion Combined surgery and radiotherapy could improve overall survival in stage IVA and IVB patients. Patients with ATC have a bad prognosis. Distant metastases, surgery, radiotherapy and tumor residue are the most important factors affecting the prognosis.	[Liu, Tian-Run; Xiao, Zhi-Wen; Long, Zhen; Wei, Fan-Qin; Zhuang, Shi-Min; Sun, Xiao-Mei; Xie, Liang-En; Zhang, Guan-Ping] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China; [Xu, Hai-Neng; Fan, Yi] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Mu, Jia-Sheng] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Gen Surg, Shanghai, Peoples R China; [Mu, Jia-Sheng] Shanghai Jiao Tong Univ, Inst Biliary Tract Dis, Sch Med, Shanghai, Peoples R China; [Yang, An-Kui] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Yang, An-Kui] Sun Yat Sen Univ, Ctr Canc, Dept Head & Neck Surg, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; University of Pennsylvania; Pennsylvania Medicine; Shanghai Jiao Tong University; Shanghai Jiao Tong University; State Key Lab Oncology South China; Sun Yat Sen University	Zhang, GP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China.; Fan, Y (corresponding author), Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA.; Yang, AK (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.; Yang, AK (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Head & Neck Surg, Guangzhou, Guangdong, Peoples R China.	yangankui123@163.com; zgp401826@aliyun.com; yi.fan@uphs.upenn.edu	Xu, Haineng/A-4345-2016; fan, yi/GYU-1036-2022	Xu, Haineng/0000-0001-7195-4897; 	National Natural Science Foundation of China [81272955, 81302368]; Guangdong Province Natural Science Foundation [2015A030313058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by National Natural Science Foundation of China (No. 81272955 and 81302368) and Guangdong Province Natural Science Foundation (2015A030313058).	Are C, 2006, ANN SURG ONCOL, V13, P453, DOI 10.1245/ASO.2006.05.042; Besic N, 2013, THYROID, V23, P709, DOI 10.1089/thy.2012.0252; Brown RF, 2013, OTOLARYNG HEAD NECK, V148, P564, DOI 10.1177/0194599813477364; Busnardo B, 2000, J ENDOCRINOL INVEST, V23, P755, DOI 10.1007/BF03345066; Glaser SM, 2016, HEAD NECK-J SCI SPEC, V38, pE2083, DOI 10.1002/hed.24384; Haigh PI, 2001, CANCER-AM CANCER SOC, V91, P2335, DOI 10.1002/1097-0142(20010615)91:12<2335::AID-CNCR1266>3.3.CO;2-T; Heron DE, 2002, AM J CLIN ONCOL-CANC, V25, P442, DOI 10.1097/00000421-200210000-00003; Ito K, 2012, HEAD NECK-J SCI SPEC, V34, P230, DOI 10.1002/hed.21721; Kebebew E, 2005, CANCER-AM CANCER SOC, V103, P1330, DOI 10.1002/cncr.20936; Kim TY, 2007, HEAD NECK-J SCI SPEC, V29, P765, DOI 10.1002/hed.20578; Lee DY, 2016, THYROID, V26, P404, DOI 10.1089/thy.2015.0316; Lo CY, 1999, AM J SURG, V177, P337, DOI 10.1016/S0002-9610(99)00052-5; McIver B, 2001, SURGERY, V130, P1028, DOI 10.1067/msy.2001.118266; McLarnon Andy, 2012, Nat Rev Endocrinol, V8, P565, DOI 10.1038/nrendo.2012.136; O'Neill JP, 2005, J LARYNGOL OTOL, V119, P585, DOI 10.1258/0022215054516197; Polistena A, 2014, INT J SURG, V12, pS170, DOI 10.1016/j.ijsu.2014.08.347; Pushkarev V. M., 2008, Experimental Oncology, V30, P190; Smallridge RC, 2012, J CLIN ENDOCR METAB, V97, P2566, DOI 10.1210/jc.2012-1314; Sugitani I, 2012, WORLD J SURG, V36, P1247, DOI 10.1007/s00268-012-1437-z; Sun CZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080011; Sun XS, 2013, CRIT REV ONCOL HEMAT, V86, P52, DOI 10.1016/j.critrevonc.2012.09.007; Tennvall J, 2002, BRIT J CANCER, V86, P1848, DOI 10.1038/sj.bjc.6600361; Xu HN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-668; Yau T, 2008, ANN SURG ONCOL, V15, P2500, DOI 10.1245/s10434-008-0005-0	24	30	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164840	10.1371/journal.pone.0164840	http://dx.doi.org/10.1371/journal.pone.0164840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760217	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204000058
J	Olivieri, BF; Mercadante, MEZ; Cyrillo, JNDG; Branco, RH; Bonilha, SFM; de Albuquerque, LG; Silva, RMD; Baldi, F				Olivieri, Bianca Ferreira; Zerlotti Mercadante, Maria Eugenia; dos Santos Goncalves Cyrillo, Joslaine Noely; Branco, Renata Helena; Martins Bonilha, Sarah Figueiredo; de Albuquerque, Lucia Galvao; de Oliveira Silva, Rafael Medeiros; Baldi, Fernando			Genomic Regions Associated with Feed Efficiency Indicator Traits in an Experimental Nellore Cattle Population	PLOS ONE			English	Article							WEIGHT-GAIN; PREDICTIONS; SELECTION; EXPRESSION; RESPONSES; CHANNEL	The objective of this study was to identify genomic regions and metabolic pathways associated with dry matter intake, average daily gain, feed efficiency and residual feed intake in an experimental Nellore cattle population. The high-density SNP chip (Illumina High-Density Bovine BeadChip, 777k) was used to genotype the animals. The SNP markers effects and their variances were estimated using the single-step genome wide association method. The (co)variance components were estimated by Bayesian inference. The chromosome segments that are responsible for more than 1.0% of additive genetic variance were selected to explore and determine possible quantitative trait loci. The bovine genome Map Viewer was used to identify genes. In total, 51 genomic regions were identified for all analyzed traits. The heritability estimated for feed efficiency was low magnitude (0.13 +/- 0.06). For average daily gain, dry matter intake and residual feed intake, heritability was moderate to high (0.43 +/- 0.05; 0.47 +/- 0.05, 0.18 +/- 0.05, respectively). A total of 8, 17, 14 and 12 windows that are responsible for more than 1% of the additive genetic variance for dry matter intake, average daily gain, feed efficiency and residual feed intake, respectively, were identified. Candidate genes GOLIM4, RFX6, CACNG7, CACNG6, CAPN8, CAPN2, AKT2, GPRC6A, and GPR45 were associated with feed efficiency traits. It was expected that the response to selection would be higher for residual feed intake than for feed efficiency. Genomic regions harboring possible QTL for feed efficiency indicator traits were identified. Candidate genes identified are involved in energy use, metabolism protein, ion transport, transmembrane transport, the olfactory system, the immune system, secretion and cellular activity. The identification of these regions and their respective candidate genes should contribute to the formation of a genetic basis in Nellore cattle for feed efficiency indicator traits, and these results would support the selection for these traits.	[Olivieri, Bianca Ferreira; de Albuquerque, Lucia Galvao; de Oliveira Silva, Rafael Medeiros; Baldi, Fernando] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Zootecnia, Via Acesso Prof Paulo Donato Castellane S-No, BR-14884900 Jaboticabal, SP, Brazil; [Zerlotti Mercadante, Maria Eugenia; dos Santos Goncalves Cyrillo, Joslaine Noely; Branco, Renata Helena; Martins Bonilha, Sarah Figueiredo] Ctr Avancado Pesquisa Tecnol Agronegocio Bovinos, Inst Zootecnia, Rodovia Carlos Tonanni,Km 94, BR-14174000 Sertaozinho, SP, Brazil	Universidade Estadual Paulista; Instituto de Zootecnia	Olivieri, BF (corresponding author), Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Zootecnia, Via Acesso Prof Paulo Donato Castellane S-No, BR-14884900 Jaboticabal, SP, Brazil.	bianca.olivieri@hotmail.com	Arnandes, Renata Helena Branco/E-4451-2014; Albuquerque, Lucia/A-7402-2013; Mercadante, Maria Eugenia/C-9536-2012; Bonilha, Sarah F M/D-1043-2012; Baldi, Fernando/E-5492-2012; Cyrillo, Joslaine/S-2637-2019	Arnandes, Renata Helena Branco/0000-0003-2126-0023; Albuquerque, Lucia/0000-0002-2030-7590; Mercadante, Maria Eugenia/0000-0002-1218-5378; Bonilha, Sarah F M/0000-0002-8055-4112; Baldi, Fernando/0000-0003-4094-2011; Cyrillo, Joslaine/0000-0002-4390-630X	Sao Paulo Research Foundation (FAPESP) [2009/16118-5]; Coordination for the Improvement of Higher Education Personnel (CAPES)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Sao Paulo Research Foundation (FAPESP, grant #2009/16118-5) for financial support, and Coordination for the Improvement of Higher Education Personnel (CAPES) for providing grants to BFO.	Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Anderson RV, 2005, J ANIM SCI, V83, P694; [Anonymous], 1992, BAYESIAN STAT; Archer JA, 1999, AUST J AGR RES, V50, P147, DOI 10.1071/A98075; Arthur J P.F., 2008, R. Bras. Zootec., V37, P269; Arthur PF, 2001, J ANIM SCI, V79, P2805; Arthur PF, 2001, LIVEST PROD SCI, V68, P131, DOI 10.1016/S0301-6226(00)00243-8; Baldi F, 2012, LIVEST SCI, V144, P148, DOI 10.1016/j.livsci.2011.11.009; Berry DP, 2012, J ANIM SCI, V90, P109, DOI 10.2527/jas.2011-4245; Bolormaa S, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-43; Burgess DL, 2001, GENOMICS, V71, P339, DOI 10.1006/geno.2000.6440; Ceacero TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161366; Chandra V, 2014, CELL REP, V9, P2206, DOI 10.1016/j.celrep.2014.11.010; de Castilhos AM, 2011, REV BRAS ZOOTECN, V40, P301, DOI 10.1590/S1516-35982011000200010; de Oliveira PSN, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0100-0; GIANOLA D, 1986, J ANIM SCI, V63, P217, DOI 10.2527/jas1986.631217x; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; GOLL DE, 1992, BIOCHIMIE, V74, P225, DOI 10.1016/0300-9084(92)90121-T; Grion AL, 2014, J ANIM SCI, V92, P955, DOI 10.2527/jas.2013-6682; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; Herd RM, 2000, LIVEST PROD SCI, V63, P111, DOI 10.1016/S0301-6226(99)00122-0; Karisa B, 2014, ANIM SCI J, V85, P374, DOI 10.1111/asj.12159; Kawasawa Y, 2000, BIOCHEM BIOPH RES CO, V276, P952, DOI 10.1006/bbrc.2000.3569; KOCH RM, 1963, J ANIM SCI, V22, P486, DOI 10.2527/jas1963.222486x; Leal D. P., 2004, BIOQUIMICA MED; Machado U.F., 1998, ARQ BRAS ENDOCRINOL, V42, P413, DOI [10.1590/s0004-27301998000600003, DOI 10.1590/S0004-27301998000600003]; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Mercadante MEZ, 2003, J ANIM SCI, V81, P376; Misztal I., 2002, BLUPF90 RELATED PROG; Mujibi FDN, 2011, J ANIM SCI, V89, P3353, DOI 10.2527/jas.2010-3361; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Rolf MM, 2012, ANIM GENET, V43, P367, DOI 10.1111/j.1365-2052.2011.02273.x; Santana MHA, 2014, LIVEST SCI, V167, P80, DOI 10.1016/j.livsci.2014.06.002; Santana MHA, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-21; Santos C, 2012, ASS PORTUGUESA NUTR, V6, P1; Serao NVL, 2011, IEEE INT C BIO BIO W, P985, DOI 10.1109/BIBMW.2011.6112531; Shakkottai VG, 2001, J BIOL CHEM, V276, P43145, DOI 10.1074/jbc.M106981200; Silva BV, 2009, QUIM NOVA, V32, P453, DOI 10.1590/S0100-40422009000200032; Silva RMO, 2016, J ANIM SCI, V94, P3613, DOI 10.2527/jas.2016-0401; Starr T, 2007, TRAFFIC, V8, P1265, DOI 10.1111/j.1600-0854.2007.00607.x; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Stranden I, 2009, J DAIRY SCI, V92, P2971, DOI 10.3168/jds.2008-1929; Tedeschi LO, 2006, J ANIM SCI, V84, P767, DOI 10.2527/2006.843767x; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Vitezica ZG, 2011, GENET RES, V93, P357, DOI 10.1017/S001667231100022X; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Zhang Z, 2010, PLOS ONE, V9, P5	49	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164390	10.1371/journal.pone.0164390	http://dx.doi.org/10.1371/journal.pone.0164390			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760167	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000033
J	Sawadogo, S; Makumbi, B; Purfield, A; Ndjavera, C; Mutandi, G; Maher, A; Kaindjee-Tjituka, F; Kaplan, JE; Park, BJ; Lowrance, DW				Sawadogo, Souleymane; Makumbi, Boniface; Purfield, Anne; Ndjavera, Christophine; Mutandi, Gram; Maher, Andrew; Kaindjee-Tjituka, Francina; Kaplan, Jonathan E.; Park, Benjamin J.; Lowrance, David W.			Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; EARLY MORTALITY; SERUM; MENINGITIS; DIAGNOSIS; URINE	Background Cryptococcal meningitis is common and associated with high mortality among HIV infected persons. The World Health Organization recommends that routine Cryptococcal antigen (CrAg) screening in ART-naive adults with a CD4(+) count <100 cells/mu L followed by preemptive antifungal therapy for CrAg-positive patients be considered where CrAg prevalence is >= 3%. The prevalence of CrAg among HIV adults in Namibia is unknown. We estimated CrAg prevalence among HIV-infected adults receiving care in Namibia for the purpose of informing routine screening strategies. Methods The study design was cross-sectional. De-identified plasma specimens collected for routine CD4(+) testing from HIV-infected adults enrolled in HIV care at 181 public health facilities from November 2013 to January 2014 were identified at the national reference laboratory. Remnant plasma from specimens with CD4(+) counts <200 cells/mu L were sampled and tested for CrAg using the IMMY (R) Lateral Flow Assay. CrAg prevalence was estimated and assessed for associations with age, sex, and CD4(+) count. Results A total of 825 specimens were tested for CrAg. The median (IQR) age of patients from whom specimens were collected was 38 (32-46) years, 45.9% were female and 62.9% of the specimens had CD4 <100 cells/mu L. CrAg prevalence was 3.3% overall and 3.9% and 2.3% among samples with CD4(+) counts of CD4(+)<100 cells/mu L and 100-200 cells/mu L, respectively. CrAg positivity was significantly higher among patients with CD4+ cells/mu L < 50 (7.2%, P = 0.001) relative to those with CD4 cells/mu L 50-200 (2.2%). Conclusion This is the first study to estimate CrAg prevalence among HIV-infected patients in Namibia. CrAg prevalence of >= 3.0% among patients with CD4(+)<100 cells/mu L justifies routine CrAg screening and preemptive treatment among HIV-infected in Namibia in line with WHO recommendations. Patients with CD4(+)<100 cells/mu L have a significantly greater risk for CrAg positivity. Revised guidelines for ART in Namibia now recommend routine screening for CrAg.	[Sawadogo, Souleymane; Mutandi, Gram; Lowrance, David W.] Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Windhoek, Namibia; [Makumbi, Boniface; Ndjavera, Christophine] Namibia Inst Pathol, Windhoek, Namibia; [Purfield, Anne; Park, Benjamin J.] Ctr Dis Control & Prevent CDC, Mycot Dis Branch, Atlanta, GA USA; [Kaindjee-Tjituka, Francina] Minist Hlth & Social Serv, Directorate Special Programs, Windhoek, Namibia; [Kaplan, Jonathan E.] Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Atlanta, GA USA; [Maher, Andrew] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco	Sawadogo, S (corresponding author), Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Windhoek, Namibia.	ssawadogo@cdc.gov	hlupeni, admire/M-1539-2018		President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention [UPS001094A]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention under the terms of Award #UPS001094A.	Alemu AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058377; [Anonymous], 2012, SPECTRUM POLICY MODE; Beyene T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075585; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Boulware DR, 2014, N ENGL J MED; DESMET P, 1989, AIDS, V3, P77, DOI 10.1097/00002030-198902000-00004; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Gaskell KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110285; Gordon SB, 2000, CLIN INFECT DIS, V31, P53, DOI 10.1086/313910; Holmes CB, 2003, CLIN INFECT DIS, V36, P652, DOI 10.1086/367655; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Jarvis JN, 2010, J INFECTION, V60, P496, DOI 10.1016/j.jinf.2010.03.007; Kisenge PR, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-39; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Lindsley MD, 2011, CLIN INFECT DIS, V53, P321, DOI 10.1093/cid/cir379; Magambo KA, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19040; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Mfinanga S, 2015, LANCET, V385, P2173, DOI 10.1016/S0140-6736(15)60164-7; Micol R, 2007, JAIDS-J ACQ IMM DEF, V45, P555, DOI 10.1097/QAI.0b013e31811ed32c; Osazuwa F, 2012, OMAN MED J, V23, P228; Oyella J, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-15; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pongsai P, 2010, J INFECTION, V60, P474, DOI 10.1016/j.jinf.2010.03.015; Rothe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067311; Rugemalila J, 2013, TROP MED INT HEALTH, V18, P1075, DOI 10.1111/tmi.12157; Sloan D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005647.pub2; Sloan DJ, 2009, CURR OPIN INFECT DIS, V22, P455, DOI 10.1097/QCO.0b013e32832fa214; TANNER DC, 1994, J CLIN MICROBIOL, V32, P1680, DOI 10.1128/JCM.32.7.1680-1684.1994; Tassie JM, 2003, JAIDS-J ACQ IMM DEF, V33, P411, DOI 10.1097/00126334-200307010-00019; Wajanga BMK, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-48; WHO, 2012, RAP ADV DIAGN PREV M	32	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0161830	10.1371/journal.pone.0161830	http://dx.doi.org/10.1371/journal.pone.0161830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760140	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204000002
J	Kawahara, A; An, GH; Miyakawa, S; Sonoda, J; Ezawa, T				Kawahara, Ai; An, Gi-Hong; Miyakawa, Sachie; Sonoda, Jun; Ezawa, Tatsuhiro			Nestedness in Arbuscular Mycorrhizal Fungal Communities along Soil pH Gradients in Early Primary Succession: Acid-Tolerant Fungi Are pH Generalists	PLOS ONE			English	Article							ALUMINUM RESISTANCE; SACCHAROMYCES-CEREVISIAE; MISCANTHUS-SINENSIS; DIVERSITY; FRAMEWORK; BACTERIAL; ARCHITECTURE; ENVIRONMENT; MECHANISMS; VEGETATION	Soil acidity is a major constraint on plant productivity. Arbuscular mycorrhizal (AM) fungi support plant colonization in acidic soil, but soil acidity also constrains fungal growth and diversity. Fungi in extreme environments generally evolve towards specialists, suggesting that AM fungi in acidic soil are acidic-soil specialists. In our previous surveys, however, some AM fungi detected in strongly acidic soils could also be detected in a soil with moderate pH, which raised a hypothesis that the fungi in acidic soils are pH generalists. To test the hypothesis, we conducted a pH-manipulation experiment and also analyzed AM fungal distribution along a pH gradient in the field using a synthesized dataset of the previous and recent surveys. Rhizosphere soils of the generalist plant Miscanthus sinensis were collected both from a neutral soil and an acidic soil, and M. sinensis seedlings were grown at three different pH. For the analysis of field communities, rhizosphere soils of M. sinensis were collected from six field sites across Japan, which covered a soil pH range of 3.0-7.4, and subjected to soil trap culture. AM fungal community compositions were determined based on LSU rDNA sequences. In the pH-manipulation experiment the acidification of medium had a significant impact on the compositions of the community from the neutral soil, but the neutralization of the medium had no effect on those of the community from the acidic soil. Furthermore, the communities in lower-pH soils were subsets of (nested in) those in higher-pH soils. In the field communities a significant nestedness pattern was observed along the pH gradient. These observations suggest that the fungi in strongly acidic soils are pH generalists that occur not only in acidic soil but also in wide ranges of soil pH. Nestedness in AM fungal community along pH gradients may have important implications for plant community resilience and early primary succession after disturbance in acidic soils.	[Kawahara, Ai; An, Gi-Hong; Miyakawa, Sachie; Sonoda, Jun; Ezawa, Tatsuhiro] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan; [Kawahara, Ai] Sumitomo Chem Co Ltd, Hlth & Crop Sci Res Lab, Takarazuka, Hyogo, Japan; [An, Gi-Hong] Bioenergy Crop Res Ctr, Muan, South Korea	Hokkaido University; Sumitomo Chem Co Ltd	Ezawa, T (corresponding author), Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan.	tatsu@res.agr.hokudai.ac.jp	Ezawa, Tatsuhiro/B-7735-2012	Ezawa, Tatsuhiro/0000-0001-6188-7635	Japan Society for the Promotion of Science [22380042, 222805]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partially supported by the Grant-in-Aid for Scientific Research (22380042 for T.E.) and by the Grant-in-Aid for JSPS Fellows (222805 for A.K.) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2003, INT J PLANT SCI, V164, pS1, DOI 10.1086/374729; Agosta SJ, 2008, ECOL LETT, V11, P1123, DOI 10.1111/j.1461-0248.2008.01237.x; Aguilera P, 2014, AGR ECOSYST ENVIRON, V186, P178, DOI 10.1016/j.agee.2014.01.029; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida M, 2007, OIKOS, V116, P716, DOI 10.1111/j.2007.0030-1299.15803.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; An GH, 2008, SOIL SCI PLANT NUTR, V54, P517, DOI 10.1111/j.1747-0765.2008.00267.x; Angelard C, 2014, ISME J, V8, P284, DOI 10.1038/ismej.2013.154; BARTOLOMEESTEBAN H, 1994, MYCOLOGIA, V86, P217, DOI 10.2307/3760640; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Basu U, 2004, MOL GENET GENOMICS, V271, P627, DOI 10.1007/s00438-004-1015-7; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Chagnon PL, 2013, TRENDS PLANT SCI, V18, P484, DOI 10.1016/j.tplants.2013.05.001; Chagnon PL, 2012, NEW PHYTOL, V194, P307, DOI 10.1111/j.1469-8137.2011.04044.x; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cheng Y, 2013, PLANT SOIL, V365, P397, DOI 10.1007/s11104-012-1398-x; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Cumming JR, 2003, J EXP BOT, V54, P1447, DOI 10.1093/jxb/erg149; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Ezaki B, 1998, FEMS MICROBIOL LETT, V159, P99, DOI 10.1016/S0378-1097(97)00554-5; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; FOY CD, 1978, ANNU REV PLANT PHYS, V29, P511, DOI 10.1146/annurev.pp.29.060178.002455; Garcia de Leon D, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw097; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Geml J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099852; Gostincar C, 2010, FEMS MICROBIOL ECOL, V71, P2, DOI 10.1111/j.1574-6941.2009.00794.x; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Hamilton CA, 2001, FEMS MICROBIOLOGY LE; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hazard C, 2013, ISME J, V7, P498, DOI 10.1038/ismej.2012.127; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Kawahara A, 2013, OECOLOGIA, V173, P533, DOI 10.1007/s00442-013-2622-y; Kayama M, 2001, INT J PLANT SCI, V162, P1025, DOI 10.1086/322890; Kelly CN, 2005, MYCORRHIZA, V15, P193, DOI 10.1007/s00572-004-0321-6; Kidd PS, 2001, J EXP BOT, V52, P791, DOI 10.1093/jexbot/52.357.791; Klugh-Stewart K, 2009, SOIL BIOL BIOCHEM, V41, P367, DOI 10.1016/j.soilbio.2008.11.013; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Kohout P, 2015, MOL ECOL, V24, P1831, DOI 10.1111/mec.13147; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lekberg Y, 2011, ECOLOGY, V92, P1292, DOI 10.1890/10-1516.1; MacDiarmid CW, 1998, J BIOL CHEM, V273, P1727, DOI 10.1074/jbc.273.3.1727; Maki T, 2008, PLANT SOIL, V310, P55, DOI 10.1007/s11104-008-9628-y; MARTIN F, 1994, PLANTA, V194, P241, DOI 10.1007/BF01101683; Martinez-Garcia LB, 2015, NEW PHYTOL, V205, P1565, DOI 10.1111/nph.13226; Montesinos-Navarro A, 2012, NEW PHYTOL, V194, P536, DOI 10.1111/j.1469-8137.2011.04045.x; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Podani J, 2013, ECOL COMPLEX, V15, P52, DOI 10.1016/j.ecocom.2013.03.002; Podani J, 2011, OIKOS, V120, P1625, DOI 10.1111/j.1600-0706.2011.19451.x; PORTER WM, 1987, J APPL ECOL, V24, P659, DOI 10.2307/2403900; PORTER WM, 1987, J APPL ECOL, V24, P663, DOI 10.2307/2403901; Rodriguez A, 2015, ISME J, V9, P1053, DOI 10.1038/ismej.2014.207; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stewart JR, 2009, GCB BIOENERGY, V1, P126, DOI 10.1111/j.1757-1707.2009.01010.x; Sykorova Z, 2007, MYCORRHIZA, V18, P1, DOI 10.1007/s00572-007-0147-0; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trouvelot S, 1999, MYCORRHIZA, V8, P203, DOI 10.1007/s005720050235; TRUOG EMIL, 1930, JOUR AMER SOC AGRON, V22, P874; Van Tuinen D, 1998, MOL ECOL, V7, P879, DOI 10.1046/j.1365-294x.1998.00410.x; Vandenkoornhuyse P, 2003, MOL ECOL, V12, P3085, DOI 10.1046/j.1365-294X.2003.01967.x; Vosatka M, 1999, BIOL PLANTARUM, V42, P289, DOI 10.1023/A:1002125005497; Yamato M, 2012, MYCORRHIZA, V22, P623, DOI 10.1007/s00572-012-0439-x	67	16	17	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0165035	10.1371/journal.pone.0165035	http://dx.doi.org/10.1371/journal.pone.0165035			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755574	Green Submitted, gold, Green Published			2022-12-26	WOS:000386203800051
J	Sen, D; Jones, SM; Oswald, EM; Pinkard, H; Corbin, K; Krummel, MF				Sen, Debasish; Jones, Stephen M.; Oswald, Erin M.; Pinkard, Henry; Corbin, Kaitlin; Krummel, Matthew F.			Tracking the Spatial and Functional Gradient of Monocyte-To-Macrophage Differentiation in Inflamed Lung	PLOS ONE			English	Article							DENDRITIC CELLS; LYMPH-NODES; ANTIGEN; DYNAMICS; INFLAMMATION; POPULATION; SUBSETS; TISSUES; MICE	Myeloid-derived cells such as monocytes, dendritic cells (DCs), and macrophages are at the heart of the immune effector function in an inflammatory response. But because of the lack of an efficient imaging system to trace these cells live during their migration and maturation in their native environment at sub-cellular resolution, our knowledge is limited to data available from specific time-points analyzed by flow cytometry, histology, genomics and other immunological methods. Here, we have developed a ratiometric imaging method for measuring monocyte maturation in inflamed mouse lungs in situ using real-time using 2-photon imaging and complementary methods. We visualized that while undifferentiated monocytes were predominantly found only in the vasculature, a semi-differentiated monocyte/macrophage population could enter the tissue and resembled more mature and differentiated populations by morphology and surface phenotype. As these cells entered and differentiated, they were already selectively localized near inflamed airways and their entry was associated with changes in motility and morphology. We were able to visualize these during the act of differentiation, a process that can be demonstrated in this way to be faster on a per-cell basis under inflammatory conditions. Finally, our in situ analyses demonstrated increases, in the differentiating cells, for both antigen uptake and the ability to mediate interactions with T cells. This work, while largely confirming proposed models for in situ differentiation, provides important in situ data on the coordinated site-specific recruitment and differentiation of these cells and helps elaborate the predominance of immune pathology at the airways. Our novel imaging technology to trace immunogenic cell maturation in situ will complement existing information available on in situ differentiation deduced from other immunological methods, and assist better understanding of the spatio-temporal cellular behavior during an inflammatory response.	[Sen, Debasish; Jones, Stephen M.; Oswald, Erin M.; Pinkard, Henry; Corbin, Kaitlin; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Sen, Debasish] Asterias Biotherapeut, 6300 Dumbarton Circle, Fremont, CA 94555 USA	University of California System; University of California San Francisco	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	Matthew.krummel@ucsf.edu		Sen, Debasish/0000-0001-9879-8345; Krummel, Matthew/0000-0001-7915-3533	NIH [U01HL111054, U19AI077439, P01 HL024136, 2U19A1077439, 1U01HL111054]; American Lung Association; IMeRA foundation; Asterias Biotherapeutics; Institut Mediterraneen de Recherches Avancees (IMeRA); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029266] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136, U01HL111054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439, T32AI007334] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; IMeRA foundation; Asterias Biotherapeutics; Institut Mediterraneen de Recherches Avancees (IMeRA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants U01HL111054, U19AI077439, and P01 HL024136. D. Sen was supported by a fellowship from the American Lung Association and M. Krummel was supported during writing by the IMeRA foundation. Asterias Biotherapeutics provided support in the form of salaries for authors [DS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; We thank Emily Thornton, Mark Looney, Dean Sheppard and Anne Sperling for advice. We thank E.E. Thornton, O. Khan and S. Peck for Imaging assistance, Mark Headley for critical reading of the manuscript and C. Lin for administrative assistance. This work was supported by NIH grants 2U19A1077439, 1U01HL111054 and P01 HL024136 and the Institut Mediterraneen de Recherches Avancees (IMeRA). D.S. is now an employee of Asterias Biotherapeutics. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The authors do not have competing financial interests.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bullen A, 2009, CURR TOP MICROBIOL, V334, P1, DOI 10.1007/978-3-540-93864-4_1; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Daniels NJ, 2016, MUCOSAL IMMUNOL, V9, P229, DOI 10.1038/mi.2015.55; Gatti E, 2003, CURR OPIN CELL BIOL, V15, P468, DOI 10.1016/S0955-0674(03)00069-3; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Hoffmann F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00107; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Khanna KM, 2010, J IMMUNOL, V185, P239, DOI 10.4049/jimmunol.0901047; Lambrecht BN, 1998, J IMMUNOL, V160, P4090; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543; Nakano H, 2015, J IMMUNOL, V194, P3808, DOI 10.4049/jimmunol.1402195; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Rodero MP, 2015, ELIFE, V4, DOI 10.7554/eLife.07847; Segura E, 2013, TRENDS IMMUNOL, V34, P440, DOI 10.1016/j.it.2013.06.001; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Tagliani E, 2011, J EXP MED, V208, P1901, DOI 10.1084/jem.20110866; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Tomita K, 2002, CLIN IMMUNOL, V102, P258, DOI 10.1006/clim.2001.5176	26	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0165064	10.1371/journal.pone.0165064	http://dx.doi.org/10.1371/journal.pone.0165064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755611	Green Submitted, Green Published, gold			2022-12-26	WOS:000386203800053
J	Kolhe, NV; Fluck, RJ; Muirhead, AW; Taal, MW				Kolhe, Nitin V.; Fluck, Richard J.; Muirhead, Andrew W.; Taal, Maarten W.			Regional Variation in Acute Kidney Injury Requiring Dialysis in the English National Health Service from 2000 to 2015-A National Epidemiological Study	PLOS ONE			English	Article							ENGLAND; CARE; BENEFICIARIES; DISEASES; TRENDS; RATES; RISK; AKI	Background The absence of effective interventions in presence of increasing national incidence and case-fatality in acute kidney injury requiring dialysis (AKI-D) warrants a study of regional variation to explore any potential for improvement. We therefore studied regional variation in the epidemiology of AKI-D in English National Health Service over a period of 15 years. Method We analysed Hospital Episode Statistics data for all patients with a diagnosis of AKI-D, using ICD-10-CM codes, in English regions between 2000 and 2015 to study temporal changes in regional incidence and case-fatality. Results Of 203,758,879 completed discharges between 1st April 2000 and 31st March 2015, we identified 54,252 patients who had AKI-D in the nine regions of England. The population incidence of AKI-D increased variably in all regions over 15 years; however, the regional variation decreased from 3.3-fold to 1.3-fold (p<0.01). In a multivariable adjusted model, using London as the reference, in the period of 2000-2005, the North East (odd ratio (OR) 1.38; 95% CI 1.01, 1.90), East Midlands (OR 1.38; 95% CI 1.01, 1.90) and West Midlands (OR 1.38; 95% CI 1.01, 1.90) had higher odds for death, while East of England had lower odds for death (OR 0.66; 95% CI 0.49, 0.90). The North East had higher OR in all three five-year periods as compared to the other eight regions. Adjusted case-fatality showed significant variability with temporary improvement in some regions but overall there was no significant improvement in any region over 15 years. Conclusions We observed considerable regional variation in the epidemiology of AKI-D that was not entirely attributable to variations in demographic or other identifiable clinical factors. These observations make a compelling case for further research to elucidate the reasons and identify interventions to reduce the incidence and case-fatality in all regions.	[Kolhe, Nitin V.; Fluck, Richard J.; Taal, Maarten W.] Royal Derby Hosp, Dept Renal Med, Uttoxeter Rd, Derby DE22 3NE, England; [Muirhead, Andrew W.] Derby City Council, Dept Publ Hlth, Corp St, Derby DE1 2FS, England; [Taal, Maarten W.] Univ Nottingham, Div Med Sci & Grad Entry Med, Uttoxeter Rd, Derby DE22 3NE, England	University of Nottingham; University of Nottingham	Kolhe, NV (corresponding author), Royal Derby Hosp, Dept Renal Med, Uttoxeter Rd, Derby DE22 3NE, England.	nitin.kolhe@nhs.net		Taal, Maarten/0000-0002-9065-212X; Kolhe, Nitin/0000-0003-2528-4436	National Kidney Federation; AKI Clinical Study Group, UK	National Kidney Federation; AKI Clinical Study Group, UK	We thank Timothy Reilly for information support and Kirsty Swinscoe for chloropleth maps. We also thank National Kidney Federation and AKI Clinical Study Group, UK for supporting the study. The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official interpretation of the United Kingdom government	Bragg F, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5065; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Hanstede MMF, 2012, ACTA OBSTET GYN SCAN, V91, P220, DOI 10.1111/j.1600-0412.2011.01309.x; Hsu RK, 2013, CLIN J AM SOC NEPHRO, V8, P1476, DOI 10.2215/CJN.12611212; Karvellas CJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10061; Kolhe NV, 2016, INT J CLIN PRACT, V70, P330, DOI 10.1111/ijcp.12774; Kolhe NV, 2015, KIDNEY INT, V88, P1161, DOI 10.1038/ki.2015.234; Kolhe NV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132279; Kolhe NV, 2014, NEPHRON CLIN PRACT, V126, P51, DOI 10.1159/000358435; Magner D, 2009, J VASC SURG, V49, P893, DOI 10.1016/j.jvs.2008.11.065; Matlock DD, 2013, JAMA-J AM MED ASSOC, V310, P155, DOI 10.1001/jama.2013.7837; Raymont A, 2008, NEW ZEAL MED J, V121, P66; Schroeck FR, 2014, J UROLOGY, V191, P957, DOI 10.1016/j.juro.2013.10.066; Skolarus LE, 2015, STROKE, V46, P1890, DOI 10.1161/STROKEAHA.115.009163; Stewart JAD, 2009, BRIT J HOSP MED, V70, P372, DOI 10.12968/hmed.2009.70.7.43116; Tomlinson LA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-58; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; Westert GP, 2004, HEALTH PLACE, V10, P215, DOI 10.1016/j.healthplace.2003.07.002; Wu VC, 2014, J AM SOC NEPHROL, V25, P595, DOI 10.1681/ASN.2013060610	21	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0162856	10.1371/journal.pone.0162856	http://dx.doi.org/10.1371/journal.pone.0162856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749903	Green Published, Green Submitted, gold			2022-12-26	WOS:000386202300001
J	Nirmal, RC; Furtado, A; Wrigley, C; Henry, RJ				Nirmal, Ravi C.; Furtado, Agnelo; Wrigley, Colin; Henry, Robert J.			Influence of Gene Expression on Hardness in Wheat	PLOS ONE			English	Article							GRAIN HARDNESS; PUROINDOLINE-B; KERNEL HARDNESS; BAKING QUALITY; STARCH; FRIABILIN; TRITICUM; SEQUENCE; LOCUS; SOFT	Puroindoline (Pina and Pinb) genes control grain texture or hardness in wheat. Wild-type/soft alleles lead to softer grain while a mutation in one or both of these genes results in a hard grain. Variation in hardness in genotypes with identical Pin alleles (wild-type or mutant) is known but the molecular basis of this is not known. We now report the identification of wheat genotypes with hard grain texture and wild-type/soft Pin alleles indicating that hardness in wheat may be controlled by factors other than mutations in the coding region of the Pin genes. RNA-Seq analysis was used to determine the variation in the transcriptome of developing grains of thirty three diverse wheat genotypes including hard (mutant Pin) and soft (wild type) and those that were hard without having Pin mutations. This defined the role of pin gene expression and identified other candidate genes associated with hardness. Pina was not expressed in hard wheat with a mutation in the Pina gene. The ratio of Pina to Pinb expression was generally lower in the hard non mutant genotypes. Hardness may be associated with differences in Pin expression and other factors and is not simply associated with mutations in the PIN protein coding sequences.	[Nirmal, Ravi C.; Furtado, Agnelo; Wrigley, Colin; Henry, Robert J.] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia	University of Queensland	Henry, RJ (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia.	robert.henry@uq.edu.au	Wrigley, Colin/Q-7771-2019; Henry, Robert J/B-5824-2008	Henry, Robert J/0000-0002-4060-0292; Furtado, Agnelo/0000-0001-6130-9026	Australian Research Council; Green Gold Seeds Ltd., Maharashtra, India	Australian Research Council(Australian Research Council); Green Gold Seeds Ltd., Maharashtra, India	Australian Research Council and Green Gold Seeds Ltd., Maharashtra, India provided funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Australian Research Council and Green Gold Seeds Ltd., Maharashtra, India for financial support.	Alfred RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075488; Amoroso MG, 2004, BIOTECHNOL LETT, V26, P1731, DOI 10.1007/s10529-004-3745-3; Beecher B, 2002, THEOR APPL GENET, V105, P870, DOI 10.1007/s00122-002-1034-x; Bhave M, 2008, PLANT MOL BIOL, V66, P205, DOI 10.1007/s11103-007-9263-7; Breseghello F, 2005, CROP SCI, V45, P1685, DOI 10.2135/cropsci2004.0310; Campbell KG, 1999, CROP SCI, V39, P1184, DOI 10.2135/cropsci1999.0011183X003900040039x; Capparelli R, 2003, THEOR APPL GENET, V107, P1463, DOI 10.1007/s00122-003-1392-z; Carter AH, 2012, THEOR APPL GENET, V124, P1079, DOI 10.1007/s00122-011-1770-x; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Chen F, 2010, THEOR APPL GENET, V120, P745, DOI 10.1007/s00122-009-1195-y; Clarke B, 2005, THEOR APPL GENET, V110, P1259, DOI 10.1007/s00122-005-1962-3; Clifton LA, 2007, BIOCHEMISTRY-US, V46, P13929, DOI 10.1021/bi701680w; Clifton LA, 2011, PHYS CHEM CHEM PHYS, V13, P8881, DOI 10.1039/c0cp02247k; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Day L, 2006, FEBS J, V273, P5358, DOI 10.1111/j.1742-4658.2006.05528.x; DOEKES GJ, 1976, EUPHYTICA, V25, P565, DOI 10.1007/BF00041594; Drea S, 2005, PLANT CELL, V17, P2172, DOI 10.1105/tpc.105.034058; Furtado A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10446; Furtado A, 2014, METHODS MOL BIOL, V1099, P1, DOI 10.1007/978-1-62703-715-0_1; Gaines CS, 1996, CEREAL CHEM, V73, P278; Gasparis S, 2011, J EXP BOT, V62, P4025, DOI 10.1093/jxb/err103; GAUTIER MF, 1994, PLANT MOL BIOL, V25, P43, DOI 10.1007/BF00024197; Gazza L, 2008, J CEREAL SCI, V47, P52, DOI 10.1016/j.jcs.2007.01.004; Giroux MJ, 2013, CROP SCI, V53, P833, DOI 10.2135/cropsci2012.06.0359; Giroux MJ, 1997, THEOR APPL GENET, V95, P857, DOI 10.1007/s001220050636; Giroux MJ, 1998, P NATL ACAD SCI USA, V95, P6262, DOI 10.1073/pnas.95.11.6262; GREENWELL P, 1986, CEREAL CHEM, V63, P379; Hogg AC, 2004, THEOR APPL GENET, V108, P1089, DOI 10.1007/s00122-003-1518-3; Igrejas G, 2001, J CEREAL SCI, V34, P37, DOI 10.1006/jcrs.2000.0381; Krishnamurthy K, 2001, NAT BIOTECHNOL, V19, P162, DOI 10.1038/84435; Li GY, 2008, J CEREAL SCI, V47, P510, DOI 10.1016/j.jcs.2007.06.003; Lillemo M, 2006, J CEREAL SCI, V44, P86, DOI 10.1016/j.jcs.2006.03.004; Maghirang EB, 2003, CEREAL CHEM, V80, P316, DOI 10.1094/CCHEM.2003.80.3.316; McIntosh S, 2007, PLANT BIOTECHNOL J, V5, P69, DOI 10.1111/j.1467-7652.2006.00218.x; Morris CF, 1999, CEREAL CHEM, V76, P249, DOI 10.1094/CCHEM.1999.76.2.249; Oda S, 1997, J CEREAL SCI, V26, P29, DOI 10.1006/jcrs.1996.0113; Osborne BG, 2001, AUST J AGR RES, V52, P1275, DOI 10.1071/AR01056; Ramalingam A, 2012, J CEREAL SCI, V56, P171, DOI 10.1016/j.jcs.2012.02.006; Swan CG, 2006, CROP SCI, V46, P1656, DOI 10.2135/cropsci2005.06-0135; SYMES KJ, 1965, AUST J AGR RES, V16, P113, DOI 10.1071/AR9650113; Tranquilli G, 2002, CROP SCI, V42, P1812, DOI 10.2135/cropsci2002.1812; Turnbull KM, 2003, GENOME, V46, P330, DOI 10.1139/G02-124; Turnbull KM, 2003, PLANTA, V216, P699, DOI 10.1007/s00425-002-0911-5; Turnbull KM, 2000, AUST J PLANT PHYSIOL, V27, P153; Wanjugi HW, 2007, CROP SCI, V47, P67, DOI 10.2135/cropsci2006.05.0310; Wilkinson M, 2008, J CEREAL SCI, V48, P722, DOI 10.1016/j.jcs.2008.03.007; Zhang JR, 2009, PLANT BIOTECHNOL J, V7, P733, DOI 10.1111/j.1467-7652.2009.00438.x	47	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164746	10.1371/journal.pone.0164746	http://dx.doi.org/10.1371/journal.pone.0164746			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741295	Green Published, gold, Green Submitted			2022-12-26	WOS:000385507000064
J	Yang, C; Li, Z; Bhatt, T; Dickler, M; Giri, D; Scaltriti, M; Baselga, J; Rosen, N; Chandarlapaty, S				Yang, C.; Li, Z.; Bhatt, T.; Dickler, M.; Giri, D.; Scaltriti, M.; Baselga, J.; Rosen, N.; Chandarlapaty, S.			Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence	ONCOGENE			English	Article							KINASE 4/6 INHIBITOR; ESTROGEN-RECEPTOR; CELL-CYCLE; ENDOCRINE THERAPY; PD 0332991; OVEREXPRESSION; D1; DIFFERENTIATION; TRANSCRIPTION; PALBOCICLIB	Dysregulated activation of the CDK4/6 kinases is a hallmark of most mammary-derived carcinomas. ATP-competitive inhibitors against this complex have been recently advanced in the clinic and have shown significant activity, particularly against tumors driven by the estrogen receptor (ER). However, resistance to these compounds has begun to emerge often months to years after their initiation. We investigated potential mechanisms of resistance using cell line models that are highly sensitive to this class of drugs. After prolonged exposure to the selective and potent CDK4/6 inhibitor LY2835219, clones emerged and several were found to harbor amplification of the CDK6 kinase. Amplification of CDK6 resulted in a marked increase in CDK6 expression and reduced response of the CDK4/6 target, phospho-Rb (pRb), to CDK4/6 inhibitors. Knockdown of CDK6 restored drug sensitivity, while enforced overexpression of CDK6 was sufficient to mediate drug resistance. Not only did CDK6 overexpression mediate resistance to CDK4/6 inhibitors but it also led to reduced expression of the ER and progesterone receptor (PR), and diminished responsiveness to ER antagonism. The reduced ER/PR expression after CDK4/6 inhibitor resistance was additionally observed in tumor biopsy specimens from patients treated with these drugs. Alternative mechanisms of resistance to CDK4/6 inhibitors such as loss of pRb and cyclin E1 overexpression also exhibited decreased hormone responsiveness, suggesting that the clinical paradigm of sequential endocrine-based therapy may be ineffective in some settings of acquired CDK4/6 resistance.	[Yang, C.; Li, Z.] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Oncol, Xian, Peoples R China; [Yang, C.; Li, Z.; Bhatt, T.; Baselga, J.; Chandarlapaty, S.] MSKCC, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10065 USA; [Dickler, M.; Baselga, J.; Chandarlapaty, S.] MSKCC, Dept Med, Breast Med Serv, New York, NY 10065 USA; [Dickler, M.; Giri, D.; Scaltriti, M.; Baselga, J.; Rosen, N.; Chandarlapaty, S.] Weill Cornell Med Coll, New York, NY USA; [Giri, D.; Scaltriti, M.] MSKCC, Dept Pathol, New York, NY 10065 USA; [Rosen, N.] MSKCC, Mol Pharmacol Program, New York, NY 10065 USA	Xi'an Jiaotong University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Chandarlapaty, S (corresponding author), MSKCC, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10065 USA.	chandars@mskcc.org	Yang, Chengcheng/AAU-1342-2021; Rosen, Neal/ABF-2677-2020		Shen Family Foundation; Susan G Komen; Breast Cancer Research Foundation; NCI Cancer Center Support Grant (CCSG) [P30 CA08748]; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA094060] Funding Source: NIH RePORTER	Shen Family Foundation; Susan G Komen(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research Foundation; NCI Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was generously supported by funds from the Shen Family Foundation, Susan G Komen and the Breast Cancer Research Foundation. The Marie-Jose and Henry R Kravis Center for Molecular Oncology as well as NCI Cancer Center Support Grant (CCSG, P30 CA08748) additionally supported this work. We thank Weiyi Toy for her critical feedback.	Alves CL, 2016, CLIN CANC RES; Bosch A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4442; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; CC O'Sullivan, 2015, INT J CANC CLIN RES, V2, pii; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Cristofanilli M, 2016, LANCET ONCOL, V17, P425, DOI 10.1016/S1470-2045(15)00613-0; Dean JL, 2010, ONCOGENE, V29, P4018, DOI 10.1038/onc.2010.154; Dean JL, 2012, CELL CYCLE, V11, P2756, DOI 10.4161/cc.21195; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Gelbert LM, 2014, INVEST NEW DRUG, V32, P825, DOI 10.1007/s10637-014-0120-7; Grossel MJ, 2006, J CELL BIOCHEM, V97, P485, DOI 10.1002/jcb.20712; Herrera-Abreu MT, 2016, CANCER RES, V76, P2301, DOI 10.1158/0008-5472.CAN-15-0728; Houston SJ, 1999, BRIT J CANCER, V79, P1220, DOI 10.1038/sj.bjc.6690196; Infante JR, 2014, ASCO ANN M P; Jansen MPHM, 2005, J CLIN ONCOL, V23, P732, DOI 10.1200/JCO.2005.05.145; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; KARNIK PS, 1994, CANCER RES, V54, P349; Konecny GE, 2011, CLIN CANCER RES, V17, P1591, DOI 10.1158/1078-0432.CCR-10-2307; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Macaluso M, 2003, ONCOGENE, V22, P3511, DOI 10.1038/sj.onc.1206578; McDermott M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00040; Miller TW, 2011, CANCER DISCOV, V1, P338, DOI 10.1158/2159-8290.CD-11-0101; Navarro F, 2009, BLOOD, V114, P2181, DOI 10.1182/blood-2009-02-205062; Patnaik A, 2014, ASCO ANN M P; Patnaik A, 2016, CANCER DISCOV, V6, P740, DOI 10.1158/2159-8290.CD-16-0095; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Tigan AS, 2016, ONCOGENE, V35, P3083, DOI 10.1038/onc.2015.407; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Umemura S, 2009, BRIT J CANCER, V100, P764, DOI 10.1038/sj.bjc.6604900; VanArsdale T, 2015, CLIN CANCER RES, V21, P2905, DOI 10.1158/1078-0432.CCR-14-0816; WATTS CKW, 1995, MOL ENDOCRINOL, V9, P1804, DOI 10.1210/me.9.12.1804; Wilcken NRC, 1997, CLIN CANCER RES, V3, P849; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	38	187	193	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 20	2017	36	16					2255	2264		10.1038/onc.2016.379	http://dx.doi.org/10.1038/onc.2016.379			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DM	27748766	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000399782700006
J	Mahapatra, G; Varughese, A; Ji, QQ; Lee, I; Liu, J; Vaishnav, A; Sinkler, C; Kapralov, AA; Moraes, CT; Sanderson, TH; Stemmler, TL; Grossman, LI; Kagan, VE; Brunzelle, JS; Salomon, AR; Edwards, BFP; Huttemanna, M				Mahapatra, Gargi; Varughese, Ashwathy; Ji, Qinqin; Lee, Icksoo; Liu, Jenney; Vaishnav, Asmita; Sinkler, Christopher; Kapralov, Alexandr A.; Moraes, Carlos T.; Sanderson, Thomas H.; Stemmler, Timothy L.; Grossman, Lawrence I.; Kagan, Valerian E.; Brunzelle, Joseph S.; Salomon, Arthur R.; Edwards, Brian F. P.; Huttemanna, Maik			Phosphorylation of Cytochrome c Threonine 28 Regulates Electron Transport Chain Activity in Kidney IMPLICATIONS FOR AMP KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDASE; MITOCHONDRIA; APOPTOSIS; LIVER; CARDIOLIPIN; RESPIRATION; SUPEROXIDE; MECHANISMS; PREDICTION; BINDING	Mammalian cytochrome c (Cytc) plays a key role in cellular life and death decisions, functioning as an electron carrier in the electron transport chain and as a trigger of apoptosis when released from the mitochondria. However, its regulation is not well understood. We show that the major fraction of Cytc isolated from kidneys is phosphorylated on Thr(28), leading to a partial inhibition of respiration in the reaction with cytochrome c oxidase. To further study the effect of Cytc phosphorylation in vitro, we generated T28E phosphomimetic Cytc, revealing superior behavior regarding protein stability and its ability to degrade reactive oxygen species compared with wild-type un-phosphorylated Cytc. Introduction of T28E phosphomimetic Cytc into Cytc knock-out cells shows that intact cell respiration, mitochondrial membrane potential (Delta Psi(m)), and ROS levels are reduced compared with wild type. As we show by high resolution crystallography of wild-type and T28E Cytc in combination with molecular dynamics simulations, Thr(28) is located at a central position near the heme crevice, the most flexible epitope of the protein apart from the N and C termini. Finally, in silico prediction and our experimental data suggest that AMP kinase, which phosphorylates Cytc on Thr(28) in vitro and colocalizes with Cytc to the mitochondrial intermembrane space in the kidney, is the most likely candidate to phosphorylate Thr(28) in vivo. We conclude that Cytc phosphorylation is mediated in a tissue-specific manner and leads to regulation of electron transport chain flux via "controlled respiration," preventing Delta Psi(m) hyperpolarization, a known cause of ROS and trigger of apoptosis.	[Mahapatra, Gargi; Varughese, Ashwathy; Lee, Icksoo; Liu, Jenney; Sinkler, Christopher; Grossman, Lawrence I.; Huttemanna, Maik] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Mahapatra, Gargi; Varughese, Ashwathy; Vaishnav, Asmita; Edwards, Brian F. P.; Huttemanna, Maik] Wayne State Univ, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Sanderson, Thomas H.] Wayne State Univ, Dept Emergency Med, Detroit, MI 48201 USA; [Stemmler, Timothy L.] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48201 USA; [Ji, Qinqin] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Salomon, Arthur R.] Brown Univ, MCB Dept, Providence, RI 02912 USA; [Lee, Icksoo] Dankook Univ, Coll Med, Cheonan Si 31116, Chungcheongnam, South Korea; [Kapralov, Alexandr A.; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA 15219 USA; [Kapralov, Alexandr A.; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Moraes, Carlos T.] Univ Miami, Sch Med, Dept Neurol, Miami, FL 33136 USA; [Brunzelle, Joseph S.] Northwestern Univ, Ctr Synchrotron Res, Life Sci Collaborat Access Team, Argonne, IL 60439 USA	Wayne State University; Wayne State University; Wayne State University; Wayne State University; Brown University; Brown University; Dankook University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Miami; Northwestern University	Huttemanna, M (corresponding author), Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA.	mhuttema@med.wayne.edu	Sanderson, Thomas H/K-6656-2012; Mahapatra, Gargi/ABC-9107-2020; Moraes, Carlos/AAT-3818-2021	Sanderson, Thomas H/0000-0003-0112-8164; Mahapatra, Gargi/0000-0003-2363-4092; Huttemann, Maik/0000-0001-6310-7081; Stemmler, Timothy/0000-0002-6298-088X; Kagan, Valerian E./0000-0002-7245-1885; Brunzelle, Joseph/0000-0001-9197-0018; Kapralov, Oleksandr/0000-0002-3006-916X	Department of Energy Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL120822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091242] Funding Source: NIH RePORTER	Department of Energy Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research used resources of the Advanced Photon Source, a United States Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation, the Michigan Technology Tri-Corridor (Grant 085P1000817), and Wayne State University Office of the Vice-President for Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cammack R., 1995, BIOENERGETICS PRACTI, P93; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Dickerson L., 2004, GALE ENCY SCI, P500; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FERGUSONMILLER S, 1976, J BIOL CHEM, V251, P1104; Firsov D, 2010, KIDNEY INT, V78, P640, DOI 10.1038/ki.2010.227; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Garcia-Heredia JM, 2011, J BIOL INORG CHEM, V16, P1155, DOI 10.1007/s00775-011-0804-9; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; GOLDBERG E, 1977, SCIENCE, V196, P1010, DOI 10.1126/science.193188; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guerra-Castellano A, 2016, BBA-BIOENERGETICS, V1857, P387, DOI 10.1016/j.bbabio.2016.01.011; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2014, CELL METAB, V20, P939, DOI 10.1016/j.cmet.2014.09.013; Hopper RK, 2006, BIOCHEMISTRY-US, V45, P2524, DOI 10.1021/bi052475e; Huttemann M, 2012, ADV EXP MED BIOL, V748, P237, DOI 10.1007/978-1-4614-3573-0_10; Ix JH, 2010, J AM SOC NEPHROL, V21, P406, DOI 10.1681/ASN.2009080820; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; Lee I, 2006, BIOCHEMISTRY-US, V45, P9121, DOI 10.1021/bi060585v; Lempiainen J, 2012, BRIT J PHARMACOL, V166, P1905, DOI 10.1111/j.1476-5381.2012.01895.x; Liu SS, 1999, J BIOENERG BIOMEMBR, V31, P367; Liu Z, 2006, P NATL ACAD SCI USA, V103, P8965, DOI 10.1073/pnas.0603327103; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pecina P, 2010, BIOCHEMISTRY-US, V49, P6705, DOI 10.1021/bi100486s; Pecinova A, 2011, MITOCHONDRION, V11, P722, DOI 10.1016/j.mito.2011.05.006; Pereverzev MO, 2003, BIOCHEM SOC T, V31, P1312; Rajagopal BS, 2013, BIOCHEM J, V456, P441, DOI 10.1042/BJ20130758; Roberts VA, 1999, J BIOL CHEM, V274, P38051, DOI 10.1074/jbc.274.53.38051; Sanderson TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078627; SANISHVILI R, 1995, STRUCTURE, V3, P707, DOI 10.1016/S0969-2126(01)00205-2; Satriano J, 2013, AM J PHYSIOL-RENAL, V305, pF727, DOI 10.1152/ajprenal.00293.2013; Sugitani R, 2009, BBA-BIOENERGETICS, V1787, P1140, DOI 10.1016/j.bbabio.2009.04.004; Takiyama Y, 2011, DIABETES, V60, P981, DOI 10.2337/db10-0655; Tong WH, 2011, CANCER CELL, V20, P315, DOI 10.1016/j.ccr.2011.07.018; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Vempati UD, 2007, MOL CELL BIOL, V27, P1771, DOI 10.1128/MCB.00287-06; Vempati UD, 2009, J BIOL CHEM, V284, P4383, DOI 10.1074/jbc.M805972200; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu H, 2008, BBA-BIOENERGETICS, V1777, P1066, DOI 10.1016/j.bbabio.2008.04.023; Zaidi S, 2014, CELL MOL LIFE SCI, V71, P229, DOI 10.1007/s00018-013-1341-1; Zhao XL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000299; Zhou MY, 2015, GENE DEV, V29, P2349, DOI 10.1101/gad.272278.115; Zuber AM, 2009, P NATL ACAD SCI USA, V106, P16523, DOI 10.1073/pnas.0904890106	56	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					64	79		10.1074/jbc.M116.744664	http://dx.doi.org/10.1074/jbc.M116.744664			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27758862	hybrid, Green Published			2022-12-26	WOS:000391578000006
J	Kratochwill, K; Boehm, M; Herzog, R; Gruber, K; Lichtenauer, AM; Kuster, L; Csaicsich, D; Gleiss, A; Alper, SL; Aufricht, C; Vychytil, A				Kratochwill, Klaus; Boehm, Michael; Herzog, Rebecca; Gruber, Katharina; Lichtenauer, Anton Michael; Kuster, Lilian; Csaicsich, Dagmar; Gleiss, Andreas; Alper, Seth L.; Aufricht, Christoph; Vychytil, Andreas			Addition of Alanyl-Glutamine to Dialysis Fluid Restores Peritoneal Cellular Stress Responses - A First-In-Man Trial	PLOS ONE			English	Article							HUMAN MESOTHELIAL CELLS; STAPHYLOCOCCUS-EPIDERMIDIS CHALLENGE; BLOOD MONONUCLEAR-CELLS; HUMAN MONOCYTIC CELLS; HEAT-SHOCK RESPONSE; RENAL-FAILURE MICE; NF-KAPPA-B; CYTOKINE PRODUCTION; IN-VITRO; BIOCOMPATIBILITY	Background Peritonitis and ultrafiltration failure remain serious complications of chronic peritoneal dialysis (PD). Dysfunctional cellular stress responses aggravate peritoneal injury associated with PD fluid exposure, potentially due to peritoneal glutamine depletion. In this randomized cross-over phase I/II trial we investigated cytoprotective effects of alanyl-glutamine (AlaGln) addition to glucose-based PDF. Methods In a prospective randomized cross-over design, 20 stable PD outpatients underwent paired peritoneal equilibration tests 4 weeks apart, using conventional acidic, single chamber 3.86% glucose PD fluid, with and without 8 mM supplemental AlaGln. Heat-shock protein 72 expression was assessed in peritoneal effluent cells as surrogate parameter of cellular stress responses, complemented by metabolomics and functional immunocompetence assays. Results AlaGln restored peritoneal glutamine levels and increased the primary outcome heat-shock protein expression (effect 1.51-fold, CI 1.07-2.14; p = 0.022), without changes in peritoneal ultrafiltration, small solute transport, or biomarkers reflecting cell mass and inflammation. Further effects were glutamine-like metabolomic changes and increased ex-vivo LPS-stimulated cytokine release from healthy donor peripheral blood monocytes. In patients with a history of peritonitis (5 of 20), AlaGln supplementation decreased dialysate interleukin-8 levels. Supplemented PD fluid also attenuated inflammation and enhanced stimulated cytokine release in a mouse model of PD-associated peritonitis. Conclusion We conclude that AlaGln-supplemented, glucose-based PD fluid can restore peritoneal cellular stress responses with attenuation of sterile inflammation, and may improve peritoneal host-defense in the setting of PD.	[Kratochwill, Klaus; Boehm, Michael; Herzog, Rebecca; Gruber, Katharina; Lichtenauer, Anton Michael; Kuster, Lilian; Csaicsich, Dagmar; Aufricht, Christoph] Med Univ Vienna, Dept Pediat & Adolescent Med, Div Pediat Nephrol & Gastroenterol, Vienna, Austria; [Kratochwill, Klaus; Herzog, Rebecca] Med Univ Vienna, Christian Doppler Lab Mol Stress Res Peritoneal D, Dept Pediat & Adolescent Med, Vienna, Austria; [Kratochwill, Klaus; Herzog, Rebecca; Lichtenauer, Anton Michael; Kuster, Lilian] Zytoprotec GmbH, Vienna, Austria; [Gleiss, Andreas] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Alper, Seth L.] Harvard Med Sch, Div Nephrol, Boston, MA USA; [Alper, Seth L.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA USA; [Vychytil, Andreas] Med Univ Vienna, Div Nephrol & Dialysis, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Medical University of Vienna	Vychytil, A (corresponding author), Med Univ Vienna, Div Nephrol & Dialysis, Vienna, Austria.	andreas.vychytil@meduniwien.ac.at		Herzog, Rebecca/0000-0003-1946-7770; Kratochwill, Klaus/0000-0003-0803-614X	ZIT Technology Agency of the City of Vienna [701333]; FFG - the Austrian Research Promotion Agency [823972, 839912]; European Union within the Marie Curie scheme	ZIT Technology Agency of the City of Vienna; FFG - the Austrian Research Promotion Agency; European Union within the Marie Curie scheme	This study was funded by ZIT Technology Agency of the City of Vienna (ID 701333) and FFG - the Austrian Research Promotion Agency (IDs 823972 and 839912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KK and CA were part of the European Training and Research in Peritoneal Dialysis (EuTRiPD) program, a project funded by the European Union within the Marie Curie scheme. We are specifically grateful for the fruitful discussions and support by the group leaders of EuTRiPD. We also thank the team of the clinical studies coordination center (Koordinationszentrum fur Klinische Studien, KKS) of the Medical University of Vienna, the staff of the dialysis ward at the Vienna General Hospital, Konstantin Bergmeister and Markus Sass for assistance with the mouse experiments, David Kasper for support regarding the metabolomics analysis, Anja Wagner and Silvia Tarantino for assistance with the proteomics analysis, Isabel Sobieszek and Katarzyna Bialas for assistance with analyses and Axana Hellmann and Markus Unterwurzacher for technical support in manuscript preparation.	[Anonymous], 2014, ESRD PAT 2013 GLOB P; Arbeiter K, 2001, KIDNEY INT, V60, P1930, DOI 10.1046/j.1523-1755.2001.00004.x; Aufricht C, 2001, PERITON DIALYSIS INT, V21, P85; Aufricht C, 2007, PERITON DIALYSIS INT, V27, P258; Bacharaki D, 2009, NEPHRON CLIN PRACT, V113, pC321, DOI 10.1159/000235951; Bender TO, 2010, PERITON DIALYSIS INT, V30, P294, DOI 10.3747/pdi.2009.00024; Bidmon B, 2004, KIDNEY INT, V66, P2300, DOI 10.1111/j.1523-1755.2004.66040.x; Boehm M, 2010, PEDIATR NEPHROL, V25, P169, DOI 10.1007/s00467-009-1284-9; Boldyrev Alexander, 2013, Curr Aging Sci, V6, P29; Brulez HFH, 1999, J CLIN PATHOL, V52, P901, DOI 10.1136/jcp.52.12.901; Cendoroglo M, 1998, AM J KIDNEY DIS, V31, P273, DOI 10.1053/ajkd.1998.v31.pm9469498; Chen Yu, 2007, Inflammation & Allergy Drug Targets, V6, P91; Cho Y, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007554.pub2; Cho Y, 2013, KIDNEY INT, V84, P969, DOI 10.1038/ki.2013.190; Coeffier M, 2010, INFLAMM BOWEL DIS, V16, P518, DOI 10.1002/ibd.21017; Csaicsich D, 2015, PERITON DIALYSIS INT, V35, P590, DOI 10.3747/pdi.2014.00118; Davies SJ, 1998, KIDNEY INT, V54, P2207, DOI 10.1046/j.1523-1755.1998.00180.x; DeMeester SL, 2001, FASEB J, V15, P270, DOI 10.1096/fj.00-0170hyp; Devuyst O, 2002, NEPHROL DIAL TRANSPL, V17, P12, DOI 10.1093/ndt/17.suppl_3.12; Eliasen MM, 2006, J MOL MED, V84, P147, DOI 10.1007/s00109-005-0004-6; Endemann M, 2007, AM J PHYSIOL-RENAL, V292, pF47, DOI 10.1152/ajprenal.00503.2005; Evans DW, 2010, NEPHROL DIAL TRANSPL, V25, P2315, DOI 10.1093/ndt/gfq003; Exner R, 2003, ANN SURG, V237, P110, DOI 10.1097/00000658-200301000-00015; Exner R, 2002, SURGERY, V131, P75, DOI 10.1067/msy.2002.118318; Ferrantelli E, 2016, KIDNEY INT, V89, P625, DOI 10.1016/j.kint.2015.12.005; Flessner MF, 2007, CLIN NEPHROL, V68, P341; Fusshoeller A, 2004, NEPHROL DIAL TRANSPL, V19, P2101, DOI 10.1093/ndt/gfh326; GALLIMORE B, 1989, AM J KIDNEY DIS, V14, P184, DOI 10.1016/S0272-6386(89)80069-1; GALLIMORE B, 1987, KIDNEY INT, V32, P678, DOI 10.1038/ki.1987.260; Garcia-Lopez E, 2012, NAT REV NEPHROL, V8, P224, DOI 10.1038/nrneph.2012.13; Haas S, 2003, J AM SOC NEPHROL, V14, P2632, DOI 10.1097/01.ASN.0000086475.83211.DF; Herzog R, 2014, J AM SOC NEPHROL, V25, P2778, DOI 10.1681/ASN.2013101128; JORRES A, 1992, INT J ARTIF ORGANS, V15, P79; Kratochwill K, 2012, NEPHROL DIAL TRANSPL, V27, P937, DOI 10.1093/ndt/gfr459; Kratochwill K, 2011, AM J PATHOL, V178, P1544, DOI 10.1016/j.ajpath.2010.12.034; Kratochwill K, 2009, J PROTEOME RES, V8, P1731, DOI 10.1021/pr800916s; Lichtenauer AM, 2014, ELECTROPHORESIS, V35, P1387, DOI 10.1002/elps.201300499; Mackenzie R, 2003, KIDNEY INT, V64, pS84, DOI 10.1046/j.1523-1755.2003.08809.x; Gomes AM, 2009, NEPHROL DIAL TRANSPL, V24, P3513, DOI 10.1093/ndt/gfp319; Marzec L, 2007, PERITON DIALYSIS INT, V27, P288; Mbodji K, 2011, CLIN NUTR, V30, P672, DOI 10.1016/j.clnu.2011.04.002; McIntyre CW, 2007, KIDNEY INT, V71, P486, DOI 10.1038/sj.ki.5002109; Mehrotra R, 2016, J AM SOC NEPHROL; Melis GC, 2005, BRIT J NUTR, V94, P19, DOI 10.1079/BJN20051463; MORIMOTO RI, 1994, BIOL HEAT SHOCK PROT; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Morinaga H, 2012, PERITON DIALYSIS INT, V32, P453, DOI 10.3747/pdi.2011.00032; Morrison AL, 2006, AM J PHYSIOL-CELL PH, V290, pC1625, DOI 10.1152/ajpcell.00635.2005; Mujais S, 2000, PERITON DIALYSIS INT, V20, pS5; Naka S, 1996, JPEN-PARENTER ENTER, V20, P417, DOI 10.1177/0148607196020006417; Nakao T, 1996, Perit Dial Int, V16 Suppl 1, pS88; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; Ni J, 2003, J AM SOC NEPHROL, V14, P3205, DOI 10.1097/01.ASN.0000099382.18284.57; Pecoits-Filho R, 2004, PERITON DIALYSIS INT, V24, P327; Pippias M, 2016, NEPHROL DIAL TRANSPL, V31, P831, DOI 10.1093/ndt/gfv327; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Riesenhuber A, 2007, PEDIATR NEPHROL, V22, P1205, DOI 10.1007/s00467-007-0484-4; Roth E, 2008, J NUTR, V138, p2025S, DOI 10.1093/jn/138.10.2025S; Schilte MN, 2009, PERITON DIALYSIS INT, V29, P605; Singleton KD, 2005, SHOCK, V24, P583, DOI 10.1097/01.shk.0000185795.96964.71; Spittler A, 1997, CLIN NUTR, V16, P97, DOI 10.1016/S0261-5614(97)80031-3; SPITTLER A, 1995, BLOOD, V86, P1564, DOI 10.1182/blood.V86.4.1564.bloodjournal8641564; Spittler A, 2001, CLIN NUTR, V20, P37, DOI 10.1054/clnu.2000.0153; Tao KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010050.pub2; TWARDOWSKI ZJ, 1987, PERITON DIALYSIS INT, V7, P138; van Diepen AT, 2014, PERIT DIAL INT; van Esch S, 2014, PERIT DIAL INT; Weitzel LRB, 2010, CRIT CARE CLIN, V26, P515, DOI 10.1016/j.ccc.2010.04.006; Wernerman J, 2008, J NUTR, V138, p2040S, DOI 10.1093/jn/138.10.2040S; Wischmeyer PE, 2001, J APPL PHYSIOL, V90, P2403, DOI 10.1152/jappl.2001.90.6.2403	70	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165045	10.1371/journal.pone.0165045	http://dx.doi.org/10.1371/journal.pone.0165045			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768727	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400046
J	Shiraishi, A; Murata, J; Matsumoto, E; Matsubara, S; Ono, E; Satake, H				Shiraishi, Akira; Murata, Jun; Matsumoto, Erika; Matsubara, Shin; Ono, Eiichiro; Satake, Honoo			De Novo Transcriptomes of Forsythia koreana Using a Novel Assembly Method: Insight into Tissue- and Species-Specific Expression of Lignan Biosynthesis-Related Gene	PLOS ONE			English	Article							GENOME; FRUITS	Forsythia spp. are perennial woody plants which are one of the most extensively used medicinal sources of Chinese medicines and functional diets owing to their lignan contents. Lignans have received widespread attention as leading compounds in the development of antitumor drugs and healthy diets for reducing the risks of lifestyle-related diseases. However, the molecular basis of Forsythia has yet to be established. In this study, we have verified de novo deep transcriptome of Forsythia koreana leaf and callus using the Illumina HiSeq 1500 platform. A total of 89 million reads were assembled into 116,824 contigs using Trinity, and 1,576 of the contigs displayed the sequence similarity to the enzymes responsible for plant specialized metabolism including lignan biosynthesis. Notably, gene ontology (GO) analysis indicated the remarkable enrichment of lignan-biosynthetic enzyme genes in the callus transcriptome. Nevertheless, precise annotation and molecular phylogenetic analyses were hindered by partial sequences of open reading frames (ORFs) of the Trinity-based contigs. To obtain more numerous contigs harboring a full-length ORF, we developed a novel overlapping layout consensus-based procedure, virtual primer-based sequence reassembly (VP-seq). VP-seq elucidated 709 full-length ORFs, whereas only 146 full-length ORFs were assembled by Trinity. The comparison of expression profiles of leaf and callus using VP-seq-based full-length ORFs revealed 50-fold upregulation of secoisolariciresinol dehydrogenase (SIRD) in callus. Expression and phylogenetic cluster analyses predicted candidates for matairesinol-glucosylating enzymes. We also performed VP-seq analysis of lignan-biosynthetic enzyme genes in the transcriptome data of other lignan-rich plants, Linum flavum, Linum usitatissimum and Podophyllum hexandrum. The comparative analysis indicated both common gene clusters involved in biosynthesis upstream of matairesinol such as SIRD and plant lineage-specific gene clusters, in particular, genes responsible for biosynthetic pathways for production of podophyllotoxin; CYP71BE54, a key enzyme gene for podophyllotoxin biosynthesis in P. hexandrum, was not found in L. flavum, although both P. hexandrum. and L. flavum yield podophyllotoxin. Altogether, these data have established the fruitful molecular basis of Forsythia and provided insight into the molecular evolution and diversity of lignan biosynthetic pathways.	[Shiraishi, Akira; Murata, Jun; Matsumoto, Erika; Matsubara, Shin; Satake, Honoo] Suntory Fdn Life Sci, Bioorgan Res Inst, Kyoto 6190284, Japan; [Ono, Eiichiro] Suntory Global Innovat Ctr SIC Ltd, Res Inst, Kyoto 6190284, Japan	Suntory Holdings Ltd; Suntory Holdings Ltd	Satake, H (corresponding author), Suntory Fdn Life Sci, Bioorgan Res Inst, Kyoto 6190284, Japan.	satake@sunbor.or.jp	Murata, Jun/AAN-9101-2020	Murata, Jun/0000-0001-7867-330X; Matsubara, Shin/0000-0002-7794-534X; Shiraishi, Akira/0000-0003-3456-3074	Plant Factory project of the Ministry of Economy, Trade and Industry, Japan; Grants-in-Aid for Scientific Research [16K07430] Funding Source: KAKEN	Plant Factory project of the Ministry of Economy, Trade and Industry, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by the Plant Factory project of the Ministry of Economy, Trade and Industry, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERCREUTZ H, 1995, J STEROID BIOCHEM, V52, P97, DOI 10.1016/0960-0760(94)00146-D; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bhattacharyya D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-748; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dalisay DS, 2015, J NAT PROD, V78, P1231, DOI 10.1021/acs.jnatprod.5b00023; Fini L, 2008, CARCINOGENESIS, V29, P139, DOI 10.1093/carcin/bgm255; Ghose K, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-82; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo H, 2007, RAPID COMMUN MASS SP, V21, P715, DOI 10.1002/rcm.2875; He ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145385; Kim HJ, 2009, PLANT CELL PHYSIOL, V50, P2200, DOI 10.1093/pcp/pcp156; Kumar P, 2017, PROTOPLASMA, V254, P217, DOI 10.1007/s00709-015-0938-7; Kuo PC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/304830; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau W, 2015, SCIENCE, V349, P1224, DOI 10.1126/science.aac7202; Lee JY, 2010, BIOL PHARM BULL, V33, P230, DOI 10.1248/bpb.33.230; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105775; MACRAE WD, 1984, PHYTOCHEMISTRY, V23, P1207, DOI 10.1016/S0031-9422(00)80428-8; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marques JV, 2013, J BIOL CHEM, V288, P466, DOI 10.1074/jbc.M112.400689; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW669, DOI 10.1093/nar/gki436; Murata J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144519; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Natsume S, 2015, PLANT CELL PHYSIOL, V56, P428, DOI 10.1093/pcp/pcu169; Ono E, 2010, PLANT BIOTECHNOL-NAR, V27, P317, DOI 10.5511/plantbiotechnology.27.317; Piao XL, 2008, BIOORG MED CHEM LETT, V18, P1980, DOI 10.1016/j.bmcl.2008.01.115; Ragamustari SK, 2013, PLANT BIOTECHNOL-NAR, V30, P375, DOI 10.5511/plantbiotechnology.13.0527b; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Satake H, 2015, METABOLITES, V5, P270, DOI 10.3390/metabo5020270; Satake H, 2013, J AGR FOOD CHEM, V61, P11721, DOI 10.1021/jf4007104; Umezawa Toshiaki, 2003, Phytochemistry Reviews, V2, P371, DOI 10.1023/B:PHYT.0000045487.02836.32; Wickramasuriya AM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1504-6; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang XS, 2014, INT J MOL SCI, V15, P5079, DOI 10.3390/ijms15035079	37	16	16	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164805	10.1371/journal.pone.0164805	http://dx.doi.org/10.1371/journal.pone.0164805			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768772	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400031
J	Walz, L; Jonsson, AK; Zilg, B; Ostgren, CJ; Druid, H				Walz, Lotta; Jonsson, Anna K.; Zilg, Brita; Ostgren, Carl Johan; Druid, Henrik			Risk Factors for Fatal Hyperglycaemia Confirmed by Forensic Postmortem Examination - A Nationwide Cohort in Sweden	PLOS ONE			English	Article							DIABETIC-KETOACIDOSIS; GLYCEMIC CONTROL; REFILL ADHERENCE; EXCESS MORTALITY; MELLITUS; MEDICATION; DEATH; COMPLICATIONS; ASSOCIATION; DIAGNOSIS	Aims/Hypothesis The aim of this study was to identify risk factors associated with confirmed fatal hyperglycaemia, which could predispose potentially preventable deaths in individuals on glucose lowering drugs. Methods A retrospective register-based case-control study conducted on a nationwide cohort with individuals who died due to hyperglycaemia as determined by forensic postmortem examination, in Sweden August 2006 to December 2012. Vitreous glucose was used to diagnose hyperglycaemia postmortem. The forensic findings stored in the National Forensic Medicine Database were linked to nationwide registers. Cases that died due to confirmed hyperglycemia with dispensed glucose lowering drugs were identified and living controls with dispensed glucose lowering drugs were randomly selected in the Swedish prescribed drug register and matched on age and sex. Information on comorbidities, dispensed pharmaceuticals, clinical data and socioeconomic factors were obtained for cases and controls. Adjusted multiple logistic regression models were used to identify risk factors associated with fatal hyperglycaemia. Results During the study period 322 individuals, mostly males (79%) with the mean age of 53.9 years (SD. +/- 14) died due to confirmed hyperglycaemia. Risk factors for fatal hyperglycaemia included; insulin treatment (OR = 4.40; 95% CI, 1.96, 9.85), poor glycaemic control (OR = 2.00 95% CI, 1.23, 3.27), inadequate refill-adherence before death (OR = 3.87; 95% CI, 1.99, 7.53), microvascular disease (OR = 3.26; 95% CI, 1.84, 5.79), psychiatric illness (OR = 2.30; 95% CI, 1.32, 4.01), substance abuse (OR = 8.85; 95% CI, 2.34, 35.0) and/or living alone (OR = 2.25; 95% CI, 1.21, 4.18). Conclusions/ Interpretation Our results demonstrate the importance of clinical attention to poor glycaemic control in subjects with psychosocial problems since it may indicate serious non-adherence, which consequently could lead to fatal hyperglycaemia.	[Walz, Lotta; Zilg, Brita; Druid, Henrik] Karolinska Inst, Dept Oncol Pathol, Forens Med Lab, Stockholm, Sweden; [Walz, Lotta] MSD AB, Stockholm, Sweden; [Jonsson, Anna K.] Natl Board Forens Med, Dept Forens Genet & Forens Toxicol, Linkoping, Sweden; [Zilg, Brita] Natl Board Forens Med, Dept Forens Med, Stockholm, Sweden; [Ostgren, Carl Johan] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden	Karolinska Institutet; Swedish National Board of Forensic Medicine; Swedish National Board of Forensic Medicine; Linkoping University	Walz, L (corresponding author), Karolinska Inst, Dept Oncol Pathol, Forens Med Lab, Stockholm, Sweden.; Walz, L (corresponding author), MSD AB, Stockholm, Sweden.	Lotta.walz@ki.se		Zilg, Brita/0000-0002-3837-1195				Agudo A, 1999, INT J EPIDEMIOL, V28, P1130, DOI 10.1093/ije/28.6.1130; Ali Z, 2012, AM J FOREN MED PATH, V33, P189, DOI 10.1097/PAF.0b013e31825192e7; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Delaney ME, 2000, ENDOCRIN METAB CLIN, V29, P683, DOI 10.1016/S0889-8529(05)70159-6; Druid H, 1996, J FORENSIC SCI, V41, P830; Druid H, 1997, J FORENSIC SCI, V42, P79; Ekstrom N, 2012, DIABETES OBES METAB, V14, P717, DOI 10.1111/j.1463-1326.2012.01591.x; FELBY S, 1994, FORENSIC SCI INT, V64, P83, DOI 10.1016/0379-0738(94)90216-X; Gudbjornsdottir S, 2003, DIABETES CARE, V26, P1270, DOI 10.2337/diacare.26.4.1270; Hess C, 2013, DRUG TEST ANAL, V5, P795, DOI 10.1002/dta.1479; Hockenhull J, 2012, FORENSIC SCI INT, V214, P142, DOI 10.1016/j.forsciint.2011.07.040; Hu G, 2005, DIABETOLOGIA, V48, P856, DOI 10.1007/s00125-005-1730-6; Iqbal N, 2008, ANN CLIN BIOCHEM, V45, P504, DOI 10.1258/acb.2008.008034; Jansson SPO, 2007, DIABETOLOGIA, V50, P703, DOI 10.1007/s00125-007-0593-4; Jonsson AK, 2014, EUR J CLIN PHARMACOL, V70, P589, DOI 10.1007/s00228-014-1649-2; Kitabchi AE, 2006, ENDOCRIN METAB CLIN, V35, P725, DOI 10.1016/j.ecl.2006.09.006; Knychala MA, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0020-9; Kokavec J, 2016, CLIN EXP OPHTHALMOL; Lesen E, 2011, PHARMACOEPIDEM DR S, V20, P1073, DOI 10.1002/pds.2204; Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; LUNDQUIST O, 1994, GRAEF ARCH CLIN EXP, V232, P71, DOI 10.1007/BF00171666; Maletkovic J, 2013, ENDOCRIN METAB CLIN, V42, P677, DOI 10.1016/j.ecl.2013.07.001; Mannucci E, 2014, J ENDOCRINOL INVEST, V37, P477, DOI 10.1007/s40618-014-0069-6; MIETTINE.OS, 1970, AM J EPIDEMIOL, V91, P111, DOI 10.1093/oxfordjournals.aje.a121118; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Mulnier HE, 2006, DIABETIC MED, V23, P516, DOI 10.1111/j.1464-5491.2006.01838.x; Nicholas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068008; Osborn CY, 2012, GEN HOSP PSYCHIAT, V34, P249, DOI 10.1016/j.genhosppsych.2012.01.015; Palmiere C, 2015, CROAT MED J, V56, P181, DOI 10.3325/cmj.2015.56.181; Palmiere C, 2013, FORENSIC SCI INT, V226, P160, DOI 10.1016/j.forsciint.2013.01.004; Parker MM, 2015, J AM MED INFORM ASSN, V22, P957, DOI 10.1093/jamia/ocv054; Peyrot M, 2012, DIABETIC MED, V29, P682, DOI 10.1111/j.1464-5491.2012.03605.x; Randall L, 2011, DIABETES CARE, V34, P1891, DOI 10.2337/dc11-0701; Rausch JR, 2012, DIABETES CARE, V35, P1219, DOI 10.2337/dc11-2163; Roglic G, 2010, DIABETES RES CLIN PR, V87, P15, DOI 10.1016/j.diabres.2009.10.006; Sadr-Azodi O, 2013, JAMA INTERN MED, V173, P444, DOI 10.1001/jamainternmed.2013.2737; Schoenthaler AM, 2012, DIABETES EDUCATOR, V38, P397, DOI 10.1177/0145721712440333; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Sweden S, 2015, THE LONGITUDINAL INT; Tancredi M, 2015, NEW ENGL J MED, V373, P1720, DOI 10.1056/NEJMoa1504347; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Wareham Nicholas J., 2010, MEDICINE, V11, P602; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; White AJS, 2012, PRIM CARE DIABETES, V6, P27, DOI 10.1016/j.pcd.2011.07.004; WHITTALL DE, 1990, MED J AUSTRALIA, V152, P598, DOI 10.5694/j.1326-5377.1990.tb125391.x; Zilg B, 2009, FORENSIC SCI INT, V185, P89, DOI 10.1016/j.forsciint.2008.12.017; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	49	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164950	10.1371/journal.pone.0164950	http://dx.doi.org/10.1371/journal.pone.0164950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768720	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400040
J	Hasselhof, V; Sperling, A; Buttler, K; Strobel, P; Becker, J; Aung, T; Felmerer, G; Wilting, J				Hasselhof, Viktoria; Sperling, Anastasia; Buttler, Kerstin; Strobel, Philipp; Becker, Jurgen; Aung, Thiha; Felmerer, Gunther; Wilting, Jorg			Morphological and Molecular Characterization of Human Dermal Lymphatic Collectors	PLOS ONE			English	Article							HUMAN THORACIC-DUCT; POLYMORPHIC VENTRICULAR-TACHYCARDIA; SMOOTH-MUSCLE; ENDOTHELIAL-CELLS; NEUROPEPTIDE-Y; SUBSTANCE-P; VESSELS; EXPRESSION; GENE; RECEPTOR	Millions of patients suffer from lymphedema worldwide. Supporting the contractility of lymphatic collectors is an attractive target for pharmacological therapy of lymphedema. However, lymphatics have mostly been studied in animals, while the cellular and molecular characteristics of human lymphatic collectors are largely unknown. We studied epifascial lymphatic collectors of the thigh, which were isolated for autologous transplantations. Our immunohistological studies identify additional markers for LECs (vimentin, CCBE1). We show and confirm differences between initial and collecting lymphatics concerning the markers ESAM1, D2-40 and LYVE-1. Our transmission electron microscopic studies reveal two types of smooth muscle cells (SMCs) in the media of the collectors with dark and light cytoplasm. We observed vasa vasorum in the media of the largest collectors, as well as interstitial Cajal-like cells, which are highly ramified cells with long processes, caveolae, and lacking a basal lamina. They are in close contact with SMCs, which possess multiple caveolae at the contact sites. Immunohistologically we identified such cells with antibodies against vimentin and PDGFR alpha, but not CD34 and cKIT. With Next Generation Sequencing we searched for highly expressed genes in the media of lymphatic collectors, and found therapeutic targets, suitable for acceleration of lymphatic contractility, such as neuropeptide Y receptors 1, and 5; tachykinin receptors 1, and 2; purinergic receptors P2RX1, and 6, P2RY12, 13, and 14; 5-hydroxytryptamine receptors HTR2B, and 3C; and adrenoceptors alpha(2A),(B),(C). Our studies represent the first comprehensive characterization of human epifascial lymphatic collectors, as a prerequisite for diagnosis and therapy.	[Hasselhof, Viktoria; Sperling, Anastasia; Buttler, Kerstin; Becker, Jurgen; Wilting, Jorg] Univ Med Sch Gottingen, Inst Anat & Cell Biol, Gottingen, Germany; [Strobel, Philipp] Univ Med Ctr Gottingen, Inst Pathol, Gottingen, Germany; [Aung, Thiha; Felmerer, Gunther] Univ Med Ctr Gottingen, Div Trauma Surg Plast & Reconstruct Surg, Gottingen, Germany; [Aung, Thiha] Univ Med Ctr Regensburg, Ctr Plast Hand & Reconstruct Surg, Regensburg, Germany	University of Gottingen; University of Gottingen; University of Regensburg	Wilting, J (corresponding author), Univ Med Sch Gottingen, Inst Anat & Cell Biol, Gottingen, Germany.	joerg.wilting@med.uni-goettingen.de		Wilting, Jorg/0000-0001-8337-2296; Becker, Juergen/0000-0002-8183-9486	Deutsche Gesellschaft fur Lymphologie; antibodies; Next Generation Sequencing	Deutsche Gesellschaft fur Lymphologie; antibodies; Next Generation Sequencing	We received funding from the Deutsche Gesellschaft fur Lymphologie, which is a non-profit society. Funding covered the costs for antibodies and Next Generation Sequencing. The society did not have any influence on the execution of the study.	Alders M, 2009, NAT GENET, V41, P1272, DOI 10.1038/ng.484; ALESSANDRINI C, 1981, LYMPHOLOGY, V14, P1; ALLEN JM, 1988, BRIT J PHARMACOL, V94, P823, DOI 10.1111/j.1476-5381.1988.tb11593.x; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Axelrod S, 2011, MT SINAI J MED, V78, P784, DOI 10.1002/msj.20288; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Baqi Y, 2011, J MED CHEM, V54, P817, DOI 10.1021/jm1012193; Baqi Y, 2009, J MED CHEM, V52, P3784, DOI 10.1021/jm9003297; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627; Boedtkjer DB, 2013, CELLS TISSUES ORGANS, V197, P145, DOI 10.1159/000342437; BOGGON RP, 1973, J ANAT, V114, P389; BOSSALLER C, 1992, HERZ, V17, P284; Buttler K, 2013, DEV BIOL, V381, P365, DOI 10.1016/j.ydbio.2013.06.028; Catherino WH, 2004, GENE CHROMOSOME CANC, V40, P204, DOI 10.1002/gcc.20035; Chakraborty S, 2011, MICROCIRCULATION, V18, P24, DOI 10.1111/j.1549-8719.2010.00064.x; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Crnkovic S, 2014, BRIT J PHARMACOL, V171, P3895, DOI 10.1111/bph.12751; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; DOBBINS DE, 1990, MICROCIRC ENDOTH LYM, V6, P409; Donato AJ, 2014, LIFE SCI, V118, P238, DOI 10.1016/j.lfs.2013.12.209; Dorn GW, 2010, PHYSIOL REV, V90, P1013, DOI 10.1152/physrev.00001.2010; Ejaz A, 2011, CTS-CLIN TRANSL SCI, V4, P346, DOI 10.1111/j.1752-8062.2011.00318.x; El-Tayeb A, 2011, J MED CHEM, V54, P2878, DOI 10.1021/jm1016297; FAHRENKRUG J, 1982, BRIT MED BULL, V38, P265, DOI 10.1093/oxfordjournals.bmb.a071771; Fahrenkrug J, 2001, SCAND J CLIN LAB INV, V61, P35, DOI 10.1080/003655101317095392; Felmerer G, 2012, MICROSURG, V32, P171, DOI 10.1002/micr.20968; FERRARI S, 1986, MOL CELL BIOL, V6, P3614, DOI 10.1128/MCB.6.11.3614; Florey H, 1927, J PHYSIOL-LONDON, V52, P267, DOI 10.1113/jphysiol.1927.sp002357; Himes BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099625; HOLLYWOOD MA, 1994, J PHYSIOL-LONDON, V481, P415, DOI 10.1113/jphysiol.1994.sp020450; Ji RC, 2001, MICROSC RES TECHNIQ, V55, P70, DOI 10.1002/jemt.1158; Kacar A, 2012, PATHOL ONCOL RES, V18, P25, DOI 10.1007/s12253-011-9412-9; Kanzleiter T, 2014, BIOCHEM BIOPH RES CO, V450, P1089, DOI 10.1016/j.bbrc.2014.06.123; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Kasten P, 2007, DEV DYNAM, V236, P2952, DOI 10.1002/dvdy.21298; Kelsey RM, 2012, PSYCHOPHYSIOLOGY, V49, P401, DOI 10.1111/j.1469-8986.2011.01319.x; KINMONTH JB, 1956, J PHYSIOL-LONDON, V133, pP3; Kornuta JA, 2015, AM J PHYSIOL-REG I, V309, pR1122, DOI 10.1152/ajpregu.00342.2014; Kostka G, 2001, MOL CELL BIOL, V21, P7025, DOI 10.1128/MCB.21.20.7025-7034.2001; LARHAMMAR D, 1992, J BIOL CHEM, V267, P10935; LEAK LV, 1968, J CELL BIOL, V36, P129, DOI 10.1083/jcb.36.1.129; LOTZWINTER H, 1990, PLANTA MED, V56, P249, DOI 10.1055/s-2006-960949; MATSUOKA R, 1991, CYTOGENET CELL GENET, V58, P2000; MAWHINNEY HJ, 1973, J PHYSIOL-LONDON, V229, P339, DOI 10.1113/jphysiol.1973.sp010141; McCarthy JJ, 2004, J MED GENET, V41, P334, DOI 10.1136/jmg.2003.016584; McCloskey KD, 2002, CELL TISSUE RES, V310, P77, DOI 10.1007/s00441-002-0623-y; McCloskey KD, 1999, J PHYSIOL-LONDON, V521, P201, DOI 10.1111/j.1469-7793.1999.00201.x; MCGEOWN JG, 1987, J PHYSIOL-LONDON, V393, P123, DOI 10.1113/jphysiol.1987.sp016814; Miano JM, 2001, MAMM GENOME, V12, P187, DOI 10.1007/s003350010266; Miettinen M, 2009, AM J SURG PATHOL, V33, P1401, DOI 10.1097/PAS.0b013e3181a90e1a; Mignini F, 2012, LYMPHAT RES BIOL, V10, P189, DOI 10.1089/lrb.2012.0013; Neligan PC, 2015, LYMPHEDEMA COMPLETE; Nemeth K, 2015, STEM CELL RES, V15, P42, DOI 10.1016/j.scr.2015.04.005; Norgall S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-105; Park SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094781; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Perrino BA, 2011, ARCH BIOCHEM BIOPHYS, V510, P174, DOI 10.1016/j.abb.2011.03.009; Priori SG, 2001, CIRCULATION, V103, P196; Rasmussen JC, 2009, CURR OPIN BIOTECH, V20, P74, DOI 10.1016/j.copbio.2009.01.009; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rizzo FM, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2111-x; Roukens MG, 2015, CIRC RES, V116, P1660, DOI 10.1161/CIRCRESAHA.116.304949; SAGRADA A, 1987, GUT, V28, P955, DOI 10.1136/gut.28.8.955; Schulz B, 2014, PATHOL RES PRACT, V210, P92, DOI 10.1016/j.prp.2013.11.006; Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962; SJOBERG T, 1991, LYMPHOLOGY, V24, P16; Song L, 2007, J CLIN INVEST, V117, P1814, DOI 10.1172/JCI31080; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tatin F, 2013, DEV CELL, V26, P31, DOI 10.1016/j.devcel.2013.05.015; Telinius N, 2014, AM J PHYSIOL-HEART C, V306, pH206, DOI 10.1152/ajpheart.00517.2013; Telinius N, 2010, AM J PHYSIOL-HEART C, V299, pH811, DOI 10.1152/ajpheart.01089.2009; TODD GL, 1973, ANAT RECORD, V177, P303, DOI 10.1002/ar.1091770210; Valasek P, 2007, DEVELOPMENT, V134, P4427, DOI 10.1242/dev.004697; von Euler US, 1931, J PHYSIOL-LONDON, V72, P74, DOI 10.1113/jphysiol.1931.sp002763; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Wilting J, 2002, FASEB J, V16, P1271, DOI 10.1096/fj.01-1010fje; Wilting J, 2015, PANVASCULAR MED, P193, DOI [10.1007/978-3-642-37078-6_252, DOI 10.1007/978-3-642-37078-6_252]; Witte MH, 2006, CANCER METAST REV, V25, P159, DOI 10.1007/s10555-006-8496-2; Witte MH, 2001, MICROSC RES TECHNIQ, V55, P122, DOI 10.1002/jemt.1163; Xu B, 2004, MOL CELL BIOL, V24, P9198, DOI 10.1128/MCB.24.20.9198-9206.2004; YAMADA H, 1995, JPN J HUM GENET, V40, P177, DOI 10.1007/BF01883574; Zhang RZ, 2013, AM J PHYSIOL-HEART C, V305, pH1494, DOI 10.1152/ajpheart.00898.2012	84	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164964	10.1371/journal.pone.0164964	http://dx.doi.org/10.1371/journal.pone.0164964			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764183	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204500086
J	Peng, YH; Lin, CH; Lin, CN; Lo, CY; Tsai, TL; Wu, HY				Peng, Yu-Hui; Lin, Ching-Houng; Lin, Chao-Nan; Lo, Chen-Yu; Tsai, Tsung-Lin; Wu, Hung-Yi			Characterization of the Role of Hexamer AGUAAA and Poly(A) Tail in Coronavirus Polyadenylation	PLOS ONE			English	Article							MESSENGER-RNA POLYADENYLATION; NEGATIVE-STRAND RNA; BOVINE CORONAVIRUS; VIRAL-RNA; 3' END; BINDING-PROTEIN; AAUAAA SEQUENCE; NUCLEAR EXPORT; VIRUS-RNA; STEM-LOOP	Similar to eukaryotic mRNA, the positive-strand coronavirus genome of similar to 30 kilobases is 5'-capped and 3'-polyadenylated. It has been demonstrated that the length of the coronaviral poly(A) tail is not static but regulated during infection; however, little is known regarding the factors involved in coronaviral polyadenylation and its regulation. Here, we show that during infection, the level of coronavirus poly(A) tail lengthening depends on the initial length upon infection and that the minimum length to initiate lengthening may lie between 5 and 9 nucleotides. By mutagenesis analysis, it was found that (i) the hexamer AGUAAA and poly(A) tail are two important elements responsible for synthesis of the coronavirus poly(A) tail and may function in concert to accomplish polyadenylation and (ii) the function of the hexamer AGUAAA in coronaviral polyadenylation is position dependent. Based on these findings, we propose a process for how the coronaviral poly(A) tail is synthesized and undergoes variation. Our results provide the first genetic evidence to gain insight into coronaviral polyadenylation.	[Peng, Yu-Hui; Lin, Ching-Houng; Lo, Chen-Yu; Tsai, Tsung-Lin; Wu, Hung-Yi] Natl Chung Hsing Univ, Grad Inst Vet Pathobiol, Coll Vet Med, Taichung 40227, Taiwan; [Lin, Chao-Nan] Natl Pingtung Univ Sci & Technol, Dept Vet Med, Pingtung 91201, Taiwan	National Chung Hsing University; National Pingtung University Science & Technology	Wu, HY (corresponding author), Natl Chung Hsing Univ, Grad Inst Vet Pathobiol, Coll Vet Med, Taichung 40227, Taiwan.	hwu2@dragon.nchu.edu.tw		Tsai, Tsung Lin/0000-0002-7585-0574; Wu, Hung-Yi/0000-0002-1260-6259; LO, CHEN-YU/0000-0003-2938-0986; Lin, Ching-Hung/0000-0003-3880-1148	Ministry of Science and Technology (MOST), R.O.C. [NSC 101-2313-6005-010-MY3]	Ministry of Science and Technology (MOST), R.O.C.	This work was supported by grant NSC 101-2313-6005-010-MY3 from the Ministry of Science and Technology (MOST), R.O.C. (https://www.most.gov.tw/?I=ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding for open access charge: Ministry of Science and Technology (MOST), R.O.C.	AHLQUIST P, 1979, NUCLEIC ACIDS RES, V7, P1195, DOI 10.1093/nar/7.5.1195; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Beilharz TH, 2009, METHODS, V48, P294, DOI 10.1016/j.ymeth.2009.02.003; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Brown CG, 2007, J VIROL, V81, P7716, DOI 10.1128/JVI.00549-07; Brown CE, 1998, MOL CELL BIOL, V18, P6548, DOI 10.1128/MCB.18.11.6548; BURD CG, 1991, MOL CELL BIOL, V11, P3419, DOI 10.1128/MCB.11.7.3419; CHANG RY, 1994, J VIROL, V68, P8223, DOI 10.1128/JVI.68.12.8223-8231.1994; CHEN F, 1995, NUCLEIC ACIDS RES, V23, P2614, DOI 10.1093/nar/23.14.2614; Chen IH, 2005, J VIROL, V79, P14555, DOI 10.1128/JVI.79.23.14555-14561.2005; Fuke H, 2008, NUCLEIC ACIDS RES, V36, P1037, DOI 10.1093/nar/gkm1120; Gustin KM, 2009, J VIROL, V83, P6087, DOI 10.1128/JVI.00160-09; Hardy RW, 2005, J VIROL, V79, P4630, DOI 10.1128/JVI.79.8.4630-4639.2005; Hausmann S, 1999, J VIROL, V73, P5568, DOI 10.1128/JVI.73.7.5568-5576.1999; HOFMANN MA, 1991, J VIROL, V65, P6331, DOI 10.1128/JVI.65.11.6331-6333.1991; HUMPHREY T, 1987, EMBO J, V6, P4159, DOI 10.1002/j.1460-2075.1987.tb02762.x; Ivshina M, 2014, ANNU REV CELL DEV BI, V30, P393, DOI 10.1146/annurev-cellbio-101011-155831; Janicke A, 2012, RNA, V18, P1289, DOI 10.1261/rna.031898.111; Jalkanen AL, 2014, SEMIN CELL DEV BIOL, V34, P24, DOI 10.1016/j.semcdb.2014.05.018; Kamasawa Masami, 2008, In Silico Biology, V8, P347; Ke TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082176; KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x; Kempf BJ, 2015, VIRUS RES, V206, P3, DOI 10.1016/j.virusres.2014.12.030; Kempf BJ, 2013, J VIROL, V87, P5629, DOI 10.1128/JVI.02590-12; KING B, 1982, J VIROL, V42, P700, DOI 10.1128/JVI.42.2.700-707.1982; Kojima S, 2012, GENE DEV, V26, P2724, DOI 10.1101/gad.208306.112; Komine Y, 2000, RNA, V6, P598, DOI 10.1017/S1355838200992252; Kuhn U, 1996, J MOL BIOL, V256, P20, DOI 10.1006/jmbi.1996.0065; LAPPS W, 1987, VIROLOGY, V157, P47, DOI 10.1016/0042-6822(87)90312-6; Liao WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098422; Liu PH, 2013, VIROLOGY, V443, P40, DOI 10.1016/j.virol.2013.04.021; Meijer HA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm830; MONTELL C, 1983, NATURE, V305, P600, DOI 10.1038/305600a0; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Ozdarendeli A, 2001, J VIROL, V75, P7362, DOI 10.1128/JVI.75.16.7362-7374.2001; Patil DP, 2014, METHODS MOL BIOL, V1125, P13, DOI 10.1007/978-1-62703-971-0_2; Poon LLM, 2000, J VIROL, V74, P418, DOI 10.1128/JVI.74.1.418-427.2000; Poon LLM, 1999, J VIROL, V73, P3473, DOI 10.1128/JVI.73.4.3473-3476.1999; Preiss T, 1998, RNA, V4, P1321, DOI 10.1017/S1355838298980669; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Salles FJ, 1999, METHODS, V17, P38, DOI 10.1006/meth.1998.0705; SHEETS MD, 1989, GENE DEV, V3, P1401, DOI 10.1101/gad.3.9.1401; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Shien JH, 2014, VIRUS GENES, V49, P383, DOI 10.1007/s11262-014-1103-7; Silvestri LS, 2006, VIROLOGY, V345, P509, DOI 10.1016/j.virol.2005.10.019; Spagnolo JF, 2000, J VIROL, V74, P5053, DOI 10.1128/JVI.74.11.5053-5065.2000; Steil BP, 2010, J VIROL, V84, P2843, DOI 10.1128/JVI.02620-08; Szymkowiak C, 2003, J VIROL METHODS, V107, P15, DOI 10.1016/S0166-0934(02)00184-2; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; TOMPKINS WA, 1974, J NATL CANCER I, V52, P1101, DOI 10.1093/jnci/52.4.1101; van Ooij MJM, 2006, NUCLEIC ACIDS RES, V34, P2953, DOI 10.1093/nar/gkl349; WEISS EA, 1991, EMBO J, V10, P215, DOI 10.1002/j.1460-2075.1991.tb07938.x; WICKENS M, 1984, SCIENCE, V226, P1045, DOI 10.1126/science.6208611; Wu HY, 2007, J VIROL, V81, P3206, DOI 10.1128/JVI.01817-06; Wu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070548; Wu HY, 2010, P NATL ACAD SCI USA, V107, P12257, DOI 10.1073/pnas.1000378107; Wu HY, 2006, J VIROL, V80, P2183, DOI 10.1128/JVI.80.5.2183-2193.2006; Wu HY, 2003, VIROLOGY, V315, P174, DOI 10.1016/S0042-6822(03)00511-7; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Yeh PY, 2014, VIRUSES-BASEL, V6, P2938, DOI 10.3390/v6082938; ZARKOWER D, 1986, MOL CELL BIOL, V6, P2317, DOI 10.1128/MCB.6.7.2317; Zheng HY, 1999, J VIROL, V73, P5240, DOI 10.1128/JVI.73.6.5240-5243.1999; Zust R, 2008, J VIROL, V82, P1214, DOI 10.1128/JVI.01690-07	64	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0165077	10.1371/journal.pone.0165077	http://dx.doi.org/10.1371/journal.pone.0165077			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760233	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204000084
J	Alric, L; Besson, C; Lapidus, N; Jeannel, J; Michot, JM; Cacoub, P; Canioni, D; Pol, S; Davi, F; Rabiega, P; Ysebaert, L; Bonnet, D; Hermine, O				Alric, Laurent; Besson, Caroline; Lapidus, Nathanael; Jeannel, Juliette; Michot, Jean-Marie; Cacoub, Patrice; Canioni, Danielle; Pol, Stanislas; Davi, Frederic; Rabiega, Pascaline; Ysebaert, Loic; Bonnet, Delphine; Hermine, Olivier			Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study	PLOS ONE			English	Article							MARGINAL ZONE LYMPHOMA; HEPATITIS-C; CRYOGLOBULINEMIA VASCULITIS; MIXED CRYOGLOBULINEMIA; VIRUS-INFECTION; THERAPY	Hepatitis C virus (HCV) infection is associated with lymphoproliferative disorders and B-cell non-Hodgkin lymphomas (B-NHLs). Evaluation of the efficacy and safety profiles of different antiviral therapies in HCV patients with B-NHL is warranted. Methods: First, we evaluated the sustained virologic response (SVR) and safety of Peg-interferon-alpha (Peg-IFN) + ribavirin +/- first protease inhibitors (PI1s) therapy in 61 HCV patients with B-NHL enrolled in a nationwide observational survey compared with 94 matched HCV-infected controls without B-NHL. In a second series, interferon-free regimens using a newly optimal combination therapy with direct-acting antiviral drugs (DAAs) were evaluated in 10 patients with HCV and B-NHL. Results: The main lymphoma type was diffuse large B-cell lymphoma (38%) followed by marginal zone lymphoma (31%). In the multivariate analysis, patients with B-NHL treated by Peg-IFN-based therapy exhibited a greater SVR rate compared with controls, 50.8% vs 30.8%, respectively, p<0.01, odds ratio (OR) = 11.2 [2.3, 52.8]. B-NHL response was better (p = 0.02) in patients with SVR (69%) than in patients without SVR (31%). Premature discontinuation of Peg-IFN-based therapy was significantly more frequent in the B-NHL group (19.6%) compared with the control group (6.3%), p<0.02. Overall, survival was significantly enhanced in the controls than in the B-NHL group (hazard ratio = 34.4 [3.9, 304.2], p<0.01). Using DAAs, SVR was achieved in 9/10 patients (90%). DAAs were both well tolerated and markedly efficient. Conclusions: The virologic response of HCV-associated B-NHL is high. Our study provides a comprehensive evaluation of different strategies for the antiviral treatment of B-NHL associated with HCV infection.	[Alric, Laurent; Jeannel, Juliette; Bonnet, Delphine] Univ Toulouse 3, IRD, UMR 152, Dept Internal Med & Digest Dis,CHU Purpan, Toulouse, France; [Besson, Caroline; Michot, Jean-Marie] Univ Paris 11, Fac Med Kremlin Bicetre, Hop Bicetre, AP HP,IMVA,INSERM,U1184, Paris, France; [Lapidus, Nathanael; Rabiega, Pascaline] Univ Paris 06, Sorbonne Univ, IPLESP,UMRS 1136, Hop St Antoine,AP HP,Dept Publ Hlth,INSERM, Paris, France; [Cacoub, Patrice] Paris 6 Univ, UMR 7211, INSERM,CNRS,Dept Internal Med, UMR S 959,UMR 7211,Hop Pitie Salpetriere,AP HP, Paris, France; [Canioni, Danielle] Paris 5 Descartes Univ, Hop Necker, AP HP, Dept Pathol, Paris, France; [Pol, Stanislas] Univ Descartes, Inst Pasteur, Hop Cochin, AP HP,Inserm,U318,Dept Hepatol, Paris, France; [Davi, Frederic] Univ Paris 06, Hop Pitie Salpetriere, AP HP, Dept Biol Hematol & Cytogenet, Paris, France; [Ysebaert, Loic] CHU, Dept Hematol IUCT Oncopole, Toulouse, France; [Hermine, Olivier] Paris 5 Descartes Univ, Hop Necker, AP HP, INSERM,U1163,CNRS,ERL 8254,Dept Adult Hematol, Paris, France; [Hermine, Olivier] Paris 5 Descartes Univ, Hop Necker, Imagine Inst, Paris, France	CHU de Toulouse; Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Alric, L (corresponding author), Univ Toulouse 3, IRD, UMR 152, Dept Internal Med & Digest Dis,CHU Purpan, Toulouse, France.	alric.l@chu-toulouse.fr	Lapidus, N./AAT-4479-2020; Ysebaert, Loic/H-1554-2016; Besson, Caroline/H-4648-2018; Michot, Jean-Marie/AAC-3028-2022; Hermine, Olivier/Q-7072-2018	Lapidus, N./0000-0002-4837-1068; Ysebaert, Loic/0000-0001-8478-5623; Besson, Caroline/0000-0003-4364-7173; Michot, Jean-Marie/0000-0003-3482-3331; Hermine, Olivier/0000-0003-2574-3874; BONNET, Delphine/0000-0002-8108-0852; Cacoub, Patrice/0000-0002-6727-4992	Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS) France Recherche Nord Sud Sida-HIV Hepatites	Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS) France Recherche Nord Sud Sida-HIV Hepatites	The Lympho-C HC-13 study was promoted and funded by the "Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS) France Recherche Nord Sud Sida-HIV Hepatites.	Agnelle V, 1992, NEW ENGL J MED, V327, P490, DOI [10.1056/NEJM199211193272104, DOI 10.1056/NEJM199211193272104]; Alric L, 2004, AM J KIDNEY DIS, V43, P617, DOI 10.1053/j.ajkd.2003.11.020; Arcaini L, 2014, ANN ONCOL, V25, P1404, DOI 10.1093/annonc/mdu166; Besson C, 2006, J CLIN ONCOL, V24, P953, DOI 10.1200/JCO.2005.01.5016; Bonnet D, 2014, WORLD J HEPATOL, V6, P660, DOI 10.4254/wjh.v6.i9.660; Cacoub P, 2002, CURR OPIN RHEUMATOL, V14, P29, DOI 10.1097/00002281-200201000-00006; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; De Sanjose S, 2008, CLIN GASTROENTEROL H, V6, P451, DOI 10.1016/j.cgh.2008.02.011; Engels EA, 2004, INT J CANCER, V111, P76, DOI 10.1002/ijc.20021; Gragnani L, 2015, HEPATOLOGY, V61, P1145, DOI 10.1002/hep.27623; Hermine O, 2002, NEW ENGL J MED, V347, P89, DOI 10.1056/NEJMoa013376; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Michot JM, 2015, AM J HEMATOL, V90, P197, DOI 10.1002/ajh.23889; Mura VL, 2008, J HEPATOL, V49, P557, DOI [10.1016/j.jhep.2008.06.025, DOI 10.1016/J.JHEP.2008.06.025]; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Negro F, 2015, GASTROENTEROLOGY; Nicot F, 2011, J MED VIROL, V83, P437, DOI 10.1002/jmv.21976; Nieters A, 2006, GASTROENTEROLOGY, V131, P1879, DOI 10.1053/j.gastro.2006.09.019; Rossotti R, 2015, J HEPATOL, V62, P234, DOI 10.1016/j.jhep.2014.09.031; Saadoun D, 2005, BLOOD, V105, P74, DOI 10.1182/blood-2004-05-1711; Saadoun D, 2015, J HEPATOL, V62, P24, DOI 10.1016/j.jhep.2014.08.015; Silvestri F, 1996, BLOOD, V87, P4296, DOI 10.1182/blood.V87.10.4296.bloodjournal87104296; Sultanik P, 2015, BLOOD, V125, P2446, DOI 10.1182/blood-2014-12-618652; Vallisa D, 2005, J CLIN ONCOL, V23, P468, DOI 10.1200/JCO.2005.06.008; 2015, HEPATOLOGY, V62, P932, DOI DOI 10.1002/HEP.27950	25	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0162965	10.1371/journal.pone.0162965	http://dx.doi.org/10.1371/journal.pone.0162965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749916	Green Published, gold, Green Submitted			2022-12-26	WOS:000386202300002
J	Wang, Z; Xia, RH; Ye, DX; Li, J				Wang, Zhen; Xia, Rong-Hui; Ye, Dong-Xia; Li, Jiang			Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population	PLOS ONE			English	Article							DISTANT METASTASES; JAPANESE PATIENTS; INCIDENCE TRENDS; CANCER INCIDENCE; ORAL-CANCER; NECK-CANCER; HEAD; P53; RISK; SURVIVAL	Objectives To investigate the clinicopathological characteristics, human papillomavirus (HPV) infection, p53 expression, and TP53 mutations in oropharyngeal squamous cell carcinoma (OPSCC) and determine their utility as prognostic predictors in a primarily eastern Chinese population. Methods The HPV infection status was tested via p16INK4A immunohistochemistry and validated using PCR, reverse blot hybridization and in situ hybridization (ISH) in 188 OPSCC samples. p53 expression levels and TP53 gene mutations were assessed through immunohistochemistry and sequencing, respectively. Clinicopathological characteristics and follow-up information were collected. Overall survival was estimated using the Log-rank test. Results Overall, 22 of the 188 OPSCC samples were associated with HPV infection. HPV16 was identified in all 22 samples, whereas no samples were positive for HPV18. All 22 HPV-associated OPSCC samples were p53 negative and lacked TP53 mutations. HPV16 positivity, female patients, non-smokers, and patients with histological grade I and stage N0 diseases showed better overall survival (p = 0.009, 0.003, 0.048, 0.009, and 0.004, respectively). No significant differences in overall survival between smoking and nonsmoking patients were observed in the HPV-associated OPSCC group. Patients without mutations in TP53 exons 5-8 had better prognoses (p = 0.031) among the 43 sequenced specimens. Multivariate analysis indicated that HPV16 infection status (p = 0.011), histological grade (p = 0.017), and N stage (p = 0.019) were independent prognostic factors for patients with OPSCC. Conclusions Distinct from the situation in Europe and America, for the patients with OPSCC in this study, HPV16 infection was relatively low, although it was still the most important independent prognostic predictor for the disease. In addition to the high smoking and drinking rate in this population, HPV16 infection and TP53 dysfunction appear to be two distinct pathogens for OPSCC patients in the eastern Chinese population.	[Wang, Zhen; Xia, Rong-Hui; Li, Jiang] Shanghai Jiao Tong Univ, Peoples Hosp 9, Shanghai Key Lab Stomatol, Dept Oral Pathol,Sch Med, Shanghai, Peoples R China; [Ye, Dong-Xia] Shanghai Jiao Tong Univ, Peoples Hosp 9, Shanghai Key Lab Stomatol, Dept Oral Maxillofacial Surg,Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, J (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Shanghai Key Lab Stomatol, Dept Oral Pathol,Sch Med, Shanghai, Peoples R China.	lijiang182000@126.com	Ye, Dongxia/AAF-2877-2019; Ye, Dongxia/S-4804-2018	Ye, Dongxia/0000-0001-8260-4569	National Natural Science Foundation of China [81372910, 81202132]; Doctoral Scientific Fund Project of the Ministry of Education of China [20120073110085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Scientific Fund Project of the Ministry of Education of China	This project was support by the National Natural Science Foundation of China (81372910 to JL, 81202132 to DXY) and Doctoral Scientific Fund Project of the Ministry of Education of China (20120073110085 to JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Applebaum KM, 2007, JNCI-J NATL CANCER I, V99, P1801, DOI 10.1093/jnci/djm233; Cabelguenne A, 2000, J CLIN ONCOL, V18, P1465, DOI 10.1200/JCO.2000.18.7.1465; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Cruz I, 2002, J CLIN PATHOL, V55, P834, DOI 10.1136/jcp.55.11.834; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Ferris RL, 2005, EUR J CANCER, V41, P807, DOI 10.1016/j.ejca.2004.11.023; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hafkamp HC, 2003, INT J CANCER, V107, P394, DOI 10.1002/ijc.11389; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; Heaton CM, 2014, LARYNGOSCOPE, V124, pE267, DOI 10.1002/lary.24595; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Huang H, 1996, INT J RADIAT BIOL, V70, P151, DOI 10.1080/095530096145148; Huang H, 2012, ASIAN PAC J CANCER P, V13, P891, DOI 10.7314/APJCP.2012.13.3.891; Hwang TZ, 2015, INT J CANCER, V137, P395, DOI 10.1002/ijc.29330; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; Joo YH, 2014, HEAD NECK-J SCI SPEC, V36, P323, DOI 10.1002/hed.23296; Kawakami H, 2013, CANCER MED-US, V2, P933, DOI 10.1002/cam4.151; Klussmann JP, 2001, CANCER-AM CANCER SOC, V92, P2875, DOI 10.1002/1097-0142(20011201)92:11&lt;2875::AID-CNCR10130&gt;3.0.CO;2-7; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Lam EWH, 2016, CANCER EPIDEM BIOMAR, V25, P165, DOI 10.1158/1055-9965.EPI-15-0869; Maxwell JH, 2010, CLIN CANCER RES, V16, P1226, DOI 10.1158/1078-0432.CCR-09-2350; Mizumachi T, 2013, INT J CLIN ONCOL, V18, P824, DOI 10.1007/s10147-012-0469-6; Neskey DM, 2015, CANCER RES, V75, P1527, DOI 10.1158/0008-5472.CAN-14-2735; Nichols AC, 2009, OTOLARYNG HEAD NECK, V140, P228, DOI 10.1016/j.otohns.2008.11.025; Nomura F, 2014, ACTA OTO-LARYNGOL, V134, P1265, DOI 10.3109/00016489.2014.944272; Rischin D, 2010, J CLIN ONCOL, V28, P4142, DOI 10.1200/JCO.2010.29.2904; Schache AG, 2011, CLIN CANCER RES, V17, P6262, DOI 10.1158/1078-0432.CCR-11-0388; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schwartz SM, 1998, JNCI-J NATL CANCER I, V90, P1626, DOI 10.1093/jnci/90.21.1626; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Singhi AD, 2010, CANCER-AM CANCER SOC, V116, P2166, DOI 10.1002/cncr.25033; SNIJDERS PJF, 1994, J GEN VIROL, V75, P2769, DOI 10.1099/0022-1317-75-10-2769; Sun JR, 2012, J KOR ASSOC ORAL MAX, V38, P20, DOI 10.5125/jkaoms.2012.38.1.20; Urashima M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080828; Westra WH, 2008, CLIN CANCER RES, V14, P366, DOI 10.1158/1078-0432.CCR-07-1402	39	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164491	10.1371/journal.pone.0164491	http://dx.doi.org/10.1371/journal.pone.0164491			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749915	Green Submitted, Green Published, gold			2022-12-26	WOS:000386202300015
J	Lenguerrand, E; Whitehouse, MR; Wylde, V; Gooberman-Hill, R; Blom, AW				Lenguerrand, Erik; Whitehouse, Michael R.; Wylde, Vikki; Gooberman-Hill, Rachael; Blom, Ashley W.			Pain and Function Recovery Trajectories following Revision Hip Arthroplasty: Short-Term Changes and Comparison with Primary Hip Arthroplasty in the ADAPT Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; JOINT REPLACEMENT; WESTERN-ONTARIO; OUTCOMES; WOMAC; SATISFACTION; PREDICTORS; INDEX; KNEE	Background and Purpose Patients report similar or better pain and function before revision hip arthroplasty than before primary arthroplasty but worse results are reported after revision surgery than after primary surgery. The trajectory of post-operative recovery during the first months and any differences by type of surgery have received little attention. We explored the trajectories of change in pain and function after revision hip arthroplasty to 12-months post-operatively and compare them with those observed after primary hip arthroplasty. Methods This study is a prospective cohort study of patients undergoing primary (n = 80 with 92% for an indication of osteoarthritis) and revision ( n = 43) hip arthroplasties. WOMAC pain and function scores and walking speed were collected pre-operatively, at 3 and 12-months post-operatively. Multilevel regression models were used to chart and compare the trajectories of change (0-3 months and 3-12 months) between types of surgery. Results The improvements in pain and function following revision arthroplasty occurred within the first 3-months with no evidence of further change beyond this initial period. While the pattern of recovery was similar to the one observed after primary arthroplasty, improvements in the first 3-months were smaller after revision compared to primary arthroplasty. Patients listed for revision surgery reported lower pre-operative pain levels but similar post-operative levels compared to those undergoing primary surgery. At 12-months post-operation patients who underwent a revision arthroplasty had not reached the same level of function achieved by those who underwent primary arthroplasty.	[Lenguerrand, Erik; Whitehouse, Michael R.; Wylde, Vikki; Gooberman-Hill, Rachael; Blom, Ashley W.] Univ Bristol, Southmead Hosp, Sch Clin Sci, Musculoskeletal Res Unit, Level 1 Learning & Res Bldg, Bristol BS10 5NB, Avon, England	Southmead Hospital; University of Bristol	Lenguerrand, E (corresponding author), Univ Bristol, Southmead Hosp, Sch Clin Sci, Musculoskeletal Res Unit, Level 1 Learning & Res Bldg, Bristol BS10 5NB, Avon, England.	erik.lenguerrand@bristol.ac.uk	Whitehouse, Michael/AAR-3898-2020	Whitehouse, Michael/0000-0003-2436-9024; Wylde, Vikki/0000-0002-8460-1529; Blom, Ashley/0000-0002-9940-1095; Gooberman-Hill, Rachael/0000-0003-3353-2882; Lenguerrand, Erik/0000-0002-0371-731X	National Institute for Health Research (NIHR) [RP-PG-0407-10070]; NIHR, through the Comprehensive Clinical Research Network; National Institute for Health Research [RP-PG-0407-10070, CL-2010-25-006, NF-SI-0515-10048] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR, through the Comprehensive Clinical Research Network; National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research (NIHR) (http://www.nihr.ac.uk/) under its Programme Grants for Applied Research programme (RP-PG-0407-10070). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.; The research team acknowledges the support of the NIHR, through the Comprehensive Clinical Research Network. The authors would like to acknowledge and thank the participants of the ADAPT study, Professor Paul Dieppe, members of the Project Steering Committee and the following research team members: Cindy Mann, Debbie Delgado, Connie Jamera, Louise Hawkins, Sue Bowman, Leigh Morrison, Dave Rea and Jenny Tyler.	Adelani MA, 2014, CLIN ORTHOP RELAT R, V472, P1518, DOI 10.1007/s11999-013-3377-9; Aghayev E, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-167; Atroshi I, 2004, ACTA ORTHOP SCAND, V75, P677, DOI 10.1080/00016470410004030; Barlow BT, 2016, J ARTHROPLASTY, V31, P857, DOI 10.1016/j.arth.2015.10.041; Barrack RL, 2006, CLIN ORTHOP RELAT R, P173, DOI 10.1097/01.blo.0000246537.67500.50; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Biring GS, 2007, J BONE JOINT SURG BR, V89B, P1446, DOI 10.1302/0301-620X.89B11.19617; Davis AM, 2006, J BONE JOINT SURG AM, V88A, P685, DOI 10.2106/JBJS.E.00150; Eisler T, 2002, J ARTHROPLASTY, V17, P457, DOI 10.1054/arth.2002.31245; Espehaug B, 1998, CLIN ORTHOP RELAT R, P135; Field RE, 2005, J BONE JOINT SURG BR, V87B, P618, DOI 10.1302/0301-620X.87B5.15390; Garbuz DS, 2006, J ARTHROPLASTY, V21, P998, DOI 10.1016/j.arth.2006.01.014; Gill S, 2008, PHYSIOTHER RES INT, V13, P141, DOI 10.1002/pri.411; Haddad FS, 2001, J ARTHROPLASTY, V16, P87, DOI 10.1054/arth.2001.17937; IZQUIERDO RJ, 1994, J BONE JOINT SURG BR, V76B, P34, DOI 10.1302/0301-620X.76B1.8300678; Judge A, 2010, ARTHRIT CARE RES, V62, P480, DOI 10.1002/acr.20038; Kennedy DM, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-3; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Leckie G, 2013, J STAT SOFTW, V52, P1; Lenguerrand E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149306; LITTLE RJA, 1995, J AM STAT ASSOC, V90, P1112, DOI 10.2307/2291350; Lubbeke A, 2007, J RHEUMATOL, V34, P394; McConnell S, 2001, ARTHRIT RHEUM-ARTHR, V45, P453, DOI 10.1002/1529-0131(200110)45:5<453::AID-ART365>3.0.CO;2-W; National Joint Registry for England and Wales, 11 NAT JOINT REG ENG; Nilsdotter A, 2011, ARTHRIT CARE RES, V63, pS200, DOI 10.1002/acr.20549; Patil S, 2008, J ARTHROPLASTY, V23, P550, DOI 10.1016/j.arth.2007.04.035; Quintana JM, 2005, OSTEOARTHR CARTILAGE, V13, P1076, DOI 10.1016/j.joca.2005.06.012; Ramisetty N, 2015, J HIP PRESERVATION S, P1; Robinson AHN, 1999, J BONE JOINT SURG BR, V81B, P42, DOI 10.1302/0301-620X.81B1.8728; Romano CL, 2010, J ORTHOP TRAUMATOL, V11, P167, DOI 10.1007/s10195-010-0106-y; Saleh KJ, 2003, CLIN ORTHOP RELAT R, P254, DOI 10.1097/01.blo.0000093006.90435.43; Senden R, 2009, GAIT POSTURE, V30, P192, DOI 10.1016/j.gaitpost.2009.04.008; Singh JA, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-210; Singh JA, 2013, RHEUMATOLOGY, V52, P1109, DOI 10.1093/rheumatology/kes416; Singh JA, 2009, CLIN RHEUMATOL, V28, P1419, DOI 10.1007/s10067-009-1267-z; Stevens M, 2009, AUST J PHYSIOTHER, V55, P185, DOI 10.1016/S0004-9514(09)70079-0; Wylde V, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-220	37	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e164839	10.1371/journal.pone.0164839	http://dx.doi.org/10.1371/journal.pone.0164839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741321	Green Published, Green Submitted, gold			2022-12-26	WOS:000385507000074
J	Park, YH; Kim, JY; Yi, S; Lim, JS; Jang, JW; Im, CH; Kim, S				Park, Young Ho; Kim, Jeong-Youn; Yi, SangHak; Lim, Jae-Sung; Jang, Jae-Won; Im, Chang-Hwan; Kim, SangYun			Transient Global Amnesia Deteriorates the Network Efficiency of the Theta Band	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; WORKING-MEMORY; BRAIN NETWORKS; SMALL-WORLD; SYNCHRONIZATION; EEG; BONFERRONI; CORTEX; RHYTHM	Acute perturbation of the hippocampus, one of the connector hubs in the brain, is a key step in the pathophysiological cascade of transient global amnesia (TGA). We tested the hypothesis that network efficiency, meaning the efficiency of information exchange over a network, is impaired during the acute stage of TGA. Graph theoretical analysis was applied to resting-state EEG data collected from 21 patients with TGA. The EEG data were obtained twice, once during the acute stage (< 24 hours after symptom onset) and once during the resolved stage (> 2 months after symptom onset) of TGA. Characteristic path lengths and clustering coefficients of functional networks constructed using phase-locking values were computed and normalized as a function of the degree in the delta, theta, alpha, beta 1, beta 2 and gamma frequency bands of the EEG. We investigated whether the normalized characteristic path length (nCPL) and normalized clustering coefficients (nCC) differed significantly between the acute and resolved stages of TGA at each frequency band using the Wilcoxon signed-rank test. For networks where the nCPL or nCC differed significantly between the two stages, we also evaluated changes in the connections of the brain networks. During the acute stage of TGA, the nCPL of the theta band networks with mean degrees of 8, 8.5, 9 and 9.5 significantly increased (P < 0.05). During the acute stage, the lost edges for these networks were mostly found between the anterior (frontal and anterior temporal) and posterior (parieto-occipital and posterior temporal) brain regions, whereas newly developed edges were primarily found between the left and right frontotemporal regions. The nCC of the theta band with a mean degree of 5.5 significantly decreased during the acute stage (P < 0.05). Our results indicate that TGA deteriorates the network efficiency of the theta frequency band. This effect might be related to the desynchronization between the anterior and posterior brain areas.	[Park, Young Ho; Yi, SangHak; Kim, SangYun] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Neurol, Seoul, South Korea; [Park, Young Ho; Yi, SangHak; Kim, SangYun] Seoul Natl Univ, Bundang Hosp, Clin Neurosci Ctr, Seoul, South Korea; [Kim, Jeong-Youn; Im, Chang-Hwan] Hanyang Univ, Dept Biomed Engn, Seoul, South Korea; [Lim, Jae-Sung] Seoul Natl Univ, Boramae Hosp, Dept Neurol, Seoul, South Korea; [Jang, Jae-Won] Kangwon Natl Univ Hosp, Dept Neurol, Chunchon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Hanyang University; Seoul National University (SNU); Seoul National University Hospital; Kangwon National University; Kangwon National University Hospital	Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Neurol, Seoul, South Korea.; Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Clin Neurosci Ctr, Seoul, South Korea.; Im, CH (corresponding author), Hanyang Univ, Dept Biomed Engn, Seoul, South Korea.	ich@hanyang.ac.kr; neuroksy@snu.ac.kr	Lim, Jae-Sung/D-5555-2012; Im, Chang-Hwan/ABB-4391-2021	Lim, Jae-Sung/0000-0001-6157-2908; Yi, SangHak/0000-0002-2701-9807; Im, Chang-Hwan/0000-0003-3795-3318				Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Babiloni C, 2016, INT J PSYCHOPHYSIOL, V103, P88, DOI 10.1016/j.ijpsycho.2015.02.008; Bartsch T, 2006, BRAIN, V129, P2874, DOI 10.1093/brain/awl248; Bartsch T, 2010, LANCET NEUROL, V9, P205, DOI 10.1016/S1474-4422(09)70344-8; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Christensen K. J., 1991, PSYCHOL ASSESSMENT J, V3, P168, DOI [10.1037/1040-3590.3.2.168, DOI 10.1037/1040-3590.3.2.168]; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; Fell J, 2003, EUR J NEUROSCI, V17, P1082, DOI 10.1046/j.1460-9568.2003.02522.x; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; Joudaki Amir, 2012, PLoS One, V7, pe35673, DOI 10.1371/journal.pone.0035673; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Nishida K, 2013, CLIN NEUROPHYSIOL, V124, P1106, DOI 10.1016/j.clinph.2013.01.005; Park YH, 2016, CLIN EEG NEUROSCI, V47, P69, DOI 10.1177/1550059414543684; Park YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067447; Peer M, 2014, ANN NEUROL, V75, P634, DOI 10.1002/ana.24137; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pikovsky A, 2003, SYNCHRONIZATION, DOI [10.4249/scholarpedia.1459, DOI 10.4249/SCHOLARPEDIA.1459]; Quinette P, 2006, BRAIN, V129, P1640, DOI 10.1093/brain/awl105; Ryoo I, 2012, NEURORADIOLOGY, V54, P329, DOI 10.1007/s00234-011-0889-4; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Storti SF, 2016, CLIN EEG NEUROSCI, V47, P276, DOI 10.1177/1550059415598905; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Vertes RP, 2005, HIPPOCAMPUS, V15, P923, DOI 10.1002/hipo.20118; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zimmerman DW, 1997, J EDUC BEHAV STAT, V22, P349, DOI 10.3102/10769986022003349	38	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e164884	10.1371/journal.pone.0164884	http://dx.doi.org/10.1371/journal.pone.0164884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741293	Green Submitted, Green Published, gold			2022-12-26	WOS:000385507000079
J	Herve, G; Evans, HG; Fernado, R; Patel, C; Hachem, F; Evans, DR				Herve, Guy; Evans, Hedeel Guy; Fernado, Roshini; Patel, Chandni; Hachem, Fatme; Evans, David R.			Activation of Latent Dihydroorotase from Aquifex aeolicus by Pressure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BISUBSTRATE ANALOG N-(PHOSPHONACETYL)-L-ASPARTATE; ASPARTATE CARBAMOYLTRANSFERASE; ESCHERICHIA-COLI; CARBAMOYL-PHOSPHATE; PYRIMIDINE BIOSYNTHESIS; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; HAMSTER-CELLS; METAL CENTER; TRANSCARBAMOYLASE	Elevated hydrostatic pressure was used to probe conformational changes of Aquifex aeolicus dihydroorotase (DHO), which catalyzes the third step in de novo pyrimidine biosynthesis. The isolated protein, a 45-kDa monomer, lacks catalytic activity but becomes active upon formation of a dodecameric complex with aspartate transcarbamoylase (ATC). X-ray crystallographic studies of the isolated DHO and of the complex showed that association induces several major conformational changes in the DHO structure. In the isolated DHO, a flexible loop occludes the active site blocking the access of substrates. The loop is mostly disordered but is tethered to the active site region by several electrostatic and hydrogen bonds. This loop becomes ordered and is displaced from the active site upon formation of DHO-ATC complex. The application of pressure to the complex causes its time-dependent dissociation and the loss of both DHO and ATC activities. Pressure induced irreversible dissociation of the obligate ATC trimer, and as a consequence the DHO is also inactivated. However, moderate hydrostatic pressure applied to the isolated DHO subunit mimics the complex formation and reversibly activates the isolated subunit in the absence of ATC, suggesting that the loop has been displaced from the active site. This effect of pressure is explained by the negative volume change associated with the disruption of ionic interactions and exposure of ionized amino acids to the solvent (electrostriction). The interpretation that the loop is relocated by pressure was validated by site-directed mutagenesis and by inhibition by small peptides that mimic the loop residues.	[Herve, Guy] Univ Paris 06, CNRS, Inst Biol Paris Seine, Lab BIOSIPE,Sorbonne Univ, F-75005 Paris, France; [Evans, Hedeel Guy; Fernado, Roshini] Eastern Michigan Univ, Dept Chem, Ypsilanti, MI 48197 USA; [Evans, Hedeel Guy; Patel, Chandni; Hachem, Fatme; Evans, David R.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, 540 E Canfield St, Detroit, MI 48201 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Eastern Michigan University; Wayne State University	Evans, DR (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, 540 E Canfield St, Detroit, MI 48201 USA.; Herve, G (corresponding author), Univ Paris 06, Inst Biol Paris Seine, Lab BIOSIPE, Sorbonne Univ, 7 Quai St Bernard, F-75005 Paris, France.	guy.herve@upmc.fr; ab2285@wayne.edu			National Institute of Health [GM47399, GM/CA60371]; National Science Foundation [MCB9810325]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047399, R01GM060371] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institute of Health Grants GM47399 and GM/CA60371 and National Science Foundation Grant MCB9810325. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahuja A, 2004, J BIOL CHEM, V279, P53136, DOI 10.1074/jbc.M403009200; Ahuja A, 2001, J BIOL CHEM, V276, P45694, DOI 10.1074/jbc.M106382200; CHRISTOPHERSON RI, 1980, J BIOL CHEM, V255, P1381; COLEMAN PF, 1977, J BIOL CHEM, V252, P6379; Davies M, 2009, J MED CHEM, V52, P2683, DOI 10.1021/jm800963t; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; DUFOUR E, 1995, BIOPOLYMERS, V35, P475, DOI 10.1002/bip.360350506; Edwards BFP, 2013, BMC BIOCHEM, V14, DOI 10.1186/1471-2091-14-36; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Evans HG, 2014, PROTEIN SCI, V23, P100, DOI 10.1002/pro.2396; Fields C., 1999, PATHS PYRIMIDINES, V7, P49; GOUAUX JE, 1988, P NATL ACAD SCI USA, V85, P4205, DOI 10.1073/pnas.85.12.4205; Grande-Garcia A, 2014, STRUCTURE, V22, P185, DOI 10.1016/j.str.2013.10.016; HEREMANS K, 1982, ANNU REV BIOPHYS BIO, V11, P1, DOI 10.1146/annurev.bb.11.060182.000245; HEREMANS L, 1989, BIOCHIM BIOPHYS ACTA, V999, P192, DOI 10.1016/0167-4838(89)90217-3; Herve G., 2010, CELL MECHANOCHEMISTR; HOA GHB, 1990, ANAL BIOCHEM, V187, P258; HONZATKO RB, 1982, J MOL BIOL, V160, P219, DOI 10.1016/0022-2836(82)90175-9; Ireton GC, 2002, J MOL BIOL, V315, P687, DOI 10.1006/jmbi.2001.5277; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; KANTROWITZ ER, 1988, SCIENCE, V241, P669, DOI 10.1126/science.3041592; Kornblatt JA, 1999, EUR J BIOCHEM, V265, P120, DOI 10.1046/j.1432-1327.1999.00695.x; KRAUSE KL, 1987, J MOL BIOL, V193, P527, DOI 10.1016/0022-2836(87)90265-8; KRAUSE KL, 1985, P NATL ACAD SCI USA, V82, P1643, DOI 10.1073/pnas.82.6.1643; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martin PD, 2005, J MOL BIOL, V348, P535, DOI 10.1016/j.jmb.2005.03.015; MONACO HL, 1978, P NATL ACAD SCI USA, V75, P5276, DOI 10.1073/pnas.75.11.5276; Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R; PASTRALANDIS SC, 1981, ANAL BIOCHEM, V118, P358, DOI 10.1016/0003-2697(81)90594-7; PRESCOTT LM, 1969, ANAL BIOCHEM, V32, P408, DOI 10.1016/S0003-2697(69)80008-4; Purcarea C, 2003, J BIOL CHEM, V278, P52924, DOI 10.1074/jbc.M309383200; Purcarea C, 2002, ACTA CRYSTALLOGR D, V58, P154, DOI 10.1107/S0907444901017528; ROSENBUSCH JP, 1971, J BIOL CHEM, V246, P1644; Thoden JB, 2001, BIOCHEMISTRY-US, V40, P6989, DOI 10.1021/bi010682i; Vincent F, 2004, J BIOL CHEM, V279, P2809, DOI 10.1074/jbc.M310165200; WEBER G, 1983, Q REV BIOPHYS, V16, P89, DOI 10.1017/S0033583500004935; WILEY DC, 1968, NATURE, V218, P1119, DOI 10.1038/2181119a0; Xu Z, 2003, J BACTERIOL, V185, P4038, DOI 10.1128/JB.185.14.4038-4049.2003; Zhang PF, 2009, BIOCHEMISTRY-US, V48, P766, DOI 10.1021/bi801831r	40	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					629	637		10.1074/jbc.M116.739862	http://dx.doi.org/10.1074/jbc.M116.739862			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27746403	Green Published, hybrid			2022-12-26	WOS:000392316100018
J	Pan, L; Zhu, B; Hao, WJ; Zeng, XL; Vlahopoulos, SA; Hazra, TK; Hegde, ML; Radak, Z; Bacsi, A; Brasier, AR; Ba, XQ; Boldogh, I				Pan, Lang; Zhu, Bing; Hao, Wenjing; Zeng, Xianlu; Vlahopoulos, Spiros A.; Hazra, Tapas K.; Hegde, Muralidhar L.; Radak, Zsolt; Bacsi, Attila; Brasier, Allan R.; Ba, Xueqing; Boldogh, Istvan			Oxidized Guanine Base Lesions Function in 8-Oxoguanine DNA Glycosylase-1-mediated Epigenetic Regulation of Nuclear Factor B-driven Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						8-oxoguanine (8-oxoG); 8-oxoguanine glycosylase (OGG1); NF-B transcription factor; promoter; reactive oxygen species (ROS)	NF-KAPPA-B; EXCISION-REPAIR; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; OXIDATIVE DAMAGE; MAMMALIAN-CELLS; POTENTIAL ROLE; TNF-ALPHA; INFLAMMATION; OGG1	A large percentage of redox-responsive gene promoters contain evolutionarily conserved guanine-rich clusters; guanines are the bases most susceptible to oxidative modification(s). Consequently, 7,8-dihydro-8-oxoguanine (8-oxoG) is one of the most abundant base lesions in promoters and is primarily repaired via the 8-oxoguanine DNA glycosylase-1 (OOG1)-initiated base excision repair pathway. In view of a prompt cellular response to oxidative challenge, we hypothesized that the 8-oxoG lesion and the cognate repair protein OGG1 are utilized in transcriptional gene activation. Here, we document TNF-induced enrichment of both 8-oxoG and OGG1 in promoters of pro-inflammatory genes, which precedes interaction of NF-B with its DNA-binding motif. OGG1 bound to 8-oxoG upstream from the NF-B motif increased its DNA occupancy by promoting an on-rate of both homodimeric and heterodimeric forms of NF-B. OGG1 depletion decreased both NF-B binding and gene expression, whereas Nei-like glycosylase-1 and -2 had a marginal effect. These results are the first to document a novel paradigm wherein the DNA repair protein OGG1 bound to its substrate is coupled to DNA occupancy of NF-B and functions in epigenetic regulation of gene expression.	[Pan, Lang; Zhu, Bing; Vlahopoulos, Spiros A.; Radak, Zsolt; Bacsi, Attila; Ba, Xueqing; Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, 301 Univ Blvd, Galveston, TX 77555 USA; [Hazra, Tapas K.; Brasier, Allan R.] Univ Texas Med Branch, Dept Med, Galveston, TX 77555 USA; [Hazra, Tapas K.; Brasier, Allan R.; Boldogh, Istvan] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Hao, Wenjing; Zeng, Xianlu; Ba, Xueqing] Northeast Normal Univ, Key Lab Mol Epigenet, Minist Educ, Inst Cytol & Genet, Changchun 130024, Peoples R China; [Hegde, Muralidhar L.] Methodist Res Inst, Dept Radiat Oncol & Neurol, Houston, TX 77030 USA; [Vlahopoulos, Spiros A.] Univ Athens, Dept Pediat 1, Horemeio Res Lab, Athens 11527, Greece; [Radak, Zsolt] Semmelweis Univ, H-1123 Budapest, Hungary; [Bacsi, Attila] Univ Debrecen, Dept Immunol, Fac Med, H-4012 Debrecen, Hungary	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Northeast Normal University - China; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; National & Kapodistrian University of Athens; Semmelweis University; University of Debrecen	Boldogh, I (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, 301 Univ Blvd, Galveston, TX 77555 USA.; Ba, XQ (corresponding author), NE Normal Univ, Key Lab Mol Epigenet, Inst Cytol & Genet, 5268 Renmin St, Changchun 130024, Jilin, Peoples R China.	baxq755@nenu.edu.cn; sboldogh@utmb.edu	Vlahopoulos, Spiros A/A-1186-2014; Vlahopoulos, Spiros/AAK-6362-2020	Vlahopoulos, Spiros A/0000-0001-6245-3863; Vlahopoulos, Spiros/0000-0001-6245-3863; Pan, Lang/0000-0003-2324-2144; Radak, Zsolt/0000-0003-1297-6804; Bacsi, Attila/0000-0002-2311-2975; Ba, Xueqing/0000-0002-1075-5496; Brasier, Allan/0000-0002-5012-4090; bing, zhu/0000-0002-8371-3182; Hegde, Muralidhar/0000-0001-7333-8123	National Institutes of Health from NIEHS [RO1 ES018948, P30 ES006676]; National Institutes of Health from NIAID [PO1-AI062885]; National Science Foundation of China [31571339]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018948, P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088645] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant RO1 ES018948 from NIEHS (to I. B.), Grant PO1-AI062885 from NIAID (to A. R. B. and I. B.), Grant P30 ES006676 from NIEHS (to A. R. B. and I. B.), and National Science Foundation of China Grant 31571339 (to X. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agresti A, 2003, BIOCHEM BIOPH RES CO, V302, P421, DOI 10.1016/S0006-291X(03)00184-0; Aguilera-Aguirre L, 2014, J IMMUNOL, V193, P4643, DOI 10.4049/jimmunol.1401625; Aguilera-Aguirre L, 2009, J IMMUNOL, V183, P5379, DOI 10.4049/jimmunol.0900228; Allgayer J, 2016, NUCLEIC ACIDS RES, V44, P7267, DOI 10.1093/nar/gkw473; Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Ba X, 2014, INT J MOL SCI, V15, P16975, DOI 10.3390/ijms150916975; Ba XQ, 2014, J IMMUNOL, V192, P2384, DOI 10.4049/jimmunol.1302472; Bacsi A, 2007, MECH AGEING DEV, V128, P637, DOI 10.1016/j.mad.2007.09.005; Bacsi A, 2013, DNA REPAIR, V12, P18, DOI 10.1016/j.dnarep.2012.10.002; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Boldogh I, 2012, J BIOL CHEM, V287, P20769, DOI 10.1074/jbc.C112.364620; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Bravard A, 2006, MOL CELL BIOL, V26, P7430, DOI 10.1128/MCB.00624-06; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Chakraborty A, 2015, J BIOL CHEM, V290, P24636, DOI 10.1074/jbc.M115.658146; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen-Park FE, 2002, J BIOL CHEM, V277, P24701, DOI 10.1074/jbc.M200007200; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033; DIZDAROGLU M, 1992, MUTAT RES, V275, P331, DOI 10.1016/0921-8734(92)90036-O; Donley N, 2015, ACS CHEM BIOL, V10, P2334, DOI 10.1021/acschembio.5b00452; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; German P, 2013, DNA REPAIR, V12, P856, DOI 10.1016/j.dnarep.2013.06.006; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Ghosh G, 2012, IMMUNOL REV, V246, P36, DOI 10.1111/j.1600-065X.2012.01097.x; Ghosh R, 1999, NUCLEIC ACIDS RES, V27, P3213, DOI 10.1093/nar/27.15.3213; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Giese B, 2002, ANNU REV BIOCHEM, V71, P51, DOI 10.1146/annurev.biochem.71.083101.134037; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hailer-Morrison MK, 2003, BIOCHEMISTRY-US, V42, P9761, DOI 10.1021/bi034546k; Hajas G, 2013, FREE RADICAL BIO MED, V61, P384, DOI 10.1016/j.freeradbiomed.2013.04.011; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hill JW, 2006, NUCLEIC ACIDS RES, V34, P1620, DOI 10.1093/nar/gkl060; Jamaluddin M, 2007, CELL SIGNAL, V19, P1419, DOI 10.1016/j.cellsig.2007.01.020; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kaplan N, 2011, FREE RADICAL RES, V45, P1124, DOI 10.3109/10715762.2011.602073; Kaur S, 2016, J BIOL CHEM, V291, P22769, DOI 10.1074/jbc.M116.735696; Kim HS, 2016, FREE RADICAL BIO MED, V93, P12, DOI 10.1016/j.freeradbiomed.2015.10.415; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Luo JX, 2014, FREE RADICAL BIO MED, V73, P430, DOI 10.1016/j.freeradbiomed.2014.03.030; Mabley JG, 2004, FASEB J, V18, P290, DOI 10.1096/fj.04-2278fje; Margolin Y, 2006, NAT CHEM BIOL, V2, P365, DOI 10.1038/nchembio796; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; Mitra S, 1997, MOL CELLS, V7, P305; Mokkapati SK, 2004, BIOCHEMISTRY-US, V43, P11596, DOI 10.1021/bi049097i; Moore SPG, 2016, J BIOL CHEM, V291, P5452, DOI 10.1074/jbc.M115.672733; Morreall J, 2015, DNA REPAIR, V26, P15, DOI 10.1016/j.dnarep.2014.11.007; Nakajima H, 2004, J BIOL CHEM, V279, P42774, DOI 10.1074/jbc.M407923200; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Norman DPG, 2003, BIOCHEMISTRY-US, V42, P1564, DOI 10.1021/bi026823d; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Pastukh V, 2007, FREE RADICAL BIO MED, V43, P1616, DOI 10.1016/j.freeradbiomed.2007.08.027; Pastukh V, 2015, AM J PHYSIOL-LUNG C, V309, pL1367, DOI 10.1152/ajplung.00236.2015; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Sampath H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051697; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; SCHRECK R, 1990, NUCLEIC ACIDS RES, V18, P6497, DOI 10.1093/nar/18.22.6497; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; Tian B, 2003, RECENT PROG HORM RES, V58, P95, DOI 10.1210/rp.58.1.95; Tian B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1707-x; Tian B, 2012, METHODS MOL BIOL, V809, P105, DOI 10.1007/978-1-61779-376-9_7; Vlahopoulos SA, 2015, CYTOKINE GROWTH F R, V26, P389, DOI 10.1016/j.cytogfr.2015.06.001; Vraetz T, 1999, NEPHROL DIAL TRANSPL, V14, P2137, DOI 10.1093/ndt/14.9.2137; Wallace SS, 2013, ENVIRON MOL MUTAGEN, V54, P691, DOI 10.1002/em.21820; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	70	111	113	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25553	25566		10.1074/jbc.M116.751453	http://dx.doi.org/10.1074/jbc.M116.751453			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27756845	hybrid, Green Published			2022-12-26	WOS:000390095300023
J	Goloviznina, NA; Verghese, SC; Yoon, YM; Taratula, O; Marks, DL; Kurre, P				Goloviznina, Natalya A.; Verghese, Santhosh Chakkaramakkil; Yoon, Young Me; Taratula, Oleh; Marks, Daniel L.; Kurre, Peter			Mesenchymal Stromal Cell-derived Extracellular Vesicles Promote Myeloid-biased Multipotent Hematopoietic Progenitor Expansion via Toll-Like Receptor Engagement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; INFLAMMATORY CYTOKINES; EXOSOMES; DIFFERENTIATION; TRAFFICKING; NICHE; MOUSE; HSC; MICROVESICLES; BIOGENESIS	Mesenchymal stromal cells (MSCs) present in the bone marrow microenvironment secrete cytokines and angiogenic factors that support the maintenance and regenerative expansion of hematopoietic stem and progenitor cells (HSPCs). Here, we tested the hypothesis that extracellular vesicles (EVs) released by MSCs contribute to the paracrine crosstalk that shapes hematopoietic function. We systematically characterized EV release by murine stromal cells and demonstrate that MSC-derived EVs prompt a loss of HSPC quiescence with concomitant expansion of murine myeloid progenitors. Our studies reveal that HSPC expansion by MSC EVs is mediated via the MyD88 adapter protein and is partially blocked by treatment with a TLR4 inhibitor. Imaging of fluorescence protein-tagged MSC EVs corroborated their cellular co-localization with TLR4 and endosomal Rab5 compartments in HSPCs. The dissection of downstream responses to TLR4 activation reveals that the mechanism by which MSC EVs impact HSPCs involves canonical NF-kappa B signaling and downstream activation of Htf-1a and CCL2 target genes. Our aggregate data identity a previously unknown role for MSC-derived EVs in the regulation of hematopoiesis through innate immune mechanisms and illustrate the expansive cell-cell crosstalk in the bone marrow microenvironment.	[Goloviznina, Natalya A.; Verghese, Santhosh Chakkaramakkil; Yoon, Young Me; Marks, Daniel L.; Kurre, Peter] Oregon Hlth & Sci Univ, Dept Pediat, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Verghese, Santhosh Chakkaramakkil; Yoon, Young Me; Marks, Daniel L.; Kurre, Peter] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Kurre, Peter] Oregon Hlth & Sci Univ, Pediat Canc Biol Program, Portland, OR 97239 USA; [Taratula, Oleh] Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA; [Goloviznina, Natalya A.] Univ Minnesota, Mol Cellular Dev Biol & Genet Program, Minneapolis, MN 55108 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon State University; University of Minnesota System; University of Minnesota Twin Cities	Kurre, P (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Kurre, P (corresponding author), Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	kurrepe@ohsu.edu		Goloviznina, Natalya/0000-0001-6002-4125	National Center for Research Resources (NCRR) [P40RR017447]; National Institutes of Health [PSI OD011092]; NATIONAL CANCER INSTITUTE [R01CA184324] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR017447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM113846] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some of the materials employed in this work were provided by the Tulane Center for Gene Therapy through the National Center for Research Resources (NCRR) Grant P40RR017447. We gratefully acknowledge the assistance of Dr Stephanie Krasnow, Dr. Xinxia Zhu, Pete Levasseur, Dr. Claudia Lopez, John Butler, Dr. Shelton Viola, Ben Doron, and Merna Labib with select experiments. We also thank Dr. David W. Erikson at The Endocrine Technologies Support Core (ETSC) at the Oregon National Primate Research Center (ONPRC) for help with the Lominex experiment The ETSC at the ONPRC is supported by National Institutes of Health Grant PSI OD011092 awarded to ONPRC.	Anderson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076979; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Boettcher S, 2014, BLOOD, V124, P1393, DOI 10.1182/blood-2014-04-570762; Boiko JR, 2012, CYTOKINE, V57, P1, DOI 10.1016/j.cyto.2011.10.005; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Bretz NP, 2013, J BIOL CHEM, V288, P36691, DOI 10.1074/jbc.M113.512806; Burberry A, 2014, CELL HOST MICROBE, V15, P779, DOI 10.1016/j.chom.2014.05.004; Buza-Vidas N, 2011, BLOOD, V118, P1291, DOI 10.1182/blood-2011-02-338046; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Ciuculescu MF, 2014, METHODS MOL BIOL, V1185, P287, DOI 10.1007/978-1-4939-1133-2_20; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cosgun KN, 2014, CELL STEM CELL, V15, P227, DOI 10.1016/j.stem.2014.06.001; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Espin-Palazon R, 2014, CELL, V159, P1070, DOI 10.1016/j.cell.2014.10.031; Fiedler K, 2013, AM J BLOOD RES, V3, P124; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Grassinger J, 2012, CYTOKINE, V58, P218, DOI 10.1016/j.cyto.2012.01.014; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; He QP, 2015, BLOOD, V125, P1098, DOI 10.1182/blood-2014-09-601542; Huan J, 2015, LEUKEMIA, V29, P2285, DOI 10.1038/leu.2015.163; Huan J, 2013, CANCER RES, V73, P918, DOI 10.1158/0008-5472.CAN-12-2184; KAULEN DR, 1983, ZH MIKROB EPID IMMUN, P84; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Lai CP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8029; Lai RC, 2015, SEMIN CELL DEV BIOL, V40, P82, DOI 10.1016/j.semcdb.2015.03.001; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Mercier FE, 2016, STEM CELL REP, V6, P985, DOI 10.1016/j.stemcr.2016.04.010; Mirantes C, 2014, EXP CELL RES, V329, P248, DOI 10.1016/j.yexcr.2014.08.017; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nagamoto-Combs K, 2014, J NEUROSCI METH, V233, P187, DOI 10.1016/j.jneumeth.2014.05.021; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Platt MO, 2009, J CELL PHYSIOL, V221, P306, DOI 10.1002/jcp.21854; Purton L.E., 2008, STEMBOOK, DOI [10.3824/stembook.1.28.1, DOI 10.3824/STEMBOOK.1.28.1]; Sahoo S, 2014, CIRC RES, V114, P333, DOI 10.1161/CIRCRESAHA.114.300639; Sawamiphak S, 2014, DEV CELL, V31, P640, DOI 10.1016/j.devcel.2014.11.007; Schuettpelz LG, 2014, LEUKEMIA, V28, P1851, DOI 10.1038/leu.2014.68; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Simon NC, 2014, INFECT IMMUN, V82, P21, DOI 10.1128/IAI.01059-13; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Vicencio JM, 2015, J AM COLL CARDIOL, V65, P1525, DOI 10.1016/j.jacc.2015.02.026; Wilson AA, 2013, MOL THER, V21, P825, DOI 10.1038/mt.2013.19; Zhang B, 2014, STEM CELLS DEV, V23, P1233, DOI 10.1089/scd.2013.0479; Zhang HJ, 2016, STEM CELL REP, V6, P940, DOI 10.1016/j.stemcr.2016.05.002; Zhao JL, 2014, CELL STEM CELL, V14, P445, DOI 10.1016/j.stem.2014.01.007; Zhou BO, 2015, ELIFE, V4, DOI 10.7554/eLife.05521; Zhu YG, 2014, STEM CELLS, V32, P116, DOI 10.1002/stem.1504; Zielske SP, 2009, INT J RADIAT ONCOL, V75, P843, DOI 10.1016/j.ijrobp.2008.06.1953	58	40	40	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24607	24617		10.1074/jbc.M116.745653	http://dx.doi.org/10.1074/jbc.M116.745653			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27758863	hybrid, Green Published			2022-12-26	WOS:000388875500022
J	Levy, E; Byrne, M; Coates, DJ; Macdonald, BM; McArthur, S; van Leeuwen, S				Levy, E.; Byrne, M.; Coates, D. J.; Macdonald, B. M.; McArthur, S.; van Leeuwen, S.			Contrasting Influences of Geographic Range and Distribution of Populations on Patterns of Genetic Diversity in Two Sympatric Pilbara Acacias	PLOS ONE			English	Article							MICROSATELLITE MARKERS; ARID ZONE; RARE; COMMON; DIFFERENTIATION; EVOLUTION; FLOW; SARRACENIACEAE; POLYMORPHISM; SUNFLOWER	The influence of geographic range on species persistence has long been of interest and there is a need for a better understanding of the genetic consequences for species with restricted distributions, particularly with the increasing rate of global species extinctions. However, the genetic effects of restricted range are often confounded by the impacts of population distribution. We compared chloroplast and nuclear genetic diversity and differentiation in two acacias, the restricted, patchily distributed Acacia atkinsiana and the widespread, semi-continuously distributed A. ancistrocarpa. Lower intra-population diversity and higher differentiation between populations were seen in A. atkinsiana compared to its widespread congener, A. ancistrocarpa. There was little evidence of geographical influences on population genetic structure in A. ancistrocarpa whereas A. atkinsiana exhibited nuclear genetic structure with isolation by distance, differentiation of near-coastal populations from those in the ranges, and differentiation of peripheral populations from those in the centre of the distribution. These results are consistent with expectations of the effect of geographic range and population distribution on genetic diversity, but indicate that distribution of populations rather than geographic range has influenced the observed genetic structure. The contrasting patterns observed here demonstrate that conservation approaches for species management and ecological restoration need to consider the distribution of populations in geographically restricted species.	[Levy, E.; Byrne, M.; Coates, D. J.; Macdonald, B. M.; McArthur, S.; van Leeuwen, S.] Dept Pk & Wildlife, Sci & Conservat Div, Perth, WA, Australia		Levy, E (corresponding author), Dept Pk & Wildlife, Sci & Conservat Div, Perth, WA, Australia.	Esther.Levy@DPAW.wa.gov.au	Byrne, Margaret/H-8198-2015	Byrne, Margaret/0000-0002-7197-5409; van Leeuwen, Stephen/0000-0003-3063-7785	Rio Tinto	Rio Tinto	This study was funded by Rio Tinto (http://www.riotinto.com/). The funders had no role in the study design, data collection and analyses, decision to publish or preparation of the maunscript.; We thank Rio Tinto for funding this study.	Allendorf F., 2007, CONSERVATION GENETIC; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbara T, 2007, MOL ECOL, V16, P1981, DOI 10.1111/j.1365-294X.2007.03272.x; Binks RM, 2015, BIOL J LINN SOC, V114, P873, DOI 10.1111/bij.12465; Broadhurst LM, 2008, EVOL APPL, V1, P587, DOI 10.1111/j.1752-4571.2008.00045.x; Butcher PA, 2009, TREE GENET GENOMES, V5, P189, DOI 10.1007/s11295-008-0169-6; Butcher PA, 2000, THEOR APPL GENET, V101, P1282, DOI 10.1007/s001220051608; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Byrne M, 2004, AUST J BOT, V52, P459, DOI 10.1071/BT03117; Byrne M, 2012, AUST J BOT, V60, P569, DOI 10.1071/BT12146; Byrne M, 2016, J BIOGEOGRA IN PRESS; Byrne M, 2008, BIOL J LINN SOC, V93, P177, DOI 10.1111/j.1095-8312.2007.00946.x; Byrne M, 2011, J APPL ECOL, V48, P1365, DOI 10.1111/j.1365-2664.2011.02045.x; Calvino-Cancela M, 2006, ECOGRAPHY, V29, P632, DOI 10.1111/j.0906-7590.2006.04677.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Chung MY, 2012, J HERED, V103, P692, DOI 10.1093/jhered/ess032; Coates DJ, 2006, CONSERV GENET, V7, P931, DOI 10.1007/s10592-006-9136-7; Coates DJ, 2000, AUST J BOT, V48, P329, DOI 10.1071/BT99018; Coates DJ, 2003, AM J BOT, V90, P997, DOI 10.3732/ajb.90.7.997; Cole CT, 2003, ANNU REV ECOL EVOL S, V34, P213, DOI 10.1146/annurev.ecolsys.34.030102.151717; Coppi A, 2014, FLORA, V209, P5, DOI 10.1016/j.flora.2013.11.002; CRACRAFT J, 1991, Australian Systematic Botany, V4, P211, DOI 10.1071/SB9910211; David P, 2007, MOL ECOL, V16, P2474, DOI 10.1111/j.1365-294X.2007.03330.x; DeChaine EG, 2005, AM J BOT, V92, P477, DOI 10.3732/ajb.92.3.477; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Duminil J, 2007, AM NAT, V169, P662, DOI 10.1086/513490; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Ellis JR, 2006, MOL ECOL, V15, P2345, DOI 10.1111/j.1365-294X.2006.02937.x; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falk DA, 1991, GENETICS CONSERVATIO; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fiedler P. L., 1995, MADRONO, V42, P127; FIEDLER PL, 1992, CONSERVATION BIOL; Finston TL, 2009, MOL PHYLOGENET EVOL, V52, P448, DOI 10.1016/j.ympev.2009.03.006; Finston TL, 2004, MAR FRESHWATER RES, V55, P619, DOI 10.1071/MF04033; Frankham R, 2005, J EVOLUTION BIOL, V18, P750, DOI 10.1111/j.1420-9101.2005.00885.x; Furches MS, 2013, AM J BOT, V100, P2092, DOI 10.3732/ajb.1300037; Gaston Kevin J., 1997, Population and Community Biology Series, V17, P12; Gevaert SD, 2013, J HERED, V104, P407, DOI 10.1093/jhered/est009; Gibson MR, 2011, DIVERS DISTRIB, V17, P911, DOI 10.1111/j.1472-4642.2011.00808.x; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; Godt MJW, 1998, SYST BOT, V23, P427, DOI 10.2307/2419375; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Harvey MS, 2008, INVERTEBR SYST, V22, P167, DOI 10.1071/IS07026; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Karron JD, 1987, EVOL ECOL, V1, P47, DOI 10.1007/BF02067268; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Levy E, 2014, CONSERV GENET RESOUR, V6, P585, DOI 10.1007/s12686-014-0146-3; Levy E, 2010, MOL ECOL, V19, P4192, DOI 10.1111/j.1365-294X.2010.04810.x; Leys R, 2003, EVOLUTION, V57, P2819, DOI 10.1111/j.0014-3820.2003.tb01523.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MASLIN B R, 1982, Nuytsia, V4, P61; Maslin B. R., 1987, Advances in legume systematics. Part 3., P443; McKenzie N.L., 2009, RECORDS W AUSTR MU S, V78, P3, DOI DOI 10.18195/ISSN.0313-122X.78(1).2009.003-089; Millar MA, 2013, BIOL J LINN SOC, V108, P871, DOI 10.1111/bij.12002; New TR, 1984, A BIOL OF ACACIAS; Ng CH, 2005, MOL ECOL NOTES, V5, P572, DOI 10.1111/j.1471-8286.2005.00994.x; Nistelberger HM, 2015, BIOL J LINN SOC, V114, P860, DOI 10.1111/bij.12464; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Ouborg NJ, 2006, J ECOL, V94, P1233, DOI 10.1111/j.1365-2745.2006.01167.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pepper M, 2013, J BIOGEOGR, V40, P1225, DOI 10.1111/jbi.12080; Pepper M, 2011, MOL PHYLOGENET EVOL, V61, P750, DOI 10.1016/j.ympev.2011.08.009; Pepper M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-152; Pons O, 1996, GENETICS, V144, P1237; Rabinowitz D., 1981, 7 FORMS RARITY BIOLO; Rousset F, 1997, GENETICS, V145, P1219; Sakaguchi S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2182; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; TAJIMA F, 1989, GENETICS, V123, P585; Takahashi Y, 2011, PLANT SPEC BIOL, V26, P13, DOI 10.1111/j.1442-1984.2010.00297.x; Tapper SL, 2014, DIVERS DISTRIB, V20, P987, DOI 10.1111/ddi.12185; Templeton A.R., 1986, P105; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Van Kranendonk MJ, 2002, ECON GEOL BULL SOC, V97, P695; van Leeuwen S, 2010, WATTLES PILBARA; Wahl H., 2004, ECOREGIONS YUKON TER, V04-01, P19; Wang ZF, 2004, J HERED, V95, P234, DOI 10.1093/jhered/esh043; Watts CD, 2008, MOL ECOL RESOUR, V8, P1344, DOI 10.1111/j.1755-0998.2008.02229.x; Wilmer JW, 1999, EVOLUTION, V53, P1582, DOI 10.1111/j.1558-5646.1999.tb05421.x; Yoichi W, 2014, TREE GENET GENOMES, V10, P827, DOI 10.1007/s11295-014-0723-3; Young AG, 1996, CONSERV BIOL, V10, P1220, DOI 10.1046/j.1523-1739.1996.10041220.x	88	22	23	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0163995	10.1371/journal.pone.0163995	http://dx.doi.org/10.1371/journal.pone.0163995			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768703	Green Submitted, gold, Green Published			2022-12-26	WOS:000386205400004
J	Voglar, M; Wamerdam, J; Kingma, I; Sarabon, N; van Dieen, JH				Voglar, Matej; Wamerdam, Jeffrey; Kingma, Idsart; Sarabon, Nejc; van Dieen, Jaap H.			Prolonged Intermittent Trunk Flexion Increases Trunk Muscles Reflex Gains and Trunk Stiffness	PLOS ONE			English	Article							LOW-BACK-PAIN; CYCLIC LUMBAR FLEXION; VISCOELASTIC TISSUE; RELAXATION PHENOMENON; REPETITIVE FLEXION; PROSPECTIVE COHORT; DEPENDENT CHANGES; POSTURAL CONTROL; GLOBAL BURDEN; RISK-FACTOR	The goal of the present study was to determine the effects of prolonged, intermittent flexion on trunk neuromuscular control. Furthermore, the potential beneficial effects of passive upper body support during flexion were investigated. Twenty one healthy young volunteers participated during two separate visits in which they performed 1 hour of intermittent 60 seconds flexion and 30 seconds rest cycles. Flexion was set at 80% lumbar flexion and was performed with or without upper body support. Before and after intermittent flexion exposure, lumbar range of motion was measured using inertial measurement units and trunk stability was assessed during perturbations applied in the forward direction with a force controlled actuator. Closed-loop system identification was used to determine the trunk translational admittance and reflexes as frequency response functions. The admittance describes the actuator displacement as a function of contact force and to assess reflexes muscle activation was related to actuator displacement. Trunk admittance gain decreased after unsupported flexion, while reflex gain and lumbar range of motion increased after both conditions. Significant interaction effects confirmed a larger increase in lumbar range of motion and reflex gains at most frequencies analysed following unsupported flexion in comparison to supported flexion, probably compensating for decreased passive tissue stiffness. In contrast with some previous studies we found that prolonged intermittent flexion decreased trunk admittance, which implies an increase of the lumped intrinsic and reflexive stiffness. This would compensate for decreased stiffness at the cost of an increase in cumulative low back load. Taking into account the differences between conditions it would be preferable to offer upper body support during activities that require prolonged trunk flexion.	[Voglar, Matej; Sarabon, Nejc] Univ Primorska, Andrej Marus Inst, Koper, Slovenia; [Wamerdam, Jeffrey; Kingma, Idsart; van Dieen, Jaap H.] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands; [Sarabon, Nejc] S2P Ltd, Lab Motor Control & Motor Learning, Ljubljana, Slovenia	University of Primorska; Vrije Universiteit Amsterdam	van Dieen, JH (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands.	j.van.dieen@vu.nl	van Dieen, Jaap/B-3937-2013	van Dieen, Jaap/0000-0002-7719-5585; Voglar, Matej/0000-0002-1496-8675	S2P Ltd; Slovene Human Resources Development and Scholarship Fund; Slovenian Research Agency [L5-4293]	S2P Ltd; Slovene Human Resources Development and Scholarship Fund; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	S2P Ltd provided support in the form of salaries for author NS. Author MV received funding for the research from the Slovene Human Resources Development and Scholarship Fund and NS received funding for the applied project "Evaluation of neuro-muscular trunk stabilization functions and development of exercise programs for lower back pain prevention (grant no. L5-4293)" funded by the Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams MA, 1996, CLIN BIOMECH, V11, P194, DOI 10.1016/0268-0033(96)00002-2; Bazrgari B, 2011, ERGONOMICS, V54, P1043, DOI 10.1080/00140139.2011.614357; BONGERS PM, 1988, INT ARCH OCC ENV HEA, V60, P129, DOI 10.1007/BF00381494; Callaghan JP, 2002, CLIN BIOMECH, V17, P353, DOI 10.1016/S0268-0033(02)00023-2; Coenen P, 2013, J OCCUP REHABIL, V23, P11, DOI 10.1007/s10926-012-9375-z; Courtney AJ, 1999, INT J IND ERGONOM, V23, P61; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Dolan P, 1998, J BIOMECH, V31, P713, DOI 10.1016/S0021-9290(98)00086-4; Forsman P, 2013, GAIT POSTURE, V38, P192, DOI 10.1016/j.gaitpost.2012.11.011; Granata KP, 2007, J ELECTROMYOGR KINES, V17, P384, DOI 10.1016/j.jelekin.2006.10.010; Granata KP, 2001, J ELECTROMYOGR KINES, V11, P247, DOI 10.1016/S1050-6411(01)00003-7; Griffioen M, 2015, J BIOMECH; Grondin Diane E, 2009, J Electromyogr Kinesiol, V19, pe237, DOI 10.1016/j.jelekin.2008.05.006; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Hendershot B, 2011, CLIN BIOMECH, V26, P250, DOI 10.1016/j.clinbiomech.2010.09.019; Herrmann CM, 2006, J ELECTROMYOGR KINES, V16, P637, DOI 10.1016/j.jelekin.2005.11.004; Hoffman SL, 2012, MANUAL THER, V17, P157, DOI 10.1016/j.math.2011.12.007; Hoogendoorn WE, 2000, SPINE, V25, P3087, DOI 10.1097/00007632-200012010-00018; Hoy D, 2010, BEST PRACT RES CL RH, V24, P155, DOI 10.1016/j.berh.2009.11.002; Kent Peter M, 2005, Chiropr Osteopat, V13, P13, DOI 10.1186/1746-1340-13-13; Kuijer PPFM, 2012, OCCUP MED-OXFORD, V62, P152, DOI 10.1093/occmed/kqr204; Lu DW, 2004, J BIOMECH, V37, P845, DOI 10.1016/j.jbiomech.2003.11.023; Maaswinkel E, 2015, J BIOMECH, V48, P298, DOI 10.1016/j.jbiomech.2014.11.030; Manire JT, 2010, J STRENGTH COND RES, V24, P1464, DOI 10.1519/JSC.0b013e3181d32e8c; McGill S M, 2001, Exerc Sport Sci Rev, V29, P26, DOI 10.1097/00003677-200101000-00006; McGill SM, 2011, SPINE J, V11, P365, DOI 10.1016/j.spinee.2011.01.034; MEDEIROS JM, 1977, PHYS THER, V57, P518, DOI 10.1093/ptj/57.5.518; Monjo F, 2014, EXP BRAIN RES, V232, P2931, DOI 10.1007/s00221-014-3975-0; Muslim K, 2013, APPL ERGON, V44, P643, DOI 10.1016/j.apergo.2012.12.004; O'Sullivan P, 2006, SPINE, V31, P2009, DOI 10.1097/01.brs.0000228845.27561.e0; Olson MW, 2009, J ELECTROMYOGR KINES, V19, P30, DOI 10.1016/j.jelekin.2007.06.011; Olson MW, 2004, CLIN BIOMECH, V19, P769, DOI 10.1016/j.clinbiomech.2004.05.007; PANJABI MM, 1992, J SPINAL DISORD, V5, P390, DOI 10.1097/00002517-199212000-00002; Parkinson RJ, 2004, CLIN BIOMECH, V19, P330, DOI 10.1016/j.clinbiomech.2004.01.002; PUNNETT L, 1991, SCAND J WORK ENV HEA, V17, P337, DOI 10.5271/sjweh.1700; Sanchez-Zuriaga D, 2010, SPINE, V35, P517, DOI 10.1097/BRS.0b013e3181b967ea; Sbriccoli P, 2007, J ELECTROMYOGR KINES, V17, P142, DOI 10.1016/j.jelekin.2006.01.014; Shin G, 2010, J ELECTROMYOGR KINES, V20, P742, DOI 10.1016/j.jelekin.2010.03.002; Solomonow M, 2003, J ELECTROMYOGR KINES, V13, P381, DOI 10.1016/S1050-6411(03)00045-2; Solomonow M, 2012, J ELECTROMYOGR KINES, V22, P155, DOI 10.1016/j.jelekin.2011.11.008; Solomonow M, 2009, J BODYW MOV THER, V13, P136, DOI 10.1016/j.jbmt.2008.02.001; Taylor DC, 1997, MED SCI SPORT EXER, V29, P1619, DOI 10.1097/00005768-199712000-00011; Toosizadeh N, 2013, ANN BIOMED ENG, V41, P1150, DOI 10.1007/s10439-013-0797-3; van der Helm FCT, 2002, J NEUROSCI METH, V119, P1, DOI 10.1016/S0165-0270(02)00147-4; van Drunen P, 2013, J BIOMECH, V46, P1440, DOI 10.1016/j.jbiomech.2013.03.007; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wai EK, 2010, SPINE J, V10, P76, DOI 10.1016/j.spinee.2009.06.005	47	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0162703	10.1371/journal.pone.0162703	http://dx.doi.org/10.1371/journal.pone.0162703			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768688	gold, Green Submitted, Green Published			2022-12-26	WOS:000386205400002
J	dos Santos, LN; da Silva, PHL; Alvim, IMP; Nery, JADC; Lara, FA; Sarno, EN; Esquenazi, D				dos Santos, Luciana Nahar; Lopes da Silva, Pedro Henrique; Peixoto Alvim, Iris Maria; Nery, Jose Augusto da Costa; Lara, Flavio Alves; Sarno, Euzenir Nunes; Esquenazi, Danuza			Role of T-EFFECTOR/ MEMORY Cells, TBX21 Gene Expression and T-Cell Homing Receptor on Type 1 Reaction in Borderline Lepromatous Leprosy Patients	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; REVERSAL REACTION; CYTOKINE PROFILE; INTERFERON-GAMMA; SKIN; RESPONSES; IL-10; TUBERCULOSIS; LYMPHOCYTES; POPULATIONS	In spite of hyporesponsivity to Mycobacterium leprae, borderline lepromatous (BL) patients show clinical and immunological instability, and undergo frequent acute inflammatory episodes such as type 1 reaction (T1R), which may cause nerve damages. This work focused on the participation of T cell subsets from blood and skin at T1R onset. We observed a significantly increased ex vivo frequency of both effector and memory CD4+ and CD8+ T cells in T1R group. Besides, ex vivo frequency of T cell homing receptor, the Cutaneous Leukocyte-associated Antigen (CLA) was significantly increased in T cells from T1R patients. M. leprae induced a higher frequency of CD4+ T-EM and CD8+ T-EF cells, as well as of CD8 +/TEMRA ( terminally differentiated effector T cells) subset, which expressed high CD69+. The presence of IFN-gamma-producing-CD4+ T-EF and naive and effector CD8+ T lymphocytes was significant in T1R. TBX21 expression was significantly higher in T1R, while BL showed increased GATA3 and FOXP3 expression. In T1R, TBX21 expression was strongly correlated with CD8+/IFN-gamma- T cells frequency. The number of double positive CD8+/CLA+ and CD45RA+/CLA+ cells was significantly higher in skin lesions from T1R, in comparison with non-reactional BL group. The observed increase of ex vivo T cells at T1R onset suggests intravascular activation at the beginning of reactional episodes. The antigen-specific response in T1R group confirmed the higher number of CD8+/CLA+ and CD45RA+/CLA+ cells in T1R lesions suggests possible migration of these cells activated by M. leprae components inside the vascular compartment to skin and participation in T1R physiopathology.	[dos Santos, Luciana Nahar; Lopes da Silva, Pedro Henrique; Nery, Jose Augusto da Costa; Sarno, Euzenir Nunes; Esquenazi, Danuza] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Leprosy Lab, Rio De Janeiro, Brazil; [Peixoto Alvim, Iris Maria; Lara, Flavio Alves] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Cellular Microbiol, Rio De Janeiro, Brazil; [Esquenazi, Danuza] Univ Estado Rio De Janeiro, Sch Med Sci, Dept Pathol & Labs, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro	Esquenazi, D (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Leprosy Lab, Rio De Janeiro, Brazil.; Esquenazi, D (corresponding author), Univ Estado Rio De Janeiro, Sch Med Sci, Dept Pathol & Labs, Rio De Janeiro, Brazil.	danuza@ioc.fiocruz.br	Lara, Flavio Alves/L-1861-2013	Nunes Sarno, Euzenir/0000-0003-0129-2159	FIOCRUZ/CAPES [14.06.38.047]; National Counsel of Technological and Scientific Development - CNPq (PAPES VI/Fiocruz) [407838/2012-0]; CNPq [305885/2014-6]	FIOCRUZ/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Counsel of Technological and Scientific Development - CNPq (PAPES VI/Fiocruz)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	LNS is a postgraduate student sponsored by FIOCRUZ/CAPES (process number 14.06.38.047). This investigation received financial support from the National Counsel of Technological and Scientific Development - CNPq (PAPES VI/Fiocruz, process number 407838/2012-0). ENS is fellow sponsored by CNPq (process number 305885/2014-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Arnez LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136282; Andrade PR, 2015, BRIT J DERMATOL, V172, P268, DOI 10.1111/bjd.13430; Andrade PR, 2015, EXPERT REV CLIN IMMU, V11, P391, DOI 10.1586/1744666X.2015.1012501; [Anonymous], 2015, RELEVE EPIDEMIOLOGIQ, V91, P405; Ashenafi S, 2014, CLIN IMMUNOL, V151, P84, DOI 10.1016/j.clim.2014.01.010; Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; BARNES PF, 1992, INFECT IMMUN, V60, P1441, DOI 10.1128/IAI.60.4.1441-1446.1992; Chakir H, 2003, J IMMUNOL METHODS, V278, P157, DOI 10.1016/S0022-1759(03)00200-X; Nery JAD, 2013, AN BRAS DERMATOL, V88, P787, DOI 10.1590/abd1806-4841.20132004; de Oliveira AL, 2013, IMMUNOLOGY, V140, P47, DOI 10.1111/imm.12108; Dong J, 2007, J IMMUNOL, V179, P2389, DOI 10.4049/jimmunol.179.4.2389; Duthie MS, 2016, APPL MICROBIOL BIOT, V100, P3267, DOI 10.1007/s00253-016-7328-8; Esquenazi D, 2008, CLIN EXP DERMATOL, V33, P294, DOI 10.1111/j.1365-2230.2007.02654.x; Geluk A, 2014, J CLIN IMMUNOL, V34, P245, DOI 10.1007/s10875-013-9979-x; Kirkaldy AA, 2003, CLIN EXP IMMUNOL, V134, P447, DOI 10.1111/j.1365-2249.2003.02306.x; Kumar S, 2014, EUR J IMMUNOL, V44, P431, DOI 10.1002/eji.201343649; Lima MCBS, 2000, SCAND J IMMUNOL, V51, P419, DOI 10.1046/j.1365-3083.2000.00703.x; Lockwood DNJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001327; Martins MVSB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001616; Mendes-Aguiar CD, 2009, CLIN EXP IMMUNOL, V157, P377, DOI 10.1111/j.1365-2249.2009.03970.x; Moraes MO, 1999, SCAND J IMMUNOL, V50, P541; Moura DF, 2012, EUR J IMMUNOL, V42, P2925, DOI 10.1002/eji.201142198; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; NARAYANAN RB, 1984, CLIN EXP IMMUNOL, V55, P623; Nery Jose A. C., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P363, DOI 10.1590/S0036-46651998000600005; Novais FO, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003504; Obar JJ, 2011, J IMMUNOL, V187, P4967, DOI 10.4049/jimmunol.1102335; Palermo ML, 2012, AM J TROP MED HYG, V86, P878, DOI 10.4269/ajtmh.2012.12-0088; Quiroga MF, 2004, J IMMUNOL, V173, P4120, DOI 10.4049/jimmunol.173.6.4120; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Saini C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004592; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sampaio EP, 1998, BRAZ J MED BIOL RES, V31, P69, DOI 10.1590/S0100-879X1998000100009; SARNO EN, 1991, CLIN EXP IMMUNOL, V84, P103; Scollard DM, 2011, CLIN VACCINE IMMUNOL, V18, P947, DOI 10.1128/CVI.00042-11; SCOLLARD DM, 1994, INT J LEPROSY, V62, P559; SIELING PA, 1993, J IMMUNOL, V150, P5501; Sieling PA, 2007, IMMUNOLOGY, V120, P518, DOI 10.1111/j.1365-2567.2006.02528.x; Sreenivasan P, 1998, IMMUNOLOGY, V95, P529, DOI 10.1046/j.1365-2567.1998.00634.x; Stefani MM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-75; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Talhari C, 2015, CLIN DERMATOL, V33, P26, DOI 10.1016/j.clindermatol.2014.07.002; Valian HK, 2013, J CLIN IMMUNOL, V33, P220, DOI 10.1007/s10875-012-9788-7; Verhagen CE, 1997, J IMMUNOL, V159, P4474; Walker SL, 2008, LEPROSY REV, V79, P372; Wang XJ, 2010, J INFECTION, V60, P133, DOI 10.1016/j.jinf.2009.10.048	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164543	10.1371/journal.pone.0164543	http://dx.doi.org/10.1371/journal.pone.0164543			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764137	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500042
J	Liu, HJ; Yan, H; Yan, J; Li, H; Chen, L; Han, LR; Yang, XF				Liu, Hai-Juan; Yan, Hua; Yan, Jun; Li, Hao; Chen, Liang; Han, Li-Ren; Yang, Xiao-Fei			Substance P Promotes the Proliferation, but Inhibits Differentiation and Mineralization of Osteoblasts from Rats with Spinal Cord Injury via RANKL/OPG System	PLOS ONE			English	Article							CELLS IN-VITRO; BONE-MARROW; BED REST; OSTEOPOROSIS; DENSITY; MARKERS; GROWTH; IMMOBILIZATION; EXPRESSION; RESORPTION	Spinal cord injury (SCI) causes a significant amount of bone loss, which results in osteoporosis (OP). The neuropeptide substance P (SP) and SP receptors may play important roles in the pathogenesis of OP after SCI. To identify the roles of SP in the bone marrow mesenchymal stem cell derived osteoblasts (BMSC-OB) in SCI rats, we investigated the expression of neurokinin-1 receptors (NK1R) in BMSC-OB and the effects of SP on bone formation by development of BMSC-OB cultures. Sixty young male Sprague-Dawley rats were randomized into two groups: SHAM and SCI. The expression of NK1R protein in BMSC-OB was observed using immunohistochemistry and Western blot analysis. The dose-and time-dependent effects of SP on the proliferation, differentiation and mineralization of BMSC-OB and the expression of osteoblastic markers by in vitro experiments. The expression of NK1R in BMSC-OB was observed on plasma membranes and in cytoplasm. One week after osteogenic differentiation, the expression of NK1R was significantly increased after SCI at mRNA and protein levels. However, this difference was gradually attenuated at 2 or 3 weeks later. SP have the function to enhance cell proliferation, inhibite cell differentiation and mineralization at a proper concentration and incubation time, and this effect would be inhibited by adding SP or NK1R antagonist. The expression of RANKL/OPG was significantly increased in tibiae after SCI. Similarly, the RANKL/OPG expression in SCI rats was significantly increased when treating with 10(-8) M SP. SP plays a very important role in the pathogenesis of OP after SCI. The direct effect of SP may lead to increased bone resorption through the RANKL/OPG axis after SCI. In addition, high expression of SP also results in the suppression of osteogenesis in SCI rats. Then, the balance between bone resorption and bone formation was broken and finally osteoporosis occurred.	[Liu, Hai-Juan] Liaocheng Peoples Hosp, Dept Endocrinol, Liaocheng, Shandong, Peoples R China; [Yan, Hua] Navy Gen Hosp, Dept Med Serv, Beijing, Peoples R China; [Yan, Jun; Li, Hao; Chen, Liang; Han, Li-Ren; Yang, Xiao-Fei] Liaocheng Peoples Hosp, Dept Orthopaed Surg, Liaocheng, Shandong, Peoples R China	Sixth Medical Center of Chinese PLA General Hospital	Yan, J (corresponding author), Liaocheng Peoples Hosp, Dept Orthopaed Surg, Liaocheng, Shandong, Peoples R China.	awpkaka@126.com			National Natural Science Foundation of ShanDong province [ZR2014HP038]; National Natural Science Foundation of China [81601892]	National Natural Science Foundation of ShanDong province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of ShanDong province (No. ZR2014HP038) and the National Natural Science Foundation of China (No. 81601892). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of ShanDong province (No. ZR2014HP038) and the National Natural Science Foundation of China (No. 81601892)	Adamus MA, 2001, J CELL BIOCHEM, V81, P499, DOI 10.1002/1097-4644(20010601)81:3<499::AID-JCB1063>3.0.CO;2-Y; Azuma H, 2004, J PERIODONTOL, V75, P974, DOI 10.1902/jop.2004.75.7.974; BJURHOLM A, 1988, PEPTIDES, V9, P165, DOI 10.1016/0196-9781(88)90023-X; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Frey-Rindova P, 2000, SPINAL CORD, V38, P26, DOI 10.1038/sj.sc.3100905; Garland DE, 2001, J BONE JOINT SURG AM, V83A, P1195, DOI 10.2106/00004623-200108000-00009; Goto T, 2007, NEUROPEPTIDES, V41, P25, DOI 10.1016/j.npep.2006.11.002; HILL EL, 1993, J ORTHOPAED RES, V11, P537, DOI 10.1002/jor.1100110408; INGRAM RR, 1989, PARAPLEGIA, V27, P133, DOI 10.1038/sc.1989.20; Jiang SD, 2007, OSTEOPOROSIS INT, V18, P339, DOI 10.1007/s00198-006-0229-4; Jiang SD, 2006, OSTEOPOROSIS INT, V17, P180, DOI 10.1007/s00198-005-2028-8; Jiang SD, 2006, CLIN ENDOCRINOL, V65, P555, DOI 10.1111/j.1365-2265.2006.02683.x; Jones LM, 2002, SPINAL CORD, V40, P230, DOI 10.1038/sj.sc.3101286; Kim H, 2003, J BONE MINER METAB, V21, P311, DOI 10.1007/s00774-003-0426-6; Kiratli BJ, 2000, J REHABIL RES DEV, V37, P225; LEBLANC AD, 1990, J BONE MINER RES, V5, P843; Lian J B, 1995, Iowa Orthop J, V15, P118; Liu D, 2008, OSTEOPOROSIS INT, V19, P559, DOI 10.1007/s00198-007-0481-2; LOTZ M, 1987, SCIENCE, V235, P893, DOI 10.1126/science.2433770; Maimoun L, 2005, CALCIFIED TISSUE INT, V76, P404, DOI 10.1007/s00223-004-0048-6; Maimoun L, 2002, METABOLISM, V51, P958, DOI [10.1053/meta.2002.34013, 10.1053/meta2002.34013]; MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317; Modlesky CM, 2004, J BONE MINER RES, V19, P48, DOI 10.1359/JBMR.0301208; Mori T, 1999, BIOCHEM BIOPH RES CO, V262, P418, DOI 10.1006/bbrc.1999.1220; NICOLL RA, 1980, ANNU REV NEUROSCI, V3, P227, DOI 10.1146/annurev.ne.03.030180.001303; NILSSON J, 1985, NATURE, V315, P61, DOI 10.1038/315061a0; OLGART L, 1977, ACTA PHYSIOL SCAND, V101, P510, DOI 10.1111/j.1748-1716.1977.tb06040.x; RAGNARSSON KT, 1981, ARCH PHYS MED REHAB, V62, P418; Rameshwar P, 1997, J IMMUNOL, V158, P3417; SHERMAN BE, 1995, OTOLARYNG HEAD NECK, V113, P569, DOI 10.1016/S0194-5998(95)70048-X; Shih C, 1997, PEPTIDES, V18, P323, DOI 10.1016/S0196-9781(96)00280-X; Takata Shinjiro, 2001, Journal of Medical Investigation, V48, P147; Togari A, 1997, NEUROSCI LETT, V233, P125, DOI 10.1016/S0304-3940(97)00649-6; UEBELHART D, 1995, PARAPLEGIA, V33, P669, DOI 10.1038/sc.1995.140; VILLABLANCA AC, 1994, CIRC RES, V75, P1113, DOI 10.1161/01.RES.75.6.1113; Warden SJ, 2002, OSTEOPOROSIS INT, V13, P586, DOI 10.1007/s001980200077; Yano K, 1999, J BONE MINER RES, V14, P518, DOI 10.1359/jbmr.1999.14.4.518	37	16	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							0165063	10.1371/journal.pone.0165063	http://dx.doi.org/10.1371/journal.pone.0165063			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764190	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204500109
J	Nguyen, H; Vanclay, J; Herbohn, J; Firn, J				Nguyen, Huong; Vanclay, Jerome; Herbohn, John; Firn, Jennifer			Drivers of Tree Growth, Mortality and Harvest Preferences in Species-Rich Plantations for Smallholders and Communities in the Tropics	PLOS ONE			English	Article							WOOD DENSITY; COSTA-RICA; MONOCULTURE PLANTATIONS; RESTORATION PLANTINGS; EUCALYPTUS-GLOBULUS; FOREST PLANTATIONS; MIXED PLANTATIONS; CARBON STOCKS; PURE; PRODUCTIVITY	There is growing interest in multi-species tropical plantations but little information exists to guide their design and silviculture. The Rainforestation Farming system is the oldest tropical polyculture planting system in the Philippines and provides a unique opportunity to understand the underlying processes affecting tree performance within diverse plantings. Data collected from 85 plots distributed across the 18 mixed-species plantations in the Philippines was used to identify the factors influencing growth, probability of harvest, and death of trees in these complex plantings. The 18 sites (aged from 6 to 11 years at time of first measurement) were measured on three occasions over a 6-year period. We used data from the first period of data collection to develop models predicting harvesting probability and growth of trees in the second period. We found little evidence that tree species diversity had an effect on tree growth and tree loss at the community level, although a negative effect was found on tree growth of specific species such as Parashorea plicata and Swietenia macrophylla. While tree density of stands at age 10+ years (more than 1000 trees/ha with diameter > 5cm) did not have an impact on growth, growth rates were decreasing in stands with a high basal area. Tree size in the first period of measure was a good predictor for both tree growth and tree status in the next period, with larger trees tending to grow faster and having a greater chance of being harvested, and a lower possibility of mortality than smaller trees. Shade-intolerant trees were both more likely to be harvested, and had a higher probability of death, than shade-tolerant individuals. Native species and exotic species were equally likely to have been lost from the plots between measurement periods. However, shade-tolerant native trees were likely to grow faster than the others at age 10+ years. Our findings suggest that species traits (e.g. shade tolerance) could play an important role in optimizing species composition for this type of plantation. Shade-intolerant species with rapid early growth could contribute early income for farmers in mixed plantings where some products may take years to realize. We also suggest selective harvesting or thinning ( for small shade-intolerant trees) applied at age 10+ years could reduce the competition for resources between individuals.	[Nguyen, Huong; Vanclay, Jerome; Herbohn, John] Univ Sunshine Coast, Trop Forests & People Res Ctr, Sunshine Coast, Qld, Australia; [Nguyen, Huong; Herbohn, John] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia; [Vanclay, Jerome] Southern Cross Univ, Sch Environm Sci & Engn, Lismore, NSW, Australia; [Firn, Jennifer] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Fac Sci & Technol, Brisbane, Qld, Australia	University of the Sunshine Coast; University of Queensland; Southern Cross University; Queensland University of Technology (QUT)	Nguyen, H (corresponding author), Univ Sunshine Coast, Trop Forests & People Res Ctr, Sunshine Coast, Qld, Australia.; Nguyen, H (corresponding author), Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia.	h.nguyen22@uq.edu.au	Vanclay, Jerome/B-9266-2009; Herbohn, John/B-3038-2008	Vanclay, Jerome/0000-0002-5639-5481; Herbohn, John/0000-0001-5701-4882	ACIAR Small holder Forestry projects [ASEM/2006/091, ASEM/2010/050]	ACIAR Small holder Forestry projects(Australian Ctr Intl Agr Res)	This study was funded by the ACIAR Small holder Forestry projects ASEM/2006/091 and ASEM/2010/050.	Adler FR, 1996, P NATL ACAD SCI USA, V93, P9980, DOI 10.1073/pnas.93.18.9980; Anderson DR, 2001, WILDLIFE SOC B, V29, P311; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Baraloto C, 2005, ECOLOGY, V86, P2461, DOI 10.1890/04-1956; BARBOUR M., 1999, TERRESTRIAL PLANT EC, V3rd; Barbour M.G., 1980, TERRESTRIAL PLANT EC; Bartlett KH, 2012, MYCOPATHOLOGIA, V173, P311, DOI 10.1007/s11046-011-9475-x; Bates D, 2014, ARXIV14065823; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Collet C, 2013, ANN BOT; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; da Cunha TA, 2016, FOREST ECOL MANAG, V365, P174, DOI 10.1016/j.foreco.2015.12.031; Davies SJ, 2001, ECOLOGY, V82, P920, DOI 10.1890/0012-9658(2001)082[0920:TMAGIS]2.0.CO;2; DeBell DS, 1997, FOREST SCI, V43, P286; DENSLOW JS, 1990, ECOLOGY, V71, P165, DOI 10.2307/1940257; Diaz S, 2009, CURR OPIN ENV SUST, V1, P55, DOI 10.1016/j.cosust.2009.08.001; EWEL JJ, 1986, ANNU REV ECOL SYST, V17, P245, DOI 10.1146/annurev.es.17.110186.001333; Forrester DI, 2010, FOREST ECOL MANAG, V259, P1761, DOI 10.1016/j.foreco.2009.07.036; Forrester DI, 2005, FOREST ECOL MANAG, V209, P147, DOI 10.1016/j.foreco.2005.01.012; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63, DOI 10.1071/PP9880063; Haggar JP, 1997, ECOLOGY, V78, P1211, DOI 10.1890/0012-9658(1997)078[1211:PPARPI]2.0.CO;2; Herbohn JL, 2014, SMALL-SCALE FOR, V13, P79, DOI 10.1007/s11842-013-9242-6; Hung TD, 2011, FOREST ECOL MANAG, V262, P440, DOI 10.1016/j.foreco.2011.04.010; Nguyen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095267; Nguyen H, 2012, FOREST ECOL MANAG, V274, P81, DOI 10.1016/j.foreco.2012.02.022; Jahn R, 2001, 8 INT SEM WORKSH TRO; Kanowski John, 2010, Ecological Management & Restoration, V11, P119, DOI 10.1111/j.1442-8903.2010.00529.x; Kelty MJ, 2006, FOREST ECOL MANAG, V233, P195, DOI 10.1016/j.foreco.2006.05.011; KELTY MJ, 1992, FOR SCI, V40, P125; King DA, 2006, J ECOL, V94, P670, DOI 10.1111/j.1365-2745.2006.01112.x; Knoke T, 2008, EUR J FOREST RES, V127, P89, DOI 10.1007/s10342-007-0186-2; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; Kolb M., 2003, THESIS; Kuznetsova A., PACKAGE LMERTEST R P; Lamb D, 2011, WORLD FORESTS, V8, P1, DOI 10.1007/978-90-481-9870-2; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Langenberger G., 2006, FOREST DIVERSITY MAN, V2, P211, DOI DOI 10.1007/978-1-4020-5208-8_12; Lawson SS, 2014, J FORESTRY RES, V25, P3, DOI 10.1007/s11676-014-0426-5; le Maire G, 2013, FOREST ECOL MANAG, V288, P31, DOI 10.1016/j.foreco.2012.03.005; Li YF, 2014, FOREST ECOL MANAG, V314, P17, DOI 10.1016/j.foreco.2013.11.012; LIEBERMAN D, 1987, J TROP ECOL, V3, P347, DOI 10.1017/S0266467400002327; Lorimer CG, 2001, J ECOL, V89, P960, DOI 10.1111/j.1365-2745.2001.00619.x; Marohn C, 2007, THESIS; Mazerolle MJ, 2006, AMPHIBIA-REPTILIA, V27, P169, DOI 10.1163/156853806777239922; Messier C, 1999, CAN J FOREST RES, V29, P812, DOI 10.1139/cjfr-29-6-812; Milan PP, 2004, EVALUATION SILVICULL; MONTAGNINI F, 2005, TROP FOR, P1; Montagnini F, 2005, SELECTING TREE SPECI, P262; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; Nguyen H, 2014, FOREST ECOL MANAG, V334, P106, DOI 10.1016/j.foreco.2014.08.022; Nguyen HV, 2011, THESIS; Nichols JD, 2006, FOREST ECOL MANAG, V233, P383, DOI 10.1016/j.foreco.2006.07.018; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; PACALA SW, 1994, CAN J FOREST RES, V24, P2172, DOI 10.1139/x94-280; Petit B, 2004, FOREST ECOL MANAG, V199, P243, DOI 10.1016/j.foreco.2004.05.039; Petit B, 2006, FOREST ECOL MANAG, V233, P338, DOI 10.1016/j.foreco.2006.05.030; Piotto D, 2004, FOREST ECOL MANAG, V190, P359, DOI 10.1016/j.foreco.2003.11.005; Piotto D, 2003, FOREST ECOL MANAG, V175, P195, DOI 10.1016/S0378-1127(02)00127-5; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Puettmann KJ, 2014, FORESTRY, V87, P1, DOI 10.1093/forestry/cpt050; Radosevich SR, 2006, CAN J FOREST RES, V36, P768, DOI 10.1139/X05-280; Richards AE, 2010, TREE PHYSIOL, V30, P1192, DOI 10.1093/treephys/tpq035; Rodrigues RR, 2011, FOREST ECOL MANAG, V261, P1605, DOI 10.1016/j.foreco.2010.07.005; Sales-Come R, 2010, FOREST ECOL MANAG, V260, P846, DOI 10.1016/j.foreco.2010.06.002; Santos Martin F, 2010, INT J FORESTRY RES, V2010; Scherer-Lorenzen M, 2005, ECOL STUD-ANAL SYNTH, V176, P347; Scherer-Lorenzen M, 2007, OIKOS, V116, P2108, DOI 10.1111/j.2007.0030-1299.16065.x; Schneider T, 2014, NEW FOREST, V45, P83, DOI 10.1007/s11056-013-9393-5; Schulte A, 2002, RAINFORESTATION FARM; Seifert T, 2014, BIOENERGY WOOD SUSTA; Semwal RL, 2013, FOREST ECOL MANAG, V310, P450, DOI 10.1016/j.foreco.2013.08.023; Siddique I, 2008, BIOGEOCHEMISTRY, V88, P89, DOI 10.1007/s10533-008-9196-5; Singh A, 2013, INDIAN J PLANT SCI, V2, P118; Son Y, 2007, J PLANT NUTR, V30, P1841, DOI 10.1080/01904160701628999; TEAM RC, 2010, R LANG ENV STAT COMP; Tolentino EL, 2008, ADV AGROFOR, V5, P319; Wadsworth FH, 2010, BOIS FOR TROP, P33; Walters MB, 1996, ECOLOGY, V77, P841, DOI 10.2307/2265505; Wightman KE, 2001, NEW FOREST, V22, P75, DOI 10.1023/A:1012020023446	79	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164957	10.1371/journal.pone.0164957	http://dx.doi.org/10.1371/journal.pone.0164957			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764186	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500083
J	Fu, JF; Wu, LP; Jiang, MJ; Li, D; Jiang, T; Hong, ZW; Wang, F; Li, SG				Fu, Jianfei; Wu, Lunpo; Jiang, Mengjie; Li, Dan; Jiang, Ting; Hong, Zhongwu; Wang, Fan; Li, Shuguang			Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer	PLOS ONE			English	Article							INVASIVE DUCTAL CARCINOMAS; PURE; VALIDATION; DISTINCT; ASSAY	Background The features related to the prognosis of patients with mucinous breast cancer (MBC) remain controversial. We aimed to explore the prognostic factors of MBC and develop a nomogram for predicting survival outcomes. Methods The Surveillance, Epidemiology, and End Results (SEER) database was searched to identify 139611 women with resectable breast cancer from 1990 to 2007. Survival curves were generated using Kaplan-Meier methods. The 5-year and 10-year cancer-specific survival (CSS) rates were calculated using the Life-Table method. Based on Cox models, a nomogram was constructed to predict the probabilities of CSS for an individual patient. The competing risk regression model was used to analyse the specific survival of patients with MBC. Results There were 136569 (97.82%) infiltrative ductal cancer (IDC) patients and 3042 (2.18%) MBC patients. Patients with MBC had less lymph node involvement, a higher frequency of well-differentiated lesions, and more estrogen receptor (ER)-positive tumors. Patients with MBC had significantly higher 5 and 10-year CSS rates (98.23 and 96.03%, respectively) than patients with IDC (91.44 and 85.48%, respectively). Univariate and multivariate analyses showed that MBC was an independent factor for better prognosis. As for patients with MBC, the event of death caused by another disease exceeded the event of death caused by breast cancer. A competing risk regression model further showed that lymph node involvement, poorly differentiated grade and advanced T-classification were independent factors of poor prognosis in patients with MBC. The Nomogram can accurately predict CSS with a high C-index (0.816). Risk scores developed from the nomogram can more accurately predict the prognosis of patients with MBC (C-index = 0.789) than the traditional TNM system (C-index = 0.704, P< 0.001). Conclusions Patients with MBC have a better prognosis than patients with IDC. Nomograms could help clinicians make more informed decisions in clinical practice. The competing risk regression model, as a more rational model, is recommended for use in the survival analysis of patients with MBC in the future.	[Fu, Jianfei; Hong, Zhongwu; Wang, Fan; Li, Shuguang] Zhejiang Univ, Jinhua Hosp, Dept Oncol, Jinhua, Zhejiang, Peoples R China; [Wu, Lunpo] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Wu, Lunpo] Zhejiang Univ, Inst Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Jiang, Mengjie] ZheJiang Chinese Med Univ, Zhejiang Prov Hosp TCM, Affiliated Hosp 1, Dept Radiat Oncol, Hangzhou, Zhejiang, Peoples R China; [Li, Dan] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China; [Li, Dan] Chinese Natl Minist Educ, Key Lab Canc Prevent & Intervent, Inst Canc, Hangzhou, Zhejiang, Peoples R China; [Li, Dan] Key Lab Mol Biol Med Sci, Hangzhou, Zhejiang, Peoples R China; [Li, Dan] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China; [Jiang, Ting] Zhejiang Univ, Jinhua Hosp, Dept Nucl Med, Jinhua, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang Chinese Medical University; Zhejiang University; Zhejiang University; Zhejiang University	Fu, JF (corresponding author), Zhejiang Univ, Jinhua Hosp, Dept Oncol, Jinhua, Zhejiang, Peoples R China.	jfu18@jhmi.edu			Zheng Shu Medical Elite Scholarship Fund	Zheng Shu Medical Elite Scholarship Fund	We acknowledge the efforts of the Surveillance, Epidemiology, and End Results (SEER) Program registries for creating the SEER database. We also thank Wei Fu, Johns Hopkins University School of Medicine, for reviewing our statistical methods and his professional advice. Also, the work was sponsored by the Zheng Shu Medical Elite Scholarship Fund.	ANDRE S, 1995, J SURG ONCOL, V58, P162, DOI 10.1002/jso.2930580305; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Cao AY, 2012, ANN SURG ONCOL, V19, P3019, DOI 10.1245/s10434-012-2322-6; de Glas NA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv366; Di Saverio S, 2008, BREAST CANCER RES TR, V111, P541, DOI 10.1007/s10549-007-9809-z; Diab SG, 1999, J CLIN ONCOL, V17, P1442, DOI 10.1200/JCO.1999.17.5.1442; Fentiman IS, 1997, BRIT J CANCER, V75, P1061, DOI 10.1038/bjc.1997.180; Fujii H, 2002, BREAST CANCER RES TR, V76, P255, DOI 10.1023/A:1020808020873; Hinchliffe SR, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-13; Howlader Nadia, 2014, Journal of the National Cancer Institute Monographs, P255, DOI 10.1093/jncimonographs/lgu022; Huang YQ, 2016, J CLIN ONCOL, V34, P2157, DOI 10.1200/JCO.2015.65.9128; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; KOMAKI K, 1988, CANCER, V61, P989, DOI 10.1002/1097-0142(19880301)61:5<989::AID-CNCR2820610522>3.0.CO;2-E; Komenaka IK, 2004, AM J SURG, V187, P528, DOI 10.1016/j.amjsurg.2003.12.039; Lacroix-Triki M, 2011, INT J CLIN EXP PATHO, V4, P22; Lacroix-Triki M, 2010, J PATHOL, V222, P282, DOI 10.1002/path.2763; Liang WH, 2015, J CLIN ONCOL, V33, P861, DOI 10.1200/JCO.2014.56.6661; Liu FF, 2015, BREAST CANCER RES TR, V151, P443, DOI 10.1007/s10549-015-3413-4; Louwman MWJ, 2007, INT J CANCER, V121, P127, DOI 10.1002/ijc.22625; Northridge ME, 1997, J CLIN EPIDEMIOL, V50, P283, DOI 10.1016/S0895-4356(96)00366-6; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paramo JC, 2002, ANN SURG ONCOL, V9, P161, DOI 10.1245/aso.2002.9.2.161; Ranade A, 2010, J CLIN PATHOL, V63, P1043, DOI 10.1136/jcp.2010.082495; RASMUSSEN BB, 1985, PATHOL RES PRACT, V180, P377; SCOPSI L, 1994, AM J SURG PATHOL, V18, P702, DOI 10.1097/00000478-199407000-00006; Skotnicki P, 2016, BREAST J; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang YZ, 2013, J CLIN ONCOL, V31, P1188, DOI 10.1200/JCO.2012.41.5984; Weigelt B, 2009, MODERN PATHOL, V22, P1401, DOI 10.1038/modpathol.2009.112	30	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164921	10.1371/journal.pone.0164921	http://dx.doi.org/10.1371/journal.pone.0164921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760180	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204000065
J	Ngaki, MN; Wang, B; Sahu, BB; Srivastava, SK; Farooqi, MS; Kambakam, S; Swaminathan, S; Bhattacharyya, MK				Ngaki, Micheline N.; Wang, Bing; Sahu, Binod B.; Srivastava, Subodh K.; Farooqi, Mohammad S.; Kambakam, Sekhar; Swaminathan, Sivakumar; Bhattacharyya, Madan K.			Tanscriptomic Study of the Soybean-Fusarium virguliforme Interaction Revealed a Novel Ankyrin-Repeat Containing Defense Gene, Expression of Whose during Infection Led to Enhanced Resistance to the Fungal Pathogen in Transgenic Soybean Plants	PLOS ONE			English	Article							SUDDEN-DEATH SYNDROME; ESSENTIAL MOLECULAR CHAPERONE; DNA-BINDING PROTEINS; F SP. GLYCINES; CAUSAL AGENT; OXALATE DECARBOXYLASE; FIELD-RESISTANCE; ROOT RESPONSE; NPR1 GENE; SOLANI	Fusarium virguliforme causes the serious disease sudden death syndrome (SDS) in soybean. Host resistance to this pathogen is partial and is encoded by a large number of quantitative trait loci, each conditioning small effects. Breeding SDS resistance is therefore challenging and identification of single-gene encoded novel resistance mechanisms is becoming a priority to fight this devastating this fungal pathogen. In this transcriptomic study we identified a few putative soybean defense genes, expression of which is suppressed during F. virguliforme infection. The F. virguliforme infection-suppressed genes were broadly classified into four major classes. The steady state transcript levels of many of these genes were suppressed to undetectable levels immediately following F. virguliforme infection. One of these classes contains two novel genes encoding ankyrin repeat-containing proteins. Expression of one of these genes, GmARP1, during F. virguliforme infection enhances SDS resistance among the transgenic soybean plants. Our data suggest that GmARP1 is a novel defense gene and the pathogen presumably suppress its expression to establish compatible interaction.	[Ngaki, Micheline N.; Wang, Bing; Sahu, Binod B.; Srivastava, Subodh K.; Farooqi, Mohammad S.; Kambakam, Sekhar; Swaminathan, Sivakumar; Bhattacharyya, Madan K.] Iowa State Univ, Dept Agron, Ames, IA USA; [Sahu, Binod B.] Natl Inst Technol, Rourkela, India; [Srivastava, Subodh K.] Clemson Univ, 317C Biosyst Res Complex, Clemson, SC 29634 USA; [Farooqi, Mohammad S.] IASRI, Ctr Agr Bioinformat, Pusa Campus, New Delhi, India	Iowa State University; National Institute of Technology (NIT System); National Institute of Technology Rourkela; Clemson University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Statistics Research Institute	Bhattacharyya, MK (corresponding author), Iowa State Univ, Dept Agron, Ames, IA USA.	mbhattac@iastate.edu	Sahu, Binod Bihari/S-4290-2019; Sahu, Binod B./C-3369-2009; Sahu, Binod B/O-8394-2017	Sahu, Binod Bihari/0000-0002-2151-0654; Sahu, Binod B/0000-0002-2151-0654; Swaminathan, Sivakumar/0000-0003-3931-275X	USDA NIFA [2013-68004-20374]; Iowa Soybean Association; National Institute of Food and Agriculture (NIFA), United States Department of Agriculture [2013-68004-20374]	USDA NIFA(United States Department of Agriculture (USDA)); Iowa Soybean Association; National Institute of Food and Agriculture (NIFA), United States Department of Agriculture	This study was supported by the USDA NIFA (grant no. 2013-68004-20374) and Iowa Soybean Association.; This work was supported by the National Institute of Food and Agriculture (NIFA), United States Department of Agriculture (Grant no. 2013-68004-20374) and Iowa Soybean Association. We are thankful to David Grant for reviewing the manuscripts, Jordan Baumbach and Yang Yang for their contributions to managing soybean transgenic plants (gaining USDA permit, planting, watering and harvesting). We are also thankful to the Iowa State University (ISU) Plant Transformation Facility for generation of soybean transgenic plants and ISU DNA Facility for sequencing the transcript samples and preparing DNA from leaf samples.	Abdel Majid K.M., 2012, J PLANT GENOME SCI, V1, P18, DOI DOI 10.5147/JPGS.2012.0053; Abeysekara NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093667; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Anderson TR, 1998, PLANT DIS, V82, P448, DOI 10.1094/PDIS.1998.82.4.448D; Antolin-Llovera M, 2012, ANNU REV PHYTOPATHOL, V50, P451, DOI 10.1146/annurev-phyto-081211-173002; Aoki T, 2003, MYCOLOGIA, V95, P660, DOI 10.2307/3761942; Aoki Takayuki, 2005, Mycoscience, V46, P162, DOI 10.1007/s10267-005-0235-y; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Becerra C, 2004, GENE, V340, P111, DOI 10.1016/j.gene.2004.06.006; BHATTACHARYYA MK, 1986, PHYSIOL MOL PLANT P, V29, P227, DOI 10.1016/S0048-4059(86)80023-6; Bottner S, 2009, PLANT J, V58, P914, DOI 10.1111/j.1365-313X.2009.03829.x; BOWLES DJ, 1990, ANNU REV BIOCHEM, V59, P873, DOI 10.1146/annurev.bi.59.070190.004301; Brar HK, 2012, MOL PLANT MICROBE IN, V25, P817, DOI 10.1094/MPMI-12-11-0317; Brar HK, 2011, MOL PLANT MICROBE IN, V24, P1179, DOI 10.1094/MPMI-12-10-0285; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Carvalho SD, 2012, MOL PLANT, V5, P1295, DOI 10.1093/mp/sss048; Catanzariti AM, 2015, NEW PHYTOL, V207, P106, DOI 10.1111/nph.13348; Chang HX, 2016, MOL PLANT MICROBE IN, V29, P96, DOI 10.1094/MPMI-09-15-0219-R; Chen CH, 2000, PLANT MOL BIOL, V42, P387, DOI 10.1023/A:1006399311615; Chen YC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05584; Choi JJ, 2008, FUNCT INTEGR GENOMIC, V8, P341, DOI 10.1007/s10142-008-0080-0; Cunha WG, 2010, PLANT PATHOL, V59, P654, DOI 10.1111/j.1365-3059.2010.02279.x; D'Ippolito S, 2010, PHYSIOL MOL PLANT P, V75, P3, DOI 10.1016/j.pmpp.2010.09.002; Datta SK, PATHOGENESIS RELATED, V1; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Frame BR, 2002, PLANT PHYSIOL, V129, P13, DOI 10.1104/pp.000653; Gao X, 2004, PLANT DIS, V88, P1372, DOI 10.1094/PDIS.2004.88.12.1372; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Hartman GL, 1997, PLANT DIS, V81, P515, DOI 10.1094/PDIS.1997.81.5.515; Hughes TJ, 2014, MYCOLOGIA, V106, P686, DOI 10.3852/13-318; Iqbal MJ, 2005, THEOR APPL GENET, V110, P1429, DOI 10.1007/s00122-005-1969-9; Jin H, 1996, PLANT DIS, V80, P922, DOI 10.1094/PD-80-0922; Kesarwani M, 2000, J BIOL CHEM, V275, P7230, DOI 10.1074/jbc.275.10.7230; Koenning SR, 2010, PLANT HLTH PROGR; Kombrink A, 2011, MICROBES INFECT, V13, P1168, DOI 10.1016/j.micinf.2011.07.010; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lanubile A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-710; Leandro L. F., 2012, CAB Reviews, V7, P1, DOI 10.1079/PAVSNNR20127053; Li HY, 2004, PLANT MOL BIOL, V54, P233, DOI 10.1023/B:PLAN.0000028790.75090.ab; Li S, 2009, J PLANT PATHOL, V91, P77; Lin JY, 2013, PLANT BIOTECHNOL J, V11, P1135, DOI 10.1111/pbi.12108; Lu H, 2003, PLANT CELL, V15, P2408, DOI 10.1105/tpc.015412; Luckew AS, 2012, CROP SCI, V52, P2215, DOI 10.2135/cropsci2011.09.0500; Minic Z, 2008, PLANTA, V227, P723, DOI 10.1007/s00425-007-0668-y; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mou SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059699; Moy P, 2004, MOL PLANT MICROBE IN, V17, P1051, DOI 10.1094/MPMI.2004.17.10.1051; Mueller DS, 2003, PLANT DIS, V87, P827, DOI 10.1094/PDIS.2003.87.7.827; Neuhaus JM, 1996, PLANT MOL BIOL REP, V14, P102, DOI 10.1007/BF02684897; Ngaki MN, 2012, NATURE, V485, P530, DOI 10.1038/nature11009; Niehaus TD, 2015, PLANT PHYSIOL, V169, P1436, DOI 10.1104/pp.15.00959; Njiti VN, 2002, THEOR APPL GENET, V104, P294, DOI 10.1007/s001220100682; Njiti VN, 1997, CROP SCI, V37, P132, DOI 10.2135/cropsci1997.0011183X003700010023x; Noll GA, 2009, PLANT MOL BIOL REP, V27, P526, DOI 10.1007/s11105-009-0120-5; Passarinho P.A., 2002, ARABIDOPSIS BOOK, V1, pe0023, DOI [10.1199/tab.0023, DOI 10.1199/TAB.0023]; Pudake RN, 2013, CURR GENET, V59, P107, DOI 10.1007/s00294-013-0392-z; Radwan O, 2011, MOL PLANT MICROBE IN, V24, P958, DOI 10.1094/MPMI-11-10-0271; Rey T, 2013, NEW PHYTOL, V198, P875, DOI 10.1111/nph.12198; Rouard M, 2011, NUCLEIC ACIDS RES, V39, pD1095, DOI 10.1093/nar/gkq811; Roy KW, 1997, PLANT DIS, V81, P259, DOI 10.1094/PDIS.1997.81.3.259; Ruping B, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-219; RUPE JC, 1989, PLANT DIS, V73, P581, DOI 10.1094/PD-73-0581; Sandhu D, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-105; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Seong ES, 2007, J BIOCHEM MOL BIOL, V40, P952; Shen GX, 2010, PLANT CELL, V22, P811, DOI 10.1105/tpc.109.065979; STEPHENS PA, 1993, CROP SCI, V33, P929, DOI 10.2135/cropsci1993.0011183X003300050010x; Swaminathan S, 2016, THEOR APPL GENET, V129, P495, DOI 10.1007/s00122-015-2643-5; Takasaki H, 2008, MOL GENET GENOMICS, V279, P359, DOI 10.1007/s00438-007-0317-y; Trewavas A, 2002, PLANT CELL, V14, pS3, DOI 10.1105/tpc.141360; Uppalapati SR, 2009, MOL PLANT MICROBE IN, V22, P7, DOI 10.1094/MPMI-22-1-0007; Valdes-Lopez O, 2011, PLANT PHYSIOL, V157, P1975, DOI 10.1104/pp.111.183327; van der Holst PPG, 2001, CURR OPIN STRUC BIOL, V11, P608, DOI 10.1016/S0959-440X(00)00255-4; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Vorwerk S, 2004, TRENDS PLANT SCI, V9, P203, DOI 10.1016/j.tplants.2004.02.005; Wang HH, 2015, J EXP BOT, V66, P1291, DOI 10.1093/jxb/eru479; Wen ZX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-809; Wrather JA, 2006, J NEMATOL, V38, P173; Wrather JA, 1997, PLANT DIS, V81, P107, DOI 10.1094/PDIS.1997.81.1.107; Yan JQ, 2002, PLANT J, V29, P193, DOI 10.1046/j.0960-7412.2001.01205.x; Yang YA, 2012, PLANT PHYSIOL, V159, P1857, DOI 10.1104/pp.112.197152; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Yuan JZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S6; Zabala G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-26; Zhang H, 2010, PLANT SIGNAL BEHAV, V5, P1520, DOI [10.1105/tpc.109.065979, 10.4161/psb.5.11.13714]; Zhu QH, 2013, GENE, V512, P259, DOI 10.1016/j.gene.2012.10.036; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004; Zou JJ, 2005, MOL PLANT MICROBE IN, V18, P1161, DOI 10.1094/MPMI-18-1161	90	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0163106	10.1371/journal.pone.0163106	http://dx.doi.org/10.1371/journal.pone.0163106			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760122	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204000007
J	Reygner, J; Lichtenberger, L; Elmhiri, G; Dou, S; Bahi-Jaber, N; Rhazi, L; Depeint, F; Bach, V; Khorsi-Cauet, H; Abdennebi-Najar, L				Reygner, Julie; Lichtenberger, Lydia; Elmhiri, Ghada; Dou, Samir; Bahi-Jaber, Narges; Rhazi, Larbi; Depeint, Flore; Bach, Veronique; Khorsi-Cauet, Hafida; Abdennebi-Najar, Latifa			Inulin Supplementation Lowered the Metabolic Defects of Prolonged Exposure to Chlorpyrifos from Gestation to Young Adult Stage in Offspring Rats	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; CHAIN FATTY-ACIDS; GUT MICROBIOTA; INSULIN-RESISTANCE; LIPID-METABOLISM; IN-VITRO; GLUCOSE; OBESITY; ASSOCIATION; TOXICOLOGY	Increasing evidence indicates that chlorpyrifos (CPF), an organophosphorus insecticide, is involved in metabolic disorders. We assess the hypothesis whether supplementation with prebiotics from gestation to adulthood, through a modulation of microbiota composition and fermentative activity, alleviates CPF induced metabolic disorders of 60 days old offspring. 5 groups of Wistar rats, from gestation until weaning, received two doses of CPF pesticide: 1 mg/kg/day (CPF1) or 3.5 mg/kg/day (CPF3.5) with free access to inulin (10g/L in drinking water). Then male pups received the same treatment as dams. Metabolic profile, leptin sensitivity, insulin receptor (IR) expression in liver, gut microbiota composition and short chain fatty acid composition (SCFAs) in the colon, were analyzed at postnatal day 60 in the offspring (PND 60). CPF3.5 increased offspring's birth body weight (BW) but decreased BW at PND60. Inulin supplementation restored the BW at PND 60 to control levels. Hyperinsulinemia and decrease in insulin receptor beta in liver were seen in CPF1 exposed rats. In contrast, hyperglycemia and decrease in insulin level were found in CPF3.5 rats. Inulin restored the levels of some metabolic parameters in CPF groups to ranges comparable with the controls. The total bacterial population, short chain fatty acid (SCFA) production and butyrate levels were enhanced in CPF groups receiving inulin. Our data indicate that developmental exposure to CPF interferes with metabolism with dose related effects evident at adulthood. By modulating microbiota population and fermentative activity, inulin corrected adult metabolic disorders of rats exposed to CPF during development. Prebiotics supply may be thus considered as a novel nutritional strategy to counteract insulin resistance and diabetes induced by a continuous pesticide exposure.	[Reygner, Julie; Elmhiri, Ghada; Dou, Samir; Bahi-Jaber, Narges; Rhazi, Larbi; Depeint, Flore; Abdennebi-Najar, Latifa] Inst Polytech LaSalle Beauvais, UP EGEAL 2012 10 101, Beauvais, France; [Reygner, Julie; Lichtenberger, Lydia; Bach, Veronique; Khorsi-Cauet, Hafida] Jules Verne Univ Picardy, UMR INERIS 101, Lab Perinatalite & Risques Tox PERITOX, Amiens, France	UniLaSalle; Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Abdennebi-Najar, L (corresponding author), Inst Polytech LaSalle Beauvais, UP EGEAL 2012 10 101, Beauvais, France.	latifa.najar60@gmail.com	Abdennebi-Najar, Latifa/AAG-3231-2021; Khorsi-Cauet, Hafida/AFO-7669-2022; Bach, Veronique/AAD-5958-2022; Rhazi, Larbi/AAX-6192-2020	Rhazi, Larbi/0000-0001-6489-3109; Abdennebi-Najar, latifa/0000-0003-3070-2639; Bach, Veronique/0000-0002-0684-0305	Picardy Regional Council	Picardy Regional Council(Region Hauts-de-France)	This work was financial supported by the Picardy Regional Council. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdennebi-Najar L, 2011, J MATERN-FETAL NEO M, V24, P1486, DOI 10.3109/14767058.2010.547638; Barker DJP, 2013, INT J EPIDEMIOL, V42, P1229, DOI 10.1093/ije/dyt131; Barker DJP, 2005, HORM RES, V64, P2, DOI 10.1159/000089311; Byrne CS, 2015, INT J OBESITY, V39, P1331, DOI 10.1038/ijo.2015.84; Campbell JM, 1997, J NUTR, V127, P130, DOI 10.1093/jn/127.1.130; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2013, CURR OPIN PHARMACOL, V13, P935, DOI 10.1016/j.coph.2013.09.008; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Cani PD, 2006, EUR J CLIN NUTR, V60, P567, DOI 10.1038/sj.ejcn.1602350; Condette CJ, 2015, J PEDIATR GASTR NUTR, V61, P30, DOI 10.1097/MPG.0000000000000734; Condette CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102217; Duncan SH, 2004, BRIT J NUTR, V91, P915, DOI 10.1079/BJN20041150; Elmhiri G, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/378284; Ettreiki C, 2012, WORLD J GASTROENTERO, V18, P2619, DOI 10.3748/wjg.v18.i21.2619; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Firmin S, 2016, J DEV ORIG HLTH DIS, P1; Geurts L, 2014, BENEF MICROBES, V5, P3, DOI 10.3920/BM2012.0065; Hur KY, 2015, DIABETES METAB J, V39, P198, DOI 10.4093/dmj.2015.39.3.198; Jaacks LM, 2015, ENVIRON INT, V76, P57, DOI 10.1016/j.envint.2014.12.001; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Khan MT, 2014, CELL METAB, V20, P753, DOI 10.1016/j.cmet.2014.07.006; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kwong TC, 2002, THER DRUG MONIT, V24, P144, DOI 10.1097/00007691-200202000-00022; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lassiter TL, 2008, ENVIRON HEALTH PERSP, V116, P1456, DOI 10.1289/ehp.11673; Lassiter TL, 1998, BRAIN RES DEV BRAIN, P105; Lecerf JM, 2012, BRIT J NUTR, V108, P1847, DOI 10.1017/S0007114511007252; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Mansour SA, 2011, TOXICOL IND HEALTH, V27, P213, DOI 10.1177/0748233710384054; Mayeur C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054335; Meggs WJ, 2007, J MED TOXICOL, V3, P89, DOI 10.1007/BF03160916; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Saldana TM, 2007, DIABETES CARE, V30, P529, DOI 10.2337/dc06-1832; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Saunders M, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-S1-S5; Scott KP, 2014, FEMS MICROBIOL ECOL, V87, P30, DOI 10.1111/1574-6941.12186; Slotkin TA, 2005, ENVIRON HEALTH PERSP, V113, P1291, DOI 10.1289/ehp.8133; Slotkin TA, 2011, REPROD TOXICOL, V31, P297, DOI 10.1016/j.reprotox.2010.07.012; Tanvir EM, 2015, HUM EXP TOXICOL; Taylor KW, 2013, ENVIRON HEALTH PERSP, V121, P774, DOI 10.1289/ehp.1205502; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Tomas J, 2015, ISME J, V9, P46, DOI 10.1038/ismej.2014.111; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; van de Wiele T, 2007, J APPL MICROBIOL, V102, P452, DOI 10.1111/j.1365-2672.2006.03084.x; Weitkunat K, 2015, J NUTR BIOCHEM, V26, P929, DOI 10.1016/j.jnutbio.2015.03.010; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088491	52	31	31	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164614	10.1371/journal.pone.0164614	http://dx.doi.org/10.1371/journal.pone.0164614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760213	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204000040
J	Jeon, WY; Shin, IS; Shin, HK; Jin, SE; Lee, MY				Jeon, Woo-Young; Shin, In-Sik; Shin, Hyeun-Kyoo; Jin, Seong Eun; Lee, Mee-Young			Aqueous Extract of Gumiganghwal-tang, a Traditional Herbal Medicine, Reduces Pulmonary Fibrosis by Transforming Growth Factor-beta 1/Smad Signaling Pathway in Murine Model of Chronic Asthma	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; FACTOR-BETA; T-CELLS; PATHOGENESIS; INHIBITION; SMAD3; MICE; MONTELUKAST; EOSINOPHILS; SUPPRESSION	Gumiganghwal-tang is a traditional herbal prescription that is used widely for the treatment of the common cold and inflammatory diseases in Korea and other Asian countries. In this study, we investigated the protective effects of a Gumiganghwal-tang aqueous extract (GGTA) against airway inflammation and pulmonary fibrosis using a mouse model of chronic asthma. Chronic asthma was modeled in BALB/c mice via sensitization/challenge with an intraperitoneal injection of 1% ovalbumin (OVA) and inhalation of nebulized 1% OVA for 4 weeks. GGTA (100 mg/kg or 200 mg/kg) was also administered by oral gavage once a day for 4 weeks. We investigated the number of inflammatory cells, production of T-helper type 2 (Th2) cytokines, chemokine and the total transforming growth factor-beta 1 (TGF-beta 1) in bronchoalveolar lavage fluid (BALF); the levels of immunoglobulin E (lgE) in the plasma; the infiltration of inflammatory cells in lung tissue; and the expression of TGF-beta 1, Smad-3, and collagen in lung tissue. Our results revealed that GGTA lowered the recruitment of inflammatory cells (particularly, lymphocyte); and decreased the production of Th2 cytokines, chemokine and total TGF-beta 1; and attenuated the levels of total and OVA-specific IgE; and decreased the infiltration of inflammatory cells. Moreover, GGTA significantly reduced the expression of TGF-beta 1 and Smad-3, and lowered collagen deposition. These results indicate that GGTA reduces airway inflammation and pulmonary fibrosis by regulating Th2 cytokines production and the TGF-beta 1/Smad-3 pathway, thus providing a potential treatment for chronic asthma.	[Jeon, Woo-Young; Shin, Hyeun-Kyoo; Jin, Seong Eun; Lee, Mee-Young] Korea Inst Oriental Med, Kherb Res Ctr, Daejeon, South Korea; [Shin, In-Sik] Chonnam Natl Univ, Coll Vet Med, Gwangju, South Korea	Korea Institute of Oriental Medicine (KIOM); Chonnam National University	Lee, MY (corresponding author), Korea Inst Oriental Med, Kherb Res Ctr, Daejeon, South Korea.	cozy11@kiom.re.kr		Jin, Seong Eun/0000-0002-9224-0735	Korea Institute of Oriental Medicine [K15251]	Korea Institute of Oriental Medicine	This research was supported by a Grant for "Construction of Scientific Evidences for Herbal Medicine Formulas (K15251)" from the Korea Institute of Oriental Medicine.; This research was supported by a Grant for "Construction of Scientific Evidences for Herbal Medicine Formulas (K16251)" from the Korea Institute of Oriental Medicine.	Al-Alawi M, 2014, RESP MED, V108, P1409, DOI 10.1016/j.rmed.2014.08.008; Bensky D., 1990, CHINESE HERBAL MED F; Chen LJ, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/790739; Chen M, 2011, IMMUNOLOGY, V132, P376, DOI 10.1111/j.1365-2567.2010.03392.x; CORRIGAN CJ, 1992, IMMUNOL TODAY, V13, P501, DOI 10.1016/0167-5699(92)90026-4; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Hamelmann E, 1999, ALLERGY, V54, P297, DOI 10.1034/j.1398-9995.1999.00085.x; Isohama Y, 1997, Nihon Yakurigaku Zasshi, V110 Suppl 1, p120P; Jeon CM, 2014, INT IMMUNOPHARMACOL, V22, P414, DOI 10.1016/j.intimp.2014.07.013; JOSE PJ, 1994, J EXP MED, V179, P881, DOI 10.1084/jem.179.3.881; Jung HW, 2011, ASIAN PAC J ALLERGY, V29, P338; Kay AB, 2005, TRENDS MOL MED, V11, P148, DOI 10.1016/j.molmed.2005.02.002; Ki KD, 2009, J GYNECOL ONCOL, V20, P117, DOI 10.3802/jgo.2009.20.2.117; Kim MC, 2013, J ACUPUNCT MERIDIAN, V6, P98, DOI 10.1016/j.jams.2012.10.007; Kim SJ, 2005, BIOL PHARM BULL, V28, P233, DOI 10.1248/bpb.28.233; Kowalewski R, 2010, PATHOBIOLOGY, V77, P1, DOI 10.1159/000272948; Lee H, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/743075; Lee MY, 2014, INT J MOL MED, V33, P978, DOI 10.3892/ijmm.2014.1654; Lee SH, 2014, EUR REV MED PHARMACO, V18, P1806; Lin RJ, 2015, MULTIDISCIP RESP MED, V10, DOI 10.1186/s40248-015-0017-0; Lynch KR, 1999, NATURE, V399, P789; Moustakas A, 2001, J CELL SCI, V114, P4359; Nam KS, 2015, ONCOL LETT, V9, P483, DOI 10.3892/ol.2014.2660; Oh SM, 2013, ONCOL LETT, V5, P305, DOI 10.3892/ol.2012.1012; Qu ZH, 2012, INT J MOL MED, V29, P564, DOI 10.3892/ijmm.2011.868; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Rogerio AP, 2010, PHARMACOL RES, V61, P288, DOI 10.1016/j.phrs.2009.10.005; Royce SG, 2014, LAB INVEST, V94, P1326, DOI 10.1038/labinvest.2014.119; Salib RJ, 2009, CLIN EXP ALLERGY, V39, P1128, DOI 10.1111/j.1365-2222.2009.03239.x; Shimbori C, 2011, EUR J PHARMACOL, V650, P424, DOI 10.1016/j.ejphar.2010.09.084; Shin IS, 2013, INT IMMUNOPHARMACOL, V17, P867, DOI 10.1016/j.intimp.2013.09.017; Shin Y. O., 2015, EVID-BASED COMPL ALT, V2015, DOI DOI 10.1155/2015/456846; Taube C, 2004, INT ARCH ALLERGY IMM, V135, P173, DOI 10.1159/000080899; Uitto J, 2000, J DERMATOL SCI, V24, pS60, DOI 10.1016/S0923-1811(00)00143-2; Umetsu DT, 1997, J ALLERGY CLIN IMMUN, V100, P1, DOI 10.1016/S0091-6749(97)70186-6; Wan Yisong Y, 2007, Proc Am Thorac Soc, V4, P271, DOI 10.1513/pats.200701-020AW; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Wu TY, 2011, AAPS J, V13, P1, DOI 10.1208/s12248-010-9239-4; Yu X, 2015, PHYTOMEDICINE, V22, P1150, DOI 10.1016/j.phymed.2015.09.002; Yun BR, 2014, J BIOSCI BIOENG, V118, P235, DOI 10.1016/j.jbiosc.2014.01.004; Zhang YF, 2015, INT J CLIN EXP PATHO, V8, P8983; Zhou ES, 2014, FITOTERAPIA, V96, P131, DOI 10.1016/j.fitote.2014.04.016	42	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e164833	10.1371/journal.pone.0164833	http://dx.doi.org/10.1371/journal.pone.0164833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741312	Green Published, gold			2022-12-26	WOS:000385507000073
J	Chen, F; Zhang, Y; Parra, E; Rodriguez, J; Behrens, C; Akbani, R; Lu, Y; Kurie, JM; Gibbons, DL; Mills, GB; Wistuba, II; Creighton, CJ				Chen, F.; Zhang, Y.; Parra, E.; Rodriguez, J.; Behrens, C.; Akbani, R.; Lu, Y.; Kurie, J. M.; Gibbons, D. L.; Mills, G. B.; Wistuba, I. I.; Creighton, C. J.			Multiplatform-based molecular subtypes of non-small-cell lung cancer	ONCOGENE			English	Article							GENE-EXPRESSION; CARCINOMA	Non-small-cell lung cancer (NSCLC) demonstrates remarkable molecular diversity. With the completion of The Cancer Genome Atlas (TCGA), there is opportunity for systematic analyses of the entire TCGA NSCLC cohort, including comparisons and contrasts between different disease subsets. On the basis of multidimensional and comprehensive molecular characterization (including DNA methylation and copy, and RNA and protein expression), 1023 NSCLC cases-519 from TCGA adenocarcinoma (AD) project and 504 from TCGA squamous cell carcinoma (SQCC) project-were classified using a 'cluster-of-clusters' analytic approach. Patterns from TCGA NSCLC subsets were examined in independent external databases, including the PROSPECT (Profiling of Resistance patterns and Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax) NSCLC data set. Nine genomic subtypes of NSCLC were identified, three within SQCC and six within AD. SQCC subtypes were associated with transcriptional targets of SOX2 or p63. One predominately AD subtype (with a large proportion of SQCC) shared molecular features with neuroendocrine tumors. Two AD subtypes manifested a CpG island methylator phenotype. Three AD subtypes showed high p38 and mTOR pathway activation. AD subtypes associated with low differentiation showed relatively worse prognosis. SQCC subtypes and two of the AD subtypes expressed cancer testis antigen genes, whereas three AD subtypes expressed several immune checkpoint genes including PDL1 and PDL2, corresponding with patterns of greater immune cell infiltration. Subtype associations for several immune-related markers -including PD1, PDL1, CD3 and CD8-were confirmed in the PROSPECT cohort using immunohistochemistry. NSCLC molecular subtypes have therapeutic implications and lend support to a personalized approach to NSCLC management based on molecular characterization.	[Chen, F.; Zhang, Y.; Creighton, C. J.] Baylor Coll Med, Div Biostat, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA; [Parra, E.; Rodriguez, J.; Behrens, C.; Wistuba, I. I.] Univ Texas MD Anderson Canc, Dept Translat Mol Pathol, Houston, TX USA; [Akbani, R.; Creighton, C. J.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Lu, Y.; Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Kurie, J. M.; Gibbons, D. L.] Univ Texas MD Anderson Canc Ctr, Dept Thoracic Head & Neck Med Oncol, Houston, TX 77030 USA; [Gibbons, D. L.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Creighton, C. J.] Baylor Coll Med, Dept Med, One Baylor Plaza MS305, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Creighton, CJ (corresponding author), Baylor Coll Med, Dept Med, One Baylor Plaza MS305, Houston, TX 77030 USA.	creighto@bcm.edu		Mills, Gordon/0000-0002-0144-9614	National Institutes of Health (NIH) [2R01CA125123-09]; MD Anderson's Institutional Tissue Bank Award [2P30CA016672]; University of Texas Lung Specialized Programs of Research Excellence grant [P50CA70907]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP120713, RP150405]; Department of Defense PROSPECT grant [W81XWH-07-1-0306]; NATIONAL CANCER INSTITUTE [U24CA199461, U24CA210949, P50CA070907, U24CA210950, P30CA125123, U24CA143883, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson's Institutional Tissue Bank Award; University of Texas Lung Specialized Programs of Research Excellence grant; Cancer Prevention and Research Institute of Texas (CPRIT); Department of Defense PROSPECT grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the following grants from the National Institutes of Health (NIH) grant 2R01CA125123-09 (C. Creighton), MD Anderson's Institutional Tissue Bank Award (2P30CA016672, I. Wistuba), and The University of Texas Lung Specialized Programs of Research Excellence grant (P50CA70907, I. Wistuba), Cancer Prevention and Research Institute of Texas (CPRIT) grant RP120713 C2 (C. Creighton) and P2 (D. Gibbons), and RP150405 (D. Gibbons) and Department of Defense PROSPECT grant (W81XWH-07-1-0306, I. Wistuba).	Aran D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9971; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Campbell JD, 2016, NAT GENET, V48, P607, DOI 10.1038/ng.3564; Chae YK, 2016, CLIN LUNG CANCER, V17, P350, DOI 10.1016/j.cllc.2016.03.011; Chen FJ, 2016, CELL REP, V14, P2476, DOI 10.1016/j.celrep.2016.02.024; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Chiriva-Internati M, 2012, INT REV IMMUNOL, V31, P321, DOI 10.3109/08830185.2012.723512; Ciuffreda L, 2014, CURR PHARM DESIGN, V20, P3944, DOI 10.2174/13816128113196660763; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Creighton Chad J, 2013, Cancer Manag Res, V5, P187, DOI 10.2147/CMAR.S35171; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Iyoda A, 2014, GEN THORAC CARDIOVAS, V62, P351, DOI 10.1007/s11748-014-0379-9; Lou YY, 2016, CLIN CANCER RES, V22, P3630, DOI 10.1158/1078-0432.CCR-15-1434; Mo QX, 2013, P NATL ACAD SCI USA, V110, P4245, DOI 10.1073/pnas.1208949110; Sato M, 2013, MOL CANCER RES, V11, P638, DOI 10.1158/1541-7786.MCR-12-0634-T; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Thomas A, 2015, NAT REV CLIN ONCOL, V12, P511, DOI 10.1038/nrclinonc.2015.90; Watanabe H, 2014, J CLIN INVEST, V124, P1636, DOI 10.1172/JCI71545; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Zhang YJ, 2012, CELL CYCLE, V11, P594, DOI 10.4161/cc.11.3.19096	25	76	78	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 9	2017	36	10					1384	1393		10.1038/onc.2016.303	http://dx.doi.org/10.1038/onc.2016.303			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2TG	27775076	Green Accepted			2022-12-26	WOS:000395862500007
J	Chintapalli, SV; Jayanthi, S; Mallipeddi, PL; Gundampati, R; Kumar, TKS; van Rossum, DB; Anishkin, A; Adams, SH				Chintapalli, Sree V.; Jayanthi, Srinivas; Mallipeddi, Prema L.; Gundampati, Ravikumar; Kumar, Thallapuranam Krishnaswamy Suresh; van Rossum, Damian B.; Anishkin, Andriy; Adams, Sean H.			Novel Molecular Interactions of Acylcarnitines and Fatty Acids with Myoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE INSULIN-RESISTANCE; BINDING-PROTEIN; SKELETAL-MUSCLE; 3-DIMENSIONAL STRUCTURE; X-RAY; AUTOMATED DOCKING; SPERM WHALE; DYNAMICS; MITOCHONDRIAL; OXYMYOGLOBIN	Previous research has indicated that long-chain fatty acids can bind myoglobin (Mb) in an oxygen-dependent manner. This suggests that oxy-Mb may play an important role in fuel delivery in Mb-rich muscle fibers (e.g. type I fibers and cardiomyocytes), and raises the possibility that Mb also serves as an acylcarnitine-binding protein. We report for the first time the putative interaction and affinity characteristics for different chain lengths of both fatty acids and acylcarnitines with oxy-Mb using molecular dynamic simulations and isothermal titration calorimetry experiments. We found that short-to medium-chain fatty acids or acylcarnitines (ranging from C2:0 to C10:0) fail to achieve a stable conformation with oxy-Mb. Furthermore, our results indicate that C12:0 is the minimum chain length essential for stable binding of either fatty acids or acylcarnitines with oxy-Mb. Importantly, the empirical lipid binding studies were consistent with structural modeling. These results reveal that: (i) the lipid binding affinity for oxy-Mb increases as the chain length increases (i.e. C12:0 to C18:1), (ii) the binding affinities of acylcarnitines are higher when compared with their respective fatty acid counterparts, and (iii) both fatty acids and acylcarnitines bind to oxy-Mb in 1:1 stoichiometry. Taken together, our results support a model in which oxy-Mb is a novel regulator of long-chain acylcarnitine and fatty acid pools in Mb-rich tissues. This has important implications for physiological fuel management during exercise, and relevance to pathophysiological conditions (e.g. fatty acid oxidation disorders and cardiac ischemia) where long-chain acylcarnitine accumulation is evident.	[Chintapalli, Sree V.; Adams, Sean H.] Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Little Rock, AR 72202 USA; [Chintapalli, Sree V.; Adams, Sean H.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72202 USA; [Jayanthi, Srinivas; Gundampati, Ravikumar; Kumar, Thallapuranam Krishnaswamy Suresh] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Mallipeddi, Prema L.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [van Rossum, Damian B.] Penn State Univ, Ctr Computat Prote, University Pk, PA 16802 USA; [van Rossum, Damian B.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Anishkin, Andriy] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Mallipeddi, Prema L.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Fayetteville; University of Houston System; University of Houston; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland College Park; University of Texas System; University of Texas Southwestern Medical Center Dallas	Adams, SH (corresponding author), Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Little Rock, AR 72202 USA.; Adams, SH (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72202 USA.; Chintapalli, SV (corresponding author), Arkansas Childrens Nutr Ctr, 15 Childrens Way, Little Rock, AR 72202 USA.	svchintapalli@uams.edu; shadams@uams.edu	KUMAR, P. SURESH/AAT-8951-2020; Kumar, Dr Suresh/HHZ-2615-2022; Jayanthi, Srinivas/AAD-2808-2019; Gundampati, Ravi Kumar/AAL-7624-2020; Kumar, Suresh Thallapuranam/R-5606-2016; ADAMS, SEAN/N-9262-2018	KUMAR, P. SURESH/0000-0003-3222-2604; Kumar, Dr Suresh/0000-0002-2539-6553; Kumar, Suresh Thallapuranam/0000-0001-7262-1373; Jayanthi, Srinivas/0000-0001-7357-760X; van Rossum, Damian/0000-0003-1011-2586; ADAMS, SEAN/0000-0002-9515-2319	U.S. Department of Agriculture, Agricultural Research Service [6026-51000-010-05S]; Arkansas Children's Research Institute; National Institutes of Health [R01DK078328-01]; Sturgis Diabetes Research Funds; Arkansas Bioscience Institute, National Institutes of Health, NCI Grant [1 RO1 CA 172631]; NATIONAL CANCER INSTITUTE [R01CA172631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078328] Funding Source: NIH RePORTER	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Arkansas Children's Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sturgis Diabetes Research Funds; Arkansas Bioscience Institute, National Institutes of Health, NCI Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. Department of Agriculture, Agricultural Research Service Project 6026-51000-010-05S and support from the Arkansas Children's Research Institute and National Institutes of Health NIDDK Grant R01DK078328-01 (to S. H. A.), pilot award funding from Sturgis Diabetes Research Funds (to S. H. A. and S. V. C.), and Arkansas Bioscience Institute, National Institutes of Health, NCI Grant 1 RO1 CA 172631 (to T. K. S. K.). The authors declare that they have no conflict of interests with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Aguer C, 2015, FASEB J, V29, P336, DOI 10.1096/fj.14-255901; Aon MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00282; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Chintapalli SV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128496; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Dube JJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE882, DOI 10.1152/ajpendo.00769.2007; Dutta-Roy AK, 2000, CELL MOL LIFE SCI, V57, P1360, DOI 10.1007/PL00000621; EISERT WG, 1979, BIOPHYS J, V25, P455, DOI 10.1016/S0006-3495(79)85315-1; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; GLATZ JFC, 1990, MOL CELL BIOCHEM, V98, P231, DOI 10.1007/BF00231389; GLATZ JFC, 1990, MOL CELL BIOCHEM, V98, P237, DOI 10.1007/BF00231390; GLOSTER J, 1977, BIOCHEM BIOPH RES CO, V74, P506, DOI 10.1016/0006-291X(77)90333-3; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; GOTZ FM, 1994, BIOL CHEM H-S, V375, P387, DOI 10.1515/bchm3.1994.375.6.387; He Y, 2007, BIOCHEMISTRY-US, V46, P12543, DOI 10.1021/bi701092r; Hersleth HP, 2007, J BIOL CHEM, V282, P23372, DOI 10.1074/jbc.M701948200; Hodsdon ME, 1996, J MOL BIOL, V264, P585, DOI 10.1006/jmbi.1996.0663; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KAIKAUS RM, 1990, EXPERIENTIA, V46, P617, DOI 10.1007/BF01939701; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; LASSEN D, 1995, EUR J BIOCHEM, V230, P266, DOI 10.1111/j.1432-1033.1995.tb20560.x; Liepinsh E, 2016, BIOCHEM J, V473, P1191, DOI 10.1042/BCJ20160164; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McCoin CS, 2015, NAT REV ENDOCRINOL, V11, P617, DOI 10.1038/nrendo.2015.129; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nelson DL, 2000, LEHNINGER PRINCIPLES; OCKNER RK, 1990, MOL CELL BIOCHEM, V98, P3; Ory JJ, 1999, BIOPHYS J, V77, P1107, DOI 10.1016/S0006-3495(99)76961-4; PERUTZ MF, 1966, J MOL BIOL, V21, P199, DOI 10.1016/0022-2836(66)90088-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PHILLIPS SEV, 1980, J MOL BIOL, V142, P531, DOI 10.1016/0022-2836(80)90262-4; Postnikova GB, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1211, DOI 10.1134/S0006297909110054; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Rutkowsky JM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1378, DOI 10.1152/ajpendo.00656.2013; SACCHETTINI JC, 1989, P NATL ACAD SCI USA, V86, P7736, DOI 10.1073/pnas.86.20.7736; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; Sharma Shruti, 2009, Drug Discov Today Dis Mech, V6, pe31; Shih L, 2015, CHEM PHYS LIPIDS, V191, P115, DOI 10.1016/j.chemphyslip.2015.07.010; Shih L, 2014, BBA-GEN SUBJECTS, V1840, P656, DOI 10.1016/j.bbagen.2013.10.028; SPENER F, 1990, MOL CELL BIOCHEM, V98, P57; Sriram R, 2008, FEBS LETT, V582, P3643, DOI 10.1016/j.febslet.2008.09.047; Steele RA, 1998, PROTEIN SCI, V7, P1332, DOI 10.1002/pro.5560070609; Suzuki T, 1998, CELL MOL LIFE SCI, V54, P979, DOI 10.1007/s000180050227; TAKANO T, 1977, J MOL BIOL, V110, P537, DOI 10.1016/S0022-2836(77)80111-3; TAKANO T, 1977, J MOL BIOL, V110, P569, DOI 10.1016/S0022-2836(77)80112-5; Terjung R. L., 1995, SPORTS SCI EXCHANGE, V8, P1; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; VINOGRADOV SN, 1993, COMP BIOCHEM PHYS B, V106, P1, DOI 10.1016/0305-0491(93)90002-M; Yamada T, 2013, J APPL PHYSIOL, V114, P490, DOI 10.1152/japplphysiol.00789.2012; ZANOTTI G, 1992, J BIOL CHEM, V267, P18541; Zhang J, 2017, EXP PHYSIOL, V102, P48, DOI 10.1113/EP086019	58	18	19	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					251133	251143		10.1074/jbc.M116.754978	http://dx.doi.org/10.1074/jbc.M116.754978			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27758871	Green Published, hybrid			2022-12-26	WOS:000388880100028
J	Puy, C; Tucker, EI; Ivanov, IS; Gailani, D; Smith, SA; Morrissey, JH; Gruber, A; McCarty, OJT				Puy, Cristina; Tucker, Erik I.; Ivanov, Ivan S.; Gailani, David; Smith, Stephanie A.; Morrissey, James H.; Gruber, Andras; McCarty, Owen J. T.			Platelet-Derived Short-Chain Polyphosphates Enhance the Inactivation of Tissue Factor Pathway Inhibitor by Activated Coagulation Factor XI	PLOS ONE			English	Article							BLOOD-COAGULATION; THROMBIN GENERATION; DEFICIENCY; ALPHA; PROTHROMBINASE; DOMAINS; SURFACE; ABSENCE; PLASMA; MICE	Introduction Factor (F) XI supports both normal human hemostasis and pathological thrombosis. Activated FXI (FXIa) promotes thrombin generation by enzymatic activation of FXI, FIX, FX, and FV, and inactivation of alpha tissue factor pathway inhibitor (TFPI alpha), in vitro. Some of these reactions are now known to be enhanced by short-chain polyphosphates (SCP) derived from activated platelets. These SCPs act as a cofactor for the activation of FXI and FV by thrombin and FXIa, respectively. Since SCPs have been shown to inhibit the anticoagulant function of TFPI alpha, we herein investigated whether SCPs could serve as cofactors for the proteolytic inactivation of TFPI alpha by FXIa, further promoting the efficiency of the extrinsic pathway of coagulation to generate thrombin. Methods and Results Purified soluble SCP was prepared by size-fractionation of sodium polyphosphate. TFPI alpha proteolysis was analyzed by western blot. TFPI alpha activity was measured as inhibition of FX activation and activity in coagulation and chromogenic assays. SCPs significantly accelerated the rate of inactivation of TFPI alpha by FXIa in both purified systems and in recalcified plasma. Moreover, platelet-derived SCP accelerated the rate of inactivation of platelet-derived TFPI alpha by FXIa. TFPI alpha activity was not affected by SCP in recalcified FXI-depleted plasma. Conclusions Our data suggest that SCP is a cofactor for TFPI alpha inactivation by FXIa, thus, expanding the range of hemostatic FXIa substrates that may be affected by the cofactor functions of platelet -derived SCP.	[Puy, Cristina; Tucker, Erik I.; Gruber, Andras; McCarty, Owen J. T.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Puy, Cristina; Gruber, Andras; McCarty, Owen J. T.] Oregon Hlth & Sci Univ, Sch Med, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Tucker, Erik I.; Gruber, Andras] Aronora Inc, Portland, OR USA; [Ivanov, Ivan S.; Gailani, David] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Ivanov, Ivan S.; Gailani, David] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Smith, Stephanie A.; Morrissey, James H.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [McCarty, Owen J. T.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Vanderbilt University; Vanderbilt University; University of Illinois System; University of Illinois Urbana-Champaign; Oregon Health & Science University	Puy, C (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA.; Puy, C (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Div Hematol & Med Oncol, Portland, OR 97201 USA.	puygarci@ohsu.edu	Morrissey, James H./GLR-5645-2022; Morrissey, James H/H-4933-2011	Morrissey, James H/0000-0002-1570-1569; Gruber, Andras/0000-0001-6212-2247; Smith, Stephanie/0000-0003-4895-6215	National Institutes of Health [R01HL101972, R44HL106919, R01GM116184, R01HL047014]; American Heart Association (AHA) Established Investigator [13EIA12630000]; Aronora Inc;  [14POST18180011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081326, R01HL058837, R01HL047014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA) Established Investigator(American Heart Association); Aronora Inc; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (R01HL101972, R44HL106919, R01GM116184, R01HL047014). O.J.T. McCarty is an American Heart Association (AHA) Established Investigator (13EIA12630000). C. Puy is an AHA Fellow (14POST18180011). A. Gruber, E.I. Tucker, and Oregon Health & Science University have a significant financial interest in Aronora Inc, a company that may have a commercial interest in the result of this research, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This potential conflict of interest has been reviewed and managed by the Oregon Health & Science University Conflict of Interest in Research Committee. J. Morrissey and S. Smith have a patent: Polyphosphate-functionalized inorganic nanoparticles as hemostatic compositions and methods of use (9,186,417). These do not alter our adherence to PLOS ONE policies on sharing data and materials. The remaining authors declare no competing financial interests.	Aslan JE, 2012, METHODS MOL BIOL, V788, P91, DOI 10.1007/978-1-61779-307-3_7; Baglia FA, 2004, J BIOL CHEM, V279, P45470, DOI 10.1074/jbc.M406727200; BOCK PE, 1981, BIOCHEMISTRY-US, V20, P7258, DOI 10.1021/bi00528a032; Buller HR, 2015, NEW ENGL J MED, V372, P232, DOI 10.1056/NEJMoa1405760; Cheng QF, 2010, BLOOD, V116, P3981, DOI 10.1182/blood-2010-02-270918; Choi SH, 2015, THROMB HAEMOSTASIS, V113, P599, DOI 10.1160/TH14-06-0515; Choi SH, 2011, BLOOD, V118, P6963, DOI 10.1182/blood-2011-07-368811; Donovan AJ, 2014, BIOMACROMOLECULES, V15, P3976, DOI 10.1021/bm501046t; Duchemin J, 2008, THROMB HAEMOSTASIS, V99, P767, DOI 10.1160/TH07-09-0581; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; GAILANI D, 1993, BLOOD COAGUL FIBRIN, V4, P15, DOI 10.1097/00001721-199304010-00003; Geng Y, 2013, J THROMB HAEMOST, V11, P2020, DOI 10.1111/jth.12414; Geng YP, 2013, BLOOD, V121, P3962, DOI 10.1182/blood-2012-12-473629; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; Gruber A, 2003, BLOOD, V102, P953, DOI 10.1182/blood-2003-01-0324; Kravtsov DV, 2009, BLOOD, V114, P452, DOI 10.1182/blood-2009-02-203604; Maroney SA, 2007, BLOOD, V109, P1931, DOI 10.1182/blood-2006-07-037283; Maroney SA, 2012, P NATL ACAD SCI USA, V109, P3927, DOI 10.1073/pnas.1119858109; Mast AE, 1996, BLOOD, V87, P1845; Matafonov A, 2013, J THROMB HAEMOST, V11, P2118, DOI 10.1111/jth.12435; Mutch NJ, 2012, J THROMB HAEMOST, V10, P2108, DOI 10.1111/j.1538-7836.2012.04890.x; Pedersen B, 2005, BLOOD, V105, P2777, DOI 10.1182/blood-2004-09-3724; Petersen LC, 1996, EUR J BIOCHEM, V235, P310, DOI 10.1111/j.1432-1033.1996.0310f.x; Pike GN, 2015, BLOOD, V126, P397, DOI 10.1182/blood-2014-12-616565; Puy C, 2013, J THROMB HAEMOST, V11, P1341, DOI 10.1111/jth.12295; Puy C, 2016, THROMB RES, V141, pS8, DOI 10.1016/S0049-3848(16)30354-1; Puy C, 2015, BLOOD, V125, P1488, DOI 10.1182/blood-2014-10-604587; SANDSET PM, 1988, THROMB RES, V50, P803, DOI 10.1016/0049-3848(88)90340-4; Seligsohn U, 2009, J THROMB HAEMOST, V7, P84, DOI 10.1111/j.1538-7836.2009.03395.x; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Smith SA, 2010, BLOOD, V116, P4353, DOI 10.1182/blood-2010-01-266791; Vincent LM, 2013, J CLIN INVEST, V123, P3777, DOI 10.1172/JCI69091; Whelihan MF, 2010, J THROMB HAEMOST, V8, P1532, DOI 10.1111/j.1538-7836.2010.03899.x; Wong PC, 2015, J THROMB THROMBOLYS, V40, P416, DOI 10.1007/s11239-015-1258-7; Wood JP, 2013, P NATL ACAD SCI USA, V110, P17838, DOI 10.1073/pnas.1310444110; Zhu S, 2015, BLOOD, V126, P1494, DOI 10.1182/blood-2015-04-641472; Zucker M, 2014, J THROMB HAEMOST, V12, P1121, DOI 10.1111/jth.12600	37	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165172	10.1371/journal.pone.0165172	http://dx.doi.org/10.1371/journal.pone.0165172			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764259	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500125
J	Rytter, D; Bech, BH; Halldorsson, TI; Henriksen, TB; Grandstrom, C; Cohen, A; Olsen, SF				Rytter, Dorte; Bech, Bodil Hammer; Halldorsson, Thorhallur Ingi; Henriksen, Tine Brink; Grandstrom, Charlotta; Cohen, Arieh; Olsen, Sjurdur Frodi			Maternal Vitamin D Status at Week 30 of Gestation and Offspring Cardio-Metabolic Health at 20 Years: A Prospective Cohort Study over Two Decades	PLOS ONE			English	Article							PREGNANT-WOMEN; D SUPPLEMENTATION; HIGH PREVALENCE; D DEFICIENCY; CARDIOVASCULAR-DISEASE; RISK; CHILDHOOD; BIRTH; ASSOCIATION; CHILDREN	Background/Objectives Vitamin D deficiency is common among pregnant women and since the fetus relies exclusively on maternal supply, deficiency could potentially interfere with fetal development. Vitamin D blood concentrations during pregnancy have been associated with offspring cardio-metabolic health in a few previous studies but the evidence is still inconsistent and only one previous study has followed the offspring into adulthood. The aim of the present study was to investigate the association between maternal serum concentration of vitamin D (25 (OH)D) in week 30 of gestation and offspring cardio-metabolic risk factors at 20 years. Subjects/Methods A follow up study of a Danish birth cohort from 1988-89 (n = 965) was conducted. A blood sample was drawn from the women in week 30 of gestation. In 2008-2009, 95% of the original mother and child dyads could be identified in the central registration registry and were alive and living in Denmark. The offspring were followed up with self-reported anthropometrics (N = 629, 69%) and a clinical examination (N = 410, 45%). Multiple linear regression was used to estimate the association between maternal 25(OH)D and offspring cardio-metabolic risk factors adjusting for potential confounders. Results No overall association was observed between maternal 25(OH)D in week 30 of gestation and offspring cardio-metabolic risk factors. However, the analyses did suggest a possible inverse association with blood pressure in females. Conclusions No clear association between maternal 25(OH)D concentration in week 30 of gestation and cardio-metabolic risk factors in the 20 year old offspring was found.	[Rytter, Dorte; Bech, Bodil Hammer] Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark; [Halldorsson, Thorhallur Ingi] Univ Iceland, Sch Hlth Sci, Fac Food Sci & Nutr, Unit Nutr Res, Reykjavik, Iceland; [Halldorsson, Thorhallur Ingi; Grandstrom, Charlotta; Olsen, Sjurdur Frodi] Statens Serum Inst, Ctr Fetal Programming, Copenhagen, Denmark; [Henriksen, Tine Brink] Aarhus Univ Hosp, Dept Pediat, Aarhus, Denmark; [Cohen, Arieh] Statens Serum Inst, Clin Mass Spectrometry Dept Clin Biochem Immunol, Copenhagen, Denmark	Aarhus University; University of Iceland; Statens Serum Institut; Aarhus University; Statens Serum Institut	Rytter, D (corresponding author), Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark.	dr@ph.au.dk	Bech, Bodil Hammer/B-9646-2016	Bech, Bodil Hammer/0000-0002-0287-3687; Henriksen, Tine Brink/0000-0001-6933-8294; Halldorsson, Thorhallur/0000-0002-3488-0777; Olsen, Sjurdur/0000-0003-3017-7096; Rytter, Dorte/0000-0003-1518-0975	Danish Council for Strategic Research [09-067124, 2101-07-0025, 2101-06-0005]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by the Danish Council for Strategic Research [grants no: 09-067124, 2101-07-0025 and 2101-06-0005]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agborsangaya C, 2010, NUTR CANCER, V62, P51, DOI 10.1080/01635580903191460; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Bowyer L, 2009, CLIN ENDOCRINOL, V70, P372, DOI 10.1111/j.1365-2265.2008.03316.x; Brekke HK, 2007, PEDIATR DIABETES, V8, P11, DOI 10.1111/j.1399-5448.2006.00223.x; Chaudhuri A, 2005, MED HYPOTHESES, V64, P608, DOI 10.1016/j.mehy.2004.06.022; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1368, DOI 10.1111/aogs.12006; Crozier SR, 2012, AM J CLIN NUTR, V96, P57, DOI 10.3945/ajcn.112.037473; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Ford L, 2013, METHODS MOL BIOL, V1065, P245, DOI 10.1007/978-1-62703-616-0_16; Gale CR, 2008, EUR J CLIN NUTR, V62, P68, DOI 10.1038/sj.ejcn.1602680; Gezmish O, 2013, J CARDIOVASC TRANSL, V6, P588, DOI 10.1007/s12265-013-9475-y; Halldorsson TI, 2012, ENVIRON HEALTH PERSP, V120, P668, DOI 10.1289/ehp.1104034; Harvey NC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18450; Kazemi A, 2009, J WOMENS HEALTH, V18, P835, DOI 10.1089/jwh.2008.0954; Krishnaveni GV, 2011, AM J CLIN NUTR, V93, P628, DOI 10.3945/ajcn.110.003921; Leffelaar ER, 2010, BRIT J NUTR, V104, P108, DOI 10.1017/S000711451000022X; Mahon P, 2010, J BONE MINER RES, V25, P14, DOI 10.1359/jbmr.090701; Mao CP, 2009, PROG NEUROBIOL, V87, P252, DOI 10.1016/j.pneurobio.2008.12.001; Matsusaka T, 2002, ANNU REV PHYSIOL, V64, P551, DOI 10.1146/annurev.physiol.64.081501.155721; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Mirzaei F, 2011, ANN NEUROL, V70, P30, DOI 10.1002/ana.22456; Nielsen NO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080686; OLSEN SF, 1995, BRIT J NUTR, V73, P397, DOI 10.1079/BJN19950042; Rytter D, 2013, BRIT J NUTR, V110, P2037, DOI 10.1017/S0007114513001335; Sachan A, 2005, AM J CLIN NUTR, V81, P1060; Scholl TO, 2009, EARLY HUM DEV, V85, P231, DOI 10.1016/j.earlhumdev.2008.10.006; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Stene LC, 2000, DIABETOLOGIA, V43, P1093, DOI 10.1007/s001250051499; Streym SV, 2013, EUR J CLIN NUTR, V67, P1022, DOI 10.1038/ejcn.2013.152; Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x; Tornhammar P, 2014, AM J CLIN NUTR, V99, P472, DOI 10.3945/ajcn.113.072520; Williams DM, 2013, HEART, V99, P1849, DOI 10.1136/heartjnl-2013-303678	35	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164758	10.1371/journal.pone.0164758	http://dx.doi.org/10.1371/journal.pone.0164758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764169	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500057
J	Dong, SY; Zuo, ZY; Chao, YS; Damas, K; Sule, B				Dong, Shi-Yong; Zuo, Zheng-Yu; Chao, Yi-Shan; Damas, Kipiro; Sule, Bernard			New Species of the Fern Genus Lindsaea (Lindsaeaceae) from New Guinea with Notes on the Phylogeny of L. sect. Synaphlebium	PLOS ONE			English	Article							CLASSIFICATION	To determine the taxonomic identities and the systematic positions of some collections of Lindsaea sect. Synaphlebium (Lindsaeaceae) from Papua New Guinea, we conducted morphological comparisons and phylogenetic analyses on the whole section. A total of 22 morphological characters were selected and coded for each of all known taxa in L. sect. Synaphlebium, and were analyzed using maximum parsimony. The datasets containing either of or combined two plastid DNA sequences (trnL-trnF spacer and trnH-psbA spacer) of 37 taxa were analyzed using maximum parsimony, maximum likelihood, and Bayesian inference. Morphological comparisons revealed two new species which are formally published here as L. subobscura and L. novoguineensis. Lindsaea subobscura is similar to sympatric L. obscura and L. modesta but differs in the obviously reduced upper pinnules and other characters. Lindsaea novoguineensis is most similar to L. pacifica from Melanesia but differs in having rhomboid pinnules with truncate apices and concave soral receptacles. Molecular analyses resolved L. sect. Synaphlebium and allied species into five well-supported clades, namely L. rigida clade, L. obtusa clade, L. pulchella clade, L. multisora clade, and L. cultrata clade. The new species L. novoguineensis is included in L. obtusa clade; L. subobscura is in L. pulchella clade; whereas the majority of L. sect. Synaphlebium is clustered in L. cultrata clade. As the section Synaphlebium sensu Kramer is strongly suggested as polyphyletic, we propose the concept of a monophyletic L. sect. Synaphlebium in a broad sense that comprises five lineages. The morphological circumscription of L. sect. Synaphlebium sensu lato and the divergence in morphology, habit, and distribution between the five lineages are briefly discussed. Further molecular study is needed to test the systematic positions of 16 other species which are supposed to be within L. sect. Synaphlebium sensu lato but have not been included in this and previous molecular analyses.	[Dong, Shi-Yong; Zuo, Zheng-Yu] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China; [Zuo, Zheng-Yu] Univ Chinese Acad Sci, Beijing 100093, Peoples R China; [Chao, Yi-Shan] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Damas, Kipiro; Sule, Bernard] PNG Forest Res Inst, Lae 411, Papua N Guinea	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kaohsiung Medical University	Dong, SY (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China.	dongshiyong@scib.ac.cn	Chao, Yi-Shan/T-1186-2019	Chao, Yi-Shan/0000-0001-7433-5987; Zuo, Zheng-Yu/0000-0002-8334-6132	National Natural Science Foundation of China [31270258]; SYD	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SYD	This study is funded by the National Natural Science Foundation of China (grant #31270258) (http://www.nsfc.gov.cn/). The grant was received by SYD and covered all aspects of this study, including the trip cost to PNG, experiments cost, and the tools of data analysis.	BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; BROWNLIE G, 1973, American Fern Journal, V63, P91, DOI 10.2307/1546185; Ching R.-C., 1978, ACTA PHYTOTAXO NOMIC, V16, P16; CHING RC, 1978, ACTA PHYTOTAX SINICA, V16, P1; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HASEBE M, 1994, P NATL ACAD SCI USA, V91, P5730, DOI 10.1073/pnas.91.12.5730; Holttum R.E., 1966, REVISED FLORA MALAYA; KRAMER K U, 1976, Telopea, V1, P91; KRAMER K U, 1988, Telopea, V3, P287; KRAMER K U, 1970, Blumea, V18, P157; KRAMER K. U., 1957, ACTA BOT NEERLANDICA, V6, P97; Kramer K. U., 1967, BLUMEA, V15, P557; Kramer K. U., 1967, BLUMEA, V15, P545; Kramer K. U., 1990, FAMILIES GENERA VASC, V1; KRAMER KU, 1967, ACTA BOT NEERL, V15, P562; Kramer KU., 1971, FLORA MALESIANA 2, VII; KRAMER KU, 1972, B JARDIN BOT NATL BE, V42, P305, DOI DOI 10.2307/3667462; Kramer KU, 1971, PTERIDOPHYTA 3, V1; KRAMER KU, 1972, GARDENS B SINGAPORE, V24, P1; Lehtonen S, 2010, BOT J LINN SOC, V163, P305, DOI 10.1111/j.1095-8339.2010.01063.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Schuettpelz E, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P395, DOI 10.1017/CBO9780511541827.016; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tate JA, 2003, SYST BOT, V28, P723; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tryon R. M., 1982, FERNS ALLIED PLANTS; Zwickl DJ., 2006, GENETIC ALGORITHM AP	35	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0163686	10.1371/journal.pone.0163686	http://dx.doi.org/10.1371/journal.pone.0163686			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760151	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204000018
J	Savneby, A; Luthman, J; Nordenskjold, F; Andersson, B; Lindberg, AM				Savneby, Anna; Luthman, Johannes; Nordenskjold, Fabian; Andersson, Bjorn; Lindberg, A. Michael			The Transcriptome of Rhabdomyosarcoma Cells Infected with Cytolytic and Non-Cytolytic Variants of Coxsackievirus B2 Ohio-1	PLOS ONE			English	Article							VIRUS INDUCES APOPTOSIS; MOUTH-DISEASE VIRUS; GENE-EXPRESSION; PERSISTENCE; ENTEROVIRUSES; VP1	The transcriptomes of cells infected with lytic and non-lytic variants of coxsackievirus B2 Ohio-1 (CVB2O) were analyzed using next generation sequencing. This approach was selected with the purpose of elucidating the effects of lytic and non-lytic viruses on host cell transcription. Total RNA was extracted from infected cells and sequenced. The resulting reads were subsequently mapped against the human and CVB2O genomes. The amount of intracellular RNA was measured, indicating lower proportions of human RNA in the cells infected with the lytic virus compared to the non-lytic virus after 48 hours. This may be explained by reduced activity of the cellular transcription/translation machinery in lytic enteroviral replication due to activities of the enteroviral proteases 2A and/or 3C. Furthermore, differential expression in the cells infected with the two virus variants was identified and a number of transcripts were singled out as possible answers to the question of how the viruses interact with the host cells, resulting in lytic or non-lytic infections.	[Savneby, Anna; Lindberg, A. Michael] Linnaeus Univ, Dept Chem & Biomed Sci, Kalmar, Sweden; [Luthman, Johannes; Nordenskjold, Fabian; Andersson, Bjorn] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Linnaeus University; Karolinska Institutet	Lindberg, AM (corresponding author), Linnaeus Univ, Dept Chem & Biomed Sci, Kalmar, Sweden.	michael.lindberg@lnu.se	Andersson, Bjorn/G-9832-2013	Andersson, Bjorn/0000-0002-4624-0259	Linnaeus University; Science for Life Laboratory-Stockholm, Sweden; National Genomic Infrastructure-Sweden; Uppmax-Sweden	Linnaeus University; Science for Life Laboratory-Stockholm, Sweden; National Genomic Infrastructure-Sweden; Uppmax-Sweden	AS and AML were funded by a faculty grant from Linnaeus University, and BA by Science for Life Laboratory-Stockholm, Sweden; the National Genomic Infrastructure-Sweden; and Uppmax-Sweden.	[Anonymous], 2014, NES CLIP VERS 0 115; [Anonymous], 2014, HOMO SAPIENS ENSEMBL; [Anonymous], 2014, CUFF VERS 2 2 1; [Anonymous], 2014, TOPHAT VERS 2 0 11; ARGO E, 1992, ARCH VIROL, V126, P215, DOI 10.1007/BF01309696; Bedard KM, 2004, MICROBES INFECT, V6, P702, DOI 10.1016/j.micinf.2004.03.001; Buenz EJ, 2006, TRENDS MICROBIOL, V14, P28, DOI 10.1016/j.tim.2005.11.003; Chen YH, 2015, CELL, V160, P619, DOI 10.1016/j.cell.2015.01.032; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; DOMINGO E, 1985, GENE, V40, P1, DOI 10.1016/0378-1119(85)90017-4; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Frisk G, 1999, ARCH VIROL, V144, P2239, DOI 10.1007/s007050050638; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Gullberg M, 2010, J VIROL, V84, P5868, DOI 10.1128/JVI.02383-09; Henke A, 2000, J VIROL, V74, P4284, DOI 10.1128/JVI.74.9.4284-4290.2000; Horsington J, 2007, VIRUS RES, V125, P114, DOI 10.1016/j.virusres.2006.12.008; JAROUSSE N, 1994, J VIROL, V68, P3364, DOI 10.1128/JVI.68.5.3364-3368.1994; Jonsson N, 2009, MICROBIOL IMMUNOL, V53, P149, DOI 10.1111/j.1348-0421.2009.00107.x; Liu J, 2002, VIROLOGY, V300, P39, DOI 10.1006/viro.2002.1482; Lukashev AN, 2005, REV MED VIROL, V15, P157, DOI 10.1002/rmv.457; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Pallansch M., 2007, FIELDS VIROLOGY, P839; Pelletier I, 1998, CELL MOL LIFE SCI, V54, P1385, DOI 10.1007/s000180050261; Peng JM, 2004, J BIOL CHEM, V279, P52168, DOI 10.1074/jbc.M403686200; Polacek C, 2005, VIRUS RES, V113, P107, DOI 10.1016/j.virusres.2005.04.021; RACANIELLO VR, 2007, FIELDS VIROLOGY, V1; Robinson SM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004045; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Schmidtke M, 2000, VIROLOGY, V275, P77, DOI 10.1006/viro.2000.0485	30	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164548	10.1371/journal.pone.0164548	http://dx.doi.org/10.1371/journal.pone.0164548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760161	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204000039
J	Sriram, U; Hill, BL; Cenna, JM; Gofman, L; Fernandes, NC; Haldar, B; Potula, R				Sriram, Uma; Hill, Beth L.; Cenna, Jonathan M.; Gofman, Larisa; Fernandes, Nicole C.; Haldar, Bijayesh; Potula, Raghava			Impaired Subset Progression and Polyfunctionality of T Cells in Mice Exposed to Methamphetamine during Chronic LCMV Infection	PLOS ONE			English	Article							DRUG-USE; PD-1 EXPRESSION; IMMUNE FUNCTION; ALTERS; EXHAUSTION; INJECTION; RESPONSES; STATE; BEHAVIORS; INTERPLAY	Methamphetamine (METH) is a widely used psychostimulant that severely impacts the host's innate and adaptive immune systems and has profound immunological implications. T cells play a critical role in orchestrating immune responses. We have shown recently how chronic exposure to METH affects T cell activation using a murine model of lymphocytic choriomeningitis virus (LCMV) infection. Using the TriCOM (trinary state combinations) feature of GemStone (TM) to study the polyfunctionality of T cells, we have analyzed how METH affected the cytokine production pattern over the course of chronic LCMV infection. Furthermore, we have studied in detail the effects of METH on splenic T cell functions, such as cytokine production and degranulation, and how they regulate each other. We used the Probability State Modeling (PSM) program to visualize the differentiation of effector/memory T cell subsets during LCMV infection and analyze the effects of METH on T cell subset progression. We recently demonstrated that METH increased PD-1 expression on T cells during viral infection. In this study, we further analyzed the impact of PD-1 expression on T cell functional markers as well as its expression in the effector/memory subsets. Overall, our study indicates that analyzing polyfunctionality of T cells can provide additional insight into T cell effector functions. Analysis of T cell heterogeneity is important to highlight changes in the evolution of memory/effector functions during chronic viral infections. Our study also highlights the impact of METH on PD-1 expression and its consequences on T cell responses.	[Sriram, Uma; Cenna, Jonathan M.; Gofman, Larisa; Fernandes, Nicole C.; Haldar, Bijayesh; Potula, Raghava] Temple Univ, Lewis Katz Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA; [Potula, Raghava] Temple Univ, Lewis Katz Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19122 USA; [Hill, Beth L.] Ver Software House, Topsham, ME USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Potula, R (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA.; Potula, R (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19122 USA.	Raghava.Potula@tuhs.temple.edu			NIH grant [R01 DA031064]; Temple Development Grant; NIAMS grant [1RO3AR065157-01A1]; NIDA Institutional Training Grant [T32 DA007237]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR065157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031064, T32DA007237] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Temple Development Grant; NIAMS grant; NIDA Institutional Training Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grant R01 DA031064 and Temple Development Grant to RP, and 1R03AR065157-01A1 NIAMS grant to US and T32 DA007237 NIDA Institutional Training Grant to LG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grant R01 DA031064 and Temple Development Grant to R. P, 1RO3AR065157-01A1 NIAMS grant to U.S and T32 DA007237 NIDA Institutional Training Grant to L.G. The authors thank Ms. Nancy Reichenbach for editorial assistance.	Allie SR, 2011, J IMMUNOL, V186, P6280, DOI 10.4049/jimmunol.1003870; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Bagwell CB, 2015, CYTOM PART A, V87A, P646, DOI 10.1002/cyto.a.22687; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Blattman JN, 2009, J VIROL, V83, P4386, DOI 10.1128/JVI.02524-08; Carrico AW, 2014, DRUG ALCOHOL DEPEN, V139, P174, DOI 10.1016/j.drugalcdep.2014.03.025; Chiang SCC, 2013, BLOOD, V121, P1345, DOI 10.1182/blood-2012-07-442558; Cofrancesco J, 2008, AIDS, V22, P357, DOI 10.1097/QAD.0b013e3282f3cc21; Dinney CM, 2015, J MICROBIOL, V53, P718, DOI 10.1007/s12275-015-5314-y; Fernandes NC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0553-3; FONTANA A, 1989, J IMMUNOL, V143, P3230; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Freese TE, 2000, J PSYCHOACTIVE DRUGS, V32, P177, DOI 10.1080/02791072.2000.10400226; Ghimire B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1238; Graham DL, 2008, J NEUROCHEM, V105, P1873, DOI 10.1111/j.1471-4159.2008.05269.x; Helmstetter C, 2015, IMMUNITY, V42, P108, DOI 10.1016/j.immuni.2014.12.018; Inokuma MS, 2013, J IMMUNOL METHODS, V397, P8, DOI 10.1016/j.jim.2013.08.003; JENSEN SS, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0139573; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kapadia F, 2005, ADDICTION, V100, P990, DOI 10.1111/j.1360-0443.2005.01098.x; Khanolkar A, 2002, IMMUNOL RES, V26, P309, DOI 10.1385/IR:26:1-3:309; Kipp AM, 2011, J SUBST ABUSE TREAT, V40, P386, DOI 10.1016/j.jsat.2011.01.001; Li L, 2014, DRUG ALCOHOL DEPEN, V138, P48, DOI 10.1016/j.drugalcdep.2014.01.021; Lin MY, 2000, MICROBES INFECT, V2, P1025, DOI 10.1016/S1286-4579(00)01257-0; Marraco SAF, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00310; Mata MM, 2015, EUR J PHARMACOL, V752, P26, DOI 10.1016/j.ejphar.2015.02.002; Newell EW, 2014, CURR TOP MICROBIOL, V377, P61, DOI 10.1007/82_2013_354; Ng CT, 2013, CELL HOST MICROBE, V13, P652, DOI 10.1016/j.chom.2013.05.014; Pauken KE, 2015, CELL, V163, P1038, DOI 10.1016/j.cell.2015.10.054; Penaloza-MacMaster P, 2014, J EXP MED, V211, P1905, DOI 10.1084/jem.20132577; Potula R, 2010, J IMMUNOL, V185, P2867, DOI 10.4049/jimmunol.0903691; Qian HZ, 2011, J SUBST ABUSE TREAT, V41, P14, DOI 10.1016/j.jsat.2011.01.007; Roychoudhuri R, 2015, CURR OPIN IMMUNOL, V33, P101, DOI 10.1016/j.coi.2015.02.003; Roychoudhuri R, 2015, VACCINE, V33, P914, DOI 10.1016/j.vaccine.2014.10.007; Sakaguchi S, 2015, J LEUKOCYTE BIOL, V97, P635, DOI 10.1189/jlb.1HI1113-597RR; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Segal DS, 2003, NEUROPSYCHOPHARMACOL, V28, P1730, DOI 10.1038/sj.npp.1300247; Semple S, 2009, AM J ADDICTION, V18, P65, DOI 10.1080/10550490802544466; Shoptaw S, 2002, J ADDICT DIS, V21, P91; Simon S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00114; Sledzinska A, 2015, MOL ONCOL, V9, P1936, DOI 10.1016/j.molonc.2015.10.008; Snyder LD, 2016, AM J RESP CRIT CARE, V193, P78, DOI 10.1164/rccm.201504-0733OC; Sriram U, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00793; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2005, J VIROL, V79, P8960, DOI 10.1128/JVI.79.14.8960-8968.2005; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wilson EB, 2010, IMMUNOL RES, V48, P3, DOI 10.1007/s12026-010-8162-1; Yu QL, 2002, INT IMMUNOPHARMACOL, V2, P951, DOI 10.1016/S1567-5769(02)00047-4; Zheng Q, 2015, CLIN EXP IMMUNOL, V180, P499, DOI 10.1111/cei.12597; Zhou X, 2012, VIRUSES-BASEL, V4, P2650, DOI 10.3390/v4112650	53	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164966	10.1371/journal.pone.0164966	http://dx.doi.org/10.1371/journal.pone.0164966			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760221	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204000072
J	Barros-Neto, JA; Souza-Machado, A; Kraychete, DC; de Jesus, RP; Cortes, ML; Lima, MDS; Freitas, MC; Santos, TMDM; Viana, GFDS; Menezes, JA				Barros-Neto, Joao Araujo; Souza-Machado, Adelmir; Kraychete, Durval Campos; de Jesus, Rosangela Passos; Cortes, Matheus Lopes; Lima, Michele dos Santos; Freitas, Mariana Carvalho; de Morais Santos, Tascya Morganna; de Sousa Viana, Gustavo Freitas; Menezes-Filho, Jose Antonio			Selenium and Zinc Status in Chronic Myofascial Pain: Serum and Erythrocyte Concentrations and Food Intake	PLOS ONE			English	Article							ATOMIC-ABSORPTION SPECTROPHOTOMETRY; TRIGGER POINTS; CLINICAL-PARAMETERS; TRACE-ELEMENTS; FIBROMYALGIA; INFLAMMATION; EXERCISE; PLASMA; WOMEN	Introduction Nutritional disorders have been reported to be important causal factors that can intensify or cause a painful response in individuals with chronic musculoskeletal pain. Aim To assess the habitual intake of and the serum and erythrocyte levels of selenium and zinc in patients with chronic myofascial pain. Materials and Methods A case- control study of 31 patients with chronic myofascial pain (group I) and 31 subjects without pain (group II). Dietary record in five days for assessing food intake were used. The serum and erythrocyte concentrations of selenium and zinc were analyzed using an atomic absorption spectrophotometry. Pain intensity was assessed using a visual analog scale. Results The group of patients with chronic myofascial pain, compared with the control group, showed a lower erythrocyte concentration of selenium (79.46 +/- 19.79 mu g/L vs. 90.80 +/- 23.12 mu g/L; p = 0.041) and zinc (30.56 +/- 7.74 mu gZn/gHb vs. 38.48 +/- 14.86 mu gZn/gHb, respectively; p = 0.004). In this study, a compromised food intake of zinc was observed in the majority of the subjects in both groups. The selenium intake was considered to be safe in 80% of the subjects in both groups; however, the likelihood of inadequate intake of this mineral was twice as high in group I (49.5% vs. 24.4%, respectively). In the logistic regression analysis, the erythrocyte concentration of zinc was associated with the presence of pain. In each additional 1 mg of Zn2+ per gram of hemoglobin, a reduction of 12.5% was observed in the risk of the individual having chronic myofascial pain (B = -0.133; adjusted OR = 0.875, 95% CI = 0.803 to 0.954, Wald = 9.187, standard error = 0.044, p = 0.002). Physical inactivity and obesity were noted more commonly in group I compared with the control group. Conclusion In this study, patients with chronic myofascial pain showed lower intracellular stores of zinc and selenium and inadequate food intake of these nutrients.	[Barros-Neto, Joao Araujo] Univ Fed Alagoas, Coll Nutr, Maceio, Alagoas, Brazil; [Souza-Machado, Adelmir] Univ Fed Bahia, Inst Hlth Sci, Salvador, BA, Brazil; [Kraychete, Durval Campos] Univ Fed Bahia, Coll Med, Salvador, BA, Brazil; [de Jesus, Rosangela Passos] Univ Fed Bahia, Coll Nutr, Salvador, BA, Brazil; [Cortes, Matheus Lopes; Lima, Michele dos Santos] Univ Fed Bahia, Multidisciplinary Inst Hlth, Vitoria Da Conquista, BA, Brazil; [Freitas, Mariana Carvalho] Univ Ctr Estacio FIC, Dept Nutr, Fortaleza, Ceara, Brazil; [de Morais Santos, Tascya Morganna] Fed Inst Alagoas, Maceio, Alagoas, Brazil; [de Sousa Viana, Gustavo Freitas; Menezes-Filho, Jose Antonio] Univ Fed Bahia, Coll Pharm, Salvador, BA, Brazil	Universidade Federal de Alagoas; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Instituto Federal de Alagoas (IFAL); Universidade Federal da Bahia	Barros-Neto, JA (corresponding author), Univ Fed Alagoas, Coll Nutr, Maceio, Alagoas, Brazil.	joao.neto@fanut.ufal.br	Barros-Neto, João/AAQ-8505-2020; de Souza Machado, Adelmir/F-7822-2012; Menezes-Filho, Jose A/D-1650-2014; Kraychete, Durval Campos/E-9576-2014; Cortes, Matheus/X-3432-2019; Menezes-Filho, José/ABE-5797-2021; Souza-Machado, Adelmir/S-3244-2019	Menezes-Filho, Jose A/0000-0002-3191-4484; Kraychete, Durval Campos/0000-0001-6561-6584; Cortes, Matheus/0000-0002-7804-7787; Menezes-Filho, José/0000-0002-3191-4484; Souza-Machado, Adelmir/0000-0002-1475-2663				Barbero M, 2012, J MAN MANIP THER, V20, P171, DOI 10.1179/2042618612Y.0000000010; Boosalis MG, 2008, NUTR CLIN PRACT, V23, P152, DOI 10.1177/0884533608314532; Bron C, 2007, J MAN MANIP THER, V15, P203, DOI 10.1179/106698107790819477; Caldwell J, 2009, J PAIN, V10, P60, DOI 10.1016/j.jpain.2008.07.005; Chen CK, 2011, KOREAN J PAIN, V24, P100, DOI 10.3344/kjp.2011.24.2.100; Coury HJCG, 2009, BRAZ J PHYS THER, V13, P461, DOI 10.1590/S1413-35552009000600002; Davis CD, 2000, AM J CLIN NUTR, V71, P781, DOI 10.1093/ajcn/71.3.781; Dommerholt J, 2006, J MAN MANIP THER, V14, P203, DOI 10.1179/106698106790819991; Eisinger J, 1997, J MUSCULOSKELET PAIN, V5, P5, DOI 10.1300/J094v05n04_02; Hernandez FMF, 2009, REUMATOL CLIN, V5, P36, DOI 10.1016/j.reuma.2009.04.004; Gerwin RD, 1997, PAIN, V69, P65, DOI 10.1016/S0304-3959(96)03248-4; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Heyland DK, 2005, INTENS CARE MED, V31, P327, DOI 10.1007/s00134-004-2522-z; Hong CZ, 1998, ARCH PHYS MED REHAB, V79, P863, DOI 10.1016/S0003-9993(98)90371-9; Hsieh YL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/342165; Institute of Medicine (U. S.), 2001, DRI DIET REF INT VIT, pxxii; Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds, 2000, DIET REF INT VIT C V; Kraychete DC, 2005, REV DOR, V6, P672; Lohman TG, 1993, MED SCI SPORTS EXERC, V25, P762, DOI [DOI 10.1249/00005'768-199306000-00021, DOI 10.1249/00005768-199306000-00021]; Lohman TJ, 1992, MED SCI SPORTS EXERC, V24, P952, DOI [10.1249/00005768-199208000-00020, DOI 10.1249/00005768-199208000-00020]; Lopes ACS, 2008, REME REV MIN ENFERM, V12, P483; Maciel Álvaro Campos Cavalcanti, 2006, Rev. bras. epidemiol., V9, P94, DOI 10.1590/S1415-790X2006000100012; Mafra Denise, 2004, Rev. Nutr., V17, P79, DOI 10.1590/S1415-52732004000100009; Martins CM, 2011, NUTR, V36, P82; Mastaloudis A, 2004, FREE RADICAL BIO MED, V36, P1329, DOI 10.1016/j.freeradbiomed.2004.02.069; McCarthy LH, 2009, J AM GERIATR SOC, V57, P115, DOI 10.1111/j.1532-5415.2008.02089.x; Milanino R, 1993, COPPER ZINC BODY LEV, V30, P195; National Pain Management Coordinating Committee Veterans Health Administration, 2000, VET HLTH ADM PAIN 5; Okumus M, 2010, J BACK MUSCULOSKELET, V23, P187, DOI 10.3233/BMR-2010-0264; Volp ACP, 2010, REV NUTR, V23, P581, DOI 10.1590/S1415-52732010000400009; Powell SR, 2000, J NUTR, V130, p1447S, DOI 10.1093/jn/130.5.1447S; Reinhard P, 1998, TOXICOL LETT, V96-7, P177, DOI 10.1016/S0378-4274(98)00066-6; RODRIGUEZ MP, 1989, ATOM SPECTROSC, V10, P68; Rokyta R, 2003, NEUROENDOCRINOL LETT, V24, P304; Ruiz FG, 2005, REV CLIN ESP, V205, P157, DOI 10.1157/13074161; Sendur OF, 2008, RHEUMATOL INT, V28, P1117, DOI 10.1007/s00296-008-0593-9; Shah JP, 2008, ARCH PHYS MED REHAB, V89, P16, DOI 10.1016/j.apmr.2007.10.018; Silva JVFP, 2012, BRAZ J SPORTS NUTR, V1, P30; Simons DG, 2008, ARCH PHYS MED REHAB, V89, P157, DOI 10.1016/j.apmr.2007.11.016; Travell JG, 1999, TRAVELL SIMONS MYOFA, V1; Turki KM, 2012, I J ADV ENG TECH, V3, P105; Van Assendelft OW, 1972, MODERN CONCEPTS HEMA, P14; Waling K, 2000, PAIN, V85, P201, DOI 10.1016/S0304-3959(99)00265-1; WHITEHOUSE RC, 1982, CLIN CHEM, V28, P475; World Health Organization, 1995, PHYS STAT US INT ANT; Wright LJ, 2010, J PAIN, V11, P628, DOI 10.1016/j.jpain.2009.10.004	46	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164302	10.1371/journal.pone.0164302	http://dx.doi.org/10.1371/journal.pone.0164302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755562	Green Published, gold, Green Submitted			2022-12-26	WOS:000386203800015
J	Massange-Sanchez, JA; Palmeros-Suarez, PA; Espitia-Rangel, E; Rodriguez-Arevalo, I; Sanchez-Segura, L; Martinez-Gallardo, NA; Alatorre-Cobos, F; Tiessen, A; Delano-Frier, JP				Massange-Sanchez, Julio A.; Palmeros-Suarez, Paola A.; Espitia-Rangel, Eduardo; Rodriguez-Arevalo, Isaac; Sanchez-Segura, Lino; Martinez-Gallardo, Norma A.; Alatorre-Cobos, Fulgencio; Tiessen, Axel; Delano-Frier, John P.			Overexpression of Grain Amaranth (Amaranthus hypochondriacus) AhERF or AhDOF Transcription Factors in Arabidopsis thaliana Increases Water Deficit- and Salt-Stress Tolerance, Respectively, via Contrasting Stress-Amelioration Mechanisms	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; ETHYLENE RESPONSE FACTORS; ABIOTIC STRESS; DNA-BINDING; FACTOR FAMILY; DROUGHT TOLERANCE; FLOWERING TIME; SIGNAL-TRANSDUCTION; PROTEOMIC ANALYSIS; PLANT-RESPONSES	Two grain amaranth transcription factor (TF) genes were overexpressed in Arabidopsis plants. The first, coding for a group VII ethylene response factor TF (i.e., AhERF-VII) conferred tolerance to water-deficit stress (WS) in transgenic Arabidopsis without affecting vegetative or reproductive growth. A significantly lower water-loss rate in detached leaves coupled to a reduced stomatal opening in leaves of plants subjected to WS was associated with this trait. WS tolerance was also associated with an increased antioxidant enzyme activity and the accumulation of putative stress-related secondary metabolites. However, microarray and GO data did not indicate an obvious correlation between WS tolerance, stomatal closure, and abscisic acid (ABA)-related signaling. This scenario suggested that stomatal closure during WS in these plants involved ABA-independent mechanisms, possibly involving reactive oxygen species (ROS). WS tolerance may have also involved other protective processes, such as those employed for methyl glyoxal detoxification. The second, coding for a class A and cluster I DNA binding with one finger TF (i.e., AhDof-AI) provided salt-stress (SS) tolerance with no evident fitness penalties. The lack of an obvious development-related phenotype contrasted with microarray and GO data showing an enrichment of categories and genes related to developmental processes, particularly flowering. SS tolerance also correlated with increased superoxide dismutase activity but not with augmented stomatal closure. Additionally, microarray and GO data indicated that, contrary to AhERF-VII, SS tolerance conferred by AhDof-AI in Arabidopsis involved ABA-dependent and ABA-independent stress amelioration mechanisms.	[Massange-Sanchez, Julio A.; Sanchez-Segura, Lino; Martinez-Gallardo, Norma A.; Tiessen, Axel; Delano-Frier, John P.] IPN, Ctr Invest & Estudios Avanzados, Unidad Irapuato, Km 9-6 Libramiento Norte Carretera Irapuato Leon, Irapuato 36821, Gto, Mexico; [Rodriguez-Arevalo, Isaac] Cinvestav Irapuato, Lab Nacl Genom Biodiversidad, Km 9-6 Libramiento Norte Carretera Irapuato Leon, Irapuato 36821, Gto, Mexico; [Espitia-Rangel, Eduardo] Inst Nacl Invest Forest Agr & Pecuarias, Km 13-5 Carrretera Los Reyes Texcoco, Coatlinchan Texcoco 56250, Estado De Mexic, Mexico; [Alatorre-Cobos, Fulgencio] Colegio Postgrad, Campus Campeche, Champoton 24450, Campeche, Mexico; [Palmeros-Suarez, Paola A.] Inst Tecnol Tlajomulco, Lab Biol Mol, Km 10 Carretera San Miguel Cuyutlan, Tlajomulco De Zuniga 45640, Jalisco, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Colegio de Postgraduados - Mexico	Delano-Frier, JP (corresponding author), IPN, Ctr Invest & Estudios Avanzados, Unidad Irapuato, Km 9-6 Libramiento Norte Carretera Irapuato Leon, Irapuato 36821, Gto, Mexico.	jdelano@ira.cinvestav.mx	Massange, Julio/M-5447-2019; Délano-Frier, John/B-5768-2015; Tiessen, Axel/AAF-2113-2020; Sánchez-Segura, Lino/O-1371-2017; Martínez Gallardo, Norma/B-6181-2015; Tiessen, Axel/D-5959-2011; Sánchez-Segura, Lino/AAM-6635-2021	Massange, Julio/0000-0002-6910-9229; Tiessen, Axel/0000-0001-5572-4274; Sánchez-Segura, Lino/0000-0001-6179-3233; Martínez Gallardo, Norma/0000-0001-5726-091X; Tiessen, Axel/0000-0001-5572-4274; Sánchez-Segura, Lino/0000-0001-6179-3233; Alatorre-Cobos, Fulgencio/0000-0001-8114-6180				Aguilar-Hernandez HS, 2011, J PLANT PHYSIOL, V168, P2102, DOI 10.1016/j.jplph.2011.06.006; Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; Castrillon-Arbelaez PA, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-163; Huerta-Ocampo JA, 2009, INT J PLANT SCI, V170, P990, DOI 10.1086/605119; Ashida Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2511, DOI 10.1271/bbb.66.2511; Atwell BJ, 2015, NEW PHYTOL, V206, P36, DOI 10.1111/nph.13173; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bahieldin A, 2014, FUNCT PLANT BIOL, V41, P87, DOI 10.1071/FP13005; Baluska F, 2003, PLANT PHYSIOL, V133, P482, DOI 10.1104/pp.103.027250; Bao Y, 2014, NEW PHYTOL, V202, P174, DOI 10.1111/nph.12644; Barajas-Lopez JD, 2013, BBA-MOL CELL RES, V1833, P425, DOI 10.1016/j.bbamcr.2012.06.020; Bischoff V, 2010, PLANT PHYSIOL, V153, P590, DOI 10.1104/pp.110.153320; Brenner D, 2009, PLANT BREEDING REV, V19, P227; Casarrubias-Castillo K, 2014, J PLANT PHYSIOL, V171, P927, DOI 10.1016/j.jplph.2014.02.004; Casique-Arroyo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099012; Chen BX, 2013, J SCI FOOD AGR, V93, P1915, DOI 10.1002/jsfa.5990; Clouse JW, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.07.0062; Corrales AR, 2014, J EXP BOT, V65, P995, DOI 10.1093/jxb/ert451; Daszkowska-Golec A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00138; Martinez-Ballesta MD, 2013, INT J MOL SCI, V14, P11607, DOI 10.3390/ijms140611607; DeLaat DM, 2014, MOL BIOL REP, V41, P1427, DOI 10.1007/s11033-013-2987-3; Delano-Frier JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-363; Densiow SA, 2007, PLANT PHYSIOL BIOCH, V45, P152, DOI 10.1016/j.plaphy.2007.01.007; Ding SC, 2015, PLANT CELL, V27, P3228, DOI 10.1105/tpc.15.00321; Dong CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-47; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Eudes A, 2016, PLANT CELL PHYSIOL, V57, P568, DOI 10.1093/pcp/pcw016; Feng RW, 2013, ENVIRON EXP BOT, V87, P58, DOI 10.1016/j.envexpbot.2012.09.002; Ferdous J, 2015, PLANT BIOTECHNOL J, V13, P293, DOI 10.1111/pbi.12318; FISCHER RA, 1965, EXP AGR, V1, P161, DOI 10.1017/S0014479700021402; Garcia-Flores M, 2012, MOL BIOSYST, V8, P1658, DOI 10.1039/c2mb25056j; Gibbs DJ, 2015, PLANT PHYSIOL, V169, P23, DOI 10.1104/pp.15.00338; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Guo KM, 2008, PHYSIOL PLANTARUM, V134, P499, DOI 10.1111/j.1399-3054.2008.01157.x; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076809; Gupta S, 2015, PLANTA, V241, P549, DOI 10.1007/s00425-014-2239-3; Ha CV, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00551; Hamayun M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00377; Hamayun M, 2010, J AGR FOOD CHEM, V58, P7226, DOI 10.1021/jf101221t; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hayat S, 2012, PLANT SIGNAL BEHAV, V7, P1456, DOI 10.4161/psb.21949; He L, 2015, BIOCHIMIE, V110, P17, DOI 10.1016/j.biochi.2014.12.017; HSIAO TC, 1973, ANNU REV PLANT PHYS, V24, P519, DOI 10.1146/annurev.pp.24.060173.002511; Huang W, 2016, BIOTECHNOL LETT, V38, P145, DOI 10.1007/s10529-015-1966-2; Huerta-Ocampo JA, 2011, PLANT BIOLOGY, V13, P472, DOI 10.1111/j.1438-8677.2010.00391.x; Huerta-Ocampo JA, 2014, J PROTEOME RES, V13, P3607, DOI 10.1021/pr500153m; Janz D, 2012, NEW PHYTOL, V194, P129, DOI 10.1111/j.1469-8137.2011.03975.x; Jarzyniak KM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00687; Jiang LX, 2005, PLANT CELL, V17, P584, DOI 10.1105/tpc.104.027631; Jiang YQ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-25; Johnson BL, 2002, AGRON J, V94, P1437, DOI 10.2134/agronj2002.1437; Kalamaki MS, 2009, J EXP BOT, V60, P1859, DOI 10.1093/jxb/erp072; Kang GZ, 2013, MOL GENET GENOMICS, V288, P591, DOI 10.1007/s00438-013-0773-5; Kang GZ, 2013, J PROTEOMICS, V83, P130, DOI 10.1016/j.jprot.2013.03.020; Kaur C, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00682; Kaur C, 2014, BIOCHEM SOC T, V42, P485, DOI 10.1042/BST20130242; Kaur G, 2015, BIOL PLANTARUM, V59, P609, DOI 10.1007/s10535-015-0549-3; Kim JM, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.2015.00114, 10.3389/fpsyg.2015.00248]; Kindgren P, 2011, PHYSIOL PLANTARUM, V141, P310, DOI 10.1111/j.1399-3054.2010.01440.x; Kishor PBK, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00544; Kishor PBK, 2014, PLANT CELL ENVIRON, V37, P300, DOI 10.1111/pce.12157; Komatsu S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00684; Kusvuran S, 2013, SCI WORLD J, DOI 10.1155/2013/253414; Kwasniewski M, 2016, J EXP BOT, V67, P1079, DOI 10.1093/jxb/erv498; Ladwig F, 2015, PLANT CELL, V27, P1718, DOI 10.1105/tpc.15.00306; Lau OS, 2012, DEVELOPMENT, V139, P3683, DOI 10.1242/dev.080523; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; Lea PJ, 2007, ANN APPL BIOL, V150, P1, DOI 10.1111/j.1744-7348.2006.00104.x; Lee Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00080; Lemtiri-Chlieh F, 2000, P NATL ACAD SCI USA, V97, P8687, DOI 10.1073/pnas.140217497; Licausi F, 2013, NEW PHYTOL, V199, P639, DOI 10.1111/nph.12291; Lijavetzky D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-17; Linda Guzman-de-Pena Dora, 2015, Mycology-An International Journal On Fungal Biology, V6, P168, DOI 10.1080/21501203.2015.1112857; Liu JH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00827; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1242-9; Maggio A, 1997, PHYSIOL PLANTARUM, V101, P240, DOI 10.1034/j.1399-3054.1997.1010131.x; Mani S, 2002, PLANT PHYSIOL, V128, P73, DOI 10.1104/pp.010572; Massange-Sanchez JA, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00602; McLoughlin F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00525; Cecchini NM, 2011, PLANT PHYSIOL, V155, P1947, DOI 10.1104/pp.110.167163; MILLER TE, 1984, J ARID ENVIRON, V7, P275; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Mlakar S.G., 2012, J LIFE SCI, V6, P283; Muller M, 2015, PLANT PHYSIOL, V169, P32, DOI 10.1104/pp.15.00677; Naika M, 2013, PLANT CELL PHYSIOL, V54, pE8, DOI 10.1093/pcp/pcs185; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nimmy MS, 2015, INDIAN J GENET PL BR, V75, P478, DOI 10.5958/0975-6906.2015.00076.0; Noguero M, 2013, PLANT SCI, V209, P32, DOI 10.1016/j.plantsci.2013.03.016; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Oh DH, 2015, NEW PHYTOL, V207, P627, DOI 10.1111/nph.13414; Omami EN, 2006, NEW ZEAL J CROP HORT, V34, P11, DOI 10.1080/01140671.2006.9514382; Palmeros-Suarez PA, 2015, PLANT SCI, V240, P25, DOI 10.1016/j.plantsci.2015.08.010; Parakhonskiy B, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0111-7; Rodriguez-Rosales M, 2009, PLANT SIGNAL BEHAV, V4, P265, DOI 10.4161/psb.4.4.7919; Planchet E, 2006, PLANT SIGNAL BEHAV, V1, P46, DOI 10.4161/psb.1.2.2435; Qi SL, 2016, PLANT CELL PHYSIOL, V57, P528, DOI 10.1093/pcp/pcw006; Qin J, 2004, PLANT SCI, V167, P1383, DOI 10.1016/j.plantsci.2004.07.012; Rastogi A, 2013, CRIT REV FOOD SCI, V53, P109, DOI 10.1080/10408398.2010.517876; Remy E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00201; Remy E, 2013, PLANT CELL, V25, P901, DOI 10.1105/tpc.113.110353; Richter R, 2013, PLANT PHYSIOL, V162, P1992, DOI 10.1104/pp.113.219238; Rizzi YS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00572; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Savoure A., 2009, TRENDS PLANT SCI, V15, P1360; Schafer M, 2015, J EXP BOT, V66, P4873, DOI 10.1093/jxb/erv214; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Seo PJ, 2012, BIOCHEM J, V442, P551, DOI 10.1042/BJ20111311; Shao HB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00902; Sharma M, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01218; Shevell DE, 2000, PLANT CELL, V12, P2047, DOI 10.1105/tpc.12.11.2047; SINGHSANGWAN N, 1994, NEW PHYTOL, V128, P173, DOI 10.1111/j.1469-8137.1994.tb04000.x; Song YW, 2014, NEW PHYTOL, V201, P1121, DOI 10.1111/nph.12565; Sorensson C, 2012, BIOCHEM J, V446, P271, DOI 10.1042/BJ20111809; Stael S, 2012, J EXP BOT, V63, P1525, DOI 10.1093/jxb/err394; Tai FJ, 2016, PLANT CELL TISS ORG, V124, P459, DOI 10.1007/s11240-015-0906-0; Tamang BG, 2015, INT J MOL SCI, V16, P30164, DOI 10.3390/ijms161226226; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tenhaken R, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00771; Terce-Laforgue T, 2015, PLANT CELL PHYSIOL, V56, P1918, DOI 10.1093/pcp/pcv114; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P79, DOI 10.4161/psb.2.2.4176; van Dongen JT, 2015, ANNU REV PLANT BIOL, V66, P345, DOI 10.1146/annurev-arplant-043014-114813; Vargas-Ortiz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067879; Venkatesh J, 2015, PLANT PHYSIOL BIOCH, V94, P73, DOI 10.1016/j.plaphy.2015.05.010; Verhertbruggen Y, 2013, PLANT CELL PHYSIOL, V54, P1278, DOI 10.1093/pcp/pct074; Voiniciuc C, 2015, PLANT PHYSIOL, V169, P403, DOI 10.1104/pp.15.00851; Vriet C, 2013, MOL PLANT, V6, P1738, DOI 10.1093/mp/sst096; Wang Y, 2014, J EXP BOT, V65, P4159, DOI 10.1093/jxb/eru190; Wang ZH, 2015, J EXP BOT, V66, P973, DOI 10.1093/jxb/eru456; Wilson PB, 2009, PLANT J, V58, P299, DOI 10.1111/j.1365-313X.2008.03780.x; Wingler A, 2000, PHILOS T R SOC B, V355, P1517, DOI 10.1098/rstb.2000.0712; Wu YR, 2009, CELL RES, V19, P1279, DOI 10.1038/cr.2009.108; Xu ZS, 2008, BOTANY, V86, P969, DOI 10.1139/B08-041; Xu ZS, 2011, J INTEGR PLANT BIOL, V53, P570, DOI 10.1111/j.1744-7909.2011.01062.x; YAMAGUCHISHINOZAKI K, 1993, MOL GEN GENET, V236, P331, DOI 10.1007/BF00277130; Yang Z, 2005, PLANT MOL BIOL, V58, P585, DOI 10.1007/s11103-005-7294-5; Yi X, 2013, NUCLEIC ACIDS RES, V41, pW98, DOI 10.1093/nar/gkt281; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	143	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164280	10.1371/journal.pone.0164280	http://dx.doi.org/10.1371/journal.pone.0164280			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749893	gold, Green Submitted, Green Published			2022-12-26	WOS:000386202300010
J	Tolentino, PLM; Poortinga, A; Kanamaru, H; Keesstra, S; Maroulis, J; David, CPC; Ritsema, CJ				Tolentino, Pamela Louise M.; Poortinga, Ate; Kanamaru, Hideki; Keesstra, Saskia; Maroulis, Jerry; David, Carlos Primo C.; Ritsema, Coen J.			Projected Impact of Climate Change on Hydrological Regimes in the Philippines	PLOS ONE			English	Article							RIVER-BASIN; REQUIREMENTS; EUROPE	The Philippines is one of the most vulnerable countries in the world to the potential impacts of climate change. To fully understand these potential impacts, especially on future hydrological regimes and water resources (2010-2050), 24 river basins located in the major agricultural provinces throughout the Philippines were assessed. Calibrated using existing historical interpolated climate data, the STREAM model was used to assess future river flows derived from three global climate models (BCM2, CNCM3 and MPEH5) under two plausible scenarios (A1B and A2) and then compared with baseline scenarios (20th century). Results predict a general increase in water availability for most parts of the country. For the A1B scenario, CNCM3 and MPEH5 models predict an overall increase in river flows and river flow variability for most basins, with higher flow magnitudes and flow variability, while an increase in peak flow return periods is predicted for the middle and southern parts of the country during the wet season. However, in the north, the prognosis is for an increase in peak flow return periods for both wet and dry seasons. These findings suggest a general increase in water availability for agriculture, however, there is also the increased threat of flooding and enhanced soil erosion throughout the country.	[Tolentino, Pamela Louise M.; David, Carlos Primo C.] Univ Philippines, Natl Inst Geol Sci, Quezon City 1101, Philippines; [Poortinga, Ate; Keesstra, Saskia; Maroulis, Jerry; Ritsema, Coen J.] Univ Wageningen & Res Ctr, Soil Phys & Land Management SLM, POB 47, NL-6700 AA Wageningen, Netherlands; [Poortinga, Ate] Water Insight, Postbus 435, NL-6700 AK Wageningen, Netherlands; [Kanamaru, Hideki] FAO, Climate Energy & Tenure Div, I-00153 Rome, Italy; [Maroulis, Jerry] USQ, ICACS, Toowoomba, Qld 4350, Australia	University of the Philippines System; University of the Philippines Diliman; Wageningen University & Research; Food & Agriculture Organization of the United Nations (FAO); University of Southern Queensland	Tolentino, PLM (corresponding author), Univ Philippines, Natl Inst Geol Sci, Quezon City 1101, Philippines.	plmtolentino@gmail.com	keesstra, saskia/Z-5477-2019; Maroulis, Jerry/H-8799-2019	Maroulis, Jerry/0000-0002-6039-8693; David, CP/0000-0002-2797-9816; Poortinga, Ate/0000-0001-9647-2317; Keesstra, Saskia/0000-0003-4129-9080; Tolentino, Pamela Louise/0000-0002-1803-9734	Japanese Government [GCP/INT/126/JPN]; Water Insights	Japanese Government; Water Insights	The work was part of the Assessments of Climate Change Impacts and Mapping of Vulnerability to Food Insecurity under Climate Change (AMICAF) under the Food and Agricultural Organization (FAO). The overall project was funded by the Japanese Government (project symbol at FAO is GCP/INT/126/JPN). AP received support in the form of salary from Water Insights. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JCJH, 1999, PHYS CHEM EARTH PT B, V24, P591, DOI 10.1016/S1464-1909(99)00049-0; Arnell NW, 1999, GLOBAL ENVIRON CHANG, V9, P5, DOI 10.1016/S0959-3780(98)00015-6; Basconcillo J, 2016, J METEOROL SOC JPN, V94A, P151, DOI 10.2151/jmsj.2015-058; Bouwer L.M., 2006, HYDROL EARTH SYST SC, V3, P1249, DOI DOI 10.5194/HESSD-3-1249-2006; Coronas J., 1920, CLIMATE WEATHER PHIL, V25; Criss RE, 2008, HYDROL PROCESS, V22, P2723, DOI 10.1002/hyp.7072; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Gumbel EJ, 1941, ANN MATH STAT, V12, P163, DOI 10.1214/aoms/1177731747; HARGREAVES GL, 1985, J IRRIG DRAIN ENG, V111, P265, DOI 10.1061/(ASCE)0733-9437(1985)111:3(265); Harmeling S., 2011, GLOBAL CLIMATE RISK, V7th; Hirabayashi Y, 2013, NAT CLIM CHANGE, V3, P816, DOI [10.1038/nclimate1911, 10.1038/NCLIMATE1911]; Hurkmans RTWL, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006168; IPCC, 2014, AV SRES SCEN RUNS AR; Jose AM, 1999, CLIMATE RES, V12, P77, DOI 10.3354/cr012077; KINTANAR RL, 1984, CLIMATE PHILIPPINES; Kummu M, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034006; Manzanas R, 2015, J CLIMATE, V28, P4171, DOI 10.1175/JCLI-D-14-00331.1; PCMDI, 2007, CMIP3 CLIM MOD DOC R; Sturck J, 2014, ECOL INDIC, V38, P198, DOI 10.1016/j.ecolind.2013.11.010; UNFCCC, 2007, CLIM CHANG IMP VULN; Ward PJ, 2008, HYDROL EARTH SYST SC, V12, P159, DOI 10.5194/hess-12-159-2008; Winsemius HC, 2006, HYDROL EARTH SYST SC, V10, P339, DOI 10.5194/hess-10-339-2006; Bui YT, 2014, HYDROL PROCESS, V28, P2961, DOI 10.1002/hyp.9860	23	28	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0163941	10.1371/journal.pone.0163941	http://dx.doi.org/10.1371/journal.pone.0163941			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749908	Green Accepted, Green Published, gold			2022-12-26	WOS:000386202300007
J	Faiao-Flores, F; Alves-Fernandes, DK; Pennacchi, PC; Sandri, S; Vicente, ALSA; Scapulatempo-Neto, C; Vazquez, VL; Reis, RM; Chauhan, J; Goding, CR; Smalley, KS; Maria-Engler, SS				Faiao-Flores, F.; Alves-Fernandes, D. K.; Pennacchi, P. C.; Sandri, S.; Vicente, A. L. S. A.; Scapulatempo-Neto, C.; Vazquez, V. L.; Reis, R. M.; Chauhan, J.; Goding, C. R.; Smalley, K. S.; Maria-Engler, S. S.			Targeting the hedgehog transcription factors GLI1 and GLI2 restores sensitivity to vemurafenib-resistant human melanoma cells	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; BRAF INHIBITOR RESISTANCE; TGF-BETA; MESENCHYMAL TRANSITION; ACQUIRED-RESISTANCE; DRUG-RESISTANCE; MEK INHIBITION; IN-VITRO; PATHWAY; EXPRESSION	BRAF inhibitor (BRAFi) therapy for melanoma patients harboring the V600E mutation is initially highly effective, but almost all patients relapse within a few months. Understanding the molecular mechanisms underpinning BRAFi-based therapy is therefore an important issue. Here we identified a previously unsuspected mechanism of BRAFi resistance driven by elevated Hedgehog (Hh) pathway activation that is observed in a cohort of melanoma patients after vemurafenib treatment. Specifically, we demonstrate that melanoma cell lines, with acquired in vitro-induced vemurafenib resistance, show increased levels of glioma-associated oncogene homolog 1 and 2 (GLI1/GLI2) compared with naive cells. We also observed these findings in clinical melanoma specimens. Moreover, the increased expression of the transcription factors GLI1/GLI2 was independent of canonical Hh signaling and was instead correlated with the noncanonical Hh pathway, involving TGF beta/SMAD (transforming growth factor-beta/Sma- and Mad-related family) signaling. Knockdown of GLI1 and GLI2 restored sensitivity to vemurafenib-resistant cells, an effect associated with both growth arrest and senescence. Treatment of vemurafenib-resistant cells with the GLI1/GLI2 inhibitor Gant61 led to decreased invasion of the melanoma cells in a three-dimensional skin reconstruct model and was associated with a decrease in metalloproteinase (MMP2/MMP9) expression and microphthalmia transcription factor upregulation. Gant61 monotherapy did not alter the drug sensitivity of naive cells, but could reverse the resistance of melanoma cells chronically treated with vemurafenib. We further noted that alternating dosing schedules of Gant61 and vemurafenib prevented the onset of BRAFi resistance, suggesting that this could be a potential therapeutic strategy for the prevention of therapeutic escape. Our results suggest that targeting the Hh pathway in BRAFi-resistant melanoma may represent a viable therapeutic strategy to restore vemurafenib sensitivity, reducing or even inhibiting the acquired chemoresistance in melanoma patients.	[Faiao-Flores, F.; Alves-Fernandes, D. K.; Pennacchi, P. C.; Sandri, S.; Maria-Engler, S. S.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin Chem & Toxicol Anal, 580 Prof Lineu Prestes Ave,Bldg 17,Room 114, BR-05508000 Sao Paulo, Brazil; [Vicente, A. L. S. A.; Scapulatempo-Neto, C.; Vazquez, V. L.; Reis, R. M.] Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, Brazil; [Scapulatempo-Neto, C.] Barretos Canc Hosp, Dept Pathol, Barretos, Brazil; [Vazquez, V. L.] Barretos Canc Hosp, Dept Surg Melanoma Sarcoma, Barretos, Brazil; [Reis, R. M.] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal; [Reis, R. M.] 3Bs PT Govt Associate Lab, Braga, Guimaraes, Portugal; [Chauhan, J.; Goding, C. R.] Univ Oxford, Ludwig Inst Canc Res, Nuffield Dept Clin Med, Oxford, England; [Smalley, K. S.] H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL USA	Universidade de Sao Paulo; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Universidade do Minho; Ludwig Institute for Cancer Research; University of Oxford; H Lee Moffitt Cancer Center & Research Institute	Maria-Engler, SS (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin Chem & Toxicol Anal, 580 Prof Lineu Prestes Ave,Bldg 17,Room 114, BR-05508000 Sao Paulo, Brazil.	silvya@usp.br	Faião-Flores, Fernanda/F-7111-2012; Vazquez, Vinicius L/F-3574-2012; Pennacchi, Paula/L-2220-2015; Engler, Silvya Stuchi Maria/K-5936-2016; Vicente, Anna Luiza SA/E-3660-2017; Maria-Engler, Silvya/ABC-2016-2020; Reis, Rui Manuel/AAD-6470-2020; Alves-Fernandes, Debora Kristina/AAC-5983-2019; Reis, Rui Manuel/B-1744-2018; de lima vazquez, Vinicius/O-7780-2019; Sandri, Silvana/A-1650-2015; Alves-Fernandes, Débora Kristina/AAQ-3385-2020	Faião-Flores, Fernanda/0000-0003-3449-9930; Vazquez, Vinicius L/0000-0002-0325-5514; Pennacchi, Paula/0000-0003-0875-0263; Engler, Silvya Stuchi Maria/0000-0003-4771-6041; Vicente, Anna Luiza SA/0000-0003-3902-7772; Maria-Engler, Silvya/0000-0003-4771-6041; Reis, Rui Manuel/0000-0002-9639-7940; Reis, Rui Manuel/0000-0002-9639-7940; de lima vazquez, Vinicius/0000-0002-0325-5514; Alves-Fernandes, Débora Kristina/0000-0002-0917-9292; Scapulatempo-Neto, Cristovam/0000-0002-8920-6579; Smalley, Keiran/0000-0003-1089-9307; Goding, Colin/0000-0002-1614-3909	Fapesp [2012/04194-1, 2013/05172-4, 2014/24400-0, 2015/10821-7]; CNPq [150447/2013-2, 471512/2013-3]; PRODOC [3193-32/2010]; National Institutes of Health [R01 CA161107, R21 CA198550]; Skin SPORE [P50 CA168536]; NATIONAL CANCER INSTITUTE [P50CA168536, R21CA198550, R01CA161107] Funding Source: NIH RePORTER	Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRODOC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skin SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Walter Turato for help with technical advice and support in colony formation studies and Renata Albuquerque for the FACS analyses. This work was supported by Fapesp-grant number 2012/04194-1, 2013/05172-4, 2014/24400-0 and 2015/10821-7, CNPq-grant number 150447/2013-2 and 471512/2013-3 and PRODOC-grant no 3193-32/2010. Work in the lab of KS Smalley was supported by the National Institutes of Health grants R01 CA161107, R21 CA198550, and Skin SPORE grant P50 CA168536.	Alexaki VI, 2010, JNCI-J NATL CANCER I, V102, P1148, DOI 10.1093/jnci/djq257; Brohem CA, 2012, PIGM CELL MELANOMA R, V25, P354, DOI 10.1111/j.1755-148X.2012.00992.x; Brohem CA, 2011, PIGM CELL MELANOMA R, V24, P35, DOI 10.1111/j.1755-148X.2010.00786.x; Carlino MS, 2014, MOL ONCOL, V8, P544, DOI 10.1016/j.molonc.2014.01.003; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chioni AM, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-8; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; Dugo M, 2015, ONCOTARGET, V6, P5118, DOI 10.18632/oncotarget.3007; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; Faiao-Flores F, 2013, TUMOR BIOL, V34, P1235, DOI 10.1007/s13277-013-0666-6; Fan HX, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0041-5; Fan YH, 2016, ONCOGENE, V35, P116, DOI 10.1038/onc.2015.67; Fedorenko IV, 2015, J INVEST DERMATOL, V135, P3115, DOI 10.1038/jid.2015.329; Fernandez Y, 2006, J BIOL CHEM, V281, P1107, DOI 10.1074/jbc.M511607200; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gary RK, 2005, ANAL BIOCHEM, V343, P329, DOI 10.1016/j.ab.2005.06.003; Girotti MR, 2013, CANCER DISCOV, V3, P158, DOI 10.1158/2159-8290.CD-12-0386; Gonnissen A, 2015, ONCOTARGET, V6, P13899, DOI 10.18632/oncotarget.4224; Green DR, 2013, NAT MED, V19, P131, DOI 10.1038/nm.3076; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Huang LL, 2014, CLIN CANCER RES, V20, P1566, DOI 10.1158/1078-0432.CCR-13-2195; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Ikram MS, 2004, J INVEST DERMATOL, V122, P1503, DOI 10.1111/j.0022-202X.2004.22612.x; Javelaud D, 2008, PIGM CELL MELANOMA R, V21, P123, DOI 10.1111/j.1755-148X.2008.00450.x; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; Javelaud D, 2011, PIGM CELL MELANOMA R, V24, P932, DOI 10.1111/j.1755-148X.2011.00893.x; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Lasfar A, 2010, CARCINOGENESIS, V31, P1710, DOI 10.1093/carcin/bgq155; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lei JJ, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-66; Li X, 2006, ONCOGENE, V25, P609, DOI 10.1038/sj.onc.1209077; Long B, 2016, CELL PHYSIOL BIOCHEM, V38, P1288, DOI 10.1159/000443075; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Long GV, 2016, J CLIN ONCOL, V34, P871, DOI 10.1200/JCO.2015.62.9345; Matise MP, 1999, ONCOGENE, V18, P7852, DOI 10.1038/sj.onc.1203243; Meani RE, 2014, AUSTRALAS J DERMATOL, V55, P218, DOI 10.1111/ajd.12196; Menon Dinoop R, 2013, Pigment Cell Melanoma Res, V26, P912, DOI 10.1111/pcmr.12139; Menzies AM, 2015, CANCER-AM CANCER SOC, V121, P3826, DOI 10.1002/cncr.29586; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Narita S, 2008, CLIN CANCER RES, V14, P5769, DOI 10.1158/1078-0432.CCR-07-4282; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Niehr F, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-76; O'Connell MP, 2013, CANCER DISCOV, V3, P1378, DOI 10.1158/2159-8290.CD-13-0005; Palle K, 2015, CANCERS, V7, P2330, DOI 10.3390/cancers7040894; Pan D, 2012, LEUKEMIA RES, V36, P742, DOI 10.1016/j.leukres.2012.02.012; Paraiso KHT, 2010, BRIT J CANCER, V102, P1724, DOI 10.1038/sj.bjc.6605714; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Penna I, 2016, ONCOTARGET, V7, P3947, DOI 10.18632/oncotarget.6600; Pennacchi PC, 2015, TISSUE ENG PT A, V21, P2417, DOI [10.1089/ten.tea.2015.0009, 10.1089/ten.TEA.2015.0009]; Pierrat MJ, 2012, J BIOL CHEM, V287, P17996, DOI 10.1074/jbc.M112.358341; Queiroz KCS, 2010, ONCOGENE, V29, P6314, DOI 10.1038/onc.2010.375; Ruiz I, 2002, NAT REV CANCER, V2, P361, DOI DOI 10.1038/NRC796; Sabbatino F, 2014, ONCOTARGET, V5, P1926, DOI 10.18632/oncotarget.1878; Sandri S, 2016, PHARMACOL RES, V111, P523, DOI 10.1016/j.phrs.2016.07.017; Sims-Mourtada J, 2007, ONCOGENE, V26, P5674, DOI 10.1038/sj.onc.1210356; Smalley KM, 2007, BRIT J CANCER, V96, P445, DOI 10.1038/sj.bjc.6603596; Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Steg AD, 2012, MOL CANCER THER, V11, P1587, DOI 10.1158/1535-7163.MCT-11-1058; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Tauro M, 2013, BIOORGAN MED CHEM, V21, P6456, DOI 10.1016/j.bmc.2013.08.054; Tirino V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.144; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Villanueva J, 2013, CELL REP, V4, P1090, DOI 10.1016/j.celrep.2013.08.023; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Wickstrom M, 2013, INT J CANCER, V132, P1516, DOI 10.1002/ijc.27820; Xu M, 2015, CANCER LETT, V369, P124, DOI 10.1016/j.canlet.2015.08.005; Yu H, 2009, AM J PATHOL, V174, P2367, DOI 10.2353/ajpath.2009.081057; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhou HM, 2012, IUBMB LIFE, V64, P889, DOI 10.1002/iub.1080; Zhou JC, 2016, CANCER LETT, V370, P313, DOI 10.1016/j.canlet.2015.11.006	84	52	53	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 30	2017	36	13					1849	1861		10.1038/onc.2016.348	http://dx.doi.org/10.1038/onc.2016.348			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EQ5NF	27748762	Green Published, hybrid			2022-12-26	WOS:000398128900010
J	Charpentier, TH; Waldo, GL; Lowery-Gionta, EG; Krajewski, K; Strahl, BD; Kash, TL; Harden, TK; Sondek, J				Charpentier, Thomas H.; Waldo, Gary L.; Lowery-Gionta, Emily G.; Krajewski, Krzysztof; Strahl, Brian D.; Kash, Thomas L.; Harden, T. Kendall; Sondek, John			Potent and Selective Peptide-based Inhibition of the G Protein G(q)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein; inhibitor; p63; peptide interaction; phospholipase C	HETEROTRIMERIC G-PROTEIN; PHOSPHOLIPASE-C-BETA; GUANINE-NUCLEOTIDE EXCHANGE; CHROMOBACTERIUM SP QS3666; REAL-TIME VISUALIZATION; COUPLED RECEPTORS; GAMMA-SUBUNITS; G-ALPHA; ACTIVATION; COMPLEX	In contrast to G protein-coupled receptors, for which chemical and peptidic inhibitors have been extensively explored, few compounds are available that directly modulate heterotrimeric G proteins. Active G(q) binds its two major classes of effectors, the phospholipase C (PLC)- isozymes and Rho guanine nucleotide exchange factors (RhoGEFs) related to Trio, in a strikingly similar fashion: a continuous helix-turn-helix of the effectors engages G(q) within its canonical binding site consisting of a groove formed between switch II and helix 3. This information was exploited to synthesize peptides that bound active G(q)in vitro with affinities similar to full-length effectors and directly competed with effectors for engagement of G(q). A representative peptide was specific for active G(q) because it did not bind inactive G(q) or other classes of active G subunits and did not inhibit the activation of PLC-3 by G(12). In contrast, the peptide robustly prevented activation of PLC-3 or p63RhoGEF by G(q); it also prevented G protein-coupled receptor-promoted neuronal depolarization downstream of G(q) in the mouse prefrontal cortex. Moreover, a genetically encoded form of this peptide flanked by fluorescent proteins inhibited G(q)-dependent activation of PLC-3 at least as effectively as a dominant-negative form of full-length PLC-3. These attributes suggest that related, cell-penetrating peptides should effectively inhibit active G(q) in cells and that these and genetically encoded sequences may find application as molecular probes, drug leads, and biosensors to monitor the spatiotemporal activation of G(q) in cells.	[Charpentier, Thomas H.; Waldo, Gary L.; Lowery-Gionta, Emily G.; Kash, Thomas L.; Harden, T. Kendall; Sondek, John] Univ N Carolina, Sch Med, Dept Pharmacol, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Krajewski, Krzysztof; Strahl, Brian D.; Sondek, John] Univ N Carolina, Sch Med, Dept Biochem & Biophys, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Krajewski, Krzysztof; Strahl, Brian D.] Univ N Carolina, Sch Med, High Throughput Peptide Synth & Array Facil, Chapel Hill, NC 27599 USA; [Charpentier, Thomas H.; Sondek, John] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sondek, J (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA.; Sondek, J (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA.; Sondek, J (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	sondek@med.unc.edu	Kash, Thomas/G-9625-2013; Peptide Synthesis and Array Facility, High-Throughput/AFI-7866-2022; Strahl, Brian D/C-7601-2012	Strahl, Brian D/0000-0002-4947-6259; Krajewski, Krzysztof/0000-0001-7159-617X	National Institutes of Health [R01-GM057391, R01-AA019454, U01-AA020911, AA022549]; Melanoma Research Foundation; American Cancer Society [PF-12-153-01-DMC]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057391, R01GM120291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019454, U01AA020911, F32AA022549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grants R01-GM057391 (to J.S. and T.K.H), R01-AA019454 and U01-AA020911 (to T.L.K.), and AA022549 (to E.G.L.G.) and by a Melanoma Research Foundation grant (to J.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the American Cancer Society (PF-12-153-01-DMC).	Adjobo-Hermans MJW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-32; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Ayoub MA, 2009, J BIOL CHEM, V284, P29136, DOI 10.1074/jbc.M109.042333; Carr DB, 2007, J NEUROPHYSIOL, V97, P3432, DOI 10.1152/jn.00828.2006; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Harden TK, 2011, CHEM REV, V111, P6120, DOI 10.1021/cr200209p; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; JHON DY, 1993, J BIOL CHEM, V268, P6654; Johnston CA, 2005, FEBS LETT, V579, P5746, DOI 10.1016/j.febslet.2005.09.059; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Johnston CA, 2008, COMB CHEM HIGH T SCR, V11, P370, DOI 10.2174/138620708784534798; Johnston CA, 2006, BIOCHEMISTRY-US, V45, P11390, DOI 10.1021/bi0613832; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li C, 2012, BIOL PSYCHIAT, V71, P725, DOI 10.1016/j.biopsych.2011.11.015; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Lyon AM, 2011, NAT STRUCT MOL BIOL, V18, P999, DOI 10.1038/nsmb.2095; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; MIYAMAE A, 1989, J CHEM SOC PERK T 1, P873, DOI 10.1039/p19890000873; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Prevost GP, 2006, CANCER RES, V66, P9227, DOI 10.1158/0008-5472.CAN-05-4205; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Rojas RJ, 2003, COMB CHEM HIGH T SCR, V6, P409; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Schmitz AL, 2014, CHEM BIOL, V21, P890, DOI 10.1016/j.chembiol.2014.06.003; Shankaranarayanan A, 2010, CELL SIGNAL, V22, P1114, DOI 10.1016/j.cellsig.2010.03.006; Smrcka AV, 2013, TRENDS PHARMACOL SCI, V34, P290, DOI 10.1016/j.tips.2013.02.006; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Taniguchi M, 2004, BIOORGAN MED CHEM, V12, P3125, DOI 10.1016/j.bmc.2004.04.006; Taniguchi M, 2003, J ANTIBIOT, V56, P358, DOI 10.7164/antibiotics.56.358; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Webb CK, 2005, J NEUROCHEM, V92, P1408, DOI 10.1111/j.1471-4159.2004.02997.x; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352; Zaima K, 2013, J NAT MED-TOKYO, V67, P196, DOI 10.1007/s11418-012-0644-0	41	15	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25608	25616		10.1074/jbc.M116.740407	http://dx.doi.org/10.1074/jbc.M116.740407			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27742837	Green Published, hybrid			2022-12-26	WOS:000390095300027
J	Zalewski, JK; Mo, JH; Heber, S; Heroux, A; Gardner, RG; Hildebrand, JD; VanDemark, AP				Zalewski, Jenna K.; Mo, Joshua H.; Heber, Simone; Heroux, Annie; Gardner, Richard G.; Hildebrand, Jeffrey D.; VanDemark, Andrew P.			Structure of the Shroom-Rho Kinase Complex Reveals a Binding Interface with Monomeric Shroom That Regulates Cell Morphology and Stimulates Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytoskeleton; Ras homolog gene family; member A (RhoA); serine; threonine protein kinase; structural biology; X-ray crystallography; Rho-kinase; RhoA; Shroom; coiled-coil	SMOOTH-MUSCLE CONTRACTION; NEURAL-TUBE MORPHOGENESIS; APICAL CONSTRICTION; MYOSIN PHOSPHATASE; PROTEIN-KINASE; ROK-ALPHA; ACTIN; PHOSPHORYLATION; ROCK; DOMAIN	Shroom-mediated remodeling of the actomyosin cytoskeleton is a critical driver of cellular shape and tissue morphology that underlies the development of many tissues including the neural tube, eye, intestines, and vasculature. Shroom uses a conserved SD2 domain to direct the subcellular localization of Rho-associated kinase (Rock), which in turn drives changes in the cytoskeleton and cellular morphology through its ability to phosphorylate and activate non-muscle myosin II. Here, we present the structure of the human Shroom-Rock binding module, revealing an unexpected stoichiometry for Shroom in which two Shroom SD2 domains bind independent surfaces on Rock. Mutation of interfacial residues impaired Shroom-Rock binding in vitro and resulted in altered remodeling of the cytoskeleton and loss of Shroom-mediated changes in cellular morphology. Additionally, we provide the first direct evidence that Shroom can function as a Rock activator. These data provide molecular insight into the Shroom-Rock interface and demonstrate that Shroom directly participates in regulating cytoskeletal dynamics, adding to its known role in Rock localization.	[Zalewski, Jenna K.; Mo, Joshua H.; Heber, Simone; Hildebrand, Jeffrey D.; VanDemark, Andrew P.] Univ Pittsburgh, Dept Biol Sci, 4249 Fifth Ave, Pittsburgh, PA 15260 USA; [Heroux, Annie] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Gardner, Richard G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Washington; University of Washington Seattle	VanDemark, AP (corresponding author), Univ Pittsburgh, Dept Biol Sci, 4249 Fifth Ave, Pittsburgh, PA 15260 USA.	andyv@pitt.edu		Heber, Simone/0000-0002-7702-9798; VanDemark, Andrew/0000-0003-3424-4831; Gardner, Richard/0000-0003-2162-6275	Department of Energy, Office of Basic Energy Sciences - National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097204] Funding Source: NIH RePORTER	Department of Energy, Office of Basic Energy Sciences - National Institutes of Health(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Andrea Berman, Dr. Joel Rosenbaum, and Ryan Corbo for helpful discussions and advice and Doowon Lee for technical assistance. Operations at the National Synchrotron Light Source are supported by the Department of Energy, Office of Basic Energy Sciences, and by the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amano M, 2015, J CELL BIOL, V209, P895, DOI 10.1083/jcb.201412008; Araki S, 2001, PFLUG ARCH EUR J PHY, V441, P596, DOI 10.1007/s004240000462; Bolinger C, 2010, DEV DYNAM, V239, P2078, DOI 10.1002/dvdy.22326; Brandt R, 2001, CELL TISSUE RES, V305, P255, DOI 10.1007/s004410000334; Chen XQ, 2002, J BIOL CHEM, V277, P12680, DOI 10.1074/jbc.M109839200; Clarkson E, 2004, J PATHOL, V204, P407, DOI 10.1002/path.1648; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Craft JW, 2013, J MOL GRAPH MODEL, V46, P74, DOI 10.1016/j.jmgm.2013.09.009; Das D, 2014, BIOL OPEN, V3, P850, DOI 10.1242/bio.20147450; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; DENT P, 1992, EUR J BIOCHEM, V210, P1037, DOI 10.1111/j.1432-1033.1992.tb17509.x; Dickson HM, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0171-5; Dietz ML, 2006, J BIOL CHEM, V281, P20542, DOI 10.1074/jbc.M512463200; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; Dye DE, 2009, CELL MOL LIFE SCI, V66, P681, DOI 10.1007/s00018-009-8645-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fairbank PD, 2006, DEVELOPMENT, V133, P4109, DOI 10.1242/dev.02563; Farber MJ, 2011, MOL BIOL CELL, V22, P795, DOI 10.1091/mbc.E10-06-0505; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Grosse AS, 2011, DEVELOPMENT, V138, P4423, DOI 10.1242/dev.065789; Hagens O, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-18; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Ihrke G, 2001, EMBO J, V20, P6256, DOI 10.1093/emboj/20.22.6256; IKEBE M, 1988, J BIOL CHEM, V263, P6432; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leung T, 1996, MOL CELL BIOL, V16, P5313; Malinova D, 2016, J LEUKOCYTE BIOL, V99, P699, DOI 10.1189/jlb.2A0215-050RR; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mohan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081075; Mohan S, 2012, MOL BIOL CELL, V23, P2131, DOI 10.1091/mbc.E11-11-0937; MOUSSAVI RS, 1993, MOL CELL BIOCHEM, V128, P219, DOI 10.1007/BF01076773; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plageman TF, 2011, DEV BIOL, V357, P227, DOI 10.1016/j.ydbio.2011.06.027; Plageman TF, 2010, DEVELOPMENT, V137, P405, DOI 10.1242/dev.045369; Renault MA, 2010, J MOL CELL CARDIOL, V49, P490, DOI 10.1016/j.yjmcc.2010.05.003; Riento K, 2006, METHOD ENZYMOL, V406, P533, DOI 10.1016/S0076-6879(06)06041-1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Sebbagh M, 2005, J EXP MED, V201, P465, DOI 10.1084/jem.20031877; SELLERS JR, 1982, J BIOL CHEM, V257, P3880; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Somlyo AV, 2000, BIOCHEM BIOPH RES CO, V269, P652, DOI 10.1006/bbrc.2000.2343; Spence EF, 2015, J BIOL CHEM, V290, P28613, DOI 10.1074/jbc.R115.655118; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Truebestein L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10029; Tu DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018080; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Yoder M, 2007, CELL MOTIL CYTOSKEL, V64, P49, DOI 10.1002/cm.20167	65	11	11	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25364	25374		10.1074/jbc.M116.738559	http://dx.doi.org/10.1074/jbc.M116.738559			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27758857	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-26	WOS:000390095300008
J	Kim, BK; Yoo, HI; Choi, K; Lee, AR; Yoon, SK				Kim, Bong-Kyu; Yoo, Hye-In; Choi, Keonwoo; Lee, Ah-Reum; Yoon, Sungjoo Kim			Regulation of Srpr Expression by miR-330-5p Controls Proliferation of Mouse Epidermal Keratinocyte	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; HAIR FOLLICLE; CANCER CELLS; RECEPTOR; SKIN; IDENTIFICATION; PHASE; CYCLE	Srpr is a gene encoding a subunit of the signal recognition particle receptor which is involved in the targeting and translocation of nascent secretory and membrane proteins to the endoplasmic reticulum. Previous studies showed aberrant expression of Srpr in several cell types with abnormal growth rate. Although Srpr is expressed in various tissues including skin, the role of Srpr in keratinocytes and regulation of its expression by miRNAs have not been studied. In this study, we investigated the role of SRPR and regulation of its expression by miRNA in skin keratinocytes. We found that SRPR was highly expressed in epidermal keratinocytes and regulated keratinocyte proliferation by affecting cell cycle progression. We also demonstrated that miR-330-5p directly inhibits Srpr expression. These data suggest that miR-330-5p-mediated regulation of the SRPR level is needed for the regulation of proliferation of epidermal keratinocytes.	[Kim, Bong-Kyu; Yoo, Hye-In; Choi, Keonwoo; Lee, Ah-Reum; Yoon, Sungjoo Kim] Catholic Univ Korea, Dept Med Lifesci, Seoul, South Korea	Catholic University of Korea	Yoon, SK (corresponding author), Catholic Univ Korea, Dept Med Lifesci, Seoul, South Korea.	sjkyoon@catholic.ac.kr		Choi, Keonwoo/0000-0002-4670-9635	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A2011821]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2011821).	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; Kim BK, 2015, FEBS J, V282, P4692, DOI 10.1111/febs.13523; Kim BK, 2015, J DERMATOL SCI, V79, P137, DOI 10.1016/j.jdermsci.2015.05.005; Legue E, 2005, DEVELOPMENT, V132, P4143, DOI 10.1242/dev.01975; Li YF, 2013, BIOCHEM BIOPH RES CO, V431, P560, DOI 10.1016/j.bbrc.2013.01.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao YQ, 2013, ONCOL REP, V30, P327, DOI 10.3892/or.2013.2452; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; Marley JJ, 1999, J PERIODONTAL RES, V34, P188, DOI 10.1111/j.1600-0765.1999.tb02241.x; Nagai K, 2003, EMBO J, V22, P3479, DOI 10.1093/emboj/cdg337; OGG SC, 1992, MOL BIOL CELL, V3, P895, DOI 10.1091/mbc.3.8.895; Schwartz T, 2003, CELL, V112, P793, DOI 10.1016/S0092-8674(03)00161-2; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Wang XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136049; Wells J, 2003, ONCOGENE, V22, P1445, DOI 10.1038/sj.onc.1206264; Yu BD, 2008, HUM MOL GENET, V17, pR54, DOI 10.1093/hmg/ddn086	20	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164896	10.1371/journal.pone.0164896	http://dx.doi.org/10.1371/journal.pone.0164896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768721	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400036
J	Meier, K; Drexler, SK; Eberle, FC; Lefort, K; Yazdi, AS				Meier, Katharina; Drexler, Stefan K.; Eberle, Franziska C.; Lefort, Karine; Yazdi, Amir S.			Silencing of ASC in Cutaneous Squamous Cell Carcinoma	PLOS ONE			English	Article							INFLAMMASOME; CANCER; SKIN; RECRUITMENT; METHYLATION; ACTIVATION; SECRETION; APOPTOSIS; DOMAIN; BETA	Apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) is an important adaptor protein for inflammasome activation, mediating the secretion of protumorigenic innate cytokines. However, ASC is also known to trigger apoptosis in tumor cells, acting as a tumor-suppressor gene, which is lost in several human cancers. The aim of this study was to evaluate the clinical significance of ASC in human cutaneous squamous cell carcinoma (SCC). Initially, ASC expression was immunohistochemically evaluated in non-metastic and metastatic SCC. While ASC expression does not correlate with metastatic potential, it correlates with the degree of dedifferentiation. Using methylation specific PCR we were able to demonstrate ASC silencing by promotor specific methylation and impaired inflammasome function in methylated cell lines, linking epigenetic modifications to innate immune activation in keratinocytes. Interestingly, upon ASC restoration by treatment with demethylating agents, we were able to restore AlM2 and NLRP3 activation. In summary, loss of ASC driven tumor development is counterbalanced in the identical cell by the inhibition of pro-tumorigenic inflammation in the tumor cell itself.	[Meier, Katharina; Eberle, Franziska C.; Yazdi, Amir S.] Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Drexler, Stefan K.; Lefort, Karine] Univ Lausanne, Dept Biochem, Epalinges, Switzerland; [Drexler, Stefan K.] Univ Basel, Biozentrum, Basel, Switzerland	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Lausanne; University of Basel	Yazdi, AS (corresponding author), Univ Tubingen, Dept Dermatol, Tubingen, Germany.	Amir.Yazdi@med.uni-tuebingen.de			Deutsche Forschungsgemeinschaft (DFG) [CRC156, CRC685]; Swiss National Fond (SNF); Canton of Basel	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Swiss National Fond (SNF)(Swiss National Science Foundation (SNSF)); Canton of Basel	FCE and ASY are supported by the Deutsche Forschungsgemeinschaft (DFG CRC156 and CRC685). SKD works in the group of Jean Pieters (University of Basel) and is supported by the Swiss National Fond (SNF) and the Canton of Basel.; The authors thank Tabea Maier and Ingrid Kumbier for excellent technical support. FCE and ASY are supported by the Deutsche Forschungsgemeinschaft (DFG CRC156 and CRC685). SKD works in the group of Jean Pieters (University of Basel) and is supported by the Swiss National Fond (SNF) and the Canton of Basel.	Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; Brantsch KD, 2008, LANCET ONCOL, V9, P713, DOI 10.1016/S1470-2045(08)70178-5; Broders AC, 1921, ANN SURG, V73, P141, DOI 10.1097/00000658-192102000-00001; Drexler SK, 2012, P NATL ACAD SCI USA, V109, P18384, DOI 10.1073/pnas.1209171109; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Greene FL, 2002, ANN SURG, V236, P416, DOI 10.1097/00000658-200210000-00003; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Le TT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153975; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Liu XF, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-5; Lodygin D, 2003, ONCOGENE, V22, P5519, DOI 10.1038/sj.onc.1206854; Machida EO, 2006, CANCER RES, V66, P6210, DOI 10.1158/0008-5472.CAN-05-4447; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Shimane T, 2013, OR SURG OR MED OR PA, V115, P799, DOI 10.1016/j.oooo.2013.03.013; Siraj AK, 2011, J CLIN ENDOCR METAB, V96, pE215, DOI 10.1210/jc.2010-0790; Termen S, 2013, J CELL PHYSIOL, V228, P801, DOI 10.1002/jcp.24229; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Yazdi AS, 2010, J CLIN IMMUNOL, V30, P623, DOI 10.1007/s10875-010-9437-y	20	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164742	10.1371/journal.pone.0164742	http://dx.doi.org/10.1371/journal.pone.0164742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768771	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400026
J	Morrone, CD; Thomason, LAM; Brown, ME; Aubert, I; McLaurin, JA				Morrone, Christopher D.; Thomason, Lynsie A. M.; Brown, Mary E.; Aubert, Isabelle; McLaurin, JoAnne			Effects of Neurotrophic Support and Amyloid-Targeted Combined Therapy on Adult Hippocampal Neurogenesis in a Transgenic Model of Alzheimer's Disease	PLOS ONE			English	Article							PATTERN SEPARATION; MOUSE MODEL; SCYLLO-INOSITOL; NEURAL PROGENITORS; IN-VIVO; MICE; NEURONS; CELLS; PATHOLOGY; PROTEIN	Although it is recognized that multi-drug therapies may be necessary to combat AD, there is a paucity of preclinical proof of concept studies. We present a combination treatment paradigm, which temporally affects different aspects of Alzheimer's disease (AD)-like pathology, specifically A beta-toxicity and neurogenesis. At early stages of AD-like pathology, in TgCRND8 mice, we found that combating A beta pathology with scyllo-inositol ameliorated deficits in neurogenesis. Older TgCRND8 mice with established amyloid load had decreased progenitor cell proliferation and survival compared to non-transgenic mice, regardless of scyllo-inositol treatment. The prolonged exposure to A beta-pathology leads to deficits in the neurogenic niche, thus targeting A beta alone is insufficient to rescue neurogenesis. To support the neurogenic niche, we combined scyllo-inositol treatment with leteprinim potassium (neotrofin), the latter of which stimulates neurotrophin expression. We show that the combination treatment of scyllo-inositol and neotrofin enhances neuronal survival and differentiation. We propose this proof of concept combination therapy of targeting A beta-pathology and neurotrophin deficits as a potential treatment for AD.	[Morrone, Christopher D.; Brown, Mary E.; Aubert, Isabelle; McLaurin, JoAnne] Sunnybrook Res Inst, Biol Sci, Toronto, ON M4N 3M5, Canada; [Morrone, Christopher D.; Aubert, Isabelle; McLaurin, JoAnne] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Thomason, Lynsie A. M.] Sunnybrook Res Inst, Phys Sci, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	McLaurin, JA (corresponding author), Sunnybrook Res Inst, Biol Sci, Toronto, ON M4N 3M5, Canada.; McLaurin, JA (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada.	jmclaurin@sri.utoronto.ca	Aubert, Isabelle/AAG-4001-2019	Aubert, Isabelle/0000-0001-5163-9961; Morrone, Christopher/0000-0002-5887-2691	Canadian Institutes of Health Research [37857, 102467]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research - 37857 to JM, and Canadian Institutes of Health Research - 102467 to JM (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018960; Ally BA, 2013, HIPPOCAMPUS, V23, P1246, DOI 10.1002/hipo.22162; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Aytan N, 2013, EXP NEUROL, V250, P228, DOI 10.1016/j.expneurol.2013.10.001; Becker M, 2007, P NATL ACAD SCI USA, V104, P1691, DOI 10.1073/pnas.0610180104; Biscaro B, 2009, J NEUROSCI, V29, P14108, DOI 10.1523/JNEUROSCI.2055-09.2009; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Budni J, 2015, AGING DIS, V6, P331, DOI 10.14336/AD.2015.0825; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Donovan MH, 2008, HIPPOCAMPUS, V18, P435, DOI 10.1002/hipo.20410; Dulak KR, 2002, SOC NEUR 32 ANN M OR, V329, P16; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Fenili D, 2007, J MOL MED, V85, P603, DOI 10.1007/s00109-007-0156-7; Fiore M, 2005, BEHAV BRAIN RES, V157, P351, DOI 10.1016/j.bbr.2004.08.024; Fiorentini A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014382; Francis BM, 2012, NEUROBIOL AGING, V33, P555, DOI 10.1016/j.neurobiolaging.2010.04.003; Frielingsdorf H, 2007, NEUROBIOL DIS, V26, P47, DOI 10.1016/j.nbd.2006.11.015; Glasky A J, 1997, Expert Opin Investig Drugs, V6, P1413, DOI 10.1517/13543784.6.10.1413; GLASKY AJ, 1994, PHARMACOL BIOCHEM BE, V47, P325, DOI 10.1016/0091-3057(94)90017-5; Glasky MS, 2001, SOC NEUR 31 ANN M SA, P137; Hamilton LK, 2013, EUR J NEUROSCI, V37, P1978, DOI 10.1111/ejn.12207; Herring A, 2009, EXP NEUROL, V216, P184, DOI 10.1016/j.expneurol.2008.11.027; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Iulita MF, 2014, TRENDS PHARMACOL SCI, V35, P338, DOI 10.1016/j.tips.2014.04.010; Ji R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115140; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Jin M, 2015, NEUROBIOL DIS, V82, P152, DOI 10.1016/j.nbd.2015.05.020; Kanemoto S, 2014, NEUROSCIENCE, V261, P52, DOI 10.1016/j.neuroscience.2013.12.021; Karkkainen E, 2015, J ALZHEIMERS DIS, V46, P929, DOI 10.3233/JAD-150059; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Krantic S, 2012, J ALZHEIMERS DIS, V29, P293, DOI 10.3233/JAD-2011-110830; Lepousez G, 2015, NEURON, V86, P387, DOI 10.1016/j.neuron.2015.01.002; Lilja AM, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/370432; Longo FM, 2013, NAT REV DRUG DISCOV, V12, P507, DOI 10.1038/nrd4024; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Marlatt Michael W, 2013, Curr Top Behav Neurosci, V15, P313, DOI 10.1007/7854_2012_237; McLaurin J, 2006, NAT MED, V12, P801, DOI 10.1038/nm1423; Meneghini V, 2013, J NEUROSCI, V33, P6047, DOI 10.1523/JNEUROSCI.2052-12.2013; MIDDLEMISS PJ, 1995, NEUROSCI LETT, V199, P131, DOI 10.1016/0304-3940(95)12029-4; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Niibori Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2261; Oomen CA, 2014, WIRES COGN SCI, V5, P573, DOI 10.1002/wcs.1304; Perry EK, 2012, NEUROBIOL DIS, V47, P155, DOI 10.1016/j.nbd.2012.03.033; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rathbone M P, 1999, Expert Opin Investig Drugs, V8, P1255, DOI 10.1517/13543784.8.8.1255; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Salloway S, 2011, NEUROLOGY, V77, P1253, DOI 10.1212/WNL.0b013e3182309fa5; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Terry AV, 2011, PHYSIOL BEHAV, V102, P149, DOI 10.1016/j.physbeh.2010.11.005; Tronel S, 2012, HIPPOCAMPUS, V22, P292, DOI 10.1002/hipo.20895; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wang BP, 2014, J NEUROSCI, V34, P13314, DOI 10.1523/JNEUROSCI.2848-14.2014; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wilson RA, 2001, SOC NEUR 31 ANN M SA, P8943; Winner B, 2011, EUR J NEUROSCI, V33, P1139, DOI 10.1111/j.1460-9568.2011.07613.x; Yetman MJ, 2013, J NEUROSCI, V33, P17335, DOI 10.1523/JNEUROSCI.1917-13.2013	60	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165393	10.1371/journal.pone.0165393	http://dx.doi.org/10.1371/journal.pone.0165393			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768761	Green Submitted, Green Published, gold			2022-12-26	WOS:000386205400082
J	Panula, S; Reda, A; Stukenborg, JB; Ramathal, C; Sukhwani, M; Albalushi, H; Edsgard, D; Nakamura, M; Soder, O; Orwig, KE; Yamanaka, S; Pera, RAR; Hovatta, O				Panula, Sarita; Reda, Ahmed; Stukenborg, Jan-Bernd; Ramathal, Cyril; Sukhwani, Meena; Albalushi, Halima; Edsgard, Daniel; Nakamura, Michiko; Soder, Olle; Orwig, Kyle E.; Yamanaka, Shinya; Pera, Renee A. Reijo; Hovatta, Outi			Over Expression of NANOS3 and DAZL in Human Embryonic Stem Cells	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; MURINE SEMINIFEROUS TUBULES; TRANSLATIONAL REPRESSION; IN-VITRO; DIFFERENTIATION; MOUSE; FATE; PROTEINS; FETAL; DERIVATION	The mechanisms underlying human germ cell development are largely unknown, partly due to the scarcity of primordial germ cells and the inaccessibility of the human germline to genetic analysis. Human embryonic stem cells can differentiate to germ cells in vitro and can be genetically modified to study the genetic requirements for germ cell development. Here, we studied NANOS3 and DAZL, which have critical roles in germ cell development in several species, via their over expression in human embryonic stem cells using global transcriptional analysis, in vitro germ cell differentiation, and in vivo germ cell formation assay by xenotransplantation. We found that NANOS3 over expression prolonged pluripotency and delayed differentiation. In addition, we observed a possible connection of NANOS3 with inhibition of apoptosis. For DAZL, our results suggest a post-transcriptional regulation mechanism in hES cells. In addition, we found that DAZL suppressed the translation of OCT4, and affected the transcription of several genes associated with germ cells, cell cycle arrest, and cell migration. Furthermore, DAZL over expressed cells formed spermatogonia-like colonies in a rare instance upon xenotransplantation. These data can be used to further elucidate the role of NANOS3 and DAZL in germ cell development both in vitro and in vivo.	[Panula, Sarita; Hovatta, Outi] Karolinska Inst, Div Obstet & Gynecol, Dept Clin Sci Intervent & Technol, SE-14186 Huddinge, Sweden; [Panula, Sarita; Hovatta, Outi] Karolinska Univ Hosp, SE-14186 Huddinge, Sweden; [Reda, Ahmed; Stukenborg, Jan-Bernd; Albalushi, Halima; Soder, Olle] Karolinska Inst, Dept Womens & Childrens Hlth, Pediat Endocrinol Unit, SE-17176 Stockholm, Sweden; [Reda, Ahmed; Stukenborg, Jan-Bernd; Albalushi, Halima; Soder, Olle] Karolinska Univ Hosp, SE-17176 Stockholm, Sweden; [Ramathal, Cyril; Pera, Renee A. Reijo] Stanford Univ, Dept Genet, Inst Stem Cell Biol & Regenerat Med, Ctr Reprod & Stem Cell Biol, Stanford, CA 94305 USA; [Ramathal, Cyril; Pera, Renee A. Reijo] Stanford Univ, Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Ctr Reprod & Stem Cell Biol, Stanford, CA 94305 USA; [Sukhwani, Meena; Orwig, Kyle E.] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Dept Obstet Gynaecol & Reprod Sci, Pittsburgh, PA 15213 USA; [Albalushi, Halima] Sultan Qaboos Univ, Coll Med & Hlth Sci, Muscat, Oman; [Edsgard, Daniel] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Nakamura, Michiko; Yamanaka, Shinya] Kyoto Univ, Ctr IPS Cell Res & Applicat, Kyoto 6068507, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Pera, Renee A. Reijo] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA; [Pera, Renee A. Reijo] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Stanford University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Sultan Qaboos University; Karolinska Institutet; Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Hovatta, O (corresponding author), Karolinska Inst, Div Obstet & Gynecol, Dept Clin Sci Intervent & Technol, SE-14186 Huddinge, Sweden.; Hovatta, O (corresponding author), Karolinska Univ Hosp, SE-14186 Huddinge, Sweden.	outi.hovatta@ki.se		Reda, Ahmed/0000-0001-7053-7979; Reijo Pera, Renee/0000-0002-6487-1329; Stukenborg, Jan-bernd/0000-0002-2839-1870	Swedish Research Council; Stockholm County Council Research Funds (ALF); NIH NICHD [P50HD068158]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD068158, U54HD068158] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council Research Funds (ALF); NIH NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants to O.H. from the Swedish Research Council and Stockholm County Council Research Funds (ALF), and to R.R.P from the NIH NICHD P50HD068158.	Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Anholt RRH, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00006; Bhandari D, 2014, GENE DEV, V28, P888, DOI 10.1101/gad.237289.113; Buytaert-Hoefen KA, 2004, STEM CELLS, V22, P669, DOI 10.1634/stemcells.22-5-669; Cauffman G, 2005, MOL HUM REPROD, V11, P405, DOI 10.1093/molehr/gah167; Chauvin TR, 2004, BIOL REPROD, V70, P744, DOI 10.1095/biolreprod.103.022731; Chen HH, 2014, STEM CELL REP, V3, P892, DOI 10.1016/j.stemcr.2014.09.003; Dominguez AA, 2014, SCI REP-UK, V4, DOI 10.1038/srep06432; Dovey SL, 2013, J CLIN INVEST, V123, P1833, DOI 10.1172/JCI65822; Dubovsky JA, 2013, BLOOD, V122, P3308, DOI 10.1182/blood-2013-05-504597; Durruthy JD, 2014, HUM MOL GENET, V23, P3071, DOI 10.1093/hmg/ddu012; Easley CA, 2012, CELL REP, V2, P440, DOI 10.1016/j.celrep.2012.07.015; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Gill ME, 2011, P NATL ACAD SCI USA, V108, P7443, DOI 10.1073/pnas.1104501108; Gkountela S, 2013, NAT CELL BIOL, V15, P113, DOI 10.1038/ncb2638; Guo F, 2015, CELL, V161, P1437, DOI 10.1016/j.cell.2015.05.015; Hauge H, 2009, CELL SIGNAL, V21, P1866, DOI 10.1016/j.cellsig.2009.08.001; Hayashi T, 2001, J ANDROL, V22, P999; Hayashi Y, 2004, P NATL ACAD SCI USA, V101, P10338, DOI 10.1073/pnas.0401647101; He ZP, 2007, BIOL REPROD, V77, P723, DOI 10.1095/biolreprod.107.062513; Hermann BP, 2007, STEM CELLS, V25, P2330, DOI 10.1634/stemcells.2007-0143; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Julaton VTA, 2011, HUM MOL GENET, V20, P2238, DOI 10.1093/hmg/ddr114; Kato Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11272; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Lesch BJ, 2012, NAT REV GENET, V13, P781, DOI 10.1038/nrg3294; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Medrano JV, 2012, STEM CELLS, V30, P441, DOI 10.1002/stem.1012; Nagano M, 2002, FERTIL STERIL, V78, P1225, DOI 10.1016/S0015-0282(02)04345-5; Ohki R, 2000, J BIOL CHEM, V275, P22627, DOI 10.1074/jbc.C000235200; Panula S, 2011, HUM MOL GENET, V20, P752, DOI 10.1093/hmg/ddq520; Park SJ, 2010, BMB REP, V43, P795, DOI 10.5483/BMBRep.2010.43.12.795; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Ramathal C, 2014, CELL REP, V7, P1284, DOI 10.1016/j.celrep.2014.03.067; Rao DS, 2001, MOL CELL BIOL, V21, P7796, DOI 10.1128/MCB.21.22.7796-7806.2001; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; Ross A, 2007, SEX DEV, V1, P127, DOI 10.1159/000100034; Sasaki K, 2015, CELL STEM CELL, V17, P178, DOI 10.1016/j.stem.2015.06.014; Sizemore GM, 2014, J BIOL CHEM, V289, P24102, DOI 10.1074/jbc.M114.593582; Smorag L, 2014, WIRES RNA, V5, P527, DOI 10.1002/wrna.1228; Strom S, 2010, IN VITRO CELL DEV-AN, V46, P337, DOI 10.1007/s11626-010-9308-0; Sudo M, 2014, SHORT HAIRPIN RNA LI; Suzuki A, 2007, DEVELOPMENT, V134, P77, DOI 10.1242/dev.02697; Suzuki A, 2010, P NATL ACAD SCI USA, V107, P3594, DOI 10.1073/pnas.0908664107; Suzuki H, 2008, DEV BIOL, V318, P133, DOI 10.1016/j.ydbio.2008.03.020; Taimen P, 2000, EXP CELL RES, V256, P140, DOI 10.1006/excr.2000.4799; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Xu XJ, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-193; Xu XB, 2013, BBA-GENE REGUL MECH, V1829, P425, DOI 10.1016/j.bbagrm.2012.12.010; Yamaji M, 2010, REPRODUCTION, V139, P381, DOI 10.1530/REP-09-0373; Zohni K, 2012, HUM REPROD, V27, P44, DOI 10.1093/humrep/der357	56	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165268	10.1371/journal.pone.0165268	http://dx.doi.org/10.1371/journal.pone.0165268			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768780	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400075
J	Yamashita, T; Yamamoto, S; Zhang, J; Kometani, M; Tomiyama, D; Kohno, K; Tozaki-Saitoh, H; Inoue, K; Tsuda, M				Yamashita, Tomohiro; Yamamoto, Shota; Zhang, Jiaming; Kometani, Miho; Tomiyama, Daisuke; Kohno, Keita; Tozaki-Saitoh, Hidetoshi; Inoue, Kazuhide; Tsuda, Makoto			Duloxetine Inhibits Microglial P2X4 Receptor Function and Alleviates Neuropathic Pain after Peripheral Nerve Injury	PLOS ONE			English	Article							SPINAL MICROGLIA; P2X(4) RECEPTORS; TRANSCRIPTION FACTOR; DIABETIC-NEUROPATHY; TACTILE ALLODYNIA; UP-REGULATION; RAT-BRAIN; MODEL; ACTIVATION; SEROTONIN	P2X4 receptors (P2X4R) are a family of ATP-gated non-selective cation channels. We previously demonstrated that activation of P2X4R in spinal microglia is crucial for neuropathic pain, a highly debilitating chronic pain condition, suggesting that P2X4R is a potential therapeutic target for treating neuropathic pain. Thus, the identification of a compound that has a potent inhibitory effect on P2X4R is an important clinical challenge. In the present study, we screened a chemical library of clinically approved drugs and show for the first time that duloxetine, a serotonin and noradrenaline reuptake inhibitor, has an inhibitory effect on rodent and human P2X4R. In primary cultured microglial cells, duloxetine also inhibited P2X4R-, but not P2X7R-, mediated responses. Moreover, intrathecal administration of duloxetine in a model of neuropathic pain produced a reversal of nerve injury-induced mechanical allodynia, a cardinal symptom of neuropathic pain. In rats that were pretreated with a serotonin-depleting agent and a noradrenaline neurotoxin, the antiallodynic effect of duloxetine was reduced, but still remained. Based on these results, we suggest that, in addition to duloxetine's primary inhibitory action on serotonin and noradrenaline transporters, an inhibitory effect on P2X4R may be involved at least in part in an antiallodynic effect of intrathecal duloxetine in a model of neuropathic pain.	[Yamashita, Tomohiro; Zhang, Jiaming; Kometani, Miho; Tomiyama, Daisuke; Tozaki-Saitoh, Hidetoshi; Inoue, Kazuhide; Tsuda, Makoto] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, Fukuoka 8128582, Japan; [Yamamoto, Shota; Kohno, Keita; Tozaki-Saitoh, Hidetoshi; Tsuda, Makoto] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Life Innovat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan	Kyushu University; Kyushu University	Inoue, K; Tsuda, M (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, Fukuoka 8128582, Japan.; Tsuda, M (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Life Innovat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	inoue@phar.kyushu-u.ac.jp; tsuda@phar.kyushu-u.ac.jp	Tsuda, Makoto/AAE-7256-2020	, hidetoshi/0000-0003-0423-2143	Eli Lilly Japan; Japan Agency for Medical Research and Development (AMED); AMED	Eli Lilly Japan(Eli Lilly); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); AMED	This work was supported by a research grant from Eli Lilly Japan (M.T.), Platform for Drug Discovery, Informatics, and Structural Life Science from Japan Agency for Medical Research and Development (AMED) (K.I.), the Research Project on Elucidation of Chronic Pain from AMED (M.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold LM, 2004, ARTHRITIS RHEUM, V50, P2974, DOI 10.1002/art.20485; Beggs S, 2012, NAT NEUROSCI, V15, P1068, DOI 10.1038/nn.3155; Bennett RM, 2009, NAT REV RHEUMATOL, V5, P188, DOI 10.1038/nrrheum.2009.48; Biber K, 2011, EMBO J, V30, P1864, DOI 10.1038/emboj.2011.89; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Dao-Ung P, 2015, PURINERG SIGNAL, V11, P481, DOI 10.1007/s11302-015-9467-2; Goldstein DJ, 2005, PAIN, V116, P109, DOI 10.1016/j.pain.2005.03.029; Guan ZH, 2016, NAT NEUROSCI, V19, P94, DOI 10.1038/nn.4189; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; He WJ, 2012, BEHAV BRAIN RES, V226, P163, DOI 10.1016/j.bbr.2011.09.015; Honore P, 2006, J PHARMACOL EXP THER, V319, P1376, DOI 10.1124/jpet.106.111559; Hoshino H, 2015, NEUROSCI LETT, V602, P62, DOI 10.1016/j.neulet.2015.06.041; Iyengar S, 2004, J PHARMACOL EXP THER, V311, P576, DOI 10.1124/jpet.104.070656; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kinoshita J, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-59; Kiso T, 2008, NEUROSCIENCE, V153, P492, DOI 10.1016/j.neuroscience.2008.02.031; Kobayashi K, 2008, J NEUROSCI, V28, P2892, DOI 10.1523/JNEUROSCI.5589-07.2008; Kobayashi K, 2011, NEUROSCI LETT, V504, P57, DOI 10.1016/j.neulet.2011.08.058; KOE BK, 1966, J PHARMACOL EXP THER, V154, P499; Kornum BR, 2006, NEUROSCI LETT, V392, P129, DOI 10.1016/j.neulet.2005.09.013; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kuhad A, 2009, INDIAN J EXP BIOL, V47, P193; Le Cudennec C, 2014, EUR J PHARMACOL, V735, P17, DOI 10.1016/j.ejphar.2014.04.003; Masuda T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4771; Masuda T, 2012, CELL REP, V1, P334, DOI 10.1016/j.celrep.2012.02.014; Matsushita K, 2014, ANESTHESIOLOGY, V120, P1491, DOI 10.1097/ALN.0000000000000190; Mico JA, 2006, TRENDS PHARMACOL SCI, V27, P348, DOI 10.1016/j.tips.2006.05.004; Mixcoatl-Zecuatl T, 2011, BRIT J PHARMACOL, V164, P159, DOI 10.1111/j.1476-5381.2011.01334.x; Nagakura Y, 2009, PAIN, V146, P26, DOI 10.1016/j.pain.2009.05.024; Nagata K, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-20; NAKAJIMA K, 1992, J NEUROCHEM, V58, P1401, DOI 10.1111/j.1471-4159.1992.tb11356.x; Nightingale S, 2012, NAT REV DRUG DISCOV, V11, P101, DOI 10.1038/nrd3624; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Perahia DGS, 2006, INT CLIN PSYCHOPHARM, V21, P311, DOI 10.1097/01.yic.0000224782.83287.3c; ROSS SB, 1976, BRIT J PHARMACOL, V58, P521, DOI 10.1111/j.1476-5381.1976.tb08619.x; Sim JA, 2010, BRIT J PHARMACOL, V160, P88, DOI 10.1111/j.1476-5381.2010.00683.x; Skljarevski V, 2011, CURR DRUG THER, V6, P296, DOI 10.2174/157488511798109592; Smith T, 2007, VASC HEALTH RISK MAN, V3, P833; STAMFORD JA, 1995, BRIT J ANAESTH, V75, P217, DOI 10.1093/bja/75.2.217; Sun YH, 2014, NEUROSCI LETT, V568, P6, DOI 10.1016/j.neulet.2014.03.046; Toulme E, 2010, J GEN PHYSIOL, V135, P333, DOI 10.1085/jgp.200910336; Toyomitsu E, 2012, PURINERG SIGNAL; Tozaki-Saitoh H, 2008, J NEUROSCI, V28, P4949, DOI 10.1523/JNEUROSCI.0323-08.2008; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00191; Tsuda M, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-28; Tsuda M, 2009, P NATL ACAD SCI USA, V106, P8032, DOI 10.1073/pnas.0810420106; UGEDO L, 1989, PSYCHOPHARMACOLOGY, V98, P45, DOI 10.1007/BF00442004; Ulmann L, 2008, J NEUROSCI, V28, P11263, DOI 10.1523/JNEUROSCI.2308-08.2008; Wang ZY, 2015, PAIN MED, V16, P1373, DOI 10.1111/pme.12800; Williamson OD, 2014, PAIN PRACT, V14, pE33, DOI 10.1111/papr.12119; Xu J, 2016, ANESTH ANALG, V122, P882, DOI 10.1213/ANE.0000000000001097	56	45	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165189	10.1371/journal.pone.0165189	http://dx.doi.org/10.1371/journal.pone.0165189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768754	Green Published, Green Submitted, gold			2022-12-26	WOS:000386205400062
J	Zhu, RS; Zhang, ZG; Li, Y; Hu, ZB; Xin, DW; Qi, ZM; Chen, QS				Zhu, Rongsheng; Zhang, Zhanguo; Li, Yang; Hu, Zhenbang; Xin, Dawei; Qi, Zhaoming; Chen, Qingshan			Discovering Numerical Differences between Animal and Plant microRNAs	PLOS ONE			English	Article							REPRESSES CELL-PROLIFERATION; INDUCED APOPTOSIS; BANTAM MICRORNA; DIFFERENTIATION; EXPRESSION; IDENTITY; ENCODES; PROTEIN; MIR156; PHASE	Previous studies have confirmed that there are many differences between animal and plant microRNAs (miRNAs), and that numerical features based on sequence and structure can be used to predict the function of individual miRNAs. However, there is little research regarding numerical differences between animal and plant miRNAs, and whether a single numerical feature or combination of features could be used to distinguish animal and plant miRNAs or not. Therefore, in current study we aimed to discover numerical features that could be used to accomplish this. We performed a large-scale analysis of 132 miRNA numerical features, and identified 17 highly significant distinguishing features. However, none of the features independently could clearly differentiate animal and plant miRNAs. By further analysis, we found a four-feature subset that included helix number, stack number, length of pre-miRNA, and minimum free energy, and developed a logistic classifier that could distinguish animal and plant miRNAs effectively. The precision of the classifier was greater than 80%. Using this tool, we confirmed that there were universal differences between animal and plant miRNAs, and that a single feature was unable to adequately distinguish the difference. This feature set and classifier represent a valuable tool for identifying differences between animal and plant miRNAs at a molecular level.	[Zhu, Rongsheng; Zhang, Zhanguo; Li, Yang] Northeast Agr Univ, Coll Sci, Harbin, Peoples R China; [Hu, Zhenbang; Xin, Dawei; Qi, Zhaoming; Chen, Qingshan] Northeast Agr Univ, Coll Agron, Harbin, Peoples R China	Northeast Agricultural University - China; Northeast Agricultural University - China	Zhu, RS; Zhang, ZG (corresponding author), Northeast Agr Univ, Coll Sci, Harbin, Peoples R China.; Chen, QS (corresponding author), Northeast Agr Univ, Coll Agron, Harbin, Peoples R China.	roshzhu@gmail.com; zhanguo7909@126.com; qshchen@126.com	Zhang, Zhanguo/AAZ-6366-2020		Heilongjiang Postdoctoral Foundation [LBH-Z12045]	Heilongjiang Postdoctoral Foundation	The research was funded by Heilongjiang Postdoctoral Foundation (LBH-Z12045). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Afanasyeva EA, 2011, CELL DEATH DIFFER, V18, P974, DOI 10.1038/cdd.2010.164; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-221; Bentwich I, 2005, FASEB J, V19, P875, DOI 10.1096/fj.04-3609hyp; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bukhari SIA, 2012, CELL RES, V22, P1034, DOI 10.1038/cr.2012.31; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Candela H, 2008, PLANT CELL, V20, P2073, DOI 10.1105/tpc.108.059709; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Cho SH, 2012, PLANT CELL, V24, P4837, DOI 10.1105/tpc.112.103176; Freyhult E, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-241; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Jaklevic B, 2008, DEV BIOL, V320, P122, DOI 10.1016/j.ydbio.2008.04.043; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Jung JH, 2012, J BIOL CHEM, V287, P16007, DOI 10.1074/jbc.M111.337485; Jung JH, 2011, PLANT MOL BIOL, V76, P35, DOI 10.1007/s11103-011-9759-z; Lee KH, 2009, EXP CELL RES, V315, P2529, DOI 10.1016/j.yexcr.2009.06.001; Li SX, 2012, J EXP BOT, V63, P2787, DOI 10.1093/jxb/err465; Liu LF, 2014, APOPTOSIS, V19, P19, DOI 10.1007/s10495-013-0899-2; Liu XS, 2013, J BIOL CHEM, V288, P12478, DOI 10.1074/jbc.M112.449025; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Millar Anthony A., 2005, Functional & Integrative Genomics, V5, P129, DOI 10.1007/s10142-005-0145-2; Onnis A, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.29; Pearl J., 1984, INTELLIGENT SEARCH S; Piper ME, 2011, SUBST USE MISUSE, V46, P492, DOI 10.3109/10826081003682222; Schietgat L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-2; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Staskiewicz G, 2013, EUR J RADIOL, V82, P1236, DOI 10.1016/j.ejrad.2013.02.004; STEPHENS MA, 1970, J ROY STAT SOC B, V32, P115; Tang GL, 2012, METHODS, V58, P118, DOI 10.1016/j.ymeth.2012.10.006; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Wheeler G, 2007, DNA CELL BIOL, V26, P251, DOI 10.1089/dna.2006.0538; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yang L, 2011, DEVELOPMENT, V138, P245, DOI 10.1242/dev.058578; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang HB, 2010, DEV BIOL, V344, P603, DOI 10.1016/j.ydbio.2010.05.018; Zhu RS, 2011, BIOCHEM BIOPH RES CO, V415, P313, DOI 10.1016/j.bbrc.2011.10.051; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165152	10.1371/journal.pone.0165152	http://dx.doi.org/10.1371/journal.pone.0165152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768749	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400057
J	Cope, AB; Ramirez, C; DeVellis, RF; Agans, R; Schoenbach, VJ; Adimora, AA				Cope, Anna B.; Ramirez, Catalina; DeVellis, Robert F.; Agans, Robert; Schoenbach, Victor J.; Adimora, Adaora A.			Measuring Concurrency Attitudes: Development and Validation of a Vignette-Based Scale	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; UNITED-STATES; PARTNER CONCURRENCY; PSYCHOMETRIC EVALUATION; RACIAL DISPARITIES; AFRICAN-AMERICANS; SOCIAL-CONTEXT; HIV; BEHAVIOR; MEN	Background Concurrent sexual partnerships (partnerships that overlap in time) may contribute to higher rates of HIV transmission in African Americans. Attitudes toward a behavior constitute an important component of most models of health-related behavior and behavioral change. We have developed a scale, employing realistic vignettes that appear to reliably measure attitudes about concurrency in young African American adults. Methods Vignette-based items to assess attitudes about concurrency were developed following focus groups and cognitive testing of items adapted from existing scales assessing psychosocial constructs surrounding related sexual behaviors. The new items were included in a telephone survey of African American adults (18-34 years old) in Eastern North Carolina immediately before and after a radio campaign designed to discourage concurrency. We performed an exploratory factor analysis on each sample (pre- and post-campaign) to cross-validate results. We retained factors with a primary loading of >= 0.50 and no secondary loading >0.30. Cronbach's coefficient alpha was used to evaluate internal reliability. Associations in the predicted direction between the mean responses to items on the final factor and known correlates of concurrency validated the scale. Results Factor analysis in a random pre-campaign subsample yielded a one-factor 6-item scale with acceptable internal consistency (Cronbach's alpha = 0.79). As expected, the attitude factor was positively associated with participation in concurrent partnerships, whether assessed by self-report (r = 0.298, p<0.0001) or deduced from dates of recent sexual partnerships (r = 0.298, p<0.0001). The factor was also positively associated with alcohol (r = 0.216, p<0.0001) and drug use (r = 0.225, p<0.0001) and negatively associated with increasing age (r = -0.088, p- = 0.02) and female gender (r = -0.232, p<0.0001). Factor analyses repeated in the second random pre-campaign subsample and post-campaign sample confirmed these results. Conclusion A vignette-based scale may be an effective measure of key attitudes related to concurrency and potentially a useful tool to evaluate interventions addressing this network pattern.	[Cope, Anna B.; Ramirez, Catalina; Adimora, Adaora A.] Univ North Carolina Chapel Hill, Sch Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [DeVellis, Robert F.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC USA; [Agans, Robert] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC USA; [Schoenbach, Victor J.; Adimora, Adaora A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cope, AB (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Div Infect Dis, Chapel Hill, NC 27599 USA.	acbarry@unc.edu		Cope, Anna/0000-0001-7599-196X	National Institute on Minority Health and Health Disparities (NIMHD), National Institute of Health (NIH) [NIH1R01MD004065]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Health (NIH) [1K24HD059358]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD059358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD004065] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities (NIMHD), National Institute of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported by grants from the National Institute on Minority Health and Health Disparities (NIMHD, http://www.nimhd.nih.gov/), National Institute of Health (NIH; grant no. NIH1R01MD004065; Adimora, Adaora, PI) and The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD, https://www.nichd.nih.gov/Pages/index.aspx), National Institutes of Health (NIH; grant no. 1K24HD059358; Adimora, Adaora, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Drs. Joan Cates, Jane Brown, and Wizdom Powell, and the Carolina Survey Research Laboratory. We thank Andre Brown, Thierry Fortune, and Diane Francis for assisting with the analysis of the focus group interviews and review of questionnaire items. We also thank the members of the Community Advisory Board for their insight and support in developing the final survey. Finally, we thank all interviewers and respondents in the pilot, pre-, and post-campaign surveys. This research was supported by grants from the National Institute on Minority Health and Health Disparities (NIMHD), National Institute of Health (NIH; grant no. NIH1R01MD004065; Adimora, Adaora, PI) and The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH; grant no. 1K24HD059358; Adimora, Adaora, PI).	Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; Adimora AA, 2004, ANN EPIDEMIOL, V14, P155, DOI 10.1016/S1047-2797(03)00129-7; Adimora AA, 2002, EPIDEMIOLOGY, V13, P320, DOI 10.1097/00001648-200205000-00013; Adimora AA, 2002, EPIDEMIOLOGY, V13, P707, DOI 10.1097/00001648-200211000-00016; Adimora AA, 2007, AM J PUBLIC HEALTH, V97, P2230, DOI 10.2105/AJPH.2006.099069; Adimora AA, 2006, SEX TRANSM DIS, V33, pS39, DOI 10.1097/01.olq.0000228298.07826.68; Adimora AA, 2013, ANN EPIDEMIOL, V23, P716, DOI 10.1016/j.annepidem.2013.08.002; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1980, UNDERSTANDING ATTITU; Basen-Engquist K, 1999, HEALTH EDUC RES, V14, P25, DOI 10.1093/her/14.1.25; Bradbury-Jones C, 2014, INT J SOC RES METHOD, V17, P427, DOI 10.1080/13645579.2012.750833; Brafford L J, 1991, J Am Coll Health, V39, P219; Carey MP, 2013, AIDS BEHAV, V17, P779, DOI 10.1007/s10461-012-0346-3; Cates JR, 2015, J HEALTH COMMUN, P1; Centers for Disease Control and Prevention, 2014, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, 2014, HIV SURV REP; Cohen Leonard A, 2005, J Dent Educ, V69, P896; DeVellis R. F., 2012, SCALE DEV THEORY APP; Fishbein M, 2003, COMMUN THEOR, V13, P164, DOI 10.1111/j.1468-2885.2003.tb00287.x; Fishbein M, 1980, Nebr Symp Motiv, V27, P65; Fishbein M, 2000, AIDS CARE, V12, P273, DOI 10.1080/09540120050042918; Fishbein M, 2006, J COMMUN, V56, pS1, DOI 10.1111/j.1460-2466.2006.00280.x; Gorbach PM, 2005, SEX TRANSM DIS, V32, P7, DOI 10.1097/01.olq.0000148302.81575.fc; KELLY JA, 1987, AM J PUBLIC HEALTH, V77, P789, DOI 10.2105/AJPH.77.7.789; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Kish L, 1965, SURVEY SAMPLING; KRAUS SJ, 1995, PERS SOC PSYCHOL B, V21, P58, DOI 10.1177/0146167295211007; Li L, 2007, INT J EPIDEMIOL, V36, P178, DOI 10.1093/ije/dyl256; Lilleston PS, 2015, AIDS BEHAV, V19, P2280, DOI 10.1007/s10461-015-1105-z; Manhart LE, 2002, SEX TRANSM DIS, V29, P133, DOI 10.1097/00007435-200203000-00003; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; MORRIS M, 1995, SOC NETWORKS, V17, P299, DOI 10.1016/0378-8733(95)00268-S; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Pulerwitz J, 2008, MEN MASC, V10, P322, DOI 10.1177/1097184X06298778; Saucier G., 1996, 5 FACTOR MODEL PERSO; Schoenberg NE, 2000, INT J SOCIAL RES MET, V3; Senn TE, 2011, ARCH SEX BEHAV, V40, P775, DOI 10.1007/s10508-010-9688-y; Simone SJ, 2001, BEHAV SCI LAW, V19, P423, DOI 10.1002/bsl.450; Smith A, 2014, APPL SPAT ANAL POLIC, P1; St Lawrence JS, 1999, ASSESSMENT, V6, P391, DOI 10.1177/107319119900600409; Thomas JC, 1999, SOC SCI MED, V49, P1075, DOI 10.1016/S0277-9536(99)00197-5; UNAIDS Consultation on Concurrent Sexual Partnerships, 2015, REC M UNAIDS REF GRO; WATTS CH, 1992, MATH BIOSCI, V108, P89, DOI 10.1016/0025-5564(92)90006-I; Whitehead TL, 1997, MED ANTHROPOL Q, V11, P411, DOI 10.1525/maq.1997.11.4.411; Wingood GM, 2000, HEALTH EDUC BEHAV, V27, P539, DOI 10.1177/109019810002700502; Yu CH, 2005, ENCY SOCIAL MEASUREM	46	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0163947	10.1371/journal.pone.0163947	http://dx.doi.org/10.1371/journal.pone.0163947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9NZ	27764104	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204500011
J	Jimenez-Garcia, AM; Ruiz-Leyva, L; Cendan, CM; Torres, C; Papini, MR; Moron, I				Jimenez-Garcia, Ana Maria; Ruiz-Leyva, Leandro; Cendan, Cruz Miguel; Torres, Carmen; Papini, Mauricio R.; Moron, Ignacio			Hypoalgesia Induced by Reward Devaluation in Rats	PLOS ONE			English	Article							SUCCESSIVE NEGATIVE CONTRAST; OPIOID RECEPTOR AGONIST; PAIN; CHLORDIAZEPOXIDE; MORPHINE; CORTICOSTERONE; NOCICEPTION; RESPONSES; RECOVERY; STIMULI	Reduced sensitivity to physical pain (hypoalgesia) has been reported after events involving reward devaluation. Reward devaluation was implemented in a consummatory successive negative contrast (cSNC) task. Food-deprived Wistar rats had access to 32% sucrose during 16 sessions followed by access to 4% sucrose during 3 additional sessions. An unshifted control group had access to 4% sucrose throughout the 19 sessions. Pain sensitivity was measured using von Frey filaments (Experiment 1) and Hargreaves thermal stimuli (Experiment 2) in pretraining baseline, 5 min, and 300 min after either the first (session 17) or second (session 18) devaluation session in the cSNC situation. Sucrose consumption was lower in downshifted groups relative to unshifted groups during postshift sessions-the cSNC effect. Hypoalgesia was observed in downshifted groups relative to unshifted controls when pain sensitivity was assessed 5 min after either the first or second devaluation session, regardless of the pain sensitivity test used. Both pain sensitivity tests yielded evidence of hypoalgesia 300 min after the second downshift session, but not 300 min after the first devaluation session. Whereas hypoalgesia was previously shown only after the second devaluation session, here we report evidence of hypoalgesia after both the first and second devaluation sessions using mechanical and thermal nociceptive stimuli. Moreover, the hypoalgesia observed 300 min after the second devaluation session in both experiments provides unique evidence of the effects of reward loss on sensitivity to physical pain 5 hours after the loss episode. The underlying neurobehavioral mechanisms remain to be identified.	[Jimenez-Garcia, Ana Maria; Ruiz-Leyva, Leandro; Cendan, Cruz Miguel] Univ Granada, Fac Med, Biomed Res Ctr CIBM, Dept Pharmacol, Campus Ciencias Salud, Granada 18016, Spain; [Jimenez-Garcia, Ana Maria; Ruiz-Leyva, Leandro; Cendan, Cruz Miguel] Univ Granada, Fac Med, Inst Neurosci, Campus Ciencias Salud, Granada 18016, Spain; [Torres, Carmen] Univ Jaen, Dept Psychol, Campus Las Lagunillas, Jaen 23071, Spain; [Papini, Mauricio R.] Texas Christian Univ, Dept Psychol, Ft Worth, TX 76129 USA; [Moron, Ignacio] Univ Granada, Fac Psychol, Dept Psychobiol, Campus Cartuja, E-18071 Granada, Spain; [Moron, Ignacio] Univ Granada, Fac Psychol, Res Ctr Mind Brain & Behav CIMCYC, Campus Cartuja, E-18071 Granada, Spain	University of Granada; University of Granada; Universidad de Jaen; Texas Christian University; University of Granada; University of Granada	Moron, I (corresponding author), Univ Granada, Fac Psychol, Dept Psychobiol, Campus Cartuja, E-18071 Granada, Spain.; Moron, I (corresponding author), Univ Granada, Fac Psychol, Res Ctr Mind Brain & Behav CIMCYC, Campus Cartuja, E-18071 Granada, Spain.	imoron@ugr.es	Leyva, Leandro Ruiz/AAM-4220-2021; Morón Henche, Ignacio/K-9724-2017; Jimenez-Garcia, Ana M./AFR-9202-2022; Torres, Carmen/K-8250-2014; Jiménez-García, Ana/AAW-6689-2020; Martínez, Cruz Miguel Cendán/ABH-1404-2020	Leyva, Leandro Ruiz/0000-0001-8865-4903; Morón Henche, Ignacio/0000-0002-1387-5602; Jimenez-Garcia, Ana M./0000-0001-6400-3436; Torres, Carmen/0000-0001-8573-0990; Martínez, Cruz Miguel Cendán/0000-0001-5431-4513	Ministry of Economy and Competitiveness, Spain [PSI-2013-44945-P]; PhD Programme in Biomedicine and the Master's program in Neuroscience and Pain, University of Granada, Spain; Fulbright US Scholar Award; Master's program in Neuroscience and Pain and PhD Programme in Biomedicine, University of Granada, Spain	Ministry of Economy and Competitiveness, Spain; PhD Programme in Biomedicine and the Master's program in Neuroscience and Pain, University of Granada, Spain; Fulbright US Scholar Award; Master's program in Neuroscience and Pain and PhD Programme in Biomedicine, University of Granada, Spain	This paper was partially supported by grant PSI-2013-44945-P from the Ministry of Economy and Competitiveness, Spain; the PhD Programme in Biomedicine and the Master's program in Neuroscience and Pain, University of Granada, Spain. MRP's participation was supported by a Fulbright US Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper was partially supported by grant PSI-2013-44945-P from the Ministry of Economy and Competitiveness, Spain, Master's program in Neuroscience and Pain and PhD Programme in Biomedicine, University of Granada, Spain. MRP's participation was supported by a Fulbright US Scholar Award. Animals were maintained according to the EU Directive 2010/63/EU for animal experiments. We thank the CTS430 group, especially M. A. Zafra, for their help. Address correspondence to I. Moron (imoron@ugr.es).	Aghajani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047218; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Wolkers CPB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071175; Bentosela M, 2006, BEHAV NEUROSCI, V120, P371, DOI 10.1037/0735-7044.120.2.371; Bradman MJG, 2015, J NEUROSCI METH, V255, P92, DOI 10.1016/j.jneumeth.2015.08.010; CARSTENS E, 1993, J NEUROPHYSIOL, V70, P621, DOI 10.1152/jn.1993.70.2.621; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; COX J, 1994, Q J EXP PSYCHOL-B, V47, P187; Cuenya L, 2015, LEARN MOTIV, V52, P22, DOI 10.1016/j.lmot.2015.08.003; Daniel AM, 2008, LEARN MOTIV, V39, P146, DOI 10.1016/j.lmot.2007.11.001; DUDLEY RT, 1995, LEARN MOTIV, V26, P63, DOI 10.1016/0023-9690(95)90011-X; Flaherty C.F., 1996, INCENTIVE RELATIVITY; FLAHERTY CF, 1986, ANIM LEARN BEHAV, V14, P315, DOI 10.3758/BF03200073; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Justel N, 2014, LEARN BEHAV, V42, P58, DOI 10.3758/s13420-013-0124-8; Le Bars D, 2001, PHARMACOL REV, V53, P597; Manzo L, 2015, BEHAV BRAIN RES, V278, P90, DOI 10.1016/j.bbr.2014.09.017; Mehrabyan A, 2011, SOMATOSENS MOT RES, V28, P31, DOI 10.3109/08990220.2011.602764; Mitchell C, 1998, PHYSIOL BEHAV, V64, P287, DOI 10.1016/S0031-9384(98)00072-9; Mogil JS, 2001, METHODS PAIN RES; Mulder GB, 2004, CONTEMP TOP LAB ANIM, V43, P54; Mustaca AE, 2005, INT J COMP PSYCHOL, V18, P255; Nirogi R, 2012, J PHARMACOL TOX MET, V66, P8, DOI 10.1016/j.vascn.2012.04.006; Ortega L. A., 2014, INT J COMP PSYCHOL, V27, P160; Ortega LA, 2014, PHARMACOL BIOCHEM BE, V116, P96, DOI 10.1016/j.pbb.2013.11.031; Ortega LA, 2011, BEHAV NEUROSCI, V125, P988, DOI 10.1037/a0025769; Ortega LA, 2011, LEARN MOTIV, V42, P203, DOI 10.1016/j.lmot.2011.03.003; Papini MR, 2015, NEUROSCI BIOBEHAV R, V48, P53, DOI 10.1016/j.neubiorev.2014.11.012; Papini S, 2014, BEHAV BRAIN RES, V275, P212, DOI 10.1016/j.bbr.2014.09.006; Pecoraro N, 2009, PHYSIOL BEHAV, V96, P651, DOI 10.1016/j.physbeh.2008.12.018; Pellegrini S, 2005, BEHAV BRAIN RES, V164, P239, DOI 10.1016/j.bbr.2005.06.035; ROWAN GA, 1987, PSYCHOPHARMACOLOGY, V93, P51, DOI 10.1007/BF02439586; Stout SC, 2003, LEARN MOTIV, V34, P437, DOI 10.1016/S0023-9690(03)00038-9; Torres C., 2014, INT J COMP PSYCHOL, V27, P446; Wegert S, 1997, PAIN, V71, P57, DOI 10.1016/S0304-3959(97)03337-X; Wiech K, 2009, NEUROIMAGE, V47, P987, DOI 10.1016/j.neuroimage.2009.05.059; Wood M, 2005, BEHAV NEUROSCI, V119, P446, DOI 10.1037/0735-7044.119.2.446; Wood MD, 2008, BEHAV BRAIN RES, V193, P28, DOI 10.1016/j.bbr.2008.04.016; Xie JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047577	39	10	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164331	10.1371/journal.pone.0164331	http://dx.doi.org/10.1371/journal.pone.0164331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764142	gold, Green Published			2022-12-26	WOS:000386204500027
J	Montague, SA; Baker, BS				Montague, Shelby A.; Baker, Bruce S.			Memory Elicited by Courtship Conditioning Requires Mushroom Body Neuronal Subsets Similar to Those Utilized in Appetitive Memory	PLOS ONE			English	Article							LONG-TERM-MEMORY; DROSOPHILA-MELANOGASTER; TRANSGENE EXPRESSION; OLFACTORY MEMORIES; NEURAL CIRCUITRY; OUTPUT NEURONS; BEHAVIOR; PROTEIN; CONSOLIDATION; OCTOPAMINE	An animal's ability to learn and to form memories is essential for its survival. The fruit fly has proven to be a valuable model system for studies of learning and memory. One learned behavior in fruit flies is courtship conditioning. In Drosophila courtship conditioning, male flies learn not to court females during training with an unreceptive female. He retains a memory of this training and for several hours decreases courtship when subsequently paired with any female. Courtship conditioning is a unique learning paradigm; it uses a positive-valence stimulus, a female fly, to teach a male to decrease an innate behavior, courtship of the female. As such, courtship conditioning is not clearly categorized as either appetitive or aversive conditioning. The mushroom body (MB) region in the fruit fly brain is important for several types of memory; however, the precise subsets of intrinsic and extrinsic MB neurons necessary for courtship conditioning are unknown. Here, we disrupted synaptic signaling by driving a shibire(ts) effector in precise subsets of MB neurons, defined by a collection of split-GAL4 drivers. Out of 75 lines tested, 32 showed defects in courtship conditioning memory. Surprisingly, we did not have any hits in the. lobe Kenyon cells, a region previously implicated in courtship conditioning memory. We did find that several. lobe extrinsic neurons were necessary for courtship conditioning memory. Overall, our memory hits in the dopaminergic neurons (DANs) and the mushroom body output neurons were more consistent with results from appetitive memory assays than aversive memory assays. For example, protocerebral anterior medial DANs were necessary for courtship memory, similar to appetitive memory, while protocerebral posterior lateral 1 (PPL1) DANs, important for aversive memory, were not needed. Overall, our results indicate that the MB circuits necessary for courtship conditioning memory coincide with circuits necessary for appetitive memory.	[Montague, Shelby A.; Baker, Bruce S.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Baker, BS (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	bakerb@janelia.hhmi.org						Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04580; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Bouzaiane E, 2015, CELL REP, V11, P1280, DOI 10.1016/j.celrep.2015.04.044; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Cervantes-Sandoval I, 2013, J NEUROSCI, V33, P9846, DOI 10.1523/JNEUROSCI.0451-13.2013; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; deBelle JS, 1996, P NATL ACAD SCI USA, V93, P9875, DOI 10.1073/pnas.93.18.9875; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Guven-Ozkan T, 2014, LEARN MEMORY, V21, P519, DOI 10.1101/lm.034363.114; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Huetteroth W, 2015, CURR BIOL, V25, P751, DOI 10.1016/j.cub.2015.01.036; Ichinose T, 2015, ELIFE, V4, DOI 10.7554/eLife.10719; Ishimoto H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003843; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Joiner MA, 2000, LEARN MEMORY, V7, P32, DOI 10.1101/lm.7.1.32; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kirkhart C, 2015, J NEUROSCI, V35, P5950, DOI 10.1523/JNEUROSCI.3930-14.2015; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Kruttner S, 2015, CELL REP, V11, P1953, DOI 10.1016/j.celrep.2015.05.037; Kruttner S, 2012, NEURON, V76, P383, DOI 10.1016/j.neuron.2012.08.028; Liu C, 2012, NATURE, P1; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Masek P, 2015, CURR BIOL, V25, P1535, DOI 10.1016/j.cub.2015.04.027; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; Mehren JE, 2004, CURR OPIN NEUROBIOL, V14, P745, DOI 10.1016/j.conb.2004.10.012; Meissner GW, 2011, GENETICS, V189, P195, DOI 10.1534/genetics.111.129940; Owald D, 2015, NEURON, V86, P417, DOI 10.1016/j.neuron.2015.03.025; Pai TP, 2013, P NATL ACAD SCI USA, V110, P7898, DOI 10.1073/pnas.1216336110; Perisse E, 2013, NEURON, V79, P945, DOI 10.1016/j.neuron.2013.07.045; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; Placais PY, 2012, NAT NEUROSCI, V15, P592, DOI 10.1038/nn.3055; Qin H, 2012, CURR BIOL, V22, P1; Redt-Clouet C, 2012, EUR J NEUROSCI, P1; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Sitnik N A, 2003, Neurosci Behav Physiol, V33, P67, DOI 10.1023/A:1021131415653; Siwicki KK, 2005, LEARN MEMORY, V12, P10; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Vogt K, 2014, ELIFE, V3, DOI 10.7554/eLife.02395; Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008; Yamagata N, 2015, P NATL ACAD SCI USA, V112, P578, DOI 10.1073/pnas.1421930112; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025; Zhou C, 2012, J NEUROSCI, V32, P14281, DOI 10.1523/JNEUROSCI.0517-12.2012	57	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164516	10.1371/journal.pone.0164516	http://dx.doi.org/10.1371/journal.pone.0164516			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764141	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204500039
J	Silva, SR; Diaz, YCA; Penha, HA; Pinheiro, DG; Fernandes, CC; Miranda, VFO; Michael, TP; Varani, AM				Silva, Saura R.; Diaz, Yani C. A.; Penha, Helen Alves; Pinheiro, Daniel G.; Fernandes, Camila C.; Miranda, Vitor F. O.; Michael, Todd P.; Varani, Alessandro M.			The Chloroplast Genome of Utricularia reniformis Sheds Light on the Evolution of the ndh Gene Complex of Terrestrial Carnivorous Plants from the Lentibulariaceae Family	PLOS ONE			English	Article							SEQUENCE; EXPRESSION; MODEL; RNA; ARCHITECTURE; DEGRADATION; INFERENCE; ALIGNMENT; MARKERS; SITES	Lentibulariaceae is the richest family of carnivorous plants spanning three genera including Pinguicula, Genlisea, and Utricularia. Utricularia is globally distributed, and, unlike Pinguicula and Genlisea, has both aquatic and terrestrial forms. In this study we present the analysis of the chloroplast (cp) genome of the terrestrial Utricularia reniformis. U. reniformis has a standard cp genome of 139,725bp, encoding a gene repertoire similar to essentially all photosynthetic organisms. However, an exclusive combination of losses and pseudogenization of the plastid NAD(P)H-dehydrogenase (ndh) gene complex were observed. Comparisons among aquatic and terrestrial forms of Pinguicula, Genlisea, and Utricularia indicate that, whereas the aquatic forms retained functional copies of the eleven ndh genes, these have been lost or truncated in terrestrial forms, suggesting that the ndh function may be dispensable in terrestrial Lentibulariaceae. Phylogenetic scenarios of the ndh gene loss and recovery among Pinguicula, Genlisea, and Utricularia to the ancestral Lentibulariaceae cladeare proposed. Interestingly, RNAseq analysis evidenced that U. reniformis cp genes are transcribed, including the truncated ndh genes, suggesting that these are not completely inactivated. In addition, potential novel RNA-editing sites were identified in at least six U. reniformis cp genes, while none were identified in the truncated ndh genes. Moreover, phylogenomic analyses support that Lentibulariaceae is monophyletic, belonging to the higher core Lamiales Glade, corroborating the hypothesis that the first Utricularia lineage emerged in terrestrial habitats and then evolved to epiphytic and aquatic forms. Furthermore, several truncated cp genes were found interspersed with U. reniformis mitochondria) and nuclear genome scaffolds, indicating that as observed in other smaller plant genomes, such as Arabidopsis thaliana, and the related and carnivorous Genlisea nigrocaulis and G. hispidula, the endosymbiotic gene transfer may also shape the U. reniformis genome in a similar fashion. Overall the comparative analysis of the U. reniformis cp genome provides new insight into the ndh genes and cp genome evolution of carnivorous plants from Lentibulariaceae family.	[Silva, Saura R.] UNESP Univ Estadual Paulista, Inst Biociencias, Campus Botucatu, Sao Paulo, Brazil; [Diaz, Yani C. A.; Miranda, Vitor F. O.] UNESP Univ Estadual Paulista, Dept Biol Aplicada Agr, Fac Ciencias Agr & Vet, Campus Jaboticabal, Sao Paulo, Brazil; [Penha, Helen Alves; Pinheiro, Daniel G.; Fernandes, Camila C.; Varani, Alessandro M.] UNESP Univ Estadual Paulista, Dept Tecnol, Fac Ciencias Agr & Vet, Campus Jaboticabal, Sao Paulo, Brazil; [Michael, Todd P.] Ibis Biosci, Computat Genom, Carlsbad, CA USA	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Miranda, VFO (corresponding author), UNESP Univ Estadual Paulista, Dept Biol Aplicada Agr, Fac Ciencias Agr & Vet, Campus Jaboticabal, Sao Paulo, Brazil.; Varani, AM (corresponding author), UNESP Univ Estadual Paulista, Dept Tecnol, Fac Ciencias Agr & Vet, Campus Jaboticabal, Sao Paulo, Brazil.	vmiranda@fcav.unesp.br; amvarani@fcav.unesp.br	Miranda, Vitor Fernandes Oliveira/AAG-2437-2020; Penha, Helen/R-2585-2016; Miranda, Vitor F. O./B-2800-2011; Varani, Alessandro M/F-6887-2011; Silva, Saura/I-1953-2015; Varani, Alessandro/Q-1637-2016; Guariz Pinheiro, Daniel/H-4604-2012	Miranda, Vitor Fernandes Oliveira/0000-0003-0574-9865; Penha, Helen/0000-0002-7156-444X; Miranda, Vitor F. O./0000-0003-0574-9865; Varani, Alessandro M/0000-0002-8876-3269; Silva, Saura/0000-0002-6333-5268; Varani, Alessandro/0000-0002-8876-3269; Guariz Pinheiro, Daniel/0000-0001-7062-5936; Aranguren-Diaz, Yani/0000-0001-6475-2787	Sao Paulo Research Foundation/Brazil, FAPESP [13/25164-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil, CNPq [309040/2014-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Brazil, CAPES	Sao Paulo Research Foundation/Brazil, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Brazil, CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by Sao Paulo Research Foundation/Brazil, FAPESP [grant number 13/25164-6]. VFOM was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil, CNPq [grant number #309040/2014-0]. SRS and YCAD were recipients of a PhD fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Brazil, CAPES.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barbrook AC, 2010, PHILOS T R SOC B, V365, P785, DOI 10.1098/rstb.2009.0250; Bock R, 2008, BIOESSAYS, V30, P556, DOI 10.1002/bies.20761; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Braukmann TWA, 2009, CURR GENET, V55, P323, DOI 10.1007/s00294-009-0249-7; Brown JR, 2003, NAT REV GENET, V4, P121, DOI 10.1038/nrg1000; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carretero-Paulet L, 2015, MOL BIOL EVOL, V32, P1284, DOI 10.1093/molbev/msv020; Carretero-Paulet L, 2015, GENOME BIOL EVOL, V7, P444, DOI 10.1093/gbe/evu288; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; CBOL PLANT WO, 2009, PNAS, V106, P12794, DOI DOI 10.1073/PNAS.0905845106; Clivati D, 2014, PLANT BIOLOGY, V16, P677, DOI 10.1111/plb.12091; Clivati D, 2012, AM J BOT, V99, pE375, DOI 10.3732/ajb.1200080; Curci PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120589; Do HDK, 2013, GENE, V530, P229, DOI 10.1016/j.gene.2013.07.100; Fleischmann A, 2014, ANN BOT-LONDON, V114, P1651, DOI 10.1093/aob/mcu189; Greilhuber J, 2006, PLANT BIOLOGY, V8, P770, DOI 10.1055/s-2006-924101; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ibarra-Laclette E, 2013, NATURE, V498, P94, DOI 10.1038/nature12132; Ibarra-Laclette E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-101; Jobson RW, 2003, SYST BOT, V28, P157; Juniper B, 1989, CARNIVIROROUS PLANTS; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kelly LJ, 2015, NEW PHYTOL, V208, P596, DOI 10.1111/nph.13471; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142215; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Li R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078568; Lin CP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129396; Lisitsky I, 1996, P NATL ACAD SCI USA, V93, P13398, DOI 10.1073/pnas.93.23.13398; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Martin M, 2010, PLANT PHYSIOL BIOCH, V48, P636, DOI 10.1016/j.plaphy.2010.04.009; Martin W, 2003, P NATL ACAD SCI USA, V100, P8612, DOI 10.1073/pnas.1633606100; Michael TP, 2014, BRIEF FUNCT GENOMICS, V13, P308, DOI 10.1093/bfgp/elu005; Miranda VFO, 2013, LENTIBULARIACEAE LIV, P614; Mower JP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-96; Muller KF, 2006, PLANT BIOLOGY, V8, P748, DOI 10.1055/s-2006-924706; Mulder Nicola, 2007, V396, P59; Muller K, 2004, PLANT BIOLOGY, V6, P477, DOI 10.1055/s-2004-817909; Nazareno AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129930; Neyland R, 1996, PLANTA, V200, P273, DOI 10.1007/BF00208318; Pellicer J, 2010, BOT J LINN SOC, V164, P10, DOI 10.1111/j.1095-8339.2010.01072.x; Peredo EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068591; Plachno BJ, 2017, PROTOPLASMA, V254, P353, DOI 10.1007/s00709-016-0956-0; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Raynal-Roques A, 2005, ACTA BOT GALLICA, V152, P177, DOI 10.1080/12538078.2005.10515468; Refulio-Rodriguez NF, 2014, AM J BOT, V101, P287, DOI 10.3732/ajb.1300394; Reifenrath K, 2006, FLORA, V201, P597, DOI 10.1016/j.flora.2005.12.004; Ruhlman TA, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0484-7; Schaferhoff B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-352; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schuster G, 1999, PLANT PHYSIOL, V120, P937, DOI 10.1104/pp.120.4.937; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Taylor P, 1989, GENUS UTRICULARIA TA; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Vu GTH, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2015.04.0021; Wade JT, 2014, NAT REV MICROBIOL, V12, P647, DOI 10.1038/nrmicro3316; Wicke S, 2013, PLANT CELL, V25, P3711, DOI 10.1105/tpc.113.113373; Wicke S, 2014, MOL BIOL EVOL, V31, P529, DOI 10.1093/molbev/mst261; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yao XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129347; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Yu YS, 2003, SCIENCE, V300, P1566, DOI 10.1126/science.1083523; Zeng WH, 2007, PLANT CELL PHYSIOL, V48, P362, DOI 10.1093/pcp/pcl058; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531; [No title captured], DOI DOI 10.1111/j.1096-0031.2008.00229.x	76	28	29	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165176	10.1371/journal.pone.0165176	http://dx.doi.org/10.1371/journal.pone.0165176			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764252	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500127
J	Sippel, S; Lange, H; Mahecha, MD; Hauhs, M; Bodesheim, P; Kaminski, T; Gans, F; Rosso, OA				Sippel, Sebastian; Lange, Holger; Mahecha, Miguel D.; Hauhs, Michael; Bodesheim, Paul; Kaminski, Thomas; Gans, Fabian; Rosso, Osvaldo A.			Diagnosing the Dynamics of Observed and Simulated Ecosystem Gross Primary Productivity with Time Causal Information Theory Quantifiers	PLOS ONE			English	Article							STATISTICAL COMPLEXITY; TERRESTRIAL BIOSPHERE; BENCHMARKING SYSTEM; PERMUTATION ENTROPY; CLIMATE; RESPIRATION; MODELS; SERIES; ASSIMILATION; VARIABILITY	Data analysis and model-data comparisons in the environmental sciences require diagnostic measures that quantify time series dynamics and structure, and are robust to noise in observational data. This paper investigates the temporal dynamics of environmental time series using measures quantifying their information content and complexity. The measures are used to classify natural processes on one hand, and to compare models with observations on the other. The present analysis focuses on the global carbon cycle as an area of research in which model-data integration and comparisons are key to improving our understanding of natural phenomena. We investigate the dynamics of observed and simulated time series of Gross Primary Productivity (GPP), a key variable in terrestrial ecosystems that quantifies ecosystem carbon uptake. However, the dynamics, patterns and magnitudes of GPP time series, both observed and simulated, vary substantially on different temporal and spatial scales. We demonstrate here that information content and complexity, or Information Theory Quantifiers (ITQ) for short, serve as robust and efficient data-analytical and model benchmarking tools for evaluating the temporal structure and dynamical properties of simulated or observed time series at various spatial scales. At continental scale, we compare GPP time series simulated with two models and an observations-based product. This analysis reveals qualitative differences between model evaluation based on ITQ compared to traditional model performance metrics, indicating that good model performance in terms of absolute or relative error does not imply that the dynamics of the observations is captured well. Furthermore, we show, using an ensemble of site-scale measurements obtained from the FLUXNET archive in the Mediterranean, that model-data or model-model mismatches as indicated by ITQ can be attributed to and interpreted as differences in the temporal structure of the respective ecological time series. At global scale, our understanding of C fluxes relies on the use of consistently applied land models. Here, we use ITQ to evaluate model structure: The measures are largely insensitive to climatic scenarios, land use and atmospheric gas concentrations used to drive them, but clearly separate the structure of 13 different land models taken from the CMIP5 archive and an observations-based product. In conclusion, diagnostic measures of this kind provide data-analytical tools that distinguish different types of natural processes based solely on their dynamics, and are thus highly suitable for environmental science applications such as model structural diagnostics.	[Sippel, Sebastian; Mahecha, Miguel D.; Bodesheim, Paul; Gans, Fabian] Max Planck Inst Biogeochem, Jena, Germany; [Lange, Holger] Norwegian Inst Bioecon Res, As, Norway; [Lange, Holger; Rosso, Osvaldo A.] Univ Fed Alagoas, Inst Fis, Maceio, Alagoas, Brazil; [Mahecha, Miguel D.] German Ctr Integrat Biodivers Res IDiv, Leipzig, Germany; [Mahecha, Miguel D.] Michael Stifel Ctr Jena Data Driven & Simulat Sci, Jena, Germany; [Hauhs, Michael] Univ Bayreuth, Bayreuth, Germany; [Kaminski, Thomas] Invers Lab, Hamburg, Germany; [Rosso, Osvaldo A.] Inst Tecnol Buenos Aires ITBA, Buenos Aires, DF, Argentina; [Rosso, Osvaldo A.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Rosso, Osvaldo A.] Univ los Andes, Fac Ingn & Ciencias Aplicadas, Complex Syst Grp, Santiago, Chile	Max Planck Society; Norwegian Institute of Bioeconomy Research; Universidade Federal de Alagoas; University of Bayreuth; University of Hamburg; University Medical Center Hamburg-Eppendorf; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de los Andes - Chile	Sippel, S (corresponding author), Max Planck Inst Biogeochem, Jena, Germany.	ssippel@bgc-jena.mpg.de	Rosso, Osvaldo/O-4929-2019; Lange, Holger/A-2458-2012; Mahecha, Miguel D/F-2443-2010; Bodesheim, Paul/AAX-3821-2021	Rosso, Osvaldo/0000-0002-1288-2528; Lange, Holger/0000-0001-7099-8740; Mahecha, Miguel D/0000-0003-3031-613X; Bodesheim, Paul/0000-0002-3564-6528; Sippel, Sebastian/0000-0002-4510-4458	German National Academic Foundation; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [310003/2016-4]; European Space Agency; STSE project CAB-LAB ("Coupled Atmosphere Biosphere virtual LABoratory"); European Commission; BACI project ("Detecting changes in essential ecosystem and biodiversity properties - towards a Biosphere Atmosphere Change Index") [640176]; CarboEuropeIP; FAO-GTOS-TCO; iLEAPS; Max Planck Institute for Biogeochemistry; National Science Foundation; University of Tuscia; Universite Laval; Environment Canada; US Department of Energy	German National Academic Foundation; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Space Agency(European Space AgencyEuropean Commission); STSE project CAB-LAB ("Coupled Atmosphere Biosphere virtual LABoratory"); European Commission(European CommissionEuropean Commission Joint Research Centre); BACI project ("Detecting changes in essential ecosystem and biodiversity properties - towards a Biosphere Atmosphere Change Index"); CarboEuropeIP(European Commission); FAO-GTOS-TCO; iLEAPS; Max Planck Institute for Biogeochemistry; National Science Foundation(National Science Foundation (NSF)); University of Tuscia; Universite Laval; Environment Canada(CGIAR); US Department of Energy(United States Department of Energy (DOE))	This work was supported by German National Academic Foundation, http://www.studienstiftung.de (no grant number), SS (Studienstiftung des Deutschen Volkes); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina, http://www.conicet.gov.ar (no grant number), OAR; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), http://cnpq.br, Grant number 310003/2016-4, HL; European Space Agency, STSE project CAB-LAB ("Coupled Atmosphere Biosphere virtual LABoratory"), http://earthsystemdatacube.net, MDM FG PB SS; European Commission, BACI project ("Detecting changes in essential ecosystem and biodiversity properties - towards a Biosphere Atmosphere Change Index"), http://baci-h2020.eu/index.php/ (Grant number 640176), MDM SS.; We thank Kirsten Thonicke and Susanne Rolinski for providing LPJmL model output, Christian Beer for providing JSBACH results, data management and the modelling protocol. Furthermore, we thank Anja Rammig and Markus Reichstein for comments and discussions. S.S. is grateful to the 'German National Academic Foundation' (Studienstiftung des Deutschen Volkes) for support and the International Max Planck Research School for Global Biogeochemical Cycles (IMPRS-gBGC) for training. H.L. is grateful to the hospitality at the Instituto de Fisica, Universidade Federal de Alagoas in Maceio, Brazil, and also to the guest researcher funding provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, fellowship no. 310003/2016-4) during a sabbatical stay. O.A.R. acknowledges support from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina. S.S., F.G., and M.D.M. thank the European Space agency for funding the STSE project CAB-LAB; S.S., F.G., and M.D.M. are also grateful to the European Commission for funding the BACI project; grant agreement No 640176. The JRC-TIP FAPAR product based on MODIS broadband albedo observations was provided by The Inversion Lab and the Joint Research Centre of the European Commission, and we thank Michael Vo beta beck, Bernhard Pinty, and Nadine Gobron for making the dataset available. This work used eddy covariance data acquired by the FLUXNET community and in particular by the following networks: CarboEuropeIP, CarboItaly, CarboMont, GreenGrass. We acknowledge the financial support to the eddy covariance data harmonization provided by CarboEuropeIP, FAO-GTOS-TCO, iLEAPS, Max Planck Institute for Biogeochemistry, National Science Foundation, University of Tuscia, Universite Laval, Environment Canada and US Department of Energy and the database development and technical support from Berkeley Water Center, Lawrence Berkeley National Laboratory, Microsoft Research eScience, Oak Ridge National Laboratory, University of California-Berkeley and the University of Virginia. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups (listed in Table 2 in S1 File) for producing and making available their model output. For CMIP the U.S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals.	Abramowitz G, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024419; Abramowitz G, 2012, GEOSCI MODEL DEV, V5, P819, DOI 10.5194/gmd-5-819-2012; Anav A, 2013, J CLIMATE, V26, P6801, DOI 10.1175/JCLI-D-12-00417.1; Aquino ALL, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60384-x; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Bandt C, 2005, ECOL MODEL, V182, P229, DOI 10.1016/j.ecolmodel.2004.04.003; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Beer C, 2014, J CLIMATE, V27, P4815, DOI 10.1175/JCLI-D-13-00543.1; Best MJ, 2015, J HYDROMETEOROL, V16, P1425, DOI 10.1175/JHM-D-14-0158.1; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Brissaud J.-B., 2005, ENTROPY-SWITZ, V7, P68, DOI [10.3390/e7010068, DOI 10.3390/E7010068]; Carvalhais N, 2014, NATURE, V514, P213, DOI 10.1038/nature13731; Chapin F.S., 2011, PRINCIPLES TERRESTRI; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; De Micco L, 2008, PHYSICA A, V387, P3373, DOI 10.1016/j.physa.2008.02.037; De Micco L, 2009, PHILOS T R SOC A, V367, P3281, DOI 10.1098/rsta.2009.0075; De Micco L, 2012, PHYSICA A, V391, P2564, DOI 10.1016/j.physa.2011.12.042; Eyring V, 2016, GEOSCI MODEL DEV, V9, P1747, DOI 10.5194/gmd-9-1747-2016; Fadlallah B, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022911; Feldman DP, 2008, CHAOS, V18, DOI 10.1063/1.2991106; Bariviera AF, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2015.0119; Bariviera AF, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60410-1; FRIEDEN BR, 2004, SCI FISHER INFORM UN; Gobron N, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043870; Gray RM, 2011, ENTROPY AND INFORMATION THEORY , SECOND EDITION, P395, DOI 10.1007/978-1-4419-7970-4; Grimm V, 2012, PHILOS T R SOC B, V367, P298, DOI 10.1098/rstb.2011.0180; Grosse I, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041905; Gupta HV, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011044; Hauhs M, 2008, GEOGR COMPASS, V2, P235, DOI 10.1111/j.1749-8198.2007.00075.x; Haxeltine A, 1996, GLOBAL BIOGEOCHEM CY, V10, P693, DOI 10.1029/96GB02344; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; Kaminski T., 2016, BIOGEOSCIENCES DISCU, DOI [10.5194/bg-2016-310,inreview, DOI 10.5194/BG-2016-310]; Kantz H., 2012, NONLINEAR ANAL PHYSL; Keller K, 2005, PHYSICA A, V356, P114, DOI 10.1016/j.physa.2005.05.022; Kelley DI, 2013, BIOGEOSCIENCES, V10, P3313, DOI 10.5194/bg-10-3313-2013; Knorr W, 2000, GLOBAL ECOL BIOGEOGR, V9, P225, DOI 10.1046/j.1365-2699.2000.00159.x; Kowalski AM, 2007, PHYSICA D, V233, P21, DOI 10.1016/j.physd.2007.06.015; Kowalski AM, 2011, PHYSICA A, V390, P2435, DOI 10.1016/j.physa.2011.02.009; Lamberti PW, 2004, PHYSICA A, V334, P119, DOI 10.1016/j.physa.2003.11.005; Lange H, 2013, EUR PHYS J-SPEC TOP, V222, P535, DOI 10.1140/epjst/e2013-01858-3; Lasslop G, 2010, GLOBAL CHANGE BIOL, V16, P187, DOI 10.1111/j.1365-2486.2009.02041.x; LopezRuiz R, 1995, PHYS LETT A, V209, P321, DOI 10.1016/0375-9601(95)00867-5; Luo YQ, 2012, BIOGEOSCIENCES, V9, P3857, DOI 10.5194/bg-9-3857-2012; Mahecha MD, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001016; Martin MT, 2006, PHYSICA A, V369, P439, DOI 10.1016/j.physa.2005.11.053; Martin MT, 2003, PHYS LETT A, V311, P126, DOI 10.1016/S0375-9601(03)00491-2; Montani F, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2015.0110; Montani F, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2015.0109; Montani F, 2014, ENTROPY-SWITZ, V16, P4677, DOI 10.3390/e16084677; Montani F, 2014, PHYSICA A, V401, P58, DOI 10.1016/j.physa.2013.12.053; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Olivares F, 2012, PHYS LETT A, V376, P1577, DOI 10.1016/j.physleta.2012.03.039; Olivares F, 2012, PHYSICA A, V391, P2518, DOI 10.1016/j.physa.2011.12.033; Osmond C. B., 1982, Encyclopedia of plant physiology. New series. Volume 12B. Physiological plant ecology. II. Water relations and carbon assimilation. [Lange, O.L.; Nobel, P.S.; Osmond, C.B.; Ziegler, H. (Editors)], P479; Piao SL, 2013, GLOBAL CHANGE BIOL, V19, P2117, DOI 10.1111/gcb.12187; Pinty B, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015373; Raddatz TJ, 2007, CLIM DYNAM, V29, P565, DOI 10.1007/s00382-007-0247-8; Re MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093532; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2011, ILEAPS NEWSLETTER, V11, P14; Reichstein M, 2008, J PLANT NUTR SOIL SC, V171, P344, DOI 10.1002/jpln.200700075; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Renyi A., 1961, PROC 4 BERKELEY SYMP, VI, P547; Ribeiro HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040689; Rosso OA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154102; Rosso OA, 2009, EUR PHYS J B, V69, P37, DOI 10.1140/epjb/e2009-00146-y; Rosso OA, 2013, EUR PHYS J B, V86, DOI [10.1140/epjb/e2013-30764-5, 10.1140/epjb/e2012-30307-8]; Rosso OA, 2012, PHYSICA A, V391, P42, DOI 10.1016/j.physa.2011.07.030; Rosso OA, 2010, PHYSICA A, V389, P4604, DOI 10.1016/j.physa.2010.06.055; Saco PM, 2010, PHYSICA A, V389, P5022, DOI 10.1016/j.physa.2010.07.006; Schurmann GJ, 2016, GEOSCIENTIFIC MODEL, V2016, P1; Serinaldi F, 2014, STOCH ENV RES RISK A, V28, P1685, DOI 10.1007/s00477-013-0825-8; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Soriano MC, 2011, IEEE J QUANTUM ELECT, V47, P252, DOI 10.1109/JQE.2010.2078799; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Teuling AJ, 2011, INT J CLIMATOL, V31, P1408, DOI 10.1002/joc.2153; Thum T, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001612; Zanin M, 2012, ENTROPY-SWITZ, V14, P1553, DOI 10.3390/e14081553; Zscheischler J, 2014, BIOGEOSCIENCES, V11, P2909, DOI 10.5194/bg-11-2909-2014; Zscheischler J, 2015, GEOPHYS RES LETT, V42, P9816, DOI 10.1002/2015GL066563; Zunino L, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.046210; Zunino L, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046212	83	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164960	10.1371/journal.pone.0164960	http://dx.doi.org/10.1371/journal.pone.0164960			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764187	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000386204500084
J	Zhu, LS; Lu, HB; Cao, YF; Gai, XC; Guo, CM; Liu, YJ; Liu, JX; Wang, XP				Zhu, Lisai; Lu, Haibing; Cao, Yufeng; Gai, Xiaochun; Guo, Changming; Liu, Yajing; Liu, Jiaxu; Wang, Xinping			Molecular Characterization of a Novel Bovine Viral Diarrhea Virus Isolate SD-15	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; NUCLEOTIDE-SEQUENCE; MUCOSAL DISEASE; IDENTIFICATION; INFECTION; STRAIN; GLYCOSYLATION; DIVERSITY; CATTLE; BVDV	As one of the major pathogens, bovine viral diarrhea virus caused a significant economic loss to the livestock industry worldwide. Although BVDV infections have increasingly been reported in China in recent years, the molecular aspects of those BVDV strains were barely characterized. In this study, we reported the identification and characterization of a novel BVDV isolate designated as SD-15 from cattle, which is associated with an outbreak characterized by severe hemorrhagic and mucous diarrhea with high morbidity and mortality in Shandong, China. SD-15 was revealed to be a noncytopathic BVDV, and has a complete genomic sequence of 12,285 nucleotides that contains a large open reading frame encoding 3900 amino acids. Alignment analysis showed that SD-15 has 93.8% nucleotide sequence identity with BVDV ZM-95 isolate, a previous BVDV strain isolated from pigs manifesting clinical signs and lesions resembling to classical swine fever. Phylogenetic analysis clustered SD-15 to a BVDV-1m subgenotype. Analysis of the deduced amino acid sequence of glycoproteins revealed that E2 has several highly conserved and variable regions within BVDV-1 genotypes. An additional N-glycosylation site (240NTT) was revealed exclusively in SD-15-encoded E2 in addition to four potential glycosylation sites (Asn-X-Ser/Thr) shared by all BVDV-1 genotypes. Furthermore, unique amino acid and linear epitope mutations were revealed in SD-15-encoded E rns glycoprotein compared with known BVDV-1 genotype. In conclusion, we have isolated a noncytopathic BVDV-1m strain that is associated with a disease characterized by high morbidity and mortality, revealed the complete genome sequence of the first BVDV-1m virus originated from cattle, and found a unique glycosylation site in E2 and a linear epitope mutation in E rns encoded by SD-15 strain. Those results will broaden the current understanding of BVDV infection and lay a basis for future investigation on SD-15-related pathogenesis.	[Zhu, Lisai; Lu, Haibing; Cao, Yufeng; Gai, Xiaochun; Guo, Changming; Liu, Yajing; Wang, Xinping] Jilin Univ, Coll Vet Med, Changchun 130062, Peoples R China; [Zhu, Lisai; Lu, Haibing; Gai, Xiaochun; Liu, Yajing; Wang, Xinping] Jilin Univ, Key Lab Zoonosis, Minist Educ, Changchun 130062, Peoples R China; [Zhu, Lisai; Lu, Haibing; Gai, Xiaochun; Liu, Yajing; Wang, Xinping] Jilin Univ, Inst Zoonosis, Changchun 130062, Peoples R China; [Cao, Yufeng] Changchun Inst Biol Prod, Changchun 130062, Peoples R China; [Liu, Jiaxu] Guangdong Haid Anim Husb & Vet Inst, Guangzhou 511400, Guangdong, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, XP (corresponding author), Jilin Univ, Coll Vet Med, Changchun 130062, Peoples R China.; Wang, XP (corresponding author), Jilin Univ, Key Lab Zoonosis, Minist Educ, Changchun 130062, Peoples R China.; Wang, XP (corresponding author), Jilin Univ, Inst Zoonosis, Changchun 130062, Peoples R China.	wangxp88@hotmail.com	Wang, Xin/GYU-1129-2022; Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	Ministry of Science and Technology of China [2016YFD0500904]; People's Government of Jilin Province for the Key Scientific and Technology [20140204064NY]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); People's Government of Jilin Province for the Key Scientific and Technology	This research was supported by the Ministry of Science and Technology of China with a grant no. 2016YFD0500904 to XPW; and by the People's Government of Jilin Province for the Key Scientific and Technology projects with grant no. 20140204064NY to XPW.	BAKER JC, 1987, J AM VET MED ASSOC, V190, P1449; Becher P, 1999, VIROLOGY, V262, P64, DOI 10.1006/viro.1999.9872; Burland T G, 2000, Methods Mol Biol, V132, P71; Carman S, 1998, J VET DIAGN INVEST, V10, P27, DOI 10.1177/104063879801000106; COLLETT MS, 1988, VIROLOGY, V165, P191, DOI 10.1016/0042-6822(88)90672-1; Deng ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121718; DENG RT, 1992, VIROLOGY, V191, P867, DOI 10.1016/0042-6822(92)90262-N; DUFFELL SJ, 1985, VET REC, V117, P240, DOI 10.1136/vr.117.10.240; El Omari K, 2013, CELL REP, V3, P30, DOI 10.1016/j.celrep.2012.12.001; Fernandez-Sainz I, 2009, VIROLOGY, V386, P210, DOI 10.1016/j.virol.2008.12.042; Flores EF, 2002, VIRUS RES, V87, P51, DOI 10.1016/S0168-1702(02)00080-1; Gao YG, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-83; Giangaspero M, 2008, J VET MED SCI, V70, P571, DOI 10.1292/jvms.70.571; Gong XW, 2013, VIRUS GENES, V46, P375, DOI 10.1007/s11262-012-0861-3; Houe H, 1999, VET MICROBIOL, V64, P89, DOI 10.1016/S0378-1135(98)00262-4; Kim SG, 2009, VET MICROBIOL, V136, P209, DOI 10.1016/j.vetmic.2008.10.029; Lang YF, 2014, VET MICROBIOL, V174, P554, DOI 10.1016/j.vetmic.2014.10.018; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Li Y, 1983, CHIN J VET SCI, V3, P546; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; LOKEN T, 1995, VET CLIN N AM-FOOD A, V11, P597, DOI 10.1016/S0749-0720(15)30469-2; Luzzago C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/147145; Nagai M, 1998, VET MICROBIOL, V60, P271, DOI 10.1016/S0378-1135(98)00158-8; PELLERIN C, 1994, VIROLOGY, V203, P260, DOI 10.1006/viro.1994.1483; REBHUN WC, 1989, J VET INTERN MED, V3, P42, DOI 10.1111/j.1939-1676.1989.tb00327.x; Risatti GR, 2007, J VIROL, V81, P924, DOI 10.1128/JVI.01824-06; Rodriguez-Prieto V, 2016, BMC VET RES, V12, DOI 10.1186/s12917-015-0630-3; RUMENAPF T, 1993, J VIROL, V67, P3288; Sainz IF, 2008, VIROLOGY, V370, P122, DOI 10.1016/j.virol.2007.08.028; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shi S, 1987, CHIN J VET DRU, V01, P26; Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0; Tao J, 2013, VIRUS GENES, V46, P81, DOI 10.1007/s11262-012-0837-3; Tautz N, 1997, J VIROL, V71, P5415, DOI 10.1128/JVI.71.7.5415-5422.1997; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vilcek S, 2005, PREV VET MED, V72, P31, DOI 10.1016/j.prevetmed.2005.08.004; Wang FI, 2015, VIRUSES-BASEL, V7, P3506, DOI 10.3390/v7072783; Wang W, 2014, VIRUS GENES, V49, P339, DOI 10.1007/s11262-014-1067-7; Wang W, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-8; Wang X, 1993, CHIN J PREV VET MED, P41; Wang XinPing, 1996, Chinese Journal of Veterinary Science, V16, P546; Wang XinPing, 1996, Chinese Journal of Veterinary Science, V16, P341; Weng XG, 2015, J VET SCI, V16, P491, DOI 10.4142/jvs.2015.16.4.491; Xu XR, 2006, VIRUS RES, V122, P164, DOI 10.1016/j.virusres.2006.05.005; Xue F, 2010, VET MICROBIOL, V143, P379, DOI 10.1016/j.vetmic.2009.11.010; Zhang SQ, 2014, INFECT GENET EVOL, V27, P230, DOI 10.1016/j.meegid.2014.07.021; Zhang SQ, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-67; Zhong FG, 2011, VIRUS GENES, V42, P204, DOI 10.1007/s11262-010-0558-4; Zhu LiSai, 2014, Chinese Journal of Veterinary Science, V34, P1065	49	10	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							0165044	10.1371/journal.pone.0165044	http://dx.doi.org/10.1371/journal.pone.0165044			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764206	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204500106
J	Amdisen, C; Keller, AK; Hansen, RS; Norregaard, R; Krag, SP; Moldrup, U; Pedersen, M; Jespersen, B; Birn, H				Amdisen, Chris; Keller, Anna K.; Hansen, Rie Schultz; Norregaard, Rikke; Krag, Soren Palmelund; Moldrup, Ulla; Pedersen, Michael; Jespersen, Bente; Birn, Henrik			Testing Danegaptide Effects on Kidney Function after Ischemia/Reperfusion Injury in a New Porcine Two Week Model	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; GAP-JUNCTIONAL HEMICHANNELS; CONNEXIN-43 MESSENGER-RNA; WARM ISCHEMIA; ATP DEPLETION; INFARCT SIZE; TUBULE CELLS; PIGS; TRANSPLANTATION; EXPRESSION	Introduction Ischemia/reperfusion injury (I/R-I) is a leading cause of acute kidney injury (AKI) and is associated with increased mortality. Danegaptide is a selective modifier of the gap junction protein connexion 43. It has cytoprotective as well as anti-arrhythmic properties and has been shown to reduce the size of myocardial infarct in pigs. The aim of this study was to investigate the ischemia-protective effect of Danegaptide in a porcine renal I/R-I model with two weeks follow up. Methods Unilateral renal I/R-I was induced in pigs by clamping the left renal artery over a two hour period. The model allowed examination of renal blood flow by magnetic resonance imaging (MRI) and the measurement of single kidney GFR two weeks after injury. Eleven animals were randomized to Danegaptide-infusion while nine animals received placebo. Kidney histology and urinary neutrophil gelatinase-associated lipocalin (NGAL) excretion were included as markers of AKI. Results Unilateral kidney I/R-I resulted in an immediate similar to 50% GFR reduction, associated with a four-fold increase in urinary NGAL-excretion. Fourteen days after I/R-I, the total GFR was similar to 75% of baseline with a significantly lower GFR in the injured left kidney compared to the right kidney. No differences in GFR were observed between the treated and non-treated animals immediately after I/R-I or at Day 14. Furthermore, no differences were observed in the urinary excretion of NGAL, renal blood flow or other markers of renal function. Conclusions As expected this porcine renal I/R-I model was associated with reduced GFR two weeks after injury. Danegaptide did not improve renal function after I/R-I.	[Amdisen, Chris; Norregaard, Rikke] Aarhus Univ, Inst Clin Med, Aarhus, Denmark; [Amdisen, Chris; Jespersen, Bente; Birn, Henrik] Aarhus Univ Hosp, Dept Renal Med, Aarhus, Denmark; [Keller, Anna K.; Moldrup, Ulla] Aarhus Univ Hosp, Dept Urol, Aarhus, Denmark; [Hansen, Rie Schultz] Zealand Pharma AS, Glostrup, Denmark; [Krag, Soren Palmelund] Aarhus Univ Hosp, Dept Pathol, Aarhus, Denmark; [Pedersen, Michael] Aarhus Univ, Comparat Med Lab, Aarhus, Denmark; [Birn, Henrik] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Zealand Pharma A/S; Aarhus University; Aarhus University; Aarhus University	Amdisen, C (corresponding author), Aarhus Univ, Inst Clin Med, Aarhus, Denmark.; Amdisen, C (corresponding author), Aarhus Univ Hosp, Dept Renal Med, Aarhus, Denmark.	camd@clin.au.dk	Birn, Henrik/C-3931-2009	Birn, Henrik/0000-0003-3715-7266; Norregaard, Rikke/0000-0002-0580-373X; Jespersen, Bente/0000-0001-7196-2870; Norregaard, Rikke/0000-0002-1287-4181; Amdisen, Chris/0000-0003-3262-8524	Zealand Pharma A/S, Glostrup Denmark	Zealand Pharma A/S, Glostrup Denmark	Zealand Pharma A/S, Glostrup Denmark funded the study. They participated in the study design (dose of Danegaptide) and preparation of the manuscript. They had no role in the data collection, analysis or decision to publish.	Abreu L de ADS, 2011, INT BRAZ J UROL, V37, P649; Arensbak B, 2001, HISTOCHEM CELL BIOL, V115, P479; Froba G, 2007, SHOCK, P1; Grossini E, 2012, J PHARMACOL EXP THER, V342, P376, DOI 10.1124/jpet.112.193961; Gulec B, 2006, TRANSPLANT P, V38, P371, DOI 10.1016/j.transproceed.2005.12.095; Guo R, 1998, AM J PHYSIOL-REG I, V275, pR439, DOI 10.1152/ajpregu.1998.275.2.R439; Hanner F, 2010, AM J PHYSIOL-REG I, V298, pR1143, DOI 10.1152/ajpregu.00808.2009; Heinzel FR, 2005, CIRC RES, V97, P583, DOI 10.1161/01.RES.0000181171.65293.65; Hennan JK, 2006, J PHARMACOL EXP THER, V317, P236, DOI 10.1124/jpet.105.096933; Hillis GS, 1997, NEPHRON, V75, P458, DOI 10.1159/000189585; Hillis GS, 1997, J PATHOL, V182, P373; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Hosgood SA, 2008, TRANSPLANTATION, V85, P88, DOI 10.1097/01.tp.0000296055.76452.1b; Jayle C, 2009, BRIT J SURG, V96, P799, DOI 10.1002/bjs.6589; Jayle C, 2006, AM J PHYSIOL-RENAL, V292, pF1082; Karger N, 2000, MAGN RESON IMAGING, V18, P641, DOI 10.1016/S0730-725X(00)00155-7; Khatir DS, 2014, J MAGN RESON IMAGING, V40, P1091, DOI 10.1002/jmri.24446; Laven BA, 2004, J UROLOGY, V172, P2471, DOI 10.1097/01.ju.0000138158.16968.8d; Lee JY, 2010, J VET MED SCI, V72, P127, DOI 10.1292/jvms.09-0255; Li X, 2004, J MOL CELL CARDIOL, V36, P161, DOI 10.1016/j.yjmcc.2003.10.019; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Parekh DJ, 2013, J AM SOC NEPHROL, V24, P506, DOI 10.1681/ASN.2012080786; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Ravlo K, 2012, PEDIATR TRANSPLANT, V16, P599, DOI 10.1111/j.1399-3046.2012.01707.x; Schulz R, 2015, PHARMACOL THERAPEUT, V153, P90, DOI 10.1016/j.pharmthera.2015.06.005; Schwanke U, 2002, AM J PHYSIOL-HEART C, V283, pH1740, DOI 10.1152/ajpheart.00442.2002; Simon F, 2011, SHOCK, V35, P156, DOI 10.1097/SHK.0b013e3181f0dc91; Skyschally A, 2013, N-S ARCH PHARMACOL, V386, P383, DOI 10.1007/s00210-013-0840-9; Soendergaard P, 2012, TRANSPL INT, V25, P1002, DOI 10.1111/j.1432-2277.2012.01522.x; Thakar CV, 2007, AM J KIDNEY DIS, V50, P703, DOI 10.1053/j.ajkd.2007.07.021; Toubas J, 2011, AM J PHYSIOL-RENAL, V301, pF24, DOI 10.1152/ajprenal.00255.2010; Vergara L, 2003, J MEMBRANE BIOL, V196, P173, DOI 10.1007/s00232-003-0636-9; Vergara L, 2003, ACTA PHYSIOL SCAND, V179, P33, DOI 10.1046/j.1365-201X.2003.01198.x; Wang Y, 2015, TOXICOLOGY REPORTS; Yang M, 2014, CELL PHYSIOL BIOCHEM, V34, P1652, DOI 10.1159/000366367; Yoshida J, 2010, AM J TRANSPLANT, V10, P763, DOI 10.1111/j.1600-6143.2010.03040.x	36	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164109	10.1371/journal.pone.0164109	http://dx.doi.org/10.1371/journal.pone.0164109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760220	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204000028
J	Contreras-Catala, F; Sanchez-Velasco, L; Beier, E; Godinez, VM; Barton, ED; Santamaria-del-Angel, E				Contreras-Catala, Fernando; Sanchez-Velasco, Laura; Beier, Emilio; Godinez, Victor M.; Barton, Eric D.; Santamaria-del-Angel, Eduardo			Effects of Geostrophic Kinetic Energy on the Distribution of Mesopelagic Fish Larvae in the Southern Gulf of California in Summer/Fall Stratified Seasons	PLOS ONE			English	Article							MESOSCALE EDDIES; 3-DIMENSIONAL DISTRIBUTION; CYCLONIC EDDY; NORTHERN GULF; CROSS-SHELF; LA-PAZ; ASSEMBLAGES; VARIABILITY; CIRCULATION; ZONE	Effects of geostrophic kinetic energy flux on the three-dimensional distribution of fish larvae of mesopelagic species (Vinciguerria lucetia, Diogenichthys laternatus, Benthosema panamense and Triphoturus mexicanus) in the southern Gulf of California during summer and fall seasons of stronger stratification were analyzed. The greatest larval abundance was found at sampling stations in geostrophic kinetic energy-poor areas (<7.5 J/m(3)), where the distribution of the dominant species tended to be stratified. Larvae of V. lucetia (average abundance of 318 larvae/10m(2)) and B. panamense (174 larvae/10m(2)) were mostly located in and above the pycnocline (typically similar to 40 m depth). In contrast, larvae of D. laternatus (60 larvae/10m(2)) were mainly located in and below the pycnocline. On the other hand, in sampling stations from geostrophic kinetic energy-rich areas (> 21 J/m(3)), where mesoscale eddies were present, the larvae of the dominant species had low abundance and were spread more evenly through the water column, in spite of the water column stratification. For example, in a cyclonic eddy, V. lucetia larvae (34 larvae/10m(2)) extended their distribution to, at least, the limit of sampling 200 m depth below the pycnocline, while D. laternatus larvae (29 larvae/10m(2)) were found right up to the surface, both probably as a consequence mixing and secondary circulation in the eddy. Results showed that the level of the geostrophic kinetic energy flux affects the abundance and the three-dimensional distribution of mesopelagic fish larvae during the seasons of stronger stratification, indicating that areas with low geostrophic kinetic energy may be advantageous for feeding and development of mesopelagic fish larvae because of greater water column stability.	[Contreras-Catala, Fernando; Sanchez-Velasco, Laura] Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, Dept Plancton & Ecol Marina, La Paz, Baja California, Mexico; [Beier, Emilio] Ctr Invest Cient & Educ Super Ensenada, Unidad La Paz, La Paz, Baja California, Mexico; [Godinez, Victor M.] Ctr Invest Cient & Educ Super Ensenada, Dept Oceanog Fis, Ensenada, Baja California, Mexico; [Barton, Eric D.] CSIC, Inst Invest Marinas, Dept Oceanog, Vigo, Spain; [Santamaria-del-Angel, Eduardo] Univ Autonoma Baja California, Fac Ciencias Marinas, Ensenada, Baja California, Mexico	Instituto Politecnico Nacional - Mexico; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Universidad Autonoma de Baja California	Sanchez-Velasco, L (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, Dept Plancton & Ecol Marina, La Paz, Baja California, Mexico.	lsvelasc@gmail.com	Godínez, Victor M./E-1519-2015; Contreras-Catala, Fernando/AAH-5788-2020; Santamaria-del-Ángel, Eduardo/S-1630-2017	Godínez, Victor M./0000-0002-6141-2012; Contreras-Catala, Fernando/0000-0002-8821-7954; Santamaria-del-Ángel, Eduardo/0000-0002-1882-7714	Consejo Nacional de Ciencia y Tecnologia [2014-236864]; Instituto Politecnico Nacional (Multidisciplinary Project) [2015-0176]; CONACyT [236864]; CONACyT PhD scholarship	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto Politecnico Nacional (Multidisciplinary Project); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT PhD scholarship	LSV contracts 2014-236864 Consejo Nacional de Ciencia y Tecnologia http://www.conacyt.mx/. Instituto Politecnico Nacional (Multidisciplinary Project 2015-0176) http://www.ipn.mx. EB SEP-2011-168034-T Consejo Nacional de Ciencia y Tecnologia http://www.conacyt.mx/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The hydrographic and biological data used for this paper are part of the monitoring inter-institutional in the Gulf of California CICIMAR-IPN and CICESE. The study was funded by the CONACyT project no. 236864. F.C.C. was recipient of a CONACyT PhD scholarship. We particularly acknowledge the contribution of the late Miguel Fernando Lavin Peregrina (CICESE), without whose contribution and encouragement, this work would not have been possible. Participation of EDB was facilitated by a Bolsa de Movilidade of the Campus do Mar, Vigo, Spain. We thank the scientific and technical staff who took part in the cruises aboard the R/V Francisco de Ulloa (especially to Alma Rosa Padilla Pilotzi of the ICMyL UNAM) and R/V El Puma. Many thanks to the anonymous reviewers for their comments and contributions to this study.	Ahlstrom E. H., 1959, Fishery Bulletin United States, V60, P107; Alvarez-Borrego S, 1991, PHYS ENV PRIMARY PRO, P555; Anderson MJ., 2003, J EXP MAR BIO ECOL, V289, P303, DOI [10.1016/s0022-0981(03)00091-1, DOI 10.1016/S0022-0981(03)00091-1, 10.1016/S0022-0981(03)00091-1]; Apango-Figueroa E, 2015, DEEP-SEA RES PT I, V103, P1, DOI 10.1016/j.dsr.2015.05.005; BADANDANGON A, 1985, OCEANOL ACTA, V8, P13; Beier E, 1997, J PHYS OCEANOGR, V27, P615, DOI 10.1175/1520-0485(1997)027<0615:ANIOTA>2.0.CO;2; Brown SL, 2008, DEEP-SEA RES PT II, V55, P1321, DOI 10.1016/j.dsr2.2008.02.012; Chelton DB, 1998, J PHYS OCEANOGR, V28, P433, DOI 10.1175/1520-0485(1998)028<0433:GVOTFB>2.0.CO;2; Chelton DB, 2011, SCIENCE, V334, P328, DOI 10.1126/science.1208897; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Contreras-Catala F, 2015, REV BIOL MAR OCEANOG, V50, P575, DOI 10.4067/S0718-19572015000400014; Contreras-Catala F, 2012, J PLANKTON RES, V34, P548, DOI 10.1093/plankt/fbs024; Crawford WR, 2007, PROG OCEANOGR, V75, P287, DOI 10.1016/j.pocean.2007.08.016; Danell-Jimenez A, 2009, ESTUAR COAST SHELF S, V85, P487, DOI 10.1016/j.ecss.2009.09.010; Davies SM, 2015, DEEP-SEA RES PT I, V101, P118, DOI 10.1016/j.dsr.2015.04.003; Eden BR, 2009, DEEP-SEA RES PT I, V56, P1757, DOI 10.1016/j.dsr.2009.05.005; Espinosa-Fuentes ML, 2004, ESTUAR COAST SHELF S, V59, P333, DOI 10.1016/j.ecss.2003.09.006; Fernandez E, 2004, J MAR BIOL ASSOC UK, V84, P501, DOI 10.1017/S0025315404009518h; Ferrari R, 2009, ANNU REV FLUID MECH, V41, P253, DOI 10.1146/annurev.fluid.40.111406.102139; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Godinez VM, 2012, DALOS HIDROGRAFICOS; Godinez VM, 2010, DALOS HIDROGRAFICOS; Godo OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030161; Gruber N, 2011, NAT GEOSCI, V4, P787, DOI [10.1038/NGEO1273, 10.1038/ngeo1273]; Haury L.R., 1978, SPATIAL PATTERN PLAN, V3, DOI DOI 10.1007/978-1-4899-2195-6_12; Holliday D, 2011, J PLANKTON RES, V33, P1696, DOI 10.1093/plankt/fbr064; HORN LH, 1963, J GEOPHYS RES, V68, P1059, DOI 10.1029/JZ068i004p01059; IOC SCOR and IAPSO, 2010, INTERGOVERNMENTAL OC, V56, DOI DOI 10.0RG/TE0S-10_MANUAL.PDF; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; Kendall A., 1981, ONTOG SYST FISHES, P1; Kramer D, 1972, 370 NOAA NMFS, V370, P38; Ladd C, 2009, DEEP-SEA RES PT II, V56, P2460, DOI 10.1016/j.dsr2.2009.02.007; Landry MR, 2012, J PLANKTON RES, V34, P739, DOI 10.1093/plankt/fbs025; LASKER R, 1975, FISH B-NOAA, V73, P453; Lavin MF, 2013, J GEOPHYS RES-OCEANS, V118, P1367, DOI 10.1002/jgrc.20132; Lavin MF, 2003, NONLINEAR PROCESSES IN GEOPHYSICAL FLUID DYNAMICS, P173; Lavin MF, 2014, J GEOPHYS RES OCEAN; Leon-Chavez CA, 2015, J GEOPHYS RES-OCEANS, V120, P3987, DOI 10.1002/2014JC010289; Lopez-Calderon J, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004630; Mahadevan A, 2008, SCIENCE, V320, DOI 10.1126/science.1152111; Martin AP, 2001, DEEP-SEA RES PT II, V48, P757, DOI 10.1016/S0967-0645(00)00096-5; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; McGillicuddy DJ, 1999, MESOSCALE VARIATIONS, V104, P381, DOI [10.1029/1999JC900021, DOI 10.1029/1999JC900021]; Moore TS, 2007, DEEP-SEA RES PT II, V54, P943, DOI 10.1016/j.dsr2.2007.02.006; Moser H.G., 1996, EARLY STAGES FISHES, P659; MOSER HG, 1993, B MAR SCI, V53, P283; MYERS RA, 1989, J MAR RES, V47, P635, DOI 10.1357/002224089785076208; Navarro-Olache LF, 2004, DEEP-SEA RES PT II, V51, P673, DOI 10.1016/j.dsr2.2004.05.014; Nieto K, 2014, J GEOPHYS RES-OCEANS, V119, P6330, DOI 10.1002/2014JC010251; Norrbin MF, 1996, DEEP-SEA RES PT II, V43, P1905, DOI 10.1016/S0967-0645(96)00046-X; Omand MM, 2015, SCIENCE, V348, P222, DOI 10.1126/science.1260062; OREILLY JE, 2000, SEAWIFS POSTLAUNCH T, V11, P1; Pawlowicz R., 2010, OCEAN SCI DISCUSS, V7, P773, DOI DOI 10.5194/OSD-7-773-2010; Pegau WS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014076; Peguero-Icaza M, 2008, ESTUAR COAST SHELF S, V79, P277, DOI 10.1016/j.ecss.2008.04.008; Peguero-Icaza M, 2011, J PLANKTON RES, V33, P517, DOI 10.1093/plankt/fbq107; Piontkovski SA, 1995, MAR ECOL PROG SER, V128, P35, DOI 10.3354/meps128035; Sanchez-Velasco L, 2007, PAC SCI, V61, P533, DOI 10.2984/1534-6188(2007)61[533:VDOFLA]2.0.CO;2; Sanchez-Velasco L, 2006, J PLANKTON RES, V28, P1081, DOI 10.1093/plankt/fbl040; Sanchez-Velasco L, 2004, DEEP-SEA RES PT II, V51, P723, DOI 10.1016/j.dsr2.2004.05.020; Sanchez-Velasco L, 2014, J MARINE SYST, V129, P368, DOI 10.1016/j.jmarsys.2013.08.004; Sanchez-Velasco L, 2013, DEEP-SEA RES PT I, V75, P39, DOI 10.1016/j.dsr.2013.01.009; Sanchez-Velasco L, 2009, CONT SHELF RES, V29, P1697, DOI 10.1016/j.csr.2009.06.001; Sangra P, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002526; SANTAMARIADELANGEL E, 1994, J GEOPHYS RES-OCEANS, V99, P7411, DOI 10.1029/93JC02154; Sassa C, 2007, MAR BIOL, V150, P1403, DOI 10.1007/s00227-006-0434-x; Siegel S., 1988, NONPARAMETRIC STAT B, V2nd; SIMPSON JH, 1981, PHILOS T R SOC A, V302, P531, DOI 10.1098/rsta.1981.0181; Smith P. E., 1979, 175 FAO, V175; Sokal R. R., 1985, BIOMETRY; Song H, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007302; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; WISHART D, 1969, BIOMETRICS, V25, P165, DOI 10.2307/2528688; Zamudio L, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004467	76	8	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164900	10.1371/journal.pone.0164900	http://dx.doi.org/10.1371/journal.pone.0164900			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760185	gold, Green Published			2022-12-26	WOS:000386204000064
J	Gardet, A; Chou, WC; Reynolds, TL; Velez, DB; Fu, K; Czerkowicz, JM; Bajko, J; Ranger, AM; Allaire, N; Kerns, HM; Ryan, S; Legault, HM; Dunstan, RW; Lafyatis, R; Lukashev, M; Viney, JL; Browning, JL; Rabah, D				Gardet, Agnes; Chou, Wei C.; Reynolds, Taylor L.; Velez, Diana B.; Fu, Kai; Czerkowicz, Julia M.; Bajko, Jeffrey; Ranger, Ann M.; Allaire, Normand; Kerns, Hannah M.; Ryan, Sarah; Legault, Holly M.; Dunstan, Robert W.; Lafyatis, Robert; Lukashev, Matvey; Viney, Joanne L.; Browning, Jeffrey L.; Rabah, Dania			Pristane-Accelerated Autoimmune Disease in (SWR X NZB) F1 Mice Leads to Prominent Tubulointerstitial Inflammation and Human Lupus Nephritis-Like Fibrosis	PLOS ONE			English	Article							I INTERFERON; INTERSTITIAL INFLAMMATION; ERYTHEMATOSUS; PATHOGENESIS; EXPRESSION; MURINE; KIDNEY; APOPTOSIS; MICE	Mouse models lupus nephritis (LN) have provided important insights into disease pathogenesis, although none have been able to recapitulate all features of the human disease. Using comprehensive longitudinal analyses, we characterized a novel accelerated mouse model of lupus using pristane treatment in SNF1 (SWR X NZB F1) lupus prone mice (pristane-SNF1 mice). Pristane treatment in SNF1 mice accelerated the onset and progression of proteinuria, autoantibody production, immune complex deposition and development of renal lesions. At week 14, the pristane-SNF1 model recapitulated kidney disease parameters and molecular signatures seen in spontaneous disease in 36 week-old SNF1 mice and in a traditional IFN alpha-accelerated NZB X NZW F1 (BWF1) model. Blood transcriptome analysis revealed interferon, plasma cell, neutrophil, T-cell and protein synthesis signatures in the pristane-SNF1 model, all known to be present in the human disease. The pristane-SNF1 model appears to be particularly useful for preclinical research, robustly exhibiting many characteristics reminiscent of human disease. These include i) a stronger upregulation of the cytosolic nucleic acid sensing pathway, which is thought to be key component of the pathogenesis of the human disease, and ii) more prominent kidney interstitial inflammation and fibrosis, which have been both associated with poor prognosis in human LN. To our knowledge, this is the only accelerated model of LN that exhibits a robust tubulointerstitial inflammatory and fibrosis response. Taken together our data show that the pristane-SNF1 model is a novel accelerated model of LN with key features similar to human disease.	[Gardet, Agnes; Chou, Wei C.; Reynolds, Taylor L.; Velez, Diana B.; Fu, Kai; Czerkowicz, Julia M.; Bajko, Jeffrey; Ranger, Ann M.; Allaire, Normand; Kerns, Hannah M.; Ryan, Sarah; Legault, Holly M.; Dunstan, Robert W.; Lukashev, Matvey; Viney, Joanne L.; Rabah, Dania] Biogen Inc, Cambridge, MA 02142 USA; [Lafyatis, Robert] Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA USA; [Browning, Jeffrey L.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	Biogen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Boston University	Gardet, A; Rabah, D (corresponding author), Biogen Inc, Cambridge, MA 02142 USA.	agnes.gardet@biogen.com; dania.rabah@biogen.com			Biogen	Biogen(Biogen)	Biogen provided support in the form of salaries for authors AG, WCC, TLR, DBV, KF, JMC, JB, AMR, NA, HMK, SR, HML, RWD, ML, JLV, JLB and DR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalid-Peralta L, 2008, KIDNEY INT, V73, P172, DOI 10.1038/sj.ki.5002625; Alsuwaida AO, 2013, LUPUS, V22, P1446, DOI 10.1177/0961203313507986; AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Berthier CC, 2012, J IMMUNOL, V189, P988, DOI 10.4049/jimmunol.1103031; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chiche L, 2014, ARTHRITIS RHEUMATOL, V66, P1583, DOI 10.1002/art.38628; Crow MK, 2014, CURR OPIN RHEUMATOL, V26, P467, DOI 10.1097/BOR.0000000000000087; Davidson A, 2016, NAT REV RHEUMATOL, V12, P143, DOI 10.1038/nrrheum.2015.159; Denny MF, 2006, J IMMUNOL, V176, P2095, DOI 10.4049/jimmunol.176.4.2095; Du Y, 2015, CURR PHARM DESIGN, V21, P2320, DOI 10.2174/1381612821666150316115727; Favoino E, 2014, CLIN EXP IMMUNOL, V175, P32, DOI 10.1111/cei.12208; Grabinski TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120120; Guerra SG, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3844; Hill GS, 2002, KIDNEY INT, V61, P2176, DOI 10.1046/j.1523-1755.2002.00357.x; Jorgensen TN, 2006, GENES IMMUN, V7, P555, DOI 10.1038/sj.gene.6364329; Kalled SL, 1998, J IMMUNOL, V160, P2158; Kalled SL, 2001, J IMMUNOL, V167, P1740, DOI 10.4049/jimmunol.167.3.1740; Kalled SL, 2001, LUPUS, V10, P9, DOI 10.1191/096120301668384751; Kuroda Y, 2004, BIOMED PHARMACOTHER, V58, P325, DOI 10.1016/j.biopha.2004.04.009; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Lee SB, 2010, KIDNEY INT, V78, pS22, DOI 10.1038/ki.2010.418; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Mathian A, 2005, J IMMUNOL, V174, P2499, DOI 10.4049/jimmunol.174.5.2499; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mosca M, 1997, LUPUS, V6, P371, DOI 10.1177/096120339700600405; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; NOSSENT HC, 1990, ARTHRITIS RHEUM, V33, P970, DOI 10.1002/art.1780330708; Peterson KS, 2004, J CLIN INVEST, V113, P1722, DOI 10.1172/JCI200419139; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Savarese E, 2006, BLOOD, V107, P3229, DOI 10.1182/blood-2005-07-2650; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thibault DL, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2771; Triantafyllopoulou A, 2010, P NATL ACAD SCI USA, V107, P3012, DOI 10.1073/pnas.0914902107; Xu Y, 2012, J IMMUNOL, V188, P4113, DOI 10.4049/jimmunol.1103113; Yoshida H, 2002, ARTHRITIS RHEUM, V46, P2235, DOI 10.1002/art.10441; Yung SS, 2017, CLIN REV ALLERG IMMU, V52, P149, DOI 10.1007/s12016-016-8533-z; Yung SS, 2015, AUTOIMMUNITY, V48, P471, DOI 10.3109/08916934.2015.1054027; Zeisberg M, 2005, METH MOLEC MED, V117, P261; Zhang WJ, 2013, J CLIN IMMUNOL, V33, P925, DOI 10.1007/s10875-013-9881-6	44	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164423	10.1371/journal.pone.0164423	http://dx.doi.org/10.1371/journal.pone.0164423			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760209	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000035
J	Ramsey, MN; Maher, LA; Macdonald, DA; Rosen, A				Ramsey, Monica N.; Maher, Lisa A.; Macdonald, Danielle A.; Rosen, Arlene			Risk, Reliability and Resilience: Phytolith Evidence for Alternative 'Neolithization' Pathways at Kharaneh IV in the Azraq Basin, Jordan	PLOS ONE			English	Article							EPIPALAEOLITHIC AGGREGATION SITE; WILD CEREAL-GRAINS; OHALO-II; SOUTHERN LEVANT; MT CARMEL; PLEISTOCENE; CAVE; GALILEE; ISRAEL; TRANSITION	'Neolithization' pathway refers to the development of adaptations that characterized subsequent Neolithic life, sedentary occupations, and agriculture. In the Levant, the origins of these human behaviors are widely argued to have emerged during the Early Epipaleolithic (ca. 23 ka cal BP). Consequently, there has been a pre-occupation with identifying and modeling the dietary shift to cereal and grains during this period, which is considered to have been a key development that facilitated increasing sedentism and, eventually, agriculture. Yet, direct evidence of plant use in the form of macrobotanical remains is extremely limited at Epipaleolithic sites and the expected 'Neolithization' pathway has not been robustly demonstrated. However, new direct microbotanical phytolith evidence from the large aggregation site of Kharaneh IV, in the Azraq Basin, suggests that increasingly settled occupation was not the result of wild grass and cereal use, but rather the result of a typical hunter-gatherer balance, based on the use of mostly reliable resources supplemented by some risky resources. Moreover, and illustrating this balance, the direct botanical evidence emphases the importance of the wetlands as an under-recognized reliable plant resource. Significantly, the use of these reliable wetland plant resources at Kharaneh IV represents an unexpected 'Neolithization' pathway.	[Ramsey, Monica N.] Univ Toronto, Dept Anthropol, Toronto, ON, Canada; [Maher, Lisa A.] Univ Calif Berkeley, Dept Anthropol, Berkeley, CA 94720 USA; [Macdonald, Danielle A.] Univ Tulsa, Dept Anthropol, Tulsa, OK 74104 USA; [Rosen, Arlene] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA	University of Toronto; University of California System; University of California Berkeley; University of Tulsa; University of Texas System; University of Texas Austin	Ramsey, MN (corresponding author), Univ Toronto, Dept Anthropol, Toronto, ON, Canada.	monica.lorelle.ramsey@gmail.com		Nicolaides Ramsey, Monica/0000-0002-1223-1725	Canadian Social Science and Humanities Research Council (SSHRC) Ph.D. fellowship [752-2011-1728]; National Science Foundation SBE DDRIG [BCS-1418462]; Council for British Research in the Levant (CBRL); Canadian SSHRC Post doctoral Fellowship [756-2015-0408]; Arts and Humanities Research Council (AHRC) [AH/E009484/1]; Arts and Humanities Research Council [AH/E009484/1] Funding Source: researchfish; AHRC [AH/E009484/1] Funding Source: UKRI	Canadian Social Science and Humanities Research Council (SSHRC) Ph.D. fellowship; National Science Foundation SBE DDRIG; Council for British Research in the Levant (CBRL); Canadian SSHRC Post doctoral Fellowship; Arts and Humanities Research Council (AHRC); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	This research was supported by a Canadian Social Science and Humanities Research Council (SSHRC) Ph.D. fellowship [award number 752-2011-1728], a National Science Foundation SBE DDRIG [grant number BCS-1418462], and two Council for British Research in the Levant (CBRL) travel grants (2011, 2012) awarded to M.N. Ramsey. This manuscript was written during the tenure of M.N. Ramsey's Canadian SSHRC Post doctoral Fellowship [award number 756-2015-0408]. The fieldwork was entirely funded by the Arts and Humanities Research Council (AHRC) (AH/E009484/1).	Al-Kharabsheh A, 2000, J ARID ENVIRON, V44, P143, DOI 10.1006/jare.1999.0580; Albert RM, 1999, J ARCHAEOL SCI, V26, P1249, DOI 10.1006/jasc.1999.0355; Albert RM, 2000, J ARCHAEOL SCI, V27, P931, DOI 10.1006/jasc.2000.0507; Albert RM, 2003, J ARCHAEOL SCI, V30, P461, DOI 10.1006/jasc.2002.0854; Albert RM, 2001, PHYTOLITHS: APPLICATIONS IN EARTH SCIENCES AND HUMAN HISTORY, P251; Anderson Patricia C., 1991, NATUFIAN CULTURE LEV, V1, P521; Andrejko M.J., 1984, OKEFENOKEE SWAMP ITS, P468; [Anonymous], [No title captured]; [Anonymous], 2010, WETLAND ECOLOGY PRIN; Asouti E, 2012, VEG HIST ARCHAEOBOT, V21, P149, DOI 10.1007/s00334-011-0332-0; Bar-Yosef O, 1998, EVOL ANTHROPOL, V6, P159, DOI 10.1002/(SICI)1520-6505(1998)6:5<159::AID-EVAN4>3.0.CO;2-7; BELFERCOHEN A, 1991, ANNU REV ANTHROPOL, V20, P167, DOI 10.1146/annurev.an.20.100191.001123; Besancon J., 1989, BRIT ARCHAEOLOGICAL, P7; Bettinger R., 1991, HUNTER GATHERERS ARC; Bettinger RL, 2011, SUBSISTENCE EC INDIG, P113; BINFORD LR, 1980, AM ANTIQUITY, V45, P4, DOI 10.2307/279653; Boyd B, 2006, WORLD ARCHAEOL, V38, P164, DOI 10.1080/00438240600688398; Bozarth S.R., 1993, CURRENT RES PHYTOLIT, V10, P95; Bozarth SR., 1992, PHYTOLITH SYSTEMATIC, P193, DOI DOI 10.1007/978-1-4899-1155-1_10; Bremond L, 2005, J BIOGEOGR, V32, P311, DOI 10.1111/j.1365-2699.2004.01162.x; Butzer KW, 1982, ARCHAEOLOGY HUMAN EC; Byrd BF, 2016, QUATERN INT, V396, P62, DOI 10.1016/j.quaint.2015.07.048; Byrd Brian F., 1991, NATUFIAN CULTURE LEV, V1, P265; Caracuta V, 2016, QUATERNARY SCI REV, V131, P20, DOI 10.1016/j.quascirev.2015.10.034; CHILDE VG, 1952, NEW LIGHT MOST ANCIE; Clark, 1991, PERSPECTIVES THEORET, P353; Copeland L., 1989, HAMMER ROCK STUDIES; Cordova CE, 2013, QUATERN INT, V300, P94, DOI 10.1016/j.quaint.2012.09.019; Ebeling W, 1986, HDB INDIAN FOODS FIB; Edwards PC, 2013, CULT HIST ANC, V59, P1; Flannery K. V., 1969, The domestication and exploitation of plants and animals., P73; FLANNERY KV, 1973, ANNU REV ANTHROPOL, V2, P271, DOI 10.1146/annurev.an.02.100173.001415; Fowler C., 1982, RESOURCE MANAGERS N, P113; Fowler C. S., 2011, SUBSISTENCE EC INDIG, P233; FOWLER CATHERINE S, 1990, TULE TECHNOLOGY NO P; Fowler CS., 1990, WETLAND ADAPTATIONS, P17; Garrard A., 1994, LEVANT, V26, P73, DOI DOI 10.1179/lev.1994.26.1.73; Garrard A., 1987, LEVANT, V19, P5, DOI DOI 10.1179/; Garrard A., 1985, LEVANT, V17, P1, DOI DOI 10.1179/007589185790212105; Garrard A.N., 1988, Paleorient, V14, P40; Garrard A. N., 1992, PALEORIENT, V18, P47, DOI DOI 10.3406/PALE0.1992.4562; Garrard A.N, 2013, FERTILE CRESCENT LAT; Gibson D. J., 2009, GRASSES GRASSLAND EC; Goring-Morris AN, 2011, CURR ANTHROPOL, V52, pS195, DOI 10.1086/658860; GOTT B, 1982, Archaeology in Oceania, V17, P59; Gott B., 1999, AUSTR ABORIGINAL STU, V1, P33; Greiss EAM., 1957, ANATOMICAL IDENTIFIC; Hather JG., 2002, HUNTER GATHERER ARCH, P128; Hayden B., 2004, LAST HUNTER GATHERER, P263; Hillman GC., 1989, PREHISTORY WADI KUBB, P162; Jochim M., 1976, HUNTER GATHERER SUBS; Jones JR, 2012, QUATERN INT, V252, P195, DOI 10.1016/j.quaint.2011.09.001; Jones MD, 2016, QUATERN INT, V396, P95, DOI 10.1016/j.quaint.2015.08.092; Jones MD, 2011, QUATERNARY RES, V76, P363, DOI 10.1016/j.yqres.2011.07.005; KISLEV ME, 1992, REV PALAEOBOT PALYNO, V73, P161, DOI 10.1016/0034-6667(92)90054-K; LECOHU MC, 1973, CR ACAD SCI D NAT, V277, P1301; Lee R.B., 1968, MAN HUNTER; Levy T. E., 1995, ARCHAEOLOGY SOC HOLY, P169; Liu LD, 2013, QUATERN INT, V304, P193, DOI 10.1016/j.quaint.2013.03.020; Macumber P.G., 2001, ARCHAEOLOGY JORDAN, P1; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Madella M, 2009, QUATERN INT, V193, P32, DOI 10.1016/j.quaint.2007.06.012; Maher L. A., 2012, CBRL B, V7, P42, DOI DOI 10.1179/1752726012Z.0000000006; Maher LA, 2013, EXCAVATIONS EPIPALAE; Maher LA, 2009, EXCAVATIONS EPIPALAE; Maher LA, 2010, EXCAVATIONS EPIPALAE; Maher LA, 2008, EXCAVATIONS EPIPALAE; Maher LA, 2016, QUATERN INT, V396, P79, DOI 10.1016/j.quaint.2015.07.054; Maher LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031447; Maher LA, 2012, EVOL ANTHROPOL, V21, P69, DOI 10.1002/evan.21307; Martin L, 2010, LEVANT, V42, P107, DOI 10.1179/175638010X12797237885613; Mellaart J., 1975, NEOLITHIC NEAR E; Metcalf CR., 1960, ANATOMY MONOCOTYLEDO; METCALF CR, 1971, ANATOMY MONOCOTYLEDO; Muheisen M., 1988, BRIT ARCHAEOLOGICAL, Vvol. 396, P353; Nadel D, 2012, ANTIQUITY, V86, P990, DOI 10.1017/S0003598X00048201; Noble P, 1998, ARID LAND RESOURCES, P103; Novello A, 2015, J ARCHAEOL SCI, V59, P10, DOI 10.1016/j.jas.2015.03.031; OLLENDORF AL, 1987, ISRAEL J BOT, V36, P125; Olszewski DI, 2004, BRIT ARCHAEOLOGIC S, V1320, P189; Perrot J, 1968, DICT BIBLE S, V8, P286; Piperno DR, 2004, NATURE, V430, P670, DOI 10.1038/nature02734; Power RC, 2014, J ANTHROPOL ARCHAEOL, V33, P49, DOI 10.1016/j.jaa.2013.11.002; Ramsey MN, SHELTERED REEDS SETT; Ramsey MN, CTR WETLANDS UNPUB; Ramsey MN, 2016, QUATERN INT, V396, P5, DOI 10.1016/j.quaint.2015.10.109; Ramsey MN, 2015, HOLOCENE, V25, P1553, DOI 10.1177/0959683615594240; Richter T, 2013, LEVANT, V45, P121, DOI 10.1179/0075891413Z.00000000020; Richter T, 2013, J QUATERNARY SCI, V28, P467, DOI 10.1002/jqs.2629; Richter T, 2011, CAMB ARCHAEOL J, V21, P95, DOI 10.1017/S0959774311000060; Rollefson G, PREHISTORY JORDAN; Rollefson G.O., 1983, B AM SCH ORIENTAL RE, V252, P25; Rosen A., 2011, EURASIAN PREHISTORY, V7, P113; Rosen A, 2012, FOUILLES TERRASSE HA, P85; Rosen A., 1999, PHYTOLITH EXTR UNPUB; Rosen A.M., 2007, J ISRAEL PREHISTORIC, V37, P340; Rosen A.M., 1999, PRACTICAL IMPACT SCI, P9; Rosen A.M., 1992, PHYTOLITH SYSTEMATIC, P129; Rosen AM., 2013, NATUFIAN CULTURE LEV, P638; Rosen AM, 2012, P NATL ACAD SCI USA, V109, P3640, DOI 10.1073/pnas.1113931109; Rosen Arlene M., 2012, NEW PERSPECTIVES HOS, P165; Rosen Arlene M., 2011, SUSTAINABLE LIFEWAYS, P128; Roskin J, 2014, QUATERNARY SCI REV, V99, P176, DOI 10.1016/j.quascirev.2014.06.018; Rowley-Conwy P, 2001, BIOSOCIAL S, V13, P39; Ryan P., 2009, THESIS; Ryan P, 2011, J ANTHROPOL ARCHAEOL, V30, P292, DOI 10.1016/j.jaa.2011.06.002; SANGSTER AG, 1969, ANN BOT-LONDON, V33, P315, DOI 10.1093/oxfordjournals.aob.a084285; Savard M, 2006, WORLD ARCHAEOL, V38, P179, DOI 10.1080/00438240600689016; Sellars J.R, 1998, BAR INT SERIES, P83; Simms, 1987, BAR INT SERIES, V381; SIMON HA, 1956, PSYCHOL REV, V63, P129, DOI 10.1037/h0042769; Snir A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131422; Snir A, 2015, J ARCHAEOL SCI, V53, P61, DOI 10.1016/j.jas.2014.09.023; Steward JH, 1934, U CALIFORNIA PUBLICA, VXXXIII, P233; Steward JH, 1938, BUR AM ETHNOL BULL, P1; Twiss KC, 2004, LAST HUNTER GATHERER, P211; Twiss P.C., 1992, PHYTOLITH SYSTEMATIC, P113, DOI DOI 10.1007/978-1-4899-1155-1; TWISS PC, 1969, SOIL SCI SOC AM PRO, V33, P109, DOI 10.2136/sssaj1969.03615995003300010030x; Twiss PC, 2001, PHYTOLITHS: APPLICATIONS IN EARTH SCIENCES AND HUMAN HISTORY, P7; Valla F.R., 2012, FOUILLES TERRASSE HA; Watkins T., 2005, HUMAN WORLD PREHISTO, P201; Watkins T, 2010, ANTIQUITY, V84, P621, DOI 10.1017/S0003598X00100122; Weinstein-Evron M., 2009, ARCHAEOLOGY ARCH UNV; Weiss E, 2004, ECON BOT, V58, pS125, DOI 10.1663/0013-0001(2004)58[S125:SWGASF]2.0.CO;2; Weiss E, 2004, P NATL ACAD SCI USA, V101, P9551, DOI 10.1073/pnas.0402362101; Weiss E, 2008, J ARCHAEOL SCI, V35, P2400, DOI 10.1016/j.jas.2008.03.012; Wollstonecroft MM, 2011, VEG HIST ARCHAEOBOT, V20, P459, DOI 10.1007/s00334-011-0305-3; Wollstonecroft MM, 2008, VEG HIST ARCHAEOBOT, V17, pS19, DOI 10.1007/s00334-008-0162-x; Wollstonecroft Michele M., 2009, FORAGERS FARMERS PAP, P127; Wollstonecroft MM, 2007, THESIS; Wrangham R, 2009, AM J PHYS ANTHROPOL, V140, P630, DOI 10.1002/ajpa.21122; Zeder MA, 2012, J ANTHROPOL ARCHAEOL, V31, P241, DOI 10.1016/j.jaa.2012.03.003	132	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164081	10.1371/journal.pone.0164081	http://dx.doi.org/10.1371/journal.pone.0164081			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760164	Green Published, Green Submitted, gold			2022-12-26	WOS:000386204000025
J	Somabhai, CA; Raghuvanshi, R; Nareshkumar, G				Somabhai, Chaudhari Archana; Raghuvanshi, Ruma; Nareshkumar, G.			Genetically Engineered Escherichia coli Nissle 1917 Synbiotics Reduce Metabolic Effects Induced by Chronic Consumption of Dietary Fructose	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; PYRROLOQUINOLINE-QUINONE; OXIDATIVE STRESS; GUT MICROBIOTA; HYPERLIPIDEMIA; PREBIOTICS; PROTECTS; SYSTEM; DAMAGE; RATS	Aims To assess protective efficacy of genetically modified Escherichia coli Nissle 1917 (EcN) on metabolic effects induced by chronic consumption of dietary fructose. Materials and Methods EcN was genetically modified with fructose dehydrogenase (fdh) gene for conversion of fructose to 5-keto-D-fructose and mannitol-2-dehydrogenase (mt/K) gene for conversion to mannitol, a prebiotic. Charles foster rats weighing 150-200 g were fed with 20% fructose in drinking water for two months. Probiotic treatment of EcN (pqq), EcN (pqq-glf-mt/K), EcN (pqq-fdh) was given once per week 109 cells for two months. Furthermore, blood and liver parameters for oxidative stress, dyslipidemia and hyperglycemia were estimated. Fecal samples were collected to determine the production of short chain fatty acids and pyrroloquinoline quinone (PQQ) production. Results EcN (pqq-glf-mtIK), EcN (pqq-fdh) transformants were confirmed by restriction digestion and functionality was checked by PQQ estimation and HPLC analysis. There was significant increase in body weight, serum glucose, liver injury markers, lipid profile in serum and liver, and decrease in antioxidant enzyme activity in high-fructose-fed rats. However the rats treated with EcN (pqq-glf-mt/K) and EcN (pqq-fdh) showed significant reduction in lipid peroxidation along with increase in serum and hepatic antioxidant enzyme activities. Restoration of liver injury marker enzymes was also seen. Increase in short chain fatty acids (SCFA) demonstrated the prebiotic effects of mannitol and gluconic acid. Conclusions Our study demonstrated the effectiveness of probiotic EcN producing PQQ and fructose metabolizing enzymes against the fructose induced hepatic steatosis suggesting that its potential for use in treating fructose induced metabolic syndrome.	[Somabhai, Chaudhari Archana; Raghuvanshi, Ruma; Nareshkumar, G.] Maharaja Sayajirao Univ Baroda, Dept Biochem, Fac Sci, Vadodara 390002, Gujarat, India	Maharaja Sayajirao University Baroda	Nareshkumar, G (corresponding author), Maharaja Sayajirao Univ Baroda, Dept Biochem, Fac Sci, Vadodara 390002, Gujarat, India.	gnaresh_k@yahoo.co.in	Gattupalli, Naresh Kumar/AAF-5987-2020		DBT and ICMR, New Delhi, India	DBT and ICMR, New Delhi, India	Chaudhari Archana Somabhai and Ruma Raghuvanshi are supported by Senior Research Fellowship of DBT and ICMR, New Delhi, India respectively.; We thank Dr. Rer. Nat. Ulrich Sonnenborn, Ardeypharm GmbH, Loerfeldstrabe 20, Herdecke (Germany) for providing Escherichia coli Nissle 1917, and the DBT-ILSPARE Program for carrying out real-time PCR and HPLC experiments. Chaudhari Archana Somabhai and Ruma Raghuvanshi are supported by Senior Research Fellowship of DBT and ICMR, New Delhi, India respectively.	Anandharaj M, 2014, CHINESE J BIOL  0227; BEERS RF, 1952, J BIOL CHEM, V195, P133; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Buch AD, 2009, MICROBIOL-SGM, V155, P2620, DOI 10.1099/mic.0.028878-0; Buege J A, 1978, Methods Enzymol, V52, P302; Busserolles J, 2003, MAGNESIUM RES, V16, P7; Chen ZY, 2014, J CLIN INVEST, V124, P3391, DOI 10.1172/JCI72517; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Frece J, 2009, J DAIRY RES, V76, P98, DOI 10.1017/S0022029908003737; Greenway F, 2014, BENEF MICROBES, V5, P29, DOI 10.3920/BM2012.0063; Gyaneshwar P, 1999, FEMS MICROBIOL LETT, V171, P223, DOI 10.1111/j.1574-6968.1999.tb13436.x; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Hsieh FC, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-35; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Kameue C, 2004, J NUTR, V134, P940, DOI 10.1093/jn/134.4.940; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Kornberg HL, 2000, P NATL ACAD SCI USA, V97, P1808, DOI 10.1073/pnas.97.4.1808; Kumar P., 2014, BIOMED RES INT; Kumazawa T, 2007, INT J MOL MED, V19, P765; Liu SQ, 2005, APPL BIOCHEM BIOTECH, V121, P391, DOI 10.1385/ABAB:121:1-3:0391; Maekawa Makiko, 2005, Microbial Ecology in Health and Disease, V17, P169, DOI 10.1080/08910600500430730; Mamikutty N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/263897; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Metabolic KA., 2010, PHYSIOL REV, V90, P23, DOI [10.1152/physrev.00019.2009, DOI 10.1152/PHYSREV.00019.2009]; Misra HS, 2012, J BIOSCIENCES, V37, P313, DOI 10.1007/s12038-012-9195-5; Pandey S, 2015, CURR MICROBIOL, V70, P690, DOI 10.1007/s00284-014-0763-9; Pandey S, 2014, APPL BIOCHEM BIOTECH, V173, P775, DOI 10.1007/s12010-014-0897-z; Park DY, 2013, WORLD J GASTROENTERO, V19, P274, DOI 10.3748/wjg.v19.i2.274; Parks EJ, 2008, J NUTR, V138, P1039, DOI 10.1093/jn/138.6.1039; Rucker R, 2009, ALTERN MED REV, V14, P268; Saier MH, 1996, RES MICROBIOL, V147, P482, DOI 10.1016/S0923-2508(96)90150-3; Sambrook J., 2001, MOL CLONING LAB MANU; Shen B, 1997, PLANT PHYSIOL, V115, P527, DOI 10.1104/pp.115.2.527; Singh AK, 2014, ALCOHOL CLIN EXP RES, V38, P2127, DOI 10.1111/acer.12456; Singh AK, 2015, EXP GERONTOL, V66, P1, DOI 10.1016/j.exger.2015.04.001; Singh DP, 2015, INT J OBESITY; SUZUKI O, 1990, LIFE SCI, V47, P2135, DOI 10.1016/0024-3205(90)90313-G; Westendorf AM, 2005, FEMS IMMUNOL MED MIC, V43, P373, DOI 10.1016/j.femsim.2004.10.023	39	12	14	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164860	10.1371/journal.pone.0164860	http://dx.doi.org/10.1371/journal.pone.0164860			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760187	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204000061
J	De Castro, O; Di Maio, A; Di Febbraro, M; Imparato, G; Innangi, M; Vela, E; Menale, B				De Castro, Olga; Di Maio, Antonietta; Di Febbraro, Mirko; Imparato, Gennaro; Innangi, Michele; Vela, Errol; Menale, Bruno			A Multi-Faceted Approach to Analyse the Effects of Environmental Variables on Geographic Range and Genetic Structure of a Perennial Psammophilous Geophyte: The Case of the Sea Daffodil Pancratium maritimum L. in the Mediterranean Basin	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; LAST GLACIAL MAXIMUM; CLIMATE-CHANGE; POPULATION-STRUCTURE; AMARYLLIDACEAE; SOFTWARE; CONSERVATION; DISPERSAL; INFERENCE; FUTURE	The Mediterranean coastline is a dynamic and complex system which owes its complexity to its past and present vicissitudes, e.g. complex tectonic history, climatic fluctuations, and prolonged coexistence with human activities. A plant species that is widespread in this habitat is the sea daffodil, Pancratium maritimum (Amaryllidaceae), which is a perennial clonal geophyte of the coastal sands of the Mediterranean and neighbouring areas, well adapted to the stressful conditions of sand dune environments. In this study, an integrated approach was used, combining genetic and environmental data with a niche modelling approach, aimed to investigate: (1) the effect of climate change on the geographic range of this species at different times {past (last inter-glacial, LIG; and last glacial maximum, LGM), present (CURR), near-future (FUT)} and (2) the possible influence of environmental variables on the genetic structure of this species in the current period. The genetic results show that 48 sea daffodil populations (867 specimens) display a good genetic diversity in which the marginal populations (i.e. Atlantic Sea populations) present lower values. Recent genetic signature of bottleneck was detected in few populations (8%). The molecular variation was higher within the populations (77%) and two genetic pools were well represented. Comparing the different climatic simulations in time, the global range of this plant increased, and a further extension is foreseen in the near future thanks to projections on the climate of areas currently-more temperate, where our model suggested a forecast for a climate more similar to the Mediterranean coast. A significant positive correlation was observed between the genetic distance and Precipitation of Coldest Quarter variable in current periods. Our analyses support the hypothesis that geomorphology of the Mediterranean coasts, sea currents, and climate have played significant roles in shaping the current genetic structure of the sea daffodil especially during LGM because of strong variation in coastline caused by glaciations.	[De Castro, Olga; Di Maio, Antonietta; Menale, Bruno] Univ Naples Federico II, Dept Biol, Naples, Italy; [Di Febbraro, Mirko] Univ Molise, Dept Biosci & Terr, Pesche, Isernia, Italy; [Imparato, Gennaro] Univ Naples Federico II, Dept Elect & Informat Technol Engn, Naples, Italy; [Innangi, Michele] Univ Naples 2, Dept Environm Biol Pharmaceut Sci & Technol, Caserta, Italy; [Vela, Errol] Univ Montpellier, Res Unit Bot & Modelling Plant Architecture & Veg, Montpellier, France	University of Naples Federico II; University of Molise; University of Naples Federico II; Universita della Campania Vanvitelli; Universite de Montpellier	De Castro, O (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	olga.decastro@unina.it	Innangi, Michele/M-2205-2015; Di Febbraro, Mirko/I-3167-2019; Di Febbraro, Mirko/GQA-4462-2022	Innangi, Michele/0000-0003-2362-6025; DE CASTRO, Olga/0000-0002-4861-3960; Di Febbraro, Mirko/0000-0001-8898-7046	Nando and Elsa Peretti Foundation [201283]	Nando and Elsa Peretti Foundation	This work was supported by the Nando and Elsa Peretti Foundation (grant number 201283), http://www.nandoperettifound.org/en/page.php?project=449, ODC.; This work was supported by the Nando and Elsa Peretti Foundation (grant number 201283).	Abeli T, 2014, J BIOGEOGR, V41, P239, DOI 10.1111/jbi.12215; Algar AC, 2009, ECOGRAPHY, V32, P22, DOI 10.1111/j.1600-0587.2009.05832.x; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2002, FSTAT VERSION 2 9 3; Arafeh R, 2006, J BIOGEOGR, V33, P1461, DOI 10.1111/j.1365-2699.2006.01512.x; Arcangeli G., 1896, B SOC BOT ITALIANA, V8, P278; Austerlitz F, 2000, GENETICS, V154, P1309; Balestri E, 2004, J COASTAL RES, V20, P761, DOI 10.2112/1551-5036(2004)20[761:GAEECO]2.0.CO;2; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Biju-Duval B, 1977, INIT REPTS DEEP SEA, P951; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; BURTT BL, 1970, ISRAEL J BOT, V19, P77; Bystriakova N, 2014, ANN BOT-LONDON, V113, P453, DOI 10.1093/aob/mct274; Camprubi A, 2012, PLANT SOIL, V351, P97, DOI 10.1007/s11104-011-0933-5; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Ciccarelli D, 2015, ESTUAR COAST SHELF S, V165, P247, DOI 10.1016/j.ecss.2015.05.023; Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003; Cornuet JM, 1996, GENETICS, V144, P2001; Correggiari AM, 1996, J QUATERNARY SCI, V9, P697; Curr R. H. F., 2000, Journal of Coastal Conservation, V6, P15, DOI 10.1007/BF02730463; DAFNI A, 1981, ANN MO BOT GARD, V68, P652, DOI 10.2307/2398893; De Castro O, 2016, PLANT BIOSYST; De Castro O, 2012, BOT J LINN SOC, V170, P12, DOI 10.1111/j.1095-8339.2012.01268.x; de Witte LC, 2010, ANN BOT-LONDON, V106, P859, DOI 10.1093/aob/mcq191; Demir Z, 2010, J FOOD AGRIC ENVIRON, V8, P890; DeWoody JA, 2006, MOL ECOL NOTES, V6, P951, DOI 10.1111/j.1471-8286.2006.01449.x; Di Febbraro M, 2015, DIVERS DISTRIB, V21, P1141, DOI 10.1111/ddi.12362; Di Maio A, 2013, CONSERV GENET RESOUR, V5, P911, DOI 10.1007/s12686-013-9931-7; Dickson ME, 2007, CLIMATIC CHANGE, V84, P141, DOI 10.1007/s10584-006-9200-9; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dubuis A, 2011, DIVERS DISTRIB, V17, P1122, DOI 10.1111/j.1472-4642.2011.00792.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EISIKOWITCH D, 1971, Journal of Animal Ecology, V40, P673, DOI 10.2307/3444; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Escudero M, 2010, MOL ECOL, V19, P352, DOI 10.1111/j.1365-294X.2009.04449.x; European Environment Agency, 2014, WHAT IS TREND MEAN S; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fascetti S, 2014, ITAL J AGRON, V9, P99, DOI 10.4081/ija.2014.595; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzpatrick MC, 2011, ECOGRAPHY, V34, P836, DOI 10.1111/j.1600-0587.2011.06653.x; Gaetano J, 2013, HOLM BONFERRONI SEQU; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Giovino A, 2015, ACTA BOT GALLICA, V162, P289, DOI 10.1080/12538078.2015.1089416; Goffredo S, 2014, Mediterranean Sea: Its History and Present Challenges, P1, DOI 10.1007/978-94-007-6704-1; Grassi F, 2005, BIODIVERS CONSERV, V14, P2159, DOI 10.1007/s10531-004-4666-0; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOLDSWORTH M., 1961, Journal of the West African Science Association, V7, P28; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Innangi M, 2015, CLIM RES, V66, P25, DOI 10.3354/cr01323; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kadereit JW, 2005, TAXON, V54, P861, DOI 10.2307/25065473; KEREN A, 1974, ISRAEL J BOT, V23, P202; Khedr AHA, 2003, J EXP BOT, V54, P2553, DOI 10.1093/jxb/erg277; Lambeck K, 2005, QUATERNARY SCI REV, V24, P1969, DOI 10.1016/j.quascirev.2004.06.025; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Lionello P, 2012, ELSEV INSIGHT, pXXXV, DOI 10.1016/b978-0-12-416042-2.00012-4; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Luikart G, 1997, USEFULNESS MOL MARKE; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Mayol M, 2015, NEW PHYTOL, V208, P973, DOI 10.1111/nph.13496; Medrano M, 1999, FLORA, V194, P13, DOI 10.1016/S0367-2530(17)30875-7; Medrano M, 2000, AM J BOT, V87, P493, DOI 10.2307/2656592; Mira S, 2012, 6 EUR BOT GARD C MAY, P102; Nevill PG, 2014, ANN BOT-LONDON, V113, P55, DOI 10.1093/aob/mct253; Nikopoulos D, 2008, J FOOD AGRIC ENVIRON, V6, P538; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrone R, 2015, FLORA, V213, P20, DOI 10.1016/j.flora.2015.03.001; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Prisco I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068850; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2012, R LANG ENV STAT COMP; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Ricciardi M., 2004, Webbia, V59, P1; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rovere A, 2012, ALP MEDLTERR QUAT, V25, P3; Sanaa A, 2016, BIOSYSTEMS, V144, P27, DOI 10.1016/j.biosystems.2016.04.006; Sanaa A, 2015, BIOSYSTEMS, V129, P19, DOI 10.1016/j.biosystems.2015.02.001; Sanaa A, 2010, SCI HORTIC-AMSTERDAM, V125, P740, DOI 10.1016/j.scienta.2010.05.014; Schlacher TA, 2008, MAR ECOL-EVOL PERSP, V29, P70, DOI 10.1111/j.1439-0485.2007.00204.x; Shaltout M, 2015, OCEANOLOGIA, V57, P293, DOI 10.1016/j.oceano.2015.06.004; Shaltout M, 2014, OCEANOLOGIA, V56, P411, DOI 10.5697/oc.56-3.411; Stanley D. J, 1985, GEOLOGICAL EVOLUTION; Strubbe D, 2015, ECOGRAPHY, V38, P321, DOI 10.1111/ecog.00632; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Wang IJ, 2013, EVOLUTION, V67, P3403, DOI 10.1111/evo.12134; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WERKER E, 1975, BOT GAZ, V136, P396, DOI 10.1086/336832; Zahreddine H, 2004, BIOL CONSERV, V120, P11, DOI 10.1016/j.biocon.2004.01.021; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	108	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164816	10.1371/journal.pone.0164816	http://dx.doi.org/10.1371/journal.pone.0164816			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749920	Green Published, gold, Green Submitted			2022-12-26	WOS:000386202300032
J	He, L; Law, PTY; Boon, SS; Zhang, C; Ho, WCS; Banks, L; Wong, CK; Chan, JCN; Chan, PKS				He, Lan; Law, Priscilla T. Y.; Boon, Slaw Shi; Zhang, Chuqing; Ho, Wendy C. S.; Banks, Lawrence; Wong, C. K.; Chan, Juliana C. N.; Chan, Paul K. S.			Increased Growth of a Newly Established Mouse Epithelial Cell Line Transformed with HPV-16 E7 in Diabetic Mice	PLOS ONE			English	Article							CERVICAL-CANCER; BINDING; BREAST; HEAD; P600	Epidemiological evidence supports that infection with high-risk types of human papillomavirus (HPV) can interact with host and environmental risk factors to contribute to the development of cervical, oropharyngeal, and other anogenital cancers. In this study, we established a mouse epithelial cancer cell line, designated as Chinese University Papillomavirus-1 (CUP-1), from C57BL/KsJ mice through persistent expression of HPV-16 E7 oncogene. After continuous culturing of up to 200 days with over 60 passages, we showed that CUP-1 became an immortalized and transformed epithelial cell line with continuous E7 expression and persistent reduction of retinoblastoma protein (a known target of E7). This model allowed in-vivo study of interaction between HPV and co-factors of tumorigenesis in syngeneic mice. Diabetes has been shown to increase HPV pathogenicity in different pathological context. Herein, with this newly-established cell line, we uncovered that diabetes promoted CUP-1 xenograft growth in syngeneic db/db mice. In sum, we successfully established a HPV-16 E7 transformed mouse epithelial cell line, which allowed subsequent studies of co-factors in multistep HPV carcinogenesis in an immunocompetent host. More importantly, this study is the very first to demonstrate the promoting effect of diabetes on HPV-associated carcinogenesis in vivo, implicating the importance of cancer surveillance in diabetic environment.	[He, Lan; Law, Priscilla T. Y.; Boon, Slaw Shi; Zhang, Chuqing; Ho, Wendy C. S.; Chan, Paul K. S.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [He, Lan; Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [He, Lan; Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Wong, C. K.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong Inst Diabet & Obes, Shatin, Hong Kong, Peoples R China; [Banks, Lawrence] Int Ctr Genet Engn & Biotechnol, Trieste, Italy	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; International Center for Genetic Engineering & Biotechnology (ICGEB)	Chan, PKS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China.	paulkschan@cuhk.edu.hk	Wong, CK/H-3256-2016; Chan, Paul KS/J-9360-2013; Chan, Juliana/B-7918-2016; Boon, Siaw Shi/AEI-9150-2022	Wong, CK/0000-0002-5637-8331; Chan, Paul KS/0000-0002-6360-4608; Chan, Juliana/0000-0003-1325-1194; Boon, Siaw Shi/0000-0001-9772-2971				BOSCH FX, 1994, INT J EPIDEMIOL, V23, P1100, DOI 10.1093/ije/23.5.1100-a; Coppock JD, 2013, NEOPLASIA, V15, P620, DOI 10.1593/neo.13432; CROOK T, 1991, CELL, V67, P547, DOI 10.1016/0092-8674(91)90529-8; DeMasi J, 2005, P NATL ACAD SCI USA, V102, P11486, DOI 10.1073/pnas.0505322102; Gammoh N, 2006, J VIROL, V80, P1787, DOI 10.1128/JVI.80.4.1787-1797.2006; Hess CB, 2014, JAMA OTOLARYNGOL, V140, P312, DOI 10.1001/jamaoto.2013.6732; Huh KW, 2005, P NATL ACAD SCI USA, V102, P11492, DOI 10.1073/pnas.0505337102; Jimenez-Garcia R, 2009, DIABETES CARE, V32, P1470, DOI 10.2337/dc09-0479; Lee CH, 2010, INT J CANCER, V127, P932, DOI 10.1002/ijc.25108; Liu CJ, 2015, ONCOTARGET, V6, P29268, DOI 10.18632/oncotarget.4922; MATLASHEWSKI G, 1989, ANTICANCER RES, V9, P1447; Navarro-Meza Monica, 2011, Ginecol Obstet Mex, V79, P771; Raaschou-Nielsen O, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-67; Richard C, 2010, ONCOGENE, V29, P3435, DOI 10.1038/onc.2010.93; Schmidt MT, 2005, ACTA BIOCHIM POL, V52, P823; Smetana K, 2008, ONCOL REP, V20, P75; Wang JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001089; Wolf I, 2006, CANCER RES, V66, P7818, DOI 10.1158/0008-5472.CAN-05-4368; Yong M, 2010, INT J STD AIDS, V21, P457, DOI 10.1258/ijsa.2010.010061; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	20	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164490	10.1371/journal.pone.0164490	http://dx.doi.org/10.1371/journal.pone.0164490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749912	gold, Green Submitted, Green Published			2022-12-26	WOS:000386202300014
J	Rehman, M; Gurrapu, S; Cagnoni, G; Capparuccia, L; Tamagnone, L				Rehman, Michael; Gurrapu, Sreeharsha; Cagnoni, Gabriella; Capparuccia, Lorena; Tamagnone, Luca			PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN PROSTATE-CANCER; MEDIATED ACTIVATION; BREAST-CANCER; SEMAPHORIN 3E; EMERGING ROLE; TUMOR-CELLS; EXPRESSION; INVASION; JAGGED-1	The secreted semaphorin Sema3E controls cell migration and invasiveness in cancer cells. Sema3E-receptor, PlexinD1, is frequently upregulated in melanoma, breast, colon, ovarian and prostate cancers; however, the mechanisms underlying PlexinD1 upregulation and the downstream events elicited in tumor cells are still unclear. Here we show that the canonical RBPjk-dependent Notch signaling cascade controls PlexinD1 expression in primary endothelial and cancer cells. Transcriptional activation was studied by quantitative PCR and promoter activity reporter assays. We found that Notch ligands and constitutively activated intracellular forms of Notch receptors upregulated PlexinD1 expression; conversely RNAi-based knock-down, or pharmacological inhibition of Notch signaling by gamma-secretase inhibitors, downregulated PlexinD1 levels. Notably, both Notch1 and Notch3 expression positively correlates with PlexinD1 levels in prostate cancer, as well as in other tumor types. In prostate cancer cells, Sema3E-PlexinD1 axis was previously reported to regulate migration; however, implicated mechanisms were not elucidated. Here we show that in these cells PlexinD1 activity induces the expression of the transcription factor Slug, down-regulates E-cadherin levels and enhances cell migration. Moreover, our mechanistic data identify PlexinD1 as a pivotal mediator of this signaling axis downstream of Notch in prostate cancer cells. In fact, on one hand, PlexinD1 is required to mediate cell migration and E-cadherin regulation elicited by Notch. On the other hand, PlexinD1 upregulation is sufficient to induce prostate cancer cell migration and metastatic potential in mice, leading to functional rescue in the absence of Notch. In sum, our work identifies PlexinD1 as a novel transcriptional target induced by Notch signaling, and reveals its role promoting prostate cancer cell migration and downregulating E-cadherin levels in Slug-dependent manner. Collectively, these findings suggest that Notch-PlexinD1 signaling axis may be targeted to impair prostate cancer cell invasiveness and metastasis.	[Rehman, Michael; Gurrapu, Sreeharsha; Cagnoni, Gabriella; Capparuccia, Lorena; Tamagnone, Luca] IRCCS, Candiolo Canc Inst FPO, Canc Cell Biol Lab, Candiolo, Italy; [Rehman, Michael; Gurrapu, Sreeharsha; Cagnoni, Gabriella; Capparuccia, Lorena; Tamagnone, Luca] Univ Turin, Dept Oncol, Turin, Italy; [Rehman, Michael] Int Ctr Genet Engn & Biotechnol, Trieste, Italy	IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; International Center for Genetic Engineering & Biotechnology (ICGEB)	Tamagnone, L (corresponding author), IRCCS, Candiolo Canc Inst FPO, Canc Cell Biol Lab, Candiolo, Italy.; Tamagnone, L (corresponding author), Univ Turin, Dept Oncol, Turin, Italy.	luca.tamagnone@ircc.it	Tamagnone, Luca/J-8948-2018; Gurrapu, Sreeharsha/AAY-7872-2020; Rehman, Michael/W-2855-2019	Tamagnone, Luca/0000-0002-2884-7946; Gurrapu, Sreeharsha/0000-0003-2195-2767; Cagnoni, Gabriella/0000-0002-9718-0321	Italian Association for Cancer Research (AIRC) [2014-15179]; Fondazione Piemontese per la Ricerca sul Cancro (FPRC-ONLUS) [Vaschetto - 5]; Italian Ministry of Health (Ricerca Corrente)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Piemontese per la Ricerca sul Cancro (FPRC-ONLUS); Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy)	The work was supported by grants from Italian Association for Cancer Research (AIRC)(IG #2014-15179) and the Fondazione Piemontese per la Ricerca sul Cancro (FPRC-ONLUS)(Grant "MIUR 2010 Vaschetto - 5 per mille 2010 MIUR").; We gratefully acknowledge Silvia Giordano and Federico Bussolino (IRCC-Candiolo, Italy), Isabella Screpanti and Claudio Talora (Sapienza University of Rome, Italy), Takayasu Kato (University of Tsukuba, Japan), Alain Israel (Pasteur Institute, France) for generously sharing reagents. We thank Massimo Accardo for excellent technical assistance with experiments in mice and Guendalina Lombardo for help with IHC analysis. We thank all members of Tamagnone laboratory for discussions. The work was supported by grants from: Italian Association for Cancer Research (AIRC; IG #2014-15179), the Fondazione Piemontese per la Ricerca sul Cancro (FPRC-ONLUS; Grant "MIUR 2010 Vaschetto-5 per mille 2010 MIUR") and the Italian Ministry of Health (Ricerca Corrente 2016).	Andersen P, 2012, TRENDS CELL BIOL, V22, P257, DOI 10.1016/j.tcb.2012.02.003; Bin Hafeez B, 2009, CLIN CANCER RES, V15, P452, DOI 10.1158/1078-0432.CCR-08-1631; Blanc V, 2011, PROSTATE, V71, P649, DOI 10.1002/pros.21281; Bolos V, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3447; Casazza A, 2011, ARTERIOSCL THROM VAS, V31, P741, DOI 10.1161/ATVBAHA.110.211920; Casazza A, 2010, J CLIN INVEST, V120, P2684, DOI 10.1172/JCI42118; Cotter M, 2000, J VIROL, V74, P1486, DOI 10.1128/JVI.74.3.1486-1494.2000; Danza G, 2013, INT J CANCER, V133, P2577, DOI 10.1002/ijc.28293; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Espinoza I, 2013, PHARMACOL THERAPEUT, V139, P95, DOI 10.1016/j.pharmthera.2013.02.003; Follenzi A, 2004, BLOOD, V103, P3700, DOI 10.1182/blood-2003-09-3217; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gay CM, 2011, DEV BIOL, V349, P1, DOI 10.1016/j.ydbio.2010.09.008; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Guichet PO, 2015, STEM CELLS, V33, P21, DOI 10.1002/stem.1767; Hansson EM, 2006, DEV NEUROSCI-BASEL, V28, P118, DOI 10.1159/000090758; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kato H, 1997, DEVELOPMENT, V124, P4133; Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011; Kong T, 2013, AFR J BIOTECHNOL ACA, V10, P17579; Luchino J, 2013, CANCER CELL, V24, P673, DOI 10.1016/j.ccr.2013.09.010; Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036; Piazzi G, 2011, ONCOTARGET, V2, P1291; Pietras A, 2011, MOL CANCER RES, V9, P626, DOI 10.1158/1541-7786.MCR-10-0508; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Reedijk M, 2008, INT J ONCOL, V33, P1223, DOI 10.3892/ijo_00000112; Rehman M, 2013, SEMIN CELL DEV BIOL, V24, P179, DOI 10.1016/j.semcdb.2012.10.005; Roodink I, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-297; Rubin MA, 2001, HUM PATHOL, V32, P690, DOI 10.1053/hupa.2001.25902; Saad S, 2010, INT J BIOCHEM CELL B, V42, P1115, DOI 10.1016/j.biocel.2010.03.016; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Samatov TR, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-107; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Shao S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0295-3; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2012, CANCER CELL, V22, P145, DOI 10.1016/j.ccr.2012.06.031; Terada N, 2014, J CELL BIOCHEM, V115, P1505, DOI 10.1002/jcb.24805; Therapontos C, 2010, DEV DYNAM, V239, P2761, DOI 10.1002/dvdy.22410; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Tolcher AW, 2012, J CLIN ONCOL, V30, P2348, DOI 10.1200/JCO.2011.36.8282; Torreggiani E, 2012, J CELL MOL MED, V16, P740, DOI 10.1111/j.1582-4934.2011.01352.x; Tseng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019396; Wang ZW, 2010, CURR DRUG TARGETS, V11, P745, DOI 10.2174/138945010791170860; Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451; ZAGOURAS P, 1995, P NATL ACAD SCI USA, V92, P6414, DOI 10.1073/pnas.92.14.6414; Zhu H, 2013, AM J TRANSL RES, V5, P368; Zygmunt T, 2011, DEV CELL, V21, P301, DOI 10.1016/j.devcel.2011.06.033	52	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2016	11	10							e0164660	10.1371/journal.pone.0164660	http://dx.doi.org/10.1371/journal.pone.0164660			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NL	27749937	Green Submitted, Green Published, gold			2022-12-26	WOS:000386202300020
J	Aho-Ozhan, HEA; Keller, J; Heimrath, J; Uttner, I; Kassubek, J; Birbaumer, N; Ludolph, AC; Lule, D				Aho-Oezhan, Helena E. A.; Keller, Juergen; Heimrath, Johanna; Uttner, Ingo; Kassubek, Jan; Birbaumer, Niels; Ludolph, Albert C.; Lule, Dorothee			Perception of Emotional Facial Expressions in Amyotrophic Lateral Sclerosis (ALS) at Behavioural and Brain Metabolic Level	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTICAL HYPEREXCITABILITY; MEMORY; METAANALYSIS; ACTIVATION; DEPRESSION; FMRI; HIPPOCAMPUS; DYSFUNCTION; RESPONSES	Introduction Amyotrophic lateral sclerosis (ALS) primarily impairs motor abilities but also affects cognition and emotional processing. We hypothesise that subjective ratings of emotional stimuli depicting social interactions and facial expressions is changed in ALS. It was found that recognition of negative emotions and ability to mentalize other's intentions is reduced. Methods Processing of emotions in faces was investigated. A behavioural test of Ekman faces expressing six basic emotions was presented to 30 ALS patients and 29 age-, gender and education matched healthy controls. Additionally, a subgroup of 15 ALS patients that were able to lie supine in the scanner and 14 matched healthy controls viewed the Ekman faces during functional magnetic resonance imaging (fMRI). Affective state and a number of daily social contacts were measured. Results ALS patients recognized disgust and fear less accurately than healthy controls. In fMRI, reduced brain activity was seen in areas involved in processing of negative emotions replicating our previous results. During processing of sad faces, increased brain activity was seen in areas associated with social emotions in right inferior frontal gyrus and reduced activity in hippocampus bilaterally. No differences in brain activity were seen for any of the other emotional expressions. Inferior frontal gyrus activity for sad faces was associated with increased amount of social contacts of ALS patients. Conclusion ALS patients showed decreased brain and behavioural responses in processing of disgust and fear and an altered brain response pattern for sadness. The negative consequences of neurodegenerative processes in the course of ALS might be counteracted by positive emotional activity and positive social interactions.	[Aho-Oezhan, Helena E. A.; Keller, Juergen; Heimrath, Johanna; Uttner, Ingo; Kassubek, Jan; Ludolph, Albert C.; Lule, Dorothee] Univ Ulm, Dept Neurol, Ulm, Germany; [Birbaumer, Niels; Lule, Dorothee] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Birbaumer, Niels] Wyss Ctr Bio & Neuroengn, Geneva, Switzerland	Ulm University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Ludolph, AC (corresponding author), Univ Ulm, Dept Neurol, Ulm, Germany.	albert.ludolph@rku.de	Kassubek, Jan/F-2774-2015; Kassubek, Jan/GPX-0910-2022; Kassubek, Jan/O-1740-2019	Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Birbaumer, Niels/0000-0002-6786-5127	EU Joint Programme - Neurodegenerative Disease Research (JPND) project [01ED1405]; Germany, Bundesministerium fur Bildung und Forschung (BMBF, FKZ); Swedan, Vetenskapradet Sverige; Poland, Narodowe, Narodowe Centrum Badan i Rozwoju (NCBR); Deutsche Forschungsgemeinschaft [DFG LU 336/13-2, BI 195/54-2]; Bundesministerium fur Bildung und Forschung (BMBF) [01GM1103A]; National Institutes of Health (NIH)	EU Joint Programme - Neurodegenerative Disease Research (JPND) project; Germany, Bundesministerium fur Bildung und Forschung (BMBF, FKZ); Swedan, Vetenskapradet Sverige; Poland, Narodowe, Narodowe Centrum Badan i Rozwoju (NCBR); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This is an EU Joint Programme - Neurodegenerative Disease Research (JPND) project (01ED1405). The project is supported through the following organisations under the aegis of JPND - www.jpnd.edu e.g. Germany, Bundesministerium fur Bildung und Forschung (BMBF, FKZ), Sweden, Vetenskapradet Sverige, Poland, Narodowe Centrum Badan i Rozwoju (NCBR). This work was additionally supported by the Deutsche Forschungsgemeinschaft (DFG LU 336/13-2 and BI 195/54-2) and the Bundesministerium fur Bildung und Forschung (BMBF #01GM1103A), and the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2013, NEUROBIOL AGING, V34, P419, DOI 10.1016/j.neurobiolaging.2012.04.015; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Bede P, 2013, NEUROLOGY, V81, P2107, DOI 10.1212/01.wnl.0000437313.80913.2c; Bistricky SL, 2011, PSYCHOL BULL, V137, P998, DOI 10.1037/a0025348; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; Deichmann R, 2002, P INT SOC MAGN RESON, V10, P1414; Enticott PG, 2008, NEUROPSYCHOLOGIA, V46, P2851, DOI 10.1016/j.neuropsychologia.2008.04.022; Fankhauser S, 2014, J GERIATR PSYCHIAT N; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Goldstein LH, 2013, LANCET NEUROL, V12, P368, DOI 10.1016/S1474-4422(13)70026-7; Gur RE, 2002, AM J PSYCHIAT, V159, P1992, DOI 10.1176/appi.ajp.159.12.1992; Hautzinger M., 1995, BECK DEPRESSIONS INV; Hecht MJ, 2003, PALLIATIVE MED, V17, P327, DOI 10.1191/0269216303pm754oa; Hickie I, 2005, BRIT J PSYCHIAT, V186, P197, DOI 10.1192/bjp.186.3.197; Kawashima T, 2001, ACTA NEUROPATHOL, V102, P467; KEW JJM, 1993, BRAIN, V116, P1399, DOI 10.1093/brain/116.6.1399; Khedr EM, 2011, NEUROPHYSIOL CLIN, V41, P73, DOI 10.1016/j.neucli.2011.03.001; Lehrl, 1989, MEHRFACHWAHL WORTSCH; LEWANDOWSKI LJ, 1984, PERCEPT MOTOR SKILL, V59, P615, DOI 10.2466/pms.1984.59.2.615; Lillo P, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-156; Ludolph A, 2015, AMYOTROPH LAT SCL FR, V16, P291, DOI 10.3109/21678421.2015.1049183; Lule D, 2005, J NEUROL, V252, P1517, DOI 10.1007/s00415-005-0907-8; Lule D, 2007, J NEUROL, V254, P519, DOI 10.1007/s00415-006-0409-3; Lule D, 2014, J NEUROL, V261, P518, DOI 10.1007/s00415-013-7229-z; Lule D, 2013, J NEUROL, V260, P2836, DOI 10.1007/s00415-013-7068-y; Lule D, 2012, J NEUROL, V259, P334, DOI 10.1007/s00415-011-6191-x; Lule D, 2010, J NEUROL NEUROSUR PS, V81, P899, DOI 10.1136/jnnp.2009.192260; Machts J, 2015, NEUROLOGY, V85, P1301, DOI 10.1212/WNL.0000000000002017; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Menon P, 2015, CLIN NEUROPHYSIOL, V126, P803, DOI 10.1016/j.clinph.2014.04.023; Mohammadi B, 2009, EXP NEUROL, V217, P147, DOI 10.1016/j.expneurol.2009.01.025; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papps B, 2005, NEUROPSYCHOLOGIA, V43, P1107, DOI 10.1016/j.neuropsychologia.2004.11.027; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pisa FE, 2015, NEUROEPIDEMIOLOGY, V44, P91, DOI 10.1159/000374119; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Robinson P, 2006, NEUROIMAGE, V31, P585, DOI 10.1016/j.neuroimage.2005.12.026; Schoenfeld MA, 2005, J NEUROL, V252, P944, DOI 10.1007/s00415-005-0787-y; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Thomas SA, 2015, HIPPOCAMPUS, V25, P415, DOI 10.1002/hipo.22394; Vucic S, 2008, BRAIN, V131, P1540, DOI 10.1093/brain/awn071; Vucic S, 2006, BRAIN, V129, P2436, DOI 10.1093/brain/awl172; Young AW, 2002, FACIAL EXPRESSIONS E; Ziemann U, 1997, NEUROLOGY, V49, P1292, DOI 10.1212/WNL.49.5.1292	53	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164655	10.1371/journal.pone.0164655	http://dx.doi.org/10.1371/journal.pone.0164655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741285	Green Published, Green Submitted, gold			2022-12-26	WOS:000385507000051
J	Freitag, MT; Maier-Hein, KH; Binczyk, F; Laun, FB; Weber, C; Bonekamp, D; Tarnawski, R; Bobek-Billewicz, B; Polanska, J; Majchrzak, H; Stieltjes, B				Freitag, Martin T.; Maier-Hein, Klaus H.; Binczyk, Francisczek; Laun, Frederik B.; Weber, Christian; Bonekamp, David; Tarnawski, Rafal; Bobek-Billewicz, Barbara; Polanska, Joanna; Majchrzak, Henryk; Stieltjes, Bram			Early Detection of Malignant Transformation in Resected WHO II Low-Grade Glioma Using Diffusion Tensor-Derived Quantitative Measures	PLOS ONE			English	Article							CONTRAST ENHANCEMENT; BRAIN-TUMORS; ANAPLASTIC TRANSFORMATION; HISTOGRAM ANALYSIS; COEFFICIENT; DIAGNOSIS; ADULTS; MAPS; OLIGODENDROGLIOMAS; GLIOBLASTOMA	Objective Here, we retrospectively investigate the value of voxel-wisely plotted diffusion tensor-derived (DTI) axial, radial and mean diffusivity for the early detection of malignant transformation (MT) in WHO II glioma compared to contrast-enhanced images. Materials and Methods Forty-seven patients underwent brain magnetic resonance imaging follow-up between 2006-2014 after gross-tumor resection of intra-axial WHO II glioma. Axial/Mean/Radial diffusivity maps (AD/MD/RD) were generated from DTI data. AD(min)/MDmin/RDmin values were quantified within tumor regions-of-interest generated by two independent readers including tumor contrast-to-noise (CNR). Sensitivity/specificity and area-under-the-curve (AUC) were calculated using receiver-operating-characteristic analysis. Inter-reader agreement was assessed (Cohen's kappa). Results Eighteen patients demonstrated malignant transformation (MT) confirmed in 8/18 by histopathology and in 10/18 through imaging follow-up. Twelve of 18 patients (66.6%) with MT showed diffusion restriction timely coincidental with contrast-enhancement (CE). In the remaining six patients (33.3%), the diffusion restriction preceded the CE. The mean gain in detection time using DTI was (0.8 +/- 0.5 years, p = 0.028). Compared to MDmin and RDmin, ROC-analysis showed best diagnostic value for AD(min) (sensitivity/specificity 94.94%/89.7%, AUC 0.96; p<0.0001) to detect MT. CNR was highest for AD (1.83 +/- 0.14), compared to MD (1.31 +/- 0.19; p<0.003) and RD (0.90 +/- 0.23; p<0.0001). Cohen's Kappa was 0.77 for AD(min), 0.71 for MDmin and 0.65 for RDmin (p<0.0001, respectively). Conclusion MT is detectable at the same time point or earlier compared to T1w-CE by diffusion restriction in diffusion-tensor-derived maps. AD demonstrated highest sensitivity/specificity/ tumor-contrast compared to radial or mean diffusivity (= apparent diffusion coefficient) to detect MT.	[Freitag, Martin T.; Stieltjes, Bram] German Canc Res Ctr, Quantitat Imaging Based Dis Characterizat, Heidelberg, Germany; [Freitag, Martin T.; Bonekamp, David] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany; [Maier-Hein, Klaus H.; Weber, Christian] German Canc Res Ctr, Jr Grp Med Image Comp, Heidelberg, Germany; [Binczyk, Francisczek; Polanska, Joanna] Silesian Tech Univ, Data Min Grp, Gliwice, Poland; [Laun, Frederik B.] German Canc Res Ctr, Div Med Phys Radiol, Heidelberg, Germany; [Tarnawski, Rafal; Bobek-Billewicz, Barbara] Maria Sklodowska Curie Mem Canc Ctr, Gliwice, Poland; [Tarnawski, Rafal; Bobek-Billewicz, Barbara] Inst Oncol, Dept Radiol, Gliwice, Poland; [Majchrzak, Henryk] Med Univ Silesia, Dept Neurosurg, Katowice, Poland; [Stieltjes, Bram] Univ Basel Hosp, Dept Radiol, Basel, Switzerland	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Silesian University of Technology; Helmholtz Association; German Cancer Research Center (DKFZ); Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Medical University Silesia; University of Basel	Freitag, MT (corresponding author), German Canc Res Ctr, Quantitat Imaging Based Dis Characterizat, Heidelberg, Germany.; Freitag, MT (corresponding author), German Canc Res Ctr, Dept Radiol, Heidelberg, Germany.	m.freitag@dkfz.de	Tarnawski, Rafal/N-7526-2016; Laun, Frederik Bernd/O-4810-2016; Weber, Christian/AAW-2153-2020; Binczyk, Franciszek/G-3873-2017; Polanska, Joanna/H-4513-2013; Maier-Hein, Klaus Hermann/AAF-8487-2020	Tarnawski, Rafal/0000-0001-6802-5093; Laun, Frederik Bernd/0000-0002-9269-5609; Weber, Christian/0000-0003-4610-8714; Polanska, Joanna/0000-0001-8004-9864; Maier-Hein, Klaus Hermann/0000-0002-6626-2463; Binczyk, Franciszek/0000-0002-1364-090X; Bobek-Billewicz, Barbara/0000-0003-3262-9738; Tarnawski, Rafal/0000-0003-3783-0297	Deutsche Forschungsgemeinschaft (DFG) [LA 2804/1-3]; Ministry of Science and Higher Education [NN 403278933]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work has been partially funded by the Deutsche Forschungsgemeinschaft (DFG) grant number LA 2804/1-3. Parts of this study were supported by the Ministry of Science and Higher Education grant number NN 403278933. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2016, RADIOLOGY, V278, P496, DOI 10.1148/radiol.2015142173; Bobek-Billewicz B, 2014, FOLIA NEUROPATHOL, V52, P128, DOI 10.5114/fn.2014.43784; Bourdillon P, 2015, J NEURO-ONCOL, V122, P529, DOI 10.1007/s11060-015-1737-x; Chen F, 2012, CNS NEUROSCI THER, V18, P667, DOI 10.1111/j.1755-5949.2012.00354.x; Chen LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079008; Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; Danchaivijitr N, 2008, RADIOLOGY, V247, P170, DOI 10.1148/radiol.2471062089; Ellingson BM, 2010, J MAGN RESON IMAGING, V31, P538, DOI 10.1002/jmri.22068; Fritzsche KH, 2012, METHOD INFORM MED, V51, P441, DOI 10.3414/ME11-02-0031; Ginsberg LE, 1998, SURG NEUROL, V49, P436, DOI 10.1016/S0090-3019(97)00360-1; Gupta A, 2011, AM J NEURORADIOL, V32, P1301, DOI 10.3174/ajnr.A2479; Higano S, 2006, RADIOLOGY, V241, P839, DOI 10.1148/radiol.2413051276; Hlaihel C, 2010, J NEURO-ONCOL, V97, P73, DOI 10.1007/s11060-009-9991-4; Kallenberg K, 2013, J NEURO-ONCOL, V112, P217, DOI 10.1007/s11060-013-1049-y; Kang Y, 2011, RADIOLOGY, V261, P882, DOI 10.1148/radiol.11110686; Khayal IS, 2009, J MAGN RESON IMAGING, V30, P209, DOI 10.1002/jmri.21810; Lee S, 2015, J NEURO-ONCOL, V121, P141, DOI 10.1007/s11060-014-1614-z; Muragaki Y, 2008, MINIM INVAS NEUROSUR, V51, P275, DOI 10.1055/s-0028-1082322; Murakami R, 2007, RADIOLOGY, V243, P493, DOI 10.1148/radiol.2432060450; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Pallud J, 2009, NEURO-ONCOLOGY, V11, P176, DOI 10.1215/15228517-2008-066; Provenzale JM, 2005, AM J ROENTGENOL, V185, P763, DOI 10.2214/ajr.185.3.01850763; Sadeghi N, 2008, AM J NEURORADIOL, V29, P476, DOI 10.3174/ajnr.A0851; Sage MR, 1998, NEUROIMAG CLIN N AM, V8, P695; Sanai N, 2011, J NEUROSURG, V115, P948, DOI [10.3171/2011.7.JNS101238, 10.3171/2011.7.JNS10238]; Scott JN, 2002, NEUROLOGY, V59, P947, DOI 10.1212/WNL.59.6.947; Simon D, 2012, CANCER IMAGING, V12, P89, DOI 10.1102/1470-7330.2012.0010; Smirniotopoulos JG, 2007, RADIOGRAPHICS, V27, P525, DOI 10.1148/rg.272065155; Soffietti R, 2010, EUR J NEUROL, V17, P1124, DOI 10.1111/j.1468-1331.2010.03151.x; Stieltjes B, 2006, NEUROIMAGE, V31, P531, DOI 10.1016/j.neuroimage.2005.12.052; Stupp R, 2010, ANN ONCOL, V21, pv190, DOI 10.1093/annonc/mdq187; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; The WHO, 2020, CLASSIFICATION TUMOU; Tonn J-C, 2006, NEUROONCOLOGY CNS TU; van den Bent MJ, 2011, LANCET ONCOL, V12, P583, DOI 10.1016/S1470-2045(11)70057-2; van den Bent MJ, 2005, LANCET, V366, P985, DOI 10.1016/S0140-6736(05)67070-5; Weller M, 2014, LANCET ONCOL, V15, pE395, DOI 10.1016/S1470-2045(14)70011-7; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; White ML, 2005, AM J NEURORADIOL, V26, P784; Zonari P, 2007, NEURORADIOLOGY, V49, P795, DOI 10.1007/s00234-007-0253-x	40	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164679	10.1371/journal.pone.0164679	http://dx.doi.org/10.1371/journal.pone.0164679			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741525	Green Published, Green Submitted, gold			2022-12-26	WOS:000385507000056
J	Esser, L; Zhou, F; Zhou, YH; Xiao, YM; Tang, WK; Yu, CA; Qin, ZH; Xia, D				Esser, Lothar; Zhou, Fei; Zhou, Yihui; Xiao, Yumei; Tang, Wai-Kwan; Yu, Chang-An; Qin, Zhaohai; Xia, Di			Hydrogen Bonding to the Substrate Is Not Required for Rieske Iron-Sulfur Protein Docking to the Quinol Oxidation Site of Complex III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; RESPIRATORY-CHAIN; ELECTRON-TRANSFER; C REDUCTASE; Q-CYCLE; MITOCHONDRIAL; INHIBITORS; BINDING	Complex III or the cytochrome (cyt) bc(1) complex constitutes an integral part of the respiratory chain of most aerobic organisms and of the photosynthetic apparatus of anoxygenic purple bacteria. The function of cyt bc(1) is to couple the reaction of electron transfer from ubiquinol to cytochrome c to proton pumping across the membrane. Mechanistically, the electron transfer reaction requires docking of its Rieske iron-sulfur protein (ISP) subunit to the quinol oxidation site (Q(P)) of the complex. Formation of an H-bond between the ISP and the bound substrate was proposed to mediate the docking. Here we show that the binding of oxazolidinedione-type inhibitors famoxadone, jg144, and fenamidone induces docking of the ISP to the QP site in the absence of the H-bond formation both in mitochondrial and bacterial cyt bc(1) complexes, demonstrating that ISP docking is independent of the proposed direct ISP-inhibitor interaction. The binding of oxazolidinedione-type inhibitors to cyt bc(1) of different species reveals a toxophore that appears to interact optimally with residues in the Q(P) site. The effect of modifications or additions to the toxophore on the binding to cyt bc(1) from different species could not be predicted from structure-based sequence alignments, as demonstrated by the altered binding mode of famoxadone to bacterial cyt bc(1).	[Esser, Lothar; Zhou, Fei; Zhou, Yihui; Xiao, Yumei; Tang, Wai-Kwan; Xia, Di] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA; [Zhou, Yihui; Xiao, Yumei; Qin, Zhaohai] China Agr Univ, Coll Sci, Beijing 100193, Peoples R China; [Yu, Chang-An] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); China Agricultural University; Oklahoma State University System; Oklahoma State University - Stillwater	Xia, D (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	xiad@mail.nih.gov	Tang, Wai Kwan/A-6158-2012		Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Basic Research Science Foundation of China [2010CB126100]; NATIONAL CANCER INSTITUTE [ZIABC010319] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Basic Research Science Foundation of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, and a grant from the National Basic Research Science Foundation of China (2010CB126100) (to Z. Q.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Berry EA, 2003, FEBS LETT, V555, P13, DOI 10.1016/S0014-5793(03)01099-8; Berry EA, 2011, BBA-BIOENERGETICS, V1807, P1349, DOI 10.1016/j.bbabio.2011.04.005; BRANDT U, 1988, EUR J BIOCHEM, V173, P499, DOI 10.1111/j.1432-1033.1988.tb14026.x; BRANDT U, 1991, EUR J BIOCHEM, V195, P163, DOI 10.1111/j.1432-1033.1991.tb15690.x; Brandt U, 1997, BBA-BIOENERGETICS, V1321, P238, DOI 10.1016/S0005-2728(97)00060-1; Chen WJ, 2007, APPL ENVIRON MICROB, V73, P5162, DOI 10.1128/AEM.00507-07; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15807, DOI 10.1021/bi990962m; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Esser L, 2008, J BIOL CHEM, V283, P2846, DOI 10.1074/jbc.M708608200; Esser L, 2006, P NATL ACAD SCI USA, V103, P13045, DOI 10.1073/pnas.0601149103; Fernandez-Ortuno D, 2008, PEST MANAG SCI, V64, P694, DOI 10.1002/ps.1544; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Gao XG, 2002, BIOCHEMISTRY-US, V41, P11692, DOI 10.1021/bi026252p; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Huang LS, 2005, J MOL BIOL, V351, P573, DOI 10.1016/j.jmb.2005.05.053; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jordan DB, 1999, PESTIC SCI, V55, P105, DOI 10.1002/(SICI)1096-9063(199902)55:2&lt;105::AID-PS879&gt;3.0.CO;2-D; Keilin D, 1925, P R SOC LOND B-CONTA, V98, P312, DOI 10.1098/rspb.1925.0039; Kleinschroth T, 2011, BBA-BIOENERGETICS, V1807, P1606, DOI 10.1016/j.bbabio.2011.09.017; LINK TA, 1993, J BIOENERG BIOMEMBR, V25, P221, DOI 10.1007/BF00762584; LJUNGDAHL O, 1987, BIOCHIM BIOPHYS ACTA, V891, P227; MITCHELL P, 1975, FEBS LETT, V56, P1, DOI 10.1016/0014-5793(75)80098-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OHNISHI T, 1988, EUR J BIOCHEM, V176, P385, DOI 10.1111/j.1432-1033.1988.tb14293.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; SERRANO L, 1991, J MOL BIOL, V218, P465, DOI 10.1016/0022-2836(91)90725-L; Steinfeld U, 2001, PEST MANAG SCI, V57, P787, DOI 10.1002/ps.356; Sternberg JA, 2001, PEST MANAG SCI, V57, P143, DOI 10.1002/1526-4998(200102)57:2<143::AID-PS282>3.0.CO;2-8; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Willis R. J., 2007, HIST ALLELOPATHY; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xia D, 2013, BBA-BIOENERGETICS, V1827, P1278, DOI 10.1016/j.bbabio.2012.11.008; Xiao YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093765; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	44	13	13	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25019	25031		10.1074/jbc.M116.744391	http://dx.doi.org/10.1074/jbc.M116.744391			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27758861	Green Published, hybrid			2022-12-26	WOS:000388880100019
J	Warren, KJ; Fang, X; Gowda, NM; Thompson, JJ; Heller, NM				Warren, Kristi J.; Fang, Xi; Gowda, Nagaraj M.; Thompson, Joshua J.; Heller, Nicola M.			The TORC1-activated Proteins, p70S6K and GRB10, Regulate IL-4 Signaling and M2 Macrophage Polarization by Modulating Phosphorylation of Insulin Receptor Substrate-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; MTOR; ACTIVATION; GROWTH; IRS-2; DEGRADATION; EXPRESSION; RAPAMYCIN; KINASE	Lung M2 macrophages are regulators of airway inflammation, associated with poor lung function in allergic asthma. Previously, we demonstrated that IL-4-induced M2 gene expression correlated with tyrosine phosphorylation of the insulin receptor substrate-2 (IRS-2) in macrophages. We hypothesized that negative regulation of IRS-2 activity after IL-4 stimulation is dependent upon serine phosphorylation of IRS-2. Herein, we describe an inverse relationship between tyrosine phosphorylation (Tyr(P)) and serine phosphorylation (Ser(P)) of IRS-2 after IL-4 stimulation. Inhibiting serine phosphatase activity increased Ser(P)-IRS-2 and decreased Tyr(P)-IRS-2 leading to reduced M2 gene expression (CD200R, CCL22, MMP12, andTGM2). We found that inhibition of p70S6K, downstream of TORC1, resulted in diminished Ser(P)-IRS-2 and prolonged Tyr(P)IRS-2 as well. Inhibition of p70S6K increased expression of CD200R and CCL22 indicating that p70S6K negatively regulates some, but not all, human M2 genes. Knocking down GRB10, another negative regulatory protein downstream of TORC1, enhanced both Tyr(P)-IRS-2 and increased expression of all four M2 genes. Furthermore, GRB10 associated with IRS-2, NEDD4.2 (an E3-ubiquitin ligase), IL-4R alpha, and gamma C after IL-4 stimulation. Both IL-4R alpha and gamma C were ubiquitinated after 30 min of IL-4 treatment, suggesting that GRB10 may regulate degradation of the IL-4 receptor-signaling complex through interactions with NEDD4.2. Taken together, these data highlight two novel regulatory proteins that could be therapeutically manipulated to limit IL-4-induced IRS-2 signaling and polarization of M2 macrophages in allergic inflammation.	[Warren, Kristi J.; Fang, Xi; Gowda, Nagaraj M.; Thompson, Joshua J.; Heller, Nicola M.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University	Heller, NM (corresponding author), Johns Hopkins Univ, Sch Med, Dept ACCM, Div Allergy & Clin Immunol, 720 Rutland Ave,Ross 367, Baltimore, MD 21205 USA.	nheller@jhmi.edu			National Institutes of Health [K99/R00 HL096897]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL096897, K99HL096897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant K99/R00 HL096897 (NHLBI; to N. M. H.). The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Binia A, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13612; Boura-Halfon S, 2009, VITAM HORM, V80, P313, DOI 10.1016/S0083-6729(08)00612-2; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Chen D, 1999, MOL CELL BIOL, V19, P4684; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Covarrubias AJ, 2016, ELIFE, V5, DOI 10.7554/eLife.11612; Covarrubias AJ, 2015, SEMIN IMMUNOL, V27, P286, DOI 10.1016/j.smim.2015.08.001; Dasgupta P, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad6724; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Festuccia WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095432; Fritsche L, 2011, AM J PHYSIOL-ENDOC M, V300, pE824, DOI 10.1152/ajpendo.00409.2010; Genuneit J, 2009, CLIN EXP ALLERGY, V39, P1875, DOI 10.1111/j.1365-2222.2009.03364.x; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Hallowell R. W., 2013, RESP CRITICAL CARE M, pA4128; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Haque SJ, 1998, J BIOL CHEM, V273, P33893, DOI 10.1074/jbc.273.51.33893; Heller NM, 2012, J BIOL CHEM, V287, P31948, DOI 10.1074/jbc.M112.348896; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Malarde V, 2009, BIOCHEM BIOPH RES CO, V387, P409, DOI 10.1016/j.bbrc.2009.07.041; Melgert BN, 2011, J ALLERGY CLIN IMMUN, V127, P831, DOI 10.1016/j.jaci.2010.10.045; Mercalli A, 2013, IMMUNOLOGY, V140, P179, DOI 10.1111/imm.12126; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pozuelo-Rubio M, 2010, CELL BIOCHEM BIOPHYS, V58, P147, DOI 10.1007/s12013-010-9101-4; Robert H., 2012, C92 CONTROL MACROPHA, pA5061; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; St-Laurent J, 2009, J ASTHMA, V46, P1, DOI 10.1080/02770900802444211; SUN XJ, 1992, J BIOL CHEM, V267, P22662; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Vercelli D, 2008, J ALLERGY CLIN IMMUN, V122, P267, DOI 10.1016/j.jaci.2008.06.008; Viksman MY, 2002, CLIN IMMUNOL, V104, P77, DOI 10.1006/clim.2002.5233; Wang HY, 1998, J BIOL CHEM, V273, P9898, DOI 10.1074/jbc.273.16.9898; Weichhart T, 2012, METHODS MOL BIOL, V821, P1, DOI 10.1007/978-1-61779-430-8_1; Wick KR, 2003, J BIOL CHEM, V278, P8460, DOI 10.1074/jbc.M208518200; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4	44	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24922	24930		10.1074/jbc.M116.756791	http://dx.doi.org/10.1074/jbc.M116.756791			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27742835	Green Published, hybrid			2022-12-26	WOS:000388880100012
J	Chalick, M; Jacobi, O; Pichinuk, E; Garbar, C; Bensussan, A; Meeker, A; Ziv, R; Zehavi, T; Smorodinsky, NI; Hilkens, J; Hanisch, FG; Rubinstein, DB; Wreschner, DH				Chalick, Michael; Jacobi, Oded; Pichinuk, Edward; Garbar, Christian; Bensussan, Armand; Meeker, Alan; Ziv, Ravit; Zehavi, Tania; Smorodinsky, Nechama I.; Hilkens, John; Hanisch, Franz-Georg; Rubinstein, Daniel B.; Wreschner, Daniel H.			MUC1-ARF-A Novel MUC1 Protein That Resides in the Nucleus and Is Expressed by Alternate Reading Frame Translation of MUC1 mRNA	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; HUMAN BREAST-CANCER; EPITHELIAL TUMOR-ANTIGEN; XL-ALPHA-S; MOLECULAR-CLONING; INTERFERON-GAMMA; CELL-LINES; SUBCELLULAR FATE; CYTOPLASMIC TAIL; BINDING-PROTEIN	Translation of mRNA in alternate reading frames (ARF) is a naturally occurring process heretofore underappreciated as a generator of protein diversity. The MUC1 gene encodes MUC1-TM, a signal-transducing trans-membrane protein highly expressed in human malignancies. Here we show that an AUG codon downstream to the MUC1-TM initiation codon initiates an alternate reading frame thereby generating a novel protein, MUC1-ARF. MUC1-ARF, like its MUC1-TM 'parent' protein, contains a tandem repeat (VNTR) domain. However, the amino acid sequence of the MUC1-ARF tandem repeat as well as N- and C-sequences flanking it differ entirely from those of MUC1-TM. In vitro protein synthesis assays and extensive immunohistochemical as well as western blot analyses with MUC1-ARF specific monoclonal antibodies confirmed MUC1-ARF expression. Rather than being expressed at the cell membrane like MUC1-TM, immunostaining showed that MUC1-ARF protein localizes mainly in the nucleus: Immunohistochemical analyses of MUC1-expressing tissues demonstrated MUC1-ARF expression in the nuclei of secretory luminal epithelial cells. MUC1-ARF expression varies in different malignancies. While the malignant epithelial cells of pancreatic cancer show limited expression, in breast cancer tissue MUC1-ARF demonstrates strong nuclear expression. Proinflammatory cytokines upregulate expression of MUC1-ARF protein and co-immunoprecipitation analyses demonstrate association of MUC1-ARF with SH3 domain-containing proteins. Mass spectrometry performed on proteins coprecipitating with MUC1-ARF demonstrated Glucose-6-phosphate 1-dehydrogenase (G6PD) and Dynamin 2 (DNM2). These studies not only reveal that the MUC1 gene generates a previously unidentified MUC1-ARF protein, they also show that just like its 'parent' MUC1-TM protein, MUC1-ARF is apparently linked to signaling and malignancy, yet a definitive link to these processes and the roles it plays awaits a precise identification of its molecular functions. Comprising at least 524 amino acids, MUC1-ARF is, furthermore, the longest ARF protein heretofore described.	[Chalick, Michael; Jacobi, Oded; Pichinuk, Edward; Ziv, Ravit; Smorodinsky, Nechama I.; Wreschner, Daniel H.] Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel; [Garbar, Christian] Inst Jean Godinoi, Dept Biopathol, Reims, France; [Bensussan, Armand] Hop St Louis, INSERM, U976, Paris, France; [Meeker, Alan] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Zehavi, Tania] Meir Med Ctr, Dept Pathol, Kefar Sava, Israel; [Hilkens, John] Netherlands Canc Inst, Div Mol Genet, Amsterdam, Netherlands; [Hanisch, Franz-Georg] Univ Cologne, Fac Med, Inst Biochem 2, Cologne, Germany; [Rubinstein, Daniel B.] BioModifying LLC, Silver Spring, MD USA	Tel Aviv University; UNICANCER; Institut Jean Godinot; Universite de Reims Champagne-Ardenne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Johns Hopkins University; Tel Aviv University; Sackler Faculty of Medicine; Netherlands Cancer Institute; University of Cologne	Wreschner, DH (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel.	danielhw@post.tau.ac.il	Garbar, Christian/W-9339-2019; Bensussan, Armand/E-5434-2017	Garbar, Christian/0000-0002-1869-494X; Bensussan, Armand/0000-0002-0409-2497; Hilkens, John/0000-0002-0932-7793; Pichinuk, Eddy/0000-0001-8488-8710	Israel Science Foundation [1167/10]; Israel Cancer Association [20112024]; BioModifying LLC, Silver Spring, Maryland	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; BioModifying LLC, Silver Spring, Maryland	This work was supported by Israel Science Foundation Grant 1167/10, http://www.isf.org.il/english/; and Israel Cancer Association 20112024, http://en.cancer.org.il/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author Dr. Daniel B. Rubinstein (DBR) is affiliated with BioModifying LLC, Silver Spring, Maryland, who provided partial support in the form of funds for research materials only. BioModifying did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz J, 2004, P NATL ACAD SCI USA, V101, P8366, DOI 10.1073/pnas.0308758101; ACLAND P, 1990, NATURE, V343, P662, DOI 10.1038/343662a0; Antoine M, 1997, J BIOL CHEM, V272, P29475, DOI 10.1074/jbc.272.47.29475; Baruch A, 1999, CANCER RES, V59, P1552; Baruch A, 1997, INT J CANCER, V71, P741; BASELGA J, 1994, PHARMACOL THERAPEUT, V64, P127, DOI 10.1016/0163-7258(94)90036-1; BASELGA J, 1994, BREAST CANCER RES TR, V29, P127, DOI 10.1007/BF00666188; Bergeron D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.472654; BUGLER B, 1991, MOL CELL BIOL, V11, P573, DOI 10.1128/MCB.11.1.573; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; CLARK S, 1994, DIS MARKERS, V12, P43, DOI 10.1155/1994/480236; Florkiewicz RZ, 1991, GROWTH FACTORS, V4, P265, DOI 10.3109/08977199109043912; Freson K, 2003, HUM MOL GENET, V12, P1121, DOI 10.1093/hmg/ddg130; Gaemers IC, 2001, J BIOL CHEM, V276, P6191, DOI 10.1074/jbc.M009449200; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; Grohmann GPM, 2003, CYTOKINE, V23, P86, DOI 10.1016/S1043-4666(03)00202-3; HAREUVENI M, 1990, EUR J BIOCHEM, V189, P475, DOI 10.1111/j.1432-1033.1990.tb15512.x; Hart GW, 2014, J BIOL CHEM, V289, P34422, DOI 10.1074/jbc.R114.609776; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hattrup CL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1515; KIEFER P, 1994, EMBO J, V13, P4126, DOI 10.1002/j.1460-2075.1994.tb06730.x; Kimura T, 2013, EXPERT OPIN BIOL TH, V13, P35, DOI 10.1517/14712598.2012.725719; Kinlough CL, 2004, J BIOL CHEM, V279, P53071, DOI 10.1074/jbc.M409360200; Kirby A, 2013, NAT GENET, V45, P299, DOI 10.1038/ng.2543; Kittaneh Muaiad, 2013, Biomark Cancer, V5, P61, DOI 10.4137/BIC.S9455; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; Koga T, 2007, AM J PHYSIOL-LUNG C, V293, pL693, DOI 10.1152/ajplung.00491.2006; Kopinke D, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-38; Lagow EL, 2002, J CELL BIOCHEM, V86, P759, DOI 10.1002/jcb.10261; LAN MS, 1990, J BIOL CHEM, V265, P15294; Landry CR, 2015, CURR OPIN STRUC BIOL, V32, P74, DOI 10.1016/j.sbi.2015.02.017; Lee MY, 2014, DEVELOPMENT, V141, P1465, DOI 10.1242/dev.104539; Levitin F, 2005, J BIOL CHEM, V280, P10655, DOI 10.1074/jbc.M406943200; Li X, 2003, J DENT RES, V82, P883, DOI 10.1177/154405910308201107; Li YY, 2009, CELL IMMUNOL, V256, P19, DOI 10.1016/j.cellimm.2009.01.001; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; LIGTENBERG MJL, 1990, J BIOL CHEM, V265, P5573; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Luo L, 2016, J BIOL CHEM, V291, P9411, DOI 10.1074/jbc.M115.703108; Mather IH, 2001, CELL TISSUE RES, V304, P91, DOI 10.1007/s004410100351; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Mehla K, 2014, BBA-REV CANCER, V1845, P126, DOI 10.1016/j.bbcan.2014.01.001; Menschaert G, 2013, MOL CELL PROTEOMICS, V12, P1780, DOI 10.1074/mcp.M113.027540; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Mori Y, 2014, J BIOL CHEM, V289, P35193, DOI 10.1074/jbc.M114.586461; Nekrutenko A, 2006, TRENDS GENET, V22, P645, DOI 10.1016/j.tig.2006.09.012; NORMARK S, 1983, ANNU REV GENET, V17, P499, DOI 10.1146/annurev.ge.17.120183.002435; Oh S, 2004, CANCER RES, V64, P2610, DOI 10.1158/0008-5472.CAN-03-2183; Okamoto PM, 1997, J BIOL CHEM, V272, P11629; PATRY V, 1994, GROWTH FACTORS, V11, P163, DOI 10.3109/08977199409046914; Pendergast AM, 1996, CURR OPIN CELL BIOL, V8, P174, DOI 10.1016/S0955-0674(96)80063-9; Perou CM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003293; Pichinuk E, 2012, CANCER RES, V72, P3324, DOI 10.1158/0008-5472.CAN-12-0067; Pierreux CE, 2006, GASTROENTEROLOGY, V130, P532, DOI 10.1053/j.gastro.2005.12.005; Poland PA, 1997, GLYCOCONJUGATE J, V14, P89, DOI 10.1023/A:1018569100438; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Poulin F, 2003, J BIOL CHEM, V278, P52290, DOI 10.1074/jbc.M310761200; QUELLE DE, 1995, CELL, V83, P993; Raina D, 2006, EMBO J, V25, P3774, DOI 10.1038/sj.emboj.7601263; Rakha EA, 2005, MODERN PATHOL, V18, P1295, DOI 10.1038/modpathol.3800445; Reddy PK, 2003, EUR J CANCER, V39, P397, DOI 10.1016/S0959-8049(02)00700-1; Ronsin C, 1999, J IMMUNOL, V163, P483; Rosenberg SA, 2002, J IMMUNOL, V168, P2402, DOI 10.4049/jimmunol.168.5.2402; Rubinstein DB, 2009, INT J CANCER, V124, P46, DOI 10.1002/ijc.23910; Russo CL, 2006, HUM REPROD, V21, P2783, DOI 10.1093/humrep/del164; Saeland E, 2012, INT J CANCER, V131, P117, DOI 10.1002/ijc.26354; Sando L, 2009, J DAIRY SCI, V92, P5276, DOI 10.3168/jds.2009-2216; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Silva F, 2001, EUR J HUM GENET, V9, P548, DOI 10.1038/sj.ejhg.5200677; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; SPICER AP, 1991, J BIOL CHEM, V266, P15099; Thompson EJ, 2006, MOL CANCER RES, V4, P489, DOI 10.1158/1541-7786.MCR-06-0038; TSUTSUMI Y, 1990, HUM PATHOL, V21, P750, DOI 10.1016/0046-8177(90)90035-4; Vanderperre B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070698; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131; Wang ZX, 1996, SCIENCE, V272, P1935, DOI 10.1126/science.272.5270.1935; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200; WRESCHNER DH, 1990, EUR J BIOCHEM, V189, P463, DOI 10.1111/j.1432-1033.1990.tb15511.x; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; ZRIHANLICHT S, 1994, EUR J BIOCHEM, V224, P787, DOI 10.1111/j.1432-1033.1994.00787.x; ZRIHANLICHT S, 1994, FEBS LETT, V356, P130, DOI 10.1016/0014-5793(94)01251-2	88	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165031	10.1371/journal.pone.0165031	http://dx.doi.org/10.1371/journal.pone.0165031			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768738	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400045
J	Connell, CJW; Thompson, B; Kuhn, G; Gant, N				Connell, Charlotte J. W.; Thompson, Benjamin; Kuhn, Gustav; Gant, Nicholas			Exercise-Induced Fatigue and Caffeine Supplementation Affect Psychomotor Performance but Not Covert Visuo-Spatial Attention	PLOS ONE			English	Article							EXOGENOUS SPATIAL ATTENTION; PROLONGED EXERCISE; VISUAL-ATTENTION; ENDURANCE PERFORMANCE; TASK-PERFORMANCE; COGNITION; HUMANS; BRAIN; DEPRIVATION; METABOLISM	Fatigue resulting from strenuous exercise can impair cognition and oculomotor control. These impairments can be prevented by administering psychostimulants such as caffeine. This study used two experiments to explore the influence of caffeine administered at rest and during fatiguing physical exercise on spatial attention-a cognitive function that is crucial for task-based visually guided behavior. In independent placebo-controlled studies, cohorts of 12 healthy participants consumed caffeine and rested or completed 180 min of stationary cycling. Covert attentional orienting was measured in both experiments using a spatial cueing paradigm. We observed no alterations in attentional facilitation toward spatial cues suggesting that covert attentional orienting is not influenced by exercise fatigue or caffeine supplementation. Response times were increased (impaired) after exercise and this deterioration was prevented by caffeine supplementation. In the resting experiment, response times across all conditions and cues were decreased (improved) with caffeine. Covert spatial attention was not influenced by caffeine. Together, the results of these experiments suggest that covert attentional orienting is robust to the effects of fatiguing exercise and not influenced by caffeine. However, exercise fatigue impairs response times, which can be prevented by caffeine, suggesting that pre-motor planning and execution of the motor responses required for performance of the cueing task are sensitive to central nervous system fatigue. Caffeine improves response time in both fatigued and fresh conditions, most likely through action on networks controlling motor function.	[Connell, Charlotte J. W.; Gant, Nicholas] Univ Auckland, Ctr Brain Res, Exercise Neurometab Lab, Auckland, New Zealand; [Thompson, Benjamin] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON, Canada; [Thompson, Benjamin] Univ Auckland, Sch Optometry & Vis Sci, Auckland, New Zealand; [Kuhn, Gustav] Goldsmiths Univ London, Dept Psychol, London, England	University of Auckland; University of Waterloo; University of Auckland; University of London; Goldsmiths University London	Gant, N (corresponding author), Univ Auckland, Ctr Brain Res, Exercise Neurometab Lab, Auckland, New Zealand.	n.gant@auckland.ac.nz		Thompson, Benjamin/0000-0002-3902-2712; Connell, Charlotte/0000-0002-2068-4097	University of Auckland	University of Auckland	This study was funded by The University of Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2000, INT J SPORT NUTR EXE, V10, P464, DOI 10.1123/ijsnem.10.4.464; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brunye TT, 2010, BRAIN COGNITION, V74, P186, DOI 10.1016/j.bandc.2010.07.006; Brunye TT, 2010, BRAIN COGNITION, V72, P181, DOI 10.1016/j.bandc.2009.07.013; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; CHAOULOFF F, 1989, ACTA PHYSIOL SCAND, V137, P1, DOI 10.1111/j.1748-1716.1989.tb08715.x; Chester N, 2008, INT J SPORTS MED, V29, P524, DOI 10.1055/s-2007-989231; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Connell CJW, 2016, SCI REP-UK, V6, DOI 10.1038/srep26614; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cox GR, 2002, J APPL PHYSIOL, V93, P990, DOI 10.1152/japplphysiol.00249.2002; Davis JM, 2003, AM J PHYSIOL-REG I, V284, pR399, DOI 10.1152/ajpregu.00386.2002; Davis JM, 1997, MED SCI SPORT EXER, V29, P45, DOI 10.1097/00005768-199701000-00008; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Einother SJL, 2013, PSYCHOPHARMACOLOGY, V225, P251, DOI 10.1007/s00213-012-2917-4; Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3; Foley TE, 2008, NEUROMOL MED, V10, P67, DOI 10.1007/s12017-008-8032-3; Hasegawa H, 2008, J PHYSIOL-LONDON, V586, P141, DOI 10.1113/jphysiol.2007.142190; Haskell CF, 2005, PSYCHOPHARMACOLOGY, V179, P813, DOI 10.1007/s00213-004-2104-3; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Jacobson BH, 1987, AVIAT SPACE ENV MED; Jeukendrup AE, 2004, SPORT NUTRITION AN I; Kenemans JL, 1998, PSYCHOPHARMACOLOGY, V135, P353, DOI 10.1007/s002130050522; Klass M, 2012, MED SCI SPORT EXER, V44, P2299, DOI 10.1249/MSS.0b013e318265f356; Klein R. M., 1980, ATTENTION PERFORM, P259, DOI DOI 10.1037/E665402011-424; Kleiner M, 2007, PERCEPTION, V36, P14; Kovacs EMR, 1998, J APPL PHYSIOL, V85, P709, DOI 10.1152/jappl.1998.85.2.709; Kuhn G, 2009, ATTEN PERCEPT PSYCHO, V71, P314, DOI 10.3758/APP.71.2.314; Llorens F, 2015, EXP PSYCHOL, V62, P20, DOI 10.1027/1618-3169/a000270; Lorist MM, 2003, BRAIN COGNITION, V53, P82, DOI 10.1016/S0278-2626(03)00206-9; LORIST MM, 1994, PSYCHOPHARMACOLOGY, V113, P411, DOI 10.1007/BF02245217; Meeusen R, 1997, ACTA PHYSIOL SCAND, V159, P335, DOI 10.1046/j.1365-201X.1997.00118.x; Meeusen R, 1996, BRAIN RES, V740, P245, DOI 10.1016/S0006-8993(96)00872-4; Nobre AC, 2000, NEUROIMAGE, V11, P210, DOI 10.1006/nimg.2000.0539; Nybo L, 2005, J PHYSIOL-LONDON, V563, P285, DOI 10.1113/jphysiol.2004.075838; Nybo L, 2003, ACTA PHYSIOL SCAND, V179, P67, DOI 10.1046/j.1365-201X.2003.01175.x; Nybo L, 2003, MED SCI SPORT EXER, V35, P589, DOI 10.1249/01.MSS.0000058433.85789.66; Nybo L, 2001, J APPL PHYSIOL, V91, P1055, DOI 10.1152/jappl.2001.91.3.1055; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; PASMAN WJ, 1995, INT J SPORTS MED, V16, P225, DOI 10.1055/s-2007-972996; Peelen MV, 2004, NEUROIMAGE, V22, P822, DOI 10.1016/j.neuroimage.2004.01.044; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Philip P, 2004, J SLEEP RES, V13, P105, DOI 10.1111/j.1365-2869.2004.00399.x; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rees K, 1999, PSYCHOPHARMACOLOGY, V145, P181, DOI 10.1007/s002130051047; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Roelands B, 2012, SCAND J MED SCI SPOR, V22, pe93, DOI 10.1111/j.1600-0838.2012.01502.x; Roelands B, 2010, SPORTS MED, V40, P229, DOI 10.2165/11533670-000000000-00000; ROYBYRNE P, 1995, BIOL PSYCHIAT, V38, P92, DOI 10.1016/0006-3223(94)00225-R; Ruijter J, 1999, J PSYCHOPHYSIOL, V13, P37, DOI 10.1027//0269-8803.13.1.37; Sanabria D, 2011, PSYCHOL SPORT EXERC, V12, P570, DOI 10.1016/j.psychsport.2011.04.002; Taylor JL, 2006, CLIN EXP PHARMACOL P, V33, P400, DOI 10.1111/j.1440-1681.2006.04363.x; Thiel CM, 2005, NEUROPSYCHOPHARMACOL, V30, P810, DOI 10.1038/sj.npp.1300633; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Turner CE, 2015, PHYSIOL BEHAV, V142, P104, DOI 10.1016/j.physbeh.2015.02.006; Turner CE, 2015, J NEUROSCI, V35, P1773, DOI 10.1523/JNEUROSCI.3113-14.2015; Van Den Berg J, 2006, PERCEPT MOTOR SKILL, V102, P589, DOI 10.2466/PMS.102.2.589-599; van Duinen H, 2005, PSYCHOPHARMACOLOGY, V180, P539, DOI 10.1007/s00213-005-2191-9	59	14	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165318	10.1371/journal.pone.0165318	http://dx.doi.org/10.1371/journal.pone.0165318			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9OE	27768747	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000386205400078
J	Hu, ZY; Hu, S; Yang, S; Chen, M; Zhang, P; Liu, J; Abbott, GW				Hu, Zhaoyang; Hu, Sheng; Yang, Shuai; Chen, Mou; Zhang, Ping; Liu, Jin; Abbott, Geoffrey W.			Remote Liver Ischemic Preconditioning Protects against Sudden Cardiac Death via an ERK/GSK-3 beta-Dependent Mechanism	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; SIGNAL-REGULATED KINASE; RANDOMIZED CONTROLLED-TRIAL; BYPASS GRAFT-SURGERY; REPERFUSION INJURY; VENTRICULAR-TACHYCARDIA; MYOCARDIAL-ISCHEMIA; CORONARY-OCCLUSION; CARDIOPROTECTION; PHOSPHORYLATION	Background Preconditioning stimuli conducted in remote organs can protect the heart against subsequent ischemic injury, but effects on arrhythmogenesis and sudden cardiac death (SCD) are unclear. Here, we investigated the effect of remote liver ischemia preconditioning (RLIPC) on ischemia/reperfusion (I/R)-induced cardiac arrhythmia and sudden cardiac death (SCD) in vivo, and determined the potential role of ERK/GSK-3 beta signaling. Methods/Results Male Sprague Dawley rats were randomized to sham-operated, control, or RLIPC groups. RLIPC was induced by alternating four 5-minute cycles of liver ischemia with 5-minute intermittent reperfusions. To investigate I/R-induced arrhythmogenesis, hearts in each group were subsequently subjected to 5-minute left main coronary artery ligation followed by 20-minute reperfusion. RLIPC reduced post-I/R ventricular arrhythmias, and decreased the incidence of SCD >threefold. RLIPC increased phosphorylation of cardiac ERK1/2, and GSK-3 beta Ser9 but not Tyr216 post-I/R injury. Inhibition of either GSK-3 beta (with SB216763) or ERK1/2 (with U0126) abolished RLIPC-induced antiarrhythmic activity and GSK-3 beta Ser9 and ERK1/2 phosphorylation, leaving GSK-3 beta Tyr216 phosphorylation unchanged. Conclusions RLIPC exerts a powerful antiarrhythmic effect and reduces predisposition to post-IR SCD. The underlying mechanism of RLIPC cardioprotection against I/R-induced early arrhythmogenesis may involve ERK1/2/GSK-3 beta Ser9-dependent pathways.	[Hu, Zhaoyang; Yang, Shuai; Chen, Mou; Zhang, Ping; Liu, Jin] Sichuan Univ, West China Hosp, Lab Anesthesiol & Crit Care Med, Translat Neurosci Ctr, Chengdu, Sichuan, Peoples R China; [Hu, Sheng] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian, Shanxi, Peoples R China; [Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Pharmacol, Bioelect Lab, Irvine, CA 92717 USA; [Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92717 USA	Sichuan University; Air Force Military Medical University; University of California System; University of California Irvine; University of California System; University of California Irvine	Liu, J (corresponding author), Sichuan Univ, West China Hosp, Lab Anesthesiol & Crit Care Med, Translat Neurosci Ctr, Chengdu, Sichuan, Peoples R China.; Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Pharmacol, Bioelect Lab, Irvine, CA 92717 USA.; Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92717 USA.	scuanesth@hotmail.com; abbottg@uci.edu		Liu, Jin/0000-0002-2026-2513	National Natural Science Foundation of China [81670300, 81271342]; US National Institutes of Health [HL079275]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grant No. 81670300 (to ZH), No. 81271342 (to SH) from the National Natural Science Foundation of China. GWA was supported by US National Institutes of Health HL079275. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Ates E, 2002, TRANSPLANTATION, V74, P1247, DOI 10.1097/01.TP.0000032752.61372.36; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Dow J, 2012, J CARDIOVASC ELECTR, V23, P1374, DOI 10.1111/j.1540-8167.2012.02397.x; Eisen A, 2004, ATHEROSCLEROSIS, V172, P201, DOI 10.1016/S0021-9150(03)00238-7; Evrengul H, 2006, CORONARY ARTERY DIS, V17, P283, DOI 10.1097/00019501-200605000-00013; Gross ER, 2004, CIRC RES, V94, P960, DOI 10.1161/01.RES.0000122392.33172.09; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hsiao ST, 2014, PHARMACOL THERAPEUT, V142, P141, DOI 10.1016/j.pharmthera.2013.12.002; Hu ZY, 2009, CAN J ANAESTH, V56, P115, DOI 10.1007/s12630-008-9016-3; Hu ZY, 2014, CIRC-CARDIOVASC GENE, V7, P33, DOI 10.1161/CIRCGENETICS.113.000315; Juhaszova M, 2009, CIRC RES, V104, P1240, DOI 10.1161/CIRCRESAHA.109.197996; Koplan BA, 2009, MAYO CLIN PROC, V84, P289, DOI 10.1016/S0025-6196(11)61149-X; Kottenberg E, 2012, ACTA ANAESTH SCAND, V56, P30, DOI 10.1111/j.1399-6576.2011.02585.x; Lentsch AB, 1998, HEPATOLOGY, V27, P1172; Li RA, 2000, CIRC RES, V87, P837, DOI 10.1161/01.RES.87.10.837; Liu TQ, 2015, FREE RADICAL BIO MED, V81, P170, DOI 10.1016/j.freeradbiomed.2014.10.509; Lujan HL, 2009, J CARDIOVASC PHARM T, V14, P199, DOI 10.1177/1074248409340160; Mortensen UM, 2006, BASIC RES CARDIOL, V101, P140, DOI 10.1007/s00395-005-0574-z; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010; Nishihara M, 2006, AM J PHYSIOL-HEART C, V291, pH748, DOI 10.1152/ajpheart.00837.2005; Nishino Y, 2008, CIRC RES, V103, P307, DOI 10.1161/CIRCRESAHA.107.169953; Noh KT, 2012, J BIOL CHEM, V287, P14226, DOI 10.1074/jbc.M111.308841; Noorbakhsh MF, 2015, IRAN J BASIC MED SCI, V18, P80; Nordin C, 2010, DIABETOLOGIA, V53, P1552, DOI 10.1007/s00125-010-1752-6; Park CH, 2013, TOXICOL SCI, V135, P380, DOI 10.1093/toxsci/kft158; Peralta C, 2003, TRANSPLANT P, V35, P1800, DOI 10.1016/S0041-1345(03)00571-2; Peralta C, 1999, HEPATOLOGY, V30, P1481, DOI 10.1002/hep.510300622; Peters J, 2011, BASIC RES CARDIOL, V106, P507, DOI 10.1007/s00395-011-0187-7; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Przyklenk K, 2011, J CARDIOVASC PHARM T, V16, P255, DOI 10.1177/1074248411409040; Rahman IA, 2010, CIRCULATION, V122, pS53, DOI 10.1161/CIRCULATIONAHA.109.926667; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Shi WW, 2012, CARDIOVASC RES, V94, P206, DOI 10.1093/cvr/cvs088; Tamareille S, 2011, BASIC RES CARDIOL, V106, P1329, DOI 10.1007/s00395-011-0210-z; Tapuria N, 2008, J SURG RES, V150, P304, DOI 10.1016/j.jss.2007.12.747; Tong HY, 2002, CIRC RES, V90, P377, DOI 10.1161/01.RES.0000012567.95445.55; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; WARLTIER DC, 1988, ANESTHESIOLOGY, V69, P552, DOI 10.1097/00000542-198810000-00016; Yue TL, 2000, CIRC RES, V86, P692, DOI 10.1161/01.RES.86.6.692; Zhai PY, 2011, CIRC RES, V109, P502, DOI 10.1161/CIRCRESAHA.111.249532; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	49	20	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165123	10.1371/journal.pone.0165123	http://dx.doi.org/10.1371/journal.pone.0165123			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768739	gold, Green Published			2022-12-26	WOS:000386205400053
J	Tian, LF; Chen, SY; Liu, HY; Guo, MZ; Xu, WT; He, XY; Luo, YB; Qi, XZ; Luo, HX; Huang, KL				Tian, Lanfang; Chen, Siyuan; Liu, Haiyan; Guo, Mingzhang; Xu, Wentao; He, Xiaoyun; Luo, Yunbo; Qi, Xiaozhe; Luo, Hongxia; Huang, Kunlun			In Vivo Effects of Pichia Pastoris-Expressed Antimicrobial Peptide Hepcidin on the Community Composition and Metabolism Gut Microbiota of Rats	PLOS ONE			English	Article							BASS HEPCIDIN; GENE	Hepcidin, one kind of antimicrobial peptides, is one of the promising alternatives to antibiotics with broad spectrum of antimicrobial activity. Hepcidins cloned from different kinds of fishes have been produced using exogenous expression systems, and their in vitro antimicrobial effects have been verified. However their in vivo effects on gut microbiota and gut health of hosts remain unclear. Here we performed a safety study of hepcidin so that it can be used to reduce microbial contaminations in the food and feed. In this study, Pichia pastoris-expressed Pseudosciaena crocea hepcidin (PC-hepc) was first assessed by simulated digestion tests and then administered to male and female Sprague-Dawley (SD) rats in different concentrations. Subchronic toxicity testing, high throughput 16S rRNA sequencing of gut microbiota, and examinations on gut metabolism and permeability were conducted. The results showed PC-hepc could be digested in simulated intestinal fluid but not in simulated gastric fluid. PC-hepc had no adverse effects on general health, except causing increase of blood glucose (still in the normal value range of this index) in all trial groups of female rats and intestinal inflammation in HD group of female rats. Community composition of gut microbiota of female MD and HD groups shifted compared with control group, of which the decrease of genus Akkermansia might be related to the increase of blood glucose and intestinal inflammation. Significant increase of fecal nitroreductase activity was also observed in female MD and HD groups. Our results suggest the uses of exogenous PC-hepc in normal dosage are safe, however excess dosage of it may cause intestinal disorder of animals.	[Tian, Lanfang; Chen, Siyuan; Guo, Mingzhang; Xu, Wentao; He, Xiaoyun; Luo, Yunbo; Qi, Xiaozhe; Huang, Kunlun] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China; [Luo, Hongxia] Beijing Vocat Coll Agr, Beijing 102442, Peoples R China; [Liu, Haiyan] North China Univ Sci & Technol, Sch Publ Hlth, Tangshan 063000, Hebei, Peoples R China; [Guo, Mingzhang; Xu, Wentao; He, Xiaoyun; Luo, Yunbo; Huang, Kunlun] Beijing Lab Food Qual & Safety, Beijing 100083, Peoples R China	China Agricultural University; North China University of Science & Technology	Huang, KL (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China.; Luo, HX (corresponding author), Beijing Vocat Coll Agr, Beijing 102442, Peoples R China.; Huang, KL (corresponding author), Beijing Lab Food Qual & Safety, Beijing 100083, Peoples R China.	hongxiajun@163.com; huangkl009@sina.com		Kunlun, Huang/0000-0002-2350-5859	Genetically Modified Organisms Breeding Major Projects of China [2014ZX08011-005]	Genetically Modified Organisms Breeding Major Projects of China	This work was supported by Genetically Modified Organisms Breeding Major Projects of China (grant number: 2014ZX08011-005). URL:http//program.most.gov.cn. Author who received the funding: KH. The funder played roles in data collection and analysis.	Anhe FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142; Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6; Berry D, 2013, BEST PRACT RES CL GA, V27, P47, DOI 10.1016/j.bpg.2013.03.005; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Bolnick DI, 2014, NAT COMMUN, P5; Bradlow HL, 2014, HORM MOL BIOL CLIN I, V17, P53, DOI 10.1515/hmbci-2013-0063; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Cao SS, 2010, REGUL TOXICOL PHARM, V58, P474, DOI 10.1016/j.yrtph.2010.08.018; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ebenhan T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/867381; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Guo MZ, 2014, TOXICOL SCI, V141, P314, DOI 10.1093/toxsci/kfu128; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hirono I, 2005, FEBS J, V272, P5257, DOI 10.1111/j.1742-4658.2005.04922.x; Karunasena E, 2014, APPL ENVIRON MICROB, V80, P4481, DOI 10.1128/AEM.01229-14; Lauth X, 2005, J BIOL CHEM, V280, P9272, DOI 10.1074/jbc.M411154200; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Petterino C, 2006, EXP TOXICOL PATHOL, V57, P213, DOI 10.1016/j.etp.2005.10.002; Rodrigues PNS, 2006, DEV COMP IMMUNOL, V30, P1156, DOI 10.1016/j.dci.2006.02.005; Rossolini GM, 2014, CURR OPIN PHARMACOL, V18, P56, DOI 10.1016/j.coph.2014.09.006; SCHEEPERS PTJ, 1994, ENVIRON HEALTH PERSP, V102, P39, DOI 10.2307/3432149; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shastri P, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0031-0; Shi JS, 2006, DEV COMP IMMUNOL, V30, P746, DOI 10.1016/j.dci.2005.10.009; Shike H, 2002, EUR J BIOCHEM, V269, P2232, DOI 10.1046/j.1432-1033.2002.02881.x; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Tennoune N, 2015, NUTRITION, V31, P498, DOI 10.1016/j.nut.2014.11.003; Wang KJ, 2009, PEPTIDES, V30, P638, DOI 10.1016/j.peptides.2008.12.014; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yuan YF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01962	34	3	4	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164771	10.1371/journal.pone.0164771	http://dx.doi.org/10.1371/journal.pone.0164771			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768776	gold, Green Published, Green Submitted			2022-12-26	WOS:000386205400028
J	Zaidi, PH; Seetharam, K; Krishna, G; Krishnamurthy, L; Gajanan, S; Babu, R; Zerka, M; Vinayan, MT; Vivek, BS				Zaidi, P. H.; Seetharam, K.; Krishna, Girish; Krishnamurthy, L.; Gajanan, S.; Babu, Raman; Zerka, M.; Vinayan, M. T.; Vivek, B. S.			Genomic Regions Associated with Root Traits under Drought Stress in Tropical Maize (Zea mays L.)	PLOS ONE			English	Article							USE EFFICIENCY; YIELD; QTLS; FIELD; IDENTIFICATION; REVEALS; MAP; LAB	An association mapping panel, named as CIMMYT Asia association mapping (CAAM) panel, involving 396 diverse tropical maize lines were phenotyped for various structural and functional traits of roots under drought and well-watered conditions. The experiment was conducted during Kharif (summer-rainy) season of 2012 and 2013 in root phenotyping facility at CIMMYT-Hyderabad, India. The CAAM panel was genotyped to generate 955, 690 SNPs through GBS v2.7 using Illumina Hi-seq 2000/2500 at Institute for Genomic Diversity, Cornell University, Ithaca, NY, USA. GWAS analysis was carried out using 331,390 SNPs filtered from the entire set of SNPs revealed a total of 50 and 67 SNPs significantly associated for root functional (transpiration efficiency, flowering period water use) and structural traits (rooting depth, root dry weight, root length, root volume, root surface area and root length density), respectively. In addition to this, 37 SNPs were identified for grain yield and shoot biomass under well-watered and drought stress. Though many SNPs were found to have significant association with the traits under study, SNPs that were common for more than one trait were discussed in detail. A total 18 SNPs were found to have common association with more than one trait, out of which 12 SNPs were found within or near the various gene functional regions. In this study we attempted to identify the trait specific maize lines based on the presence of favorable alleles for the SNPs associated with multiple traits. Two SNPs S3_128533512 and S7_151238865 were associated with transpiration efficiency, shoot biomass and grain yield under well-watered condition. Based on favorable allele for these SNPs seven inbred lines were identified. Similarly, four lines were identified for transpiration efficiency and shoot biomass under drought stress based on the presence of favorable allele for the common SNPs S1_211520521, S2_20017716, S3_57210184 and S7_130878458 and three lines were identified for flowering period water-use, transpiration efficiency, root dry weight and root volume based on the presence of favorable allele for the common SNPs S3_162065732 and S3_225760139.	[Zaidi, P. H.; Seetharam, K.; Krishna, Girish; Gajanan, S.; Babu, Raman; Zerka, M.; Vinayan, M. T.; Vivek, B. S.] Int Maize & Wheat Improvement Ctr CIMMYT, Asia Reg Off, Hyderabad, Andhra Pradesh, India; [Krishnamurthy, L.] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Babu, Raman] Dupont Pioneer, Hyderabad, Andhra Pradesh, India	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Zaidi, PH (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Asia Reg Off, Hyderabad, Andhra Pradesh, India.	phzaidi@cgiar.org			Syngenta Foundation for Sustainable Agriculture [Triple A]; Syngenta Foundation for Sustainable Agriculture (SFSA)	Syngenta Foundation for Sustainable Agriculture(Syngenta); Syngenta Foundation for Sustainable Agriculture (SFSA)(Syngenta)	Syngenta Foundation for Sustainable Agriculture, Grant Number: Triple A, URL: www.syngentafoundation.org/, BSV. Staff-time of the coauthors (BV, RB, MTV and PHZ) supported by CGIAR Research Program on MAIZE is duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was carried out as an objective under the Affordable, Accessible, Asian (Triple A) Drought Tolerant Maize Project funded by the Syngenta Foundation for Sustainable Agriculture (SFSA). The funding from SFSA is gratefully acknowledged. Staff-time of the co-authors (BV, RB, MTV and PHZ) supported by CGIAR Research Program on MAIZE is duly acknowledged.	Almeida GD, 2013, THEOR APPL GENET, V126, P583, DOI 10.1007/s00122-012-2003-7; Araus L, 2008, BREEDING YIELD POTEN, P377, DOI [10.1080/07352680802467736, DOI 10.1080/07352680802467736]; Asare D. K., 2011, Agricultural Sciences, V2, P125, DOI 10.4236/as.2011.22018; Bayuelo-jimenez JS, 2011, GENOTYPIC VARIATION, DOI [10.1016/j.fcr.2011.01.001, DOI 10.1016/J.FCR.2011.01.001]; Blum A, 2009, FIELD CROP RES, V112, P119, DOI 10.1016/j.fcr.2009.03.009; Brown DE, 2001, FLAVONOIDS ACT NEGAT, DOI [10.1104/pp.126.2.524, DOI 10.1104/PP.126.2.524]; Buckler ES, 2002, CURR OPIN PLANT BIOL, V5, P107, DOI 10.1016/S1369-5266(02)00238-8; Burton AL, 2015, QTL MAPPING PHENOTYP, P93, DOI [10.1007/s00122-014-2414-8, DOI 10.1007/S00122-014-2414-8]; Cai HG, 2012, THEOR APPL GENET, V125, P1313, DOI 10.1007/s00122-012-1915-6; Castilhos G, 2014, PLANT SCI, V223, P1, DOI 10.1016/j.plantsci.2014.02.010; Comas LH, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00442; Edmeades G.O., 1997, AGR ECON-BLACKWELL, V1997; GenStat, 2020, GENSTAT WINDOWS, V9th ed.; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; GRANT RF, 1989, AGRON J, V81, P61, DOI 10.2134/agronj1989.00021962008100010011x; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Hodge A, 2009, PLANT SOIL, V321, P153, DOI 10.1007/s11104-009-9929-9; Kell DB, 2011, BREEDING CROP PLANTS, P407, DOI [10.1093/aob/mcr175, DOI 10.1093/AOB/MCR175]; Krill AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009958; Ku LX, 2012, MOL BREEDING, V30, P697, DOI 10.1007/s11032-011-9655-x; Kuijken RCP, 2015, J EXP BOT, V66, P5389, DOI 10.1093/jxb/erv239; Li Q, 2010, RELATIONSHIP EVOLUTI, P1; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; Mano Y, 2008, MOL BREEDING, V21, P327, DOI 10.1007/s11032-007-9132-8; Narayanan S, 2014, VARIABILITY ROOT TRA, V9, DOI [10.1371/journal.pone.0100317, DOI 10.1371/JOURNAL.PONE.0100317]; Nardini A., 2002, PLANT ROOTS HIDDEN H, P683; Ober ES, 2003, J EXP BOT, V54, P813, DOI 10.1093/jxb/erg060; Pace J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1226-9; Paez-garcia A, 2015, ROOT TRAITS PHENOTYP, P334, DOI [10.3390/plants402033427135332, DOI 10.3390/PLANTS402033427135332]; Pandey MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105228; Pestsova E, 2016, QTL MAPPING SEEDING, P585, DOI [10.1007/s10681-015-1625-7, DOI 10.1007/S10681-015-1625-7]; Pingali PL., 2007, TROPICAL SUBTROPICAL; Rockstrom J, 2010, AGR WATER MANAGE, V97, P543, DOI 10.1016/j.agwat.2009.09.009; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Ruta N, 2010, THEOR APPL GENET, V120, P621, DOI 10.1007/s00122-009-1180-5; Salvi S, 2007, CONSERVED NONCODING, V104, P3; Semagn K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-313; Setter TL, 2011, J EXP BOT, V62, P701, DOI 10.1093/jxb/erq308; Suwarno WB, 2015, GENOME WIDE ASS ANAL, P851, DOI [10.1007/s00122-015-2475-3, DOI 10.1007/S00122-015-2475-3]; Suwarno WB, 2014, CROP SCI, V54, P14, DOI 10.2135/cropsci2013.02.0096; Tenaillon M, 2001, P NATL ACAD SCI, V98; Thirunavukkarasu N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1182; Tuberosa R, 2002, PLANT MOL BIOL, V48, P697, DOI 10.1023/A:1014897607670; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P79, DOI 10.4161/psb.3.2.5303; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Vadez V, 2011, CROP PASTURE SCI, V62, P645, DOI 10.1071/CP11007; Variation T, 2009, EPISTATIC INTERACTIO, V150, P506, DOI [10.1104/pp.108.131888, DOI 10.1104/PP.108.131888]; Varshney RK, 2005, TRENDS PLANT SCI, V10, P621, DOI 10.1016/j.tplants.2005.10.004; Xue Y, 2013, GENOME WIDE ASS ANAL, P2587, DOI [10.1007/s00122-013-2158-x, DOI 10.1007/S00122-013-2158-X]; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Zaidi P. H., 2014, 12th Asian Maize Conference and Expert Consultation on maize for food, feed, nutrition and environmental security, Bangkok, Thailand, 30 October - 1 November 2014. Book of Extended Summaries, P104; Zhu JM, 2011, CURR OPIN PLANT BIOL, V14, P310, DOI 10.1016/j.pbi.2011.03.020; Zurek PR, 2015, PLANT PHYSIOL, V167, P1487, DOI 10.1104/pp.114.251751	58	36	37	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164340	10.1371/journal.pone.0164340	http://dx.doi.org/10.1371/journal.pone.0164340			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768702	gold, Green Submitted, Green Published			2022-12-26	WOS:000386205400009
J	Ellamil, M; Berson, J; Wong, J; Buckley, L; Margulies, DS				Ellamil, Melissa; Berson, Joshua; Wong, Jen; Buckley, Louis; Margulies, Daniel S.			One in the Dance: Musical Correlates of Group Synchrony in a Real-World Club Environment	PLOS ONE			English	Article							MOVEMENT; SPECTATORS; DYNAMICS; ROCKING	Previous research on interpersonal synchrony has mainly investigated small groups in isolated laboratory settings, which may not fully reflect the complex and dynamic interactions of real-life social situations. The present study expands on this by examining group synchrony across a large number of individuals in a naturalistic environment. Smartphone acceleration measures were recorded from participants during a music set in a dance club and assessed to identify how group movement synchrony covaried with various features of the music. In an evaluation of different preprocessing and analysis methods, giving more weight to front-back movement provided the most sensitive and reliable measure of group synchrony. During the club music set, group synchrony of torso movement was most strongly associated with pulsations that approximate walking rhythm (100-150 beats per minute). Songs with higher real-world play counts were also correlated with greater group synchrony. Group synchrony thus appears to be constrained by familiarity of the movement (walking action and rhythm) and of the music (song popularity). These findings from a real world, large-scale social and musical setting can guide the development of methods for capturing and examining collective experiences in the laboratory and for effectively linking them to synchrony across people in daily life.	[Ellamil, Melissa; Berson, Joshua; Margulies, Daniel S.] Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Neuroanat & Connect, Leipzig, Germany; [Wong, Jen; Buckley, Louis] Guerilla Sci, London, England	Max Planck Society	Margulies, DS (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Neuroanat & Connect, Leipzig, Germany.	margulies@cbs.mpg.de	Margulies, Daniel/L-4719-2016	Margulies, Daniel/0000-0002-8880-9204	Wellcome Trust Society Award [100393/Z/12/Z]	Wellcome Trust Society Award	This work was supported by a Wellcome Trust Society Award granted to J.W. on behalf of Guerilla Science (100393/Z/12/Z).	Abrams DA, 2013, EUR J NEUROSCI, V37, P1458, DOI 10.1111/ejn.12173; Alluri V, 2010, MUSIC PERCEPT, V27, P223, DOI 10.1525/mp.2010.27.3.223; Brown, 1922, ANDAMAN ISLANDERS ST; Codrons E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107538; Dunbar R., 2012, MUSIC LANGUAGE HUMAN, P201, DOI DOI 10.1093/ACPROF:OSOBL/9780199227341.003.0008; Durkheim Emile, 1915, ELEMENTARY FORMS REL; Ehrenreich B., 2007, DANCING STREETS HIST; Frank TD, 2010, PHYSICA D, V239, P2084, DOI 10.1016/j.physd.2010.07.015; Fuchs A, 1996, BIOL CYBERN, V74, P21, DOI 10.1007/BF00199134; Gafurov D, 2006, J COMPUT, V1, P51, DOI 10.4304/jcp.1.7.51-59; Glerean E, 2012, BRAIN CONNECT, V2, P91, DOI 10.1089/brain.2011.0068; Hadar U., 1989, J LANG SOC PSYCHOL, V8, P221, DOI DOI 10.1177/0261927X8983004; Harte C., 2006, P 1 ACM WORKSH AUD M, P21, DOI [10.1145/1178723.1178727, DOI 10.1145/1178723.1178727]; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Jensen K. K., 1999, TIMBRE MODELS MUSICA; Jola C, 2013, I-PERCEPTION, V4, P265, DOI 10.1068/i0536; Juslin PN, 2000, J EXP PSYCHOL HUMAN, V26, P1797, DOI 10.1037//0096-1523.26.6.1797; Kauppi JP, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00002; Keller PE, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0394; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Konvalinka I, 2011, P NATL ACAD SCI USA, V108, P8514, DOI 10.1073/pnas.1016955108; Kuhl PK, 2007, DEVELOPMENTAL SCI, V10, P110, DOI 10.1111/j.1467-7687.2007.00572.x; Lakens D, 2011, SOC COGNITION, V29, P1, DOI 10.1521/soco.2011.29.1.1; Lartillot O, 2013, P INT C MUS EM; Lartillot O, 2008, ISMIR 2008 9 INT C M, P521; Lartillot O, 2008, ST CLASS DAT ANAL, P261, DOI 10.1007/978-3-540-78246-9_31; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; McNeill W.H., 1997, KEEPING TOGETHER TIM; Merker BH, 2009, CORTEX, V45, P4, DOI 10.1016/j.cortex.2008.06.011; Muller V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024893; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Neda Z, 2000, PHYS REV E, V61, P6987, DOI 10.1103/PhysRevE.61.6987; Olaveson Tim, 2004, RAVE CULTURE RELIG, P85; Peeters G., 2006, IEEE INT C AC SPEECH IEEE INT C AC SPEECH; Phillips-Silver J, 2010, MUSIC PERCEPT, V28, P3, DOI 10.1525/MP.2010.28.1.3; Ragert M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00368; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Richardson MJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00405; Schmidt RC, 2011, HUM MOVEMENT SCI, V30, P834, DOI 10.1016/j.humov.2010.05.014; SCHMIDT RC, 1994, BIOL CYBERN, V70, P369, DOI 10.1007/BF00200334; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sethares WA., 1998, TUNING TIMBRE SPECTR; Tzanetakis G., 1999, Proceedings of the 1999 IEEE Workshop on Applications of Signal Processing to Audio and Acoustics. WASPAA'99 (Cat. No.99TH8452), P103, DOI 10.1109/ASPAA.1999.810860; van Ulzen NR, 2008, NEUROSCI LETT, V432, P88, DOI 10.1016/j.neulet.2007.11.070; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x	47	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164783	10.1371/journal.pone.0164783	http://dx.doi.org/10.1371/journal.pone.0164783			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ9NZ	27764167	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500062
J	Lawrence, CL; Baldwin, AS				Lawrence, Cortney L.; Baldwin, Albert S.			Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast Cancer	PLOS ONE			English	Article							NF-KAPPA-B; PROSTATE-CANCER; STEM-CELLS; TRANSGENIC MICE; BASAL-LIKE; PATHWAY; EXPRESSION; ESTROGEN; PHOSPHORYLATION; METHYLATION	Enhancer of zeste homology 2 (EZH2) is the methyltransferase component of the polycomb repressive complex (PRC2) which represses gene transcription via histone H3 trimethylation at lysine 23 (H3K27me3). EZH2 activity has been linked with oncogenesis where it is thought to block expression of certain tumor suppressors. Relative to a role in cancer, EZH2 functions to promote self-renewal and has been shown to be important for the tumorinitiating cell (TIC) phenotype in breast cancer. Recently a non-canonical role for EZH2 has been identified where it promotes transcriptional activation of certain genes. Here we show that EZH2, through a methyltransferase-independent mechanism, promotes the transcriptional activation of the non-canonical NF-kappa B subunit RelB to drive self-renewal and the TIC phenotype of triple-negative breast cancer cells.	[Lawrence, Cortney L.; Baldwin, Albert S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Baldwin, AS (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27514 USA.	abaldwin@med.unc.edu			Nation Institutes of Health [R35 CA197684]; Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R35CA197684] Funding Source: NIH RePORTER	Nation Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Nation Institutes of Health, https://www.nih.gov/, R35 CA197684, AB; and Waxman Cancer Research Foundation, http://www.waxmancancer.org/, AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradford JW, 2014, ADV CANCER RES, V121, P125, DOI 10.1016/B978-0-12-800249-0.00003-2; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Bronder JL, 2003, J BIOL CHEM, V278, P48861, DOI 10.1074/jbc.M304844200; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Demicco EG, 2005, MOL CELL BIOL, V25, P10136, DOI 10.1128/MCB.25.22.10136-10147.2005; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gonzalez ME, 2014, P NATL ACAD SCI USA, V111, P3098, DOI 10.1073/pnas.1308953111; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Holm K, 2012, MOL ONCOL, V6, P494, DOI 10.1016/j.molonc.2012.06.002; Kendellen MF, 2014, ONCOGENE, V33, P1297, DOI 10.1038/onc.2013.64; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kim KH, 2015, NAT MED, V21, P1491, DOI 10.1038/nm.3968; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133J, 10.1021/cb400133j]; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lee HE, 2011, BRIT J CANCER, V104, P1730, DOI 10.1038/bjc.2011.159; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu M, 2010, CANCER RES, V70, P10464, DOI 10.1158/0008-5472.CAN-10-0732; Luo M, 2015, METHODS MOL BIOL, V1293, P1, DOI 10.1007/978-1-4939-2519-3_1; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Mineva ND, 2009, J CELL PHYSIOL, V220, P593, DOI 10.1002/jcp.21765; Naderi A, 2012, NEOPLASIA, V14, P283, DOI 10.1593/neo.12294; Nakshatri H, 2009, CURR STEM CELL RES T, V4, P50, DOI 10.2174/157488809787169110; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Van Laere SJ, 2006, CLIN CANCER RES, V12, P3249, DOI 10.1158/1078-0432.CCR-05-2800; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Xu BW, 2015, BLOOD, V125, P346, DOI 10.1182/blood-2014-06-581082; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Xu Y, 2009, CANCER RES, V69, P3267, DOI 10.1158/0008-5472.CAN-08-4635; Yamaguchi H, 2014, CANCER RES TREAT, V46, P209, DOI 10.4143/crt.2014.46.3.209; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x; Yang CC, 2015, AM J TRANSL RES, V7, P1009	42	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0165005	10.1371/journal.pone.0165005	http://dx.doi.org/10.1371/journal.pone.0165005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764181	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204500100
J	Li, J; Zhen, W; Long, DK; Ding, L; Gong, AH; Xiao, CH; Jiang, WK; Liu, XQ; Zhou, T; Huang, LQ				Li, Jun; Zhen, Wei; Long, Dengkai; Ding, Ling; Gong, Anhui; Xiao, Chenghong; Jiang, Weike; Liu, Xiaoqing; Zhou, Tao; Huang, Luqi			De Novo Sequencing and Assembly Analysis of the Pseudostellaria heterophylla Transcriptome	PLOS ONE			English	Article							FUSARIUM-OXYSPORUM; GINSENOSIDES BIOSYNTHESIS; RNA-SEQ; GENES; ROOT; NOTOGINSENG; METABOLISM; SAPONINS; INSIGHTS; LEAVES	Pseudostellaria heterophylla (Miq.) Pax is a mild tonic herb widely cultivated in the Southern part of China. The tuberous roots of P. heterophylla accumulate high levels of secondary metabolism products of medicinal value such as saponins, flavonoids, and isoquinoline alkaloids. Despite numerous studies on the pharmacological importance and purification of these compounds in P. heterophylla, their biosynthesis is not well understood. In the present study, we used Illumina HiSeq 4000 sequencing platform to sequence the RNA from flowers, leaves, stem, root cortex and xylem tissues of P. heterophylla. We obtained 616,413,316 clean reads that we assembled into 127, 334 unique sequences with an N50 length of 951 bp. Among these unigenes, 53,184 unigenes (41.76%) were annotated in a public database and 39, 795 unigenes were assigned to 356 KEGG pathways; 23,714 unigenes (8.82%) had high homology with the genes from Beta vulgaris. We discovered 32, 095 DEGs in different tissues and performed GO and KEGG enrichment analysis. The most enriched KEGG pathway of secondary metabolism showed up-regulated expression in tuberous roots as compared with the ground parts of P. heterophylla. Moreover, we identified 72 candidate genes involved in triterpenoids saponins biosynthesis in P. heterophylla. The expression profiles of 11 candidate unigenes were analyzed by quantitative real-time PCR (RT-qPCR). Our study established a global transcriptome database of P. heterophylla for gene identification and regulation. We also identified the candidate unigenes involved in triterpenoids saponins biosynthesis. Our results provide an invaluable resource for the secondary metabolites and physiological processes in different tissues of P. heterophylla.	[Li, Jun; Zhen, Wei; Long, Dengkai; Ding, Ling; Gong, Anhui; Xiao, Chenghong; Jiang, Weike; Liu, Xiaoqing; Zhou, Tao] Guiyang Univ Chinese Med, Guiyang 550025, Peoples R China; [Li, Jun; Zhen, Wei; Long, Dengkai; Ding, Ling; Gong, Anhui; Xiao, Chenghong; Jiang, Weike; Liu, Xiaoqing; Zhou, Tao] Natl Engn Res Ctr Miaos Med, Guiyang 550025, Peoples R China; [Huang, Luqi] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, State Key Lab Breeding Base Dao Di Herbs, Beijing 100700, Peoples R China	China Academy of Chinese Medical Sciences; National Resource Center for Chinese Materia Medica, CACMS	Zhou, T (corresponding author), Guiyang Univ Chinese Med, Guiyang 550025, Peoples R China.; Zhou, T (corresponding author), Natl Engn Res Ctr Miaos Med, Guiyang 550025, Peoples R China.	taozhou88@163.com			National Natural Science Foundation of China [81460579]; Science and Technology Department of Guizhou Province [QKHSY[2015]3030]; Graduate Student Work Station Project of Guizhou Province [JYSZ [2014]016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Guizhou Province; Graduate Student Work Station Project of Guizhou Province	This work was supported by grants from the National Natural Science Foundation of China (81460579), the Science and Technology Department of Guizhou Province (QKHSY[2015]3030) and Graduate Student Work Station Project of Guizhou Province (JYSZ [2014]016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohman S, 2004, PLANT J, V37, P9, DOI 10.1046/j.1365-313X.2003.01927.x; Breinholt J, 1997, J NAT PROD, V60, P33, DOI 10.1021/np9605596; Bucheli E, 2001, MOL ECOL, V10, P285, DOI 10.1046/j.1365-294x.2001.01146.x; Cai QY, 2011, J FUJIAN U TCM, V21, P41; De Donato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062137; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guillen Y, 2015, GENOME BIOL EVOL, V7, P349, DOI 10.1093/gbe/evu291; Haralampidis K, 2002, ADV BIOCHEM ENG BIOT, V75, P31; Hatfield MJ, 2013, J NAT PROD, V76, P36, DOI 10.1021/np300628a; Hayashi H, 2001, BIOL PHARM BULL, V24, P912, DOI 10.1248/bpb.24.912; He B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00819; Hua YJ, 2016, GENE, V588, P7, DOI 10.1016/j.gene.2016.04.043; Lee HS, 2012, J BIOSCI BIOENG, V113, P58, DOI 10.1016/j.jbiosc.2011.09.013; Li CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-245; Liu J., 2008, J SCI TECH COLL U, V4, P62; Liu MH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1477-5; Liu XH, 2000, JIANGSU PHARM CLIN R, V8, P6; Ma QF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151994; Moses T, 2015, PLANT CELL, V27, P286, DOI 10.1105/tpc.114.134486; Muriira NG, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1908-3; Musavi SF, 2013, J MYCOL, DOI [10.1155/2013/172056, DOI 10.1155/2013/172056]; Pang WS, 2011, MOLECULES, V16, P3360, DOI 10.3390/molecules16043360; Rainey PB, 1999, ENVIRON MICROBIOL, V1, P243, DOI 10.1046/j.1462-2920.1999.00040.x; REINECKE MG, 1988, J NAT PROD, V51, P1236, DOI 10.1021/np50060a030; Sangwan RS, 2013, GENE, V525, P58, DOI 10.1016/j.gene.2013.04.057; Sawai S, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00025; Sun P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00396; Valcu CM, 2009, J PROTEOME RES, V8, P4077, DOI 10.1021/pr900456c; Wang Z, 2013, J ETHNOPHARMACOL, V147, P540, DOI 10.1016/j.jep.2013.03.053; Wang ZX, 1992, CHINESE J MED CHEM, V2, P65; WASHIO K, 1994, PLANT PHYSIOL, V105, P1275, DOI 10.1104/pp.105.4.1275; Wiebe MG, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-26; WONG CK, 1992, INT J IMMUNOPHARMACO, V14, P1315, DOI 10.1016/0192-0561(92)90002-3; Wu Q, 2010, PHYSIOL PLANTARUM, V138, P134, DOI 10.1111/j.1399-3054.2009.01309.x; Yang Y, 2014, GENE, V534, P155, DOI 10.1016/j.gene.2013.10.073; Yoshikawa M, 1997, CHEM PHARM BULL, V45, P1039, DOI 10.1248/cpb.45.1039; Zeng LN, 2014, UJIAN LINYE, V2, P25; Zhang GH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1332-8; Zhao YP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08197; Zheng CJ, 2009, PLANTA MED, V75, P870, DOI 10.1055/s-0029-1185382	40	7	8	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164235	10.1371/journal.pone.0164235	http://dx.doi.org/10.1371/journal.pone.0164235			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764127	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204500023
J	Chen, C; Pan, JF; Yang, XB; Guo, CH; Ding, W; Si, MR; Zhang, Y; Shen, XH; Wang, Y				Chen, Can; Pan, Junfeng; Yang, Xiaobing; Guo, Chenghao; Ding, Wei; Si, Meiru; Zhang, Yi; Shen, Xihui; Wang, Yao			Global Transcriptomic Analysis of the Response of Corynebacterium glutamicum to Vanillin	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASE; MYCOBACTERIUM-TUBERCULOSIS; 4-CRESOL CATABOLISM; ETHANOL-PRODUCTION; ESCHERICHIA-COLI; OXIDATIVE STRESS; STATIONARY-PHASE; GENE-EXPRESSION; PROTEIN; LIGNOCELLULOSE	Lignocellulosic biomass is an abundant and renewable resource for biofuels and bio-based chemicals. Vanillin is one of the major phenolic inhibitors in biomass production using lignocellulose. To assess the response of Corynebacterium glutamicum to vanillin stress, we performed a global transcriptional response analysis. The transcriptional data showed that the vanillin stress not only affected the genes involved in degradation of vanillin, but also differentially regulated several genes related to the stress response, ribosome/translation, protein secretion, and the cell envelope. Moreover, deletion of the sigH or msrA gene in C. glutamicum resulted in a decrease in cell viability under vanillin stress. These insights will promote further engineering of model industrial strains, with enhanced tolerance or degradation ability to vanillin to enable suitable production of biofuels and bio-based chemicals from lignocellulosic biomass.	[Chen, Can; Pan, Junfeng; Yang, Xiaobing; Guo, Chenghao; Ding, Wei; Si, Meiru; Shen, Xihui; Wang, Yao] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Chen, Can; Pan, Junfeng; Yang, Xiaobing; Guo, Chenghao; Ding, Wei; Si, Meiru; Zhang, Yi; Shen, Xihui; Wang, Yao] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Chen, Can; Pan, Junfeng; Guo, Chenghao; Wang, Yao] Northwest A&F Univ, Coll Life Sci, Dept Biochem & Mol Biol, Yangling 712100, Shaanxi, Peoples R China; [Chen, Can] Zhoukou Normal Univ, Coll Life Sci & Agron, Zhoukou 466001, Henan, Peoples R China; [Si, Meiru] Qufu Normal Univ, Coll Life Sci, Qufu 273165, Shandong, Peoples R China; [Zhang, Yi] Northwest A&F Univ, Bioinformat Ctr, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; Zhoukou Normal University; Qufu Normal University; Northwest A&F University - China	Shen, XH; Wang, Y (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.; Shen, XH; Wang, Y (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.; Wang, Y (corresponding author), Northwest A&F Univ, Coll Life Sci, Dept Biochem & Mol Biol, Yangling 712100, Shaanxi, Peoples R China.	xihuishen@nwsuaf.edu.cn; wangyao@nwsuaf.edu.cn	DING, Wei/CVK-8505-2022	DING, Wei/0000-0002-1847-244X; pan, junfeng/0000-0001-8666-4446	National Natural Science Foundation of China [31270078, 31370150, 31500087]; Key Science and Technology Research and Development Program of Shaanxi Province, China [2014K02-12-01]; Natural Science Foundation of Shandong Province, China [ZR2015CM012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Research and Development Program of Shaanxi Province, China; Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province)	National Natural Science Foundation of China (31270078, 31370150 and 31500087 http://www.nsfc.gov.cn) XS YW MS, Key Science and Technology Research and Development Program of Shaanxi Province, China (2014K02-12-01 http://www.sninfo.gov.cn:8083/initSnFirstPageList.do?method=initSnFirstPageList) XS, the Natural Science Foundation of Shandong Province, China (ZR2015CM012 http://www.sdnsf.gov.cn/portal) MS.; This work was supported by the National Natural Science Foundation of China (Nos. 31270078, 31370150 and 31500087), Key Science and Technology Research and Development Program of Shaanxi Province, China (2014K02-12-01) and the Natural Science Foundation of Shandong Province, China (ZR2015CM012).	Bayan N, 2003, J BIOTECHNOL, V104, P55, DOI 10.1016/S0168-1656(03)00163-9; Becker J, 2012, CURR OPIN BIOTECH, V23, P631, DOI 10.1016/j.copbio.2011.11.012; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Calamita H, 2005, CELL MICROBIOL, V7, P233, DOI 10.1111/j.1462-5822.2004.00454.x; Chen HP, 2012, APPL ENVIRON MICROB, V78, P586, DOI 10.1128/AEM.06876-11; Chen X, 2012, APPL ENVIRON MICROB, V78, P5796, DOI 10.1128/AEM.01588-12; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; Darwin AJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003388; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; Ding W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08044; Du L, 2016, J BIOL CHEM, V291, P6583, DOI 10.1074/jbc.M115.695320; Dutta NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010069; El Meouche I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083748; Fitzgerald DJ, 2005, J AGR FOOD CHEM, V53, P1769, DOI 10.1021/jf048575t; Fitzgerald DJ, 2004, J APPL MICROBIOL, V97, P104, DOI 10.1111/j.1365-2672.2004.02275.x; Greetham D, 2014, J IND MICROBIOL BIOT, V41, P931, DOI 10.1007/s10295-014-1431-6; He Q, 2013, J BIOSCI BIOENG, V115, P298, DOI 10.1016/j.jbiosc.2012.09.017; Heravi KM, 2015, J BACTERIOL, V197, P959, DOI 10.1128/JB.02431-14; Huang Y, 2008, APPL MICROBIOL BIOT, V78, P75, DOI 10.1007/s00253-007-1286-0; Iwaki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061748; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; KAWAGUCHI H, 2016, CURR OPIN BIOTECH, V42, P30, DOI DOI 10.1016/J.C0PBI0.2016.02.031.[; Kim TH, 2005, BIOCHEM BIOPH RES CO, V331, P1542, DOI 10.1016/j.bbrc.2005.04.073; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Larisch C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-4; Li T, 2014, J BIOTECHNOL, V192, P355, DOI 10.1016/j.jbiotec.2014.01.017; Liu XX, 2016, CRIT REV BIOTECHNOL, V36, P652, DOI 10.3109/07388551.2015.1004519; Liu YB, 2014, BIOTECHNOL LETT, V36, P1453, DOI 10.1007/s10529-014-1501-x; Liu YB, 2013, ARCH MICROBIOL, V195, P419, DOI 10.1007/s00203-013-0889-3; Merkens H, 2005, CURR MICROBIOL, V51, P59, DOI 10.1007/s00284-005-4531-8; Moradi F, 2013, FUEL, V112, P8, DOI 10.1016/j.fuel.2013.05.011; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Priefert H, 1997, J BACTERIOL, V179, P2595, DOI 10.1128/JB.179.8.2595-2607.1997; Radmacher E, 2005, MICROBIOL-SGM, V151, P1359, DOI 10.1099/mic.0.27804-0; Schroder J, 2010, FEMS MICROBIOL REV, V34, P685, DOI 10.1111/j.1574-6976.2010.00228.x; Schurig-Briccio LA, 2009, ARCH BIOCHEM BIOPHYS, V483, P106, DOI 10.1016/j.abb.2008.12.009; Shen XH, 2005, APPL ENVIRON MICROB, V71, P3442, DOI 10.1128/AEM.71.7.3442-3452.2005; Shen XH, 2012, APPL MICROBIOL BIOT, V95, P77, DOI 10.1007/s00253-012-4139-4; Si MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131634; Si MR, 2015, APPL ENVIRON MICROB, V81, P2781, DOI 10.1128/AEM.04221-14; Si MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115075; Singh R, 2014, RENEW SUST ENERG REV, V32, P713, DOI 10.1016/j.rser.2014.01.051; van Ooyen J, 2011, J BIOTECHNOL, V154, P140, DOI 10.1016/j.jbiotec.2010.07.004; Wang TT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005020; Wieschalka S, 2013, MICROB BIOTECHNOL, V6, P87, DOI 10.1111/1751-7915.12013; Zhang YHP, 2007, BIOTECHNOL BIOENG, V97, P214, DOI 10.1002/bit.21386	46	6	6	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164955	10.1371/journal.pone.0164955	http://dx.doi.org/10.1371/journal.pone.0164955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760214	Green Submitted, gold, Green Published			2022-12-26	WOS:000386204000070
J	Ciesla, J; Kopycinska, M; Lukowska, M; Bieganowski, A; Janczarek, M				Ciesla, Jolanta; Kopycinska, Magdalena; Lukowska, Malgorzata; Bieganowski, Andrzej; Janczarek, Monika			Surface Properties of Wild-Type Rhizobium leguminosarum bv. trifolii Strain 24.2 and Its Derivatives with Different Extracellular Polysaccharide Content	PLOS ONE			English	Article							POPULATION-DYNAMICS; BIOFILM FORMATION; CELL; EXOPOLYSACCHARIDE; INFECTION; SOILS; HYDROPHOBICITY; ATTACHMENT; NODULATION; ACIDITY	Rhizobium leguminosarum bv. trifolii is a soil bacterium able to establish symbiosis with agriculturally important legumes, i.e., clover plants (Trifolium spp.). Cell surface properties of rhizobia play an essential role in their interaction with both biotic and abiotic surfaces. Physicochemical properties of bacterial cells are underpinned by the chemical composition of their envelope surrounding the cells, and depend on various environmental conditions. In this study, we performed a comprehensive characterization of cell surface properties of a wild-type R. leguminosarum bv. trifolii strain 24.2 and its derivatives producing various levels of exopolysaccharide (EPS), namely, pssA mutant Rt5819 deficient in EPS synthesis, rosR mutant Rt2472 producing diminished amounts of this polysaccharide, and two EPS-overproducing strains, Rt24.2(pBA1) and Rt24.2(pBR1), under different growth conditions (medium type, bacterial culture age, cell viability, and pH). We established that EPS plays an essential role in the electrophoretic mobility of rhizobial cells, and that higher amounts of EPS produced resulted in greater negative electrophoretic mobility and higher acidity (lower pK(app,av)) of the bacterial cell surface. From the tested strains, the electrophoretic mobility was lowest in EPS-deficient pssA mutant. Moreover, EPS produced by rhizobial strains resulted not only in an increase of negative surface charge but also in increased hydrophobicity of bacterial cell surface. This was determined by measurements of water contact angle, surface free energy, and free energy of bacterial surface-water-bacterial surface interaction. Electrophoretic mobility of the studied strains was also affected by the structure of the bacterial population (i.e., live/dead cell ratio), medium composition (ionic strength and mono-and divalent cation concentrations), and pH.	[Kopycinska, Magdalena; Janczarek, Monika] Marie Curie Sklodowska Univ, Dept Genet & Microbiol, Akad 19, PL-20033 Lublin, Poland; [Ciesla, Jolanta; Lukowska, Malgorzata; Bieganowski, Andrzej] Polish Acad Sci, Inst Agrophys, Doswiadczalna 4, PL-20290 Lublin, Poland	Maria Curie-Sklodowska University; Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences	Janczarek, M (corresponding author), Marie Curie Sklodowska Univ, Dept Genet & Microbiol, Akad 19, PL-20033 Lublin, Poland.	mon.jan@poczta.umcs.lublin.pl		Ciesla, Jolanta/0000-0002-8038-3050; Bieganowski, Andrzej/0000-0002-3571-3241; Janczarek, Monika/0000-0002-2250-6358	grant of the National Science Centre [2012/07/B/NZ1/00099]	grant of the National Science Centre	This work was supported by a grant of the National Science Centre (https://www.ncn.gov.pl/) no. 2012/07/B/NZ1/00099 (MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ferreira PAA, 2012, WORLD J MICROB BIOT, V28, P1947, DOI 10.1007/s11274-011-0997-7; Barthelemy-Delaux C, 2014, PLANT SOIL, V382, P165, DOI 10.1007/s11104-014-2155-0; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; BHAT UR, 1992, J BACTERIOL, V174, P2230, DOI 10.1128/JB.174.7.2230-2235.1992; Boonaert CJP, 2000, APPL ENVIRON MICROB, V66, P2548, DOI 10.1128/AEM.66.6.2548-2554.2000; BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980, DOI 10.1128/AEM.48.5.980-983.1984; Carlson RW, 2010, SUBCELL BIOCHEM, V53, P339, DOI 10.1007/978-90-481-9078-2_16; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Ciesla J, 2009, ANTON LEEUW INT J G, V96, P471, DOI [10.1007/s10482-009-9362-3, DOI 10.1007/S10482-009-9362-3]; Ciesla J, 2011, J MICROBIOL METH, V85, P199, DOI 10.1016/j.mimet.2011.03.004; Crespo-Rivas JC, 2016, ENVIRON MICROBIOL, V18, P2392, DOI 10.1111/1462-2920.13101; DEMAAGD RA, 1989, J BACTERIOL, V171, P1136, DOI 10.1128/jb.171.2.1136-1142.1989; Dittrich M, 2005, J COLLOID INTERF SCI, V286, P487, DOI 10.1016/j.jcis.2005.01.029; Dong J, 2011, MICROBIOL-SGM, V157, P3049, DOI 10.1099/mic.0.051045-0; Downie JA, 2014, CURR BIOL, V24, pR184, DOI 10.1016/j.cub.2014.01.028; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; FREY SD, 1994, PLANT SOIL, V163, P157, DOI 10.1007/BF00007964; Glenn R, 1999, NOVART FDN SYMP, V221, P112; Hirsch PR, 1996, NEW PHYTOL, V133, P159, DOI 10.1111/j.1469-8137.1996.tb04351.x; Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014; Janczarek M, 2015, PLANT SOIL, V396, P257, DOI 10.1007/s11104-015-2567-5; Janczarek M, 2015, PLANT SOIL, V388, P211, DOI 10.1007/s11104-014-2320-5; Janczarek M, 2015, APPL SOIL ECOL, V85, P94, DOI 10.1016/j.apsoil.2014.08.010; Janczarek M, 2013, INT J MOL SCI, V14, P23711, DOI 10.3390/ijms141223711; Jozefaciuk G, 2004, PLANT SOIL, V260, P137, DOI 10.1023/B:PLSO.0000030175.23904.5a; Kawaharada Y, 2015, NATURE, V523, P308, DOI 10.1038/nature14611; Kelly SJ, 2013, MOL PLANT MICROBE IN, V26, P319, DOI 10.1094/MPMI-09-12-0227-R; KOWALCZUK E, 1979, ACTA MICROBIOL POL, V28, P221; Laus MC, 2006, MOL MICROBIOL, V59, P1704, DOI 10.1111/j.1365-2958.2006.05057.x; Liu Y, 2004, J BIOTECHNOL, V110, P251, DOI 10.1016/j.jbiotec.2004.02.012; LOEWUS FA, 1952, ANAL CHEM, V24, P219, DOI 10.1021/ac60061a050; Lopez-Leal G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-770; Lytle DA, 2002, COLLOID SURFACE B, V24, P91, DOI 10.1016/S0927-7765(01)00219-3; Maccio D, 2002, SOIL BIOL BIOCHEM, V34, P201, DOI 10.1016/S0038-0717(01)00174-2; Margaret-Oliver I, 2012, ARCH MICROBIOL, V194, P87, DOI 10.1007/s00203-011-0729-2; MARSHALL KC, 1967, AUST J BIOL SCI, V20, P429, DOI 10.1071/BI9670429; Maynaud G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-292; Mehmannavaz R, 2001, PROCESS BIOCHEM, V36, P683, DOI 10.1016/S0032-9592(00)00266-1; Mendis HC, 2016, MBIO, V7, DOI 10.1128/mBio.00606-16; More TT, 2014, J ENVIRON MANAGE, V144, P1, DOI 10.1016/j.jenvman.2014.05.010; MOZES N, 1988, BIOCHIM BIOPHYS ACTA, V945, P324, DOI 10.1016/0005-2736(88)90495-6; Mozes N, 1990, MICROBIAL CELL SURFA, P75; NEDERLOF MM, 1993, ENVIRON SCI TECHNOL, V27, P846, DOI 10.1021/es00042a006; PHILIPHOLLINGSWORTH S, 1989, J BIOL CHEM, V264, P1461; Piersiak T, 2014, PLANT SOIL, V376, P75; Poortinga AT, 2002, SURF SCI REP, V47, P3, DOI 10.1016/S0167-5729(02)00032-8; POSTMA J, 1991, APPL ENVIRON MICROB, V57, P649, DOI 10.1128/AEM.57.3.649-654.1991; Rachwal K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2332-4; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Rolfe BG, 1996, AUST J PLANT PHYSIOL, V23, P285, DOI 10.1071/PP9960285; Russo DM, 2015, APPL ENVIRON MICROB, V81, P1013, DOI 10.1128/AEM.03175-14; Shi WY, 1996, J BACTERIOL, V178, P1113, DOI 10.1128/jb.178.4.1113-1119.1996; Tourney J, 2008, CHEM GEOL, V247, P1, DOI 10.1016/j.chemgeo.2007.09.012; Tourney J, 2014, CHEM GEOL, V386, P115, DOI 10.1016/j.chemgeo.2014.08.011; van Oss CJ, 2007, COLLOID SURFACE B, V54, P2, DOI 10.1016/j.colsurfb.2006.05.024; van Oss CJ, 2003, COLLOID SURFACE B, V30, P25, DOI 10.1016/S0927-7765(03)00025-0; van Workum WAT, 1998, MOL PLANT MICROBE IN, V11, P1233, DOI 10.1094/MPMI.1998.11.12.1233; Vanderinde EM, 2016, J BIOL CHEM, DOI [10.1074/jbc.M116.743856, DOI 10.1074/JBC.M116.743856]; Vanderlinde EM, 2009, MICROBIOL-SGM, V155, P3055, DOI 10.1099/mic.0.025031-0; Vanderlinde EM, 2011, GLYCOBIOLOGY, V21, P55, DOI [10.1093/glycob/cwq131, DOI 10.1093/GLYCOB/CWQ131]; VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7; VANOSS CJ, 1987, ADV COLLOID INTERFAC, V28, P35, DOI 10.1016/0001-8686(87)80008-8; Watkin ELJ, 1997, SOIL BIOL BIOCHEM, V29, P1427, DOI 10.1016/S0038-0717(97)00046-1; Williams A, 2008, J BACTERIOL, V190, P4706, DOI 10.1128/JB.01694-07; Wilson WW, 2001, J MICROBIOL METH, V43, P153, DOI 10.1016/S0167-7012(00)00224-4	65	15	16	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0165080	10.1371/journal.pone.0165080	http://dx.doi.org/10.1371/journal.pone.0165080			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760230	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000085
J	Li, P; Li, F; Han, YQ; Yang, L; Liao, XL; Hou, ML				Li, Pei; Li, Fei; Han, Yongqiang; Yang, Lang; Liao, Xiaolan; Hou, Maolin			Asymmetric Spread of SRBSDV between Rice and Corn Plants by the Vector Sogatella furcifera (Hemiptera: Delphacidae)	PLOS ONE			English	Article							STREAKED-DWARF-VIRUS; FEEDING-BEHAVIOR; HOST-PLANT; TRANSMISSION CHARACTERISTICS; HOMOPTERA; INFECTION; PLANTHOPPER; POPULATIONS	Plant viruses are mostly transmitted by sucking insects via their piercing behaviors, which may differ due to host plant species and their developmental stages. We characterized the transmission of a fijivirus, southern rice black-streaked dwarf virus (SRBSDV), by the planthopper vector Sogatella furcifera Horvath (Hemiptera: Delphacidae), between rice and corn plants of varying developmental stages. SRBSDV was transmitted from infected rice to uninfected corn plants as efficiently as its transmission between rice plants, while was acquired by S. furcifera nymphs at a much lower rate from infected corn plants than from infected rice plants. We also recorded a high mortality of S. furcifera nymphs on corn plants. It is evident that young stages of both the virus donor and recipient plants added to the transmission efficiency of SRBSDV from rice to corn plants. Feeding behaviors of the vector recorded by electrical penetration graph showed that phloem sap ingestion, the behavioral event that is linked with plant virus acquisition, was impaired on corn plants, which accounts for the high mortality of and low virus acquisition by S. furcifera nymphs on corn plants. Our results reveal an asymmetric spread of SRBSDV between its two host plants and the underlying behavioral mechanism, which is of significance for assessing SRBSDV transmission risks and field epidemiology, and for developing integrated management approaches for SRBSDV disease.	[Li, Pei; Liao, Xiaolan] Hunan Agr Univ, Coll Plant Protect, Changsha 410128, Hunan, Peoples R China; [Li, Pei; Li, Fei; Han, Yongqiang; Yang, Lang; Hou, Maolin] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Li, Pei; Li, Fei; Han, Yongqiang; Yang, Lang; Hou, Maolin] Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha 410128, Hunan, Peoples R China	Hunan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Liao, XL (corresponding author), Hunan Agr Univ, Coll Plant Protect, Changsha 410128, Hunan, Peoples R China.; Hou, ML (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.; Hou, ML (corresponding author), Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha 410128, Hunan, Peoples R China.	359437372@qq.com; mlhou@ippcaas.cn			National Natural Science Foundation of China [31371951]; Ministry of Science and Technology of China [2012BAD19B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was financially supported by National Natural Science Foundation of China (31371951) and Ministry of Science and Technology of China (2012BAD19B03) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hoang AT, 2011, PLANT DIS, V95, P1063, DOI 10.1094/PDIS-07-10-0535; Backus EA, 2007, ANN ENTOMOL SOC AM, V100, P296, DOI 10.1603/0013-8746(2007)100[296:LHHMFO]2.0.CO;2; CALATAYUD PA, 1994, ENTOMOL EXP APPL, V72, P219, DOI 10.1007/BF02383809; Cao Yang, 2011, Chinese Journal of Applied Entomology, V48, P1314; Cook Anthea G., 1994, P114; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; Hao PY, 2008, PLANT PHYSIOL, V146, P1810, DOI 10.1104/pp.107.111484; Harrewijn P., 1990, APHID PLANT GENOTYPE, P117; He P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-136; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Jia DS, 2012, VIRUS RES, V167, P404, DOI 10.1016/j.virusres.2012.05.023; Jiang YX, 2000, ANN ENTOMOL SOC AM, V93, P573, DOI 10.1603/0013-8746(2000)093[0573:CBWHAF]2.0.CO;2; Kimmins FM, 1996, ENTOMOL EXP APPL, V80, P46, DOI 10.1007/BF00194722; Koch KG, 2015, BIOENERG RES, V8, P165, DOI 10.1007/s12155-014-9510-0; Lei WB, 2016, SCI REP-UK, V6, DOI 10.1038/srep30240; Lei WB, 2014, J ECON ENTOMOL, V107, P1721, DOI 10.1603/EC13569; Li YZ, 2012, J INTEGR AGR, V11, P621, DOI 10.1016/S2095-3119(12)60049-5; [刘丹凤 Liu Danfeng], 2016, [植物保护, Plant Protection], V42, P129; Matsukura K, 2013, PHYTOPATHOLOGY, V103, P509, DOI 10.1094/PHYTO-10-12-0261-R; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; Moreno-Delafuente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061543; Niemeyer H.M., 1990, P187; Ornaghi JA, 1999, MAYDICA, V44, P219; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; PATHAK PK, 1982, J ECON ENTOMOL, V75, P194, DOI 10.1093/jee/75.2.194; Power Alison G., 2008, P15, DOI 10.1007/978-3-540-75763-4_2; PRADO E, 1994, ENTOMOL EXP APPL, V72, P157, DOI 10.1007/BF02383550; Pu LL, 2012, CROP PROT, V41, P71, DOI 10.1016/j.cropro.2012.04.026; Sarria E, 2009, COMPUT ELECTRON AGR, V67, P35, DOI 10.1016/j.compag.2009.02.006; Seo Bo Yoon, 2009, Journal of Asia-Pacific Entomology, V12, P89, DOI 10.1016/j.aspen.2009.02.002; Shen JH., 2003, CHINESE J RICE SCI, V17, P7; Tu Z, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-145; [王强 Wang Qiang], 2012, [植物病理学报, Acta Phytopathologica Sinica], V42, P84; Wang YK, 2003, ACTA ENTOMOL SINICA, V47, P467, DOI [10.1104/pp.107.111484, DOI 10.1104/PP.107.111484]; Wijkamp I, 1996, ENTOMOL EXP APPL, V81, P285, DOI 10.1007/BF00187037; Wintermantel WM, 2016, PLANT DIS, V100, P92, DOI 10.1094/PDIS-11-14-1119-RE; Wosula EN, 2012, PLANT DIS, V96, P1331, DOI 10.1094/PDIS-11-11-0934-RE; Zhang P, 2000, ACTA ENTOMOL SINICA, V44, P395; Zhou GH, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00270; [周国辉 Zhou Guohui], 2010, [植物保护, Plant Protection], V36, P144; Zhou GH, 2008, CHINESE SCI BULL, V53, P3677, DOI 10.1007/s11434-008-0467-2	41	6	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0165014	10.1371/journal.pone.0165014	http://dx.doi.org/10.1371/journal.pone.0165014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760223	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204000074
J	Miller, S; Henry, AP; Hodge, E; Kheirallah, AK; Billington, CK; Rimington, TL; Bhaker, SK; Obeidat, M; Melen, E; Merid, SK; Swan, C; Gowland, C; Nelson, CP; Stewart, CE; Bolton, CE; Kilty, I; Malarstig, A; Parker, SG; Moffatt, MF; Wardlaw, AJ; Hall, IP; Sayers, I				Miller, Suzanne; Henry, Amanda P.; Hodge, Emily; Kheirallah, Alexander K.; Billington, Charlotte K.; Rimington, Tracy L.; Bhaker, Sangita K.; Obeidat, Ma'en; Melen, Erik; Merid, Simon K.; Swan, Caroline; Gowland, Catherine; Nelson, Carl P.; Stewart, Ceri E.; Bolton, Charlotte E.; Kilty, Iain; Malarstig, Anders; Parker, Stuart G.; Moffatt, Miriam F.; Wardlaw, Andrew J.; Hall, Ian P.; Sayers, Ian			The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; SOLUBLE RECEPTOR; DEVELOPMENTAL EXPRESSION; EMPHYSEMA; GENE; OVEREXPRESSION; GLYCOSYLATION; POLYMORPHISMS; ENDPRODUCTS; BIOMARKER	Introduction Genome-Wide Association Studies have identified associations between lung function measures and Chronic Obstructive Pulmonary Disease (COPD) and chromosome region 6p21 containing the gene for the Advanced Glycation End Product Receptor (AGER, encoding RAGE). We aimed to (i) characterise RAGE expression in the lung, (ii) identify AGER transcripts, (iii) ascertain if SNP rs2070600 (Gly82Ser C/T) is associated with lung function and serum sRAGE levels and (iv) identify whether the Gly82Ser variant is functionally important in altering sRAGE levels in an airway epithelial cell model. Methods Immunohistochemistry was used to identify RAGE protein expression in 26 human tissues and qPCR was used to quantify AGER mRNA in lung cells. Gene expression array data was used to identify AGER expression during lung development in 38 fetal lung samples. RNA-Seq was used to identify AGER transcripts in lung cells. sRAGE levels were assessed in cells and patient serum by ELISA. BEAS2B-R1 cells were transfected to overexpress RAGE protein with either the Gly82 or Ser82 variant and sRAGE levels identified. Results Immunohistochemical assessment of 6 adult lung samples identified high RAGE expression in the alveoli of healthy adults and individuals with COPD. AGER/RAGE expression increased across developmental stages in human fetal lung at both the mRNA (38 samples) and protein levels (20 samples). Extensive AGER splicing was identified. The rs2070600T (Ser82) allele is associated with higher FEV1, FEV1/FVC and lower serum sRAGE levels in UK smokers. Using an airway epithelium model overexpressing the Gly82 or Ser82 variants we found that HMGB1 activation of the RAGE-Ser82 receptor results in lower sRAGE production. Conclusions This study provides new information regarding the expression profile and potential role of RAGE in the human lung and shows a functional role of the Gly82Ser variant. These findings advance our understanding of the potential mechanisms underlying COPD particularly for carriers of this AGER polymorphism.	[Miller, Suzanne; Henry, Amanda P.; Hodge, Emily; Kheirallah, Alexander K.; Billington, Charlotte K.; Rimington, Tracy L.; Bhaker, Sangita K.; Obeidat, Ma'en; Gowland, Catherine; Nelson, Carl P.; Stewart, Ceri E.; Bolton, Charlotte E.; Hall, Ian P.; Sayers, Ian] Univ Nottingham, Div Resp Med, Nottingham, England; [Melen, Erik; Merid, Simon K.] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Swan, Caroline] Univ York, Dept Biol, York, N Yorkshire, England; [Kilty, Iain] Pfizer Worldwide Res & Dev, Cambridge, MA USA; [Malarstig, Anders] Pfizer Worldwide Res & Dev, Cambridge, England; [Parker, Stuart G.] Newcastle Univ, Inst Ageing & Hlth, Campus Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England; [Moffatt, Miriam F.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Wardlaw, Andrew J.] Univ Leicester, Inst Lung Hlth Immun & Inflammat, Leicester, Leics, England; [Obeidat, Ma'en] Univ British Columbia, Inst Heart & Lung Hlth, James Hogg Res Ctr, Vancouver, BC, Canada; [Melen, Erik] Sachs Childrens Hosp, Stockholm, Sweden	University of Nottingham; Karolinska Institutet; University of York - UK; Pfizer; Pfizer; Newcastle University - UK; Imperial College London; University of Leicester; University of British Columbia	Miller, S (corresponding author), Univ Nottingham, Div Resp Med, Nottingham, England.	Suzanne.Miller@nottingham.ac.uk	Nelson, Carl/H-6782-2014; Bolton, Charlotte E/S-9589-2017	Nelson, Carl/0000-0003-1034-140X; Bolton, Charlotte E/0000-0002-9578-2249; Hall, Ian/0000-0001-9933-3216; Wardlaw, Andrew/0000-0001-6583-0791; Sayers, Ian/0000-0001-5601-5410; Miller, Suzanne/0000-0001-8508-1871; Malarstig, Anders/0000-0003-2608-1358; Kebede Merid, Simon/0000-0001-5974-7676; Parker, Stuart/0000-0002-8675-6276; Rimington, Tracy/0000-0002-0059-123X; Henry, Amanda/0000-0001-6299-7676	Medical Research Council, UK [G1000861]; Pfizer Inc.; Swedish Research Council; Swedish Heart-Lung Foundation; Stockholm County Council (ALF); National Institute for Health Research Leicester Respiratory Biomedical Research Unit; Joint MRC/Wellcome Trust Human Developmental Biology Resource [099175/Z/12/Z]; Pfizer; Medical Research Council [MC_PC_15004, G1000861, G0700089] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10030] Funding Source: researchfish; MRC [MC_PC_15004, G1000861, G0700089] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer Inc.(Pfizer); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council (ALF)(Stockholm County Council); National Institute for Health Research Leicester Respiratory Biomedical Research Unit; Joint MRC/Wellcome Trust Human Developmental Biology Resource(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by grants from the Medical Research Council, UK (G1000861) and Pfizer Inc. EM has received funding from The Swedish Research Council, The Swedish Heart-Lung Foundation and Stockholm County Council (ALF). AJW is supported by the National Institute for Health Research Leicester Respiratory Biomedical Research Unit. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The human embryonic and fetal material was provided by the Joint MRC/Wellcome Trust (grant #099175/Z/12/Z) Human Developmental Biology Resource (www.hdbr.org).The funder (Pfizer) provided support in the form of salaries for authors [IK and AM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Artigas MS, 2011, AM J RESP CRIT CARE, V184, P786, DOI 10.1164/rccm.201102-0192OC; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; Cheng DT, 2013, AM J RESP CRIT CARE, V188, P948, DOI 10.1164/rccm.201302-0247OC; Cockayne DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038629; Ferhani N, 2010, AM J RESP CRIT CARE, V181, P917, DOI 10.1164/rccm.200903-0340OC; Fineschi S, 2013, AM J RESP CELL MOL, V48, P164, DOI 10.1165/rcmb.2012-0111OC; Gaens KHJ, 2009, J CLIN ENDOCR METAB, V94, P5174, DOI 10.1210/jc.2009-1067; Gopal P, 2012, EUR J CLIN INVEST, V42, P807, DOI 10.1111/j.1365-2362.2012.02646.x; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hobbs BD, 2016, AM J RESP CRIT CARE, V194, P48, DOI 10.1164/rccm.201510-2053OC; Hodge E, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-77; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Katsuoka F, 1997, BIOCHEM BIOPH RES CO, V238, P512, DOI 10.1006/bbrc.1997.7263; Kho AT, 2010, AM J RESP CRIT CARE, V181, P54, DOI 10.1164/rccm.200907-1063OC; Lizotte PP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-15; Lopez-Diez R, 2013, GENOME BIOL EVOL, V5, P2420, DOI 10.1093/gbe/evt188; Loth DW, 2014, NAT GENET, V46, P669, DOI 10.1038/ng.3011; Melen E, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-86; Miniati M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-37; Osawa M, 2007, BBA-GEN SUBJECTS, V1770, P1468, DOI 10.1016/j.bbagen.2007.07.003; Park SJ, 2011, J BIOL CHEM, V286, P21384, DOI 10.1074/jbc.M111.241281; Portelli MA, 2014, FASEB J, V28, P923, DOI 10.1096/fj.13-240879; Reddel R R, 1988, Oncogene Res, V3, P401; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Reynolds PR, 2008, AM J PHYSIOL-LUNG C, V294, pL1094, DOI 10.1152/ajplung.00318.2007; Reynolds PR, 2011, AM J RESP CELL MOL, V45, P1195, DOI 10.1165/rcmb.2011-0170OC; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Stewart CE, 2012, THORAX, V67, P477, DOI 10.1136/thoraxjnl-2011-200508; Stewart CE, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-112; Stogsdill JA, 2012, AM J RESP CELL MOL, V47, P60, DOI 10.1165/rcmb.2011-0385OC; Stogsdill MP, 2013, AM J RESP CELL MOL, V49, P128, DOI 10.1165/rcmb.2013-0013OC; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Winden DR, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-108; Wu LA, 2011, RESP MED, V105, P329, DOI 10.1016/j.rmed.2010.11.001; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yin NC, 2015, GENET MOL RES, V14, P17776, DOI 10.4238/2015.December.22.2; Yonchuk JG, 2015, AM J RESP CRIT CARE, V192, P785, DOI 10.1164/rccm.201501-0137PP	41	27	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164041	10.1371/journal.pone.0164041	http://dx.doi.org/10.1371/journal.pone.0164041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755550	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000386203800010
J	Liao, PH; Hsu, HH; Chen, TS; Chen, MC; Day, CH; Tu, CC; Lin, YM; Tsai, FJ; Kuo, WW; Huang, CY				Liao, P-H; Hsu, H-H; Chen, T-S; Chen, M-C; Day, C-H; Tu, C-C; Lin, Y-M; Tsai, F-J; Kuo, W-W; Huang, C-Y			Phosphorylation of cofilin-1 by ERK confers HDAC inhibitor resistance in hepatocellular carcinoma cells via decreased ROS-mediated mitochondria injury	ONCOGENE			English	Article							HISTONE DEACETYLASE INHIBITORS; SIGNALING PATHWAY; PROSTATE-CANCER; MAMMARY-TUMORS; OVARIAN-CANCER; IN-VITRO; APICIDIN; TRANSLOCATION; ACTIVATION; EXPRESSION	Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Despite the availability of several treatment strategies, resistance to chemotherapeutic agents, which limits the effectiveness of anticancer drugs, is a major problem in cancer therapy. In this study, we used a histone deacetylases inhibitor (HDACi) to establish drug-resistant HCC cells and further analyzed the molecular mechanisms underlying the development of resistance in HCC cells. Compared with the parental cells, HDACi-resistant cells showed high metastatic and pro-survival abilities. Two-dimensional electrophoresis data showed that the cofilin-1 (CFL-1) protein was altered in HDACi-resistant cells and was highly expressed in resistant cells compared with parental cells. The molecular function of CFL-1 is actin depolymerization, and it is involved in tumor metastasis. In this study, we showed that CFL-1 inhibition decreased cell migration and increased cell apoptosis in HDACi-resistant cells. We observed that HDACi induced ROS accumulation in cells and apoptosis via promotion of the CFL-1 interaction with Bax and CFL-1 translocation to the mitochondria, resulting in cytochrome C release. Importantly, phosphorylation of CFL-1 by activated extracellular signal-regulated kinases 1 and 2 (ERK1/2) confers strong protection against HDAC inhibitor-induced cell injury. p-CFL-1 shows a loss of affinity with Bax and will not translocate to mitochondria, stably remaining in the cytoplasm. These results indicate that phosphorylation to inactivate CFL-1 decreased the chemosensitivity to HDAC inhibitors and resulting in drug resistance of HCC cells.	[Liao, P-H; Huang, C-Y] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Hsu, H-H] Mackay Mem Hosp, Div Colorectal Surg, Taipei, Taiwan; [Hsu, H-H] Nursing & Management Coll, Dept Mackay Med, Taipei, Taiwan; [Chen, T-S] China Med Univ Hosp, Biomat Translat Res Ctr, Taichung, Taiwan; [Chen, M-C] Taichung Vet Gen Hosp, Div Colorectal Surg, Taichung, Taiwan; [Day, C-H] Mei Ho Univ, Dept Nursing, Pingtung, Taiwan; [Tu, C-C] Armed Force Taichung Gen Hosp, Div Chest Med, Dept Internal Med, Taichung, Taiwan; [Lin, Y-M] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan; [Tsai, F-J; Huang, C-Y] China Med Univ, Grad Inst Chinese Med Sci, 91 Hsueh Shih Rd, Taichung 404, Taiwan; [Kuo, W-W] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan; [Huang, C-Y] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan	China Medical University Taiwan; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taichung Veterans General Hospital; Changhua Christian Hospital; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Huang, CY (corresponding author), China Med Univ, Grad Inst Chinese Med Sci, 91 Hsueh Shih Rd, Taichung 404, Taiwan.	cyhuang@mail.cmu.edu.tw	Chen, Tung-Sheng/U-4788-2019; Chen, Tung-Sheng/GPK-0411-2022	Chen, Tung-Sheng/0000-0002-4400-3428	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019).	Baylin SB, 2011, NAT MED, V17, P288, DOI 10.1038/nm0311-288; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Collazo J, 2014, CANCER RES, V74, P2362, DOI 10.1158/0008-5472.CAN-13-3058; CSORDAS A, 1990, BIOCHEM J, V265, P23, DOI 10.1042/bj2650023; Ding YM, 2008, MOL CELL BIOL, V28, P3742, DOI 10.1128/MCB.01832-07; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Hsieh CH, 2013, BIOSCI BIOTECH BIOCH, V77, P2397, DOI 10.1271/bbb.130503; Hsieh YC, 2010, CHEM RES TOXICOL, V23, P1256, DOI 10.1021/tx100116a; Hsu HH, 2014, TUMOR BIOL, V35, P303, DOI 10.1007/s13277-013-1041-3; Huang X, 2013, J BIOL CHEM, V288, P36418, DOI 10.1074/jbc.M113.495713; Kim MS, 2000, CANCER LETT, V157, P23, DOI 10.1016/S0304-3835(00)00465-1; Klamt F, 2009, NAT CELL BIOL, V11, P1241, DOI 10.1038/ncb1968; Kotiadis VN, 2012, J CELL SCI, V125, P2288, DOI 10.1242/jcs.099390; Lai JP, 2009, J HEPATOL, V50, P1112, DOI 10.1016/j.jhep.2008.12.031; Li GB, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-50; Li M, 2013, ONCOL REP, V29, P58, DOI 10.3892/or.2012.2078; Lu L, 2015, ONCOL LETT, V9, P2757, DOI 10.3892/ol.2015.3133; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Posadas I, 2012, J NEUROCHEM, V120, P515, DOI 10.1111/j.1471-4159.2011.07599.x; Serezani CH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002448; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P659; Stresing V, 2013, ONCOGENE, V32, P724, DOI 10.1038/onc.2012.93; Tahtamouni LH, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-45; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Tu CC, 2013, CHINESE J PHYSIOL, V56, P326, DOI 10.4077/CJP.2013.BAB158; Wabnitz GH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.36; Wang WG, 2007, CANCER RES, V67, P3505, DOI 10.1158/0008-5472.CAN-06-3714; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Wang ZQ, 2010, J CELL PHYSIOL, V224, P559, DOI 10.1002/jcp.22160; Weiller M, 2011, EXP TOXICOL PATHOL, V63, P511, DOI 10.1016/j.etp.2010.04.001; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Zhang HH, 2015, MOL ENDOCRINOL, V29, P434, DOI 10.1210/me.2014-1297; Zhou JW, 2012, ONCOL LETT, V4, P1187, DOI 10.3892/ol.2012.897; Zhou Y, 2013, ONCOL REP, V29, P394, DOI 10.3892/or.2012.2115	34	30	31	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 6	2017	36	14					1978	1990		10.1038/onc.2016.357	http://dx.doi.org/10.1038/onc.2016.357			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ER6EQ	27748761				2022-12-26	WOS:000398898500008
J	Koga, T; Yao, PL; Goudarzi, M; Murray, IA; Balandaram, G; Gonzalez, FJ; Perdew, GH; Fornace, AJ; Peters, JM				Koga, Takayuki; Yao, Pei-Li; Goudarzi, Maryam; Murray, Iain A.; Balandaram, Gayathri; Gonzalez, Frank J.; Perdew, Gary H.; Fornace, Albert J., Jr.; Peters, Jeffrey M.			Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-beta/delta Modulation of SP1 Promoter Occupancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; PPAR-DELTA AGONIST; NUCLEAR TRANSLOCATION; LIGAND ACTIVATION; CELLS; DISEASE; ALPHA; CAR; MICE; GENE	Alcoholic liver disease is a pathological condition caused by overconsumption of alcohol. Because of the high morbidity and mortality associated with this disease, there remains a need to elucidate the molecular mechanisms underlying its etiology and to develop new treatments. Because peroxisome proliferator-activated receptor-beta/delta (PPAR beta/delta) modulates ethanol-induced hepatic effects, the present study examined alterations in gene expression that may contribute to this disease. Chronic ethanol treatment causes increased hepatic CYP2B10 expression in Ppar beta/delta(+/+) mice but not in Ppar beta/delta(-/-) mice. Nuclear and cytosolic localization of the constitutive androstane receptor (CAR), a transcription factor known to regulate Cyp2b10 expression, was not different between genotypes. PPAR gamma co-activator 1 alpha, a co-activator of both CAR and PPAR beta/delta, was up-regulated in Ppar beta/delta(+/+) liver following ethanol exposure, but not in Ppar beta/delta(-/-) liver. Functional mapping of the Cyp2b10 promoter and ChIP assays revealed that PPAR beta/delta-dependent modulation of SP1 promoter occupancy up-regulated Cyp2b10 expression in response to ethanol. These results suggest that PPAR beta/delta regulates Cyp2b10 expression indirectly by modulating SP1 and PPAR gamma co-activator 1 alpha expression and/or activity independent of CAR activity. Ligand activation of PPAR beta/delta attenuates ethanol-induced Cyp2b10 expression in Ppar beta/delta(+/+) liver but not in Ppar beta/delta(-/-) liver. Strikingly, Cyp2b10 suppression by ligand activation of PPAR beta/delta following ethanol treatment occurred in hepatocytes and was mediated by paracrine signaling from Kupffer cells. Combined, results from the present study demonstrate a novel regulatory role of PPAR beta/delta in modulating CYP2B10 that may contribute to the etiology of alcoholic liver disease.	[Koga, Takayuki; Yao, Pei-Li; Murray, Iain A.; Balandaram, Gayathri; Perdew, Gary H.; Peters, Jeffrey M.] Penn State Univ, Dept Vet & Biomed Sci, 312 Life Sci Bldg, University Pk, PA 16802 USA; [Koga, Takayuki; Yao, Pei-Li; Murray, Iain A.; Balandaram, Gayathri; Perdew, Gary H.; Peters, Jeffrey M.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, 312 Life Sci Bldg, University Pk, PA 16802 USA; [Goudarzi, Maryam; Fornace, Albert J., Jr.] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Peters, JM (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, 312 Life Sci Bldg, University Pk, PA 16802 USA.; Peters, JM (corresponding author), Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, 312 Life Sci Bldg, University Pk, PA 16802 USA.	jmp21@psu.edu	Goudarzi, Maryam/O-9472-2015	Goudarzi, Maryam/0000-0003-4961-3935; Koga, Takayuki/0000-0001-9782-6746; Yao, Pei-Li/0000-0003-0832-3771; Peters, Jeffrey/0000-0003-2782-2998	National Institute of Alcohol Abuse and Alcoholism [CA124533, CA141029, AA018863]; National Institutes of Health NCI Intramural Research Program [ZIABC005561, ZIABC005562, ZIABC005708]; NATIONAL CANCER INSTITUTE [ZIABC005561, ZIABC005562, R01CA141029, ZIABC005708, R01CA124533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018863] Funding Source: NIH RePORTER	National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institutes of Health NCI Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institute of Alcohol Abuse and Alcoholism Grants CA124533 and CA141029 (to J. M. P.) and AA018863 (to A. J. F. and J. M. P.) and National Institutes of Health NCI Intramural Research Program Grants ZIABC005561, ZIABC005562, and ZIABC005708 (to F. J. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balandaram G, 2016, TOXICOLOGY, V363, P1, DOI 10.1016/j.tox.2016.07.010; Bale SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25329; Bogdanowicz DR, 2013, BIOTECHNOL J, V8, P395, DOI 10.1002/biot.201300054; Bojic LA, 2014, J LIPID RES, V55, P1254, DOI 10.1194/jlr.M046037; Borland MG, 2014, CARCINOGENESIS, V35, P1602, DOI 10.1093/carcin/bgu067; Chacko KR, 2016, CLIN LIVER DIS, V20, P419, DOI 10.1016/j.cld.2016.02.002; Chen XS, 2011, LAB INVEST, V91, P1136, DOI 10.1038/labinvest.2011.68; Corton JC, 2005, J GERONTOL A-BIOL, V60, P1494, DOI 10.1093/gerona/60.12.1494; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Dunn W, 2016, CLIN LIVER DIS, V20, P445, DOI 10.1016/j.cld.2016.02.004; Goers L, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0065; Goudarzi M, 2013, TOXICOLOGY, V311, P87, DOI 10.1016/j.tox.2013.07.002; Goyak KMO, 2008, TOXICOL APPL PHARM, V231, P216, DOI 10.1016/j.taap.2008.04.024; Gyamfi MA, 2010, EXP BIOL MED, V235, P547, DOI 10.1258/ebm.2009.009249; Hansen B, 2002, MOL CELL BIOCHEM, V240, P1, DOI 10.1023/A:1020660303855; HAWKSWORTH GM, 1994, HUM EXP TOXICOL, V13, P568, DOI 10.1177/096032719401300811; Hondares E, 2007, BIOCHEM BIOPH RES CO, V354, P1021, DOI 10.1016/j.bbrc.2007.01.092; Hosseinpour F, 2006, MOL PHARMACOL, V69, P1095, DOI 10.1124/mol.105.019505; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Khozoie C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-665; Kobayashi K, 2003, MOL PHARMACOL, V64, P1069, DOI 10.1124/mol.64.5.1069; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lieber CS, 2003, ALCOHOL RES HEALTH, V27, P220; Moriya T, 2009, J OCCUP HEALTH, V51, P391, DOI 10.1539/joh.K9001; Muangmoonchai R, 2001, BIOCHEM J, V355, P71, DOI 10.1042/0264-6021:3550071; Nagasawa T, 2006, EUR J PHARMACOL, V536, P182, DOI 10.1016/j.ejphar.2006.02.028; NAKAJIMA T, 1994, BIOCHEM PHARMACOL, V48, P637; Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399; Pang MY, 2009, J HEPATOL, V50, P1192, DOI 10.1016/j.jhep.2009.01.021; Peters JM, 2011, CANCER METAST REV, V30, P619, DOI 10.1007/s10555-011-9320-1; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Qatanani M, 2005, CURR DRUG METAB, V6, P329, DOI 10.2174/1389200054633899; Salatino S, 2016, MOL ENDOCRINOL, V30, P809, DOI 10.1210/me.2016-1036; Shan W, 2008, TOXICOL SCI, V105, P418, DOI 10.1093/toxsci/kfn142; Shan WW, 2008, HEPATOLOGY, V47, P225, DOI 10.1002/hep.21925; Shin SW, 2015, INT J ONCOL, V46, P1328, DOI 10.3892/ijo.2015.2834; Soldatow VY, 2013, TOXICOL RES-UK, V2, P23, DOI 10.1039/c2tx20051a; Yao PL, 2015, ONCOTARGET, V6, P36319, DOI 10.18632/oncotarget.5415; Yao PL, 2015, J BIOL CHEM, V290, P23416, DOI 10.1074/jbc.M115.664508; Yao PL, 2014, MOL CANCER THER, V13, P1008, DOI 10.1158/1535-7163.MCT-13-0836; Yao PL, 2011, BIOL REPROD, V85, P1203, DOI 10.1095/biolreprod.111.093484; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245	42	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25255	25263		10.1074/jbc.M116.755447	http://dx.doi.org/10.1074/jbc.M116.755447			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27765815	hybrid, Green Published			2022-12-26	WOS:000388880100039
J	Tam, JHK; Cobb, MR; Seah, C; Pasternak, SH				Tam, Joshua H. K.; Cobb, M. Rebecca; Seah, Claudia; Pasternak, Stephen H.			Tyrosine Binding Protein Sites Regulate the Intracellular Trafficking and Processing of Amyloid Precursor Protein through a Novel Lysosome-Directed Pathway	PLOS ONE			English	Article							KINASE-C-ALPHA; PKC-EPSILON; ALZHEIMERS-DISEASE; ADAPTER PROTEIN-2; GAMMA-SECRETASE; PHOSPHORYLATION; GOLGI; ENDOCYTOSIS; RECEPTOR; APP	The amyloid hypothesis posits that the production of beta-amyloid (A beta) aggregates leads to neurodegeneration and cognitive decline associated with AD. A beta is produced by sequential cleavage of the amyloid precursor protein (APP) by beta- and gamma-secretase. While nascent APP is well known to transit to the endosomal/lysosomal system via the cell surface, we have recently shown that APP can also traffic to lysosomes intracellularly via its interaction with AP-3. Because AP-3 interacts with cargo protein via interaction with tyrosine motifs, we mutated the three tyrosines motif in the cytoplasmic tail of APP. Here, we show that the YTSI motif interacts with AP-3, and phosphorylation of the serine in this motif disrupts the interaction and decreases APP trafficking to lysosomes. Furthermore, we show that phosphorylation at this motif can decrease the production of neurotoxic A beta 42. This demonstrates that reducing APP trafficking to lysosomes may be a strategy to reduce A beta 42 in Alzheimer's disease.	[Tam, Joshua H. K.; Seah, Claudia; Pasternak, Stephen H.] Western Univ, Roberts Res Inst, Mol Med Res Grp, J Allyn Taylor Ctr Cell Biol, London, ON N6A 5B7, Canada; [Tam, Joshua H. K.; Pasternak, Stephen H.] Western Univ, Dept Physiol & Pharmacol, London, ON N6A 5B7, Canada; [Cobb, M. Rebecca; Pasternak, Stephen H.] Western Univ, Program Neurosci, London, ON N6A 5B7, Canada; [Pasternak, Stephen H.] Western Univ, Schulich Sch Med & Dent, Dept Clin Neurol Sci, London, ON N6A 5B7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Pasternak, SH (corresponding author), Western Univ, Roberts Res Inst, Mol Med Res Grp, J Allyn Taylor Ctr Cell Biol, London, ON N6A 5B7, Canada.; Pasternak, SH (corresponding author), Western Univ, Dept Physiol & Pharmacol, London, ON N6A 5B7, Canada.; Pasternak, SH (corresponding author), Western Univ, Program Neurosci, London, ON N6A 5B7, Canada.; Pasternak, SH (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Clin Neurol Sci, London, ON N6A 5B7, Canada.	spasternak@robarts.ca	Pasternak, Stephen Howard/A-3136-2011	Pasternak, Stephen Howard/0000-0002-0204-0255; Tam, Josh/0000-0003-0293-3165	CIHR [MOP-82890]; Canadian Institute for Health Research [MOP-82890]	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by CIHR www.cihr-irsc.gc.ca/e/193.html MOP-82890.; This work was funded by the Canadian Institute for Health Research Operating Grant MOP-82890 to SHP. The authors wish to thank G.H. Patterson and J. Lippincott Schwartz for the paGFP construct.	[Anonymous], 2015, PARKINSON DIS OTHER, V16, P126, DOI [10.1038/nrn3896PMID: 25669742, DOI 10.1038/NRN3896]; Bagshaw RD, 2003, BIOCHEM BIOPH RES CO, V300, P615, DOI 10.1016/S0006-291X(02)02865-6; Benussi L, 1998, NEUROSCI LETT, V240, P97, DOI 10.1016/S0304-3940(97)00894-X; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Cai J, 2011, J BIOL CHEM, V286, P42514, DOI 10.1074/jbc.M111.296590; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Chen ZP, 2006, AM J RESP CELL MOL, V35, P127, DOI 10.1165/rcmb.2006-0044OC; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; GABUZDA D, 1993, J NEUROCHEM, V61, P2326, DOI 10.1111/j.1471-4159.1993.tb07479.x; Gajadhar A, 2010, BIOTECHNIQUES, V48, P145, DOI 10.2144/000113354; GANDY S, 1988, P NATL ACAD SCI USA, V85, P6218, DOI 10.1073/pnas.85.16.6218; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAMMOND DN, 1986, SCIENCE, V234, P1237, DOI 10.1126/science.3775382; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; Icking A, 2007, TRAFFIC, V8, P285, DOI 10.1111/j.1600-0854.2006.00526.x; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Kanno T, 2006, J LIPID RES, V47, P1146, DOI 10.1194/jlr.M500329-JLR200; Khan TK, 2015, J ALZHEIMERS DIS, V43, P491, DOI 10.3233/JAD-141221; KINOUCHI T, 1995, FEBS LETT, V364, P203, DOI 10.1016/0014-5793(95)00392-M; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; Lai A, 1998, J BIOL CHEM, V273, P3732, DOI 10.1074/jbc.273.6.3732; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lanni C, 2004, EUR J BIOCHEM, V271, P3068, DOI 10.1111/j.1432-1033.2004.04240.x; Le WD, 1997, J NEUROCHEM, V69, P978; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; LEHEL C, 1995, P NATL ACAD SCI USA, V92, P1406, DOI 10.1073/pnas.92.5.1406; Lemjabbar-Alaoui H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017489; Lorenzen A, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-11; Nelson TJ, 2009, J BIOL CHEM, V284, P34514, DOI 10.1074/jbc.M109.016683; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Pasternak SH, 2004, J ALZHEIMERS DIS, V6, P53; Patterson GH, 2004, METHODS, V32, P445, DOI 10.1016/j.ymeth.2003.10.006; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pedersen WA, 1996, P NATL ACAD SCI USA, V93, P8068, DOI 10.1073/pnas.93.15.8068; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Petanceska SS, 2000, J NEUROCHEM, V74, P1878, DOI 10.1046/j.1471-4159.2000.0741878.x; Poulsen ET, 2015, INT J MOL SCI, V16, P29446, DOI 10.3390/ijms161226181; Racchi M, 2003, MOL PSYCHIATR, V8, P209, DOI 10.1038/sj.mp.4001204; Saraceno C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.492; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; SchraderFischer G, 1996, BRAIN RES, V716, P91, DOI 10.1016/0006-8993(96)00002-9; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; SUZUKI T, 1992, NEUROSCIENCE, V48, P755, DOI 10.1016/0306-4522(92)90264-3; Tam JHK, 2015, JOVE-J VIS EXP, DOI 10.3791/53153; Tam JHK, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0054-1; Tang WH, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0129-7; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tian Y, 2013, P NATL ACAD SCI USA, V110, P17071, DOI 10.1073/pnas.1315110110; Vieira SI, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-40; Vieira SI, 2009, MOL CELL BIOCHEM, V328, P145, DOI 10.1007/s11010-009-0084-7; Yeon SW, 2001, BIOCHEM BIOPH RES CO, V280, P782, DOI 10.1006/bbrc.2000.4181	60	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0161445	10.1371/journal.pone.0161445	http://dx.doi.org/10.1371/journal.pone.0161445			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776132	Green Published, Green Submitted, gold			2022-12-26	WOS:000389009200002
J	Utz, S; Carbon, CC				Utz, Sandra; Carbon, Claus-Christian			Is the Thatcher Illusion Modulated by Face Familiarity? Evidence from an Eye Tracking Study	PLOS ONE			English	Article							CONFIGURAL INFORMATION; UNFAMILIAR FACES; INVERSION; RECOGNITION; PERCEPTION; THATCHER,MARGARET; DISCRIMINATION; ROBUST	Thompson (1980) first detected and described the Thatcher Illusion, where participants instantly perceive an upright face with inverted eyes and mouth as grotesque, but fail to do so when the same face is inverted. One prominent but controversial explanation is that the processing of configural information is disrupted in inverted faces. Studies investigating the Thatcher Illusion either used famous faces or non-famous faces. Highly familiar faces were often thought to be processed in a pronounced configural mode, so they seem ideal candidates to be tested in one Thatcher study against unfamiliar faces-but this has never been addressed so far. In our study, participants evaluated 16 famous and 16 non-famous faces for their grotesqueness. We tested whether familiarity (famous/non-famous faces) modulates reaction times, correctness of grotesqueness assessments (accuracy), and eye movement patterns for the factors orientation (upright/inverted) and Thatcherisation (Thatcherised/non-Thatcherised). On a behavioural level, familiarity effects were only observable via face inversion (higher accuracy and sensitivity for famous compared to non-famous faces) but not via Thatcherisation. Regarding eye movements, however, Thatcherisation influenced the scanning of famous and non-famous faces, for instance, in scanning the mouth region of the presented faces (higher number, duration and dwell time of fixations for famous compared to non-famous faces if Thatcherised). Altogether, famous faces seem to be processed in a more elaborate, more expertise-based way than non-famous faces, whereas non-famous, inverted faces seem to cause difficulties in accurate and sensitive processing. Results are further discussed in the face of existing studies of familiar vs. unfamiliar face processing.	[Utz, Sandra; Carbon, Claus-Christian] Univ Bamberg, Dept Gen Psychol & Methodol, Bamberg, Germany; [Carbon, Claus-Christian] Bamberg Grad Sch Affect & Cognit Sci BaGrACS, Bamberg, Germany	Otto Friedrich University Bamberg	Utz, S (corresponding author), Univ Bamberg, Dept Gen Psychol & Methodol, Bamberg, Germany.	sandra.utz@uni-bamberg.de	Carbon, Claus-Christian/GLQ-6274-2022	Carbon, Claus-Christian/0000-0002-3446-9347				Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; Avidan G, 2011, NEUROPSYCHOLOGIA, V49, P2541, DOI 10.1016/j.neuropsychologia.2011.05.002; BARTLETT JC, 1993, COGNITIVE PSYCHOL, V25, P281, DOI 10.1006/cogp.1993.1007; Barton JJS, 2006, PERCEPTION, V35, P1089, DOI 10.1068/p5547; Bertin E, 2004, DEVELOPMENTAL SCI, V7, P431, DOI 10.1111/j.1467-7687.2004.00363.x; Bombari D, 2009, PERCEPTION, V38, P1508, DOI 10.1068/p6117; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Bruce V, 2001, J EXP PSYCHOL-APPL, V7, P207, DOI 10.1037/1076-898X.7.3.207; Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; Burton AM, 2005, COGNITIVE PSYCHOL, V51, P256, DOI 10.1016/j.cogpsych.2005.06.003; Carbon CC, 2005, PERCEPTION, V34, P1117, DOI 10.1068/p5192; Carbon CC, 2005, COGNITIVE BRAIN RES, V24, P544, DOI 10.1016/j.cogbrainres.2005.03.008; Carbon CC, 2008, PERCEPTION, V37, P801, DOI 10.1068/p5789; Carbon CC, 2007, PERCEPTION, V36, P1635, DOI 10.1068/p5467; Cornes K, 2011, J EXP PSYCHOL HUMAN, V37, P645, DOI 10.1037/a0020985; de Gelder B, 2000, NEUROREPORT, V11, P3145, DOI 10.1097/00001756-200009280-00021; Donnelly N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023340; ELLIS HD, 1979, PERCEPTION, V8, P431, DOI 10.1068/p080431; Goffaux V, 2007, J EXP PSYCHOL HUMAN, V33, P995, DOI 10.1037/0096-1523.33.4.995; Gruter T, 2009, NEUROSCI LETT, V453, P135, DOI 10.1016/j.neulet.2009.02.021; Hancock PJB, 2000, TRENDS COGN SCI, V4, P330, DOI 10.1016/S1364-6613(00)01519-9; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Heisz JJ, 2008, J VISION, V8, DOI 10.1167/8.1.9; Hole Graham, 2010, FACE PROCESSING PSYC; Kaufmann JM, 2004, PERCEPTION, V33, P399, DOI 10.1068/p5083; Kimchi R, 2012, COGN NEUROPSYCHOL, V29, P447, DOI 10.1080/02643294.2012.752723; KLATZKY RL, 1984, MEM COGNITION, V12, P60, DOI 10.3758/BF03196998; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; Leder H, 2006, BRIT J PSYCHOL, V97, P19, DOI 10.1348/000712605X54794; Lewis MB, 1997, PERCEPTION, V26, P225, DOI 10.1068/p260225; Lewis MB, 2001, PERCEPTION, V30, P769, DOI 10.1068/p3174; Lobmaier JS, 2007, PERCEPTION, V36, P1660, DOI 10.1068/p5642; Lykins AD, 2006, ARCH SEX BEHAV, V35, P569, DOI 10.1007/s10508-006-9065-z; Manor BR, 2003, J NEUROSCI METH, V128, P85, DOI 10.1016/S0165-0270(03)00151-1; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McKone E, 2007, PERCEPTION, V36, P224, DOI 10.1068/p5499; Murray JE, 2000, PSYCHOL SCI, V11, P492, DOI 10.1111/1467-9280.00294; Osborne CD, 2013, Q J EXP PSYCHOL, V66, P108, DOI 10.1080/17470218.2012.699077; Rakover SS, 1997, PERCEPT PSYCHOPHYS, V59, P752, DOI 10.3758/BF03206021; Rakover SS, 1999, PERCEPTION, V28, P1227, DOI 10.1068/p2774; Rayner K., 1989, PSYCHOL READING; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; Sandford A, 2014, COGNITION, V132, P262, DOI 10.1016/j.cognition.2014.04.005; Schweinberger SR, 1998, J EXP PSYCHOL HUMAN, V24, P1748, DOI 10.1037/0096-1523.24.6.1748; Stacey PC, 2005, BRIT J PSYCHOL, V96, P407, DOI 10.1348/000712605X47422; Talati Z, 2010, PSYCHOL SCI, V21, P219, DOI 10.1177/0956797609357854; Tanaka JW, 2014, ATTEN PERCEPT PSYCHO, V76, P1000, DOI 10.3758/s13414-014-0628-0; THOMPSON P, 1980, PERCEPTION, V9, P483, DOI 10.1068/p090483; Townsend J.T., 1978, COGNITIVE THEORY, V3, P200; Townsend JT, 1983, STOCHASTIC MODELLING; Williams CC, 2007, MEM COGNITION, V35, P1977, DOI 10.3758/BF03192930; Xu BY, 2013, J VISION, V13, DOI 10.1167/13.2.22; Young AW, 2011, BRIT J PSYCHOL, V102, P959, DOI 10.1111/j.2044-8295.2011.02045.x; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7	54	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0163933	10.1371/journal.pone.0163933	http://dx.doi.org/10.1371/journal.pone.0163933			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED7AX	27776145	gold, Green Published, Green Submitted			2022-12-26	WOS:000389009200008
J	Horimoto, Y; Arakawa, A; Sasahara, N; Tanabe, M; Sai, S; Himuro, T; Saito, M				Horimoto, Yoshiya; Arakawa, Atsushi; Sasahara, Noriko; Tanabe, Masahiko; Sai, Sei; Himuro, Takanori; Saito, Mitsue			Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases	PLOS ONE			English	Article							EXPRESSION; THERAPY; GROWTH	The combination of CD44 and CD24, or aldehyde dehydrogenase 1 (ALDH1) alone, is a widely used cancer stem cell marker in breast cancer. However, no conclusion has yet been reached as to which marker is the best for characterizing cancer stemness. Immunohistochemical evaluation using cancer stem cell markers is clearly less common clinically than in basic experiments and how the expressions of these markers relate to patient outcomes remains controversial. To investigate whether combining these markers might improve the prediction of patient outcomes, we immunohistochemically examined clinical samples. Primary invasive breast cancer samples from 61 patients who eventually developed distant metastases after curative surgery were immunohistochemically examined. All patients were free of metastatic disease at the time of surgery and received standard adjuvant systemic treatments. CD44(+)/24(-) and ALDH1-positive rates in primary tumors differed according to intrinsic subtype. ER-positive patients with CD44(+)/24(-) tumors had significantly longer disease-free-survival than all other ER-positive patients (p = 0.0047). On the other hand, CD44(+)/24(-) tumors were associated with poor outcomes of ER-negative patients (p = 0.038). Finally, expression patterns of CD44 and ALDH1 in single tumors were strikingly different and there were virtually no individual double-stained cells. Thus, this combination does not allow evaluation of relationships with patient outcomes. Our results raise the possibility of CD44(+)/24(-) being a good prognostic marker, one which would allow treatment effects and outcomes to be predicted in patients with recurrent breast cancer.	[Horimoto, Yoshiya; Himuro, Takanori; Saito, Mitsue] Juntendo Univ, Dept Breast Oncol, Sch Med, Tokyo, Japan; [Horimoto, Yoshiya] Juntendo Univ, Pathol & Oncol, Sch Med, Tokyo, Japan; [Arakawa, Atsushi; Sasahara, Noriko] Juntendo Univ, Human Pathol, Sch Med, Tokyo, Japan; [Tanabe, Masahiko] Kyoundo Hosp, Dept Breast Surg, Tokyo, Japan; [Sai, Sei] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Med Phys Res Program, Chiba, Japan	Juntendo University; Juntendo University; Juntendo University; National Institutes for Quantum Science & Technology	Horimoto, Y (corresponding author), Juntendo Univ, Dept Breast Oncol, Sch Med, Tokyo, Japan.; Horimoto, Y (corresponding author), Juntendo Univ, Pathol & Oncol, Sch Med, Tokyo, Japan.	yoshiyahorimoto@hotmail.com	Horimoto, Yoshiya/AAC-1407-2019; Tanabe, Masahiko/ABI-3717-2020	Horimoto, Yoshiya/0000-0001-8935-0768; 				Ablett MP, 2012, EUR J CANCER, V48, P2104, DOI 10.1016/j.ejca.2012.03.019; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ali HR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3061; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Bonito Maurizio Di, 2013, J Clin Med Res, V5, P325, DOI 10.4021/jocmr1302w; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; de Beca FF, 2013, J CLIN PATHOL, V66, P187, DOI 10.1136/jclinpath-2012-201169; Douville J, 2009, STEM CELLS DEV, V18, P17, DOI 10.1089/scd.2008.0055; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Gangopadhyay S, 2013, CLIN BREAST CANCER, V13, P7, DOI 10.1016/j.clbc.2012.09.017; Guler G, 2012, MODERN PATHOL, V25, P949, DOI 10.1038/modpathol.2012.37; Hashimoto K, 2012, ONCOLOGY-BASEL, V82, P168, DOI 10.1159/000336078; Lin Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-59; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Miyoshi Y, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0731-3; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Sai S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0429-7; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shitara K., 2016, GASTRIC CANCER, V20, P1, DOI DOI 10.1007/S10120-015-0573-1; Zhong Y, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0864-0	25	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165253	10.1371/journal.pone.0165253	http://dx.doi.org/10.1371/journal.pone.0165253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768764	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400071
J	Melleby, AO; Strand, ME; Romaine, A; Herum, KM; Skrbic, B; Dahl, CP; Sjaastad, I; Fiane, AE; Filmus, J; Christensen, G; Lunde, IG				Melleby, Arne O.; Strand, Mari E.; Romaine, Andreas; Herum, Kate M.; Skrbic, Biljana; Dahl, Christen P.; Sjaastad, Ivar; Fiane, Arnt E.; Filmus, Jorge; Christensen, Geir; Lunde, Ida G.			The Heparan Sulfate Proteoglycan Glypican-6 Is Upregulated in the Failing Heart, and Regulates Cardiomyocyte Growth through ERK1/2 Signaling	PLOS ONE			English	Article							PRESSURE-OVERLOADED HEART; CARDIAC-HYPERTROPHY; HEPATOCELLULAR-CARCINOMA; ANGIOTENSIN-II; CELL-SURFACE; FAILURE; EXPRESSION; SYNDECAN-4; FAMILY; MICE	Pressure overload is a frequent cause of heart failure. Heart failure affects millions of patients worldwide and is a major cause of morbidity and mortality. Cell surface proteoglycans are emerging as molecular players in cardiac remodeling, and increased knowledge about their regulation and function is needed for improved understanding of cardiac pathogenesis. Here we investigated glypicans (GPC1-6), a family of evolutionary conserved heparan sulfate proteoglycans anchored to the extracellular leaflet of the cell membrane, in experimental and clinical heart failure, and explored the function of glypican-6 in cardiac cells in vitro. In mice subjected to pressure overload by aortic banding (AB), we observed elevated glypican-6 levels during hypertrophic remodeling and dilated, end-stage heart failure. Consistently, glypican-6 mRNA was elevated in left ventricular myocardium from explanted hearts of patients with end-stage, dilated heart failure with reduced ejection fraction. Glypican-6 levels correlated negatively with left ventricular ejection fraction in patients, and positively with lung weight after AB in mice. Glypican-6 mRNA was expressed in both cardiac fibroblasts and cardiomyocytes, and the corresponding protein displayed different sizes in the two cell types due to tissue-specific glycanation. Importantly, adenoviral overexpression of glypican-6 in cultured cardiomyocytes increased protein synthesis and induced mRNA levels of the pro-hypertrophic signature gene ACTA1 and the hypertrophy and heart failure signature genes encoding natriuretic peptides, NPPA and NPPB. Overexpression of GPC6 induced ERK1/2 phosphorylation, and co-treatment with the ERK inhibitor U0126 attenuated the GPC6-induced increase in NPPA, NPPB and protein synthesis. In conclusion, our data suggests that glypican-6 plays a role in clinical and experimental heart failure progression by regulating cardiomyocyte growth through ERK signaling.	[Melleby, Arne O.; Strand, Mari E.; Romaine, Andreas; Herum, Kate M.; Skrbic, Biljana; Sjaastad, Ivar; Christensen, Geir; Lunde, Ida G.] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway; [Melleby, Arne O.; Strand, Mari E.; Romaine, Andreas; Herum, Kate M.; Skrbic, Biljana; Sjaastad, Ivar; Christensen, Geir; Lunde, Ida G.] Univ Oslo, Oslo, Norway; [Melleby, Arne O.; Strand, Mari E.; Romaine, Andreas; Herum, Kate M.; Skrbic, Biljana; Dahl, Christen P.; Sjaastad, Ivar; Christensen, Geir; Lunde, Ida G.] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Skrbic, Biljana; Fiane, Arnt E.] Oslo Univ Hosp, Dept Cardiothorac Surg, Oslo, Norway; [Dahl, Christen P.] Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway; [Sjaastad, Ivar; Filmus, Jorge] Univ Toronto, Sunnybrook Res Inst, Div Mol & Cellular Biol, Toronto, ON, Canada; [Sjaastad, Ivar; Filmus, Jorge] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Melleby, AO (corresponding author), Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway.; Melleby, AO (corresponding author), Univ Oslo, Oslo, Norway.; Melleby, AO (corresponding author), Univ Oslo, Ctr Heart Failure Res, Oslo, Norway.	a.o.melleby@medisin.uio.no	Lunde, Ida Gjervold/ABN-5567-2022	Lunde, Ida Gjervold/0000-0001-9502-6841; Romaine, Andreas/0000-0002-4952-7052	Research Council of Norway; Anders Jahre's Fund for the Promotion of Science; South-Eastern Regional Health Authority; Olav Raagholt and Gerd Meidel Raagholt's Fund for Science, Norway; Simon Fougner Hartmanns Family Fund, Denmark	Research Council of Norway(Research Council of Norway); Anders Jahre's Fund for the Promotion of Science; South-Eastern Regional Health Authority; Olav Raagholt and Gerd Meidel Raagholt's Fund for Science, Norway; Simon Fougner Hartmanns Family Fund, Denmark	This work was supported by the Research Council of Norway, Anders Jahre's Fund for the Promotion of Science, the South-Eastern Regional Health Authority, the Olav Raagholt and Gerd Meidel Raagholt's Fund for Science, Norway, and the Simon Fougner Hartmanns Family Fund, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2000, BIOCHEM J, V347, P275, DOI 10.1042/0264-6021:3470275; BAXOVA A, 1994, AM J MED GENET, V49, P263, DOI 10.1002/ajmg.1320490303; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bleuming SA, 2007, CANCER RES, V67, P8149, DOI 10.1158/0008-5472.CAN-06-4659; BOROCHOWITZ Z, 1991, AM J MED GENET, V39, P91, DOI 10.1002/ajmg.1320390120; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Burbach BJ, 2003, MATRIX BIOL, V22, P163, DOI 10.1016/S0945-053X(03)00009-X; Campos-Xavier AB, 2009, AM J HUM GENET, V84, P760, DOI 10.1016/j.ajhg.2009.05.002; Capurro M, 2014, J CELL SCI, V127, P1565, DOI 10.1242/jcs.140871; Capurro MI, 2005, J BIOL CHEM, V280, P41201, DOI 10.1074/jbc.M507004200; Dirkx E, 2013, BBA-MOL BASIS DIS, V1832, P2414, DOI 10.1016/j.bbadis.2013.07.023; Dunlay SM, 2009, AM J MED, V122, P1023, DOI 10.1016/j.amjmed.2009.04.022; Dwivedi PP, 2013, BONE, V55, P367, DOI 10.1016/j.bone.2013.04.013; Elcioglu NH, 2004, PEDIATR RADIOL, V34, P75, DOI 10.1007/s00247-003-1064-9; Fico A, 2011, CELL MOL LIFE SCI, V68, P923, DOI 10.1007/s00018-007-7471-6; Filmus J, 2001, J CLIN INVEST, V108, P497, DOI 10.1172/JCI13712; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Finsen AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028302; Finsen AV, 2004, PHYSIOL GENOMICS, V16, P301, DOI 10.1152/physiolgenomics.00144.2002; Grisaru S, 2001, DEV BIOL, V231, P31, DOI 10.1006/dbio.2000.0127; Hartwg S, 2005, MECH DEVELOP, V122, P928, DOI 10.1016/j.mod.2005.03.007; Herum KM, 2015, CARDIOVASC RES, V106, P217, DOI 10.1093/cvr/cvv002; Herum KM, 2013, J MOL CELL CARDIOL, V54, P73, DOI 10.1016/j.yjmcc.2012.11.006; Hoffmann A, 2001, CRIT REV EUKAR GENE, V11, P23; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; Kaye DM, 2007, NAT REV DRUG DISCOV, V6, P127, DOI 10.1038/nrd2219; Langenfeld EM, 2005, ANN THORAC SURG, V80, P1028, DOI 10.1016/j.athoracsur.2005.03.094; Lin AE, 1999, AM J MED GENET, V83, P378, DOI 10.1002/(SICI)1096-8628(19990423)83:5<378::AID-AJMG7>3.0.CO;2-A; Lunde IG, 2011, J APPL PHYSIOL, V111, P1278, DOI 10.1152/japplphysiol.01383.2010; Maria Albano L, 2007, CLINICS, V62, P531, DOI 10.1590/S1807-59322007000400023; McCulley DJ, 2008, DEV DYNAM, V237, P3200, DOI 10.1002/dvdy.21743; Midorikawa Y, 2003, INT J CANCER, V103, P455, DOI 10.1002/ijc.10856; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Paine-Saunders S, 1999, GENOMICS, V57, P455, DOI 10.1006/geno.1999.5793; Paine-Saunders S, 2000, DEV BIOL, V225, P179, DOI 10.1006/dbio.2000.9831; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Ruppert C, 2013, P NATL ACAD SCI USA, V110, P7440, DOI 10.1073/pnas.1221999110; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Skrbic B, 2015, CARDIOVASC RES, V106, P32, DOI 10.1093/cvr/cvv041; Strand ME, 2015, J MOL CELL CARDIOL, V88, P133, DOI 10.1016/j.yjmcc.2015.10.003; Strand ME, 2013, FEBS J, V280, P2228, DOI 10.1111/febs.12161; Strunz CMC, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-35; Sun B, 2013, HYPERTENSION, V61, P352, DOI 10.1161/HYPERTENSIONAHA.111.00562; Tatrai P, 2010, J HISTOCHEM CYTOCHEM, V58, P429, DOI 10.1369/jhc.2010.955161; Traister A, 2008, BIOCHEM J, V410, P503, DOI 10.1042/BJ20070511; Veugelers M, 1999, J BIOL CHEM, V274, P26968, DOI 10.1074/jbc.274.38.26968; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Weyers A, 2012, OMICS, V16, P79, DOI 10.1089/omi.2011.0102; Yue TL, 2000, J BIOL CHEM, V275, P37895, DOI 10.1074/jbc.M007037200; Zhang Weihua, 2003, Exp Clin Cardiol, V8, P173; Zile MR, 2002, CIRCULATION, V105, P1503, DOI 10.1161/hc1202.105290	54	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0165079	10.1371/journal.pone.0165079	http://dx.doi.org/10.1371/journal.pone.0165079			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768722	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400047
J	Nobre, T; Oliveira, M; Arnholdt-Schmitt, B				Nobre, Tania; Oliveira, Manuela; Arnholdt-Schmitt, Birgit			Wild Carrot Differentiation in Europe and Selection at DcAOX1 Gene?	PLOS ONE			English	Article							PLANT SECONDARY METABOLISM; ALTERNATIVE OXIDASE GENE; DAUCUS-CAROTA L.; MOLECULAR PHYLOGENY; FUNCTIONAL MARKER; DNA POLYMORPHISM; BIOTIC STRESS; DIVERSITY; INTRON; ARABIDOPSIS	By definition, the domestication process leads to an overall reduction of crop genetic diversity. This lead to the current search of genomic regions in wild crop relatives (CWR), an important task for modern carrot breeding. Nowadays massive sequencing possibilities can allow for discovery of novel genetic resources in wild populations, but this quest could be aided by the use of a surrogate gene (to first identify and prioritize novel wild populations for increased sequencing effort). Alternative oxidase (AOX) gene family seems to be linked to all kinds of abiotic and biotic stress reactions in various organisms and thus have the potential to be used in the identification of CWR hotspots of environment-adapted diversity. High variability of DcAOX1 was found in populations of wild carrot sampled across a West-European environmental gradient. Even though no direct relation was found with the analyzed climatic conditions or with physical distance, population differentiation exists and results mainly from the polymorphisms associated with DcAOX1 exon 1 and intron 1. The relatively high number of amino acid changes and the identification of several unusually variable positions (through a likelihood ratio test), suggests that DcAOX1 gene might be under positive selection. However, if positive selection is considered, it only acts on some specific populations (i.e. is in the form of adaptive differences in different population locations) given the observed high genetic diversity. We were able to identify two populations with higher levels of differentiation which are promising as hot spots of specific functional diversity.	[Nobre, Tania; Arnholdt-Schmitt, Birgit] Univ Evora, EU Marie Curie Chair, ICAAM Inst Ciencias Agr & Ambientais Mediterran, Evora, Portugal; [Oliveira, Manuela] Univ Evora, Inst Invest & Formacao Avancada, Ctr Invest Matemat & Aplicacoes, Evora, Portugal	University of Evora; University of Evora	Nobre, T (corresponding author), Univ Evora, EU Marie Curie Chair, ICAAM Inst Ciencias Agr & Ambientais Mediterran, Evora, Portugal.	tnobre@uevora.pt	Oliveira, Manuela/M-3420-2013; Nobre, Tania/C-9925-2012	Oliveira, Manuela/0000-0002-8435-1136; Nobre, Tania/0000-0002-1855-7451	Marie Curie Career Integration grant (FP7-PEOPLE-CIG) [321725]; Foundation for Science and Technology (FCT, Portugal) fellowship [SFRH/BCC/52187/2013]; FCT [UID/MAT/04674/2013 (CIMA)]; National Funds through FCT [UID/AGR/00115/2013]	Marie Curie Career Integration grant (FP7-PEOPLE-CIG); Foundation for Science and Technology (FCT, Portugal) fellowship; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); National Funds through FCT(Portuguese Foundation for Science and Technology)	TN was supported by a Marie Curie Career Integration grant (FP7-PEOPLE-2012-CIG ref. 321725) and a Foundation for Science and Technology (FCT, Portugal) fellowship (SFRH/BCC/52187/2013). MO thanks FCT for the support given under the program UID/MAT/04674/2013 (CIMA). This work is funded by National Funds through FCT under the Project UID/AGR/00115/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2002, FEBS LETT, V527, P181, DOI 10.1016/S0014-5793(02)03218-0; Arbizu C, 2014, AM J BOT, V101, P1666, DOI 10.3732/ajb.1400106; Arnholdt-Schmitt B, 2006, TRENDS PLANT SCI, V11, P281, DOI 10.1016/j.tplants.2006.05.001; Baek JM, 2008, PLANT MOL BIOL, V67, P499, DOI 10.1007/s11103-008-9334-4; Baranski R, 2012, GENET RESOUR CROP EV, V59, P163, DOI 10.1007/s10722-011-9777-3; Benderoth M, 2006, P NATL ACAD SCI USA, V103, P9118, DOI 10.1073/pnas.0601738103; Bradeen JM, 2002, J AM SOC HORTIC SCI, V127, P383, DOI 10.21273/JASHS.127.3.383; Brozynska M, 2016, PLANT BIOTECHNOL J, V14, P1070, DOI 10.1111/pbi.12454; Campos C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142339; Cardoso H, 2011, PLANT GENET RESOUR-C, V9, P177, DOI 10.1017/S1479262111000591; Cardoso HG, 2009, PHYSIOL PLANTARUM, V137, P592, DOI 10.1111/j.1399-3054.2009.01299.x; Carmel L, 2007, GENOME RES, V17, P1045, DOI 10.1101/gr.5978207; Clifton R, 2006, BBA-BIOENERGETICS, V1757, P730, DOI 10.1016/j.bbabio.2006.03.009; Costa JH, 2010, J PLANT PHYSIOL, V167, P561, DOI 10.1016/j.jplph.2009.11.001; Costa JH, 2009, PHYSIOL PLANTARUM, V137, P553, DOI 10.1111/j.1399-3054.2009.01267.x; Cvetkovska M, 2013, PLANT CELL ENVIRON, V36, P721, DOI 10.1111/pce.12009; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Campos MD, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00001; Emami S, 2013, PLANT BIOTECHNOL J, V11, P555, DOI 10.1111/pbi.12043; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Cavalcanti JHF, 2013, J PLANT PHYSIOL, V170, P1609, DOI 10.1016/j.jplph.2013.06.012; Fu YB, 2015, THEOR APPL GENET, V128, P2131, DOI 10.1007/s00122-015-2585-y; Giani S, 2003, CELL BIOL INT, V27, P203, DOI 10.1016/S1065-6995(02)00301-3; Grzebelus D, 2014, MOL BREEDING, V33, P625, DOI 10.1007/s11032-013-9979-9; Henry RJ, 2014, PLANT BIOTECHNOL J, V12, P655, DOI 10.1111/pbi.12215; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iorizzo M, 2013, AM J BOT, V100, P930, DOI 10.3732/ajb.1300055; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Jeffares DC, 2008, TRENDS GENET, V24, P375, DOI 10.1016/j.tig.2008.05.006; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kelly JK, 1997, GENETICS, V146, P1197; Kroymann J, 2011, CURR OPIN PLANT BIOL, V14, P246, DOI 10.1016/j.pbi.2011.03.021; Larsson H, 2013, G3-GENES GENOM GENET, V3, P795, DOI 10.1534/g3.112.005462; Lee B.Y, 2014, J SPECIES RES, V3, P39, DOI 10.12651/JSR.2014.3.1.039; Li SC, 2008, NUCLEIC ACIDS RES, V36, pD184, DOI 10.1093/nar/gkm610; Macedo ES, 2009, PHYSIOL PLANTARUM, V137, P532, DOI 10.1111/j.1399-3054.2009.01302.x; Magnussen LS, 2007, HEREDITY, V99, P185, DOI 10.1038/sj.hdy.6800982; McDonald AE, 2008, FUNCT PLANT BIOL, V35, P535, DOI 10.1071/FP08025; Nogales A., 2016, PLANT GENE, V5, P49, DOI [10.1016/j.plgene.2015.11.001, DOI 10.1016/J.PLGENE.2015.11.001]; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rauf S., 2010, INT J PLANT BREED, V4, P1, DOI DOI 10.3923/ijpbg.2010.1.12; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saisho D, 1997, PLANT MOL BIOL, V35, P585, DOI 10.1023/A:1005818507743; Sitaramam V., 2008, Physiology and Molecular Biology of Plants, V14, P235, DOI 10.1007/s12298-008-0023-1; Spooner D, 2013, SYST BOT, V38, P850, DOI 10.1600/036364413X670449; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; TAJIMA F, 1989, GENETICS, V123, P585; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; Umbach AL, 2005, PLANT PHYSIOL, V139, P1806, DOI 10.1104/pp.105.070763; Van Aken O, 2009, PHYSIOL PLANTARUM, V137, P354, DOI 10.1111/j.1399-3054.2009.01240.x; van de Wiel CCM, 2010, PLANT GENET RESOUR-C, V8, P171, DOI 10.1017/S1479262110000134; van de Wouw M, 2010, THEOR APPL GENET, V120, P1241, DOI 10.1007/s00122-009-1252-6; Vanlerberghe GC, 2013, INT J MOL SCI, V14, P6805, DOI 10.3390/ijms14046805; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zmienko A, 2014, THEOR APPL GENET, V127, P1, DOI 10.1007/s00122-013-2177-7	59	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164872	10.1371/journal.pone.0164872	http://dx.doi.org/10.1371/journal.pone.0164872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768735	Green Submitted, Green Published, gold			2022-12-26	WOS:000386205400034
J	Gao, DM; Zhang, YY; Zhu, MY; Liu, SA; Wang, XL				Gao, Dongmei; Zhang, Yuanyuan; Zhu, Mingyue; Liu, Shuang; Wang, Xinling			miRNA Expression Profiles of HPV-Infected Patients with Cervical Cancer in the Uyghur Population in China	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE-16 E6; MICRORNA EXPRESSION; DOWN-REGULATION; BINDING; UBIQUITINATION; PROLIFERATION; CONTRIBUTES; TELOMERASE; ACTIVATION; INDUCTION	The study aimed to investigate the state of human papillomavirus (HPV) infection in patients with cervical cancer in the Uyghur population in China and to identify miRNA as biomarker for cervical cancer and HPV infection. We also performed genotyping to determine the variation in the types of HPV. Using microRNA (miRNA) microarray technology, differential miRNA expression between HPV-infected cervical cancer and uninfected normal cervical tissues was determined; the microarray results were verified by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) using 20 samples of both the tissues. The infection rate of HPV in patients with cervical cancer was 96.7% (29 of 30), and the main subtype identified was HPV16 (29 of 29). HPV16 integration assay demonstrated that the majority of infectious cases were of the integrated form (26 of 29). Analysis of 140 miRNAs demonstrated greater than two-fold change in miRNA expression in HPV-infected cervical cancer tissue as compared to that in uninfected cervical tissue. The qRT-PCR analysis verified that the expression of miR-15a-5p, miR-17-5p, miR-20a-5p, miR-215p, miR-96, miR-106b-5p, and miR-3653 was higher, while the expression of miR-497-5p was lower in cancer tissues than in normal tissues. The results demonstrate significant changes in miRNA expression in cervical cancer tissues associated with HPV infection as compared to that in normal tissues. These molecular markers may be useful for an early diagnosis and prognosis of cervical cancer in specific human populations.	[Gao, Dongmei; Zhang, Yuanyuan; Zhu, Mingyue; Liu, Shuang; Wang, Xinling] Xinjiang Med Univ, Canc Hosp, Dept Gynecol, Urumqi 830011, Peoples R China	Xinjiang Medical University	Wang, XL (corresponding author), Xinjiang Med Univ, Canc Hosp, Dept Gynecol, Urumqi 830011, Peoples R China.	Wangxinling0516@126.com	zhang, yuanyuan/GYA-4428-2022		Regional Fund of National Natural Science Foundation of China [8136302]; Open Program, Laboratory of Molecular Biology, Xinjiang Endemic Diseases 257 [XJDX0208-2013-03]; General Program, Natural Science Foundation of Xinjiang [2013211A071]	Regional Fund of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Program, Laboratory of Molecular Biology, Xinjiang Endemic Diseases 257; General Program, Natural Science Foundation of Xinjiang	The study was supported by the Regional Fund of National Natural Science Foundation of China (no. 8136302), Open Program, Laboratory of Molecular Biology, Xinjiang Endemic Diseases 257 (no. XJDX0208-2013-03) and General Program, Natural Science Foundation of Xinjiang (no. 2013211A071).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cheung JLK, 2006, J INFECT DIS, V194, P1706, DOI 10.1086/509622; Cricca M, 2007, GYNECOL ONCOL, V106, P549, DOI 10.1016/j.ygyno.2007.05.004; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; de Freitas AC, 2015, CURR DRUG TARGETS, V16, P77, DOI 10.2174/1389450116666141205150942; Ding H, 2014, ASIAN PAC J CANCER P, V15, P1675, DOI 10.7314/APJCP.2014.15.4.1675; Gardiner AS, 2015, BIOMOLECULES, V5, P2903, DOI 10.3390/biom5042903; Gewin L, 2001, J VIROL, V75, P7198, DOI 10.1128/JVI.75.15.7198-7201.2001; Han Jiming, 2014, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V30, P597; Haws ALF, 2004, J VIROL METHODS, V122, P87, DOI 10.1016/j.jviromet.2004.08.007; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; Jiang S, 2006, CHIN J PRACT GYNECOL, V20, P379; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Li J, 2009, VACCINE, V27, P1210, DOI 10.1016/j.vaccine.2008.12.020; Li W, 2008, J CANCER RES CLIN, V134, P1355, DOI 10.1007/s00432-008-0413-3; Liu S, 2015, ONCOL REP, V33, P2853, DOI 10.3892/or.2015.3929; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Narisawa-Saito M, 2007, CANCER SCI, V98, P1505, DOI 10.1111/j.1349-7006.2007.00546.x; Nees M, 2001, J VIROL, V75, P4283, DOI 10.1128/JVI.75.9.4283-4296.2001; Obeidat B, 2013, EUR J GYNAECOL ONCOL, V34, P257; Oh ST, 2001, J VIROL, V75, P5559, DOI 10.1128/JVI.75.12.5559-5566.2001; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wu ZY, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0235-8; Xia HF, 2014, BIOMED PHARMACOTHER, V68, P951, DOI 10.1016/j.biopha.2014.10.023; Xu JW, 2014, ONCOTARGET, V5, P6983, DOI 10.18632/oncotarget.2184; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Zeng KK, 2015, ARCH GYNECOL OBSTET, V292, P905, DOI 10.1007/s00404-015-3702-5; Zhao XL, 2015, INT J CLIN EXP PATHO, V8, P758; Zhu XL, 2015, MOL MED REP, V12, P55, DOI 10.3892/mmr.2015.3363	36	35	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164701	10.1371/journal.pone.0164701	http://dx.doi.org/10.1371/journal.pone.0164701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764149	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204500052
J	Liu, LJ; Yin, YF; Zhang, ZH; Malaiya, YK				Liu, Lijun; Yin, Yongfeng; Zhang, Zenghu; Malaiya, Yashwant K.			Redundant Design in Interdependent Networks	PLOS ONE			English	Article							ROBUSTNESS; FAILURES	Modern infrastructure networks are often coupled together and thus could be modeled as interdependent networks. Overload and interdependent effect make interdependent networks more fragile when suffering from attacks. Existing research has primarily concentrated on the cascading failure process of interdependent networks without load, or the robustness of isolated network with load. Only limited research has been done on the cascading failure process caused by overload in interdependent networks. Redundant design is a primary approach to enhance the reliability and robustness of the system. In this paper, we propose two redundant methods, node back-up and dependency redundancy, and the experiment results indicate that two measures are effective and costless. Two detailed models about redundant design are introduced based on the non-linear load-capacity model. Based on the attributes and historical failure distribution of nodes, we introduce three static selecting strategies-Random-based, Degree-based, Initial load-based and a dynamic strategy-HFD (historical failure distribution) to identify which nodes could have a back-up with priority. In addition, we consider the cost and efficiency of different redundant proportions to determine the best proportion with maximal enhancement and minimal cost. Experiments on interdependent networks demonstrate that the combination of HFD and dependency redundancy is an effective and preferred measure to implement redundant design on interdependent networks. The results suggest that the redundant design proposed in this paper can permit construction of highly robust interactive networked systems.	[Liu, Lijun; Yin, Yongfeng; Zhang, Zenghu] Beihang Univ, Sch Reliabil & Syst Engn, Beijing, Peoples R China; [Malaiya, Yashwant K.] Colorado State Univ, Dept Comp Sci, Ft Collins, CO 80523 USA	Beihang University; Colorado State University	Yin, YF (corresponding author), Beihang Univ, Sch Reliabil & Syst Engn, Beijing, Peoples R China.	yyf@buaa.edu.cn	Yin, Yongfeng/W-1457-2019		National Aerospace Science Foundation of China [20140751008]; Beihang University Innovation and Practice Fund for Graduate [YCSJ-02-2016-09]	National Aerospace Science Foundation of China; Beihang University Innovation and Practice Fund for Graduate	This work was supported by National Aerospace Science Foundation of China (No.20140751008); Beihang University Innovation and Practice Fund for Graduate (YCSJ-02-2016-09).	Brummitt CD, 2012, P NATL ACAD SCI USA, V109, pE680, DOI 10.1073/pnas.1110586109; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Clark L, 2016, MECH MACH THEORY, V105, P129, DOI 10.1016/j.mechmachtheory.2016.06.017; Dou BL, 2010, PHYSICA A, V389, P2310, DOI 10.1016/j.physa.2010.02.002; ERDdS P, 1959, PUBL MATH-DEBRECEN, V6, P290; Gong MG, 2015, SCI REP-UK, V5, DOI 10.1038/srep08439; Hong S, 2015, PROGNOST SYST HEALT; Hong S, 2016, J PHYS A-MATH THEOR, V49, DOI 10.1088/1751-8113/49/19/195101; Hong S, 2016, INT J SYST SCI, V47, P2745, DOI 10.1080/00207721.2015.1022890; Hong S, 2016, MOD PHYS LETT B, V30, DOI 10.1142/S0217984916500494; Hong S, 2015, J PHYS A-MATH THEOR, V48, DOI 10.1088/1751-8113/48/48/485101; Hong S, 2014, APPL MATH COMPUT, V247, P1021, DOI 10.1016/j.amc.2014.09.029; Hong S, 2014, INT J MOD PHYS B, V28, DOI 10.1142/S0217979214501495; Kim DH, 2008, J PHYS A, V41; Liu CR, 2014, EPL-EUROPHYS LETT, V107, DOI 10.1209/0295-5075/107/68003; Motter AE, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.065102; Niyato D, 2012, IEEE WIREL COMMUN, V19, P38, DOI 10.1109/MWC.2012.6231158; Parshani R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.048701; Qun L, 2012, FIRE CONTROL COMMAND, V8; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; Shao J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036116; Su H-P, 2013, AUTOMATION INSTRUMEN, V1; Tan F, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/28009; WANG Q, 2015, J NANCHANG HANGKONG, V2, P003; Zhu Jin, 2013, T CHINA ELECTROTECHN, V28, P319	25	13	15	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2016	11	10							e0164777	10.1371/journal.pone.0164777	http://dx.doi.org/10.1371/journal.pone.0164777			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NZ	27764174	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204500060
J	Aaron, GJ; Sodani, PR; Sankar, R; Fairhurst, J; Siling, K; Guevarra, E; Norris, A; Myatt, M				Aaron, Grant J.; Sodani, Prahlad R.; Sankar, Rajan; Fairhurst, John; Siling, Katja; Guevarra, Ernest; Norris, Alison; Myatt, Mark			Household Coverage of Fortified Staple Food Commodities in Rajasthan, India	PLOS ONE			English	Article							TOOL	A spatially representative statewide survey was conducted in Rajasthan, India to assess household coverage of atta wheat flour, edible oil, and salt. An even distribution of primary sampling units were selected based on their proximity to centroids on a hexagonal grid laid over the survey area. A sample of n = 18 households from each of m = 252 primary sampling units PSUs was taken. Demographic data on all members of these households were collected, and a broader dataset was collected about a single caregiver and a child in the first 2 years of life. Data were collected on demographic and socioeconomic status; education; housing conditions; recent infant and child mortality; water, sanitation, and hygiene practices; food security; child health; infant and young child feeding practices; maternal dietary diversity; coverage of fortified staples; and maternal and child anthropometry. Data were collected from 4,627 households and the same number of caregiver/child pairs. Atta wheat flour was widely consumed across the state (83%); however, only about 7% of the atta wheat flour was classified as fortifiable, and only about 6% was actually fortified (mostly inadequately). For oil, almost 90% of edible oil consumed by households in the survey was classified as fortifiable, but only about 24% was fortified. For salt, coverage was high, with almost 85% of households using fortified salt and 66% of households using adequately fortified salt. Iodized salt coverage was also high; however, rural and poor population groups were less likely to be reached by the intervention. Voluntary fortification of atta wheat flour and edible oil lacked sufficient industry consolidation to cover significant portions of the population. It is crucial that appropriate delivery channels are utilized to effectively deliver essential micronutrients to at-risk population groups. Government distribution systems are likely the best means to accomplish this goal.	[Aaron, Grant J.; Sankar, Rajan; Fairhurst, John] Global Alliance Improved Nutr, Geneva, Switzerland; [Sodani, Prahlad R.] Indian Inst Hlth Management Res, Jaipur, Rajasthan, India; [Siling, Katja; Guevarra, Ernest; Norris, Alison] Valid Int, Oxford, England; [Myatt, Mark] Brixton Hlth, Llawryglyn, Wales		Aaron, GJ (corresponding author), Global Alliance Improved Nutr, Geneva, Switzerland.	grant@grantjaaron.com	Sodani, Prahlad Rai/CAG-5905-2022	Sodani, Prahlad Rai/0000-0003-4419-1243; Guevarra, Ernest/0000-0002-4887-4415	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding for this research was provided by the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org) to GAIN. The funding covered the costs of implementing the research only. The funder played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Aaron GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162462; Alkire S, 2014, WORLD DEV, V59, P251, DOI 10.1016/j.worlddev.2014.01.026; Allen L, 2006, GUIDELINES FOOD FORT; [Anonymous], 2005, STUDIES METHODS DE F, V98; [Anonymous], 2007, ASS IOD DEF DIS MON; Ategbo EA, 2008, ASIA PAC J CLIN NUTR, V17, P56; Baker J. E., 1987, P 2 INT C GEN ALG TH; BENNETT S, 1994, INT J EPIDEMIOL, V23, P1282, DOI 10.1093/ije/23.6.1282; Bhagwat Sadhana, 2014, Asia Pac J Clin Nutr, V23 Suppl 1, pS4, DOI 10.6133/apjcn.2014.23.s1.04; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Census of India, 2011, TABL C 13 SINGL YEAR, V27; Copenhagen Consensus, 2015, 3 COP CONS OUTC DOC; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; GEISSER S, 1975, J AM STAT ASSOC, V70, P320, DOI 10.2307/2285815; Gilbert R. O., 1987, STAT METHODS ENV POL; Guevarra E., 2014, Field Exchange - Emergency Nutrition Network ENN, P60; Hess SY, 2013, FOOD NUTR BULL, V34, P21, DOI 10.1177/156482651303400104; Hoffmeyer-Zlotnik JH, PRIVATE HOUSEHOLD CO; India National Institute for Nutrition, DIET GUID IND MAN; Isaaks EH, 1989, APPL GEOSTATISTICS; Kennedy G., 2010, GUID MEAS HOUS IND D; Laillou A, 2013, FOOD NUTR BULL, V34, pS124, DOI 10.1177/15648265130342S114; Liu P, 2014, FOOD FORTIFICATION I; Micronutrient Initiative, 2003, FORT RAP ASS TOOL FR; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; Piazza T., 2010, HDB SURVEY RES; Rah JH, 2015, MATERN CHILD NUTR, V11, P483, DOI 10.1111/mcn.12044; Shepard D., 1968, P 1968 23 ACM NATL C, P517, DOI [10.1145/800186.810616, DOI 10.1145/800186.810616]; Sridhar KK, 113721 MICR IN, P32; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Weisell R, 2012, FOOD NUTR BULL, V33, pS157, DOI 10.1177/15648265120333S203	31	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0163176	10.1371/journal.pone.0163176	http://dx.doi.org/10.1371/journal.pone.0163176			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760123	Green Submitted, Green Published, gold			2022-12-26	WOS:000386204000008
J	Oliveira, C; Carvalho, PC; Alves, LR; Goldenberg, S				Oliveira, Camila; Carvalho, Paulo Costa; Alves, Lysangela Ronalte; Goldenberg, Samuel			The Role of the Trypanosoma cruzi TcNRBD1 Protein in Translation	PLOS ONE			English	Article							RNA-BINDING-PROTEINS; DEVELOPMENTAL REGULATION; GENE-EXPRESSION; MESSENGER-RNAS; BRUCEI; RACK1; INITIATION	The regulation of gene expression in trypanosomatids occurs mainly at the post-transcriptional level. Despite the importance of this type of control in Trypanosome cruzi, few RNA binding proteins have been characterized. The RRM domain (RNA Recognition Motif) is one of the most abundant domains found in RNA-binding proteins in higher eukaryotes. Proteins containing the RRM domain are involved in the majority of post-transcriptional processes regulating gene expression. In this work, we aimed to characterize the protein TcNRBD1 from T. cruzi. TcNRBD1 is an RNA-binding protein that contains 2 RRM domains and is the ortholog of the P34 and P37 proteins from Trypanosome brucei. The TcNRBD1 protein is expressed in all developmental stages of T. cruzi, and its localization pattern is concentrated at the perinuclear region. TcNRBD1 is associated with polysomes and with the 80S monosomes. Furthermore, sequencing of the mRNAs bound to TcNRBD1 allowed the identification of several transcripts that encode ribosomal proteins. Immunoprecipitation assays followed by mass spectrometry showed that the protein complexes with several ribosomal proteins from both the 40S and 60S subunits. In summary, the results indicate that TcNRBD1 is associated with different parts of the translation process, either by regulating mRNAs that encode ribosomal proteins or by acting in some step of ribosome assembly in T. cruzi.	[Oliveira, Camila; Carvalho, Paulo Costa; Alves, Lysangela Ronalte; Goldenberg, Samuel] Fiocruz Parana, Inst Carlos Chagas, Rua Prof Algacyr Munhoz Mader 3775, BR-81350010 Curitiba, Parana, Brazil	Fundacao Oswaldo Cruz	Alves, LR; Goldenberg, S (corresponding author), Fiocruz Parana, Inst Carlos Chagas, Rua Prof Algacyr Munhoz Mader 3775, BR-81350010 Curitiba, Parana, Brazil.	lysalves@fiocruz.br; sgoldenb@fiocruz.br	GOLDENBERG, SAMUEL/B-4116-2009; Alves, Lysangela Ronalte/H-5599-2012; Goldenberg, Samuel/ABD-8908-2022	GOLDENBERG, SAMUEL/0000-0002-4892-163X; Alves, Lysangela Ronalte/0000-0002-1972-2658; 	Fundacao Araucaria [255/2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) [474292/2013-4]	Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR)	This work was funded by Fundacao Araucaria 255/2013 (to Dr Samuel Goldenberg) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) 474292/2013-4 (to Dr. Lysangela Ronalte Alves). The funders (CNPq - Conselho Nacional de Desenvolvimento Cinetifico e Tecnologico and Fundacao Araucaria) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081375; Alves LR, 2010, GENE, V452, P72, DOI 10.1016/j.gene.2009.12.009; Alves LR, 2014, RNA BIOL, V11, P921, DOI 10.4161/rna.29622; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; Brener Z, 2000, TRYPANOSOMA CRUZI DO, p[Guanabara/Koogan, 127]; Carvalho PC, 2012, PROTEOMICS, V12, P944, DOI 10.1002/pmic.201100529; Carvalho PC., 2012, CURR PROTOC BIOINFOR, VChapter 13, pUNIT13.19, DOI DOI 10.1002/0471250953.BI1319S40; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; D'Orso I, 2002, J BIOL CHEM, V277, P50520, DOI 10.1074/jbc.M209092200; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; De Gaudenzi JG, 2011, ESSAYS BIOCHEM, V51, P31, DOI [10.1042/bse0510031, 10.1042/BSE0510031]; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Guerra-Slompo EP, 2012, BIOCHEM BIOPH RES CO, V420, P302, DOI 10.1016/j.bbrc.2012.02.154; Guo JJ, 2009, J EXP BOT, V60, P3819, DOI 10.1093/jxb/erp221; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Mani J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022463; Martinez-Calvillo S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525241; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; Perez-Diaz L, 2012, MEM I OSWALDO CRUZ, V107, P1076, DOI 10.1590/S0074-02762012000800021; Picchi GFA, 2011, EXP PARASITOL, V127, P147, DOI 10.1016/j.exppara.2010.07.009; Pichon X, 2012, CURR PROTEIN PEPT SC, V13, P294, DOI 10.2174/138920312801619475; Pitula J, 2002, BIOCHEM BIOPH RES CO, V290, P569, DOI 10.1006/bbrc.2001.6226; Regmi S, 2008, MOL MICROBIOL, V70, P724, DOI 10.1111/j.1365-2958.2008.06443.x; Sagliocco F A, 1996, Methods Mol Biol, V53, P297; Umaer K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131323; Valasek L, 2001, EMBO J, V20, P891, DOI 10.1093/emboj/20.4.891; Volta V, 2013, CELL MOL LIFE SCI, V70, P1439, DOI 10.1007/s00018-012-1215-y; Yatime L, 2011, J MOL BIOL, V411, P486, DOI 10.1016/j.jmb.2011.06.017; Zhang J, 1998, MOL BIOCHEM PARASIT, V92, P79, DOI 10.1016/S0166-6851(97)00228-4; Zhang J, 1997, MOL BIOCHEM PARASIT, V87, P145, DOI 10.1016/S0166-6851(97)00060-1	34	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164650	10.1371/journal.pone.0164650	http://dx.doi.org/10.1371/journal.pone.0164650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760165	gold, Green Submitted, Green Published			2022-12-26	WOS:000386204000041
J	Pazhamala, LT; Agarwal, G; Bajaj, P; Kumar, V; Kulshreshtha, A; Saxena, RK; Varshney, RK				Pazhamala, Lekha T.; Agarwal, Gaurav; Bajaj, Prasad; Kumar, Vinay; Kulshreshtha, Akanksha; Saxena, Rachit K.; Varshney, Rajeev K.			Deciphering Transcriptional Programming during Pod and Seed Development Using RNA-Seq in Pigeonpea (Cajanus cajan)	PLOS ONE			English	Article							REGULATORY NETWORKS; DIFFERENTIAL GENE; ARABIDOPSIS; EXPRESSION; IDENTIFICATION; ALIGNMENT; LEVEL	Seed development is an important event in plant life cycle that has interested humankind since ages, especially in crops of economic importance. Pigeonpea is an important grain legume of the semi-arid tropics, used mainly for its protein rich seeds. In order to understand the transcriptional programming during the pod and seed development, RNA-seq data was generated from embryo sac from the day of anthesis (0 DAA), seed and pod wall (5, 10, 20 and 30 DAA) of pigeonpea variety "Asha" (ICPL 87119) using Illumina HiSeq 2500. About 684 million sequencing reads have been generated from nine samples, which resulted in the identification of 27,441 expressed genes after sequence analysis. These genes have been studied for their differentially expression, co-expression, temporal and spatial gene expression. We have also used the RNA-seq data to identify important seed-specific transcription factors, biological processes and associated pathways during seed development process in pigeonpea. The comprehensive gene expression study from flowering to mature pod development in pigeonpea would be crucial in identifying candidate genes involved in seed traits directly or indirectly related to yield and quality. The dataset will serve as an important resource for gene discovery and deciphering the molecular mechanisms underlying various seed related traits.	[Pazhamala, Lekha T.; Agarwal, Gaurav; Bajaj, Prasad; Kumar, Vinay; Kulshreshtha, Akanksha; Saxena, Rachit K.; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Varshney, Rajeev K.] Univ Western Australia, Sch Plant Biol, 35 Stirling Highway, Crawley, WA 6009, Australia; [Varshney, Rajeev K.] Univ Western Australia, Inst Agr, 35 Stirling Highway, Crawley, WA 6009, Australia	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University of Western Australia; University of Western Australia	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India.; Varshney, RK (corresponding author), Univ Western Australia, Sch Plant Biol, 35 Stirling Highway, Crawley, WA 6009, Australia.; Varshney, RK (corresponding author), Univ Western Australia, Inst Agr, 35 Stirling Highway, Crawley, WA 6009, Australia.	r.k.varshney@cgiar.org	Varshney, Rajeev K/C-5295-2014	Varshney, Rajeev K/0000-0002-4562-9131				Baud S, 2002, PLANT PHYSIOL BIOCH, V40, P151, DOI 10.1016/S0981-9428(01)01350-X; Bewley J. D., 2013, SEEDS, DOI [10.1017/S0960258513000287, DOI 10.1007/978-1-4614-4693-4_1]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen J, 2014, PLANT PHYSIOL, V166, P252, DOI 10.1104/pp.114.240689; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dubbs WE, 2000, PLANT PHYSIOL, V123, P1269, DOI 10.1104/pp.123.4.1269; EVERITT BS, 2005, HDB STAT ANAL USING; Fait A, 2006, PLANT PHYSIOL, V142, P839, DOI 10.1104/pp.106.086694; Gibson SI, 2004, J EXP BOT, V55, P253, DOI 10.1093/jxb/erh048; Guo ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05150; Hollender CA, 2014, PLANT PHYSIOL, V165, P1062, DOI 10.1104/pp.114.237529; Ikeda Y, 2006, PLANT CELL PHYSIOL, V47, P1443, DOI 10.1093/pcp/pcl023; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Jones SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059270; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Moller B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001545; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; OHTO M, 2007, ANN PLANT REV, V27, P1; Pazhamala L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00050; Pradhan S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00698; Quint M, 2006, CURR OPIN PLANT BIOL, V9, P448, DOI [10.1016/j.pbi.2006.07.006, 10.1104/pp.17.00765]; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sahoo D, 2007, NUCLEIC ACIDS RES, V35, P3705, DOI 10.1093/nar/gkm284; Santos-Mendoza M, 2008, PLANT J, V54, P608, DOI 10.1111/j.1365-313X.2008.03461.x; Singh VK, 2013, PLANT BIOTECHNOL J, V11, P691, DOI 10.1111/pbi.12059; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Wang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26586; Weber H, 2005, ANNU REV PLANT BIOL, V56, P253, DOI 10.1146/annurev.arplant.56.032604.144201; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yasuaki K, 2005, PLANT CELL PHYSL, V46, P399; Yu KQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-10; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	39	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164959	10.1371/journal.pone.0164959	http://dx.doi.org/10.1371/journal.pone.0164959			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760186	gold, Green Published, Green Submitted			2022-12-26	WOS:000386204000071
J	Schneider, U; Vasi, F; Besserer, J				Schneider, Uwe; Vasi, Fabiano; Besserer, Jurgen			The Impact of the Geometrical Structure of the DNA on Parameters of the Track-Event Theory for Radiation Induced Cell Kill	PLOS ONE			English	Article							LOW-ENERGY ELECTRONS; LIQUID WATER; CHROMATIN STRUCTURE; MAMMALIAN CELLS; SURVIVAL-CURVE; RADIOTHERAPY; RESOLUTION; LOOPS; FIBER	Background and Purpose When fractionation schemes for hypofractionation and stereotactic body radiotherapy are considered, a reliable cell survival model at high dose is needed for calculating doses of similar biological effectiveness. An alternative to the LQ-model is the track-event theory which is based on the probabilities for one- and two two-track events. A one-track-event (OTE) is always represented by at least two simultaneous double strand breaks. A two track-event (TTE) results in one double strand break. Therefore at least two two-track events on the same or different chromosomes are necessary to produce an event which leads to cell sterilization. It is obvious that the probabilities of OTEs and TTEs must somehow depend on the geometrical structure of the chromatin. In terms of the track-event theory the ratio epsilon of the probabilities of OTEs and TTEs includes the geometrical dependence and is obtained in this work by simple Monte Carlo simulations. Materials and Methods For this work it was assumed that the anchors of loop forming chromatin are most sensitive to radiation induced cell deaths. Therefore two adjacent tetranucleosomes representing the loop anchors were digitized. The probability ratio epsilon of OTEs and TTEs was factorized into a radiation quality dependent part and a geometrical part: epsilon = epsilon(ion). epsilon(geo). epsilon(geo) was obtained for two situations, by applying Monte Carlo simulation for DNA on the tetranucleosomes itself and for linker DNA. Low energy electrons were represented by randomly distributed ionizations and high energy electrons by ionizations which were simulated on rays. epsilon(ion) was determined for electrons by using results from nanodosimetric measurements. The calculated epsilon was compared to the epsilon obtained from fits of the track event model to 42 sets of experimental human cell survival data. Results When the two tetranucleosomes are in direct contact and the hits are randomly distributed epsilon(geo) and epsilon are 0.12 and 0.85, respectively. When the hits are simulated on rays epsilon(geo) and epsilon are 0.10 and 0.71. For the linker-DNA epsilon(geo) and epsilon for randomly distributed hits are 0.010 and 0.073, and for hits on rays 0.0058 and 0.041, respectively. The calculated epsilon fits the experimentally obtained epsilon = 0.64 +/- 0.32 best for hits on the tetranucleosome when they are close to each other both, for high and low energy electrons. Conclusions The parameter epsilon(geo) of the track event model was obtained by pure geometrical considerations of the chromatin structure and is 0.095 +/- 0.022. It can be used as a fixed parameter in the track-event theory.	[Schneider, Uwe; Vasi, Fabiano; Besserer, Jurgen] Univ Zurich, Fac Sci, Dept Phys, Zurich, Switzerland; [Schneider, Uwe; Vasi, Fabiano; Besserer, Jurgen] Radiotherapy Hirslanden, Witellikerstr 40, CH-8032 Zurich, Switzerland	University of Zurich	Schneider, U (corresponding author), Univ Zurich, Fac Sci, Dept Phys, Zurich, Switzerland.; Schneider, U (corresponding author), Radiotherapy Hirslanden, Witellikerstr 40, CH-8032 Zurich, Switzerland.	uwe.schneider@uzh.ch	Schneider, Uwe/E-9594-2011	Schneider, Uwe/0000-0002-6403-204X; Vasi, Fabiano/0000-0001-5744-4321				Alper T., 1979, CELLULAR RADIOBIOLOG; ATWOOD KC, 1949, P NATL ACAD SCI USA, V35, P696, DOI 10.1073/pnas.35.12.696; Bantsar A, 2006, RADIAT PROT DOSIM, V122, P82, DOI 10.1093/rpd/ncl406; Bantsar A, 2009, NUCL INSTRUM METH A, V599, P270, DOI 10.1016/j.nima.2008.11.021; Batnsar A, 2010, THESIS; Besserer J, 2015, Z MED PHYS, V25, P168, DOI 10.1016/j.zemedi.2014.10.001; Besserer J, 2015, RADIAT ENVIRON BIOPH, V54, P167, DOI 10.1007/s00411-015-0584-7; CHADWICK KH, 1973, PHYS MED BIOL, V18, P78, DOI 10.1088/0031-9155/18/1/007; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; DINGFELDER M, 2008, RADIAT RES, V169, P584, DOI DOI 10.1667/RR1099.1; Ekstrand KE, 2010, PHYS MED BIOL, V55, pN267, DOI 10.1088/0031-9155/55/10/N01; ELKIND MM, 1959, NATURE, V184, P1293, DOI 10.1038/1841293a0; Emfietzoglou D, 2000, PHYS MED BIOL, V45, P3171, DOI 10.1088/0031-9155/45/11/305; FOWLER JF, 1989, BRIT J RADIOL, V62, P679, DOI 10.1259/0007-1285-62-740-679; Friedrich T, 2012, RADIAT RES, V178, P385, DOI 10.1667/RR2964.1; HUG O., 1963, BIOPHYSIK, V1, P20, DOI 10.1007/BF01192565; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; Meesungnoen J, 2002, RADIAT RES, V158, P657, DOI 10.1667/0033-7587(2002)158[0657:LEEPRI]2.0.CO;2; OUDET P, 1975, CELL, V4, P281, DOI 10.1016/0092-8674(75)90149-X; Park C, 2008, INT J RADIAT ONCOL, V70, P847, DOI 10.1016/j.ijrobp.2007.10.059; PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; THOMA F, 1977, CELL, V12, P101, DOI 10.1016/0092-8674(77)90188-X; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Wiklund K, 2011, PHYS MED BIOL, V56, P1985, DOI 10.1088/0031-9155/56/7/005; Wilson WE, 2004, RADIAT RES, V161, P591, DOI 10.1667/RR3179	27	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164929	10.1371/journal.pone.0164929	http://dx.doi.org/10.1371/journal.pone.0164929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760196	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000068
J	Tirone, M; Conti, V; Manenti, F; Nicolosi, PA; D'Orlando, C; Azzoni, E; Brunelli, S				Tirone, Mario; Conti, Valentina; Manenti, Fabio; Nicolosi, Pier Andrea; D'Orlando, Cristina; Azzoni, Emanuele; Brunelli, Silvia			Nitric Oxide Donor Molsidomine Positively Modulates Myogenic Differentiation of Embryonic Endothelial Progenitors	PLOS ONE			English	Article							MUSCULAR-DYSTROPHIES EVIDENCE; STEM-CELL FUNCTION; SKELETAL-MUSCLE; MOUSE MODEL; HEDGEHOG; THERAPY; ADULT; MESOANGIOBLASTS; HEMATOPOIESIS; EXPRESSION	Embryonic VE-Cadherin-expressing progenitors (eVE-Cad(+)), including hemogenic endothelium, have been shown to generate hematopoietic stem cells and a variety of other progenitors, including mesoangioblasts, or MABs. MABs are vessel-associated progenitors with multilineage mesodermal differentiation potential that can physiologically contribute to skeletal muscle development and regeneration, and have been used in an ex vivo cell therapy setting for the treatment of muscular dystrophy. There is currently a therapeutic need for molecules that could improve the efficacy of cell therapy protocols; one such good candidate is nitric oxide. Several studies in animal models of muscle dystrophy have demonstrated that nitric oxide donors provide several beneficial effects, including modulation of the activity of endogenous cell populations involved in muscle repair and the delay of muscle degeneration. Here we used a genetic lineage tracing approach to investigate whether the therapeutic effect of nitric oxide in muscle repair could derive from an improvement in the myogenic differentiation of eVE-Cad(+) progenitors during embryogenesis. We show that early in vivo treatment with the nitric oxide donor molsidomine enhances eVE-Cad(+) contribution to embryonic and fetal myogenesis, and that this effect could originate from a modulation of the properties of yolk sac hemogenic endothelium.	[Tirone, Mario; Manenti, Fabio; Nicolosi, Pier Andrea; D'Orlando, Cristina; Brunelli, Silvia] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy; [Tirone, Mario] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, Milan, Italy; [Conti, Valentina] Ist Sci San Raffaele, Div Regenerat Med Stem Cells & Gene Therapy, Milan, Italy; [Azzoni, Emanuele] Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, MRC Mol Hematol Unit, Oxford, England	University of Milano-Bicocca; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Oxford	Brunelli, S (corresponding author), Univ Milano Bicocca, Sch Med & Surg, Monza, Italy.; Azzoni, E (corresponding author), Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, MRC Mol Hematol Unit, Oxford, England.	emanuele.azzoni@imm.ox.ac.uk; silvia.brunelli@unimib.it	Conti, Valentina/AAN-2591-2020; Brunelli, Silvia/P-3853-2019; Brunelli, Silvia/J-3248-2014; Azzoni, Emanuele/AAE-8064-2022; Manenti, Fabio/ABG-3772-2020	Conti, Valentina/0000-0001-7287-2658; Brunelli, Silvia/0000-0003-1753-5346; Brunelli, Silvia/0000-0003-1753-5346; Azzoni, Emanuele/0000-0002-4572-5692; Manenti, Fabio/0000-0003-0709-1550	European Community [241440]	European Community(European Commission)	This work was supported by the European Community's Seventh Framework Programme under grant agreement no. 241440 (ENDOSTEM to SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Azzoni E, 2014, DEVELOPMENT, V141, P1821, DOI 10.1242/dev.103242; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bertrand JY, 2010, BLOOD, V115, P2777, DOI 10.1182/blood-2009-09-244590; Biressi S, 2007, DEV BIOL, V304, P633, DOI 10.1016/j.ydbio.2007.01.016; Boiers C, 2013, CELL STEM CELL, V13, P535, DOI 10.1016/j.stem.2013.08.012; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Brunelli S, 2007, P NATL ACAD SCI USA, V104, P264, DOI 10.1073/pnas.0608277104; Buono R, 2012, STEM CELLS, V30, P197, DOI 10.1002/stem.783; Cazzato D, 2014, EXP CELL RES, V320, P269, DOI 10.1016/j.yexcr.2013.11.006; Chen MJ, 2011, CELL STEM CELL, V9, P541, DOI 10.1016/j.stem.2011.10.003; Cooper CL, 2012, BLOOD, V119, P5438, DOI 10.1182/blood-2011-12-397976; Cordani N, 2014, STEM CELLS, V32, P874, DOI 10.1002/stem.1587; Cossu G, 2015, EMBO MOL MED, V7, P1513, DOI 10.15252/emmm.201505636; Cossu MV, 2014, DRUG DES DEV THER, V8, P411, DOI 10.2147/DDDT.S58803; D'Angelo MG, 2012, PHARMACOL RES, V65, P472, DOI 10.1016/j.phrs.2012.01.006; De Palma C, 2010, CELL DEATH DIFFER, V17, P1684, DOI 10.1038/cdd.2010.48; De Palma C, 2012, MOL NEUROBIOL, V46, P682, DOI 10.1007/s12035-012-8311-8; Diaz-Manera J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.35; Frame JM, 2016, STEM CELLS, V34, P431, DOI 10.1002/stem.2213; Galvez BG, 2006, J CELL BIOL, V174, P231, DOI 10.1083/jcb.200512085; Hofmann I, 2009, CELL STEM CELL, V4, P559, DOI 10.1016/j.stem.2009.03.016; Huang NF, 2010, STEM CELLS DEV, V19, P1617, DOI 10.1089/scd.2009.0417; Loeffler D, 2011, CELL STEM CELL, V9, P2, DOI 10.1016/j.stem.2011.06.011; Lu-Nguyen NB, 2015, MOL THER, V23, P1341, DOI 10.1038/mt.2015.88; Mar BG, 2011, LEUKEMIA, V25, P1665, DOI 10.1038/leu.2011.143; Marques MJ, 2005, NEUROSCI LETT, V382, P342, DOI 10.1016/j.neulet.2005.03.023; Merchant A, 2010, BLOOD, V115, P2391, DOI 10.1182/blood-2009-09-241703; Merrick D, 2009, DIS MODEL MECH, V2, P374, DOI 10.1242/dmm.001008; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Monteiro R, 2016, DEV CELL; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Peeters M, 2009, DEVELOPMENT, V136, P2613, DOI 10.1242/dev.034728; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Pouget C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6588; Richard C, 2013, DEV CELL, V24, P600, DOI 10.1016/j.devcel.2013.02.011; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Sciorati C, 2006, J CELL SCI, V119, P5114, DOI 10.1242/jcs.03300; Sciorati C, 2011, PHARMACOL RES, V64, P210, DOI 10.1016/j.phrs.2011.05.003; Sciorati C, 2010, BRIT J PHARMACOL, V160, P1550, DOI 10.1111/j.1476-5381.2010.00809.x; Sciorati C, 2009, J CELL SCI, V122, P1119, DOI 10.1242/jcs.041665; Singbrant S, 2010, BLOOD, V115, P4689, DOI 10.1182/blood-2009-05-220988; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Tran HT, 2010, P NATL ACAD SCI USA, V107, P16160, DOI 10.1073/pnas.1007725107; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; Voisin V, 2005, NEUROBIOL DIS, V20, P123, DOI 10.1016/j.nbd.2005.02.010; Wang GQ, 2009, MOL PHARMACEUT, V6, P895, DOI 10.1021/mp800226z; Wilkinson RN, 2009, DEV CELL, V16, P909, DOI 10.1016/j.devcel.2009.04.014; Zordan P, 2013, EUR J PHARMACOL, V715, P296, DOI 10.1016/j.ejphar.2013.05.007	52	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2016	11	10							e0164893	10.1371/journal.pone.0164893	http://dx.doi.org/10.1371/journal.pone.0164893			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NW	27760216	Green Published, gold, Green Submitted			2022-12-26	WOS:000386204000063
J	Wabwire-Mangen, F; Mimbe, DE; Erima, B; Mworozi, EA; Millard, M; Kibuuka, H; Lukwago, L; Bwogi, J; Kiconco, J; Tugume, T; Mulei, S; Ikomera, C; Tsui, S; Malinzi, S; Kasasa, S; Coldren, R; Byarugaba, DK				Wabwire-Mangen, Fred; Mimbe, Derrick E.; Erima, Bernard; Mworozi, Edison A.; Millard, Monica; Kibuuka, Hannah; Lukwago, Luswa; Bwogi, Josephine; Kiconco, Jocelyn; Tugume, Titus; Mulei, Sophia; Ikomera, Christine; Tsui, Sharon; Malinzi, Stephen; Kasasa, Simon; Coldren, Rodney; Byarugaba, Denis K.			Epidemiology and Surveillance of Influenza Viruses in Uganda between 2008 and 2014	PLOS ONE			English	Article							SEASONAL INFLUENZA; H1N1 INFLUENZA; ILLNESS; AFRICA	Introduction Influenza surveillance was conducted in Uganda from October 2008 to December 2014 to identify and understand the epidemiology of circulating influenza strains in out-patient clinic attendees with influenza-like illness and inform control strategies. Methodology Surveillance was conducted at five hospital-based sentinel sites. Nasopharyngeal and/or oropharyngeal samples, epidemiological and clinical data were collected from enrolled patients. Real-time reverse transcription polymerase chain reaction (RT-PCR) was performed to identify and subtype influenza strains. Data were double-entered into an Epi Info 3.5.3 database and exported to STATA 13.0 software for analysis. Results Of the 6,628 patient samples tested, influenza virus infection was detected in 10.4% (n = 687/6,628) of the specimens. Several trends were observed: influenza circulates throughout the year with two peaks; the major one from September to November and a minor one from March to June. The predominant strains of influenza varied over the years: Seasonal Influenza A(H3) virus was predominant from 2008 to 2009 and from 2012 to 2014; Influenza A (H1N1) pdm01 was dominant in 2010; and Influenza B virus was dominant in 2011. The peaks generally coincided with times of higher humidity, lower temperature, and higher rainfall. Conclusion Influenza circulated throughout the year in Uganda with two major peaks of outbreaks with similar strains circulating elsewhere in the region. Data on the circulating strains of influenza and its patterns of occurrence provided critical insights to informing the design and timing of influenza vaccines for influenza prevention in tropical regions of sub-Saharan Africa.	[Wabwire-Mangen, Fred; Mworozi, Edison A.; Kasasa, Simon] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda; [Wabwire-Mangen, Fred; Mimbe, Derrick E.; Erima, Bernard; Millard, Monica; Kibuuka, Hannah; Kiconco, Jocelyn; Tugume, Titus; Mulei, Sophia; Ikomera, Christine; Malinzi, Stephen; Byarugaba, Denis K.] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Lukwago, Luswa] Minist Hlth, Kampala, Uganda; [Bwogi, Josephine] Uganda Virus Res Inst, Entebbe, Uganda; [Tsui, Sharon] Johns Hopkins Univ, Baltimore, MD USA; [Coldren, Rodney] US Army Med Res Directorate Kenya, Nairobi, Kenya; [Byarugaba, Denis K.] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Kampala, Uganda	Makerere University; Makerere University; Uganda Virus Research Institute; Johns Hopkins University; Walter Reed Army Institute of Research (WRAIR); US Army Medical Research Directorate Kenya (USAMRU-K); Makerere University	Wabwire-Mangen, F (corresponding author), Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda.; Wabwire-Mangen, F (corresponding author), Makerere Univ, Walter Reed Project, Kampala, Uganda.	fwabwire@musph.ac.ug	Bwogi, Josephine/AGJ-4829-2022	Bwogi, Josephine/0000-0001-6975-7106; Byarugaba, Denis K./0000-0002-4175-5659	US Department of Defense through Armed Forces Health Surveillance Branch - Global Emerging Infections Surveillance and Response System (DoD AFHSB-GEIS); Henry Jackson Foundation for Advancement of Medicine [W81XWH-09-R-0041]	US Department of Defense through Armed Forces Health Surveillance Branch - Global Emerging Infections Surveillance and Response System (DoD AFHSB-GEIS)(United States Department of Defense); Henry Jackson Foundation for Advancement of Medicine	This study was supported by the US Department of Defense through the Armed Forces Health Surveillance Branch - Global Emerging Infections Surveillance and Response System (DoD AFHSB-GEIS) and Henry Jackson Foundation for Advancement of Medicine Grant #W81XWH-09-R-0041. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	AFP, 2014, ZEENEWSINDIACOM 1212; [Anonymous], 2014, EV SUMM HIGHL PATH A; Anyah RO, 2007, INT J CLIMATOL, V27, P357, DOI 10.1002/joc.1401; Bonney JHK, 2012, J INFECT DIS, V206, pS108, DOI 10.1093/infdis/jis577; Burmaa A, 2014, INFLUENZA OTHER RESP, V8, P530, DOI 10.1111/irv.12268; Byarugaba DK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-11; Byarugaba DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027803; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Chowell G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041069; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; German R R, 2001, MMWR Recomm Rep, V50, P1; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Hirve S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153003; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kadjo HA, 2013, INFLUENZA OTHER RESP, V7, P296, DOI 10.1111/j.1750-2659.2012.00389.x; Katz MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098615; Katz MA, 2012, J INFECT DIS, V206, pS1, DOI 10.1093/infdis/jis548; Lekana-Douki SE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-373; Lera E, 2011, EUR J PEDIATR, V170, P371, DOI 10.1007/s00431-011-1399-4; Liu D, 2014, SCI CHINA LIFE SCI, V57, P731, DOI 10.1007/s11427-014-4677-3; Lutwama JJ, 2012, J INFECT DIS, V206, pS87, DOI 10.1093/infdis/jis578; Matheka DM, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.138.2612; Nabikolo D., 2012, African Crop Science Journal, V20, P203; OIE, 2014, HIGHL PATH AV INFL; Prachayangprecha S, 2013, J INFECT DEV COUNTR, V7, P734, DOI 10.3855/jidc.2929; Ssemwanga M, 2015, GLOBAL J ENV SCI TEC, V2, P339; Sylvan S, 2013, RES J INFECT DIS, V7, DOI [10.7243/2052-5958-1-6, DOI 10.7243/2052-5958-1-6]; Wang RXE, 2010, EXPERT REV ANTI-INFE, V8, P517, DOI 10.1586/ERI.10.24; Watanabe T, 2014, TRENDS MICROBIOL, V22, P623, DOI 10.1016/j.tim.2014.08.008; WHO Regional Office for Africa, 2015, PROT NAT INFL SENT S; Zaman RU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008452	32	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164861	10.1371/journal.pone.0164861	http://dx.doi.org/10.1371/journal.pone.0164861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755572	Green Published, gold, Green Submitted			2022-12-26	WOS:000386203800039
J	Wang, SB; Xu, ZR				Wang, Shoubing; Xu, Ziran			Effects of Dihydroartemisinin and Artemether on the Growth, Chlorophyll Fluorescence, and Extracellular Alkaline Phosphatase Activity of the Cyanobacterium Microcystis aeruginosa	PLOS ONE			English	Article							SUSTAINED-RELEASE GRANULES; CHLORELLA-VULGARIS; PHOSPHORUS; PHOTOSYNTHESIS; AVAILABILITY; TOXICITY; ARTEMISININ; INTEGRITY; CADMIUM; PROTEIN	Increased eutrophication in the recent years has resulted in considerable research focus on identification of methods for preventing cyanobacterial blooms that are rapid and efficient. The objectives of this study were to investigate the effects of dihydroartemisinin and artemether on the growth of Microcystis aeruginosa and to elucidate its mode of action. Variations in cell density, chlorophyll a, soluble protein, malondialdehyde, extracellular alkaline phosphatase activity (APA), and chlorophyll fluorescence parameters (Fv/Fm, Phi PSII, ETR, rapid light curves, fast chlorophyll fluorescence curves on fluorescence intensity, and relative variable fluorescence) were evaluated by lab-cultured experiments. Our results demonstrated that both dihydroartemisinin and artemether inhibited the growth of M. aeruginosa by impairing the photosynthetic center in photosystem II and reducing extracellular APA, with a higher sensitivity exhibited toward artemether. The inhibitory effects of dihydroartemisinin on M. aeruginosa increased with concentration, and the maximum growth inhibitory rate was 42.17% at 24 mg.L-1 after 120h exposure, whereas it was 55.72% at 6 mg.L-1 artemetherafter 120h exposure. Moreover, the chlorophyll fluorescence was significantly inhibited (p<0.05) after 120h exposure to 12 and 24 mg.L-1 dihydroartemisinin. Furthermore, after 120h exposure to 6 mg.L-1 artemether, Fv/Fm, Phi PSII, ETR and rETR(max) showed a significant decrease (p<0.01) from initial values of 0.490, 0.516, 17.333, and 104.800, respectively, to 0. One-way analysis of variance showed that 6 mg.L-1 artemether and 24 mg.L-1 dihydroartemisinin had significant inhibitory effects on extracellular APA (p<0.01). The results of this study would be useful to further studies to validate the feasibility of dihydroartemisinin and artemether treatment to inhibit overall cyanobacterial growth in water bodies, before this can be put into practice.	[Wang, Shoubing; Xu, Ziran] Fudan Univ, Dept Environm Sci & Engn, Shanghai, Peoples R China	Fudan University	Wang, SB (corresponding author), Fudan Univ, Dept Environm Sci & Engn, Shanghai, Peoples R China.	sbwang@fudan.edu.cn			Major Science and Technology program for water pollution control and treatment [2012ZX07102-004]	Major Science and Technology program for water pollution control and treatment	This work was supported by the Major Science and Technology program for water pollution control and treatment, grant# 2012ZX07102-004. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenroth KJ, 2001, ENVIRON POLLUT, V115, P49, DOI 10.1016/S0269-7491(01)00091-4; Becagli S, 2013, ATMOS ENVIRON, V79, P681, DOI 10.1016/j.atmosenv.2013.07.032; BERMAN T, 1970, LIMNOL OCEANOGR, V15, P663, DOI 10.4319/lo.1970.15.5.0663; Chia MA, 2016, ENVIRON SCI POLLUT R, V23, P23092, DOI 10.1007/s11356-016-7538-8; Chia MA, 2015, AQUAT TOXICOL, V160, P87, DOI 10.1016/j.aquatox.2015.01.002; Clesceri L. S. A. E., 1999, STANDARD METHODS EXA; Deng LP, 2012, IND CROP PROD, V39, P154, DOI 10.1016/j.indcrop.2012.02.031; FITZGERALD GP, 1966, J PHYCOL, V2, P32, DOI 10.1111/j.1529-8817.1966.tb04589.x; GASPAROV VS, 1994, BIOCHEMISTRY-MOSCOW+, V59, P563; Gibson D. T., 1984, MICROBIAL DEGRADATIO, P181; Harke MJ, 2012, MICROB ECOL, V63, P188, DOI 10.1007/s00248-011-9894-8; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; Juneja A, 2013, ENERGIES, V6, P4607, DOI 10.3390/en6094607; Khozin-Goldberg I, 2006, PHYTOCHEMISTRY, V67, P696, DOI 10.1016/j.phytochem.2006.01.010; Kim HG, 2006, ECOL STU AN, V189, P327, DOI 10.1007/978-3-540-32210-8_25; Kong QX, 2010, J HAZARD MATER, V178, P282, DOI 10.1016/j.jhazmat.2010.01.074; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; KRUPA Z, 1993, PHYSIOL PLANTARUM, V88, P626, DOI 10.1111/j.1399-3054.1993.tb01381.x; Labry C, 2015, J EXPT MARINE BIOL E, V318, P213; Larkum AWD, 2003, PHOTOSYNTHESIS ALGAE, P479; Li JH, 2015, MAR POLLUT BULL, V92, P52, DOI 10.1016/j.marpolbul.2015.01.001; Magnusson M, 2010, MAR POLLUT BULL, V60, P1978, DOI 10.1016/j.marpolbul.2010.07.031; Mikula P, 2012, EUR J PHYCOL, V47, P195, DOI 10.1080/09670262.2012.687144; Ni LX, 2015, ENVIRON SCI POLLUT R, V22, P18637, DOI 10.1007/s11356-015-5438-y; Ni LX, 2013, CHEMOSPHERE, V91, P608, DOI 10.1016/j.chemosphere.2012.12.064; Ni LX, 2012, B ENVIRON CONTAM TOX, V89, P1165, DOI 10.1007/s00128-012-0843-0; Ni LX, 2012, CHEMOSPHERE, V88, P1051, DOI 10.1016/j.chemosphere.2012.05.009; Ni LX, 2011, SCI CHINA CHEM, V54, P1123, DOI 10.1007/s11426-011-4269-z; Okubo Y, 2014, WATER SCI TECHNOL, V69, P1205, DOI 10.2166/wst.2013.825; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Qian HF, 2012, ENVIRON TOXICOL, V27, P229, DOI 10.1002/tox.20636; Qiu HM, 2013, J HAZARD MATER, V248, P172, DOI 10.1016/j.jhazmat.2012.12.033; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Renuka N, 2015, INT J ENVIRON SCI TE, V12, P1443, DOI 10.1007/s13762-014-0700-2; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Srivastava A, 1998, BBA-BIOENERGETICS, V1364, P326, DOI 10.1016/S0005-2728(98)00014-0; [王寿兵 Wang Shoubing], 2016, [水资源保护, Water Resources Protection], V32, P88; Wang SB, 2016, ENVIRON SCI POLLUT R, V23, P5712, DOI 10.1007/s11356-015-5809-4; Wu ZX, 2007, ENVIRON POLLUT, V147, P324, DOI 10.1016/j.envpol.2006.05.022; Zhou LH, 2007, HARMFUL ALGAE, V6, P354, DOI 10.1016/j.hal.2006.10.002; Zhou SQ, 2013, SCI TOTAL ENVIRON, V463, P111, DOI 10.1016/j.scitotenv.2013.05.064; Zhu JY, 2010, AQUAT TOXICOL, V98, P196, DOI 10.1016/j.aquatox.2010.02.011	43	8	8	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164842	10.1371/journal.pone.0164842	http://dx.doi.org/10.1371/journal.pone.0164842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	27755566	Green Published, Green Submitted, gold			2022-12-26	WOS:000386203800038
J	Yiannakas, MC; Grussu, F; Louka, P; Prados, F; Samson, RS; Battiston, M; Altmann, DR; Ourselin, S; Miller, DH; Wheeler-Kingshott, CAMG				Yiannakas, Marios C.; Grussu, Francesco; Louka, Polymnia; Prados, Ferran; Samson, Rebecca S.; Battiston, Marco; Altmann, Daniel R.; Ourselin, Sebastien; Miller, David H.; Wheeler-Kingshott, Claudia A. M. Gandini			Reduced Field-of-View Diffusion-Weighted Imaging of the Lumbosacral Enlargement: A Pilot In Vivo Study of the Healthy Spinal Cord at 3T	PLOS ONE			English	Article							BLADDER DYSFUNCTION; THE-ART; ECHO; MRI; DISABILITY; FIBERS; MATTER; INJURY; BRAIN; DTI	Diffusion tensor imaging (DTI) has recently started to be adopted into clinical investigations of spinal cord (SC) diseases. However, DTI applications to the lower SC are limited due to a number of technical challenges, related mainly to the even smaller size of the SC structure at this level, its position relative to the receiver coil elements and the effects of motion during data acquisition. Developing methods to overcome these problems would offer new means to gain further insights into microstructural changes of neurological conditions involving the lower SC, and in turn could help explain symptoms such as bladder and sexual dysfunction. In this work, the feasibility of obtaining grey and white matter (GM/WM) DTI indices such as axial/radial/mean diffusivity (AD/RD/MD) and fractional anisotropy (FA) within the lumbosacral enlargement (LSE) was investigated using a reduced field-of-view (rFOV) single-shot echo-planar imaging (ss-EPI) acquisition in 14 healthy participants using a clinical 3T MR system. The scan-rescan reproducibility of the measurements was assessed by calculating the percentage coefficient of variation (% COV). Mean FA was higher in WM compared to GM (0.58 and 0.4 in WM and GM respectively), AD and MD were higher in WM compared to GM (1.66 mu m(2) ms(-1) and 0.94 mu m(2) ms(-1) in WM and 1.2 mu m(2) ms(-1) and 0.82 mu m(2) ms(-1) in GM for AD and MD respectively) and RD was lower in WM compared to GM (0.58 mu m(2) ms(-1) and 0.63 mu m(2) ms(-1) respectively). The scan-rescan % COV was lower than 10% in all cases with the highest values observed for FA and the lowest for MD. This pilot study demonstrates that it is possible to obtain reliable tissue-specific estimation of DTI indices within the LSE using a rFOV ss-EPI acquisition. The DTI acquisition and analysis protocol presented here is clinically feasible and may be used in future investigations of neurological conditions implicating the lower SC.	[Yiannakas, Marios C.; Grussu, Francesco; Louka, Polymnia; Prados, Ferran; Samson, Rebecca S.; Battiston, Marco; Altmann, Daniel R.; Miller, David H.; Wheeler-Kingshott, Claudia A. M. Gandini] UCL, UCL Inst Neurol, Queen Sq MS Ctr, Dept Neuroinflammat,NMR Res Unit, London, England; [Prados, Ferran; Ourselin, Sebastien] UCL, Ctr Med Image Comp Med Phys & Biomed Engn, Translat Imaging Grp, London, England; [Altmann, Daniel R.] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Prados, Ferran; Ourselin, Sebastien; Miller, David H.] UCL, Univ Coll London Hosp, Biomed Res Ctr, NIHR, London, England; [Wheeler-Kingshott, Claudia A. M. Gandini] C Mondino Natl Neurol Inst, Brain MRI Mondino Res Ctr 3T, Pavia, Italy; [Wheeler-Kingshott, Claudia A. M. Gandini] Univ Pavia, Dept Brain & Behav Sci, Pavia, PV, Italy	University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; King's College London; University College London; IRCCS Fondazione Casimiro Mondino; University of Pavia	Yiannakas, MC (corresponding author), UCL, UCL Inst Neurol, Queen Sq MS Ctr, Dept Neuroinflammat,NMR Res Unit, London, England.	m.yiannakas@ucl.ac.uk	Grussu, Francesco/AAE-8109-2019; Wheeler-Kingshott, Claudia A M Gandini/AAH-7480-2019; Carrasco, Ferran Prados/AAR-4157-2021; Ourselin, Sebastien/K-6960-2015	Grussu, Francesco/0000-0002-0945-3909; Wheeler-Kingshott, Claudia A M Gandini/0000-0002-4832-1300; Samson, Rebecca/0000-0002-0197-702X; Prados Carrasco, Ferran/0000-0002-7872-0142; Ourselin, Sebastien/0000-0002-5694-5340	U.K Multiple Sclerosis Society; National Institute for Health Research University College London Hospitals Biomedical Research Centre; NIHR BRC UCLH/UCL High Impact Initiative; EPSRC [EP/H046410/1, EP/J020990/1, EP/K005278]; MRC [MR/J01107X/1]; NIHR Biomedical Research Unit (Dementia) at UCL; NIHR BRC UCLH/UCL; National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL); NIHR BRC UCLH/UCL High Impact Initiative [BW.mn.BRC10269]; Engineering and Physical Sciences Research Council [EP/J020990/1, EP/H046410/1] Funding Source: researchfish; Medical Research Council [MR/J01107X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10058] Funding Source: researchfish	U.K Multiple Sclerosis Society; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); NIHR BRC UCLH/UCL High Impact Initiative; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Biomedical Research Unit (Dementia) at UCL; NIHR BRC UCLH/UCL; National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL); NIHR BRC UCLH/UCL High Impact Initiative; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work and the NMR Research Unit are supported by the U.K Multiple Sclerosis Society (http://www.mssociety.org.uk/). This work was supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre. FP is funded by NIHR BRC UCLH/UCL High Impact Initiative. SO receives funding from the EPSRC (EP/H046410/1, EP/J020990/1, EP/K005278), the MRC (MR/J01107X/1), the NIHR Biomedical Research Unit (Dementia) at UCL and the NIHR BRC UCLH/UCL.; This work and the NMR Research Unit are funded by the U.K Multiple Sclerosis Society (http://www.mssociety.org.uk/). This work was supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL). FP and SO are funded by NIHR BRC UCLH/UCL High Impact Initiative (BW.mn.BRC10269). SO also receives funding from the EPSRC (EP/H046410/1, EP/J020990/1, EP/K005278), the MRC (MR/J01107X/1) and the NIHR Biomedical Research Unit (Dementia) at UCL.	Anderson KD, 2007, SPINAL CORD, V45, P328, DOI 10.1038/sj.sc.3101977; Bammer R, 2003, AM J NEURORADIOL, V24, P5; Bammer R, 2002, J MAGN RESON IMAGING, V15, P364, DOI 10.1002/jmri.10075; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bosma RL, 2012, RADIOL RES PRACT, V2012, DOI 10.1155/2012/143705; Cercignani M, 2003, AM J NEURORADIOL, V24, P1254; Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926; DUBOULAY GH, 1966, BRIT J RADIOL, V39, P255, DOI 10.1259/0007-1285-39-460-255; Ellingson BM, 2008, AM J NEURORADIOL, V29, P1279, DOI 10.3174/ajnr.A1064; Feirabend HKP, 2002, BRAIN, V125, P1137, DOI 10.1093/brain/awf111; Fernandez O, 2002, J NEUROL, V249, P1, DOI 10.1007/PL00007835; Gaggl W, 2014, MAGN RESON MED, V72, P1668, DOI 10.1002/mrm.25092; Goto N, 1997, NEUROPATHOLOGY, V17, P25, DOI 10.1111/j.1440-1789.1997.tb00007.x; Gregory S, 2015, J HUNTINGTONS DIS, V4, P333, DOI 10.3233/JHD-150173; Grussu F, 2015, NEUROIMAGE, V111, P590, DOI 10.1016/j.neuroimage.2015.01.045; Gudbjartsson H, 1996, MAGNET RESON MED, V36, P509, DOI 10.1002/mrm.1910360403; Jansons KM, 2003, INVERSE PROBL, V19, P1031, DOI 10.1088/0266-5611/19/5/303; Jeong EK, 2005, MAGNET RESON MED, V54, P1575, DOI 10.1002/mrm.20711; Jones Derek K, 2010, Top Magn Reson Imaging, V21, P87, DOI 10.1097/RMR.0b013e31821e56ac; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Kearney H, 2015, J NEUROL NEUROSUR PS, V86, P608, DOI 10.1136/jnnp-2014-308241; LANE B, 1974, RADIOLOGY, V110, P579, DOI 10.1148/110.3.579; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Roux PH, 2002, MAGN RESON MATER PHY, V14, P243, DOI 10.1016/S1352-8661(02)00069-8; Mahoney CJ, 2015, ANN NEUROL, V77, P33, DOI 10.1002/ana.24296; Mamata H, 2006, NEUROIMAGE, V31, P24, DOI 10.1016/j.neuroimage.2005.11.038; McCombe PA, 2009, EXPERT REV NEUROTHER, V9, P331, DOI 10.1586/14737175.9.3.331; Naismith RT, 2013, NEUROLOGY, V80, P2201, DOI 10.1212/WNL.0b013e318296e8f1; Papadakis NG, 2000, MAGN RESON IMAGING, V18, P671, DOI 10.1016/S0730-725X(00)00151-X; Petersen JA, 2012, J NEUROTRAUM, V29, P1556, DOI 10.1089/neu.2011.2027; Rieseberg S, 2002, MAGN RESON MED, V47, P1186, DOI 10.1002/mrm.10157; Sakakibara R, 2000, J NEUROL NEUROSUR PS, V68, P65, DOI 10.1136/jnnp.68.1.65; SAKAKIBARA R, 1993, JPN J PSYCHIAT NEUR, V47, P591; Samson RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155557; Saritas EU, 2008, MAGN RESON MED, V60, P468, DOI 10.1002/mrm.21640; Stroman PW, 2014, NEUROIMAGE, V84, P1070, DOI 10.1016/j.neuroimage.2013.04.124; Tsuchiya K, 2005, AM J NEURORADIOL, V26, P398; TURNER R, 1990, J MAGN RESON, V86, P445, DOI 10.1016/0022-2364(90)90023-3; Watanabe T, 1998, J UROLOGY, V159, P965, DOI 10.1016/S0022-5347(01)63786-8; Wheeler-Kingshott CA, 2014, NEUROIMAGE, V84, P1082, DOI 10.1016/j.neuroimage.2013.07.014; Wheeler-Kingshott CAM, 2002, NEUROIMAGE, V16, P93, DOI 10.1006/nimg.2001.1022; Wilm BJ, 2007, MAGN RESON MED, V57, P625, DOI 10.1002/mrm.21167; Wilm BJ, 2009, NMR BIOMED, V22, P174, DOI 10.1002/nbm.1298; Xu JQ, 2013, NEUROIMAGE, V67, P64, DOI 10.1016/j.neuroimage.2012.11.014; Yiannakas MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105544	46	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e164890	10.1371/journal.pone.0164890	http://dx.doi.org/10.1371/journal.pone.0164890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741303	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000385507000080
J	Wang, W; Zhang, WS; Alayi, A; Yan, C; Zhang, WW; Cao, MQ				Wang Wei; Zhang Wei-Sheng; Alayi Ahan; Yan Ci; Zhang Wei-Wen; Cao Ming-Qin			The Characteristics of TB Epidemic and TB/HIV Co-Infection Epidemic: A 2007-2013 Retrospective Study in Urumqi, Xinjiang Province, China	PLOS ONE			English	Article							SPATIAL-ANALYSIS; DRUG-USERS; TUBERCULOSIS; MIGRANTS; SHANGHAI	Objective This study was aimed to find out epidemiologic characteristic of tuberculosis (TB) cases, and Human Immunodeficiency Virus (HIV) positive cases among TB patients (TB/HIV co-infection) through demographic, temporal, and spatial study in Urumqi. Methods Descriptive statistics and multivariate logistic regression were applied to identify the epidemiologic characteristics and risk factors of TB epidemic and TB/HIV co-infection epidemic. All addresses of each TB case, TB/HIV co-infection case, and administrative street were transformed into geographical coordinate. Subsequently, the geocoded address for 82 streets was transformed into a dot map used as the basis of spatial datasets. In addition, the paper also used quantile map and the spatial scan statistic in order to identify the spatial distribution and spatial clusters of TB epidemic and TB/HIV co-infection epidemic. Result There was a declining trend of the notification rates of TB epidemic from 2007 to 2009, as well as a rising trend from 2010 to 2013. However, the notification rates of TB/HIV co-infection epidemic showed a rising trend from 2007 to 2010, and a declining trend from 2011 to 2013. Moreover, a significant share of TB epidemic and TB/HIV co-infection epidemic happened between the age of 15 to 45 years old, indicating an increase in risk of TB and TB/HIV infection. It is worth noting that the risk of HIV infection for male TB patients was 2.947 times (95% CI [2.178, 3.988]) than that of female patients. Han ethnicity and Uygur ethnicity in urban region accounted for a large proportion of total TB and TB/HIV co-infection cases. Most of the TB cases of minorities in Urumqi showed a statistically significant increase in risk of HIV infection than Han ethnicity in Urumqi. In addition, the spatial distribution of TB epidemic and TB/HIV co-infection epidemic was highly skewed. Most of the local clusters were located in urban area and rural-urban continuum where showed an increase in risk of TB and TB/HIV infection. Conclusion The epidemiologic and spatial-temporal analysis of TB epidemic and TB/HIV co-infection epidemic demonstrates a potential connection between TB and HIV in Urumqi. Demographic, temporal, geographic factors are the reasons of causing TB and TB/HIV co-infection epidemic.	[Wang Wei; Alayi Ahan; Yan Ci; Zhang Wei-Wen; Cao Ming-Qin] Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Urumqi, Xinjiang, Peoples R China; [Zhang Wei-Sheng] Urumqi Ctr Dis Control & Prevent CDC, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University	Cao, MQ (corresponding author), Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Urumqi, Xinjiang, Peoples R China.	573596229@qq.com	Yin, Xue-ren/B-3893-2008; Ge, Hang/GZB-0729-2022	Yin, Xue-ren/0000-0002-1282-4432; 	Natural Science Fund of Xinjiang Uyghur Autonomous Region [2016D01C167]	Natural Science Fund of Xinjiang Uyghur Autonomous Region	This study was funded by the Natural Science Fund of Xinjiang Uyghur Autonomous Region (grant number: 2016D01C167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This article was funded by the Natural Science Fund of Xinjiang Uyghur Autonomous Region (grant number: 2016D01C167). We would like to express our gratitude to anonymous peer reviewers for carefully revising our manuscript and for his or her useful comments.	Ahmed AB, 2007, THORAX, V62, P672, DOI 10.1136/thx.2006.072611; Chen YangGui, 2012, Modern Preventive Medicine, V39, P5410; Chimoyi LA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-555; Chinese Center for Disease Control Prevention, DAT REP NOT INF DIS; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Feng W, 2002, INT MIGR REV, V36, P520, DOI 10.1111/j.1747-7379.2002.tb00091.x; Vendramini SHF, 2010, REV SOC BRAS MED TRO, V43, P536, DOI 10.1590/S0037-86822010000500013; Gelaw Sifrash Meseret, 2016, Tuberc Res Treat, V2016, P6207457, DOI 10.1155/2016/6207457; Goujon-Bellec S, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-53; Jia ZW, 2008, EMERG INFECT DIS, V14, P1413, DOI [10.3201/1409.071543, 10.3201/eid1409.071543]; Kulldorff M, 2006, AM J PREV MED, V30, pS37, DOI 10.1016/j.amepre.2005.09.009; Li WG, 2015, TRANSPL P, V47, P2456, DOI 10.1016/j.transproceed.2015.09.017; Pereira AGL, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005470; Martinez AN, 2014, INT J ENV RES PUB HE, V11, P3937, DOI 10.3390/ijerph110403937; MIJITI Peierdun, 2016, CHIN J ANTITUBERE, V38, P93; Uthman OA, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-65; Wang LY, 2010, JAIDS-J ACQ IMM DEF, V53, pS61, DOI 10.1097/QAI.0b013e3181c7db2e; Wang YP, 2000, INT J URBAN REGIONAL, V24, P397, DOI 10.1111/1468-2427.00254; Wei XL, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-9; Wong DFK, 2007, INT J SOC WELF, V16, P32, DOI 10.1111/j.1468-2397.2007.00475.x; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Wubuli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144010; Zhang Y, 2007, J INFECTION, V54, P285, DOI 10.1016/j.jinf.2006.06.001; Zhao RL, 2009, CHIN J ANTITUBERCUL, V31, P308	24	66	72	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164947	10.1371/journal.pone.0164947	http://dx.doi.org/10.1371/journal.pone.0164947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768740	Green Published, gold, Green Submitted			2022-12-26	WOS:000386205400039
J	Kim, SS; Rawat, R; Mwangi, EM; Tesfaye, R; Abebe, Y; Baker, J; Frongillo, EA; Ruel, MT; Menon, P				Kim, Sunny S.; Rawat, Rahul; Mwangi, Edina M.; Tesfaye, Roman; Abebe, Yewelsew; Baker, Jean; Frongillo, Edward A.; Ruel, Marie T.; Menon, Purnima			Exposure to Large-Scale Social and Behavior Change Communication Interventions Is Associated with Improvements in Infant and Young Child Feeding Practices in Ethiopia	PLOS ONE			English	Article							HEALTH EXTENSION PROGRAM; EVALUATION DESIGNS; NUTRITION; IMPACT; PROVISION; COUNTRIES; EDUCATION; GROWTH	Optimal breastfeeding (BF) practices in Ethiopia are far below the government's targets, and complementary feeding practices are poor. The Alive & Thrive initiative aimed to improve infant and young child feeding (IYCF) practices through large-scale implementation of social and behavior change communication interventions in four regions of Ethiopia. The study assessed the effects of the interventions on IYCF practices and anthropometry over time in two regions-Southern Nations, Nationalities and Peoples Region and Tigray. A pre- and post-intervention adequacy evaluation design was used; repeated cross-sectional surveys of households with children aged 0-23.9 mo (n = 1481 and n = 1494) and with children aged 24-59.9 mo (n = 1481 and n = 1475) were conducted at baseline (2010) and endline (2014), respectively. Differences in outcomes over time were estimated using regression models, accounting for clustering and covariates. Plausibility analyses included tracing recall of key messages and promoted foods and dose-response analyses. We observed improvements in most WHO-recommended IYCF indicators. Early BF initiation and exclusive BF increased by 13.7 and 9.4 percentage points (pp), respectively. Differences for timely introduction of complementary foods, minimum dietary diversity (MDD), minimum meal frequency (MMF), minimum acceptable diet (MAD), and consumption of iron-rich foods were 22.2, 3.3, 26.2, 3.5, and 2.7 pp, respectively. Timely introduction and intake of foods promoted by the interventions improved significantly, but anthropometric outcomes did not. We also observed a dose-response association between health post visits and early initiation of BF (OR: 1.8); higher numbers of home visits by community volunteers and key messages recalled were associated with 1.8-4.4 times greater odds of achieving MDD, MMF, and MAD, and higher numbers of radio spots heard were associated with 3 times greater odds of achieving MDD and MAD. The interventions were associated with plausible improvements in IYCF practices, but large gaps in improving children's diets in Ethiopia remain, particularly during complementary feeding.	[Kim, Sunny S.; Mwangi, Edina M.; Ruel, Marie T.] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA; [Rawat, Rahul] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Dakar, Senegal; [Tesfaye, Roman] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Addis Ababa, Ethiopia; [Abebe, Yewelsew] Alive & Thrive, FHI 360, Addis Ababa, Ethiopia; [Baker, Jean] Alive & Thrive, FHI 360, Washington, DC USA; [Frongillo, Edward A.] Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC USA; [Menon, Purnima] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, New Delhi, India	CGIAR; International Food Policy Research Institute (IFPRI); CGIAR; International Food Policy Research Institute (IFPRI); CGIAR; International Food Policy Research Institute (IFPRI); University of South Carolina System; University of South Carolina Columbia; CGIAR; International Food Policy Research Institute (IFPRI)	Kim, SS (corresponding author), Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA.	sunny.kim@cgiar.org		Ruel, Marie/0000-0002-9506-348X	Regional Health Bureaus of Tigray; SNNPR; A&T implementing partners; Bill & Melinda Gates Foundation, through Alive Thrive; CGIAR Research Program on Agriculture for Nutrition and Health [A4NH]	Regional Health Bureaus of Tigray; SNNPR; A&T implementing partners; Bill & Melinda Gates Foundation, through Alive Thrive(CGIAR); CGIAR Research Program on Agriculture for Nutrition and Health(CGIAR)	Funding for this evaluation and the implementation of the interventions was provided by the Bill & Melinda Gates Foundation, through Alive & Thrive, managed by FHI360; additional financial support to the evaluation study was provided by the CGIAR Research Program on Agriculture for Nutrition and Health (A4NH), led by the International Food Policy Research Institute (IFPRI).; The support from the Regional Health Bureaus of Tigray and SNNPR, woreda health officials, health extension workers, community health volunteers, and the A&T implementing partners, particularly Integrated Family Health Program (IFHP) and Relief Society of Tigray (REST), were critical for data collection. We gratefully acknowledge data collection by Addis Continental Institute of Public Health (ACIPH), Addis Ababa. We thank all the study participants for sharing their time and information. We also gratefully acknowledge comments on this manuscript from Ellen Piwoz (Bill & Melinda Gates Foundation), Silvia Alayon (A&T and Save the Children), and Kim Winnard (FHI 360).	Abebe Bekele, 2008, Ethiopian Journal of Health Development, V22, P302; Ali D, J NUTR; Alive & Thrive, 2014, IMPROVING CHILD FEED; Baker J, 2013, FOOD NUTR BULL, V34, pS146, DOI 10.1177/15648265130343S202; Banteyerga H, 2011, MEDICC REV, V13, P46, DOI 10.37757/MR2011V13.N3.11; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bhutta ZA, 2011, LANCET, V378, P378, DOI 10.1016/S0140-6736(11)60897-0; Caulfield Laura E., 1999, Food and Nutrition Bulletin, V20, P183; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Central Statistical Agency, 2014, 2014 ETH MIN HLTH SU; Central statistics agency ORC, 2006, ETH DEM HLTH SURV 20; Cogill B, 2003, ANTHROPOMETRIC INDIC; Daelmans B, 2009, FOOD NUTR BULL, V30, pS256, DOI 10.1177/15648265090302S210; Devereux S., 2000, FOOD INSECURITY ETHI; Dewey KG, 2008, REV ARTICLE SYSTEMAT, P24; Ethiopian Public Health Institute, 2015, ETH NAT NUTR PROGR E; Ethiopian Public Health Institute, 2013, ETH NAT FOOD CONS SU; Federal Democratic Republic of Ethiopia Ministry of Health, 2010, HLTH SECT DEV PROGR; Gillespie S, 2015, ADV NUTR, V6, P440, DOI 10.3945/an.115.008276; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Haroon S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S20; Hoddinott J., 2002, DIETARY DIVERSITY FO; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S24; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S25; Kim SS, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1650-4; Lassi ZS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S13; Menon P, COMBINING INTE UNPUB; Menon P, 2013, FOOD NUTR BULL, V34, pS195, DOI 10.1177/15648265130343S206; Perez-Escamilla R, 2012, ADV NUTR, V3, P790, DOI 10.3945/an.112.002873; Rawat R, INCORPORATI IN PRESS; REYNOLDS WM, 1982, J CLIN PSYCHOL, V38, P119, DOI 10.1002/1097-4679(198201)38:1<119::AID-JCLP2270380118>3.0.CO;2-I; Sanghvi T, 2013, FOOD NUTR BULL, V34, pS169, DOI 10.1177/15648265130343S204; Sima, 2013, EVALUATION ETHIOPIAS; Sinha B, 2015, ACTA PAEDIATR, V104, P114, DOI 10.1111/apa.13127; Teklehaimanot HD, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-39; White J., 2012, ASSESSING IMPACT CHI; WHO Multicentre Growth Reference Study Group, 2006, PAEDIATRIA CROATIC S; WHO; UNICEF USAID AED UCDAVIS IFPRI, 2008, IND ASS INF YOUNG 2; World Bank, 2014, WORLD DEV IND 2014	39	178	186	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164800	10.1371/journal.pone.0164800	http://dx.doi.org/10.1371/journal.pone.0164800			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	26881746	Green Published, gold, Green Submitted			2022-12-26	WOS:000386203800035
J	Wang, WQ; Zhang, J; Ge, H; Li, SJ; Li, X; Yin, XR; Grierson, D; Chen, KS				Wang, Wen-qiu; Zhang, Jing; Ge, Hang; Li, Shao-jia; Li, Xian; Yin, Xue-ren; Grierson, Donald; Chen, Kun-song			EjMYB8 Transcriptionally Regulates Flesh Lignification in Loquat Fruit	PLOS ONE			English	Article							SECONDARY WALL BIOSYNTHESIS; CHILLING INJURY; LIGNIN BIOSYNTHESIS; DIRECT TARGET; ARABIDOPSIS; GENES; PATHWAY; EXPRESSION; MYB46; REPRESSOR	Transcriptional regulatory mechanisms underlying lignin metabolism have been widely studied in model plants and woody trees, but seldom in fruits such as loquat, which undergo lignification. Here, twelve EjMYB genes, designed as EjMYB3-14, were isolated based on RNA-seq. Gene expression indicated that EjMYB8 and EjMYB9 were significantly induced in fruit with higher lignin content resulting from storage at low temperature (0 degrees C), while two treatments (low temperature conditioning, LTC; heat treatment, HT) both alleviated fruit lignification and inhibited EjMYB8 and EjMYB9 expression. Dual-luciferase assays indicated that EjMYB8, but not EjMYB9, could trans-activate promoters of lignin-related genes EjPAL1, Ej4CL1 and Ej4CL5. Yeast one-hybrid assay indicated that EjMYB8 physically bind to Ej4CL1 promoter. Furthermore, the putative functions of EjMYB8 were verified using transient over-expression in both N. tabacum and loquat leaves, which increased lignin content. Moreover, combination of EjMYB8 and previously isolated EjMYB1 generated strong transactivation effects on the Ej4CL1 promoter, indicating that EjMYB8 is a novel regulator of loquat fruit lignification.	[Wang, Wen-qiu; Zhang, Jing; Ge, Hang; Li, Shao-jia; Li, Xian; Yin, Xue-ren; Grierson, Donald; Chen, Kun-song] Zhejiang Univ, Zhejiang Prov Key Lab Hort Plant Integrat Biol, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Wen-qiu; Zhang, Jing; Li, Xian; Yin, Xue-ren; Chen, Kun-song] Zhejiang Univ, State Agr Minist, Lab Hort Plant Growth Dev & Qual Improvement, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China; [Grierson, Donald] Univ Nottingham, Plant & Crop Sci Div, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England	Zhejiang University; Zhejiang University; University of Nottingham	Yin, XR (corresponding author), Zhejiang Univ, Zhejiang Prov Key Lab Hort Plant Integrat Biol, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.; Yin, XR (corresponding author), Zhejiang Univ, State Agr Minist, Lab Hort Plant Growth Dev & Qual Improvement, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	xuerenyin@zju.edu.cn	Yin, Xue-ren/B-3893-2008; Ge, Hang/GZB-0729-2022	Yin, Xue-ren/0000-0002-1282-4432; 	Program of the International Science and Technology Cooperation [2011DFB31580]; National Basic Research Program of China [2013CB127104]; National Natural Science Foundation of China [31372041, 31471922]; Natural Science Foundation of Zhejiang Province, China [LR16C150001]	Program of the International Science and Technology Cooperation; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This research was supported by the Program of the International Science and Technology Cooperation [2011DFB31580], National Basic Research Program of China [2013CB127104], the National Natural Science Foundation of China [31372041, 31471922], and the Natural Science Foundation of Zhejiang Province, China [LR16C150001]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhargava A, 2013, PLANTA, V237, P1199, DOI 10.1007/s00425-012-1821-9; Cai C, 2006, POSTHARVEST BIOL TEC, V41, P252, DOI 10.1016/j.postharvbio.2006.04.015; Cai C, 2006, POSTHARVEST BIOL TEC, V40, P155, DOI 10.1016/j.postharvbio.2005.12.014; Craven-Bartle B, 2013, PLANT J, V74, P755, DOI 10.1111/tpj.12158; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin P, 2014, FOOD BIOPROCESS TECH, V7, P2259, DOI 10.1007/s11947-013-1232-3; Kamdee C, 2014, POSTHARVEST BIOL TEC, V97, P68, DOI 10.1016/j.postharvbio.2014.06.004; Kosma DK, 2014, PLANT J, V80, P216, DOI 10.1111/tpj.12624; Legay S, 2007, PLANT SCI, V173, P542, DOI 10.1016/j.plantsci.2007.08.007; Liu XF, 2013, PLANT CELL TISS ORG, V115, P285, DOI 10.1007/s11240-013-0361-8; McCarthy RL, 2010, PLANT CELL PHYSIOL, V51, P1084, DOI 10.1093/pcp/pcq064; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; Min T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097043; Ohman D, 2013, PLANT J, V73, P63, DOI 10.1111/tpj.12018; Tang XF, 2015, SCI REP-UK, V5, DOI 10.1038/srep12240; Tian J, 2015, PLANT BIOTECHNOL J, V13, P948, DOI 10.1111/pbi.12331; Velez-Bermudez IC, 2015, PLANT CELL, V27, P3245, DOI 10.1105/tpc.15.00545; Vermerris W, 2015, CURR OPIN BIOTECH, V32, P104, DOI 10.1016/j.copbio.2014.11.024; Xu Q, 2015, POSTHARVEST BIOL TEC, V102, P25, DOI 10.1016/j.postharvbio.2015.02.002; Xu Q, 2014, J EXP BOT, V65, P4349, DOI 10.1093/jxb/eru208; Yang CY, 2007, PLANT CELL, V19, P534, DOI 10.1105/tpc.106.046391; Yauk YK, 2014, PLANT J, V80, P317, DOI 10.1111/tpj.12634; Yin XR, 2012, PLANTA, V235, P895, DOI 10.1007/s00425-011-1553-2; Yin XR, 2012, POSTHARVEST BIOL TEC, V66, P1, DOI 10.1016/j.postharvbio.2011.11.009; Ying Z, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0388-y; Zeng JK, 2015, PLANT BIOTECHNOL J, V13, P1325, DOI 10.1111/pbi.12351; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	34	66	72	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154399	10.1371/journal.pone.0154399	http://dx.doi.org/10.1371/journal.pone.0154399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27768740	Green Published, gold, Green Submitted			2022-12-26	WOS:000374970600065
J	Kim, SB; Kang, OH; Lee, YS; Han, SH; Ahn, YS; Cha, SW; Seo, YS; Kong, R; Kwon, DY				Kim, Sung-Bae; Kang, Ok-Hwa; Lee, Young-Seob; Han, Sin-Hee; Ahn, Young-Sup; Cha, Seon-Woo; Seo, Yun-Soo; Kong, Ryong; Kwon, Dong-Yeul			Hepatoprotective Effect and Synergism of Bisdemethoycurcumin against MCD Diet-Induced Nonalcoholic Fatty Liver Disease in Mice	PLOS ONE			English	Article							CURCUMA-LONGA; HEPATIC STEATOSIS; 3T3-L1 ADIPOCYTES; PPAR-GAMMA; STEATOHEPATITIS; ACID; POPULATION; OBESITY; ALPHA; BISDEMETHOXYCURCUMIN	Nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, has become one of the most common causes of chronic liver disease over the last decade in developed countries. NAFLD includes a spectrum of pathological hepatic changes, such as steatosis, steatohepatitis, advanced fibrosis, and cirrhosis. Bisdemethoxycurcumin (BDMC) is polyphenolic compounds with a diarylheptanoid skeleton, curcumin close analogues, which is derived from the Curcumae Longae Rhizoma. While the rich bioavailability research of curcumin, BDMC is the poor studies. We investigated whether BDMC has the hepatoprotective effect and combinatory preventive effect with silymarin on methionine choline deficient (MCD)-diet-induced NAFLD in C57BL/6J mice. C57BL/6J mice were divided into five groups of normal (normal diet without any treatment), MCD diet (MCD diet only), MCD + silymarin (SIL) 100 mg/kg group, MCD + BDMC 100 mg/kg group, MCD + SIL 50 mg/kg + BDMC 50 mg/kg group. Body weight, liver weight, liver function tests, histological changes were assessed and quantitative real-time polymerase chain reaction and Western blot analyses were conducted after 4 weeks. Mice lost body weight on the MCD-diet, but BDMC did not lose less than the MCD-diet group. Liver weights decreased from BDMC, but they increased significantly in the MCD-diet groups. All liver function test values decreased from the MCD-diet, whereas those from the BDMC increased significantly. The MCD-diet induced severe hepatic fatty accumulation, but the fatty change was reduced in the BDMC. The BDMC showed an inhibitory effect on liver lipogenesis by reducing associated gene expression caused by the MCD-diet. In all experiments, the combinations of BDMC with SIL had a synergistic effect against MCD-diet models. In conclusion, our findings indicate that BDMC has a potential suppressive effect on NAFLD. Therefore, our data suggest that BDMC may act as a novel and potent therapeutic agent against NAFLD.	[Kim, Sung-Bae; Kang, Ok-Hwa; Seo, Yun-Soo; Kwon, Dong-Yeul] Wonkwang Univ, Wonkwang Oriental Med Res Inst, Dept Oriental Pharm, Coll Pharm, Iksan 570749, Jeonbuk, South Korea; [Lee, Young-Seob; Kong, Ryong] Wonkwang Univ, Profess Grad Sch Oriental Med, Plus Team BK21, Iksan 570749, Jeonbuk, South Korea; [Han, Sin-Hee; Ahn, Young-Sup; Cha, Seon-Woo] RDA, Dept Herbal Crop Res, Natl Inst Hort & Herbal Sci, 92 Bisanro, Eumsung 369873, Chungbuk, South Korea	Wonkwang University; Wonkwang University; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Kwon, DY (corresponding author), Wonkwang Univ, Wonkwang Oriental Med Res Inst, Dept Oriental Pharm, Coll Pharm, Iksan 570749, Jeonbuk, South Korea.	sssimi@wku.ac.kr		Ruel, Marie/0000-0002-9506-348X	Basic Science Research Program through the National Research Foundation (NRF) of Korea - Ministry of Education [NRF-2013R1A1A2064673, 2013060380]; Korea government (MSIP) [20080062484]; Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea [PJ00962201]	Basic Science Research Program through the National Research Foundation (NRF) of Korea - Ministry of Education; Korea government (MSIP); Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This study was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education (NRF-2013R1A1A2064673), 2013060380, the Korea government (MSIP) (20080062484), and Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ00962201), Rural Development Administration, Republic of Korea.	Abdelmegeed MA, 2011, J NUTR, V141, P603, DOI 10.3945/jn.110.135210; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Ahsan H, 1999, CHEM-BIOL INTERACT, V121, P161, DOI 10.1016/S0009-2797(99)00096-4; Alappat L, 2010, NUTR REV, V68, P729, DOI 10.1111/j.1753-4887.2010.00341.x; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; de Melo CL, 2010, CHEM-BIOL INTERACT, V185, P59, DOI 10.1016/j.cbi.2010.02.028; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Heikkinen S, 2007, BBA-MOL CELL BIOL L, V1771, P999, DOI 10.1016/j.bbalip.2007.03.006; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hu YC, 2014, J SEP SCI, V37, P404, DOI 10.1002/jssc.201301102; Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307; Jang HH, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-27; Jayaprakasha GK, 2002, J AGR FOOD CHEM, V50, P3668, DOI 10.1021/jf025506a; Kim DSHL, 2001, NEUROSCI LETT, V303, P57, DOI 10.1016/S0304-3940(01)01677-9; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Koteish A, 2002, BEST PRACT RES CL GA, V16, P679, DOI 10.1053/bega.2002.0332; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Lee YK, 2009, J AGR FOOD CHEM, V57, P305, DOI 10.1021/jf802737z; Li YY, 2013, BIOCHEM PHARMACOL, V86, P1517, DOI 10.1016/j.bcp.2013.08.015; Mesa M. D., 2000, ARS PHARM, V41, P307; Nan YM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-124; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Oguz A, 2013, EUR REV MED PHARMACO, V17, P457; OSAWA T, 1995, BIOSCI BIOTECH BIOCH, V59, P1609, DOI 10.1271/bbb.59.1609; Ramadori G, 1999, SEMIN LIVER DIS, V19, P141, DOI 10.1055/s-2007-1007106; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Salamone F, 2012, DIGEST LIVER DIS, V44, P334, DOI 10.1016/j.dld.2011.11.010; Semenkovich CF, 1997, PROG LIPID RES, V36, P43, DOI 10.1016/S0163-7827(97)00003-9; Semwal AD, 1997, J FOOD SCI TECH MYS, V34, P67; Simon A, 1998, CANCER LETT, V129, P111, DOI 10.1016/S0304-3835(98)00092-5; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Suzuki A, 2005, HEPATOLOGY, V41, P64, DOI 10.1002/hep.20543; TODA S, 1985, CHEM PHARM BULL, V33, P1725; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; YAO Z, 1990, BIOCHEM CELL BIOL, V68, P552, DOI 10.1139/o90-079; You Y, 2010, FOOD CHEM TOXICOL, V48, P1632, DOI 10.1016/j.fct.2010.03.037; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	44	178	186	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147745	10.1371/journal.pone.0147745	http://dx.doi.org/10.1371/journal.pone.0147745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881746	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000006
